PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ali, H; Ries, MI; Nijland, JG; Lankhorst, PP; Hankemeier, T; Bovenberg, RAL; Vreeken, RJ; Driessen, AJM				Ali, Hazrat; Ries, Marco I.; Nijland, Jeroen G.; Lankhorst, Peter P.; Hankemeier, Thomas; Bovenberg, Roel A. L.; Vreeken, Rob J.; Driessen, Arnold J. M.			A Branched Biosynthetic Pathway Is Involved in Production of Roquefortine and Related Compounds in Penicillium chrysogenum	PLOS ONE			English	Article							GENE CLUSTERS; ALKALOIDS; METABOLITES; CULTURES; IDENTIFICATION; PURIFICATION; INHIBITION; MYCOTOXINS; EXPRESSION; EVOLUTION	Profiling and structural elucidation of secondary metabolites produced by the filamentous fungus Penicillium chrysogenum and derived deletion strains were used to identify the various metabolites and enzymatic steps belonging to the roquefortine/meleagrin pathway. Major abundant metabolites of this pathway were identified as histidyltryptophanyldi-ketopiperazine (HTD), dehydrohistidyltryptophanyldi-ketopiperazine (DHTD), roquefortine D, roquefortine C, glandicoline A, glandicoline B and meleagrin. Specific genes could be assigned to each enzymatic reaction step. The nonribosomal peptide synthetase RoqA accepts L-histidine and L-tryptophan as substrates leading to the production of the diketopiperazine HTD. DHTD, previously suggested to be a degradation product of roquefortine C, was found to be derived from HTD involving the cytochrome P450 oxidoreductase RoqR. The dimethylallyltryptophan synthetase RoqD prenylates both HTD and DHTD yielding directly the products roquefortine D and roquefortine C without the synthesis of a previously suggested intermediate and the involvement of RoqM. This leads to a branch in the otherwise linear pathway. Roquefortine C is subsequently converted into glandicoline B with glandicoline A as intermediates, involving two monooxygenases (RoqM and RoqO) which were mixed up in an earlier attempt to elucidate the biosynthetic pathway. Eventually, meleagrin is produced from glandicoline B involving a methyltransferase (RoqN). It is concluded that roquefortine C and meleagrin are derived from a branched biosynthetic pathway.	[Ali, Hazrat; Nijland, Jeroen G.; Driessen, Arnold J. M.] Univ Groningen, Zernike Inst Adv Mat, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Ali, Hazrat; Nijland, Jeroen G.; Driessen, Arnold J. M.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Ries, Marco I.; Hankemeier, Thomas; Vreeken, Rob J.] Leiden Univ, Leiden Amsterdam Ctr Drug, Div Analyt Biosci, Leiden, Netherlands; [Lankhorst, Peter P.; Bovenberg, Roel A. L.] DSM Biotechnol Ctr, Delft, Netherlands; [Hankemeier, Thomas; Vreeken, Rob J.] Leiden Univ, Netherlands Metabol Ctr, Leiden, Netherlands; [Bovenberg, Roel A. L.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	University of Groningen; Leiden University; Leiden University - Excl LUMC; DSM NV; Leiden University; Leiden University - Excl LUMC; University of Groningen	Driessen, AJM (corresponding author), Univ Groningen, Zernike Inst Adv Mat, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands.	a.j.m.driessen@rug.nl	Driessen, Arnold J.M./D-1876-2012; Hankemeier, Thomas/V-5407-2019; Vreeken, Rob/AAA-4563-2021; Institute, Zernike/W-7033-2019	Hankemeier, Thomas/0000-0001-7871-2073; Driessen, Arnold J.M./0000-0001-9258-9104; Vreeken, Rob/0000-0003-3568-1371; Lankhorst, Peter/0000-0002-0373-5673	Perspective Genbiotics program; STW (Stichting Technische Wetenschappen); NWO-ACTS ibos program; Netherlands Metabolomics Centre (NMC), which is a part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	Perspective Genbiotics program; STW (Stichting Technische Wetenschappen)(Technologiestichting STW); NWO-ACTS ibos program; Netherlands Metabolomics Centre (NMC), which is a part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Perspective Genbiotics program subsidized by STW (Stichting Technische Wetenschappen) and by the NWO-ACTS ibos program and co-financed by the Netherlands Metabolomics Centre (NMC), which is a part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ E, 1987, ANTIMICROB AGENTS CH, V31, P1675, DOI 10.1128/AAC.31.11.1675; Aninat C, 2001, CHEM RES TOXICOL, V14, P1259, DOI 10.1021/tx015512l; BARROW KD, 1979, J CHEM SOC CHEM COMM, P225, DOI 10.1039/c39790000225; Challis GL, 2008, MICROBIOL-SGM, V154, P1555, DOI 10.1099/mic.0.2008/018523-0; Covert SF, 1996, MOL GEN GENET, V251, P397; Demain AL, 2000, ADV BIOCHEM ENG BIOT, V69, P1; Donadio S, 2005, MOL GENET GENOMICS, V274, P40, DOI 10.1007/s00438-005-1156-3; Fischbach MA, 2008, P NATL ACAD SCI USA, V105, P4601, DOI 10.1073/pnas.0709132105; Fleming A, 2001, B WORLD HEALTH ORGAN, V79, P780; Frisvad JC, 2004, STUD MYCOL, P201; Garcia-Estrada C, 2011, CHEM BIOL, V18, P1499, DOI 10.1016/j.chembiol.2011.08.012; Harju S, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-8; Kasper PT, 2012, RAPID COMMUN MASS SP, V26, P2275, DOI 10.1002/rcm.6340; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; KOLAR M, 1988, GENE, V62, P127, DOI 10.1016/0378-1119(88)90586-0; KOPP B, 1981, EUR J APPL MICROBIOL, V13, P232, DOI 10.1007/BF00500104; Kopp-Holtwiesche B, 1990, J Environ Pathol Toxicol Oncol, V10, P41; Kovalchuk A, 2012, METHODS MOL BIOL, V835, P1, DOI 10.1007/978-1-61779-501-5_1; Kulakovskaya TV, 1997, PROCESS BIOCHEM, V32, P29, DOI 10.1016/S0032-9592(96)00041-6; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Martins MB, 2007, TETRAHEDRON, V63, P9923, DOI 10.1016/j.tet.2007.04.105; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Nielsen KF, 2006, J AGR FOOD CHEM, V54, P3756, DOI 10.1021/jf060114f; Nijland JG, 2008, FUNGAL GENET BIOL, V45, P1415, DOI 10.1016/j.fgb.2008.07.008; OHMOMO S, 1975, AGR BIOL CHEM TOKYO, V39, P1333, DOI 10.1080/00021369.1975.10861780; OHMOMO S, 1980, AGR BIOL CHEM TOKYO, V44, P1929, DOI 10.1080/00021369.1980.10864236; Overy DP, 2005, J CHEM ECOL, V31, P2373, DOI 10.1007/s10886-005-7107-y; POLONSKY J, 1977, ANN NUTR ALIMENT, V31, P693; POULSEN C, 1993, EUR J BIOCHEM, V212, P431, DOI 10.1111/j.1432-1033.1993.tb17679.x; Rojas-Cherto M, 2012, ANAL CHEM, V84, P5524, DOI 10.1021/ac2034216; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Scherlach K, 2006, ORG BIOMOL CHEM, V4, P3517, DOI 10.1039/b607011f; SCOTT PM, 1976, J AGR FOOD CHEM, V24, P865, DOI 10.1021/jf60206a028; SCOTT PM, 1979, J AGR FOOD CHEM, V27, P201, DOI 10.1021/jf60221a052; Shwab EK, 2008, MYCOL RES, V112, P225, DOI 10.1016/j.mycres.2007.08.021; STEYN PS, 1983, J CHEM SOC CHEM COMM, P560, DOI 10.1039/c39830000560; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; Vinokurova NG, 2001, J ANAL CHEM+, V56, P258, DOI 10.1023/A:1009458623849; Weber SS, 2012, BIOTECHNOL J, V7, P225, DOI 10.1002/biot.201100065; Yin WB, 2009, J BIOL CHEM, V284, P100, DOI 10.1074/jbc.M807606200	41	61	71	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65328	10.1371/journal.pone.0065328	http://dx.doi.org/10.1371/journal.pone.0065328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776469	Green Published, gold			2022-12-25	WOS:000320322400018
J	Brown, MJ; Thacker, LR; Cohen, SA				Brown, Monique J.; Thacker, Leroy R.; Cohen, Steven A.			Association between Adverse Childhood Experiences and Diagnosis of Cancer	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; HOUSEHOLD DYSFUNCTION; SUBSTANCE-ABUSE; 5 STATES; RISK; SMOKING; ADULTS; DISORDERS; NEGLECT; WOMEN	Objective: Adverse childhood experiences (ACEs) are linked to multiple adverse health outcomes. This study examined the association between ACEs and cancer diagnosis. Methods: Data from the 2010 Behavioral Risk Factor Surveillance System (BRFSS) survey were used. The BRFSS is the largest ongoing telephone health survey, conducted in all US states, the District of Columbia, Puerto Rico, Guam and the U. S. Virgin Islands, and provides data on a variety of health issues among the non-institutionalized adult population. Principal component analysis (PCA) was used to derive components for ACEs. Multivariable logistic regression models were used to provide adjusted odds ratios (OR) and 95% confidence intervals (CI) for the association between ACE components and overall, childhood and adulthood cancer, adjusting for confounders such as age, gender, race/ethnicity, income, educational status, marital status, and insurance status. Results: Approximately 62% of respondents reported being exposed to ACEs and about one in ten respondents reported ever having been diagnosed with cancer. Component 1, which had the sexual abuse variables with the highest weights, was significantly associated with adulthood cancer (adjusted OR: 1.21; 95% CI: 1.03-1.43). Conclusion: The association between ACEs and adulthood cancer may be attributable to disease progression through association of ACEs with risk factors for other chronic diseases. More research should focus on the impact of sexual abuse ACEs and adverse health outcomes.	[Brown, Monique J.; Cohen, Steven A.] Virginia Commonwealth Univ, Sch Med, Dept Family Med & Populat Hlth, Richmond, VA 23284 USA; [Thacker, Leroy R.] Virginia Commonwealth Univ, Sch Med, Dept Biostat, Richmond, VA USA; [Thacker, Leroy R.] Virginia Commonwealth Univ, Sch Med, Ctr Clin & Translat Res, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Brown, MJ (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Family Med & Populat Hlth, Richmond, VA 23284 USA.	brownmj7@vcu.edu			National Institutes of Health (NIH) from the National Centers for Advancing Translational Sciences [UL1TR00058]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the National Centers for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Dr. Thacker's efforts on this research were supported in part by National Institutes of Health (NIH) Grant # UL1TR00058 from the National Centers for Advancing Translational Sciences. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	American Cancer Society, CANC PREV MAN PEOPL; Anda RF, 1999, JAMA-J AM MED ASSOC, V282, P1652, DOI 10.1001/jama.282.17.1652; Anda RF, 2008, AM J PREV MED, V34, P396, DOI 10.1016/j.amepre.2008.02.002; Anda RF, 2010, AM J PREV MED, V39, P93, DOI 10.1016/j.amepre.2010.03.015; [Anonymous], BREAST CANC STAT; BARKER DJP, 1986, LANCET, V1, P1077; Brown DW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-20; Brown DW, 2009, AIDS, V23, P2231, DOI 10.1097/QAD.0b013e3283314769; Cambois E, 2011, EUR J PUBLIC HEALTH, V21, P667, DOI 10.1093/eurpub/ckq119; Centers for Disease Control and Prevention, PROST CANC RISK AG; Centers for Disease Control and Prevention, BEH RISK FACT SURV S; Centers for Disease Control and Prevention, 2010, BEH RISK FACT SURV S; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1609; Centers for Disease Control and Prevention (CDC), CANC PREV CONTR CANC; Centers for Disease Control and Prevention (CDC), BREAST CANC RISK AG; Centers for Disease Control and Prevention (CDC), COL COL CANC RAT RAC; Centers for Disease Control and Prevention (CDC), CANC PREV CONTR CAN; Centers for Disease Control and Prevention (CDC), BRESAT CANC RAT RAC; Chapman DP, 2004, J AFFECT DISORDERS, V82, P217, DOI 10.1016/j.jad.2003.12.013; Dong M, 2003, CHILD ABUSE NEGLECT, V27, P625, DOI 10.1016/S0145-2134(03)00105-4; Dong MX, 2004, CIRCULATION, V110, P1761, DOI 10.1161/01.CIR.0000143074.54995.7F; Dong MX, 2004, CHILD ABUSE NEGLECT, V28, P771, DOI 10.1016/j.chiabu.2004.01.008; Dube SR, 2010, PREV CHRONIC DIS, V7; Dube SR, 2004, CHILD ABUSE NEGLECT, V28, P729, DOI 10.1016/j.chiabu.2003.08.009; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Ford ES, 2011, PREV MED, V53, P188, DOI 10.1016/j.ypmed.2011.06.015; Gupta V, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-72; Hillis SD, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e11; Jewkes RK, 2010, CHILD ABUSE NEGLECT, V34, P833, DOI 10.1016/j.chiabu.2010.05.002; Jun HJ, 2008, J ADOLESCENT HEALTH, V43, P55, DOI 10.1016/j.jadohealth.2007.12.003; Kelly-Irving M., 2012, INT J PUBLIC HLTH; Klein H, 2007, CHILD ABUSE NEGLECT, V31, P39, DOI 10.1016/j.chiabu.2006.08.005; Lanoue M, 2012, COMMUNITY MENT HLTH; LaNoue M, 2012, COMMUNITY MENT HLT J, V48, P187, DOI 10.1007/s10597-010-9369-2; Mock SE, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00246; Oladeji BD, 2010, BRIT J PSYCHIAT, V196, P186, DOI 10.1192/bjp.bp.109.063677; Pickles A, 2010, PSYCHOL MED, V40, P1453, DOI 10.1017/S0033291709991905; Slopen N, 2012, PSYCHONEUROENDOCRINO; Stavrou E, 2011, CANCER EPIDEMIOL, V35, pE75, DOI 10.1016/j.canep.2011.02.005; Strine TW, 2012, AM J HEALTH BEHAV, V36, P408, DOI 10.5993/AJHB.36.3.11; U.S. Census Bureau, 2010 CENS PROF GEN P; van der Meer LB, 2012, CLIN GENET, V81, P18, DOI 10.1111/j.1399-0004.2011.01778.x; Vander Weg MW, 2011, NICOTINE TOB RES, V13, P616, DOI 10.1093/ntr/ntr023; Wu NS, 2010, ADDICT BEHAV, V35, P68, DOI 10.1016/j.addbeh.2009.09.003	44	104	104	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65524	10.1371/journal.pone.0065524	http://dx.doi.org/10.1371/journal.pone.0065524			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	169CU	23776494	Green Published, gold			2022-12-25	WOS:000320755400037
J	Fleuchot, B; Guillot, A; Mezange, C; Besset, C; Chambellon, E; Monnet, V; Gardan, R				Fleuchot, Betty; Guillot, Alain; Mezange, Christine; Besset, Colette; Chambellon, Emilie; Monnet, Veronique; Gardan, Rozenn			Rgg-Associated SHP Signaling Peptides Mediate Cross-Talk in Streptococci	PLOS ONE			English	Article							QUORUM-SENSING SYSTEM; SEX-PHEROMONE; GENOME SEQUENCE; MOLECULAR-BASIS; COMPETENCE; SPECIFICITY; IDENTIFICATION; THERMOPHILUS; POLYMORPHISM; AGALACTIAE	We described a quorum-sensing mechanism in the streptococci genus involving a short hydrophobic peptide (SHP), which acts as a pheromone, and a transcriptional regulator belonging to the Rgg family. The shp/rgg genes, found in nearly all streptococcal genomes and in several copies in some, have been classified into three groups. We used a genetic approach to evaluate the functionality of the SHP/Rgg quorum-sensing mechanism, encoded by three selected shp/rgg loci, in pathogenic and non-pathogenic streptococci. We characterized the mature form of each SHP pheromone by mass-spectrometry. We produced synthetic peptides corresponding to these mature forms, and used them to study functional complementation and cross-talk between these different SHP/Rgg systems. We demonstrate that a SHP pheromone of one system can influence the activity of a different system. Interestingly, this does not seem to be dependent on the SHP/Rgg group and cross-talk between pathogenic and non-pathogenic streptococci is observed.	[Fleuchot, Betty; Guillot, Alain; Mezange, Christine; Besset, Colette; Chambellon, Emilie; Monnet, Veronique; Gardan, Rozenn] INRA, MICALIS, UMR1319, Jouy En Josas, France; [Fleuchot, Betty; Guillot, Alain; Mezange, Christine; Besset, Colette; Chambellon, Emilie; Monnet, Veronique; Gardan, Rozenn] AgroParistech, UMR MICALIS, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Gardan, R (corresponding author), INRA, MICALIS, UMR1319, Jouy En Josas, France.	rozenn.gardan@jouy.inra.fr	Monnet, Veronique/E-9022-2014	Monnet, Veronique/0000-0001-7438-5618	Institut National de la Recherche Agronomique (INRA); Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT); Ile de France regional council; CEMAGREF; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, R37DK041122] Funding Source: NIH RePORTER	Institut National de la Recherche Agronomique (INRA); Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT); Ile de France regional council(Region Ile-de-France); CEMAGREF; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Institut National de la Recherche Agronomique (INRA) and the Ministere de l'Education Nationale de la Recherche et de la Technologie (MENRT). The PAPPSO platform received the financial support from the Ile de France regional council and from CEMAGREF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Altstein M, 2004, PEPTIDES, V25, P1373, DOI 10.1016/j.peptides.2004.07.002; An FY, 1999, J BACTERIOL, V181, P5915, DOI 10.1128/JB.181.19.5915-5921.1999; An FY, 2002, J BACTERIOL, V184, P1880, DOI 10.1128/JB.184.7.1880-1887.2002; BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/JB.175.11.3628-3635.1993; Bouillaut L, 2008, NUCLEIC ACIDS RES, V36, P3791, DOI 10.1093/nar/gkn149; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chandler JR, 2008, J BACTERIOL, V190, P1172, DOI 10.1128/JB.01327-07; Chen T., 2010, DATABASE, V2010; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; DEBARBOUILLE M, 1990, J BACTERIOL, V172, P3966, DOI 10.1128/jb.172.7.3966-3973.1990; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dubern JF, 2006, J BACTERIOL, V188, P2898, DOI 10.1128/JB.188.8.2898-2906.2006; Fleuchot B, 2011, MOL MICROBIOL, V80, P1102, DOI 10.1111/j.1365-2958.2011.07633.x; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Gardan R, 2013, J BACTERIOL, V195, P1845, DOI 10.1128/JB.02196-12; Gardan R, 2009, J BACTERIOL, V191, P4647, DOI 10.1128/JB.00257-09; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Gordon CP, 2012, J MED CHEM; Henry R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-223; Higgins D, 2012, FEMS MICROBIOL REV, V36, P131, DOI 10.1111/j.1574-6976.2011.00310.x; Ibrahim M, 2007, J BACTERIOL, V189, P8844, DOI 10.1128/JB.01057-07; Ibrahim M, 2007, MICROBIOL-SGM, V153, P3631, DOI 10.1099/mic.0.2007/006205-0; Jarraud S, 2000, J BACTERIOL, V182, P6517, DOI 10.1128/JB.182.22.6517-6522.2000; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; LaSarre B, 2012, MBIO, V3, DOI 10.1128/mBio.00333-12; Lazazzera BA, 2001, PEPTIDES, V22, P1519, DOI 10.1016/S0196-9781(01)00488-0; Letort C, 2001, J APPL MICROBIOL, V91, P1023, DOI 10.1046/j.1365-2672.2001.01469.x; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; Rocha-Estrada J, 2010, APPL MICROBIOL BIOT, V87, P913, DOI 10.1007/s00253-010-2651-y; Samen UM, 2006, INFECT IMMUN, V74, P5625, DOI 10.1128/IAI.00667-06; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Slamti L, 2005, J BACTERIOL, V187, P1182, DOI 10.1128/JB.187.3.1182-1187.2005; Stefanic P, 2012, ENVIRON MICROBIOL, V14, P1378, DOI 10.1111/j.1462-2920.2012.02717.x; Tortosa P, 2001, J BACTERIOL, V183, P451, DOI 10.1128/JB.183.2.451-460.2001; Tran LSP, 2000, MOL MICROBIOL, V37, P1159, DOI 10.1046/j.1365-2958.2000.02069.x; Zadoks RN, 2004, J FOOD PROTECT, V67, P2644, DOI 10.4315/0362-028X-67.12.2644	41	33	34	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66042	10.1371/journal.pone.0066042	http://dx.doi.org/10.1371/journal.pone.0066042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776602	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400104
J	Messaritakis, I; Christodoulou, V; Mazeris, A; Koutala, E; Vlahou, A; Papadogiorgaki, S; Antoniou, M				Messaritakis, Ippokratis; Christodoulou, Vasiliki; Mazeris, Apostolos; Koutala, Eleni; Vlahou, Antonia; Papadogiorgaki, Sevasti; Antoniou, Maria			Drug Resistance in Natural Isolates of Leishmania donovani s.l. Promastigotes Is Dependent of Pgp 170 Expression	PLOS ONE			English	Article							P-GLYCOPROTEIN GENE; MULTIDRUG-RESISTANCE; VISCERAL LEISHMANIASIS; ABC TRANSPORTERS; INFANTUM; AMPLIFICATION; PROTEIN; CYPRUS; TARENTOLAE; MEMBRANE	Resistance of pathogens to drugs is a growing concern regarding many diseases. Parasites like Leishmania, Plasmodium and Entamoeba histolytica; and neoplastic cells, present the multidrug-resistant phenotype rendering chemotherapy ineffective. The acquired resistance of Leishmania to antimony has generated intense research on the mechanisms involved but the question has not yet been resolved. To test the hypothesis that drug efflux in Leishmania, as measured by flow cytometry using the fluorescent dye Rhodamine-123, is largely dependent on the number of efflux pumps an isolate can express, the amount of Pgp 170 molecules was assessed in ten field isolates (5 "resistant'' and 5 "susceptible'') using: Western Blotting, Confocal and Transmission Electron Microscopy, and proteomics. Their survival after exposure to three antileishmanial drugs, in vitro, was evaluated and clinical data were compared to the in vitro results. All isolates were resistant to Glucantime but susceptible to Miltefosine, whilst Amphotericin B was more effective on the ``susceptible'' isolates. The MDR gene, expressing the transmembrane efflux pump Pgp 170, appears to play a key role in the phenomenon of drug resistance. When "susceptible'' versus "resistant'' parasites were compared, it was shown that the higher the number of Pgp 170 molecules the higher the Rhodamine-123 efflux from the parasite body and, when exposed to the drug, the number of efflux pumps increased. However, the rate of this increase was not linear and it is possible that there is a maximum number of Pgp 170 molecules an isolate can express. Nevertheless, the phenomenon is a complex one and other factors and proteins are involved in which the HSP-70 group proteins, detected in the "resistant'' isolates, may play a significant role.	[Messaritakis, Ippokratis; Christodoulou, Vasiliki; Antoniou, Maria] Univ Crete, Fac Med, Lab Clin Bacteriol Parasitol Zoonoses & Geog Med, Iraklion, Greece; [Christodoulou, Vasiliki; Mazeris, Apostolos] Vet Serv Cyprus, Nicosia, Cyprus; [Koutala, Eleni] Univ Crete, Fac Med, Lab Flow Cytometry, Iraklion, Greece; [Vlahou, Antonia] Acad Athens, Inst Biomed Res, Athens, Greece; [Papadogiorgaki, Sevasti] Univ Crete, Dept Biol, Vassilis Galanopoulos Electron Microscope Facil, Iraklion, Greece	University of Crete; University of Crete; Academy of Athens; University of Crete	Antoniou, M (corresponding author), Univ Crete, Fac Med, Lab Clin Bacteriol Parasitol Zoonoses & Geog Med, Iraklion, Greece.	antoniou@med.uoc.gr	Messaritakis, Ippokratis/H-6668-2019; Antoniou, Maria-Christina/GVT-7881-2022	Vlahou, Antonia/0000-0003-3284-5713; Messaritakis, Ippokratis/0000-0003-1877-500X	ELKE (Research Committee of the University of Crete) [2561/2007]	ELKE (Research Committee of the University of Crete)	The work was supported by the ELKE (Research Committee of the University of Crete, Grant No. 2561/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Antoniou M, 2004, AM J TROP MED HYG, V71, P71, DOI 10.4269/ajtmh.2004.71.71; Antoniou M, 2008, LANCET INFECT DIS, V8, P6, DOI 10.1016/S1473-3099(07)70297-9; Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; Basu JM, 2008, ANTIMICROB AGENTS CH, V52, P1080, DOI 10.1128/AAC.01196-07; CALLAHAN HL, 1991, J BIOL CHEM, V266, P18427; CHOW LMC, 1993, MOL BIOCHEM PARASIT, V60, P195, DOI 10.1016/0166-6851(93)90131-G; Coelho AC, 2007, ANTIMICROB AGENTS CH, V51, P3030, DOI 10.1128/AAC.00404-07; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Cuervo P, 2007, MOL BIOCHEM PARASIT, V154, P6, DOI 10.1016/j.molbiopara.2007.03.013; Da Silva EC, 2008, PARASITOL LATINOAM, V70, P4; Delgadillo DM, 2002, MICROB DRUG RESIST, V8, P15, DOI 10.1089/10766290252913719; Dey S, 1996, P NATL ACAD SCI USA, V93, P2192, DOI 10.1073/pnas.93.5.2192; DEY S, 1994, MOL BIOCHEM PARASIT, V67, P49, DOI 10.1016/0166-6851(94)90095-7; Gouzelou E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001507; GRAMICCIA M, 1992, ANN TROP MED PARASIT, V86, P613, DOI 10.1080/00034983.1992.11812717; Haralambous C, 2008, DIAGN MICR INFEC DIS, V60, P33, DOI 10.1016/j.diagmicrobio.2007.07.019; HENDERSON DM, 1992, MOL CELL BIOL, V12, P2855, DOI 10.1128/MCB.12.6.2855; HENDRICKSON N, 1993, MOL BIOCHEM PARASIT, V60, P53, DOI 10.1016/0166-6851(93)90028-V; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HUGHES AL, 1994, MOL BIOL EVOL, V11, P899; Jha TK, 1998, BRIT MED J, V316, P1200, DOI 10.1136/bmj.316.7139.1200; Kamau SW, 2000, CYTOMETRY, V40, P353, DOI 10.1002/1097-0320(20000801)40:4&lt;353::AID-CYTO11&gt;3.0.CO;2-0; KATAKURA K, 1989, MOL BIOCHEM PARASIT, V34, P189, DOI 10.1016/0166-6851(89)90010-8; Koliou MG, 2008, J PEDIAT HEMATOL ONC, V30, P704, DOI 10.1097/MPH.0b013e31816916f6; Kumar A, 2010, BRIT J CLIN PHARMACO, V70, P609, DOI 10.1111/j.1365-2125.2010.03716.x; Lee GY, 1998, BIOL REPROD, V58, P330, DOI 10.1095/biolreprod58.2.330; LEMESRE JL, 1988, ACTA TROP, V45, P99; Leu JIJ, 2011, MOL CANCER RES, V9, P936, DOI 10.1158/1541-7786.MCR-11-0019; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; LIGHTNER LK, 1983, AM J TROP MED HYG, V32, P296, DOI 10.4269/ajtmh.1983.32.296; Ling V, 1997, CANCER CHEMOTH PHARM, V40, pS3, DOI 10.1007/s002800051053; Mandal G, 2009, INDIAN J BIOCHEM BIO, V46, P86; MARY C, 2010, INT J MICROBIOL, V2010, DOI DOI 10.811155/812010/819060; Mazeris A, 2010, AM J TROP MED HYG, V82, P441, DOI 10.4269/ajtmh.2010.09-0282; Messaritakis I, 2010, EXP PARASITOL, V125, P384, DOI 10.1016/j.exppara.2010.03.006; OUELLETTE M, 1991, EMBO J, V10, P1009, DOI 10.1002/j.1460-2075.1991.tb08035.x; OUELLETTE M, 1990, EMBO J, V9, P1027, DOI 10.1002/j.1460-2075.1990.tb08206.x; Ouellette M W S, 2002, MOL MED PARASITOLOGY, P395; Purkait B, 2012, ANTIMICROB AGENTS CH, V56, P1031, DOI 10.1128/AAC.00030-11; Ravel C, 2006, INT J PARASITOL, V36, P1383, DOI 10.1016/j.ijpara.2006.06.019; RIORDAN JR, 1985, NATURE, V316, P817, DOI 10.1038/316817a0; RIOUX JA, 1990, ANN PARASIT HUM COMP, V65, P111, DOI 10.1051/parasite/1990653111; Roubelakis MG, 2007, STEM CELLS DEV, V16, P931, DOI 10.1089/scd.2007.0036; Schonian G, 2008, TRENDS PARASITOL, V24, P135, DOI 10.1016/j.pt.2007.12.006; SINGH AK, 1994, MOL BIOCHEM PARASIT, V66, P161, DOI 10.1016/0166-6851(94)90049-3; Singh R, 2010, INT J ANTIMICROB AG, V36, P50, DOI 10.1016/j.ijantimicag.2010.03.012; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; THAKUR CP, 1991, AM J TROP MED HYG, V45, P435, DOI 10.4269/ajtmh.1991.45.435; TWENTYMAN PR, 1994, EUR J CANCER, V30A, P1360, DOI 10.1016/0959-8049(94)90187-2; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Vergnes B, 2007, MOL CELL PROTEOMICS, V6, P88, DOI 10.1074/mcp.M600319-MCP200; Yah CS, 2010, J COMPUT BIOL BIOINF, V2, P005	53	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65467	10.1371/journal.pone.0065467	http://dx.doi.org/10.1371/journal.pone.0065467			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776486	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400033
J	Sun, P; Wang, T; Zhou, YR; Liu, H; Jiang, HL; Zhu, WL; Wang, HY				Sun, Peng; Wang, Ting; Zhou, Yuren; Liu, Hong; Jiang, Hualiang; Zhu, Weiliang; Wang, Heyao			DC260126: A Small-Molecule Antagonist of GPR40 that Protects against Pancreatic beta-Cells Dysfunction in db/db Mice	PLOS ONE			English	Article							FREE FATTY-ACIDS; STIMULATED INSULIN-SECRETION; ENDOPLASMIC-RETICULUM STRESS; IMPAIRED GLUCOSE-TOLERANCE; IN-VIVO; ELEVATED GLUCOSE; RECEPTOR GPR40; DIABETIC MICE; ER STRESS; PALMITATE	G protein-coupled receptor 40 (GPR40) mediates both acute and chronic effects of free fatty acids (FFAs) on insulin secretion. However, it remains controversial whether inhibition of GPR40 would be beneficial in prevention of type 2 diabetes. This study is designed to evaluate the potential effects of DC260126, a small molecule antagonist of GPR40, on beta-cell function following administration of 10 mg/kg dose of DC260126 to obese diabetic db/db mice. Oral glucose tolerance test, glucose stimulated insulin secretion and insulin tolerance test were used to investigate the pharmacological effects of DC260126 on db/db mice after 21-days treatment. Immunohistochemistry and serum biochemical analysis were also performed in this study. Although no significant change of blood glucose levels was found in DC260126-treated mice, DC260126 significantly inhibited glucose stimulated insulin secretion, reduced blood insulin level and improved insulin sensitivity after 3 weeks administration in db/db mice. Moreover, DC260126 reduced the proinsulin/insulin ratio and the apoptotic rate of pancreatic beta-cells remarkably in DC260126-treated db/db mice compared to vehicle-treated mice (p<0.05, n = 8). The results suggest that although DC260126 could not provide benefit for improving hyperglycemia, it could protect against pancreatic b-cells dysfunction through reducing overload of beta-cells, and it increases insulin sensitivity possibly via alleviation of hyperinsulinemia in db/db mice.	[Sun, Peng; Wang, Ting; Zhou, Yuren; Liu, Hong; Jiang, Hualiang; Zhu, Weiliang; Wang, Heyao] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Zhu, WL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China.	wlzhu@mail.shcnc.ac.cn; hywang@mail.shcnc.ac.cn	Sun, Peng/AAU-2124-2021	Sun, Peng/0000-0002-7820-712X	National Nature Science Foundation of China [81072681]; National High Technology Research and Development Program of China (863 Program) [2007AA02Z301]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by Grant from the National Nature Science Foundation of China (81072681), from the National High Technology Research and Development Program of China (863 Program) (2007AA02Z301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaraviciene SM, 2008, CELL MOL LIFE SCI, V65, P2256, DOI 10.1007/s00018-008-8100-8; Bindom SM, 2010, DIABETES, V59, P2540, DOI 10.2337/db09-0782; Bjorklund A, 1999, DIABETES, V48, P1409, DOI 10.2337/diabetes.48.7.1409; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Giacca A, 2011, AM J PHYSIOL-ENDOC M, V300, pE255, DOI 10.1152/ajpendo.00416.2010; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Han MS, 2009, DIABETES, V58, P329, DOI 10.2337/db08-0080; Hu H, 2009, BIOCHEM BIOPH RES CO, V390, P557, DOI 10.1016/j.bbrc.2009.10.004; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; KAHN SE, 1995, DIABETES, V44, P173, DOI 10.2337/diabetes.44.2.173; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kebede M, 2008, DIABETES, V57, P2432, DOI 10.2337/db08-0553; Lan H, 2008, DIABETES, V57, P2999, DOI 10.2337/db08-0596; Larsson H, 1999, J CLIN ENDOCR METAB, V84, P2068, DOI 10.1210/jc.84.6.2068; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Nagasumi K, 2009, DIABETES, V58, P1067, DOI 10.2337/db08-1233; Nijpels G, 1996, DIABETOLOGIA, V39, P113; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Remizov O, 2003, MOL CELL ENDOCRINOL, V212, P1, DOI 10.1016/j.mce.2003.09.026; Rizzuto R, 2003, ONCOGENE, V22, P8619, DOI 10.1038/sj.onc.1207105; Salehi A, 2005, CELL TISSUE RES, V322, P207, DOI 10.1007/s00441-005-0017-z; Schnell S, 2007, MOL CELL ENDOCRINOL, V263, P173, DOI 10.1016/j.mce.2006.09.013; Shafrir E, 1996, DIABETES METAB, V22, P122; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Tan CP, 2008, DIABETES, V57, P2211, DOI 10.2337/db08-0130; Tikellis C, 2004, DIABETES, V53, P989, DOI 10.2337/diabetes.53.4.989; Tsujihata Y, 2011, J PHARMACOL EXP THER, V339, P228, DOI 10.1124/jpet.111.183772; Wilding JPH, 2007, DIABETIC MED, V24, P934, DOI 10.1111/j.1464-5491.2007.02186.x; Wu JW, 2012, J CELL BIOCHEM, V113, P1152, DOI 10.1002/jcb.23450; Zhang XD, 2010, BIOMED PHARMACOTHER, V64, P647, DOI 10.1016/j.biopha.2010.06.008	41	39	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66744	10.1371/journal.pone.0066744	http://dx.doi.org/10.1371/journal.pone.0066744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776696	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400155
J	Vuyyuri, SB; Rinkinen, J; Worden, E; Shim, H; Lee, S; Davis, KR				Vuyyuri, Saleha B.; Rinkinen, Jacob; Worden, Erin; Shim, Hyekyung; Lee, Sukchan; Davis, Keith R.			Ascorbic Acid and a Cytostatic Inhibitor of Glycolysis Synergistically Induce Apoptosis in Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							DOSE VITAMIN-C; HYDROGEN-PEROXIDE; SODIUM ASCORBATE; PHARMACOLOGICAL ASCORBATE; ENZYME-INHIBITORS; PANCREATIC-CANCER; REACTIVE OXYGEN; MELANOMA-CELLS; CULTURE-MEDIUM; UP-REGULATION	Ascorbic acid (AA) exhibits significant anticancer activity at pharmacologic doses achievable by parenteral administration that have minimal effects on normal cells. Thus, AA has potential uses as a chemotherapeutic agent alone or in combination with other therapeutics that specifically target cancer-cell metabolism. We compared the effects of AA and combinations of AA with the glycolysis inhibitor 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3-PO) on the viability of three non-small cell lung cancer (NSCLC) cell lines to the effects on an immortalized lung epithelial cell line. AA concentrations of 0.5 to 5 mM caused a complete loss of viability in all NSCLC lines compared to a <10% loss of viability in the lung epithelial cell line. Combinations of AA and 3-PO synergistically enhanced cell death in all NSCLC cell lines at concentrations well below the IC50 concentrations for each compound alone. A synergistic interaction was not observed in combination treatments of lung epithelial cells and combination treatments that caused a complete loss of viability in NSCLC cells had modest effects on normal lung cell viability and reactive oxygen species (ROS) levels. Combination treatments induced dramatically higher ROS levels compared to treatment with AA and 3-PO alone in NSCLC cells and combination-induced cell death was inhibited by addition of catalase to the medium. Analyses of DNA fragmentation, poly (ADP-ribose) polymerase cleavage, annexin V-binding, and caspase activity demonstrated that AA-induced cell death is caused via the activation of apoptosis and that the combination treatments caused a synergistic induction of apoptosis. These results demonstrate the effectiveness of AA against NSCLC cells and that combinations of AA with 3-PO synergistically induce apoptosis via a ROS-dependent mechanism. These results support further evaluation of pharmacologic concentrations of AA as an adjuvant treatment for NSCLC and that combination of AA with glycolysis inhibitors may be a promising therapy for the treatment of NSCLC.	[Vuyyuri, Saleha B.; Rinkinen, Jacob; Worden, Erin; Shim, Hyekyung; Davis, Keith R.] Owensboro Canc Res Program, Owensboro, KY USA; [Lee, Sukchan] Sungkyunkwan Univ, Coll Biotechnol & Bioengn, Dept Genet Engn, Suwon, South Korea; [Shim, Hyekyung; Davis, Keith R.] Univ Louisville, James Graham Brown Canc Ctr, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	Sungkyunkwan University (SKKU); University of Louisville	Davis, KR (corresponding author), Owensboro Canc Res Program, Owensboro, KY USA.	keith.davis@louisville.edu	Davis, Keith/H-3242-2019	Davis, Keith/0000-0002-7432-8610	U.S. Army Medical Research & Materiel Command (USAMRMC); Telemedicine & Advanced Technology Research Center (TATRC) [W81XWH-09-2-0022]	U.S. Army Medical Research & Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Telemedicine & Advanced Technology Research Center (TATRC)	Portions of this project were made possible by a contract that was awarded and administered by the U.S. Army Medical Research & Materiel Command (USAMRMC) and the Telemedicine & Advanced Technology Research Center (TATRC), under Contract Number: W81XWH-09-2-0022. The views, opinions and/or findings contained in this research are those of the authors and do not necessarily reflect the views of the Department of Defense and should not be construed as an official DoD/Army position, policy or decision unless so designated by other documentation. No official endorsement should be made. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akers LJ, 2011, LEUKEMIA RES, V35, P814, DOI 10.1016/j.leukres.2010.12.028; An SH, 2011, BMB REP, V44, P211, DOI 10.5483/BMBRep.2011.44.3.211; Atsumi T, 2002, CANCER RES, V62, P5881; Belin S, 2010, CURR GENOMICS, V11, P52, DOI 10.2174/138920210790217936; Belin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004409; BRAM S, 1980, NATURE, V284, P629, DOI 10.1038/284629a0; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cardaci S, 2012, J BIOENERG BIOMEMBR; Chen P, 2011, FREE RADICAL BIO MED, V51, P681, DOI 10.1016/j.freeradbiomed.2011.05.031; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Cho D, 2003, MELANOMA RES, V13, P549, DOI 10.1097/00008390-200312000-00002; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Clement MV, 2001, ANTIOXID REDOX SIGN, V3, P157, DOI 10.1089/152308601750100687; CREAGAN ET, 1979, NEW ENGL J MED, V301, P687, DOI 10.1056/NEJM197909273011303; DREWINKO B, 1976, CANCER BIOCHEM BIOPH, V1, P187; Du JA, 2010, CLIN CANCER RES, V16, P509, DOI 10.1158/1078-0432.CCR-09-1713; Duconge J, 2008, P R HEALTH SCI J, V27, P7; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Espey MG, 2011, FREE RADICAL BIO MED, V50, P1610, DOI 10.1016/j.freeradbiomed.2011.03.007; FENG J, 1977, IN VITRO CELL DEV B, V13, P91; Floridi A, 1998, BIOCHEM PHARMACOL, V56, P841, DOI 10.1016/S0006-2952(98)00054-9; Fromberg A, 2010, CANCER CHEMOTH PHARM, P1; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Ha YM, 2009, CANCER LETT, V277, P48, DOI 10.1016/j.canlet.2008.11.020; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Harakeh S, 2007, ANTICANCER RES, V27, P289; Heaney ML, 2008, CANCER RES, V68, P8031, DOI 10.1158/0008-5472.CAN-08-1490; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hong SW, 2007, ONCOL REP, V18, P811; Hsieh BS, 2011, J NUTR BIOCHEM, V22, P234, DOI 10.1016/j.jnutbio.2010.01.009; Hsieh BS, 2010, J NUTR BIOCH; Kaya F, 2007, NEUROMUSCULAR DISORD, V17, P248, DOI 10.1016/j.nmd.2006.12.008; KIPP DE, 1990, J NUTR, V120, P185, DOI 10.1093/jn/120.2.185; Kurbacher CM, 1996, CANCER LETT, V103, P183, DOI 10.1016/0304-3835(96)04212-7; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Levine M, 2011, ADV NUTR, V2, P78, DOI 10.3945/an.110.000109; Levine M, 2009, FREE RADICAL BIO MED, V47, P27, DOI 10.1016/j.freeradbiomed.2009.04.001; Levy AG, 2012, INVEST NEW DRUG, V30, P191, DOI 10.1007/s10637-010-9551-y; Lin SY, 2006, MELANOMA RES, V16, P509, DOI 10.1097/01.cmr.0000232297.99160.9e; MA M, 1992, P NATL ACAD SCI USA, V89, P7924, DOI 10.1073/pnas.89.17.7924; Madhok BM, 2011, AM J CLIN ONCOL-CANC, V34, P628, DOI 10.1097/COC.0b013e3181e84dec; Mandl J, 2009, BRIT J PHARMACOL, V157, P1097, DOI 10.1111/j.1476-5381.2009.00282.x; Martin DS, 2001, APOPTOSIS, V6, P125, DOI 10.1023/A:1009692631748; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; MOERTEL CG, 1985, NEW ENGL J MED, V312, P137, DOI 10.1056/NEJM198501173120301; Monti DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029794; Ohno S, 2009, ANTICANCER RES, V29, P809; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; Padayatty SJ, 2004, ANN INTERN MED, V140, P533, DOI 10.7326/0003-4819-140-7-200404060-00010; Pathi SS, 2011, NUTR CANCER, V63, P1133, DOI 10.1080/01635581.2011.605984; PRASAD KN, 1979, P NATL ACAD SCI USA, V76, P829, DOI 10.1073/pnas.76.2.829; Queiros O, 2012, J BIOENERG BIOMEMBR; Ranzato E, 2011, AM J RESP CELL MOL, V44, P108, DOI 10.1165/rcmb.2009-0340OC; Sakagami H, 1996, LIFE SCI, V58, P1131, DOI 10.1016/0024-3205(96)00071-9; Scatena R, 2008, EXPERT OPIN INV DRUG, V17, P1533, DOI 10.1517/13543784.17.10.1533 ; Seo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024179; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SONG EJ, 1995, EUR J PHARM-ENVIRON, V292, P119; Sram RJ, 2011, MUTAT RES; Tang Z, 2012, J BIOENERG BIOMEMBR; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Traber MG, 2011, FREE RADICAL BIO MED, V51, P1000, DOI 10.1016/j.freeradbiomed.2011.05.017; Ullah MF, 2010, CANC CHEMOTHER PHARM; Verrax J, 2009, FREE RADICAL BIO MED, V47, P32, DOI 10.1016/j.freeradbiomed.2009.02.016; Villani MG, 2006, CANCER RES, V66, P3238, DOI 10.1158/0008-5472.CAN-05-3362; Yeom CH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-70	75	39	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e67081	10.1371/journal.pone.0067081	http://dx.doi.org/10.1371/journal.pone.0067081			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776707	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400160
J	Xu, J; Yin, ZQ; Li, L; Cheng, AC; Jia, RY; Song, X; Lu, HK; Dai, SJ; Lv, C; Liang, XX; He, CL; Zhao, L; Su, G; Ye, G; Shi, F				Xu, Jiao; Yin, Zhongqiong; Li, Li; Cheng, Anchun; Jia, Renyong; Song, Xu; Lu, Hongke; Dai, Shujun; Lv, Cheng; Liang, Xiaoxia; He, Changliang; Zhao, Ling; Su, Gang; Ye, Gang; Shi, Fei			Inhibitory Effect of Resveratrol against Duck Enteritis Virus In Vitro	PLOS ONE			English	Article							VIRULENT; DEV	Duck viral enteritis (DVE) is an acute, contagious herpesvirus infection of ducks, geese, and swans of all ages and species. This disease has been responsible for significant economic losses in domestic and wild waterfowl as a result of mortality, and decreased egg production. Resveratrol is a naturally occurring phytoalexin in specific plants and exhibits inhibitory activity against many kinds of virus. In this paper, resveratrol was found to inhibit duck enteritis virus (DEV) replication in a dose-dependent manner, with a 50% inhibition concentration of 3.85 mu g/mL. The inhibition in virus multiplication in the presence of resveratrol was not attributed to direct inactivation or inhibition of virus attachment to the host cells, but to the inhibition of viral multiplication in host cells. The assay of the time of addition limited the drug effect during the first 8 h of infection. This conclusion was supported by the ultrastructure images of the early stage of DEV infection, which showed that the replication of virus nucleic acid and the formation of the capsid in the cell nucleus were suppressed. In the indirect immunofluorescence assay, proteins expression in DEV infected duck embryo fibroblasts (DEFs) within 24 h post-infection (p.i.) was also effectively suppressed by resveratrol. In summary, the resveratrol has a good activity against DEV infection in vitro, which could be attributed to that fact that several essential immediate early viral proteins for virus replication were impacted by resveratrol.	[Xu, Jiao; Yin, Zhongqiong; Li, Li; Cheng, Anchun; Jia, Renyong; Song, Xu; Lu, Hongke; Dai, Shujun; Lv, Cheng; Liang, Xiaoxia; He, Changliang; Zhao, Ling; Su, Gang; Ye, Gang; Shi, Fei] Sichuan Agr Univ, Coll Vet Med, Yaan, Peoples R China; [Yin, Zhongqiong; Cheng, Anchun; Jia, Renyong] Sichuan Agr Univ, Inst Prevent Vet Med, Chengdu, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Yin, ZQ (corresponding author), Sichuan Agr Univ, Coll Vet Med, Yaan, Peoples R China.	yinzhongq@163.com	Dai, Shujun/D-5777-2013	Dai, Shujun/0000-0002-2918-470X; Yin, Zhongqiong/0000-0003-1752-644X	National Science & Technology Program in Rural Areas [2011BAD34B03-4]; Foundation for the Author of Excellent Doctoral Dissertation of Sichuan agriculture university	National Science & Technology Program in Rural Areas; Foundation for the Author of Excellent Doctoral Dissertation of Sichuan agriculture university	These studies were supported by National Science & Technology Program in Rural Areas During the 12th Five Year Plan Period (2011BAD34B03-4) and Foundation for the Author of Excellent Doctoral Dissertation of Sichuan agriculture university. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOYLE P, 1995, UROLOGY, V46, P47, DOI 10.1016/S0090-4295(99)80250-7; Briskin DP, 2000, PLANT PHYSIOL, V124, P507, DOI 10.1104/pp.124.2.507; Cheng AnChun, 2004, Chinese Journal of Virology, V20, P364; Clouser CL, 2012, BIOORG MED CHEM LETT, V22, P6642, DOI 10.1016/j.bmcl.2012.08.108; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Docherty JJ, 1999, ANTIVIR RES, V43, P145, DOI 10.1016/S0166-3542(99)00042-X; Docherty JJ, 2005, ANTIVIR RES, V67, P155, DOI 10.1016/j.antiviral.2005.06.008; Docherty JJ, 2004, ANTIVIR RES, V61, P19, DOI 10.1016/j.antiviral.2003.07.001; Docherty JJ, 2006, ANTIVIR RES, V72, P171, DOI 10.1016/j.antiviral.2006.07.004; Evers DL, 2004, ANTIVIR RES, V63, P85, DOI 10.1016/j.antiviral.2004.03.002; Fioravanti R, 2012, BIOORGAN MED CHEM, V20, P5046, DOI 10.1016/j.bmc.2012.05.062; Galindo I, 2011, ANTIVIR RES, V91, P57, DOI 10.1016/j.antiviral.2011.04.013; Guo Yu-fei, 2008, Chinese Journal of Virology, V24, P352; [郭宇飞 GUO Yufei], 2006, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V37, P274; Heredia A, 2000, J ACQ IMMUN DEF SYND, V25, P246, DOI 10.1097/00126334-200011010-00006; HUSSAIN RF, 1993, J IMMUNOL METHODS, V160, P89, DOI 10.1016/0022-1759(93)90012-V; Jassim SAA, 2003, J APPL MICROBIOL, V95, P412, DOI 10.1046/j.1365-2672.2003.02026.x; Johnson DC, 2011, NAT REV MICROBIOL, V9, P382, DOI 10.1038/nrmicro2559; Kaleta EF, 2007, DEUT TIERARZTL WOCH, V114, P3; KALETA EF, 1990, AVIAN PATHOL, V19, P193, DOI 10.1080/03079459008418673; Lee JW, 2010, KOREAN J UROL, V51, P870, DOI 10.4111/kju.2010.51.12.870; Li T, 2013, ANTIVIR RES, V97, P1, DOI 10.1016/j.antiviral.2012.10.006; Li YL, 2005, ANTIVIR RES, V68, P1, DOI 10.1016/j.antiviral.2005.06.004; Li YQ, 2006, EUR J MED CHEM, V41, P1084, DOI 10.1016/j.ejmech.2006.03.024; Mimaki Y, 2001, BIOL PHARM BULL, V24, P1286, DOI 10.1248/bpb.24.1286; Mondal B, 2010, BIOLOGICALS, V38, P401, DOI 10.1016/j.biologicals.2010.01.016; Naesens L, 2006, J CLIN VIROL, V37, pS69, DOI 10.1016/S1386-6532(06)70015-4; Reed L., 1938, AM J HYG, V27, P943; Saif Y., 2003, Diseases of poultry; Seth A.F., 2006, ANTIVIR RES, V72, P242; Wang J, 2011, VIRUS RES, V160, P316, DOI 10.1016/j.virusres.2011.07.004; Wang JC, 2011, VIRUS RES, V159, P23, DOI 10.1016/j.virusres.2011.04.013; Williams J E, 2001, Altern Med Rev, V6, P567; Wu Y, 2012, J VIROL, V86, P5965, DOI 10.1128/JVI.00529-12; Xu J, 2012, POULTRY SCI, V91, P2802, DOI 10.3382/ps.2012-02468; Xu J, 2012, CHINESE VET SCI, V41, P1302; Yiu CY, 2010, MOLECULES, V15, P7115, DOI 10.3390/molecules15107115	37	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65213	10.1371/journal.pone.0065213	http://dx.doi.org/10.1371/journal.pone.0065213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776451	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400014
J	Zhang, L; Xu, JW; Qu, X; Liu, DR; Liu, P; Zhao, XZ				Zhang, Lu; Xu, Jia-Wei; Qu, Xin; Liu, Dong-Rui; Liu, Ping; Zhao, Xin-Zhi			Association of a Rare Haplotype in Kinesin Light Chain 1 Gene with Age-Related Cataract in a Han Chinese Population	PLOS ONE			English	Article							TRANSPORT; DISEASES; PITX3	Purpose: The causal genes for congenital cataract are good candidates for the genetic susceptibility for age-related cataract (ARC). The aim of this study was to investigate association between the polymorphisms in the causal genes for congenital cataract and ARC in a Chinese population. Meanwhile, we performed the replication study for previous identified risk genes for ARC. Methods: We recruited 212 sporadic Han Chinese patients with age-related cataracts (ARC) and 172 normal controls in this study. We analyzed 31 SNPs from 13 genes which mostly possible contributes the progress of ARC in a Chinese population, comprising 212 cataract patients and 172 controls. Polymorphism-spanning fragments were amplified by using the multiplex polymerase chain reaction (PCR) and genotyped using primer extension method in MassARRAY platform. Allelic and haplotypic difference in the frequencies were estimated using the SHEsis software platform. P-value was adjusted by the Bonferroni correction. Results: There was no difference in the frequencies of the genotype and allele of the all SNPs between the patients with ARC and the controls. In the haplotypic analysis, the haplotypes consisting of rs7154572, rs7150141 and rs12432994 in Kinesin Light Chain 1 Gene (KLC1) showed significant association with ARC (p = 0.000878). A rare haplotype CGT was more frequent in patients (p = 0.000106, and p = 0.00795 after corrected for 75 tests). Conclusions: Our study provides evidence that the combined effect of three variants within the KLC1 gene may predispose to ARC, but the precise mechanism needs further investigating.	[Zhang, Lu; Liu, Dong-Rui; Liu, Ping] Harbin Med Univ, Affiliated Hosp 1, Hosp Eye, Harbin, Peoples R China; [Xu, Jia-Wei; Zhao, Xin-Zhi] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Xu, Jia-Wei; Zhao, Xin-Zhi] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Qu, Xin] Harbin Med Univ, Affiliated Hosp 3, Harbin, Peoples R China	Harbin Medical University; Fudan University; Fudan University; Harbin Medical University	Zhang, L (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Hosp Eye, Harbin, Peoples R China.	13796089809@163.com; xzzhao@fudan.edu.cn	xu, jiawei/GWM-9710-2022		Natural Science Foundation of China [81200722]; Heilongjiang Postdoctoral Science-Research Foundation [LBH-Q10032]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Postdoctoral Science-Research Foundation	This research was supported with funds from the Natural Science Foundation of China (81200722) and the Heilongjiang Postdoctoral Science-Research Foundation (LBH-Q10032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson ME, 2007, MOL VIS, V13, P993; Asbell PA, 2005, LANCET, V365, P599; Berry V, MOL VIS, V17, P1249; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Goldstein LSB, 2001, P NATL ACAD SCI USA, V98, P6999, DOI 10.1073/pnas.111145298; Hammond CJ, 2000, NEW ENGL J MED, V342, P1786, DOI 10.1056/NEJM200006153422404; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P601; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Jamieson RV, 2002, HUM MOL GENET, V11, P33, DOI 10.1093/hmg/11.1.33; Jun G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000584; Medina-Martinez O, 2009, DEV DYNAM, V238, P2193, DOI 10.1002/dvdy.21924; Reddy MA, 2004, SURV OPHTHALMOL, V49, P300, DOI 10.1016/j.survophthal.2004.02.013; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Robman L, 2005, EYE, V19, P1074, DOI 10.1038/sj.eye.6701964; Semina EV, 1998, NAT GENET, V19, P167, DOI 10.1038/527; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shiels A, 2008, MOL VIS, V14, P2042; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Sundaresan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033001; von Otter M, 2010, NEUROMOL MED, V12, P229, DOI 10.1007/s12017-009-8103-0; Zhang TX, 2009, HUM MUTAT, V30, pE603, DOI 10.1002/humu.20995; Zhang Y, 2011, MOL VIS, V17, P2325	22	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e64052	10.1371/journal.pone.0064052	http://dx.doi.org/10.1371/journal.pone.0064052			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776437	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400006
J	Cai, QQ; Huang, HQ; Qian, D; Chen, KL; Luo, JH; Tian, Y; Lin, TX; Lin, TY				Cai, Qingqing; Huang, Huiqiang; Qian, Dong; Chen, Kailin; Luo, Junhua; Tian, Ying; Lin, Tianxin; Lin, Tongyu			13-Methyltetradecanoic Acid Exhibits Anti-Tumor Activity on T-Cell Lymphomas In Vitro and In Vivo by Down-Regulating p-AKT and Activating Caspase-3	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; NF-KAPPA-B; CANCER-CELLS; MULTIDRUG-RESISTANCE; FATTY-ACIDS; MEDIATED APOPTOSIS; ENDOTHELIAL-CELLS; GERMINAL CENTER; OVARIAN-CANCER; EXPRESSION	13-Methyltetradecanoic acid (13-MTD), a saturated branched-chain fatty acid purified from soy fermentation products, induces apoptosis in human cancer cells. We investigated the inhibitory effects and mechanism of action of 13-MTD on T-cell non-Hodgkin's lymphoma (T-NHL) cell lines both in vitro and in vivo. Growth inhibition in response to 13-MTD was evaluated by the cell counting kit-8 (CCK-8) assay in three T-NHL cell lines (Jurkat, Hut78, EL4 cells). Flow cytometry analyses were used to monitor the cell cycle and apoptosis. Proteins involved in 13-MTD-induced apoptosis were examined in Jurkat cells by western blotting. We found that 13-MTD inhibited proliferation and induced the apoptosis of T-NHL cell lines. 13-MTD treatment also induced a concentration-dependent arrest of Jurkat cells in the G(1)-phase. During 13-MTD-induced apoptosis in Jurkat cells, the cleavage of caspase-3 and poly ADP-ribose polymerase (PARP, a caspase enzymolysis product) were detected after incubation for 2 h, and increased after extending the incubation time. However, there was no change in the expression of Bcl-2 or c-myc proteins. The appearance of apoptotic Jurkat cells was accompanied by the inhibition of AKT and nuclear factor-kappa B (NF-kappa B) phosphorylation. In addition, 13-MTD could also effectively inhibit the growth of T-NHL tumors in vivo in a xenograft model. The tumor inhibition rate in the experimental group was 40%. These data indicate that 13-MTD inhibits proliferation and induces apoptosis through the down-regulation of AKT phosphorylation followed by caspase activation, which may provide a new approach for treating T-cell lymphomas.	[Cai, Qingqing; Huang, Huiqiang; Chen, Kailin; Lin, Tongyu] Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Cai, Qingqing; Huang, Huiqiang; Qian, Dong; Chen, Kailin; Tian, Ying; Lin, Tongyu] State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China; [Luo, Junhua; Lin, Tianxin] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China; [Luo, Junhua; Lin, Tianxin] Sun Yat Sen Univ, Lin Bai Xin Med Res Ctr, Affiliated Hosp 2, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Lin, TX (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou 510275, Guangdong, Peoples R China.	tianxinl@sina.com; tongyulin@hotmail.com			National Nature Scientific Research Fund of China [81001052]; Science and Technology Planning Project of Guangdong Province, China [2011B031800222]; Young Talents project of Sun Yat-sen University Cancer Center; Yat-sen Scholarship for Young Scientists; Program for New Century Excellent Talents in University [NCET-10-0852]; Guangdong Province Natural Scientific Grant [8151008901000043]	National Nature Scientific Research Fund of China; Science and Technology Planning Project of Guangdong Province, China; Young Talents project of Sun Yat-sen University Cancer Center; Yat-sen Scholarship for Young Scientists; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Guangdong Province Natural Scientific Grant	This work was supported by National Nature Scientific Research Fund of China (grant number: 81001052); Science and Technology Planning Project of Guangdong Province, China (grant number: 2011B031800222); Young Talents project of Sun Yat-sen University Cancer Center; Yat-sen Scholarship for Young Scientists (to Tianxin, Lin) and Program for New Century Excellent Talents in University (NCET-10-0852), to Tianxin, Lin and Guangdong Province Natural Scientific Grant (8151008901000043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE JO, 1989, J CLIN ONCOL, V7, P1783, DOI 10.1200/JCO.1989.7.12.1783; Bailey HH, 2006, CANCER-AM CANCER SOC, V107, P2462, DOI 10.1002/cncr.22308; Bao-hua Yu, 2011, Chinese Journal of Pathology, V40, P246, DOI 10.3760/cma.j.issn.0529-5807.2011.04.006; Barancik M, 2006, EUR J PHARM SCI, V29, P426, DOI 10.1016/j.ejps.2006.08.006; Bartling B, 2000, BIOCHEM BIOPH RES CO, V278, P740, DOI 10.1006/bbrc.2000.3873; BUTTKE TM, 1984, IMMUNOLOGY, V53, P235; Cai QQ, 2012, CL LYMPH MYELOM LEUK, V12, P106, DOI 10.1016/j.clml.2011.12.002; Calviello G, 1999, LIPIDS, V34, P599, DOI 10.1007/s11745-999-0404-6; Coiffier B, 1990, J CLIN ONCOL, V9, P45; Creagh EM, 2003, IMMUNOL REV, V193, P10, DOI 10.1034/j.1600-065X.2003.00048.x; Dahia PLM, 1999, HUM MOL GENET, V8, P185, DOI 10.1093/hmg/8.2.185; El-Deiry Wafik S., 1997, Current Opinion in Oncology, V9, P79; Fraser M, 2003, CANCER RES, V63, P7081; Garcia MG, 2009, LEUKEMIA RES, V33, P288, DOI 10.1016/j.leukres.2008.06.010; Ghia P, 1998, BLOOD, V91, P244, DOI 10.1182/blood.V91.1.244.244_244_251; Graham SH, 2001, J CEREBR BLOOD F MET, V21, P99, DOI 10.1097/00004647-200102000-00001; GROGAN TM, 1985, AM J CLIN PATHOL, V83, P279, DOI 10.1093/ajcp/83.3.279; Henshall DC, 2002, J NEUROSCI, V22, P8458; Ip MM, 1999, EXP CELL RES, V250, P22, DOI 10.1006/excr.1999.4499; Jiang YH, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-70; Jillella AP, 2000, CANCER INVEST, V18, P609, DOI 10.3109/07357900009032827; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Lam LT, 2005, CLIN CANCER RES, V11, P28; Lin TX, 2012, UROL ONCOL-SEMIN ORI, V30, P339, DOI 10.1016/j.urolonc.2010.04.011; Liu XG, 2009, JPN J CLIN ONCOL, V39, P418, DOI 10.1093/jjco/hyp037; Liu YH, 2008, HUM PATHOL, V39, P875, DOI 10.1016/j.humpath.2007.10.013; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Miles RR, 2008, PEDIATR BLOOD CANCER, V51, P369, DOI 10.1002/pbc.21619; Nakata S, 2004, ONCOGENE, V23, P6261, DOI 10.1038/sj.onc.1207830; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Qiao M, 2008, CELL CYCLE, V7, P2991, DOI 10.4161/cc.7.19.6784; Russo RIC, 2008, INT J CANCER, V122, P1012, DOI 10.1002/ijc.23122; Shao WL, 2010, INT J CANCER, V127, P2199, DOI 10.1002/ijc.25218; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; Sun XC, 2000, AM J PHYSIOL-CELL PH, V279, pC1648, DOI 10.1152/ajpcell.2000.279.5.C1648; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Uddin S, 2006, BLOOD, V108, P4178, DOI 10.1182/blood-2006-04-016907; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Volbracht C, 2001, MOL MED, V7, P36, DOI 10.1007/BF03401837; Vose JM, 2008, HEMATOL ONCOL CLIN N, V22, P997, DOI 10.1016/j.hoc.2008.07.010; Wongtangtintharn Sawitree, 2005, Lipids Health Dis, V4, P29, DOI 10.1186/1476-511X-4-29; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Yang ZH, 2000, CANCER RES, V60, P505; Yao D, 2010, PLOS ONE, V5; ZHANG CL, 1992, THROMB RES, V65, P65; Zhang LJ, 2010, EUR J PHARMACOL, V643, P195, DOI 10.1016/j.ejphar.2010.06.045	48	19	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65308	10.1371/journal.pone.0065308	http://dx.doi.org/10.1371/journal.pone.0065308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762338	Green Submitted, Green Published, gold			2022-12-25	WOS:000321094800037
J	Papazzo, A; Conlan, XA; Lexis, L; Charchar, FJ; Lewandowski, PA				Papazzo, Annateresa; Conlan, Xavier A.; Lexis, Louise; Charchar, Fadi J.; Lewandowski, Paul A.			Salt Loading in Canola Oil Fed SHRSP Rats Induces Endothelial Dysfunction	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; 13-WEEK DIETARY-INTAKE; WISTAR-KYOTO RATS; OXIDATIVE STRESS; RAPESEED OIL; VEGETABLE-OILS; SURVIVAL-TIME; NADPH OXIDASE; SOYBEAN OIL; BLOOD-PRESSURE	This study aimed to determine if 50 days of canola oil intake in the absence or presence of salt loading affects: (1) antioxidant and oxidative stress markers, (2) aortic mRNA of NADPH oxidase (NOX) subunits and superoxide dismutase (SOD) isoforms and (3) endothelial function in SHRSP rats. SHRSP rats were fed a diet containing 10 wt/wt% soybean oil or 10 wt/wt% canola oil, and given tap water or water containing 1% NaCl for 50 days. Without salt, canola oil significantly increased RBC SOD, plasma cholesterol and triglycerides, aortic p22(phox), NOX2 and CuZn-SOD mRNA, and decreased RBC glutathione peroxidase activity. With salt, canola oil reduced RBC SOD and catalase activity, LDL-C, and p22(phox) mRNA compared with canola oil alone, whereas plasma malondialdehyde (MDA) was reduced and RBC MDA and LDL-C were higher. With salt, the canola oil group had significantly reduced endothelium-dependent vasodilating responses to ACh and contractile responses to norepinephrine compared with the canola oil group without salt and to the WKY rats. These results indicate that ingestion of canola oil increases O-2(-) generation, and that canola oil ingestion in combination with salt leads to endothelial dysfunction in the SHRSP model.	[Papazzo, Annateresa; Lewandowski, Paul A.] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia; [Conlan, Xavier A.] Deakin Univ, Sch Life & Environm Sci, Ctr Chem & Biotechnol, Geelong, Vic 3217, Australia; [Lexis, Louise] La Trobe Univ, Dept Human Biosci, Bundoora, Vic 3086, Australia; [Charchar, Fadi J.] Univ Ballarat, Sch Hlth Sci, Ballarat, Vic 3353, Australia	Deakin University; Deakin University; La Trobe University; Federation University Australia	Lewandowski, PA (corresponding author), Deakin Univ, Sch Med, Geelong, Vic 3217, Australia.	paul.lewandowski@deakin.edu.au	Charchar, Fadi/I-6656-2017	Charchar, Fadi/0000-0002-6164-9941; Conlan, Xavier/0000-0003-0829-0551				Ballantyne C, 2005, EUR HEART J, V26, P2224, DOI 10.1093/eurheartj/ehi373; Berry C, 2001, CURR OPIN NEPHROL HY, V10, P247, DOI 10.1097/00041552-200103000-00014; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Bragulat Ernesto, 2002, J Clin Hypertens (Greenwich), V4, P41, DOI 10.1111/j.1524-6175.2002.00503.x; Cediel E, 2003, AM J PHYSIOL-REG I, V285, pR674, DOI 10.1152/ajpregu.00643.2002; Chabrashvili T, 2003, AM J PHYSIOL-REG I, V285, pR117, DOI 10.1152/ajpregu.00476.2002; Chen QX, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-11; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; Datla SR, 2010, HYPERTENSION, V56, P325, DOI 10.1161/HYPERTENSIONAHA.109.142422; Davies PF, 2009, NAT CLIN PRACT CARD, V6, P16, DOI 10.1038/ncpcardio1397; de Cavanagh EMV, 2010, AM J HYPERTENS, V23, P1318, DOI 10.1038/ajh.2010.167; Huang MZ, 1996, BIOL PHARM BULL, V19, P554, DOI 10.1248/bpb.19.554; Huang MZ, 1997, LIPIDS, V32, P745, DOI 10.1007/s11745-997-0095-z; Jiang F, 2004, ENDOTHELIUM-J ENDOTH, V11, P79, DOI 10.1080/10623320490482600; Kalenikova EI, 2004, BIOCHEMISTRY-MOSCOW+, V69, P311, DOI 10.1023/B:BIRY.0000022063.32185.7c; Kitiyakara C, 2003, J AM SOC NEPHROL, V14, P2775, DOI 10.1097/01.ASN.0000092145.90389.65; Li J, 2009, J NUTR, V139, P447, DOI 10.3945/jn.108.097451; Naito Y, 2000, PHARMACOL TOXICOL, V87, P144, DOI 10.1111/j.0901-9928.2000.870308.x; Naito Y, 2000, FOOD CHEM TOXICOL, V38, P811, DOI 10.1016/S0278-6915(00)00076-4; Naito Y, 2003, TOXICOLOGY, V187, P205, DOI 10.1016/S0300-483X(03)00052-0; Natio Y, 2000, TOXICOL LETT, V117, P209; Ogawa H, 2003, CLIN EXP PHARMACOL P, V30, P919, DOI 10.1111/j.1440-1681.2003.03939.x; Ohara N, 2008, FOOD CHEM TOXICOL, V46, P2573, DOI 10.1016/j.fct.2008.04.015; Ohara N, 2006, FOOD CHEM TOXICOL, V44, P952, DOI 10.1016/j.fct.2005.11.004; Ohara N, 2009, FOOD CHEM TOXICOL, V47, P157, DOI 10.1016/j.fct.2008.10.022; Papazzo A, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-180; Papazzo A, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-98; Ratnayake WMN, 2000, J NUTR, V130, P1166, DOI 10.1093/jn/130.5.1166; Ratnayake WMN, 2000, LIPIDS, V35, P409, DOI 10.1007/s11745-000-539-5; Reinehr R, 2007, GLIA, V55, P758, DOI 10.1002/glia.20504; Schulz E, 2011, HYPERTENS RES, V34, P665, DOI 10.1038/hr.2011.39; SHARMA AM, 1990, KLIN WOCHENSCHR, V68, P664, DOI 10.1007/BF01667013; Sim AS, 2003, J CHROMATOGR B, V785, P337, DOI 10.1016/S1570-0232(02)00956-X; Tatematsu K, 2004, FOOD CHEM TOXICOL, V42, P1443, DOI 10.1016/j.fct.2004.04.005; Adler Alma J, 2014, Cochrane Database Syst Rev, pCD009217, DOI [10.1002/14651858.CD009217, 10.1002/14651858.CD009217.pub3]; Ulker S, 2003, HYPERTENSION, V41, P534, DOI 10.1161/01.HYP.0000057421.28533.37; WARNICK GR, 1990, CLIN CHEM, V36, P15; Zalba G, 2000, HYPERTENSION, V35, P1055, DOI 10.1161/01.HYP.35.5.1055	38	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66655	10.1371/journal.pone.0066655	http://dx.doi.org/10.1371/journal.pone.0066655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762494	Green Published, Green Submitted, gold			2022-12-25	WOS:000321094800102
J	Song, LG; Zhu, QQ; Liu, TW; Yu, M; Xiao, KW; Kong, QN; Zhao, RL; Li, GD; Zhou, Y				Song, Lige; Zhu, Qianqian; Liu, Tianwei; Yu, Ming; Xiao, Kewei; Kong, Qingnuan; Zhao, Renliang; Li, Guo-Dong; Zhou, Yu			Ghrelin Modulates Lateral Amygdala Neuronal Firing and Blocks Acquisition for Conditioned Taste Aversion	PLOS ONE			English	Article							ACYLATED-GHRELIN; MESSENGER-RNA; MEMORY; RECEPTOR; EXCITABILITY; RAT; EXPRESSION; CONSOLIDATION; INACTIVATION; HIPPOCAMPUS	Ghrelin is an orexigenic brain-gut hormone promoting feeding and regulating energy metabolism in human and rodents. An increasing number of studies have reported that ghrelin and its identified receptor, the growth hormone secretagogue receptor 1a (GHS-R1a), produces remarkably wide and complex functions and biological effects on specific populations of neurons in central nervous system. In this study, we sought to explore the in vivo effects of acute ghrelin exposure on lateral amygdala (LA) neurons at the physiological and behavioral levels. In vivo extracellular single-unit recordings showed that ghrelin with the concentration of several nanomolars (nM) stimulated spontaneous firing of the LA neurons, an effect that was dose-dependent and could be blocked by co-application of a GHS-R1a antagonist D-Lys3-GHRP-6. We also found that D-Lys3-GHRP-6 inhibited spontaneous firing of the LA neurons in a dose-dependent manner, revealing that tonic GHS-R1a activity contributes to orchestrate the basal activity of the LA neurons. Behaviorally, we found that microinfusion of ghrelin (12 ng) into LA before training interfered with the acquisition of conditioned taste aversion (CTA) as tested at 24 h after conditioning. Pre-treatment with either purified IgG against GHS-R1a or GHS-R1a antagonist blocked ghrelin's effect on CTA memory acquisition. Ghrelin (12 ng) had no effect on CTA memory consolidation or the expression of acquired CTA memory; neither did it affect the total liquid consumption of tested rats. Altogether, our data indicated that ghrelin locally infused into LA blocks acquisition of CTA and its modulation effects on neuronal firing may be involved in this process.	[Song, Lige; Zhu, Qianqian; Liu, Tianwei; Yu, Ming; Xiao, Kewei; Kong, Qingnuan; Zhou, Yu] Qingdao Univ, Coll Med, Dept Physiol, Qingdao 266071, Shandong, Peoples R China; [Song, Lige; Zhao, Renliang] Affiliated Gen Hosp, Coll Med, Dept Neurol, Qingdao, Shandong, Peoples R China; [Liu, Tianwei] Qingdao Univ, Coll Med, Res Inst Cerebrovas Dis, Qingdao 266071, Shandong, Peoples R China; [Li, Guo-Dong] Univ Calif Los Angeles, Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA	Qingdao University; Qingdao University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Li, GD (corresponding author), Univ Calif Los Angeles, Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA.	guodongli@mednet.ucla.edu; yuzhou7310@gmail.com			National Natural Science Foundation of China [31171079, 81070881, 31222027]; Provincial Natural Science Foundation of Shandong [JQ201209]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province)	This work was supported by grants from the National Natural Science Foundation of China (31171079, 81070881 and 31222027 to YZ) and the Provincial Natural Science Foundation of Shandong (JQ201209 to YZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Crespo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046321; Andrews ZB, 2009, J NEUROSCI, V29, P14057, DOI 10.1523/JNEUROSCI.3890-09.2009; Bahar A, 2003, EUR J NEUROSCI, V17, P1527, DOI 10.1046/j.1460-9568.2003.02551.x; Carlini VP, 2008, NEUROSCIENCE, V153, P929, DOI 10.1016/j.neuroscience.2008.03.015; Carlini VP, 2010, PHYSIOL BEHAV, V101, P117, DOI 10.1016/j.physbeh.2010.04.026; Carlini VP, 2002, BIOCHEM BIOPH RES CO, V299, P739, DOI 10.1016/S0006-291X(02)02740-7; Carlini VP, 2004, BIOCHEM BIOPH RES CO, V313, P635, DOI 10.1016/j.bbrc.2003.11.150; Carvajal P, 2009, NEUROBIOL LEARN MEM, V91, P402, DOI 10.1016/j.nlm.2008.12.008; Chen LA, 2011, EUR J NEUROSCI, V33, P266, DOI 10.1111/j.1460-9568.2010.07491.x; Chung H, 2007, ENDOCRINOLOGY, V148, P148, DOI 10.1210/en.2006-0991; Cong WN, 2010, CNS NEUROL DISORD-DR, V9, P557, DOI 10.2174/187152710793361513; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Davis JF, 2011, PHYSIOL BEHAV, V103, P39, DOI 10.1016/j.physbeh.2010.10.017; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Dresler M, 2010, PHARMACOPSYCHIATRY, V43, P277, DOI 10.1055/s-0030-1263175; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Faber ESL, 2001, J NEUROPHYSIOL, V85, P714, DOI 10.1152/jn.2001.85.2.714; Ferrini F, 2009, CURR NEUROPHARMACOL, V7, P37, DOI 10.2174/157015909787602779; Frago LM, 2011, FRONT MOL NEUROSCI, V4, DOI [10.3389/fnmo1.2011.00023, 10.3389/fnmol.2011.00023]; Garcia-DeLaTorre P, 2009, LEARN MEMORY, V16, P514, DOI 10.1101/lm.1356509; Giese KP, 2001, PHYSIOL BEHAV, V73, P803, DOI 10.1016/S0031-9384(01)00517-0; Giese KP, 1998, LEARN MEMORY, V5, P257; Goshadrou F, 2012, BEHAV BRAIN RES, V232, P391, DOI 10.1016/j.bbr.2012.03.035; Granata R, 2007, ENDOCRINOLOGY, V148, P512, DOI 10.1210/en.2006-0266; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Hansson C, 2011, NEUROSCIENCE, V180, P201, DOI 10.1016/j.neuroscience.2011.02.002; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Jacoby SM, 2011, NEUROSCI LETT, V504, P316, DOI 10.1016/j.neulet.2011.09.056; Jiang H, 2006, MOL ENDOCRINOL, V20, P1772, DOI 10.1210/me.2005-0084; Kern A, 2012, NEURON, V73, P317, DOI 10.1016/j.neuron.2011.10.038; Kim MJ, 2010, NEUROBIOL LEARN MEM, V93, P406, DOI 10.1016/j.nlm.2009.12.007; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lodeiro M, 2011, MOL BIOL CELL, V22, P4182, DOI 10.1091/mbc.E11-04-0373; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; MCDONALD AJ, 1982, J COMP NEUROL, V212, P293, DOI 10.1002/cne.902120307; McGaugh JL, 2002, TRENDS NEUROSCI, V25, P456, DOI 10.1016/S0166-2236(02)02211-7; Mitchell V, 2001, J COMP NEUROL, V429, P469, DOI 10.1002/1096-9861(20010115)429:3<469::AID-CNE8>3.0.CO;2-#; Mozzachiodi R, 2010, TRENDS NEUROSCI, V33, P17, DOI 10.1016/j.tins.2009.10.001; Nanzer AM, 2004, EUR J ENDOCRINOL, V151, P233, DOI 10.1530/eje.0.1510233; Nicholls JGM, 2012, NEURON BRAIN, P229; Osterstock G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009159; Rosenkranz JA, 1999, J NEUROSCI, V19, P11027, DOI 10.1523/JNEUROSCI.19-24-11027.1999; Sato T, 2005, ENDOCRINOLOGY, V146, P2510, DOI 10.1210/en.2005-0174; Shi LM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2439; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Spitznagel MB, 2010, PSYCHIAT CLIN NEUROS, V64, P608, DOI 10.1111/j.1440-1819.2010.02145.x; Toth K, 2008, BRAIN RES BULL, V77, P105, DOI 10.1016/j.brainresbull.2008.06.008; Toth K, 2009, BEHAV BRAIN RES, V202, P308, DOI 10.1016/j.bbr.2009.03.031; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; Viosca J, 2009, LEARN MEMORY, V16, P198, DOI 10.1101/lm.1220309; Viosca J, 2009, LEARN MEMORY, V16, P193, DOI 10.1101/lm.1254209; Welzl H, 2001, BEHAV BRAIN RES, V125, P205, DOI 10.1016/S0166-4328(01)00302-3; Xue Y, 2007, EXP NEUROL, V205, P108, DOI 10.1016/j.expneurol.2007.01.031; Yasoshima Y, 1995, NEUROREPORT, V6, P2424, DOI 10.1097/00001756-199511270-00034; Yasoshima Y, 1998, NEUROSCIENCE, V84, P1, DOI 10.1016/S0306-4522(97)00636-2; Yasoshima Y, 2000, BRAIN RES, V869, P15, DOI 10.1016/S0006-8993(00)02397-0; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	62	51	53	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65422	10.1371/journal.pone.0065422	http://dx.doi.org/10.1371/journal.pone.0065422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762368	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800048
J	Armstrong, SP; Seeber, RM; Ayoub, MA; Feldman, BJ; Pfleger, KDG				Armstrong, Stephen P.; Seeber, Ruth M.; Ayoub, Mohammed Akli; Feldman, Brian J.; Pfleger, Kevin D. G.			Characterization of Three Vasopressin Receptor 2 Variants: An Apparent Polymorphism (V266A) and Two Loss-of-Function Mutations (R181C and M311V)	PLOS ONE			English	Article							NEPHROGENIC DIABETES-INSIPIDUS; PROTEIN-PROTEIN INTERACTIONS; V2 VASOPRESSIN; HORMONE-RECEPTORS; COUPLED RECEPTORS; AVPR2 VARIANTS; IDENTIFICATION; AGONIST; STIMULATION; INSIGHTS	Arginine vasopressin (AVP) is released from the posterior pituitary and controls water homeostasis. AVP binding to vasopressin V2 receptors (V2Rs) located on kidney collecting duct epithelial cells triggers activation of Gs proteins, leading to increased cAMP levels, trafficking of aquaporin-2 water channels, and consequent increased water permeability and antidiuresis. Typically, loss-of-function V2R mutations cause nephrogenic diabetes insipidus (NDI), whereas gain-of-function mutations cause nephrogenic syndrome of inappropriate antidiuresis (NSIAD). Here we provide further characterization of two mutant V2Rs, R181C and M311V, reported to cause complete and partial NDI respectively, together with a V266A variant, in a patient diagnosed with NSIAD. Our data in HEK293FT cells revealed that for cAMP accumulation, AVP was about 500- or 30-fold less potent at the R181C and M311V mutants than at the wild-type receptor respectively (and about 4000- and 60-fold in COS7 cells respectively). However, in contrast to wild type V2R, the R181C mutant failed to increase inositol phosphate production, while with the M311V mutant, AVP exhibited only partial agonism in addition to a 37-fold potency decrease. Similar responses were detected in a BRET assay for beta-arrestin recruitment, with the R181C receptor unresponsive to AVP, and partial agonism with a 23-fold decrease in potency observed with M311V in both HEK293FT and COS7 cells. Notably, the V266A V2R appeared functionally identical to the wild-type receptor in all assays tested, including cAMP and inositol phosphate accumulation, b-arrestin interaction, and in a BRET assay of receptor ubiquitination. Each receptor was expressed at comparable levels. Hence, the M311V V2R retains greater activity than the R181C mutant, consistent with the milder phenotype of NDI associated with this mutant. Notably, the R181C mutant appears to be a Gs protein-biased receptor incapable of signaling to inositol phosphate or recruiting b-arrestin. The etiology of NSIAD in the patient with V266A V2R remains unknown.	[Armstrong, Stephen P.; Seeber, Ruth M.; Ayoub, Mohammed Akli; Pfleger, Kevin D. G.] Univ Western Australia, Western Australian Inst Med Res, Lab Mol Endocrinol G Prot Coupled Receptors, Perth, WA 6009, Australia; [Armstrong, Stephen P.; Seeber, Ruth M.; Ayoub, Mohammed Akli; Pfleger, Kevin D. G.] Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia; [Ayoub, Mohammed Akli] King Saud Univ, Coll Sci, Dept Biochem, Prot Res Chair, Riyadh 11451, Saudi Arabia; [Feldman, Brian J.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	University of Western Australia; University of Western Australia; King Saud University; Stanford University	Pfleger, KDG (corresponding author), Univ Western Australia, Western Australian Inst Med Res, Lab Mol Endocrinol G Prot Coupled Receptors, Perth, WA 6009, Australia.	kevin.pfleger@waimr.uwa.edu.au	Seeber, Ruth/AAS-9411-2021; Pfleger, Kevin/H-5629-2014	Seeber, Ruth/0000-0003-3265-7931; Pfleger, Kevin/0000-0001-8261-9189; AYOUB, Mohammed Akli/0000-0003-0022-578X	Australian Research Council [FT100100271]; Raine Medical Research Foundation	Australian Research Council(Australian Research Council); Raine Medical Research Foundation	This research was funded by the Australian Research Council (www.arc.gov.au) Future Fellowship (FT100100271) and a Priming Grant from the Raine Medical Research Foundation (www.raine.uwa.edu.au), both awarded to KDGP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SP, 2011, MOL CELL ENDOCRINOL, V331, P194, DOI 10.1016/j.mce.2010.07.008; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Balasubramanian L, 2008, PFLUG ARCH EUR J PHY, V456, P747, DOI 10.1007/s00424-007-0371-7; Ball SG, 2007, ANN CLIN BIOCHEM, V44, P417, DOI 10.1258/000456307781646030; Baylis PH, 2003, INT J BIOCHEM CELL B, V35, P1495, DOI 10.1016/S1357-2725(03)00139-0; Bernier V, 2006, J AM SOC NEPHROL, V17, P232, DOI 10.1681/ASN.2005080854; BICHET DG, 1994, AM J HUM GENET, V55, P278; BIRNBAUMER M, 1992, NATURE, V357, P333, DOI 10.1038/357333a0; Carpentier E, 2012, J AM SOC NEPHROL, V23, P1635, DOI 10.1681/ASN.2012010077; Chang WC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001317; Dalrymple MB, 2011, J BIOL CHEM, V286, P16726, DOI 10.1074/jbc.M111.223537; Feldman BJ, 2005, NEW ENGL J MED, V352, P1884, DOI 10.1056/NEJMoa042743; Finch AR, 2010, MOL ENDOCRINOL, V24, P423, DOI 10.1210/me.2009-0343; Grasberger H, 2007, J CLIN ENDOCR METAB, V92, P2816, DOI 10.1210/jc.2007-0366; Hermosilla R, 2004, TRAFFIC, V5, P993, DOI 10.1111/j.1600-0854.2004.00239.x; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; KNOERS NVAM, 1994, KIDNEY INT, V46, P170, DOI 10.1038/ki.1994.256; Kocan Martina, 2010, Front Endocrinol (Lausanne), V1, P12, DOI 10.3389/fendo.2010.00012; Kocan M, 2009, MOL ENDOCRINOL, V23, P559, DOI 10.1210/me.2008-0321; Lan HX, 2009, MOL PHARMACOL, V75, P113, DOI 10.1124/mol.108.050534; Leach K, 2012, ENDOCRINOLOGY, V153, P4304, DOI 10.1210/en.2012-1449; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; LOLAIT SJ, 1992, NATURE, V357, P336, DOI 10.1038/357336a0; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; Morello JP, 2001, ANNU REV PHYSIOL, V63, P607, DOI 10.1146/annurev.physiol.63.1.607; Mustafa S, 2012, J BIOL CHEM, V287, P12952, DOI 10.1074/jbc.M111.322834; Nakajima K, 2012, MOL PHARMACOL, V82, P575, DOI 10.1124/mol.112.080358; PAN Y, 1994, J BIOL CHEM, V269, P31933; PAN Y, 1992, NAT GENET, V2, P103, DOI 10.1038/ng1092-103; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Pfleger KDG, 2006, CELL SIGNAL, V18, P1664, DOI 10.1016/j.cellsig.2006.01.004; Rahmeh R, 2012, P NATL ACAD SCI USA, V109, P6733, DOI 10.1073/pnas.1201093109; Rochdi MD, 2010, MOL PHARMACOL, V77, P836, DOI 10.1124/mol.109.061804; ROSENTHAL W, 1993, J BIOL CHEM, V268, P13030; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Sahakitrungruang T, 2010, HORM RES PAEDIAT, V73, P349, DOI 10.1159/000308167; Sands JM, 2006, ANN INTERN MED, V144, P186, DOI 10.7326/0003-4819-144-3-200602070-00007; Schoneberg T, 1998, HUM MUTAT, V12, P196, DOI 10.1002/(SICI)1098-1004(1998)12:3<196::AID-HUMU7>3.0.CO;2-F; Schulein R, 2001, J BIOL CHEM, V276, P8384, DOI 10.1074/jbc.M007045200; Schulz A, 2000, J BIOL CHEM, V275, P2381, DOI 10.1074/jbc.275.4.2381; Schulz A, 2002, J CLIN ENDOCR METAB, V87, P5247, DOI 10.1210/jc.2002-020286; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Slusarz MJ, 2006, J PEPT SCI, V12, P180, DOI 10.1002/psc.714; Spanakis E, 2008, J CELL PHYSIOL, V217, P605, DOI 10.1002/jcp.21552; Takahashi K, 2012, J BIOL CHEM, V287, P2099, DOI 10.1074/jbc.M111.268797; Tenenbaum J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008383; Vassart G, 2011, NAT REV ENDOCRINOL, V7, P362, DOI 10.1038/nrendo.2011.20; Wildin RS, 1998, KIDNEY INT, V54, P1909, DOI 10.1046/j.1523-1755.1998.00214.x; Zhong M, 2007, AM J PHYSIOL-ENDOC M, V292, pE977, DOI 10.1152/ajpendo.00531.2005; Zhu X, 1996, P NATL ACAD SCI USA, V93, P2827, DOI 10.1073/pnas.93.7.2827	52	20	21	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65885	10.1371/journal.pone.0065885	http://dx.doi.org/10.1371/journal.pone.0065885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762448	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000116
J	Jha, RM; Chrenek, R; Magnotti, LM; Cardozo, DL				Jha, Ruchira M.; Chrenek, Ryan; Magnotti, Laura M.; Cardozo, David L.			The Isolation, Differentiation, and Survival In Vivo of Multipotent Cells from the Postnatal Rat filum terminale	PLOS ONE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; ADULT MAMMALIAN FOREBRAIN; SPINAL-CORD; PROGENITOR CELLS; MOTOR-NEURONS; CHOLINERGIC NEURONS; DOPAMINERGIC DIFFERENTIATION; STEM/PROGENITOR CELLS; SUBEPENDYMAL CELLS	Neural stem cells (NSCs) are undifferentiated cells in the central nervous system (CNS) that are capable of self-renewal and can be induced to differentiate into neurons and glia. Current sources of mammalian NSCs are confined to regions of the CNS that are critical to normal function and surgically difficult to access, which limits their therapeutic potential in human disease. We have found that the filum terminale (FT), a previously unexplored, expendable, and easily accessible tissue at the caudal end of the spinal cord, is a source of multipotent cells in postnatal rats and humans. In this study, we used a rat model to isolate and characterize the potential of these cells. Neurospheres derived from the rat FT are amenable to in vitro expansion in the presence of a combination of growth factors. These proliferating, FT-derived cells formed neurospheres that could be induced to differentiate into neural progenitor cells, neurons, astrocytes, and oligodendrocytes by exposure to serum and/or adhesive substrates. Through directed differentiation using sonic hedgehog and retinoic acid in combination with various neurotrophic factors, FT-derived neurospheres generated motor neurons that were capable of forming neuromuscular junctions in vitro. In addition, FT-derived progenitors that were injected into chick embryos survived and could differentiate into both neurons and glia in vivo.	[Jha, Ruchira M.; Chrenek, Ryan; Magnotti, Laura M.; Cardozo, David L.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Chrenek, Ryan] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Magnotti, LM (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	laura_magnotti@hms.harvard.edu			Vertex Pharmaceuticals	Vertex Pharmaceuticals(Vertex Pharmaceuticals)	This work was supported by a grant from Vertex Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht PJ, 2002, EXP NEUROL, V173, P46, DOI 10.1006/exnr.2001.7834; Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Arvidsson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027393; Ashkenazi E, 1998, J SPINAL DISORD, V11, P540; BAKKERNIEZEN SH, 1984, Z KINDERCHIR, V39, P100; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Chipperfield H, 2005, BRAIN RES PROTOC, V14, P146, DOI 10.1016/j.brainresprot.2004.12.003; CHOI BH, 1992, HUM PATHOL, V23, P916, DOI 10.1016/0046-8177(92)90405-R; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; Deshpande DM, 2006, ANN NEUROL, V60, P32, DOI 10.1002/ana.20901; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Durston AJ, 1998, CURR TOP DEV BIOL, V40, P111, DOI 10.1016/S0070-2153(08)60366-X; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Fontes RBV, 2006, NEUROSURGERY, V58, P978, DOI 10.1227/01.NEU.0000210224.54816.40; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; GAGLIARDI FM, 1993, CHILD NERV SYST, V9, P3, DOI 10.1007/BF00301925; Ge D., 2012, AFR J BIOTECHNOL, V11, P3976; Goldman SA, 2006, PHILOS T R SOC B, V361, P1463, DOI 10.1098/rstb.2006.1886; Gritti A, 1996, J NEUROSCI, V16, P1091; Harmeier JW, 1933, ARCH NEURO PSYCHIATR, V29, P308, DOI 10.1001/archneurpsyc.1933.02240080098008; Harper JM, 2004, P NATL ACAD SCI USA, V101, P7123, DOI 10.1073/pnas.0401103101; Hirano M, 2003, DEV DYNAM, V228, P664, DOI 10.1002/dvdy.10425; Horner PJ, 2000, J NEUROSCI, V20, P2218; Jha RM, 2013, NEUROSURGERY, V72, P118, DOI 10.1227/NEU.0b013e318276b445; Jordan PM, 2008, J NEUROSCI RES, V86, P35, DOI 10.1002/jnr.21460; JOYCE GF, 2005, HLTH AFF MILLWOOD S2, V24; KAMALIAN N, 1987, J NEUROL, V235, P56, DOI 10.1007/BF00314201; Kasahara K, 2006, SPINE, V31, P2059, DOI 10.1097/01.brs.0000231893.21964.f2; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015; Koeller KK, 2000, RADIOGRAPHICS, V20, P1721, DOI 10.1148/radiographics.20.6.g00nv151721; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lad Shivanand P, 2007, Neurosurg Focus, V23, pE3; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lobo MVT, 2003, J HISTOCHEM CYTOCHEM, V51, P89, DOI 10.1177/002215540305100111; Lu FL, 1998, PEDIATR NEUROL, V19, P230, DOI 10.1016/S0887-8994(98)00046-0; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; MILLER C, 1968, J COMP NEUROL, V132, P547, DOI 10.1002/cne.901320405; Mori H, 2006, J NEUROSCI RES, V84, P1682, DOI 10.1002/jnr.21082; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Ooto S, 2003, INVEST OPHTH VIS SCI, V44, P2689, DOI 10.1167/iovs.02-1168; Pagano SF, 2000, STEM CELLS, V18, P295, DOI 10.1634/stemcells.18-4-295; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Rakowicz WP, 2002, J NEUROSCI, V22, P3953, DOI 10.1523/JNEUROSCI.22-10-03953.2002; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Ren WW, 2006, NEUROL RES, V28, P87, DOI 10.1179/016164106X91933; Rethelyi M, 2004, BRAIN RES, V1028, P133, DOI 10.1016/j.brainres.2004.08.069; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roy NS, 2000, NAT MED, V6, P271; Shihabuddin LS, 1999, MOL MED TODAY, V5, P474, DOI 10.1016/S1357-4310(99)01596-8; Soundararajan P, 2006, J NEUROSCI, V26, P3256, DOI 10.1523/JNEUROSCI.5537-05.2006; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Streeter GL, 1919, AM J ANAT, V22, P1; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Suzuki M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000689; Tang Jun, 2007, Neurosci Bull, V23, P263, DOI 10.1007/s12264-007-0039-5; Tarasenko YI, 2004, J NEUROSCI RES, V78, P625, DOI 10.1002/jnr.20316; Tarlov IM, 1938, ARCH NEURO PSYCHIATR, V40, P1; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Varghese M, 2009, STEM CELLS DEV, V18, P603, DOI 10.1089/scd.2008.0144; Vugler A, 2007, MECH DEVELOP, V124, P807, DOI 10.1016/j.mod.2007.08.002; Wang TTH, 2006, NEUROREPORT, V17, P1433, DOI 10.1097/01.wnr.0000227980.06013.31; Weiss S, 1996, J NEUROSCI, V16, P7599; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yamasaki TR, 2007, J NEUROSCI, V27, P11925, DOI 10.1523/JNEUROSCI.1627-07.2007; Yasuhara T, 2006, J NEUROSCI, V26, P12497, DOI 10.1523/JNEUROSCI.3719-06.2006; Yu YQ, 2007, J NEUROL SCI, V255, P81, DOI 10.1016/j.jns.2007.01.076; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925	80	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65974	10.1371/journal.pone.0065974	http://dx.doi.org/10.1371/journal.pone.0065974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762453	gold, Green Published, Green Submitted			2022-12-25	WOS:000321099000121
J	Wild, AT; Gandhi, N; Chettiar, ST; Aziz, K; Gajula, RP; Williams, RD; Kumar, R; Taparra, K; Zeng, J; Cades, JA; Velarde, E; Menon, S; Geschwind, JF; Cosgrove, D; Pawlik, TM; Maitra, A; Wong, J; Hales, RK; Torbenson, MS; Herman, JM; Tran, PT				Wild, Aaron T.; Gandhi, Nishant; Chettiar, Sivarajan T.; Aziz, Khaled; Gajula, Rajendra P.; Williams, Russell D.; Kumar, Rachit; Taparra, Kekoa; Zeng, Jing; Cades, Jessica A.; Velarde, Esteban; Menon, Siddharth; Geschwind, Jean F.; Cosgrove, David; Pawlik, Timothy M.; Maitra, Anirban; Wong, John; Hales, Russell K.; Torbenson, Michael S.; Herman, Joseph M.; Tran, Phuoc T.			Concurrent versus Sequential Sorafenib Therapy in Combination with Radiation for Hepatocellular Carcinoma	PLOS ONE			English	Article							PHASE-II; TRANSARTERIAL CHEMOEMBOLIZATION; RAF/MEK/ERK PATHWAY; TUMOR PROGRESSION; UNITED-STATES; RAF KINASE; GROWTH; BAY-43-9006; INHIBITOR; ANGIOGENESIS	Sorafenib (SOR) is the only systemic agent known to improve survival for hepatocellular carcinoma (HCC). However, SOR prolongs survival by less than 3 months and does not alter symptomatic progression. To improve outcomes, several phase I-II trials are currently examining SOR with radiation (RT) for HCC utilizing heterogeneous concurrent and sequential treatment regimens. Our study provides preclinical data characterizing the effects of concurrent versus sequential RT-SOR on HCC cells both in vitro and in vivo. Concurrent and sequential RT-SOR regimens were tested for efficacy among 4 HCC cell lines in vitro by assessment of clonogenic survival, apoptosis, cell cycle distribution, and gamma-H2AX foci formation. Results were confirmed in vivo by evaluating tumor growth delay and performing immunofluorescence staining in a hind-flank xenograft model. In vitro, concurrent RT-SOR produced radioprotection in 3 of 4 cell lines, whereas sequential RT-SOR produced decreased colony formation among all 4. Sequential RT-SOR increased apoptosis compared to RT alone, while concurrent RT-SOR did not. Sorafenib induced reassortment into less radiosensitive phases of the cell cycle through G(1)-S delay and cell cycle slowing. More double-strand breaks (DSBs) persisted 24 h post-irradiation for RT alone versus concurrent RT-SOR. In vivo, sequential RT-SOR produced the greatest tumor growth delay, while concurrent RT-SOR was similar to RT alone. More persistent DSBs were observed in xenografts treated with sequential RT-SOR or RT alone versus concurrent RT-SOR. Sequential RT-SOR additionally produced a greater reduction in xenograft tumor vascularity and mitotic index than either concurrent RT-SOR or RT alone. In conclusion, sequential RT-SOR demonstrates greater efficacy against HCC than concurrent RT-SOR both in vitro and in vivo. These results may have implications for clinical decision-making and prospective trial design.	[Wild, Aaron T.; Gandhi, Nishant; Chettiar, Sivarajan T.; Aziz, Khaled; Gajula, Rajendra P.; Williams, Russell D.; Kumar, Rachit; Taparra, Kekoa; Zeng, Jing; Velarde, Esteban; Menon, Siddharth; Wong, John; Hales, Russell K.; Herman, Joseph M.; Tran, Phuoc T.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Cades, Jessica A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Geschwind, Jean F.] Johns Hopkins Univ, Sch Med, Dept Radiol, Baltimore, MD 21205 USA; [Cosgrove, David; Herman, Joseph M.; Tran, Phuoc T.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Pawlik, Timothy M.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Maitra, Anirban; Torbenson, Michael S.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Tran, Phuoc T.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Herman, JM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Radiat Oncol & Mol Radiat Sci, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	jherma15@jhmi.edu; tranp@jhmi.edu	Pawlik, Timothy/AAO-9335-2020; Chettiar, Sivarajan T/K-2766-2014; Aziz, Khaled/AAZ-7061-2021; Tran, Phuoc/W-2084-2019	Chettiar, Sivarajan T/0000-0002-6864-7308; Tran, Phuoc/0000-0002-0147-0376; Taparra, Kekoa/0000-0001-8493-3868	RSNA Research Medical Student Grant; National Institutes of Health (NIH) [1R01CA158100, P30 CA006973]; ASTRO; Parker B. Francis Fellowship; Phyllis and Brian L. Harvey Scholar Award from the Patrick C. Walsh Cancer Research Fund; DoD [W81XWH-11-1-0272]; NATIONAL CANCER INSTITUTE [P50CA103175, T32CA121937, R01CA158100, P30CA006973] Funding Source: NIH RePORTER	RSNA Research Medical Student Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASTRO; Parker B. Francis Fellowship; Phyllis and Brian L. Harvey Scholar Award from the Patrick C. Walsh Cancer Research Fund; DoD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	AT Wild was funded by an RSNA Research Medical Student Grant (https://www.rsna.org/Research_Medical_Student_Grant.aspx). RD Williams was a Johns Hopkins Laboratory Radiation Oncology Training Fellow (NIH-T32CA121937) (http://www.nih.gov/). J Wong was funded by the National Institutes of Health (NIH) (1R01CA158100) (http://www.nih.gov/). PT Tran was funded by an ASTRO Junior Faculty Career Research Training Award (https://www.astro.org/Research/Funding-Opportunities/ASTRO-Supported-Grants/Junior-Faculty/Index.aspx), Parker B. Francis Fellowship (http://www.francisfellowships.org/), the Phyllis and Brian L. Harvey Scholar Award from the Patrick C. Walsh Cancer Research Fund (http://prostatecancerprogram.onc.jhmi.edu/PCW/) and a DoD Cancer Physician Research Training Award (W81XWH-11-1-0272) (http://www.grants.gov/search/search.do?mode = VIEW&oppId = 88953). The Sidney Kimmel Comprehensive Cancer Center was funded by the NIH (P30 CA006973) (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Alfa GK, 2010, JAMA-J AM MED ASSOC, V304, P2154, DOI 10.1001/jama.2010.1672; ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Biade S, 1997, RADIAT RES, V147, P416, DOI 10.2307/3579497; Cao ZW, 2011, CANCER RES, V71, P2286, DOI 10.1158/0008-5472.CAN-10-3367; Chang YS, 2007, CANCER CHEMOTH PHARM, V59, P561, DOI 10.1007/s00280-006-0393-4; Chen HH, 2011, RADIAT RES, V175, P214, DOI 10.1667/RR2323.1; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Choi BI, 2010, J HEPATO-BIL-PAN SCI, V17, P369, DOI 10.1007/s00534-009-0227-y; Clark JW, 2005, CLIN CANCER RES, V11, P5472, DOI 10.1158/1078-0432.CCR-04-2658; Degos F, 2000, GUT, V47, P131, DOI 10.1136/gut.47.1.131; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; FERTIL B, 1984, RADIAT RES, V99, P73, DOI 10.2307/3576448; GERDES J, 1985, INT J CANCER, V35, P169, DOI 10.1002/ijc.2910350205; Heim M, 2005, ANTI-CANCER DRUG, V16, P129, DOI 10.1097/00001813-200502000-00003; Hill AA, 1999, INT J RADIAT BIOL, V75, P1395, DOI 10.1080/095530099139269; Hsu CH, 2010, J HEPATOL, V53, P126, DOI 10.1016/j.jhep.2010.01.035; Huynh H, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-19; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kim S, 2007, MOL CANCER THER, V6, P1785, DOI 10.1158/1535-7163.MCT-06-0595; Li QQ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-485; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; London WT, 2006, CANC EPIDEMIOLOGY PR, P763, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0039; Milas L, 2000, CLIN CANCER RES, V6, P701; Morgan MA, 2008, CLIN CANCER RES, V14, P5142, DOI 10.1158/1078-0432.CCR-07-4072; Murphy DA, 2006, AM J PATHOL, V169, P1875, DOI 10.2353/ajpath.2006.050711; Park JW, 2012, J HEPATOL, V56, P1336, DOI 10.1016/j.jhep.2012.01.006; Pawlik TM, 2011, J CLIN ONCOL, V29, P3960, DOI 10.1200/JCO.2011.37.1021; Petrini I, 2012, CANCER CHEMOTH PHARM, V69, P773, DOI 10.1007/s00280-011-1753-2; Plastaras JP, 2007, CANCER RES, V67, P9443, DOI 10.1158/0008-5472.CAN-07-1473; Plaza-Menacho I, 2007, J BIOL CHEM, V282, P29230, DOI 10.1074/jbc.M703461200; Qu XD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-263; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Sanoff Hanna K, 2011, Gastrointest Cancer Res, V4, P78; Stobbe CC, 2002, INT J RADIAT BIOL, V78, P1149, DOI 10.1080/09553000210166570; Sugimoto K, 2012, EUR RADIOL, V22, P1205, DOI 10.1007/s00330-011-2372-3; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT DAT INC SE; TERASIMA T, 1963, SCIENCE, V140, P490, DOI 10.1126/science.140.3566.490; TERASIMA T, 1961, NATURE, V190, P1210, DOI 10.1038/1901210a0; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Wong J, 2008, INT J RADIAT ONCOL, V71, P1591, DOI 10.1016/j.ijrobp.2008.04.025; Xie BR, 2012, DIGEST DIS SCI, V57, P1122, DOI 10.1007/s10620-012-2136-1; Zaidi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035436	46	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65726	10.1371/journal.pone.0065726	http://dx.doi.org/10.1371/journal.pone.0065726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762417	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000098
J	Zheng, J; Zhang, L; Zhang, JB; Wang, XX; Ye, KQ; Xi, Z; Du, Q; Liang, ZC				Zheng, Jie; Zhang, Lei; Zhang, Junbin; Wang, Xiaoxia; Ye, Keqiong; Xi, Zhen; Du, Quan; Liang, Zicai			Single modification at position 14 of siRNA strand abolishes its gene-silencing activity by decreasing both RISC loading and target degradation	FASEB JOURNAL			English	Article						RNA immunoprecipitation; AGO; computational modeling	CRYSTAL-STRUCTURE; CHEMICAL-MODIFICATIONS; MAMMALIAN-CELLS; COMPLEX; IMPROVEMENTS; THERAPEUTICS; ARGONAUTE2; RNAS; DNA	Normally siRNA has to be chemically stabilized in therapeutic applications. It is a challenge to obtain optimal stabilizing effects while maintaining full silencing activity due to a lack of understanding of how different chemical modifications would influence the efficacy of siRNA. In the current study, the effect of single 2-sugar modifications was profiled across the length of the siRNA guide strand. This led to the surprising finding that a single 2-OMe modification at position 14 of the siRNA guide strand substantially compromised its gene-silencing activity in a manner that was independent of the nucleotide identity at this site or the sequence context around it. We found that modification at position 14 of the siRNA guide strand reduced its RNA-induced silencing complex (RISC) loading tremendously, whereas the loading of the siRNA sense strand was only marginally affected. When comparing the silencing potency of 14th position-modified siRNA (transfected at 16.7 nM) and native control (transfected at 1 nM) at equivalent Ago2 loading levels, the silencing potency of modified siRNA was much lower, even lower than the level of native siRNA transfected at 0.1 nM. These data indicated that modification at position 14 of the siRNA guide strand abolishes its gene-silencing activity by decreasing both RISC loading and target degradation. Using a computational modeling approach, we demonstrated an intimate interaction between the 14th nucleotide of guide strand and the amino acid Q675 in the AGO protein, which is located in a highly conserved loop of PIWI domain. In addition to gaining insights into siRNA-AGO interactions, this study of structure-activity relationship further established a general principle for siRNA modification in siRNA drug development.Zheng, J., Zhang, L., Zhang, J., Wang, X., Ye, K., Xi, Z., Du, Q., Liang, Z. Single modification at position 14 of siRNA strand abolishes its gene-silencing activity by decreasing both RISC loading and target degradation.	[Zheng, Jie; Zhang, Lei; Wang, Xiaoxia; Du, Quan; Liang, Zicai] Peking Univ, Inst Mol Med, Sch Pharmaceut Sci, Beijing 100871, Peoples R China; [Du, Quan] Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing 100871, Peoples R China; [Zhang, Junbin; Xi, Zhen] Nankai Univ, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China; [Ye, Keqiong] Natl Inst Biol Sci, Beijing, Peoples R China	Peking University; Peking University; Nankai University; National Institute of Biological Sciences, Beijing	Liang, ZC (corresponding author), Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.	zhenxi@nankai.edu.cn; liangz@pku.edu.cn			National Natural Science Foundation of China [81273422]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [31221002]; National High-Tech R&D Program of China [2012AA022501]; National Basic Research Program of China [2011CBA01100]; National Drug Program [2011ZX09102-011-12, 2012ZX09102301-006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech R&D Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); National Drug Program	This work was supported by the National Natural Science Foundation of China (81273422), the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (31221002), the National High-Tech R&D Program of China (2012AA022501), the National Basic Research Program of China (2011CBA01100), and the National Drug Program (2011ZX09102-011-12, 2012ZX09102301-006).	Boland A, 2011, P NATL ACAD SCI USA, V108, P10466, DOI 10.1073/pnas.1103946108; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Clark PR, 2008, NUCLEIC ACIDS RES, V36, P1081, DOI 10.1093/nar/gkm630; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Dowler T, 2006, NUCLEIC ACIDS RES, V34, P1669, DOI 10.1093/nar/gkl033; Du Q, 2004, BIOCHEM BIOPH RES CO, V325, P243, DOI 10.1016/j.bbrc.2004.09.222; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Elmen J, 2005, NUCLEIC ACIDS RES, V33, P439, DOI 10.1093/nar/gki193; Hong J, 2008, BIOCHEM BIOPH RES CO, V368, P703, DOI 10.1016/j.bbrc.2008.01.116; Kraynack BA, 2006, RNA, V12, P163, DOI 10.1261/rna.2150806; Prakash TP, 2005, J MED CHEM, V48, P4247, DOI 10.1021/jm050044o; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Shukla S, 2010, CHEMMEDCHEM, V5, P328, DOI 10.1002/cmdc.200900444; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666	17	22	24	2	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4017	4026		10.1096/fj.13-228668	http://dx.doi.org/10.1096/fj.13-228668			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23771927				2022-12-25	WOS:000329747100016
J	Rout, AK; Patel, S; Somlata; Shukla, M; Saraswathi, D; Bhattacharya, A; Chary, KVR				Rout, Ashok K.; Patel, Sunita; Somlata; Shukla, Manish; Saraswathi, Deepa; Bhattacharya, Alok; Chary, Kandala V. R.			Functional Manipulation of a Calcium-binding Protein from Entamoeba histolytica Guided by Paramagnetic NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL-SHIFTS; SENSOR PROTEIN; RESONANCE ASSIGNMENTS; STRUCTURAL BASIS; C-13; CA2+; DOMAINS; SEQUENCE; DYNAMICS; H-1	EhCaBP1, one of the calcium-binding proteins from Entamoeba histolytica, is a two-domain EF-hand protein. The two domains of EhCaBP1 are structurally and functionally different from each other. However, both domains are required for structural stability and a full range of functional diversity. Analysis of sequence and structure of EhCaBP1 and other CaBPs indicates that the C-terminal domain of EhCaBP1 possesses a unique structure compared with other family members. This had been attributed to the absence of a Phe-Phe interaction between highly conserved Phe residues at the -4 position in EF-hand III (F[-4]; Tyr(81)) and at the 13th position in EF-hand IV (F[+13]; Phe(129)) of the C-terminal domain. Against this backdrop, we mutated the Tyr residue at the -4th position of EF III to the Phe residue (Y81F), to bring in the Phe-Phe interaction and understand the nature of structural and functional changes in the protein by NMR spectroscopy, molecular dynamics (MD) simulation, isothermal titration calorimetry (ITC), and biological assays, such as imaging and actin binding. The Y81F mutation in EhCaBP1 resulted in a more compact structure for the C-terminal domain of the mutant as in the case of calmodulin and troponin C. The compact structure is favored by the presence of a pi-pi interaction between Phe(81) and Phe(129) along with several hydrophobic interactions of Phe(81), which are not seen in the wild-type protein. Furthermore, the biological assays reveal preferential membrane localization of the mutant, loss of its colocalization with actin in the phagocytic cups, whereas retaining its ability to bind G- and F-actin.	[Rout, Ashok K.; Patel, Sunita; Shukla, Manish; Saraswathi, Deepa; Chary, Kandala V. R.] Tata Inst Fundamental Res, Bombay 400005, Maharashtra, India; [Patel, Sunita; Chary, Kandala V. R.] Tata Inst Fundamental Res, Ctr Interdisciplinary Sci, Hyderabad, Andhra Pradesh, India; [Somlata; Bhattacharya, Alok] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Tata Institute of Fundamental Research (TIFR); Tata Institute of Fundamental Research (TIFR); TIFR Centre for Interdisciplinary Sciences (TCIS), Hyderabad; Jawaharlal Nehru University, New Delhi	Chary, KVR (corresponding author), Tata Inst Fundamental Res, Dept Chem Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	chary@tifr.res.in		, SOMLATA/0000-0003-1928-5280; Rout, Ashok Kumar/0000-0003-1448-300X	Tata Institute of Fundamental Research (TIFR), Mumbai, India	Tata Institute of Fundamental Research (TIFR), Mumbai, India	This work was supported by the Tata Institute of Fundamental Research (TIFR), Mumbai, India.	Allegrozzi M, 2000, J AM CHEM SOC, V122, P4154, DOI 10.1021/ja993691b; Atreya HS, 2000, J BIOMOL NMR, V17, P125, DOI 10.1023/A:1008315111278; Atreya HS, 2003, PROTEIN SCI, V12, P412, DOI 10.1110/ps.0225603; Atreya HS, 2001, BIOCHEMISTRY-US, V40, P14392, DOI 10.1021/bi0114978; Barnwal RP, 2008, J BIOMOL NMR, V41, P191, DOI 10.1007/s10858-008-9254-2; Barnwal RP, 2007, J BIOMOL NMR, V39, P259, DOI 10.1007/s10858-007-9200-8; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; Bunick CG, 2004, J AM CHEM SOC, V126, P5990, DOI 10.1021/ja0397456; Chazin WJ, 2011, ACCOUNTS CHEM RES, V44, P171, DOI 10.1021/ar100110d; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P531, DOI 10.1016/0022-2836(91)90755-U; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jain R, 2008, CELL MICROBIOL, V10, P1373, DOI 10.1111/j.1462-5822.2008.01134.x; Jain R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005269; Keller RLJ, 2004, THESIS ETH ZURICH SW; Khurana B, 2002, EMBO J, V21, P5331, DOI 10.1093/emboj/cdf550; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Mohan PMK, 2008, PROTEINS, V70, P1147, DOI 10.1002/prot.21751; MONTELIONE GT, 1992, J AM CHEM SOC, V114, P10974, DOI 10.1021/ja00053a051; Mukherjee S., 2006, CALCIUM BIND PROTEIN, V2, P115; Mukherjee S, 2007, BIOCHEMISTRY-US, V46, P9911, DOI 10.1021/bi700477h; Mukherjee S, 2007, BIOCHEMISTRY-US, V46, P3835, DOI 10.1021/bi0621260; Mustafi SM, 2004, BIOCHEMISTRY-US, V43, P9320, DOI 10.1021/bi049657d; Mustafi SM, 2009, J BIOL INORG CHEM, V14, P471, DOI 10.1007/s00775-008-0463-7; Nelson MR, 1998, BIOMETALS, V11, P297, DOI 10.1023/A:1009253808876; Nelson MR, 2002, PROTEIN SCI, V11, P198, DOI 10.1110/ps.33302; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Patel S, 2008, J STRUCT BIOL, V164, P60, DOI 10.1016/j.jsb.2008.06.003; Rout AK, 2011, BIOCHEMISTRY-US, V50, P181, DOI 10.1021/bi101411q; Rout AK, 2010, MAGN RESON CHEM, V48, P793, DOI 10.1002/mrc.2664; Sahoo N, 2004, J CELL SCI, V117, P3625, DOI 10.1242/jcs.01198; Sahu SC, 1999, J BIOMOL NMR, V14, P93, DOI 10.1023/A:1008387531570; Sahu SC, 1999, FEBS LETT, V459, P51, DOI 10.1016/S0014-5793(99)01204-1; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; SKELTON NJ, 1993, J MAGN RESON SER B, V102, P253, DOI 10.1006/jmrb.1993.1095; Somlata, 2012, J BIOL CHEM, V287, P10844, DOI 10.1074/jbc.M111.308874; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; van Gunsteren W. F., 1996, GROMOS96 MANUAL USER, P1; Veeraraghavan S, 2002, J BIOL CHEM, V277, P28564, DOI 10.1074/jbc.M112232200; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Yadava N, 1997, MOL BIOCHEM PARASIT, V84, P69, DOI 10.1016/S0166-6851(96)02782-X	49	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23473	23487		10.1074/jbc.M112.411058	http://dx.doi.org/10.1074/jbc.M112.411058			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23782698	hybrid, Green Published			2022-12-25	WOS:000330598200053
J	Hannemann, H; Sung, PY; Chiu, HC; Yousuf, A; Bird, J; Lim, SP; Davidson, AD				Hannemann, Holger; Sung, Po-Yu; Chiu, Han-Chen; Yousuf, Amjad; Bird, Jim; Lim, Siew Pheng; Davidson, Andrew D.			Serotype-specific Differences in Dengue Virus Non-structural Protein 5 Nuclear Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; IMPORTIN ALPHA PROTEINS; NS5 PROTEIN; VIRAL-RNA; CRYSTAL-STRUCTURE; CELLULAR PROLIFERATION; TRANSPORT RECEPTOR; SEQUENCE-BINDING; STRUCTURAL BASIS; REPLICATION	The four serotypes of dengue virus (DENV-1 to -4) cause the most important arthropod-borne viral disease of humans. DENV non-structural protein 5 (NS5) contains enzymatic activities required for capping and replication of the viral RNA genome that occurs in the host cytoplasm. However, previous studies have shown that DENV-2 NS5 accumulates in the nucleus during infection. In this study, we examined the nuclear localization of NS5 for all four DENV serotypes. We demonstrate for the first time that there are serotypic differences in NS5 nuclear localization. Whereas the DENV-2 and -3 proteins accumulate in the nucleus, DENV-1 and -4 NS5 are predominantly if not exclusively localized to the cytoplasm. Comparative studies on the DENV-2 and -4 NS5 proteins revealed that the difference in DENV-4 NS5 nuclear localization was not due to rapid nuclear export but rather the lack of a functional nuclear localization sequence. Interaction studies using DENV-2 and -4 NS5 and human importin-alpha isoforms failed to identify an interaction that supported the differential nuclear localization of NS5. siRNA knockdown of the human importin-alpha isoform KPNA2, corresponding to the murine importin-alpha isoform previously shown to bind to DENV-2 NS5, did not substantially affect DENV-2 NS5 nuclear localization, whereas knockdown of importin-beta did. The serotypic differences in NS5 nuclear localization did not correlate with differences in IL-8 gene expression. The results show that NS5 nuclear localization is not strictly required for virus replication but is more likely to have an auxiliary function in the life cycle of specific DENV serotypes.	[Hannemann, Holger; Sung, Po-Yu; Chiu, Han-Chen; Yousuf, Amjad; Bird, Jim; Davidson, Andrew D.] Univ Bristol, Fac Med & Vet Sci, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Yousuf, Amjad] Taif Univ, Coll Med, At Taif 21944, Saudi Arabia; [Lim, Siew Pheng] Novartis Inst Trop Dis, Singapore 138670, Singapore	University of Bristol; Taif University; Novartis	Davidson, AD (corresponding author), Univ Bristol, Fac Med & Vet Sci, Sch Cellular & Mol Med, Univ Walk, Bristol BS8 1TD, Avon, England.	andrew.davidson@bristol.ac.uk	Yousuf, Amjad/AGZ-4356-2022; Pheng, Lim Siew/AAG-4368-2021; Lim, Siew Pheng/P-8528-2016	Yousuf, Amjad/0000-0003-2573-8645; Pheng, Lim Siew/0000-0002-7377-5662; 	Medical Research Council [G0801973]; MRC [G0801973] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0801973 (to A. D. D.).	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007; Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08; Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005; Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; CHU PWG, 1992, ARCH VIROL, V125, P177, DOI 10.1007/BF01309636; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Depping R, 2008, BBA-MOL CELL RES, V1783, P394, DOI 10.1016/j.bbamcr.2007.12.006; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Fontes MRM, 2003, BIOCHEM J, V375, P339, DOI 10.1042/BJ20030510; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Forwood JK, 1999, BIOCHEM BIOPH RES CO, V257, P731, DOI 10.1006/bbrc.1999.0370; Friedrich B, 2006, MOL CELL BIOL, V26, P8697, DOI 10.1128/MCB.00708-06; Fulcher AJ, 2011, BBA-MOL CELL RES, V1813, P2176, DOI 10.1016/j.bbamcr.2011.03.019; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hanley KA, 2002, J VIROL, V76, P525, DOI 10.1128/JVI.76.2.525-531.2002; Iglesias NG, 2011, J VIROL, V85, P5745, DOI 10.1128/JVI.02343-10; Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709; Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]; Kohler M, 2002, CELL PHYSIOL BIOCHEM, V12, P335; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kroschewski H, 2008, J BIOL CHEM, V283, P19410, DOI 10.1074/jbc.M800613200; Kumar A, 2013, J VIROL, V87, P4545, DOI 10.1128/JVI.03083-12; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09; Le Breton M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-234; Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Mackenzie JM, 2007, J GEN VIROL, V88, P1163, DOI 10.1099/vir.0.82552-0; Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Marfori M, 2012, TRAFFIC, V13, P532, DOI 10.1111/j.1600-0854.2012.01329.x; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Mason DA, 2009, J MOL EVOL, V68, P351, DOI 10.1007/s00239-009-9215-8; Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847; Medin CL, 2005, J VIROL, V79, P11053, DOI 10.1128/JVI.79.17.11053-11061.2005; Melen K, 2003, J BIOL CHEM, V278, P28193, DOI 10.1074/jbc.M303571200; Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200; Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x; Pryor MJ, 2001, AM J TROP MED HYG, V65, P427, DOI 10.4269/ajtmh.2001.65.427; Quensel C, 2004, MOL CELL BIOL, V24, P10246, DOI 10.1128/MCB.24.23.10246-10255.2004; Rawlinson SM, 2009, J BIOL CHEM, V284, P15589, DOI 10.1074/jbc.M808271200; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Reid SP, 2007, J VIROL, V81, P13469, DOI 10.1128/JVI.01097-07; Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05; Resch W, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-65; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandrock K, 2010, TRAFFIC, V11, P198, DOI 10.1111/j.1600-0854.2009.01015.x; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Sinnecker D, 2005, BIOCHEMISTRY-US, V44, P7085, DOI 10.1021/bi047881x; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Taylor RT, 2011, CELL HOST MICROBE, V10, P185, DOI 10.1016/j.chom.2011.08.004; Taylor SL, 2009, J VIROL, V83, P1271, DOI 10.1128/JVI.00986-08; Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200; Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Werme K, 2008, CELL MICROBIOL, V10, P696, DOI 10.1111/j.1462-5822.2007.01076.x; Williams BJL, 2005, BIOCHEM J, V387, P295, DOI 10.1042/BJ20041223; World Health Organization, 2009, DENGUE GUIDELINES DI; Yang SNY, 2010, J BIOL CHEM, V285, P19935, DOI 10.1074/jbc.M109.079574; Yap LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012836; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06	73	61	62	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22621	22635		10.1074/jbc.M113.481382	http://dx.doi.org/10.1074/jbc.M113.481382			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23770669	Green Published, hybrid			2022-12-25	WOS:000330596300042
J	Ong, EC; Nesin, V; Long, CL; Bai, CX; Guz, JL; Ivanov, IP; Abramowitz, J; Birnbaumer, L; Humphrey, MB; Tsiokas, L				Ong, E-Ching; Nesin, Vasyl; Long, Courtney L.; Bai, Chang-Xi; Guz, Jan L.; Ivanov, Ivaylo P.; Abramowitz, Joel; Birnbaumer, Lutz; Humphrey, Mary Beth; Tsiokas, Leonidas			A TRPC1 Protein-dependent Pathway Regulates Osteoclast Formation and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRAC CHANNEL; TERMINAL DIFFERENTIATION; ION SELECTIVITY; CA2+ SENSOR; STORE; STIM1; ORAI1; ACTIVATION; INFLUX; IDENTIFICATION	Ca2+ signaling is essential for bone homeostasis and skeletal development. Here, we show that the transient receptor potential canonical 1 (TRPC1) channel and the inhibitor of MyoD family, I-mfa, function antagonistically in the regulation of osteoclastogenesis. I-mfa null mice have an osteopenic phenotype characterized by increased osteoclast numbers and surface, which are normalized in mice lacking both Trpc1 and I-mfa. In vitro differentiation of pre-osteoclasts derived from I-mfa-deficient mice leads to an increased number of mature osteoclasts and higher bone resorption per osteoclast. These parameters return to normal levels in osteoclasts derived from double mutant mice. Consistently, whole cell currents activated in response to the depletion of intracellular Ca2+ stores are larger in pre-osteoclasts derived from I-mfa knock-out mice compared with currents in wild type mice and normalized in cells derived from double mutant mice, suggesting a cell-autonomous effect of I-mfa on TRPC1 in these cells. A new splice variant of TRPC1 (TRPC1 epsilon) was identified in early pre-osteoclasts. Heterologous expression of TRPC1 epsilon in HEK293 cells revealed that it is unique among all known TRPC1 isoforms in its ability to amplify the activity of the Ca2+ release-activated Ca2+ (CRAC) channel, mediating store-operated currents. TRPC1 epsilon physically interacts with Orai1, the pore-forming subunit of the CRAC channel, and I-mfa is recruited to the TRPC1 epsilon-Orai1 complex through TRPC1 epsilon suppressing CRAC channel activity. We propose that the positive and negative modulation of the CRAC channel by TRPC1 epsilon and I-mfa, respectively, fine-tunes the dynamic range of the CRAC channel regulating osteoclastogenesis.	[Ong, E-Ching; Nesin, Vasyl; Bai, Chang-Xi; Guz, Jan L.; Tsiokas, Leonidas] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73014 USA; [Long, Courtney L.; Humphrey, Mary Beth] Univ Oklahoma, Hlth Sci Ctr, Dept Med Rheumatol, Oklahoma City, OK 73014 USA; [Ivanov, Ivaylo P.] Natl Univ Ireland Univ Coll Cork, BioSci Inst, Cork, Ireland; [Ivanov, Ivaylo P.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Abramowitz, Joel; Birnbaumer, Lutz] NIEHS, Neurobiol Lab, Div Intramural Res, NIH,Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Humphrey, Mary Beth] Vet Affairs Med Ctr, Oklahoma City, OK 73014 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University College Cork; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Oklahoma System; University of Oklahoma Health Sciences Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Tsiokas, L (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 975 NE 10th St, Oklahoma City, OK 73014 USA.	ltsiokas@ouhsc.edu	Abramowitz, Joel/A-2620-2015	Tsiokas, Leonidas/0000-0002-3659-1813; Ivanov, Ivaylo/0000-0002-4793-5466; Ivanov, Ivaylo/0000-0002-6008-3261	National Institutes of Health Intramural Research Program from NIEHS [Z01 ES101684]; NIDDK [DE019398NIDCR, R01DK59599]; Oklahoma Center for Adult Stem Cells;  [P20GM103639];  [P20GM104934NIGMS]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101643, ZIAES101684] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program from NIEHS; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Oklahoma Center for Adult Stem Cells; ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program Project Z01 ES101684 from NIEHS (to L. B.), Grant DE019398NIDCR (to M. B. H.), Grant R01DK59599 from NIDDK, and Grants P20GM103639 and P20GM104934NIGMS (to L. T.). This work was also supported by the Oklahoma Center for Adult Stem Cells.	Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Chen CMA, 1996, CELL, V86, P731, DOI 10.1016/S0092-8674(00)80148-8; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Dietrich A, 2007, PFLUG ARCH EUR J PHY, V455, P465, DOI 10.1007/s00424-007-0314-3; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Hwang SY, 2012, FASEB J, V26, P1484, DOI 10.1096/fj.11-194399; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Kajiya H, 2010, CELL CALCIUM, V48, P260, DOI 10.1016/j.ceca.2010.09.010; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kraut N, 1998, EMBO J, V17, P6276, DOI 10.1093/emboj/17.21.6276; Kusano S, 2002, MOL CELL BIOL, V22, P6393, DOI 10.1128/MCB.22.18.6393-6405.2002; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Ma R, 2003, J BIOL CHEM, V278, P52763, DOI 10.1074/jbc.M309610200; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Pan WJ, 2005, P NATL ACAD SCI USA, V102, P17378, DOI 10.1073/pnas.0505922102; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Robinson LJ, 2012, LAB INVEST, V92, P1071, DOI 10.1038/labinvest.2012.72; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sakura H, 1997, DIABETOLOGIA, V40, P528, DOI 10.1007/s001250050711; Scrimgeour N, 2009, J PHYSIOL-LONDON, V587, P2903, DOI 10.1113/jphysiol.2009.170662; Shi J, 2012, FASEB J, V26, P409, DOI 10.1096/fj.11-185611; Singh BB, 2002, MOL CELL, V9, P739, DOI 10.1016/S1097-2765(02)00506-3; Snider L, 2005, MOL CELL BIOL, V25, P5061, DOI 10.1128/MCB.25.12.5061-5072.2005; Snider L, 2001, MOL CELL BIOL, V21, P1866, DOI 10.1128/MCB.21.5.1866-1873.2001; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; van der Eerden BCJ, 2005, P NATL ACAD SCI USA, V102, P17507, DOI 10.1073/pnas.0505789102; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou YD, 2011, J CELL PHYSIOL, V226, P1082, DOI 10.1002/jcp.22423	58	46	48	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22219	22232		10.1074/jbc.M113.459826	http://dx.doi.org/10.1074/jbc.M113.459826			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23770672	Green Published, hybrid			2022-12-25	WOS:000330596300005
J	Riley, LM; Weadge, JT; Baker, P; Robinson, H; Codee, JDC; Tipton, PA; Ohman, DE; Howell, PL				Riley, Laura M.; Weadge, Joel T.; Baker, Perrin; Robinson, Howard; Codee, Jeroen D. C.; Tipton, Peter A.; Ohman, Dennis E.; Howell, P. Lynne			Structural and Functional Characterization of Pseudomonas aeruginosa AlgX ROLE OF AlgX IN ALGINATE ACETYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHETIC GENE-CLUSTER; BIOFILM FORMATION; EXTRACELLULAR POLYSACCHARIDES; ACETYLPEPTIDOGLYCAN ESTERASE; EVOLUTIONARY CONSERVATION; INDUCED DISPERSION; PROTEIN-STRUCTURE; ACTIVE-SITE; IDENTIFICATION; SEQUENCE	The exopolysaccharide alginate, produced by mucoid Pseudomonas aeruginosa in the lungs of cystic fibrosis patients, undergoes two different chemical modifications as it is synthesized that alter the properties of the polymer and hence the biofilm. One modification, acetylation, causes the cells in the biofilm to adhere better to lung epithelium, form microcolonies, and resist the effects of the host immune system and/or antibiotics. Alginate biosynthesis requires 12 proteins encoded by the algD operon, including AlgX, and although this protein is essential for polymer production, its exact role is unknown. In this study, we present the X-ray crystal structure of AlgX at 2.15 angstrom resolution. The structure reveals that AlgX is a two-domain protein, with an N-terminal domain with structural homology to members of the SGNH hydrolase superfamily and a C-terminal carbohydrate-binding module. A number of residues in the carbohydrate-binding module form a substrate recognition "pinch point" that we propose aids in alginate binding and orientation. Although the topology of the N-terminal domain deviates from canonical SGNH hydrolases, the residues that constitute the Ser-His-Asp catalytic triad characteristic of this family are structurally conserved. In vivo studies reveal that site-specific mutation of these residues results in non-acetylated alginate. This catalytic triad is also required for acetylesterase activity in vitro. Our data suggest that not only does AlgX protect the polymer as it passages through the periplasm but that it also plays a role in alginate acetylation. Our results provide the first structural insight for a wide group of closely related bacterial polysaccharide acetyltransferases.	[Howell, P. Lynne] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Robinson, Howard] Brookhaven Natl Lab, Photon Sci Div, Upton, NY 11973 USA; [Codee, Jeroen D. C.] Leiden Univ, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; [Tipton, Peter A.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Ohman, Dennis E.] Virginia Commonwealth Univ, Med Ctr, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Ohman, Dennis E.] Virginia Commonwealth Univ, Med Ctr, McGuire Vet Affairs Med Ctr, Richmond, VA 23298 USA; [Howell, P. Lynne] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); United States Department of Energy (DOE); Brookhaven National Laboratory; Leiden University; Leiden University - Excl LUMC; University of Missouri System; University of Missouri Columbia; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; University of Toronto	Howell, PL (corresponding author), Hosp Sick Children, Program Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	howell@sickkids.ca			United States Department of Energy Office of Biological and Environmental Research; National Institutes of Health National Center for Research Resources; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI019146, R01AI019146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081419] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000477] Funding Source: NIH RePORTER	United States Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank Yura Lobsanov, Francis Wolfram, Dustin J. Little, Jason Koo, John C. C. Whitney, and G. David Smith for helpful discussions and Patrick Yip for technical assistance. National Synchrotron Light Source beamline X29 is supported by the United States Department of Energy Office of Biological and Environmental Research and the National Institutes of Health National Center for Research Resources.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bernard E, 2011, J BIOL CHEM, V286, P23950, DOI 10.1074/jbc.M111.241414; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cerca N, 2007, INFECT IMMUN, V75, P3406, DOI 10.1128/IAI.00078-07; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chibba A, 2012, ORG BIOMOL CHEM, V10, P7103, DOI 10.1039/c2ob26105g; CHITNIS CE, 1990, J BACTERIOL, V172, P2894, DOI 10.1128/jb.172.6.2894-2900.1990; CHITNIS CE, 1993, MOL MICROBIOL, V8, P583, DOI 10.1111/j.1365-2958.1993.tb01602.x; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Codee JDC, 2009, J ORG CHEM, V74, P38, DOI 10.1021/jo8020192; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; Damron FH, 2011, J BACTERIOL, V193, P286, DOI 10.1128/JB.01132-10; DARZINS A, 1985, J BACTERIOL, V164, P516, DOI 10.1128/JB.164.2.516-524.1985; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Douthit SA, 2005, J BACTERIOL, V187, P4573, DOI 10.1128/JB.187.13.4573-4583.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS LR, 1973, J BACTERIOL, V116, P915, DOI 10.1128/JB.116.2.915-924.1973; Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167; FRANKLIN MJ, 1993, J BACTERIOL, V175, P5057, DOI 10.1128/JB.175.16.5057-5065.1993; Franklin MJ, 2004, J BACTERIOL, V186, P4759, DOI 10.1128/JB.186.14.4759-4773.2004; FRANKLIN MJ, 1994, J BACTERIOL, V176, P1821, DOI 10.1128/JB.176.7.1821-1830.1994; Franklin MJ, 2002, J BACTERIOL, V184, P3000, DOI 10.1128/JB.184.11.3000-3007.2002; Franklin MJ, 1996, J BACTERIOL, V178, P2186, DOI 10.1128/jb.178.8.2186-2195.1996; GACESA P, 1988, CARBOHYD POLYM, V8, P161, DOI 10.1016/0144-8617(88)90001-X; Ghafoor A, 2011, APPL ENVIRON MICROB, V77, P5238, DOI 10.1128/AEM.00637-11; Gjermansen M, 2010, MOL MICROBIOL, V75, P815, DOI 10.1111/j.1365-2958.2009.06793.x; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; GRASDALEN H, 1979, CARBOHYD RES, V68, P23, DOI 10.1016/S0008-6215(00)84051-3; GRASDALEN H, 1983, CARBOHYD RES, V118, P255, DOI 10.1016/0008-6215(83)88053-7; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Gutsche J, 2006, BIOCHIMIE, V88, P245, DOI 10.1016/j.biochi.2005.06.003; Hashimoto H, 2006, CELL MOL LIFE SCI, V63, P2954, DOI 10.1007/s00018-006-6195-3; Hay ID, 2012, APPL MICROBIOL BIOT, V93, P215, DOI 10.1007/s00253-011-3430-0; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; HESTRIN S, 1949, J BIOL CHEM, V180, P249; Hoiby N, 2001, MICROBES INFECT, V3, P23, DOI 10.1016/S1286-4579(00)01349-6; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; HOLLOWAY BW, 1969, BACTERIOL REV, V33, P419, DOI 10.1128/MMBR.33.3.419-443.1969; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Jain S, 2003, MOL MICROBIOL, V47, P1123, DOI 10.1046/j.1365-2958.2003.03361.x; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KNUTSON CA, 1968, ANAL BIOCHEM, V24, P470, DOI 10.1016/0003-2697(68)90154-1; Koo J, 2008, J BACTERIOL, V190, P6961, DOI 10.1128/JB.00996-08; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lee JE, 2001, STRUCTURE, V9, P941, DOI 10.1016/S0969-2126(01)00656-6; Li ZH, 2005, JAMA-J AM MED ASSOC, V293, P581, DOI 10.1001/jama.293.5.581; LINKER A, 1966, J BIOL CHEM, V241, P3845; Ma JM, 2011, PROTEINS, V79, P662, DOI 10.1002/prot.22865; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMullen TWP, 2000, PROTEIN ENG, V13, P865, DOI 10.1093/protein/13.12.865; Montanier C, 2009, PLOS BIOL, V7, P687, DOI 10.1371/journal.pbio.1000071; Moynihan PJ, 2010, J BIOL CHEM, V285, P13264, DOI 10.1074/jbc.M110.107086; Nivens DE, 2001, J BACTERIOL, V183, P1047, DOI 10.1128/JB.183.3.1047-1057.2001; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Pearson WR, 1996, METHOD ENZYMOL, V266, P227; Pfeffer JM, 2013, J BIOL CHEM, V288, P2605, DOI 10.1074/jbc.M112.436352; Pickens LB, 2011, J BIOL CHEM, V286, P41539, DOI 10.1074/jbc.M111.299859; Pier GB, 2001, INFECT IMMUN, V69, P1895, DOI 10.1128/IAI.69.3.1895-1901.2001; Reina JJ, 2007, J EXP BOT, V58, P2717, DOI 10.1093/jxb/erm136; ROBERTSON DL, 1994, J BIOL CHEM, V269, P2146; Robles-Price A, 2004, J BACTERIOL, V186, P7369, DOI 10.1128/JB.186.21.7369-7377.2004; SALAMITOU S, 1994, J BACTERIOL, V176, P2828, DOI 10.1128/JB.176.10.2828-2834.1994; Sauer K, 2004, J BACTERIOL, V186, P7312, DOI 10.1128/JB.186.21.7312-7326.2004; SHINABARGER D, 1993, MOL MICROBIOL, V9, P1027, DOI 10.1111/j.1365-2958.1993.tb01232.x; Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x; Suh SJ, 2004, J MICROBIOL METH, V58, P203, DOI 10.1016/j.mimet.2004.03.018; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Teutschbein J, 2010, J BIOL CHEM, V285, P38374, DOI 10.1074/jbc.M110.171637; Tielen P, 2005, MICROBIOL RES, V160, P165, DOI 10.1016/j.micres.2004.11.003; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Weadge JT, 2010, ACTA CRYSTALLOGR F, V66, P588, DOI 10.1107/S1744309110011851; Weadge JT, 2006, BIOCHEMISTRY-US, V45, P839, DOI 10.1021/bi051679s; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Wood LF, 2006, J BACTERIOL, V188, P3134, DOI 10.1128/JB.188.8.3134-3137.2006; Wood LF, 2006, MOL MICROBIOL, V62, P412, DOI 10.1111/j.1365-2958.2006.05390.x; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086	94	40	43	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22299	22314		10.1074/jbc.M113.484931	http://dx.doi.org/10.1074/jbc.M113.484931			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23779107	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000330596300012
J	Rabus, M; Sollradl, T; Clausen-Schaumann, H; Laforsch, C				Rabus, Max; Soellradl, Thomas; Clausen-Schaumann, Hauke; Laforsch, Christian			Uncovering Ultrastructural Defences in Daphnia magna - An Interdisciplinary Approach to Assess the Predator-Induced Fortification of the Carapace	PLOS ONE			English	Article							INDUCIBLE DEFENSES; MORPHOLOGICAL DEFENSES; PHENOTYPIC PLASTICITY; WATERBORNE CUES; RESPONSES; PLANKTON; ELASTICITY; INDUCTION; ECOLOGY; BIOLOGY	The development of structural defences, such as the fortification of shells or exoskeletons, is a widespread strategy to reduce predator attack efficiency. In unpredictable environments these defences may be more pronounced in the presence of a predator. The cladoceran Daphnia magna (Crustacea: Branchiopoda: Cladocera) has been shown to develop a bulky morphotype as an effective inducible morphological defence against the predatory tadpole shrimp Triops cancriformis (Crustacea: Branchiopoda: Notostraca). Mediated by kairomones, the daphnids express an increased body length, width and an elongated tail spine. Here we examined whether these large scale morphological defences are accompanied by additional ultrastructural defences, i.e. a fortification of the exoskeleton. We employed atomic force microscopy (AFM) based nanoindentation experiments to assess the cuticle hardness along with tapping mode AFM imaging to visualise the surface morphology for predator exposed and non-predator exposed daphnids. We used semi-thin sections of the carapace to measure the cuticle thickness, and finally, we used fluorescence microscopy to analyse the diameter of the pillars connecting the two carapace layers. We found that D. magna indeed expresses ultrastructural defences against Triops predation. The cuticle in predator exposed individuals is approximately five times harder and two times thicker than in control daphnids. Moreover, the pillar diameter is significantly increased in predator exposed daphnids. These predator-cue induced changes in the carapace architecture should provide effective protection against being crushed by the predator's mouthparts and may add to the protective effect of bulkiness. This study highlights the potential of interdisciplinary studies to uncover new and relevant aspects even in extensively studied fields of research.	[Rabus, Max] Ludwig Maximilians Univ Munchen, Dept Biol 2, Munich, Germany; [Rabus, Max; Laforsch, Christian] Univ Bayreuth, Dept Anim Ecol 1, Bayreuth, Germany; [Soellradl, Thomas; Clausen-Schaumann, Hauke] Univ Appl Sci Munich, Dept Precis & Microengn Engn Phys, Munich, Germany; [Clausen-Schaumann, Hauke] Ludwig Maximilians Univ Munchen, Ctr NanoSci, Munich, Germany; [Laforsch, Christian] Ludwig Maximilians Univ Munchen, Geo Bio Ctr, Munich, Germany	University of Munich; University of Bayreuth; University of Munich; University of Munich	Rabus, M (corresponding author), Ludwig Maximilians Univ Munchen, Dept Biol 2, Munich, Germany.	rabus@bio.lmu.de	Clausen-Schaumann, Hauke/W-1830-2017	Clausen-Schaumann, Hauke/0000-0002-9413-0310	Universitat Bayern e.V.; German Excellence Initiative via the "Nanosystems Initiative Munich (NIM)"; ESF; DFG [LA 2159/6-1]	Universitat Bayern e.V.; German Excellence Initiative via the "Nanosystems Initiative Munich (NIM)"; ESF(European Commission); DFG(German Research Foundation (DFG))	MR was funded by a research scholarschip awarded by the Universitat Bayern e.V. http://www.unibayern.de/ TS and HCS were funded by the German Excellence Initiative via the "Nanosystems Initiative Munich (NIM)". http://www.nano-initiative-munich.de/en/ CL was funded by the ESF (project "stressflea") and the DFG (project LA 2159/6-1). www.esf.org/www.dfg.de/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BG, 1933, BIOL BULL-US, V64, P70, DOI 10.2307/1537501; Auld JR, 2011, EVOL ECOL, V25, P189, DOI 10.1007/s10682-010-9394-1; Barry MJ, 2000, OECOLOGIA, V124, P396, DOI 10.1007/s004420000420; Beyer MK, 2005, CHEM REV, V105, P2921, DOI 10.1021/cr030697h; BILODEAU GG, 1992, J APPL MECH-T ASME, V59, P519, DOI 10.1115/1.2893754; BLACK AR, 1990, OECOLOGIA, V83, P117, DOI 10.1007/BF00324642; BRONMARK C, 1992, SCIENCE, V258, P1348, DOI 10.1126/science.258.5086.1348; Bronmark C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021773; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Clausen-Schaumann H, 2000, CURR OPIN CHEM BIOL, V4, P524, DOI 10.1016/S1367-5931(00)00126-5; Clausen-Schaumann H, 2000, BIOPHYS J, V78, P1997, DOI 10.1016/S0006-3495(00)76747-6; Docheva D, 2008, J CELL MOL MED, V12, P537, DOI 10.1111/j.1582-4934.2007.00138.x; Docheva D, 2010, BIOCHEM BIOPH RES CO, V402, P361, DOI 10.1016/j.bbrc.2010.10.034; DODSON SI, 1984, ECOLOGY, V65, P1249, DOI 10.2307/1938331; DODSON SI, 1974, LIMNOL OCEANOGR, V19, P721, DOI 10.4319/lo.1974.19.5.0721; Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006; Flenner I, 2009, ECOL ENTOMOL, V34, P735, DOI 10.1111/j.1365-2311.2009.01129.x; FRYER G, 1988, PHILOS T ROY SOC B, V321, P27, DOI 10.1098/rstb.1988.0091; GILBERT JJ, 1966, SCIENCE, V151, P1234, DOI 10.1126/science.151.3715.1234; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Grandbois M, 1998, BIOPHYS J, V74, P2398, DOI 10.1016/S0006-3495(98)77948-2; GRANT JWG, 1981, LIMNOL OCEANOGR, V26, P201, DOI 10.4319/lo.1981.26.2.0201; Harvell CD, 1999, ECOLOGY EVOLUTION IN; HAVEL JE, 1985, HYDROBIOLOGIA, V124, P141, DOI 10.1007/BF00006796; HAVEL JE, 1984, LIMNOL OCEANOGR, V29, P487, DOI 10.4319/lo.1984.29.3.0487; HEBERT PDN, 1985, LIMNOL OCEANOGR, V30, P1291, DOI 10.4319/lo.1985.30.6.1291; Kerfoot W. C., 1987, PREDATION DIRECT IND; Kishida O, 2010, POPUL ECOL, V52, P37, DOI 10.1007/s10144-009-0182-0; KRUEGER DA, 1981, LIMNOL OCEANOGR, V26, P219, DOI 10.4319/lo.1981.26.2.0219; Laforsch C, 2004, P NATL ACAD SCI USA, V101, P15911, DOI 10.1073/pnas.0404860101; Laforsch C, 2004, ECOLOGY, V85, P2302, DOI 10.1890/03-0286; Laforsch C, 2000, ARCH HYDROBIOL, V149, P587; Laforsch C, 2009, ENCY INLAND WATERS, P643; LAMPERT W, 1989, FUNCT ECOL, V3, P21, DOI 10.2307/2389671; Lampert W, 2011, DAPHNIA DEV MODEL OR, P5; Lass S, 2003, HYDROBIOLOGIA, V491, P221, DOI 10.1023/A:1024487804497; Leonard GH, 1999, ECOLOGY, V80, P1; Lively CM, 2000, ECOLOGY, V81, P1240, DOI 10.1890/0012-9658(2000)081[1240:PIDVFI]2.0.CO;2; Lord JP, 2012, MAR BIOL, V159, P1177, DOI 10.1007/s00227-012-1896-7; Petrusek A, 2009, P NATL ACAD SCI USA, V106, P2248, DOI 10.1073/pnas.0808075106; Pijanowska J, 1997, FRESHWATER BIOL, V37, P649, DOI 10.1046/j.1365-2427.1997.00192.x; Rabus M, 2012, J PLANKTON RES, V34, P152, DOI 10.1093/plankt/fbr092; Rabus M, 2011, FUNCT ECOL, V25, P1137, DOI 10.1111/j.1365-2435.2011.01840.x; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1999, NAT STRUCT BIOL, V6, P346; Riessen HP, 2012, P NATL ACAD SCI USA, V109, P15377, DOI 10.1073/pnas.1209938109; Riessen HP, 2009, ECOLOGY, V90, P3455, DOI 10.1890/08-1652.1; Schmidt SW, 2012, ACS NANO, V6, P1314, DOI 10.1021/nn204111w; Seda J, 2011, J LIMNOL, V70, P337, DOI 10.4081/jlimnol.2011.337; Selden R, 2009, MAR BIOL, V156, P1057, DOI 10.1007/s00227-009-1150-0; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Spaak Piet, 1997, Aquatic Ecology, V31, P89, DOI 10.1023/A:1009935100804; Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/nnano.2008.410, 10.1038/NNANO.2008.410]; TALBOT P, 1972, TISSUE CELL, V4, P613, DOI 10.1016/S0040-8166(72)80034-X; TOLLRIAN R, 1994, ARCH HYDROBIOL, V130, P69; Tollrian R, 1999, ENCY ECOLOGY; Trussell GC, 2002, ECOLOGY, V83, P1635, DOI 10.2307/3071984; Trussell GC, 1996, EVOLUTION, V50, P448, DOI 10.1111/j.1558-5646.1996.tb04507.x; WEIDER LJ, 1993, OIKOS, V67, P385, DOI 10.2307/3545351	60	32	33	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e67856	10.1371/journal.pone.0067856	http://dx.doi.org/10.1371/journal.pone.0067856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776711	gold, Green Published, Green Submitted			2022-12-25	WOS:000320322400127
J	Zajac, RN; Vozarik, JM; Gibbons, BR				Zajac, Roman N.; Vozarik, Joseph M.; Gibbons, Brittney R.			Spatial and Temporal Patterns in Macrofaunal Diversity Components Relative to Sea Floor Landscape Structure	PLOS ONE			English	Article							LONG-ISLAND SOUND; SPECIES-DIVERSITY; BETA-DIVERSITY; MARINE BIODIVERSITY; ALPHA-DIVERSITY; DEEP-SEA; BENTHIC COMMUNITIES; CONTINENTAL-SHELF; HABITAT STRUCTURE; SCALES	We examined temporal changes in macrofaunal alpha- and beta-diversity over several spatial scales (within patches, among patches, across landscapes and across regions) in Long Island Sound on the northeast USA coast. Regional epsilon-diversity was estimated at 144 taxa, however gamma-diversity fluctuated over time as did alpha- and beta-diversity components. Based on additive partitioning, patch-and region-scale beta-diversity components generally had the highest contributions to gamma-diversity; lower percentages were found at within-patch and landscape scales. Multiplicative diversity partitioning indicated highest species turnover at within-and among patch scales. For all partition results, within-patch and patch-scale beta-diversity increased sharply when hypoxia impacted benthic communities. Spatial variation in diversity components can be attributed to the collection of different patch types at varying spatial scales and their associated habitats across the benthic landscapes, as well as gradients in depth and other estuarine-scale characteristics. Temporal variation in diversity components across spatial scales may be related to seasonal changes in habitat heterogeneity, species population dynamics, and seasonal disturbances. Rare species were significant and temporally consistent components of macrofaunal diversity patterns over different spatial scales. Our findings agree with other marine and terrestrial studies that show diversity components vary significantly over different spatial scales and the importance of habitat/landscape heterogeneity in supporting diversity. However, our results indicate that the relative contributions of scale-specific beta-diversity components can also change significantly over time. Thus, studies of diversity patterns across patches and landscapes based on data collected at one time, or assembled into a single data set from different times, may not capture the full suite of diversity patterns that occur over varying spatial scales and any time-specific determinants of those patterns. Many factors that shape and maintain sedimentary communities vary temporally, and appear to play an important role in determining and maintaining macrofaunal diversity over different spatial scales.	[Zajac, Roman N.; Gibbons, Brittney R.] Univ New Haven, Dept Biol & Environm Sci, West Haven, CT USA; [Vozarik, Joseph M.] Millstone Power Stn, Millstone Environm Lab, Waterford, CT USA	University New Haven	Zajac, RN (corresponding author), Univ New Haven, Dept Biol & Environm Sci, West Haven, CT USA.	rzajac@newhaven.edu			Connecticut Department of Environmental Protection; Long Island Sound Research Fund [CWF-317-R]; University of New Haven	Connecticut Department of Environmental Protection; Long Island Sound Research Fund; University of New Haven	This work was supported, in part, by the Connecticut Department of Environmental Protection, Long Island Sound Research Fund Grant CWF-317-R and a University of New Haven Research Award to R.N. Zajac; additional funding was provided by the University of New Haven for graduate student assistantships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belmaker J, 2008, ECOLOGY, V89, P2829, DOI 10.1890/07-1464.1; Bevilacqua S, 2012, ECOL INDIC, V18, P140, DOI 10.1016/j.ecolind.2011.11.006; Capriulo GM, 2002, HYDROBIOLOGIA, V475, P263, DOI 10.1023/A:1020387325081; Colwell RK, 2013, ESTIMATES STAT ESTIM; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Crist TO, 2006, ECOL LETT, V9, P923, DOI 10.1111/j.1461-0248.2006.00941.x; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; DAYTON PK, 1972, DEEP-SEA RES, V19, P199, DOI 10.1016/0011-7471(72)90031-9; Declerck SAJ, 2011, ECOGRAPHY, V34, P296, DOI 10.1111/j.1600-0587.2010.06462.x; DOBBS FC, 1983, MAR ECOL PROG SER, V11, P273, DOI 10.3354/meps011273; Ellingsen KE, 2007, J SEA RES, V58, P291, DOI 10.1016/j.seares.2007.10.001; Ellingsen KE, 2002, MAR ECOL PROG SER, V232, P15, DOI 10.3354/meps232015; Ellingsen KE, 2002, J ANIM ECOL, V71, P373, DOI 10.1046/j.1365-2656.2002.00606.x; Ellingsen KE, 2001, MAR ECOL PROG SER, V218, P1, DOI 10.3354/meps218001; Ellis J. I., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P57, DOI 10.1023/A:1009923530894; Eros T, 2007, FRESHWATER BIOL, V52, P1400, DOI 10.1111/j.1365-2427.2007.01777.x; ETTER RJ, 1992, NATURE, V360, P576, DOI 10.1038/360576a0; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Gabriel D, 2006, ECOL APPL, V16, P2011, DOI 10.1890/1051-0761(2006)016[2011:BDADSS]2.0.CO;2; Gering JC, 2003, CONSERV BIOL, V17, P488, DOI 10.1046/j.1523-1739.2003.01465.x; Golodets C, 2011, J APPL ECOL, V48, P1260, DOI 10.1111/j.1365-2664.2011.02031.x; Gossner MM, 2011, LANDSCAPE ECOL, V26, P411, DOI 10.1007/s10980-010-9568-9; GRASSLE JF, 1992, AM NAT, V139, P313, DOI 10.1086/285329; Gray JS, 2001, SCI MAR, V65, P41, DOI 10.3989/scimar.2001.65s241; Gray JS, 2002, MAR ECOL PROG SER, V244, P285, DOI 10.3354/meps244285; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; Harris PT, 2012, ELSEV INSIGHT, P1; Hewitt JE, 2005, ECOLOGY, V86, P1619, DOI 10.1890/04-1099; Hewitt JE, 2004, ECOL APPL, V14, P1203, DOI 10.1890/03-5177; Hirao T, 2007, ECOL ENTOMOL, V32, P627, DOI 10.1111/j.1365-2311.2007.00913.x; Josefson AB, 2009, MAR ECOL PROG SER, V396, P283, DOI 10.3354/meps08375; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kostylev V., 2007, SPEC PAP GEOL ASS CA, V47, P171; Kraufvelin P, 2011, MAR ECOL PROG SER, V426, P13, DOI 10.3354/meps09038; Levin LA, 2001, ECOSYSTEMS, V4, P430, DOI 10.1007/s10021-001-0021-4; MAY RM, 1994, PHILOS T R SOC B, V343, P105, DOI 10.1098/rstb.1994.0014; O'Dor R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011871; Rodriguez D, 2011, J ARID ENVIRON, V75, P424, DOI 10.1016/j.jaridenv.2010.12.007; Rodriguez-Zaragoza FA, 2008, CARIBB J SCI, V44, P90; Sala E, 2006, ANNU REV ENV RESOUR, V31, P93, DOI 10.1146/annurev.energy.31.020105.100235; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Schlacher TA, 1998, MAR ECOL PROG SER, V174, P159, DOI 10.3354/meps174159; Signell RP, 2000, J COASTAL RES, V16, P551; Snelgrove PVR, 2002, OCEANOGR MAR BIOL, V40, P311; Snelgrove PVR, 1999, BIOSCIENCE, V49, P129, DOI 10.2307/1313538; Snelgrove PVR, 2000, BIOSCIENCE, V50, P1076, DOI 10.1641/0006-3568(2000)050[1076:LBAABT]2.0.CO;2; Stendera SES, 2005, FRESHWATER BIOL, V50, P1360, DOI 10.1111/j.1365-2427.2005.01403.x; Stireman JO, 2008, ANN ENTOMOL SOC AM, V101, P362, DOI 10.1603/0013-8746(2008)101[362:ADOATP]2.0.CO;2; Summerville KS, 2003, CONSERV BIOL, V17, P1045, DOI 10.1046/j.1523-1739.2003.02059.x; Thrush SF, 2001, MAR ECOL PROG SER, V221, P255, DOI 10.3354/meps221255; Thrush SF, 2006, ECOL APPL, V16, P1636, DOI 10.1890/1051-0761(2006)016[1636:PTEOHH]2.0.CO;2; Thrush SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011899; Twichell DC, 1997, GEOLOGIC INVESTIGATI; Twichell DC, 1998, GEOLOGIC INVESTIGATI; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Veech JA., 2009, PARTITION SOFTWARE H; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Witman JD, 2004, P NATL ACAD SCI USA, V101, P15664, DOI 10.1073/pnas.0404300101; Zajac RN, 2003, LIMNOL OCEANOGR, V48, P829, DOI 10.4319/lo.2003.48.2.0829; Zajac RN, 2000, J COASTAL RES, V16, P627; Zajac RN, 1999, NATO ASI 2, V59, P211; ZAJAC RN, 1998, SPATIAL TEMPORAL CHA; Zajac RN, 2008, J EXP MAR BIOL ECOL, V366, P198, DOI 10.1016/j.jembe.2008.07.025; Zvuloni A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009941	65	32	32	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65823	10.1371/journal.pone.0065823	http://dx.doi.org/10.1371/journal.pone.0065823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776552	Green Published, gold			2022-12-25	WOS:000320322400058
J	Huang, L; Zhang, QY; Li, SQ; Guan, LP; Xiao, XS; Zhang, JG; Jia, XY; Sun, WM; Zhu, ZH; Gao, Y; Yin, Y; Wang, PF; Guo, XM; Wang, J; Zhang, QJ				Huang, Li; Zhang, Qingyan; Li, Shiqiang; Guan, Liping; Xiao, Xueshan; Zhang, Jianguo; Jia, Xiaoyun; Sun, Wenmin; Zhu, Zhihong; Gao, Yang; Yin, Ye; Wang, Panfeng; Guo, Xiangming; Wang, Jun; Zhang, Qingjiong			Exome Sequencing of 47 Chinese Families with Cone-Rod Dystrophy: Mutations in 25 Known Causative Genes	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT CONE; RECESSIVE RETINAL DYSTROPHIES; GUANYLATE-CYCLASE; JAPANESE FAMILY; HOMEOBOX GENE; ABCA4 GENE; VARIANTS; PHOTORECEPTOR; GUCA1A; IDENTIFICATION	Objective: The goal of this study was to identify mutations in 25 known causative genes in 47 unrelated Chinese families with cone-rod dystrophy (CORD). Methods: Forty-seven probands from unrelated families with CORD were recruited. Genomic DNA prepared from leukocytes was analyzed by whole exome sequencing. Variants in the 25 genes were selected and then validated by Sanger sequencing. Results: Fourteen potential pathogenic mutations, including nine novel and five known, were identified in 10 of the 47 families (21.28%). Homozygous, compound heterozygous, and hemizygous mutations were detected in three, four, or three families, respectively. The 14 mutations in the 10 families were distributed among CNGB3 (three families), PDE6C (two families), ABCA4 (one family), RPGRIP1 (one family), RPGR (two families), and CACNA1F (one family). Conclusions: This study provides a brief view on mutation spectrum of the 25 genes in a Chinese cohort with CORD. Identification of novel mutations enriched our understanding of variations in these genes and their associated phenotypes. To our knowledge, this is the first systemic exome-sequencing analysis of all of the 25 CORD-associated genes.	[Huang, Li; Li, Shiqiang; Xiao, Xueshan; Jia, Xiaoyun; Sun, Wenmin; Gao, Yang; Wang, Panfeng; Guo, Xiangming; Zhang, Qingjiong] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Qingyan; Guan, Liping; Zhang, Jianguo; Zhu, Zhihong; Yin, Ye; Wang, Jun] BGI Shenzhen, Shenzhen, Guangdong, Peoples R China	Sun Yat Sen University; Beijing Genomics Institute (BGI)	Wang, J (corresponding author), BGI Shenzhen, Shenzhen, Guangdong, Peoples R China.	wangj@genomics.cn; zhangqji@mail.sysu.edu.cn	Zhang, Qingjiong/AAR-6331-2021; Wang, Jun/A-7261-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Zhang, Qingjiong/0000-0001-7508-848X; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	National Natural Science Foundation of China [81170881, U1201221]; Guangdong Translational Medicine Public Platform; Sun Yat-sen University; Fundamental Research Funds of the State Key Laboratory of Ophthalmology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Translational Medicine Public Platform; Sun Yat-sen University; Fundamental Research Funds of the State Key Laboratory of Ophthalmology	This study was supported by the National Natural Science Foundation of China (81170881, U1201221, http://www.nsfc.gov.cn/Portal0/default152.htm), Guangdong Translational Medicine Public Platform, the "985 project" of Sun Yat-sen University, and the Fundamental Research Funds of the State Key Laboratory of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid A, 2006, J MED GENET, V43, P378, DOI 10.1136/jmg.2005.035055; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; den Dunnen JT, 2000, HUM MUTAT, V15, P7; den Hollander AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258; Ducroq D, 2002, AM J HUM GENET, V71, P1480, DOI 10.1086/344829; Estrada-Cuzcano A, 2012, AM J HUM GENET, V90, P102, DOI 10.1016/j.ajhg.2011.11.015; Fishman GA, 2003, ARCH OPHTHALMOL-CHIC, V121, P851, DOI 10.1001/archopht.121.6.851; Fishman GA, 1997, OPHTHALMOLOGY, V104, P299, DOI 10.1016/S0161-6420(97)30320-0; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Garcia-Hoyos M, 2011, MOL VIS, V17, P1103; Hameed A, 2003, J MED GENET, V40, P616, DOI 10.1136/jmg.40.8.616; Huang L, 2013, MOL MED REP, V7, P1779, DOI 10.3892/mmr.2013.1415; Huang L, 2013, NEUROSCI LETT, V541, P179, DOI 10.1016/j.neulet.2013.02.013; Huang L, 2012, BIOCHEM BIOPH RES CO, V426, P498, DOI 10.1016/j.bbrc.2012.08.110; Ito S, 2004, INVEST OPHTH VIS SCI, V45, P1480, DOI 10.1167/iovs.03-0315; Jalkanen R, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.040741; Kelsell RE, 1998, AM J HUM GENET, V63, P274, DOI 10.1086/301905; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; Kitiratschky VBD, 2009, HUM MUTAT, V30, pE782, DOI 10.1002/humu.21055; Kobayashi A, 2000, INVEST OPHTH VIS SCI, V41, P3268; Kohl S, 2012, ADV EXP MED BIOL, V723, P337, DOI 10.1007/978-1-4614-0631-0_44; Kohn L, 2007, EUR J HUM GENET, V15, P664, DOI 10.1038/sj.ejhg.5201817; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019458; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li YR, 2010, NAT GENET, V42, P969, DOI 10.1038/ng.680; Littink KW, 2010, INVEST OPHTH VIS SCI, V51, P5943, DOI 10.1167/iovs.10-5797; Maugeri A, 2000, AM J HUM GENET, V67, P960, DOI 10.1086/303079; Michaelides M, 2004, INVEST OPHTH VIS SCI, V45, P1975, DOI 10.1167/iovs.03-0898; Ostergaard E, 2010, J MED GENET, V47, P665, DOI 10.1136/jmg.2009.069120; Parry DA, 2009, AM J HUM GENET, V84, P683, DOI 10.1016/j.ajhg.2009.04.005; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rozen S, 2000, Methods Mol Biol, V132, P365; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sohocki MM, 2000, MOL GENET METAB, V70, P142, DOI 10.1006/mgme.2000.3001; Thiadens AAHJ, 2012, OPHTHALMOLOGY, V119, P819, DOI 10.1016/j.ophtha.2011.10.011; Thiadens AAHJ, 2009, AM J HUM GENET, V85, P240, DOI 10.1016/j.ajhg.2009.06.016; Wada Y, 2001, ARCH OPHTHALMOL-CHIC, V119, P1059, DOI 10.1001/archopht.119.7.1059; Wang Q, 2010, MOL VIS, V16, P303; Wang QL, 2004, HUM MOL GENET, V13, P1025, DOI 10.1093/hmg/ddh117; Wu HM, 2006, AM J HUM GENET, V79, P574, DOI 10.1086/507568; Wycisk KA, 2006, INVEST OPHTH VIS SCI, V47, P3523, DOI 10.1167/iovs.06-0271; Xiao XS, 2011, MOL VIS, V17, P3271; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Yesim F, 2002, AM J HUM GENET, V70, P1049, DOI 10.1086/339620	50	43	43	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65546	10.1371/journal.pone.0065546	http://dx.doi.org/10.1371/journal.pone.0065546			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776498	gold, Green Submitted, Green Published			2022-12-25	WOS:000320755400040
J	Knap, N; Avsic-Zupanc, T				Knap, Natasa; Avsic-Zupanc, Tatjana			Correlation of TBE Incidence with Red Deer and Roe Deer Abundance in Slovenia	PLOS ONE			English	Article							TICK-BORNE ENCEPHALITIS; IXODES-RICINUS TICKS; GEOGRAPHICAL-DISTRIBUTION; RISK-ASSESSMENT; LYME-DISEASE; VIRUS; DENSITY; ACARI; INFESTATION; PREVALENCE	Tick-borne encephalitis (TBE) is a virus infection which sometimes causes human disease. The TBE virus is found in ticks and certain vertebrate tick hosts in restricted endemic localities termed TBE foci. The formation of natural foci is a combination of several factors: the vectors, a suitable and numerous enough number of hosts and in a habitat with suitable vegetation and climate. The present study investigated the influence of deer on the incidence of tick-borne encephalitis. We were able to obtain data from deer culls. Using this data, the abundance of deer was estimated and temporal and spatial analysis was performed. The abundance of deer has increased in the past decades, as well as the incidence of tick-borne encephalitis. Temporal analysis confirmed a correlation between red deer abundance and tick-borne encephalitis occurrence. Additionally, spatial analysis established, that in areas with high incidence of tick-borne encephalitis red deer density is higher, compared to areas with no or few human cases of tick-borne encephalitis. However, such correlation could not be confirmed between roe deer density and the incidence of tick-borne encephalitis. This is presumably due to roe deer density being above a certain threshold so that availability of tick reproduction hosts has no apparent effect on ticks' host finding and consequently may not be possible to correlate with incidence of human TBE.	[Knap, Natasa; Avsic-Zupanc, Tatjana] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia	University of Ljubljana	Avsic-Zupanc, T (corresponding author), Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia.	tatjana.avsic@mf.uni-lj.si		Knap, Natasa/0000-0002-8068-7302; AVSIC ZUPANC, TATJANA/0000-0001-6243-0688	EU [GOCE-2003-010284 EDEN]; Ministry of Higher Education, Science and Sport of Slovenia [P3-0083]	EU(European Commission); Ministry of Higher Education, Science and Sport of Slovenia	This study was partially funded by EU grant GOCE-2003-010284 EDEN and by the Ministry of Higher Education, Science and Sport of Slovenia (grant no. P3-0083). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achazi K, 2011, VECTOR-BORNE ZOONOT, V11, P641, DOI 10.1089/vbz.2010.0236; Adamic M, 1990, THESIS BELGRADE U; Brinkley C, 2008, INT J MED MICROBIOL, V298, P73, DOI 10.1016/j.ijmm.2007.12.005; Brokera M, 2008, VACCINE, V26, P863, DOI 10.1016/j.vaccine.2007.11.046; Cagnacci F, 2012, INT J PARASITOL, V42, P365, DOI 10.1016/j.ijpara.2012.02.012; Carpi G, 2008, EPIDEMIOL INFECT, V136, P1416, DOI 10.1017/S0950268807000039; Cernac J, 2004, LOV LOVCI SKOZI CAS; Daniel M, 2003, EUR J CLIN MICROBIOL, V22, P327, DOI 10.1007/s10096-003-0918-2; Daniel M, 2006, INT J MED MICROBIOL, V296, P41, DOI 10.1016/j.ijmm.2006.02.008; Danielova V, 2010, VECTOR-BORNE ZOONOT, V10, P223, DOI 10.1089/vbz.2009.0020; Dobson ADM, 2011, J APPL ECOL, V48, P1029, DOI 10.1111/j.1365-2664.2011.02004.x; GRAY JS, 1992, J MED ENTOMOL, V29, P915, DOI 10.1093/jmedent/29.6.915; Hartemink NA, 2008, AM NAT, V171, P743, DOI 10.1086/587530; Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024; Hudson PJ, 2001, MED VET ENTOMOL, V15, P304, DOI 10.1046/j.0269-283x.2001.00317.x; Jaaskelainen AE, 2011, EMERG INFECT DIS, V17, P323, DOI 10.3201/eid1702.101487; JAENSON TGT, 1994, J MED ENTOMOL, V31, P240, DOI 10.1093/jmedent/31.2.240; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-184; Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-8; Jaenson TGT, 2011, TICKS TICK-BORNE DIS, V2, P44, DOI 10.1016/j.ttbdis.2010.10.006; Jensen PM, 2000, SCAND J INFECT DIS, V32, P545, DOI 10.1080/003655400458857; Jordan RA, 2007, J MED ENTOMOL, V44, P752, DOI 10.1603/0022-2585(2007)44[752:EORDDO]2.0.CO;2; Kiffner C, 2012, MED VET ENTOMOL, V26, P18, DOI 10.1111/j.1365-2915.2011.00961.x; Kiffner C, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-42; Knap N, 2012, VECTOR-BORNE ZOONOT, V12, P236, DOI 10.1089/vbz.2011.0728; Knap N, 2009, VET PARASITOL, V164, P275, DOI 10.1016/j.vetpar.2009.06.001; KOZUCH O, 1981, ACTA VIROL, V25, P219; Krech T, 2002, INT J MED MICROBIOL, V291, P30, DOI 10.1016/S1438-4221(02)80006-6; Krystufek B., 1991, SESALCI SLOVENIJE; Labuda M, 1997, VIROLOGY, V235, P138, DOI 10.1006/viro.1997.8622; Labuda M, 2002, INT J MED MICROBIOL, V291, P43, DOI 10.1016/S1438-4221(02)80008-X; Labuda M, 1996, VIROLOGY, V219, P357, DOI 10.1006/viro.1996.0261; LABUDA M, 1993, EXPERIENTIA, V49, P802, DOI 10.1007/BF01923553; Lindgren E, 2001, LANCET, V358, P16, DOI 10.1016/S0140-6736(00)05250-8; Medlock JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-1; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Perkins SE, 2006, ECOLOGY, V87, P1981, DOI 10.1890/0012-9658(2006)87[1981:LDALTT]2.0.CO;2; Perkins SE, 2003, INT J PARASITOL, V33, P909, DOI 10.1016/S0020-7519(03)00128-0; Pugliese A, 2008, PARASITOLOGY, V135, P1531, DOI 10.1017/S003118200800036X; Rand PW, 2003, J MED ENTOMOL, V40, P179, DOI 10.1603/0022-2585-40.2.179; Randolph S, 2001, LANCET, V358, P1731, DOI 10.1016/S0140-6736(01)06754-X; Randolph SE, 2008, MICROBES INFECT, V10, P209, DOI 10.1016/j.micinf.2007.12.005; Randolph SE, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-44; Randolph SE, 1996, PARASITOL TODAY, V12, P472, DOI 10.1016/S0169-4758(96)10072-7; Randolph SE, 2000, PARASITOLOGY, V121, P15, DOI 10.1017/S0031182099006083; Rizzoli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004336; Sumilo D, 2009, CLIN MICROBIOL INFEC, V15, P75, DOI 10.1111/j.1469-0691.2008.02121.x; Sumilo D, 2008, REV MED VIROL; Sumilo D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000500; Suss J, 2008, Euro Surveill, V13; Suss J, 2003, VACCINE, V21, pS19, DOI 10.1016/S0264-410X(02)00812-5; Talleklint L, 1997, EXP APPL ACAROL, V21, P755, DOI 10.1023/A:1018473122070; Talleklint L, 1996, J MED ENTOMOL, V33, P805, DOI 10.1093/jmedent/33.5.805; Tonteri E, 2011, EMERG INFECT DIS, V17, P72, DOI 10.3201/eid1701.100051; Vor T, 2010, EXP APPL ACAROL, V51, P405, DOI 10.1007/s10493-010-9337-0	55	17	17	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66380	10.1371/journal.pone.0066380	http://dx.doi.org/10.1371/journal.pone.0066380			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776668	gold, Green Published, Green Submitted			2022-12-25	WOS:000320755400143
J	Liu, D; Okwor, I; Mou, ZR; Beverley, SM; Uzonna, JE				Liu, Dong; Okwor, Ifeoma; Mou, Zhirong; Beverley, Stephen M.; Uzonna, Jude E.			Deficiency of Leishmania Phosphoglycans Influences the Magnitude but Does Not Affect the Quality of Secondary (Memory) Anti-Leishmania Immunity	PLOS ONE			English	Article							INTERFERON-GAMMA; CUTANEOUS LEISHMANIASIS; PROTECTIVE IMMUNITY; T-CELLS; MICE; VACCINATION; VACCINES; IMMUNIZATION; RESISTANCE; VIRULENCE	Despite inducing very low IFN-gamma response and highly attenuated in vivo, infection of mice with phosphoglycan (PG) deficient Leishmania major (lpg2-) induces protection against virulent L. major challenge. Here, we show that mice infected with lpg2-L. major generate Leishmania-specific memory T cells. However, in vitro and in vivo proliferation, IL-10 and IFN-gamma production by lpg2- induced memory cells were impaired in comparison to those induced by wild type (WT) parasites. Interestingly, TNF recall response was comparable to WT infected mice. Despite the impaired proliferation and IFN-gamma response, lpg2- infected mice were protected against virulent L. major challenge and their T cells mediated efficient infection-induced immunity. In vivo depletion and neutralization studies with mAbs demonstrated that lpg2-L. major-induced resistance was strongly dependent on IFN-gamma, but independent of TNF and CD8(+) T cells. Collectively, these data show that the effectiveness of secondary anti-Leishmania immunity depends on the quality (and not the magnitude) of IFN-gamma response. These observations provide further support for consideration of lpg2-L. major as a live-attenuated candidate for leishmanization in humans since it protects strongly against virulent challenge, without inducing pathology in infected animals.	[Liu, Dong; Mou, Zhirong; Uzonna, Jude E.] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Okwor, Ifeoma; Uzonna, Jude E.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Beverley, Stephen M.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	University of Manitoba; University of Manitoba; Washington University (WUSTL)	Uzonna, JE (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.	uzonna@cc.umanitoba.ca		Okwor, Ifeoma/0000-0003-0297-3589; Beverley, Stephen/0000-0001-5319-0811	Canadian Institutes of Health Research; Manitoba Health Research Council; National Institutes of Health (NIH) [AI31078]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031078] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Manitoba Health Research Council; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided by the Canadian Institutes of Health Research and the Manitoba Health Research Council (JU) and National Institutes of Health (NIH) AI31078 (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 1998, J IMMUNOL, V161, P6794; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Amante FH, 2010, J IMMUNOL, V185, P3632, DOI 10.4049/jimmunol.1000944; Anderson CF, 2005, J IMMUNOL, V174, P2934, DOI 10.4049/jimmunol.174.5.2934; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Belkaid Y, 2001, J EXP MED, V194, P1497, DOI 10.1084/jem.194.10.1497; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Brodskyn C, 2000, CLIN EXP IMMUNOL, V119, P299, DOI 10.1046/j.1365-2249.2000.01122.x; Capul AA, 2007, INFECT IMMUN; Capul AA, 2007, J BIOL CHEM, V282, P14006, DOI 10.1074/jbc.M610869200; Chakravarty J, 2010, J GLOB INFECT DIS, V2, P167, DOI 10.4103/0974-777X.62887; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; GREENBLATT CL, 1988, PARASITOL TODAY, V4, P53, DOI 10.1016/0169-4758(88)90067-1; Handman E, 2008, ADV EXP MED BIOL, V625, P48, DOI 10.1007/978-0-387-77570-8_5; HUANG CC, 1993, J BIOL CHEM, V268, P24060; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kebaier C, 2006, INFECT IMMUN, V74, P777, DOI 10.1128/IAI.74.1.777-780.2006; Kedzierski L, 2006, PARASITOLOGY, V133, pS87, DOI 10.1017/S0031182006001831; Khamesipour A, 2005, VACCINE, V23, P3642, DOI 10.1016/j.vaccine.2005.02.015; Korner H, 2010, INT J PARASITOL, V40, P879, DOI 10.1016/j.ijpara.2010.03.011; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; LIEW FY, 1991, IMMUNOLOGY, V74, P304; Liu D, 2010, J IMMUNOL, V184, P3098, DOI 10.4049/jimmunol.0903177; Liu D, 2009, J IMMUNOL, V183, P1921, DOI 10.4049/jimmunol.0901099; Liu D, 2009, INFECT IMMUN, V77, P3272, DOI 10.1128/IAI.01447-08; LOCKSLEY RM, 1991, IMMUNOPARASITOL TOD, pA58, DOI 10.1016/S0167-5699(05)80017-9; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Markey KA, 2010, BLOOD, V115, P122, DOI 10.1182/blood-2009-01-199927; MULLER I, 1993, INFECT IMMUN, V61, P3730; Okwor I, 2009, HUM VACCINES, V5, P291, DOI 10.4161/hv.5.5.7607; Puig L, 2003, ANN TROP MED PARASIT, V97, P107, DOI 10.1179/000349803225002589; REINER SL, 1995, CURR OPIN IMMUNOL, V7, P360, DOI 10.1016/0952-7915(95)80111-1; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Scott P, 2004, IMMUNOL REV, V201, P318, DOI 10.1111/j.0105-2896.2004.00198.x; SCOTT P, 1987, J IMMUNOL, V139, P221; Selvapandiyan A, 2006, INDIAN J MED RES, V123, P455; Singer SM, 2000, J INFECT DIS, V181, P1510, DOI 10.1086/315409; Singh N, 2006, INDIAN J MED RES, V123, P411; Spath GF, 2000, P NATL ACAD SCI USA, V97, P9258, DOI 10.1073/pnas.160257897; Spath GF, 2004, INFECT IMMUN, V72, P3622, DOI 10.1128/IAI.72.6.3622-3627.2004; Spath GF, 2003, SCIENCE, V301, P1241, DOI 10.1126/science.1087499; TITUS RG, 1989, J EXP MED, V170, P2097, DOI 10.1084/jem.170.6.2097; TITUS RG, 1995, P NATL ACAD SCI USA, V92, P10267, DOI 10.1073/pnas.92.22.10267; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; Uzonna JE, 2004, J EXP MED, V199, P1559, DOI 10.1084/jem.20040172; Uzonna JE, 2004, J IMMUNOL, V172, P3793, DOI 10.4049/jimmunol.172.6.3793; Uzonna JE, 2001, J IMMUNOL, V167, P6967, DOI 10.4049/jimmunol.167.12.6967; WANG ZE, 1994, J EXP MED, V179, P1367, DOI 10.1084/jem.179.4.1367	50	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66058	10.1371/journal.pone.0066058	http://dx.doi.org/10.1371/journal.pone.0066058			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776605	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400106
J	Millet, JP; Shaw, E; Orcau, A; Casals, M; Miro, JM; Cayla, JA				Millet, Juan-Pablo; Shaw, Evelyn; Orcau, Angels; Casals, Marti; Miro, Jose M.; Cayla, Joan A.		Barcelona TB Recurrence Working Gr	Tuberculosis Recurrence after Completion Treatment in a European City: Reinfection or Relapse?	PLOS ONE			English	Article							EXOGENOUS REINFECTION; RISK-FACTORS; HIV-INFECTION; UNITED-STATES; EPIDEMIOLOGY; COHORT	Background: Tuberculosis (TB) recurrence can be due to reinfection or relapse. The contribution of each to TB incidence and the factors associated with recurrence are not well known. Effectiveness of TB control programs is assessed in part by recurrence rates. The aim of this study was to establish the recurrence rate of TB in Barcelona, the associated risk factors and the role of reinfection. Methods: A population-based retrospective longitudinal study was performed in Barcelona, Spain. TB patients with positive culture results who completed treatment between Jan 1st, 2003 and Dec 31st, 2006 were followed-up until December 31st, 2009 by the TB Control Program. The incidence rate of recurrence was calculated per person-year of follow-up (py). Kaplan-Meier and Cox regression methods were used for the survival analysis by calculating the hazard ratio (HR) with 95% confidence intervals (CI). Results: Of the 1,823 TB cases identified, 971 fulfilled the inclusion criteria and 13 (1.3%) had recurrent TB. The recurrence rate was 341 cases per 100,000 py, 13 times higher than the TB incidence of the general population. Likelihood of TB recurrence at the 1st, 3rd and 5th year of follow-up was 0.1%, 1.4% and 1.6%, respectively. Factors associated with recurrence were HIV infection (HR: 4.7, CI: 1.4-15.7), living in the inner city district (HR: 3.9, CI: 1.3-11.8) and history of TB treatment (HR: 5.2, CI: 1.7-16.2). Genotyping results of recurrent cases were available for 6 patients (3 reinfections and 3 relapses). Conclusion: The rate of TB recurrence in Barcelona is low and most episodes occur within the first three years. Patients at higher risk of recurrence are co-infected with HIV, living in neighborhoods with high TB incidence or with a history of TB treatment. When available, genotyping results help determine whether the recurrence is due to reinfection or relapse.	[Millet, Juan-Pablo; Shaw, Evelyn; Orcau, Angels; Casals, Marti; Cayla, Joan A.] Publ Hlth Agcy Barcelona, Epidemiol Serv, Barcelona, Spain; [Millet, Juan-Pablo; Orcau, Angels; Casals, Marti; Cayla, Joan A.] CIBER Epidemiol & Salud Publ, Barcelona, Spain; [Millet, Juan-Pablo] Univ Autonoma Barcelona, Dept Pediat Ginecol & Med Prevent, E-08193 Barcelona, Spain; [Casals, Marti] Univ Barcelona, Dept Salut Publ, Barcelona, Spain; [Casals, Marti] Univ Int Catalunya, Dept Ciencies Basiques, Barcelona, Spain; [Miro, Jose M.] Hosp Clin Univ IDIBAPS Barcelona, Infect Dis Serv, Barcelona, Spain	Public Health Agency of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Barcelona; University of Barcelona; Universitat Internacional de Catalunya (UIC); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Millet, JP (corresponding author), Publ Hlth Agcy Barcelona, Epidemiol Serv, Barcelona, Spain.	jmillet@aspb.es	Casals, Martí/M-8388-2019; Fernández, María Teresa Tórtola/ABC-8046-2020	Casals, Martí/0000-0002-1775-8331; Fernández, María Teresa Tórtola/0000-0002-9188-298X; Cayla, Joan A./0000-0003-3891-111X; Coll, Pere/0000-0003-1782-9782; Shaw, Evelyn/0000-0002-1882-1259; Millet, Joan Pau/0000-0003-0200-2459; de Souza Galvao, Maria Luiza/0000-0001-9703-989X; Tudo, Griselda/0000-0002-9241-7051	CIBER de Epidemiologia y Salud Publica, (CIBERESP), Spain	CIBER de Epidemiologia y Salud Publica, (CIBERESP), Spain	This work was supported by CIBER de Epidemiologia y Salud Publica, (CIBERESP), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bandera A, 2001, J CLIN MICROBIOL, V39, P2213, DOI 10.1128/JCM.39.6.2213-2218.2001; Bang D, 2010, INT J TUBERC LUNG D, V14, P447; Borrell S, 2009, J CLIN MICROBIOL, V47, P198, DOI 10.1128/JCM.00507-08; Cacho J, 2007, EUR RESPIR J, V30, P333, DOI 10.1183/09031936.00005107; Caminero JA, 2001, AM J RESP CRIT CARE, V163, P717, DOI 10.1164/ajrccm.163.3.2003070; CDC, 2009, REP TUB US; Charalambous S, 2008, INT J TUBERC LUNG D, V12, P942; Crofts JP, 2010, THORAX, V65, P310, DOI 10.1136/thx.2009.124677; Dobler CC, 2009, EUR RESPIR J, V33, P160, DOI 10.1183/09031936.00104108; Ospina JE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-158; [European Center for Disease Prevention and Control (ECDC) WHO], 2012, TUB SURV MON EUR; Faustini A, 2005, EUR RESPIR J, V26, P503, DOI 10.1183/09031936.05.00103504; Fine PEM, 1999, NEW ENGL J MED, V341, P1226, DOI 10.1056/NEJM199910143411609; Garcia de Viedma D, 2002, ARCH INTERN MED, V162, P1873, DOI 10.1001/archinte.162.16.1873; Grp de Trabajo de TB de las Soc Ci, 2009, ARCH BRONCONEUMOL, V45, P139, DOI 10.1016/j.arbres.2009.01.001; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P1360, DOI 10.1164/rccm.200408-1081OC; Kim L, 2013, INT J TUBERC LUNG D, V17, P357, DOI 10.5588/ijtld.12.0640; Millet JP, 2009, J EPIDEMIOL COMMUN H, V63, P799, DOI 10.1136/jech.2008.077560; Millet JP, 2013, ENFERM INFEC MICR CL, V31, P227, DOI 10.1016/j.eimc.2012.08.008; Narayanan S, 2010, J INFECT DIS, V201, P691, DOI 10.1086/650528; Orcau A, 2010, TUBERCULOSIS BARCELO; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; Pettit AC, 2011, INT J TUBERC LUNG D, V15, P906, DOI 10.5588/ijtld.10.0448; Pfyffer GE, 2003, J CLIN MICROBIOL; Poblacio i demografia, 2009, AN EST CIUT BARC 200; Shen GM, 2006, EMERG INFECT DIS, V12, P1776, DOI 10.3201/eid1211.051207; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Supply PC, 2006, J CLIN MICROBIOL; Supply PE, 2000, MOL MICROBIOL, P36762; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC; World Health Organization, 2003, TREATM TUB GUID NAT	34	53	56	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e64898	10.1371/journal.pone.0064898	http://dx.doi.org/10.1371/journal.pone.0064898			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776440	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400009
J	Singh, AN; Singh, S; Dubey, VK				Singh, Abhay Narayan; Singh, Sushant; Dubey, Vikash Kumar			Immobilization of Procerain B, a Cysteine Endopeptidase, on Amberlite MB-150 Beads	PLOS ONE			English	Article							ENZYMES; PROTEASES; LATEX; WATER	Proteases are involved in several crucial biological processes and reported to have important physiological functions. They also have multifarious applications in different industries. The immobilized form of the enzyme further improves its industrial applicability. Here, we report covalent immobilization of a novel cysteine endopeptidase (procerain B) on amberlite MB-150 beads through glutaraldehyde by Schiff base linkage. The immobilized product was examined extensively by Fourier Transform Infrared Spectroscopy (FTIR), Scanning electron microscopy (SEM) and Energy Dispersive X-ray (EDX) analysis. The characterization of the immobilized product showed broader pH and thermal optima compared to the soluble form of the enzyme. The immobilized form of procerain B also showed lower Km (180.27 +/- 6 mu M) compared to the soluble enzyme using azocasein as substrate. Further, immobilized procerain B retains 38.6% activity till the 10th use, which strongly represents its industrial candidature.	[Singh, Abhay Narayan; Dubey, Vikash Kumar] Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India; [Singh, Sushant; Dubey, Vikash Kumar] Indian Inst Technol Guwahati, Ctr Environm, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Dubey, VK (corresponding author), Indian Inst Technol Guwahati, Dept Biotechnol, Gauhati, Assam, India.	vdubey@iitg.ernet.in	Dubey, Vikash Kumar/B-3542-2008; Singh, Sushant/AAP-3860-2020; Singh, Sushant/AAQ-7930-2021	Dubey, Vikash Kumar/0000-0002-4281-2504; Singh, Sushant/0000-0002-0858-4405; NARAYAN SINGH, ABHAY/0000-0001-6875-9775; Dubey, Vikash Kumar/0000-0002-3870-2660	Indian Institute of Technology Guwahati	Indian Institute of Technology Guwahati	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Department of Biotechnology, Government of India in the form of infrastructure; Indian Institute of Technology Guwahati for research fellowship to ANS and SS.	Anwar A., 2009, WORLD APPL SCI J, V7, P1281; Ashie INA, 2002, J FOOD SCI, V67, P2138, DOI 10.1111/j.1365-2621.2002.tb09516.x; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Bernholdt HF, 1975, ENZYMES FOOD PROCESS, P473; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao LQ, 2000, ORG LETT, V2, P1361, DOI 10.1021/ol005593x; Dubey VK, 2007, AFR J BIOTECHNOL, V6, P1077; Dubey VK, 2003, PHYTOCHEMISTRY, V62, P1057, DOI 10.1016/S0031-9422(02)00676-3; Duran N, 2000, APPL CATAL B-ENVIRON, V28, P83, DOI 10.1016/S0926-3373(00)00168-5; Dwevedi A, 2009, BIORESOURCE TECHNOL, V100, P2667, DOI 10.1016/j.biortech.2008.12.048; FALCH EA, 1991, BIOTECHNOL ADV, V9, P643, DOI 10.1016/0734-9750(91)90736-F; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; Katchalski-Katzir E, 2000, J MOL CATAL B-ENZYM, V10, P157, DOI 10.1016/S1381-1177(00)00124-7; Khan A. A., 2010, RES J BIOL SCI, V5, P565, DOI DOI 10.3923/rjbsci.2010.565.575; Kirk O, 2002, CURR OPIN BIOTECH, V13, P345, DOI 10.1016/S0958-1669(02)00328-2; KLIBANOV AM, 1983, SCIENCE, V219, P722, DOI 10.1126/science.219.4585.722; Krajewska B, 2004, ENZYME MICROB TECH, V35, P126, DOI 10.1016/j.enzmictec.2003.12.013; Kumar S, 2001, J ETHNOPHARMACOL, V76, P115, DOI 10.1016/S0378-8741(01)00219-7; Lalonde J., 2008, ENZYME CATALYSIS ORG; LYONS TP, 1982, BIOCHEM SOC T, V10, P287, DOI 10.1042/bst0100287; Mateo C, 2007, ENZYME MICROB TECH, V40, P1451, DOI 10.1016/j.enzmictec.2007.01.018; RAHMAN MA, 1991, NORD J BOT, V11, P301, DOI 10.1111/j.1756-1051.1991.tb01408.x; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Sarath G., 1989, PROTEOLYTIC ENZYMES, P25; Silva CJSM, 2006, ENZYME MICROB TECH, V39, P634, DOI 10.1016/j.enzmictec.2005.11.016; Singh A. N., 2013, PLOS ONE, DOI [10.1371/journal.pone.0059806, DOI 10.1371/J0URNAL.P0NE.0059806]; Singh AN, 2010, PROCESS BIOCHEM, V45, P399, DOI 10.1016/j.procbio.2009.10.014; Singh AN, 2011, J AGR FOOD CHEM, V59, P6256, DOI 10.1021/jf200472x; Singh AN, 2011, APPL BIOCHEM BIOTECH, V164, P573, DOI 10.1007/s12010-011-9158-6; Tischer W, 1999, TOP CURR CHEM, V200, P95; Warren SJ, 1992, European Patent Appl EP, Patent No. [04: 714-770, 04714770]	31	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66000	10.1371/journal.pone.0066000	http://dx.doi.org/10.1371/journal.pone.0066000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776589	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400095
J	Bassler, C; Hothorn, T; Brandl, R; Muller, J				Baessler, Claus; Hothorn, Torsten; Brandl, Roland; Mueller, Joerg			Insects Overshoot the Expected Upslope Shift Caused by Climate Warming	PLOS ONE			English	Article							RANGE SHIFTS; NATIONAL-PARK; SPECIES RICHNESS; PLANTS; BIODIVERSITY; 20TH-CENTURY; BUTTERFLIES; INDICATORS; RESPONSES; IMPACTS	Along elevational gradients, climate warming may lead to an upslope shift of the lower and upper range margin of organisms. A recent meta-analysis concluded that these shifts are species specific and considerably differ among taxonomic lineages. We used the opportunity to compare upper range margins of five lineages (plants, beetles, flies, hymenoptera, and birds) between 1902-1904 and 2006-2007 within one region (Bavarian Forest, Central Europe). Based on the increase in the regional mean annual temperature during this period and the regional lapse rate, the upslope shift is expected to be between 51 and 201 m. Averaged across species within lineages, the range margin of all animal lineages shifted upslope, but that of plants did not. For animals, the observed shifts were probably due to shifts in temperature and not to changes in habitat conditions. The range margin of plants is therefore apparently not constrained by temperature, a result contrasting recent findings. The mean shift of birds (165 m) was within the predicted range and consistent with a recent global meta-analysis. However, the upslope shift of the three insect lineages (>260 m) exceeded the expected shift even after considering several sources of uncertainty, which indicated a non-linear response to temperature. Our analysis demonstrated broad differences among lineages in their response to climate change even within one region. Furthermore, on the considered scale, the response of ectothermic animals was not consistent with expectations based on shifts in the mean annual temperature. Irrespective of the reasons for the overshooting of the response of the insects, these shifts lead to reorganizations in the composition of assemblages with consequences for ecosystem processes.	[Baessler, Claus; Mueller, Joerg] Bavarian Forest Natl Pk, Dept Res, Grafenau, Germany; [Hothorn, Torsten] Univ Munich, Inst Stat, Munich, Germany; [Brandl, Roland] Univ Marburg, Fac Biol, Dept Anim Ecol, Marburg, Germany	University of Munich; Philipps University Marburg	Bassler, C (corresponding author), Bavarian Forest Natl Pk, Dept Res, Grafenau, Germany.	claus.baessler@npv-bw.bayern.de		Bassler, Claus/0000-0001-8177-8997; Muller, Jorg/0000-0002-1409-1586	Bavarian State Ministry of the Environment and Public Health	Bavarian State Ministry of the Environment and Public Health	The study was financed by the Bavarian State Ministry of the Environment and Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Bassler C, 2010, FOLIA GEOBOT, V45, P163, DOI 10.1007/s12224-010-9059-4; Bassler C, 2010, ECOL INDIC, V10, P341, DOI 10.1016/j.ecolind.2009.06.014; Bassler C., 2004, KLIMA NATIONALPARK B; Bassler C., 2008, SILVA GABRETA, V14, P1; Buse J, 2007, BIOL CONSERV, V137, P372, DOI 10.1016/j.biocon.2007.02.025; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Davis M.B., 1986, COMMUNITY ECOL, P269; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; EBER S, 1994, J ANIM ECOL, V63, P187, DOI 10.2307/5594; Gavrilov L.A., 1991, BIOL LIFE SPAN QUANT; Gehrig-Fasel J, 2007, J VEG SCI, V18, P571, DOI 10.1111/j.1654-1103.2007.tb02571.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; HENNEVOGEL FE, 1905, KAFERFAUNA BOHMERWAL; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hill JK, 2002, P ROY SOC B-BIOL SCI, V269, P2163, DOI 10.1098/rspb.2002.2134; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Lehnert L, 2013, J NAT CONSE IN PRESS; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Muller J, 2008, BIODIVERS CONSERV, V17, P2979, DOI 10.1007/s10531-008-9409-1; Muller J, 2008, MALACOLOGIA, V51, P133; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Partel M, 2002, ECOLOGY, V83, P1199, DOI 10.1890/0012-9658(2002)083[1199:RDASPI]2.0.CO;2; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Popy S, 2010, J BIOGEOGR, V37, P57, DOI 10.1111/j.1365-2699.2009.02197.x; R Development Core Team, LANG ENV STAT COMP; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; Shoo LP, 2006, AUSTRAL ECOL, V31, P22, DOI 10.1111/j.1442-9993.2006.01539.x; Sibly R. M., 2012, METABOLIC ECOLOGY SC; Somodi I, 2008, APPL VEG SCI, V11, P187, DOI 10.3170/2008-7-18354; Tackenberg O, 2003, ECOL MONOGR, V73, P191, DOI 10.1890/0012-9615(2003)073[0191:AOWDPI]2.0.CO;2; Thiem F.M., 1906, ABHANDLUNGEN NATURHI, V16, P6; Thuiller W, 2007, NATURE, V448, P550, DOI 10.1038/448550a; Walentowski H., 2004, HDB NATURLICHEN WALD; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; WATT WB, 1968, EVOLUTION, V22, P437, DOI 10.1111/j.1558-5646.1968.tb03985.x; WIEGAND T, 1995, ECOLOGY, V76, P2205, DOI 10.2307/1941694; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x; [No title captured]	45	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65842	10.1371/journal.pone.0065842	http://dx.doi.org/10.1371/journal.pone.0065842			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762439	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800079
J	Brega, S; Caliot, E; Trieu-Cuot, P; Dramsi, S				Brega, Sara; Caliot, Elise; Trieu-Cuot, Patrick; Dramsi, Shaynoor			SecA Localization and SecA-Dependent Secretion Occurs at New Division Septa in Group B Streptococcus	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; SURFACE-PROTEINS; CELL-WALL; STAPHYLOCOCCUS-AUREUS; CAMP-FACTOR; EPITHELIAL-CELLS; VIRULENCE; AGALACTIAE; PEPTIDOGLYCAN; PYOGENES	Exported proteins of Streptococcus agalactiae (GBS), which include proteins localized to the bacterial surface or secreted into the extracellular environment, are key players for commensal and pathogenic interactions in the mammalian host. These proteins are transported across the cytoplasmic membrane via the general SecA secretory pathway and those containing the so-called LPXTG sorting motif are covalently attached to the peptidoglycan by sortase A. How SecA, sortase A, and LPXTG proteins are spatially distributed in GBS is not known. In the close relative Streptococcus pyogenes, it was shown that presence of the YSIRKG/S motif (literally YSIRK(X3)Gx(2)S) in the signal peptide (SP) constitutes the targeting information for secretion at the septum. Here, using conventional and deconvolution immunofluorescence analyses, we have studied in GBS strain NEM316 the localization of SecA, SrtA, and the secreted protein Bsp whose signal peptide contains a canonical YSIRKG/S motif (YSLRKykfGlaS). Replacing the SP of Bsp with four other SPs containing or not the YSIRKG/S motif did not alter the localized secretion of Bsp at the equatorial ring. Our results indicate that secretion and cell wall-anchoring machineries are localized at the division septum. Cell wall- anchored proteins displayed polar (PilB, Gbs0791), punctuate (CspA) or uniform distribution (Alp2) on the bacterial surface. De novo secretion of Gbs0791 following trypsin treatment indicates that it is secreted at the septum, then redistributed along the lateral sides, and finally accumulated to the poles. We conclude that the +/- YSIRK SP rule driving compartimentalized secretion is not true in S. agalactiae.	[Brega, Sara; Caliot, Elise; Trieu-Cuot, Patrick; Dramsi, Shaynoor] Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, Paris, France; [Brega, Sara; Caliot, Elise; Trieu-Cuot, Patrick; Dramsi, Shaynoor] CNRS, ERL 3526, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Dramsi, S (corresponding author), Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, Paris, France.	shaynoor.dramsi@pasteur.fr		TRIEU-CUOT, Patrick/0000-0002-2768-9587; Brega, Sara/0000-0001-6378-842X	Agence Nationale de la Recherche [ANR-06-PATHO-001-01]; Institut Pasteur; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases'' [nuANR-10-LABX-62-IBEID]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut Pasteur(European Commission); French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases''(French National Research Agency (ANR))	This work was supported in part by grant ANR-06-PATHO-001-01 from the Agence Nationale de la Recherche "ERA-NET PathoGenoMics'' (to P.T.-C.) and by the Institut Pasteur. The authors also acknowledge funding from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases'' (grant nuANR-10-LABX-62-IBEID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae T, 2003, J BACTERIOL, V185, P2910, DOI 10.1128/JB.185.9.2910-2919.2003; Bierne H, 2012, CURR OPIN MICROBIOL, V15, P715, DOI 10.1016/j.mib.2012.10.010; Bryan JD, 2009, J BACTERIOL, V191, P1847, DOI 10.1128/JB.01124-08; Campo N, 2004, MOL MICROBIOL, V53, P1583, DOI 10.1111/j.1365-2958.2004.04278.x; Carlsson F, 2006, NATURE, V442, P943, DOI 10.1038/nature05021; Chaffin DO, 2000, J BACTERIOL, V182, P4466, DOI 10.1128/JB.182.16.4466-4477.2000; DeDent A, 2008, EMBO J, V27, P2656, DOI 10.1038/emboj.2008.185; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Harris TO, 2003, J CLIN INVEST, V111, P61, DOI 10.1172/JCI200316270; Hensler ME, 2008, MICROB PATHOGENESIS, V44, P84, DOI 10.1016/j.micpath.2007.08.005; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Lalioui L, 2005, INFECT IMMUN, V73, P3342, DOI 10.1128/IAI.73.6.3342-3350.2005; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Lang SH, 2003, J BIOL CHEM, V278, P38167, DOI 10.1074/jbc.M303544200; Lee SG, 2006, J BACTERIOL, V188, P389, DOI 10.1128/JB.188.2.389-398.2006; Lee SG, 2002, J BIOL CHEM, V277, P46912, DOI 10.1074/jbc.M208660200; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; Mistou MY, 2009, J BACTERIOL, V191, P4195, DOI 10.1128/JB.01673-08; Ng WL, 2004, MOL MICROBIOL, V53, P1161, DOI 10.1111/j.1365-2958.2004.04196.x; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; PODBIELSKI A, 1994, MED MICROBIOL IMMUN, V183, P239, DOI 10.1007/BF00198458; Poyart C, 2001, INFECT IMMUN, V69, P5098, DOI 10.1128/IAI.69.8.5098-5106.2001; Raz A, 2012, MOL MICROBIOL, V84, P631, DOI 10.1111/j.1365-2958.2012.08047.x; Reinscheid DJ, 2002, MICROBIOL-SGM, V148, P3245, DOI 10.1099/00221287-148-10-3245; Rioux S, 2001, INFECT IMMUN, V69, P5162, DOI 10.1128/IAI.69.8.5162-5165.2001; Rosch J, 2004, SCIENCE, V304, P1513, DOI 10.1126/science.1097404; Rosch JW, 2007, J BACTERIOL, V189, P801, DOI 10.1128/JB.01549-06; Rosch JW, 2005, MOL MICROBIOL, V58, P959, DOI 10.1111/j.1365-2958.2005.04887.x; RUBENS CE, 1993, MOL MICROBIOL, V8, P843, DOI 10.1111/j.1365-2958.1993.tb01631.x; Sambrook J., 2002, MOL CLONING LAB MANU; Stalhammar-Carlemalm M, 1999, MOL MICROBIOL, V33, P208, DOI 10.1046/j.1365-2958.1999.01470.x; Tiyanont K, 2006, P NATL ACAD SCI USA, V103, P11033, DOI 10.1073/pnas.0600829103; Tsui HCT, 2011, MBIO, V2, DOI 10.1128/mBio.00202-11; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Yu WQ, 2012, PLOS ONE, V7, P384, DOI 10.1371/journal.pone.0030076; Zapun A, 2008, FEMS MICROBIOL REV, V32, P345, DOI 10.1111/j.1574-6976.2007.00098.x	40	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65832	10.1371/journal.pone.0065832	http://dx.doi.org/10.1371/journal.pone.0065832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762438	Green Published, Green Submitted, gold			2022-12-25	WOS:000321094800078
J	Huang, H; Quint, M; Gray, WM				Huang, He; Quint, Marcel; Gray, William M.			The eta7/csn3-3 Auxin Response Mutant of Arabidopsis Defines a Novel Function for the CSN3 Subunit of the COP9 Signalosome	PLOS ONE			English	Article							CONSTITUTIVE PHOTOMORPHOGENIC9 SIGNALOSOME; MULTIFACETED DEVELOPMENTAL PROCESSES; MEDIATING LIGHT CONTROL; E3 UBIQUITIN LIGASE; BOX PROTEIN TIR1; AUX/IAA PROTEINS; GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; CULLIN ATCUL1; CELL-CYCLE	The COP9 signalosome (CSN) is an eight subunit protein complex conserved in all higher eukaryotes. In Arabidopsis thaliana, the CSN regulates auxin response by removing the ubiquitin-like protein NEDD8/RUB1 from the CUL1 subunit of the SCFTIR1/AFB ubiquitin-ligase (deneddylation). Previously described null mutations in any CSN subunit result in the pleiotropic cop/det/fus phenotype and cause seedling lethality, hampering the study of CSN functions in plant development. In a genetic screen to identify enhancers of the auxin response defects conferred by the tir1-1 mutation, we identified a viable csn mutant of subunit 3 (CSN3), designated eta7/csn3-3. In addition to enhancing tir1-1 mutant phenotypes, the csn3-3 mutation alone confers several phenotypes indicative of impaired auxin signaling including auxin resistant root growth and diminished auxin responsive gene expression. Unexpectedly however, csn3-3 plants are not defective in either the CSN-mediated deneddylation of CUL1 or in SCFTIR1-mediated degradation of Aux/IAA proteins. These findings suggest that csn3-3 is an atypical csn mutant that defines a novel CSN or CSN3-specific function. Consistent with this possibility, we observe dramatic differences in double mutant interactions between csn3-3 and other auxin signaling mutants compared to another weak csn mutant, csn1-10. Lastly, unlike other csn mutants, assembly of the CSN holocomplex is unaffected in csn3-3 plants. However, we detected a small CSN3-containing protein complex that is altered in csn3-3 plants. We hypothesize that in addition to its role in the CSN as a cullin deneddylase, CSN3 functions in a distinct protein complex that is required for proper auxin signaling.	[Huang, He; Quint, Marcel; Gray, William M.] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Gray, WM (corresponding author), Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA.	grayx051@umn.edu	Huang, He/K-1176-2016; Gray, William M/F-9402-2010; quint, marcel/J-8483-2012; Huang, He/E-4579-2017	Huang, He/0000-0002-4564-7604; Gray, William M/0000-0002-1320-290X; Huang, He/0000-0002-4564-7604; Quint, Marcel/0000-0003-2935-4083	National Institutes of Health [GM067203]; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (GM067203 to WMG) and a postdoctoral fellowship from the Deutsche Forschungsgemeinschaft (to MQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chamovitz DA, 1996, CELL, V86, P115, DOI 10.1016/S0092-8674(00)80082-3; Chen HD, 2006, PLANT CELL, V18, P1991, DOI 10.1105/tpc.106.043224; Chuang HW, 2004, PLANT CELL, V16, P1883, DOI 10.1105/tpc.021923; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; del Pozo JC, 1999, P NATL ACAD SCI USA, V96, P15342, DOI 10.1073/pnas.96.26.15342; del Pozo JC, 2002, PLANT CELL, V14, P421, DOI 10.1105/tpc.010282; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dharmasiri N, 2007, PLANT J, V52, P114, DOI 10.1111/j.1365-313X.2007.03211.x; Dharmasiri S, 2003, EMBO J, V22, P1762, DOI 10.1093/emboj/cdg190; Dohmann EMN, 2005, PLANT CELL, V17, P1967, DOI 10.1105/tpc.105.032870; Dohmann EMN, 2010, EUR J CELL BIOL, V89, P163, DOI 10.1016/j.ejcb.2009.12.001; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Enchev RI, 2012, CELL REPORTS, V2, P616, DOI 10.1016/j.celrep.2012.08.019; Feng SH, 2003, PLANT CELL, V15, P1083, DOI 10.1105/tpc.010207; Fukumoto A, 2005, FEBS LETT, V579, P1047, DOI 10.1016/j.febslet.2004.12.076; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Gray WM, 2003, PLANT CELL, V15, P1310, DOI 10.1105/tpc.010884; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Gusmaroli G, 2004, PLANT CELL, V16, P2984, DOI 10.1105/tpc.104.025999; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; Harari-Steinberg O, 2007, GENES CELLS, V12, P183, DOI 10.1111/j.1365-2443.2007.01049.x; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Hobbie L, 2000, DEVELOPMENT, V127, P23; Ito H, 2006, PLANT PHYSIOL, V142, P63, DOI 10.1104/pp.106.084533; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kwok SF, 1998, PLANT CELL, V10, P1779, DOI 10.1105/tpc.10.11.1779; LINCOLN C, 1990, PLANT CELL, V2, P1071, DOI 10.1105/tpc.2.11.1071; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Lykke-Andersen K, 2003, MOL CELL BIOL, V23, P6790, DOI 10.1128/MCB.23.19.6790-6797.2003; Maraschin FD, 2009, PLANT J, V59, P100, DOI 10.1111/j.1365-313X.2009.03854.x; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Mirjam E, 2008, PLANT PHYSIOL, V147, P1369, DOI 10.1104/pp.108.121061; Mundt KE, 2002, MOL BIOL CELL, V13, P493, DOI 10.1091/mbc.01-10-0521; Olma MH, 2009, J CELL SCI, V122, P1035, DOI 10.1242/jcs.043539; Oono Y, 1998, PLANT CELL, V10, P1649, DOI 10.1105/tpc.10.10.1649; Oron E, 2002, DEVELOPMENT, V129, P4399; Oron E, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100150; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Peng ZH, 2001, DEVELOPMENT, V128, P4277; Peng ZH, 2001, PLANT CELL, V13, P2393, DOI 10.1105/tpc.13.11.2393; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; PRINGLE JR, 1989, METHOD CELL BIOL, V31, P357; Quint M, 2005, PLANT J, V43, P371, DOI 10.1111/j.1365-313X.2005.02449.x; Quint M, 2009, PLANT PHYSIOL, V150, P748, DOI 10.1104/pp.109.136671; Rubio V, 2005, PLANT J, V41, P767, DOI 10.1111/j.1365-313X.2004.02328.x; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Serino G, 1999, PLANT CELL, V11, P1967, DOI 10.1105/tpc.11.10.1967; Serino G, 2003, PLANT CELL, V15, P719, DOI 10.1105/tpc.009092; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Strader LC, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-41; Stuttmann J, 2009, J BIOL CHEM, V284, P7920, DOI 10.1074/jbc.M809069200; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Tsuge T, 2001, J MOL BIOL, V305, P1, DOI 10.1006/jmbi.2000.4288; Uhle S, 2003, EMBO J, V22, P1302, DOI 10.1093/emboj/cdg127; Ullah Z, 2007, MOL BIOL CELL, V18, P1179, DOI 10.1091/mbc.E06-09-0790; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; WEI N, 1994, CELL, V78, P117, DOI 10.1016/0092-8674(94)90578-9; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Wu JT, 2006, TRENDS CELL BIOL, V16, P362, DOI 10.1016/j.tcb.2006.05.001; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Zhang WD, 2008, ECON LETT, V99, P1, DOI 10.1016/j.econlet.2007.09.029; Zhou CS, 2003, MOL CELL, V11, P927, DOI 10.1016/S1097-2765(03)00136-9	78	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66578	10.1371/journal.pone.0066578	http://dx.doi.org/10.1371/journal.pone.0066578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762492	Green Submitted, gold, Green Published			2022-12-25	WOS:000321094800100
J	Li, J; Sung, MH; Rutkove, SB				Li, Jia; Sung, Minhee; Rutkove, Seward B.			Electrophysiologic Biomarkers for Assessing Disease Progression and the Effect of Riluzole in SOD1 G93A ALS Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ELECTRICAL-IMPEDANCE MYOGRAPHY; TRANSGENIC MOUSE MODEL; UNIT NUMBER ESTIMATION; MOTOR FUNCTION; TRIAL; SURVIVAL; ONSET	Objective: To compare electrical impedance myography (EIM) 50 kHz phase to weight, motor score, paw grip endurance (PGE), CMAP amplitude, and MUNE for the identification of disease progression and the effect of riluzole in the SOD1 G93A mouse. Methods: Twenty-three animals received 8 mg/kg/day riluzole in the drinking water starting at 6 weeks of age; 22 animals served as controls. Weight, motor score, PGE, CMAP, MUNE, and EIM were performed weekly to evaluate disease progression. Results: No difference in clinical disease onset or survival was found between treated and untreated groups. In addition, all methods failed to identify any beneficial effect of riluzole. Thus, data from all animals were combined for additional analyses. Of the 4 parameters, EIM phase showed the earliest change from baseline and the most linear decline throughout the entire measurement period. In addition, EIM phase correlated with PGE, CMAP amplitude, and MUNE (Spearman r = 0.92, 0.90, and 0.72, respectively, p<0.01 for all). The rate of EIM phase decline also correlated with individual animal survival (Spearman r = -0.31, p<0.05). Conclusions: At this dose, riluzole is ineffective in slowing progression of ALS. However, EIM phase shows early linear declines, supporting its potential as a useful new biomarker for preclinical drug testing.	[Li, Jia; Sung, Minhee; Rutkove, Seward B.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Rutkove, SB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA.	srutkove@bidmc.harvard.edu		Rutkove, Seward/0000-0002-6375-3312	National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01 NS055099]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055099] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health/National Institute of Neurological Disorders and Stroke grant R01 NS055099. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzouz M, 1997, MUSCLE NERVE, V20, P45, DOI 10.1002/(SICI)1097-4598(199701)20:1<45::AID-MUS6>3.0.CO;2-H; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Cudkowicz M, 2011, NAT MED, V17, P1652, DOI 10.1038/nm.2579; Cudkowicz ME, 2006, ANN NEUROL, V60, P22, DOI 10.1002/ana.20903; Cudkowicz ME, 2010, AMYOTROPH LATERAL SC, V11, P259, DOI 10.3109/17482960903358865; Frey D, 2000, J NEUROSCI, V20, P2534; Gordon PH, 2008, AMYOTROPH LATERAL SC, V9, P212, DOI 10.1080/17482960802195632; Gurney ME, 1998, NEUROLOGY, V50, P62, DOI 10.1212/WNL.50.1.62; Gurney ME, 1996, ANN NEUROL, V39, P147, DOI 10.1002/ana.410390203; Hu WT, 2010, NEUROLOGY, V75, P595, DOI 10.1212/WNL.0b013e3181ed9c52; Jafarpoor M, 2013, T BIOMED EN IN PRESS; Kennel P, 2000, J NEUROL SCI, V180, P55, DOI 10.1016/S0022-510X(00)00423-8; Knippenberg S, 2010, BEHAV BRAIN RES, V213, P82, DOI 10.1016/j.bbr.2010.04.042; Lewelt A, 2010, MUSCLE NERVE, V42, P703, DOI 10.1002/mus.21838; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045004; Ludolph Albert C, 2009, Ther Adv Neurol Disord, V2, P319, DOI 10.1177/1756285609336399; Mattson MP, 2008, CRIT REV TOXICOL, V38, P633, DOI 10.1080/10408440802026406; Pambo-Pambo A, 2009, J NEUROPHYSIOL, V102, P3627, DOI 10.1152/jn.00482.2009; Poonawalla AH, 2010, MULT SCLER J, V16, P1117, DOI 10.1177/1352458510374892; Rutkove SB, 2006, CLIN NEUROPHYSIOL, V117, P1244, DOI 10.1016/j.clinph.2005.12.029; Rutkove SB, 2012, AMYOTROPHIC LATERAL; Rutkove SB, 2009, MUSCLE NERVE, V40, P936, DOI 10.1002/mus.21362; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Shefner JM, 2011, NEUROLOGY, V77, P235, DOI 10.1212/WNL.0b013e318225aabf; Shefner JM, 2006, MUSCLE NERVE, V34, P603, DOI 10.1002/mus.20628; Wang LL, 2011, CLIN NEUROPHYSIOL, V122, P2505, DOI 10.1016/j.clinph.2011.04.021; Weydt P, 2003, NEUROREPORT, V14, P1051, DOI 10.1097/01.wnr.0000073685.00308.89	27	12	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65976	10.1371/journal.pone.0065976	http://dx.doi.org/10.1371/journal.pone.0065976			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762454	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000122
J	Wang, XL; Wu, EX; Wu, J; Wang, TL; Hsieh, HP; Liu, XL				Wang, Xiaolei; Wu, Erxi; Wu, Jun; Wang, Tian-Li; Hsieh, Hsing-Pang; Liu, Xinli			An Antimitotic and Antivascular Agent BPR0L075 Overcomes Multidrug Resistance and Induces Mitotic Catastrophe in Paclitaxel-Resistant Ovarian Cancer Cells	PLOS ONE			English	Article							HELA S3 CELLS; BREAST-CANCER; SPINDLE CHECKPOINT; TUMOR-CELLS; TUBULIN ISOTYPES; ALTERED EXPRESSION; CASPASE ACTIVATION; INDUCED APOPTOSIS; DRUG-RESISTANCE; CARCINOMA CELLS	Paclitaxel plays a major role in the treatment of ovarian cancer; however, resistance to paclitaxel is frequently observed. Thus, new therapy that can overcome paclitaxel resistance will be of significant clinical importance. We evaluated antiproliferative effects of an antimitotic and antivascular agent BPR0L075 in paclitaxel-resistant ovarian cancer cells. BPR0L075 displays potent and broad-spectrum cytotoxicity at low nanomolar concentrations (IC50 = 2-7 nM) against both parental ovarian cancer cells (OVCAR-3, SKOV-3, and A2780-1A9) and paclitaxel-resistant sublines (OVCAR-3-TR, SKOV-3-TR, 1A9-PTX10), regardless of the expression levels of the multidrug resistance transporter P-gp and class III beta-tubulin or mutation of beta-tubulin. BPR0L075 blocks cell cycle at the G2/M phase in paclitaxel-resistant cells while equal concentration of paclitaxel treatment was ineffective. BPR0L075 induces cell death by a dual mechanism in parental and paclitaxel-resistant ovarian cancer cells. In the parental cells (OVCAR-3 and SKOV-3), BPR0L075 induced apoptosis, evidenced by poly(ADPribose) polymerase (PARP) cleavage and DNA ladder formation. BPR0L075 induced cell death in paclitaxel-resistant ovarian cancer cells (OVCAR-3-TR and SKOV-3-TR) is primarily due to mitotic catastrophe, evidenced by formation of giant, multinucleated cells and absence of PARP cleavage. Immunoblotting analysis shows that BPR0L075 treatment induced up-regulation of cyclin B1, BubR1, MPM-2, and survivin protein levels and Bcl-XL phosphorylation in parental cells; however, in resistant cells, the endogenous expressions of BubR1 and survivin were depleted, BPR0L075 treatment failed to induce MPM-2 expression and phosphorylation of Bcl-XL. BPR0L075 induced cell death in both parental and paclitaxel-resistant ovarian cancer cells proceed through caspase-3 independent mechanisms. In conclusion, BPR0L075 displays potent cytotoxic effects in ovarian cancer cells with a potential to overcome paclitaxel resistance by bypassing efflux transporters and inducing mitotic catastrophe. BPR0L075 represents a novel microtubule therapeutic to overcome multidrug resistance and trigger alternative cell death by mitotic catastrophe in ovarian cancer cells that are apoptosis-resistant.	[Wang, Xiaolei; Liu, Xinli] Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA; [Wu, Erxi] N Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA; [Wu, Jun] City Hope Natl Med Ctr, Beckman Res Inst, Div Comparat Med, Duarte, CA USA; [Wang, Tian-Li] Johns Hopkins Univ, Dept Gynecol Obstet, Baltimore, MD USA; [Wang, Tian-Li] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Hsieh, Hsing-Pang] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Taipei, Taiwan	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; North Dakota State University Fargo; City of Hope; Beckman Research Institute of City of Hope; Johns Hopkins University; Johns Hopkins University; National Health Research Institutes - Taiwan	Liu, XL (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Sch Pharm, Dept Pharmaceut Sci, Amarillo, TX USA.	xinli.liu@ttuhsc.edu	Hsieh, Hsing-Pang/B-2649-2010	Hsieh, Hsing-Pang/0000-0002-1332-005X; Wu, Erxi/0000-0002-1680-3639	Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy; NATIONAL CANCER INSTITUTE [R01CA148826] Funding Source: NIH RePORTER	Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by Texas Tech University Health Sciences Center (TTUHSC) School of Pharmacy (X. Liu). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 1999, CANCER RES, V59, P4237; ARCECI RJ, 1993, BLOOD, V81, P2215; Belotti D, 1996, CLIN CANCER RES, V2, P1725; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Cenciarelli C, 2008, APOPTOSIS, V13, P659, DOI 10.1007/s10495-008-0200-2; Chen CP, 2010, ANTICANCER RES, V30, P2813; Cheung CHA, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-43; Clarke-Pearson DL, 2009, NEW ENGL J MED, V361, P170, DOI 10.1056/NEJMcp0901926; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; DEMARCQ C, 1994, CELL GROWTH DIFFER, V5, P983; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Friedrich TD, 1998, CYTOMETRY, V31, P260, DOI 10.1002/(SICI)1097-0320(19980401)31:4<260::AID-CYTO5>3.0.CO;2-N; Fu YF, 2007, GYNECOL ONCOL, V105, P66, DOI 10.1016/j.ygyno.2006.10.061; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gazitt Y, 1998, INT J ONCOL, V13, P839; Giannakakou P, 2000, P NATL ACAD SCI USA, V97, P2904, DOI 10.1073/pnas.040546297; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Gonzalez-Garay ML, 1999, J BIOL CHEM, V274, P23875, DOI 10.1074/jbc.274.34.23875; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Ianzini F, 1997, INT J RADIAT BIOL, V72, P409, DOI 10.1080/095530097143185; Ianzini F, 1998, MUTAGENESIS, V13, P337, DOI 10.1093/mutage/13.4.337; Jinawath N, 2009, ONCOGENE, V28, P1941, DOI 10.1038/onc.2009.37; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kanakkanthara A, 2011, MOL CANCER THER, V10, P1419, DOI 10.1158/1535-7163.MCT-10-1057; Kavallaris M, 1997, J CLIN INVEST, V100, P1282, DOI 10.1172/JCI119642; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Knauer SK, 2007, CELL CYCLE, V6, P518, DOI 10.4161/cc.6.5.3902; Kuo CC, 2004, CANCER RES, V64, P4621, DOI 10.1158/0008-5472.CAN-03-3474; Lamers F, 2011, ENDOCR-RELAT CANCER, V18, P657, DOI 10.1530/ERC-11-0207; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Liou JP, 2002, J MED CHEM, V45, P2556, DOI 10.1021/jm010365+; Liu JR, 1998, GYNECOL ONCOL, V70, P398, DOI 10.1006/gyno.1998.5125; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043314; Lock RB, 1996, CANCER RES, V56, P4006; Mansilla S, 2006, CELL CYCLE, V5, P53, DOI 10.4161/cc.5.1.2267; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Montgomery RB, 2000, J BIOL CHEM, V275, P17358, DOI 10.1074/jbc.M000966200; Monzo M, 1999, J CLIN ONCOL, V17, P1786, DOI 10.1200/JCO.1999.17.6.1786; Mozzetti S, 2005, CLIN CANCER RES, V11, P298; Nabha SM, 2002, CLIN CANCER RES, V8, P2735; NAKAGAWA M, 1992, CANCER RES, V52, P6175; Nakahata K, 2002, INT J HYPERTHER, V18, P332, DOI 10.1080/02656730210129736; Ogretmen B, 1996, INT J CANCER, V67, P608, DOI 10.1002/(SICI)1097-0215(19960904)67:5<608::AID-IJC3>3.0.CO;2-Y; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; Ozols RF, 2006, ANN ONCOL, V17, pV181, DOI 10.1093/annonc/mdj978; Panvichian R, 1998, CANCER RES, V58, P4667; Paradiso A, 2005, ANN ONCOL, V16, P14, DOI 10.1093/annonc/mdi902; Poruchynsky MS, 1998, CANCER RES, V58, P3331; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Ross DD, 1999, J NATL CANCER I, V91, P429, DOI 10.1093/jnci/91.5.429; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; Scheffer GL, 2000, CANCER RES, V60, P2589; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Shankar SL, 2001, J NEUROCHEM, V79, P426, DOI 10.1046/j.1471-4159.2001.00596.x; Singh R, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-4; Stauber RH, 2007, CANCER RES, V67, P5999, DOI 10.1158/0008-5472.CAN-07-0494; Sudo T, 2004, CANCER RES, V64, P2502, DOI 10.1158/0008-5472.CAN-03-2013; Tseng HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036006; Tu SP, 2003, CANCER RES, V63, P7724; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P555, DOI 10.1038/sj.cdd.4402286; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Verdier-Pinard P, 2003, BIOCHEMISTRY-US, V42, P5349, DOI 10.1021/bi027293o; Vitale I, 2007, APOPTOSIS, V12, P155, DOI 10.1007/s10495-006-0491-0; Wang YF, 2005, CELL CYCLE, V4, P1847, DOI 10.4161/cc.4.12.2264; Yu DH, 1998, ONCOGENE, V16, P2087, DOI 10.1038/sj.onc.1201729; Zhang R, 2010, CANCER GENE THER, V17, P275, DOI 10.1038/cgt.2009.68; Zhou J, 2004, CANCER RES, V64, P8708, DOI 10.1158/0008-5472.CAN-04-2538	72	21	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65686	10.1371/journal.pone.0065686	http://dx.doi.org/10.1371/journal.pone.0065686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762410	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000093
J	Zhou, W; Srinivasan, S; Nawaz, Z; Slingerland, JM				Zhou, W.; Srinivasan, S.; Nawaz, Z.; Slingerland, J. M.			ER alpha, SKP2 and E2F-1 form a feed forward loop driving late ER alpha targets and G1 cell cycle progression	ONCOGENE			English	Article						cyclin E-CDK2; ER alpha; E2F-1; SCFSKP2; ubiquitylation; coactivator	ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER-CELLS; UBIQUITIN LIGASE COMPLEX; CDK INHIBITOR P27; BOX PROTEIN SKP2; TRANSCRIPTIONAL ACTIVATION; HORMONE-RECEPTORS; DOWN-REGULATION; BINDING-SITES; DEPENDENT PHOSPHORYLATION	Estrogen triggers transactivation coupled estrogen receptor a (ER alpha) proteolysis, but mechanisms thereof remain obscure. Present data link estrogen: ER alpha-driven transcription with cell cycle progression. Although liganded ER alpha induces many genes within 1-4 h, gene activation after 6 h is thought to be indirect. Here, we identify SKP2 as a late-acting coactivator that drives ERa targets to promote G1-to-S progression. Data support a model in which estrogen-activated cyclin E-CDK2 binds and phosphorylates ER alpha S341, to prime ER alpha-SCFSKP2 binding via SKP2-L(248)QTLL(252) in late G1. SKP2 activates ERa ubiquitylation and proteolysis. Putative late ER alpha targets were identified by expression profiling. SKP2 knockdown attenuated E2F-1 and BLM induction. SKP2 overexpression, but not coactivator motif mutant SKP2-L(248)QTAA(252), enhanced estrogen-induced E2F-1 and BLM expression. SKP2 knockdown impaired estrogen-stimulated ER alpha, SKP2, SRC3 and RNA polymerase II recruitment to E2F-1 and BLM promoters. This work not only identifies these late-activated genes as bona fide ERa targets but describes a novel mechanism for their periodic activation. SKP2 serves as dual ER alpha E3 ligase/coactivator for late-activated target genes, revealing a novel mechanism whereby ER alpha/SCFSKP2 transactivation of E2F-1 feeds forward to drive G1-to-S.	[Zhou, W.; Srinivasan, S.; Nawaz, Z.; Slingerland, J. M.] Univ Miami, Sylvester Comprehens Canc Ctr, Braman Family Breast Canc Inst, Miami, FL 33136 USA; [Zhou, W.; Srinivasan, S.; Nawaz, Z.; Slingerland, J. M.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Slingerland, J. M.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Slingerland, JM (corresponding author), Univ Miami, Sylvester Comprehens Canc Ctr, Braman Family Breast Canc Inst, 1501 NW 10th Ave,BRB708, Miami, FL 33136 USA.	jslingerland@med.miami.edu	Zhou, Wen/A-5763-2010	Zhou, Wen/0000-0002-5496-5815	NIH [R01CA123415]; US DOD Pre-doctoral grant [W81XWH-11-1-0097]; NATIONAL CANCER INSTITUTE [R01CA123415] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US DOD Pre-doctoral grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M Pagano for bacculovirus stocks (CUL1, SKP1, RBX1, SKP2), WL Kraus for pPK-FLAG-ER alpha plasmid, H-K Lin for pcDNA4-His-Max-Xpress SKP2, and J Sun for technical intellectual input. This work was supported by NIH R01CA123415 (JMS and ZN), and a US DOD Pre-doctoral grant W81XWH-11-1-0097 (WZ).	Alarid ET, 1999, MOL ENDOCRINOL, V13, P1522, DOI 10.1210/me.13.9.1522; Alarid ET, 2003, ENDOCRINOLOGY, V144, P3469, DOI 10.1210/en.2002-0092; Atsriku C, 2009, MOL CELL PROTEOMICS, V8, P467, DOI 10.1074/mcp.M800282-MCP200; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Bhatt S, 2012, MOL CELL BIOL, V32, P1928, DOI 10.1128/MCB.06561-11; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Chu I, 2007, J CLIN INVEST, V117, P2205, DOI 10.1172/JCI21739; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Dace A, 2000, P NATL ACAD SCI USA, V97, P8985, DOI 10.1073/pnas.160257997; DALY RJ, 1990, CANCER RES, V50, P5868; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; DUBIK D, 1987, CANCER RES, V47, P6517; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Fan MY, 2004, MOL ENDOCRINOL, V18, P2603, DOI 10.1210/me.2004-0164; Fan S, 1999, SCIENCE, V284, P1354, DOI 10.1126/science.284.5418.1354; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Harper JW, 2001, CHEM REV, V101, P2511, DOI 10.1021/cr0001030; Held JM, 2012, MOL CANCER RES, V10, P1120, DOI 10.1158/1541-7786.MCR-12-0099; Iso T, 2007, BIOL PHARM BULL, V30, P266, DOI 10.1248/bpb.30.266; Johnson AE, 2007, MOL CELL BIOCHEM, V301, P13, DOI 10.1007/s11010-006-9392-3; Kennedy BA, 2010, NUCLEIC ACIDS RES, V38, pD676, DOI 10.1093/nar/gkp734; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Lin ZH, 2007, CANCER RES, V67, P5017, DOI 10.1158/0008-5472.CAN-06-3696; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; Migliaccio A, 1996, EMBO J, V15, P1292, DOI 10.1002/j.1460-2075.1996.tb00471.x; Moro L, 2006, J BIOL CHEM, V281, P22100, DOI 10.1074/jbc.M604636200; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Nawaz Z, 2004, MOL ENDOCRINOL, V18, P493, DOI 10.1210/me.2003-0388; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Nilsson S, 2000, BREAST CANCER RES, V2, P360, DOI 10.1186/bcr81; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; PAGANO M, 1993, J CELL BIOL, V121, P101, DOI 10.1083/jcb.121.1.101; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Saji S, 2001, BIOCHEM BIOPH RES CO, V281, P259, DOI 10.1006/bbrc.2001.4339; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Shen TJ, 2001, MOL CELL BIOL, V21, P6122, DOI 10.1128/MCB.21.18.6122-6131.2001; Sherr CJ, 2000, CANCER RES, V60, P3689; Sun J, 2007, MOL ENDOCRINOL, V21, P2651, DOI 10.1210/me.2007-0082; Sun J, 2012, MOL ENDOCRINOL, V26, P1567, DOI 10.1210/me.2012-1140; Tansey WP, 2001, GENE DEV, V15, P1045, DOI 10.1101/gad.896501; TSAI LH, 1993, ONCOGENE, V8, P1593; Wang WL, 1999, MOL ENDOCRINOL, V13, P1373, DOI 10.1210/me.13.8.1373; Wirbelauer C, 2000, EMBO J, V19, P5362, DOI 10.1093/emboj/19.20.5362; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Woo RA, 2003, CELL CYCLE, V2, P316, DOI 10.4161/cc.2.4.468; Wu J, 2012, MOL CELL, V46, P351, DOI 10.1016/j.molcel.2012.02.018; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; Zhang L, 2006, ONCOGENE, V25, P2615, DOI 10.1038/sj.onc.1209286	62	15	18	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 1	2014	33	18					2341	2353		10.1038/onc.2013.197	http://dx.doi.org/10.1038/onc.2013.197			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AG5ID	23770852				2022-12-25	WOS:000335451800007
J	Choi, UB; Kazi, R; Stenzoski, N; Wollmuth, LP; Uversky, VN; Bowen, ME				Choi, Ucheor B.; Kazi, Rashek; Stenzoski, Natalie; Wollmuth, Lonnie P.; Uversky, Vladimir N.; Bowen, Mark E.			Modulating the Intrinsic Disorder in the Cytoplasmic Domain Alters the Biological Activity of the N-Methyl-D-aspartate-sensitive Glutamate Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC PLASTICITY; SCAFFOLD PROTEINS; BINDING DOMAIN; NR2 SUBUNITS; PDZ DOMAINS; RECOGNITION; REGIONS; TRAFFICKING; PREDICTION; PROLINE	The NMDA-sensitive glutamate receptor is a ligand-gated ion channel that mediates excitatory synaptic transmission in the nervous system. Extracellular zinc allosterically regulates the NMDA receptor by binding to the extracellular N-terminal domain, which inhibits channel gating. Phosphorylation of the intrinsically disordered intracellular C-terminal domain alleviates inhibition by extracellular zinc. The mechanism for this functional effect is largely unknown. Proline is a hallmark of intrinsic disorder, so we used proline mutagenesis to modulate disorder in the cytoplasmic domain. Proline depletion selectively uncoupled zinc inhibition with little effect on receptor biogenesis, surface trafficking, or ligand-activated gating. Proline depletion also reduced the affinity for a PDZ domain involved in synaptic trafficking and affected small molecule binding. To understand the origin of these phenomena, we used single molecule fluorescence and ensemble biophysical methods to characterize the structural effects of proline mutagenesis. Proline depletion did not eliminate intrinsic disorder, but the underlying conformational dynamics were changed. Thus, we altered the form of intrinsic disorder, which appears sufficient to affect the biological activity. These findings suggest that conformational dynamics within the intrinsically disordered cytoplasmic domain are important for the allosteric regulation of NMDA receptor gating.	[Choi, Ucheor B.; Bowen, Mark E.] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Kazi, Rashek; Wollmuth, Lonnie P.] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Stenzoski, Natalie] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142290, Moscow Region, Russia	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University System of Florida; University of South Florida; Russian Academy of Sciences	Bowen, ME (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, BST 5-121, Stony Brook, NY 11794 USA.	mark.bowen@stonybrook.edu	Uversky, Vladimir N./F-4515-2011	Uversky, Vladimir N./0000-0002-4037-5857; Wollmuth, Lonnie/0000-0002-8179-1259; Bowen, Mark/0000-0002-9525-6986	National Institutes of Health from the National Institute of Mental Health [MH081923]; Hartman Center for Parkinson's Disease; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081923] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute of Mental Health; Hartman Center for Parkinson's Disease; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH081923 from the National Institute of Mental Health (to M. E. B.). This work was also supported by a research award from the Hartman Center for Parkinson's Disease (to L. P. W. and M. E. B.).	BERGER A, 1954, J AM CHEM SOC, V76, P5552, DOI 10.1021/ja01650a082; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Choi Ucheor B, 2012, Methods Mol Biol, V896, P3, DOI 10.1007/978-1-4614-3704-8_1; Choi UB, 2011, J BIOL CHEM, V286, P29904, DOI 10.1074/jbc.M111.258897; Choi UB, 2011, STRUCTURE, V19, P566, DOI 10.1016/j.str.2011.01.011; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Ivarsson Y, 2012, FEBS LETT, V586, P2638, DOI 10.1016/j.febslet.2012.04.015; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Marsh JA, 2010, BIOPHYS J, V98, P2383, DOI 10.1016/j.bpj.2010.02.006; McCann JJ, 2012, P NATL ACAD SCI USA, V109, P15775, DOI 10.1073/pnas.1200254109; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Metallo SJ, 2010, CURR OPIN CHEM BIOL, V14, P481, DOI 10.1016/j.cbpa.2010.06.169; Meuvis J, 2010, BIOCHEMISTRY-US, V49, P9345, DOI 10.1021/bi1010927; Minezaki Y, 2007, J MOL BIOL, V368, P902, DOI 10.1016/j.jmb.2007.02.033; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Ryan TJ, 2013, NAT NEUROSCI, V16, P25, DOI 10.1038/nn.3277; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Theillet Francois-Xavier, 2013, Intrinsically Disord Proteins, V1, pe24360, DOI 10.4161/idp.24360; Tochio H, 2000, J MOL BIOL, V295, P225, DOI 10.1006/jmbi.1999.3350; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Williams R M, 2001, Pac Symp Biocomput, P89; Xue B, 2009, MOL BIOSYST, V5, P1688, DOI [10.1039/b905913j, 10.1039/B905913J]; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004; Zheng F, 1998, NAT NEUROSCI, V1, P185, DOI 10.1038/634; Zhou HX, 2012, TRENDS BIOCHEM SCI, V37, P43, DOI 10.1016/j.tibs.2011.11.002	41	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22506	22515		10.1074/jbc.M113.477810	http://dx.doi.org/10.1074/jbc.M113.477810			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782697	hybrid, Green Published			2022-12-25	WOS:000330596300031
J	Jin, SX; Arai, J; Tian, XJ; Kumar-Singh, R; Feig, LA				Jin, Shan-Xue; Arai, Junko; Tian, Xuejun; Kumar-Singh, Rajendra; Feig, Larry A.			Acquisition of Contextual Discrimination Involves the Appearance of a RAS-GRF1/p38 Mitogen-activated Protein (MAP) Kinase-mediated Signaling Pathway That Promotes Long Term Potentiation (LTP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glutamate Receptors Ionotropic (AMPA; NMDA); Neurobiology; Neurons; p38 MAPK; RAS; Signal Transduction; Synaptic Plasticity; RAS-GRF; Hippocampus	GLUR2-LACKING AMPA RECEPTORS; SYNAPTIC PLASTICITY; NMDA RECEPTOR; GLUTAMATE RECEPTORS; COMPLEX-FORMATION; MICE LACKING; ERK PATHWAY; RAS; MEMORY; STIMULATION	RAS-GRF1 is a guanine nucleotide exchange factor with the ability to activate RAS and RAC GTPases in response to elevated calcium levels. We previously showed that beginning at 1 month of age, RAS-GRF1 mediates NMDA-type glutamate receptor (NMDAR)-induction of long term depression in the CA1 region of the hippocampus of mice. Here we show that beginning at 2 months of age, when mice first acquire the ability to discriminate between closely related contexts, RAS-GRF1 begins to contribute to the induction of long term potentiation (LTP) in the CA1 hippocampus by mediating the action of calcium-permeable, AMPA-type glutamate receptors (CP-AMPARs). Surprisingly, LTP induction by CP-AMPARs through RAS-GRF1 occurs via activation of p38 MAP kinase rather than ERK MAP kinase, which has more frequently been linked to LTP. Moreover, contextual discrimination is blocked by knockdown of Ras-Grf1 expression specifically in the CA1 hippocampus, infusion of a p38 MAP kinase inhibitor into the CA1 hippocampus, or the injection of an inhibitor of CP-AMPARs. These findings implicate the CA1 hippocampus in the developmentally dependent capacity to distinguish closely related contexts through the appearance of a novel LTP-supporting signaling pathway.	[Jin, Shan-Xue; Arai, Junko; Tian, Xuejun; Feig, Larry A.] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Kumar-Singh, Rajendra] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Tufts University; Tufts University	Feig, LA (corresponding author), Tufts Univ, Sch Med, Dept Biochem, 136 Harrison Ave, Boston, MA 02111 USA.	larry.feig@tufts.edu		Kumar-Singh, Rajendra/0000-0002-7754-0713	National Institutes of Health [R01 MH083324]; Tufts Center for Neuroscience Research [P30 NS047243]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts Center for Neuroscience Research; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 MH083324 (to L. A. F.) and Grant P30 NS047243 through the Tufts Center for Neuroscience Research.	Adams JP, 2000, ACTA NEUROBIOL EXP, V60, P377; Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Albensi BC, 2007, EXP NEUROL, V204, P1, DOI 10.1016/j.expneurol.2006.12.009; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Butler MP, 2004, NEUROSCIENCE, V124, P319, DOI 10.1016/j.neuroscience.2003.11.040; Cashman SM, 2002, MOL THER, V6, P813, DOI 10.1006/mthe.2002.0806; Connolly BA, 2005, MOL CELL BIOL, V25, P4602, DOI 10.1128/MCB.25.11.4602-4614.2005; d'Isa R, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00078; Dumas TC, 2005, HIPPOCAMPUS, V15, P562, DOI 10.1002/hipo.20077; Duncan K, 2012, HIPPOCAMPUS, V22, P389, DOI 10.1002/hipo.20933; Fasano S, 2009, BIOL PSYCHIAT, V66, P758, DOI 10.1016/j.biopsych.2009.03.014; Feig Larry A, 2011, Genes Cancer, V2, P306, DOI 10.1177/1947601911408077; Giese KP, 2001, NEUROPHARMACOLOGY, V41, P791, DOI 10.1016/S0028-3908(01)00096-X; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Izumi Y, 2008, HIPPOCAMPUS, V18, P258, DOI 10.1002/hipo.20383; Jin SX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011732; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kesner RP, 2010, BEHAV BRAIN RES, V215, P299, DOI 10.1016/j.bbr.2009.12.029; Klesse LJ, 1999, MICROSC RES TECHNIQ, V45, P210, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<210::AID-JEMT4>3.3.CO;2-6; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Langston RF, 2010, BEHAV BRAIN RES, V215, P275, DOI 10.1016/j.bbr.2010.07.006; Li SM, 2006, CURR BIOL, V16, P2303, DOI 10.1016/j.cub.2006.10.028; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Man HY, 2011, CURR OPIN NEUROBIOL, V21, P291, DOI 10.1016/j.conb.2011.01.001; Peineau S, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-22; Perez Y, 1999, NEUROSCIENCE, V90, P747, DOI 10.1016/S0306-4522(98)00531-4; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Rozov A, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00022; RUDY JW, 1994, BEHAV NEUROSCI, V108, P227, DOI 10.1037/0735-7044.108.2.227; Rush AM, 2002, J NEUROSCI, V22, P6121; Saleshando G, 2000, NEUROSCI LETT, V288, P119, DOI 10.1016/S0304-3940(00)01210-6; Selcher JC, 2003, LEARN MEMORY, V10, P26, DOI 10.1101/lm.51103; Silingardi D, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00084; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tian XJ, 2006, J BIOL CHEM, V281, P7578, DOI 10.1074/jbc.M512060200; Tian XJ, 2004, EMBO J, V23, P1567, DOI 10.1038/sj.emboj.7600151; Trempolec N, 2013, CELL, V152, P656, DOI [10.1016/j.cell.2013.01.029, 10.1016/j.cell.2013.01.047]; Wiltgen BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012818; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006; Yassa MA, 2011, HIPPOCAMPUS, V21, P968, DOI 10.1002/hipo.20808; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	49	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21703	21713		10.1074/jbc.M113.471904	http://dx.doi.org/10.1074/jbc.M113.471904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23766509	Green Published, hybrid			2022-12-25	WOS:000328841900022
J	Bianchi, M; Crinelli, R; Giacomini, E; Carloni, E; Radici, L; Magnani, M				Bianchi, Marzia; Crinelli, Rita; Giacomini, Elisa; Carloni, Elisa; Radici, Lucia; Magnani, Mauro			Yin Yang 1 Intronic Binding Sequences and Splicing Elicit Intron-Mediated Enhancement of Ubiquitin C Gene Expression	PLOS ONE			English	Article							MESSENGER-RNA; 1ST INTRON; IN-VIVO; PROMOTER; YY1; ELEMENT; MECHANISM; PROTEINS; REVEALS; FAMILY	In a number of organisms, introns affect expression of the gene in which they are contained. Our previous studies revealed that the 59-UTR intron of human ubiquitin C (UbC) gene is responsible for the boost of reporter gene expression and is able to bind, in vitro, Yin Yang 1 (YY1) trans-acting factor. In this work, we demonstrate that intact YY1 binding sequences are required for maximal promoter activity and YY1 silencing causes downregulation of luciferase mRNA levels. However, YY1 motifs fail to enhance gene expression when the intron is moved upstream of the proximal promoter, excluding the typical enhancer hypothesis and supporting a context-dependent action, like intron-mediated enhancement (IME). Yet, almost no expression is seen in the construct containing an unspliceable version of UbC intron, indicating that splicing is essential for promoter activity. Moreover, mutagenesis of YY1 binding sites and YY1 knockdown negatively affect UbC intron removal from both endogenous and reporter transcripts. Modulation of splicing efficiency by YY1 cis-elements and protein factor may thus be part of the mechanism(s) by which YY1 controls UbC promoter activity. Our data highlight the first evidence of the involvement of a sequence-specific DNA binding factor in IME.	[Bianchi, Marzia; Crinelli, Rita; Giacomini, Elisa; Carloni, Elisa; Radici, Lucia; Magnani, Mauro] Univ Urbino Carlo Bo, Biochem & Mol Biol Sect, Dept Biomol Sci, Urbino, Italy	University of Urbino	Bianchi, M (corresponding author), Univ Urbino Carlo Bo, Biochem & Mol Biol Sect, Dept Biomol Sci, Urbino, Italy.	marzia.bianchi@uniurb.it	Magnani, Mauro/A-1919-2008; Giacomini, Elisa/K-3208-2016	Giacomini, Elisa/0000-0003-3289-3221; Crinelli, Rita/0000-0002-1235-8910; Carloni, Elisa/0000-0003-1178-9353; Bianchi, Marzia/0000-0001-9352-7319; Magnani, Mauro/0000-0001-6456-6626	MINISTERO DELL'ISTRUZIONE DELL'UNIVERSITA E DELLA RICERCA [2008BP25KN_001]	MINISTERO DELL'ISTRUZIONE DELL'UNIVERSITA E DELLA RICERCA(Ministry of Education, Universities and Research (MIUR))	This work was supported by MINISTERO DELL'ISTRUZIONE DELL'UNIVERSITA E DELLA RICERCA (PRIN 2008 2008BP25KN_001) granted to M. Magnani. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2001, J CELL BIOL, V154, P25, DOI 10.1083/jcb.200010059; Akua T, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-93; BAKER RT, 1987, NUCLEIC ACIDS RES, V15, P443, DOI 10.1093/nar/15.2.443; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Bartlett JG, 2009, PLANT BIOTECHNOL J, V7, P856, DOI 10.1111/j.1467-7652.2009.00448.x; Baum C, 2011, HUM GENE THER, V22, P255, DOI 10.1089/hum.2011.2280; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Belak ZR, 2008, BIOCHEM CELL BIOL, V86, P31, DOI [10.1139/O07-155, 10.1139/o07-155]; Bianchi M, 2009, GENE, V448, P88, DOI 10.1016/j.gene.2009.08.013; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Byun HM, 2005, BIOCHEM BIOPH RES CO, V332, P518, DOI 10.1016/j.bbrc.2005.04.155; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Charron M, 2007, BIOL REPROD, V76, P813, DOI 10.1095/biolreprod.106.057851; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Crinelli R, 2002, NUCLEIC ACIDS RES, V30, P2435, DOI 10.1093/nar/30.11.2435; Culler SJ, 2010, NUCLEIC ACIDS RES, V38, P5152, DOI 10.1093/nar/gkq248; Do Kim J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-108; Do Kim J, 2009, GENOMICS, V93, P152, DOI 10.1016/j.ygeno.2008.09.013; Eliassen KA, 1998, MOL CELL BIOL, V18, P7106, DOI 10.1128/MCB.18.12.7106; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; FORNACE AJ, 1989, NUCLEIC ACIDS RES, V17, P1215, DOI 10.1093/nar/17.3.1215; Foti DN, 2004, J MOL ENDOCRINOL, V33, P99, DOI 10.1677/jme.0.0330099; Galvagni F, 1998, J BIOL CHEM, V273, P33708, DOI 10.1074/jbc.273.50.33708; Gazdhar A, 2006, J GENE MED, V8, P910, DOI 10.1002/jgm.911; Gill DR, 2001, GENE THER, V8, P1539, DOI 10.1038/sj.gt.3301561; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Guo AM, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat007; Hasannia S, 2006, BIOTECHNOL LETT, V28, P1545, DOI 10.1007/s10529-006-9121-8; Ho SH, 2001, DEV DYNAM, V221, P422, DOI 10.1002/dvdy.1161; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Kimura Y, 2010, J BIOCHEM, V147, P793, DOI 10.1093/jb/mvq044; Krupka N, 2010, PLASMID, V63, P155, DOI 10.1016/j.plasmid.2010.01.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lalmansingh AS, 2011, J BIOL CHEM, V286, P10970, DOI 10.1074/jbc.M110.166587; Liu HF, 2005, MOL B INT U, P182; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUND PK, 1985, J BIOL CHEM, V260, P7609; MAGIN TM, 1992, GENE, V122, P289, DOI 10.1016/0378-1119(92)90217-D; Marinovic AC, 2002, J BIOL CHEM, V277, P16673, DOI 10.1074/jbc.M200501200; Morello L, 2008, CURR GENOMICS, V9, P227, DOI 10.2174/138920208784533629; Morello L, 2011, J EXP BOT, V62, P533, DOI 10.1093/jxb/erq273; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Parra G, 2011, NUCLEIC ACIDS RES, V39, P5328, DOI 10.1093/nar/gkr043; Ratajewski M, 2009, GENOMICS, V94, P407, DOI 10.1016/j.ygeno.2009.08.014; Rose AB, 2008, CURR TOP MICROBIOL, V326, P277; Rose AB, 2000, PLANT PHYSIOL, V122, P535, DOI 10.1104/pp.122.2.535; Rose AB, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00098; Rylski M, 2008, J BIOL CHEM, V283, P35140, DOI 10.1074/jbc.M804540200; Ryu KY, 2007, EMBO J, V26, P2693, DOI 10.1038/sj.emboj.7601722; Samadder P, 2008, MOL GENET GENOMICS, V279, P429, DOI 10.1007/s00438-008-0323-8; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Schug J., 2008, CURR PROTOC BIOINFOR, V2; Selth LA, 2011, METHODS MOL BIOL, V791, P253, DOI 10.1007/978-1-61779-316-5_19; Takahashi K, 2001, EUR J IMMUNOL, V31, P590, DOI 10.1002/1521-4141(200102)31:2<590::AID-IMMU590>3.3.CO;2-4; Towbin H, 1992, Biotechnology, V24, P145; Varma NRS, 2011, J STEM CELLS REGEN, V7, P41; WIBORG O, 1985, EMBO J, V4, P755, DOI 10.1002/j.1460-2075.1985.tb03693.x; Yokoyama NN, 2010, NUCLEIC ACIDS RES, V38, P6375, DOI 10.1093/nar/gkq492; Zaravinos A, 2010, CELL CYCLE, V9, P512, DOI 10.4161/cc.9.3.10588	61	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65932	10.1371/journal.pone.0065932	http://dx.doi.org/10.1371/journal.pone.0065932			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776572	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400064
J	Chen, YJ; Sheu, ML; Tsai, KS; Sen Yang, R; Liu, SH				Chen, Ying Ju; Sheu, Meei Ling; Tsai, Keh Sung; Sen Yang, Rong; Liu, Shing Hwa			Advanced Glycation End Products Induce Peroxisome Proliferator-Activated Receptor gamma Down-Regulation-Related Inflammatory Signals in Human Chondrocytes via Toll-Like Receptor-4 and Receptor for Advanced Glycation End Products	PLOS ONE			English	Article							HUMAN OSTEOARTHRITIC CHONDROCYTES; MAILLARD REACTION-PRODUCTS; HUMAN ARTICULAR-CARTILAGE; SYNOVIAL FIBROBLASTS; PPAR-GAMMA; KAPPA-B; EXPRESSION; COLLAGEN; MATRIX-METALLOPROTEINASE-13; STIMULATION	Accumulation of advanced glycation end products (AGEs) in joints is important in the development of cartilage destruction and damage in age-related osteoarthritis (OA). The aim of this study was to investigate the roles of peroxisome proliferator-activated receptor gamma (PPAR gamma), toll-like receptor 4 (TLR4), and receptor for AGEs (RAGE) in AGEs-induced inflammatory signalings in human OA chondrocytes. Human articular chondrocytes were isolated and cultured. The productions of metalloproteinase-13 and interleukin-6 were quantified using the specific ELISA kits. The expressions of related signaling proteins were determined by Western blotting. Our results showed that AGEs enhanced the productions of interleukin-6 and metalloproteinase-13 and the expressions of cyclooxygenase-2 and high-mobility group protein B1 and resulted in the reduction of collagen II expression in human OA chondrocytes. AGEs could also activate nuclear factor (NF)-kappa B activation. Stimulation of human OA chondrocytes with AGEs significantly induced the up-regulation of TLR4 and RAGE expressions and the down-regulation of PPAR gamma expression in a time-and concentration-dependent manner. Neutralizing antibodies of TLR4 and RAGE effectively reversed the AGEs-induced inflammatory signalings and PPAR gamma down-regulation. PPAR gamma agonist pioglitazone could also reverse the AGEs-increased inflammatory signalings. Specific inhibitors for p38 mitogen-activated protein kinases, c-Jun N-terminal kinase and NF-kappa B suppressed AGEs-induced PPAR gamma down-regulation and reduction of collagen II expression. Taken together, these findings suggest that AGEs induce PPAR gamma down-regulation-mediated inflammatory signalings and reduction of collagen II expression in human OA chondrocytes via TLR4 and RAGE, which may play a crucial role in the development of osteoarthritis pathogenesis induced by AGEs accumulation.	[Chen, Ying Ju; Liu, Shing Hwa] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 10764, Taiwan; [Sheu, Meei Ling] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Sheu, Meei Ling] Taichung Vet Gen Hosp, Dept Educ & Res, Taichung, Taiwan; [Tsai, Keh Sung] Natl Taiwan Univ, Coll Med, Dept Lab Med, Taipei 10764, Taiwan; [Sen Yang, Rong] Natl Taiwan Univ, Coll Med, Dept Orthopaed, Taipei 10764, Taiwan	National Taiwan University; National Chung Hsing University; Taichung Veterans General Hospital; National Taiwan University; National Taiwan University	Sen Yang, R (corresponding author), Natl Taiwan Univ, Coll Med, Dept Orthopaed, Taipei 10764, Taiwan.	rsyang@ntuh.gov.tw; shinghwaliu@ntu.edu.tw	Sheu, Meei-Ling/AAT-3401-2020	Sheu, Meei-Ling/0000-0002-0431-1282; LIU, SHING-HWA/0000-0002-9976-1197; TSAI, KEH-SUNG/0000-0001-8528-1566; Yang, Rong-Sen/0000-0002-0553-4779	National Science Council of Taiwan [NSC97-2314-B-002-052-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the grant from the National Science Council of Taiwan (NSC97-2314-B-002-052-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afif H, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2151; AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; Andersson U, 2004, J INTERN MED, V255, P344, DOI 10.1111/j.1365-2796.2003.01303.x; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Berenbaum F, 2011, ANN RHEUM DIS, V70, P1354, DOI 10.1136/ard.2010.146399; Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316; Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Cho MC, 2008, PPAR RES, V2008, DOI 10.1155/2008/679137; DeGroot J, 2004, CURR OPIN PHARMACOL, V4, P301, DOI 10.1016/j.coph.2004.01.007; DeGroot J, 2001, OSTEOARTHR CARTILAGE, V9, P720, DOI 10.1053/joca.2001.0469; Fahmi H, 2002, OSTEOARTHR CARTILAGE, V10, P845, DOI 10.1053/joca.2002.0835; Fahmi H, 2002, OSTEOARTHR CARTILAGE, V10, P100, DOI 10.1053/joca.2001.0485; Fahmi H, 2001, ARTHRITIS RHEUM, V44, P595, DOI 10.1002/1529-0131(200103)44:3<595::AID-ANR108>3.3.CO;2-#; Fahmi H, 2011, MOD RHEUMATOL, V21, P1, DOI 10.1007/s10165-010-0347-x; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Glass GG, 2006, DM-DIS MON, V52, P343, DOI 10.1016/j.disamonth.2006.09.001; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Ji JD, 2001, J AUTOIMMUN, V17, P215, DOI 10.1006/jaut.2001.0542; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kim HA, 2006, ARTHRITIS RHEUM-US, V54, P2152, DOI 10.1002/art.21951; Kobayashi T, 2005, ARTHRITIS RHEUM-US, V52, P479, DOI 10.1002/art.20792; Lin L, 2009, FRONT BIOSCI-LANDMRK, V14, P1403, DOI 10.2741/3315; Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199; MCCANCE DR, 1993, J CLIN INVEST, V91, P2470, DOI 10.1172/JCI116482; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Nah SS, 2007, FEBS LETT, V581, P1928, DOI 10.1016/j.febslet.2007.03.090; Noguchi T, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/490406; Qin YH, 2009, J IMMUNOL, V183, P6244, DOI 10.4049/jimmunol.0900390; Rasheed Z, 2012, BBA-MOL CELL RES, V1823, P2179, DOI 10.1016/j.bbamcr.2012.08.021; Rasheed Z, 2011, RHEUMATOLOGY, V50, P838, DOI 10.1093/rheumatology/keq380; Schelbergen RFP, 2012, ARTHRITIS RHEUM-US, V64, P1477, DOI 10.1002/art.33495; Schett G, 2013, DIABETES CARE, V36, P403, DOI 10.2337/dc12-0924; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Steenvoorden MMC, 2006, ARTHRITIS RHEUM-US, V54, P253, DOI 10.1002/art.21523; Takano H, 2009, CIRC J, V73, P214, DOI 10.1253/circj.CJ-08-1071; Terada C, 2011, ACTA MED OKAYAMA, V65, P369; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; van Lent PLEM, 2007, ANN RHEUM DIS, V66, P334, DOI 10.1136/ard.2006.057471; Verzijl N, 2000, BIOCHEM J, V350, P381, DOI 10.1042/0264-6021:3500381; Verzijl N, 2002, ARTHRITIS RHEUM, V46, P114, DOI 10.1002/1529-0131(200201)46:1<114::AID-ART10025>3.0.CO;2-P; Wada J, 2013, CLIN SCI, V124, P139, DOI 10.1042/CS20120198; WOLFF DA, 1992, J ORTHOPAED RES, V10, P49, DOI 10.1002/jor.1100100106; Yammani RR, 2006, ARTHRITIS RHEUM-US, V54, P2901, DOI 10.1002/art.22042; Yang QS, 2010, EUR J PHARMACOL, V649, P108, DOI 10.1016/j.ejphar.2010.09.025	47	69	71	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66611	10.1371/journal.pone.0066611	http://dx.doi.org/10.1371/journal.pone.0066611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776688	Green Submitted, Green Published, gold			2022-12-25	WOS:000320322400113
J	Cohen, CA; Shea, AA; Heffron, CL; Schmelz, EM; Roberts, PC				Cohen, Courtney A.; Shea, Amanda A.; Heffron, C. Lynn; Schmelz, Eva M.; Roberts, Paul C.			Intra-Abdominal Fat Depots Represent Distinct Immunomodulatory Microenvironments: A Murine Model	PLOS ONE			English	Article							DIET-INDUCED OBESITY; OMENTAL MILKY SPOTS; ADIPOSE-TISSUE; GENE-EXPRESSION; B-CELLS; MICE; CAVITY; WOMEN; TRANSPLANTATION; MACROPHAGES	White adipose tissue (WAT) is a multi-faceted endocrine organ involved in energy storage, metabolism, immune function and disease pathogenesis. In contrast to subcutaneous fat, visceral fat (V-WAT) has been associated with numerous diseases and metabolic disorders, indicating specific functions related to anatomical location. Although visceral depots are often used interchangeably in V-WAT-associated disease studies, there has been a recent subdivision of V-WAT into "true visceral" and non-visceral intra-abdominal compartments. These were associated with distinct physiological roles, illustrating a need for depot-specific information. Here, we use FACS analysis to comparatively characterize the leukocyte and progenitor populations in the stromal vascular fraction (SVF) of peritoneal serous fluid (PSF), parametrial (pmWAT), retroperitoneal (rpWAT), and omental (omWAT) adipose tissue from seven-month old C57BL/6 female mice. We found significant differences in SVF composition between all four microenvironments. PSF SVF was comprised almost entirely of CD45(+) leukocytes (>99%), while omWAT contained less, but still almost two-fold more leukocytes than pmWAT and rpWAT (75%, 38% and 38% respectively; p<0.01). PmWAT was composed primarily of macrophages, whereas rpWAT more closely resembled omWAT, denoted by high levels of B1 B-cell and monocyte populations. Further, omWAT harbored significantly higher proportions of T-cells than the other tissues, consistent with its role as a secondary lymphoid organ. These SVF changes were also reflected in the gene expression profiles of the respective tissues. Thus, intra-abdominal fat pads represent independent immunomodulatory microenvironments and should be evaluated as distinct entities with unique contributions to physiological and pathological processes.	[Cohen, Courtney A.; Heffron, C. Lynn; Roberts, Paul C.] Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Shea, Amanda A.; Schmelz, Eva M.] Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Schmelz, EM (corresponding author), Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA.	eschmelz@vt.edu; pcroberts@vt.edu	Schmelz, Eva M/E-6579-2012	Shea, Amanda/0000-0002-8846-8841	National Institutes of Health [R01 CA118846]; Fralin Life Sciences Institute at Virginia Tech; NATIONAL CANCER INSTITUTE [R01CA118846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fralin Life Sciences Institute at Virginia Tech; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by National Institutes of Health R01 CA118846 (EMS, PCR) and funds provided by the Fralin Life Sciences Institute at Virginia Tech (PCR, EMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Baglioni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036569; Berberich S, 2008, J IMMUNOL, V180, P2196, DOI 10.4049/jimmunol.180.4.2196; BJORNTORP P, 1990, ARTERIOSCLEROSIS, V10, P493, DOI 10.1161/01.ATV.10.4.493; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Caspar-Bauguil S, 2005, FEBS LETT, V579, P3487, DOI 10.1016/j.febslet.2005.05.031; Dromard C, 2011, EXP CELL RES, V317, P770, DOI 10.1016/j.yexcr.2011.01.001; Fang ST, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001407; Foster M, 2011, DIABETOLOGIA, V54, P2890, DOI 10.1007/s00125-011-2259-5; Foster MT, 2010, PHYSIOL BEHAV, V101, P282, DOI 10.1016/j.physbeh.2010.05.014; Gerber SA, 2006, AM J PATHOL, V169, P1739, DOI 10.2353/ajpath.2006.051222; Horikawa K, 2006, IMMUNOLOGY, V118, P497, DOI 10.1111/j.1365-2567.2006.02382.x; Kawanishi N, 2010, EXERC IMMUNOL REV, V16, P105; Khan SM, 2010, CLIN EXP METASTAS, V27, P185, DOI 10.1007/s10585-010-9317-0; Kidd S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030563; Kwon EY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-450; Lee M. J., 2012, MOL ASPECTS MED; Linder K, 2004, J LIPID RES, V45, P148, DOI 10.1194/jlr.M300256-JLR200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Macotela Y, 2012, DIABETES, V61, P1691, DOI 10.2337/db11-1753; Matsushita T, 2011, METHODS MOL BIOL, V677, P99, DOI 10.1007/978-1-60761-869-0_7; Montague CT, 1998, DIABETES, V47, P1384, DOI 10.2337/diabetes.47.9.1384; Montecino-Rodriguez E, 2006, TRENDS IMMUNOL, V27, P428, DOI 10.1016/j.it.2006.07.005; Park HT, 2012, CLIN ENDOCRINOL, V76, P59, DOI 10.1111/j.1365-2265.2011.04141.x; Poe JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022464; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; Ray A, 2010, J VIS EXP; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Rubtsova K, 2012, EXPERT REV CLIN IMMU, V8, P5, DOI [10.1586/ECI.11.83, 10.1586/eci.11.83]; Sandoval P, 2010, LAB INVEST, V90, P1517, DOI 10.1038/labinvest.2010.111; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Wueest S, 2012, AM J PHYSIOL-ENDOC M, V302, pE153, DOI 10.1152/ajpendo.00338.2011; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yu G, 2011, METHODS MOL BIOL, V702, P29, DOI 10.1007/978-1-61737-960-4_3; Yu JH, 2009, J IMMUNOL, V183, P4968, DOI 10.4049/jimmunol.0900907; Zhang Yan, 2010, World J Stem Cells, V2, P103, DOI 10.4252/wjsc.v2.i5.103	39	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66477	10.1371/journal.pone.0066477	http://dx.doi.org/10.1371/journal.pone.0066477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776677	Green Published, gold			2022-12-25	WOS:000320322400105
J	Hol, WHG; de Boer, W; ten Hooven, F; van der Putten, WH				Hol, W. H. Gera; de Boer, Wietse; ten Hooven, Freddy; van der Putten, Wim H.			Competition Increases Sensitivity of Wheat (Triticum aestivum) to Biotic Plant-Soil Feedback	PLOS ONE			English	Article							COMMUNITY STRUCTURE; ECOLOGY; PATHOGENS; DIVERSITY; DISEASES; FUNGI	Plant-soil feedback (PSF) and plant competition play an important role in structuring vegetation composition, but their interaction remains unclear. Recent studies suggest that competing plants could dilute pathogenic effects, whereas the standing view is that competition may increase the sensitivity of the focal plant to PSF. In agro-ecosystems each of these two options would yield contrasting outcomes: reduced versus enhanced effects of weeds on crop biomass production. To test the effect of competition on sensitivity to PSF, we grew Triticum aestivum (Common wheat) with and without competition from a weed community composed of Vicia villosa, Chenopodium album and Myosotis arvensis. Plants were grown in sterilized soil, with or without living field inoculum from 4 farms in the UK. In the conditioning phase, field inocula had both positive and negative effects on T. aestivum shoot biomass, depending on farm. In the feedback phase the differences between shoot biomass in T. aestivum monoculture on non-inoculated and inoculated soils had mostly disappeared. However, T. aestivum plants growing in mixtures in the feedback phase were larger on non-inoculated soil than on inoculated soil. Hence, T. aestivum was more sensitive to competition when the field soil biota was present. This was supported by the statistically significant negative correlation between shoot biomass of weeds and T. aestivum, which was absent on sterilized soil. In conclusion, competition in cereal crop-weed systems appears to increase cereal crop sensitivity to soil biota.	[Hol, W. H. Gera; ten Hooven, Freddy; van der Putten, Wim H.] Netherlands Inst Ecol, Dept Terr Ecol, Wageningen, Netherlands; [de Boer, Wietse] Netherlands Inst Ecol, Dept Microbial Ecol, Wageningen, Netherlands; [de Boer, Wietse] Wageningen Univ, Dept Soil Qual, NL-6700 AP Wageningen, Netherlands; [van der Putten, Wim H.] Wageningen Univ, Nematol Lab, NL-6700 AP Wageningen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; Wageningen University & Research	Hol, WHG (corresponding author), Netherlands Inst Ecol, Dept Terr Ecol, Wageningen, Netherlands.	g.hol@nioo.knaw.nl	de Boer, Wietse/C-2737-2011; van der Putten, Wim H/C-3707-2011; Hol, Gera W. H./B-4490-2008; KNAW, NIOO-KNAW/A-4320-2012	de Boer, Wietse/0000-0002-5380-2993; van der Putten, Wim H/0000-0002-9341-4442; Hol, Gera W. H./0000-0002-1256-495X; KNAW, NIOO-KNAW/0000-0002-3835-159X	EU	EU(European Commission)	The work was funded by the EU project SOILSERVICE. SOILSERVICE is a collaborative, medium scale focussed research project, which is funded by EU's Seventh Framework Programme. (http://www4.lu.se/soil-ecology-group/research/soilservice.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera AG, 2011, ECOL MODEL, V222, P3413, DOI 10.1016/j.ecolmodel.2011.06.018; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Brandt AJ, 2009, ECOLOGY, V90, P1063, DOI 10.1890/08-0054.1; Brinkman EP, 2010, J ECOL, V98, P1063, DOI 10.1111/j.1365-2745.2010.01695.x; BULLOCK DG, 1992, CRIT REV PLANT SCI, V11, P309, DOI 10.1080/07352689209382349; Callaway RM, 2004, ECOLOGY, V85, P1062, DOI 10.1890/02-0775; Callaway RM, 2004, NATURE, V427, P731, DOI 10.1038/nature02322; Callaway RM, 2003, ECOLOGY, V84, P129, DOI 10.1890/0012-9658(2003)084[0129:SFATEO]2.0.CO;2; Casper BB, 2007, ECOL LETT, V10, P394, DOI 10.1111/j.1461-0248.2007.01030.x; Eviner VT, 2008, RESTOR ECOL, V16, P713, DOI 10.1111/j.1526-100X.2008.00482.x; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; Gilbert GS, 2002, ANNU REV PHYTOPATHOL, V40, P13, DOI 10.1146/annurev.phyto.40.021202.110417; Harrison KA, 2010, J ECOL, V98, P384, DOI 10.1111/j.1365-2745.2009.01614.x; Hauggaard-Nielsen H, 2009, NUTR CYCL AGROECOSYS, V85, P141, DOI 10.1007/s10705-009-9254-y; Hendriks M, 2013, J ECOL, V101, P287, DOI 10.1111/1365-2745.12032; HOAGLAND D. R., 1938, Annual Report of the Smithsonian Institution, P461; Hol WHG, 2011, FRONT ECOL ENVIRON, V9, P431, DOI 10.1890/11.WB.024; Inderjit, 2010, TRENDS ECOL EVOL, V25, P512, DOI 10.1016/j.tree.2010.06.006; Jiang LL, 2010, ECOL RES, V25, P1101, DOI 10.1007/s11284-010-0735-x; Jordan NR, 2011, INVAS PLANT SCI MANA, V4, P11, DOI 10.1614/IPSM-D-10-00004.1; Kardol P, 2007, ECOL MONOGR, V77, P147, DOI 10.1890/06-0502; Kardol P, 2006, ECOL LETT, V9, P1080, DOI 10.1111/j.1461-0248.2006.00953.x; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Lundkvist A, 2008, EUR J AGRON, V28, P570, DOI 10.1016/j.eja.2008.01.001; Manning P, 2008, OECOLOGIA, V157, P661, DOI 10.1007/s00442-008-1104-0; Maron JL, 2011, ECOL LETT, V14, P36, DOI 10.1111/j.1461-0248.2010.01547.x; Otten W, 2006, EUR J SOIL SCI, V57, P26, DOI 10.1111/j.1365-2389.2006.00766.x; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; R Core Team, 2022, R LANG ENV STAT COMP; Reynolds HL, 2003, ECOLOGY, V84, P2281, DOI 10.1890/02-0298; Schnitzer SA, 2011, ECOLOGY, V92, P296, DOI 10.1890/10-0773.1; Shannon S, 2012, OECOLOGIA, V169, P235, DOI 10.1007/s00442-011-2195-6; SNAYDON RW, 1991, J APPL ECOL, V28, P930, DOI 10.2307/2404218; Tilman D., 1982, Monographs in Population Biology, pi; VanderPutten WH, 1997, ECOLOGY, V78, P1785, DOI 10.1890/0012-9658(1997)078[1785:HSBPMA]2.0.CO;2	36	28	28	6	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66085	10.1371/journal.pone.0066085	http://dx.doi.org/10.1371/journal.pone.0066085			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776610	Green Published, gold			2022-12-25	WOS:000320322400078
J	Chung, YE; Kim, MJ; Kim, YE; Park, MS; Choi, JY; Kim, KW				Chung, Yong Eun; Kim, Myeong-Jin; Kim, Yeo-Eun; Park, Mi-Suk; Choi, Jin Young; Kim, Ki Whang			Characterization of Incidental Liver Lesions: Comparison of Multidetector CT versus Gd-EOB-DTPA-Enhanced MR Imaging	PLOS ONE			English	Article							FOCAL NODULAR HYPERPLASIA; HEPATOCELLULAR-CARCINOMA; HEPATIC HEMANGIOMA; DIAGNOSIS; DIMEGLUMINE; TUMORS	As a result of recent developments in imaging modalities and wide spread routine medical checkups and screening, more incidental liver lesions are found frequently on US these days. When incidental liver lesions are found on US, physicians have to make a decision whether to just follow up or to undergo additional imaging studies for lesion characterization. In order to choose the next appropriate imaging modality, the diagnostic accuracy of each imaging study needs to be considered. Therefore, we tried to compare the accuracy of contrast-enhanced multidetector CT (MDCT) and Gd-EOB-DTPA-enhanced MRI for characterization of incidental liver masses. We included 127 incidentally found focal liver lesions (94 benign and 33 malignant) from 80 patients (M: F = 45: 35) without primary extrahepatic malignancy or chronic liver disease. Two radiologists independently reviewed Gd-EOB-DTPA-enhanced MRI and MDCT. The proportion of confident interpretations for differentiation of benign and malignant lesions and for the specific diagnosis of diseases were compared. The proportion of confident interpretations for the differentiation of benign and malignant lesions was significantly higher with EOB-MRI(94.5%-97.6%) than with MDCT (74.0%-92.9%). In terms of specific diagnosis, sensitivity and accuracy were significantly higher with EOB-MRI than with MDCT for the diagnosis of focal nodular hyperplasia (FNH) and focal eosinophilic infiltration. The diagnoses of the remaining diseases were comparable between EOB-MRI and MDCT. Hence, our results suggested that Gd-EOB-MRI may provide a higher proportion of confident interpretations than MDCT, especially for the diagnosis of incidentally found FNH and focal eosinophilic infiltration.	[Chung, Yong Eun; Kim, Myeong-Jin; Kim, Yeo-Eun; Park, Mi-Suk; Choi, Jin Young; Kim, Ki Whang] Yonsei Univ, Coll Med, Dept Radiol, Severance Hosp, Seoul, South Korea	Yonsei University; Yonsei University Health System	Kim, KW (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Severance Hosp, Seoul, South Korea.	kimnex@yuhs.ac	; Kim, Myeong-Jin/E-1623-2011	Chung, Yong Eun/0000-0003-0811-9578; Choi, Jin-Young/0000-0002-9025-6274; Kim, Myeong-Jin/0000-0001-7949-5402; Park, Mi-Suk/0000-0001-5817-2444				Ahn SS, 2010, RADIOLOGY, V255, P459, DOI 10.1148/radiol.10091388; Bartolotta TV, 2011, INVEST RADIOL, V46, P106, DOI 10.1097/RLI.0b013e3181f44184; Boutros C, 2010, SURG CLIN N AM, V90, P699, DOI 10.1016/j.suc.2010.04.005; Brancatelli G, 2002, RADIOLOGY, V222, P89, DOI 10.1148/radiol.2221010767; Cicchetti DV., 1971, AM J EEG TECHNOL, V11, P101, DOI [10.1080/00029238.1971.11080840, DOI 10.1080/00029238.1971.11080840]; Doo KW, 2009, AM J ROENTGENOL, V193, pW490, DOI 10.2214/AJR.08.1732; Furtado CD, 2005, RADIOLOGY, V237, P385, DOI 10.1148/radiol.2372041741; Gore RM, 2011, RADIOL CLIN N AM, V49, P291, DOI 10.1016/j.rcl.2010.10.004; Grazioli L, 2003, J MAGN RESON IMAGING, V17, P593, DOI 10.1002/jmri.10289; Jang HJ, 2003, AM J ROENTGENOL, V180, P135, DOI 10.2214/ajr.180.1.1800135; KARHUNEN PJ, 1986, J CLIN PATHOL, V39, P183, DOI 10.1136/jcp.39.2.183; Kim MJ, 2011, GUT LIVER, V5, P15, DOI 10.5009/gnl.2011.5.1.15; Kovach SJ, 2006, J SURG ONCOL, V94, P385, DOI 10.1002/jso.20516; Lee J, 2010, MAGN RESON IMAGING, V28, P1327, DOI 10.1016/j.mri.2010.06.013; Park G, 2010, BRIT J RADIOL, V83, P1010, DOI 10.1259/bjr/66686028; Purysko AS, 2011, CLIN RADIOL, V66, P673, DOI 10.1016/j.crad.2011.01.014; Soussan M, 2010, EUR RADIOL, V20, P1715, DOI 10.1007/s00330-009-1700-3; Yoon SS, 2003, J AM COLL SURGEONS, V197, P392, DOI 10.1016/S1072-7515(03)00420-4; Yu JS, 2005, J COMPUT ASSIST TOMO, V29, P765, DOI 10.1097/01.rct.0000182856.75273.dd; Zech CJ, 2008, INVEST RADIOL, V43, P504, DOI 10.1097/RLI.0b013e3181705cd1	20	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66141	10.1371/journal.pone.0066141	http://dx.doi.org/10.1371/journal.pone.0066141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776623	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400115
J	Gulec, S; Collins, JF				Gulec, Sukru; Collins, James F.			Investigation of Iron Metabolism in Mice Expressing a Mutant Menke's Copper Transporting ATPase (Atp7a) Protein with Diminished Activity (Brindled; Mo-Br/y)	PLOS ONE			English	Article							MOTTLED MOUSE MUTANTS; INDUCIBLE FACTOR-I; DEFICIENT MICE; GENE-EXPRESSION; RAT DUODENUM; CERULOPLASMIN; HEPHAESTIN; HYPOXIA; ABSORPTION; DIETARY	During iron deficiency, perturbations in copper homeostasis have frequently been documented. Previous studies in iron-deprived rats demonstrated that enterocyte and hepatic copper levels increase and a copper transporter (the Menkes Copper ATPase; Atp7a) is induced in the duodenal epithelium in parallel to iron transport-related genes (e.g. Dmt1, Dcytb, Fpn1). Moreover, two ferroxidase proteins involved in iron homeostasis, hephaestin expressed in enterocytes and ceruloplasmin, produced and secreted into blood by the liver, are copper-dependent enzymes. We thus aimed to test the hypothesis that Atp7a function is important for the copper-related compensatory response of the intestinal epithelium to iron deficiency. Accordingly, iron homeostasis was studied for the first time in mice expressing a mutant Atp7a protein with minimal activity (Brindled [Mo-Br/y]). Mutant mice were rescued by perinatal copper injections, and, after a 7-8 week recovery period, were deprived of dietary iron for 3 weeks (along with WT littermates). Adult Mo-Br/y mice displayed copper-deficiency anemia but had normal iron status; in contrast, iron-deprived Mo-Br/y mice were iron deficient and more severely anemic with partial amelioration of the copper-deficient phenotype. Intestinal iron absorption in both genotypes (WT and Mo-Br/y) increased similar to 3-fold when mice consumed a low-iron diet and similar to 6-fold when mice were concurrently bled. WT mice exhibited no alterations in copper homeostasis in response to iron deprivation or phlebotomy. Conversely, upregulation of iron absorption was associated with increased enterocyte and liver copper levels and serum ferroxidase (ceruloplasmin) activity in Mo-Br/y mice, typifying the response to iron deprivation in many mammalian species. We thus speculate that a copper threshold exists that is necessary to allow appropriate regulate of iron absorption. In summary, Mo-Br/y mice were able to adequately regulate iron absorption, but unlike in WT mice, concurrent increases in enterocyte and liver copper levels and serum ferroxidase activity may have contributed to maintenance of iron homeostasis.	[Gulec, Sukru; Collins, James F.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Collins, JF (corresponding author), Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL 32611 USA.	jfcollins@ufl.edu		Gulec, Sukru/0000-0002-6789-1050	National Institutes of Health [DK074867]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by National Institutes of Health grant DK074867 (J.F.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GJ, 2002, BLOOD CELL MOL DIS, V29, P367, DOI 10.1006/bcmd.2002.0576; Auclair S, 2006, BLOOD CELL MOL DIS, V36, P15, DOI 10.1016/j.bcmd.2005.11.003; Bellier S, 2005, AM J PHYSIOL-GASTR L, V288, pG151, DOI 10.1152/ajpgi.00048.2004; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; CAMAKARIS J, 1979, BIOCHEM J, V180, P597, DOI 10.1042/bj1800597; CHASE MS, 1952, J BIOL CHEM, V199, P757; Chen HJ, 2006, J NUTR, V136, P1236, DOI 10.1093/jn/136.5.1236; Chen HJ, 2003, BLOOD, V102, P1893, DOI 10.1182/blood-2003-02-0347; Cherukuri S, 2005, CELL METAB, V2, P309, DOI 10.1016/j.cmet.2005.10.003; Collins JF, 2009, AM J PHYSIOL-GASTR L, V297, pG695, DOI 10.1152/ajpgi.00203.2009; Collins JF, 2005, AM J PHYSIOL-GASTR L, V288, pG964, DOI 10.1152/ajpgi.00489.2004; Donsante A, 2011, MOL THER, V19, P2114, DOI 10.1038/mt.2011.143; Ece A, 1997, BIOL TRACE ELEM RES, V59, P31, DOI 10.1007/BF02783227; Fox PL, 2003, BIOMETALS, V16, P9, DOI 10.1023/A:1020799512190; Ganz T, 2009, SEMIN HEMATOL, V46, P387, DOI 10.1053/j.seminhematol.2009.06.001; Gitlin JD, 1998, PEDIATR RES, V44, P271, DOI 10.1203/00006450-199809000-00001; Grimes A, 1997, HUM MOL GENET, V6, P1037, DOI 10.1093/hmg/6.7.1037; Hellman NE, 2002, ANNU REV NUTR, V22, P439, DOI 10.1146/annurev.nutr.22.012502.114457; Hu ZH, 2010, AM J PHYSIOL-CELL PH, V299, pC930, DOI 10.1152/ajpcell.00238.2010; Jenkitkasemwong S, 2010, J NUTR, V140, P723, DOI 10.3945/jn.109.117077; Kim BE, 2007, J MED GENET, V44, P641, DOI 10.1136/jmg.2007.049627; Klevay LM, 1997, J NUTR, V127, pS1034; Kuo YM, 2004, GUT, V53, P201, DOI 10.1136/gut.2003.019026; LEE GR, 1968, J CLIN INVEST, V47, P2058, DOI 10.1172/JCI105891; MANN JR, 1979, BIOCHEM J, V180, P605, DOI 10.1042/bj1800605; MANN JR, 1980, BIOCHEM J, V186, P629, DOI 10.1042/bj1860629; MANN JR, 1979, BIOCHEM J, V180, P613, DOI 10.1042/bj1800613; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Mukhopadhyay CK, 2000, J BIOL CHEM, V275, P21048, DOI 10.1074/jbc.M000636200; NAVEH Y, 1981, PEDIATRICS, V68, P397; Prohaska J. R., 1981, Nutrition Research, V1, P159, DOI 10.1016/S0271-5317(81)80098-X; Prohaska JR, 2012, BIOMETALS, V25, P633, DOI 10.1007/s10534-012-9521-2; PROHASKA JR, 1982, J NUTR, V112, P1706, DOI 10.1093/jn/112.9.1706; Prohaska JR, 2006, COMP BIOCHEM PHYS B, V143, P360, DOI 10.1016/j.cbpb.2005.12.010; PROHASKA JR, 1984, J NUTR, V114, P422, DOI 10.1093/jn/114.2.422; Ranganathan PN, 2012, BIOMETALS, V25, P687, DOI 10.1007/s10534-012-9527-9; Ranganathan PN, 2011, BLOOD, V118, P3146, DOI 10.1182/blood-2011-05-352112; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Ravia JJ, 2005, J BIOL CHEM, V280, P36221, DOI 10.1074/jbc.M506727200; Reeves PG, 2005, J NUTR, V135, P92, DOI 10.1093/jn/135.1.92; ROYCE PM, 1982, BIOCHEM J, V202, P369, DOI 10.1042/bj2020369; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; SHERMAN AR, 1984, J NUTR, V114, P298, DOI 10.1093/jn/114.2.298; SOURKES TL, 1968, CAN J BIOCHEM CELL B, V46, P267, DOI 10.1139/o68-038; SUZUKI K, 1981, ACTA NEUROPATHOL, V55, P251, DOI 10.1007/BF00690986; Taylor M, 2011, GASTROENTEROLOGY, V140, P2044, DOI 10.1053/j.gastro.2011.03.007; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Yamamoto K, 2002, BBA-MOL BASIS DIS, V1588, P195, DOI 10.1016/S0925-4439(02)00165-5; YOKOI K, 1991, BIOL TRACE ELEM RES, V29, P257, DOI 10.1007/BF03032682	49	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66010	10.1371/journal.pone.0066010	http://dx.doi.org/10.1371/journal.pone.0066010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776592	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400098
J	Kainz, KP; Krenn, L; Erdem, Z; Kaehlig, H; Zehl, M; Bursch, W; Berger, W; Marian, B				Kainz, Kerstin P.; Krenn, Liselotte; Erdem, Zeynep; Kaehlig, Hanspeter; Zehl, Martin; Bursch, Wilfried; Berger, Walter; Marian, Brigitte			2-Deprenyl-Rheediaxanthone B Isolated from Metaxya rostrata Induces Active Cell Death in Colorectal Tumor Cells	PLOS ONE			English	Article							INDUCED MITOTIC CATASTROPHE; ALPHA-MANGOSTIN; CANCER-CELLS; COLON-CANCER; IN-VITRO; APOPTOSIS; EXPRESSION; XANTHONES; MITOCHONDRIA; PROGRESSION	Metaxya rostrata C. Presl (Metaxyaceae) is a common tree fern in Central and South America that is used for the treatment of intestinal ulcers and tumours in ethnic medicine. Using a bioactivity-guided strategy 2-deprenyl-rheediaxanthone B (XB) has been isolated as one of the active principles in this plant. XB induced loss of cell viability in colorectal cancer cell lines at IC50 concentrations of 11-23 mu M. This was caused by both accumulation of cells in the G2- and S-phase as well as by induction of active cell death in a time and concentration-dependent manner. Cells exposed to XB were incapable of undergoing regular mitosis due to down-regulation of FoxM1 and absence of chromosome condensation. The apoptosis-related proteins Bcl(2) and Bcl(xl) were up-regulated so that Caspase 3 was not activated and classical apoptosis was not observed. However, XB triggered damage pathways down-stream of ATR and activated Caspase 2 causing cell death by a mechanism similar to mitotic catastrophe. Our observations are the first to show the cytotoxic activity of 2-deprenyl-rheediaxanthone B and indicate that XB is an interesting new lead compound for cancer therapy that merits further development.	[Kainz, Kerstin P.; Erdem, Zeynep; Bursch, Wilfried; Berger, Walter; Marian, Brigitte] Med Univ Vienna, Dept Med 1, Inst Canc Res, Vienna, Austria; [Kainz, Kerstin P.; Krenn, Liselotte; Zehl, Martin] Univ Vienna, Dept Pharmacognosy, Vienna, Austria; [Kaehlig, Hanspeter] Univ Vienna, Dept Organ Chem, Vienna, Austria	Medical University of Vienna; University of Vienna; University of Vienna	Marian, B (corresponding author), Med Univ Vienna, Dept Med 1, Inst Canc Res, Vienna, Austria.	brigitte.marian@meduniwien.ac.at	Zehl, Martin/B-5901-2008	Zehl, Martin/0000-0001-9685-0373; Berger, Walter/0000-0003-0014-1658; Krenn, Liselotte/0000-0002-9526-4396; Kaehlig, Hanspeter/0000-0002-3898-6501	Austrian Science Foundation [P20354]	Austrian Science Foundation(Austrian Science Fund (FWF))	The study was suppported by the Austrian Science Foundation (P20354). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2008, INT J MOL SCI, V9, P355, DOI 10.3390/ijms9030355; Batova A, 2010, MOL CANCER THER, V9, P2869, DOI 10.1158/1535-7163.MCT-10-0517; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Castanheiro RAP, 2009, PHARMACEUTICALS, V2, P33, DOI 10.3390/ph2020033; Chao AC, 2011, J AGR FOOD CHEM, V59, P2086, DOI 10.1021/jf1042757; Cheng JH, 2011, EUR J MED CHEM, V46, P1222, DOI 10.1016/j.ejmech.2011.01.043; de Bruin EC, 2008, CANCER TREAT REV, V34, P737, DOI 10.1016/j.ctrv.2008.07.001; Ding L, 2009, TOXICOL IN VITRO, V23, P408, DOI 10.1016/j.tiv.2009.01.010; Eng C, 2010, ONCOLOGIST, V15, P73, DOI 10.1634/theoncologist.2009-0167; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Garcia-Rivera D, 2011, CANCER LETT, V305, P21, DOI 10.1016/j.canlet.2011.02.011; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hausott B, 2004, INT J CANCER, V109, P933, DOI 10.1002/ijc.20033; Hay AE, 2004, LIFE SCI, V75, P3077, DOI 10.1016/j.lfs.2004.07.009; Hinoshita E, 2000, CLIN CANCER RES, V6, P2401; Ianzini F, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-11; Kalabis J, 2003, FASEB J, V17, P1115, DOI 10.1096/fj.02-0852fje; Kim Jinwoong, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P485; Krajarng A, 2011, J AGR FOOD CHEM, V59, P5746, DOI 10.1021/jf200620n; Krajewska M, 1996, CANCER RES, V56, P2422; Lavaud A, 2012, BIOCHEM PHARMACOL, V83, P514, DOI 10.1016/j.bcp.2011.12.002; Lim CK, 2011, LETT DRUG DES DISCOV, V8, P523; Macdonald JS, 2001, SEMIN ONCOL, V28, P30, DOI 10.1053/sonc.2001.20750; Matsumoto K, 2004, BIOORGAN MED CHEM, V12, P5799, DOI 10.1016/j.bmc.2004.08.034; Monache FD, 1981, J CHEM SOC, V1, P484; Nakagawa Y, 2007, BIOORGAN MED CHEM, V15, P5620, DOI 10.1016/j.bmc.2007.04.071; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Niu SL, 2012, PHYTOCHEMISTRY, V77, P280, DOI 10.1016/j.phytochem.2012.01.010; Palmeira A, 2010, CHEM BIOL DRUG DES, V76, P43, DOI 10.1111/j.1747-0285.2010.00978.x; Partik G, 1998, VIRCHOWS ARCH, V432, P415, DOI 10.1007/s004280050185; Pekarek B, 2003, THESIS U NATURAL RES; Peng KC, 1999, J HISTOCHEM CYTOCHEM, V47, P757, DOI 10.1177/002215549904700605; Peterson C, 2011, EUR J CLIN PHARMACOL, V67, P437, DOI 10.1007/s00228-011-1011-x; Portugal J, 2010, CURR PHARM DESIGN, V16, P69, DOI 10.2174/138161210789941801; Ragnhammar P, 2001, ACTA ONCOL, V40, P282, DOI 10.1080/02841860151116367; Rath G, 1996, PHYTOCHEMISTRY, V43, P513, DOI 10.1016/0031-9422(96)00284-1; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Richter M, 2002, EUR J CANCER, V38, P1937, DOI 10.1016/S0959-8049(02)00158-2; Shen R, 2010, J FLUORESC, V20, P1287, DOI 10.1007/s10895-010-0680-7; Singh R, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-4; Virtbauer J, 2008, Z NATURFORSCH C, V63, P469; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Watanapokasin R, 2011, WORLD J GASTROENTERO, V17, P2086, DOI 10.3748/wjg.v17.i16.2086; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7	44	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65745	10.1371/journal.pone.0065745	http://dx.doi.org/10.1371/journal.pone.0065745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776538	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400064
J	Margadant, C; Kreft, M; Zambruno, G; Sonnenberg, A				Margadant, Coert; Kreft, Maaike; Zambruno, Giovanna; Sonnenberg, Arnoud			Kindlin-1 Regulates Integrin Dynamics and Adhesion Turnover	PLOS ONE			English	Article							KINDLER-SYNDROME; EXTRACELLULAR-MATRIX; KERATINOCYTE MIGRATION; PROTEIN; BETA-1-INTEGRIN; MUTATIONS; LAMININ-5; GROWTH; SKIN; PROLIFERATION	Loss-of-function mutations in the gene encoding the integrin co-activator kindlin-1 cause Kindler syndrome. We report a novel kindlin-1-deficient keratinocyte cell line derived from a Kindler syndrome patient. Despite the expression of kindlin-2, the patient's cells display several hallmarks related to reduced function of beta 1 integrins, including abnormal cell morphology, cell adhesion, cell spreading, focal adhesion assembly, and cell migration. Defective cell adhesion was aggravated by kindlin-2 depletion, indicating that kindlin-2 can compensate to a certain extent for the loss of kindlin-1. Intriguingly, beta b1 at the cell-surface was aberrantly glycosylated in the patient's cells, and its expression was considerably reduced, both in cells in vitro and in the patient's epidermis. Reconstitution with wild-type kindlin-1 but not with a beta 1-binding defective mutant restored the aberrant beta 1 expression and glycosylation, and normalized cell morphology, adhesion, spreading, and migration. Furthermore, the expression of wild-type kindlin-1, but not of the integrin-binding-defective mutant, increased the stability of integrin-mediated cell-matrix adhesions and enhanced the redistribution of internalized integrins to the cell surface. Thus, these data uncover a role for kindlin-1 in the regulation of integrin trafficking and adhesion turnover.	[Margadant, Coert; Kreft, Maaike; Sonnenberg, Arnoud] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands; [Zambruno, Giovanna] IDI IRCCS, Lab Mol & Cell Biol, Rome, Italy	Netherlands Cancer Institute; IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Sonnenberg, A (corresponding author), Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands.	a.sonnenberg@nki.nl	Zambruno, Giavanna/K-2933-2018	Zambruno, Giovanna/0000-0002-1295-056X	DEBRA UK	DEBRA UK	The work was supported by a grant from DEBRA UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton GHS, 2004, CLIN EXP DERMATOL, V29, P116, DOI 10.1111/j.1365-2230.2004.01465.x; Bandyopadhyay A, 2012, J CELL SCI, V125, P2172, DOI 10.1242/jcs.096214; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Brakebusch C, 2000, EMBO J, V19, P3990, DOI 10.1093/emboj/19.15.3990; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; DeHart GW, 2003, EXP CELL RES, V283, P67, DOI 10.1016/S0014-4827(02)00028-9; DiPersio CM, 1997, J CELL BIOL, V137, P729, DOI 10.1083/jcb.137.3.729; GagnouxPalacios L, 1996, J BIOL CHEM, V271, P18437, DOI 10.1074/jbc.271.31.18437; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Hamill KJ, 2009, J CELL SCI, V122, P4409, DOI 10.1242/jcs.041095; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hartwig B, 2007, EXP CELL RES, V313, P1575, DOI 10.1016/j.yexcr.2007.02.003; Has C, 2008, BRIT J DERMATOL, V159, P1192, DOI 10.1111/j.1365-2133.2008.08760.x; Has C, 2006, J INVEST DERMATOL, V126, P1776, DOI 10.1038/sj.jid.5700339; Has C, 2012, NEW ENGL J MED, V366, P1508, DOI 10.1056/NEJMoa1110813; Has C, 2011, HUM MUTAT, V32, P1204, DOI 10.1002/humu.21576; Has C, 2009, AM J PATHOL, V175, P1442, DOI 10.2353/ajpath.2009.090203; He YH, 2011, AM J PATHOL, V178, P975, DOI 10.1016/j.ajpath.2010.11.053; Herz C, 2006, J BIOL CHEM, V281, P36082, DOI 10.1074/jbc.M606259200; Hodivala-Dilke KM, 1998, J CELL BIOL, V142, P1357, DOI 10.1083/jcb.142.5.1357; Jobard F, 2003, HUM MOL GENET, V12, P925, DOI 10.1093/hmg/ddg097; Kern J S, 2007, J Pathol, V213, P462, DOI 10.1002/path.2253; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; KIM JP, 1992, J INVEST DERMATOL, V98, P764, DOI 10.1111/1523-1747.ep12499947; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Lai-Cheong JE, 2008, J INVEST DERMATOL, V128, P2156, DOI 10.1038/jid.2008.58; Lai-Cheong JE, 2010, DERMATOL CLIN, V28, P119, DOI 10.1016/j.det.2009.10.013; Lai-Cheong JE, 2009, AM J PATHOL, V175, P1431, DOI 10.2353/ajpath.2009.081154; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Margadant C, 2012, CURR BIOL, V22, P1554, DOI 10.1016/j.cub.2012.06.060; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Margadant C, 2010, FASEB J, V24, P4133, DOI 10.1096/fj.09-151449; Margadant C, 2009, J CELL SCI, V122, P278, DOI 10.1242/jcs.029108; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Miquel C, 1996, EXP CELL RES, V224, P279, DOI 10.1006/excr.1996.0138; OToole EA, 1997, EXP CELL RES, V233, P330, DOI 10.1006/excr.1997.3586; Postel R, 2013, J INVEST DERMATOL, V133, P2180, DOI 10.1038/jid.2013.154; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Qu HY, 2012, AM J PATHOL, V180, P1581, DOI 10.1016/j.ajpath.2012.01.005; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Sadler E, 2006, ARCH DERMATOL, V142, P1619, DOI 10.1001/archderm.142.12.1619; Schaapveld RQJ, 1998, J CELL BIOL, V142, P271, DOI 10.1083/jcb.142.1.271; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Wen TT, 2010, WOUND REPAIR REGEN, V18, P325, DOI 10.1111/j.1524-475X.2010.00590.x; White SJ, 2005, J DERMATOL SCI, V38, P169, DOI 10.1016/j.jdermsci.2004.12.026	53	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65341	10.1371/journal.pone.0065341	http://dx.doi.org/10.1371/journal.pone.0065341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776470	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400024
J	Patwardhan, RS; Checker, R; Sharma, D; Sandur, SK; Sainis, KB				Patwardhan, Raghavendra S.; Checker, Rahul; Sharma, Deepak; Sandur, Santosh K.; Sainis, Krishna B.			Involvement of ERK-Nrf-2 Signaling in Ionizing Radiation Induced Cell Death in Normal and Tumor Cells	PLOS ONE			English	Article							NF-KAPPA-B; TARGETING INFLAMMATORY PATHWAYS; GENE-EXPRESSION; PRO-OXIDANTS; NRF2; CANCER; ACTIVATION; MECHANISMS; APOPTOSIS; ROS	Prolonged oxidative stress favors tumorigenic environment and inflammation. Oxidative stress may trigger redox adaptation mechanism(s) in tumor cells but not normal cells. This may increase levels of intracellular antioxidants and establish a new redox homeostasis. Nrf-2, a master regulator of battery of antioxidant genes is constitutively activated in many tumor cells. Here we show that, murine T cell lymphoma EL-4 cells show constitutive and inducible radioresistance via activation of Nrf-2/ERK pathway. EL-4 cells contained lower levels of ROS than their normal counterpart murine splenic lymphocytes. In response to radiation, the thiol redox circuits, GSH and thioredoxin were modified in EL-4 cells. Pharmacological inhibitors of ERK and Nrf-2 significantly enhanced radiosensitivity and reduced clonogenic potential of EL-4 cells. Unirradiated lymphoma cells showed nuclear accumulation of Nrf-2, upregulation of its dependent genes and protein levels. Interestingly, MEK inhibitor abrogated its nuclear translocation suggesting role of ERK in basal and radiation induced Nrf-2 activation in tumor cells. Double knockdown of ERK and Nrf-2 resulted in higher sensitivity to radiation induced cell death as compared to individual knockdown cells. Importantly, NF-kB which is reported to be constitutively active in many tumors was not present at basal levels in EL-4 cells and its inhibition did not influence radiosensitivity of EL-4 cells. Thus our results reveal that, tumor cells which are subjected to heightened oxidative stress employ master regulator cellular redox homeostasis Nrf-2 for prevention of radiation induced cell death. Our study reveals the molecular basis of tumor radioresistance and highlights role of Nrf-2 and ERK.	[Patwardhan, Raghavendra S.; Checker, Rahul; Sharma, Deepak; Sandur, Santosh K.; Sainis, Krishna B.] Bhabha Atom Res Ctr, Biomed Grp, Radiat Biol & Hlth Sci Div, Bombay 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Sainis, KB (corresponding author), Bhabha Atom Res Ctr, Biomed Grp, Radiat Biol & Hlth Sci Div, Bombay 400085, Maharashtra, India.	kbsainis@barc.gov.in		Sharma, Deepak/0000-0002-7529-5574; patwardhan, Raghvendra/0000-0001-6608-8779; Checker, Rahul/0000-0001-7704-3613	Department of Atomic Energy, Government of India	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	Funding was provided by Department of Atomic Energy, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Aggarwal BB, 2009, CLIN CANCER RES, V15, P425, DOI 10.1158/1078-0432.CCR-08-0149; Cakir Y, 2005, ANTIOXID REDOX SIGN, V7, P726, DOI 10.1089/ars.2005.7.726; Checker R, 2008, INT IMMUNOPHARMACOL, V8, P661, DOI 10.1016/j.intimp.2008.01.012; Checker R, 2009, INT IMMUNOPHARMACOL, V9, P949, DOI 10.1016/j.intimp.2009.03.022; Copple IM, 2008, TOXICOLOGY, V246, P24, DOI 10.1016/j.tox.2007.10.029; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; den Hertog J, 2005, ARCH BIOCHEM BIOPHYS, V434, P11, DOI 10.1016/j.abb.2004.05.024; Deorukhkar A, 2010, BIOCHEM PHARMACOL, V80, P1904, DOI 10.1016/j.bcp.2010.06.039; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Fang J, 2009, ADV DRUG DELIVER REV, V61, P290, DOI 10.1016/j.addr.2009.02.005; Hayes JD, 2006, MOL CELL, V21, P732, DOI 10.1016/j.molcel.2006.03.004; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Ikeda H, 2004, BIOCHEM J, V380, P515, DOI 10.1042/BJ20031948; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jackson AL, 2001, MUTAT RES-FUND MOL M, V477, P7, DOI 10.1016/S0027-5107(01)00091-4; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Khan NM, 2011, FREE RADICAL BIO MED, V51, P115, DOI 10.1016/j.freeradbiomed.2011.03.037; Kim AN, 2010, FREE RADICAL BIO MED, V49, P323, DOI 10.1016/j.freeradbiomed.2010.04.015; Klaunig JE, 2011, TOXICOL APPL PHARM, V254, P86, DOI 10.1016/j.taap.2009.11.028; Kunwar A, 2011, ARCH TOXICOL; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Li F, 2011, BIOCHIM BIOPHYS ACTA, V1805, P167; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; McDonald JT, 2010, CANCER RES, V70, P8886, DOI 10.1158/0008-5472.CAN-10-0171; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Muppidi Jagan, 2004, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0317s59; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Paine A, 2011, BIOCHEM PHARMACOL, V80, P1895; Patwardhan RS, 2011, BIOCHEM PHARMACOL, V82, P642, DOI 10.1016/j.bcp.2011.06.024; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rodemann HP, 2009, RADIOTHER ONCOL, V92, P293, DOI 10.1016/j.radonc.2009.08.023; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sandur SK, 2007, FREE RADICAL BIO MED, V43, P568, DOI 10.1016/j.freeradbiomed.2007.05.009; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Shankar B, 2003, RADIAT RES, V160, P478, DOI 10.1667/RR3050; Singh A, 2008, CANCER RES, V68, P7975, DOI 10.1158/0008-5472.CAN-08-1401; Sun Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006588; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Surh YJ, 2008, GENES NUTR, V2, P313, DOI 10.1007/s12263-007-0063-0; Surh YJ, 2008, ASIA PAC J CLIN NUTR, V17, P269; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083	50	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65929	10.1371/journal.pone.0065929	http://dx.doi.org/10.1371/journal.pone.0065929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776571	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400083
J	Trentin, DS; Silva, DB; Amaral, MW; Zimmer, KR; Silva, MV; Lopes, NP; Giordani, RB; Macedo, AJ				Trentin, Danielle S.; Silva, Denise B.; Amaral, Matheus W.; Zimmer, Karine R.; Silva, Marcia V.; Lopes, Norberto P.; Giordani, Raquel B.; Macedo, Alexandre J.			Tannins Possessing Bacteriostatic Effect Impair Pseudomonas aeruginosa Adhesion and Biofilm Formation	PLOS ONE			English	Review							TOF MASS-SPECTROMETRY; POLYFLAVONOID TANNINS; BACTERIAL BIOFILMS; CONDENSED TANNINS; RESISTANCE; PLANTS; DEATH; LIFE	Plants produce many compounds that are biologically active, either as part of their normal program of growth and development or in response to pathogen attack or stress. Traditionally, Anadenanthera colubrina, Commiphora leptophloeos and Myracrodruon urundeuva have been used by communities in the Brazilian Caatinga to treat several infectious diseases. The ability to impair bacterial adhesion represents an ideal strategy to combat bacterial pathogenesis, because of its importance in the early stages of the infectious process; thus, the search for anti-adherent compounds in plants is a very promising alternative. This study investigated the ability of stem-bark extracts from these three species to control the growth and prevent biofilm formation of Pseudomonas aeruginosa, an important opportunistic pathogen that adheres to surfaces and forms protective biofilms. A kinetic study (0-72 h) demonstrated that the growth of extract-treated bacteria was inhibited up to 9 h after incubation, suggesting a bacteriostatic activity. Transmission electron microscopy and fluorescence microscopy showed both viable and nonviable cells, indicating bacterial membrane damage; crystal violet assay and scanning electron microscopy demonstrated that treatment strongly inhibited biofilm formation during 6 and 24 h and that matrix production remained impaired even after growth was restored, at 24 and 48 h of incubation. Herein, we propose that the identified (condensed and hydrolyzable) tannins are able to inhibit biofilm formation via bacteriostatic properties, damaging the bacterial membrane and hindering matrix production. Our findings demonstrate the importance of this abundant class of Natural Products in higher plants against one of the most challenging issues in the hospital setting: biofilm resilience.	[Trentin, Danielle S.; Amaral, Matheus W.; Zimmer, Karine R.; Macedo, Alexandre J.] Univ Fed Rio Grande do Sul, Fac Farm, Porto Alegre, RS, Brazil; [Trentin, Danielle S.; Zimmer, Karine R.; Macedo, Alexandre J.] Univ Fed Rio Grande do Sul, Ctr Biotecnol Estado Rio Grande Sul, Porto Alegre, RS, Brazil; [Silva, Denise B.; Lopes, Norberto P.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, NPPNS, Sao Paulo, Brazil; [Silva, Denise B.] Lychnoflora Pesquisa & Desenvolvimento Prod Nat L, Incubadora Supera, Sao Paulo, Brazil; [Silva, Marcia V.] Univ Fed Pernambuco, Ctr Ciencias Biol, Recife, PE, Brazil; [Silva, Marcia V.] Univ Fed Pernambuco, Dept Bioquim, Recife, PE, Brazil; [Giordani, Raquel B.] Univ Fed Rio Grande do Norte, Dept Farm, Ctr Ciencias Saude, BR-59072970 Natal, RN, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade de Sao Paulo; Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Federal do Rio Grande do Norte	Macedo, AJ (corresponding author), Univ Fed Rio Grande do Sul, Fac Farm, Porto Alegre, RS, Brazil.	alexandre.macedo@ufrgs.br	Macedo, Alexandre J/C-5178-2013; da Silva, Denise Brentan/G-1460-2012; Zimmer, Karine Rigon/H-3357-2013; Trentin, Danielle/AFJ-8173-2022; Fapesp, Biota/F-8655-2017; Lopes, Norberto P/C-7148-2012; Trentin, Danielle/AAF-5027-2022; GIORDANI, RAQUEL/B-8671-2014	Macedo, Alexandre J/0000-0002-8951-4029; da Silva, Denise Brentan/0000-0003-0872-2756; Trentin, Danielle/0000-0002-8622-1052; Fapesp, Biota/0000-0002-9887-8449; Lopes, Norberto P/0000-0002-8159-3658; Trentin, Danielle/0000-0002-8622-1052; Brandt Giordani, Raquel/0000-0001-6500-0755; Dague, Etienne/0000-0003-3290-9166	FAPERGS; FAPESP; MCTI/CNPq; INCT-IF/CNPq; NANOBIOTEC-Brasil from CAPES [703/2009]	FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); MCTI/CNPq; INCT-IF/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NANOBIOTEC-Brasil from CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors acknowledge FAPERGS, FAPESP, MCTI/CNPq, INCT-IF/CNPq and NANOBIOTEC-Brasil (703/2009) from CAPES for fellowships and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agra Maria de Fátima, 2007, Rev. bras. farmacogn., V17, P114, DOI 10.1590/S0102-695X2007000100021; Agra MF, 2007, J ETHNOPHARMACOL, V111, P383, DOI 10.1016/j.jep.2006.12.007; Bavington C, 2005, RESPIRATION, V72, P335, DOI 10.1159/000086243; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Behrens A, 2003, PHYTOCHEMISTRY, V62, P1159, DOI 10.1016/S0031-9422(02)00660-X; de Almeida CDCBR, 2012, PHARM BIOL, V50, P201, DOI 10.3109/13880209.2011.596205; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Chaieb K, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-29; CHUNG KT, 2008, CRIT REV FOOD SCI NU, V38, P421; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; da Silva VC, 2011, EUR J MASS SPECTROM, V17, P365, DOI 10.1255/ejms.1141; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Siqueira CFD, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/434782; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Luna JM, 2011, CURR MICROBIOL, V62, P1527, DOI 10.1007/s00284-011-9889-1; Madigan M.T., 2010, MICROBIOLOGIA BROCK, V12th; Monagas M, 2010, J PHARMACEUT BIOMED, V51, P358, DOI 10.1016/j.jpba.2009.03.035; Mueller-Harvey I, 2001, ANIM FEED SCI TECH, V91, P3, DOI 10.1016/S0377-8401(01)00227-9; Noferi M, 1997, J APPL POLYM SCI, V63, P475, DOI 10.1002/(SICI)1097-4628(19970124)63:4<475::AID-APP9>3.0.CO;2-O; Pankey GA, 2004, CLIN INFECT DIS, V38, P864, DOI 10.1086/381972; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Pasch H, 2001, POLYMER, V42, P7531, DOI 10.1016/S0032-3861(01)00216-6; Radebe N, 2013, J APPL POLYM SCI, V127, P1937, DOI 10.1002/app.37568; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; Rocha TD, 2012, PARASITOL RES, V110, P2551, DOI 10.1007/s00436-011-2798-1; Rossi F, 2011, CLIN INFECT DIS, V52, P1138, DOI 10.1093/cid/cir120; Sa NC, 2012, ARCH ORAL BIOL, V57, P550, DOI 10.1016/j.archoralbio.2011.10.016; SCALBERT A, 1991, PHYTOCHEMISTRY, V30, P3875, DOI 10.1016/0031-9422(91)83426-L; Schillaci D, 2010, J APPL MICROBIOL, V108, P17, DOI 10.1111/j.1365-2672.2009.04394.x; Schofield P, 2001, ANIM FEED SCI TECH, V91, P21, DOI 10.1016/S0377-8401(01)00228-0; Trentin DD, 2011, J ETHNOPHARMACOL, V137, P327, DOI 10.1016/j.jep.2011.05.030; WAISBREN SJ, 1980, ANTIMICROB AGENTS CH, V18, P969, DOI 10.1128/AAC.18.6.969; Wang W, 2012, PEPTIDES, V33, P212, DOI 10.1016/j.peptides.2012.01.006	35	62	64	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66257	10.1371/journal.pone.0066257	http://dx.doi.org/10.1371/journal.pone.0066257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776646	Green Submitted, gold, Green Published			2022-12-25	WOS:000320755400128
J	Van de Waal, DB; John, U; Ziveri, P; Reichart, GJ; Hoins, M; Sluijs, A; Rost, B				Van de Waal, Dedmer B.; John, Uwe; Ziveri, Patrizia; Reichart, Gert-Jan; Hoins, Mirja; Sluijs, Appy; Rost, Bjoern			Ocean Acidification Reduces Growth and Calcification in a Marine Dinoflagellate	PLOS ONE			English	Article							THORACOSPHAERA-HEIMII DINOPHYCEAE; CARBON-ISOTOPE FRACTIONATION; LIFE-CYCLE; CONCENTRATING MECHANISMS; CO2; SEAWATER; WATER; LIGHT; ACID; PHYTOPLANKTON	Ocean acidification is considered a major threat to marine ecosystems and may particularly affect calcifying organisms such as corals, foraminifera and coccolithophores. Here we investigate the impact of elevated pCO(2) and lowered pH on growth and calcification in the common calcareous dinoflagellate Thoracosphaera heimii. We observe a substantial reduction in growth rate, calcification and cyst stability of T. heimii under elevated pCO(2). Furthermore, transcriptomic analyses reveal CO2 sensitive regulation of many genes, particularly those being associated to inorganic carbon acquisition and calcification. Stable carbon isotope fractionation for organic carbon production increased with increasing pCO(2) whereas it decreased for calcification, which suggests interdependence between both processes. We also found a strong effect of pCO(2) on the stable oxygen isotopic composition of calcite, in line with earlier observations concerning another T. heimii strain. The observed changes in stable oxygen and carbon isotope composition of T. heimii cysts may provide an ideal tool for reconstructing past seawater carbonate chemistry, and ultimately past pCO(2). Although the function of calcification in T. heimii remains unresolved, this trait likely plays an important role in the ecological and evolutionary success of this species. Acting on calcification as well as growth, ocean acidification may therefore impose a great threat for T. heimii.	[Van de Waal, Dedmer B.; John, Uwe; Hoins, Mirja; Rost, Bjoern] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Van de Waal, Dedmer B.] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [Ziveri, Patrizia] Univ Autonoma Barcelona, Inst Environm Sci & Technol ICTA, E-08193 Barcelona, Spain; [Ziveri, Patrizia] Vrije Univ Amsterdam, Dept Earth Sci, Amsterdam, Netherlands; [Reichart, Gert-Jan; Hoins, Mirja; Sluijs, Appy] Univ Utrecht, Dept Earth Sci, Utrecht, Netherlands; [Reichart, Gert-Jan] Royal Netherlands Inst Sea Res NIOZ, Dept Geol, Den Hoorn, Texel, Netherlands	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Autonomous University of Barcelona; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Van de Waal, DB (corresponding author), Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany.	d.vandewaal@nioo.knaw.nl	john, uwe/S-3009-2016; Rost, Bjoern/B-4447-2015; Reichart, Gert-Jan/N-6308-2018; Van de Waal, Dedmer B/B-8002-2012; Ziveri, Patrizia/I-3856-2015; Sluijs, Appy/B-3726-2009; KNAW, NIOO-KNAW/A-4320-2012	john, uwe/0000-0002-1297-4086; Rost, Bjoern/0000-0001-5452-5505; Reichart, Gert-Jan/0000-0002-7256-2243; Van de Waal, Dedmer B/0000-0001-8803-1247; Ziveri, Patrizia/0000-0002-5576-0301; Sluijs, Appy/0000-0003-2382-0215; KNAW, NIOO-KNAW/0000-0002-3835-159X	BIOACID; German Ministry of Education and Research; European Community's Seventh Framework Programme/ERC [205150, 259627]; EC [211384, 265103]	BIOACID; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Community's Seventh Framework Programme/ERC; EC(European CommissionEuropean Commission Joint Research Centre)	The work was funded by BIOACID, financed by the German Ministry of Education and Research. Furthermore, this work was supported by the European Community's Seventh Framework Programme/ERC grant agreements #205150 and #259627, and contributes to the EC FP7 projects EPOCA, grant agreement #211384, and MedSeA, grant agreement #265103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 1998, J PHYCOL, V34, P79, DOI 10.1046/j.1529-8817.1998.340079.x; Bach LT, 2011, LIMNOL OCEANOGR, V56, P2040, DOI 10.4319/lo.2011.56.6.2040; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Beck WC, 2005, GEOCHIM COSMOCHIM AC, V69, P3493, DOI 10.1016/j.gca.2005.02.003; Bemis BE, 1998, PALEOCEANOGRAPHY, V13, P150, DOI 10.1029/98PA00070; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Collins S, 2004, NATURE, V431, P566, DOI 10.1038/nature02945; Dale B., 1992, DINOFLAGELLATE CONTR; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Evitt WR, 1985, SPOROPOLLEN DINOFLAG; Freeman KH, 1992, GLOBAL BIOGEOCHEM CY, V6, P185, DOI 10.1029/92GB00190; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; Gussone N, 2010, EARTH PLANET SC LETT, V289, P180, DOI 10.1016/j.epsl.2009.11.006; Hildebrand-Habel T, 2000, INT J EARTH SCI, V88, P694, DOI 10.1007/s005310050298; Hoppe CJM, 2011, J EXP MAR BIOL ECOL, V406, P54, DOI 10.1016/j.jembe.2011.06.008; INOUYE I, 1983, S AFR J BOT, V2, P63, DOI 10.1016/S0022-4618(16)30147-4; Karwath B, 2000, INT J EARTH SCI, V88, P668, DOI 10.1007/s005310050296; Kohn M, 2011, PALAEOGEOGR PALAEOCL, V302, P311, DOI 10.1016/j.palaeo.2011.01.019; Kranz SA, 2010, PLANT PHYSIOL, V154, P334, DOI 10.1104/pp.110.159145; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/NGEO1441, 10.1038/ngeo1441]; Mackinder L, 2011, EUR J PHYCOL, V46, P142; Mackinder L, 2010, GEOMICROBIOL J, V27, P585, DOI 10.1080/01490451003703014; MCCREA JM, 1950, J CHEM PHYS, V18, P849, DOI 10.1063/1.1747785; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Meier KJS, 2007, EUR J PHYCOL, V42, P81, DOI 10.1080/09670260600937833; MOOK WG, 1974, EARTH PLANET SC LETT, V22, P169, DOI 10.1016/0012-821X(74)90078-8; Moy AD, 2009, NAT GEOSCI, V2, P276, DOI 10.1038/NGEO460; Nelson ST, 2000, RAPID COMMUN MASS SP, V14, P1044, DOI 10.1002/1097-0231(20000630)14:12<1044::AID-RCM987>3.0.CO;2-3; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pierrot D., 2006, ORNLCDIAC105A US DEP; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Rokitta SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052212; Rokitta SD, 2012, LIMNOL OCEANOGR, V57, P607, DOI 10.4319/lo.2012.57.2.0607; Rost B, 2002, LIMNOL OCEANOGR, V47, P120, DOI 10.4319/lo.2002.47.1.0120; Rost B, 2008, MAR ECOL PROG SER, V373, P227, DOI 10.3354/meps07776; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sharkey TD, 1985, INORGANIC CARBON UPT; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; TANGEN K, 1982, MAR MICROPALEONTOL, V7, P193, DOI 10.1016/0377-8398(82)90002-0; Taylor AR, 2012, TRENDS PLANT SCI, V17, P675, DOI 10.1016/j.tplants.2012.06.009; Taylor AR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001085; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; Trimborn S, 2008, PHYSIOL PLANTARUM, V133, P92, DOI 10.1111/j.1399-3054.2007.01038.x; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; von Dassow P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r114; Wendler I, 2002, MAR MICROPALEONTOL, V46, P1, DOI 10.1016/S0377-8398(02)00049-X; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Zeebe RE, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001663; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB; Zeebe RE, 1999, GEOCHIM COSMOCHIM AC, V63, P2001, DOI 10.1016/S0016-7037(99)00091-5; ZHANG J, 1995, GEOCHIM COSMOCHIM AC, V59, P107, DOI 10.1016/00167-0379(59)1550D-; Ziveri P, 2012, BIOGEOSCIENCES, V9, P1025, DOI 10.5194/bg-9-1025-2012; Ziveri P, 2003, EARTH PLANET SC LETT, V210, P137, DOI 10.1016/S0012-821X(03)00101-8; Ziveri P, 2000, DEEP-SEA RES PT II, V47, P1853, DOI 10.1016/S0967-0645(00)00009-6; Zonneveld K, 2004, MAR MICROPALEONTOL, V50, P307, DOI 10.1016/S0377-8398(03)00097-5; Zonneveld KAF, 2007, MAR MICROPALEONTOL, V64, P80, DOI 10.1016/j.marmicro.2007.03.002	63	36	36	1	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65987	10.1371/journal.pone.0065987	http://dx.doi.org/10.1371/journal.pone.0065987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776586	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000320755400093
J	Stauffert, M; Cravo-Laureau, C; Jezequel, R; Barantal, S; Cuny, P; Gilbert, F; Cagnon, C; Militon, C; Amouroux, D; Mahdaoui, F; Bouyssiere, B; Stora, G; Merlin, FX; Duran, R				Stauffert, Magalie; Cravo-Laureau, Cristiana; Jezequel, Ronan; Barantal, Sandra; Cuny, Philippe; Gilbert, Franck; Cagnon, Christine; Militon, Cecile; Amouroux, David; Mahdaoui, Fatima; Bouyssiere, Brice; Stora, Georges; Merlin, Francois-Xavier; Duran, Robert			Impact of Oil on Bacterial Community Structure in Bioturbated Sediments	PLOS ONE			English	Article							POLYCHAETE NEREIS-DIVERSICOLOR; POLYCYCLIC AROMATIC-HYDROCARBONS; 16S RIBOSOMAL-RNA; MARINE-SEDIMENTS; PETROLEUM-HYDROCARBONS; MICROBIAL-DEGRADATION; DEGRADING BACTERIA; OXIDIZING BACTERIA; BENTHIC METABOLISM; SEQUENCE ALIGNMENT	Oil spills threaten coastlines where biological processes supply essential ecosystem services. Therefore, it is crucial to understand how oil influences the microbial communities in sediments that play key roles in ecosystem functioning. Ecosystems such as sediments are characterized by intensive bioturbation due to burrowing macrofauna that may modify the microbial metabolisms. It is thus essential to consider the bioturbation when determining the impact of oil on microbial communities. In this study, an experimental laboratory device maintaining pristine collected mudflat sediments in microcosms closer to true environmental conditions - with tidal cycles and natural seawater - was used to simulate an oil spill under bioturbation conditions. Different conditions were applied to the microcosms including an addition of: standardized oil (Blend Arabian Light crude oil, 25.6 mg.g(-1) wet sediment), the common burrowing organism Hediste (Nereis) diversicolor and both the oil and H. diversicolor. The addition of H. diversicolor and its associated bioturbation did not affect the removal of petroleum hydrocarbons. After 270 days, 60% of hydrocarbons had been removed in all microcosms irrespective of the H. diversicolor addition. However, 16S-rRNA gene and 16S-cDNA T-RFLP and RT-PCR-amplicon libraries analysis showed an effect of the condition on the bacterial community structure, composition, and dynamics, supported by PerMANOVA analysis. The 16S-cDNA libraries from microcosms where H. diversicolor was added (oiled and un-oiled) showed a marked dominance of sequences related to Gammaproteobacteria. However, in the oiled-library sequences associated to Deltaproteobacteria and Bacteroidetes were also highly represented. The 16S-cDNA libraries from oiled-microcosms (with and without H. diversicolor addition) revealed two distinct microbial communities characterized by different phylotypes associated to known hydrocarbonoclastic bacteria and dominated by Gammaproteobacteria and Deltaproteobacteria. In the oiled-microcosms, the addition of H. diversicolor reduced the phylotype-richness, sequences associated to Actinobacteria, Firmicutes and Plantomycetes were not detected. These observations highlight the influence of the bioturbation on the bacterial community structure without affecting the biodegradation capacities.	[Stauffert, Magalie; Cravo-Laureau, Cristiana; Barantal, Sandra; Cagnon, Christine; Duran, Robert] Univ Pau & Pays Adour, Inst Pluridisciplinaire Rech Environm & Mat, Equipe Environm & Microbiol, Pau, France; [Jezequel, Ronan; Merlin, Francois-Xavier] Ctr Documentat Rech & Experimentat Pollut Acciden, Brest, France; [Cuny, Philippe; Militon, Cecile; Stora, Georges] Aix Marseille Univ, Mediterranean Inst Oceanog, Equipe Microbiol Environm & Biotechnol, Marseille, France; [Gilbert, Franck] Univ Toulouse, Lab Ecol Fonct & Environm, Toulouse, France; [Amouroux, David; Mahdaoui, Fatima; Bouyssiere, Brice] Univ Pau & Pays Adour, Inst Pluridisciplinaire Rech Environm & Mat, Equipe Chim Analyt Bioinorgan & Environm, Pau, France	Universite de Pau et des Pays de l'Adour; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Pau et des Pays de l'Adour	Duran, R (corresponding author), Univ Pau & Pays Adour, Inst Pluridisciplinaire Rech Environm & Mat, Equipe Environm & Microbiol, Pau, France.	robert.duran@univ-pau.fr	militon, cecile/G-1027-2017; Gilbert, Franck/G-3294-2010; Cagnon, Christine/B-8874-2013; Duran, Robert/F-1521-2011	militon, cecile/0000-0002-5230-1732; Gilbert, Franck/0000-0002-2989-3776; Cagnon, Christine/0000-0003-0622-8754; Duran, Robert/0000-0002-2351-8553; Amouroux, David/0000-0002-0056-8590; BOUYSSIERE, Brice/0000-0001-5878-6067	French program ANR DHYVA [ANR-06-SEST-09]	French program ANR DHYVA(French National Research Agency (ANR))	This work was supported by the French program ANR DHYVA (project ANR-06-SEST-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Gonzalez A, 2013, ENVIRON MICROBIOL, V15, P77, DOI 10.1111/j.1462-2920.2012.02782.x; ALLER RC, 1994, CHEM GEOL, V114, P331, DOI 10.1016/0009-2541(94)90062-0; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alzaga R, 2004, J CHROMATOGR A, V1025, P133, DOI 10.1016/j.chroma.2003.10.080; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ATLAS RM, 1972, CAN J MICROBIOL, V18, P1851, DOI 10.1139/m72-289; Banta GT, 2003, VIE MILIEU, V53, P233; Beazley MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041305; Berthe-Corti L, 2005, PALAEOGEOGR PALAEOCL, V219, P171, DOI 10.1016/j.palaeo.2004.10.020; Bertics VJ, 2010, ENVIRON MICROBIOL, V12, P3022, DOI 10.1111/j.1462-2920.2010.02279.x; Bertics VJ, 2009, ISME J, V3, P1269, DOI 10.1038/ismej.2009.62; Cheong CJ, 2001, WATER SCI TECHNOL, V43, P171, DOI 10.2166/wst.2001.0087; Christensen M, 2002, MAR ECOL PROG SER, V237, P159, DOI 10.3354/meps237159; Chung IY, 2004, MAR POLLUT BULL, V49, P959, DOI 10.1016/j.marpolbul.2004.06.021; Coates JD, 1997, APPL ENVIRON MICROB, V63, P3589, DOI 10.1128/AEM.63.9.3589-3593.1997; Cuny P, 2007, MAR POLLUT BULL, V54, P452, DOI 10.1016/j.marpolbul.2006.12.008; Dunbar J, 2001, APPL ENVIRON MICROB, V67, P190, DOI 10.1128/AEM.67.1.190-197.2001; Duport E, 2006, J EXP MAR BIOL ECOL, V336, P33, DOI 10.1016/j.jembe.2006.04.005; Fenchel T, 1996, MAR BIOL, V127, P289, DOI 10.1007/BF00942114; GILBERT F, 1994, CHEMOSPHERE, V29, P1, DOI 10.1016/0045-6535(94)90084-1; Gilbert F, 1996, CHEMOSPHERE, V33, P1449, DOI 10.1016/0045-6535(96)00283-4; Gilbert F, 2007, J EXP MAR BIOL ECOL, V348, P133, DOI 10.1016/j.jembe.2007.04.015; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Greenwood PF, 2009, ORG GEOCHEM, V40, P293, DOI 10.1016/j.orggeochem.2008.12.009; Gribsholt B, 2003, LIMNOL OCEANOGR, V48, P2151, DOI 10.4319/lo.2003.48.6.2151; Grossi V, 2002, CHEMOSPHERE, V48, P947, DOI 10.1016/S0045-6535(02)00122-4; Grossi V, 2008, ORG GEOCHEM, V39, P1197, DOI 10.1016/j.orggeochem.2008.02.010; Hansen K, 1998, J EXP MAR BIOL ECOL, V231, P201, DOI 10.1016/S0022-0981(98)00070-7; Hansen K, 1996, AQUAT MICROB ECOL, V10, P181, DOI 10.3354/ame010181; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Head IM, 2006, NAT REV MICROBIOL, V4, P173, DOI 10.1038/nrmicro1348; Holmer M, 1997, MAR BIOL, V128, P679, DOI 10.1007/s002270050135; Kleikemper J, 2002, APPL ENVIRON MICROB, V68, P1516, DOI 10.1128/AEM.68.4.1516-1523.2002; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Laverock B, 2010, ISME J; LEAHY JG, 1990, MICROBIOL REV, V54, P305, DOI 10.1128/MMBR.54.3.305-315.1990; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Mayer LM, 1997, J MAR RES, V55, P785, DOI 10.1357/0022240973224247; Mayer LM, 1996, ENVIRON SCI TECHNOL, V30, P2641, DOI 10.1021/es960110z; MCKENNA EJ, 1971, P NATL ACAD SCI USA, V68, P1552, DOI 10.1073/pnas.68.7.1552; Mermillod-Blondin F, 2004, AQUAT MICROB ECOL, V36, P271, DOI 10.3354/ame036271; Mills HJ, 2004, APPL ENVIRON MICROB, V70, P5447, DOI 10.1128/AEM.70.9.5447-5458.2004; Miralles G, 2007, MICROB ECOL, V54, P646, DOI 10.1007/s00248-007-9221-6; Naslund J, 2010, ISME J, V4, P1421, DOI 10.1038/ismej.2010.63; Oksanen J., 2016, R PACKAG; Paisse S, 2008, FEMS MICROBIOL ECOL, V66, P295, DOI 10.1111/j.1574-6941.2008.00589.x; Pinheiro J, 2007, NLME LINEAR NONLINEA, V31, P339; Quintana CO, 2007, J EXP MAR BIOL ECOL, V352, P392, DOI 10.1016/j.jembe.2007.08.015; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rothermich MM, 2002, ENVIRON SCI TECHNOL, V36, P4811, DOI 10.1021/es0200241; Sasaki T, 1998, ENVIRON SCI TECHNOL, V32, P3618, DOI 10.1021/es980287o; Satoh H, 2007, APPL ENVIRON MICROB, V73, P1341, DOI 10.1128/AEM.02073-06; Sauret C, 2012, MAR ENVIRON RES, V79, P70, DOI 10.1016/j.marenvres.2012.05.006; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shao MF, 2010, APPL MICROBIOL BIOT, V88, P1027, DOI 10.1007/s00253-010-2847-1; SIMBERLOFF D, 1972, AM NAT, V106, P414, DOI 10.1086/282781; Sorokin DY, 2007, ARCH MICROBIOL, V187, P441, DOI 10.1007/s00203-006-0208-3; Sorokin DY, 2001, INT J SYST EVOL MICR, V51, P565, DOI 10.1099/00207713-51-2-565; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wada M., 2005, MICROBES ENVIRON, V20, P191, DOI DOI 10.1264/JSME2.20.191; Warnes GR, 2011, GPLOTS VARIOUS R PRO; Wright AL, 1997, WATER AIR SOIL POLL, V95, P179, DOI 10.1023/A:1026408107505; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yakimov MM, 2005, ENVIRON MICROBIOL, V7, P1426, DOI 10.1111/j.1462-5822.2005.00829.x; Yoshida A, 2006, MAR POLLUT BULL, V52, P89, DOI 10.1016/j.marpolbul.2005.08.015	68	49	50	0	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65347	10.1371/journal.pone.0065347	http://dx.doi.org/10.1371/journal.pone.0065347			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762350	Green Submitted, Green Published, gold			2022-12-25	WOS:000320440500032
J	Jonas, A; Gweshe, J; Siboleka, M; DeKlerk, M; Gawanab, M; Badi, A; Sumbi, V; Pereko, D; Blom, A; Mwinga, S; Jordan, MR; Jerger, L; Lau, K; Hong, SY				Jonas, Anna; Gweshe, Justice; Siboleka, Milner; DeKlerk, Michael; Gawanab, Michael; Badi, Alfons; Sumbi, Victor; Pereko, Dawn; Blom, Abraham; Mwinga, Samson; Jordan, Michael R.; Jerger, Logan; Lau, Kiger; Hong, Steven Y.			HIV Drug Resistance Early Warning Indicators in Namibia for Public Health Action	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; COUNTRIES; PREVENTION	Background: HIV drug resistance (HIVDR) testing is not routinely available in many resource-limited settings, therefore antiretroviral therapy (ART) program and site factors known to be associated with emergence of HIVDR should be monitored to optimize the quality of patient care and minimize the emergence of preventable HIVDR. Methods: In 2010, Namibia selected five World Health Organization Early Warning Indicators (EWIs) and scaled-up monitoring from 9 to 33 ART sites: ART prescribing practices, Patients lost to follow-up (LTFU) at 12 months, Patients switched to a second-line regimen at 12 months, On-time antiretroviral (ARV) drug pick-up, and ARV drug-supply continuity. Results: Records allowed reporting on three of the five selected EWIs. 22 of 33 (67%) sites met the target of 100% initiated on appropriate first-line regimens. 17 of 33 (52%) sites met the target of <= 20% LTFU. 15 of 33 (45%) sites met the target of 0% switched to a second-line regimen. Conclusions: EWI monitoring directly resulted in public health action which will optimize the quality of care, specifically the strengthening of ART record systems, engagement of ART sites, and operational research for improved adherence assessment and ART patient defaulter tracing.	[Jonas, Anna; Gweshe, Justice; Siboleka, Milner; DeKlerk, Michael; Gawanab, Michael; Badi, Alfons; Blom, Abraham] Republ Namibia Minist Hlth & Social Serv, Directorate Special Programmes, Windhoek, Namibia; [Sumbi, Victor; Mwinga, Samson] Management Sci Hlth, Windhoek, Namibia; [Pereko, Dawn] Abt Associate Inc, Strengthening Hlth Outcomes Private Sect, Windhoek, Namibia; [Jordan, Michael R.; Jerger, Logan; Lau, Kiger; Hong, Steven Y.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Jordan, Michael R.; Hong, Steven Y.] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA	ABT Associates; Massachusetts Department of Public Health; Tufts University; Tufts Medical Center	Hong, SY (corresponding author), Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA.	shong@tuftsmedicalcenter.org			Republic of Namibia Ministry of Health and Social Services; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI097010] Funding Source: NIH RePORTER	Republic of Namibia Ministry of Health and Social Services; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the Republic of Namibia Ministry of Health and Social Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WORLD FACTB; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2012, CLIN INFECT DIS, V54, pS280, DOI 10.1093/cid/cis207; Billong SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036777; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Daoni E, 2012, CLIN INFECT DIS, V54, pS303, DOI 10.1093/cid/cir994; Dzangare J, 2012, CLIN INFECT DIS, V54, pS313, DOI 10.1093/cid/cir1014; Eholie SP, 2007, JAIDS-J ACQ IMM DEF, V45, P355; Hong SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056307; Hong SY, 2010, JAIDS-J ACQ IMM DEF, V55, pE27, DOI 10.1097/QAI.0b013e3181f5376d; Jordan MR, 2008, ANTIVIR THER, V13, P15; Jordan MR, 2011, CLIN INFECT DIS, V52, P1058, DOI 10.1093/cid/cir093; Ma Y, 2012, CLIN INFECT DIS, V54, pS300, DOI 10.1093/cid/cir1018; Marcellin F, 2008, TROP MED INT HEALTH, V13, P1470, DOI 10.1111/j.1365-3156.2008.02170.x; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Republic of Namibia Ministry of Health and Social Services, 2012, REP 2012 NAT HIV SEN; Republic of Namibia Ministry of Health and Social Services Directorate of Special Programmes, 2010, NAT GUID ANT THER; Sigaloff KCE, 2012, CLIN INFECT DIS, V54, pS294, DOI 10.1093/cid/cir1015; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; UNAIDS, 2012, TOG WE WILL END AIDS; van Oosterhout JJ, 2005, TROP MED INT HEALTH, V10, P464, DOI 10.1111/j.1365-3156.2005.01409.x; Vergne L, 2002, J ACQ IMMUN DEF SYND, V29, P165, DOI 10.1097/00042560-200202010-00009; WHO, 2012, ASS WHO HIV DRUG RES; WHO UNAIDS, 2011, UN ACC SCAL PRIOR HI; World Health Organization, 2010, WHO IND MON HIV DRUG	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65653	10.1371/journal.pone.0065653	http://dx.doi.org/10.1371/journal.pone.0065653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762406	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800068
J	Hanrahan, CF; Selibas, K; Deery, CB; Dansey, H; Clouse, K; Bassett, J; Scott, L; Stevens, W; Sanne, I; Van Rie, A				Hanrahan, Colleen F.; Selibas, Katerina; Deery, Christopher B.; Dansey, Heather; Clouse, Kate; Bassett, Jean; Scott, Lesley; Stevens, Wendy; Sanne, Ian; Van Rie, Annelies			Time to Treatment and Patient Outcomes among TB Suspects Screened by a Single Point-of-Care Xpert MTB/RIF at a Primary Care Clinic in Johannesburg, South Africa	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; ASSAY; DIAGNOSIS; RESISTANCE; ACCURACY; COST	Introduction: In December 2010, the World Health Organization recommended a single Xpert MTB/RIF assay as the initial diagnostic in people suspected of HIV-associated or drug resistant tuberculosis. Few data are available on the impact of this recommendation on patient outcomes. We describe the diagnostic follow-up, clinical characteristics and outcomes of a cohort of tuberculosis suspects screened using a single point-of-care Xpert. Methods: Consecutive tuberculosis suspects at a primary care clinic in Johannesburg, South Africa were assessed for tuberculosis using point-of-care Xpert. Sputum smear microscopy and liquid culture were performed as reference standards. Xpert-negatives were evaluated clinically, and further assessed at the discretion of clinicians. Participants were followed for six months. Results: From July-September 2011, 641 tuberculosis suspects were enrolled, of whom 69% were HIV-infected. Eight percent were positive by a single Xpert. Among 116 individuals diagnosed with TB, 66 (57%) were Xpert negative, of which 44 (67%) were empirical or radiological diagnoses and 22 (33%) were Xpert negative/culture-positive. The median time to tuberculosis treatment was 0 days (IQR:0-0) for Xpert positives, 14 days ( IQR: 5-35) for those diagnosed empirically, 14 days ( IQR: 7-29) for radiological diagnoses, and 144 days ( IQR: 28-180) for culture positives. Xpert negative tuberculosis cases were clinically similar to Xpert positives, including HIV status and CD4 count, and had similar treatment outcomes including mortality and time to antiretroviral treatment initiation. Conclusions: In a high HIV-burden setting, a single Xpert identified less than half of those started on tuberculosis treatment, highlighting the complexity of TB diagnosis even in the Xpert era. Xpert at point-of-care resulted in same day treatment initiation in Xpert-positives, but had no impact on tuberculosis treatment outcomes or mortality.	[Hanrahan, Colleen F.; Clouse, Kate; Van Rie, Annelies] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA; [Selibas, Katerina; Deery, Christopher B.; Clouse, Kate; Sanne, Ian] Univ Witwatersrand, Dept Med, Clin HIV Res Unit, ZA-2001 Johannesburg, South Africa; [Dansey, Heather; Bassett, Jean] Witkoppen Hlth & Welf Ctr, Johannesburg, South Africa; [Scott, Lesley; Stevens, Wendy] Univ Witwatersrand, Dept Mol Med & Hematol, Johannesburg, South Africa; [Stevens, Wendy] Natl Hlth Lab Serv, Johannesburg, South Africa	University of North Carolina; University of North Carolina Chapel Hill; University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service	Hanrahan, CF (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.	colleen_hanrahan@unc.edu	Sanne, Ian/ABH-2231-2020; Van Rie, Annelies/C-2082-2017; Trajman, Anete/C-7679-2016	Van Rie, Annelies/0000-0001-7666-3263; Trajman, Anete/0000-0002-4000-4984; Clouse, Kate/0000-0002-0190-7398; Hanrahan, Colleen/0000-0002-4544-4591; Scott, Lesley/0000-0001-6573-9525	PEPFAR; National Institutes of Health [UM1 AI069463]; United States Agency for International Development in a grant to Right to Care [674-A-00-08-00007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069463] Funding Source: NIH RePORTER	PEPFAR; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Agency for International Development in a grant to Right to Care(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by PEPFAR and National Institutes of Health grant UM1 AI069463, United States Agency for International Development in a grant to Right to Care 674-A-00-08-00007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB TUB CONTR; Banada PP, 2010, J CLIN MICROBIOL, V48, P3551, DOI 10.1128/JCM.01053-10; Blakemore R, 2011, AM J RESP CRIT CARE, V184, P1076, DOI 10.1164/rccm.201103-0536OC; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Clouse K, 2012, SAMJ S AFR MED J, V102, P805, DOI [10.7196/SAMJ.5851, 10.7196/samj.5851]; Harries AD, 1997, PHARMACOL THERAPEUT, V73, P1, DOI 10.1016/S0163-7258(96)00115-5; Kufa T, 2012, JAIDS-J ACQ IMM DEF, V60, pE22, DOI 10.1097/QAI.0b013e318251ae0b; Lawn SD, 2012, INT J TUBERC LUNG D, V16, P701, DOI 10.5588/ijtld.12.0131; Lawn SD, 2012, CLIN INFECT DIS, V54, P1071, DOI 10.1093/cid/cir1039; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Meyer-Rath G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036966; Schnippel K, 2012, TROP MED INT HEALTH, V17, P1142, DOI 10.1111/j.1365-3156.2012.03028.x; Scott LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001061; Straetemans M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020755; Theron G, 2012, EUR RESPIR J, V40, P161, DOI 10.1183/09031936.00145511; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; WHO, 2011, POL STAT AUT REAL TI; Yoon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048599; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	20	69	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65421	10.1371/journal.pone.0065421	http://dx.doi.org/10.1371/journal.pone.0065421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762367	Green Submitted, gold, Green Published			2022-12-25	WOS:000321099000065
J	Takenaka, M; Zehrmann, A; Brennicke, A; Graichen, K				Takenaka, Mizuki; Zehrmann, Anja; Brennicke, Axel; Graichen, Knut			Improved Computational Target Site Prediction for Pentatricopeptide Repeat RNA Editing Factors	PLOS ONE			English	Article							PPR PROTEIN; MITOCHONDRIA; GENE; MOTIF	Pentatricopeptide repeat (PPR) proteins with an E domain have been identified as specific factors for C to U RNA editing in plant organelles. These PPR proteins bind to a unique sequence motif 59 of their target editing sites. Recently, involvement of a combinatorial amino acid code in the P (normal length) and S type (short) PPR domains in sequence specific RNA binding was reported. PPR proteins involved in RNA editing, however, contain not only P and S motifs but also their long variants L (long) and L2 (long2) and the S2 (short2) motifs. We now find that inclusion of these motifs improves the prediction of RNA editing target sites. Previously overlooked RNA editing target sites are suggested from the PPR motif structures of known E-class PPR proteins and are experimentally verified. RNA editing target sites are assigned for the novel PPR protein MEF32 (mitochondrial editing factor 32) and are confirmed in the cDNA.	[Takenaka, Mizuki; Zehrmann, Anja; Brennicke, Axel] Univ Ulm, D-89069 Ulm, Germany; [Graichen, Knut] Univ Ulm, Inst Mess Regel & Mikrotech, D-89069 Ulm, Germany	Ulm University; Ulm University	Takenaka, M (corresponding author), Univ Ulm, D-89069 Ulm, Germany.	mizuki.takenaka@uni-ulm.de	Takenaka, Mizuki/AAK-9884-2020	Takenaka, Mizuki/0000-0002-3242-5092; Graichen, Knut/0000-0003-2865-8093	DFG [TA624/2-2, TA624/3-1, TA624/4-1, BR726/11-1]	DFG(German Research Foundation (DFG))	This work was supported by grants TA624/2-2, TA624/3-1, TA624/4-1 and BR726/11-1 from the DFG (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres C, 2007, PHYSIOL PLANTARUM, V129, P14, DOI 10.1111/j.1399-3054.2006.00766.x; Arenas A, 2013, FEBS LETT, V587, P887, DOI 10.1016/j.febslet.2013.02.009; Barkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002910; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Doniwa Y, 2010, GENE, V454, P39, DOI 10.1016/j.gene.2010.01.008; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Fujii S, 2011, P NATL ACAD SCI USA, V108, P1723, DOI 10.1073/pnas.1007667108; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Kobayashi K, 2012, NUCLEIC ACIDS RES, V40, P2712, DOI 10.1093/nar/gkr1084; Kondo J, 2011, NUCLEIC ACIDS RES, V39, P8628, DOI 10.1093/nar/gkr452; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Nakamura T, 2012, PLANT CELL PHYSIOL, V53, P1171, DOI 10.1093/pcp/pcs069; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Rivals E, 2006, PLANT PHYSIOL, V141, P825, DOI 10.1104/pp.106.077826; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Takenaka M, 2012, NAT PROTOC, V7, P1931, DOI 10.1038/nprot.2012.117; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; Verbitskiy D, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.397992; Verbitskiy D, 2012, PLANT CELL PHYSIOL, V53, P358, DOI 10.1093/pcp/pcr182; Verbitskiy D, 2010, PLANT J, V61, P446, DOI 10.1111/j.1365-313X.2009.04076.x; Yagi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057286; Zhu Q, 2012, PLANT J, V71, P836, DOI 10.1111/j.1365-313X.2012.05036.x	24	146	148	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65343	10.1371/journal.pone.0065343	http://dx.doi.org/10.1371/journal.pone.0065343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762347	Green Submitted, Green Published, gold			2022-12-25	WOS:000321099000057
J	Ross, JS; Hu, W; Rosen, B; Snider, AJ; Obeid, LM; Cowart, LA				Ross, Jessica S.; Hu, Wei; Rosen, Bess; Snider, Ashley J.; Obeid, Lina M.; Cowart, L. Ashley			Sphingosine Kinase 1 Is Regulated by Peroxisome Proliferator-activated Receptor alpha in Response to Free Fatty Acids and Is Essential for Skeletal Muscle Interleukin-6 Production and Signaling in Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; INDUCED INSULIN-RESISTANCE; MYOGENIC DIFFERENTIATION; CERAMIDE BIOSYNTHESIS; ADIPOSE-TISSUE; DEPENDENT ACTIVATION; GENE-EXPRESSION; DOWN-REGULATION; CELL-GROWTH; PPAR-ALPHA	We previously demonstrated that sphingosine kinase 1 (Sphk1) expression and activity are up-regulated by exogenous palmitate (PAL) in a skeletal muscle model system and in diet-induced obesity in mice; however, potential functions and in vivo relevance of this have not been addressed. Here, we aimed to determine the mechanism by which PAL regulates SphK1 in muscle, and to determine potential roles for its product, sphingosine-1-phosphate (S1P), in muscle biology in the context of obesity. Cloning and analysis of the mouse Sphk1 promoter revealed a peroxisome proliferator-activated receptor (PPAR) alpha cis-element that mediated activation of a reporter under control of the Sphk1 promoter; direct interaction of PPAR alpha was demonstrated by chromatin immunoprecipitation. PAL treatment induced the proinflammatory cytokine interleukin (IL)-6 in a manner dependent on SphK1, and this was attenuated by inhibition of the sphingosine-1-phosphate receptor 3 (S1PR3). Diet-induced obesity in mice demonstrated that IL-6 expression in muscle, but not adipose tissue, increased in obesity, but this was attenuated in Sphk1(-/-)mice. Moreover, plasma IL-6 levels were significantly decreased in obese Sphk1(-/-) mice relative to obese wild type mice, and muscle, but not adipose tissue IL-6 signaling was activated. These data indicate that PPAR alpha regulates Sphk1 expression in the context of fatty acid oversupply and links PAL to muscle IL-6 production. Moreover, this function of SphK1 in diet-induced obesity suggests a potential role for SphK1 in obesity-associated pathological outcomes.	[Ross, Jessica S.; Hu, Wei; Cowart, L. Ashley] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Ross, Jessica S.] Med Univ S Carolina, Dept Mol & Cellular Biol, Charleston, SC 29425 USA; [Ross, Jessica S.] Med Univ S Carolina, Pathobiol Program, Charleston, SC 29425 USA; [Snider, Ashley J.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Rosen, Bess] Boston Univ, Sch Med, Ctr Regenerat Med, Boston, MA 02118 USA; [Obeid, Lina M.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11790 USA; [Obeid, Lina M.] Northport Vet Affairs Med Ctr, Northpoint, NY 11768 USA; [Snider, Ashley J.; Cowart, L. Ashley] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Boston University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Cowart, LA (corresponding author), Med Univ S Carolina, Ralph H Johnson Vet Affairs Med Ctr, Dept Biochem & Mol Biol, 173 Ashley Ave,MSC509, Charleston, SC 29425 USA.	cowartl@musc.edu		obeid, lina/0000-0002-0734-0847	National Institutes of Health COBREaward [P20 RR017677]; Veterans Affairs Merit award; GAANN fellowship in Lipidomics and Systems Biology; Office of the Director of the National Institutes of Health [C06 RR018823]; National Center for Research Resources; Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina Grant [P30 CA138313]; Lipidomics Core in the South Carolina Lipidomics and Pathobiology COBRE Grant [P20 RR017677]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823, P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM072643] Funding Source: NIH RePORTER	National Institutes of Health COBREaward(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit award(US Department of Veterans Affairs); GAANN fellowship in Lipidomics and Systems Biology; Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina Grant; Lipidomics Core in the South Carolina Lipidomics and Pathobiology COBRE Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health COBREaward P20 RR017677 (to L. A. C.), a Veterans Affairs Merit award, and a GAANN fellowship in Lipidomics and Systems Biology (to J. S. R.). Lipidomic analysis was performed by the Medical University of South Carolina Lipidomic Core supported by the National Center for Research Resources and the Office of the Director of the National Institutes of Health through Grant C06 RR018823. Research was supported in part by the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina Grant P30 CA138313, and the Lipidomics Core in the South Carolina Lipidomics and Pathobiology COBRE Grant P20 RR017677.	AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Ammit AJ, 2001, FASEB J, V15, P1212, DOI 10.1096/fj.00-0742fje; Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Belfort R, 2005, DIABETES, V54, P1640, DOI 10.2337/diabetes.54.6.1640; Benamer N, 2011, BIOCHEM BIOPH RES CO, V408, P6, DOI 10.1016/j.bbrc.2011.03.072; Betanzos-Cabrera G, 2012, NUTR HOSP, V27, P1196, DOI 10.3305/nh.2012.27.4.5842; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bruni P, 2008, CELL MOL LIFE SCI, V65, P3725, DOI 10.1007/s00018-008-8236-6; Cammarota R, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-112; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chavez JA, 2005, J BIOL CHEM, V280, P20148, DOI 10.1074/jbc.M412769200; Coll T, 2010, ENDOCRINOLOGY, V151, P537, DOI 10.1210/en.2009-0874; Cowart LA, 2009, TRENDS ENDOCRIN MET, V20, P34, DOI 10.1016/j.tem.2008.09.004; DeOliveira CC, 2012, MOL CELL ENDOCRINOL, V361, P92, DOI 10.1016/j.mce.2012.03.016; Djouadi F, 2005, J CLIN ENDOCR METAB, V90, P1791, DOI 10.1210/jc.2004-1936; Drastich P, 2011, FOLIA MICROBIOL, V56, P185, DOI 10.1007/s12223-011-0018-0; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Fernandez-Real JM, 2003, ENDOCR REV, V24, P278, DOI 10.1210/er.2002-0010; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Forman BM, 1996, ANN NY ACAD SCI, V804, P266, DOI 10.1111/j.1749-6632.1996.tb18621.x; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Green CJ, 2011, BIOCHEM J, V435, P463, DOI 10.1042/BJ20101517; Gurgui M, 2010, CELL SIGNAL, V22, P1727, DOI 10.1016/j.cellsig.2010.06.013; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hansen BC, 1999, ANN NY ACAD SCI, V892, P1, DOI 10.1111/j.1749-6632.1999.tb07782.x; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hoene M, 2013, AM J PHYSIOL-CELL PH, V304, pC128, DOI 10.1152/ajpcell.00025.2012; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hu W, 2011, J BIOL CHEM, V286, P16596, DOI 10.1074/jbc.M110.186916; Hu W, 2009, J LIPID RES, V50, P1852, DOI 10.1194/jlr.M800635-JLR200; Imamura T, 2001, GENOMICS, V76, P117, DOI 10.1006/geno.2001.6607; Jove M, 2005, ENDOCRINOLOGY, V146, P3087, DOI 10.1210/en.2004-1560; Keller C, 2001, FASEB J, V15, P2748, DOI 10.1096/fj.01-0507fje; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kleuser B, 1998, CANCER RES, V58, P1817; Kluk MJ, 2002, BBA-MOL CELL BIOL L, V1582, P72, DOI 10.1016/S1388-1981(02)00139-7; Lempiainen P, 1999, CIRCULATION, V100, P123, DOI 10.1161/01.CIR.100.2.123; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li Y, 2010, GUT, V59, P227, DOI 10.1136/gut.2009.184176; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Mckay BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006027; Meacci E, 2003, BBA-MOL CELL BIOL L, V1633, P133, DOI 10.1016/S1388-1981(03)00106-9; Meacci E, 2008, J CELL PHYSIOL, V214, P210, DOI 10.1002/jcp.21187; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mitrou P, 2011, EXP CLIN ENDOCR DIAB, V119, P484, DOI 10.1055/s-0030-1269846; MODAN M, 1985, J CLIN INVEST, V75, P809, DOI 10.1172/JCI111776; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Muoio DM, 2002, DIABETES, V51, P901, DOI 10.2337/diabetes.51.4.901; Nakade Y, 2003, BBA-MOL CELL BIOL L, V1635, P104, DOI 10.1016/j.bbalip.2003.11.001; Olivera A, 1999, FASEB J, V13, P1593, DOI 10.1096/fasebj.13.12.1593; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen Bente Klarlund, 2011, J Exp Biol, V214, P337, DOI 10.1242/jeb.048074; Pettus BJ, 2004, CURR MOL MED, V4, P405, DOI 10.2174/1566524043360573; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Ren B, 1996, J BIOL CHEM, V271, P17167, DOI 10.1074/jbc.271.29.17167; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Ringseis R, 2011, MOL NUTR FOOD RES, V55, P109, DOI 10.1002/mnfr.201000424; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Samad F, 2011, ADV EXP MED BIOL, V721, P67, DOI 10.1007/978-1-4614-0650-1_5; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Schrauwen P, 2007, P NUTR SOC, V66, P33, DOI 10.1017/S0029665107005277; Schrauwen-Hinderling VB, 2005, OBES RES, V13, P2088, DOI 10.1038/oby.2005.259; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Shu XD, 2002, MOL CELL BIOL, V22, P7758, DOI 10.1128/MCB.22.22.7758-7768.2002; Sobue S, 2005, J NEUROCHEM, V95, P940, DOI 10.1111/j.1471-4159.2005.03399.x; Sparagna GC, 2000, AM J PHYSIOL-HEART C, V279, pH2124, DOI 10.1152/ajpheart.2000.279.5.H2124; SPRINGER ML, 1997, CURRENT PROTOCOLS HU; Steensberg A, 2002, AM J PHYSIOL-ENDOC M, V283, pE1272, DOI 10.1152/ajpendo.00255.2002; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; Straczkowski M, 2007, DIABETOLOGIA, V50, P2366, DOI 10.1007/s00125-007-0781-2; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Takeda K, 2000, CYTOKINE GROWTH F R, V11, P199, DOI 10.1016/S1359-6101(00)00005-8; Toth KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017392; Turpin SM, 2009, J PHYSIOL-LONDON, V587, P1593, DOI 10.1113/jphysiol.2008.166033; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Varma V, 2009, AM J PHYSIOL-ENDOC M, V296, pE1300, DOI 10.1152/ajpendo.90885.2008; Veret J, 2013, BBA-MOL CELL BIOL L, V1831, P251, DOI 10.1016/j.bbalip.2012.10.003; Vusse G. V. D., 1996, HDB PHYSL 12, P952; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Xia P, 1998, P NATL ACAD SCI USA, V95, P14196, DOI 10.1073/pnas.95.24.14196; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008; Zanin M, 2008, AM J PHYSIOL-CELL PH, V294, pC36, DOI 10.1152/ajpcell.00164.2007; Zhao CQ, 2008, J LIPID RES, V49, P2323, DOI 10.1194/jlr.M800143-JLR200; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	100	35	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22193	2206		10.1074/jbc.M113.477786	http://dx.doi.org/10.1074/jbc.M113.477786			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23766515	Green Published, hybrid			2022-12-25	WOS:000330596300002
J	Steinmann, S; Coulibaly, A; Ohnheiser, J; Jakobs, A; Klempnauer, KH				Steinmann, Simone; Coulibaly, Anna; Ohnheiser, Johanna; Jakobs, Anke; Klempnauer, Karl-Heinz			Interaction and Cooperation of the CCAAT-box Enhancer-binding Protein beta (C/EBP beta) with the Homeodomain-interacting Protein Kinase 2 (Hipk2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; ADIPOCYTE DIFFERENTIATION; TRANSLATIONAL CONTROL; TRANSCRIPTION FACTORS; INHIBITORY PROTEIN; COACTIVATOR P300; GENE-EXPRESSION; MESSENGER-RNA; STEM-CELL; PHOSPHORYLATION	CCAAT box/enhancer-binding protein beta (C/EBP beta) is a bZip transcription factor that plays crucial roles in important cellular processes such as differentiation and proliferation of specific cell types. Previously, we showed that C/EBP beta cooperates with the coactivator p300 through a novel mechanism that involves the C/EBP beta-induced phosphorylation of multiple sites in the carboxyl-terminal domain of p300 by protein kinase Hipk2. We have now examined the interaction and cooperation of C/EBP beta, p300, and Hipk2 in more detail. We show that Hipk2 and C/EBP beta are direct physical binding partners whose interaction is mediated by sequences located in the amino-terminal and central domains of Hipk2 and the amino-terminal part of C/EBP beta. In addition to phosphorylating p300 recruited to C/EBP beta, Hipk2 also phosphorylates C/EBP beta at sites that have previously been shown to plays key roles in the regulation of C/EBP beta activity. Silencing of Hipk2 expression disrupts adipocyte differentiation of 3T3-L1 cells, a physiological C/EBP beta dependent differentiation process indicating that the cooperation of C/EBP beta and Hipk2 is functionally relevant. Finally, we demonstrate that C/EBP beta, a related C/EBP family member whose amino-terminal sequences differ significantly from that of C/EBP beta, is unable to interact and cooperate with Hipk2. Instead, our data suggest that C/EBP beta cooperates with the protein kinase Jnk to induce phosphorylation of p300. Overall, our data identify Hipk2 as a novel regulator of C/EBP beta and implicate different protein kinases in the cooperation of p300 with C/EBP beta and C/EBP beta.	[Steinmann, Simone; Coulibaly, Anna; Ohnheiser, Johanna; Jakobs, Anke; Klempnauer, Karl-Heinz] Univ Munster, Inst Biochem, D-48149 Munster, Germany	University of Munster	Klempnauer, KH (corresponding author), Univ Munster, Inst Biochem, Wilhelm Klemm Str 2, D-48149 Munster, Germany.	klempna@uni-muenster.de		Coulibaly, Anna/0000-0001-5746-4496	Deutsche Forschungsgemeinschaft [KL461/12-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant KL461/12-1.	Aikawa Y, 2006, EMBO J, V25, P3955, DOI 10.1038/sj.emboj.7601273; Atwood AA, 2010, ONCOGENE, V29, P6004, DOI 10.1038/onc.2010.336; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Bundy LM, 2003, ONCOGENE, V22, P869, DOI 10.1038/sj.onc.1206216; Calkhoven CF, 2000, GENE DEV, V14, P1920; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Choi CY, 2005, J BIOL CHEM, V280, P21427, DOI 10.1074/jbc.M500496200; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Eaton EM, 2003, J BIOL CHEM, V278, P33416, DOI 10.1074/jbc.M305680200; Erickson RL, 2001, J BIOL CHEM, V276, P16348, DOI 10.1074/jbc.M100128200; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Joo M, 2004, J BIOL CHEM, V279, P6658, DOI 10.1074/jbc.M306267200; Kim EA, 2006, J BIOL CHEM, V281, P7489, DOI 10.1074/jbc.M507227200; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Li X, 2007, P NATL ACAD SCI USA, V104, P11597, DOI 10.1073/pnas.0703771104; LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533; Lincoln AJ, 1998, J BIOL CHEM, V273, P9552, DOI 10.1074/jbc.273.16.9552; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Muller C, 1995, EMBO J, V14, P6127, DOI 10.1002/j.1460-2075.1995.tb00303.x; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Nerlov C, 2004, NAT REV CANCER, V4, P394, DOI 10.1038/nrc1363; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Pedersen TA, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901; Plachetka A, 2008, MOL CELL BIOL, V28, P2102, DOI 10.1128/MCB.01943-07; Pless O, 2008, J BIOL CHEM, V283, P26357, DOI 10.1074/jbc.M802132200; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Raught B, 1996, CANCER RES, V56, P4382; Ross SE, 2004, MOL CELL BIOL, V24, P675, DOI 10.1128/MCB.24.2.675-686.2004; Schubert S, 2004, ONCOGENE, V23, P1392, DOI 10.1038/sj.onc.1207255; Schwartz C, 2003, EMBO J, V22, P882, DOI 10.1093/emboj/cdg076; Shuman JD, 2004, MOL CELL BIOL, V24, P7380, DOI 10.1128/MCB.24.17.7380-7391.2004; Smink JJ, 2012, GENE, V497, P10, DOI 10.1016/j.gene.2012.01.043; Steinmann S, 2009, ONCOGENE, V28, P2446, DOI 10.1038/onc.2009.90; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; Trivedi AK, 2007, ONCOGENE, V26, P1789, DOI 10.1038/sj.onc.1209964; Wethmar K, 2010, GENE DEV, V24, P15, DOI 10.1101/gad.557910; Xu M, 2003, EMBO J, V22, P893, DOI 10.1093/emboj/cdg094; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zahnow CA, 2001, CANCER RES, V61, P261; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zhang QC, 2007, J PROTEOME RES, V6, P4711, DOI 10.1021/pr700571d	53	14	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22257	22269		10.1074/jbc.M113.487769	http://dx.doi.org/10.1074/jbc.M113.487769			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782693	Green Published, hybrid			2022-12-25	WOS:000330596300008
J	Qin, ZZ; Wang, YR; Cao, SY; He, YS; Ma, HX; Jin, GF; Hu, ZB; Guan, XX; Shen, HB				Qin, Zhenzhen; Wang, Yanru; Cao, Songyu; He, Yisha; Ma, Hongxia; Jin, Guangfu; Hu, Zhibin; Guan, Xiaoxiang; Shen, Hongbing			Genetic Variants at 12p11 and 12q24 Are Associated with Breast Cancer Risk in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; CONFER SUSCEPTIBILITY; LOCUS; ALLELES; 9Q31.2; 9P21; ASIA	Background: A recent genome-wide association study (GWAS) has identified three new breast cancer susceptibility loci at 12p11, 12q24 and 21q21 in populations of European descent. However, because of the genetic heterogeneity, it is largely unknown for the role of these loci in the breast cancer susceptibility in the populations of non-European descent. Methodology/Principal Findings: Here, we genotyped three variants (rs10771399 at 12p11, rs1292011 at 12q24 and rs2823093 at 21q21) in an independent case-control study with a total of 1792 breast cancer cases and 1867 cancer-free controls in a Chinese population. We found that rs10771399 and rs1292011 were significantly associated with risk of breast cancer with per-allele odds ratios (ORs) of 0.85 (95% confidence interval (CI): 0.76-0.96; P = 0.010) and 0.84 (95% CI: 0.76-0.95; P = 4.50x10(-3)), respectively, which was consistent with those reported in populations of European descent. Similar effects were observed between ER/PR positive and negative breast cancer for both loci. However, we did not found significant association between rs2823093 and breast cancer risk (OR = 0.97, 95% CI = 0.76-1.24; P = 0.795). Conclusions/Significance: Our results indicate that genetic variants at 12p11 and 12q24 may also play an important role in breast cancer development in Chinese women.	[Qin, Zhenzhen; Ma, Hongxia; Jin, Guangfu; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Qin, Zhenzhen; Cao, Songyu; He, Yisha; Ma, Hongxia; Jin, Guangfu; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, MOE Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Qin, Zhenzhen; Ma, Hongxia; Jin, Guangfu; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Clin Epidemiol Sect, Nanjing, Jiangsu, Peoples R China; [Wang, Yanru; Guan, Xiaoxiang] Southern Med Univ, Jinling Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Southern Medical University - China	Shen, HB (corresponding author), Southern Med Univ, Jinling Hosp, Dept Med Oncol, Nanjing, Jiangsu, Peoples R China.	xxguan@hotmail.com; hbshen@njmu.edu.cn		Guan, Xiaoxiang/0000-0001-6145-0046	National Natural Science Foundation of China [81071715, 81102179]; Key Project of the National Natural Science Foundation of China [81230067]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0631]; Young Talents Support Program from the Organization Department of the CPC Central Committee; Priority Academic Program for the Development of Jiangsu Higher Education Institutions [Public Health and Preventive Medicine]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Young Talents Support Program from the Organization Department of the CPC Central Committee; Priority Academic Program for the Development of Jiangsu Higher Education Institutions [Public Health and Preventive Medicine]	This work was supported in part by National Natural Science Foundation of China (81071715; 81102179); Key Project of the National Natural Science Foundation of China (81230067); The Program for Changjiang Scholars and Innovative Research Team in University (IRT0631), The Young Talents Support Program from the Organization Department of the CPC Central Committee and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions [Public Health and Preventive Medicine]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Antoniou AC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3121; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Cai QY, 2011, HUM MOL GENET, V20, P4991, DOI 10.1093/hmg/ddr405; Chen JP, 2012, BREAST CANCER RES TR, V132, P741, DOI 10.1007/s10549-011-1927-y; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kakonen SM, 2003, CANCER-AM CANCER SOC, V97, P834, DOI 10.1002/cncr.11132; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; Long N, 2010, ASIAN PAC J CANCER P, V11, P107; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Zheng W, 2013, HUM MOL GENET   0327, V27; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	22	5	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66519	10.1371/journal.pone.0066519	http://dx.doi.org/10.1371/journal.pone.0066519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776684	gold, Green Published, Green Submitted			2022-12-25	WOS:000320322400109
J	Thyagarajan, B; Wang, R; Nelson, H; Barcelo, H; Koh, WP; Yuan, JM				Thyagarajan, Bharat; Wang, Renwei; Nelson, Heather; Barcelo, Helene; Koh, Woon-Puay; Yuan, Jian-Min			Mitochondrial DNA Copy Number Is Associated with Breast Cancer Risk	PLOS ONE			English	Article							OXIDATIVE STRESS; D-LOOP; MUTATIONS; CELLS; TRANSCRIPTION; DEPLETION; DECREASE; INCREASE; SAMPLES	Mitochondrial DNA (mtDNA) copy number in peripheral blood is associated with increased risk of several cancers. However, data from prospective studies on mtDNA copy number and breast cancer risk are lacking. We evaluated the association between mtDNA copy number in peripheral blood and breast cancer risk in a nested case-control study of 183 breast cancer cases with pre-diagnostic blood samples and 529 individually matched controls among participants of the Singapore Chinese Health Study. The mtDNA copy number was measured using real time PCR. Conditional logistic regression analyses showed that there was an overall positive association between mtDNA copy number and breast cancer risk (P-trend = 0.01). The elevated risk for higher mtDNA copy numbers was primarily seen for women with,3 years between blood draw and cancer diagnosis; ORs (95% CIs) for 2nd, 3rd, 4th, and 5th quintile of mtDNA copy number were 1.52 (0.61, 3.82), 2.52 (1.03, 6.12), 3.12 (1.31, 7.43), and 3.06 (1.25, 7.47), respectively, compared with the 1st quintile (P-trend = 0.004). There was no association between mtDNA copy number and breast cancer risk among women who donated a blood sample >= 3 years before breast cancer diagnosis (P-trend = 0.41). This study supports a prospective association between increased mtDNA copy number and breast cancer risk that is dependent on the time interval between blood collection and breast cancer diagnosis. Future studies are warranted to confirm these findings and to elucidate the biological role of mtDNA copy number in breast cancer risk.	[Thyagarajan, Bharat; Barcelo, Helene] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Wang, Renwei; Yuan, Jian-Min] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Nelson, Heather] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Nelson, Heather] Univ Minnesota, Dept Epidemiol & Community Hlth, Minneapolis, MN USA; [Koh, Woon-Puay] Duke NUS Grad Med Sch Singapore, Singapore, Singapore; [Koh, Woon-Puay] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National University of Singapore; National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Thyagarajan, B (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	thya0003@umn.edu		Nelson, Heather/0000-0003-1901-9513; Yuan, Jian-Min/0000-0002-4620-3108	Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD) [K12HD055887]; Office of Research on Women's Health; National Institute on Aging, National Institutes of Health; National Cancer Institute, Bethesda, Maryland, United States of America [R01 CA55069, R35 CA53890, R01 CA80205, R01 CA144034]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD055887] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA144034, R01CA055069, R35CA053890, R01CA080205] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute, Bethesda, Maryland, United States of America; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research study was supported by the Building Interdisciplinary Research Careers in Women's Health Grant (K12HD055887) from the Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD), the Office of Research on Women's Health, and the National Institute on Aging, National Institutes of Health, administered by the University of Minnesota Deborah E. Powell Center for Women's Health. The Singapore Chinese Health Study was supported by grants R01 CA55069, R35 CA53890, R01 CA80205, and R01 CA144034 from the National Cancer Institute, Bethesda, Maryland, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Chang SC, 2009, INT J COLORECTAL DIS, V24, P623, DOI 10.1007/s00384-009-0663-9; Dai Q, 2009, J CLIN ONCOL, V27, P2482, DOI 10.1200/JCO.2008.19.7970; Delsite RL, 2003, MUTAGENESIS, V18, P497, DOI 10.1093/mutage/geg027; Fan AXC, 2009, J CANCER RES CLIN, V135, P983, DOI 10.1007/s00432-008-0533-9; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; Hankin JH, 2001, NUTR CANCER, V39, P187, DOI 10.1207/S15327914nc392_5; Hosgood HD, 2010, CARCINOGENESIS, V31, P847, DOI 10.1093/carcin/bgq045; Hsu CW, 2010, BREAST J, V16, P264, DOI 10.1111/j.1524-4741.2010.00908.x; Lan Q, 2008, BLOOD, V112, P4247, DOI 10.1182/blood-2008-05-157974; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Liao LM, 2011, CANC EPIDEMIOL BIOMA; Lin PC, 2008, INT J COLORECTAL DIS, V23, P1223, DOI 10.1007/s00384-008-0539-4; Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342; Losanoff JE, 2008, BREAST, V17, P540, DOI 10.1016/j.breast.2008.04.005; Lynch SM, 2011, CANCER PREV RES, V4, P1912, DOI 10.1158/1940-6207.CAPR-11-0002; Mambo E, 2005, INT J CANCER, V116, P920, DOI 10.1002/ijc.21110; Meierhofer D, 2004, CARCINOGENESIS, V25, P1005, DOI 10.1093/carcin/bgh104; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; Parkin DM, 2002, CANC INCIDENCE 5 CON; Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9; Purdue MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043149; Qu FL, 2011, CANCER-AM CANCER SOC, V117, P3148, DOI 10.1002/cncr.25906; Radpour R, 2009, BREAST J, V15, P505, DOI 10.1111/j.1524-4741.2009.00767.x; Rossner P, 2006, CANCER EPIDEM BIOMAR, V15, P639, DOI 10.1158/1055-9965.EPI-05-0554; SEOW A, 2004, TRENDS CANC INCIDENC; Shen J, 2010, MITOCHONDRION, V10, P62, DOI 10.1016/j.mito.2009.09.004; Society AC, 2012, CANC FACTS FIG 2012; Thyagarajan B, 2012, CANCER EPIDEM BIOMAR, V21, P1574, DOI 10.1158/1055-9965.EPI-12-0138-T; Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377; Wang Y, 2005, GYNECOL ONCOL, V98, P104, DOI 10.1016/j.ygyno.2005.04.015; Wu CW, 2005, GENE CHROMOSOME CANC, V44, P19, DOI 10.1002/gcc.20213; Xia P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-454; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Yu M, 2007, IUBMB LIFE, V59, P450, DOI 10.1080/15216540701509955; Yu M, 2011, LIFE SCI, V89, P65, DOI 10.1016/j.lfs.2011.05.010	40	60	60	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65968	10.1371/journal.pone.0065968	http://dx.doi.org/10.1371/journal.pone.0065968			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776581	Green Published, gold, Green Accepted			2022-12-25	WOS:000320322400066
J	Addabbo, F; Chen, QY; Patel, DP; Rabadi, M; Ratliff, B; Zhang, F; Jasmin, JF; Wolin, M; Lisanti, M; Gross, SS; Goligorsky, MS				Addabbo, Francesco; Chen, Qiuying; Patel, Dhara P.; Rabadi, May; Ratliff, Brian; Zhang, Frank; Jasmin, Jean-Francois; Wolin, Michael; Lisanti, Michael; Gross, Steven S.; Goligorsky, Michael S.			Glutamine Supplementation Alleviates Vasculopathy and Corrects Metabolic Profile in an In Vivo Model of Endothelial Cell Dysfunction	PLOS ONE			English	Article							OXIDE SYNTHASE INHIBITION; NITRIC-OXIDE; L-ARGININE; ASYMMETRICAL DIMETHYLARGININE; PULMONARY-HYPERTENSION; CARDIOVASCULAR RISK; RELAXING FACTOR; UREMIC TOXINS; RENAL-DISEASE; RAT	Endothelial Cell Dysfunction (ECD) is a recognized harbinger of a host of chronic cardiovascular diseases. Using a mouse model of ECD triggered by treatment with L-Nv-methylarginine (L-NMMA), we previously demonstrated that renal microvasculature displays a perturbed protein profile, including diminished expression of two key enzymes of the Krebs cycle associated with a Warburg-type suppression of mitochondrial metabolism. We hypothesized that supplementation with L-glutamine (GLN), that can enter the Krebs cycle downstream this enzymatic bottleneck, would normalize vascular function and alleviate mitochondrial dysfunction. To test this hypothesis, mice with chronic L-NMMA-induced ECD were cotreated with GLN at different concentrations for 2 months. Results confirmed that L-NMMA led to a defect in acetylcholineinduced relaxation of aortic rings that was dose-dependently prevented by GLN. In caveolin-1 transgenic mice characterized by eNOS inactivation, L-NMMA further impaired vasorelaxation which was partially rescued by GLN co-treatment. Proinflammatory profile induced by L-NMMA was blunted in mice co-treated with GLN. Using an LC/MS platform for metabolite profiling, we sought to identify metabolic perturbations associated with ECD and offset by GLN supplementation. 3453 plasma molecules could be detected with 100% frequency in mice from at least one treatment group. Among these, 37 were found to be differentially expressed in a 4-way comparison of control vs. LNMMA both with and without GLN. One of such molecules, hippuric acid, an "uremic toxin'' was found to be elevated in our non-uremic mice receiving L-NMMA, but normalized by treatment with GLN. Ex vivo analysis of hippuric acid effects on vasomotion demonstrated that it significantly reduced acetylcholine-induced vasorelaxation of vascular rings. In conclusion, functional and metabolic profiling of animals with early ECD revealed macrovasculopathy and that supplementation GLN is capable of improving vascular function. Metabolomic analyses reveal elevation of hippuric acid, which may further exacerbate vasculopathy even before the development of uremia.	[Addabbo, Francesco; Patel, Dhara P.; Rabadi, May; Ratliff, Brian; Zhang, Frank; Wolin, Michael; Goligorsky, Michael S.] New York Med Coll, Dept Med, Valhalla, NY 10595 USA; [Addabbo, Francesco; Patel, Dhara P.; Rabadi, May; Ratliff, Brian; Zhang, Frank; Wolin, Michael; Goligorsky, Michael S.] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; [Addabbo, Francesco; Patel, Dhara P.; Rabadi, May; Ratliff, Brian; Zhang, Frank; Wolin, Michael; Goligorsky, Michael S.] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA; [Chen, Qiuying; Gross, Steven S.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA; [Jasmin, Jean-Francois; Lisanti, Michael] Thomas Jefferson Univ, Ctr Canc, Philadelphia, PA 19107 USA; [Lisanti, Michael] Univ Manchester, Breakthrough Breast Canc Res Unit, Manchester M13 9PL, Lancs, England	New York Medical College; New York Medical College; New York Medical College; Cornell University; Jefferson University; University of Manchester	Addabbo, F (corresponding author), New York Med Coll, Dept Med, Valhalla, NY 10595 USA.	f.addabbo@biologia.uniba.it; Michael_goligorsky@nymc.edu	Lisanti, Michael/B-6131-2018	Lisanti, Michael/0000-0003-2034-1382; Patel (Lakhkar), Dr. Dhara/0000-0002-2547-0645	NIH [DK54602, DK052783, DK45462]; Westchester Artificial Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052783, R01DK045462, R01DK054602] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Westchester Artificial Kidney Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported in part by NIH grants DK54602, DK052783, DK45462 and the Westchester Artificial Kidney Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUSOUD HM, 1994, J BIOL CHEM, V269, P32318; Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Addabbo F, 2009, AM J PATHOL, V174, P34, DOI 10.2353/ajpath.2009.080650; ARNAL JF, 1995, J CLIN INVEST, V95, P2565, DOI 10.1172/JCI117957; Bogle RG, 1996, J PHYSIOL-LONDON, V490, P229, DOI 10.1113/jphysiol.1996.sp021138; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037149, 10.1371/journal.pone.0042971]; Ciborowski M, 2011, J PROTEOME RES, V10, P1374, DOI 10.1021/pr101138m; Coeffier M, 2005, NUTR REV, V63, P65, DOI 10.1111/j.1753-4887.2005.tb00123.x; Deguchi T, 2005, J PHARMACOL EXP THER, V314, P932, DOI 10.1124/jpet.105.085613; Feron O, 1998, J BIOL CHEM, V273, P3125, DOI 10.1074/jbc.273.6.3125; Goligorsky MS, 2000, ACTA PHYSIOL SCAND, V168, P33; Goligorsky MS, 2005, AM J PHYSIOL-RENAL, V288, pF871, DOI 10.1152/ajprenal.00333.2004; Goligorsky MS, 1999, AM J PHYSIOL-CELL PH, V276, pC1271, DOI 10.1152/ajpcell.1999.276.6.C1271; Gorg B, 2005, HEPATOLOGY, V41, P1065, DOI 10.1002/hep.20662; Hassan GS, 2004, BIOCHEMISTRY-US, V43, P8312, DOI 10.1021/bi049609t; Hayashi Y, 2002, CIRCULATION, V106, P2601, DOI 10.1161/01.CIR.0000035651.72240.07; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; KREBS HA, 1966, BIOCHEM J, V101, P242, DOI 10.1042/bj1010242; Levey AS, 1998, AM J KIDNEY DIS, V32, P853, DOI 10.1016/S0272-6386(98)70145-3; Linder AE, 2005, J CARDIOVASC PHARM, V46, P438, DOI 10.1097/01.fjc.0000175879.14994.63; LINDNER A, 1974, NEW ENGL J MED, V290, P697, DOI 10.1056/NEJM197403282901301; Morris CR, 2008, BLOOD, V111, P402, DOI 10.1182/blood-2007-04-081703; Murphy C, 1998, CLIN SCI, V95, P397, DOI 10.1042/CS19980194; Mutsaers HAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018438; Noiri E, 1998, AM J PHYSIOL-CELL PH, V274, pC236, DOI 10.1152/ajpcell.1998.274.1.C236; O'Riordan E, 2007, AM J PHYSIOL-HEART C, V292, pH285, DOI 10.1152/ajpheart.00560.2006; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Park HC, 2010, AM J PHYSIOL-RENAL, V298, pF357, DOI 10.1152/ajprenal.00542.2009; PARRYBILLINGS M, 1990, LANCET, V336, P523, DOI 10.1016/0140-6736(90)92083-T; Razani B, 2001, J BIOL CHEM, V276, P38121; Reid MA, 2013, MOL CELL, V50, P200, DOI 10.1016/j.molcel.2013.02.008; Roth E, 2008, J NUTR, V138, p2025S, DOI 10.1093/jn/138.10.2025S; Satoh M, 2003, NEPHRON EXP NEPHROL, V95, pE111, DOI 10.1159/000074327; Schachter D, 2007, AM J PHYSIOL-CELL PH, V293, pC142, DOI 10.1152/ajpcell.00589.2006; SESSA WC, 1990, P NATL ACAD SCI USA, V87, P8607, DOI 10.1073/pnas.87.21.8607; Shanware NP, 2011, J MOL MED, V89, P229, DOI 10.1007/s00109-011-0731-9; Spustova V, 1987, Czech Med, V10, P79; Stoessel A, 2008, AM J PHYSIOL-RENAL, V295, pF717, DOI 10.1152/ajprenal.00071.2008; SWIERKOSZ TA, 1990, BIOCHEM BIOPH RES CO, V172, P143, DOI 10.1016/S0006-291X(05)80184-6; Tourkina E, 2008, AM J PHYSIOL-LUNG C, V294, pL843, DOI 10.1152/ajplung.00295.2007; Valkonen VP, 2001, LANCET, V358, P2127, DOI 10.1016/S0140-6736(01)07184-7; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Vallance P, 2001, LANCET, V358, P2096, DOI 10.1016/S0140-6736(01)07229-4; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vita JA, 2002, CIRCULATION, V106, P640, DOI 10.1161/01.CIR.0000028581.07992.56; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wernerman J, 2008, J NUTR, V138, p2040S, DOI 10.1093/jn/138.10.2040S; Wernerman J, 2008, CURR OPIN ANESTHESIO, V21, P155, DOI 10.1097/ACO.0b013e3282f54fd6; Wilmore DW, 2001, J NUTR, V131, p2543S, DOI 10.1093/jn/131.9.2543S; Wischmeyer PE, 2007, CRIT CARE MED, V35, pS541, DOI 10.1097/01.CCM.0000278064.32780.D3; XU H, 1994, PHARMACOLOGY, V48, P260, DOI 10.1159/000139188; ZIEGLER TR, 1990, JPEN-PARENTER ENTER, V14, pS137, DOI 10.1177/0148607190014004201; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8	54	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65458	10.1371/journal.pone.0065458	http://dx.doi.org/10.1371/journal.pone.0065458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776484	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400031
J	Gajewska-Wozniak, O; Skup, M; Kasicki, S; Ziemlinska, E; Czarkowska-Bauch, J				Gajewska-Wozniak, Olga; Skup, Malgorzata; Kasicki, Stefan; Ziemlinska, Ewelina; Czarkowska-Bauch, Julita			Enhancing Proprioceptive Input to Motoneurons Differentially Affects Expression of Neurotrophin 3 and Brain-Derived Neurotrophic Factor in Rat Hoffmann-Reflex Circuitry	PLOS ONE			English	Article							SPINAL-CORD; MESSENGER-RNAS; SCHWANN-CELLS; HORSERADISH-PEROXIDASE; MUSCLE AFFERENTS; FIRING PATTERNS; NERVOUS-SYSTEM; MOTOR-NEURONS; TRK-RECEPTORS; ADULT RATS	The importance of neurotrophin 3 (NT-3) for motor control prompted us to ask the question whether direct electrical stimulation of low-threshold muscle afferents, strengthening the proprioceptive signaling, could effectively increase the endogenous pool of this neurotrophin and its receptor TrkC in the Hoffmann-reflex (H-reflex) circuitry. The effects were compared with those of brain-derived neurotrophic factor (BDNF) and its TrkB receptor. Continuous bursts of stimuli were delivered unilaterally for seven days, 80 min daily, by means of a cuff-electrode implanted over the tibial nerve in awake rats. The H-reflex was recorded in the soleus muscle to control the strength of stimulation. Stimulation aimed at activation of Ia fibers produced a strong increase of NT-3 protein, measured with ELISA, in the lumbar L3-6 segments of the spinal cord and in the soleus muscle. This stimulation exerted much weaker effect on BDNF protein level which slightly increased only in L3-6 segments of the spinal cord. Increased protein level of NT-3 and BDNF corresponded to the changes of NT-3 mRNA and BDNF mRNA expression in L3-6 segments but not in the soleus muscle. We disclosed tissue-specificity of TrkC mRNA and TrkB mRNA responses. In the spinal cord TrkC and TrkB transcripts tended to decrease, whereas in the soleus muscle TrkB mRNA decreased and TrkC mRNA expression strongly increased, suggesting that stimulation of Ia fibers leads to sensitization of the soleus muscle to NT-3 signaling. The possibility of increasing NT-3/TrkC signaling in the neuromuscular system, with minor effects on BDNF/TrkB signaling, by means of low-threshold electrical stimulation of peripheral nerves, which in humans might be applied in non-invasive way, offers an attractive therapeutic tool.	[Gajewska-Wozniak, Olga; Skup, Malgorzata; Kasicki, Stefan; Ziemlinska, Ewelina; Czarkowska-Bauch, Julita] Nencki Inst Expt Biol, Dept Neurophysiol, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Skup, M (corresponding author), Nencki Inst Expt Biol, Dept Neurophysiol, Warsaw, Poland.	m.skup@nencki.gov.pl; j.czarkowska@nencki.gov.pl	Kasicki, Stefan/Q-1227-2016; Czarkowska-Bauch, Julita/AAB-6872-2020	Kasicki, Stefan/0000-0001-7472-8422; Skup, Malgorzata/0000-0002-2605-0124; Ziemlinska, Ewelina/0000-0002-7602-3239; Gajewska-Wozniak, Olga/0000-0003-3529-5788	Ministry of Science and Higher Education [0480/B/P01/2007/33 (N N 401 048033)]; EU FP 7 Capacities Programme BIOIMAGINE funds	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); EU FP 7 Capacities Programme BIOIMAGINE funds	This study was supported by grant of the Ministry of Science and Higher Education 0480/B/P01/2007/33 (N N 401 048033), by EU FP 7 Capacities Programme BIOIMAGINE funds and by statutory funds for the Nencki Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Majed AA, 2000, EUR J NEUROSCI, V12, P4381, DOI 10.1046/j.1460-9568.2000.01341.x; Arvanian VL, 2003, J NEUROSCI, V23, P8706; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Bawa P, 2008, MUSCLE NERVE, V38, P1604, DOI 10.1002/mus.21184; Boyce VS, 2012, EUR J NEUROSCI, V35, P221, DOI 10.1111/j.1460-9568.2011.07950.x; Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burke RE, 1996, J COMP NEUROL, V372, P465; Carp JS, 2001, EXP BRAIN RES, V136, P269, DOI 10.1007/s002210000608; Carroll P, 1998, NAT NEUROSCI, V1, P42, DOI 10.1038/242; COPRAY JCVM, 1994, NEUROSCIENCE, V63, P1125, DOI 10.1016/0306-4522(94)90578-9; Copray S, 2000, NEUROSCI LETT, V289, P217, DOI 10.1016/S0304-3940(00)01305-7; Cote MP, 2011, J NEUROTRAUM, V28, P299, DOI 10.1089/neu.2010.1594; CZARKOWSKA J, 1976, BRAIN RES, V118, P115, DOI 10.1016/0006-8993(76)90844-1; CZARKOWSKA J, 1981, J PHYSIOL-LONDON, V310, P367, DOI 10.1113/jphysiol.1981.sp013555; de Carrizosa MADL, 2009, J NEUROSCI, V29, P575, DOI 10.1523/JNEUROSCI.5312-08.2009; ECCLES JC, 1951, PROC R SOC SER B-BIO, V138, P475, DOI 10.1098/rspb.1951.0036; Elmer E, 1996, BRAIN RES, V712, P19, DOI 10.1016/0006-8993(95)01424-1; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; FUNAKOSHI H, 1995, SCIENCE, V268, P1495, DOI 10.1126/science.7770776; Gajewska-Wozniak O, 2012, LOW THRESHOLD STIMUL; Gomez-Pinilla F, 2001, EUR J NEUROSCI, V13, P1078, DOI 10.1046/j.0953-816x.2001.01484.x; Gonzalez M, 1997, J NEUROPHYSIOL, V77, P502, DOI 10.1152/jn.1997.77.1.502; Gonzalez-Martinez T, 2005, NEUROSCI LETT, V377, P12, DOI 10.1016/j.neulet.2004.11.078; Heckman CJ, 2008, NEUROSCIENTIST, V14, P264, DOI 10.1177/1073858408314986; Hess DM, 2007, J COMP NEUROL, V501, P465, DOI 10.1002/cne.21163; Hyngstrom AS, 2007, NAT NEUROSCI, V10, P363, DOI 10.1038/nn1852; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Jankowska E, 2008, J NEUROSCI, V28, P3615, DOI 10.1523/JNEUROSCI.0466-08.2008; Jankowska E, 2008, BRAIN RES REV, V57, P46, DOI 10.1016/j.brainresrev.2007.06.022; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Kokaia Z, 1996, NEUROSCIENCE, V75, P197, DOI 10.1016/0306-4522(96)00257-6; LAPORTE Y, 1952, AM J PHYSIOL, V169, P609, DOI 10.1152/ajplegacy.1952.169.3.609; Loeb G. E., 1986, ELECTROMYOGRAPHY EXP; Lu P, 2008, EXP NEUROL, V209, P313, DOI 10.1016/j.expneurol.2007.08.004; Macias M, 2002, NEUROREPORT, V13, P2527, DOI 10.1097/00001756-200212200-00029; Macias M, 2007, EUR J NEUROSCI, V25, P2425, DOI 10.1111/j.1460-9568.2007.05498.x; Macias M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-144; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; Meier C, 1999, J NEUROSCI, V19, P3847; Mendell LM, 1999, J NEUROSCI, V19, P3162; Mentis GZ, 2010, ANN NY ACAD SCI, V1198, P220, DOI 10.1111/j.1749-6632.2010.05538.x; MERLIO JP, 1992, NEUROSCIENCE, V51, P513, DOI 10.1016/0306-4522(92)90292-A; Munson JB, 1997, J NEUROSCI, V17, P470, DOI 10.1523/JNEUROSCI.17-01-00470.1997; Omura T, 2005, J PERIPHER NERV SYST, V10, P293, DOI 10.1111/j.1085-9489.2005.10307.x; Petruska JC, 2010, EUR J NEUROSCI, V32, P997, DOI 10.1111/j.1460-9568.2010.07392.x; Riley CP, 2004, J MOL HISTOL, V35, P771, DOI 10.1007/s10735-004-0778-9; SCHIEPPATI M, 1987, PROG NEUROBIOL, V28, P345, DOI 10.1016/0301-0082(87)90007-4; Shen H, 1999, MOL BRAIN RES, V64, P186, DOI 10.1016/S0169-328X(98)00314-3; Skup M, 2002, EXP NEUROL, V176, P289, DOI 10.1006/exnr.2002.7943; Skup M, 2012, EUR J NEUROSCI, V36, P2679, DOI 10.1111/j.1460-9568.2012.08182.x; STEIN RB, 1977, BRAIN RES, V128, P21, DOI 10.1016/0006-8993(77)90233-5; Tauszig-Delamasure S, 2007, P NATL ACAD SCI USA, V104, P13361, DOI 10.1073/pnas.0701243104; Wang TH, 2008, NEUROCHEM RES, V33, P1, DOI 10.1007/s11064-007-9398-6; Wilson-Gerwing TD, 2008, EXP NEUROL, V213, P303, DOI 10.1016/j.expneurol.2008.06.002; Woolley AG, 2008, GLIA, V56, P306, DOI 10.1002/glia.20614; Wright DE, 1997, NEURON, V19, P503, DOI 10.1016/S0896-6273(00)80367-0; Ying Z, 2003, BRAIN RES, V987, P93, DOI 10.1016/S0006-8993(03)03258-X; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017; Ziemlinska E, 2010, ADENO ASS VIRAL VECT	61	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65937	10.1371/journal.pone.0065937	http://dx.doi.org/10.1371/journal.pone.0065937			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776573	gold, Green Submitted, Green Published			2022-12-25	WOS:000320755400084
J	Milaneschi, Y; Cesari, M; Simonsick, EM; Vogelzangs, N; Kanaya, AM; Yaffe, K; Patrignani, P; Metti, A; Kritchevsky, SB; Pahor, M; Ferrucci, L; Penninx, BWJH				Milaneschi, Yuri; Cesari, Matteo; Simonsick, Eleanor M.; Vogelzangs, Nicole; Kanaya, Alka M.; Yaffe, Kristine; Patrignani, Paola; Metti, Andrea; Kritchevsky, Stephen B.; Pahor, Marco; Ferrucci, Luigi; Penninx, Brenda W. J. H.		Hlth ABC Study	Lipid Peroxidation and Depressed Mood in Community-Dwelling Older Men and Women	PLOS ONE			English	Article							C-REACTIVE PROTEIN; OXIDATIVE STRESS; MAJOR DEPRESSION; PLATELET ACTIVATION; 8-ISO-PROSTAGLANDIN F2-ALPHA; SEX-DIFFERENCES; INFLAMMATION; RISK; GLUCOCORTICOIDS; OBESITY	It has been hypothesized that cellular damage caused by oxidative stress is associated with late-life depression but epidemiological evidence is limited. In the present study we evaluated the association between urinary 8-iso-prostaglandin F-2 alpha (8-iso-PGF(2 alpha) ), a biomarker of lipid peroxidation, and depressed mood in a large sample of community-dwelling older adults. Participants were selected from the Health, Aging and Body Composition study, a community-based longitudinal study of older persons (aged 70-79 years). The present analyses was based on a subsample of 1027 men and 948 women free of mobility disability. Urinary concentration of 8-iso-PGF(2 alpha) was measured by radioimmunoassay methods and adjusted for urinary creatinine. Depressed mood was defined as a score greater than 5 on the 15-item Geriatric Depression Scale and/or use of antidepressant medications. Depressed mood was present in 3.0% of men and 5.5% of women. Depressed men presented higher urinary concentrations of 8-iso-PGF(2 alpha) than non-depressed men even after adjustment for multiple sociodemographic, lifestyle and health factors (p= 0.03, Cohen's d = 0.30). This association was not present in women (depressed status-by-sex interaction p = 0.04). Our study showed that oxidative damage may be linked to depression in older men from a large sample of the general population. Further studies are needed to explore whether the modulation of oxidative stress may break down the link between late-life depression and its deleterious health consequences.	[Milaneschi, Yuri; Vogelzangs, Nicole; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr GGZ InGeest, Dept Psychiat, Amsterdam, Netherlands; [Milaneschi, Yuri; Vogelzangs, Nicole; Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr GGZ InGeest, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Milaneschi, Yuri; Simonsick, Eleanor M.; Ferrucci, Luigi] NIH, Longitudinal Studies Sect, Clin Res Branch, Baltimore, MD USA; [Cesari, Matteo] Univ Toulouse, Inst Vieillissement, Toulouse, France; [Cesari, Matteo; Pahor, Marco] Univ Florida, Dept Aging & Geriatr Res, Inst Aging, Gainesville, FL USA; [Kanaya, Alka M.] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Patrignani, Paola] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Patrignani, Paola] Univ G DAnnunzio, Ctr Excellent Aging, Chieti, Italy; [Metti, Andrea] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Kritchevsky, Stephen B.] Wake Forest Univ, Bowman Gray Sch Med, Sticht Ctr Aging, Winston Salem, NC USA	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Universite de Toulouse; State University System of Florida; University of Florida; University of California System; University of California San Francisco; University of California System; University of California San Francisco; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wake Forest University; Wake Forest Baptist Medical Center	Milaneschi, Y (corresponding author), Vrije Univ Amsterdam, Med Ctr GGZ InGeest, Dept Psychiat, Amsterdam, Netherlands.	y.milaneschi@ggzingeest.nl	Cesari, Matteo/A-4649-2008; Patrignani, Paola/B-4844-2011; Simonsick, Eleanor/W-6864-2019; Penninx, Brenda WJH/S-7627-2017	Cesari, Matteo/0000-0002-0348-3664; Patrignani, Paola/0000-0003-1419-2691; Penninx, Brenda WJH/0000-0001-7779-9672; Kritchevsky, Stephen/0000-0003-3336-6781	National Institute on Aging (NIA) Contracts [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106]; NIA [R01-AG028050]; National Institute of Nursing Research [R01-NR012459]; Intramural Research Program of the National Institutes of Health; National Institute on Aging; National Institute on Aging [R01AG26556]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740, ZIAAG000015, N01AG062103, R01AG026556, R01AG028050, N01AG062101, N01AG062106] Funding Source: NIH RePORTER	National Institute on Aging (NIA) Contracts; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institute on Aging (NIA) Contracts N01-AG-6-2101; N01-AG-6-2103; N01-AG-6-2106; NIA grant R01-AG028050, and National Institute of Nursing Research grant R01-NR012459. This research was supported (in part) by the Intramural Research Program of the National Institutes of Health, National Institute on Aging. Assaying of 8-iso-PGF2 alpha was supported by the by the National Institute on Aging (R01AG26556). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915; Almeida OP, 1999, INT J GERIATR PSYCH, V14, P858, DOI 10.1002/(SICI)1099-1166(199910)14:10<858::AID-GPS35>3.0.CO;2-8; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Beasley LE, 2009, OBESITY, V17, P1062, DOI 10.1038/oby.2008.627; Bilici M, 2001, J AFFECT DISORDERS, V64, P43, DOI 10.1016/S0165-0327(00)00199-3; Cesari M, 2012, J GERONTOL A-BIOL, V67, P671, DOI 10.1093/gerona/glr246; Cohen D, 1998, STAT POWER ANAL BEHA; Davi G, 2004, CHEM PHYS LIPIDS, V128, P149, DOI 10.1016/j.chemphyslip.2003.10.001; Davi G, 1999, CIRCULATION, V99, P224; Dimopoulos N, 2008, PSYCHIAT RES, V161, P59, DOI 10.1016/j.psychres.2007.07.019; Dworski R, 2001, CLIN EXP ALLERGY, V31, P387, DOI 10.1046/j.1365-2222.2001.01055.x; Facecchia K, 2011, J TOXICOL IN PRESS; Forlenza MJ, 2006, PSYCHOSOM MED, V68, P1, DOI 10.1097/01.psy.0000195780.37277.2a; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Galecki P, 2009, HUM PSYCHOPHARM CLIN, V24, P277, DOI 10.1002/hup.1014; Halliwell B, 2000, CARDIOVASC RES, V47, P410, DOI 10.1016/S0008-6363(00)00097-3; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; IL'Yasova D, 2008, BIOMARKERS, V13, P41, DOI 10.1080/13547500701617708; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; Kendler KS, 2005, AM J PSYCHIAT, V162, P250, DOI 10.1176/appi.ajp.162.2.250; Koster A, 2010, OBESITY, V18, P2354, DOI 10.1038/oby.2010.86; Maciejewski PK, 2001, PSYCHOL MED, V31, P593, DOI 10.1017/S0033291701003877; MacQueen G, 2011, MOL PSYCHIATR, V16, P252, DOI 10.1038/mp.2010.80; Maes M, 2009, NEUROENDOCRINOL LETT, V30, P715; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; McIntosh LJ, 1996, EXP NEUROL, V141, P201, DOI 10.1006/exnr.1996.0154; McIntosh LJ, 1996, NEUROTOXICOLOGY, V17, P873; McIntosh LJ, 1998, BRAIN RES, V791, P209, DOI 10.1016/S0006-8993(98)00115-2; Milaneschi Y, 2012, WORLD J BIOL PSYCHIA, V13, P588, DOI 10.3109/15622975.2011.597876; Milaneschi Y, 2012, J CLIN PSYCHIAT, V73, P1205, DOI 10.4088/JCP.11m07552; Minuz Pietro, 2006, Pharmacol Rep, V58 Suppl, P57; Molendijk ML, 2011, MOL PSYCHIATR, V16, P1088, DOI 10.1038/mp.2010.98; Montorio I, 1996, Int Psychogeriatr, V8, P103, DOI 10.1017/S1041610296002505; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Pomara N, 2012, AM J PSYCHIAT, V169, P523, DOI 10.1176/appi.ajp.2011.11081153; Schwedhelm E, 2004, CIRCULATION, V109, P843, DOI 10.1161/01.CIR.0000116761.93647.30; Slinin Y, 2010, NEUROLOGY, V74, P33, DOI 10.1212/WNL.0b013e3181c7197b; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Terracciano A, 2010, GENES BRAIN BEHAV, V9, P512, DOI 10.1111/j.1601-183X.2010.00579.x; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; van Gool CH, 2003, AGE AGEING, V32, P81, DOI 10.1093/ageing/32.1.81; vanKooten F, 1997, STROKE, V28, P1557, DOI 10.1161/01.STR.28.8.1557; Vogelzangs N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.8; Vogelzangs N, 2010, J CLIN PSYCHIAT, V71, P391, DOI 10.4088/JCP.08m04743blu; Volpato S, 2004, CIRCULATION, V109, P607, DOI 10.1161/01.CIR.0000109503.13955.00; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; Wang B, 2006, ATHEROSCLEROSIS, V184, P425, DOI 10.1016/j.atherosclerosis.2005.05.008; WANG ZY, 1995, J PHARMACOL EXP THER, V275, P94; Wilson RS, 1999, ARCH NEUROL-CHICAGO, V56, P1274, DOI 10.1001/archneur.56.10.1274; Yager S, 2010, PSYCHONEUROENDOCRINO, V35, P1356, DOI 10.1016/j.psyneuen.2010.03.010; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zanjani FAK, 2006, BEHAV MED, V32, P36, DOI 10.3200/BMED.32.2.36-46	55	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65406	10.1371/journal.pone.0065406	http://dx.doi.org/10.1371/journal.pone.0065406			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776478	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000320755400028
J	Roth, B; Gustafsson, RJ; Ohlsson, B				Roth, Bodil; Gustafsson, Rita J.; Ohlsson, Bodil			Auto-Antibodies and Their Association with Clinical Findings in Women Diagnosed with Microscopic Colitis	PLOS ONE			English	Article							QUALITY-OF-LIFE; IRRITABLE-BOWEL-SYNDROME; GASTROINTESTINAL SYMPTOMS; LYMPHOCYTIC-COLITIS; COLLAGENOUS COLITIS; CIGARETTE-SMOKING; DOUBLE-BLIND; ANTIBODIES; DISEASE; RISK	Background: Microscopic colitis (MC) is a disease manifested by diarrhoea and is divided into collagenous and lymphocytic colitis. The aetiology is unknown, but auto-immunity is suggested. Auto-antibodies have been only rarely examined in this entity. The aim of the study was to examine the prevalence of auto-antibodies, and to examine associations between the presence of antibodies and clinical findings. Methods and Findings: Women with MC verified by biopsy and younger than 73 years, at any Department of Gastroenterology, in the district of Skane, between 2002 and 2010 were invited to participate in this study. The patients were asked to complete both a questionnaire describing their medical history and the Gastrointestinal Symptom Rating Scale (GSRS). Blood samples were collected. Anti-nuclear antibodies (ANA), anti-neutrophil cytoplasmic antibodies (ANCA), anti-Saccharomyces cerevisiae antibodies (ASCA), and antibodies against glutamic acid decarboxylase (anti-GAD), islet antigens-like insulin 2 (anti-IA2), thyroid peroxidase (anti-TPO), and thyrotropin receptor (TRAK) were analysed. Of 240 women identified, 133 were finally included in the study, median age 63 (59-67) years. Apart from the MC diagnosis, 52% also suffered from irritable bowel syndrome, 31% from hypertension and 31% from allergy. The prevalence of ANA (14%), ASCA IgG (13%), and anti-TPO antibodies (14%) for these patients was slightly higher than for the general population, and were found together with other concomitant diseases. Patients had more of all gastrointestinal symptoms compared with norm values, irrespective of antibody expression. Conclusions: Women with MC have a slightly increased prevalence of some auto-antibodies. These antibodies are not associated with symptoms, but are expressed in patients with concomitant diseases, obscuring the pathophysiology and clinical picture of MC.	[Ohlsson, Bodil] Skane Univ Hosp, Dept Clin Sci, Dept Gastroenterol, Malmo, Sweden; Lund Univ, Lund, Sweden	Lund University; Skane University Hospital; Lund University	Ohlsson, B (corresponding author), Skane Univ Hosp, Dept Clin Sci, Dept Gastroenterol, Malmo, Sweden.	bodil.ohlsson@med.lu.se			Bengt Ihre Foundation; Development Foundation of Region Skane	Bengt Ihre Foundation; Development Foundation of Region Skane	This study was sponsored by the Bengt Ihre Foundation and the Development Foundation of Region Skane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjornbak C, 2011, ALIMENT PHARM THER, V34, P1225, DOI 10.1111/j.1365-2036.2011.04865.x; Bohr J, 1996, GUT, V39, P73, DOI 10.1136/gut.39.1.73; Bonderup OK, 2009, GUT, V58, P68, DOI 10.1136/gut.2008.156513; Bonifacio E, 1997, ACTA DIABETOL, V34, P185, DOI 10.1007/s005920050072; Carmack SW, 2009, ADV ANAT PATHOL, V16, P290, DOI 10.1097/PAP.0b013e3181b5073a; Costagliola S, 1999, J CLIN ENDOCR METAB, V84, P90, DOI 10.1210/jc.84.1.90; Dahlquist GG, 2011, DIABETES CARE, V34, P1754, DOI 10.2337/dc11-0056; DIMENAS E, 1995, SCAND J GASTROENTERO, V30, P1046, DOI 10.3109/00365529509101605; DIMENAS E, 1993, SCAND J GASTROENTERO, V28, P681, DOI 10.3109/00365529309098272; Dimenas E, 1996, SCAND J GASTROENTERO, V31, P8, DOI 10.3109/00365529609095544; Drossman D, 2006, ROME 3 FUNCTIONAL GA; DUERR RH, 1991, GASTROENTEROLOGY, V100, P1590, DOI 10.1016/0016-5085(91)90657-7; Fernandez-Banares F, 2007, AM J GASTROENTEROL, V102, P324, DOI 10.1111/j.1572-0241.2006.00902.x; Gal AA, 2002, MODERN PATHOL, V15, P197, DOI 10.1038/modpathol.3880516; Holstein A, 2006, J GASTROEN HEPATOL, V21, P1016, DOI 10.1111/j.1440-1746.2005.04027.x; Karabulut G, 2011, MOD RHEUMATOL, V21, P602, DOI 10.1007/s10165-011-0446-3; Koskela RM, 2008, EUR J GASTROEN HEPAT, V20, P276, DOI 10.1097/MEG.0b013e3282f2468d; Lee S, 2009, HISTOPATHOLOGY, V55, P660, DOI 10.1111/j.1365-2559.2009.03431.x; Mankai A, 2013, RHEUMATOL INT, V33, P665, DOI 10.1007/s00296-012-2431-3; Matthiesen LS, 1999, EUR J OBSTET GYN R B, V83, P21, DOI 10.1016/S0301-2115(98)00233-4; Miehlke S, 2009, GASTROENTEROLOGY, V136, P2092, DOI 10.1053/j.gastro.2009.02.078; Olesen M, 2004, GUT, V53, P536, DOI 10.1136/gut.2003.023440; Op de Beeck K, 2012, ARTHRITIS RHEUM-US, V64, P213, DOI 10.1002/art.33327; Pardi DS, 2011, GASTROENTEROLOGY, V140, P1155, DOI 10.1053/j.gastro.2011.02.003; Persson A, 2010, EXP DIABETES RES, DOI 10.1155/2010/173652; Pilia S, 2011, DIABETIC MED, V28, P896, DOI 10.1111/j.1464-5491.2011.03313.x; Prideaux L, 2012, INFLAMM BOWEL DIS, V18, P1340, DOI 10.1002/ibd.21903; Prummel MF, 2005, BEST PRACT RES CL EN, V19, P1, DOI 10.1016/j.beem.2004.11.003; Rahmati K, 2008, CLIN LAB, V54, P227; Rasmussen MA, 2012, ALIMENT PHARM THER, V36, P79, DOI 10.1111/j.1365-2036.2012.05166.x; Reichlin M, 2006, MEASUREMENT CLIN SIG; Roth B, 2013, SCAND J GASTROENTERO, V48, P27, DOI 10.3109/00365521.2012.741614; Simren M, 2001, SCAND J GASTROENTERO, V36, P545, DOI 10.1080/003655201750153476; Stewart M, 2011, ALIMENT PHARM THER, V33, P1340, DOI 10.1111/j.1365-2036.2011.04666.x; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Symmons DPM, 2002, BEST PRACT RES CL RH, V16, P707, DOI 10.1053/berh.2002.0257; Tuomilehto J, 1998, NUTRITION, V14, P403; Weng JP, 2002, DIABETES CARE, V25, P68, DOI 10.2337/diacare.25.1.68; Westman KWA, 1998, KIDNEY INT, V53, P1230, DOI 10.1046/j.1523-1755.1998.00873.x; Yen EF, 2012, INFLAMM BOWEL DIS, V18, P1835, DOI 10.1002/ibd.22838	40	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66088	10.1371/journal.pone.0066088	http://dx.doi.org/10.1371/journal.pone.0066088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776613	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400109
J	Heimer, SR; Evans, DJ; Mun, JJ; Stern, ME; Fleiszig, SMJ				Heimer, Susan R.; Evans, David J.; Mun, James J.; Stern, Michael E.; Fleiszig, Suzanne M. J.			Surfactant Protein D Contributes to Ocular Defense against Pseudomonas aeruginosa in a Murine Model of Dry Eye Disease	PLOS ONE			English	Article							HUMAN TEAR FLUID; CORNEAL EPITHELIAL-CELLS; DESICCATING STRESS; CONJUNCTIVAL EPITHELIUM; MICROBIAL KERATITIS; BACTERIAL KERATITIS; INFECTIVE KERATITIS; CYTOKINE PROFILES; SJOGRENS-SYNDROME; MOUSE MODEL	Dry eye disease can cause ocular surface inflammation that disrupts the corneal epithelial barrier. While dry eye patients are known to have an increased risk of corneal infection, it is not known whether there is a direct causal relationship between these two conditions. Here, we tested the hypothesis that experimentally-induced dry eye (EDE) increases susceptibility to corneal infection using a mouse model. In doing so, we also examined the role of surfactant protein D (SP-D), which we have previously shown is involved in corneal defense against infection. Scopolamine injections and fan-driven air were used to cause EDE in C57BL/6 or Black Swiss mice (wild-type and SP-D gene-knockout). Controls received PBS injections and were housed normally. After 5 or 10 days, otherwise uninjured corneas were inoculated with 10(9) cfu of Pseudomonas aeruginosa strain PAO1. Anesthesia was maintained for 3 h post-inoculation. Viable bacteria were quantified in ocular surface washes and corneal homogenates 6 h post-inoculation. SP-D was measured by Western immunoblot, and corneal pathology assessed from 6 h to 4 days. EDE mice showed reduced tear volumes after 5 and 10 days (each by similar to 75%, p<0.001) and showed fluorescein staining (i.e. epithelial disruption). Surprisingly, there was no significant difference in corneal pathology between EDE mice and controls (similar to 10-14% incidence). Before bacterial inoculation, EDE mice showed elevated SP-D in ocular washes. After inoculation, fewer bacteria were recovered from ocular washes of EDE mice (<2% of controls, p = 0.0004). Furthermore, SP-D knockout mice showed a significant increase in P. aeruginosa corneal colonization under EDE conditions. Taken together, these data suggest that SP-D contributes to corneal defense against P. aeruginosa colonization and infection in EDE despite the loss of barrier function to fluorescein.	[Heimer, Susan R.; Evans, David J.; Mun, James J.; Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Heimer, Susan R.; Evans, David J.; Fleiszig, Suzanne M. J.] Touro Univ Calif, Coll Pharm, Vallejo, CA USA; [Stern, Michael E.] Allergan Pharmaceut Inc, Irvine, CA USA; [Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Grad Grp Vis Sci, Berkeley, CA 94720 USA; [Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Grad Grp Microbiol, Berkeley, CA 94720 USA; [Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Grad Grp Infect Dis & Immun, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Touro University California; AbbVie; Allergan; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Fleiszig, SMJ (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	fleiszig@berkeley.edu		Evans, David/0000-0002-6885-2053; Fleiszig, Suzanne/0000-0001-6324-3462	National Institutes of Health (NIH) [EY011221]; Allergan Inc.; University of California, Berkeley; NATIONAL EYE INSTITUTE [R01EY011221] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allergan Inc.(AbbVieAllergan); University of California, Berkeley(University of California System); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by the National Institutes of Health (NIH) EY011221 (SMJF) and by Allergan Inc. Funding from Allergan Inc. was provided under a research agreement with the University of California, Berkeley. The NIH had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Stern is a paid employee of Allergan Inc., and contributed to this work in his capacity as an expert in dry eye disease. Dr. Stern contributed to conception of the project idea, and to the study design and writing of the manuscript. No other external funding was received for this work.	Al-Yousuf N, 2009, MIDDLE EAST AFR J OP, V16, P3, DOI 10.4103/0974-9233.48855; Argueso P, 2002, INVEST OPHTH VIS SCI, V43, P1004; Augustin DK, 2011, INFECT IMMUN, V79, P595, DOI 10.1128/IAI.00854-10; Beardsley RM, 2008, CORNEA, V27, P935, DOI 10.1097/ICO.0b013e3181757997; Bourcier T, 2003, BRIT J OPHTHALMOL, V87, P834, DOI 10.1136/bjo.87.7.834; Bufler P, 2003, AM J RESP CELL MOL, V28, P249, DOI 10.1165/rcmb.4896; Butler TKH, 2005, BRIT J OPHTHALMOL, V89, P591, DOI 10.1136/bjo.2004.049072; Caffery B, 2008, OPTOMETRY VISION SCI, V85, P661, DOI 10.1097/OPX.0b013e318181ae4f; Caffery B, 2010, MOL VIS, V16, P1720; Chauhan SK, 2009, J IMMUNOL, V182, P1247, DOI 10.4049/jimmunol.182.3.1247; Chen DM, 2009, EXP EYE RES, V88, P880, DOI 10.1016/j.exer.2008.11.035; Corrales RM, 2007, CORNEA, V26, P579, DOI 10.1097/ICO.0b013e318033a729; Corrales RM, 2006, INVEST OPHTH VIS SCI, V47, P3293, DOI 10.1167/iovs.05-1382; Danjo Y, 1998, INVEST OPHTH VIS SCI, V39, P2602; De Paiva CS, 2009, MUCOSAL IMMUNOL, V2, P243, DOI 10.1038/mi.2009.5; De Paiva CS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1625, DOI 10.1001/archophthalmol.2009.316; Douda DN, 2011, J IMMUNOL, V187, P1856, DOI 10.4049/jimmunol.1004201; Dursun D, 2002, INVEST OPHTH VIS SCI, V43, P632; Enriquez-de-Salamanca A, 2010, MOL VIS, V16, P862; FLEISZIG SMJ, 1994, INFECT IMMUN, V62, P1799, DOI 10.1128/IAI.62.5.1799-1804.1994; Fleiszig SMJ, 2003, INFECT IMMUN, V71, P3866, DOI 10.1128/IAI.71.7.3866-3874.2003; FLEISZIG SMJ, 1994, ADV EXP MED BIOL, V350, P359; Giannoni E, 2006, AM J RESP CELL MOL, V34, P704, DOI 10.1165/rcmb.2005-0461OC; Gipson IK, 2011, CORNEA, V30, P1346, DOI 10.1097/ICO.0b013e31820d852a; Green M, 2008, CORNEA, V27, P22, DOI 10.1097/ICO.0b013e318156caf2; Hazlett Linda D, 2007, Chem Immunol Allergy, V92, P185, DOI 10.1159/000099269; He YC, 2000, J BIOL CHEM, V275, P31051, DOI 10.1074/jbc.M003499200; Jhanji V, 2009, BRIT J OPHTHALMOL, V93, P1639, DOI 10.1136/bjo.2008.154468; Kawasaki S, 2003, EXP EYE RES, V77, P17, DOI 10.1016/S0014-4835(03)00087-3; Kwong MSF, 2007, INFECT IMMUN, V75, P2325, DOI 10.1128/IAI.01404-06; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Lee EJ, 2003, INVEST OPHTH VIS SCI, V44, P5220, DOI 10.1167/iovs.03-0229; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; Madan T, 2005, J IMMUNOL, V174, P6943, DOI 10.4049/jimmunol.174.11.6943; McCormick CC, 2007, OCUL IMMUNOL INFLAMM, V15, P371, DOI 10.1080/09273940701486423; McDermott AM, 2009, OPHTHALMIC RES, V41, P60, DOI 10.1159/000187622; Mun JJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00008; Mun JJ, 2009, INFECT IMMUN, V77, P2392, DOI 10.1128/IAI.00173-09; Narayanan S, 2003, INVEST OPHTH VIS SCI, V44, P3795, DOI 10.1167/iovs.02-1301; Ni M, 2005, INFECT IMMUN, V73, P2147, DOI 10.1128/IAI.73.4.2147-2156.2005; Ni MJ, 2008, FEMS IMMUNOL MED MIC, V54, P177, DOI 10.1111/j.1574-695X.2008.00461.x; Niederkorn JY, 2006, J IMMUNOL, V176, P3950, DOI 10.4049/jimmunol.176.7.3950; Pearlman E, 2008, OCUL SURF, V6, P108, DOI 10.1016/S1542-0124(12)70279-3; Pflugfelder SC, 2005, AM J PATHOL, V166, P61, DOI 10.1016/S0002-9440(10)62232-8; Pitcher JD, 2011, INVEST OPHTH VIS SCI, V52, P3221, DOI 10.1167/iovs.09-4212; Redfern RL, 2011, EXP EYE RES, V92, P209, DOI 10.1016/j.exer.2010.12.005; Schaefer F, 2001, BRIT J OPHTHALMOL, V85, P842, DOI 10.1136/bjo.85.7.842; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; Stapleton F, 2012, EYE, V26, P185, DOI 10.1038/eye.2011.288; Stern ME, 2004, EXP EYE RES, V78, P409, DOI 10.1016/j.exer.2003.09.003; Tam C, 2010, INVEST OPHTH VIS SCI, V51, P3100, DOI 10.1167/iovs.09-4593; Wei Y, 2011, INVEST OPHTH VIS SCI, V52, P4780, DOI 10.1167/iovs.10-6350; Whitsett JA, 2010, INNATE IMMUN-LONDON, V16, P138, DOI 10.1177/1753425910366879; Wong T, 2003, BRIT J OPHTHALMOL, V87, P1103, DOI 10.1136/bjo.87.9.1103; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Yu DF, 2008, EXP EYE RES, V86, P403, DOI 10.1016/j.exer.2007.11.013; Zhou L, 2009, J PROTEOME RES, V8, P4889, DOI 10.1021/pr900686s	57	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65797	10.1371/journal.pone.0065797	http://dx.doi.org/10.1371/journal.pone.0065797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762428	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000106
J	Sandoval-Montiel, AA; Zentella-de-Pina, M; Ventura-Gallegos, JL; Frias-Gonzalez, S; Lopez-Macay, A; Zentella-Dehesa, A				Sandoval-Montiel, Alvaro A.; Zentella-de-Pina, Martha; Ventura-Gallegos, Jose L.; Frias-Gonzalez, Susana; Lopez-Macay, Ambar; Zentella-Dehesa, Alejandro			HSP-72 Accelerated Expression in Mononuclear Cells Induced In Vivo by Acetyl Salicylic Acid Can Be Reproduced In Vitro when Combined with H2O2	PLOS ONE			English	Article							HEAT-SHOCK RESPONSE; SODIUM-SALICYLATE; OXIDATIVE STRESS; TRANSCRIPTIONAL REGULATION; ANTIINFLAMMATORY DRUGS; INDUCED APOPTOSIS; DNA-BINDING; ACTIVATION; ASPIRIN; PHOSPHORYLATION	Background: Among NSAIDs acetyl salicylic acid remains as a valuable tool because of the variety of benefic prophylactic and therapeutic effects. Nevertheless, the molecular bases for these responses have not been complete understood. We explored the effect of acetyl salicylic acid on the heat shock response. Results: Peripheral blood mononuclear cells from rats challenged with acetyl salicylic acid presented a faster kinetics of expression of HSP-72 messenger RNA and protein in response to in vitro heat shock. This effect reaches its maximum 2 h after treatment and disappeared after 5 h. On isolated peripheral blood mononuclear cells from untreated rats, incubation with acetyl salicylic acid was ineffective to produce priming, but this effect was mimicked when the cells were incubated with the combination of H2O2 + ASA. Conclusions: Administration of acetyl salicylic acid to rats alters HSP-72 expression mechanism in a way that it becomes more efficient in response to in vitro heat shock. The fact that in vitro acetyl salicylic acid alone did not induce this priming effect implies that in vivo other signals are required. Priming could be reproduces in vitro with the combination of acetyl salicylic acid+H2O2.	[Sandoval-Montiel, Alvaro A.; Ventura-Gallegos, Jose L.; Frias-Gonzalez, Susana; Zentella-Dehesa, Alejandro] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, Mexico City 04510, DF, Mexico; [Sandoval-Montiel, Alvaro A.; Zentella-Dehesa, Alejandro] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Unidad Bioquim, Mexico City, DF, Mexico; [Zentella-de-Pina, Martha] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico; [Lopez-Macay, Ambar] Inst Nacl Rehabil, Lab Liquido Sinovial, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico	Zentella-Dehesa, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, Mexico City 04510, DF, Mexico.	azentell@biomedicas.unam.mx	Zentella-Dehesa, Alejandro/AAW-1647-2020; Macay, ambar Lopez/ABH-9850-2020	Zentella-Dehesa, Alejandro/0000-0002-5595-1466; Lopez Macay, Ambar/0000-0002-2916-7424	DGAPA-UNAM [IN 229607]; CONACyT-Mexico [45519-M, 45003-M]; Posgrado de Ciencias Biologicas; UNAM; Comecyt	DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Posgrado de Ciencias Biologicas; UNAM(Universidad Nacional Autonoma de Mexico); Comecyt	This work was supported by DGAPA-UNAM grant IN 229607 and CONACyT-Mexico grants 45519-M and 45003-M. ASM was supported by a doctoral fellowship from CONACyT-Mexico, the Posgrado de Ciencias Biologicas, UNAM and Comecyt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2007, HISTOL HISTOPATHOL, V22, P437, DOI 10.14670/HH-22.437; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chong KY, 1998, J MOL CELL CARDIOL, V30, P599, DOI 10.1006/jmcc.1997.0623; Chung YM, 2003, FREE RADICAL BIO MED, V34, P434, DOI 10.1016/S0891-5849(02)01301-1; Cotto JJ, 1996, J BIOL CHEM, V271, P3355; de Pina MZ, 2002, J PHARM PHARMACOL, V54, P577, DOI 10.1211/0022357021778709; Fawcett TW, 1997, CELL STRESS CHAPERON, V2, P104, DOI 10.1379/1466-1268(1997)002<0104:POHSIH>2.3.CO;2; Holmberg CI, 2002, TRENDS BIOCHEM SCI, V27, P619, DOI 10.1016/S0968-0004(02)02207-7; Horowitz M, 2007, PROG BRAIN RES, V162, P433, DOI 10.1016/S0079-6123(06)62021-9; JURIVICH DA, 1992, SCIENCE, V255, P1243, DOI 10.1126/science.1546322; JURIVICH DA, 1995, J BIOL CHEM, V270, P24489, DOI 10.1074/jbc.270.41.24489; LEE BS, 1995, P NATL ACAD SCI USA, V92, P7207, DOI 10.1073/pnas.92.16.7207; Liu EJ, 2005, CANCER EPIDEM BIOMAR, V14, P1315, DOI 10.1158/1055-9965.EPI-05-0032; Liu PCC, 1999, J BIOL CHEM, V274, P17219, DOI 10.1074/jbc.274.24.17219; MAYS DC, 1984, J CHROMATOGR, V311, P301, DOI 10.1016/S0378-4347(00)84723-4; Morimoto R I, 1996, EXS, V77, P139; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; MORIMOTO RI, 1992, J BIOL CHEM, V267, P21987; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Nakahara T, 2006, METABOLISM, V55, P843, DOI 10.1016/j.metabol.2006.02.009; Rodondi Nicolas, 2005, Comprehensive Therapy, V31, P186, DOI 10.1385/COMP:31:3:186; Saito T, 2004, J MOL CELL CARDIOL, V37, P71, DOI 10.1016/j.yjmcc.2004.04.002; Scandalios JG, 2005, BRAZ J MED BIOL RES, V38, P995, DOI 10.1590/S0100-879X2005000700003; Schoffl F, 1998, PLANT PHYSIOL, V117, P1135, DOI 10.1104/pp.117.4.1135; Seo MS, 2005, INT J MOL MED, V16, P841; Silva AM, 2007, J BIOL CHEM, V282, P10164, DOI 10.1074/jbc.M609996200; Soncin F, 2003, BIOCHEM BIOPH RES CO, V303, P700, DOI 10.1016/S0006-291X(03)00398-X; Ulcova-Gallova Z, 2005, CHEM IMMUNOL ALLERGY, V88, P139, DOI 10.1159/000087831; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Xu QB, 1997, J CLIN INVEST, V100, P1089, DOI 10.1172/JCI119619; Yenari MA, 1999, MOL MED TODAY, V5, P525, DOI 10.1016/S1357-4310(99)01599-3; YOKOYAMA H, 1995, BIOCHEM PHARMACOL, V49, P991, DOI 10.1016/0006-2952(94)00542-T; de Pina MZ, 2007, ARCH MED RES, V38, P269, DOI 10.1016/j.arcmed.2006.09.019	33	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65449	10.1371/journal.pone.0065449	http://dx.doi.org/10.1371/journal.pone.0065449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762376	Green Submitted, Green Published, gold			2022-12-25	WOS:000321099000068
J	Zemp, FJ; McKenzie, BA; Lun, XQ; Maxwell, L; Reilly, KM; McFadden, G; Yong, VW; Forsyth, PA				Zemp, Franz J.; McKenzie, Brienne A.; Lun, Xueqing; Maxwell, Lori; Reilly, Karlyne M.; McFadden, Grant; Yong, V. Wee; Forsyth, Peter A.			Resistance to Oncolytic Myxoma Virus Therapy in Nf1(-/-)/Trp53(-/-) Syngeneic Mouse Glioma Models Is Independent of Anti-Viral Type-I Interferon	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; CENTRAL-NERVOUS-SYSTEM; IMMUNOCOMPETENT ANIMAL-MODELS; MALIGNANT GLIOMAS; PANCREATIC-CANCER; GLIOBLASTOMA; CELLS; MUTANT; MICE; VIROTHERAPY	Despite promising preclinical studies, oncolytic viral therapy for malignant gliomas has resulted in variable, but underwhelming results in clinical evaluations. Of concern are the low levels of tumour infection and viral replication within the tumour. This discrepancy between the laboratory and the clinic could result from the disparity of xenograft versus syngeneic models in determining in vivo viral infection, replication and treatment efficacy. Here we describe a panel of primary mouse glioma lines derived from Nf1(+/-)Trp53(+/-) mice in the C57Bl/6J background for use in the preclinical testing of the oncolytic virus Myxoma (MYXV). These lines show a range of susceptibility to MYXV replication in vitro, but all succumb to viral-mediated cell death. Two of these lines orthotopically grafted produced aggressive gliomas. Intracranial injection of MYXV failed to result in sustained viral replication or treatment efficacy, with minimal tumour infection that was completely resolved by 7 days post-infection. We hypothesized that the stromal production of Type-I interferons (IFN alpha/beta) could explain the resistance seen in these models; however, we found that neither the cell lines in vitro nor the tumours in vivo produce any IFN alpha/beta in response to MYXV infection. To confirm IFN alpha/beta did not play a role in this resistance, we ablated the ability of tumours to respond to IFN alpha/beta via IRF9 knockdown, and generated identical results. Our studies demonstrate that these syngeneic cell lines are relevant preclinical models for testing experimental glioma treatments, and show that IFN alpha/beta is not responsible for the MYXV treatment resistance seen in syngeneic glioma models.	[Zemp, Franz J.; McKenzie, Brienne A.; Lun, Xueqing; Maxwell, Lori; Forsyth, Peter A.] Univ Calgary, Southern Alberta Canc Res Inst, Tom Baker Canc Ctr, Clark H Smith Brain Tumor Ctr,Dept Oncol, Calgary, AB, Canada; [Zemp, Franz J.; McKenzie, Brienne A.; Lun, Xueqing; Maxwell, Lori; Forsyth, Peter A.] Univ Calgary, Clark H Smith Brain Tumor Ctr, Calgary, AB, Canada; [Reilly, Karlyne M.] NCI, Mouse Canc Genet Program, Frederick, MD 21701 USA; [McFadden, Grant] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Yong, V. Wee] Univ Calgary, Dept Clin Neurosci, Hotchkiss Brain Inst, Calgary, AB, Canada; [Yong, V. Wee] Univ Calgary, Dept Oncol, Hotchkiss Brain Inst, Calgary, AB, Canada; [Forsyth, Peter A.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Forsyth, Peter A.] Univ S Florida, Tampa, FL USA	Tom Baker Cancer Clinic; University of Calgary; University of Calgary; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University System of Florida; University of Florida; University of Calgary; University of Calgary; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Forsyth, PA (corresponding author), Univ Calgary, Southern Alberta Canc Res Inst, Tom Baker Canc Ctr, Clark H Smith Brain Tumor Ctr,Dept Oncol, Calgary, AB, Canada.	Peter.Forsyth@moffitt.org	Reilly, Karlyne/V-4475-2019; McKenzie, Brienne/AAY-6533-2020	Reilly, Karlyne/0000-0001-9109-4409; McFadden, Grant/0000-0002-2556-3526; Yong, V. Wee/0000-0002-2600-3563; McKenzie, Brienne/0000-0001-6829-9828	Canadian Cancer Society Research Institute (CCSRI); Canadian Cancer Society (PAF); Terry Fox Foundation; V Foundation; Canadian Institutes of Health Research (CIHR); Alberta Innovates Health Solutions; Izaak Walton Killam scholarship; NIH [R01 AI080607, R21 CA149869, R01 CA138541]; Bankhead Coley Foundation [1BT02]; NIH, NCI [ZIA BC 010541]; NATIONAL CANCER INSTITUTE [R21CA149869, R01CA138541, ZIABC010540, ZIABC010541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080607] Funding Source: NIH RePORTER	Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Canadian Cancer Society (PAF); Terry Fox Foundation; V Foundation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions; Izaak Walton Killam scholarship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bankhead Coley Foundation; NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Canadian Cancer Society Research Institute (CCSRI) with funds raised by the Canadian Cancer Society (PAF), a Program Project Grant from the Terry Fox Foundation (PAF), the V Foundation (PAF), and the Canadian Institutes of Health Research (CIHR) (VWY). During this work FJZ was funded by Alberta Innovates Health Solutions, Vanier Scholarship from CIHR, and the Izaak Walton Killam scholarship. BAM was funded by CIHR. GM's lab is funded by NIH grants (R01 AI080607, R21 CA149869 and R01 CA138541) and by the Bankhead Coley Foundation (1BT02). KMR's lab is funded by the Intramural Research Program of NIH, NCI (ZIA BC 010541). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain T, 2010, P NATL ACAD SCI USA, V107, P1576, DOI 10.1073/pnas.0912344107; [Anonymous], 2009, ASTR SEC GLIOBL DISS, P93; [Anonymous], 2008, NATURE, V455, P1061; Balachandran S, 2004, CANCER CELL, V5, P51, DOI 10.1016/S1535-6108(03)00330-1; Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Cantin E, 1999, J VIROL, V73, P3418, DOI 10.1128/JVI.73.4.3418-3423.1999; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Christensen JE, 2012, J VIROL, V86, P7384, DOI 10.1128/JVI.07090-11; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; France MR, 2011, J GEN VIROL, V92, P195, DOI 10.1099/vir.0.026690-0; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; GRAY PW, 1983, P NATL ACAD SCI-BIOL, V80, P5842, DOI 10.1073/pnas.80.19.5842; Gursel DB, 2011, NEURO-ONCOLOGY, V13, P610, DOI 10.1093/neuonc/nor035; Hamilton SR, WHO CLASSIFICATION T; Hellums EK, 2005, NEURO-ONCOLOGY, V7, P213, DOI 10.1215/S1152851705000074; Kastrukoff Lorne F, 2012, Herpesviridae, V3, P4, DOI 10.1186/2042-4280-3-4; Kelly JJP, 2009, STEM CELLS, V27, P1722, DOI 10.1002/stem.98; LANDO Z, 1980, NATURE, V287, P551, DOI 10.1038/287551a0; Lasner TM, 1996, J NEUROPATH EXP NEUR, V55, P1259, DOI 10.1097/00005072-199612000-00010; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lun XQ, 2005, CANCER RES, V65, P9982, DOI 10.1158/0008-5472.CAN-05-1201; Lun XQ, 2007, CANCER RES, V67, P8818, DOI 10.1158/0008-5472.CAN-07-1214; Lun XQ, 2010, MOL THER, V18, P1927, DOI 10.1038/mt.2010.183; Lun XQ, 2010, CANCER RES, V70, P598, DOI 10.1158/0008-5472.CAN-09-1510; Markert JM, 2009, MOL THER, V17, P199, DOI 10.1038/mt.2008.228; MCKEEVER PE, 1991, CRIT REV NEUROBIOL, V6, P119; MINETA T, 1995, NAT MED, V1, P938, DOI 10.1038/nm0995-938; Motomura K, 2011, CANCER-AM CANCER SOC, V117, P1721, DOI 10.1002/cncr.25637; Noyce RS, 2011, J VIROL, V85, P10926, DOI 10.1128/JVI.00862-11; Oertel Joachim, 2005, Neurosurg Focus, V18, pe12; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Papanastassiou V, 2002, GENE THER, V9, P398, DOI 10.1038/sj.gt.3301664; Paul S, 2007, BIOCHIMIE, V89, P770, DOI 10.1016/j.biochi.2007.02.009; PAULUS W, 1994, INT J CANCER, V58, P841, DOI 10.1002/ijc.2910580616; Qin XQ, 2001, MOL THER, V4, P356, DOI 10.1006/mthe.2001.0464; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Reilly KM, 2004, P NATL ACAD SCI USA, V101, P13008, DOI 10.1073/pnas.0401236101; Savarin C, 2008, CURR OPIN PHARMACOL, V8, P472, DOI 10.1016/j.coph.2008.05.002; Smallwood Sherin E, 2010, Curr Protoc Microbiol, VChapter 14, DOI 10.1002/9780471729259.mc14a01s17; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tada H, 2001, J CLIN INVEST, V108, P83, DOI 10.1172/JCI9841; UZE G, 1992, P NATL ACAD SCI USA, V89, P4774, DOI 10.1073/pnas.89.10.4774; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wennier S, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001876; Wennier ST, 2012, MOL THER, V20, P759, DOI 10.1038/mt.2011.293; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wollmann G, 2012, CANCER J, V18, P69, DOI 10.1097/PPO.0b013e31824671c9; Yoshino A, 2005, J NEURO-ONCOL, V74, P249, DOI 10.1007/s11060-004-7316-1; Yuki K, 2009, CANCER LETT, V284, P71, DOI 10.1016/j.canlet.2009.04.020; Zemp F, 2013, NEURO-ONCOLOGY, DOI [10.1093/neuonc/not035, DOI 10.1093/NEU0NC/N0T035]; Zemp FJ, 2010, CYTOKINE GROWTH F R, V21, P103, DOI 10.1016/j.cytogfr.2010.04.001	56	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65801	10.1371/journal.pone.0065801	http://dx.doi.org/10.1371/journal.pone.0065801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762429	gold, Green Submitted, Green Published			2022-12-25	WOS:000321099000107
J	Matsakas, A; Yadav, V; Lorca, S; Narkar, V				Matsakas, Antonios; Yadav, Vikas; Lorca, Sabina; Narkar, Vihang			Muscle ERR gamma mitigates Duchenne muscular dystrophy via metabolic and angiogenic reprogramming	FASEB JOURNAL			English	Article						estrogen-related receptors; fiber type; nuclear receptors; muscle degenerative diseases	SKELETAL-MUSCLE; OXIDATIVE-PHOSPHORYLATION; TRANSCRIPTIONAL CONTROL; DEFICIENT MUSCLES; NOS TRANSGENE; FULL-LENGTH; MDX MICE; EXPRESSION; UTROPHIN; RECEPTOR	Treatment of Duchenne muscular dystrophy (DMD) by replacing mutant dystrophin or restoring dystrophin-associated glycoprotein complex (DAG) has been clinically challenging. Instead, identifying and targeting muscle pathways deregulated in DMD will provide new therapeutic avenues. We report that the expression of nuclear receptor estrogen-related receptor- (ERR), and its metabolic and angiogenic targets are down-regulated (50-85%) in skeletal muscles of mdx mice (DMD model) vs. wild-type mice. Corelatively, oxidative myofibers, muscle vasculature, and exercise tolerance (33%) are decreased in mdx vs. wild-type mice. Overexpressing ERR selectively in the dystrophic muscles of the mdx mice restored metabolic and angiogenic gene expression compared with control mdx mice. Further, ERR enhanced muscle oxidative myofibers, vasculature, and blood flow (by 33-66%) and improved exercise tolerance (by 75%) in the dystrophic mice. Restoring muscle ERR pathway ameliorated muscle damage and also prevented DMD hallmarks of postexercise muscle damage, hypoxia, and fatigue in mdx mice. Notably, ERR did not restore sarcolemmal DAG complex, which is thus dispensable for antidystrophic effects of ERR. In summary, ERR-dependent metabolic and angiogenic gene program is defective in DMD, and we demonstrate that its restoration is a potential strategy for treating muscular dystrophy.Matsakas, A., Yadav, V., Lorca, S., Narkar, V. Muscle ERR mitigates Duchenne muscular dystrophy via metabolic and angiogenic reprogramming.	[Matsakas, Antonios; Yadav, Vikas; Lorca, Sabina; Narkar, Vihang] Univ Texas Med Sch Houston, Ctr Metab & Degenerat Dis, Inst Mol Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Narkar, V (corresponding author), Univ Texas Med Sch Houston, Ctr Metab & Degenerat Dis, Brown Fdn Inst Mol Med, IMM SRB 430F,1825 Pressler St, Houston, TX 77030 USA.	vihang.a.narkar@uth.tmc.edu	Antonios Matsakas, SFHEA/I-6565-2019	Antonios Matsakas, SFHEA/0000-0003-0746-0088	University of Texas Medical School at Houston intramural funds; Muscular Dystrophy Association [MDA 174408]; American Heart Association [AHA 11SDG7600213]; American Diabetes Association [ADA 1-13-BS-127]	University of Texas Medical School at Houston intramural funds; Muscular Dystrophy Association(Muscular Dystrophy Association); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association)	The authors thank Ron Evans (Salk Institute, La Jolla, CA, USA) for generously providing the muscle-specific ERR gamma transgenic mice for this study. The authors also thank Drs. Eun Ran Kim and Qingchun Tong, at the Institute of Molecular Medicine, for help with Comprehensive Lab Animal Monitoring System to measure spontaneous ambulatory activity. This work was supported by University of Texas Medical School at Houston intramural funds, as well as grants from the Muscular Dystrophy Association (MDA 174408), the American Heart Association (AHA 11SDG7600213), and the American Diabetes Association (ADA 1-13-BS-127).	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106; Chakkalakal JV, 2005, FASEB J, V19, P880, DOI 10.1096/fj.04-1956rev; Chakkalakal JV, 2004, HUM MOL GENET, V13, P379, DOI 10.1093/hmg/ddh037; Chakkalakal JV, 2003, P NATL ACAD SCI USA, V100, P7791, DOI 10.1073/pnas.0932671100; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Deasy BM, 2009, MOL THER, V17, P1788, DOI 10.1038/mt.2009.136; Deconinck N, 1997, NAT MED, V3, P1216, DOI 10.1038/nm1197-1216; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Fairclough RJ, 2011, EXP PHYSIOL, V96, P1101, DOI 10.1113/expphysiol.2010.053025; Faist V, 2001, ANN NUTR METAB, V45, P58, DOI 10.1159/000046707; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Goyenvalle A, 2011, HUM MOL GENET, V20, pR69, DOI 10.1093/hmg/ddr105; Gramolini AO, 2001, AM J PHYSIOL-CELL PH, V281, pC1300, DOI 10.1152/ajpcell.2001.281.4.C1300; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Heard DJ, 2000, MOL ENDOCRINOL, V14, P382, DOI 10.1210/me.14.3.382; Hong H, 1999, J BIOL CHEM, V274, P22618, DOI 10.1074/jbc.274.32.22618; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jahnke VE, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-16; Khairallah RJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002829; Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085; Kobayashi YM, 2008, NATURE, V456, P511, DOI 10.1038/nature07414; Kuznetsov AV, 1998, MOL CELL BIOCHEM, V183, P87, DOI 10.1023/A:1006868130002; Li S, 2006, HUM MOL GENET, V15, P1610, DOI 10.1093/hmg/ddl082; Ljubicic V, 2011, HUM MOL GENET, V20, P3478, DOI 10.1093/hmg/ddr265; Matsakas A, 2012, CIRC RES, V110, P1087, DOI 10.1161/CIRCRESAHA.112.266478; Matsakas A, 2012, EXP PHYSIOL, V97, P125, DOI 10.1113/expphysiol.2011.063008; Matsakas A, 2010, J MUSCLE RES CELL M, V31, P111, DOI 10.1007/s10974-010-9214-9; Messina S, 2007, FASEB J, V21, P3737, DOI 10.1096/fj.07-8459com; Miura P, 2009, HUM MOL GENET, V18, P4640, DOI 10.1093/hmg/ddp431; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Murray J, 2013, FASEB J, V27, P135, DOI 10.1096/fj.12-212290; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Neuhaus P, 2003, MOL CELL BIOL, V23, P6037, DOI 10.1128/MCB.23.17.6037-6048.2003; Pauly M, 2012, AM J PATHOL, V181, P583, DOI 10.1016/j.ajpath.2012.04.004; Percival JM, 2013, HUM MOL GENET, V22, P153, DOI 10.1093/hmg/dds415; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; PHELPS SF, 1995, HUM MOL GENET, V4, P1251, DOI 10.1093/hmg/4.8.1251; Porter JD, 1998, J CELL SCI, V111, P1801; Rafael JA, 1998, NAT GENET, V19, P79, DOI 10.1038/ng0598-79; RAFAEL JA, 1994, HUM MOL GENET, V3, P1725, DOI 10.1093/hmg/3.10.1725; Rangwala SM, 2010, J BIOL CHEM, V285, P22619, DOI 10.1074/jbc.M110.125401; Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200; RYDERCOOK AS, 1988, EMBO J, V7, P3017, DOI 10.1002/j.1460-2075.1988.tb03165.x; Sander M, 2000, P NATL ACAD SCI USA, V97, P13818, DOI 10.1073/pnas.250379497; Selsby JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030063; Shiao T, 2004, HUM MOL GENET, V13, P1873, DOI 10.1093/hmg/ddh204; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Tidball JG, 2004, MOL GENET METAB, V82, P312, DOI 10.1016/j.ymgme.2004.06.006; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Tinsley JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019189; Wang SCM, 2010, MOL CELL ENDOCRINOL, V315, P146, DOI 10.1016/j.mce.2009.07.012; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110	59	45	46	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4004	4016		10.1096/fj.13-228296	http://dx.doi.org/10.1096/fj.13-228296			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23781095				2022-12-25	WOS:000329747100015
J	Thomas, F; Lundqvist, LCE; Jam, M; Jeudy, A; Barbeyron, T; Sandstrom, C; Michel, G; Czjzek, M				Thomas, Franois; Lundqvist, Lena C. E.; Jam, Murielle; Jeudy, Alexandra; Barbeyron, Tristan; Sandstrom, Corine; Michel, Gurvan; Czjzek, Mirjam			Comparative Characterization of Two Marine Alginate Lyases from Zobellia galactanivorans Reveals Distinct Modes of Action and Exquisite Adaptation to Their Natural Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL-CHARACTERIZATION; MOLECULAR-IDENTIFICATION; OLIGOALGINATE LYASE; ENZYMATIC FORMATION; ACID METABOLISM; URONIC-ACID; SEQUENCE; OLIGOSACCHARIDES; BACTERIUM	Cell walls of brown algae are complex supramolecular assemblies containing various original, sulfated, and carboxylated polysaccharides. Among these, the major marine polysaccharide component, alginate, represents an important biomass that is successfully turned over by the heterotrophic marine bacteria. In the marine flavobacterium Zobellia galactanivorans, the catabolism and uptake of alginate are encoded by operon structures that resemble the typical Bacteroidetes polysaccharide utilization locus. The genome of Z. galactanivorans contains seven putative alginate lyase genes, five of which are localized within two clusters comprising additional carbohydrate-related genes. This study reports on the detailed biochemical and structural characterization of two of these. We demonstrate here that AlyA1(PL7) is an endolytic guluronate lyase, and AlyA5 cleaves unsaturated units, alpha-L-guluronate or beta-D-manuronate residues, at the nonreducing end of oligo-alginates in an exolytic fashion. Despite a common jelly roll-fold, these striking differences of the mode of action are explained by a distinct active site topology, an open cleft in AlyA1(PL7), whereas AlyA5 displays a pocket topology due to the presence of additional loops partially obstructing the catalytic groove. Finally, in contrast to PL7 alginate lyases from terrestrial bacteria, both enzymes proceed according to a calcium-dependent mechanism suggesting an exquisite adaptation to their natural substrate in the context of brown algal cell walls.	[Thomas, Franois; Jam, Murielle; Barbeyron, Tristan; Michel, Gurvan; Czjzek, Mirjam] Univ Paris 06, UMR 7139, Stn Biol Roscoff, F-29682 Roscoff, Brittany, France; [Thomas, Franois; Jam, Murielle; Barbeyron, Tristan; Michel, Gurvan; Czjzek, Mirjam] CNRS, UMR 7139, Stn Biol Roscoff, F-29682 Roscoff, Brittany, France; [Lundqvist, Lena C. E.; Sandstrom, Corine] Swedish Univ Agr Sci, Dept Chem, SE-75007 Uppsala, Sweden; [Jeudy, Alexandra] Univ Paris 06, FR2424, Stn Biol Roscoff, F-29682 Roscoff, Brittany, France; [Jeudy, Alexandra] CNRS, FR2424, Stn Biol Roscoff, F-29682 Roscoff, Brittany, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Swedish University of Agricultural Sciences; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Czjzek, M (corresponding author), Univ Paris 06, UMR 7139, Stn Biol Roscoff, F-29682 Roscoff, Brittany, France.	czjzek@sb-roscoff.fr		Thomas, Francois/0000-0003-1896-0774; MICHEL, Gurvan/0000-0002-3009-6205	European Community [222628]; Region Bretagne; CNRS	European Community(European Commission); Region Bretagne(Region Bretagne); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by European Community's Seventh Framework Programme FP7/2007-2013 under Grant Agreement 222628 and by the Region Bretagne and the CNRS.	ABDELAKHER MA, 1951, ARCH BIOCHEM, V30, P407; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charrier B, 2008, NEW PHYTOL, V177, P319, DOI 10.1111/j.1469-8137.2007.02304.x; Chavagnat F, 1998, CARBOHYD RES, V308, P409, DOI 10.1016/S0008-6215(98)00095-0; COWMAN MK, 1984, BIOCHEM J, V221, P707, DOI 10.1042/bj2210707; CRAIGIE JS, 1984, CARBOHYD POLYM, V4, P237, DOI 10.1016/0144-8617(84)90001-8; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Duarte CM, 2005, BIOGEOSCIENCES, V2, P1, DOI 10.5194/bg-2-1-2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ertesvag H, 1998, J BACTERIOL, V180, P3779; GACESA P, 1988, CARBOHYD POLYM, V8, P161, DOI 10.1016/0144-8617(88)90001-X; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gimmestad M, 2009, J BACTERIOL, V191, P4845, DOI 10.1128/JB.00455-09; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7; Groisillier A, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-45; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hashimoto W, 2000, J BACTERIOL, V182, P4572, DOI 10.1128/JB.182.16.4572-4577.2000; Hashimoto Wataru, 2010, Bioeng Bugs, V1, P97, DOI 10.4161/bbug.1.2.10322; HAUG A, 1974, CARBOHYD RES, V32, P217, DOI 10.1016/S0008-6215(00)82100-X; Hehemann JH, 2012, J BIOL CHEM, V287, P30571, DOI 10.1074/jbc.M112.377184; Heyraud A, 1996, CARBOHYD RES, V289, P11, DOI 10.1016/0008-6215(96)00060-2; Jam M, 2005, BIOCHEM J, V385, P703, DOI 10.1042/BJ20041044; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; KIDBY DK, 1973, ANAL BIOCHEM, V55, P321, DOI 10.1016/0003-2697(73)90323-0; KLOAREG B, 1988, OCEANOGR MAR BIOL, V26, P259; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Kuorelahti S, 2006, MOL MICROBIOL, V61, P1060, DOI 10.1111/j.1365-2958.2006.05294.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; Michel G, 2010, NEW PHYTOL, V188, P82, DOI 10.1111/j.1469-8137.2010.03374.x; Miyake O, 2004, J BACTERIOL, V186, P2891, DOI 10.1128/JB.186.9.2891-2896.2004; Momma K, 2000, J BACTERIOL, V182, P3998, DOI 10.1128/JB.182.14.3998-4004.2000; MURATA K, 1993, J FERMENT BIOENG, V76, P427, DOI 10.1016/0922-338X(93)90040-F; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nyvall P, 2003, PLANT PHYSIOL, V133, P726, DOI 10.1104/pp.103.025981; Ochiai A, 2006, RES MICROBIOL, V157, P642, DOI 10.1016/j.resmic.2006.02.006; Ochiai A, 2010, J BIOL CHEM, V285, P24519, DOI 10.1074/jbc.M110.125450; Ogura K, 2008, J MOL BIOL, V380, P373, DOI 10.1016/j.jmb.2008.05.008; Ogura K, 2009, J BIOL CHEM, V284, P35572, DOI 10.1074/jbc.M109.068056; Osawa T, 2005, J MOL BIOL, V345, P1111, DOI 10.1016/j.jmb.2004.10.081; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; PREISS J, 1962, J BIOL CHEM, V237, P309; PREISS J, 1963, J BIOL CHEM, V238, P1571; PREISS J, 1962, J BIOL CHEM, V237, P317; QUATRANO RS, 1976, PLANT PHYSIOL, V58, P224, DOI 10.1104/pp.58.2.224; Ramsey DM, 2005, MOL MICROBIOL, V56, P309, DOI 10.1111/j.1365-2958.2005.04552.x; Rebuffet E, 2011, ENVIRON MICROBIOL, V13, P1253, DOI 10.1111/j.1462-2920.2011.02426.x; Remminghorst U, 2006, FEBS LETT, V580, P3883, DOI 10.1016/j.febslet.2006.05.077; Roeder V, 2005, J PHYCOL, V41, P1227, DOI 10.1111/j.1529-8817.2005.00150.x; Scavetta RD, 1999, PLANT CELL, V11, P1081, DOI 10.1105/tpc.11.6.1081; Schoenwaelder MEA, 2000, PLANT BIOLOGY, V2, P24, DOI 10.1055/s-2000-9178; Shimokawa T, 1997, CARBOHYD RES, V304, P125, DOI 10.1016/S0008-6215(97)00230-9; SKJAKBRAEK G, 1986, CARBOHYD RES, V154, P239; Skriptsova A, 2004, J APPL PHYCOL, V16, P17, DOI 10.1023/B:JAPH.0000019049.74140.61; Smidsrod O., 1996, CARBOHYDR EUR, V14, P6; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suzuki H, 2006, CARBOHYD RES, V341, P1809, DOI 10.1016/j.carres.2006.04.032; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas F, 2012, ENVIRON MICROBIOL, V14, P2379, DOI 10.1111/j.1462-2920.2012.02751.x; Thomas F, 2011, J MICROBIOL METH, V84, P61, DOI 10.1016/j.mimet.2010.10.016; Vreeland V, 1998, J PHYCOL, V34, P1, DOI 10.1046/j.1529-8817.1998.340001.x; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200; Yoon HJ, 2001, J MOL BIOL, V307, P9, DOI 10.1006/jmbi.2000.4509; ZABLACKIS E, 1990, BOT MAR, V33, P273, DOI 10.1515/botm.1990.33.3.273; Zhang ZQ, 2004, CARBOHYD RES, V339, P1475, DOI 10.1016/j.carres.2004.03.010	74	127	134	5	74	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23021	23037		10.1074/jbc.M113.467217	http://dx.doi.org/10.1074/jbc.M113.467217			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23782694	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000330598200012
J	Kubiak, X; de la Sierra-Gallay, IL; Chaffotte, AF; Pluvinage, B; Weber, P; Haouz, A; Dupret, JM; Rodrigues-Lima, F				Kubiak, Xavier; de la Sierra-Gallay, Ines Li; Chaffotte, Alain F.; Pluvinage, Benjamin; Weber, Patrick; Haouz, Ahmed; Dupret, Jean-Marie; Rodrigues-Lima, Fernando			Structural and Biochemical Characterization of an Active Arylamine N-Acetyltransferase Possessing a Non-canonical Cys-His-Glu Catalytic Triad	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; BACILLUS-ANTHRACIS; ESCHERICHIA-COLI; PROTEIN; MECHANISM; IDENTIFICATION; STABILITY; BINDING; SULFAMETHOXAZOLE; INTERMEDIATE	Arylamine N-acetyltransferases (NATs), a class of xenobiotic-metabolizing enzymes, catalyze the acetylation of aromatic amine compounds through a strictly conserved Cys-His-Asp catalytic triad. Each residue is essential for catalysis in both prokaryotic and eukaryotic NATs. Indeed, in(HUMAN) NAT2 variants, mutation of the Asp residue to Asn, Gln, or Glu dramatically impairs enzyme activity. However, a putative atypical NAT harboring a catalytic triad Glu residue was recently identified in Bacillus cereus ((BACCR)NAT3) but has not yet been characterized. We report here the crystal structure and functional characterization of this atypical NAT. The overall fold of (BACCR) NAT3 and the geometry of its Cys-His-Glu catalytic triad are similar to those present in functional NATs. Importantly, the enzyme was found to be active and to acetylate prototypic arylamine NAT substrates. In contrast to (HUMAN) NAT2, the presence of a Glu or Asp in the triad of (BACCR) NAT3 did not significantly affect enzyme structure or function. Computational analysis identified differences in residue packing and steric constraints in the active site of (BACCR) NAT3 that allow it to accommodate a Cys-His-Glu triad. These findings overturn the conventional view, demonstrating that the catalytic triad of this family of acetyltransferases is plastic. Moreover, they highlight the need for further study of the evolutionary history of NATs and the functional significance of the predominant Cys-His-Asp triad in both prokaryotic and eukaryotic forms.	[Kubiak, Xavier; Pluvinage, Benjamin; Dupret, Jean-Marie; Rodrigues-Lima, Fernando] Univ Paris Diderot, Sorbonne Paris Cite, CNRS EAC4413, Unite Biol Fonctionnelle & Adaptat, F-75013 Paris, France; [de la Sierra-Gallay, Ines Li] Univ Paris 11, CNRS UMR8619, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France; [Chaffotte, Alain F.] Inst Pasteur, Unite Resonance Magnet Nucl Biomol, F-75015 Paris, France; [Weber, Patrick; Haouz, Ahmed] Inst Pasteur, CNRS UMR3528, F-75724 Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Rodrigues-Lima, F (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, CNRS EAC4413, Unite Biol Fonctionnelle & Adaptat, 4 Rue Marie Andree Lagroua Weill Halle, F-75013 Paris, France.	fernando.rodrigues-lima@univ-paris-diderot.fr		Li de la Sierra-Gallay, Ines/0000-0003-2770-7439; HAOUZ, Ahmed/0000-0003-1196-1635	Universite Paris Diderot-Paris 7; Delegation Generale de l'Armement (DGA); Institut Pasteur Paris; CNRS; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; DGA	Universite Paris Diderot-Paris 7; Delegation Generale de l'Armement (DGA); Institut Pasteur Paris; CNRS(Centre National de la Recherche Scientifique (CNRS)); French Infrastructure for Integrated Structural Biology (FRISBI); DGA	This work was supported in part by the Universite Paris Diderot-Paris 7, Delegation Generale de l'Armement (DGA), the Institut Pasteur Paris, the CNRS and French Infrastructure for Integrated Structural Biology (FRISBI) Grant ANR-10-INSB-05-01.; Supported by a fellowship from the DGA. Present address: Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia BC V8P 5C2, Canada.	Bricogne G., 2011, BUSTER VERSION 2 10; Brooke EW, 2003, BIOORGAN MED CHEM, V11, P1227, DOI 10.1016/S0968-0896(02)00642-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chu XM, 2008, APPL MICROBIOL BIOT, V80, P615, DOI 10.1007/s00253-008-1566-3; Cleland WW, 1995, FASEB J, V9, P1585, DOI 10.1096/fasebj.9.15.8529838; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; DUPRET JM, 1992, J BIOL CHEM, V267, P7381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fullam E, 2008, J MOL BIOL, V375, P178, DOI 10.1016/j.jmb.2007.10.019; Glenn AE, 2010, FEBS LETT, V584, P3158, DOI 10.1016/j.febslet.2010.05.063; Gonnelli G, 2012, J BIOTECHNOL, V161, P287, DOI 10.1016/j.jbiotec.2012.06.020; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hammarstrom P, 1999, J BIOL CHEM, V274, P32897, DOI 10.1074/jbc.274.46.32897; Hein DW, 2002, MUTAT RES-FUND MOL M, V506, P65, DOI 10.1016/S0027-5107(02)00153-7; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; King SM, 1999, PROTEINS, V35, P313, DOI 10.1002/(SICI)1097-0134(19990515)35:3<313::AID-PROT5>3.3.CO;2-T; Krekel F, 2000, BIOCHEMISTRY-US, V39, P12671, DOI 10.1021/bi001310x; Kubiak X, 2013, EXPERT OPIN DRUG MET, V9, P349, DOI 10.1517/17425255.2013.742505; Kubiak X, 2012, ACTA CRYSTALLOGR F, V68, P196, DOI 10.1107/S1744309111053942; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le HT, 2009, J MOL BIOL, V393, P58, DOI 10.1016/j.jmb.2009.07.072; LONDON J, 1974, EUR J BIOCHEM, V47, P409, DOI 10.1111/j.1432-1033.1974.tb03707.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mehta D. K., 2005, TRANSGLUTAMINASES FA; MITRAKI A, 1987, EUR J BIOCHEM, V163, P29, DOI 10.1111/j.1432-1033.1987.tb10732.x; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pillay D, 2010, PROTEIN EXPRES PURIF, V74, P264, DOI 10.1016/j.pep.2010.06.021; Pluvinage B, 2007, BIOCHEMISTRY-US, V46, P7069, DOI 10.1021/bi700351w; Pluvinage B, 2011, FEBS LETT, V585, P3947, DOI 10.1016/j.febslet.2011.10.041; Rajasekaran M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025801; RIDDLE B, 1971, J BIOL CHEM, V246, P3250; Rodrigues-Lima F, 2002, BIOCHEM BIOPH RES CO, V293, P783, DOI 10.1016/S0006-291X(02)00299-1; Rodrigues-Lima F, 2001, BIOCHEM J, V356, P327, DOI 10.1042/0264-6021:3560327; Saleh L, 2011, BIOCHEMISTRY-US, V50, P10576, DOI 10.1021/bi200810j; Sandy J, 2005, BIOCHEM J, V390, P115, DOI 10.1042/BJ20050277; Sandy J, 2005, PROTEIN SCI, V14, P775, DOI 10.1110/ps.041163505; Sikora AL, 2008, BIOCHEMISTRY-US, V47, P10781, DOI 10.1021/bi800398c; Sim E, 2012, ADV PHARMACOL, V63, P169, DOI 10.1016/B978-0-12-398339-8.00005-7; Sim E, 2008, TOXICOLOGY, V254, P170, DOI 10.1016/j.tox.2008.08.022; Sinclair JC, 2000, NAT STRUCT BIOL, V7, P560; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Southworth MW, 2000, EMBO J, V19, P5019, DOI 10.1093/emboj/19.18.5019; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang HQ, 2004, BIOCHEMISTRY-US, V43, P8234, DOI 10.1021/bi0497244; WEBER WW, 1985, PHARMACOL REV, V37, P25; Westwood Isaac M., 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-3; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu H, 2007, J BIOL CHEM, V282, P30189, DOI 10.1074/jbc.M704138200; Xu Q, 2004, PROTEIN SCI, V13, P1851, DOI 10.1110/ps.04699904; Zang Y, 2007, PHARMACOGENET GENOM, V17, P37, DOI 10.1097/01.fpc.0000236325.73186.2c; Zhou X, 2009, FEBS J, V276, P6928, DOI 10.1111/j.1742-4658.2009.07389.x	53	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22493	22505		10.1074/jbc.M113.468595	http://dx.doi.org/10.1074/jbc.M113.468595			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23770703	Green Published, hybrid			2022-12-25	WOS:000330596300030
J	Stephenson, JR; Paavola, KJ; Schaefer, SA; Kaur, B; Van Meir, EG; Hall, RA				Stephenson, Jason R.; Paavola, Kevin J.; Schaefer, Stacy A.; Kaur, Balveen; Van Meir, Erwin G.; Hall, Randy A.			Brain-specific Angiogenesis Inhibitor-1 Signaling, Regulation, and Enrichment in the Postsynaptic Density	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; EMERGING ROLES; ADHESION-GPCRS; APOPTOTIC CELLS; BETA-ARRESTINS; BAI1; GENE; SCAFFOLD; FAMILY; VASCULOSTATIN	Brain-specific angiogenesis inhibitor-1 (BAI1) is an adhesion G protein-coupled receptor that has been studied primarily for its anti-angiogenic and anti-tumorigenic properties. We found that overexpression of BAI1 results in activation of the Rho pathway via a G alpha(12/13)-dependent mechanism, with truncation of the BAI1 N terminus resulting in a dramatic enhancement in receptor signaling. This constitutive activity of the truncated BAI1 mutant also resulted in enhanced downstream phosphorylation of ERK as well as increased receptor association with beta-arrestin2 and increased ubiquitination of the receptor. To gain insights into the regulation of BAI1 signaling, we screened the C terminus of BAI1 against a proteomic array of PDZ domains to identify novel interacting partners. These screens revealed that the BAI1 C terminus interacts with a variety of PDZ domains from synaptic proteins, including MAGI-3. Removal of the BAI1 PDZ-binding motif resulted in attenuation of receptor signaling to Rho but had no effect on ERK activation. Conversely, co-expression with MAGI-3 was found to potentiate signaling to ERK by constitutively active BAI1 in a manner that was dependent on the PDZ-binding motif of the receptor. Biochemical fractionation studies revealed that BAI1 is highly enriched in post-synaptic density fractions, a finding consistent with our observations that BAI1 can interact with PDZ proteins known to be concentrated in the post-synaptic density. These findings demonstrate that BAI1 is a synaptic receptor that can activate both the Rho and ERK pathways, with the N-terminal and C-terminal regions of the receptor playing key roles in the regulation of BAI1 signaling activity.	[Stephenson, Jason R.; Paavola, Kevin J.; Schaefer, Stacy A.; Hall, Randy A.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Kaur, Balveen; Van Meir, Erwin G.] Emory Univ, Mol Neurooncol Lab, Atlanta, GA 30322 USA; [Kaur, Balveen; Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA; [Kaur, Balveen; Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Kaur, Balveen; Van Meir, Erwin G.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University	Hall, RA (corresponding author), Emory Univ, Sch Med, Rollins Res Ctr, Rm 5113,1510 Clifton Rd, Atlanta, GA 30322 USA.	rhall@pharm.emory.edu	kaur, Balveen/E-3355-2011	Van Meir, Erwin G./0000-0003-2444-7707; Stephenson, Jason/0000-0002-7926-8055; Hall, Randy/0000-0002-8318-8728	National Institutes of Health [NS072394, CA086335, CA163722]; NATIONAL CANCER INSTITUTE [R01CA150153, R01CA163722, R01CA086335, P01CA163205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072394, P30NS045758, R01NS064607] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health Grants NS072394 (to R. A. H.) and CA086335 and CA163722 (to E. G. V. M.).	Albrecht DE, 2002, NEUROSIGNALS, V11, P123, DOI 10.1159/000065053; Apperson ML, 1996, J NEUROSCI, V16, P6839; Arac D, 2012, ANN NY ACAD SCI, V1276, P1, DOI 10.1111/j.1749-6632.2012.06820.x; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Bjarnadottir TK, 2007, CELL MOL LIFE SCI, V64, P2104, DOI 10.1007/s00018-007-7067-1; Blanpied TA, 2004, BIOL PSYCHIAT, V55, P1121, DOI 10.1016/j.biopsych.2003.10.006; Bohnekamp J, 2011, J BIOL CHEM, V286, P41912, DOI 10.1074/jbc.C111.265934; Bolliger MF, 2011, P NATL ACAD SCI USA, V108, P2534, DOI 10.1073/pnas.1019577108; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cork SM, 2012, ONCOGENE, V31, P5144, DOI 10.1038/onc.2012.1; Cork SM, 2011, J MOL MED, V89, P743, DOI 10.1007/s00109-011-0759-x; Danielson E, 2012, J NEUROSCI, V32, P6967, DOI 10.1523/JNEUROSCI.0025-12.2012; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Duman JG, 2013, J NEUROSCI, V33, P6964, DOI 10.1523/JNEUROSCI.3978-12.2013; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; Fam SR, 2005, P NATL ACAD SCI USA, V102, P8042, DOI 10.1073/pnas.0408818102; Ferrari SL, 2001, MOL ENDOCRINOL, V15, P149, DOI 10.1210/me.15.1.149; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Giovannini MG, 2006, REV NEUROSCIENCE, V17, P619; Goldin M, 2003, EUR J NEUROSCI, V17, P2529, DOI 10.1046/j.1460-9568.2003.02694.x; Gupte J, 2012, FEBS LETT, V586, P1214, DOI 10.1016/j.febslet.2012.03.014; He JQ, 2006, J BIOL CHEM, V281, P2820, DOI 10.1074/jbc.M509503200; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Huang YS, 2012, MOL CELL BIOL, V32, P1408, DOI 10.1128/MCB.06557-11; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Ito H, 2012, J NEUROSCI RES, V90, P1776, DOI 10.1002/jnr.23074; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Kaur B, 2005, ONCOGENE, V24, P3632, DOI 10.1038/sj.onc.1208317; Kaur B, 2003, AM J PATHOL, V162, P19, DOI 10.1016/S0002-9440(10)63794-7; Kaur B, 2009, CANCER RES, V69, P1212, DOI 10.1158/0008-5472.CAN-08-1166; Koh JT, 2001, MOL BRAIN RES, V87, P223, DOI 10.1016/S0169-328X(01)00004-3; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kudo S, 2007, ONCOL REP, V18, P785; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Lanoue V, 2013, MOL PSYCHIATR, V18, P943, DOI 10.1038/mp.2013.46; Lelianova VG, 1997, J BIOL CHEM, V272, P21504, DOI 10.1074/jbc.272.34.21504; Lim IA, 2002, J BIOL CHEM, V277, P21697, DOI 10.1074/jbc.M112339200; Mhaouty-Kodja S, 1999, MOL PHARMACOL, V55, P339, DOI 10.1124/mol.55.2.339; Mori K, 2002, NEUROSCI RES, V43, P69, DOI 10.1016/S0168-0102(02)00018-4; Nishimori H, 1997, ONCOGENE, V15, P2145, DOI 10.1038/sj.onc.1201542; Okajima D, 2011, J PHYSIOL SCI, V61, P47, DOI 10.1007/s12576-010-0120-0; Okajima D, 2010, J RECEPT SIG TRANSD, V30, P143, DOI 10.3109/10799891003671139; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park D, 2010, ADV EXP MED BIOL, V706, P167; Rahman MA, 1999, PHILOS T ROY SOC B, V354, P379, DOI 10.1098/rstb.1999.0390; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Shiratsuchi T, 1998, BIOCHEM BIOPH RES CO, V247, P597, DOI 10.1006/bbrc.1998.8603; Sokolowski JD, 2011, BRAIN BEHAV IMMUN, V25, P915, DOI 10.1016/j.bbi.2010.09.021; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Valtschanoff JG, 2000, EUR J NEUROSCI, V12, P3605, DOI 10.1046/j.1460-9568.2000.00256.x; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Xiao Xin-ru, 2006, Zhonghua Yi Xue Za Zhi, V86, P1342; Yang XM, 2010, FEBS LETT, V584, P2207, DOI 10.1016/j.febslet.2010.03.039; Yao R, 2004, ONCOGENE, V23, P6023, DOI 10.1038/sj.onc.1207817; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Yoon KC, 2005, GENE THER, V12, P617, DOI 10.1038/sj.gt.3302442; Zhang HC, 2007, CELL SIGNAL, V19, P261, DOI 10.1016/j.cellsig.2006.06.008; Zhu D, 2011, CANCER RES, V71, P5859, DOI 10.1158/0008-5472.CAN-11-1157	64	74	76	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22248	22256		10.1074/jbc.M113.489757	http://dx.doi.org/10.1074/jbc.M113.489757			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782696	hybrid, Green Published			2022-12-25	WOS:000330596300007
J	van den Berg, MCW; van Gogh, IJA; Smits, AMM; van Triest, M; Dansen, TB; Visscher, M; Polderman, PE; Vliem, MJ; Rehmann, H; Burgering, BMT				van den Berg, Maaike C. W.; van Gogh, Inkie J. A.; Smits, Alida M. M.; van Triest, Miranda; Dansen, Tobias B.; Visscher, Marieke; Polderman, Paulien E.; Vliem, Marjolein J.; Rehmann, Holger; Burgering, Boudewijn M. T.			The Small GTPase RALA Controls c-Jun N-terminal Kinase-mediated FOXO Activation by Regulation of a JIP1 Scaffold Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C; elegans; MAP Kinases (MAPKs); Reactive Oxygen Species (ROS); Scaffold Proteins; Signal Transduction; Small GTPases; Transcription Factors	EMBRYONIC STEM-CELLS; FORKHEAD BOX O; PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; SYNERGISTIC ACTIVATION; TRANSCRIPTION FACTORS; OXIDATIVE STRESS; LIFE-SPAN; CELLULAR-TRANSFORMATION; EFFECTOR COMPLEX	FOXO (forkhead box O) transcription factors are tumor suppressors and increase the life spans of model organisms. Cellular stress, in particular oxidative stress caused by an increase in levels of reactive oxygen species (ROS), activates FOXOs through JNK-mediated phosphorylation. Importantly, JNK regulation of FOXO is evolutionarily conserved. Here we identified the pathway that mediates ROS-induced JNK-dependent FOXO regulation. Following increased ROS, RALA is activated by the exchange factor RLF (RalGDS-like factor), which is in complex with JIP1 (C-Jun-amino-terminal-interacting protein 1) and JNK. Active RALA consequently regulates assembly and activation of MLK3, MKK4, and JNK onto the JIP1 scaffold. Furthermore, regulation of FOXO by RALA and JIP1 is conserved in C. elegans, where both ral-1 and jip-1 depletion impairs heat shock-induced nuclear translocation of the FOXO orthologue DAF16.	[van den Berg, Maaike C. W.; van Gogh, Inkie J. A.; Smits, Alida M. M.; van Triest, Miranda; Dansen, Tobias B.; Visscher, Marieke; Polderman, Paulien E.; Vliem, Marjolein J.; Rehmann, Holger; Burgering, Boudewijn M. T.] Univ Med Ctr Utrecht, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Burgering, BMT (corresponding author), Univ Med Ctr Utrecht, Dept Mol Canc Res, Univ Weg 100,STR 3-201, NL-3584 CG Utrecht, Netherlands.	b.m.t.burgering@umcutrecht.nl		Dansen, Tobias/0000-0001-5259-8815	Dutch Cancer Society; Center for Biomedical Genetics; Cancer Genomics Center	Dutch Cancer Society(KWF Kankerbestrijding); Center for Biomedical Genetics; Cancer Genomics Center	This work was supported by grants from the Dutch Cancer Society, the Center for Biomedical Genetics, and the Cancer Genomics Center.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Balakireva M, 2006, MOL CELL BIOL, V26, P8953, DOI 10.1128/MCB.00506-06; Barthwal MK, 2003, J BIOL CHEM, V278, P3897, DOI 10.1074/jbc.M211598200; Bock BC, 2000, J BIOL CHEM, V275, P14231, DOI 10.1074/jbc.275.19.14231; Bridge D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011686; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; de Keizer PLJ, 2011, ANTIOXID REDOX SIGN, V14, P1093, DOI 10.1089/ars.2010.3403; de Keizer PLJ, 2010, CANCER RES, V70, P8526, DOI 10.1158/0008-5472.CAN-10-1563; De Ruiter ND, 2000, MOL CELL BIOL, V20, P8480, DOI 10.1128/MCB.20.22.8480-8488.2000; De Ruiter ND, 2001, MOL CELL BIOL, V21, P8225, DOI 10.1128/MCB.21.23.8225-8235.2001; deGroot RP, 1997, J BIOL CHEM, V272, P2319; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Du Y, 2005, J BIOL CHEM, V280, P42984, DOI 10.1074/jbc.M502671200; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Figueroa C, 2003, J BIOL CHEM, V278, P47922, DOI 10.1074/jbc.M307357200; Fleming Y, 2000, BIOCHEM J, V352, P145, DOI 10.1042/0264-6021:3520145; Frankel P, 2005, EMBO J, V24, P54, DOI 10.1038/sj.emboj.7600497; Frische EW, 2007, EMBO J, V26, P5083, DOI 10.1038/sj.emboj.7601922; Girardin SE, 2001, EMBO J, V20, P3437, DOI 10.1093/emboj/20.13.3437; Hao YS, 2008, MOL CELL BIOL, V28, P2851, DOI 10.1128/MCB.01917-07; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Henry DO, 2000, MOL CELL BIOL, V20, P8084, DOI 10.1128/MCB.20.21.8084-8092.2000; Heo JY, 2011, ANTIOXID REDOX SIGN, V14, P689, DOI 10.1089/ars.2009.2984; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hofer F, 1998, CURR BIOL, V8, P839, DOI 10.1016/S0960-9822(98)70327-6; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hu SQ, 2012, J BIOL CHEM, V287, P2364, DOI 10.1074/jbc.M111.227124; Jullien-Flores V, 2000, J CELL SCI, V113, P2837; Kim AH, 2003, J BIOL CHEM, V278, P29830, DOI 10.1074/jbc.M305349200; Kim AH, 2002, NEURON, V35, P697, DOI 10.1016/S0896-6273(02)00821-8; Kishimoto H, 2003, J BIOL CHEM, V278, P16595, DOI 10.1074/jbc.M213182200; KOIDE H, 1993, P NATL ACAD SCI USA, V90, P8683, DOI 10.1073/pnas.90.18.8683; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lawler S, 1998, CURR BIOL, V8, P1387, DOI 10.1016/S0960-9822(98)00019-0; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Marasa BS, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000442; Marti A, 1997, J BIOL CHEM, V272, P2620, DOI 10.1074/jbc.272.5.2620; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; Mitchell L, 2013, ANTIOXID REDOX SIGN, V18, P250, DOI 10.1089/ars.2012.4687; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Nakashima S, 1999, EMBO J, V18, P3629, DOI 10.1093/emboj/18.13.3629; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Rehmann H, 2006, METHOD ENZYMOL, V407, P159, DOI 10.1016/S0076-6879(05)07014-X; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sawamoto K, 1999, J CELL BIOL, V146, P361, DOI 10.1083/jcb.146.2.361; Song JJ, 2005, J BIOL CHEM, V280, P26845, DOI 10.1074/jbc.M502318200; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van Drogen F, 2002, CURR BIOL, V12, pR53, DOI 10.1016/S0960-9822(01)00672-8; Wada T, 2001, J BIOL CHEM, V276, P30892, DOI 10.1074/jbc.M011780200; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; White MA, 1996, J BIOL CHEM, V271, P16439, DOI 10.1074/jbc.271.28.16439; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; Wolthuis RMF, 1998, CURR BIOL, V8, P471, DOI 10.1016/S0960-9822(98)70183-6; Wolthuis RMF, 1997, EMBO J, V16, P6748, DOI 10.1093/emboj/16.22.6748; Zand TP, 2011, DEV CELL, V20, P84, DOI 10.1016/j.devcel.2010.12.004	71	22	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21729	21741		10.1074/jbc.M113.463885	http://dx.doi.org/10.1074/jbc.M113.463885			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23770673	hybrid, Green Published			2022-12-25	WOS:000328841900024
J	Lu, P; Bar-Yoseph, F; Levi, L; Lifshitz, Y; Witte-Bouma, J; de Bruijn, ACJM; Korteland-van Male, AM; van Goudoever, JB; Renes, IB				Lu, Peng; Bar-Yoseph, Fabiana; Levi, Liora; Lifshitz, Yael; Witte-Bouma, Janneke; de Bruijn, Adrianus C. J. M.; Korteland-van Male, Anita M.; van Goudoever, Johannes B.; Renes, Ingrid B.			High Beta-Palmitate Fat Controls the Intestinal Inflammatory Response and Limits Intestinal Damage in Mucin Muc2 Deficient Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; PROLIFERATOR-ACTIVATED RECEPTOR; HUMAN-MILK FAT; SN-2 POSITION; PPAR-GAMMA; OXIDATIVE STRESS; INDUCED COLITIS; HOST-DEFENSE; ACID; TRIACYLGLYCEROLS	Background: Palmitic-acid esterified to the sn-1,3 positions of the glycerol backbone (alpha, alpha'-palmitate), the predominant palmitate conformation in regular infant formula fat, is poorly absorbed and might cause abdominal discomfort. In contrast, palmitic-acid esterified to the sn-2 position (beta-palmitate), the main palmitate conformation in human milk fat, is well absorbed. The aim of the present study was to examine the influence of high alpha, alpha'-palmitate fat (HAPF) diet and high beta-palmitate fat (HBPF) diet on colitis development in Muc2 deficient (Muc2(-/-)) mice, a well-described animal model for spontaneous enterocolitis due to the lack of a protective mucus layer. Methods: Muc2(-/-) mice received AIN-93G reference diet, HAPF diet or HBPF diet for 5 weeks after weaning. Clinical symptoms, intestinal morphology and inflammation in the distal colon were analyzed. Results: Both HBPF diet and AIN-93G diet limited the extent of intestinal erosions and morphological damage in Muc2(-/-) mice compared with HAPF diet. In addition, the immunosuppressive regulatory T (Treg) cell response as demonstrated by the up-regulation of Foxp3, Tgfb1 and Ebi3 gene expression levels was enhanced by HBPF diet compared with AIN-93G and HAPF diets. HBPF diet also increased the gene expression of Pparg and enzymatic antioxidants (Sod1, Sod3 and Gpx1), genes all reported to be involved in promoting an immunosuppressive Treg cell response and to protect against colitis. Conclusions: This study shows for the first time that HBPF diet limits the intestinal mucosal damage and controls the inflammatory response in Muc2(-/-) mice by inducing an immunosuppressive Treg cell response.	[Lu, Peng; Witte-Bouma, Janneke; de Bruijn, Adrianus C. J. M.; Korteland-van Male, Anita M.; Renes, Ingrid B.] Erasmus MC Sophia, Dept Pediat, Div Neonatol, Rotterdam, Netherlands; [Lu, Peng; van Goudoever, Johannes B.; Renes, Ingrid B.] Emma Childrens Hosp AMC, Dept Pediat, Amsterdam, Netherlands; [Bar-Yoseph, Fabiana; Levi, Liora; Lifshitz, Yael] Enzymotec LTD, Kfar Baruch, Israel; [van Goudoever, Johannes B.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Renes, IB (corresponding author), Erasmus MC Sophia, Dept Pediat, Div Neonatol, Rotterdam, Netherlands.	i.b.renes@amc.uva.nl	van Goudoever, Johannes Bernard/Y-4520-2018; Renes, Ingrid/C-4801-2013	van Goudoever, Johannes (Hans)/0000-0003-3960-1703	Enzymotec LTD.	Enzymotec LTD.	The study was funded by Enzymotec LTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bento AF, 2011, AM J PATHOL, V178, P1153, DOI 10.1016/j.ajpath.2010.11.052; Boden EK, 2008, CURR OPIN GASTROEN, V24, P733, DOI 10.1097/MOG.0b013e328311f26e; Bommireddy R, 2007, TRENDS MOL MED, V13, P492, DOI 10.1016/j.molmed.2007.08.005; Burger-van Paassen N, 2011, AM J PHYSIOL-GASTR L, V301, pG667, DOI 10.1152/ajpgi.00199.2010; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; DEFOUW NJ, 1994, LIPIDS, V29, P765, DOI 10.1007/BF02536698; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Esworthy RS, 2001, AM J PHYSIOL-GASTR L, V281, pG848, DOI 10.1152/ajpgi.2001.281.3.G848; Forsythe CE, 2007, BRIT J NUTR, V98, P337, DOI 10.1017/S0007114507704993; Guri AJ, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-60; Hecht G, 1999, AM J PHYSIOL-CELL PH, V277, pC351, DOI 10.1152/ajpcell.1999.277.3.C351; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hontecillas R, 2007, J IMMUNOL, V178, P2940, DOI 10.4049/jimmunol.178.5.2940; Jeffery NM, 1997, BBA-LIPID LIPID MET, V1345, P223, DOI 10.1016/S0005-2760(96)00174-9; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Lee Yeon-Sook, 2008, Nutr Res Pract, V2, P3, DOI 10.4162/nrp.2008.2.1.3; Lei J, 2010, J IMMUNOL, V185, P7186, DOI 10.4049/jimmunol.1001437; Lopez-Lopez A, 2002, EUR J CLIN NUTR, V56, P1242, DOI 10.1038/sj.ejcn.1601470; Lopez-Lopez A, 2001, EARLY HUM DEV, V65, pS83, DOI 10.1016/S0378-3782(01)00210-9; Lu P., 2011, INFLAMM BOWEL DIS; Ma X, 2007, HEPATOLOGY, V46, P1519, DOI 10.1002/hep.21823; Manson WG, 1997, ARCH DIS CHILD-FETAL, V76, pF206, DOI 10.1136/fn.76.3.F206; Mohapatra SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010215; Nelson CM, 1999, AM J CLIN NUTR, V70, P62; Pina-Rodriguez AM, 2009, J AGR FOOD CHEM, V57, P4657, DOI 10.1021/jf900242g; Reeves PG, 1997, J NUTR, V127, pS838; Renes IB, 2002, INT J COLORECTAL DIS, V17, P317, DOI 10.1007/s00384-002-0409-4; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sanders TAB, 2011, AM J CLIN NUTR, V94, P1433, DOI 10.3945/ajcn.111.017459; Segui J, 2004, J LEUKOCYTE BIOL, V76, P537, DOI 10.1189/jlb.0304196; Suzuki Y, 2008, COLORECTAL DIS, V10, P931, DOI 10.1111/j.1463-1318.2008.01487.x; Tan PH, 2005, J IMMUNOL, V174, P7633, DOI 10.4049/jimmunol.174.12.7633; Teichert SA, 2011, J AGR FOOD CHEM, V59, P5692, DOI 10.1021/jf200336t; Tsai PY, 2011, FREE RADICAL BIO MED, V51, P744, DOI 10.1016/j.freeradbiomed.2011.05.016; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Velcich A, 1997, J BIOL CHEM, V272, P7968, DOI 10.1074/jbc.272.12.7968; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094	40	19	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65878	10.1371/journal.pone.0065878	http://dx.doi.org/10.1371/journal.pone.0065878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776564	gold, Green Submitted, Green Published			2022-12-25	WOS:000320322400061
J	Morfini, GA; Bosco, DA; Brown, H; Gatto, R; Kaminska, A; Song, YY; Molla, L; Baker, L; Marangoni, MN; Berth, S; Tavassoli, E; Bagnato, C; Tiwari, A; Hayward, LJ; Pigino, GF; Watterson, DM; Huang, CF; Banker, G; Brown, RH; Brady, ST				Morfini, Gerardo A.; Bosco, Daryl A.; Brown, Hannah; Gatto, Rodolfo; Kaminska, Agnieszka; Song, Yuyu; Molla, Linda; Baker, Lisa; Marangoni, M. Natalia; Berth, Sarah; Tavassoli, Ehsan; Bagnato, Carolina; Tiwari, Ashutosh; Hayward, Lawrence J.; Pigino, Gustavo F.; Watterson, D. Martin; Huang, Chun-Fang; Banker, Gary; Brown, Robert H., Jr.; Brady, Scott T.			Inhibition of Fast Axonal Transport by Pathogenic SOD1 Involves Activation of p38 MAP Kinase	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; ZINC SUPEROXIDE-DISMUTASE; SQUID GIANT-AXON; PROTEIN-KINASE; MOUSE MODEL; CYTOPLASMIC DYNEIN; IN-VIVO; NEUROFILAMENT PROTEIN; HEXANUCLEOTIDE REPEAT	Dying-back degeneration of motor neuron axons represents an established feature of familial amyotrophic lateral sclerosis (FALS) associated with superoxide dismutase 1 (SOD1) mutations, but axon-autonomous effects of pathogenic SOD1 remained undefined. Characteristics of motor neurons affected in FALS include abnormal kinase activation, aberrant neurofilament phosphorylation, and fast axonal transport (FAT) deficits, but functional relationships among these pathogenic events were unclear. Experiments in isolated squid axoplasm reveal that FALS-related SOD1 mutant polypeptides inhibit FAT through a mechanism involving a p38 mitogen activated protein kinase pathway. Mutant SOD1 activated neuronal p38 in mouse spinal cord, neuroblastoma cells and squid axoplasm. Active p38 MAP kinase phosphorylated kinesin-1, and this phosphorylation event inhibited kinesin-1. Finally, vesicle motility assays revealed previously unrecognized, isoform-specific effects of p38 on FAT. Axon-autonomous activation of the p38 pathway represents a novel gain of toxic function for FALS-linked SOD1 proteins consistent with the dying-back pattern of neurodegeneration characteristic of ALS.	[Morfini, Gerardo A.; Gatto, Rodolfo; Kaminska, Agnieszka; Song, Yuyu; Marangoni, M. Natalia; Berth, Sarah; Tavassoli, Ehsan; Pigino, Gustavo F.; Brady, Scott T.] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60607 USA; [Morfini, Gerardo A.; Brown, Hannah; Kaminska, Agnieszka; Song, Yuyu; Molla, Linda; Baker, Lisa; Marangoni, M. Natalia; Berth, Sarah; Pigino, Gustavo F.; Brady, Scott T.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Bosco, Daryl A.; Hayward, Lawrence J.; Brown, Robert H., Jr.] Univ Massachusetts, Med Ctr, Dept Neurol, Worcester, MA 01655 USA; [Tiwari, Ashutosh] Michigan Technol Univ, Dept Chem, Houghton, MI 49931 USA; [Brown, Hannah] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Watterson, D. Martin] Northwestern Univ, Ctr Mol Innovat & Drug Discovery, Chicago, IL 60611 USA; [Watterson, D. Martin] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Huang, Chun-Fang; Banker, Gary] Oregon Hlth & Sci Univ, Jungers Ctr Neurosci Res, Portland, OR 97201 USA; [Bagnato, Carolina] Natl Univ Rio Negro, Dept Nat Sci & Engn, Rio Negro, Argentina	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Marine Biological Laboratory - Woods Hole; University of Massachusetts System; University of Massachusetts Worcester; Michigan Technological University; Harvard University; Massachusetts General Hospital; Northwestern University; Northwestern University; Oregon Health & Science University	Morfini, GA (corresponding author), Univ Illinois, Dept Anat & Cell Biol, Chicago, IL 60607 USA.	gmorfini@uic.edu; stbrady@uic.edu	Gatto, Rodolfo/R-7155-2018; Song, Yuyu/J-8939-2019; Tiwari, Ashutosh/A-7458-2008; Pigino, Gustavo/L-7002-2019	Gatto, Rodolfo/0000-0003-2170-6662; Song, Yuyu/0000-0002-9196-1610; Tiwari, Ashutosh/0000-0001-7373-349X; Watterson, Daniel/0000-0001-7605-5866; Hayward, Lawrence/0000-0003-0579-0358	Marine Biological Laboratory; NIH [NS066942A, R01NS44170, NS23868, NS23320, NS41170, MH066179, R01AG031311, R01NS055951, U01NS05225, R01NS050557, 1RC1NS068391, 1RC2NS070342, R01NS067206]; Howard Hughes Medical Institute-USE [52006287]; Muscular Dystrophy Association (MDA); ALS Association; ALS/CVS Therapy Alliance; Angel Fund; DeBourgknecht Fund for ALS Research; P2ALS; Project ALS; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023868, R01NS055951, R01NS067206, RC2NS070342, R56NS023868, R01NS044170, R01NS023320, R01NS050557, R01NS066942, R01NS041170, RC1NS068391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG043415, R01AG031311] Funding Source: NIH RePORTER	Marine Biological Laboratory; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute-USE(Howard Hughes Medical Institute); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); ALS Association; ALS/CVS Therapy Alliance; Angel Fund; DeBourgknecht Fund for ALS Research; P2ALS; Project ALS; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support was provided by 2007/2008 Marine Biological Laboratory summer fellowships and NIH (NS066942A) grants to GM; Howard Hughes Medical Institute-USE Grant #52006287 to Hunter College of CUNY (LM); Muscular Dystrophy Association (MDA) and NIH (R01NS44170) grants to LJH; MDA and NIH (NS23868, NS23320, NS41170) grants to STB; NIH grant MH066179 to GB; NIH grants R01AG031311 and R01NS055951 to DMW; NIH (U01NS05225, R01NS050557, 1RC1NS068391, 1RC2NS070342) grants to RHB; R01NS067206 to DAB; ALS Association grants to GM, AT, RHB, and STB; and ALS/CVS Therapy Alliance grants to RHB, GM, AT, LJH, and DAB. RHB and AT received support from the Angel Fund. RHB also received support from the DeBourgknecht Fund for ALS Research, P2ALS and Project ALS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley S, 2004, MOL CELL NEUROSCI, V26, P354, DOI 10.1016/j.mcn.2004.02.009; Banks GT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-214; Barr RK, 2002, J BIOL CHEM, V277, P10987, DOI 10.1074/jbc.M107565200; Bendotti C, 2004, J NEUROPATH EXP NEUR, V63, P113, DOI 10.1093/jnen/63.2.113; Bilsland LG, 2010, P NATL ACAD SCI USA, V107, P20523, DOI 10.1073/pnas.1006869107; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bosco DA, 2010, CNS NEUROL DISORD-DR, V9, P779; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; BRADY ST, 1993, METHOD CELL BIOL, V39, P191, DOI 10.1016/S0091-679X(08)60171-5; BRADY ST, 1990, CELL MOTIL CYTOSK S2, V17, P22; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; COHEN RS, 1987, J NEUROSCI, V7, P2056; Conforti L, 2007, TRENDS NEUROSCI, V30, P159, DOI 10.1016/j.tins.2007.02.004; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dadon-Nachum M, 2011, J MOL NEUROSCI, V43, P470, DOI 10.1007/s12031-010-9467-1; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; DeBoer SR, 2008, BIOCHEMISTRY-US, V47, P4535, DOI 10.1021/bi702445j; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dewil M, 2007, NEUROBIOL DIS, V26, P332, DOI 10.1016/j.nbd.2006.12.023; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Dong Hang, 2007, Zhonghua Yi Xue Za Zhi, V87, P53; Dupuis L, 2009, EXP NEUROL, V215, P146, DOI 10.1016/j.expneurol.2008.09.019; Elluru R, 1995, J NEUROSCI RES UNPUB; ELLURU RG, 1995, MOL BIOL CELL, V6, P21, DOI 10.1091/mbc.6.1.21; Eschbach J, 2011, PHARMACOL THERAPEUT, V130, P348, DOI 10.1016/j.pharmthera.2011.03.004; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; Grant P, 2000, J NEUROCYTOL, V29, P843, DOI 10.1023/A:1010999509251; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; GURNEY ME, 1994, NEW ENGL J MED, V331, P1721, DOI 10.1056/NEJM199412223312516; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; HOLLENBECK PJ, 1993, J NEUROCHEM, V60, P2265, DOI 10.1111/j.1471-4159.1993.tb03513.x; HOLLENBECK PJ, 1990, J CELL BIOL, V115, pA390; Ilieva HS, 2008, P NATL ACAD SCI USA, V105, P12599, DOI 10.1073/pnas.0805422105; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamenecka T, 2009, J BIOL CHEM, V284, P12853, DOI 10.1074/jbc.M809430200; Kieran D, 2005, J CELL BIOL, V169, P561, DOI 10.1083/jcb.200501085; Krieger C, 2003, TRENDS PHARMACOL SCI, V24, P535, DOI 10.1016/j.tips.2003.08.003; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; LaPointe NE, 2009, J NEUROSCI RES, V87, P440, DOI 10.1002/jnr.21850; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; LEE KD, 1995, J BIOL CHEM, V270, P5600, DOI 10.1074/jbc.270.10.5600; Lee SH, 2000, J NEUROSCI RES, V60, P623, DOI 10.1002/(SICI)1097-4547(20000601)60:5<623::AID-JNR7>3.0.CO;2-4; Levy JR, 2006, INT J DEV NEUROSCI, V24, P103, DOI 10.1016/j.ijdevneu.2005.11.013; Lobsiger CS, 2005, P NATL ACAD SCI USA, V102, P10351, DOI 10.1073/pnas.0503862102; MANETTO V, 1988, J NEUROPATH EXP NEUR, V47, P642, DOI 10.1097/00005072-198811000-00007; Marinkovic P, 2012, P NATL ACAD SCI USA, V109, P4296, DOI 10.1073/pnas.1200658109; MARTZ D, 1984, CELL MOTIL CYTOSKEL, V4, P89, DOI 10.1002/cm.970040203; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Morfini G, 2007, P NATL ACAD SCI USA, V104, P2442, DOI 10.1073/pnas.0611231104; Morfini G, 2007, J NEUROSCI RES, V85, P2620, DOI 10.1002/jnr.21154; Morfini G, 2006, NAT NEUROSCI, V9, P907, DOI 10.1038/nn1717; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Morfini GA, 2009, NAT NEUROSCI, V12, P864, DOI 10.1038/nn.2346; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21; Murakata C, 2002, BIOORG MED CHEM LETT, V12, P147, DOI 10.1016/S0960-894X(01)00690-4; PANT HC, 1978, J CELL BIOL, V78, pR23, DOI 10.1083/jcb.78.2.R23; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Perlson E, 2009, J NEUROSCI, V29, P9903, DOI 10.1523/JNEUROSCI.0813-09.2009; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Sack S, 1997, BIOCHEMISTRY-US, V36, P16155, DOI 10.1021/bi9722498; Sau D, 2011, BIOL CELL, V103, P87, DOI 10.1042/BC20100093; Saxton WM, 2012, J CELL SCI; Sharma R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013463; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P707, DOI 10.1016/j.bbadis.2010.05.008; Song YY, 2013, P NATL ACAD SCI USA, V110, P5428, DOI 10.1073/pnas.1303279110; Strom AL, 2008, J NEUROCHEM, V106, P495, DOI 10.1111/j.1471-4159.2008.05393.x; Szodorai A, 2009, J NEUROSCI, V29, P14534, DOI 10.1523/JNEUROSCI.1546-09.2009; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Teuchert M, 2006, EXP NEUROL, V198, P271, DOI 10.1016/j.expneurol.2005.12.005; Tortarolo M, 2003, MOL CELL NEUROSCI, V23, P180, DOI 10.1016/S1044-7431(03)00022-8; Tsai MY, 2000, MOL BIOL CELL, V11, P2161, DOI 10.1091/mbc.11.6.2161; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Veglianese P, 2006, MOL CELL NEUROSCI, V31, P218, DOI 10.1016/j.mcn.2005.09.009; Warita H, 1999, BRAIN RES, V819, P120, DOI 10.1016/S0006-8993(98)01351-1; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	90	71	73	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65235	10.1371/journal.pone.0065235	http://dx.doi.org/10.1371/journal.pone.0065235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776455	Green Published, gold			2022-12-25	WOS:000320322400010
J	Moriyama, H; Moriyama, M; Sawaragi, K; Okura, H; Ichinose, A; Matsuyama, A; Hayakawa, T				Moriyama, Hiroyuki; Moriyama, Mariko; Sawaragi, Kei; Okura, Hanayuki; Ichinose, Akihiro; Matsuyama, Akifumi; Hayakawa, Takao			Tightly Regulated and Homogeneous Transgene Expression in Human Adipose-Derived Mesenchymal Stem Cells by Lentivirus with Tet-Off System	PLOS ONE			English	Article							MULTILINEAGE PROGENITOR CELLS; INSULIN-PRODUCING CELLS; STROMAL CELLS; PROMOTER SUPPRESSION; GENE DELIVERY; CMV PROMOTER; VECTORS; TRANSPLANTATION; GENERATION; ISCHEMIA	Genetic modification of human adipose tissue-derived multilineage progenitor cells (hADMPCs) is highly valuable for their exploitation in therapeutic applications. Here, we have developed a novel single tet-off lentiviral vector platform. This vector combines (1) a modified tetracycline (tet)-response element composite promoter, (2) a multi-cistronic strategy to express an improved version of the tet-controlled transactivator and the blasticidin resistance gene under the control of a ubiquitous promoter, and (3) acceptor sites for easy recombination cloning of the gene of interest. In the present study, we used the cytomegalovirus (CMV) or the elongation factor 1 alpha (EF-1 alpha) promoter as the ubiquitous promoter, and EGFP was introduced as the gene of interest. hADMPCs transduced with a lentiviral vector carrying either the CMV promoter or the EF-1 alpha promoter were effectively selected by blasticidin without affecting their stem cell properties, and EGFP expression was strictly regulated by doxycycline (Dox) treatment in these cells. However, the single tet-off lentiviral vector carrying the EF-1 alpha promoter provided more homogenous expression of EGFP in hADMPCs. Intriguingly, differentiated cells from these Dox-responsive cell lines constitutively expressed EGFP only in the absence of Dox. This single tet-off lentiviral vector thus provides an important tool for applied research on hADMPCs.	[Moriyama, Hiroyuki; Moriyama, Mariko; Sawaragi, Kei; Hayakawa, Takao] Kinki Univ, Pharmaceut Res & Technol Inst, Higashiosaka, Osaka 577, Japan; [Moriyama, Mariko; Okura, Hanayuki; Matsuyama, Akifumi] Fdn Biomed Res & Innovat, Platform Realizat Regenerat Med, Chuo Ku, Kobe, Hyogo, Japan; [Ichinose, Akihiro] Kobe Univ Hosp, Dept Plast Surg, Chuo Ku, Kobe, Hyogo, Japan	Kindai University (Kinki University); Institute for Biomedical Research & Innovation (IBRI); Kobe University	Moriyama, H (corresponding author), Kinki Univ, Pharmaceut Res & Technol Inst, Higashiosaka, Osaka 577, Japan.	moriyama@phar.kindai.ac.jp			MEXT KAKENHI [23791304, 24791927]; Ministry of Health, Labor, and Welfare of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation)	This work was supported in part by MEXT KAKENHI Grant Number 23791304 to M. M. and 24791927 to H. M. This work was also supported in part by grants from the Ministry of Health, Labor, and Welfare of Japan and a grant from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benabdellah K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023734; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Chinnasamy D, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-14; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Duan HF, 2003, MOL THER, V8, P467, DOI 10.1016/S1525-0016(03)00186-2; EMERMAN M, 1986, NUCLEIC ACIDS RES, V14, P9381, DOI 10.1093/nar/14.23.9381; Fan L, 2009, EUR J HEART FAIL, V11, P1023, DOI 10.1093/eurjhf/hfp135; Ghosh SS, 2006, APPL BIOCHEM BIOTECH, V133, P9, DOI 10.1385/ABAB:133:1:9; Goudenege S, 2009, MOL THER, V17, P1064, DOI 10.1038/mt.2009.67; Hioki H, 2009, NEUROSCI RES, V63, P149, DOI 10.1016/j.neures.2008.10.010; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Ikegame Y, 2011, CYTOTHERAPY, V13, P675, DOI 10.3109/14653249.2010.549122; Karnieli O, 2007, STEM CELLS, V25, P2837, DOI 10.1634/stemcells.2007-0164; Kawabata K, 2005, MOL THER, V12, P547, DOI 10.1016/j.ymthe.2005.04.015; Kim S, 2007, STEM CELLS DEV, V16, P537, DOI 10.1089/scd.2006.0088; Lee EY, 2009, WOUND REPAIR REGEN, V17, P540, DOI 10.1111/j.1524-475X.2009.00499.x; Leu S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-63; Li YH, 2007, J CELL PHYSIOL, V211, P36, DOI 10.1002/jcp.20897; Liang ZX, 2007, BIOCHEM BIOPH RES CO, V363, P542, DOI 10.1016/j.bbrc.2007.09.007; McGinley L, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt53; Meilinger D, 2009, EMBO REP, V10, P1259, DOI 10.1038/embor.2009.201; Moriyama M, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-21; Okura H, 2010, TISSUE ENG PART C-ME, V16, P417, DOI 10.1089/ten.TEC.2009.0362; Okura H, 2010, TISSUE ENG PART C-ME, V16, P761, DOI [10.1089/ten.tec.2009.0208, 10.1089/ten.TEC.2009.0208]; Okura H, 2011, TISSUE ENG PART C-ME, V17, P145, DOI [10.1089/ten.tec.2010.0139, 10.1089/ten.TEC.2010.0139]; Okura H, 2009, J ARTIF ORGANS, V12, P123, DOI 10.1007/s10047-009-0455-6; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Reid AJ, 2011, NEUROSCIENCE; Safford KM, 2004, EXP NEUROL, V187, P319, DOI 10.1016/j.expneurol.2004.01.027; Saga A, 2011, BIOCHEM BIOPH RES CO, V412, P50, DOI 10.1016/j.bbrc.2011.07.035; Shi Q, 2011, RHEUMATOL INT; Tai K, 2008, TISSUE ENG PT A, V14, P1709, DOI 10.1089/ten.tea.2007.0241; Tan B, 2011, NEUROSCIENCE, V181, P40, DOI 10.1016/j.neuroscience.2011.02.038; Temple G, 2009, GENOME RES, V19, P2324, DOI 10.1101/gr.095976.109; Tian J, 2009, GENE THER, V16, P874, DOI 10.1038/gt.2009.46; Villemure JF, 2001, J MOL BIOL, V312, P963, DOI 10.1006/jmbi.2001.5015; Weber W, 2006, J GENE MED, V8, P535, DOI 10.1002/jgm.903; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Wu H, 2011, MOL PHARMACEUT, V8, P1458, DOI 10.1021/mp200135e	42	9	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66274	10.1371/journal.pone.0066274	http://dx.doi.org/10.1371/journal.pone.0066274			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776652	gold, Green Submitted, Green Published			2022-12-25	WOS:000320322400094
J	White, DJ; Unwin, RD; Bindels, E; Pierce, A; Teng, HY; Muter, J; Greystoke, B; Somerville, TD; Griffiths, J; Lovell, S; Somervaille, TCP; Delwel, R; Whetton, AD; Meyer, S				White, Daniel J.; Unwin, Richard D.; Bindels, Eric; Pierce, Andrew; Teng, Hsiang-Ying; Muter, Joanne; Greystoke, Brigit; Somerville, Tim D.; Griffiths, John; Lovell, Simon; Somervaille, Tim C. P.; Delwel, Ruud; Whetton, Anthony D.; Meyer, Stefan			Phosphorylation of the Leukemic Oncoprotein EVI1 on Serine 196 Modulates DNA Binding, Transcriptional Repression and Transforming Ability	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; FANCONI-ANEMIA; ZINC-FINGER; MEDIATED PHOSPHORYLATION; MYELODYSPLASTIC SYNDROME; INTEGRATION SITE; RAT1 FIBROBLASTS; PROTEIN; GENE	The EVI1 (ecotropic viral integration site 1) gene at 3q26 codes for a transcriptional regulator with an essential role in haematopoiesis. Overexpression of EVI1 in acute myeloid leukaemia (AML) is frequently associated with 3q26 rearrangements and confers extremely poor prognosis. EVI1 mediates transcriptional regulation, signalling, and epigenetic modifications by interacting with DNA, proteins and protein complexes. To explore to what extent protein phosphorylation impacts on EVI1 functions, we analysed endogenous EVI1 protein from a high EVI1 expressing Fanconi anaemia (FA) derived AML cell line. Mass spectrometric analysis of immunoprecipitated EVI1 revealed phosphorylation at serine 196 (S196) in the sixth zinc finger of the N-terminal zinc finger domain. Mutated EVI1 with an aspartate substitution at serine 196 (S196D), which mimics serine phosphorylation of this site, exhibited reduced DNA-binding and transcriptional repression from a gene promotor selectively targeted by the N-terminal zinc finger domain. Forced expression of the S196D mutant significantly reduced EVI1 mediated transformation of Rat1 fibroblasts. While EVI1-mediated serial replating of murine haematopoietic progenitors was maintained by EVI1-S196D, this was associated with significantly higher Evi1-trancript levels compared with WT-EVI1 or EVI1-S196A, mimicking S196 non-phosphorylated EVI1. These data suggest that EVI1 function is modulated by phosphorylation of the first zinc finger domain.	[White, Daniel J.; Unwin, Richard D.; Pierce, Andrew; Teng, Hsiang-Ying; Muter, Joanne; Griffiths, John; Whetton, Anthony D.; Meyer, Stefan] Univ Manchester, Manchester Acad Hlth Sci Ctr, Stem Cell & Leukaemia Prote Lab, Manchester, Lancs, England; [Bindels, Eric; Delwel, Ruud] Erasmus Univ, Dept Hematol, Rotterdam, Netherlands; [Greystoke, Brigit; Somerville, Tim D.; Somervaille, Tim C. P.] Paterson Inst Canc Res, Canc Res UK Leukaemia Biol Lab, Manchester M20 9BX, Lancs, England; [Lovell, Simon] Univ Manchester, Fac Life Sci, Acad Hlth Sci Ctr, Manchester, Lancs, England; [Meyer, Stefan] Manchester Acad Hlth Sci Ctr, Royal Manchester Childrens Hosp, Manchester, Lancs, England; [Meyer, Stefan] Manchester Acad Hlth Sci Ctr, Christie NHS Fdn Trust, Manchester, Lancs, England	University of Manchester; Erasmus University Rotterdam; Paterson Institute for Cancer Research; University of Manchester; Royal Manchester Children's Hospital; University of Manchester; Christie NHS Foundation Trust; University of Manchester	Meyer, S (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Stem Cell & Leukaemia Prote Lab, Manchester, Lancs, England.	stefan.meyer@manchester.ac.uk	Unwin, Richard/C-1258-2008	Unwin, Richard/0000-0001-7955-9111; Pierce, Andrew/0000-0001-5995-2469; Lovell, Simon/0000-0002-4092-8458; Somervaille, Tim/0000-0002-9188-4379; WHETTON, ANTHONY D/0000-0002-1098-3878	Cancer Research UK (CRUK); Clinician Scientist Fellowship [C1860/A5901]; LLR (UK)	Cancer Research UK (CRUK)(Cancer Research UK); Clinician Scientist Fellowship; LLR (UK)	This work was funded by a Cancer Research UK (CRUK, http://www.cancerresearchuk.org/) Clinician Scientist Fellowship to SM (C1860/A5901) and LLR (UK) (http://leukaemialymphomaresearch.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard-Chapeau EA, 2012, P NATL ACAD SCI USA, V109, P2168, DOI 10.1073/pnas.1119229109; Bartholomew C, 1997, ONCOGENE, V14, P569, DOI 10.1038/sj.onc.1200864; Black AR, 1999, J BIOL CHEM, V274, P1207, DOI 10.1074/jbc.274.3.1207; Buitenhuis M, 2008, BLOOD, V111, P112, DOI 10.1182/blood-2006-07-037572; Buonamici S, 2004, J CLIN INVEST, V114, P713, DOI 10.1172/JCI200421716; Castillo P, 2011, DNA REPAIR, V10, P518, DOI 10.1016/j.dnarep.2011.02.007; Chen VB, 2009, PROTEIN SCI, V18, P2403, DOI 10.1002/pro.250; Costoya JA, 2008, ONCOGENE, V27, P3789, DOI 10.1038/onc.2008.7; DELWEL R, 1993, MOL CELL BIOL, V13, P4291, DOI 10.1128/MCB.13.7.4291; Dickstein J, 2010, P NATL ACAD SCI USA, V107, P9783, DOI 10.1073/pnas.1004297107; Du Y, 2005, BLOOD, V106, P3932, DOI 10.1182/blood-2005-03-1113; FUNABIKI T, 1994, ONCOGENE, V9, P1575; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Jin GA, 2007, BLOOD, V109, P3998, DOI 10.1182/blood-2006-08-041202; Kilbey A, 1998, ONCOGENE, V16, P2287, DOI 10.1038/sj.onc.1201732; Kilbey A, 1999, CELL GROWTH DIFFER, V10, P601; KUROKAWA M, 1995, ONCOGENE, V11, P833; Kustikova OS, 2012, LEUKEMIA; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Lugthart S, 2008, BLOOD, V111, P4329, DOI 10.1182/blood-2007-10-119230; Lugthart S, 2011, BLOOD, V117, P234, DOI 10.1182/blood-2010-04-281337; MATSUGI T, 1990, MOL CELL BIOL, V10, P1259, DOI 10.1128/MCB.10.3.1259; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Metais JY, 2008, MOL THER, V16, P439, DOI 10.1038/sj.mt.6300372; Meyer S, 2005, GENE CHROMOSOME CANC, V42, P404, DOI 10.1002/gcc.20153; Meyer S, 2007, GENE CHROMOSOME CANC, V46, P359, DOI 10.1002/gcc.20417; Meyer S, 2011, BLOOD, V117, P6047, DOI 10.1182/blood-2011-03-343897; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Palmer S, 2001, J BIOL CHEM, V276, P25834, DOI 10.1074/jbc.M102343200; PERKINS AS, 1991, MOL CELL BIOL, V11, P2665, DOI 10.1128/MCB.11.5.2665; Pradhan AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025370; Sakamoto Y, 1997, ONCOGENE, V15, P2001, DOI 10.1038/sj.onc.1201391; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sasaki MS, 2002, MUTAT RES-FUND MOL M, V504, P101, DOI 10.1016/S0027-5107(02)00084-2; Shimabe M, 2009, ONCOGENE, V28, P4364, DOI 10.1038/onc.2009.288; Shimahara A, 2010, J BIOL CHEM, V285, P16967, DOI 10.1074/jbc.M110.102046; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Takahashi S, 2002, LEUKEMIA, V16, P1755, DOI 10.1038/sj.leu.2402682; Tonnies H, 2003, BLOOD, V101, P3872, DOI 10.1182/blood-2002-10-3243; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P1134, DOI 10.1074/mcp.M500113-MCP200; Unwin RD, 2009, NAT PROTOC, V4, P870, DOI 10.1038/nprot.2009.57; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; Vijapurkar U, 2004, MOL CELL BIOL, V24, P3827, DOI 10.1128/MCB.24.9.3827-3837.2004; Yoshimi A, 2011, BLOOD, V117, P3617, DOI 10.1182/blood-2009-12-261602; Zhang SC, 2011, J CELL BIOL, V193, P295, DOI 10.1083/jcb.201009074	49	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66510	10.1371/journal.pone.0066510	http://dx.doi.org/10.1371/journal.pone.0066510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776681	gold, Green Published			2022-12-25	WOS:000320322400107
J	Aihara, K; Handa, T; Oga, T; Watanabe, K; Tanizawa, K; Ikezoe, K; Taguchi, Y; Sato, H; Chin, K; Nagai, S; Narumiya, S; Wells, AU; Mishima, M				Aihara, Kensaku; Handa, Tomohiro; Oga, Toru; Watanabe, Kizuku; Tanizawa, Kiminobu; Ikezoe, Kohei; Taguchi, Yoshio; Sato, Hiroe; Chin, Kazuo; Nagai, Sonoko; Narumiya, Shuh; Wells, Athol U.; Mishima, Michiaki			Clinical Relevance of Plasma Prostaglandin F-2 alpha Metabolite Concentrations in Patients with Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; SURVIVAL; LUNG; PREVALENCE; PREDICTION; PHYSIOLOGY	Background: Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease of unknown etiology with few current treatment options. Recently, we determined an important role of prostaglandin F-2 alpha (PGF(2 alpha)) in pulmonary fibrosis by using a bleomycin-induced pulmonary fibrosis model and found an abundance of PGF(2 alpha) in bronchoalveolar lavage fluid of IPF patients. We investigated the role of PGF(2 alpha) in human IPF by assessing plasma concentrations of 15-keto-dihydro PGF(2 alpha), a stable metabolite of PGF(2 alpha). Methods: We measured plasma concentrations of 15-keto-dihydro PGF(2 alpha) in 91 IPF patients and compared these values with those of controls (n = 25). We further investigated the relationships of plasma 15-keto-dihydro PGF(2 alpha) concentrations with disease severity and mortality. Results: Plasma concentrations of 15-keto-dihydro PGF(2 alpha) were significantly higher in IPF patients than controls (p<0.001). Plasma concentrations of this metabolite were significantly correlated with forced expiratory volume in 1 second (Rs [correlation coefficient] = -0.34, p = 0.004), forced vital capacity (Rs = -0.33, p = 0.005), diffusing capacity for carbon monoxide (Rs = -0.36, p = 0.003), the composite physiologic index (Rs = 0.40, p = 0.001), 6-minute walk distance (Rs = -0.24, p = 0.04) and end-exercise oxygen saturation (Rs = -0.25, p = 0.04) when patients with emphysema were excluded. Multivariate analysis using stepwise Cox proportional hazards model showed that a higher composite physiologic index (relative risk = 1.049, p = 0.002) and plasma 15-keto-dihydro PGF(2 alpha) concentrations (relative risk = 1.005, p = 0.002) were independently associated with an increased risk of mortality. Conclusions: We demonstrated significant associations of plasma concentrations of PGF(2 alpha) metabolites with disease severity and prognosis, which support a potential pathogenic role for PGF(2 alpha) in human IPF.	[Aihara, Kensaku; Handa, Tomohiro; Watanabe, Kizuku; Tanizawa, Kiminobu; Ikezoe, Kohei; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Handa, Tomohiro] Kyoto Univ Hosp, Dept Rehabil Med, Kyoto 606, Japan; [Oga, Toru; Chin, Kazuo] Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan; [Taguchi, Yoshio] Tenri Hosp, Dept Resp Med, Tenri, Nara 632, Japan; [Sato, Hiroe; Wells, Athol U.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Nagai, Sonoko] Clin Res Ctr, Kyoto Cent Clin, Kyoto, Japan; [Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan; [Wells, Athol U.] Royal Brompton Hosp, London SW3 6LY, England	Kyoto University; Kyoto University; Kyoto University; Tenri Hospital; Imperial College London; Kyoto University; Royal Brompton Hospital	Handa, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan.	hanta@kuhp.kyoto-u.ac.jp	Aihara, Kensaku/AAB-9889-2021; Tanizawa, Kiminobu/GPC-4728-2022	Ikezoe, Kohei/0000-0003-1097-2084; Tanizawa, Kiminobu/0000-0002-5719-0744	Diffuse Lung Diseases Research Group; Respiratory Failure study group; Research Program of Intractable Disease from the Ministry of Health, Labour and Welfare, Japan; Kato Memorial Trust for Nambyo Research; Kanae Foundation for the Promotion of Medical Science	Diffuse Lung Diseases Research Group; Respiratory Failure study group; Research Program of Intractable Disease from the Ministry of Health, Labour and Welfare, Japan; Kato Memorial Trust for Nambyo Research(Kato Memorial Trust for Nambyo Research); Kanae Foundation for the Promotion of Medical Science	This study was partly supported by grants to the Diffuse Lung Diseases Research Group, the Respiratory Failure study group, and the Research Program of Intractable Disease from the Ministry of Health, Labour and Welfare, Japan. This study was also supported by a grant from the Kato Memorial Trust for Nambyo Research and Kanae Foundation for the Promotion of Medical Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Basu S, 2007, MED RES REV, V27, P435, DOI 10.1002/med.20098; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Farkas L, 2011, AM J RESP CELL MOL, V45, P1, DOI 10.1165/rcmb.2010-0365TR; Flaherty KR, 2006, AM J RESP CRIT CARE, V174, P803, DOI 10.1164/rccm.200604-488OC; Fukui M, 1996, J HISTOCHEM CYTOCHEM, V44, P251, DOI 10.1177/44.3.8648085; Hamada K, 2007, CHEST, V131, P650, DOI 10.1378/chest.06-1466; Handa T, 2006, CHEST, V129, P1246, DOI 10.1378/chest.129.5.1246; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hirata T, 2011, CHEM REV, V111, P6209, DOI 10.1021/cr200010h; HSUEH W, 1979, AM J PATHOL, V97, P137; Huang SK, 2008, CHEST, V133, P1442, DOI 10.1378/chest.08-0306; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; KOHNO N, 1989, CHEST, V96, P68, DOI 10.1378/chest.96.1.68; Lappi-Blanco E, 2006, AM J CLIN PATHOL, V126, P717, DOI 10.1309/PFGXCLNG2N17PJX9; Lettieri CJ, 2006, CHEST, V129, P746, DOI 10.1378/chest.129.3.746; Ley B, 2012, AM J RESP CRIT CARE, V185, P6, DOI 10.1164/rccm.201111-1960ED; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Mason RJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1, DOI 10.1152/ajplung.1998.275.1.L1; Mogulkoc N, 2001, THORAX, V56, P916, DOI 10.1136/thorax.56.12.916; Nagase T, 2002, NAT MED, V8, P480, DOI 10.1038/nm0502-480; Oga T, 2009, NAT MED, V15, P1426, DOI 10.1038/nm.2066; Perez ERF, 2010, CHEST, V137, P129, DOI [10.1378/chest.09-1002, 10.1378/chest.09-1871]; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Schmidt SL, 2011, EUR RESPIR J, V38, P176, DOI 10.1183/09031936.00114010; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; TAYLOR L, 1979, BIOCHIM BIOPHYS ACTA, V572, P502, DOI 10.1016/0005-2760(79)90157-7; Wells AU, 2003, AM J RESP CRIT CARE, V167, P962, DOI 10.1164/rccm.2111053; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551	33	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66017	10.1371/journal.pone.0066017	http://dx.doi.org/10.1371/journal.pone.0066017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776595	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400101
J	Blarquez, O; Finsinger, W; Carcaillet, C				Blarquez, Olivier; Finsinger, Walter; Carcaillet, Christopher			Assessing Paleo-Biodiversity Using Low Proxy Influx	PLOS ONE			English	Article							MODEL-BASED RECONSTRUCTION; SPECIES-AREA RELATIONSHIPS; PLANT MACROFOSSILS; POLLEN DIVERSITY; BOREAL FOREST; FOSSIL POLLEN; SAMPLE-SIZE; SWISS ALPS; HOLOCENE; VEGETATION	We developed an algorithm to improve richness assessment based on paleoecological series, considering sample features such as their temporal resolutions or their volumes. Our new method can be applied to both high- and low-count size proxies, i.e. pollen and plant macroremain records, respectively. While pollen generally abounds in sediments, plant macroremains are generally rare, thus leading to difficulties to compute paleo-biodiversity indices. Our approach uses resampled macroremain influxes that enable the computation of the rarefaction index for the low influx records. The raw counts are resampled to a constant resolution and sample volume by interpolating initial sample ages at a constant time interval using the age similar to depth model. Then, the contribution of initial counts and volume to each interpolated sample is determined by calculating a proportion matrix that is in turn used to obtain regularly spaced time series of pollen and macroremain influx. We applied this algorithm to sedimentary data from a subalpine lake situated in the European Alps. The reconstructed total floristic richness at the study site increased gradually when both pollen and macroremain records indicated a decrease in relative abundances of shrubs and an increase in trees from 11,000 to 7,000 cal BP. This points to an ecosystem change that favored trees against shrubs, whereas herb abundance remained stable. Since 6,000 cal BP, local richness decreased based on plant macroremains, while pollen-based richness was stable. The reconstructed richness and evenness are interrelated confirming the difficulty to distinguish these two aspects for the studies in paleo-biodiversity. The present study shows that low-influx bio-proxy records (here macroremains) can be used to reconstruct stand diversity and address ecological issues. These developments on macroremain and pollen records may contribute to bridge the gap between paleoecology and biodiversity studies.	[Blarquez, Olivier; Finsinger, Walter; Carcaillet, Christopher] Univ Montpellier 2, CNRS, Ctr Bioarchaeol & Ecol, Montpellier, France; [Blarquez, Olivier; Carcaillet, Christopher] Ecole Prat Hautes Etud, Montpellier, France; [Blarquez, Olivier] Univ Quebec, Ctr Forest Res, Montreal, PQ H3C 3P8, Canada	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; University of Quebec; University of Quebec Montreal	Blarquez, O (corresponding author), Univ Montpellier 2, CNRS, Ctr Bioarchaeol & Ecol, Montpellier, France.	blarquez@gmail.com	Carcaillet, Christopher/G-1218-2011; Finsinger, Walter/A-7937-2011	Carcaillet, Christopher/0000-0002-6632-1507; Finsinger, Walter/0000-0002-8297-0574	FP7 European Research Area Programme (ANR/ERA-net BiodivERsA); FIREMAN program (ANR/ERA-net BiodivERsA); Ecole Pratique des Hautes Etudes (EPHE-Paris)	FP7 European Research Area Programme (ANR/ERA-net BiodivERsA)(French National Research Agency (ANR)); FIREMAN program (ANR/ERA-net BiodivERsA)(French National Research Agency (ANR)); Ecole Pratique des Hautes Etudes (EPHE-Paris)	This research was funded by the FP7 European Research Area Programme (ANR/ERA-net BiodivERsA). This work was developed following a FIREMAN Project's Workshop held in Montpellier. Financial support was provided by the FIREMAN program (ANR/ERA-net BiodivERsA) to CC and by grants from the Ecole Pratique des Hautes Etudes (EPHE-Paris) to OB. The research was carried out in the framework of the International Associated Laboratory (LIA France-Canada) CNRS-UM2-EPHE-UQAT-UQAM-UQAC "MONTABOR: Forets montagnardes et boreales : chrono-ecologie et amenagement ecosystemique durable". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthelme F, 2007, J VEG SCI, V18, P355, DOI 10.1111/j.1654-1103.2007.tb02547.x; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Birks HJB, 1992, HOLOCENE, V2, P1, DOI 10.1177/095968369200200101; Birks HH, 2000, J BIOGEOGR, V27, P31, DOI 10.1046/j.1365-2699.2000.00375.x; Blarquez O, 2012, HOLOCENE, V22, P579, DOI 10.1177/0959683611427333; Blarquez O, 2010, J ECOL, V98, P1358, DOI 10.1111/j.1365-2745.2010.01721.x; BRADSHAW RHW, 1985, ECOLOGY, V66, P721, DOI 10.2307/1940533; Carcaillet C, 2010, INT J WILDLAND FIRE, V19, P1026, DOI 10.1071/WF09097; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Crist TO, 2006, ECOL LETT, V9, P923, DOI 10.1111/j.1461-0248.2006.00941.x; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Elzein TM, 2011, ALPINE BOT, V121, P129, DOI 10.1007/s00035-011-0095-3; Finsinger W, 2007, HOLOCENE, V17, P1119, DOI 10.1177/0959683607082552; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Heiri C, 2006, J ECOL, V94, P206, DOI 10.1111/j.1365-2745.2005.01072.x; Heiri O, 2001, J PALEOLIMNOL, V26, P343, DOI 10.1023/A:1017568913302; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; JACKSON ST, 1991, ECOLOGY, V72, P641, DOI 10.2307/2937204; Jackson ST, 2007, ENCY QUATERNARY SCI, P2413; Karger DN, 2011, J BIOGEOGR, V38, P1177, DOI 10.1111/j.1365-2699.2010.02468.x; Long CJ, 1998, CAN J FOREST RES, V28, P774, DOI 10.1139/cjfr-28-5-774; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; Nyman M, 2008, HOLOCENE, V18, P215, DOI 10.1177/0959683607086760; Odgaard Bent Vad, 2001, Diversity and Distributions, V7, P197, DOI 10.1111/j.1472-4642.2001.00110.x; Odgaard BV, 1999, J BIOGEOGR, V26, P7, DOI 10.1046/j.1365-2699.1999.00280.x; Olszewski TD, 2004, OIKOS, V104, P377, DOI 10.1111/j.0030-1299.2004.12519.x; Oris F, 2013, J PALEOLIMNOL, V49, P633, DOI 10.1007/s10933-013-9680-3; Peros MC, 2008, J PALEOLIMNOL, V40, P357, DOI 10.1007/s10933-007-9166-2; Ponel P, 2003, BIODIVERS CONSERV, V12, P2077, DOI 10.1023/A:1024121327109; RAUP D M, 1975, Paleobiology, V1, P333; Renssen H, 2009, NAT GEOSCI, V2, P410, DOI 10.1038/NGEO513; RULL V, 1987, Pollen et Spores, V29, P471; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Stahli M, 2006, HOLOCENE, V16, P805, DOI 10.1191/0959683606hol967rp; Tappeiner U, 2008, ECOSYSTEMS, V11, P1383, DOI 10.1007/s10021-008-9195-3; Tinner W, 2005, J ECOL, V93, P936, DOI 10.1111/j.1365-2745.2005.01023.x; Tinner W, 2001, GEOLOGY, V29, P551, DOI 10.1130/0091-7613(2001)029<0551:CEVRTA>2.0.CO;2; TIPPER JC, 1979, PALEOBIOLOGY, V5, P423, DOI 10.1017/S0094837300016924; van der Knaap WO, 2009, HOLOCENE, V19, P159, DOI 10.1177/0959683608098962; Weng CY, 2006, DIVERS DISTRIB, V12, P310, DOI 10.1111/j.1366-9516.2006.00230.x; White EP, 2010, PHILOS T R SOC B, V365, P3633, DOI 10.1098/rstb.2010.0280; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Willis KJ, 2010, TRENDS ECOL EVOL, V25, P583, DOI 10.1016/j.tree.2010.07.006; Wolfe AP, 2003, HOLOCENE, V13, P29, DOI 10.1191/0959683603hl592rp	46	8	8	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65852	10.1371/journal.pone.0065852	http://dx.doi.org/10.1371/journal.pone.0065852			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776556	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400072
J	Chen, DF; Li, Y; Zhou, ZY; Wu, CG; Xing, YG; Zou, XN; Tian, W; Zhang, C				Chen, Dafu; Li, Yang; Zhou, Zhiyu; Wu, Chengai; Xing, Yonggang; Zou, Xuenong; Tian, Wei; Zhang, Chi			HIF-1 alpha Inhibits Wnt Signaling Pathway by Activating Sost Expression in Osteoblasts	PLOS ONE			English	Article							TRANSCRIPTION FACTOR OSTERIX; RECEPTOR-MEDIATED TRANSCRIPTION; GROWTH-FACTOR VEGF; BONE-FORMATION; SKELETAL DEVELOPMENT; MASS; OSX; SCLEROSTIN; HYPOXIA; PROTEIN	The nature of the cellular and molecular mechanisms for the transition of avascular cartilage replacement with bone during endochondral ossification remains poorly understood. One of the driving forces is hypoxia. As a master regulator of hypoxia, hypoxia-inducible factor-1 alpha (HIF-1 alpha) has been reported to couple angiogenesis to osteogenesis. Our recent study has demonstrated that osteoblast growth is inhibited under hypoxia and that HIF-1 alpha cooperates with Osterix (Osx) to inhibit Wnt pathway. However, molecular mechanisms for inhibitory effects of HIF-1 alpha on Wnt pathway are not well understood. In this study, our quantitative RT-PCR results revealed that the expression of a Wnt antagonist Sclerostin (Sost) was upregulated in osteoblasts during hypoxia while HIF-1 alpha was upregulated. Treatment of desferrioxamine (DFO), a HIF-1 alpha activator, led to further increase of Sost expression, suggesting that HIF-1 alpha may activate Sost expression. The regulation of Sost gene expression by HIF-1 alpha was then investigated. We performed loss-of-function experiments to examine Sost expression by using siRNA approach against HIF-1 alpha, and found that the inhibition of HIF-1 alpha by siRNA in osteoblasts led to the decrease of Sost expression. To address transcriptional regulation of Sost gene by HIF-1 alpha, transient transfection assay was performed and showed that HIF-1 alpha activated Sost-1 kb promoter reporter activity in a dose-dependent manner. To narrow down the minimal region of Sost promoter activated by HIF-1 alpha, we generated a series of deletion mutants of Sost constructs. It was demonstrated that Sost-260 was the minimal region of Sost promoter for HIF-1 alpha activation and that Sost-106 construct, which lack hypoxia response element, abolished HIF-1 alpha-mediated Sost reporter activation. Gel shift assay showed that HIF-1 bound to the promoter sequence of Sost directly. These findings support our hypothesis that HIF-1 alpha activates Sost expression. This study provides a novel molecular mechanism through which HIF-1 alpha inhibits Wnt signaling in osteoblasts.	[Chen, Dafu; Wu, Chengai; Xing, Yonggang; Tian, Wei] Beijing JiShuiTan Hosp, Beijing Res Inst Traumatol & Orthopaed, Lab Bone Tissue Engn, Beijing, Peoples R China; [Li, Yang; Zhang, Chi] Univ Texas SW Med Ctr Dallas, Texas Scottish Rite Hosp Children, Bone Res Lab, Dallas, TX 75390 USA; [Zhou, Zhiyu; Zou, Xuenong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Spine, Guangzhou 510275, Guangdong, Peoples R China	Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sun Yat Sen University	Tian, W (corresponding author), Beijing JiShuiTan Hosp, Beijing Res Inst Traumatol & Orthopaed, Lab Bone Tissue Engn, Beijing, Peoples R China.	tianweijst@yahoo.com.cn; Chi5.Zhang@utsouthwestern.edu	ZHOU, ZHIYU/AAU-5036-2021; Zhang, Chi/K-4467-2012	ZHOU, ZHIYU/0000-0002-8101-2083; 	Arthritis Foundation; National Basic Research Program of China (973 Program) [2012CB619105]; Ministry of Science and Technology of the China [2012BAI10B02]	Arthritis Foundation; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of the China(Ministry of Science and Technology, China)	Work in Bone Research Laboratory is supported by Research Grant from Arthritis Foundation (To Chi Zhang). This work is also supported by National Basic Research Program of China (973 Program, No. 2012CB619105 to Xuenong Zou). This work is also in part supported by The Ministry of Science and Technology of the China (Grants 2012BAI10B02 to Wei Tian). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini G, 2002, J BIOL CHEM, V277, P34601, DOI 10.1074/jbc.M205172200; Balemans W, 2008, CALCIFIED TISSUE INT, V82, P445, DOI 10.1007/s00223-008-9130-9; Baron R, 2006, CURR TOP DEV BIOL, V76, P103, DOI 10.1016/S0070-2153(06)76004-5; Chen DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052948; Chen DF, 2012, BIOCHEM BIOPH RES CO, V424, P176, DOI 10.1016/j.bbrc.2012.06.104; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Harper J, 1999, NAT MED, V5, P617, DOI 10.1038/9460; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Issack Paul S, 2008, HSS J, V4, P66, DOI 10.1007/s11420-007-9072-1; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Maxwell PH, 2002, CLIN MED, V2, P356, DOI 10.7861/clinmedicine.2-4-356; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Piters E, 2008, ARCH BIOCHEM BIOPHYS, V473, P112, DOI 10.1016/j.abb.2008.03.006; Rajpurohit R, 1996, J CELL PHYSIOL, V168, P424, DOI 10.1002/(SICI)1097-4652(199608)168:2<424::AID-JCP21>3.0.CO;2-1; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Tang WJ, 2012, J BIOL CHEM, V287, P1671, DOI 10.1074/jbc.M111.288472; Tang WJ, 2011, J BIOL CHEM, V286, P32995, DOI 10.1074/jbc.M111.244236; ten Dijke P, 2008, J BONE JOINT SURG AM, V90A, P31, DOI 10.2106/JBJS.G.01183; Wan C, 2010, ANN NY ACAD SCI, V1192, P322, DOI 10.1111/j.1749-6632.2009.05238.x; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Wergedal JE, 2003, J CLIN ENDOCR METAB, V88, P5778, DOI 10.1210/jc.2003-030201; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Zhang C, 2001, J BIOL CHEM, V276, P40614, DOI 10.1074/jbc.M106263200; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050525; Zhang Chi, 2012, Beijing Da Xue Xue Bao Yi Xue Ban, V44, P659; Zhang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026504; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37	35	33	33	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65940	10.1371/journal.pone.0065940	http://dx.doi.org/10.1371/journal.pone.0065940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776575	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400086
J	Fan, HX; Yan, XL; Zhang, Y; Zhang, XJ; Gao, YZ; Xu, YX; Wang, FS; Meng, SD				Fan, Hongxia; Yan, Xiaoli; Zhang, Yu; Zhang, Xiaojun; Gao, Yanzhou; Xu, Yaxing; Wang, Fusheng; Meng, Songdong			Increased Expression of Gp96 by HBx-Induced NF-kappa B Activation Feedback Enhances Hepatitis B Virus Production	PLOS ONE			English	Article							SHOCK-PROTEIN GP96; CHAPERONE; GRP94; REPLICATION; STRESS	Elevated expression of heat shock protein gp96 in hepatitis B virus (HBV)-infected patients is positively correlated with the progress of HBV-induced diseases, but little is known regarding the molecular mechanism of virus-induced gp96 expression and its impact on HBV infection. In this study, up-regulation of gp96 by HBV replication was confirmed both in vitro and in vivo. Among HBV components, HBV x protein (HBx) was found to increase gp96 promoter activity and enhance gp96 expression by using a luciferase reporter system, and western blot analysis. Further, we found that HBx-mediated regulation of gp96 expression requires a NF-kappa B cis-regulatory element on the gp96 promoter, and chromatin immunoprecipitation results demonstrated that HBx promotes the binding of NF-kappa B to the gp96 promoter. Significantly, both gain-and loss-of-function studies showed that gp96 enhances HBV production in HBV-transfected cells and a mouse model based on hydrodynamic transfection. Moreover, up-regulated gp96 expression was observed in HBV-infected patients, and gp96 levels were correlated with serum viral loads. Thus, our work demonstrates a positive feedback regulatory pathway involving gp96 and HBV, which may contribute to persistent HBV infection. Our data also indicate that modulation of gp96 function may represent a novel strategy for the intervention of HBV infection.	[Fan, Hongxia; Yan, Xiaoli; Zhang, Yu; Zhang, Xiaojun; Gao, Yanzhou; Xu, Yaxing; Meng, Songdong] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Wang, Fusheng] Beijing 302 Hosp, Beijing Inst Infect Dis, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Fifth Medical Center of Chinese PLA General Hospital	Meng, SD (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	mengsd@im.ac.cn	zhang, jin/GXV-9154-2022		National Natural Science Foundation of China [31230026, 30970146, 91029724, 81021003, 81102018]; Key Projects in the National Science and Technology Program [2013ZX10002001-003-003]; Beijing Natural Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science and Technology Program; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (31230026, 30970146, 91029724, 81021003 and 81102018), a grant from Key Projects in the National Science and Technology Program (2013ZX10002001-003-003), and a grant from Beijing Natural Science Foundation (Role of heat-shock protein gp96 in antigen presentation and development of new gp96-based vaccines). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENN J, 1994, P NATL ACAD SCI USA, V91, P10350, DOI 10.1073/pnas.91.22.10350; Cho HK, 2011, BIOCHEM J, V435, P431, DOI 10.1042/BJ20102071; Chung TW, 2004, FASEB J, V18, P1123, DOI 10.1096/fj.03-1429fje; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004; Hicks DG, 2005, HUM PATHOL, V36, P250, DOI 10.1016/j.humpath.2004.11.010; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Hu JM, 2004, J VIROL, V78, P13122, DOI 10.1128/JVI.78.23.13122-13131.2004; Koo BH, 2010, J BIOL CHEM, V285, P197, DOI 10.1074/jbc.M109.039677; Lambert C, 2003, P NATL ACAD SCI USA, V100, P5199, DOI 10.1073/pnas.0930813100; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Li L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005489; Lim SO, 2005, WORLD J GASTROENTERO, V11, P2072, DOI 10.3748/wjg.v11.i14.2072; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Liu Z, 2009, EUR J IMMUNOL, V39, P3110, DOI 10.1002/eji.200939593; McLaughlin M, 2011, BRIT J PHARMACOL, V162, P328, DOI 10.1111/j.1476-5381.2010.01064.x; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nguyen DH, 2008, J CELL PHYSIOL, V216, P289, DOI 10.1002/jcp.21416; Ostrovsky O, 2010, BBA-MOL CELL RES, V1803, P333, DOI 10.1016/j.bbamcr.2009.11.005; Ostrovsky O, 2009, MOL BIOL CELL, V20, P1855, DOI 10.1091/mbc.E08-04-0346; Park SG, 2001, J VIROL, V75, P6962, DOI 10.1128/JVI.75.15.6962-6968.2001; Prange R, 1999, BIOL CHEM, V380, P305, DOI 10.1515/BC.1999.042; Seeger C., 2007, FIELDS VIROLOGY, V1, P2977; Staron M, 2011, BLOOD, V117, P7136, DOI 10.1182/blood-2011-01-330464; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Wang HC, 2003, AM J PATHOL, V163, P2441, DOI 10.1016/S0002-9440(10)63599-7; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Wang XT, 2002, J BIOL CHEM, V277, P24361, DOI 10.1074/jbc.M202198200; Xia LM, 2012, J IMMUNOL, V188, P753, DOI 10.4049/jimmunol.1101652; Xu ZC, 1997, J VIROL, V71, P7387, DOI 10.1128/JVI.71.10.7387-7392.1997; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Yao Deng-Fu, 2006, Hepatobiliary Pancreat Dis Int, V5, P381; Yuan TTT, 1998, J VIROL, V72, P2168, DOI 10.1128/JVI.72.3.2168-2176.1998; Yue X, 2012, J IMMUNOL, V189, P279, DOI 10.4049/jimmunol.1103405; Zhu XD, 2004, WORLD J GASTROENTERO, V10, P1141	37	27	31	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65588	10.1371/journal.pone.0065588	http://dx.doi.org/10.1371/journal.pone.0065588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776506	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400045
J	Hansen, CF; Bueter, M; Theis, N; Lutz, T; Paulsen, S; Dalboge, LS; Vrang, N; Jelsing, J				Hansen, Carl Frederik; Bueter, Marco; Theis, Nadine; Lutz, Thomas; Paulsen, Sarah; Dalboge, Louise S.; Vrang, Niels; Jelsing, Jacob			Hypertrophy Dependent Doubling of L-Cells in Roux-en-Y Gastric Bypass Operated Rats	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; INTESTINAL EPITHELIAL PROLIFERATION; BARIATRIC SURGERY; WEIGHT-LOSS; GUT HORMONES; BILIOPANCREATIC DIVERSION; JEJUNOILEAL BYPASS; INCRETIN LEVELS; GLUCOSE; ADAPTATION	Background and Aims: Roux-en-Y gastric bypass (RYGB) leads to a rapid remission of type 2 diabetes mellitus (T2DM), but the underlying mode of action remains incompletely understood. L-cell derived gut hormones such as glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) are thought to play a central role in the anti-diabetic effects of RYGB; therefore, an improved understanding of intestinal endocrine L-cell adaptability is considered pivotal. Methods: The full rostrocaudal extension of the gut was analyzed in rats after RYGB and in sham-operated controls ad libitum fed or food restricted to match the body weight of RYGB rats. Total number of L-cells, as well as regional numbers, densities and mucosa volumes were quantified using stereological methods. Preproglucagon and PYY mRNA transcripts were quantified by qPCR to reflect the total and relative hormone production capacity of the L-cells. Results: RYGB surgery induced hypertrophy of the gut mucosa in the food exposed regions of the small intestine coupled with a doubling in the total number of L-cells. No changes in L-cell density were observed in any region regardless of surgery or food restriction. The total gene expression capacity of the entire gut revealed a near 200% increase in both PYY and preproglucagon mRNA levels in RYGB rats associated with both increased L-cell number as well as region-specific increased transcription per cell. Conclusions: Collectively, these findings indicate that RYGB in rats is associated with gut hypertrophy, an increase in L-cell number, but not density, and increased PYY and preproglucagon gene expression. This could explain the enhanced gut hormone dynamics seen after RYGB.	[Hansen, Carl Frederik; Paulsen, Sarah; Dalboge, Louise S.; Vrang, Niels; Jelsing, Jacob] Gubra, Dept Histol, Horsholm, Denmark; [Hansen, Carl Frederik] Univ Copenhagen, Dept Human Nutr, Frederiksberg, Denmark; [Bueter, Marco] Univ Zurich Hosp, Dept Visceral & Transplant Surg, CH-8091 Zurich, Switzerland; [Bueter, Marco; Lutz, Thomas] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland; [Theis, Nadine; Lutz, Thomas] Univ Zurich, Vetsuisse Fac, Inst Vet Physiol, Zurich, Switzerland	University of Copenhagen; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich	Jelsing, J (corresponding author), Gubra, Dept Histol, Horsholm, Denmark.	Jacob@gubra.dk		Lutz, Thomas/0000-0002-5056-8548; Dalboge, Louise Schjellerup/0000-0001-7773-6313				Adrian TE, 2012, DIABETOLOGIA, V55, P2343, DOI 10.1007/s00125-012-2593-2; ADRIAN TE, 1986, GASTROENTEROLOGY, V90, P379, DOI 10.1016/0016-5085(86)90936-4; Bertoni S, 2001, J ANAT, V199, P725, DOI 10.1046/j.1469-7580.2001.19960725.x; BESTERMAN HS, 1982, GUT, V23, P854, DOI 10.1136/gut.23.10.854; Borg CM, 2007, OBES SURG, V17, P1193, DOI 10.1007/s11695-007-9211-2; Bueter M, 2011, PHYSIOL BEHAV, V104, P709, DOI 10.1016/j.physbeh.2011.07.025; Bueter M, 2012, JOVE-J VIS EXP, DOI 10.3791/3940; Bueter M, 2010, GASTROENTEROLOGY, V138, P1845, DOI 10.1053/j.gastro.2009.11.012; Bueter M, 2010, OBES SURG, V20, P616, DOI 10.1007/s11695-010-0075-5; Clements RH, 2004, AM SURGEON, V70, P1; de Wit NJW, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-14; DeMaria EJ, 2007, NEW ENGL J MED, V356, P2176, DOI 10.1056/NEJMct067019; Dirksen C, 2012, DIABETOLOGIA, V55, P1890, DOI 10.1007/s00125-012-2556-7; Dou Y, 2002, NEUROGASTROENT MOTIL, V14, P43, DOI 10.1046/j.1365-2982.2002.00301.x; DOWLING RH, 1982, SCAND J GASTROENTERO, V17, P53; Drucker DJ, 1996, P NATL ACAD SCI USA, V93, P7911, DOI 10.1073/pnas.93.15.7911; DUDRICK SJ, 1977, ANN SURG, V185, P642, DOI 10.1097/00000658-197706000-00005; EISSELE R, 1992, EUR J CLIN INVEST, V22, P283, DOI 10.1111/j.1365-2362.1992.tb01464.x; Eldar S, 2011, INT J OBESITY, V35, pS16, DOI 10.1038/ijo.2011.142; EVRARD S, 1993, INT J OBESITY, V17, P541; Field BCT, 2010, NAT REV ENDOCRINOL, V6, P444, DOI 10.1038/nrendo.2010.93; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Ghatei MA, 2001, DIGEST DIS SCI, V46, P1255, DOI 10.1023/A:1010615429639; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hansen CF, 2013, AM J TRANSL RES, V5, P347; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; HOLST JJ, 1979, SCAND J GASTROENTERO, V14, P205, DOI 10.3109/00365527909179871; Jorgensen NB, 2012, AM J PHYSIOL-ENDOC M, V303, pE122, DOI 10.1152/ajpendo.00073.2012; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Korner J, 2009, INT J OBESITY, V33, P786, DOI 10.1038/ijo.2009.79; Laferrere B, 2008, J CLIN ENDOCR METAB, V93, P2479, DOI 10.1210/jc.2007-2851; Laferrere B, 2007, DIABETES CARE, V30, P1709, DOI 10.2337/dc06-1549; le Roux CW, 2007, ANN SURG, V246, P780, DOI 10.1097/SLA.0b013e3180caa3e3; le Roux CW, 2010, ANN SURG, V252, P50, DOI 10.1097/SLA.0b013e3181d3d21f; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; Morinigo R, 2006, J CLIN ENDOCR METAB, V91, P1735, DOI 10.1210/jc.2005-0904; Mortensen K, 2003, REGUL PEPTIDES, V114, P189, DOI 10.1016/S0167-0115(03)00125-3; Mumphrey MB, 2012, NEUROGASTROENTEROL M; Nadreau E, 2006, INT J OBESITY, V30, P419, DOI 10.1038/sj.ijo.0803166; O'Brien PE, 2010, J GASTROEN HEPATOL, V25, P1358, DOI 10.1111/j.1440-1746.2010.06391.x; Ockander L, 2003, OBES SURG, V13, P584, DOI 10.1381/096089203322190781; Olivan B, 2009, ANN SURG, V249, P948, DOI 10.1097/SLA.0b013e3181a6cdb0; ORSKOV C, 1986, ENDOCRINOLOGY, V119, P1467, DOI 10.1210/endo-119-4-1467; PAKKENBERG B, 1988, J MICROSC-OXFORD, V150, P1, DOI 10.1111/j.1365-2818.1988.tb04582.x; Rubino F, 2004, ANN SURG, V240, P236, DOI 10.1097/01.sla.0000133117.12646.48; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; SOLHAUG JH, 1978, SCAND J GASTROENTERO, V13, P401, DOI 10.3109/00365527809181913; SOLHAUG JH, 1976, SCAND J GASTROENTERO, V11, P155; Stearns AT, 2009, AM J PHYSIOL-GASTR L, V297, pG950, DOI 10.1152/ajpgi.00253.2009; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; STOCKDAMGE C, 1986, SCAND J GASTROENTERO, V21, P1115, DOI 10.3109/00365528608996431; Strader AD, 2006, PHYSIOL BEHAV, V88, P277, DOI 10.1016/j.physbeh.2006.05.034; Suzuki K, 2010, ENDOCR J, V57, P359, DOI 10.1507/endocrj.K10E-077; Taqia E, 2010, J PEDIATR SURG, V45, P987, DOI 10.1016/j.jpedsurg.2010.02.036; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Vrang N, 2007, BRAIN RES, V1149, P118, DOI 10.1016/j.brainres.2007.02.043; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007	63	80	82	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65696	10.1371/journal.pone.0065696	http://dx.doi.org/10.1371/journal.pone.0065696			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776529	Green Published, gold, Green Accepted			2022-12-25	WOS:000320755400057
J	Harris, L; Dixon, C; Cato, K; Heng, YHE; Kurniawan, ND; Ullmann, JFP; Janke, AL; Gronostajski, RM; Richards, LJ; Burne, THJ; Piper, M				Harris, Lachlan; Dixon, Chantelle; Cato, Kathleen; Heng, Yee Hsieh Evelyn; Kurniawan, Nyoman D.; Ullmann, Jeremy F. P.; Janke, Andrew L.; Gronostajski, Richard M.; Richards, Linda J.; Burne, Thomas H. J.; Piper, Michael			Heterozygosity for Nuclear Factor One X Affects Hippocampal-Dependent Behaviour in Mice	PLOS ONE			English	Article							DNA-BINDING/DIMERIZATION DOMAIN; PROTEIN MESSENGER-RNA; MORRIS WATER MAZE; SOTOS-LIKE; DEVELOPMENTAL EXPRESSION; CEREBELLAR CONTRIBUTION; NFIA CONTROLS; POPULATIONS; IMPAIRMENT; PRECURSORS	Identification of the genes that regulate the development and subsequent functioning of the hippocampus is pivotal to understanding the role of this cortical structure in learning and memory. One group of genes that has been shown to be critical for the early development of the hippocampus is the Nuclear factor one (Nfi) family, which encodes four site-specific transcription factors, NFIA, NFIB, NFIC and NFIX. In mice lacking Nfia, Nfib or Nfix, aspects of early hippocampal development, including neurogenesis within the dentate gyrus, are delayed. However, due to the perinatal lethality of these mice, it is not clear whether this hippocampal phenotype persists to adulthood and affects hippocampal-dependent behaviour. To address this we examined the hippocampal phenotype of mice heterozygous for Nfix (Nfix(+/-)), which survive to adulthood. We found that Nfix(+/-) mice had reduced expression of NFIX throughout the brain, including the hippocampus, and that early hippocampal development in these mice was disrupted, producing a phenotype intermediate to that of wild-type mice and Nfix(+/-) mice. The abnormal hippocampal morphology of Nfix(-/-) mice persisted to adulthood, and these mice displayed a specific performance deficit in the Morris water maze learning and memory task. These findings demonstrate that the level of Nfix expression during development and within the adult is essential for the function of the hippocampus during learning and memory.	[Harris, Lachlan; Dixon, Chantelle; Cato, Kathleen; Heng, Yee Hsieh Evelyn; Richards, Linda J.; Burne, Thomas H. J.; Piper, Michael] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Heng, Yee Hsieh Evelyn; Richards, Linda J.; Burne, Thomas H. J.; Piper, Michael] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Kurniawan, Nyoman D.; Ullmann, Jeremy F. P.; Janke, Andrew L.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Gronostajski, Richard M.] SUNY Buffalo, Dept Biochem, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14214 USA; [Gronostajski, Richard M.] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Dev Genom Grp, Program Neurosci, Buffalo, NY 14260 USA	University of Queensland; University of Queensland; University of Queensland; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Piper, M (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	m.piper@uq.edu.au	Harris, Lachlan/Y-6438-2018; Piper, Michael J/B-2805-2010; Janke, Andrew L/E-6149-2011; Kurniawan, Nyoman/D-9764-2011; Ullmann, Jeremy/E-6170-2011; Burne, Thomas H/C-5656-2009; Richards AO, Linda/P-6372-2014	Harris, Lachlan/0000-0002-7820-0921; Piper, Michael J/0000-0002-6759-2560; Janke, Andrew L/0000-0003-0547-5171; Kurniawan, Nyoman/0000-0001-6340-182X; Ullmann, Jeremy/0000-0002-3073-9151; Burne, Thomas H/0000-0003-3502-9789; Gronostajski, Richard/0000-0003-4264-208X; Richards AO, Linda/0000-0002-7590-7390	National Health and Medical Research Council (NHMRC) project [1003462, 1022308]; Australian Research Council discovery project [DP0984643]; NYSTEM [C026429]; National Institutes of Health (NIH) [HL080624]; NHMRC fellowships; LJR; University of Queensland International Scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080624] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC) project(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council discovery project(Australian Research Council); NYSTEM; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC fellowships(National Health and Medical Research Council (NHMRC) of Australia); LJR; University of Queensland International Scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Health and Medical Research Council (NHMRC) project grants (grant numbers 1003462 and 1022308; MP), an Australian Research Council discovery project grant (DP0984643 to LJR) and by awards from NYSTEM (C026429; RMG) and the National Institutes of Health (NIH) (HL080624; RMG). The following authors were supported by NHMRC fellowships: MP (Biomedical Career Development Fellowship) and LJR (Principal Research Fellowship). YHEH was supported by a University of Queensland International Scholarship. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adriano F, 2012, NEUROSCIENTIST, V18, P180, DOI 10.1177/1073858410395147; ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1990, J COMP NEUROL, V301, P325, DOI 10.1002/cne.903010302; Barry G, 2008, J NEUROSCI, V28, P12328, DOI 10.1523/JNEUROSCI.4000-08.2008; Brun M, 2009, J MOL BIOL, V391, P282, DOI 10.1016/j.jmb.2009.06.041; Campbell CE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-52; Chen J, 2009, GENESIS, V47, P122, DOI 10.1002/dvg.20465; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Fox IJ, 2004, DEV BRAIN RES, V153, P121, DOI 10.1016/j.devbrainres.2004.07.011; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Heng YHE, 2014, CEREB CORTEX, V24, P261, DOI 10.1093/cercor/bhs307; LANDRY CF, 1990, J NEUROSCI RES, V25, P194, DOI 10.1002/jnr.490250207; Leggio MG, 1999, EXP BRAIN RES, V127, P1, DOI 10.1007/s002210050768; LEHERICY S, 1995, AM J NEURORADIOL, V16, P617; Malan V, 2010, AM J HUM GENET, V87, P189, DOI 10.1016/j.ajhg.2010.07.001; Marin-Burgin A, 2012, BEHAV BRAIN RES, V227, P391, DOI 10.1016/j.bbr.2011.07.001; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MOSER E, 1993, J NEUROSCI, V13, P3916; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; Nedelska Z, 2012, P NATL ACAD SCI USA, V109, P2590, DOI 10.1073/pnas.1121588109; Petrosini L, 1996, EUR J NEUROSCI, V8, P1882, DOI 10.1111/j.1460-9568.1996.tb01332.x; Piper M, 2011, J COMP NEUROL, V519, P3532, DOI 10.1002/cne.22721; Piper M, 2010, J NEUROSCI, V30, P9127, DOI 10.1523/JNEUROSCI.6167-09.2010; Piper M, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-43; Piper M, 2009, CEREB CORTEX, V19, pI11, DOI 10.1093/cercor/bhp027; Plachez C, 2008, J COMP NEUROL, V508, P385, DOI 10.1002/cne.21645; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Priolo M, 2012, GENE, V511, P103, DOI 10.1016/j.gene.2012.08.040; Richards K, 2011, NEUROIMAGE, V58, P732, DOI 10.1016/j.neuroimage.2011.06.025; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Shu TZ, 2003, J NEUROSCI, V23, P203; Tatton-Brown K, 2005, AM J HUM GENET, V77, P193, DOI 10.1086/432082; van Balkom IDC, 2011, J INTELL DISABIL RES, V55, P973, DOI 10.1111/j.1365-2788.2011.01451.x; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Wahlsten D, 2005, BEHAV BRAIN RES, V165, P36, DOI 10.1016/j.bbr.2005.06.047; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang W, 2007, J NEUROSCI, V27, P6115, DOI 10.1523/JNEUROSCI.0180-07.2007; Wang W, 2010, J NEUROSCI RES, V88, P258, DOI 10.1002/jnr.22199; Yoneda Y, 2012, J HUM GENET, V57, P207, DOI 10.1038/jhg.2012.7	43	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65478	10.1371/journal.pone.0065478	http://dx.doi.org/10.1371/journal.pone.0065478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776487	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400034
J	Liu, XJ; Gao, N; Li, MT; Xu, D; Hou, Y; Wang, Q; Zhang, GH; Sun, QN; Zhang, HH; Zeng, XF				Liu, Xinjuan; Gao, Na; Li, Mengtao; Xu, Dong; Hou, Yong; Wang, Qian; Zhang, Guohua; Sun, Qiuning; Zhang, Henghui; Zeng, Xiaofeng			Elevated Levels of CD4(+)CD25(+)FoxP3(+) T Cells in Systemic Sclerosis Patients Contribute to the Secretion of IL-17 and Immunosuppression Dysfunction	PLOS ONE			English	Article							TGF-BETA; INCREASED FREQUENCY; REGULATORY CELLS; CTLA-4 GENE; EXPRESSION; TH17; ASSOCIATION; DISEASE; FOXP3; ACTIVATION	Objective: Immune imbalance between regulatory T (Treg) and Th17 cells is a characteristic of systemic sclerosis (SSc). The functional heterogeneity among Treg can be elucidated by separating Treg into different subsets based on the expression of FoxP3 and CD45RA. The aim of this study was to investigate the role of Treg subsets in the immune imbalance in naive SSc. Methods: Peripheral blood mononuclear cells (PBMCs) of 31 SSc patients and 33 healthy controls were analyzed for the expression of CD4, CD25, CD45RA, CTLA-4, FoxP3, and IL-17 using flow cytometry. Treg immunesuppression capacity was measured in co-culture experiments. The expression of FoxP3, CTLA-4, IL-17A, and RORC mRNA was measured by real-time PCR. Results: The frequency of CD4(+)CD25(+)FoxP3(+) Treg cells was significantly elevated in patients with SSc (3.62 +/- 1.14 vs 1.97 +/- 0.75, p<0.001) with diminished immunosuppression capacity. In SSc, the proportion of FoxP3(high)CD45RA(-) activated Treg cells (aTreg) was decreased, the proportion of FoxP3(low)CD45RA(-) T cells was increased, and the proportion of FoxP3(low)CD45RA(+) resting Treg cells (rTreg) was decreased. The immune suppression capacity of aTreg and rTreg was diminished, while FoxP3(low)CD45RA(-) T cells exhibited a lack of suppression capacity. The immune dysfunction of aTreg was accompanied by the abnormal expression of CTLA-4. Th17 cell numbers were elevated in SSc, FoxP3(low)CD45RA(-) T cells produced IL-17, confirming their Th17 potential, which was consistent with the elevated levels of FoxP3(+)IL-17(+) cells in SSc. Conclusion: A decrease in aTreg levels, along with functional deficiency, and an increase in the proportion of FoxP3(low)CD45RA(-) T cells, was the reason for the increase in dysfunctional Treg in SSc patients, potentially causing the immune imbalance between Treg and Th17 cells.	[Liu, Xinjuan; Gao, Na; Li, Mengtao; Xu, Dong; Hou, Yong; Wang, Qian; Zhang, Guohua; Zeng, Xiaofeng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China; [Liu, Xinjuan; Gao, Na; Li, Mengtao; Xu, Dong; Hou, Yong; Wang, Qian; Zhang, Guohua; Sun, Qiuning; Zeng, Xiaofeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Sun, Qiuning] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Dermatol, Beijing 100730, Peoples R China; [Zhang, Henghui] Peking Univ, Inst Hepatol, Peoples Hosp, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing 100871, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Peking University	Zhang, HH (corresponding author), Peking Univ, Inst Hepatol, Peoples Hosp, Beijing Key Lab Hepatitis C & Immunotherapy Liver, Beijing 100871, Peoples R China.	zhhbao@163.com; zengxfpumc@yahoo.cn	Sun, Qiuning/AAJ-3692-2021; meng, li/GVT-2063-2022	Sun, Qiuning/0000-0002-1912-341X; 	National Natural Science Foundation of China [81072485, 81001072, 81071300, 81102268]; EULAR Scleroderma Trial & Research group (EUSTAR), Fund of Capital Medical Development and Research	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EULAR Scleroderma Trial & Research group (EUSTAR), Fund of Capital Medical Development and Research	This study was supported by National Natural Science Foundation of China (81072485, 81001072, 81071300, and 81102268), and EULAR Scleroderma Trial & Research group (EUSTAR), Fund of Capital Medical Development and Research (2009-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham DJ, 2009, RHEUMATOLOGY, V48, P3, DOI 10.1093/rheumatology/ken481; Antiga E, 2010, BRIT J DERMATOL, V162, P1056, DOI 10.1111/j.1365-2133.2010.09633.x; Balbi G, 2007, CLIN EXP IMMUNOL, V149, P40, DOI 10.1111/j.1365-2249.2007.03394.x; Besliu Alina Nicoleta, 2009, Roum Arch Microbiol Immunol, V68, P5; Bovenschen HJ, 2011, J INVEST DERMATOL, V131, P1853, DOI 10.1038/jid.2011.139; Chavele KM, 2011, FEBS LETT; Chen WJ, 2003, CYTOKINE GROWTH F R, V14, P85, DOI 10.1016/S1359-6101(03)00003-0; El-Far M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054295; Fenoglio D, 2011, CLIN IMMUNOL, V139, P249, DOI 10.1016/j.clim.2011.01.013; Fife BT, 2008, IMMUNOL REV, V224, P166, DOI 10.1111/j.1600-065X.2008.00662.x; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Jago CB, 2004, CLIN EXP IMMUNOL, V136, P463, DOI 10.1111/j.1365-2249.2004.02478.x; Khoury SJ, 2011, CLIN IMMUNOL, V139, P231, DOI 10.1016/j.clim.2011.03.014; Kurasawa K, 2000, ARTHRITIS RHEUM-US, V43, P2455, DOI 10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K; Kurusu S, 2007, PROSTAG OTH LIPID M, V83, P250, DOI 10.1016/j.prostaglandins.2006.12.003; LeRoy EC, 2001, J RHEUMATOL, V28, P1573; Li RB, 2007, J IMMUNOL, V179, P5191, DOI 10.4049/jimmunol.179.8.5191; Linsley PS, 1996, IMMUNITY, V4, P535, DOI 10.1016/S1074-7613(00)80480-X; Maitra U, 2009, J IMMUNOL, V182, P5763, DOI 10.4049/jimmunol.0900124; Mathian A, 2012, ANN RHEUM DIS, V71, P1227, DOI 10.1136/annrheumdis-2011-200709; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Murata M, 2008, J DERMATOL SCI, V50, P240, DOI 10.1016/j.jdermsci.2008.01.001; Nocentini G, 2007, EUR J IMMUNOL, V37, P1165, DOI 10.1002/eji.200636933; Oida T, 2006, J IMMUNOL, V177, P2331, DOI 10.4049/jimmunol.177.4.2331; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Radstake TRDJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005903; Radstake TRDJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005981; Rajaee A, 2006, RHEUMATOL INT, V26, P687, DOI 10.1007/s00296-005-0047-6; Rodriguez-Reyna TS, 2012, RHEUMATOL INT, V32, P2653, DOI 10.1007/s00296-011-2056-y; Rodriguez-Reyna TS, 2011, RHEUMATOL INT; Sakaguchi S, 2011, J IMMUNOL, V186, P3808; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Slobodin G, 2010, CELL IMMUNOL, V261, P77, DOI 10.1016/j.cellimm.2009.12.009; Steen VD, 2007, ANN RHEUM DIS, V66, P940, DOI 10.1136/ard.2006.066068; Takeuchi F, 2002, CLIN EXP RHEUMATOL, V20, P395; Takeuchi F, 2007, RHEUMATOL INT, V27, P785, DOI 10.1007/s00296-006-0298-x; Truchetet ME, 2012, ANN RHEUM DIS, V71, P2044, DOI 10.1136/annrheumdis-2012-201400; Truchetet ME, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3486; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zheng SG, 2006, J IMMUNOL, V176, P3321, DOI 10.4049/jimmunol.176.6.3321; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhou XY, 2009, CURR OPIN IMMUNOL, V21, P281, DOI 10.1016/j.coi.2009.05.007; Zuber JP, 2006, RHEUMATOLOGY, V45, P23, DOI 10.1093/rheumatology/kel285	48	51	55	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e64531	10.1371/journal.pone.0064531	http://dx.doi.org/10.1371/journal.pone.0064531			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776439	gold, Green Submitted, Green Published			2022-12-25	WOS:000320755400008
J	Overman, MJ; Zhang, JX; Kopetz, S; Davies, M; Jiang, ZQ; Stemke-Hale, K; Rummele, P; Pilarsky, C; Grutzmann, R; Hamilton, S; Hwang, R; Abbruzzese, JL; Varadhachary, G; Broom, B; Wang, HM				Overman, Michael J.; Zhang, Jiexin; Kopetz, Scott; Davies, Michael; Jiang Zhi-Qin; Stemke-Hale, Katherine; Ruemmele, Petra; Pilarsky, Christian; Gruetzmann, Robert; Hamilton, Stanley; Hwang, Rosa; Abbruzzese, James L.; Varadhachary, Gauri; Broom, Bradley; Wang, Huamin			Gene Expression Profiling of Ampullary Carcinomas Classifies Ampullary Carcinomas into Biliary-Like and Intestinal-Like Subtypes That Are Prognostic of Outcome	PLOS ONE			English	Article							PAPILLA; SURVIVAL; VATER; ADENOCARCINOMAS; GEMCITABINE; MUTATIONS; CLUSTERIN; PROTEIN	Background: Adenocarcinomas of the ampulla of Vater are classified as biliary cancers, though the exact epithelium of origin for these cancers is not known. We sought to molecularly classify ampullary adenocarcinomas in comparison to known adenocarcinomas of the pancreas, bile duct, and duodenum by gene expression analysis. Methods: We analyzed 32 fresh-frozen resected, untreated periampullary adenocarcinomas (8 pancreatic, 2 extrahepatic biliary, 8 duodenal, and 14 ampullary) using the Affymetrix U133 Plus 2.0 genome array. Unsupervised and supervised hierarchical clustering identified two subtypes of ampullary carcinomas that were molecularly and histologically characterized. Results: Hierarchical clustering of periampullary carcinomas segregated ampullary carcinomas into two subgroups, which were distinctly different from pancreatic carcinomas. Non-pancreatic periampullary adenocarcinomas were segregated into two subgroups with differing prognoses: 5 year RFS (77% vs. 0%, p = 0.007) and 5 year OS (100% vs. 35%, p = 0.005). Unsupervised clustering analysis of the 14 ampullary samples also identified two subgroups: a good prognosis intestinal-like subgroup and a poor prognosis biliary-like subgroup with 5 year OS of 70% vs. 28%, P = 0.09. Expression of CK7+/CK20- but not CDX-2 correlated with these two subgroups. Activation of the AKT and MAPK pathways were both increased in the poor prognostic biliary-like subgroup. In an independent 80 patient ampullary validation dataset only histological subtype (intestinal vs. pancreaticobiliary) was significantly associated with OS in both univariate (p = 0.006) and multivariate analysis (P = 0.04). Conclusions: Gene expression analysis discriminated pancreatic adenocarcinomas from other periampullary carcinomas and identified two prognostically relevant subgroups of ampullary adenocarcinomas. Histological subtype was an independent prognostic factor in ampullary adenocarcinomas.	[Overman, Michael J.; Kopetz, Scott; Jiang Zhi-Qin; Abbruzzese, James L.; Varadhachary, Gauri] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Zhang, Jiexin; Broom, Bradley] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Hamilton, Stanley; Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Davies, Michael] Univ Texas MD Anderson Canc Ctr, Dept Melanoma, Houston, TX 77030 USA; [Stemke-Hale, Katherine] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Hwang, Rosa] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Ruemmele, Petra] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany; [Pilarsky, Christian; Gruetzmann, Robert] Univ Hosp Carl Gustav Carus, Dept Visceral Thorac & Vasc Surg, Dresden, Germany	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Regensburg; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Overman, MJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA.	moverman@mdanderson.org	Davies, Michael/GWV-2527-2022; Jiang, Zhi-Qin/O-8999-2014; Stemke-Hale, Katherine/K-9113-2013; Kopetz, Scott/AAC-1387-2019	Jiang, Zhi-Qin/0000-0002-0931-5418; Stemke-Hale, Katherine/0000-0002-1231-4192; Kopetz, Scott/0000-0001-9647-3416; Pilarsky, Christian/0000-0002-7968-3283	Kavanagh Family Foundation; National Cancer Institute [CA 16672]; NATIONAL CANCER INSTITUTE [P01CA130821, P30CA016672] Funding Source: NIH RePORTER	Kavanagh Family Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank the Kavanagh Family Foundation and National Cancer Institute Core Grant #CA 16672 for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berberat PO, 2009, EJSO-EUR J SURG ONC, V35, P187, DOI 10.1016/j.ejso.2008.01.030; Chen QF, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-59; Djeu JY, 2009, ADV CANCER RES, V105, P77, DOI 10.1016/S0065-230X(09)05005-2; Ehehalt F, 2011, ANN SURG, V254, P302, DOI 10.1097/SLA.0b013e31821994a8; Fischer HP, 2004, J HEPATO-BILIARY-PAN, V11, P301, DOI 10.1007/s00534-004-0898-3; Freund JN, 1998, BIOCHEM CELL BIOL, V76, P957, DOI 10.1139/bcb-76-6-957; Hansel DE, 2005, J CLIN ONCOL, V23, P1811, DOI 10.1200/JCO.2005.03.068; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jiang Z VG, 2013, ANN ONCOLOG IN PRESS; KIMURA W, 1994, JPN J CANCER RES, V85, P161, DOI 10.1111/j.1349-7006.1994.tb02077.x; Kohler I, 2011, AM J CLIN PATHOL, V135, P202, DOI 10.1309/AJCPCTCUQSYI89YT; Levi E, 2004, J CLIN PATHOL, V57, P456, DOI 10.1136/jcp.2003.013292; Matsubayashi H, 1999, CANCER-AM CANCER SOC, V86, P596, DOI 10.1002/(SICI)1097-0142(19990815)86:4<596::AID-CNCR8>3.3.CO;2-8; Morris-Stiff G, 2009, EJSO-EUR J SURG ONC, V35, P746, DOI 10.1016/j.ejso.2008.10.010; Neoptolemos JP, 2012, JAMA-J AM MED ASSOC, V308, P147, DOI 10.1001/jama.2012.7352; Overman MJ, 2009, J CLIN ONCOL, V27, P2598, DOI 10.1200/JCO.2008.19.7145; Park ES, 2010, MOL CANCER THER, V9, P257, DOI 10.1158/1535-7163.MCT-09-0743; Rechreche H, 1997, EUR J BIOCHEM, V248, P225, DOI 10.1111/j.1432-1033.1997.00225.x; Ritter G, 1997, BIOCHEM BIOPH RES CO, V236, P682, DOI 10.1006/bbrc.1997.6966; Roh YH, 2007, HEPATO-GASTROENTEROL, V54, P1641; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Ruemmele P, 2009, AM J SURG PATHOL, V33, P691, DOI 10.1097/PAS.0b013e3181983ef7; Santini D, 2008, ANN ONCOL, V19, P724, DOI 10.1093/annonc/mdm576; Sessa F, 2007, VIRCHOWS ARCH, V451, P649, DOI 10.1007/s00428-007-0444-1; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Vincenzi B, 2009, ANN ONCOL, V20, P78, DOI 10.1093/annonc/mdn558; Waldman SA, 2009, JAMA-J AM MED ASSOC, V301, P745, DOI 10.1001/jama.2009.141; Westgaard A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-5; Zhou H, 2004, AM J SURG PATHOL, V28, P875, DOI 10.1097/00000478-200407000-00005	32	46	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65144	10.1371/journal.pone.0065144	http://dx.doi.org/10.1371/journal.pone.0065144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776447	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400011
J	Perea, R; Venturas, M; Gil, L				Perea, Ramon; Venturas, Martin; Gil, Luis			Empty Seeds Are Not Always Bad: Simultaneous Effect of Seed Emptiness and Masting on Animal Seed Predation	PLOS ONE			English	Article							EVOLUTIONARY ECOLOGY; POSTDISPERSAL PREDATION; WIND POLLINATION; DISPERSAL; SATIATION; PARTHENOCARPY; BENEFITS; REMOVAL; FORESTS; MODELS	Seed masting and production of empty seeds have often been considered independently as different strategies to reduce seed predation by animals. Here, we integrate both phenomena within the whole assemblage of seed predators (both pre and post-dispersal) and in two contrasting microsites (open vs. sheltered) to improve our understanding of the factors controlling seed predation in a wind-dispersed tree (Ulmus laevis). In years with larger crop sizes more avian seed predators were attracted with an increase in the proportion of full seeds predated on the ground. However, for abundant crops, the presence of empty seeds decreased the proportion of full seeds predated. Empty seeds remained for a very long period in the tree, making location of full seeds more difficult for pre-dispersal predators and expanding the overall seed drop period at a very low cost (in dry biomass and allocation of C, N and P). Parthenocarpy (non-fertilized seeds) was the main cause of seed emptiness whereas seed abortion was produced in low quantity. These aborted seeds fell prematurely and, thus, could not work as deceptive seeds. A proportion of 50% empty seeds significantly reduced ground seed predation by 26%. However, a high rate of parthenocarpy (beyond 50% empty seeds) did not significantly reduce seed predation in comparison to 50% empty seeds. We also found a high variability and unpredictability in the production of empty seeds, both at tree and population level, making predator deception more effective. Open areas were especially important to facilitate seed survival since rodents (the main post-dispersal predators) consumed seeds mostly under shrub cover. In elm trees parthenocarpy is a common event that might work as an adaptive strategy to reduce seed predation. Masting per se did not apparently reduce the overall proportion of seeds predated in this wind-dispersed tree, but kept great numbers of seeds unconsumed.	[Perea, Ramon; Venturas, Martin; Gil, Luis] Univ Politecn Madrid, ETSI, Dept Silvopascicultura, Montes, Madrid, Spain	Universidad Politecnica de Madrid	Gil, L (corresponding author), Univ Politecn Madrid, ETSI, Dept Silvopascicultura, Montes, Ciudad Univ, Madrid, Spain.	luis.gil@upm.es	Perea, Ramon/A-9120-2017; Gil, Luis/E-3216-2014; Venturas, Martin D./J-2423-2014	Perea, Ramon/0000-0002-2206-3614; Gil, Luis/0000-0002-5252-2607; Venturas, Martin D./0000-0001-5972-9064	Comunidad de Madrid [S2009AMB-1668]	Comunidad de Madrid(Comunidad de Madrid)	Financial support was provided by the Comunidad de Madrid(project S2009AMB-1668). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, PLANT ANIMAL INTERAC; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bonal R, 2007, EVOL ECOL, V21, P367, DOI 10.1007/s10682-006-9107-y; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; BURNHAM KP, 1980, WILDLIFE MONOGR, P7; Burns R.M., 1990, AGR HDB, V654; Castro J, 1999, PLANT ECOL, V145, P115, DOI 10.1023/A:1009865703906; Crawley M. J., 2000, Seeds: the ecology of regeneration in plant communities, P167, DOI 10.1079/9780851994321.0167; Crawley M.J., 1997, PLANT ECOL; CRAWLEY MJ, 1995, J ECOL, V83, P683, DOI 10.2307/2261636; DAVIDAR P, 1986, ECOLOGY, V67, P262, DOI 10.2307/1938529; Fedriani JM, 2011, ECOLOGY, V92, P304, DOI 10.1890/09-2194.1; Fenner M., 2000, SEEDS ECOLOGY REGENE; Forget PM, 1999, J TROP ECOL, V15, P61, DOI 10.1017/S026646749900067X; Fuentes M, 1998, EVOL ECOL, V12, P823, DOI 10.1023/A:1006594532392; Garcia D, 2001, J ECOL, V89, P639, DOI 10.1046/j.1365-2745.2001.00577.x; Honek A, 2005, J ECOL, V93, P345, DOI 10.1111/j.1365-2745.2005.00987.x; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; HULME PE, 1994, J ECOL, V82, P645, DOI 10.2307/2261271; Hulme PE, 1999, PLANT ECOL, V145, P149, DOI 10.1023/A:1009821919855; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JANZEN DH, 1969, EVOLUTION, V23, P1, DOI [10.2307/2406478, 10.1111/j.1558-5646.1969.tb03489.x]; Karkkainen K, 1999, EVOL ECOL, V13, P305, DOI 10.1023/A:1006746900736; KELLY D, 1994, TRENDS ECOL EVOL, V9, P465, DOI 10.1016/0169-5347(94)90310-7; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Kelly D, 1997, OIKOS, V78, P143, DOI 10.2307/3545810; Kelly D, 2001, ECOLOGY, V82, P117, DOI 10.1890/0012-9658(2001)082[0117:ETWPBO]2.0.CO;2; Koenig WD, 2003, OIKOS, V102, P581, DOI 10.1034/j.1600-0706.2003.12272.x; LIMA SL, 1990, OIKOS, V58, P151, DOI 10.2307/3545422; Lopez-Almansa J. C., 2004, Investigacion Agraria, Sistemas y Recursos Forestales, V13, P17; Lopez-Almansa JC, 2003, SILVAE GENET, V52, P241; MUSTART PJ, 1995, AFR J ECOL, V33, P224, DOI 10.1111/j.1365-2028.1995.tb00799.x; NILSSON SG, 1987, ECOLOGY, V68, P260, DOI 10.2307/1939256; Nystrand O, 1997, OECOLOGIA, V110, P353, DOI 10.1007/s004420050169; Perea R, 2013, OIKOS, V122, P943, DOI 10.1111/j.1600-0706.2012.20940.x; Perea R, 2011, BASIC APPL ECOL, V12, P432, DOI 10.1016/j.baae.2011.05.002; Perea R, 2011, J ECOL, V99, P194, DOI 10.1111/j.1365-2745.2010.01749.x; Pizo MA, 1997, J TROP ECOL, V13, P559, DOI 10.1017/S0266467400010713; Ramos-Ordonez MF, 2011, J ARID ENVIRON, V75, P757, DOI 10.1016/j.jaridenv.2011.04.013; SHAW MW, 1968, J ECOL, V56, P565, DOI 10.2307/2258251; SILVERTOWN JW, 1980, BIOL J LINN SOC, V14, P235, DOI 10.1111/j.1095-8312.1980.tb00107.x; TRAVESET A, 1993, EVOL ECOL, V7, P357, DOI 10.1007/BF01237867; Vander Wall SB, 2001, BOT REV, V67, P74, DOI 10.1007/BF02857850; Vander Wall SB, 2002, ECOLOGY, V83, P3508, DOI 10.2307/3072099; VANDERWALL SB, 1994, OIKOS, V69, P125, DOI 10.2307/3545292; Venturas M, 2013, PLANT ECOL, V214, P317, DOI 10.1007/s11258-013-0170-5; Verdu M, 2001, PLANT ECOL, V156, P245, DOI 10.1023/A:1012653002598; WALLER DM, 1979, J THEOR BIOL, V80, P223, DOI 10.1016/0022-5193(79)90207-8; WILLSON MF, 1983, B TORREY BOT CLUB, V110, P298, DOI 10.2307/2996182; ZANGERL AR, 1991, EVOL ECOL, V5, P136, DOI 10.1007/BF02270830	50	20	20	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65573	10.1371/journal.pone.0065573	http://dx.doi.org/10.1371/journal.pone.0065573			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776503	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400043
J	Perino, MG; Moldobaeva, A; Jenkins, J; Wagner, EM				Perino, Maria Grazia; Moldobaeva, Aigul; Jenkins, John; Wagner, Elizabeth M.			Chemokine Localization in Bronchial Angiogenesis	PLOS ONE			English	Article							INDUCED NEUTROPHIL CHEMOATTRACTANT; MACROPHAGE INFLAMMATORY PROTEIN-2; CXC CHEMOKINES; TUMOR ANGIOGENESIS; IL-8 RECEPTOR; LUNG INJURY; GROWTH; DEXAMETHASONE; EXPRESSION; CELLS	Angiogenesis in the lung involves the systemic bronchial vasculature and becomes prominent when chronic inflammation prevails. Mechanisms for neovascularization following pulmonary ischemia include growth factor transit from ischemic parenchyma to upstream bronchial arteries, inflammatory cell migration/recruitment through the perfusing artery, and paracrine effects of lung cells within the left bronchus, the niche where arteriogenesis takes place. We analyzed left lung bronchoalveolar lavage (BAL) fluid and left bronchus homogenates after left pulmonary artery ligation (LPAL) in rats, immediately after the onset of ischemia (0 h), 6 h and 24 h later. Additionally, we tested the effectiveness of dexamethasone on decreasing inflammation (0-24 h LPAL) and angiogenesis at early (3 d LPAL; bronchial endothelial proliferation) and late (14 d LPAL; blood flow) stages. After LPAL (6 h), BAL protein, total inflammatory cells, macrophages, and polymorphonuclear cells increased significantly. In parallel, pro-angiogenic CXC chemokines increased in BAL and the left main-stem bronchus (CXCL1) or only within the bronchus (CXCL2). Dexamethasone treatment reduced total BAL protein, inflammatory cells (total and polymorphonuclear cells), and CXCL1 but not CXCL2 in BAL. By contrast, no decrease was seen in either chemokine within the bronchial tissue, in proliferating bronchial endothelial cells, or in systemic perfusion of the left lung. Our results confirm the presence of CXC chemokines within BAL fluid as well as within the left mainstem bronchus. Despite significant reduction in lung injury and inflammation with dexamethasone treatment, chemokine expression within the bronchial tissue as well as angiogenesis were not affected. Our results suggest that early changes within the bronchial niche contribute to subsequent neovascularization during pulmonary ischemia.	[Perino, Maria Grazia; Moldobaeva, Aigul; Jenkins, John; Wagner, Elizabeth M.] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine	Wagner, EM (corresponding author), Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA.	wagnerem@jhmi.edu			NIH NHLBI [RO1 HL088005]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113392, R01HL088005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053503] Funding Source: NIH RePORTER	NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by NIH NHLBI, RO1 HL088005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenberg DA, 1997, J LEUKOCYTE BIOL, V62, P554, DOI 10.1002/jlb.62.5.554; Baluk P, 1997, AM J PHYSIOL-LUNG C, V273, pL565, DOI 10.1152/ajplung.1997.273.3.L565; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; BOWDEN JJ, 1994, AM J RESP CRIT CARE, V150, P1391, DOI 10.1164/ajrccm.150.5.7524980; Brinson GM, 1998, AM J RESP CRIT CARE, V157, P1951, DOI 10.1164/ajrccm.157.6.9708067; Cai SS, 2010, J IMMUNOL, V185, P6214, DOI 10.4049/jimmunol.0903843; Chao J, 2012, AM J PHYSIOL-HEART C, V303, pH168, DOI 10.1152/ajpheart.00106.2012; Endrys J, 1997, HEART, V78, P171, DOI 10.1136/hrt.78.2.171; Garcia CSNB, 2006, BRAZ J MED BIOL RES, V39, P697, DOI 10.1590/S0100-879X2006000600001; Heil M, 2004, CIRC RES, V95, P449, DOI 10.1161/01.RES.0000141145.78900.44; Hsieh CS, 2006, J PEDIATR SURG, V41, P1669, DOI 10.1016/j.jpedsurg.2006.05.039; Keane MP, 2002, J IMMUNOL, V169, P6515, DOI 10.4049/jimmunol.169.11.6515; Li X, 1997, AM J RESP CRIT CARE, V156, P229, DOI 10.1164/ajrccm.156.1.9607066; LIU MY, 1995, AM J PHYSIOL-LUNG C, V269, pL178, DOI 10.1152/ajplung.1995.269.2.L178; Matzer SP, 2004, INT IMMUNOL, V16, P1675, DOI 10.1093/intimm/dxh169; McDonald DM, 2001, AM J RESP CRIT CARE, V164, pS39, DOI 10.1164/ajrccm.164.supplement_2.2106065; Moore BB, 1998, J LAB CLIN MED, V132, P97, DOI 10.1016/S0022-2143(98)90004-X; Moore BB, 1998, J INVEST MED, V46, P113; MULLER KM, 1978, PATHOL RES PRACT, V163, P34; Murphy PM, 2001, NEW ENGL J MED, V345, P833, DOI 10.1056/NEJM200109133451113; Nakao S, 2012, INVEST OPHTH VIS SCI, V53, P3296, DOI 10.1167/iovs.11-8114; Oynebraten I, 2005, J IMMUNOL, V175, P5358, DOI 10.4049/jimmunol.175.8.5358; Pappa CA, 2011, CYTOKINE, V56, P616, DOI 10.1016/j.cyto.2011.08.034; Quinton LJ, 2004, AM J PHYSIOL-LUNG C, V286, pL465, DOI 10.1152/ajplung.00153.2003; Remy-Jardin M, 2004, RADIOLOGY, V233, P741, DOI 10.1148/radiol.2333040031; Ribeiro JCML, 2012, OPHTHALMIC RES, V48, P177, DOI 10.1159/000337137; Rocco PRM, 2001, AM J RESP CRIT CARE, V164, P1067, DOI 10.1164/ajrccm.164.6.2007062; Sabroe I, 1997, J IMMUNOL, V158, P1361; Sanchez J, 2007, J APPL PHYSIOL, V103, P594, DOI 10.1152/japplphysiol.00037.2007; Sevaljevic L, 2001, BIOL SIGNAL RECEPT, V10, P299; Stillie R, 2009, J LEUKOCYTE BIOL, V86, P529, DOI 10.1189/jlb.0208125; STRIETER RM, 1995, SHOCK, V4, P155, DOI 10.1097/00024382-199509000-00001; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Strieter RM, 2007, J CLIN INVEST, V117, P549, DOI 10.1172/JCI30562; Sukkar A, 2008, J APPL PHYSIOL, V104, P1470, DOI 10.1152/japplphysiol.00974.2007; Tang KH, 2012, HEPATOLOGY, V55, P807, DOI 10.1002/hep.24739; Vanderbilt JN, 2003, AM J RESP CELL MOL, V29, P661, DOI 10.1165/rcmb.2002-0227OC; Wagner EM, 2011, J APPL PHYSIOL, V110, P538, DOI 10.1152/japplphysiol.01308.2010; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Yao LC, 2012, AM J PATHOL, V180, P2561, DOI 10.1016/j.ajpath.2012.02.019; Zamjahn JB, 2011, AM J PHYSIOL-LUNG C, V301, pL568, DOI 10.1152/ajplung.00340.2010; Zhang P, 2002, SHOCK, V17, P104, DOI 10.1097/00024382-200202000-00004	42	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66432	10.1371/journal.pone.0066432	http://dx.doi.org/10.1371/journal.pone.0066432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776670	gold, Green Published, Green Submitted			2022-12-25	WOS:000320755400144
J	Torres-Martin, M; Lassaletta, L; de Campos, JM; Isla, A; Gavilan, J; Pinto, GR; Burbano, RR; Latif, F; Melendez, B; Castresana, JS; Rey, JA				Torres-Martin, Miguel; Lassaletta, Luis; de Campos, Jose M.; Isla, Alberto; Gavilan, Javier; Pinto, Giovanny R.; Burbano, Rommel R.; Latif, Farida; Melendez, Barbara; Castresana, Javier S.; Rey, Juan A.			Global Profiling in Vestibular Schwannomas Shows Critical Deregulation of MicroRNAs and Upregulation in Those Included in Chromosomal Region 14q32	PLOS ONE			English	Article							GENE-EXPRESSION; TUMOR-SUPPRESSOR; NF2 GENE; MICROARRAY ANALYSIS; CELL PROLIFERATION; DOWN-REGULATION; METHYLATION; MIGRATION; CANCER; PROMOTES	Background: Vestibular schwannomas are benign tumors that arise from Schwann cells in the VIII cranial pair and usually present NF2 gene mutations and/or loss of heterozygosity on chromosome 22q. Deregulation has also been found in several genes, such as ERBB2 and NRG1. MicroRNAs are non-coding RNAs approximately 21 to 23 nucleotides in length that regulate mRNAs, usually by degradation at the post-transcriptional level. Methods: We used microarray technology to test the deregulation of miRNAs and other non-coding RNAs present in GeneChip miRNA 1.0 (Affymetrix) over 16 vestibular schwannomas and 3 control-nerves, validating 10 of them by qRT-PCR. Findings: Our results showed the deregulation of 174 miRNAs, including miR-10b, miR-206, miR-183 and miR-204, and the upregulation of miR-431, miR-221, miR-21 and miR-720, among others. The results also showed an aberrant expression of other non-coding RNAs. We also found a general upregulation of the miRNA cluster located at chromosome 14q32. Conclusion: Our results suggest that several miRNAs are involved in tumor formation and/or maintenance and that global upregulation of the 14q32 chromosomal site contains miRNAs that may represent a therapeutic target for this neoplasm.	[Torres-Martin, Miguel; Rey, Juan A.] IdiPAZ, La Paz Univ Hosp, Neurooncol Lab, Res Unit, Madrid, Spain; [Lassaletta, Luis; Gavilan, Javier] IdiPAZ, La Paz Univ Hosp, Dept Otolaryngol, Madrid, Spain; [de Campos, Jose M.] Fdn Jimenez Diaz, Dept Neurosurg, E-28040 Madrid, Spain; [Isla, Alberto] IdiPAZ, La Paz Univ Hosp, Dept Neurosurg, Madrid, Spain; [Pinto, Giovanny R.] Univ Fed Piaui, Genet & Mol Biol Lab, Parnaiba, Brazil; [Burbano, Rommel R.] Fed Univ Para, Human Cytogenet Lab, BR-66059 Belem, Para, Brazil; [Latif, Farida] Univ Birmingham, Sch Clin & Expt Med, Ctr Rare Dis & Personalised Med, Birmingham, W Midlands, England; [Melendez, Barbara] Virgen Salud Hosp, Mol Pathol Res Unit, Toledo, Spain; [Castresana, Javier S.] Univ Navarra, Sch Sci, Brain Tumor Biol Unit, E-31080 Pamplona, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz; Universidade Federal do Piaui; Universidade Federal do Para; University of Birmingham; University of Navarra	Torres-Martin, M (corresponding author), IdiPAZ, La Paz Univ Hosp, Neurooncol Lab, Res Unit, Madrid, Spain.	migtorres.martin@gmail.com	Pinto, Giovanny R/G-9852-2012; Burbano, Rommel R/C-4149-2012; Melendez, Barbara/E-1216-2017; Rey, Juan A/H-5026-2013; Castresana, Javier S/AFT-2167-2022; Pinto, Giovanny Rebouças/AAB-9308-2020	Pinto, Giovanny R/0000-0001-9110-1840; Burbano, Rommel R/0000-0002-4872-234X; Melendez, Barbara/0000-0001-5004-8895; Torres Martin, Miguel/0000-0003-1589-8936; Castresana, Javier S./0000-0002-2373-482X	FIS, Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain [PI 07/0577, 10/1972]; Fundacion Sociosanitaria de Castilla-La Mancha of the Consejeria de Salud y Bienestar Social, Junta de Comunidades de Castilla-La Mancha, Spain [PI10-045]	FIS, Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain; Fundacion Sociosanitaria de Castilla-La Mancha of the Consejeria de Salud y Bienestar Social, Junta de Comunidades de Castilla-La Mancha, Spain(Junta de Comunidades de Castilla-La Mancha)	Supported by grants PI 07/0577 and 10/1972 from FIS, Ministerio de Sanidad, Servicios Sociales e Igualdad, Spain and grant PI10-045 from the Fundacion Sociosanitaria de Castilla-La Mancha of the Consejeria de Salud y Bienestar Social, Junta de Comunidades de Castilla-La Mancha, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarhus M, 2010, NEUROSURGERY, V67, P998, DOI 10.1227/NEU.0b013e3181ec7b71; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Bai AHC, 2012, ACTA NEUROPATHOL, V123, P529, DOI 10.1007/s00401-011-0924-x; Bello MJ, 2007, CANCER GENET CYTOGEN, V172, P84, DOI 10.1016/j.cancergencyto.2006.02.022; BELLO MJ, 1993, GENE CHROMOSOME CANC, V6, P206, DOI 10.1002/gcc.2870060403; Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Caye-Thomasen P, 2010, OTOL NEUROTOL, V31, P256, DOI 10.1097/MAO.0b013e3181be6478; Cioffi JA, 2010, OTOL NEUROTOL, V31, P1455, DOI 10.1097/MAO.0b013e3181f20655; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; de Vries M, 2013, VIRCHOWS ARCH, V462, P211, DOI 10.1007/s00428-012-1342-8; Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141; Dong XY, 2009, J GENET GENOMICS, V36, P447, DOI 10.1016/S1673-8527(08)60134-4; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Evans DGR, 2000, J MED GENET, V37, P897, DOI 10.1136/jmg.37.12.897; Gabriely G, 2011, CANCER RES, V71, P3563, DOI 10.1158/0008-5472.CAN-10-3568; Garcia-Orti L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047717; Gong M, 2012, NEURO-ONCOLOGY, V14, P1007, DOI 10.1093/neuonc/nos124; Gonzalez-Gomez P, 2003, CLIN CANCER RES, V9, P5601; Hadfield KD, 2010, ONCOGENE, V29, P6216, DOI 10.1038/onc.2010.363; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jesuraj NJ, 2012, J NEUROSCI RES, V90, P96, DOI 10.1002/jnr.22752; Kim BS, 2011, AGING CELL, V10, P277, DOI 10.1111/j.1474-9726.2011.00670.x; Kino T, 2001, GENES CELLS, V6, P441, DOI 10.1046/j.1365-2443.2001.00432.x; Koutsimpelas D, 2012, ORL J OTO-RHINO-LARY, V74, P33, DOI 10.1159/000334968; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kullar PJ, 2010, NEUROPATH APPL NEURO, V36, P505, DOI 10.1111/j.1365-2990.2010.01090.x; Lallemand D, 2009, ONCOGENE, V28, P854, DOI 10.1038/onc.2008.427; Lavon I, 2010, NEURO-ONCOLOGY, V12, P422, DOI 10.1093/neuonc/nop061; Leone PE, 1998, INT J MOL MED, V1, P889; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; Liu ZL, 2013, MOL CELL BIOCHEM, V372, P35, DOI 10.1007/s11010-012-1443-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martinez-Glez V, 2009, INT J ONCOL, V34, P493, DOI 10.3892/ijo_00000174; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Nakata K, 2011, SURGERY, V150, P916, DOI 10.1016/j.surg.2011.06.017; Nohata N, 2012, ONCOTARGET, V3, P9; ODA Y, 1989, J NEUROSCI METH, V28, P163, DOI 10.1016/0165-0270(89)90032-0; Papagiannakopoulos T, 2012, ONCOGENE, V31, P1884, DOI 10.1038/onc.2011.380; REY JA, 1987, CANCER GENET CYTOGEN, V28, P187, DOI 10.1016/0165-4608(87)90372-4; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sandberg A.A., 2008, GENETICS MOL BIOL NE; Saydam O, 2011, CANCER RES, V71, P852, DOI 10.1158/0008-5472.CAN-10-1219; Saydam O, 2009, MOL CELL BIOL, V29, P5923, DOI 10.1128/MCB.00332-09; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Torres-Martin M, 2013, CLIN TRANSL ONCOL, V15, P409, DOI 10.1007/s12094-012-0937-5; Torres-Martin M, 2013, INT J ONCOL, V42, P848, DOI 10.3892/ijo.2013.1798; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Ueno K, 2012, MOL CANCER THER, V11, P244, DOI 10.1158/1535-7163.MCT-11-0592; Valleron W, 2012, LEUKEMIA, V26, P2052, DOI 10.1038/leu.2012.111; Wang GF, 2008, FEBS LETT, V582, P3663, DOI 10.1016/j.febslet.2008.09.051; Wang Y, 2012, FASEB J, V26, P3032, DOI 10.1096/fj.11-201855; Warren C, 2003, J MED GENET, V40, P802, DOI 10.1136/jmg.40.11.802; Welling DB, 2002, OTOL NEUROTOL, V23, P736, DOI 10.1097/00129492-200209000-00022; Wu ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045825; Yu B, 2012, NUCLEIC ACIDS RES, V40, P10356, DOI 10.1093/nar/gks750; Yu B, 2012, J CELL SCI, V125, P2675, DOI 10.1242/jcs.098996; Yuan QG, 2013, HEPATOLOGY, V57, P299, DOI 10.1002/hep.25984; Zhang W, 2012, MOL BIOL+, V46, P557, DOI 10.1134/S0026893312040139; Zhu JF, 2012, AM J PATHOL, V180, P2440, DOI 10.1016/j.ajpath.2012.02.023	65	25	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65868	10.1371/journal.pone.0065868	http://dx.doi.org/10.1371/journal.pone.0065868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776562	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400078
J	Labrecque, P; Roy, SJ; Frechette, L; Iorio-Morin, C; Gallant, MA; Parent, JL				Labrecque, Pascale; Roy, Sebastien J.; Frechette, Louis; Iorio-Morin, Christian; Gallant, Maxime A.; Parent, Jean-Luc			Inverse Agonist and Pharmacochaperone Properties of MK-0524 on the Prostanoid DP1 Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; PROSTAGLANDIN D-2 RECEPTOR; PHARMACOLOGICAL CHAPERONE ACTION; BETA(2) ADRENERGIC-RECEPTOR; PARATHYROID-HORMONE PTH; ENDOPLASMIC-RETICULUM; DRUG DISCOVERY; HYPOGONADOTROPIC HYPOGONADISM; INTRACELLULAR TRAFFICKING; FUNCTIONAL SELECTIVITY	Prostaglandin D-2 (PGD(2)) acts through two G protein-coupled receptors (GPCRs), the prostanoid DP receptor and CRTH2 also known as DP1 and DP2, respectively. Several previously characterized GPCR antagonists are now classified as inverse agonists and a number of GPCR ligands are known to display pharmacochaperone activity towards a given receptor. Here, we demonstrate that a DP1 specific antagonist, MK-0524 (also known as laropiprant), decreased basal levels of intracellular cAMP produced by DP1, a G alpha(s)-coupled receptor, in HEK293 cells. This reduction in cAMP levels was not altered by pertussis toxin treatment, indicating that MK-0524 did not induce coupling of DP1 to G alpha(i/o) proteins and that this ligand is a DP1 inverse agonist. Basal ERK1/2 activation by DP1 was not modulated by MK-0524. Interestingly, treatment of HEK293 cells expressing Flag-tagged DP1 with MK-0524 promoted DP1 cell surface expression time-dependently to reach a maximum increase of 50% compared to control after 24 h. In contrast, PGD(2) induced the internalization of 75% of cell surface DP1 after the same time of stimulation. The increase in DP1 cell surface targeting by MK-0524 was inhibited by Brefeldin A, an inhibitor of transport from the endoplasmic reticulum-Golgi to the plasma membrane. Confocal microscopy confirmed that a large population of DP1 remained trapped intracellularly and co-localized with calnexin, an endoplasmic reticulum marker. Redistribution of DP1 from intracellular compartments to the plasma membrane was observed following treatment with MK-0524 for 24 h. Furthermore, MK-0524 promoted the interaction between DP1 and the ANKRD13C protein, which we showed previously to display chaperone-like effects towards the receptor. We thus report that MK-0524 is an inverse agonist and a pharmacochaperone of DP1. Our findings may have important implications during therapeutic treatments with MK-0524 and for the development of new molecules targeting DP1.	[Labrecque, Pascale; Roy, Sebastien J.; Frechette, Louis; Iorio-Morin, Christian; Gallant, Maxime A.; Parent, Jean-Luc] Univ Sherbrooke, Dept Med, Sherbrooke, PQ J1K 2R1, Canada; [Labrecque, Pascale; Roy, Sebastien J.; Frechette, Louis; Iorio-Morin, Christian; Gallant, Maxime A.; Parent, Jean-Luc] Ctr Rech Clin Etienne Le Bel, Sherbrooke, PQ, Canada; [Labrecque, Pascale; Roy, Sebastien J.; Frechette, Louis; Iorio-Morin, Christian; Gallant, Maxime A.; Parent, Jean-Luc] Inst Pharmacol Sherbrooke, Sherbrooke, PQ, Canada	University of Sherbrooke	Parent, JL (corresponding author), Univ Sherbrooke, Dept Med, Sherbrooke, PQ J1K 2R1, Canada.	Jean-Luc.Parent@USherbrooke.ca	Iorio-Morin, Christian/I-8696-2019; Fréchette, Luc G./AAF-2042-2020	Iorio-Morin, Christian/0000-0003-2995-7255; Fréchette, Luc G./0000-0001-7138-0811	Canadian Institutes of Health Research [MOP184095]; Fonds de la Recherche en Sante du Quebec; Institut de Pharmacologie de Sherbrooke/Centre de Recherche en Inflammation de l'Universite de Sherbrroke	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Institut de Pharmacologie de Sherbrooke/Centre de Recherche en Inflammation de l'Universite de Sherbrroke	This work was supported by a grant from the Canadian Institutes of Health Research No MOP184095 to JLP. CIM and SJR received a PhD scholarships from the Fonds de la Recherche en Sante du Quebec and Institut de Pharmacologie de Sherbrooke/Centre de Recherche en Inflammation de l'Universite de Sherbrroke, respectively, during this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVING K, 1991, ACTA PHYSIOL SCAND, V143, P93, DOI 10.1111/j.1748-1716.1991.tb09204.x; Andersson H, 2003, MOL PHARMACOL, V64, P570, DOI 10.1124/mol.64.3.570; Arai I, 2004, EUR J PHARMACOL, V505, P229, DOI 10.1016/j.ejphar.2004.10.031; Arai I, 2007, EUR J PHARMACOL, V556, P207, DOI 10.1016/j.ejphar.2006.10.064; Arakawa T, 2006, BBA-PROTEINS PROTEOM, V1764, P1677, DOI 10.1016/j.bbapap.2006.08.012; Arimura A, 2001, J PHARMACOL EXP THER, V298, P411; Audet N, 2005, J BIOL CHEM, V280, P7808, DOI 10.1074/jbc.M411695200; Baker JG, 2003, MOL PHARMACOL, V64, P1357, DOI 10.1124/mol.64.6.1357; Bernier V, 2004, CURR OPIN PHARMACOL, V4, P528, DOI 10.1016/j.coph.2004.08.001; Bernier V, 2004, MOL ENDOCRINOL, V18, P2074, DOI 10.1210/me.2004-0080; Bhattacherjee P, 1996, EXP EYE RES, V62, P491, DOI 10.1006/exer.1996.0059; BOIE Y, 1995, J BIOL CHEM, V270, P18910, DOI 10.1074/jbc.270.32.18910; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Bosier B, 2007, TRENDS PHARMACOL SCI, V28, P438, DOI 10.1016/j.tips.2007.06.001; Canals M, 2009, BIOCHEM J, V417, P161, DOI 10.1042/BJ20081227; CASTELEIJN E, 1988, BIOCHEM J, V250, P77, DOI 10.1042/bj2500077; Charest PG, 2007, CELL SIGNAL, V19, P32, DOI 10.1016/j.cellsig.2006.05.020; Chiba T, 2006, INT ARCH ALLERGY IMM, V141, P300, DOI 10.1159/000095436; Conn PM, 2006, MOL ENDOCRINOL, V20, P3035, DOI 10.1210/me.2006-0066; Conn PM, 2006, J ENDOCRINOL, V190, P13, DOI 10.1677/joe.1.06771; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; Crider JY, 1999, BRIT J PHARMACOL, V127, P204, DOI 10.1038/sj.bjp.0702490; DARIUS H, 1994, EUR J PHARMACOL, V258, P207, DOI 10.1016/0014-2999(94)90482-0; Durand M, 2008, J BONE MINER RES, V23, P1097, DOI [10.1359/jbmr.080228, 10.1359/JBMR.080228]; Evanko DS, 2000, J BIOL CHEM, V275, P1327, DOI 10.1074/jbc.275.2.1327; FISHBURN CS, 1995, J BIOL CHEM, V270, P29819; FORSTERMANN U, 1985, PROSTA LEUKOTR MED, V18, P301, DOI 10.1016/0262-1746(85)90062-9; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gallant MA, 2005, J BONE MINER RES, V20, P672, DOI 10.1359/JBMR.041211; Gallant MA, 2007, EUR J PHARMACOL, V557, P115, DOI 10.1016/j.ejphar.2006.11.058; Gallant MA, 2010, J RHEUMATOL, V37, P644, DOI 10.3899/jrheum.090622; Gardella TJ, 1996, ENDOCRINOLOGY, V137, P3936, DOI 10.1210/en.137.9.3936; Gbahou F, 2003, P NATL ACAD SCI USA, V100, P11086, DOI 10.1073/pnas.1932276100; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; GILES H, 1989, BRIT J PHARMACOL, V96, P291, DOI 10.1111/j.1476-5381.1989.tb11816.x; Greasley PJ, 2006, EUR J PHARMACOL, V553, P1, DOI 10.1016/j.ejphar.2006.09.032; Grisaru-Granovsky S, 2010, J PERINATOL, V30, P33, DOI 10.1038/jp.2009.127; Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200; HAMIDBLOOMFIELD S, 1989, BRIT J PHARMACOL, V96, P307, DOI 10.1111/j.1476-5381.1989.tb11818.x; Hammad H, 2007, J EXP MED, V204, P357, DOI 10.1084/jem.20061196; HARDY CC, 1984, NEW ENGL J MED, V311, P209, DOI 10.1056/NEJM198407263110401; Hayaishi O, 2002, NEUROSCIENTIST, V8, P12, DOI 10.1177/107385840200800105; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; HIRATA M, 1994, P NATL ACAD SCI USA, V91, P11192, DOI 10.1073/pnas.91.23.11192; Ishizuka T, 2004, CARDIOVASC DRUG REV, V22, P71; Janovick JA, 2002, J CLIN ENDOCR METAB, V87, P3255, DOI 10.1210/jc.87.7.3255; Jean-Alphonse F, 2009, J AM SOC NEPHROL, V20, P2190, DOI 10.1681/ASN.2008121289; Jones RL, 2009, BRIT J PHARMACOL, V158, P104, DOI 10.1111/j.1476-5381.2009.00317.x; Kabashima K, 2003, PROSTAG LEUKOTR ESS, V69, P187, DOI 10.1016/S0952-3278(03)00080-2; Kenakin T, 2004, MOL PHARMACOL, V65, P2, DOI 10.1124/mol.65.1.2; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Lai E, 2007, CLIN PHARMACOL THER, V81, P849, DOI 10.1038/sj.clpt.6100180; Leanos-Miranda A, 2005, J CLIN ENDOCR METAB, V90, P3001, DOI 10.1210/jc.2004-2071; Leff P, 1997, TRENDS PHARMACOL SCI, V18, P355, DOI 10.1016/S0165-6147(97)90664-7; Leurs R, 2002, CLIN EXP ALLERGY, V32, P489, DOI 10.1046/j.0954-7894.2002.01314.x; Liu YJ, 1996, EUR J PHARMACOL, V304, P117, DOI 10.1016/0014-2999(96)00129-X; Lu M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-34; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Maicas N, 2012, ARTHRITIS RHEUM-US, V64, P130, DOI 10.1002/art.30656; Malaga-Dieguez L, 2010, MOL PHARMACOL, V77, P940, DOI 10.1124/mol.110.063511; Mathurin K, 2011, J BIOL CHEM, V286, P2696, DOI 10.1074/jbc.M110.178277; MATSUGI T, 1995, EUR J PHARMACOL, V275, P245, DOI 10.1016/0014-2999(94)00788-9; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Murata T, 2013, P NATL ACAD SCI USA, V110, P5205, DOI 10.1073/pnas.1218091110; Nagata K, 2003, PROSTAG LEUKOTR ESS, V69, P169, DOI 10.1016/S0952-3278(03)00078-4; NARUMIYA S, 1985, BRIT J PHARMACOL, V85, P367, DOI 10.1111/j.1476-5381.1985.tb08870.x; Nelson CP, 2007, BIOCHEM PHARMACOL, V73, P737, DOI 10.1016/j.bcp.2006.09.005; Parent A, 2010, J BIOL CHEM, V285, P40838, DOI 10.1074/jbc.M110.142257; Parent JL, 2001, J BIOL CHEM, V276, P7079, DOI 10.1074/jbc.M009375200; Parent JL, 1999, J BIOL CHEM, V274, P8941, DOI 10.1074/jbc.274.13.8941; Parra S, 2007, CURR OPIN PHARMACOL, V7, P146, DOI 10.1016/j.coph.2006.10.005; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Philip G, 2009, J ALLERGY CLIN IMMUN, V124, P942, DOI 10.1016/j.jaci.2009.07.006; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Roy SJ, 2010, EUR J PHARMACOL, V630, P10, DOI 10.1016/j.ejphar.2009.12.022; Sawyer N, 2002, BRIT J PHARMACOL, V137, P1163, DOI 10.1038/sj.bjp.0704973; Shapiro DA, 2003, NEUROPSYCHOPHARMACOL, V28, P1400, DOI 10.1038/sj.npp.1300203; Sharif NA, 2000, J PHARMACOL EXP THER, V293, P321; Sneddon WB, 2004, ENDOCRINOLOGY, V145, P2815, DOI 10.1210/en.2003-1185; Sturino CF, 2007, J MED CHEM, V50, P794, DOI 10.1021/jm0603668; Sturzebecher S, 1989, Prog Clin Biol Res, V301, P365; Sugimoto M, 2007, EUR J PHARMACOL, V564, P196, DOI 10.1016/j.ejphar.2007.01.080; TRIST DG, 1989, BRIT J PHARMACOL, V96, P301, DOI 10.1111/j.1476-5381.1989.tb11817.x; Trivedi RR, 2012, BIOCHEM BIOPH RES CO, V427, P185, DOI 10.1016/j.bbrc.2012.09.040; Ulloa-Aguirre A, 2004, TRAFFIC, V5, P821, DOI 10.1111/j.1600-0854.2004.00232.x; Ulloa-Aguirre A, 2009, FRONT BIOSCI-LANDMRK, V14, P973, DOI 10.2741/3290; Werry TD, 2005, J NEUROCHEM, V93, P1603, DOI 10.1111/j.1471-4159.2005.03161.x; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Wright DH, 1998, BRIT J PHARMACOL, V123, P1317; Wuller S, 2004, J BIOL CHEM, V279, P47254, DOI 10.1074/jbc.M408154200; Yue L, 2012, BONE, V51, P338, DOI 10.1016/j.bone.2012.06.003	97	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65767	10.1371/journal.pone.0065767	http://dx.doi.org/10.1371/journal.pone.0065767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762421	Green Submitted, gold, Green Published			2022-12-25	WOS:000320440500050
J	Bonato, FOB; Lemos, MM; Cassiolato, JL; Canziani, MEF				Bastos Bonato, Fabiana Oliveira; Lemos, Marcelo Montebello; Cassiolato, Jose Luiz; Fernandes Canziani, Maria Eugenia			Prevalence of Ventricular Arrhythmia and Its Associated Factors in Nondialyzed Chronic Kidney Disease Patients	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; HEART-RATE-VARIABILITY; STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; VASCULAR CALCIFICATION; CORONARY CALCIFICATION; PARATHYROID-HORMONE; GENDER-DIFFERENCES; RISK-FACTORS; HEMOGLOBIN	Background and Objectives: Sudden cardiac death is the most common cause of mortality in chronic kidney disease patients, and it occurs mostly due to ventricular arrhythmias. In this study, we aimed at investigating the prevalence of ventricular arrhythmia and the factors associated with its occurrence in nondialyzed chronic kidney disease patients. Design, Setting, Participants and Measurements: This cross-sectional study evaluated 111 chronic kidney disease patients (estimated glomerular filtration rate 34.7 +/- 16.1 mL/min/1.73 m(2), 57 +/- 11.4 years, 60% male, 24% diabetics). Ventricular arrhythmia was assessed by 24-hour electrocardiogram. Left ventricular hypertrophy (echocardiogram), 24-hour ambulatory blood pressure monitoring, and coronary artery calcification (multi-slice computed tomography) and laboratory parameters were also evaluated. Results: Ventricular arrhythmia was found in 35% of the patients. Non-controlled hypertension was observed in 21%, absence of systolic decency in 29%, left ventricular hypertrophy in 27%, systolic dysfunction in 10%, and coronary artery calcification in 49%. Patients with ventricular arrhythmia were older (p<0.001), predominantly men (p = 0.009), had higher estimated glomerular filtration rate (p = 0.03) and hemoglobin (p = 0.005), and lower intact parathyroid hormone (p = 0.024) and triglycerides (p = 0.011) when compared to patients without ventricular arrhythmia. In addition, a higher left ventricular mass index (p = 0.002) and coronary calcium score (p = 0.002), and a lower ejection fraction (p = 0.001) were observed among patients with ventricular arrhythmia. In the multiple logistic regression analysis, aging, increased hemoglobin levels and reduced ejection fraction were independently related to the presence of ventricular arrhythmia. Conclusions: Ventricular arrhythmia is prevalent in nondialyzed chronic kidney disease patients. Age, hemoglobin levels and ejection fraction were the factors associated with ventricular arrhythmia in these patients.	[Bastos Bonato, Fabiana Oliveira; Lemos, Marcelo Montebello; Fernandes Canziani, Maria Eugenia] Univ Fed Sao Paulo, Dept Internal Med, Div Nephrol, Sao Paulo, Brazil; [Cassiolato, Jose Luiz] Cardiol Res Inst, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Canziani, MEF (corresponding author), Univ Fed Sao Paulo, Dept Internal Med, Div Nephrol, Sao Paulo, Brazil.	dialisefor@uol.com.br	Canziani, Maria E F/AGI-3240-2022; Bonato, Fabiana O Bastos/K-1253-2014	Bonato, Fabiana O Bastos/0000-0003-1566-4224				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Barreto DV, 2005, KIDNEY INT, V67, P1576, DOI 10.1111/j.1523-1755.2005.00239.x; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; BIGGER JT, 1984, CIRCULATION, V69, P250, DOI 10.1161/01.CIR.69.2.250; Bleyer AJ, 2006, KIDNEY INT, V69, P2268, DOI 10.1038/sj.ki.5000446; Busari O, 2010, CARDIOL J, V17, P281; Canziani M E, 1993, Perit Dial Int, V13 Suppl 2, pS409; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060008; Cheung AK, 2004, KIDNEY INT, V65, P2380, DOI 10.1111/j.1523-1755.2004.00657.x; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; Churchill DN, 1996, J AM SOC NEPHROL, V7, P198; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Eloot S, 2011, CLIN J AM SOC NEPHRO, V6, P1266, DOI 10.2215/CJN.09981110; Floege J, 2004, NEPHROL DIAL TRANSPL, V19, P59, DOI 10.1093/ndt/gfh1058; Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; GOWDA R.M., 2006, CARDIOLOGY, V15, P296; Herzog CA, 2008, SEMIN DIALYSIS, V21, P300, DOI 10.1111/j.1525-139X.2008.00455.x; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Kalantar-Zadeh K, 2009, J AM SOC NEPHROL, V20, P479, DOI 10.1681/ASN.2007070728; Kleiger RE, 2005, ANN NONINVAS ELECTRO, V10, P88, DOI 10.1111/j.1542-474X.2005.10101.x; Kong MH, 2011, CARDIOL J, V18, P503, DOI 10.5603/CJ.2011.0005; Lampert R, 2004, J AM COLL CARDIOL, V43, P2293, DOI 10.1016/j.jacc.2004.03.031; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Marcassi AP, 2011, TRANSPL INT, V24, P67, DOI 10.1111/j.1432-2277.2010.01149.x; McCullough PA, 2011, AM J KIDNEY DIS, V57, pS1, DOI 10.1053/j.ajkd.2010.11.011; Moe SM, 2004, NEPHROL DIAL TRANSPL, V19, P2387, DOI 10.1093/ndt/gfh303; MUKHARJI J, 1984, AM J CARDIOL, V54, P31, DOI 10.1016/0002-9149(84)90299-6; Neirynck N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044201; OBRIEN E, 1988, LANCET, V2, P397; Oxenham H, 2003, EUR J HEART FAIL, V5, P427, DOI 10.1016/S1388-9842(03)00011-4; Paoletti E, 2004, NEPHROL DIAL TRANSPL, V19, P1829, DOI 10.1093/ndt/gfh288; Parfrey PS, 2005, J AM SOC NEPHROL, V16, P2180, DOI 10.1681/ASN.2004121039; Pun PH, 2012, BLOOD PURIFICAT, V33, P183, DOI 10.1159/000334154; Pun PH, 2009, KIDNEY INT, V76, P652, DOI 10.1038/ki.2009.219; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Ranpuria R, 2008, NEPHROL DIAL TRANSPL, V23, P444, DOI 10.1093/ndt/gfm634; Reed MJ, 2005, QJM-INT J MED, V98, P87, DOI 10.1093/qjmed/hci018; Regidor DL, 2006, J AM SOC NEPHROL, V17, P1181, DOI 10.1681/ASN.2005090997; Rivero A, 2010, CURR OPIN CARDIOL, V25, P8, DOI 10.1097/HCO.0b013e328333f95f; Roberts MA, 2011, AM J KIDNEY DIS, V58, P64, DOI 10.1053/j.ajkd.2011.01.024; Royal College of Physicians (The National Collaborating Centre for Chronic Conditions - UK), 2008, NATL I HLTH CLIN EXC, V73, P1; Russo D, 2004, AM J KIDNEY DIS, V44, P1024, DOI 10.1053/j.ajkd.2004.07.022; SARAGOCA MA, 1991, J CARDIOVASC PHARM, V17, pS136, DOI 10.1097/00005344-199117002-00032; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Slinin Y, 2005, J AM SOC NEPHROL, V16, P1788, DOI 10.1681/ASN.2004040275; Tomiyama C, 2006, NEPHROL DIAL TRANSPL, V21, P2464, DOI 10.1093/ndt/gfl291; Verrier RL, 2004, CURR OPIN CARDIOL, V19, P2, DOI 10.1097/00001573-200401000-00003; Wang AYM, 2010, HYPERTENSION, V56, P210, DOI 10.1161/HYPERTENSIONAHA.110.151167; Watanabe R, 2010, CLIN J AM SOC NEPHRO, V5, P189, DOI 10.2215/CJN.06240909; WEBB JG, 1986, CAN MED ASSOC J, V135, P753; Wolbrette D, 2002, CLIN CARDIOL, V25, P49, DOI 10.1002/clc.4950250203; Yang W, 2007, J AM SOC NEPHROL, V18, P3164, DOI 10.1681/ASN.2007010058; Zoccali C, 2010, HYPERTENSION, V56, P187, DOI 10.1161/HYPERTENSIONAHA.110.151829	54	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66036	10.1371/journal.pone.0066036	http://dx.doi.org/10.1371/journal.pone.0066036			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762460	Green Published, Green Submitted, gold			2022-12-25	WOS:000321094800084
J	Casteels, C; Vunckx, K; Aelvoet, SA; Baekelandt, V; Bormans, G; Van Laere, K; Koole, M				Casteels, Cindy; Vunckx, Kathleen; Aelvoet, Sarah-Ann; Baekelandt, Veerle; Bormans, Guy; Van Laere, Koen; Koole, Michel			Construction and Evaluation of Quantitative Small-Animal PET Probabilistic Atlases for [F-18]FDG and [F-18]FECT Functional Mapping of the Mouse Brain	PLOS ONE			English	Article							PERFORMANCE EVALUATION; GLUCOSE-METABOLISM; TRANSPORTER; SPECT; REGISTRATION; MICE; QUANTIFICATION; STABILITY; MICROPET; F-18-FDG	Automated voxel-based or pre-defined volume-of-interest (VOI) analysis of small-animal PET data in mice is necessary for optimal information usage as the number of available resolution elements is limited. We have mapped metabolic ([F-18]FDG) and dopamine transporter ([F-18]FECT) small-animal PET data onto a 3D Magnetic Resonance Microscopy (MRM) mouse brain template and aligned them in space to the Paxinos co-ordinate system. In this way, ligand-specific templates for sensitive analysis and accurate anatomical localization were created. Next, using a pre-defined VOI approach, test-retest and intersubject variability of various quantification methods were evaluated. Also, the feasibility of mouse brain statistical parametric mapping (SPM) was explored for [F-18]FDG and [F-18]FECT imaging of 6-hydroxydopamine-lesioned (6-OHDA) mice. Methods: Twenty-three adult C57BL6 mice were scanned with [F-18]FDG and [F-18]FECT. Registrations and affine spatial normalizations were performed using SPM8. [F-18]FDG data were quantified using (1) an image-derived-input function obtained from the liver (cMR(glc)), using (2) standardized uptake values (SUVglc) corrected for blood glucose levels and by (3) normalizing counts to the whole-brain uptake. Parametric [F-18]FECT binding images were constructed by reference to the cerebellum. Registration accuracy was determined using random simulated misalignments and vectorial mismatch determination. Results: Registration accuracy was between 0.21-1.11 mm. Regional intersubject variabilities of cMR(glc) ranged from 15.4% to 19.2%, while test-retest values were between 5.0% and 13.0%. For [F-18]FECT uptake in the caudate-putamen, these values were 13.0% and 10.3%, respectively. Regional values of cMR(glc) positively correlated to SUVglc measured within the 45-60 min time frame (spearman r = 0.71). Next, SPM analysis of 6-OHDA-lesioned mice showed hypometabolism in the bilateral caudate-putamen and cerebellum, and an unilateral striatal decrease in DAT availability. Conclusion: MRM-based small-animal PET templates facilitate accurate assessment and spatial localization of mouse brain function using VOI or voxel-based analysis. Regional intersubject- and test-retest variations indicate that for these targets accuracy comparable to humans can be achieved.	[Casteels, Cindy; Vunckx, Kathleen; Van Laere, Koen; Koole, Michel] Katholieke Univ Leuven, Dept Imaging & Pathol, Div Nucl Med, Louvain, Belgium; [Casteels, Cindy; Aelvoet, Sarah-Ann; Baekelandt, Veerle; Bormans, Guy; Van Laere, Koen; Koole, Michel] Katholieke Univ Leuven, MoSAIC Mol Small Anim Imaging Ctr, Louvain, Belgium; [Vunckx, Kathleen] Univ Hosp, MIRC, Louvain, Belgium; [Vunckx, Kathleen] Katholieke Univ Leuven, Louvain, Belgium; [Aelvoet, Sarah-Ann; Baekelandt, Veerle] Katholieke Univ Leuven, Dept Neurosci, Lab Neurobiol & Gene Therapy, Louvain, Belgium; [Bormans, Guy] Katholieke Univ Leuven, Lab Radiopharmaceut Chem, Dept Pharmaceut & Pharmacol Sci, Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven; KU Leuven; KU Leuven	Casteels, C (corresponding author), Katholieke Univ Leuven, Dept Imaging & Pathol, Div Nucl Med, Louvain, Belgium.	cindy.casteels@med.kuleuven.be	Van der Linden, Annemie/L-7855-2017; Baekelandt, Veerle/ABB-9736-2020	Van der Linden, Annemie/0000-0003-2941-6520; Baekelandt, Veerle/0000-0001-8966-2921; Koole, Michel/0000-0001-5862-640X	government agency for Innovation by Science and Technology (IWT) [IWT-SBO-060819 Quantiviam]; European Commission (INMiND) [278850]; KU Leuven In Vivo Molecular Imaging (IMIR) Consortium [KUL PF/10/017]	government agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); European Commission (INMiND); KU Leuven In Vivo Molecular Imaging (IMIR) Consortium	Financial support of the government agency for Innovation by Science and Technology (IWT; IWT-SBO-060819 Quantiviam), the European Commission (FP7/2007-2013, INMiND, grant agreement number 278850) and the KU Leuven In Vivo Molecular Imaging (IMIR) Consortium (KUL PF/10/017) is gratefully acknowledged. Cindy Casteels and Kathleen Vunckx are postdoctoral fellows of the Flemish Fund for Scientific Research (FWO), Sarah-Ann Aelvoet is a doctoral fellow of the IWT and Koen Van Laere is a senior clinical investigator of FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Boellaard R, 2001, J NUCL MED, V42, P808; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Casteels C, 2006, J NUCL MED, V47, P1858; Chitneni SK, 2008, NUCL MED BIOL, V35, P75, DOI 10.1016/j.nucmedbio.2007.09.001; Constantinescu CC, 2009, PHYS MED BIOL, V54, P2885, DOI 10.1088/0031-9155/54/9/020; Dogdas B, 2007, PHYS MED BIOL, V52, P577, DOI 10.1088/0031-9155/52/3/003; Eberl S, 1996, J NUCL MED, V37, P137; Fischer K, 2012, NEUROIMAGE, V59, P2413, DOI 10.1016/j.neuroimage.2011.08.109; FOX PT, 1985, J COMPUT ASSIST TOMO, V9, P141, DOI 10.1097/00004728-198501000-00025; Ghosh A, 2005, J BIOL CHEM, V280, P11114, DOI 10.1074/jbc.M410894200; Gutierrez DF, 2012, EUR J NUCL MED MOL I, V39, P1807, DOI 10.1007/s00259-012-2188-7; Haller J, 2012, CURR OPIN PSYCHIATR, V25, P59, DOI 10.1097/YCO.0b013e32834de34f; Hjornevik Trine, 2007, Front Neuroinform, V1, P4, DOI 10.3389/neuro.11.004.2007; Huang SC, 2000, NUCL MED BIOL, V27, P643; Ichise M, 2003, J CEREBR BLOOD F MET, V23, P1096, DOI 10.1097/01.WCB.0000085441.37552.CA; Johnson GA, 2002, RADIOLOGY, V222, P789, DOI 10.1148/radiol.2223010531; KEYES JW, 1995, J NUCL MED, V36, P1836; Kovacevic N, 2005, CEREB CORTEX, V15, P639, DOI 10.1093/cercor/bhh165; Ma Y, 2008, FRONT NEUROANAT, V2, DOI 10.3389/neuro.05.001.2008; MacKenzie-Graham A, 2004, J ANAT, V204, P93, DOI 10.1111/j.1469-7580.2004.00264.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Paxinos G., 2001, MOUSE BRAIN ATLAS ST; Poisnel G, 2012, NEUROBIOL AGING, V33, P1995, DOI 10.1016/j.neurobiolaging.2011.09.026; Rowland DJ, 2008, SEMIN NUCL MED, V38, P209, DOI 10.1053/j.semnuclmed.2008.01.004; Rubins DJ, 2003, NEUROIMAGE, V20, P2100, DOI 10.1016/j.neuroimage.2003.07.011; Schiffer WK, 2007, J NUCL MED, V48, P277; Schweinhardt P, 2003, J NEUROSCI METH, V129, P105, DOI 10.1016/S0165-0270(03)00192-4; St James S, 2009, PHYS MED BIOL, V54, P4605, DOI 10.1088/0031-9155/54/14/015; SYCHRA JJ, 1994, MED PHYS, V21, P1585, DOI 10.1118/1.597412; Tai YC, 2005, J NUCL MED, V46, P455; Toyama H, 2004, NUCL MED BIOL, V31, P251, DOI 10.1016/S0969-8051(03)00124-0; Tsuchida T, 2004, ANN NUCL MED, V18, P609, DOI 10.1007/BF02984583; TYLER JL, 1988, J NUCL MED, V29, P631; Van Laere KJ, 2002, J NUCL MED, V43, P458; Votaw JR, 2004, ANESTHESIOLOGY, V101, P1128, DOI 10.1097/00000542-200411000-00012; Wong KP, 2011, J NUCL MED, V52, P800, DOI 10.2967/jnumed.110.085092; Wu HM, 2007, J NUCL MED, V48, P837, DOI 10.2967/jnumed.106.038182; Yu AS, 2009, J NUCL MED, V50, P966, DOI 10.2967/jnumed.108.060533	39	16	16	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65286	10.1371/journal.pone.0065286	http://dx.doi.org/10.1371/journal.pone.0065286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762335	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800034
J	Lu, ZH; Huang, XL; Ouyang, YD; Yao, JL				Lu, Zhanhua; Huang, Xiaolong; Ouyang, Yidan; Yao, Jialing			Genome-Wide Identification, Phylogenetic and Co-Expression Analysis of OsSET Gene Family in Rice	PLOS ONE			English	Article							SET-DOMAIN PROTEINS; POLYCOMB-GROUP GENE; MADS-BOX PROTEIN; DNA METHYLATION; HISTONE H3; LYSINE METHYLTRANSFERASES; ARABIDOPSIS HOMOLOGS; TRANSCRIPTION FACTOR; CONTROLS EXPRESSION; MERISTEM IDENTITY	Background: SET domain is responsible for the catalytic activity of histone lysine methyltransferases (HKMTs) during developmental process. Histone lysine methylation plays a crucial and diverse regulatory function in chromatin organization and genome function. Although several SET genes have been identified and characterized in plants, the understanding of OsSET gene family in rice is still very limited. Methodology/Principal Findings: In this study, a systematic analysis was performed and revealed the presence of at least 43 SET genes in rice genome. Phylogenetic and structural analysis grouped SET proteins into five classes, and supposed that the domains out of SET domain were significant for the specific of histone lysine methylation, as well as the recognition of methylated histone lysine. Based on the global microarray, gene expression profile revealed that the transcripts of OsSET genes were accumulated differentially during vegetative and reproductive developmental stages and preferentially up or down-regulated in different tissues. Cis-elements identification, co-expression analysis and GO analysis of expression correlation of 12 OsSET genes suggested that OsSET genes might be involved in cell cycle regulation and feedback. Conclusions/Significance: This study will facilitate further studies on OsSET family and provide useful clues for functional validation of OsSETs.	[Lu, Zhanhua] Huazhong Agr Univ, Coll Hort & Forestry Sci, Wuhan, Peoples R China; [Huang, Xiaolong; Yao, Jialing] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan, Peoples R China; [Ouyang, Yidan] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Ouyang, Yidan] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Ouyang, YD (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	diana1983941@mail.hzau.edu.cn; yaojlmy@mail.hzau.edu.cn			National Natural Science Foundation of China [30971551]; Fundamental Research Funds for the Central Universities [2012MBDX012]; Specialized Research Fund for the Doctoral Program of Higher Education [20100146120034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported by grants from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm; grant number 30971551), the Fundamental Research Funds for the Central Universities (http://www.dost.moe.edu.cn/; grant number 2012MBDX012), and the Specialized Research Fund for the Doctoral Program of Higher Education (http://www.cutech.edu.cn/cn/index.htm; grant number 20100146120034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Adamczyk BJ, 2009, PLANT PHYSIOL, V149, P1713, DOI 10.1104/pp.109.135806; Ageez A, 2005, GENES GENET SYST, V80, P403, DOI 10.1266/ggs.80.403; Alvarez-Venegas R, 2003, CURR BIOL, V13, P627, DOI 10.1016/S0960-9822(03)00243-4; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Avramova Z, 2009, INT J DEV BIOL, V53, P371, DOI 10.1387/ijdb.082664za; Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; Baumbusch LO, 2001, NUCLEIC ACIDS RES, V29, P4319, DOI 10.1093/nar/29.21.4319; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Caro E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002995; de Jager SM, 2001, PLANT MOL BIOL, V47, P555, DOI 10.1023/A:1011848528377; Valencia-Morales MD, 2012, J PLANT RES, V125, P679, DOI 10.1007/s10265-012-0485-7; Dimova DK, 2003, GENE DEV, V17, P2308, DOI 10.1101/gad.1116703; Ding B, 2007, PLANT SCI, V172, P1072, DOI 10.1016/j.plantsci.2007.03.009; Ding Y, 2007, PLANT CELL, V19, P9, DOI 10.1105/tpc.106.048124; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Ebbs ML, 2005, MOL CELL BIOL, V25, P10507, DOI 10.1128/MCB.25.23.10507-10515.2005; Erilova A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000663; Fu FF, 2010, PLANT PHYSIOL, V154, P927, DOI 10.1104/pp.110.159517; Gao XC, 2010, PLANT PHYSIOL, V153, P728, DOI 10.1104/pp.110.156711; Gendler K, 2008, NUCLEIC ACIDS RES, V36, pD298, DOI 10.1093/nar/gkm768; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; Grini PE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007817; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Guo J, 2007, PLANT MOL BIOL, V64, P349, DOI 10.1007/s11103-007-9154-y; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Helin K, 1998, CURR OPIN GENET DEV, V8, P28, DOI 10.1016/S0959-437X(98)80058-0; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Horton JR, 2007, PROTEINS, V67, P1198, DOI 10.1002/prot.21352; Hu P, 2008, J AM CHEM SOC, V130, P3806, DOI 10.1021/ja075896n; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; Kim GT, 1998, PLANTA, V206, P175, DOI 10.1007/s004250050389; Kinoshita T, 1999, PLANT CELL, V11, P1945, DOI 10.1105/tpc.11.10.1945; Kobayashi K, 2012, PLANT CELL, V24, P1848, DOI 10.1105/tpc.112.097105; Kobayashi K, 2010, PLANT CELL PHYSIOL, V51, P47, DOI 10.1093/pcp/pcp166; Kohler C, 2010, CURR OPIN GENET DEV, V20, P541, DOI 10.1016/j.gde.2010.04.015; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Kosugi S, 2002, PLANT J, V29, P45, DOI 10.1046/j.1365-313x.2002.01196.x; Kyozuka J, 2000, PLANT CELL PHYSIOL, V41, P710, DOI 10.1093/pcp/41.6.710; La HG, 2006, MOL GENET GENOMICS, V275, P374, DOI 10.1007/s00438-005-0093-5; Lee JS, 2007, MUTAT RES-FUND MOL M, V618, P130, DOI 10.1016/j.mrfmmm.2006.08.014; Liang YK, 2003, J EXP BOT, V54, P1995, DOI 10.1093/jxb/erg201; Luo M, 2009, MOL PLANT, V2, P711, DOI 10.1093/mp/ssp036; Marmorstein R, 2003, TRENDS BIOCHEM SCI, V28, P59, DOI 10.1016/S0968-0004(03)00007-0; Ng DWK, 2007, BBA-GENE STRUCT EXPR, V1769, P316, DOI 10.1016/j.bbaexp.2007.04.003; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nowack MK, 2012, DEV CELL, V22, P1030, DOI 10.1016/j.devcel.2012.02.015; Ouyang YD, 2012, BMC GENOMICS, V13, DOI [10.1186/1471-2164-13-100, 10.1186/1471-2164-14-396]; Ouyang YD, 2009, PLANT MOL BIOL, V70, P341, DOI 10.1007/s11103-009-9477-y; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Pontvianne F, 2012, GENE DEV, V26, P945, DOI 10.1101/gad.182865.111; Pontvianne F, 2010, ADV BOT RES, V53, P1, DOI 10.1016/S0065-2296(10)53001-5; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Qi RH, 2007, PLANT PHYSIOL, V144, P1587, DOI 10.1104/pp.107.096834; Qin FJ, 2010, MOL PLANT, V3, P773, DOI 10.1093/mp/ssq030; Rattray AMJ, 2012, BIOCHEM SOC T, V40, P880, DOI 10.1042/BST20120065; Raynaud C, 2006, PLANT J, V47, P395, DOI 10.1111/j.1365-313X.2006.02799.x; ROBERTS MR, 1993, PLANT J, V3, P111, DOI 10.1111/j.1365-313X.1993.tb00014.x; Saleh A, 2008, PLANT CELL, V20, P568, DOI 10.1105/tpc.107.056614; Saleh A, 2007, NUCLEIC ACIDS RES, V35, P6290, DOI 10.1093/nar/gkm464; Sanchez MD, 2008, SEMIN CELL DEV BIOL, V19, P537, DOI 10.1016/j.semcdb.2008.07.014; Sang XC, 2012, PLANT PHYSIOL, V160, P788, DOI 10.1104/pp.112.200980; Schatlowski N, 2010, PLANT CELL, V22, P2291, DOI 10.1105/tpc.109.073403; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shen WH, 2002, TRENDS PLANT SCI, V7, P505, DOI 10.1016/S1360-1385(02)02351-8; Shultz RW, 2007, PLANT PHYSIOL, V144, P1697, DOI 10.1104/pp.107.101105; Spiliotopoulos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046902; Springer NM, 2003, PLANT PHYSIOL, V132, P907, DOI 10.1104/pp.102.013722; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sun CH, 2012, PLANT CELL, V24, P3235, DOI 10.1105/tpc.112.101436; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thakur JK, 2003, GENE, V314, P1, DOI 10.1016/S0378-1119(03)00723-6; Thorstensen T, 2008, PLANT MOL BIOL, V66, P47, DOI 10.1007/s11103-007-9251-y; Trievel RC, 2003, NAT STRUCT BIOL, V10, P545, DOI 10.1038/nsb946; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; van Ingen H, 2008, STRUCTURE, V16, P1245, DOI 10.1016/j.str.2008.04.015; Vandepoele K, 2005, PLANT PHYSIOL, V139, P316, DOI 10.1104/pp.105.066290; Veiseth SV, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001325; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Wang Y, 2009, MOL CELL, V33, P428, DOI 10.1016/j.molcel.2009.02.002; Williams L, 2000, TRENDS PLANT SCI, V5, P239, DOI 10.1016/S1360-1385(00)01653-8; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Xu L, 2008, CURR BIOL, V18, P1966, DOI 10.1016/j.cub.2008.11.019; Yao SG, 2008, PLANT CELL PHYSIOL, V49, P853, DOI 10.1093/pcp/pcn050; Yu Y, 2009, PROG NAT SCI-MATER, V19, P407, DOI 10.1016/j.pnsc.2008.07.015; Zhao XA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002847	100	20	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65426	10.1371/journal.pone.0065426	http://dx.doi.org/10.1371/journal.pone.0065426			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762371	gold, Green Published, Green Submitted			2022-12-25	WOS:000321094800049
J	Makinodan, M; Okuda-Yamamoto, A; Ikawa, D; Toritsuka, M; Takeda, T; Kimoto, S; Tatsumi, K; Okuda, H; Nakamura, Y; Wanaka, A; Kishimoto, T				Makinodan, Manabu; Okuda-Yamamoto, Aya; Ikawa, Daisuke; Toritsuka, Michihiro; Takeda, Tomohiko; Kimoto, Sohei; Tatsumi, Kouko; Okuda, Hiroaki; Nakamura, Yu; Wanaka, Akio; Kishimoto, Toshifumi			Oligodendrocyte Plasticity with an Intact Cell Body In Vitro	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; NMDA RECEPTORS; RAT MODEL; MYELINATION; PATHOGENESIS; INJURY; DEATH	Demyelination is generally regarded as a consequence of oligodendrocytic cell death. Oligodendrocyte processes that form myelin sheaths may, however, degenerate and regenerate independently of the cell body, in which case cell death does not necessarily occur. We provide here the first evidence of retraction and regeneration of oligodendrocyte processes with no cell death in vitro, using time-lapse imaging. When processes were severed mechanically in vitro, the cells did not undergo cell death and the processes regenerated in 36 h. In a separate experiment, moderate N-methyl-D-aspartate (NMDA) stimuli caused process retraction without apparent cell death, and the processes regained their elaborate morphology after NMDA was removed from the culture medium. These results strongly suggest that demyelination and remyelination can take place without concomitant cell death, at least in vitro. Process regeneration may therefore become a target for future therapy of demyelinating disorders.	[Makinodan, Manabu; Ikawa, Daisuke; Toritsuka, Michihiro; Takeda, Tomohiko; Kimoto, Sohei; Kishimoto, Toshifumi] Nara Med Univ, Dept Psychiat, Nara, Japan; [Tatsumi, Kouko; Okuda, Hiroaki; Wanaka, Akio] Nara Med Univ, Dept Anat & Neurosci, Nara, Japan; [Okuda-Yamamoto, Aya; Nakamura, Yu] Kagawa Univ, Dept Psychiat & Neurol, Takamatsu, Kagawa 760, Japan	Nara Medical University; Nara Medical University; Kagawa University	Makinodan, M (corresponding author), Nara Med Univ, Dept Psychiat, Nara, Japan.	mmm@naramed-u.ac.jp	Wanaka, Akio/GPW-8926-2022; Okuda, Hiroaki/S-4959-2019; Wanaka, Akio/AAC-9754-2019; Wanaka, Akio/ABE-4671-2020; Okuda, Hiroaki/E-9418-2018	Okuda, Hiroaki/0000-0002-6252-9634; Wanaka, Akio/0000-0001-9951-9862; Okuda, Hiroaki/0000-0002-6252-9634; Kimoto, Sohei/0000-0002-3148-690X	Ministry of Education, Culture, Sports, and Science of Japanese Government	Ministry of Education, Culture, Sports, and Science of Japanese Government	Grant-in-Aid from the Ministry of Education, Culture, Sports, and Science of Japanese Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butt AM, 2006, GLIA, V54, P666, DOI 10.1002/glia.20424; Colaianna M, 2013, ANTIOXID REDOX SIGN, V18, P1385, DOI 10.1089/ars.2012.4569; Cudrici C, 2006, J REHABIL RES DEV, V43, P123, DOI 10.1682/JRRD.2004.08.0111; Duncan ID, 2008, J NEUROL SCI, V265, P89, DOI 10.1016/j.jns.2007.04.043; Fernandez-Gamba A, 2012, J NEUROCHEM, V121, P985, DOI 10.1111/j.1471-4159.2012.07742.x; Greenberg BM, 2008, SEMIN NEUROL, V28, P121, DOI 10.1055/s-2007-1019133; Islam MS, 2009, NEUROCHEM INT, V54, P192, DOI 10.1016/j.neuint.2008.10.011; Itoh K, 2002, BRAIN RES PROTOC, V10, P23; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Jiang Z, 2013, BIOL PSYCHI IN PRESS; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Korde AS, 2012, J BIOL CHEM, V287, P35192, DOI 10.1074/jbc.M111.322032; Lassmann H, 2003, BRAIN, V126, P1347, DOI 10.1093/brain/awg127; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Manning SM, 2008, J NEUROSCI, V28, P6670, DOI 10.1523/JNEUROSCI.1702-08.2008; Matute C, 2005, TRENDS NEUROSCI, V28, P173, DOI 10.1016/j.tins.2005.01.006; Matute C, 2007, NEURON GLIA BIOL, V3, P281, DOI 10.1017/S1740925X08000033; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Micu I, 2007, NAT MED, V13, P874, DOI 10.1038/nm1568; Mirsky R, 2008, J PERIPHER NERV SYST, V13, P122, DOI 10.1111/j.1529-8027.2008.00168.x; Newcombe J, 2008, BRAIN PATHOL, V18, P52, DOI 10.1111/j.1750-3639.2007.00101.x; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Rodriguez M, 1999, NEUROLOGY, V53, P1615, DOI 10.1212/WNL.53.8.1615; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; SHOLL DA, 1953, J ANAT, V87, P387; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J	28	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66124	10.1371/journal.pone.0066124	http://dx.doi.org/10.1371/journal.pone.0066124			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762472	Green Submitted, Green Published, gold			2022-12-25	WOS:000321094800090
J	McRae, AF; Richter, MM; Lind, PA				McRae, Allan F.; Richter, Melinda M.; Lind, Penelope A.			Case-Control Association Testing of Common Variants from Sequencing of DNA Pools	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ADH4 GENE VARIATION; ALCOHOL DEPENDENCE; ETHANOL-METABOLISM; DRUG-DEPENDENCE; RISK	While genome-wide association studies (GWAS) have been successful in identifying a large number of variants associated with disease, the challenge of locating the underlying causal loci remains. Sequencing of case and control DNA pools provides an inexpensive method for assessing all variation in a genomic region surrounding a significant GWAS result. However, individual variants need to be ranked in terms of the strength of their association to disease in order to prioritise follow-up by individual genotyping. A simple method for testing for case-control association in sequence data from DNA pools is presented that allows the partitioning of the variance in allele frequency estimates into components due to the sampling of chromosomes from the pool during sequencing, sampling individuals from the population and unequal contribution from individuals during pool construction. The utility of this method is demonstrated on a sequence from the alcohol dehydrogenase (ADH) gene cluster on a case-control sample for heavy alcohol consumption.	[McRae, Allan F.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [McRae, Allan F.; Richter, Melinda M.; Lind, Penelope A.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	University of Queensland; QIMR Berghofer Medical Research Institute	McRae, AF (corresponding author), Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia.	a.mcrae@uq.edu.au	McRae, Allan F/J-2644-2014; Lind, Penelope A/B-2553-2009; Lind, Penelope A/ABC-5341-2021	McRae, Allan F/0000-0001-5286-5485; Lind, Penelope A/0000-0002-3887-2598; Lind, Penelope A/0000-0002-3887-2598	Alcohol and Health Research Grant Scheme; Lion Nathan Limited; Australian National Health and Medical Research Council [NHMRC 552482, 1010374]	Alcohol and Health Research Grant Scheme; Lion Nathan Limited; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a grant from the Alcohol and Health Research Grant Scheme funded by Lion Nathan Limited and Australian National Health and Medical Research Council project grants (NHMRC 552482 and 1010374). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Anderson CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000580; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Chen XW, 2012, GENET EPIDEMIOL, V36, P549, DOI 10.1002/gepi.21648; Chen YC, 2009, CHEM-BIOL INTERACT, V178, P2, DOI 10.1016/j.cbi.2008.10.029; Craig JE, 2009, GENOME RES, V19, P2075, DOI 10.1101/gr.094680.109; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Druley TE, 2009, NAT METHODS, V6, P263, DOI [10.1038/NMETH.1307, 10.1038/nmeth.1307]; Edenberg HJ, 2006, HUM MOL GENET, V15, P1539, DOI 10.1093/hmg/ddl073; Grant JD, 2009, BIOL PSYCHIAT, V66, P795, DOI 10.1016/j.biopsych.2009.05.018; Heath AC, 2011, BIOL PSYCHIAT, V70, P513, DOI 10.1016/j.biopsych.2011.02.028; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Kim SY, 2010, GENET EPIDEMIOL, V34, P479, DOI 10.1002/gepi.20501; Kimura Y, 2009, J TOXICOL SCI, V34, P89, DOI 10.2131/jts.34.89; Lee JS, 2011, GENET EPIDEMIOL, V35, P139, DOI 10.1002/gepi.20561; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo XG, 2006, NEUROPSYCHOPHARMACOL, V31, P1085, DOI 10.1038/sj.npp.1300925; Luo XG, 2005, PHARMACOGENET GENOM, V15, P755, DOI 10.1097/01.fpc.0000180141.77036.dc; Macgregor S, 2009, HUM MOL GENET, V18, P580, DOI 10.1093/hmg/ddn372; Macgregor S, 2007, EUR J HUM GENET, V15, P501, DOI 10.1038/sj.ejhg.5201768; Niranjan TS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r93; Preuss UW, 2011, ADDICT BIOL, V16, P323, DOI 10.1111/j.1369-1600.2010.00236.x; Quertemont E, 2004, MOL PSYCHIATR, V9, P570, DOI 10.1038/sj.mp.4001497; Turchi C, 2012, PHARMACOGENET GENOM, V22, P79, DOI 10.1097/FPC.0b013e32834d05c8; Visscher PM, 2003, GENET EPIDEMIOL, V24, P291, DOI 10.1002/gepi.10240; Wang T, 2010, GENET EPIDEMIOL, V34, P492, DOI 10.1002/gepi.20502; Wray NR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000579	29	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65410	10.1371/journal.pone.0065410	http://dx.doi.org/10.1371/journal.pone.0065410			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762362	Green Published, Green Submitted, gold			2022-12-25	WOS:000321094800045
J	Pal, P; Lochab, S; Kanaujiya, JK; Kapoor, I; Sanyal, S; Behre, G; Trivedi, AK				Pal, Pooja; Lochab, Savita; Kanaujiya, Jitendra Kumar; Kapoor, Isha; Sanyal, Sabyasachi; Behre, Gerhard; Trivedi, Arun Kumar			E3 Ubiquitin Ligase E6AP Negatively Regulates Adipogenesis by Downregulating Proadipogenic Factor C/EBPalpha	PLOS ONE			English	Article							ENHANCER-BINDING-PROTEIN; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; PROTEOMIC IDENTIFICATION; ANGELMAN-SYNDROME; ALPHA; DEGRADATION; MULTIPLE; PROMOTES	CCAAT/Enhancer Binding Protein Alpha (C/EBP alpha) is a key transcription factor involved in the adipocyte differentiation. Here for the first time we demonstrate that E6AP, an E3 ubiquitin ligase inhibits adipocyte differentiation in 3T3-L1 cells as revealed by reduced lipid staining with oil red. Knock down of E6AP in mouse 3T3L1 preadipocytes is sufficient to convert them to adipocytes independent of external hormonal induction. C/EBP alpha protein level is drastically increased in E6AP deficient 3T3L1 preadipocytes while inverse is observed when wild type E6AP is over expressed. We show that transient transfection of wild type E6AP downregulates C/EBP alpha protein expression in a dose dependent manner while catalytically inactive E6AP-C843A rather stabilizes it. In addition, wild type E6AP inhibits expression of proadipogenic genes while E6AP-C843A enhances them. More importantly, overexpression of E6AP-C843A in mesenchymal progenitor cells promotes accumulation of lipid droplets while there is drastically reduced lipid droplet formation when E6AP is over expressed. Taken together, our finding suggests that E6AP may negatively control adipogenesis by inhibiting C/EBP alpha expression by targeting it to ubiquitin-proteasome pathway for degradation.	[Pal, Pooja; Lochab, Savita; Kanaujiya, Jitendra Kumar; Kapoor, Isha; Sanyal, Sabyasachi; Trivedi, Arun Kumar] CSIR Cent Drug Res Inst, DTDD Div, LSS008, Lucknow, Uttar Pradesh, India; [Behre, Gerhard] Univ Hosp Leipzig, Div Hematol & Oncol, Leipzig, Germany	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Leipzig University	Trivedi, AK (corresponding author), CSIR Cent Drug Res Inst, DTDD Div, LSS008, Lucknow, Uttar Pradesh, India.	arun3vedi@cdri.res.in	Sanyal, Sabyasachi/E-8034-2010; Kanaujiya, Jitendra Kumar/W-1688-2019; Trivedi, Arun Kumar/W-1883-2019	Sanyal, Sabyasachi/0000-0002-8603-3828; Kanaujiya, Jitendra Kumar/0000-0002-0701-2210; Trivedi, Arun Kumar/0000-0002-6316-0947	CSIR-Central Drug Research Institute; CSIR [HCP0004, BSC0201i]; DBT grant [GAP00068]; ICMR Senior research fellowship	CSIR-Central Drug Research Institute; CSIR(Council of Scientific & Industrial Research (CSIR) - India); DBT grant; ICMR Senior research fellowship	The authors are sincerely thankful to CSIR-Central Drug Research Institute for its financial support in the completion of this project. This work was supported by CSIR grants HCP0004, BSC0201i and DBT grant GAP00068 to AKT, and ICMR Senior research fellowship to P Pal. Institutional (CSIR-CDRI), Institutional manuscript number for this article is 49/2012/AKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attie AD, 2009, J LIPID RES, V50, pS395, DOI 10.1194/jlr.R800057-JLR200; Auld CA, 2006, OBESITY, V14, P2136, DOI 10.1038/oby.2006.250; Bengoechea-Alonso MT, 2010, P NATL ACAD SCI USA, V107, P11817, DOI 10.1073/pnas.0913367107; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Cassidy SB, 1997, J MED GENET, V34, P917, DOI 10.1136/jmg.34.11.917; CHRISTY RJ, 1989, GENE DEV, V3, P1323, DOI 10.1101/gad.3.9.1323; Cooke PS, 2004, EXP BIOL MED, V229, P1127, DOI 10.1177/153537020422901107; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Eastman SW, 2009, J CELL BIOL, V184, P881, DOI 10.1083/jcb.200808041; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Gillessen-Kaesbach G, 1999, EUR J HUM GENET, V7, P638, DOI 10.1038/sj.ejhg.5200362; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P5249, DOI 10.1073/pnas.92.11.5249-a; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Lochab S, 2012, PROTEOMICS, V12, P1363, DOI 10.1002/pmic.201100572; Louria-Hayon I, 2009, CELL DEATH DIFFER, V16, P1156, DOI 10.1038/cdd.2009.31; MACDOUGALD OA, 1995, P NATL ACAD SCI USA, V92, P9034, DOI 10.1073/pnas.92.20.9034; MACDOUGALD OA, 1995, CURR BIOL, V5, P618, DOI 10.1016/S0960-9822(95)00125-4; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mishra A, 2009, NEUROBIOL DIS, V36, P26, DOI 10.1016/j.nbd.2009.06.010; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Muraglia A, 2000, J CELL SCI, V113, P1161; Pal P SL, 2013, CELL DEATH DIS, V4, DOI [10.1038/cddis.2013.1120, DOI 10.1038/CDDIS.2013.1120]; Pal P, 2011, PROTEOMICS, V11, P1517, DOI 10.1002/pmic.201000720; Pal P, 2010, MOL CELL BIOCHEM, V337, P111, DOI 10.1007/s11010-009-0290-3; Poyatos D, 2002, J Med Genet, V39, pE4, DOI 10.1136/jmg.39.2.e4; Rosen ED, 2000, GENE DEV, V14, P1293; Seufert J, 2004, DIABETES, V53, pS152, DOI 10.2337/diabetes.53.2007.S152; Shimoji T, 2009, J CELL BIOCHEM, V106, P1123, DOI 10.1002/jcb.22096; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Subramanian L, 2003, J BIOL CHEM, V278, P9134, DOI 10.1074/jbc.M210440200; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; Trivedi AK, 2008, EUR J CANCER, V44, P1516, DOI 10.1016/j.ejca.2008.04.022; Trivedi AK, 2007, ONCOGENE, V26, P1789, DOI 10.1038/sj.onc.1209964; UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644; Van Buggenhout G, 2009, EUR J HUM GENET, V17, P1367, DOI 10.1038/ejhg.2009.67	38	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65330	10.1371/journal.pone.0065330	http://dx.doi.org/10.1371/journal.pone.0065330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762344	Green Published, Green Submitted, gold			2022-12-25	WOS:000321094800040
J	Spate, LD; Murphy, CN; Prather, RS				Spate, Lee D.; Murphy, Clifton N.; Prather, Randall S.			High-Throughput Cryopreservation of In Vivo-Derived Swine Embryos	PLOS ONE			English	Article							LOW-TEMPERATURE PRESERVATION; VITRIFIED PORCINE EMBRYOS; VITRO-MATURED OOCYTES; LITTER SIZE; PIG EMBRYO; PIGLETS; BLASTOCYSTS; BIRTH; VITRIFICATION; DELIPATION	Cryopreservation of swine embryos is inefficient. Our goal was to develop a non-invasive method for "relatively" high-throughput cryopreservation of in vivo-produced swine embryos. Since removal of the lipid droplets within early swine embryos improves cryosurvival we wanted to apply a technique of high osmolality treatment followed by centrifugation that was first developed for in vitro-produced swine embryos to in vivo-produced swine embryos. The first aim was to determine how sensitive the in vivo-produced zygote and 2-cell stage embryo was to various high osmolality conditions for a short duration. Culture for 6, 12 or 18 min at 300, 400 or 500 milliosmoles (mOsm) had no detectable affect on the resulting blastocyst stage embryos (number of inner cell mass nuclei, trophectoderm nuclei, total number of nuclei, ratio of the trophectoderm to inner cell mass nuclei or percent blastocyst). However there was an effect of gilt on each of these parameters. For the second aim we focused on 300 mOsm for 6 min, 400 mOsm for 12 min, 500 mOsm for 12 min, and 500 mOsm for 18 min. The embryos were centrifuged for the duration of high osmolality treatment, then cultured to the blastocyst stage and vitrified. After vitrification and thawing the 500 mOsm for 18 min had the highest percent re-expansion with no difference in the total number of nuclei. While requiring a different base culture medium than in vitro-produced embryos, in vivo-derived embryos also survive cryopreservation without damage to their zona pellucida.	[Spate, Lee D.; Murphy, Clifton N.; Prather, Randall S.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Prather, RS (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	PratherR@Missouri.Edu		Prather, Randall/0000-0002-6012-4035	National Institutes of Health [R21 RR25879, U42 OD011140]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025879] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [U42OD011140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by the National Institutes of Health R21 RR25879 and U42 OD011140. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beebe LFS, 2005, THERIOGENOLOGY, V64, P879, DOI 10.1016/j.theriogenology.2004.12.014; Beebe LFS, 2002, THERIOGENOLOGY, V57, P2155, DOI 10.1016/S0093-691X(01)00720-8; Berthelot F, 2001, REPROD NUTR DEV, V41, P267, DOI 10.1051/rnd:2001129; Cameron RDA, 2004, THERIOGENOLOGY, V61, P1533, DOI 10.1016/j.theriogenology.2003.09.003; Dobrinsky JR, 2000, BIOL REPROD, V62, P564, DOI 10.1095/biolreprod62.3.564; Dobrinsky JR, 2002, THERIOGENOLOGY, V57, P285, DOI 10.1016/S0093-691X(01)00672-0; Dobrinsky JR, 1996, THERIOGENOLOGY, V45, P17, DOI 10.1016/0093-691X(95)00351-8; Du Y, 2007, CRYOBIOLOGY, V54, P181, DOI 10.1016/j.cryobiol.2007.01.001; Esaki R, 2004, BIOL REPROD, V71, P432, DOI 10.1095/biolreprod.103.026542; Fujino Y, 2007, THERIOGENOLOGY, V67, P413, DOI 10.1016/j.theriogenology.2006.08.008; HAGEN DR, 1991, J ANIM SCI, V69, P1147; Im GS, 2004, THERIOGENOLOGY, V61, P1125, DOI 10.1016/j.theriogenology.2003.06.006; Kikuchi K, 2002, ZYGOTE, V10, P355, DOI 10.1017/S0967199402004100; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; Li R, 2002, CHINESE J SCI AGR SI, V35, P1125; Li R, 2006, BIOL REPROD, V75, P226, DOI 10.1095/biolreprod.106.052514; Li RF, 2009, BIOL REPROD, V80, P563, DOI 10.1095/biolreprod.108.073387; Machaty Z, 1998, BIOL REPROD, V59, P451, DOI 10.1095/biolreprod59.2.451; McEvoy TG, 2000, J REPROD FERTIL, V118, P163, DOI 10.1530/reprod/118.1.163; Men H, 2011, THERIOGENOLOGY, V76, P280, DOI 10.1016/j.theriogenology.2011.02.004; Men HS, 2006, THERIOGENOLOGY, V66, P2008, DOI 10.1016/j.theriogenology.2006.05.018; Men HS, 2005, CRYOBIOLOGY, V51, P119, DOI 10.1016/j.cryobiol.2005.05.005; Misumi K, 2003, THERIOGENOLOGY, V60, P253, DOI 10.1016/S0093-691X(02)01364-X; Mullen SF, 2007, CRYOBIOLOGY, V54, P281, DOI 10.1016/j.cryobiol.2007.03.005; NAGASHIMA H, 1994, BIOL REPROD, V51, P618, DOI 10.1095/biolreprod51.4.618; NAGASHIMA H, 1989, Japanese Journal of Animal Reproduction, V35, P130; NAGASHIMA H, 1992, THERIOGENOLOGY, V37, P839, DOI 10.1016/0093-691X(92)90045-S; NAGASHIMA H, 1995, NATURE, V374, P416, DOI 10.1038/374416a0; Nagashima H, 2007, BIOL REPROD, V76, P900, DOI 10.1095/biolreprod.106.052779; Nagashima Hiroshi, 1999, Journal of Reproduction and Development, V45, P167, DOI 10.1262/jrd.45.167; NORBERG HS, 1973, Z ANAT ENTWICKLUNGS, V143, P95, DOI 10.1007/BF00519913; PETTERS RM, 1990, J REPROD FERTIL, V89, P269, DOI 10.1530/jrf.0.0890269; POLGE C, 1974, CRYOBIOLOGY, V11, P560, DOI 10.1016/0011-2240(74)90195-3; PRATHER RS, 1995, THERIOGENOLOGY, V43, P1001, DOI 10.1016/0093-691X(95)00064-F; Stringfellow D. A, 1998, MANUAL INT EMBRYO TR, P79; WILMUT I, 1972, J REPROD FERTIL, V31, P513; Wrathall AE, 1998, MANUAL INT EMBRYO TR, P17; Yoshioka K, 2002, BIOL REPROD, V66, P112, DOI 10.1095/biolreprod66.1.112	38	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65545	10.1371/journal.pone.0065545	http://dx.doi.org/10.1371/journal.pone.0065545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762391	Green Submitted, gold, Green Published			2022-12-25	WOS:000321094800062
J	Coni, S; Antonucci, L; D'Amico, D; Di Magno, L; Infante, P; De Smaele, E; Giannini, G; Di Marcotullio, L; Screpanti, I; Gulino, A; Canettieri, G				Coni, Sonia; Antonucci, Laura; D'Amico, Davide; Di Magno, Laura; Infante, Paola; De Smaele, Enrico; Giannini, Giuseppe; Di Marcotullio, Lucia; Screpanti, Isabella; Gulino, Alberto; Canettieri, Gianluca			Gli2 Acetylation at Lysine 757 Regulates Hedgehog-Dependent Transcriptional Output by Preventing Its Promoter Occupancy	PLOS ONE			English	Article							HISTONE DEACETYLASE; CANCER; CELLS	The morphogenic Hedgehog (Hh) signaling regulates postnatal cerebellar development and its aberrant activation leads to medulloblastoma. The transcription factors Gli1 and Gli2 are the activators of Hh pathway and their function is finely controlled by different covalent modifications, such as phosphorylation and ubiquitination. We show here that Gli2 is endogenously acetylated and that this modification represents a key regulatory step for Hedgehog signaling. The histone acetyltransferase (HAT) coactivator p300, but not other HATs, acetylates Gli2 at the conserved lysine K757 thus inhibiting Hh target gene expression. By generating a specific anti acetyl-Gli2(Lys757) antisera we demonstrated that Gli2 acetylation is readily detectable at endogenous levels and is attenuated by Hh agonists. Moreover, Gli2 K757R mutant activity is higher than wild type Gli2 and is no longer enhanced by Hh agonists, indicating that acetylation represents an additional level of control for signal dependent activation. Consistently, in sections of developing mouse cerebella Gli2 acetylation correlates with the activation status of Hedgehog signaling. Mechanistically, acetylation at K757 prevents Gli2 entry into chromatin. Together, these data illustrate a novel mechanism of regulation of the Hh signaling whereby, in concert with Gli1, Gli2 acetylation functions as a key transcriptional checkpoint in the control of morphogen-dependent processes.	[Coni, Sonia] CNRS, Ctr Biochim, Inst Biol Valrose iBV, UMR 7277,Inserm 1091, F-06034 Nice, France; [Coni, Sonia] Univ Nice Sophia Antipolis, F-06189 Nice, France; [Antonucci, Laura; D'Amico, Davide; Di Magno, Laura; Di Marcotullio, Lucia; Screpanti, Isabella; Gulino, Alberto; Canettieri, Gianluca] Univ Roma La Sapienza, Dept Mol Med, I-00185 Rome, Italy; [Infante, Paola; Screpanti, Isabella] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [De Smaele, Enrico; Giannini, Giuseppe] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Gulino, Alberto] IRCCS Neuromed, Pozzilli, Isernia, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; Sapienza University Rome; IRCCS Neuromed	Gulino, A (corresponding author), Univ Roma La Sapienza, Dept Mol Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	alberto.gulino@uniroma1.it; gianluca.canettieri@uniroma1.it	D'Amico, Davide/AAY-6183-2021; Giannini, Giuseppe/B-5672-2013; De Smaele, Enrico/C-1124-2013; Infante, Paola/G-9094-2018	D'Amico, Davide/0000-0002-8499-9514; Giannini, Giuseppe/0000-0003-0299-4056; De Smaele, Enrico/0000-0003-4524-4423; Di Magno, Laura/0000-0001-9446-8752; CANETTIERI, Gianluca/0000-0001-6694-2613; Infante, Paola/0000-0003-0682-3916; Antonucci, Laura/0000-0001-8965-2432; DI MARCOTULLIO, LUCIA/0000-0003-0274-7178	AIRC (Associazione Italiana per la Ricerca sul Cancro); MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca); PRIN (Programmi di ricerca di Rilevante Interesse Nazionale); FIRB (Fondo per gli Investimenti della Ricerca di Base); IIT (Italian Institute of Technology); Istituto pasteur - Fondazione Cenci Bolognetti	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR)); PRIN (Programmi di ricerca di Rilevante Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); FIRB (Fondo per gli Investimenti della Ricerca di Base)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); IIT (Italian Institute of Technology)(Istituto Italiano di Tecnologia - IIT); Istituto pasteur - Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	This work was supported by the following grants: 1) AIRC (Associazione Italiana per la Ricerca sul Cancro) (www.airc.it); 2) MIUR (Ministero dell'Istruzione, dell'Universita e della Ricerca), PRIN (Programmi di ricerca di Rilevante Interesse Nazionale), FIRB (Fondo per gli Investimenti della Ricerca di Base) (www.istruzione.it); 3) IIT (Italian Institute of Technology)(www.iit.it); 4) Istituto pasteur - Fondazione Cenci Bolognetti (http://www.istitutopasteur.it/). The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Canettieri G, 2009, P NATL ACAD SCI USA, V106, P1445, DOI 10.1073/pnas.0808749106; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Coni S, 2013, BIOCHEM PHARMACOL, V85, P623, DOI 10.1016/j.bcp.2012.11.001; De Smaele E, 2011, NEOPLASIA, V13, P374, DOI 10.1593/neo.101630; Di Marcotullio L, 2011, ONCOGENE, V30, P65, DOI 10.1038/onc.2010.394; Di Marcotullio L, 2007, CELL CYCLE, V6, P390, DOI 10.4161/cc.6.4.3809; Di Marcotullio L, 2011, BBA-REV CANCER, V1815, P241, DOI 10.1016/j.bbcan.2011.01.002; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Altaba ARI, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002540; RUPPERT JM, 1991, MOL CELL BIOL, V11, P1724, DOI 10.1128/MCB.11.3.1724; Ryan KE, 2012, J BIOL CHEM, V287, P17905, DOI 10.1074/jbc.R112.356006; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zhan XM, 2011, P NATL ACAD SCI USA, V108, P12758, DOI 10.1073/pnas.1018510108	18	56	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65718	10.1371/journal.pone.0065718	http://dx.doi.org/10.1371/journal.pone.0065718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762415	gold, Green Published, Green Submitted			2022-12-25	WOS:000321099000097
J	Cooley, MB; Jay-Russell, M; Atwill, ER; Carychao, D; Nguyen, K; Quinones, B; Patel, R; Walker, S; Swimley, M; Pierre-Jerome, E; Gordus, AG; Mandrell, RE				Cooley, Michael B.; Jay-Russell, Michele; Atwill, Edward R.; Carychao, Diana; Nguyen, Kimberly; Quinones, Beatriz; Patel, Ronak; Walker, Samarpita; Swimley, Michelle; Pierre-Jerome, Edith; Gordus, Andrew G.; Mandrell, Robert E.			Development of a Robust Method for Isolation of Shiga Toxin-Positive Escherichia coli (STEC) from Fecal, Plant, Soil and Water Samples from a Leafy Greens Production Region in California	PLOS ONE			English	Article							REAL-TIME PCR; IMMUNOMAGNETIC-SEPARATION; CONTAMINATED MANURE; VARIABLE-NUMBER; 5'-NUCLEASE PCR; UNITED-STATES; GROUND-BEEF; GENES STX1; O157; CATTLE	During a 2.5-year survey of 33 farms and ranches in a major leafy greens production region in California, 13,650 produce, soil, livestock, wildlife, and water samples were tested for Shiga toxin (stx)-producing Escherichia coli (STEC). Overall, 357 and 1,912 samples were positive for E. coli O157:H7 (2.6%) or non-O157 STEC (14.0%), respectively. Isolates differentiated by O-typing ELISA and multilocus variable number tandem repeat analysis (MLVA) resulted in 697 O157: H7 and 3,256 non-O157 STEC isolates saved for further analysis. Cattle (7.1%), feral swine (4.7%), sediment (4.4%), and water (3.3%) samples were positive for E. coli O157: H7; 7/32 birds, 2/145 coyotes, 3/88 samples from elk also were positive. Non-O157 STEC were at approximately 5-fold higher incidence compared to O157 STEC: cattle (37.9%), feral swine (21.4%), birds (2.4%), small mammals (3.5%), deer or elk (8.3%), water (14.0%), sediment (12.3%), produce (0.3%) and soil adjacent to produce (0.6%). stx1, stx2 and stx1/stx2 genes were detected in 63%, 74% and 35% of STEC isolates, respectively. Subtilase, intimin and hemolysin genes were present in 28%, 25% and 79% of non-O157 STEC, respectively; 23% were of the "Top 60" O-types. The initial method was modified twice during the study revealing evidence of culture bias based on differences in virulence and O-antigen profiles. MLVA typing revealed a diverse collection of O157 and non-O157 STEC strains isolated from multiple locations and sources and O157 STEC strains matching outbreak strains. These results emphasize the importance of multiple approaches for isolation of non-O157 STEC, that livestock and wildlife are common sources of potentially virulent STEC, and evidence of STEC persistence and movement in a leafy greens production environment.	[Cooley, Michael B.; Carychao, Diana; Nguyen, Kimberly; Quinones, Beatriz; Walker, Samarpita; Swimley, Michelle; Mandrell, Robert E.] USDA ARS, Produce Safety & Microbiol Res Unit, Albany, CA USA; [Jay-Russell, Michele; Atwill, Edward R.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Jay-Russell, Michele; Atwill, Edward R.] Univ Calif Davis, Western Inst Food Safety & Secur, Davis, CA 95616 USA; [Patel, Ronak] USDA ARS, Natl Clonal Germplasm Repository Citrus & Dates, Riverside, CA USA; [Pierre-Jerome, Edith] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Gordus, Andrew G.] Calif Dept Fish & Game, Fresno, CA USA	United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Agriculture (USDA); University of Washington; University of Washington Seattle	Cooley, MB (corresponding author), USDA ARS, Produce Safety & Microbiol Res Unit, Albany, CA USA.	michael.cooley@ars.usda.gov	Mandrell, Robert E/O-9814-2018	Quinones, Beatriz/0000-0001-5010-9889	National Research Initiative Competitive from the USDA National Institute of Food and Agriculture [2006-55212-16927, 2007-35212-18239]; USDA Agricultural Research Service CRIS [5325-42000-044, 5325-42000-045]	National Research Initiative Competitive from the USDA National Institute of Food and Agriculture; USDA Agricultural Research Service CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported by National Research Initiative Competitive Grant nos. 2006-55212-16927 and 2007-35212-18239 from the USDA National Institute of Food and Agriculture and USDA Agricultural Research Service CRIS projects 5325-42000-044 and -045. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allerberger F., 2009, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V4, P1, DOI 10.1079/PAVSNNR20094019; Amezquita-Lopez BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051565; [Anonymous], 2010, FEDERAL STATE OFFICI; [Anonymous], 2007, MMWR-MORBID MORTAL W, V56, P29; Arthur TM, 2009, APPL ENVIRON MICROB, V75, P6515, DOI 10.1128/AEM.00081-09; Auvray F, 2009, LETT APPL MICROBIOL, V48, P554, DOI 10.1111/j.1472-765X.2009.02561.x; Barkocy-Gallagher GA, 2003, J FOOD PROTECT, V66, P1978, DOI 10.4315/0362-028X-66.11.1978; BARRETT TJ, 1980, J CLIN MICROBIOL, V11, P385, DOI 10.1128/JCM.11.4.385-388.1980; Belanger SD, 2002, J CLIN MICROBIOL, V40, P1436, DOI 10.1128/JCM.40.4.1436-1440.2002; Beutin L, 2004, J CLIN MICROBIOL, V42, P1099, DOI 10.1128/JCM.42.3.1099-1108.2004; Bielaszewska M, 2000, WORLD J MICROB BIOT, V16, P711, DOI 10.1023/A:1008972605514; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Bonardi S, 1999, VET MICROBIOL, V67, P203, DOI 10.1016/S0378-1135(99)00039-5; Bonardi S, 2007, J FOOD PROTECT, V70, P1493, DOI 10.4315/0362-028X-70.6.1493; Bosilevac JM, 2011, APPL ENVIRON MICROB, V77, P2103, DOI 10.1128/AEM.02833-10; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Chassagne L, 2009, DIAGN MICR INFEC DIS, V64, P98, DOI 10.1016/j.diagmicrobio.2009.01.031; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Cooley MB, 2010, APPL ENVIRON MICROB, V76, P3398, DOI 10.1128/AEM.02373-09; Fedio WM, 2011, INT J FOOD MICROBIOL, V148, P87, DOI 10.1016/j.ijfoodmicro.2011.05.005; Feng PCH, 2011, APPL ENVIRON MICROB, V77, P6699, DOI 10.1128/AEM.00370-11; Feng PCH, 2010, FEMS MICROBIOL LETT, V308, P62, DOI 10.1111/j.1574-6968.2010.01990.x; Frank C., 2011, EUROSURVEILLANCE, V16, P1; Fratamico PM, 2011, FOODBORNE PATHOG DIS, V8, P601, DOI 10.1089/fpd.2010.0773; Friedrich AW, 2002, J INFECT DIS, V185, P74, DOI 10.1086/338115; Galli L, 2010, VET MICROBIOL, V143, P307, DOI 10.1016/j.vetmic.2009.11.028; Garthright WE, 2003, FOOD MICROBIOL, V20, P439, DOI 10.1016/S0740-0020(02)00144-2; Grys TE, 2009, J CLIN MICROBIOL, V47, P2008, DOI 10.1128/JCM.02013-08; Guion CE, 2008, J CLIN MICROBIOL, V46, P1752, DOI 10.1128/JCM.02341-07; Hedican EB, 2009, CLIN INFECT DIS, V49, P358, DOI 10.1086/600302; Hussein HS, 2005, J FOOD PROTECT, V68, P2224, DOI 10.4315/0362-028X-68.10.2224; Hyytia-Trees E, 2006, FOODBORNE PATHOG DIS, V3, P118, DOI 10.1089/fpd.2006.3.118; Ibekwe AM, 2002, APPL ENVIRON MICROB, V68, P4853, DOI 10.1128/AEM.68.10.4853-4862.2002; Ingham SC, 2005, J FOOD PROTECT, V68, P1134, DOI 10.4315/0362-028X-68.6.1134; Islam M, 2005, FOOD MICROBIOL, V22, P63, DOI 10.1016/j.fm.2004.04.007; Jay MT, 2007, EMERG INFECT DIS, V13, P1908, DOI 10.3201/eid1312.070763; Jelacic JK, 2003, J INFECT DIS, V188, P719, DOI 10.1086/376999; Jinneman KC, 2003, APPL ENVIRON MICROB, V69, P6327, DOI 10.1128/AEM.69.10.6327-6333.2003; Johannessen GS, 2005, APPL ENVIRON MICROB, V71, P2221, DOI 10.1128/AEM.71.5.2221-2225.2005; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; Kanki M, 2011, LETT APPL MICROBIOL, V53, P167, DOI 10.1111/j.1472-765X.2011.03085.x; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Lindstedt BA, 2007, J MICROBIOL METH, V69, P197, DOI 10.1016/j.mimet.2007.01.001; Mandrell RE, 2010, WOODHEAD PUBL FOOD S, P548; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Manning SD, 2007, EMERG INFECT DIS, V13, P318, DOI 10.3201/eid1302.060813; Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103; Nielsen EM, 2003, J CLIN MICROBIOL, V41, P2884, DOI 10.1128/JCM.41.7.2884-2893.2003; Ogden ID, 2004, FEMS MICROBIOL LETT, V233, P297, DOI 10.1111/j.1574-6968.2004.tb09495.x; Ogden ID, 2001, J APPL MICROBIOL, V91, P373, DOI 10.1046/j.1365-2672.2001.01397.x; Parham N, 2003, J MICROBIOL METH, V53, P1, DOI 10.1016/S0167-7012(02)00206-3; Paton AW, 1999, J CLIN MICROBIOL, V37, P3357, DOI 10.1128/JCM.37.10.3357-3361.1999; Pavlovic M, 2010, FOODBORNE PATHOG DIS, V7, P801, DOI 10.1089/fpd.2009.0457; Perelle S, 2004, MOL CELL PROBE, V18, P185, DOI 10.1016/j.mcp.2003.12.004; Quinones B, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00061; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Reischl U, 2002, J CLIN MICROBIOL, V40, P2555, DOI 10.1128/JCM.40.7.2555-2565.2002; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rivera-Betancourt M, 2000, APPL ENVIRON MICROB, V66, P4124, DOI 10.1128/AEM.66.9.4124-4127.2000; Schmidt H, 2000, APPL ENVIRON MICROB, V66, P1205, DOI 10.1128/AEM.66.3.1205-1208.2000; Schuurman T, 2007, J MICROBIOL METH, V70, P406, DOI 10.1016/j.mimet.2007.05.016; Sekse C, 2005, MOL CELL PROBE, V19, P363, DOI 10.1016/j.mcp.2005.06.006; Sharma VK, 2003, VET MICROBIOL, V93, P247, DOI 10.1016/S0378-1135(03)00039-7; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Solomon EB, 2002, APPL ENVIRON MICROB, V68, P397, DOI 10.1128/AEM.68.1.397-400.2002; Stephens PJ, 1998, LETT APPL MICROBIOL, V27, P147; Sugiyama K, 2001, LETT APPL MICROBIOL, V33, P193, DOI 10.1046/j.1472-765X.2001.00974.x; Synge BA, 2003, EPIDEMIOL INFECT, V130, P301, DOI 10.1017/S0950268802008208; Teunis P, 2004, RISK ANAL, V24, P401, DOI 10.1111/j.0272-4332.2004.00441.x; Tillman GE, 2012, J FOOD PROTECT, V75, P1548, DOI 10.4315/0362-028X.JFP-12-110; Toma C, 2004, J CLIN MICROBIOL, V42, P4937, DOI 10.1128/JCM.42.11.4937-4946.2004; Tomoyasu T, 1998, APPL ENVIRON MICROB, V64, P376; Toth I, 2009, APPL ENVIRON MICROB, V75, P6282, DOI 10.1128/AEM.00873-09; Tzschoppe M, 2012, INT J FOOD MICROBIOL, V152, P19, DOI 10.1016/j.ijfoodmicro.2011.10.009; Verstraete K, 2010, VET MICROBIOL, V145, P106, DOI 10.1016/j.vetmic.2010.03.004; Willford J, 2009, J FOOD PROTECT, V72, P741, DOI 10.4315/0362-028X-72.4.741; Yang JR, 2007, J CLIN MICROBIOL, V45, P3620, DOI 10.1128/JCM.00596-07; Yoshitomi KJ, 2006, MOL CELL PROBE, V20, P31, DOI 10.1016/j.mcp.2005.09.002; Zheng J, 2008, APPL ENVIRON MICROB, V74, P5645, DOI 10.1128/AEM.00503-08	79	82	83	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65716	10.1371/journal.pone.0065716	http://dx.doi.org/10.1371/journal.pone.0065716			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762414	Green Submitted, gold, Green Published			2022-12-25	WOS:000321099000096
J	Hoeboer, SH; Groeneveld, ABJ				Hoeboer, Sandra H.; Groeneveld, A. B. Johan			Changes in Circulating Procalcitonin Versus C-Reactive Protein in Predicting Evolution of Infectious Disease in Febrile, Critically Ill Patients	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; TIME-COURSE; PLASMA-CONCENTRATIONS; ANTIBIOTIC-THERAPY; SEPSIS; BIOMARKERS; KINETICS; RESOLUTION; PROGNOSIS; SURVIVAL	Objective: Although absolute values for C-reactive protein (CRP) and procalcitonin (PCT) are well known to predict sepsis in the critically ill, it remains unclear how changes in CRP and PCT compare in predicting evolution of: infectious disease, invasiveness and severity (e.g. development of septic shock, organ failure and non-survival) in response to treatment. The current study attempts to clarify these aspects. Methods: In 72 critically ill patients with new onset fever, CRP and PCT were measured on Day 0, 1, 2 and 7 after inclusion, and clinical courses were documented over a week with follow up to Day 28. Infection was microbiologically defined, while septic shock was defined as infection plus shock. The sequential organ failure assessment (SOFA) score was assessed. Results: From peak at Day 0-2 to Day 7, CRP decreased when (bloodstream) infection and septic shock (Day 0-2) resolved and increased when complications such as a new (bloodstream) infection or septic shock (Day 3-7) supervened. PCT decreased when septic shock resolved and increased when a new bloodstream infection or septic shock supervened. Increased or unchanged SOFA scores were best predicted by PCT increases and Day 7 PCT, in turn, was predictive for 28-day outcome. Conclusion: The data, obtained during ICU-acquired fever and infections, suggest that CRP may be favoured over PCT courses in judging response to antibiotic treatment. PCT, however, may better indicate the risk of complications, such as bloodstream infection, septic shock, organ failure and mortality, and therefore might help deciding on safe discontinuation of antibiotics. The analysis may thus help interpreting current literature and design future studies on guiding antibiotic therapy in the ICU.	[Hoeboer, Sandra H.; Groeneveld, A. B. Johan] Vrije Univ Amsterdam, Med Ctr, Dept Intens Care, Amsterdam, Netherlands; [Hoeboer, Sandra H.; Groeneveld, A. B. Johan] Erasmus MC, Dept Intens Care Med, Rotterdam, Netherlands	Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC	Hoeboer, SH (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Intens Care, Amsterdam, Netherlands.	s.hoeboer@erasmusmc.nl		Hoeboer, Sandra/0000-0002-0966-8459				Bruns AHW, 2008, EUR RESPIR J, V32, P726, DOI 10.1183/09031936.00003608; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Castelli GP, 2009, CRIT CARE MED, V37, P1845, DOI 10.1097/CCM.0b013e31819ffd5b; Castelli GP, 2004, CRIT CARE, V8, pR234, DOI 10.1186/cc2877; Charles PE, 2009, CRIT CARE, V13, DOI 10.1186/cc7751; Coelho L, 2007, CRIT CARE, V11, DOI 10.1186/cc6105; Coelho LM, 2012, CRIT CARE, V16, DOI 10.1186/cc11291; Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; Crouzet J, 2011, EUR J CLIN MICROBIOL, V30, P299, DOI 10.1007/s10096-010-1088-7; de Kruif MD, 2008, INTENS CARE MED, V34, P518, DOI 10.1007/s00134-007-0955-x; Gibot S, 2005, CRIT CARE MED, V33, P792, DOI 10.1097/01.CCM.0000159089.16462.4A; Hillas G, 2010, EUR RESPIR J, V35, P805, DOI 10.1183/09031936.00051309; Hoeboer SH, 2012, J INFECTION, V64, P484, DOI 10.1016/j.jinf.2012.01.002; Lacoma A, 2012, EUR J CLIN MICROBIOL, V31, P825, DOI 10.1007/s10096-011-1381-0; Lannergard A, 2009, SCAND J INFECT DIS, V41, P663, DOI 10.1080/00365540903127417; Laupland KB, 2008, CRIT CARE MED, V36, P1531, DOI 10.1097/CCM.0b013e318170efd3; Lavrentieva A, 2012, BURNS, V38, P356, DOI 10.1016/j.burns.2011.08.021; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Lisboa T, 2008, CRIT CARE MED, V36, P166, DOI 10.1097/01.CCM.0000297886.32564.CF; Luyt CE, 2005, AM J RESP CRIT CARE, V171, P48, DOI 10.1164/rccm.200406-746Oc; Luzzani A, 2003, CRIT CARE MED, V31, P1737, DOI 10.1097/01.CCM.0000063440.19188.ED; Meisner M, 1999, CRIT CARE, V3, P45, DOI 10.1186/cc306; Nijsten MWN, 2000, CRIT CARE MED, V28, P458, DOI 10.1097/00003246-200002000-00028; Persson L, 2005, EUR J HAEMATOL, V74, P297, DOI 10.1111/j.1600-0609.2004.00387.x; Povoa P, 2006, CRIT CARE, V10, DOI 10.1186/cc4892; Povoa P, 2011, CRIT CARE, V15, DOI 10.1186/cc10313; Rau BM, 2007, ARCH SURG-CHICAGO, V142, P134, DOI 10.1001/archsurg.142.2.134; Reynolds SC, 2012, CRIT CARE MED, V40, P2781, DOI 10.1097/CCM.0b013e31825b89cc; Schmit X, 2008, INFECTION, V36, P213, DOI 10.1007/s15010-007-7077-9; Schuetz P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007498.pub2; Seligman R, 2006, CRIT CARE, V10, DOI 10.1186/cc5036; Su LX, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-157; Theodorou VP, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-247; Tsangaris I, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-213; Viallon A, 2005, CRIT CARE, V9, pR344, DOI 10.1186/cc3722; von Lilienfeld-Toal M, 2006, SUPPORT CARE CANCER, V14, P1241, DOI 10.1007/s00520-006-0081-2; YENTIS SM, 1995, INTENS CARE MED, V21, P602, DOI 10.1007/BF01700168	37	27	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65564	10.1371/journal.pone.0065564	http://dx.doi.org/10.1371/journal.pone.0065564			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762396	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000079
J	Qian, J; Liu, HP; Lin, Y; Chen, WQ; Gao, HJ				Qian, Jin; Liu, Haipei; Lin, Yuan; Chen, Weiqiu; Gao, Huajian			A Mechanochemical Model of Cell Reorientation on Substrates under Cyclic Stretch	PLOS ONE			English	Article							SLIPPING ADHESIVE CONTACT; STRESS FIBERS; ENDOTHELIAL-CELL; FOCAL ADHESIONS; ORIENTATION RESPONSE; FORCE; ALIGNMENT; DYNAMICS; ELASTICITY; REORGANIZATION	We report a theoretical study on the cyclic stretch-induced reorientation of spindle-shaped cells. Specifically, by taking into account the evolution of sub-cellular structures like the contractile stress fibers and adhesive receptor-ligand clusters, we develop a mechanochemical model to describe the dynamics of cell realignment in response to cyclically stretched substrates. Our main hypothesis is that cells tend to orient in the direction where the formation of stress fibers is energetically most favorable. We show that, when subjected to cyclic stretch, the final alignment of cells reflects the competition between the elevated force within stress fibers that accelerates their disassembly and the disruption of cell-substrate adhesion as well, and an effectively increased substrate rigidity that promotes more stable focal adhesions. Our model predictions are consistent with various observations like the substrate rigidity dependent formation of stable adhesions and the stretching frequency, as well as stretching amplitude, dependence of cell realignment. This theory also provides a simple explanation on the regulation of protein Rho in the formation of stretch-induced stress fibers in cells.	[Qian, Jin; Chen, Weiqiu] Zhejiang Univ, Soft Matter Res Ctr, Dept Engn Mech, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Haipei; Lin, Yuan] Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China; [Gao, Huajian] Brown Univ, Sch Engn, Providence, RI 02912 USA	Zhejiang University; University of Hong Kong; Brown University	Lin, Y (corresponding author), Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China.	ylin@hku.hk	Gao, Huajian/F-9360-2010; Qian, Jin/C-6115-2008	Gao, Huajian/0000-0002-8656-846X; 	"Thousand Young Talents Program" of China; Fundamental Research Funds for Central Universities of China [2012QNA4023, 2011XZZX002]; National Natural Science Foundation of China [11202184]; Research Grants Council of the Hong Kong Special Administration Region [HKU 7148/10E]; University of Hong Kong [201111159112]; University of Hong Kong through the Distinguished Visiting Scholars Scheme (DVSS)	"Thousand Young Talents Program" of China(Chinese Academy of Sciences); Fundamental Research Funds for Central Universities of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Grants Council of the Hong Kong Special Administration Region(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong); University of Hong Kong through the Distinguished Visiting Scholars Scheme (DVSS)	This work was supported from the "Thousand Young Talents Program" of China, the Fundamental Research Funds for Central Universities (Nos. 2012QNA4023 and 2011XZZX002) of China, the National Natural Science Foundation of China (No. 11202184), the Research Grants Council (Project No. HKU 7148/10E) of the Hong Kong Special Administration Region, as well as a seed fund (Project No. 201111159112) from the University of Hong Kong. H. G. also gratefully acknowledges support from the University of Hong Kong through the Distinguished Visiting Scholars Scheme (DVSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Berg, 2018, RANDOM WALKS BIOL; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Boal D. H., 2002, MECH CELL; Brown RA, 1998, J CELL PHYSIOL, V175, P323, DOI 10.1002/(SICI)1097-4652(199806)175:3<323::AID-JCP10>3.0.CO;2-6; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Chen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048346; Chen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012035; Chen SH, 2006, P ROY SOC A-MATH PHY, V462, P211, DOI 10.1098/rspa.2005.1553; Chen S, 2006, J MECH PHYS SOLIDS, V54, P1548, DOI 10.1016/j.jmps.2006.03.001; Collinsworth AM, 2000, CELL TISSUE RES, V302, P243, DOI 10.1007/s004410000224; DARTSCH PC, 1986, EUR J CELL BIOL, V41, P339; De R, 2008, BIOPHYS J, V94, pL29, DOI 10.1529/biophysj.107.126060; De R, 2007, NAT PHYS, V3, P655, DOI 10.1038/nphys680; Deguchi S, 2006, J BIOMECH, V39, P2603, DOI 10.1016/j.jbiomech.2005.08.026; Deng LH, 2006, NAT MATER, V5, P636, DOI 10.1038/nmat1685; Eastwood M, 1998, CELL MOTIL CYTOSKEL, V40, P13, DOI 10.1002/(SICI)1097-0169(1998)40:1<13::AID-CM2>3.0.CO;2-G; Endlich N, 2007, CELL MOTIL CYTOSKEL, V64, P966, DOI 10.1002/cm.20237; Faust U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028963; Fernandez P, 2006, BIOPHYS J, V90, P3796, DOI 10.1529/biophysj.105.072215; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Goldyn AM, 2010, CYTOSKELETON, V67, P241, DOI 10.1002/cm.20439; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hsu HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004853; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jannat RA, 2011, BIOPHYS J, V101, P575, DOI 10.1016/j.bpj.2011.05.040; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kong D, 2008, BIOPHYS J, V95, P4034, DOI [10.1529/biophysj.108.131342, 10.1529/biophysj.l08.131342]; Krishnan R, 2012, AM J PHYSIOL-CELL PH, V303, pC368, DOI 10.1152/ajpcell.00074.2012; Krishnan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005486; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Ladoux B, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/11/116601; LAWRENCE MB, 1991, CELL, V65, P859, DOI 10.1016/0092-8674(91)90393-D; Leckband D, 2001, Q REV BIOPHYS, V34, P105, DOI 10.1017/S0033583501003687; Lin Y, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.021909; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lotters JC, 1997, J MICROMECH MICROENG, V7, P145, DOI 10.1088/0960-1317/7/3/017; Moretti M, 2004, J MATER SCI-MATER M, V15, P1159, DOI 10.1023/B:JMSM.0000046400.18607.72; Neidlinger-Wilke C, 2001, J ORTHOP RES, V19, P286, DOI 10.1016/S0736-0266(00)00029-2; NEIDLINGERWILKE C, 1994, J ORTHOP RES, V12, P70, DOI 10.1002/jor.1100120109; Nicolas A, 2006, BIOPHYS J, V91, P61, DOI 10.1529/biophysj.105.077115; Nicolas A, 2008, BIOPHYS J, V95, P527, DOI 10.1529/biophysj.107.127399; Novak IL, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268109; Paszek MJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000604; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Qian J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012342; Qian J, 2009, BIOPHYS J, V97, P2438, DOI 10.1016/j.bpj.2009.08.027; Rinko LJ, 2004, BIOPHYS J, V86, P544, DOI 10.1016/S0006-3495(04)74133-8; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Saez A, 2005, BIOPHYS J, V89, pL52, DOI 10.1529/biophysj.105.071217; Safran SA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.060901; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Stricker J, 2011, BIOPHYS J, V100, P2883, DOI 10.1016/j.bpj.2011.05.023; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Walcott S, 2010, P NATL ACAD SCI USA, V107, P7757, DOI 10.1073/pnas.0912739107; Wang HC, 1995, J BIOMECH, V28, P1543, DOI 10.1016/0021-9290(95)00101-8; Wang JHC, 2000, J BIOMECH, V33, P729, DOI 10.1016/S0021-9290(00)00013-0; Wang JHC, 2001, J BIOMECH, V34, P1563, DOI 10.1016/S0021-9290(01)00150-6; Wang JHC, 2000, J THEOR BIOL, V202, P33, DOI 10.1006/jtbi.1999.1035; Wei ZS, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907745; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zamir E, 2001, J CELL SCI, V114, P3577; Zhong Y, 2011, CELL MOL BIOENG, V4, P442, DOI 10.1007/s12195-011-0187-6	68	32	33	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65864	10.1371/journal.pone.0065864	http://dx.doi.org/10.1371/journal.pone.0065864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762444	gold, Green Published			2022-12-25	WOS:000321099000113
J	Li, J; Zhang, YJ; Liu, YC; Dai, X; Li, WY; Cai, X; Yin, Y; Wang, Q; Xue, YX; Wang, C; Li, DM; Hou, DX; Jiang, XH; Zhang, JF; Zen, K; Chen, X; Zhang, CY				Li, Jing; Zhang, Yujing; Liu, Yuchen; Dai, Xin; Li, Wenyang; Cai, Xing; Yin, Yuan; Wang, Qiang; Xue, Yunxing; Wang, Cheng; Li, Dameng; Hou, Dongxia; Jiang, Xiaohong; Zhang, Junfeng; Zen, Ke; Chen, Xi; Zhang, Chen-Yu			Microvesicle-mediated Transfer of MicroRNA-150 from Monocytes to Endothelial Cells Promotes Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYB; DISEASES; OBESITY; MACROPHAGES; MECHANISMS; MIGRATION; CANCER; TARGET	Recent studies by our group and others show that microRNAs can be actively secreted into the extracellular environment through microvesicles (MVs) and function as secretory signaling molecules that influence the recipient cell phenotypes. Here we investigate the role of monocyte-secreted miR-150 in promoting the capillary tube formation of endothelial cells and in enhancing angiogenesis. In vitro capillary tube formation and in vivo angiogenesis assays showed that monocyte-derived MVs have strong pro-angiogenic activities. By depleting miR-150 from monocytic MVs and increasing miR-150 in MVs derived from cells that normally contain low levels of miR-150, we further demonstrated that the miR-150 content accounted for the pro-angiogenic activity of monocytic MVs in these assays. Using tumor-implanted mice and ob/ob mice as models, we revealed that miR-150 secretion, which is increased for diseases such as cancers and diabetes, significantly promotes angiogenesis. The delivery of anti-miR-150 antisense oligonucleotides into tumor-implanted mice and ob/ob mice via MVs, however, strongly reduced angiogenesis in both types of mice. Our results collectively demonstrate that secretion of miR-150 via MVs can promote angiogenesis in vitro and in vivo, and we also present a novel microRNA-based therapeutic approach for disease treatment.	[Li, Jing; Zhang, Yujing; Liu, Yuchen; Li, Wenyang; Cai, Xing; Yin, Yuan; Wang, Cheng; Li, Dameng; Hou, Dongxia; Jiang, Xiaohong; Zhang, Junfeng; Zen, Ke; Chen, Xi; Zhang, Chen-Yu] Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Dai, Xin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Gastroenterol, Shanghai 200025, Peoples R China; [Wang, Qiang; Xue, Yunxing] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Thorac Surg, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Shanghai Jiao Tong University; Nanjing University	Zen, K (corresponding author), Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	kzen@nju.edu.cn; xichen@nju.edu.cn; cyzhang@nju.edu.cn	Wang, Cheng/O-7206-2016; 殷, 媛/GSE-4523-2022; Yin, Yuan/AAG-1707-2020	Wang, Cheng/0000-0002-1834-2119; Liu, Yuchen/0000-0001-8922-9976	National Natural Science Foundation of China [31200969, 31200874, 81101330, 31271378, 81250044]; National Science Fund for Distinguished Young Scholars [81025019]; Natural Science Foundation of Jiangsu Province [BK2011013, BK2012014]; program for New Century Excellent Talents in University from the Ministry of Education, China [NCET-12-0261]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); program for New Century Excellent Talents in University from the Ministry of Education, China	This work was supported by National Natural Science Foundation of China Grants 31200969, 31200874, 81101330, 31271378, and 81250044, National Science Fund for Distinguished Young Scholars Grant 81025019, and Natural Science Foundation of Jiangsu Province Grants BK2011013 and BK2012014. This work was also supported by the program for New Century Excellent Talents in University from the Ministry of Education, China (NCET-12-0261).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Cao YH, 2010, NAT REV DRUG DISCOV, V9, P107, DOI 10.1038/nrd3055; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Dirkx AEM, 2006, J LEUKOCYTE BIOL, V80, P1183, DOI 10.1189/jlb.0905495; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lijnen HR, 2008, CARDIOVASC RES, V78, P286, DOI 10.1093/cvr/cvm007; Lin YC, 2008, MOL BIOL EVOL, V25, P2189, DOI 10.1093/molbev/msn165; Malinda Katherine M., 2009, V467, P287, DOI 10.1007/978-1-59745-241-0_17; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Moldovan L, 2005, EXP SUPPL, V94, P127; Moldovan NI, 2002, J HEMATOTH STEM CELL, V11, P179, DOI 10.1089/152581602753658394; Naldini Antonella, 2005, Current Drug Targets - Inflammation and Allergy, V4, P3, DOI 10.2174/1568010053622830; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	22	146	165	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23586	23596		10.1074/jbc.M113.489302	http://dx.doi.org/10.1074/jbc.M113.489302			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23766514	hybrid, Green Published			2022-12-25	WOS:000330598200062
J	Aly, H; Rohatgi, N; Marshall, CA; Grossenheider, TC; Miyoshi, H; Stappenbeck, TS; Matkovich, SJ; McDaniel, ML				Aly, Haytham; Rohatgi, Nidhi; Marshall, Connie A.; Grossenheider, Tiffani C.; Miyoshi, Hiroyuki; Stappenbeck, Thaddeus S.; Matkovich, Scot J.; McDaniel, Michael L.			A Novel Strategy to Increase the Proliferative Potential of Adult Human beta-Cells While Maintaining Their Differentiated Phenotype	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; INSULIN-RECEPTOR SUBSTRATE-1; PROTEIN-KINASE; GROWTH-FACTOR; SIGNALING PATHWAY; RHO-KINASE; MAMMALIAN TARGET; GENE-EXPRESSION; ROK-ALPHA; CATENIN	Our previous studies demonstrated that Wnt/GSK-3/beta-catenin and mTOR signaling are necessary to stimulate proliferative processes in adult human beta-cells. Direct inhibition of GSK-3, that engages Wnt signaling downstream of the Wnt receptor, increases beta-catenin nuclear translocation and beta-cell proliferation but results in lower insulin content. Our current goal was to engage canonical and non-canonical Wnt signaling at the receptor level to significantly increase human beta-cell proliferation while maintaining a beta-cell phenotype in intact islets. We adopted a system that utilized conditioned medium from L cells that expressed Wnt3a, R-spondin-3 and Noggin (L-WRN conditioned medium). In addition we used a ROCK inhibitor (Y-27632) and SB-431542 (that results in RhoA inhibition) in these cultures. Treatment of intact human islets with L-WRN conditioned medium plus inhibitors significantly increased DNA synthesis similar to 6 fold in a rapamycin-sensitive manner. Moreover, this treatment strikingly increased human beta-cell proliferation similar to 20 fold above glucose alone. Only the combination of L-WRN conditioned medium with RhoA/ROCK inhibitors resulted in substantial proliferation. Transcriptome-wide gene expression profiling demonstrated that L-WRN medium provoked robust changes in several signaling families, including enhanced beta-catenin-mediated and beta-cell-specific gene expression. This treatment also increased expression of Nr4a2 and Irs2 and resulted in phosphorylation of Akt. Importantly, glucose-stimulated insulin secretion and content were not downregulated by L-WRN medium treatment. Our data demonstrate that engaging Wnt signaling at the receptor level by this method leads to necessary crosstalk between multiple signaling pathways including activation of Akt, mTOR, Wnt/beta-catenin, PKA/CREB, and inhibition of RhoA/ROCK that substantially increase human beta-cell proliferation while maintaining the beta-cell phenotype.	[Aly, Haytham; Rohatgi, Nidhi; Marshall, Connie A.; Miyoshi, Hiroyuki; Stappenbeck, Thaddeus S.; McDaniel, Michael L.] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Grossenheider, Tiffani C.; Matkovich, Scot J.] Washington Univ, Dept Med, Ctr Pharmacogenom, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	McDaniel, ML (corresponding author), Washington Univ, Dept Pathol & Immunol, St Louis, MO 63130 USA.	mmcdaniel@wustl.edu	Matkovich, Scot J/B-9077-2009; Rohatgi, Nidhi/GWR-1096-2022; Matkovich, Scot J/AFP-0908-2022	Matkovich, Scot J/0000-0002-7398-6857; Matkovich, Scot J/0000-0002-7398-6857; Miyoshi, Hiroyuki/0000-0001-7400-0714	NIH [DK006181, DK00618146S1, DK07296]; NIH Washington University Diabetes Research Center Morphology and Metabolic Analysis Core [DK20579]; American Diabetes Association [7-04-MN-32]; Barnes-Jewish Hospital Foundation [7401-00]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Juvenile Diabetes Research Foundation International (JDRFI); JDRFI Sponsored Islets for Research Program at Washington University [JDRF-31-2008-382]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579, T32DK007296, R01DK006181, R56DK006181, R01DK071619, P60DK020579] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Washington University Diabetes Research Center Morphology and Metabolic Analysis Core; American Diabetes Association(American Diabetes Association); Barnes-Jewish Hospital Foundation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation International (JDRFI)(Juvenile Diabetes Research Foundation); JDRFI Sponsored Islets for Research Program at Washington University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by NIH Grants DK006181 (MLM), NIH DK00618146S1 (MLM), DK07296 (MLM), NIH Washington University Diabetes Research Center Morphology and Metabolic Analysis Core DK20579 (MLM), American Diabetes Association Grant 7-04-MN-32 (MLM), Barnes-Jewish Hospital Foundation Grant 7401-00 (MLM). Human islets were obtained from the Integrated Islet Distribution Program (IIDP) sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Juvenile Diabetes Research Foundation International (JDRFI) and the JDRFI Sponsored Islets for Research Program at Washington University (JDRF-31-2008-382). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Aspenstrom P, 1999, CURR OPIN CELL BIOL, V11, P95, DOI 10.1016/S0955-0674(99)80011-8; Begum N, 2002, J BIOL CHEM, V277, P6214, DOI 10.1074/jbc.M110508200; Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200; Buongiorno P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-73; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Cozar-Castellano I, 2004, DIABETES, V53, P149, DOI 10.2337/diabetes.53.1.149; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Farah S, 1998, J BIOL CHEM, V273, P4740, DOI 10.1074/jbc.273.8.4740; Fiaschi-Taesch N, 2009, DIABETES, V58, P882, DOI 10.2337/db08-0631; Fiaschi-Taesch NM, 2013, DIABETES, V62, P2460, DOI 10.2337/db12-0778; Fiaschi-Taesch NM, 2010, DIABETES, V59, P1926, DOI 10.2337/db09-1776; Fiaschi-Taesch NM, 2013, DIABETES; Filippa N, 1999, MOL CELL BIOL, V19, P4989; FIOL CJ, 1994, J BIOL CHEM, V269, P32187; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Gurevitch D, 2010, DIABETES, V59, P2188, DOI 10.2337/db09-0890; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Hu YX, 2012, P NATL ACAD SCI USA, V109, P19864, DOI 10.1073/pnas.1214996109; Impey S, 2001, SCI STKE; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kaidanovich-Beilin O, 2006, J PHARMACOL EXP THER, V316, P17, DOI 10.1124/jpet.105.090266; Kanda T, 2005, FASEB J, V19, P169, DOI 10.1096/fj.05-4197fje; Karslioglu E, 2011, MOL ENDOCRINOL, V25, P1760, DOI 10.1210/me.2011-1074; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kondegowda NG, 2010, DIABETES, V59, P3131, DOI 10.2337/db09-1796; Liu AJ, 2011, CHINESE MED J-PEKING, V124, P3098, DOI 10.3760/cma.j.issn.0366-6999.2011.19.027; Liu H, 2009, DIABETES, V58, P663, DOI 10.2337/db07-1208; Liu YM, 2009, DIABETES OBES METAB, V11, P54, DOI 10.1111/j.1463-1326.2009.01107.x; Liu ZY, 2010, ADV EXP MED BIOL, V654, P391, DOI 10.1007/978-90-481-3271-3_17; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu ZM, 2004, CELL CYCLE, V3, P571; Matkovich SJ, 2012, CIRC RES, V111, P521, DOI 10.1161/CIRCRESAHA.112.265736; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Mizukami Y, 2006, J BIOL CHEM, V281, P13957, DOI 10.1074/jbc.M511763200; Negash S, 2008, FASEB J, V22; NIELSEN JH, 1979, DIABETOLOGIA, V16, P97, DOI 10.1007/BF01225457; Noguchi M, 2007, J BIOL CHEM, V282, P29574, DOI 10.1074/jbc.M705972200; Pirone DM, 2006, J CELL BIOL, V174, P277, DOI 10.1083/jcb.200510062; Portha B, 2011, EXP DIABETES RES, DOI [10.1155/2011/105076, 10.1155/2011/376509]; Pradeep A, 2004, ONCOGENE, V23, P3689, DOI 10.1038/sj.onc.1207454; Rieck S, 2012, MOL ENDOCRINOL, V26, P1590, DOI 10.1210/me.2012-1019; Rohatgi N, 2013, PLOS ONE, DOI [10.1371/journal.pone.0062012, DOI 10.1371/J0URNAL.P0NE.0062012]; Rohatgi N, 2010, TOEJ, V4, P40; Russ HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025566; Rutti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035801; Sable CL, 1997, FEBS LETT, V409, P253, DOI 10.1016/S0014-5793(97)00518-8; Seasholtz TM, 1999, MOL PHARMACOL, V55, P949, DOI 10.1124/mol.55.6.949; Shang YC, 2007, ACTA PHARMACOL SIN, V28, P1761, DOI 10.1111/j.1745-7254.2007.00671.x; Summers SA, 1999, J BIOL CHEM, V274, P17934, DOI 10.1074/jbc.274.25.17934; Teramura T, 2012, BIOCHEM BIOPH RES CO, V417, P836, DOI 10.1016/j.bbrc.2011.12.052; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tura A, 2009, INVEST OPHTH VIS SCI, V50, P452, DOI 10.1167/iovs.08-1973; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velmurugan K, 2012, ENDOCRINOLOGY, V153, P1116, DOI 10.1210/en.2011-1895; Wang Y, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/395974; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wong VSC, 2010, J BIOL CHEM, V285, P21292, DOI 10.1074/jbc.M110.129874; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	70	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66131	10.1371/journal.pone.0066131	http://dx.doi.org/10.1371/journal.pone.0066131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776620	Green Published, Green Submitted, gold			2022-12-25	WOS:000320322400083
J	Juarez, SP; Merlo, J				Juarez, Sol Pia; Merlo, Juan			The Effect of Swedish Snuff (Snus) on Offspring Birthweight: A Sibling Analysis	PLOS ONE			English	Article							MATERNAL SMOKING; GESTATIONAL-AGE; CARBON-MONOXIDE; PUBLIC-HEALTH; TOBACCO-SMOKE; PRETERM BIRTH; PREGNANCY; NICOTINE; RISK; EXPOSURE	Current observational evidence indicates that maternal smoking during pregnancy is associated with reduced birthweight in offspring. However, less is known about the effect of smokeless tobacco on birthweight and about the possible mechanisms involved in this relationship. This paper studies the effect of Swedish smokeless tobacco (snus) on offspring birthweight comparing the results obtained from a conventional linear regression analysis and from a quasi-experimental sibling design using a multilevel linear regression analysis. From the Swedish Medical Birth Register, we investigated 604,804 singletons born between 2002 and 2010. From them, we isolated 8,861 siblings from 4,104 mothers with discrepant snus-use habits (i.e., women who had at least one pregnancy during which they used snus and at least one other pregnancy in which they did not). The conventional analysis shows that continuous snus use throughout the pregnancy reduces birthweight in 47 g while quitting or relapsing snus has a minor and statistically non-significant effect (-6 g and -4 g, respectively). However, using a sibling analysis the effect observed for mothers who continue to use snus during pregnancy is less intense than that observed with previous conventional analyses (-20 g), and this effect is not statistically significant. Sibling analysis shows that quitting or relapsing snus use after the first trimester slightly reduces birthweight (14 g). However, this small change is not statistically significant. The sibling analysis provides strong causal evidence indicating that exposure to snus during pregnancy has a minor effect on birthweight reduction. Our findings provide a new piece of causal evidence concerning the effect of tobacco on birthweight and support the hypothesis that the harmful effect of smoking on birthweight is not mainly due to nicotine.	[Juarez, Sol Pia] Lund Univ, Ctr Econ Demog, Lund, Sweden; [Juarez, Sol Pia; Merlo, Juan] Lund Univ, Fac Med, Dept Clin Sci, Unit Social Epidemiol, Lund, Sweden	Lund University; Lund University	Juarez, SP (corresponding author), Lund Univ, Ctr Econ Demog, Lund, Sweden.	sol.juarez@ekh.lu.se	Merlo, Juan/E-2136-2011	Merlo, Juan/0000-0001-8379-9708; Juarez, Sol Pia/0000-0001-9086-7588	Swedish Council for Working Life and Social Research (FAS) [Dnr 2010-0402]; Swedish Research Council (VR) [Dnr K2011-69X-15377-07-6]	Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council (VR)(Swedish Research Council)	This work was supported by the Swedish Council for Working Life and Social Research (FAS)(Dnr 2010-0402, PI Juan Merlo), the Swedish Research Council (VR) (Dnr K2011-69X-15377-07-6, PI Juan Merlo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia IB, 1997, AM J EPIDEMIOL, V146, P42; Aubard Y, 2000, BRIT J OBSTET GYNAEC, V107, P833, DOI 10.1111/j.1471-0528.2000.tb11078.x; Baba S, 2013, BJOG-INT J OBSTET GY, V120, P456, DOI 10.1111/1471-0528.12067; Boffetta P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3060; Browne WJ, 2009, J R STAT SOC A STAT, V172, P579, DOI 10.1111/j.1467-985X.2009.00586.x; Carlin JB, 2005, INT J EPIDEMIOL, V34, P1089, DOI 10.1093/ije/dyi153; Carmines EL, 2008, TOXICOL SCI, V102, P383, DOI 10.1093/toxsci/kfn009; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Cunningham FG, 2005, WILLIAMS OBSTET; D'Onofrio BM, 2008, DEV PSYCHOPATHOL, V20, P139, DOI 10.1017/S0954579408000072; D'Onofrio BM, 2010, ARCH GEN PSYCHIAT, V67, P529, DOI 10.1001/archgenpsychiatry.2010.33; Donovan SJ, 2011, INT J EPIDEMIOL, V40, P345, DOI 10.1093/ije/dyr057; England LJ, 2003, AM J OBSTET GYNECOL, V189, P939, DOI 10.1067/S0002-9378(03)00661-6; England LJ, 2012, ACTA OBSTET GYN SCAN, V91, P93, DOI 10.1111/j.1600-0412.2011.01273.x; Foulds J, 2003, TOB CONTROL, V12, P349, DOI 10.1136/tc.12.4.349; Foulds J, 2007, LANCET, V369, P1976, DOI 10.1016/S0140-6736(07)60679-5; Frisell T, 2012, EPIDEMIOLOGY, V23, P713, DOI 10.1097/EDE.0b013e31825fa230; George L, 2006, ACTA OBSTET GYN SCAN, V85, P1331, DOI 10.1080/00016340600935433; Goldstein H., 2003, MULTILEVEL STAT MODE; Gonzalez A, 2005, TRATADO OBSTETRICIA, P162; Gray N, 2005, LANCET, V366, P966, DOI 10.1016/S0140-6736(05)67352-7; Haug K, 2000, ACTA OBSTET GYN SCAN, V79, P485, DOI 10.1034/j.1600-0412.2000.079006485.x; Hegaard HK, 2006, ACTA OBSTET GYN SCAN, V85, P675, DOI 10.1080/00016340600607032; HILL AE, 1988, ULSTER MED J, V57, P22; HOLM H, 1992, PSYCHOPHARMACOLOGY, V108, P507, DOI 10.1007/BF02247429; Holmes D, 2007, NATURE REV CANC, V7; Huizink AC, 2006, NEUROSCI BIOBEHAV R, V30, P24, DOI 10.1016/j.neubiorev.2005.04.005; Iliadou AN, 2010, INT J EPIDEMIOL, V39, P1193, DOI 10.1093/ije/dyq064; Jaddoe VWV, 2008, PAEDIATR PERINAT EP, V22, P162, DOI 10.1111/j.1365-3016.2007.00916.x; Kotlyar M, 2011, CANCER EPIDEM BIOMAR, V20, P91, DOI 10.1158/1055-9965.EPI-10-0349; Kyrklund-Blomberg NB, 1998, AM J OBSTET GYNECOL, V179, P1051, DOI 10.1016/S0002-9378(98)70214-5; Kyrklund-Blomberg NB, 2005, ACTA OBSTET GYN SCAN, V84, P572, DOI 10.1111/j.0001-6349.2005.00848.x; Lahey BB, 2010, CURR DIR PSYCHOL SCI, V19, P319, DOI 10.1177/0963721410383977; Lassen TH, 2010, PAEDIATR PERINAT EP, V24, P272, DOI 10.1111/j.1365-3016.2010.01104.x; Lawlor DA, 2009, FAMILY MATTERS DESIG; Lee PN, 2011, REGUL TOXICOL PHARM, V59, P197, DOI 10.1016/j.yrtph.2010.12.002; Luo J, 2007, LANCET, V369, P2015, DOI 10.1016/S0140-6736(07)60678-3; Merlo J, 2010, INT J EPIDEMIOL, V39, P936; Merlo J, 2013, SOC SCI MED, V76, P39, DOI 10.1016/j.socscimed.2012.08.034; Meyer S, 2009, EUR J OBSTET GYN R B, V146, P37, DOI 10.1016/j.ejogrb.2009.05.031; NORDSTROM ML, 1994, EARLY HUM DEV, V37, P195, DOI 10.1016/0378-3782(94)90079-5; Rasbash J., 2004, USERS GUIDE MLWIN VE; Rogers JM, 2003, TOXICOL SCI, V75, P227, DOI 10.1093/toxsci/kfg215; Rogers John M., 2008, Birth Defects Research, V84, P1, DOI 10.1002/bdrc.20119; Salihu HM, 2007, EARLY HUM DEV, V83, P713, DOI 10.1016/j.earlhumdev.2007.08.002; Wickstrom R, 2007, CURR NEUROPHARMACOL, V5, P213, DOI 10.2174/157015907781695955; Wikstrom AK, 2010, BJOG-INT J OBSTET GY, V117, P1005, DOI 10.1111/j.1471-0528.2010.02575.x; Wikstrom AK, 2010, EPIDEMIOLOGY, V21, P772, DOI 10.1097/EDE.0b013e3181f20d7e; Zdravkovic T, 2005, PLACENTA, V26, pS81, DOI 10.1016/j.placenta.2005.02.003	50	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65611	10.1371/journal.pone.0065611	http://dx.doi.org/10.1371/journal.pone.0065611			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776512	gold, Green Submitted, Green Published			2022-12-25	WOS:000320322400038
J	Morlat, P; Vivot, A; Vandenhende, MA; Dauchy, FA; Asselineau, J; Deti, E; Gerard, Y; Lazaro, E; Duffau, P; Neau, D; Bonnet, F; Chene, G				Morlat, Philippe; Vivot, Alexandre; Vandenhende, Marie-Anne; Dauchy, Frederic-Antoine; Asselineau, Julien; Deti, Edouard; Gerard, Yann; Lazaro, Estibaliz; Duffau, Pierre; Neau, Didier; Bonnet, Fabrice; Chene, Genevieve		Grp D'epidemiologie Clin du Sida e	Role of Traditional Risk Factors and Antiretroviral Drugs in the Incidence of Chronic Kidney Disease, ANRS CO3 Aquitaine Cohort, France, 2004-2012	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; HIV-INFECTED PATIENTS; TENOFOVIR DISOPROXIL FUMARATE; CHRONIC-RENAL-FAILURE; THERAPY; SAFETY; INDIVIDUALS; PROTEINURIA; DYSFUNCTION; PROGRESSION	Objective: To examine the role of antiretroviral drugs (ART), HIV-related and traditional risk factors on the incidence of chronic kidney disease (CKD) in HIV-infected patients. Design: Prospective hospital-based cohort of HIV-infected patients from 2004 to 2012. Methods: CKD was defined using MDRD equation as an estimated glomerular filtration rate (eGFR) less than 60 ml/mn/1.73 m 2 at 2 consecutive measurements >= 3 months apart. Poisson regression models were used to study determinants of CKD either measured at baseline or updated. ART exposure was classified as ever or never. We additionally tested the role of tenofovir (TDF), whether or not prescribed concomitantly with a Protease Inhibitor (PI), taking into account the cumulative exposure to the drug. Results: 4,350 patients (74% men) with baseline eGFR > 60 ml/mn/1.73 m(2) were followed for a median of 5.8 years. At the end of follow-up, 96% had received ART, one third of them (35%) jointly received TDF and a PI. Average incidence rate of CKD was 0.95% person-years of follow-up. Incidence of CKD was higher among women (IRR = 2.2), older patients (> 60 y vs,45 y: IRR = 2.5 and 45-60 y: IRR = 1.7), those with diabetes (IRR = 1.9), high blood pressure (IRR = 1.5), hyperlipidemia (IRR = 1.5), AIDS stage (IRR = 1.4), low baseline eGFR (IRR = 15.8 for 60, eGFR, 70 ml/mn/1.73 m(2) vs > 90 and IRR = 7.1 for 70<eGFR<80 ml/mn/1.73 m(2)), current CD4+<200 cells/mm(3) vs>500/mm(3) (IRR = 2.5), and exposure to TDF (IRR = 2.0). Exposure to TDF was even strongly associated with CKD when co-administered with PIs (IRR = 3.1 vs 1.3 when not, p<0,001). A higher risk of CKD was found when tenofovir exposure was>12 months [IRR = 3.0 with joint PIs vs 1.3 without (p<0.001)]. A vast majority of those developing CKD (76.6%) had a baseline eGFR between 60 and 80 ml/mn/1.73 m(2). Conclusion: In patients with eGFR between 60 and 80 mL/min/1.73 m(2), a thorough control of CKD risk factors is warranted. The use of TDF, especially when co-administered with PIs, should be mentioned as a relative contraindication in presence of at least one of these risk factors.	[Morlat, Philippe; Vandenhende, Marie-Anne; Bonnet, Fabrice; Chene, Genevieve] Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Morlat, Philippe; Vandenhende, Marie-Anne; Bonnet, Fabrice; Chene, Genevieve] INSERM, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Morlat, Philippe; Vandenhende, Marie-Anne; Bonnet, Fabrice; Chene, Genevieve] CIC EC7, Bordeaux, France; [Vivot, Alexandre; Asselineau, Julien; Deti, Edouard; Chene, Genevieve] CHU Bordeaux, Clin Epidemiol Unit USMR, Pole Sante Publ, Bordeaux, France; [Morlat, Philippe; Vandenhende, Marie-Anne; Dauchy, Frederic-Antoine; Lazaro, Estibaliz; Duffau, Pierre; Neau, Didier; Bonnet, Fabrice] CHU Bordeaux, Pole Sante Publ, Coordinat Reg Lutte VIH COREVIH, Bordeaux, France; [Gerard, Yann] CH Dax, Serv Malad Infectieuses, Dax, France; [Lazaro, Estibaliz; Neau, Didier] Univ Bordeaux, UFR Sci Med, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Morlat, P (corresponding author), Univ Bordeaux, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France.	philippe.morlat@chu-bordeaux.fr	chene, genevieve/H-8665-2014; Dauchy, Frédéric-Antoine/T-4652-2019; Vivot, Alexandre/K-3816-2017; Vandenhende, Marie-Anne/T-6625-2019; Bonnet, Fabrice/T-3254-2019	chene, genevieve/0000-0002-8368-6460; Vivot, Alexandre/0000-0001-9281-3129; 	Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS, France)	Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS, France)(ANRS)	The ANRS CO3 Aquitaine Cohort is supported by a grant from the Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (ANRS, France) within the Coordinated Action no. 7 (AC7): http://www.anrs.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini L, 2012, JAIDS-J ACQ IMM DEF, V59, P18, DOI 10.1097/QAI.0b013e31823a6124; Bige N, 2012, NEPHROL DIAL TRANSPL, V27, P1114, DOI 10.1093/ndt/gfr376; Brennan A, 2011, AIDS, V25, P1603, DOI 10.1097/QAD.0b013e32834957da; Buehring B, 2011, J CLIN DENSITOM, DOI [10.1016/j.jocd.2011.10.003, DOI 10.1016/J.J0CD.2011.10.003]; Campbell LJ, 2009, HIV MED, V10, P329, DOI 10.1111/j.1468-1293.2008.00691.x; Clark WF, 2011, J AM SOC NEPHROL, V22, P1729, DOI 10.1681/ASN.2010111217; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Dauchy FA, 2011, KIDNEY INT, V80, P302, DOI 10.1038/ki.2011.124; De Beaudrap P, 2010, AIDS RES HUM RETROV, V26, P1221, DOI 10.1089/aid.2009.0261; Deti EK, 2010, HIV MED, V11, P308, DOI 10.1111/j.1468-1293.2009.00780.x; Di Angelantonio E, 2007, PLOS MED, V4, P1497, DOI 10.1371/journal.pmed.0040270; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fux CA, 2007, AIDS, V21, P1483, DOI 10.1097/QAD.0b013e328216f15b; Gallant JE, 2008, AIDS, V22, P2155, DOI 10.1097/QAD.0b013e3283112b8e; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Goicoechea M, 2008, J INFECT DIS, V197, P102, DOI 10.1086/524061; Gupta SK, 2008, AIDS PATIENT CARE ST, V22, P99, DOI 10.1089/apc.2007.0052; Gupta SK, 2005, CLIN INFECT DIS, V41, P570, DOI 10.1086/432124; Horberg M, 2010, JAIDS-J ACQ IMM DEF, V53, P62, DOI 10.1097/QAI.0b013e3181be6be2; Jones C, 2006, NEPHROL DIAL TRANSPL, V21, P2133, DOI 10.1093/ndt/gfl198; Kalayjian RC, 2012, AIDS, V26, P1907, DOI 10.1097/QAD.0b013e328357f5ed; Kearney BP, 2006, JAIDS-J ACQ IMM DEF, V43, P278, DOI 10.1097/01.qai.0000243103.03265.2b; Kiser JJ, 2008, CLIN PHARMACOL THER, V83, P265, DOI 10.1038/sj.clpt.6100269; Krawczyk CS, 2004, AIDS, V18, P2171, DOI 10.1097/00002030-200411050-00009; Leport C, 2009, CLIN INFECT DIS, V49, P1950, DOI 10.1086/648445; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Lucas GM, 2008, J INFECT DIS, V197, P1548, DOI 10.1086/587994; Mocroft A, 2007, AIDS, V21, P1119, DOI 10.1097/QAD.0b013e3280f774ee; Mocroft A, 2010, AIDS, V24, P1667, DOI 10.1097/QAD.0b013e328339fe53; Peters L, 2012, AIDS, V26, P1917, DOI 10.1097/QAD.0b013e3283574e71; Rodriguez-Novoa S, 2009, CLIN INFECT DIS, V48, pE108, DOI 10.1086/598507; Saydah S., 2007, Morbidity and Mortality Weekly Report, V56, P161; Scherzer R, 2012, AIDS, V26, P867, DOI 10.1097/QAD.0b013e328351f68f; Sorli ML, 2008, JAIDS-J ACQ IMM DEF, V48, P506, DOI 10.1097/QAI.0b013e31817bbecb; Szczech LA, 2002, KIDNEY INT, V61, P195, DOI 10.1046/j.1523-1755.2002.00094.x; Thiebaut R, 2000, AIDS, V14, P971, DOI 10.1097/00002030-200005260-00008; Tordato F, 2011, HIV MED, V12, P4, DOI 10.1111/j.1468-1293.2010.00855.x; Winston J, 2008, CLIN INFECT DIS, V47, P1449, DOI 10.1086/593099; Young J, 2012, AIDS, V26, P567, DOI 10.1097/QAD.0b013e32834f337c	41	48	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66223	10.1371/journal.pone.0066223	http://dx.doi.org/10.1371/journal.pone.0066223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776637	Green Published, Green Submitted, gold			2022-12-25	WOS:000320322400089
J	Spikman, JM; Milders, MV; Visser-Keizer, AC; Westerhof-Evers, HJ; Herben-Dekker, M; van der Naalt, J				Spikman, Jacoba M.; Milders, Maarten V.; Visser-Keizer, Annemarie C.; Westerhof-Evers, Herma J.; Herben-Dekker, Meike; van der Naalt, Joukje			Deficits in Facial Emotion Recognition Indicate Behavioral Changes and Impaired Self-Awareness after Moderate to Severe Traumatic Brain Injury	PLOS ONE			English	Article							DYSEXECUTIVE QUESTIONNAIRE; EXECUTIVE DYSFUNCTION; EXPRESSION; IMPAIRMENTS; VALIDITY; ADULTS; METAANALYSIS; ASSOCIATION; RELIABILITY; PERCEPTION	Traumatic brain injury (TBI) is a leading cause of disability, specifically among younger adults. Behavioral changes are common after moderate to severe TBI and have adverse consequences for social and vocational functioning. It is hypothesized that deficits in social cognition, including facial affect recognition, might underlie these behavioral changes. Measurement of behavioral deficits is complicated, because the rating scales used rely on subjective judgement, often lack specificity and many patients provide unrealistically positive reports of their functioning due to impaired self-awareness. Accordingly, it is important to find performance based tests that allow objective and early identification of these problems. In the present study 51 moderate to severe TBI patients in the sub-acute and chronic stage were assessed with a test for emotion recognition (FEEST) and a questionnaire for behavioral problems (DEX) with a self and proxy rated version. Patients performed worse on the total score and on the negative emotion subscores of the FEEST than a matched group of 31 healthy controls. Patients also exhibited significantly more behavioral problems on both the DEX self and proxy rated version, but proxy ratings revealed more severe problems. No significant correlation was found between FEEST scores and DEX self ratings. However, impaired emotion recognition in the patients, and in particular of Sadness and Anger, was significantly correlated with behavioral problems as rated by proxies and with impaired self-awareness. This is the first study to find these associations, strengthening the proposed recognition of social signals as a condition for adequate social functioning. Hence, deficits in emotion recognition can be conceived as markers for behavioral problems and lack of insight in TBI patients. This finding is also of clinical importance since, unlike behavioral problems, emotion recognition can be objectively measured early after injury, allowing for early detection and treatment of these problems.	[Spikman, Jacoba M.; Visser-Keizer, Annemarie C.; Westerhof-Evers, Herma J.] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Spikman, Jacoba M.; Herben-Dekker, Meike; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Milders, Maarten V.] Heriot Watt Univ, Sch Life Sci, Edinburgh, Midlothian, Scotland; [Visser-Keizer, Annemarie C.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Haren, Netherlands; [Herben-Dekker, Meike] Rehabil Ctr Friesland, Beetsterzwaag, Netherlands	University of Groningen; University of Groningen; Heriot Watt University; University of Groningen	Spikman, JM (corresponding author), Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands.	j.m.spikman@rug.nl	Milders, Maarten/GWD-1508-2022	van der Naalt, Joukje/0000-0001-9873-2418; Spikman, Jacoba/0000-0002-6477-0763	Dutch Brain Foundation [F2008-1-18]	Dutch Brain Foundation	The study was partly funded by the Dutch Brain Foundation (grant nr F2008-1-18) [https://www.hersenstichting.nl/]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. No additional external funding received for this study.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P606, DOI 10.1017/S1355617705050721; Biehl M, 1997, J NONVERBAL BEHAV, V21, P3, DOI 10.1023/A:1024902500935; Blair RJR, 2003, PHILOS T R SOC B, V358, P561, DOI 10.1098/rstb.2002.1220; Bodenburg S, 2008, J NERV MENT DIS, V196, P75, DOI 10.1097/NMD.0b013e31815faa2b; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Chan RCK, 2008, J NEUROL NEUROSUR PS, V79, P86, DOI 10.1136/jnnp.2007.117184; Chaytor N, 2007, BRAIN INJURY, V21, P615, DOI 10.1080/02699050701426949; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Diehl-Schmid J, 2007, ARCH CLIN NEUROPSYCH, V22, P459, DOI 10.1016/j.acn.2007.01.024; Ekman P., 1976, PICTURES FACIAL AFFE; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; HOLM S, 1979, SCAND J STAT, V6, P65; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; Marsh AA, 2011, J CHILD PSYCHOL PSYC, V52, P834, DOI 10.1111/j.1469-7610.2010.02353.x; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; Milders M, 2003, NEUROPSYCHOLOGIA, V41, P1484, DOI 10.1016/S0028-3932(03)00079-4; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Rapcsak SZ, 2000, NEUROLOGY, V54, P575, DOI 10.1212/WNL.54.3.575; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI [10.1080/09602011.2010.531216, 10.1080/09602011.2011.592099]; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Spikman JM, 2010, J NEUROTRAUMA; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Stuss D.T., 2011, J INT NEUROPSYCH SOC, V17, P1; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Wilson B.A., 1996, BEHAV ASSESSMENT DYS; Wise K, 2005, BRAIN INJURY, V19, P765, DOI 10.1080/0269905050019977; Young AW, 2002, FACIAL EXPRESSIONS E; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	59	89	90	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65581	10.1371/journal.pone.0065581	http://dx.doi.org/10.1371/journal.pone.0065581			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163FW	23776505	gold, Green Published, Green Submitted			2022-12-25	WOS:000320322400035
J	Wei, W; Qi, XG; Garber, PA; Guo, ST; Zhang, P; Li, BG				Wei, Wei; Qi, XiaoGuang; Garber, Paul A.; Guo, SongTao; Zhang, Pei; Li, BaoGuo			Supply and Demand Determine the Market Value of Access to Infants in the Golden Snub-Nosed Monkey (Rhinopithecus roxellana)	PLOS ONE			English	Article							WILD CEBUS-CAPUCINUS; QINLING MOUNTAINS; SOCIAL RELATIONSHIPS; FEMALE PRIMATES; BABOONS; RECIPROCATION; INTERCHANGE; MANGABEYS; DYNAMICS; EXCHANGE	According to a biological market paradigm, trading decisions between partners will be influenced by the current 'exchange rate' of commodities (good and services), which is affected by supply and demand, and the trader's ability to outbid competitors. In several species of nonhuman primates, newborn infants are attractive to female group members and may become a desired commodity that can be traded for grooming within a biological market place. We investigated whether grooming was interchanged for infant handling in female golden snub-nosed monkeys (Rhinopithecus roxellana) inhabiting the Qinling Mountains of central China. R. roxellana exhibit a multilevel social organization characterized by over 100 troop members organized into 6-11 one-male units each composed one adult male and several adult females and their offspring. Behavioral data were collected over the course of 28 months on grooming patterns between mothers with infants less than 6 months old (N = 36) and other adult female troop members. Our results provide strong evidence for the interchange of grooming for access to infants. Grooming for infant access was more likely to be initiated by potential handlers (nonmothers) and less likely reciprocated by mothers. Moreover, grooming bout duration was inversely related to the number of infants per female present in each one-male unit indicating the possibility of a supply and demand market effect. The rank difference between mothers and handlers was negatively correlated with grooming duration. With increasing infant age, the duration of grooming provided by handlers was shorter suggesting that the 'value' of older infants had decreased. Finally, frequent grooming partners were allowed to handle and maintain access to infants longer than infrequent groomers. These results support the contention that grooming and infant handling may be traded in R. roxellana and that the price individuals paid for access to infants fluctuated with supply and demand.	[Wei, Wei; Qi, XiaoGuang; Guo, SongTao; Zhang, Pei; Li, BaoGuo] Northwest Univ, Coll Life Sci, Key Lab Resource Biol & Biotechnol Western China, Xian, Peoples R China; [Li, BaoGuo] Shaanxi Acad Sci, Inst Zool, Xian, Peoples R China; [Garber, Paul A.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA	Northwest University Xi'an; University of Illinois System; University of Illinois Urbana-Champaign	Li, BG (corresponding author), Northwest Univ, Coll Life Sci, Key Lab Resource Biol & Biotechnol Western China, Xian, Peoples R China.	baoguoli@nwu.edu.cn		Qi, Xiao-Guang/0000-0003-2602-4441	National Nature Science Foundation of China [31130061, 31270438, 31270441, 31201721]; Research Fund for the Doctoral Program of Higher Education of China [20106101110005]; Specialized Foundation of Department of Education of Shaanxi Province, China [12JK0825]; Academy of Sciences of Shaanxi Province [2012k-01]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Specialized Foundation of Department of Education of Shaanxi Province, China; Academy of Sciences of Shaanxi Province	This research was supported by the grants from the Key Program of National Nature Science Foundation of China (31130061); the National Nature Science Foundation of China (31270438, 31270441, 31201721); the Research Fund for the Doctoral Program of Higher Education of China (20106101110005); Specialized Foundation of Department of Education of Shaanxi Province, China (12JK0825); Key Program of Academy of Sciences of Shaanxi Province (2012k-01). The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Altmann J., 1980, BABOON MOTHERS INFAN; Aureli F, 1999, J COMP PSYCHOL, V113, P59, DOI 10.1037/0735-7036.113.1.59; Bales K, 2000, FOLIA PRIMATOL, V71, P27, DOI 10.1159/000021728; Barrett L, 2000, ANIM BEHAV, V59, P763, DOI 10.1006/anbe.1999.1361; Barrett L, 2002, ANIM BEHAV, V63, P1047, DOI 10.1006/anbe.2002.3008; Barrett L, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P209, DOI 10.1007/3-540-28277-7_12; Barrett Louise, 2001, P119, DOI 10.1017/CBO9780511752421.009; Chancellor RL, 2009, BEHAV ECOL, V20, P79, DOI 10.1093/beheco/arn117; CHEN F, 1983, Acta Theriologica Sinica, V3, P141; Cheney D., 1990, MONKEYS SEE WORLD IN, DOI [10.7208/chicago/9780226218526.001.0001, DOI 10.7208/CHICAGO/9780226218526.001.0001]; Clutton-Brock T, 1995, ANIM BEHAV; de Waal FBM, 1997, EVOL HUM BEHAV, V18, P375, DOI 10.1016/S1090-5138(97)00085-8; Dunbar R.I.M., 1988, PRIMATE SOCIAL SYSTE; Frank RE, 2009, BEHAVIOUR, V146, P889, DOI 10.1163/156853908X396656; Fruteau C, 2011, ANIM BEHAV, V81, P153, DOI 10.1016/j.anbehav.2010.09.028; Fruteau C, 2009, P NATL ACAD SCI USA, V106, P12007, DOI 10.1073/pnas.0812280106; Garber Paul A., 1997, Evolutionary Anthropology, V5, P187, DOI 10.1002/(SICI)1520-6505(1997)5:6<187::AID-EVAN1>3.0.CO;2-A; Goldizen A.W., 1987, P34; Gumert MD, 2007, ANIM BEHAV, V74, P1655, DOI 10.1016/j.anbehav.2007.03.009; Gumert MD, 2007, INT J PRIMATOL, V28, P1059, DOI 10.1007/s10764-007-9202-0; Guo SG, 2007, PRIMATES, V48, P268, DOI 10.1007/s10329-007-0048-z; Henzi SP, 2002, ANIM BEHAV, V63, P915, DOI 10.1006/anbe.2001.1986; Henzi SP, 1999, PRIMATES, V40, P47, DOI 10.1007/BF02557701; Hrdy SB., 1976, ADV STUD BEHAV, P101, DOI [DOI 10.1016/S0065-3454(08)60083-2, DOI 10.1002/AJP.22456]; Hu Songmei, 2006, Acta Theriologica Sinica, V26, P417; Kirkpatrick RC, 2011, PRIMATES PERSPECTIVE, P189; Kutsukake N, 2006, ANIM BEHAV, V72, P1059, DOI 10.1016/j.anbehav.2006.02.016; LANCASTER JB, 1971, FOLIA PRIMATOL, V15, P161, DOI 10.1159/000155377; Lazaro-Perea C, 2004, ANIM BEHAV, V67, P627, DOI 10.1016/j.anbehav.2003.06.004; Li BG, 2007, PRIMATES, V48, P190, DOI 10.1007/s10329-006-0029-7; Li BG, 2000, FOLIA PRIMATOL, V71, P375, DOI 10.1159/000052734; MAESTRIPIERI D, 1994, FOLIA PRIMATOL, V63, P192, DOI 10.1159/000156819; MAESTRIPIERI D, 1994, INT J PRIMATOL, V15, P531, DOI 10.1007/BF02735970; Manson JH, 2004, ANIM BEHAV, V67, P493, DOI 10.1016/j.anbehav.2003.05.009; Manson JH, 1999, ANIM BEHAV, V57, P911, DOI 10.1006/anbe.1998.1052; Manson JH, 1999, INT J PRIMATOL, V20, P679, DOI 10.1023/A:1020700718458; Nicolson NA, 1987, PRIMATE SOC; NOE R, 1994, BEHAV ECOL SOCIOBIOL, V35, P1; NOE R, 1995, TRENDS ECOL EVOL, V10, P336, DOI 10.1016/S0169-5347(00)89123-5; Noe R., 2001, EC NATURE SOCIAL DIL; Norscia I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004679; Payne HFP, 2003, BEHAVIOUR, V140, P453, DOI 10.1163/156853903322127931; Port M, 2009, ANIM BEHAV, V77, P29, DOI 10.1016/j.anbehav.2008.08.032; Qi XG, 2008, AM J PRIMATOL, V70, P311, DOI 10.1002/ajp.20480; Qi Xiao-Guang, 2004, Acta Zoologica Sinica, V50, P697; Qi XG, 2009, AM J PRIMATOL, V71, P670, DOI 10.1002/ajp.20702; Ren R, 2000, FIELD STUDY SOC RHIN; Schaffner CM, 2005, INT J PRIMATOL, V26, P1093, DOI 10.1007/s10764-005-6460-6; SCHINO G, 1988, AM J PRIMATOL, V16, P43, DOI 10.1002/ajp.1350160106; Schino G, 2008, BIOL LETTERS, V4, P9, DOI 10.1098/rsbl.2007.0506; Schino G, 2007, BEHAV ECOL, V18, P115, DOI 10.1093/beheco/arl045; SEYFARTH RM, 1976, ANIM BEHAV, V24, P917, DOI 10.1016/S0003-3472(76)80022-X; SEYFARTH RM, 1984, NATURE, V308, P541, DOI 10.1038/308541a0; Silk JB, 2003, SCIENCE, V302, P1231, DOI 10.1126/science.1088580; Slater KY, 2007, ANIM BEHAV, V74, P455, DOI 10.1016/j.anbehav.2006.11.026; Stopka P, 1999, ETHOLOGY, V105, P969, DOI 10.1046/j.1439-0310.1999.00485.x; Stopka P, 2001, BEHAV ECOL, V12, P584, DOI 10.1093/beheco/12.5.584; Stumpf Rebecca, 2011, PRIMATES PERSPECTIVE, V2nd, P608; Tiddi B, 2010, ANIM BEHAV, V79, P1115, DOI 10.1016/j.anbehav.2010.02.008; Watts DP, 2002, BEHAVIOUR, V139, P343, DOI 10.1163/156853902760102708; Wei W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036802; Xi WZ, 2008, INT J PRIMATOL, V29, P593, DOI 10.1007/s10764-008-9260-y; Zhang P, 2006, PRIMATES, V47, P374, DOI 10.1007/s10329-006-0178-8; Zhang SY, 2000, AM J PRIMATOL, V51, P265, DOI 10.1002/1098-2345(200008)51:4<265::AID-AJP6>3.3.CO;2-#; Zhao HT, 2011, STUDY CORRELATIONSHI; ZUMPE D, 1986, AM J PRIMATOL, V10, P291, DOI 10.1002/ajp.1350100402	67	10	12	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65962	10.1371/journal.pone.0065962	http://dx.doi.org/10.1371/journal.pone.0065962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776580	Green Published, Green Submitted, gold			2022-12-25	WOS:000320322400065
J	Xiang, L; Su, JT; Zheng, GL; Liang, J; Zhang, GY; Wang, HZ; Xie, LP; Zhang, RQ				Xiang, Liang; Su, Jingtan; Zheng, Guilan; Liang, Jian; Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing			Patterns of Expression in the Matrix Proteins Responsible for Nucleation and Growth of Aragonite Crystals in Flat Pearls of Pinctada fucata	PLOS ONE			English	Article							INNER-SHELL FILM; NACREOUS LAYER; CARBONIC-ANHYDRASE; HALIOTIS-RUFESCENS; OYSTER; BIOMINERALIZATION; FRAMEWORK; GENES; MACROMOLECULES; BIOFABRICATION	The initial growth of the nacreous layer is crucial for comprehending the formation of nacreous aragonite. A flat pearl method in the presence of the inner-shell film was conducted to evaluate the role of matrix proteins in the initial stages of nacre biomineralization in vivo. We examined the crystals deposited on a substrate and the expression patterns of the matrix proteins in the mantle facing the substrate. In this study, the aragonite crystals nucleated on the surface at 5 days in the inner-shell film system. In the film-free system, the calcite crystals nucleated at 5 days, a new organic film covered the calcite, and the aragonite nucleated at 10 days. This meant that the nacre lamellae appeared in the inner-shell film system 5 days earlier than that in the film-free system, timing that was consistent with the maximum level of matrix proteins during the first 20 days. In addition, matrix proteins (Nacrein, MSI60, N19, N16 and Pif80) had similar expression patterns in controlling the sequential morphologies of the nacre growth in the inner-film system, while these proteins in the film-free system also had similar patterns of expression. These results suggest that matrix proteins regulate aragonite nucleation and growth with the inner-shell film in vivo.	[Xiang, Liang; Su, Jingtan; Zheng, Guilan; Liang, Jian; Zhang, Guiyou; Wang, Hongzhong; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China; [Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Xie, LP (corresponding author), Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn			National Basic Research Program of China [2010CB126405]; National High Technology Research and Development Program of China [2010AA09Z405]; National Natural Science Foundation of China [31172382, U0831001]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090002110055]; Independent Research Projects of Tsinghua University [20111080964]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Independent Research Projects of Tsinghua University	This work was supported by the National Basic Research Program of China Grant 2010CB126405, http://www.973.gov.cn/English/Index.aspx, the National High Technology Research and Development Program of China 2010AA09Z405, http://www.most.gov.cn/eng/index.htm, the National Natural Science Foundation of China Grants 31172382 and U0831001 (Joint Fund with Guangdong) http://www.nsfc.gov.cn/Portal0/default124.htm, the Specialized Research Fund for the Doctoral Program of Higher Education of China Grant 20090002110055, and Independent Research Projects of Tsinghua University Grant 20111080964. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Addadi L, 1997, NATURE, V389, P912, DOI 10.1038/40010; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Bezares J, 2008, J STRUCT BIOL, V163, P61, DOI 10.1016/j.jsb.2008.04.009; Bezares J, 2010, J STRUCT BIOL, V170, P484, DOI 10.1016/j.jsb.2010.01.006; Chec AG, 2009, P NATL ACAD SCI USA, V106, P38, DOI 10.1073/pnas.0808796106; Dauphin Y, 2008, ANAL BIOANAL CHEM, V390, P1659, DOI 10.1007/s00216-008-1860-z; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Fang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035715; Fang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021860; FRITZ M, 1994, NATURE, V371, P49, DOI 10.1038/371049a0; Gaume B, 2011, MAR BIOL, V158, P341, DOI 10.1007/s00227-010-1562-x; Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548; Gries K, 2011, CRYST GROWTH DES, V11, P729, DOI 10.1021/cg101240e; Heinemann F, 2006, BIOCHEM BIOPH RES CO, V344, P45, DOI 10.1016/j.bbrc.2006.03.150; Inoue N, 2011, MAR BIOTECHNOL, V13, P48, DOI 10.1007/s10126-010-9267-1; Kinoshita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021238; Lin AYM, 2008, ACTA BIOMATER, V4, P131, DOI 10.1016/j.actbio.2007.05.005; Liu XJ, 2012, P ROY SOC B-BIOL SCI, V279, P1000, DOI 10.1098/rspb.2011.1661; LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Masaoka T, 2013, AQUACULTURE, V384, P56, DOI 10.1016/j.aquaculture.2012.12.019; Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994; Miyamoto H, 2005, ZOOL SCI, V22, P311, DOI 10.2108/zsj.22.311; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Miyazaki Y, 2010, COMP BIOCHEM PHYS B, V155, P241, DOI 10.1016/j.cbpb.2009.11.009; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339; SARIKAYA M, 1994, MICROSC RES TECHNIQ, V27, P360, DOI 10.1002/jemt.1070270503; Saruwatari K, 2009, BIOMATERIALS, V30, P3028, DOI 10.1016/j.biomaterials.2009.03.011; Schaffer TE, 1997, CHEM MATER, V9, P1731, DOI 10.1021/cm960429i; Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Takeuchi T, 2006, MAR BIOTECHNOL, V8, P52, DOI 10.1007/s10126-005-5037-x; Wang N, 2012, MAR BIOTECHNOL, V14, P177, DOI 10.1007/s10126-011-9400-9; Wang N, 2009, COMP BIOCHEM PHYS B, V154, P346, DOI 10.1016/j.cbpb.2009.07.012; WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036; Wilt FH, 2005, DEV BIOL, V280, P15, DOI 10.1016/j.ydbio.2005.01.019; Wilt FH, 2003, DIFFERENTIATION, V71, P237, DOI 10.1046/j.1432-0436.2003.7104501.x; Yan ZG, 2008, CHEMBIOCHEM, V9, P1093, DOI 10.1002/cbic.200700553; Yan ZG, 2011, ACTA OCEANOL SIN, V30, P87, DOI 10.1007/s13131-011-0094-7; Yano M, 2007, BIOCHEM BIOPH RES CO, V362, P158, DOI 10.1016/j.bbrc.2007.07.172; Zaremba CM, 1996, CHEM MATER, V8, P679, DOI 10.1021/cm9503285; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6	48	28	28	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66564	10.1371/journal.pone.0066564	http://dx.doi.org/10.1371/journal.pone.0066564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776687	gold, Green Published, Green Submitted			2022-12-25	WOS:000320322400112
J	Ek-Ramos, MJ; Zhou, WQ; Valencia, CU; Antwi, JB; Kalns, LL; Morgan, GD; Kerns, DL; Sword, GA				Ek-Ramos, Maria J.; Zhou, Wenqing; Valencia, Cesar U.; Antwi, Josephine B.; Kalns, Lauren L.; Morgan, Gaylon D.; Kerns, David L.; Sword, Gregory A.			Spatial and Temporal Variation in Fungal Endophyte Communities Isolated from Cultivated Cotton (Gossypium hirsutum)	PLOS ONE			English	Article							BEAUVERIA-BASSIANA; PLANT; DIVERSITY; LEAVES; GROWTH; PATHOGENS; PROGRESS; ECOLOGY; TISSUES; DISEASE	Studies of fungi in upland cotton (Gossypium hirsutum) cultivated in the United States have largely focused on monitoring and controlling plant pathogens. Given increasing interest in asymptomatic fungal endophytes as potential biological control agents, surveys are needed to better characterize their diversity, distribution patterns and possible applications in integrated pest management. We sampled multiple varieties of cotton in Texas, USA and tested for temporal and spatial variation in fungal endophyte diversity and community composition, as well as for differences associated with organic and conventional farming practices. Fungal isolates were identified by morphological and DNA identification methods. We found members of the genera Alternaria, Colletotrichum and Phomopsis, previously isolated as endophytes from other plant species. Other recovered species such as Drechslerella dactyloides (formerly Arthrobotrys dactyloides) and Exserohilum rostratum have not, to our knowledge, been previously reported as endophytes in cotton. We also isolated many latent pathogens, but some species such as Alternaria tennuissima, Epicoccum nigrum, Acremonium alternatum, Cladosporium cladosporioides, Chaetomium globosum and Paecilomyces sp., are known to be antagonists against plant pathogens, insects and nematode pests. We found no differences in endophyte species richness or diversity among different cotton varieties, but did detect differences over time and in different plant tissues. No consistent patterns of community similarity associated with variety, region, farming practice, time of the season or tissue type were observed regardless of the ecological community similarity measurements used. Results indicated that local fungal endophyte communities may be affected by both time of the year and plant tissue, but the specific community composition varies across sites. In addition to providing insights into fungal endophyte community structure, our survey provides candidates for further evaluation as potential management tools against a variety of pests and diseases when present as endophytes in cotton and other plants.	[Ek-Ramos, Maria J.; Zhou, Wenqing; Valencia, Cesar U.; Antwi, Josephine B.; Kalns, Lauren L.; Kerns, David L.; Sword, Gregory A.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Morgan, Gaylon D.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Morgan, Gaylon D.] Texas A&M Univ, Texas AgriLife Extens, College Stn, TX 77843 USA; [Kerns, David L.] Texas A&M Univ, AgriLife Extens Serv, Lubbock, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System	Ek-Ramos, MJ (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	ekramos@neo.tamu.edu	Zhou, Wenqing/GPS-7266-2022; Ramos, Maria Julissa Ek/W-1017-2018	Ramos, Maria Julissa Ek/0000-0002-1556-0823; Kalns, Lauren/0000-0002-5924-7118	Texas A&M University Department of Entomology	Texas A&M University Department of Entomology	This work was supported by Texas A&M University Department of Entomology start-up funds (to GAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, EVOL BIOINFORM, V6, P189, DOI 10.4137/EBO.S6271; Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Alva P, 2002, FUNG DIVERS RES SER, V7, P167; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Azevedo J.L., 2000, ELECTRON J BIOTECHN, V3, P40, DOI [DOI 10.2225/V0L3-ISSUE, 10.2225/vol3-issue1-fulltext-4.228, DOI 10.2225/VOL3-ISSUE1-FULLTEXT-4.228]; Azevedo JL, 2007, FUNGI MULTIFACETED M, P189; Bae H, 2009, J EXP BOT, V60, P3279, DOI 10.1093/jxb/erp165; Baird R., 1998, Journal of Cotton Science, V2, P27; Barnes HA, 1998, INST MATH A, P1; BASHAN Y, 1994, CAN J BOT, V72, P1580, DOI 10.1139/b94-195; Bayman P., 2006, Microbial ecology of aerial plant surfaces, P37, DOI 10.1079/9781845930615.0037; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Bing L.A., 1992, Biocontrol Science and Technology, V2, P39, DOI 10.1080/09583159209355216; Boyle C, 2001, SYMBIOSIS, V31, P259; CARROLL G, 1995, CAN J BOT, V73, pS1316, DOI 10.1139/b95-393; CAYROL J-C, 1983, Revue de Nematologie, V6, P265; Cheplick G. P., 2009, ECOLOGY EVOLUTION GR, P1; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; COTTY PJ, 1987, PLANT DIS, V71, P1082, DOI 10.1094/PD-71-1082; Crawford RF, 1923, PHYTOPATHOLOGY, V13, P501; Dugan FM, 2008, IDENTIFICATION FUNGI, P1; Faeth SH, 2002, OIKOS, V98, P25, DOI 10.1034/j.1600-0706.2002.980103.x; Farr D. F., 1989, Fungi on plants and plant products in the United States.; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Frohlich J, 2000, MYCOL RES, V104, P1202, DOI 10.1017/S095375620000263X; Gamboa Miguel A., 2002, Mycopathologia, V156, P41, DOI 10.1023/A:1021362217723; Gonthier P, 2006, FUNGAL DIVERS, V21, P69; Guo LD, 2001, MOL PHYLOGENET EVOL, V20, P1, DOI 10.1006/mpev.2001.0942; Gurulingappa P, 2010, BIOL CONTROL, V55, P34, DOI 10.1016/j.biocontrol.2010.06.011; Hyde KD, 2008, FUNGAL DIVERS, V33, P163; Jeyarani S., 2011, Journal of Entomology, V8, P274, DOI 10.3923/je.2011.274.279; Johnson J. Michal, 2009, ENDOCYTOBIOSIS CELL, V19, P81; Kasselaki AM, 2006, EUR J PLANT PATHOL, V115, P263, DOI 10.1007/s10658-006-9010-y; KLICH MA, 1986, MYCOLOGIA, V78, P706, DOI 10.2307/3807514; Li WC, 2007, FUNGAL DIVERS, V25, P69; Lingfei L, 2005, MYCORRHIZA, V17, P103; Liu CH, 2001, J BIOTECHNOL, V88, P277, DOI 10.1016/S0168-1656(01)00285-1; Lodge DJ, 1996, MYCOLOGIA, V88, P733, DOI 10.2307/3760967; Mao BZ, 2010, AFR J BIOTECHNOL, V9, P5955; McGee PA, 2002, AUST J EXP AGR, V42, P995, DOI 10.1071/EA01124; McKenna JE, 2003, ENVIRON MODELL SOFTW, V18, P205, DOI 10.1016/S1364-8152(02)00094-4; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; Oses R, 2008, FUNGAL DIVERS, V33, P77; Ownley BH, 2008, J INVERTEBR PATHOL, V98, P267, DOI 10.1016/j.jip.2008.01.010; Ownley BH, 2010, BIOCONTROL, V55, P113, DOI 10.1007/s10526-009-9241-x; Palmateer AJ, 2004, MYCOPATHOLOGIA, V157, P303, DOI 10.1023/B:MYCO.0000024184.56337.f5; PETRINI O, 1982, CAN J BOT, V60, P789, DOI 10.1139/b82-102; Pineda A, 2010, TRENDS PLANT SCI, V15, P507, DOI 10.1016/j.tplants.2010.05.007; Pinto LSRC, 2000, NEW PHYTOL, V147, P609, DOI 10.1046/j.1469-8137.2000.00722.x; Porras-Alfaro A, 2008, PLANT SOIL, V296, P65; Porras-Alfaro A, 2011, ANNU REV PHYTOPATHOL, V49, P291, DOI 10.1146/annurev-phyto-080508-081831; Quinn GP, 2002, EXPT DESIGN DATA ANA, P473, DOI DOI 10.1017/CBO9780511806384.019; Ragazzi A, 1997, Z PFLANZENK PFLANZEN, V104, P133; Raps A, 1998, OECOLOGIA, V114, P541, DOI 10.1007/s004420050478; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; RODRIGUES KF, 1994, MYCOLOGIA, V86, P376, DOI 10.2307/3760568; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; ROY KW, 1982, PHYTOPATHOLOGY, V72, P868, DOI 10.1094/Phyto-72-868; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Sambrook J., 1989, MOL CLONING LAB MANU, V1; Santamaria J, 2005, MICROB ECOL, V50, P1, DOI 10.1007/s00248-004-0002-1; SAYRE RM, 1986, CROP PROT, V5, P268, DOI 10.1016/0261-2194(86)90062-1; Schardl C.L., 1997, PLANT RELATIONSHIPS, V5B, DOI DOI 10.1007/978-3-642-60647-2_14; Schardl CL, 1997, PLANT DIS, V81, P430, DOI 10.1094/PDIS.1997.81.5.430; Schulz B, 1998, SYMBIOSIS, V25, P213; Schulz B, 2002, MYCOL RES, V106, P996, DOI 10.1017/S0953756202006342; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Selosse MA, 2004, CR BIOL, V327, P639, DOI 10.1016/j.crvi.2003.12.008; Sikora RA, 2008, BIOL CONTROL, V46, P15, DOI 10.1016/j.biocontrol.2008.02.011; Stone JK, 2000, BOOK SOIL P, P3; Taylor JE, 1999, NEW PHYTOL, V142, P335, DOI 10.1046/j.1469-8137.1999.00391.x; Vega FE, 2008, J INVERTEBR PATHOL, V98, P277, DOI 10.1016/j.jip.2008.01.008; Vieira P. D. de S., 2011, Mycology - An International Journal on Fungal Biology, V2, P91, DOI 10.1080/21501203.2011.584390; Vralstad T, 2011, MOL ECOL, V20, P2873, DOI 10.1111/j.1365-294X.2011.05149.x; Wang B, 2007, MYCOL RES, V111, P347, DOI 10.1016/j.mycres.2006.11.004; Wilson D, 2000, BOOK SOIL P, P389; Yan XN, 2011, J ZHEJIANG UNIV-SC B, V12, P219, DOI 10.1631/jzus.B1000165; Zimmerman NB, 2012, P NATL ACAD SCI USA, V109, P13022, DOI 10.1073/pnas.1209872109	82	55	71	3	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66049	10.1371/journal.pone.0066049	http://dx.doi.org/10.1371/journal.pone.0066049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776604	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400105
J	Gao, JL; Gu, XF; Mahuran, DJ; Wang, ZG; Zhang, HW				Gao, Jialin; Gu, Xuefan; Mahuran, Don J.; Wang, Zhugang; Zhang, Huiwen			Impaired Glucose Tolerance in a Mouse Model of Sidt2 Deficiency	PLOS ONE			English	Article							KISS-AND-RUN; EXOCYTOSIS; RELEASE; HOMEOSTASIS; LANGERHANS; VESICLES; SYSTEM; ISLETS; ENZYME	Sidt2 was identified as a novel integral lysosomal membrane protein recently. We generated global Sidt2 knockout mice by gene targeting. These mice have a comparatively higher random and fasting glucose concentration. Intraperitoneal and oral glucose tolerance tests in Sidt2 knockout mice indicated glucose intolerance and decreased serum insulin level. Notably, the Sidt2(-/-) mice had hypertrophic islets compared with control mice. By Western blot and immunofluorescence, Sidt2(-/-) mouse islets were shown to have increased insulin protein, which actually contained more insulin secretory granules than their controls, demonstrated by electromicroscopy. Consistent with the in vivo study, isolated islet culture from the Sidt2(-/-) mice produced less insulin when stimulated by a high concentration of glucose or a depolarizing concentration of KCl. Under electromicroscope less empty vesicles and more mature ones in Sidt2(-/-) mice islets were observed, supporting impaired insulin secretory granule release. In conclusion, Sidt2 may play a critical role in the regulation of mouse insulin secretory granule secretion.	[Gao, Jialin; Gu, Xuefan; Zhang, Huiwen] Shanghai Jiao Tong Univ, Sch Med, Dept Pediat Endocrinol & Genet Metab, Xinhua Hosp,Shanghai Inst Pediat Res, Shanghai 200030, Peoples R China; [Mahuran, Don J.] Univ Toronto, Hosp Sick Children, Res Inst, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X8, Canada; [Wang, Zhugang] Shanghai Res Ctr Model Organisms, Shanghai, Peoples R China	Shanghai Jiao Tong University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Gu, XF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pediat Endocrinol & Genet Metab, Xinhua Hosp,Shanghai Inst Pediat Res, Shanghai 200030, Peoples R China.	gu_xf53@yahoo.com.cn; huiwenzhang@yahoo.com	GAO, JIALIN/GWN-1905-2022		National Science and Technology Program [81071121, 81270936]; Shanghai Rising-Star Program [12QH1401800]; Major Program of Shanghai Committee of Science and Technology [11dz195030]; National Key Technology RD Program [2012BAI09B04]	National Science and Technology Program; Shanghai Rising-Star Program; Major Program of Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); National Key Technology RD Program(National Key Technology R&D Program)	This work was supported by grants from the National Science and Technology Program (81071121, 81270936), Shanghai Rising-Star Program (12QH1401800), the Major Program of Shanghai Committee of Science and Technology (11dz195030), and The National Key Technology R&D Program (2012BAI09B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejewski N, 1999, J BIOL CHEM, V274, P12692, DOI 10.1074/jbc.274.18.12692; Boadu E, 2012, BBA-MOL CELL BIOL L, V1821, P396, DOI 10.1016/j.bbalip.2011.11.013; BONNERWEIR S, 1982, DIABETES, V31, P883, DOI 10.2337/diabetes.31.10.883; Brunner Y, 2007, MOL CELL PROTEOMICS, V6, P1007, DOI 10.1074/mcp.M600443-MCP200; Ceridono M, 2011, TRAFFIC, V12, P72, DOI 10.1111/j.1600-0854.2010.01125.x; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; Cullen Peter J, 2012, Subcell Biochem, V59, P65, DOI 10.1007/978-94-007-3015-1_3; Dixit SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058655; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Elhassan MO, 2012, J BIOL CHEM, V287, P5267, DOI 10.1074/jbc.M111.318865; Gao JL, 2010, BIOCHEM BIOPH RES CO, V402, P588, DOI 10.1016/j.bbrc.2010.09.133; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Hanna ST, 2009, PFLUG ARCH EUR J PHY, V457, P1343, DOI 10.1007/s00424-008-0588-0; Kos CH, 2004, NUTR REV, V62, P243, DOI 10.1301/nr2004.jun243-246; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; LaPlante JM, 2006, MOL GENET METAB, V89, P339, DOI 10.1016/j.ymgme.2006.05.016; Lloyd-Evans E, 2011, CELL CALCIUM, V50, P200, DOI 10.1016/j.ceca.2011.03.010; LUNDQUIST I, 1983, HORM METAB RES, V15, P11, DOI 10.1055/s-2007-1018615; Lundquist I, 1996, ENDOCRINOLOGY, V137, P1219, DOI 10.1210/en.137.4.1219; MacDonald PE, 2005, DIABETES, V54, P736, DOI 10.2337/diabetes.54.3.736; Meijer AJ, 2008, CELL METAB, V8, P275, DOI 10.1016/j.cmet.2008.09.001; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; O'Prey J, 2009, CELL CYCLE, V8, P2260, DOI 10.4161/cc.8.14.9050; Obermuller S, 2005, J CELL SCI, V118, P4271, DOI 10.1242/jcs.02549; Obermuller S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008936; POON PYW, 1979, CLIN ENDOCRINOL, V11, P625, DOI 10.1111/j.1365-2265.1979.tb03117.x; Ramonet D, 2012, HUM MOL GENET, V21, P1725, DOI 10.1093/hmg/ddr606; Ren RW, 2011, DEV COMP IMMUNOL, V35, P692, DOI 10.1016/j.dci.2011.02.003; Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007; Rutter GA, 2006, CELL CALCIUM, V40, P539, DOI 10.1016/j.ceca.2006.08.015; Rutter GA, 2006, PHYSIOLOGY, V21, P189, DOI 10.1152/physiol.00002.2006; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Salehi A, 1999, ENDOCRINOLOGY, V140, P3045, DOI 10.1210/en.140.7.3045; Schroder B, 2007, TRAFFIC, V8, P1676, DOI 10.1111/j.1600-0854.2007.00643.x; Schwake M, 2013, TRAFFIC; WATERS PJ, 1992, DIABETOLOGIA, V35, P991, DOI 10.1007/BF00401431; Zhang HW, 2007, J PROTEOME RES, V6, P240, DOI 10.1021/pr060407o; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000	38	21	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66139	10.1371/journal.pone.0066139	http://dx.doi.org/10.1371/journal.pone.0066139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776622	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400114
J	Halbherr, SJ; Brostoff, T; Tippenhauer, M; Locher, S; Rentsch, MB; Zimmer, G				Halbherr, Stefan J.; Brostoff, Terza; Tippenhauer, Merve; Locher, Samira; Rentsch, Marianne Berger; Zimmer, Gert			Vaccination with Recombinant RNA Replicon Particles Protects Chickens from H5N1 Highly Pathogenic Avian Influenza Virus	PLOS ONE			English	Article							A VIRUS; SINGLE VACCINATION; CELL-DEATH; TRANSMISSION; HEMAGGLUTININS; HOST; SUBTYPES; VACCINES; DUCKS; H2	Highly pathogenic avian influenza viruses (HPAIV) of subtype H5N1 not only cause a devastating disease in domestic chickens and turkeys but also pose a continuous threat to public health. In some countries, H5N1 viruses continue to circulate and evolve into new clades and subclades. The rapid evolution of these viruses represents a problem for virus diagnosis and control. In this work, recombinant vesicular stomatitis virus (VSV) vectors expressing HA of subtype H5 were generated. To comply with biosafety issues the G gene was deleted from the VSV genome. The resulting vaccine vector VSV*Delta G(HA) was propagated on helper cells providing the VSV G protein in trans. Vaccination of chickens with a single intramuscular dose of 2x10(8) infectious replicon particles without adjuvant conferred complete protection from lethal H5N1 infection. Subsequent application of the same vaccine strongly boosted the humoral immune response and completely prevented shedding of challenge virus and transmission to sentinel birds. The vaccine allowed serological differentiation of infected from vaccinated animals (DIVA) by employing a commercially available ELISA. Immunized chickens produced antibodies with neutralizing activity against multiple H5 viruses representing clades 1, 2.2, 2.5, and low-pathogenic avian influenza viruses (classical clade). Studies using chimeric H1/H5 hemagglutinins showed that the neutralizing activity was predominantly directed against the globular head domain. In summary, these results suggest that VSV replicon particles are safe and potent DIVA vaccines that may help to control avian influenza viruses in domestic poultry.	[Halbherr, Stefan J.; Brostoff, Terza; Tippenhauer, Merve; Locher, Samira; Rentsch, Marianne Berger; Zimmer, Gert] Inst Immunol & Virol, Mittelhausern, Switzerland; [Brostoff, Terza] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis	Zimmer, G (corresponding author), Inst Immunol & Virol, Mittelhausern, Switzerland.	gert.zimmer@ivi.admin.ch		Zimmer, Gert/0000-0002-2708-2507	Swiss National Science Foundation [129669]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by Swiss National Science Foundation (www.snf.ch), grant no. 129669. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownie C, 2011, BIOLOGICALS, V39, P224, DOI 10.1016/j.biologicals.2011.06.007; Cai ZP, 2012, J MOL BIOL, V422, P145, DOI 10.1016/j.jmb.2012.05.011; Capua I, 2004, DEV BIOLOGICALS, V119, P229; Capua I, 2009, REV SCI TECH OIE, V28, P245, DOI 10.20506/rst.28.1.1861; Cattoli G, 2011, J VIROL, V85, P8718, DOI 10.1128/JVI.02403-10; Chen HL, 2009, SCI CHINA SER C, V52, P419, DOI 10.1007/s11427-009-0068-6; Eggert D, 2010, AVIAN DIS, V54, P1224, DOI 10.1637/9410-052810-Reg.1; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fung K P, 1989, J Singapore Paediatr Soc, V31, P129; Gambaryan AS, 2012, INFLUENZA OTHER RESP, V6, P188, DOI 10.1111/j.1750-2659.2011.00291.x; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Grund C, 2011, VACCINE, V29, P5567, DOI 10.1016/j.vaccine.2011.01.006; Hai R, 2012, J VIROL, V86, P5774, DOI 10.1128/JVI.00137-12; Han T, 2011, ANN NY ACAD SCI, V1217, P178, DOI 10.1111/j.1749-6632.2010.05829.x; Hanika A, 2005, J GEN VIROL, V86, P1455, DOI 10.1099/vir.0.80788-0; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hoffmann M, 2010, J GEN VIROL, V91, P2782, DOI 10.1099/vir.0.023978-0; Hofmann MA, 2008, VIRUS GENES, V37, P407, DOI 10.1007/s11262-008-0285-2; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Isoda N, 2008, ARCH VIROL, V153, P1685, DOI 10.1007/s00705-008-0171-1; Kalhoro NH, 2009, VACCINE, V27, P1174, DOI 10.1016/j.vaccine.2008.12.019; Kayali G, 2013, POULTRY SCI, V92, P114, DOI 10.3382/ps.2012-02637; Kepp O, 2009, CELL CYCLE, V8, P860, DOI 10.4161/cc.8.6.7939; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; Lyles DS, 2000, MICROBIOL MOL BIOL R, V64, P709, DOI 10.1128/MMBR.64.4.709-724.2000; Manzoor R, 2009, J VIROL, V83, P1572, DOI 10.1128/JVI.01879-08; Marangon S, 2008, ZOONOSES PUBLIC HLTH, V55, P65, DOI 10.1111/j.1863-2378.2007.01086.x; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Nicolson C, 2005, VACCINE, V23, P2943, DOI 10.1016/j.vaccine.2004.08.054; Ocana-Macchi M, 2009, J VIROL, V83, P12947, DOI 10.1128/JVI.00468-09; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Poetri ON, 2009, VACCINE, V27, P2864, DOI 10.1016/j.vaccine.2009.02.085; Poetri O, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-74; Rentsch MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025858; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Sakabe S, 2010, ANTIVIR RES, V88, P249, DOI 10.1016/j.antiviral.2010.09.007; Schwartz JA, 2007, VIROLOGY, V366, P166, DOI 10.1016/j.virol.2007.04.021; Smirnov YA, 1999, ACTA VIROL, V43, P237; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Soda K, 2008, JPN J VET RES, V55, P93; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stech J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn646; SUTTER G, 1995, FEBS LETT, V371, P9, DOI 10.1016/0014-5793(95)00843-X; Swayne DE, 2012, AVIAN DIS, V56, P818, DOI 10.1637/10183-041012-Review.1; van der Goot JA, 2005, P NATL ACAD SCI USA, V102, P18141, DOI 10.1073/pnas.0505098102; van der Goot JA, 2008, VIROLOGY, V382, P91, DOI 10.1016/j.virol.2008.08.037; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Veits J, 2012, P NATL ACAD SCI USA, V109, P2579, DOI 10.1073/pnas.1109397109; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; Wu WL, 2008, J VIROL, V82, P1798, DOI 10.1128/JVI.02256-07	55	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66059	10.1371/journal.pone.0066059	http://dx.doi.org/10.1371/journal.pone.0066059			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762463	Green Submitted, Green Published, gold			2022-12-25	WOS:000320440500060
J	Wozniak, DF; Diggs-Andrews, KA; Conyers, S; Yuede, CM; Dearborn, JT; Brown, JA; Tokuda, K; Izumi, Y; Zorumski, CF; Gutmann, DH				Wozniak, David F.; Diggs-Andrews, Kelly A.; Conyers, Sara; Yuede, Carla M.; Dearborn, Joshua T.; Brown, Jacquelyn A.; Tokuda, Kazuhiro; Izumi, Yukitoshi; Zorumski, Charles F.; Gutmann, David H.			Motivational Disturbances and Effects of L-dopa Administration in Neurofibromatosis-1 Model Mice	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ATTENTION-DEFICIT; NONSELECTIVE ATTENTION; MOUSE MODEL; TYPE-1; HYPERACTIVITY; ACQUISITION; DISRUPTION; DEPRESSION; OLFACTION	Children with neurofibromatosis type 1 (NF1) frequently have cognitive and behavioral deficits. Some of these deficits have been successfully modeled in Nf1 genetically-engineered mice that develop optic gliomas (Nf1 OPG mice). In the current study, we show that abnormal motivational influences affect the behavior of Nf1 OPG mice, particularly with regard to their response to novel environmental stimuli. For example, Nf1 OPG mice made fewer spontaneous alternations in a Y-maze and fewer arm entries relative to WT controls. However, analysis of normalized alternation data demonstrated that these differences were not due to a spatial working memory deficit. Other reported behavioral results (e. g., open-field test, below) suggest that differential responses to novelty and/or other motivational influences may be more important determinants of these kinds of behavior than simple differences in locomotor activity/spontaneous movements. Importantly, normal long-term depression was observed in hippocampal slices from Nf1 OPG mice. Results from elevated plus maze testing showed that differences in exploratory activity between Nf1 OPG and WT control mice may be dependent on the environmental context (e. g., threatening or non-threatening) under which exploration is being measured. Nf1 OPG mice also exhibited decreased exploratory hole poking in a novel holeboard and showed abnormal olfactory preferences, although L-dopa (50 mg/kg) administration resolved the abnormal olfactory preference behaviors. Nf1 OPG mice displayed an attenuated response to a novel open field in terms of decreased ambulatory activity and rearing but only during the first 10 min of the session. Importantly, Nf1 OPG mice demonstrated investigative rearing deficits with regard to a novel hanging object suspended on one side of the field which were not rescued by L-dopa administration. Collectively, our results provide new data important for evaluating therapeutic treatments aimed at ameliorating NF1-associated cognitive/behavioral deficits.	[Wozniak, David F.; Conyers, Sara; Dearborn, Joshua T.; Tokuda, Kazuhiro; Izumi, Yukitoshi; Zorumski, Charles F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Diggs-Andrews, Kelly A.; Yuede, Carla M.; Brown, Jacquelyn A.; Gutmann, David H.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Wozniak, David F.; Izumi, Yukitoshi; Zorumski, Charles F.] Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Wozniak, DF (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	wozniakd@psychiatry.wustl.edu		Brown, Jacquelyn/0000-0002-2002-3010; Gutmann, David/0000-0002-3127-5045; Dearborn, Joshua/0000-0003-0335-1087	Department of Defense; National Cancer Institute [U01-CA141549]; National Cancer Center Diversity Supplement Award (KADA); National Institute of Health and Human Development Center [P30 HD062171]; Neuroscience Blueprint Center Core Grant [P30 NS057105]; National Institute of Mental Health [MH077791]; Bantly Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD062171] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA141549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Center Diversity Supplement Award (KADA); National Institute of Health and Human Development Center; Neuroscience Blueprint Center Core Grant; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Bantly Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from the Department of Defense (DHG, DFW), the National Cancer Institute (U01-CA141549; DHG), National Cancer Center Diversity Supplement Award (KADA), National Institute of Health and Human Development Center Grant P30 HD062171 (DFW), Neuroscience Blueprint Center Core Grant (P30 NS057105) to Washington University (DFW, CFZ), National Institute of Mental Health (MH077791; CFZ), and the Bantly Foundation (CFZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspide R, 2000, NEUROSCI BIOBEHAV R, V24, P59, DOI 10.1016/S0149-7634(99)00045-7; Bajenaru ML, 2003, CANCER RES, V63, P8573; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Brosnan-Watters G, 1997, BRAIN RES PROTOC, V1, P331, DOI 10.1016/S1385-299X(97)00007-X; Brown JA, 2011, EXP NEUROL, V232, P333, DOI 10.1016/j.expneurol.2011.09.005; Brown JA, 2010, HUM MOL GENET, V19, P4515, DOI 10.1093/hmg/ddq382; Cave JW, 2009, ADV EXP MED BIOL, V651, P15; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; Diggs-Andrews KA, 2013, ANN NEUROL, V73, P309, DOI 10.1002/ana.23793; Doty RL, 2012, NEUROBIOL DIS, V46, P527, DOI 10.1016/j.nbd.2011.10.026; Dougherty JD, 2013, J NEUROSCI, V33, P2732, DOI 10.1523/JNEUROSCI.4762-12.2013; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; FILE SE, 1975, PSYCHOPHARMACOLOGIA, V44, P53, DOI 10.1007/BF00421184; Gallitano-Mendel A, 2007, NEUROSCIENCE, V148, P633, DOI 10.1016/j.neuroscience.2007.05.050; Ghoshal N, 2012, NEUROBIOL DIS, V45, P395, DOI 10.1016/j.nbd.2011.08.029; Guilding C, 2007, EUR J NEUROSCI, V25, P99, DOI 10.1111/j.1460-9568.2006.05238.x; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; Hyman SL, 2006, DEV MED CHILD NEUROL, V48, P973, DOI 10.1017/S0012162206002131; Hyman SL, 2005, NEUROLOGY, V65, P1037, DOI 10.1212/01.wnl.0000179303.72345.ce; Kemp A, 2004, P NATL ACAD SCI USA, V101, P8192, DOI 10.1073/pnas.0402650101; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Li WD, 2005, CURR BIOL, V15, P1961, DOI 10.1016/j.cub.2005.09.043; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Mautner VF, 2002, DEV MED CHILD NEUROL, V44, P164, DOI 10.1017/S0012162201001876; Moy SS, 2008, BEHAV BRAIN RES, V188, P178, DOI 10.1016/j.bbr.2007.10.029; Nakao K, 2002, EUR J NEUROSCI, V16, P970, DOI 10.1046/j.1460-9568.2002.02159.x; North KN, 1997, NEUROLOGY, V48, P1121, DOI 10.1212/WNL.48.4.1121; Sato C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048180; Schaefer ML, 2000, J NEUROSCI, V20, P4809; Schecklmann M, 2013, J NEURAL TRANSM, V120, P121, DOI 10.1007/s00702-012-0855-2; Vallone D, 2002, BEHAV BRAIN RES, V130, P141, DOI 10.1016/S0166-4328(01)00428-4; Wozniak DF, 2007, NEUROBIOL DIS, V26, P14, DOI 10.1016/j.nbd.2006.11.014; Wozniak DF, 2004, NEUROBIOL DIS, V17, P403, DOI 10.1016/j.nbd.2004.08.006; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	35	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66024	10.1371/journal.pone.0066024	http://dx.doi.org/10.1371/journal.pone.0066024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762458	Green Submitted, gold, Green Published			2022-12-25	WOS:000320440500059
J	Huang, H; Cao, Y; Wei, W; Liu, W; Lu, SY; Chen, YB; Wang, Y; Yan, H; Wu, YL				Huang, He; Cao, Yang; Wei, Wei; Liu, Wei; Lu, Shao-Yong; Chen, Yu-Bao; Wang, Yan; Yan, Hua; Wu, Ying-Li			Targeting Poly (ADP-Ribose) Polymerase Partially Contributes to Bufalin-Induced Cell Death in Multiple Myeloma Cells	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; HUMAN LEUKEMIA-CELLS; POLY(ADP-RIBOSE) POLYMERASE; CANCER-CELLS; TOPOISOMERASE-II; OVARIAN-CANCER; LUNG-CANCER; APOPTOSIS; INHIBITORS; INDUCTION	Despite recent pharmaceutical advancements in therapeutic drugs, multiple myeloma (MM) remains an incurable disease. Recently, ploy(ADP-ribose) polymerase 1 (PARP1) has been shown as a potentially promising target for MM therapy. A previous report suggested bufalin, a component of traditional Chinese medicine ("Chan Su''), might target PARP1. However, this hypothesis has not been verified. We here showed that bufalin could inhibit PARP1 activity in vitro and reduce DNA-damage-induced poly(ADP-ribosyl)ation in MM cells. Molecular docking analysis revealed that the active site of bufalin interaction is within the catalytic domain of PAPR1. Thus, PARP1 is a putative target of bufalin. Furthermore, we showed, for the first time that the proliferation of MM cell lines (NCI-H929, U266, RPMI8226 and MM. 1S) and primary CD138(+) MM cells could be inhibited by bufalin, mainly via apoptosis and G(2)-M phase cell cycle arrest. MM cell apoptosis was confirmed by apoptotic cell morphology, Annexin-V positive cells, and the caspase3 activation. We further evaluated the role of PARP1 in bufalin-induced apoptosis, discovering that PARP1 overexpression partially suppressed bufalin-induced cell death. Moreover, bufalin can act as chemosensitizer to enhance the cell growth-inhibitory effects of topotecan, camptothecin, etoposide and vorinostat in MM cells. Collectively, our data suggest that bufalin is a novel PARP1 inhibitor and a potentially promising therapeutic agent against MM alone or in combination with other drugs.	[Huang, He; Cao, Yang; Wei, Wei; Chen, Yu-Bao; Wang, Yan; Yan, Hua] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Hematol, Shanghai 200030, Peoples R China; [Liu, Wei; Lu, Shao-Yong; Wu, Ying-Li] Shanghai Jiao Tong Univ, Shanghai Univ E Inst, Sch Med,Key Lab Cell Differentiat & Apoptos, Chem Biol,Chinese Minist Educ,Dept Pathoph, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yan, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Hematol, Shanghai 200030, Peoples R China.	yanhua_candy@yahoo.com.cn; wuyingli@shsmu.edu.cn	Wei, Weijun/AAZ-3551-2021		National Basic Research Program of China (973 Program) [2010CB912104]; National Natural Science Foundation of China [91013008, 81070433, 81170509, 81272886]; Science and Technology Committee of Shanghai [11JC1406500]; SMC Program of Shanghai Jiao Tong University	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Committee of Shanghai(Shanghai Science & Technology Committee); SMC Program of Shanghai Jiao Tong University	This work was supported partly by grants from National Basic Research Program of China (973 Program) (No. 2010CB912104), National Natural Science Foundation of China (91013008, 81070433, 81170509, 81272886), Science and Technology Committee of Shanghai (11JC1406500), SMC Program of Shanghai Jiao Tong University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajan M, 2010, NAT BIOTECHNOL, V28, P738, DOI 10.1038/nbt.1645; Arnaud-Batista FJ, 2012, AM J PHYSIOL-RENAL, V302, pF959, DOI 10.1152/ajprenal.00130.2011; Banasik M, 2004, ACTA NEUROBIOL EXP, V64, P467; Beevers CS, 2009, CANCER RES, V69, P1000, DOI 10.1158/0008-5472.CAN-08-2367; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; CARSON DA, 1986, EXP CELL RES, V164, P273, DOI 10.1016/0014-4827(86)90028-5; Chen AL, 2009, BIOTECHNOL LETT, V31, P487, DOI 10.1007/s10529-008-9888-x; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Han KQ, 2007, WORLD J GASTROENTERO, V13, P3374, DOI 10.3748/wjg.v13.i24.3374; Hashimoto S, 1997, LEUKEMIA RES, V21, P875, DOI 10.1016/S0145-2126(97)00061-1; Hideshima T, 2002, NAT REV CANCER, V2, P927, DOI 10.1038/nrc952; HONG Z, 1992, J PHARM PHARMACOL, V44, P1023, DOI 10.1111/j.2042-7158.1992.tb07086.x; Javle M, 2011, Ther Adv Med Oncol, V3, P257, DOI 10.1177/1758834011417039; Jeggo PA, 1998, CURR BIOL, V8, pR49, DOI 10.1016/S0960-9822(98)70032-6; Kameoka M, 2004, J VIROL, V78, P8931, DOI 10.1128/JVI.78.16.8931-8934.2004; Kawazoe N, 1999, J BIOCHEM-TOKYO, V126, P278, DOI 10.1093/oxfordjournals.jbchem.a022446; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Li D, 2009, ANTI-CANCER DRUG, V20, P59, DOI 10.1097/CAD.0b013e3283160fd6; Lomenick B, 2011, ACS CHEM BIOL, V6, P34, DOI 10.1021/cb100294v; Lu SY, 2011, J COMPUT CHEM, V32, P1907, DOI 10.1002/jcc.21775; Ma HY, 2009, J NANJING U TRADITIO, V25, P370; Marchetti C, 2012, EXPERT OPIN INV DRUG, V21, P1575, DOI 10.1517/13543784.2012.707189; Meng ZQ, 2009, CANCER-AM CANCER SOC, V115, P5309, DOI 10.1002/cncr.24602; Meyer-Ficca ML, 2005, INT J BIOCHEM CELL B, V37, P920, DOI 10.1016/j.biocel.2004.09.011; MORISHITA S, 1986, FOLIA PHARMACOL JPN, V87, P361, DOI 10.1254/fpj.87.361; Neri P, 2011, BLOOD, V118, P6368, DOI 10.1182/blood-2011-06-363911; Pastor N, 2003, DNA REPAIR, V2, P1353, DOI 10.1016/j.dnarep.2003.08.001; Penning TD, 2010, J MED CHEM, V53, P3142, DOI 10.1021/jm901775y; Petruccelli LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020987; Premkumar DR, 2013, MOL CARCINOGEN, V52, P118, DOI 10.1002/mc.21835; Pyndiah S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001556; Qi FH, 2010, J ETHNOPHARMACOL, V128, P654, DOI 10.1016/j.jep.2010.02.022; SCHRAUFSTATTER IU, 1986, P NATL ACAD SCI USA, V83, P4908, DOI 10.1073/pnas.83.13.4908; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Takai N, 2008, INT J MOL MED, V21, P637; Takai N, 2012, ASIAN PAC J CANCER P, V13, P399, DOI 10.7314/APJCP.2012.13.1.399; Watabe M, 1997, CELL GROWTH DIFFER, V8, P871; WIELCKENS K, 1983, J BIOL CHEM, V258, P4098; Yeh JY, 2003, PROSTATE, V54, P112, DOI 10.1002/pros.10172; Zhang JX, 2012, HEPATOLOGY, V55, P1840, DOI 10.1002/hep.25566; ZHANG L, 1991, BIOCHEM BIOPH RES CO, V178, P686, DOI 10.1016/0006-291X(91)90162-Z; ZHANG LS, 1992, CANCER RES, V52, P4634; Zhao Y, 2009, J NAT PROD, V72, P988, DOI 10.1021/np9000366; Zhu ZT, 2012, INT J MOL SCI, V13, P2025, DOI 10.3390/ijms13022025	44	11	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66130	10.1371/journal.pone.0066130	http://dx.doi.org/10.1371/journal.pone.0066130			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762475	Green Submitted, Green Published, gold			2022-12-25	WOS:000321094800092
J	Osaki, LH; Gama, P				Osaki, Luciana H.; Gama, Patricia			MAPK Signaling Pathway Regulates p27 Phosphorylation at Threonin 187 as Part of the Mechanism Triggered by Early-Weaning to Induce Cell Proliferation in Rat Gastric Mucosa	PLOS ONE			English	Article							GROWTH-FACTOR-ALPHA; KINASE-ACTIVITY; CDK INHIBITORS; FACTOR-BETA; EPITHELIAL MONOLAYERS; P27(KIP1) DEGRADATION; MAMMALIAN-CELLS; CYCLIN E-CDK2; ADULT RATS; ACTIVATION	During rat postnatal development, gastric cell proliferation and differentiation depend on many elements, which include dietary pattern, hormones, growth factors and their signaling pathways. Among them, EGFR activity is increased through MAPK and Src cascades in response to early weaning that represents the abrupt transition from milk to solid food. We herein investigated the direct involvement of ERK pathway in the control of cell cycle progression during early weaning, and studied the specific role of p27. At 15 days, Wistar rats were separated from dams, fed with powdered chow and daily injected with PD98059 (MEK inhibitor, 300 mu g/kg) or 0.5% DMSO (control). By using HE staining and immunohistochemistry for PCNA, we respectively detected mitotic (MI) and proliferative (PI) indices in 18-day-old pups, and observed that both were reduced by PD98059. As cell cycle-related proteins (cyclin E, CDK2, cyclin D1, CDK4, p21 and p27) are involved in proliferative regulation, we compared samples obtained at 17 days in the morning (17 d) and evening (17.5 d). We found that they were not altered after ERK inhibition, but cyclin D1, p21 and p27 levels changed throughout the day in the control group. As p27 activity depends on its integrity, we studied p27 phosphorylation (threonin 187), and observed that ERK inhibition reduced this process. We suggest that MAPK pathway interferes in the regulation of p27 function in the gastric mucosa during early weaning, possibly by controlling its degradation, and altogether this mechanism might contribute to the increase of epithelial proliferation at this condition.	[Osaki, Luciana H.; Gama, Patricia] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil	Universidade de Sao Paulo	Osaki, LH (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil.	luciana.osaki@usp.br	Gama, Patricia/D-4756-2012; Osaki, Luciana H/I-3624-2012	Gama, Patricia/0000-0002-1863-893X; Osaki, Luciana/0000-0003-0665-7567	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Sao Paulo, Brazil) [2011/07089-1]; CAPES-PNPD; FAPESP [2010/17851-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Sao Paulo, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES-PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Sao Paulo, Brazil) (2011/07089-1). LHO was a recipient of CAPES-PNPD and FAPESP (2010/17851-5) postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares E P, 1987, Prog Clin Biol Res, V227A, P353; Alvares EP, 2007, HISTOL HISTOPATHOL, V22, P147, DOI 10.14670/HH-22.147; ALVARES EP, 1993, BRAZ J MED BIOL RES, V26, P869; Blain SW, 2008, CELL CYCLE, V7, P892, DOI 10.4161/cc.7.7.5637; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; de Andrade Sa Eunice Ribeiro, 2008, Regul Pept, V146, P293, DOI 10.1016/j.regpep.2007.11.001; Delmas C, 2001, J BIOL CHEM, V276, P34958, DOI 10.1074/jbc.M101714200; Gama P, 2000, J NUTR, V130, P2594, DOI 10.1093/jn/130.10.2594; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Huang KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046072; Jasleen J, 2000, J SURG RES, V90, P13, DOI 10.1006/jsre.2000.5818; Jiang RL, 2012, INT J BIOCHEM CELL B, V44, P91, DOI 10.1016/j.biocel.2011.10.002; Jiang RL, 2011, J CELL PHYSIOL, V226, P3022, DOI 10.1002/jcp.22650; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kanai M, 2001, GASTROENTEROLOGY, V121, P56, DOI 10.1053/gast.2001.25544; Kawada M, 1997, ONCOGENE, V15, P629, DOI 10.1038/sj.onc.1201228; KOFF A, 1992, SCIENCE, V257, P1689, DOI 10.1126/science.1388288; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lee JG, 2011, INVEST OPHTH VIS SCI, V52, P417, DOI 10.1167/iovs.10-6140; Lin CH, 2001, DIGESTION, V63, P214, DOI 10.1159/000051892; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Luo JC, 2008, BIOCHEM PHARMACOL, V76, P841, DOI 10.1016/j.bcp.2008.07.010; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; Nakajima N, 1995, J CLIN GASTROENTEROL, V21, pS45; NAKAJIMA N, 1993, J CLIN GASTROENTEROL, V17, pS121, DOI 10.1097/00004836-199312001-00022; Nakamizo H, 2012, DIGEST DIS SCI, V57, P2545, DOI 10.1007/s10620-012-2208-2; Ogias D, 2010, NUTRITION, V26, P224, DOI 10.1016/j.nut.2009.03.014; Ogias D, 2010, AM J PHYSIOL-GASTR L, V298, pG117, DOI 10.1152/ajpgi.00245.2009; Osaki LH, 2011, CELL PROLIFERAT, V44, P174, DOI 10.1111/j.1365-2184.2011.00733.x; Osaki LH, 2010, DIFFERENTIATION, V79, P48, DOI 10.1016/j.diff.2009.09.001; Osawa H, 2006, BIOCHEM BIOPH RES CO, V344, P680, DOI 10.1016/j.bbrc.2006.03.188; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Qiao WL, 2006, J GASTROENTEROL, V41, P1158, DOI 10.1007/s00535-006-1902-2; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Rivard N, 1999, AM J PHYSIOL-CELL PH, V277, pC652, DOI 10.1152/ajpcell.1999.277.4.C652; Sasaki E, 2003, DIGEST DIS SCI, V48, P2257, DOI 10.1023/B:DDAS.0000007860.87503.09; Schneider R, 2001, HORM METAB RES, V33, P1, DOI 10.1055/s-2001-12617; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; SLINGERLAND JM, 1994, MOL CELL BIOL, V14, P3683, DOI 10.1128/MCB.14.6.3683; Starostina NG, 2012, TRENDS CELL BIOL, V22, P33, DOI 10.1016/j.tcb.2011.10.004; Tetreault MP, 2008, J CELL PHYSIOL, V214, P545, DOI 10.1002/jcp.21239; Tetreault MP, 2008, J CELL BIOCHEM, V105, P1240, DOI 10.1002/jcb.21924; Xiao ZQ, 2003, AM J PHYSIOL-GASTR L, V285, pG396, DOI 10.1152/ajpgi.00530.2002; Xu RJ, 1996, REPROD FERT DEVELOP, V8, P35, DOI 10.1071/RD9960035	48	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66651	10.1371/journal.pone.0066651	http://dx.doi.org/10.1371/journal.pone.0066651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762493	gold, Green Submitted, Green Published			2022-12-25	WOS:000321094800101
J	Ozhand, A; Lee, E; Wu, AH; Ellingjord-Dale, M; Akslen, LA; McKean-Cowdin, R; Ursin, G				Ozhand, Ali; Lee, Eunjung; Wu, Anna H.; Ellingjord-Dale, Merete; Akslen, Lars A.; McKean-Cowdin, Roberta; Ursin, Giske			Variation in Inflammatory Cytokine/Growth-Factor Genes and Mammographic Density in Premenopausal Women Aged 50-55	PLOS ONE			English	Article							SINGAPORE CHINESE WOMEN; BREAST-CANCER RISK; POSTMENOPAUSAL HORMONE-THERAPY; IGF-BINDING PROTEIN-3; GROWTH-FACTOR; SUSCEPTIBILITY LOCI; PARENCHYMAL PATTERNS; MULTIETHNIC COHORT; RANDOMIZED-TRIAL; NORWEGIAN WOMEN	Background: Mammographic density (MD) has been found to be an independent risk factor for breast cancer. Although data from twin studies suggest that MD has a strong genetic component, the exact genes involved remain to be identified. Alterations in stromal composition and the number of epithelial cells are the most predominant histopathological determinants of mammographic density. Interactions between the breast stroma and epithelium are critically important in the maturation and development of the mammary gland and the cross-talk between these cells are mediated by paracrine growth factors and cytokines. The potential impact of genetic variation in growth factors and cytokines on MD is largely unknown. Methods: We investigated the association between 89 single nucleotide polymorphisms (SNPs) in 7 cytokine/growth-factor genes (FGFR2, IGFBP1, IGFBP3, TGFB1, TNF, VEGF, IL6) and percent MD in 301 premenopausal women (aged 50 to 55 years) participating in the Norwegian Breast Cancer Screening Program. We evaluated the suggestive associations in 216 premenopausal Singapore Chinese Women of the same age. Results: We found statistically significant associations between 9 tagging SNPs in the IL6 gene and MD in Norwegian women; the effect ranged from 3-5% in MD per variant allele (p-values = 0.02 to 0.0002). One SNP in the IL6 (rs10242595) significantly influenced MD in Singapore Chinese women. Conclusion: Genetic variations in IL6 may be associated with MD and therefore may be an indicator of breast cancer risk in premenopausal women.	[Ozhand, Ali; Lee, Eunjung; Wu, Anna H.; McKean-Cowdin, Roberta; Ursin, Giske] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Ellingjord-Dale, Merete; Ursin, Giske] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Akslen, Lars A.] Univ Bergen, Dept Clin Med, Gade Laboratorium Pathol, Ctr Canc Biomarkers, Bergen, Norway; [Ursin, Giske] Canc Registry Norway, Oslo, Norway	University of Southern California; University of Oslo; University of Bergen; University of Oslo	Ursin, G (corresponding author), Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA.	giske.ursin@kreftregisteret.no	Akslen, Lars A./AAG-6097-2021; Akslen, Lars A/C-1202-2017; Ursin, Giske/U-6637-2017	Akslen, Lars A./0000-0003-2710-9543; Akslen, Lars A/0000-0003-2710-9543; Ursin, Giske/0000-0002-0835-9507; Lee, Eunjung/0000-0002-8287-6131				Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Alowami S, 2003, BREAST CANCER RES, V5, pR129, DOI 10.1186/bcr622; Andersson N, 2010, INT J OBESITY, V34, P1011, DOI 10.1038/ijo.2010.27; BASOLO F, 1993, INT J CANCER, V55, P926, DOI 10.1002/ijc.2910550609; Biong M, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-9; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; Boyd NF, 2002, NEW ENGL J MED, V347, P886, DOI 10.1056/NEJMoa013390; Boyd NF, 2002, BRIT J CANCER, V87, P876, DOI 10.1038/sj.bjc.6600537; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; Boyd NF, 1998, BREAST IMAGING, P113, DOI 10.3233/BD-1998-103-412; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Bremnes Y, 2007, CANCER EPIDEM BIOMAR, V16, P57, DOI 10.1158/1055-9965.EPI-06-0788; Byrne C, 2000, CANCER RES, V60, P3744; Cullen K J, 1992, Cancer Treat Res, V61, P413; DICKSON RB, 1995, ENDOCR REV, V16, P559, DOI 10.1210/er.16.5.559; Diorio C, 2005, CANCER EPIDEM BIOMAR, V14, P1065, DOI 10.1158/1055-9965.EPI-04-0706; Edlund CK, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-174; Ellingjord-Dale M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3337; Fletcher O, 2011, JNCI-J NATL CANCER I, V103, P425, DOI 10.1093/jnci/djq563; Greendale GA, 2003, J NATL CANCER I, V95, P30, DOI 10.1093/jnci/95.1.30; Guo YP, 2001, CANCER EPIDEM BIOMAR, V10, P243; Hawes D, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1408; Hofvind S, 2007, EUR J EPIDEMIOL, V22, P447, DOI 10.1007/s10654-007-9137-y; Jakes RW, 2002, CANCER EPIDEM BIOMAR, V11, P608; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; KLEINBAUM DG, 2007, APPL REGRESSION ANAL; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Lee E, 2008, CANCER EPIDEM BIOMAR, V17, P258, DOI 10.1158/1055-9965.EPI-07-2749; Lee E, 2012, CANCER EPIDEM BIOMAR, V21, P635, DOI 10.1158/1055-9965.EPI-11-1042; Lindstrom S, 2011, NAT GENET, V43, P185, DOI 10.1038/ng.760; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; McTiernan A, 2005, JNCI-J NATL CANCER I, V97, P1366, DOI 10.1093/jnci/dji279; Mulhall C, 2005, CANCER EPIDEM BIOMAR, V14, P2648, DOI 10.1158/1055-9965.EPI-04-0374; Ng EH, 1998, CANCER-AM CANCER SOC, V82, P1521, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1521::AID-CNCR14>3.3.CO;2-B; Purohit A, 2002, BREAST CANCER RES, V4, P65, DOI 10.1186/bcr425; Qureshi SA, 2011, NUTR CANCER, V63, P1011, DOI 10.1080/01635581.2011.605983; Reeves KW, 2010, BREAST CANC RES TREA; SAKAKURA T, 1991, INT REV CYTOL, V125, P165, DOI 10.1016/S0074-7696(08)61219-X; Silva ID, 2006, CANCER EPIDEM BIOMAR, V15, P449, DOI 10.1158/1055-9965.EPI-05-0555; Sternlicht MD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1368; Stone J, 2007, CANCER EPIDEM BIOMAR, V16, P1479, DOI 10.1158/1055-9965.EPI-07-0107; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Tamimi RM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1655; Taverne CW, 2010, BREAST CANCER RES TR, V123, P843, DOI 10.1007/s10549-010-0778-2; Ursin G, 2003, CANCER EPIDEM BIOMAR, V12, P332; Ursin G, 2009, CANCER EPIDEM BIOMAR, V18, P102, DOI 10.1158/1055-9965.EPI-07-2857; Ursin G, 2006, NUTR CANCER, V56, P128, DOI 10.1207/s15327914nc5602_2; Vachon CM, 2000, CANCER CAUSE CONTROL, V11, P653, DOI 10.1023/A:1008926607428; Verheus M, 2008, BREAST CANCER RES TR, V112, P109, DOI 10.1007/s10549-007-9827-x; Verheus M, 2010, INT J CANCER, V127, P1115, DOI 10.1002/ijc.25142; Woolcott CG, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2229; Wu AH, 2008, CANCER EPIDEM BIOMAR, V17, P3358, DOI 10.1158/1055-9965.EPI-08-0132; Yang WT, 2010, BREAST CANCER RES TR, V119, P305, DOI 10.1007/s10549-009-0350-0; Zhang XQ, 2009, INT J MOL MED, V23, P485, DOI 10.3892/ijmm_00000155	55	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65313	10.1371/journal.pone.0065313	http://dx.doi.org/10.1371/journal.pone.0065313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762340	Green Submitted, gold, Green Published			2022-12-25	WOS:000321094800039
J	Wang, Y; Xu, LX; Pan, YL; Wang, ZX; Zhang, ZB				Wang, Yu; Xu, Linxi; Pan, Yongliang; Wang, Zuoxin; Zhang, Zhibin			Species Differences in the Immunoreactive Expression of Oxytocin, Vasopressin, Tyrosine Hydroxylase and Estrogen Receptor Alpha in the Brain of Mongolian Gerbils (Meriones unguiculatus) and Chinese Striped Hamsters (Cricetulus barabensis)	PLOS ONE			English	Article							MEDIAL PREOPTIC AREA; ANTEROVENTRAL PERIVENTRICULAR NUCLEUS; VOLES MICROTUS-OCHROGASTER; MESSENGER-RIBONUCLEIC-ACID; FEMALE SEXUAL RECEPTIVITY; PAIR BOND FORMATION; MATERNAL-BEHAVIOR; PRAIRIE VOLES; ANTERIOR HYPOTHALAMUS; AGGRESSIVE-BEHAVIOR	Species differences in neurochemical expression and activity in the brain may play an important role in species-specific patterns of social behavior. In the present study, we used immunoreactive (ir) labeling to compare the regional density of cells containing oxytocin (OT), vasopressin (AVP), tyrosine hydroxylase (TH), or estrogen receptor alpha (ER alpha) staining in the brains of social Mongolian gerbils (Meriones unguiculatus) and solitary Chinese striped hamsters (Cricetulus barabensis). Multiple region-and neurochemical-specific species differences were found. In the anterior hypothalamus (AH), Mongolian gerbils had higher densities of AVP-ir and ER alpha-ir cells than Chinese striped hamsters. In the lateral hypothalamus (LH), Mongolian gerbils also had higher densities of AVP-ir and TH-ir cells, but a lower density of OT-ir cells, than Chinese striped hamsters. Furthermore, in the anterior nucleus of the medial preoptic area (MPOAa), Mongolian gerbils had higher densities of OT-ir and AVP-ir cells than Chinese striped hamsters, and an opposite pattern was found in the posterior nucleus of the MPOA (MPOAp). Some sex differences were also observed. Females of both species had higher densities of TH-ir cells in the MPOAa and of OT-ir cells in the intermediate nucleus of the MPOA (MPOAi) than males. Given the role of these neurochemicals in social behaviors, our data provide additional evidence to support the notion that species-specific patterns of neurochemical expression in the brain may be involved in species differences in social behaviors associated with different life strategies.	[Wang, Yu; Xu, Linxi; Pan, Yongliang; Zhang, Zhibin] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Wang, Yu; Xu, Linxi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Zuoxin] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Wang, Zuoxin] Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Zhang, ZB (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	zhangzb@ioz.ac.cn			National Natural Science Foundation of China [30930016, 31272321]; National Basic Research Program of China [2007CB109101]; National Science and Technology Ministry [2009BAI83B01]; Chinese Academy of Sciences [CZBZX-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Science and Technology Ministry; Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by grants from the National Natural Science Foundation of China (30930016 and 31272321), the National Basic Research Program of China (2007CB109101), the National Science and Technology Ministry (2009BAI83B01) and the Chinese Academy of Sciences (CZBZX-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN G, 1989, ANIM BEHAV, V37, P11, DOI 10.1016/0003-3472(89)90002-X; AGREN G, 1989, ANIM BEHAV, V37, P28, DOI 10.1016/0003-3472(89)90003-1; AGREN G, 1984, ANIM BEHAV, V32, P528, DOI 10.1016/S0003-3472(84)80291-2; AKAISHI T, 1985, BRAIN RES, V335, P302, DOI 10.1016/0006-8993(85)90481-0; Aragona BJ, 2006, NAT NEUROSCI, V9, P133, DOI 10.1038/nn1613; Aragona BJ, 2003, J NEUROSCI, V23, P3483, DOI 10.1523/jneurosci.23-08-03483.2003; Aragona Brandon J., 2002, Hormones and Behavior, V41, P455; BAMSHAD M, 1993, J NEUROENDOCRINOL, V5, P247, DOI 10.1111/j.1365-2826.1993.tb00480.x; BARTFAI T, 1988, ANNU REV PHARMACOL, V28, P285, DOI 10.1146/annurev.pa.28.040188.001441; Beery AK, 2008, J COMP NEUROL, V507, P1847, DOI 10.1002/cne.21638; Bester-Meredith JK, 2003, BEHAV NEUROSCI, V117, P455, DOI 10.1037/0735-7044.117.3.455; Bester-Meredith JK, 2001, HORM BEHAV, V40, P51, DOI 10.1006/hbeh.2001.1666; Bester-Meredith JK, 1999, HORM BEHAV, V36, P25, DOI 10.1006/hbeh.1999.1522; Bodo C, 2006, ENDOCRINOLOGY, V147, P415, DOI 10.1210/en.2005-0834; Bridges NJ, 2004, PHYSIOL BEHAV, V83, P119, DOI 10.1016/j.physbeh.2004.08.002; Buccafusco JJ, 2000, J PHARMACOL EXP THER, V295, P438; Caldwell HK, 2004, HORM BEHAV, V46, P444, DOI 10.1016/j.yhbeh.2004.04.006; CALDWELL JD, 1989, BEHAV NEUROSCI, V103, P655, DOI 10.1037/0735-7044.103.3.655; CALDWELL JD, 1987, NEUROENDOCRINOLOGY, V46, P39, DOI 10.1159/000124794; Caldwell JD, 1999, HORM BEHAV, V35, P38, DOI 10.1006/hbeh.1998.1494; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; Consiglio AR, 2005, PHYSIOL BEHAV, V85, P354, DOI 10.1016/j.physbeh.2005.05.002; Cushing BS, 2008, J NEUROSCI, V28, P10399, DOI 10.1523/JNEUROSCI.1928-08.2008; Cushing BS, 2006, J COMP NEUROL, V494, P595, DOI 10.1002/cne.20826; Cushing BS, 2004, BRAIN RES, V1016, P247, DOI 10.1016/j.brainres.2004.05.010; DASILVA RKP, 1995, J AUTONOM NERV SYST, V53, P195, DOI 10.1016/0165-1838(94)00176-K; DELGADO JMR, 1953, AM J PHYSIOL, V172, P162, DOI 10.1152/ajplegacy.1952.172.1.162; Dellovade TL, 1999, J NEUROENDOCRINOL, V11, P1, DOI 10.1046/j.1365-2826.1999.00250.x; Delville W, 1996, PHYSIOL BEHAV, V60, P25, DOI 10.1016/0031-9384(95)02246-5; Delville Y, 2000, BRAIN BEHAV EVOLUT, V55, P53, DOI 10.1159/000006642; Dudas B, 2006, J NEUROENDOCRINOL, V18, P895, DOI 10.1111/j.1365-2826.2006.01487.x; ELWOOD RW, 1978, ANIM BEHAV, V26, P438, DOI 10.1016/0003-3472(78)90061-1; ELWOOD RW, 1975, ANIM BEHAV, V23, P766, DOI 10.1016/0003-3472(75)90104-9; ENGELMANN M, 1994, PHYSIOL BEHAV, V55, P145, DOI 10.1016/0031-9384(94)90022-1; EVERITT BJ, 1990, NEUROSCI BIOBEHAV R, V14, P217, DOI 10.1016/S0149-7634(05)80222-2; Ferguson JN, 2001, J NEUROSCI, V21, P8278; FERRIS CF, 1992, ANN NY ACAD SCI, V652, P456, DOI 10.1111/j.1749-6632.1992.tb34382.x; FERRIS CF, 1988, PHYSIOL BEHAV, V44, P235, DOI 10.1016/0031-9384(88)90144-8; Ferris CF, 1997, J NEUROSCI, V17, P4331; Fowler CD, 2005, J COMP NEUROL, V489, P166, DOI 10.1002/cne.20638; Francis DD, 2002, J NEUROENDOCRINOL, V14, P349, DOI 10.1046/j.0007-1331.2002.00776.x; Gammie SC, 1999, J NEUROSCI, V19, P8027; GERLING S, 1979, ANIM BEHAV, V27, P310, DOI 10.1016/0003-3472(79)90153-2; Gingrich B, 2000, BEHAV NEUROSCI, V114, P173, DOI 10.1037/0735-7044.114.1.173; Giovenardi M, 1998, PHYSIOL BEHAV, V63, P351, DOI 10.1016/S0031-9384(97)00434-4; Giuliano F, 1996, NEUROSCI LETT, V209, P1, DOI 10.1016/0304-3940(96)12594-5; Gobrogge KL, 2007, J COMP NEUROL, V502, P1109, DOI 10.1002/cne.21364; Gobrogge KL, 2009, P NATL ACAD SCI USA, V106, P19144, DOI 10.1073/pnas.0908620106; GRAY P, 1984, BEHAV NEUROSCI, V98, P703, DOI 10.1037/0735-7044.98.4.703; Greco B, 2001, ENDOCRINOLOGY, V142, P5172, DOI 10.1210/en.142.12.5172; GROMOV IM, 1963, FAUNA USSR, P513; HANSEN S, 1994, PHYSIOL BEHAV, V55, P615, DOI 10.1016/0031-9384(94)90034-5; Harmon AC, 2002, J NEUROENDOCRINOL, V14, P963, DOI 10.1046/j.1365-2826.2002.00863.x; HENNESSEY AC, 1994, PHYSIOL BEHAV, V55, P905, DOI 10.1016/0031-9384(94)90078-7; INSEL TR, 1994, J NEUROSCI, V14, P5381; INSEL TR, 1992, P NATL ACAD SCI USA, V89, P5981, DOI 10.1073/pnas.89.13.5981; Kawamata M, 2004, BIOCHEM BIOPH RES CO, V321, P695, DOI 10.1016/j.bbrc.2004.07.019; Keer SE, 1999, PHYSIOL BEHAV, V67, P659, DOI 10.1016/S0031-9384(99)00116-X; Landgraf R, 2003, EUR J NEUROSCI, V18, P403, DOI 10.1046/j.1460-9568.2003.02750.x; Lei K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008931; Liu W, 2009, J ZOOL, V278, P249, DOI 10.1111/j.1469-7998.2009.00574.x; Liu Y, 2003, NEUROSCIENCE, V121, P537, DOI 10.1016/S0306-4522(03)00555-4; Liu Y, 2001, BEHAV NEUROSCI, V115, P910, DOI 10.1037//0735-7044.115.4.910; Lonstein JS, 2000, NEUROENDOCRINOLOGY, V72, P91, DOI 10.1159/000054576; Lubin DA, 2003, PHARMACOL BIOCHEM BE, V74, P449, DOI 10.1016/S0091-3057(02)01027-4; Luo Z.X., 2000, FAUNA SINICA MAMMALI, V6, P121; MADISON DM, 1984, AM MIDL NAT, V112, P201, DOI 10.2307/2425476; MALLON DP, 1985, MAMMAL REV, V15, P71, DOI 10.1111/j.1365-2907.1985.tb00389.x; MCDERMOTT JL, 1980, BEHAV NEURAL BIOL, V29, P63, DOI 10.1016/S0163-1047(80)92484-X; McGinnis MY, 2002, BRAIN RES BULL, V59, P227, DOI 10.1016/S0361-9230(02)00869-9; Mohankumar PS, 1997, BRAIN RES BULL, V42, P265, DOI 10.1016/S0361-9230(96)00210-9; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Northcutt KV, 2007, J COMP NEUROL, V500, P103, DOI 10.1002/cne.21148; Numan M, 2005, BEHAV NEUROSCI, V119, P1588, DOI 10.1037/0735-7044.119.6.1588; NYBY J, 1973, HORM BEHAV, V4, P283, DOI 10.1016/0018-506X(73)90027-5; Ogawa S, 1998, ENDOCRINOLOGY, V139, P5070, DOI 10.1210/en.139.12.5070; Olazabal DE, 2006, NEUROSCIENCE, V141, P559, DOI 10.1016/j.neuroscience.2006.04.017; OSTERMEYER MC, 1984, BEHAVIOUR, V91, P61, DOI 10.1163/156853984X00218; Pan Y, 2011, J NEUROENDOCRINOL, V23, P926, DOI 10.1111/j.1365-2826.2011.02210.x; PANAYOTACOPOULOU MT, 1994, DEV BRAIN RES, V83, P59, DOI 10.1016/0165-3806(94)90179-1; PEDERSEN CA, 1994, BEHAV NEUROSCI, V108, P1163, DOI 10.1037/0735-7044.108.6.1163; PELLIS SM, 1993, NEUROSCI LETT, V158, P13, DOI 10.1016/0304-3940(93)90600-P; PFAUS JG, 1991, BEHAV NEUROSCI, V105, P727, DOI 10.1037/0735-7044.105.5.727; Plumari L, 2002, J NEUROENDOCRINOL, V14, P971, DOI 10.1046/j.1365-2826.2002.00866.x; Popik P, 1991, Eur Neuropsychopharmacol, V1, P555, DOI 10.1016/0924-977X(91)90010-R; POPIK P, 1992, BEHAV PHARMACOL, V3, P351; Prates EJ, 2005, BEHAV PROCESS, V70, P104, DOI 10.1016/j.beproc.2005.04.010; Reuss S, 1999, NEUROSCI LETT, V266, P29, DOI 10.1016/S0304-3940(99)00245-1; Rissman EF, 2008, J NEUROENDOCRINOL, V20, P873, DOI 10.1111/j.1365-2826.2008.01738.x; Riters LV, 1997, ANN NY ACAD SCI, V807, P478, DOI 10.1111/j.1749-6632.1997.tb51943.x; Rosen GJ, 2008, NEUROSCIENCE, V155, P809, DOI 10.1016/j.neuroscience.2008.05.039; Rosenblatt JS, 1996, HORM BEHAV, V30, P201, DOI 10.1006/hbeh.1996.0025; Schradin C, 1999, NEWS PHYSIOL SCI, V14, P223, DOI 10.1152/physiologyonline.1999.14.6.223; Scordalakes EM, 2004, GENES BRAIN BEHAV, V3, P20, DOI 10.1111/j.1601-183X.2004.00036.x; SHUGHRUE PJ, 1992, ENDOCRINOLOGY, V131, P381, DOI 10.1210/en.131.1.381; Silva MRP, 2003, PHARMACOL TOXICOL, V93, P42, DOI 10.1034/j.1600-0773.2003.930106.x; SIMERLY RB, 1989, MOL BRAIN RES, V6, P297, DOI 10.1016/0169-328X(89)90075-2; SIMERLY RB, 1985, NEUROENDOCRINOLOGY, V40, P501, DOI 10.1159/000124122; Simerly RB, 1997, P NATL ACAD SCI USA, V94, P14077, DOI 10.1073/pnas.94.25.14077; Simerly RB, 1996, J NEUROENDOCRINOL, V8, P45, DOI 10.1111/j.1365-2826.1996.tb00685.x; SIMERLY RB, 1985, BRAIN RES, V330, P55, DOI 10.1016/0006-8993(85)90007-1; SKIRROW MH, 1976, CAN J ZOOL, V54, P361, DOI 10.1139/z76-040; Sorensen DB, 2005, APPL ANIM BEHAV SCI, V94, P181, DOI 10.1016/j.applanim.2005.02.004; Spiteri T, 2010, NEUROENDOCRINOLOGY, V91, P142, DOI 10.1159/000255766; Tabak J, 2010, ENDOCRINOLOGY, V151, P1806, DOI 10.1210/en.2009-1267; Tetel MJ, 2010, BBA-GEN SUBJECTS, V1800, P1084, DOI 10.1016/j.bbagen.2010.01.008; Trainor BC, 2006, HORM BEHAV, V50, P338, DOI 10.1016/j.yhbeh.2006.04.002; WANG MJ, 1998, ECOLOGY MANAGEMENT R, P221; Wang YZ, 1998, ECOLOGY MANAGEMENT R, P20; Wang ZX, 1996, J COMP NEUROL, V366, P726; Wang ZX, 1999, BEHAV NEUROSCI, V113, P602, DOI 10.1037/0735-7044.113.3.602; WANG ZX, 1995, BEHAV NEUROSCI, V109, P305, DOI 10.1037/0735-7044.109.2.305; Wang ZX, 1998, PROG BRAIN RES, V119, P483; Wang ZX, 1997, BRAIN RES, V767, P321, DOI 10.1016/S0006-8993(97)00617-3; WARNER RK, 1991, BRAIN RES, V540, P177, DOI 10.1016/0006-8993(91)90505-P; WEITZMAN RE, 1979, WESTERN J MED, V131, P373; Wu RY, 2011, J COMP PHYSIOL A, V197, P267, DOI 10.1007/s00359-010-0609-2; Xia W., 1982, Acta Theriologica Sinica, V2, P51; Xu L, 2010, NEUROSCIENCE, V169, P1235, DOI 10.1016/j.neuroscience.2010.05.064; Yang Yu-ping, 2002, NeiMongol Daxue Xuebao Ziran Kexue Ban, V33, P201; Young KA, 2008, COMP BIOCHEM PHYS C, V148, P401, DOI 10.1016/j.cbpc.2008.02.004; Young LJ, 2001, HORM BEHAV, V40, P133, DOI 10.1006/hbeh.2001.1691; Zup SL, 2003, J NEUROSCI, V23, P2357	124	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65807	10.1371/journal.pone.0065807	http://dx.doi.org/10.1371/journal.pone.0065807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762431	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800074
J	Sallam, MF; Al Ahmed, AM; Abdel-Dayem, MS; Abdullah, MAR				Sallam, Mohamed F.; Al Ahmed, Azzam M.; Abdel-Dayem, Mahmoud S.; Abdullah, Mohamed A. R.			Ecological Niche Modeling and Land Cover Risk Areas for Rift Valley Fever Vector, Culex tritaeniorhynchus Giles in Jazan, Saudi Arabia	PLOS ONE			English	Article							DAR-ES-SALAAM; JAPANESE ENCEPHALITIS; HABITAT CHARACTERIZATION; ENVIRONMENTAL VARIABLES; SPECIES DISTRIBUTIONS; MALARIA TRANSMISSION; DIPTERA-CULICIDAE; SEASONAL ACTIVITY; LARVAL HABITATS; MOSQUITO LARVAE	Background: The mosquito, Culex tritaeniorhynchus Giles is a prevalent and confirmed Rift Valley Fever virus (RVFV) vector. This vector, in association with Aedimorphus arabiensis (Patton), was responsible for causing the outbreak of 2000 in Jazan Province, Saudi Arabia. Methodology/Principal Findings: Larval occurrence records and a total of 19 bioclimatic and three topographic layers imported from Worldclim Database were used to predict the larval suitable breeding habitats for this vector in Jazan Province using ArcGIS ver.10 and MaxEnt modeling program. Also, a supervised land cover classification from SPOT5 imagery was developed to assess the land cover distribution within the suitable predicted habitats. Eleven bioclimatic and slope attributes were found to be the significant predictors for this larval suitable breeding habitat. Precipitation and temperature were strong predictors of mosquito distribution. Among six land cover classes, the linear regression model (LM) indicated wet muddy substrate is significantly associated with high-very high suitable predicted habitats (R-2 = 73.7%, P < 0.05). Also, LM indicated that total dissolved salts (TDS) was a significant contributor (R-2 = 23.9%, P<0.01) in determining mosquito larval abundance. Conclusion/Significance: This model is a first step in understanding the spatial distribution of Cx. tritaeniorhynchus and consequently the risk of RVFV in Saudi Arabia and to assist in planning effective mosquito surveillance and control programs by public health personnel and researchers.	[Sallam, Mohamed F.; Al Ahmed, Azzam M.; Abdel-Dayem, Mahmoud S.] King Saud Univ, Dept Plant Protect, Coll Food Sci & Agr, Riyadh, Saudi Arabia; [Abdullah, Mohamed A. R.] Jazan Univ, Jazan, Saudi Arabia	King Saud University; Jazan University	Sallam, MF (corresponding author), King Saud Univ, Dept Plant Protect, Coll Food Sci & Agr, Riyadh, Saudi Arabia.	mwsallam2009@aol.com	Abdel-Dayem, Mahmoud/AAE-2687-2020; Abdel-Dayem, Mahmoud/AAM-2344-2021	Abdel-Dayem, Mahmoud/0000-0002-6276-1740; 	king Abdul Azziz City for Science and Technology, Riyadh, Kingdom of Saudi Arabia [A-S-12-0892]; King Saud University of Scientific Research and College of Food and Agricultural Science Research Center; National Plan for Sciences and Technology, KSU, Riyadh, KSA; NATIONAL CANCER INSTITUTE [R01CA138541, R21CA149869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080607] Funding Source: NIH RePORTER	king Abdul Azziz City for Science and Technology, Riyadh, Kingdom of Saudi Arabia; King Saud University of Scientific Research and College of Food and Agricultural Science Research Center; National Plan for Sciences and Technology, KSU, Riyadh, KSA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is funded by king Abdul Azziz City for Science and Technology, Riyadh, Kingdom of Saudi Arabia through a scientific project # A-S-12-0892 (http://gdrg.kacst.edu.sa/). Also, the funding was shared by King Saud University, Deanship of Scientific Research and College of Food and Agricultural Science Research Center and The National Plan for Sciences and Technology, KSU, Riyadh, KSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Dayem MS, 2012, J MED ENTOMOL, V49, P739, DOI 10.1603/ME11225; Ageel ARM, 1997, ANN TROP MED PARASIT, V91, P907, DOI 10.1080/00034989760293; Al Ahmad AM, 2011, J MED ENTOMOL, V48, P717, DOI 10.1603/ME10146; Al-Husseini H, 2009, SAUDI ARABIA AM BEDU; Al-Turbak AS, 1999, FUTURE WATER SUPPLY; Alahmedi A. M., 2009, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V39, P991; [Anonymous], P 21 INT C MACH LEAR; Anyamba A, 2002, PHOTOGRAMM ENG REM S, V68, P137; Balkhy HH, 2003, INT J ANTIMICROB AG, V21, P153, DOI 10.1016/S0924-8579(02)00295-9; Bogh C, 2007, AM J TROP MED HYG, V76, P875; CDSI, 2010, GEN CENS POP 2010; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P982; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P905; Dambach P, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-8; DILLAHA TA, 1985, WATER RES, V19, P741, DOI 10.1016/0043-1354(85)90121-6; Eisen L, 2011, ANNU REV ENTOMOL, V56, P41, DOI 10.1146/annurev-ento-120709-144847; Elfadil AA, 2006, REV SCI TECH OIE, V25, P1137, DOI 10.20506/rst.25.3.1722; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Foley Desmond H, 2008, US Army Med Dep J, P46; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hills SL, 2011, J TROP PEDIATRICS, V57, P241, DOI 10.1093/tropej/fmp133; Hills SL, 2010, AM J TROP MED HYG, V82, P930, DOI 10.4269/ajtmh.2010.09-0676; Jacob BG, 2005, J MED ENTOMOL, V42, P751, DOI 10.1603/0022-2585(2005)042[0751:EOEDFI]2.0.CO;2; Jupp PG, 2002, MED VET ENTOMOL, V16, P245, DOI 10.1046/j.1365-2915.2002.00371.x; Keating Joseph, 2004, Int J Health Geogr, V3, P9, DOI 10.1186/1476-072X-3-9; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-268; Kheir S. M., 2010, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V40, P215; Kulkarni MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009396; Lin Ting-Hsiang, 1995, Chinese Journal of Entomology, V15, P1; Madani TA, 2003, CLIN INFECT DIS, V37, P1084, DOI 10.1086/378747; Masuoka P, 2010, GEOSPATIAL HEALTH, V5, P45, DOI 10.4081/gh.2010.186; Murty US, 2010, J VECTOR DIS, V47, P26; Pandey B, 2003, EPIDEMIOL INFECT, V131, P881, DOI 10.1017/S0950268803008835; Parham PE, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-271; PEIRIS JSM, 1993, T ROY SOC TROP MED H, V87, P541, DOI 10.1016/0035-9203(93)90080-A; Peterson I, 2009, AM J TROP MED HYG, V81, P944, DOI 10.4269/ajtmh.2009.08-0662; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Rohani A, 2010, SE ASIAN J TROP MED, V41, P821; Sattler MA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-4; SGS, 2012, KINGD SAUD AR FACTS, P144; Sheikho KMA, 2006, USE REMOTE SENSING G; Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0; Vanek MJ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-154; WILLS WM, 1985, T ROY SOC TROP MED H, V79, P63, DOI 10.1016/0035-9203(85)90238-X; Wood BL, 2000, ADV PARASIT, V47, P331, DOI 10.1016/S0065-308X(00)47014-4; Zhou G, 2007, AM J TROP MED HYG, V77, P29, DOI 10.4269/ajtmh.2007.77.29	47	29	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65786	10.1371/journal.pone.0065786	http://dx.doi.org/10.1371/journal.pone.0065786			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762424	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000105
J	Nakayama, K				Nakayama, Koh			cAMP-response Element-binding Protein (CREB) and NF-kappa B Transcription Factors Are Activated during Prolonged Hypoxia and Cooperatively Regulate the Induction of Matrix Metalloproteinase MMP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; CELLS; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; KINASE; PHOSPHORYLATION; CHONDROCYTES; FIBROBLASTS; RECRUITMENT; HIF-1-ALPHA; PATHWAY	Responses to low levels of oxygen (hypoxia) are essential to maintain homeostasis. During the hypoxic response, gene expression is altered by various transcription factors. The transcription factor, hypoxia-inducible factor (HIF), plays a central role in the hypoxic response. The alpha subunit of HIF, which is actively degraded during normoxia, becomes stabilized during hypoxia, which leads to HIF activation. A microarray analysis of HeLa cells showed that expression of matrix metalloproteinase 1 (MMP1) was markedly induced during prolonged hypoxia. CREB and NF-kappa B binding sites were identified in the MMP1 promoter region between 1945 and 1896 nucleotides upstream of the transcription start site. Assays with luciferase reporters demonstrated that HIF activity was induced during the early phase of hypoxia, whereas CREB and NF-kappa B were activated during the later (prolonged) phase. Depletion of CREB and/or NF-kappa B reduced MMP1 induction during prolonged hypoxia both at the mRNA and protein levels. A chromatin immunoprecipitation assay demonstrated binding of CREB and NF-kappa B to the MMP1 promoter. Finally, cell migration and invasion on a collagen matrix and pulmonary metastasis in nude mice were inhibited after depletion of CREB and NF-kappa B in MDA-MB-231 cells. Taken together, these results suggest that the cooperative action of CREB and NF-kappa B plays an important role to induce MMP1 expression during prolonged hypoxia and regulates cell migration and invasion in cancer cells.	Tokyo Med & Dent Univ, Med Res Inst, Oxygen Biol Lab, Bunkyo Ku, Tokyo 1138510, Japan	Tokyo Medical & Dental University (TMDU)	Nakayama, K (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Oxygen Biol Lab, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	nakayama.mtt@mri.tmd.ac.jp	Nakayama, Koh/U-9232-2019		Japan Society for the Promotion of Science; Takeda Science Foundation; Uehara Memorial Foundation; Sumitomo Foundation; Nakajima Foundation; Kanzawa Medical Research Foundation; Osaka Cancer Research Foundation; Fugaku Trust for Medicinal Research; Astellas Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Sumitomo Foundation; Nakajima Foundation; Kanzawa Medical Research Foundation(Kanzawa Medical Research Foundation); Osaka Cancer Research Foundation; Fugaku Trust for Medicinal Research; Astellas Foundation(Astellas Pharmaceuticals)	This study was supported by a Grant-in-Aid for Scientific Research C (Japan Society for the Promotion of Science).; Supported by the Takeda Science Foundation, the Uehara Memorial Foundation, the Sumitomo Foundation, the Nakajima Foundation, the Kanzawa Medical Research Foundation, the Osaka Cancer Research Foundation, the Fugaku Trust for Medicinal Research, and a research grant from the Astellas Foundation. To whom correspondence should be addressed: Oxygen Biology Laboratory, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan. Tel.: 813-5803-4815; E-mail: nakayama.mtt@mri.tmd.ac.jp.	Ahn JK, 2008, RHEUMATOLOGY, V47, P834, DOI 10.1093/rheumatology/ken086; Akiyama Y., 1995, TFSEARCH SEARCHING T; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Beitner-Johnson D, 1998, J BIOL CHEM, V273, P19834, DOI 10.1074/jbc.273.31.19834; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Bui C, 2012, FASEB J, V26, P3000, DOI 10.1096/fj.12-206367; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Hadad N, 2011, J IMMUNOL, V186, P1816, DOI 10.4049/jimmunol.1000193; Han YP, 2001, J CELL SCI, V114, P131; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Koh MY, 2011, CANCER RES, V71, P4015, DOI 10.1158/0008-5472.CAN-10-4142; Lin JL, 2008, FEBS LETT, V582, P2615, DOI 10.1016/j.febslet.2008.06.033; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; O'Reilly SM, 2006, AM J PHYSIOL-CELL PH, V290, pC592, DOI 10.1152/ajpcell.00278.2005; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Park JK, 2010, INT J ONCOL, V36, P181, DOI 10.3892/ijo_00000489; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Sato M, 2010, EXP CELL RES, V316, P2871, DOI 10.1016/j.yexcr.2010.06.018; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shyu KG, 2007, EXP CELL RES, V313, P1181, DOI 10.1016/j.yexcr.2007.01.013; Spooren A, 2010, CELL SIGNAL, V22, P871, DOI 10.1016/j.cellsig.2010.01.018; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Taylor CT, 2000, P NATL ACAD SCI USA, V97, P12091, DOI 10.1073/pnas.220211797; Vincenti MP, 1998, ARTHRITIS RHEUM, V41, P1987, DOI 10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.3.CO;2-#; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yamanaka M, 2000, J DERMATOL SCI, V24, P99, DOI 10.1016/S0923-1811(00)00086-4; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Yokoo T, 1996, AM J PHYSIOL-RENAL, V270, pF123, DOI 10.1152/ajprenal.1996.270.1.F123	39	45	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22584	22595		10.1074/jbc.M112.421636	http://dx.doi.org/10.1074/jbc.M112.421636			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23775082	Green Published, hybrid			2022-12-25	WOS:000330596300039
J	Yuan, DP; Keeble, AH; Hibbert, RG; Fabiane, S; Gould, HJ; McDonnell, JM; Beavil, AJ; Sutton, BJ; Dhaliwal, B				Yuan, Daopeng; Keeble, Anthony H.; Hibbert, Richard G.; Fabiane, Stella; Gould, Hannah J.; McDonnell, James M.; Beavil, Andrew J.; Sutton, Brian J.; Dhaliwal, Balvinder			Ca2+-dependent Structural Changes in the B-cell Receptor CD23 Increase Its Affinity for Human Immunoglobulin E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allergy; Calcium; FC Receptors; Immunology; X-ray Crystallography; CD23; Immunoglobulin E	MANNOSE-BINDING PROTEIN; FC-EPSILON-RI; LECTIN DOMAIN; CRYSTAL-STRUCTURE; IGE SYNTHESIS; CALCIUM; SITE; FC-EPSILON-RII/CD23; CARBOHYDRATE; REFINEMENT	Immunoglobulin E (IgE) antibodies play a fundamental role in allergic disease and are a target for therapeutic intervention. IgE functions principally through two receptors, FcERI and CD23 (FcERII). Minute amounts of allergen trigger mast cell or basophil degranulation by cross-linking IgE-bound FcERI, leading to an inflammatory response. The interaction between IgE and CD23 on B-cells regulates IgE synthesis. CD23 is unique among Ig receptors in that it belongs to the C-type (calcium-dependent) lectin-like superfamily. Although the interaction of CD23 with IgE is carbohydrate-independent, calcium has been reported to increase the affinity for IgE, but the structural basis for this activity has previously been unknown. We have determined the crystal structures of the human lectin-like head domain of CD23 in its Ca2+-free and Ca2+-bound forms, as well as the crystal structure of the Ca2+-bound head domain of CD23 in complex with a subfragment of IgE-Fc consisting of the dimer of CE3 and CE4 domains (FcE3-4). Together with site-directed mutagenesis, the crystal structures of four Ca2+ ligand mutants, isothermal titration calorimetry, surface plasmon resonance, and stopped-flow analysis, we demonstrate that Ca2+ binds at the principal and evolutionarily conserved binding site in CD23. Ca2+ binding drives Pro-250, at the base of an IgE-binding loop (loop 4), from the trans to the cis configuration with a concomitant conformational change and ordering of residues in the loop. These Ca2+-induced structural changes in CD23 lead to additional interactions with IgE, a more entropically favorable interaction, and a 30-fold increase in affinity of a single head domain of CD23 for IgE. Taken together, these results suggest that binding of Ca2+ brings an extra degree of modulation to CD23 function.	[Yuan, Daopeng; Keeble, Anthony H.; Fabiane, Stella; Gould, Hannah J.; McDonnell, James M.; Beavil, Andrew J.; Sutton, Brian J.; Dhaliwal, Balvinder] Kings Coll London, London SE1 1UL, England; [Yuan, Daopeng; Keeble, Anthony H.; Fabiane, Stella; Gould, Hannah J.; McDonnell, James M.; Beavil, Andrew J.; Sutton, Brian J.; Dhaliwal, Balvinder] MRC, London SE1 1UL, England; [Yuan, Daopeng; Keeble, Anthony H.; Fabiane, Stella; Gould, Hannah J.; McDonnell, James M.; Beavil, Andrew J.; Sutton, Brian J.; Dhaliwal, Balvinder] Asthma UK Ctr Allerg Mech Asthma, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Hibbert, Richard G.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of London; King's College London; University of London; King's College London; University of Oxford	Sutton, BJ (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London SE1 1UL, England.	brian.sutton@kcl.ac.uk; bal.dhaliwal@kcl.ac.uk		Beavil, Andrew/0000-0002-0768-122X; Dhaliwal, Balvinder/0000-0001-5455-3303; Keeble, Anthony/0000-0002-4873-6960; Gould, Hannah/0000-0003-0411-688X; McDonnell, James/0000-0001-9037-2980	Wellcome Trust, Asthma UK; Medical Research Council (United Kingdom); Diamond Light Source; MRC [G1100090, G0501494] Funding Source: UKRI; Medical Research Council [G1000758, MR/J006742/1, G1100090, G0501494, G1000758B] Funding Source: researchfish; Asthma UK [08/039, MRC-AsthmaUKCentre] Funding Source: researchfish	Wellcome Trust, Asthma UK; Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diamond Light Source; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	This work was supported by the Wellcome Trust, Asthma UK, the Medical Research Council (United Kingdom), and Diamond Light Source.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Atkins P., 2001, MOL SUBSTANCES; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BEAVIL AJ, 1992, P NATL ACAD SCI USA, V89, P753, DOI 10.1073/pnas.89.2.753; BETTLER B, 1992, J BIOL CHEM, V267, P185; Borthakur S, 2012, J BIOL CHEM, V287, P31457, DOI 10.1074/jbc.C112.397059; Carlsson F, 2007, SCAND J IMMUNOL, V66, P261, DOI 10.1111/j.1365-3083.2007.01953.x; Chen BH, 2002, IMMUNOLOGY, V107, P373, DOI 10.1046/j.1365-2567.2002.01512.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cooper AM, 2012, J IMMUNOL, V188, P3199, DOI 10.4049/jimmunol.1102689; Dhaliwal B, 2012, P NATL ACAD SCI USA, V109, P12686, DOI 10.1073/pnas.1207278109; DIERKS SE, 1993, J IMMUNOL, V150, P2372; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabiola F, 2006, ACTA CRYSTALLOGR D, V62, P227, DOI 10.1107/S0907444905040680; Feinberg H, 2007, J BIOL CHEM, V282, P4202, DOI 10.1074/jbc.M609689200; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P544, DOI 10.1016/j.jaci.2007.05.025; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Hibbert RG, 2005, J EXP MED, V202, P751, DOI 10.1084/jem.20050811; Kelly AE, 1998, J IMMUNOL, V161, P6696; LARSSON L, 1978, CLIN CHEM, V24, P1962; Lemieux GA, 2007, J BIOL CHEM, V282, P14836, DOI 10.1074/jbc.M608414200; McCloskey N, 2007, J BIOL CHEM, V282, P24083, DOI 10.1074/jbc.M703195200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meier M, 2000, J MOL BIOL, V300, P857, DOI 10.1006/jmbi.2000.3853; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; NAGHIBI H, 1995, P NATL ACAD SCI USA, V92, P5597, DOI 10.1073/pnas.92.12.5597; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; Ng KKS, 1998, BIOCHEMISTRY-US, V37, P17965, DOI 10.1021/bi981972a; Ng KKS, 1998, BIOCHEMISTRY-US, V37, P17977, DOI 10.1021/bi9819733; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2005, ACTA CRYSTALLOGR D, V61, P465, DOI 10.1107/S0907444905001897; Petersen OH, 2002, BIOL RES, V35, P177, DOI 10.4067/S0716-97602002000200008; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; RICHARDS ML, 1990, J IMMUNOL, V144, P2638; Schrodinger L., 2011, PYMOL GRAPH SYST VER; Schulz O, 1997, EUR J IMMUNOL, V27, P584, DOI 10.1002/eji.1830270303; Shi JG, 1997, BIOCHEMISTRY-US, V36, P2112, DOI 10.1021/bi961231e; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; VERCELLI D, 1989, NATURE, V338, P649, DOI 10.1038/338649a0; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Weskamp G, 2006, NAT IMMUNOL, V7, P1293, DOI 10.1038/ni1399; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wurzburg BA, 2006, STRUCTURE, V14, P1049, DOI 10.1016/j.str.2006.03.017; Wurzburg BA, 2009, J MOL BIOL, V393, P176, DOI 10.1016/j.jmb.2009.08.012; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zelensky AN, 2003, PROTEINS, V52, P466, DOI 10.1002/prot.10626	50	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21667	21677		10.1074/jbc.M113.480657	http://dx.doi.org/10.1074/jbc.M113.480657			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23775083	hybrid, Green Published			2022-12-25	WOS:000328841900019
J	Corlett, PR; Cambridge, V; Gardner, JM; Piggot, JS; Turner, DC; Everitt, JC; Arana, FS; Morgan, HL; Milton, AL; Lee, JL; Aitken, MRF; Dickinson, A; Everitt, BJ; Absalom, AR; Adapa, R; Subramanian, N; Taylor, JR; Krystal, JH; Fletcher, PC				Corlett, Philip R.; Cambridge, Victoria; Gardner, Jennifer M.; Piggot, Jennifer S.; Turner, Danielle C.; Everitt, Jessica C.; Arana, Fernando Sergio; Morgan, Hannah L.; Milton, Amy L.; Lee, Jonathan L.; Aitken, Michael R. F.; Dickinson, Anthony; Everitt, Barry J.; Absalom, Anthony R.; Adapa, Ram; Subramanian, Naresh; Taylor, Jane R.; Krystal, John H.; Fletcher, Paul C.			Ketamine Effects on Memory Reconsolidation Favor a Learning Model of Delusions	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; PREDICTION-ERROR SIGNAL; SPONTANEOUS CONFABULATION; SCHIZOPHRENIA-PATIENTS; INDIVIDUAL-DIFFERENCES; HEALTHY-VOLUNTEERS; PREFRONTAL CORTEX; KAMIN BLOCKING; FRONTAL-CORTEX; FEAR MEMORIES	Delusions are the persistent and often bizarre beliefs that characterise psychosis. Previous studies have suggested that their emergence may be explained by disturbances in prediction error-dependent learning. Here we set up complementary studies in order to examine whether such a disturbance also modulates memory reconsolidation and hence explains their remarkable persistence. First, we quantified individual brain responses to prediction error in a causal learning task in 18 human subjects (8 female). Next, a placebo-controlled within-subjects study of the impact of ketamine was set up on the same individuals. We determined the influence of this NMDA receptor antagonist (previously shown to induce aberrant prediction error signal and lead to transient alterations in perception and belief) on the evolution of a fear memory over a 72 hour period: they initially underwent Pavlovian fear conditioning; 24 hours later, during ketamine or placebo administration, the conditioned stimulus (CS) was presented once, without reinforcement; memory strength was then tested again 24 hours later. Re-presentation of the CS under ketamine led to a stronger subsequent memory than under placebo. Moreover, the degree of strengthening correlated with individual vulnerability to ketamine's psychotogenic effects and with prediction error brain signal. This finding was partially replicated in an independent sample with an appetitive learning procedure (in 8 human subjects, 4 female). These results suggest a link between altered prediction error, memory strength and psychosis. They point to a core disruption that may explain not only the emergence of delusional beliefs but also their persistence.	[Corlett, Philip R.; Taylor, Jane R.; Krystal, John H.] Yale Univ, Dept Psychiat, Ribicoff Res Facil, New Haven, CT 06520 USA; [Cambridge, Victoria; Arana, Fernando Sergio; Morgan, Hannah L.; Subramanian, Naresh; Fletcher, Paul C.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Brain Mapping Unit,Dept Psychiat, Cambridge CB2 2QQ, England; [Gardner, Jennifer M.; Piggot, Jennifer S.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge CB2 2QQ, England; [Turner, Danielle C.; Everitt, Jessica C.; Milton, Amy L.; Aitken, Michael R. F.; Dickinson, Anthony; Everitt, Barry J.] Univ Cambridge, Dept Psychol, Cambridge, England; [Lee, Jonathan L.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Absalom, Anthony R.] Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, Groningen, Netherlands; [Adapa, Ram] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Div Anaesthesia, Cambridge CB2 2QQ, England; [Fletcher, Paul C.] Fulbourn Hosp, Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England	Yale University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Birmingham; University of Groningen; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Corlett, PR (corresponding author), Yale Univ, Dept Psychiat, Ribicoff Res Facil, New Haven, CT 06520 USA.	philip.corlett@yale.edu	Absalom, Anthony/GPG-1582-2022; Lee, Jonathan LC/A-9629-2008; Adapa, Ram/D-7925-2012; Milton, Amy L/B-6839-2009; Fletcher, Paul/F-5380-2011	Lee, Jonathan LC/0000-0002-2284-2482; Adapa, Ram/0000-0002-9845-8532; Milton, Amy L/0000-0003-0175-9417; Everitt, Barry/0000-0003-4431-6536; Absalom, Anthony/0000-0001-7563-9157; Aitken Deakin, Michael/0000-0001-9763-8999; Corlett, Philip/0000-0002-5368-1992; Fletcher, Paul/0000-0001-8257-1517; Everitt, Jeffrey/0000-0003-0273-6284	Wellcome Trust; Bernard Wolfe Health Neuroscience fund; Medical Research Council; MRC [G1002231] Funding Source: UKRI; Medical Research Council [G1000183B, G0001354B, G1002231, G0001354] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Bernard Wolfe Health Neuroscience fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Wellcome Trust and the Bernard Wolfe Health Neuroscience fund. It was conducted at the Wellcome Trust Clinical Research Facility and the Wolfson Brain Imaging Centre (Addenbrooke's Hospital, Cambridge) and within the Behavioral and Clinical Neuroscience Institute supported by the Medical Research Council and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren T, 2012, SCIENCE, V337, P1550, DOI 10.1126/science.1223006; Anand A, 2000, ARCH GEN PSYCHIAT, V57, P270, DOI 10.1001/archpsyc.57.3.270; Anticevic A, 2012, P NATL ACAD SCI USA, V109, P16720, DOI 10.1073/pnas.1208494109; BEGG IM, 1992, J EXP PSYCHOL GEN, V121, P446, DOI 10.1037/0096-3445.121.4.446; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Bhatt R, 2010, PSYCHIAT RES, V178, P260, DOI 10.1016/j.psychres.2009.02.006; Bleuler E., 1908, ALLG Z PSYCHIAT, V65, P436; Bouton ME, 2000, HEALTH PSYCHOL, V19, P57, DOI 10.1037/0278-6133.19.Suppl1.57; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Bremner JD, 1998, J TRAUMA STRESS, V11, P125, DOI 10.1023/A:1024465317902; Corlett PR, 2007, BRAIN, V130, P2387, DOI 10.1093/brain/awm173; Corlett PR, 2007, J PSYCHOPHARMACOL, V21, P238, DOI 10.1177/0269881107077716; Corlett PR, 2012, NEUROPSYCHOLOGIA, V50, P3612, DOI 10.1016/j.neuropsychologia.2012.09.045; Corlett PR, 2009, PSYCHOPHARMACOLOGY, V206, P515, DOI 10.1007/s00213-009-1561-0; Corlett PR, 2006, ARCH GEN PSYCHIAT, V63, P611, DOI 10.1001/archpsyc.63.6.611; Corlett Philip R, 2010, Biol Psychiatry, V68, pe1, DOI 10.1016/j.biopsych.2010.02.015; Corlett PR, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.053.2009; Corlett PR, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.012.2009; Corlett PR, 2004, NEURON, V44, P877, DOI 10.1016/j.neuron.2004.11.022; Corlett PR, 2010, PROG NEUROBIOL; Corlett PR, 2010, NEUROPSYCHOPHARMACOL; Daw ND, 2011, NEURON, V69, P1204, DOI 10.1016/j.neuron.2011.02.027; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Deakin JFW, 2008, ARCH GEN PSYCHIAT, V65, P154, DOI 10.1001/archgenpsychiatry.2007.37; Dickinson A, 2001, Q J EXP PSYCHOL-B, V54, P3, DOI 10.1080/02724990042000010; Duman RS, 2012, NEUROPHARMACOLOGY, V62, P35, DOI 10.1016/j.neuropharm.2011.08.044; Duvarci S, 2005, EUR J NEUROSCI, V21, P283, DOI 10.1111/j.1460-9568.2004.03824.x; Eisenhardt D, 2007, NEUROBIOL LEARN MEM, V87, P167, DOI 10.1016/j.nlm.2006.09.005; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Fletcher PC, 2006, TRENDS COGN SCI, V10, P167, DOI 10.1016/j.tics.2006.02.008; Fletcher PC, 2001, NAT NEUROSCI, V4, P1043, DOI 10.1038/nn733; Freeman TP, 2012, PSYCHOPHARMACOLOGY; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; GOLD JM, 1992, J ABNORM PSYCHOL, V101, P487, DOI 10.1037/0021-843X.101.3.487; GRAY JA, 1991, BEHAV BRAIN SCI, V14, P1, DOI 10.1017/S0140525X00065055; GROSS G, 1972, ARCH PSYCHIAT NERVEN, V216, P119, DOI 10.1007/BF00346414; Hamm AO, 2005, INT J PSYCHOPHYSIOL, V57, P5, DOI 10.1016/j.ijpsycho.2005.01.006; Hoffken O, 2012, EXPT BRAIN RES EXPT; HOLLAND PC, 1984, J EXP PSYCHOL ANIM B, V10, P476, DOI 10.1037/0097-7403.10.4.476; Holt DJ, 2008, BIOL PSYCHIAT; Honey GD, 2008, J NEUROSCI, V28, P6295, DOI 10.1523/JNEUROSCI.0910-08.2008; Jaspers Karl, 1963, GEN PSYCHOPATHOLOGY; Javadi AH, 2012, BRAIN STIMULATION; Jensen J, 2008, NEUROPSYCHOPHARMACOL, V33, P473, DOI 10.1038/sj.npp.1301437; Kamin L, 1969, PUNISHMENT AVERSIVE; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kiekkas P, 2010, INT NURS REV, V57, P288, DOI 10.1111/j.1466-7657.2010.00809.x; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Kosslyn SM, 2002, AM PSYCHOL, V57, P341, DOI 10.1037//0003-066X.57.5.341; Le Pelley ME, 2005, J EXP PSYCHOL ANIM B, V31, P56, DOI 10.1037/0097-7403.31.1.56; Lee JLC, 2008, NAT NEUROSCI, V11, P1264, DOI 10.1038/nn.2205; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lovibond PF, 2008, Q J EXP PSYCHOL, V61, P1199, DOI 10.1080/17470210701503229; Lovibond PF, 2009, BEHAV RES THER, V47, P716, DOI 10.1016/j.brat.2009.04.013; Lovibond PF, 2004, LEARN MEMORY, V11, P495, DOI 10.1101/lm.79604; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McDannald MA, 2011, J NEUROSCI, V31, P2700, DOI 10.1523/JNEUROSCI.5499-10.2011; McGhee LL, 2008, J TRAUMA, V64, pS195, DOI 10.1097/TA.0b013e318160ba1d; MCGHIE A, 1961, BRIT J MED PSYCHOL, V34, P103, DOI 10.1111/j.2044-8341.1961.tb00936.x; McNally JM, 2011, NEUROSCIENCE, V199, P51, DOI 10.1016/j.neuroscience.2011.10.015; Menon M, 2007, BIOL PSYCHIAT, V62, P765, DOI 10.1016/j.biopsych.2006.10.020; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Mishara AL, 2009, BEHAV BRAIN SCI, V32, P530, DOI 10.1017/S0140525X09991464; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Moore JW, 2011, COGN NEUROPSYCHIATRY, V16, P364, DOI 10.1080/13546805.2010.546074; Moran PM, 2003, J PSYCHIAT RES, V37, P155, DOI 10.1016/S0022-3956(02)00099-7; Morgan HL, 2011, BIOL PSYCHIAT, V69, P35, DOI 10.1016/j.biopsych.2010.07.032; Moritz S, 2012, J BEHAV THERAPY EXPT; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; Murray JD, 2012, CEREBRAL CORTEX; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Narimatsu E, 2002, BRAIN RES, V953, P272, DOI 10.1016/S0006-8993(02)03375-9; Nomura H, 2008, NEUROPSYCHOPHARMACOL, V33, P2912, DOI 10.1038/npp.2008.13; O'Tuathaigh CMP, 2003, BEHAV PHARMACOL, V14, P315, DOI 10.1097/01.fbp.0000080416.18561.3e; Ohman A, 1998, J EXP PSYCHOL GEN, V127, P69, DOI 10.1037/0096-3445.127.1.69; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; Pan WX, 2008, J NEUROSCI, V28, P9619, DOI 10.1523/JNEUROSCI.0255-08.2008; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Pedreira ME, 2004, LEARN MEMORY, V11, P579, DOI 10.1101/lm.76904; Petrakis IL, 2004, AM J PSYCHIAT, V161, P1776, DOI 10.1176/appi.ajp.161.10.1776; Pomarol-Clotet E, 2006, BRIT J PSYCHIAT, V189, P173, DOI 10.1192/bjp.bp.105.015263; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rao-Ruiz P, 2011, NAT NEUROSCI, V14, P1302, DOI 10.1038/nn.2907; Rescorla R.A., 1972, CLASSICAL CONDITIONI; Romaniuk L, 2010, ARCH GEN PSYCHIAT, V67, P1246, DOI 10.1001/archgenpsychiatry.2010.169; Samartgis JR, 2012, NEUROBIOLOGY LEARNIN; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Schlagenhauf F, 2009, BIOL PSYCHIAT, V65, P1032, DOI 10.1016/j.biopsych.2008.12.016; Schmidt A, 2012, NEUROPSYCHOPHARMACOL, V37, P865, DOI 10.1038/npp.2011.261; Schnider A, 2005, NEUROLOGY, V65, P1117, DOI 10.1212/01.wnl.0000178900.37611.8d; Schnider A, 2001, BRAIN RES REV, V36, P150, DOI 10.1016/S0165-0173(01)00090-X; Schonenberg M, 2008, J PSYCHOPHARMACOL, V22, P493, DOI 10.1177/0269881107082481; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Schwabe L, 2012, BIOL PSYCHIAT, V71, P380, DOI 10.1016/j.biopsych.2011.10.028; Sevenster D, 2012, NEUROBIOL LEARN MEM, V97, P338, DOI 10.1016/j.nlm.2012.01.009; Soeter M, 2010, NEUROBIOL LEARN MEM, V94, P30, DOI 10.1016/j.nlm.2010.03.004; STEINBER.HR, 1969, PSYCHOL REP, V25, P195, DOI 10.2466/pr0.1969.25.1.195; Turner DC, 2004, CEREB CORTEX, V14, P872, DOI 10.1093/cercor/bhh046; UNDERWOOD BJ, 1975, AM PSYCHOL, V30, P128, DOI 10.1037/h0076759; Vul E, 2012, NEUROIMAGE; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Weike AI, 2007, PSYCHOPHYSIOLOGY, V44, P170, DOI 10.1111/j.1469-8986.2006.00469.x; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zhai HF, 2008, BEHAV PHARMACOL, V19, P211, DOI 10.1097/FBP.0b013e3282fe88a0	108	39	39	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65088	10.1371/journal.pone.0065088	http://dx.doi.org/10.1371/journal.pone.0065088			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776445	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400008
J	de Seny, D; Cobraiville, G; Charlier, E; Neuville, S; Esser, N; Malaise, D; Malaise, O; Calvo, FQ; Relic, B; Malaise, MG				de Seny, Dominique; Cobraiville, Gael; Charlier, Edith; Neuville, Sophie; Esser, Nathalie; Malaise, Denis; Malaise, Olivier; Calvo, Florence Quesada; Relic, Biserka; Malaise, Michel G.			Acute-Phase Serum Amyloid A in Osteoarthritis: Regulatory Mechanism and Proinflammatory Properties	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; RHEUMATOID-ARTHRITIS; ARTICULAR CHONDROCYTES; GENE-EXPRESSION; SYNOVIAL-FLUID; IN-VITRO; KAPPA-B; RECEPTOR; BINDING	Objective: To determine if serum amyloid A (A-SAA) could be detected in human osteoarthritic (OA) joints and further clarify if high A-SAA level in joints result from a local production or from a diffusion process from abnormally elevated plasma concentration. Regulatory mechanism of A-SAA expression and its pro-inflammatory properties were also investigated. Methods: A-SAA levels in serum and synovial fluid of OA (n = 29) and rheumatoid arthritis (RA) (n = 27) patients were measured and compared to matched-healthy volunteers (HV) (n = 35). In vitro cell cultures were performed on primary joint cells provided from osteoarthritis patients. Regulatory mechanisms were studied using Western-blotting, ELISA and lentiviral transfections. Results: A-SAA was statistically increased in OA plasma patients compared to HV. Moreover, A-SAA level in OA plasma and synovial fluid increased with the Kellgren & Lauwrence grade. For all OA and RA patients, A-SAA plasma level was higher and highly correlated with its corresponding level in the synovial fluid, therefore supporting that A-SAA was mainly due to the passive diffusion process from blood into the joint cavity. However, A-SAA expression was also observed in vitro under corticosteroid treatment and/or under IL-1beta stimuli. A-SAA expression was down-regulated by PPAR-gamma agonists (genistein and rosiglitazone) and up-regulated by TGF-beta 1 through Alk1 (Smad1/5) pathway. RhSAA induced proinflammatory cytokines (IL-6, IL-8, GRO-alpha and MCP-1) and metalloproteinases (MMP-1, MMP-3 and MMP-13) expression in FLS and chondrocytes, which expression was downregulated by TAK242, a specific TLR4 inhibitor. Conclusion: Systemic or local A-SAA expression inside OA joint cavity may play a key role in inflammatory process seen in osteoarthritis, which could be counteracted by TLR4 inhibition.	[de Seny, Dominique; Cobraiville, Gael; Charlier, Edith; Neuville, Sophie; Malaise, Denis; Malaise, Olivier; Calvo, Florence Quesada; Relic, Biserka; Malaise, Michel G.] Univ Liege, CHU Liege, GIGA Res, Lab Rheumatol, Liege, Belgium; [Esser, Nathalie] Univ Liege, GIGA Res, Virol & Immunol Unit, Liege, Belgium	University of Liege; University of Liege	de Seny, D (corresponding author), Univ Liege, CHU Liege, GIGA Res, Lab Rheumatol, Liege, Belgium.	ddeseny@chu.ulg.ac.be		Malaise, Denis/0000-0001-7454-819X	"Fond d'Investissement pour la Recherche Scientifique" (FIRS), CHU Liege, Belgium	"Fond d'Investissement pour la Recherche Scientifique" (FIRS), CHU Liege, Belgium	This study was supported by the "Fond d'Investissement pour la Recherche Scientifique" (FIRS), CHU Liege, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baranova IN, 2010, J BIOL CHEM, V285, P8492, DOI 10.1074/jbc.M109.007526; BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9; Bozinovski S, 2012, P NATL ACAD SCI USA, V109, P935, DOI 10.1073/pnas.1109382109; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Cai H, 2007, J IMMUNOL, V178, P1852, DOI 10.4049/jimmunol.178.3.1852; Cai L, 2005, J BIOL CHEM, V280, P2954, DOI 10.1074/jbc.M411555200; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; Conde J, 2011, ARTHRITIS, DOI 10.1155/2011/203901; Conde J, 2011, ANN RHEUM DIS, V70, P551, DOI 10.1136/ard.2010.132399; Connolly M, 2012, ARTHRITIS RHEUM-US, V64, P1035, DOI 10.1002/art.33455; Connolly M, 2010, J IMMUNOL, V184, P6427, DOI 10.4049/jimmunol.0902941; Cunnane G, 2000, J RHEUMATOL, V27, P58; Dahaghin S, 2007, ANN RHEUM DIS, V66, P916, DOI 10.1136/ard.2005.045724; Davidson ENB, 2009, J IMMUNOL, V182, P7937, DOI 10.4049/jimmunol.0803991; de Seny D, 2008, CLIN CHEM, V54, P1066, DOI 10.1373/clinchem.2007.099549; EMI N, 1991, J VIROL, V65, P1202, DOI 10.1128/JVI.65.3.1202-1207.1991; Fukui N, 2011, ARTHRITIS RHEUM-US, V63, P1938, DOI 10.1002/art.30351; GANAPATHI MK, 1991, J IMMUNOL, V147, P1261; Gomez R, 2011, NAT REV RHEUMATOL, V7, P528, DOI 10.1038/nrrheum.2011.107; Hayes AJ, 2007, J HISTOCHEM CYTOCHEM, V55, P853, DOI 10.1369/jhc.7A7210.2007; Jousilahti P, 2001, ATHEROSCLEROSIS, V156, P451, DOI 10.1016/S0021-9150(00)00681-X; Katz JD, 2010, CURR OPIN RHEUMATOL, V22, P512, DOI 10.1097/BOR.0b013e32833bfb4b; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Koga T, 2008, FEBS LETT, V582, P579, DOI 10.1016/j.febslet.2008.01.022; Kumon Y, 2002, SCAND J IMMUNOL, V56, P504, DOI 10.1046/j.1365-3083.2002.01169.x; KUSHNER I, 1994, BAILLIERE CLIN RHEUM, V8, P513, DOI 10.1016/S0950-3579(05)80113-X; KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x; Lee MS, 2006, J IMMUNOL, V177, P5585, DOI 10.4049/jimmunol.177.8.5585; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Miida T, 2006, BBA-MOL CELL BIOL L, V1761, P424, DOI 10.1016/j.bbalip.2006.03.013; Mullan RH, 2006, ARTHRITIS RHEUM-US, V54, P105, DOI 10.1002/art.21518; Mullan RH, 2010, AM J PATHOL, V176, P1999, DOI 10.2353/ajpath.2010.090014; Nair A, 2012, ARTHRITIS RHEUM-US, V64, P2268, DOI 10.1002/art.34495; O'Hara R, 2000, ARTHRITIS RES, V2, P142, DOI 10.1186/ar78; O'Hara R, 2004, ARTHRITIS RHEUM-US, V50, P1788, DOI 10.1002/art.20301; Okamoto H, 2008, J RHEUMATOL, V35, P752; Oliviero F, 2012, CLIN CHIM ACTA, V413, P303, DOI 10.1016/j.cca.2011.10.019; Pottie P, 2006, ANN RHEUM DIS, V65, P1403, DOI 10.1136/ard.2006.061994; Puenpatom RA, 2009, POSTGRAD MED, V121, P9, DOI 10.3810/pgm.2009.11.2073; Relic B, 2002, LAB INVEST, V82, P1661, DOI 10.1097/01.LAB.0000041714.05322.C0; Relic B, 2006, J BIOL CHEM, V281, P22597, DOI 10.1074/jbc.M512807200; Relic B, 2009, LAB INVEST, V89, P811, DOI 10.1038/labinvest.2009.41; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Stokes DG, 2001, BIOCHEM J, V360, P461, DOI 10.1042/0264-6021:3600461; Thorn CF, 2004, SCAND J IMMUNOL, V59, P152, DOI 10.1111/j.0300-9475.2004.01369.x; Thorn CF, 2002, J IMMUNOL, V169, P399, DOI 10.4049/jimmunol.169.1.399; Vallon R, 2001, J IMMUNOL, V166, P2801, DOI 10.4049/jimmunol.166.4.2801; van den Berg WB, 2011, OSTEOARTHR CARTILAGE, V19, P338, DOI 10.1016/j.joca.2011.01.022; van der Westhuyzen DR, 2005, J BIOL CHEM, V280, P35890, DOI 10.1074/jbc.M505685200; Vlasova MA, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1051, DOI 10.1134/S0006297906100014; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Yang RZ, 2006, PLOS MED, V3, P884, DOI 10.1371/journal.pmed.0030287; Yoon YM, 2002, J BIOL CHEM, V277, P8412, DOI 10.1074/jbc.M110608200; Zeddou M, 2012, STEM CELLS DEV, V21, P1948, DOI 10.1089/scd.2011.0321	57	55	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66769	10.1371/journal.pone.0066769	http://dx.doi.org/10.1371/journal.pone.0066769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776697	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400117
J	Acosta-Gonzalez, G; Rodriguez-Zaragoza, FA; Hernandez-Landa, RC; Arias-Gonzalez, JE				Acosta-Gonzalez, Gilberto; Rodriguez-Zaragoza, Fabian A.; Hernandez-Landa, Roberto C.; Arias-Gonzalez, Jesus E.			Additive Diversity Partitioning of Fish in a Caribbean Coral Reef Undergoing Shift Transition	PLOS ONE			English	Article							MULTIPLE SPATIAL SCALES; BETA-DIVERSITY; SPECIES-DIVERSITY; PHASE-SHIFTS; ECOSYSTEM FUNCTION; ALPHA-DIVERSITY; BIODIVERSITY; COMMUNITY; HABITAT; CONSERVATION	Shift transitions in dominance on coral reefs from hard coral cover to fleshy macroalgae are having negative effects on Caribbean coral reef communities. Data on spatiotemporal changes in biodiversity during these modifications are important for decision support for coral reef biodiversity protection. The main objective of this study is to detect the spatiotemporal patterns of coral reef fish diversity during this transition using additive diversity-partitioning analysis. We examined alpha, beta and gamma fish diversity from 2000 to 2010, during which time a shift transition occurred at Mahahual Reef, located in Quintana Roo, Mexico. Data on coral reef fish and benthic communities were obtained from 12 transects per geomorphological unit (GU) in two GUs (reef slope and terrace) over six years (2000, 2005, 2006, 2007, 2008, 2010). Spatial analysis within and between the GUs indicated that the gamma-diversity was primarily related to higher beta-diversity. Throughout the six study years, there were losses of alpha, beta and gamma-diversity associated spatially with the shallow (reef slope) and deeper (reef terrace) GUs and temporally with the transition in cover from mound corals to fleshy macroalgae and boulder corals. Despite a drastic reduction in the number of species over time, beta-diversity continues to be the highest component of gamma-diversity. The shift transition had a negative effect on alpha, beta and gamma-diversity, primarily by impacting rare species, leading a group of small and less vulnerable fish species to become common and an important group of rare species to become locally extinct. The maintenance of fish heterogeneity (beta-diversity) over time may imply the abetment of vulnerability in the face of local and global changes.	[Acosta-Gonzalez, Gilberto; Hernandez-Landa, Roberto C.; Arias-Gonzalez, Jesus E.] IPN, Unidad Merida, Ctr Invest & Estudios Avanzados, Lab Ecol Ecosistemas Arrecifes Coralinos, Merida, Yucatan, Mexico; [Rodriguez-Zaragoza, Fabian A.] Univ Guadalajara, CUCBA, Dept Ecol, LEMA, Guadalajara, Jalisco, Mexico	Instituto Politecnico Nacional - Mexico; Universidad de Guadalajara	Arias-Gonzalez, JE (corresponding author), IPN, Unidad Merida, Ctr Invest & Estudios Avanzados, Lab Ecol Ecosistemas Arrecifes Coralinos, Merida, Yucatan, Mexico.	earias@mda.cinvestav.mx	Zaragoza, Fabian Alejandro Rodriguez/B-3477-2015	Zaragoza, Fabian Alejandro Rodriguez/0000-0002-0066-4275; Arias-Gonzalez, Jesus Ernesto/0000-0003-4601-710X	Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACyT) [201]; Laboratorio de Ecologia de Ecosistemas de Arrecifes Coralinos (LEEAC); Centro de Investigacion y de Estudios Avanzados del I.P.N.	Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Laboratorio de Ecologia de Ecosistemas de Arrecifes Coralinos (LEEAC); Centro de Investigacion y de Estudios Avanzados del I.P.N.	This study was funded by the Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACyT: project 201); the Laboratorio de Ecologia de Ecosistemas de Arrecifes Coralinos (LEEAC) and by the Centro de Investigacion y de Estudios Avanzados del I.P.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2004, OIKOS, V106, P275, DOI 10.1111/j.0030-1299.2004.13193.x; Alvarez-Filip L, 2009, P ROYAL SOC BIOL SCI, V276, P1669; Alvarez-Filip L, 2011, CORAL REEFS, V30, P1051, DOI 10.1007/s00338-011-0795-6; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Andrefouet S, 2005, CORAL REEFS, V24, P31, DOI 10.1007/s00338-004-0444-4; Arias-Gonzalez JE, 2011, CIENC MAR, V37, P87, DOI 10.7773/cm.v37i1.1746; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; Bellwood DR, 2006, P ROY SOC B-BIOL SCI, V273, P101, DOI 10.1098/rspb.2005.3276; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Belmaker J, 2008, ECOLOGY, V89, P2829, DOI 10.1890/07-1464.1; Bozec YM, 2008, P 11 INT COR REEF S, V18, P691; Bozec YM, 2011, MAR BIOL, V158, P969, DOI 10.1007/s00227-011-1623-9; Bruckner A. W, 2006, Rev. biol. trop, V54, P45; Chabanet P, 1997, CORAL REEFS, V16, P93, DOI 10.1007/s003380050063; CHATTERJEE S, 2000, REGRESION ANAL EXAMP; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; DeVries PJ, 1997, BIOL J LINN SOC, V62, P343, DOI 10.1111/j.1095-8312.1997.tb01630.x; Diekotter T, 2008, BASIC APPL ECOL, V9, P298, DOI 10.1016/j.baae.2007.03.003; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Edmunds PJ, 2000, MAR ECOL PROG SER, V202, P113, DOI 10.3354/meps202113; Arias-Gonzalez JE, 2012, BIODIVERS CONSERV, V21, P115, DOI 10.1007/s10531-011-0169-y; Arias-Gonzalez JE, 2008, J EXP MAR BIOL ECOL, V366, P28, DOI 10.1016/j.jembe.2008.07.035; Fisher WS, 2008, MAR POLLUT BULL, V56, P1737, DOI 10.1016/j.marpolbul.2008.07.002; Folke C, 1996, ECOL APPL, V6, P1018, DOI 10.2307/2269584; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Garcia-Lopez A, 2010, ANN ENTOMOL SOC AM, V103, P956, DOI 10.1603/AN10078; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gering JC, 2003, CONSERV BIOL, V17, P488, DOI 10.1046/j.1523-1739.2003.01465.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Grotan V, 2012, J ANIM ECOL, V81, P714, DOI 10.1111/j.1365-2656.2011.01950.x; Harborne AR, 2011, MAR ECOL PROG SER, V437, P201, DOI 10.3354/meps09280; Harrison S, 2006, J ECOL, V94, P110, DOI 10.1111/j.1365-2745.2005.01078.x; Hewitt J, 2010, BIODIVERS CONSERV, V19, P1315, DOI 10.1007/s10531-009-9763-7; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Holland SM, 2010, PALAEONTOLOGY, V53, P1237, DOI 10.1111/j.1475-4983.2010.01017.x; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Humann P, 2002, REEF CORAL IDENTIFIC, P86; Idjadi JA, 2006, CORAL REEFS, V25, P209, DOI 10.1007/s00338-006-0088-7; Johansen JL, 2008, MAR ECOL PROG SER, V360, P219, DOI 10.3354/meps07482; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Lande R., 2003, OXFORD SERIES ECOLOG; Lara EN, 1998, J FISH BIOL, V53, P209, DOI 10.1111/j.1095-8649.1998.tb01028.x; Layou KM, 2007, PALEOBIOLOGY, V33, P116, DOI 10.1666/06025.1; Lyons KG, 2001, ECOL LETT, V4, P358, DOI 10.1046/j.1461-0248.2001.00235.x; Magurran A.E., 2004, MEASURING BIOL DIVER, P162; Maliao RJ, 2008, MAR BIOL, V154, P841, DOI 10.1007/s00227-008-0977-0; McManus JW, 2000, ICES J MAR SCI, V57, P572, DOI 10.1006/jmsc.2000.0720; Moreno CE, 2001, BIODIVERS CONSERV, V10, P367, DOI 10.1023/A:1016614510040; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Nunez-Lara E, 2005, J EXP MAR BIOL ECOL, V324, P157, DOI 10.1016/j.jembe.2005.04.011; Oksanen J., 2016, R PACKAG; Pandolfi JM, 2006, ECOL LETT, V9, P818, DOI 10.1111/j.1461-0248.2006.00933.x; R Development Core Team, 2011, R LANG ENV STAT COMP; Ricotta C, 2003, ACTA BIOTHEOR, V51, P91, DOI 10.1023/A:1024539526618; Rodriguez-Zaragoza FA, 2008, CARIBB J SCI, V44, P90; Rodriguez-Zaragoza FA, 2011, BIODIVERS CONSERV, V20, P1655, DOI 10.1007/s10531-011-0053-9; Rosenzweig ML, 1999, SCIENCE, V284, P276, DOI 10.1126/science.284.5412.276; Ruiz-Zarate Miguel A., 2003, Atoll Research Bulletin, V496, P318; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SEPKOSKI JJ, 1988, PALEOBIOLOGY, V14, P221, DOI 10.1017/S0094837300011969; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; SOLOW AR, 1993, J ANIM ECOL, V62, P191, DOI 10.2307/5493; Stendera SES, 2005, FRESHWATER BIOL, V50, P1360, DOI 10.1111/j.1365-2427.2005.01403.x; Summerville KS, 2005, BIODIVERS CONSERV, V14, P3393, DOI 10.1007/s10531-004-0546-x; Syms C, 2001, OECOLOGIA, V127, P560, DOI 10.1007/s004420000617; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Ter Braak CJF, 1991, BOOTSTRAPPING RELATE, P79; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Veech JA., 2009, PARTITION SOFTWARE H; Veech JA, 2007, GLOBAL ECOL BIOGEOGR, V16, P650, DOI 10.1111/j.1466-8238.2007.00315.x; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER RH, 1960, ECOL MONOGR, V30, P280, DOI 10.2307/1943563; Wiens JA, 1996, ECOL APPL, V6, P828, DOI 10.2307/2269488; Zar JH, 1999, BIOSTATISTICAL ANAL; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zvuloni A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009941	88	32	32	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65665	10.1371/journal.pone.0065665	http://dx.doi.org/10.1371/journal.pone.0065665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776521	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400054
J	Fujieda, Y; Manno, A; Hayashi, Y; Rhodes, N; Guo, LN; Arita, M; Bamba, T; Fukusaki, E				Fujieda, Yusuke; Manno, Atsushi; Hayashi, Yasuhiro; Rhodes, Nelson; Guo, Lining; Arita, Makoto; Bamba, Takeshi; Fukusaki, Eiichiro			Inflammation and Resolution Are Associated with Upregulation of Fatty Acid beta-Oxidation in Zymosan-Induced Peritonitis	PLOS ONE			English	Article							PPAR-ALPHA; SKELETAL-MUSCLE; NICOTINIC-ACID; IDENTIFICATION; RECEPTOR; MECHANISMS; MEDIATORS; KETOACIDOSIS; ACTIVATION; INFLUENZA	Inflammation is a fundamental defensive response to harmful stimuli. However, it can cause damage if it does not subside. To avoid such damage, organisms have developed a mechanism called resolution of inflammation. Here we applied an untargeted metabolomics approach to a sterile and self-resolving animal model of acute inflammation, namely zymosan-induced peritonitis in mice, to examine the effect of inflammation and resolution on the metabolomic profiles. Significant and time-dependent changes in metabolite profiles after zymosan administration were observed in both peritoneal wash fluid (PWF) and plasma. These metabolomic changes correlated well with inflammatory chemokine or cytokine production. In PWF, most of metabolites that could detected increased in zymosan-treated mice, which is suggestive of inflammation, oxidative stress and increased energy demands. In plasma, most metabolites in the central metabolic pathway (glycolysis and TCA cycle) were significantly downregulated after zymosan administration. The concentration of the ketone body 3-hydroxybutyric acid (3-HB) in plasma and PWF increased in zymosan-injected animals indicating upregulation of fatty acid beta-oxidation. Increased 3-HB level was observed in the cells that infiltrated into the peritoneal cavity and these infiltrated cells might contribute, at least in part, to the production of 3-HB in the peritoneal cavity.	[Fujieda, Yusuke; Bamba, Takeshi; Fukusaki, Eiichiro] Osaka Univ, Dept Biotechnol, Grad Sch Engn, Suita, Osaka, Japan; [Fujieda, Yusuke; Manno, Atsushi; Hayashi, Yasuhiro] Asubio Pharma Co Ltd, Kobe, Hyogo, Japan; [Rhodes, Nelson; Guo, Lining] Metabolon Inc, Durham, NC USA; [Arita, Makoto] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Tokyo 1138654, Japan	Osaka University; Asubio Pharma Co., Ltd.; Metabolon; University of Tokyo	Fujieda, Y (corresponding author), Osaka Univ, Dept Biotechnol, Grad Sch Engn, Suita, Osaka, Japan.	fujieda.yusuke.aw@asubio.co.jp; fukusaki@bio.eng.osaka-u.ac.jp		Arita, Makoto/0000-0001-9902-0463				Azuma YT, 2010, INT IMMUNOPHARMACOL, V10, P1261, DOI 10.1016/j.intimp.2010.07.007; BOUTER KP, 1991, DIABETES RES CLIN PR, V12, P61, DOI 10.1016/0168-8227(91)90131-V; Cash JL, 2009, METHOD ENZYMOL, V461, P379, DOI 10.1016/S0076-6879(09)05417-2; Csoka B, 2010, J IMMUNOL, V185, P542, DOI 10.4049/jimmunol.0901295; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P669, DOI 10.1161/ATVBAHA.111.241836; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fujieda Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043152; Gambhir D, 2012, INVEST OPHTH VIS SCI, V53, P2208, DOI 10.1167/iovs.11-8447; Gijon MA, 1999, J LEUKOCYTE BIOL, V65, P330, DOI 10.1002/jlb.65.3.330; Guyton JR, 2007, CURR OPIN LIPIDOL, V18, P415, DOI 10.1097/MOL.0b013e3282364add; Hasko G, 2008, J LEUKOCYTE BIOL, V83, P447, DOI 10.1189/jlb.0607359; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Konig B, 2008, BBA-GEN SUBJECTS, V1780, P899, DOI 10.1016/j.bbagen.2008.03.002; LI PK, 1980, CLIN CHEM, V26, P1713; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Minnich A, 2001, AM J PHYSIOL-ENDOC M, V280, pE270, DOI 10.1152/ajpendo.2001.280.2.E270; Muoio DM, 2002, DIABETES, V51, P901, DOI 10.2337/diabetes.51.4.901; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Navarro-Xavier RA, 2010, J IMMUNOL, V184, P1516, DOI 10.4049/jimmunol.0902866; Nguyen DH, 2011, BRIT J PHARMACOL, V162, P1119, DOI 10.1111/j.1476-5381.2010.01117.x; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Ramanan S, 2008, FREE RADICAL BIO MED, V45, P1695, DOI 10.1016/j.freeradbiomed.2008.09.002; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2011, CURR TOP MED CHEM, V11, P629; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Sha W, 2010, FASEB J, V24, P2962, DOI 10.1096/fj.09-154054; Shiomi Y, 2011, INFLAMM BOWEL DIS, V17, P2261, DOI 10.1002/ibd.21616; Shriver LP, 2011, SCI REP-UK, V1, DOI 10.1038/srep00079; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Soudijn W, 2007, MED RES REV, V27, P417, DOI 10.1002/med.20102; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; Tan HW, 2012, AM J MED SCI, V343, P180, DOI 10.1097/MAJ.0b013e3182376cc4; Tsugawa H, 2011, J BIOSCI BIOENG, V112, P292, DOI 10.1016/j.jbiosc.2011.05.001; Tsugawa H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-131; Wang WY, 1998, CRIT CARE MED, V26, P101, DOI 10.1097/00003246-199801000-00023; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; Yue TL, 2003, CIRCULATION, V108, P2393, DOI 10.1161/01.CIR.0000093187.42015.6C	43	29	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66270	10.1371/journal.pone.0066270	http://dx.doi.org/10.1371/journal.pone.0066270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776651	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400133
J	Leviatan, N; Alkan, N; Leshkowitz, D; Fluhr, R				Leviatan, Noam; Alkan, Noam; Leshkowitz, Dena; Fluhr, Robert			Genome-Wide Survey of Cold Stress Regulated Alternative Splicing in Arabidopsis thaliana with Tiling Microarray	PLOS ONE			English	Article							MESSENGER-RNA DECAY; FULL-LENGTH; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVITY; INTRON RETENTION; HIGH-SALINITY; SR PROTEINS; DROUGHT; NORMALIZATION; TOLERANCE	Alternative splicing plays a major role in expanding the potential informational content of eukaryotic genomes. It is an important post-transcriptional regulatory mechanism that can increase protein diversity and affect mRNA stability. Alternative splicing is often regulated in a tissue-specific and stress-responsive manner. Cold stress, which adversely affects plant growth and development, regulates the transcription and splicing of plant splicing factors. This can affect the prem-RNA processing of many genes. To identify cold regulated alternative splicing we applied Affymetrix Arabidopsis tiling arrays to survey the transcriptome under cold treatment conditions. A novel algorithm was used for detection of statistically relevant changes in intron expression within a transcript between control and cold growth conditions. A reverse transcription polymerase chain reaction (RT-PCR) analysis of a number of randomly selected genes confirmed the changes in splicing patterns under cold stress predicted by tiling array. Our analysis revealed new types of cold responsive genes. While their expression level remains relatively unchanged under cold stress their splicing pattern shows detectable changes in the relative abundance of isoforms. The majority of cold regulated alternative splicing introduced a premature termination codon (PTC) into the transcripts creating potential targets for degradation by the nonsense mediated mRNA decay (NMD) process. A number of these genes were analyzed in NMD-defective mutants by RT-PCR and shown to evade NMD. This may result in new and truncated proteins with altered functions or dominant negative effects. The results indicate that cold affects both quantitative and qualitative aspects of gene expression.	[Leviatan, Noam; Alkan, Noam; Fluhr, Robert] Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel; [Leshkowitz, Dena] Weizmann Inst Sci, Biol Serv Dept, Bioinformat Unit, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Fluhr, R (corresponding author), Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel.	robert.fluhr@weizmann.ac.il	Alkan, Noam/GRJ-3904-2022	Leviatan, Noam/0000-0001-8743-3789	Ministry of Agriculture and Rural Development ERA-NET Plant Genomics Grant [403/8]; Dr. Angel Faivovich Foundation	Ministry of Agriculture and Rural Development ERA-NET Plant Genomics Grant; Dr. Angel Faivovich Foundation	The research was funded by the Ministry of Agriculture and Rural Development ERA-NET Plant Genomics Grant 403/8 and supported by a research grant from the Dr. Angel Faivovich Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; [Anonymous], [No title captured]; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.2307/1165312; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chung HS, 2010, PLANT J, V63, P613, DOI 10.1111/j.1365-313X.2010.04265.x; Culbertson MR, 2003, CURR OPIN GENET DEV, V13, P207, DOI 10.1016/S0959-437X(03)00014-5; Downey T, 2006, METHOD ENZYMOL, V411, P256, DOI 10.1016/S0076-6879(06)11013-7; Egawa C, 2006, GENES GENET SYST, V81, P77, DOI 10.1266/ggs.81.77; Farlow A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000819; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Gullerova M, 2006, RNA, V12, P631, DOI 10.1261/rna.2226106; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hartemink A., 2001, SPIE BIOS; He Q, 2011, MOL BIOL REP; Hess A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-96; Hori K, 2005, PLANT J, V43, P530, DOI 10.1111/j.1365-313X.2005.02473.x; Hori K, 2007, PLANT CELL PHYSIOL, V48, P1072, DOI 10.1093/pcp/pcm075; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Iida K, 2004, NUCLEIC ACIDS RES, V32, P5096, DOI 10.1093/nar/gkh845; Iida K, 2009, DNA RES, V16, P155, DOI 10.1093/dnares/dsp009; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaillon O, 2008, NATURE, V451, P359, DOI 10.1038/nature06495; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kalyna M, 2012, NUCLEIC ACIDS RES, V40, P2454, DOI 10.1093/nar/gkr932; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Kurihara Y, 2009, P NATL ACAD SCI USA, V106, P2453, DOI 10.1073/pnas.0808902106; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lareau LF, 2007, ADV EXP MED BIOL, V623, P190, DOI 10.1007/978-0-387-77374-2_12; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lee BH, 2006, PLANT CELL, V18, P1736, DOI 10.1105/tpc.106.042184; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li L, 2006, NAT GENET, V38, P124, DOI 10.1038/ng1704; Macknight R, 2002, PLANT CELL, V14, P877, DOI 10.1105/tpc.010456; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Martienssen RA, 2005, CHROMOSOME RES, V13, P299, DOI 10.1007/s10577-005-1507-2; Mastrangelo AM, 2005, PLANTA, V221, P705, DOI 10.1007/s00425-004-1475-3; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Morello L, 2008, CURR GENOMICS, V9, P227, DOI 10.2174/138920208784533629; Naef F, 2002, GENOME BIOL, V3; Nagasaki H, 2005, GENE, V364, P53, DOI 10.1016/j.gene.2005.07.027; Ner-Gaon H, 2004, PLANT J, V39, P877, DOI 10.1111/j.1365-313X.2004.02172.x; Ner-Gaon H, 2007, PLANT PHYSIOL, V144, P1632, DOI 10.1104/pp.107.098640; Ner-Gaon H, 2006, DNA RES, V13, P111, DOI 10.1093/dnares/dsl003; Palusa SG, 2010, NEW PHYTOL, V185, P83, DOI 10.1111/j.1469-8137.2009.03065.x; Palusa SG, 2007, PLANT J, V49, P1091, DOI 10.1111/j.1365-313X.2006.03020.x; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rayson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031917; Royce TE, 2005, TRENDS GENET, V21, P466, DOI 10.1016/j.tig.2005.06.007; Savaldi-Goldstein S, 2003, PLANT CELL, V15, P926, DOI 10.1105/tpc.011056; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Seo PJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1303; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Stolc V, 2005, P NATL ACAD SCI USA, V102, P4453, DOI 10.1073/pnas.0408203102; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Szecsi J, 2006, EMBO J, V25, P3912, DOI 10.1038/sj.emboj.7601270; Tan S, 2007, FEBS LETT, V581, P1081, DOI 10.1016/j.febslet.2007.02.009; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Volodarsky D, 2009, PLANT PHYSIOL, V150, P1796, DOI 10.1104/pp.109.138289; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b; Xin ZG, 2007, PLANT J, V49, P786, DOI 10.1111/j.1365-313X.2006.02994.x; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yazaki J, 2007, CURR OPIN PLANT BIOL, V10, P534, DOI 10.1016/j.pbi.2007.07.006; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zhang JZ, 2004, PLANT PHYSIOL, V135, P615, DOI 10.1104/pp.104.040295; Zhang XC, 2003, PLANT CELL, V15, P2333, DOI 10.1105/tpc.013474; Zhang XN, 2009, PLANT PHYSIOL, V150, P1450, DOI 10.1104/pp.109.138180; Zhang XC, 2007, PLANT PHYSIOL, V145, P1577, DOI 10.1104/pp.107.108720; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010	92	46	52	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66511	10.1371/journal.pone.0066511	http://dx.doi.org/10.1371/journal.pone.0066511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776682	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400150
J	Ramanunninair, M; Le, JH; Onodera, S; Fulvini, AA; Pokorny, BA; Silverman, J; Devis, R; Arroyo, JM; He, Y; Boyne, A; Bera, J; Halpin, R; Hine, E; Spiro, DJ; Bucher, D				Ramanunninair, Manojkumar; Le, Jianhua; Onodera, Shiroh; Fulvini, Andrew A.; Pokorny, Barbara A.; Silverman, Jeanmarie; Devis, Rene; Arroyo, Jennifer M.; He, Yu; Boyne, Alex; Bera, Jayati; Halpin, Rebecca; Hine, Erin; Spiro, David J.; Bucher, Doris			Molecular Signature of High Yield (Growth) Influenza A Virus Reassortants Prepared as Candidate Vaccine Seeds	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTIONS; SYNONYMOUS MUTATIONS; MESSENGER-RNA; GENE SEGMENTS; NS1 PROTEIN; HEMAGGLUTININ; EVOLUTION; REPLICATION; GENERATION; NEURAMINIDASE	Background: Human influenza virus isolates generally grow poorly in embryonated chicken eggs. Hence, gene reassortment of influenza A wild type (wt) viruses is performed with a highly egg adapted donor virus, A/Puerto Rico/8/1934 (PR8), to provide the high yield reassortant (HYR) viral 'seeds' for vaccine production. HYR must contain the hemagglutinin (HA) and neuraminidase (NA) genes of wt virus and one to six 'internal' genes from PR8. Most studies of influenza wt and HYRs have focused on the HA gene. The main objective of this study is the identification of the molecular signature in all eight gene segments of influenza A HYR candidate vaccine seeds associated with high growth in ovo. Methodology: The genomes of 14 wt parental viruses, 23 HYRs (5 H1N1; 2, 1976 H1N1-SOIV; 2, 2009 H1N1pdm; 2 H2N2 and 12 H3N2) and PR8 were sequenced using the high-throughput sequencing pipeline with big dye terminator chemistry. Results: Silent and coding mutations were found in all internal genes derived from PR8 with the exception of the M gene. The M gene derived from PR8 was invariant in all 23 HYRs underlining the critical role of PR8 M in high yield phenotype. None of the wt virus derived internal genes had any silent change(s) except the PB1 gene in X-157. The highest number of recurrent silent and coding mutations was found in NS. With respect to the surface antigens, the majority of HYRs had coding mutations in HA; only 2 HYRs had coding mutations in NA. Significance: In the era of application of reverse genetics to alter influenza A virus genomes, the mutations identified in the HYR gene segments associated with high growth in ovo may be of great practical benefit to modify PR8 and/or wt virus gene sequences for improved growth of vaccine 'seed' viruses.	[Ramanunninair, Manojkumar; Le, Jianhua; Onodera, Shiroh; Fulvini, Andrew A.; Pokorny, Barbara A.; Silverman, Jeanmarie; Devis, Rene; Arroyo, Jennifer M.; He, Yu; Bucher, Doris] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Boyne, Alex; Bera, Jayati; Halpin, Rebecca; Hine, Erin] J Craig Venter Inst, Dept Infect Dis, Rockville, MD USA; [Spiro, David J.] NIAID, SARS & Related Viral Resp Dis Branch, Div Microbiol & Infect Dis, NIH,DHHS, Bethesda, MD 20892 USA	New York Medical College; J. Craig Venter Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bucher, D (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.	doris_bucher@nymc.edu			National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900007C]; International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)-Influenza Vaccine Supply Task Force	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)-Influenza Vaccine Supply Task Force	Research support for preparation of the NYMC reassortants was provided by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)-Influenza Vaccine Supply Task Force. This project has been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract number HHSN272200900007C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEZ M, 1980, J INFECT DIS, V141, P362, DOI 10.1093/infdis/141.3.362; Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; Bergeron C, 2010, PLOS CURR, V5; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Chen GL, 2009, CURR TOP MICROBIOL, V333, P109, DOI 10.1007/978-3-540-92165-3_5; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; DOWNIE JC, 1984, J BIOL STAND, V12, P101, DOI 10.1016/S0092-1157(84)80026-8; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; FRANCIS T, 1945, AM J HYG, V42, P1; Fulvini AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020823; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Garcia-Sastre A, 2001, VIROLOGY, V279, P375, DOI 10.1006/viro.2000.0756; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Gonzalez S, 1996, NUCLEIC ACIDS RES, V24, P4456, DOI 10.1093/nar/24.22.4456; GORMAN OT, 1991, J VIROL, V65, P3704, DOI 10.1128/JVI.65.7.3704-3714.1991; Greenbaum BD, 2012, P NATL ACAD SCI USA, V109, P3341, DOI 10.1073/pnas.1113300109; Greenbaum BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005969; GREENSPAN D, 1988, J VIROL, V62, P3020, DOI 10.1128/JVI.62.8.3020-3026.1988; Guu TSY, 2008, VIROLOGY, V379, P135, DOI 10.1016/j.virol.2008.06.022; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hamano T, 2007, J VIROL, V81, P1528, DOI 10.1128/JVI.01596-06; Hara K, 2001, GENES CELLS, V6, P87, DOI 10.1046/j.1365-2443.2001.00399.x; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; Horimoto T, 2007, VIROLOGY, V366, P23, DOI 10.1016/j.virol.2007.07.002; Iwai A, 2010, J BIOL CHEM, V285, P32064, DOI 10.1074/jbc.M110.112458; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jin H, 2005, VIROLOGY, V336, P113, DOI 10.1016/j.virol.2005.03.010; JUKES TH, 1980, SCIENCE, V210, P973, DOI 10.1126/science.7434017; KILBOURN.ED, 1971, J INFECT DIS, V124, P449, DOI 10.1093/infdis/124.5.449; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; KILBOURNE ED, 1983, P NATL ACAD SCI-BIOL, V80, P6399, DOI 10.1073/pnas.80.20.6399; KILBOURNE ED, 1988, P NATL ACAD SCI USA, V85, P7782, DOI 10.1073/pnas.85.20.7782; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; KLIMOV A, 1983, ACTA VIROL, V27, P434; KLIMOV AI, 1991, VIRUS RES, V19, P105, DOI 10.1016/0168-1702(91)90098-G; Kryazhimskiy S, 2008, J VIROL, V82, P4938, DOI 10.1128/JVI.02415-07; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; Lamb R. A., 1996, FIELDS VIROLOGY, P1353; LAMB RA, 1983, ANNU REV BIOCHEM, V52, P467, DOI 10.1146/annurev.bi.52.070183.002343; LAMB RA, 1979, P NATL ACAD SCI USA, V76, P4908, DOI 10.1073/pnas.76.10.4908; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; LAZAROWITZ SG, 1971, VIROLOGY, V46, P830, DOI 10.1016/0042-6822(71)90084-5; Liu T, 2002, VIROLOGY, V304, P89, DOI 10.1006/viro.2002.1669; Liu T, 2002, J VIROL, V76, P13055, DOI 10.1128/JVI.76.24.13055-13061.2002; Lu B, 2006, VACCINE, V24, P6691, DOI 10.1016/j.vaccine.2006.05.062; LUBECK MD, 1978, J VIROL, V28, P710, DOI 10.1128/JVI.28.3.710-716.1978; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; Marion RM, 1997, J GEN VIROL, V78, P2447, DOI 10.1099/0022-1317-78-10-2447; MARKOFF L, 1982, VIROLOGY, V119, P288, DOI 10.1016/0042-6822(82)90089-7; Marsh GA, 2008, J VIROL, V82, P2295, DOI 10.1128/JVI.02267-07; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; MIYATA T, 1980, J MOL EVOL, V16, P23, DOI 10.1007/BF01732067; Muramoto Y, 2006, J VIROL, V80, P2318, DOI 10.1128/JVI.80.5.2318-2325.2006; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nichol KL, 2006, J INFECT DIS, V194, pS111, DOI 10.1086/507544; Nicolson C, 2005, VACCINE, V23, P2943, DOI 10.1016/j.vaccine.2004.08.054; Novella IS, 2004, J MOL BIOL, V342, P1415, DOI 10.1016/j.jmb.2004.08.003; O'Neill E, 2009, CURR TOP MICROBIOL, V333, P83, DOI 10.1007/978-3-540-92165-3_4; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Offringa DP, 2000, J VIROL METHODS, V88, P15, DOI 10.1016/S0166-0934(00)00180-4; OXFORD JS, 1978, NATURE, V273, P778, DOI 10.1038/273778a0; Pancucharova H, 2006, ACTA VIROL, V50, P269; Parmley JL, 2007, BIOESSAYS, V29, P515, DOI 10.1002/bies.20592; PAYNE A M, 1953, Bull World Health Organ, V8, P755; PEREZ DR, 1995, J VIROL, V69, P6932; PLYUSNIN A, 1995, VIRUS RES, V38, P25, DOI 10.1016/0168-1702(95)00038-R; Rabadan R, 2006, J VIROL, V80, P11887, DOI 10.1128/JVI.01414-06; Robb NC, 2009, J GEN VIROL, V90, P1398, DOI 10.1099/vir.0.009639-0; Robertson JS, 2011, VACCINE, V29, P1836, DOI 10.1016/j.vaccine.2010.12.044; ROBERTSON JS, 1987, VIROLOGY, V160, P31, DOI 10.1016/0042-6822(87)90040-7; Sanz-Ezquerro JJ, 1996, J VIROL, V69, P2420; Schickli JH, 2001, PHILOS T ROY SOC B, V356, P1965, DOI 10.1098/rstb.2001.0979; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sironen T, 2001, J VIROL, V75, P11803, DOI 10.1128/JVI.75.23.11803-11810.2001; Stevens J, 2010, J VIROL, V84, P8287, DOI 10.1128/JVI.00058-10; Stohr Klaus, 2012, Methods Mol Biol, V865, P147, DOI 10.1007/978-1-61779-621-0_9; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TIAN SF, 1985, J VIROL, V53, P771, DOI 10.1128/JVI.53.3.771-775.1985; Varga ZT, 2011, VIRULENCE, V2, P542, DOI 10.4161/viru.2.6.17812; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Varich NL, 2008, ARCH VIROL, V153, P1149, DOI 10.1007/s00705-008-0070-5; Verity EE, 2012, INFLUENZA OTHER RESP, V6, P101, DOI 10.1111/j.1750-2659.2011.00273.x; Vodeiko GM, 2003, VACCINE, V21, P3867, DOI 10.1016/S0264-410X(03)00312-8; Wang TT, 2009, CELL, V137, P983, DOI 10.1016/j.cell.2009.05.032; Wanitchang A, 2010, VIRUS RES, V147, P145, DOI 10.1016/j.virusres.2009.10.010; Widjaja L, 2006, VIROLOGY, V350, P137, DOI 10.1016/j.virol.2006.02.020; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; YASUDA J, 1994, J VIROL, V68, P8141, DOI 10.1128/JVI.68.12.8141-8146.1994; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06	101	13	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65955	10.1371/journal.pone.0065955	http://dx.doi.org/10.1371/journal.pone.0065955			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776579	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400090
J	Steede, NK; Rust, BJ; Hossain, MM; Freytag, LC; Robinson, JE; Landry, SJ				Steede, N. Kalaya; Rust, Blake J.; Hossain, Mohammad M.; Freytag, Lucy C.; Robinson, James E.; Landry, Samuel J.			Shaping T Cell - B Cell Collaboration in the Response to Human Immunodeficiency Virus Type 1 Envelope Glycoprotein gp120 by Peptide Priming	PLOS ONE			English	Article							ANTIBODY-RESPONSES; ESCHERICHIA-COLI; IMMUNE-RESPONSES; HELPER-CELLS; ANTIGEN; HIV-1; SPECIFICITY; INFECTION; VACCINE; DETERMINANTS	Prime-boost vaccination regimes have shown promise for obtaining protective immunity to HIV. Poorly understood mechanisms of cellular immunity could be responsible for improved humoral responses. Although CD4+ T-cell help promotes B-cell development, the relationship of CD4+ T-cell specificity to antibody specificity has not been systematically investigated. Here, protein and peptide-specific immune responses to HIV-1 gp120 were characterized in groups of ten mucosally immunized BALB/c mice. Protein and peptide reactivity of serum antibody was tested for correlation with cytokine secretion by splenocytes restimulated with individual gp120 peptides. Antibody titer for gp120 correlated poorly with the peptide-stimulated T-cell response. In contrast, titers for conformational epitopes, measured as crossreactivity or CD4-blocking, correlated with average interleukin-2 and interleukin-5 production in response to gp120 peptides. Antibodies specific for conformational epitopes and individual gp120 peptides typically correlated with T-cell responses to several peptides. In order to modify the specificity of immune responses, animals were primed with a gp120 peptide prior to immunization with protein. Priming induced distinct peptide-specific correlations of antibodies and T-cells. The majority of correlated antibodies were specific for the primed peptides or other peptides nearby in the gp120 sequence. These studies suggest that the dominant B-cell subsets recruit the dominant T-cell subsets and that T-B collaborations can be shaped by epitope-specific priming.	[Steede, N. Kalaya; Rust, Blake J.; Hossain, Mohammad M.; Landry, Samuel J.] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Freytag, Lucy C.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Robinson, James E.] Tulane Univ, Sch Med, Dept Pediat, New Orleans, LA 70112 USA	Tulane University; Tulane University; Tulane University	Landry, SJ (corresponding author), Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	landry@tulane.edu	Landry, Samuel/AAK-5778-2020	Landry, Samuel/0000-0002-4082-0543; Rust, Blake/0000-0002-7197-0990	National Institutes of Health [R01-AI080367]; Bill and Melinda Gates Foundation Phase I Grand Challenges program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation Phase I Grand Challenges program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (R01-AI080367) and the Bill and Melinda Gates Foundation Phase I Grand Challenges program to SJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022848; BERZOFSKY JA, 1983, SURV IMMUNOL RES, V2, P223; Bonsignori M, 2012, TRENDS MICROBIOL, V20, P532, DOI 10.1016/j.tim.2012.08.011; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Chong C, 1998, VACCINE, V16, P732, DOI 10.1016/S0264-410X(97)00255-7; CROFT M, 1992, J IMMUNOL, V149, P3157; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dai GX, 2001, J BIOL CHEM, V276, P41913, DOI 10.1074/jbc.M106018200; DAVIDSON HW, 1989, J CELL BIOL, V109, P85, DOI 10.1083/jcb.109.1.85; Depoil D, 2005, IMMUNITY, V22, P185, DOI 10.1016/j.immuni.2004.12.010; Dzuris JL, 2001, J VIROL, V75, P10958, DOI 10.1128/JVI.75.22.10958-10968.2001; Gao F, 2003, AIDS RES HUM RETROV, V19, P817, DOI 10.1089/088922203769232610; Harvey BP, 2008, J IMMUNOL, V181, P4043, DOI 10.4049/jimmunol.181.6.4043; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Horikawa K, 2006, IMMUNOLOGY, V118, P497, DOI 10.1111/j.1365-2567.2006.02382.x; Illick MM, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-161; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Jin H, 2006, J LEUKOCYTE BIOL, V80, P1416, DOI 10.1189/jlb.0206096; Lai LL, 2011, J INFECT DIS, V204, P164, DOI 10.1093/infdis/jir199; Lang KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001162; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Li HL, 2009, J IMMUNOL, V182, P6369, DOI 10.4049/jimmunol.0804287; Ma CS, 2012, J EXP MED, V209, P1241, DOI 10.1084/jem.20120994; MANCA F, 1988, J IMMUNOL, V140, P2893; MANCA F, 1985, EUR J IMMUNOL, V15, P345, DOI 10.1002/eji.1830150408; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; McLellan AD, 2009, CRIT REV IMMUNOL, V29, P203, DOI 10.1615/CritRevImmunol.v29.i3.20; Mirano-Bascos D, 2010, J VIROL, V84, P3303, DOI 10.1128/JVI.02242-09; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Moss CX, 2007, EMBO J, V26, P2137, DOI 10.1038/sj.emboj.7601660; Nayak JL, 2013, J INFECT DIS, V207, P297, DOI 10.1093/infdis/jis684; NOELLE RJ, 1992, J IMMUNOL, V149, P1164; Nutt SL, 2011, SEMIN IMMUNOL, V23, P341, DOI 10.1016/j.smim.2011.08.010; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; PUNNONEN J, 1994, J IMMUNOL, V152, P1094; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Sangster MY, 2003, J EXP MED, V198, P1011, DOI 10.1084/jem.20021745; Schwickert TA, 2011, J EXP MED; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; SIMITSEK PD, 1995, J EXP MED, V181, P1957, DOI 10.1084/jem.181.6.1957; Singh A, 2007, J VIROL, V81, P6502, DOI 10.1128/JVI.00163-07; Turcanu V, 2008, CLIN EXP ALLERGY, V38, P1132, DOI 10.1111/j.1365-2222.2008.03016.x; Watts C, 1998, IMMUNOL REV, V164, P11, DOI 10.1111/j.1600-065X.1998.tb01203.x; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532	47	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65748	10.1371/journal.pone.0065748	http://dx.doi.org/10.1371/journal.pone.0065748			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776539	Green Submitted, gold, Green Published			2022-12-25	WOS:000320755400065
J	Xu, HY; Sun, QS; Luo, N; Cao, G; Xia, DS				Xu, Huanyu; Sun, Quansen; Luo, Nan; Cao, Guo; Xia, Deshen			Iterative Nonlocal Total Variation Regularization Method for Image Restoration	PLOS ONE			English	Article							TOTAL VARIATION MINIMIZATION; ALGORITHM; PARAMETER; TV; SELECTION	In this paper, a Bregman iteration based total variation image restoration algorithm is proposed. Based on the Bregman iteration, the algorithm splits the original total variation problem into sub-problems that are easy to solve. Moreover, non-local regularization is introduced into the proposed algorithm, and a method to choose the non-local filter parameter locally and adaptively is proposed. Experiment results show that the proposed algorithms outperform some other regularization methods.	[Xu, Huanyu; Sun, Quansen; Luo, Nan; Cao, Guo; Xia, Deshen] Nanjing Univ Sci & Technol, Sch Comp Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing University of Science & Technology	Sun, QS (corresponding author), Nanjing Univ Sci & Technol, Sch Comp Sci & Technol, Nanjing, Jiangsu, Peoples R China.	qssun@126.com	, Guo/AAC-1388-2022	, Guo/0000-0002-2689-0932	Programs of the National Natural Science Foundation of China [61273251, 61003108]; Ministry of Education of China [200802880017]; Fundamental Research Funds for the Central Universities [NUST2011ZDJH26]	Programs of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from Programs of the National Natural Science Foundation of China (61273251, 61003108), (http://www.nsfc.gov.cn) Doctoral Fund of Ministry of Education of China (200802880017) (http://www.cutech.edu.cn) and the Fundamental Research Funds for the Central Universities No. NUST2011ZDJH26. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almansa A, 2008, J SCI COMPUTING, V34, P612; [Anonymous], TR0710 CAAM; [Anonymous], P VLSM; Babacan SD, 2008, IEEE T IMAGE PROCESS, V17, P326, DOI 10.1109/TIP.2007.916051; Bertalmio M, 2003, J SCI COMPUT, V19, P95, DOI 10.1023/A:1025391506181; Buades A, 2005, MULTISCALE MODEL SIM, V4, P490, DOI 10.1137/040616024; Cai JF, 2009, SIAM J IMAGING SCI, V2, P226, DOI 10.1137/080733371; Carter J, 2001, DUAL METHODS TOTAL V; Chambolle A, 2004, J MATH IMAGING VIS, V20, P89; Chan TF, 2006, MULTISCALE MODEL SIM, V5, P615, DOI 10.1137/050644999; Chantas G, 2010, IEEE T IMAGE PROCESS, V19, P351, DOI 10.1109/TIP.2009.2033398; Chantas G, 2008, IEEE T IMAGE PROCESS, V17, P1795, DOI 10.1109/TIP.2008.2002828; Chen DQ, 2010, OPT ENG, V49, DOI 10.1117/1.3463019; Combettes PL, 2005, MULTISCALE MODEL SIM, V4, P1168, DOI 10.1137/050626090; Esser E, 2009, GEN FRAMEWORK CLASS, P1; Esser J, 2010, PRIMAL DUAL ALGORITH; Gilboa G, 2008, MULTISCALE MODEL SIM, V7, P1005, DOI 10.1137/070698592; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Hintermuller M, 2006, SIAM J SCI COMPUT, V28, P1, DOI 10.1137/040613263; Huang YM, 2008, MULTISCALE MODEL SIM, V7, P774, DOI 10.1137/070703533; Kindermann S, 2005, MULTISCALE MODEL SIM, V4, P1091, DOI 10.1137/050622249; Li F, 2009, J VIS COMMUN IMAGE R, V20, P293, DOI 10.1016/j.jvcir.2009.01.003; Liao HY, 2009, J OPT SOC AM A, V26, P2311, DOI 10.1364/JOSAA.26.002311; Liu HT, 2010, IEEE T IMAGE PROCESS, V19, P1414, DOI 10.1109/TIP.2010.2041406; Lou YF, 2010, J SCI COMPUT, V42, P185, DOI 10.1007/s10915-009-9320-2; Nasonov A, 2010, IEEE INT C IM PROC I, P2793; Neelamani R, 2004, IEEE T SIGNAL PROCES, V52, P418, DOI 10.1109/TSP.2003.821103; Ng MK, 2007, J MATH IMAGING VIS, V27, P265, DOI 10.1007/s10851-007-0650-0; Nikolova M, 2005, SIAM J SCI COMPUT, V27, P937, DOI 10.1137/030600862; Nikolova M, 2004, J MATH IMAGING VIS, V20, P99, DOI 10.1023/B:JMIV.0000011920.58935.9c; Oliveira JP, 2009, SIGNAL PROCESS, V89, P1683, DOI 10.1016/j.sigpro.2009.03.018; Osher S, 2005, MULTISCALE MODEL SIM, V4, P460, DOI 10.1137/040605412; Pang ZF, 2011, IMAGE VISION COMPUT, V29, P117, DOI 10.1016/j.imavis.2010.08.012; Prasath VBS, 2009, ICAPR 2009: SEVENTH INTERNATIONAL CONFERENCE ON ADVANCES IN PATTERN RECOGNITION, PROCEEDINGS, P333, DOI 10.1109/ICAPR.2009.57; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Takeda H, 2008, IEEE T IMAGE PROCESS, V17, P550, DOI 10.1109/TIP.2007.918028; Wang YL, 2008, SIAM J IMAGING SCI, V1, P248, DOI 10.1137/080724265; Wen YW, 2009, NUMER MATH-THEORY ME, V2, P427, DOI 10.4208/nmtma.2009.m9005s; Wu CL, 2010, SIAM J IMAGING SCI, V3, P300, DOI 10.1137/090767558; Yin WT, 2008, SIAM J IMAGING SCI, V1, P143, DOI 10.1137/070703983; Zhang XQ, 2010, SIAM J IMAGING SCI, V3, P253, DOI 10.1137/090746379	41	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65865	10.1371/journal.pone.0065865	http://dx.doi.org/10.1371/journal.pone.0065865			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776560	Green Submitted, gold, Green Published			2022-12-25	WOS:000320755400076
J	Lingham-Soliar, T; Murugan, N				Lingham-Soliar, Theagarten; Murugan, Nelisha			A New Helical Crossed-Fibre Structure of beta-Keratin in Flight Feathers and Its Biomechanical Implications	PLOS ONE			English	Article							SELECTIVE BIODEGRADATION; SKIN; MORPHOLOGY; MECHANICS; PROTEINS; MATRIX; MODEL; SHARK; SHAPE; HAIR	The feather aerofoil is unequalled in nature. It is comprised of a central rachis, serial paired branches or barbs, from which arise further branches, the barbules. Barbs and barbules arise from the significantly thinner lateral walls (the epicortex) of the rachis and barbs respectively, as opposed to the thicker dorsal and ventral walls (the cortex). We hypothesized a microstructural design of the epicortex that would resist the vertical or shearing stresses. The microstructures of the cortex and epicortex of the rachis and barbs were investigated in several bird species by microbe-assisted selective disassembly and conventional methods via scanning electron microscopy. We report, preeminent of the finds, a novel system of crossed fibres (ranging from similar to 100-800 nm in diameter), oppositely oriented in alternate layers of the epicortex in the rachis and barbs. It represents the first cross-fibre microstructure, not only for the feather but in keratin per se. The cortex of the barbs is comprised of syncitial barbule cells, definitive structural units shown in the rachidial cortex in a related study. The structural connection between the cortex of the rachis and barbs appears uninterrupted. A new model on feather microstructure incorporating the findings here and in the related study is presented. The helical fibre system found in the integument of a diverse range of invertebrates and vertebrates has been implicated in profound functional strategies, perhaps none more so potentially than in the aerofoil microstructure of the feather here, which is central to one of the marvels of nature, bird flight.	[Lingham-Soliar, Theagarten] Univ KwaZulu Natal, Durban, Kwazulu Natal, South Africa; [Murugan, Nelisha] Univ KwaZulu Natal, Elect Microscopy Unit, Durban, Kwazulu Natal, South Africa	University of Kwazulu Natal; University of Kwazulu Natal	Lingham-Soliar, T (corresponding author), Univ KwaZulu Natal, Durban, Kwazulu Natal, South Africa.	linghamst@ukzn.ac.za		Murugan, Nelisha/0000-0003-3936-5798				ALEXANDER RM, 1987, J THEOR BIOL, V124, P97, DOI 10.1016/S0022-5193(87)80255-2; Alibardi L, 2008, PROG HISTOCHEM CYTO, V43, P1, DOI 10.1016/j.proghi.2008.01.001; Barthelat F, 2007, PHILOS T R SOC A, V365, P2907, DOI 10.1098/rsta.2007.0006; Bodde SG, 2011, J MECH BEHAV BIOMED, DOI [10.1016/j.jmbbm.2011.01.010, DOI 10.1016/J.JMBBM.2011.01.010)]; BONSER RHC, 1995, J EXP BIOL, V198, P1029; Bonser RHC, 2001, J MATER SCI LETT, V20, P941, DOI 10.1023/A:1010993219791; BOULIGAND Y, 1971, J MICROSC-PARIS, V11, P441; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Butler M, 2004, J EXP BIOL, V207, P285, DOI 10.1242/jeb.00746; CLARK RB, 1958, J EXP BIOL, V35, P731; D'Alba L, 2011, BIOL LETTERS, V7, P543, DOI 10.1098/rsbl.2010.1163; Dawson MA, 2006, PRESS WIT T ECOLOGY, V87; EARLAND C, 1962, NATURE, V196, P1287, DOI 10.1038/1961287a0; Eckhart L, 2008, P NATL ACAD SCI USA, V105, P18419, DOI 10.1073/pnas.0805154105; Ennos AR, 2010, P ROY SOC B-BIOL SCI, V277, P1253, DOI 10.1098/rspb.2009.2093; ENNOS AR, 1995, J EXP BIOL, V198, P1219; FILSHIE K, 1962, J CELL BIOL, V13, P1, DOI 10.1083/jcb.13.1.1; Fraser RDB, 2008, J STRUCT BIOL, V162, P1, DOI 10.1016/j.jsb.2008.01.011; Fraser RDB, 2011, J STRUCT BIOL, V173, P391, DOI 10.1016/j.jsb.2010.09.020; FREINKEL WD, 1975, S AFR J SCI, V71, P280; Gordon J.E., 1978, STRUCTURES; HARRIS JE, 1957, J EXP BIOL, V34, P116; HEBRANK MR, 1986, BIOL BULL, V171, P236, DOI 10.2307/1541920; HEBRANK MR, 1980, BIOL BULL, V158, P58, DOI 10.2307/1540758; Lingham-Soliar T, 1999, P ROY SOC B-BIOL SCI, V266, P2367, DOI 10.1098/rspb.1999.0933; Lingham-Soliar T, 2005, J MORPHOL, V264, P233, DOI 10.1002/jmor.10328; Lingham-Soliar T, 2005, J MORPHOL, V263, P1, DOI 10.1002/jmor.10207; Lingham-Soliar T, 2008, P ROY SOC B-BIOL SCI, V275, P2207, DOI 10.1098/rspb.2008.0489; Lingham-Soliar T, 2008, P ROY SOC B-BIOL SCI, V275, P775, DOI 10.1098/rspb.2007.1342; Lingham-Soliar T, 2010, P ROY SOC B-BIOL SCI, V277, P1161, DOI 10.1098/rspb.2009.1980; Maderson PFA, 2009, J MORPHOL, V270, P1166, DOI 10.1002/jmor.10747; Meyers MA, 2003, JOM, P36; MOTTA PJ, 1977, COPEIA, P454, DOI 10.2307/1443263; Naraghi M, 2010, ACS NANO, DOI [10.1021/nn101404u, DOI 10.1021/NN101404U)]; NEVILLE A C, 1969, Tissue and Cell, V1, P689, DOI 10.1016/S0040-8166(69)80041-8; Ng CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002748; Pabst DA, 1996, AM ZOOL, V36, P723; Pabst DA, 1996, J ZOOL, V238, P35, DOI 10.1111/j.1469-7998.1996.tb05378.x; PENNYCUICK CJ, 1976, J EXP BIOL, V64, P677; Shadwick RE, 2008, J EXP BIOL, V211, P289, DOI 10.1242/jeb.008912; Stettenheim PR, 2000, AM ZOOL, V40, P461, DOI 10.1668/0003-1569(2000)040[0461:TIMOMB]2.0.CO;2; Wainwright S.A., 1976, MECH DESIGN ORGANISM; WAINWRIGHT SA, 1978, SCIENCE, V202, P747, DOI 10.1126/science.202.4369.747; Weiss IM, 2010, J EXP ZOOL PART A, V313A, P690, DOI 10.1002/jez.641; Wilson AS, 2007, BRIT J DERMATOL, V157, P450, DOI 10.1111/j.1365-2133.2007.07973.x	45	27	27	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65849	10.1371/journal.pone.0065849	http://dx.doi.org/10.1371/journal.pone.0065849			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762440	gold, Green Published, Green Submitted			2022-12-25	WOS:000320440500053
J	Zinck, L; Lima, SQ				Zinck, Lea; Lima, Susana Q.			Mate Choice in Mus musculus Is Relative and Dependent on the Estrous State	PLOS ONE			English	Article							ANDROGEN-BINDING PROTEIN; HOUSE MOUSE; REPRODUCTIVE ISOLATION; SEXUAL ISOLATION; WILD MICE; RECOGNITION; PREFERENCES; BEHAVIOR; SIGNALS; MALES	Mate choice is a critical behavioral decision process with profound impact on evolution. However, the mechanistic basis of mate choice is poorly understood. In this study we focused on assortative mate choice, which is known to contribute to the reproductive isolation of the two European subspecies of house mouse, Mus musculus musculus and Mus musculus domesticus. To understand the decision process, we developed both full mating and limited-contact paradigms and tested musculus females' preference for musculus versus domesticus males, mimicking the natural musculus/domesticus contact zone. As hypothesized, when allowed to mate we found that sexually receptive musculus females exhibited a robust preference to mate with musculus males. In contrast, when non-receptive, females did not exhibit a preference and rather alternated between males in response to male mount attempts. Moreover in a no-choice condition, females mated readily with males from both subspecies. Finally, when no physical contact was allowed, and therefore male's behavior could not influence female's behavior, female's preference for its own subspecies was maintained independently of the estrous state. Together, our results suggest that the assortative preference is relative and based on a comparison of the options available rather than on an absolute preference. The results of the limited-contact experiments highlight the interplay between female's internal state and the nature of the interaction with prospective mates in the full mating conditions. With these experiments we believe we established an assortative mate preference assay that is appropriate for the investigation of its underlying substrates.	[Zinck, Lea; Lima, Susana Q.] Champalimaud Ctr Unknown, Champalimaud Neurosci Program, Lisbon, Portugal; [Zinck, Lea; Lima, Susana Q.] Inst Gulbenkian Ciencias, Oeiras, Portugal	Fundacao Champalimaud; Instituto Gulbenkian de Ciencia	Lima, SQ (corresponding author), Champalimaud Ctr Unknown, Champalimaud Neurosci Program, Lisbon, Portugal.	susana.lima@neuro.fchampalimaud.org		Lima, Susana/0000-0003-2446-9869	Fundacao Champalimaud; Instituto Gulbenkian de Ciencia; Fundacao Bial [176/08]; Marie Curie Reintegration [FP7-MC-IRG239546/MCM]; IEF Marie Curie Postdoctoral Fellowship [PIEF-GA-2009-236113]	Fundacao Champalimaud; Instituto Gulbenkian de Ciencia; Fundacao Bial(Bial Foundation); Marie Curie Reintegration(European Commission); IEF Marie Curie Postdoctoral Fellowship	This work was supported by Fundacao Champalimaud (www.fchampalimaud.org), Instituto Gulbenkian de Ciencia (www.igc.gulbenkian.pt), Fundacao Bial (176/08) (www.bial.com/en), a Marie Curie Reintegration grant to SQL (FP7-MC-IRG239546/MCM) and an IEF Marie Curie Postdoctoral Fellowship to LZ (PIEF-GA-2009-236113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmo A., 2007, FUNCTIONAL DYSFUNCTI; Anderson M, 1994, SEXUAL SELECTION; Bateson M, 2005, TRENDS ECOL EVOL, V20, P659, DOI 10.1016/j.tree.2005.08.013; Bimova B, 2005, BIOL J LINN SOC, V84, P349, DOI 10.1111/j.1095-8312.2005.00439.x; Bimova B, 2009, BEHAV PROCESS, V80, P20, DOI 10.1016/j.beproc.2008.08.004; Bimova BV, 2011, MOL ECOL, V20, P2403, DOI 10.1111/j.1365-294X.2011.05106.x; Bolnick DI, 2012, CURR ZOOL, V58, P484, DOI 10.1093/czoolo/58.3.484; Bourne GR, 2003, NATURWISSENSCHAFTEN, V90, P402, DOI 10.1007/s00114-003-0444-1; BOURSOT P, 1993, ANNU REV ECOL SYST, V24, P119, DOI 10.1146/annurev.es.24.110193.001003; Caligioni C. S., 2009, CURRENT PROTOCOLS NE; Cheetham SA, 2007, CURR BIOL, V17, P1771, DOI 10.1016/j.cub.2007.10.007; Christophe N, 1998, ANIM BEHAV, V56, P365, DOI 10.1006/anbe.1998.0798; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; COLLINS SA, 1994, BEHAV ECOL SOCIOBIOL, V35, P21, DOI 10.1007/s002650050065; Dean MD, 2009, EVOLUTION, V63, P20, DOI 10.1111/j.1558-5646.2008.00499.x; DIXON, 2004, SOCIAL BEHAV MOUSE I; ERSKINE MS, 1989, HORM BEHAV, V23, P473, DOI 10.1016/0018-506X(89)90037-8; FOREJT J, 1974, GENET RES, V24, P189, DOI 10.1017/S0016672300015214; Ganem G, 2008, HEREDITY, V100, P594, DOI 10.1038/hdy.2008.20; Grant PR, 2008, P ROY SOC B-BIOL SCI, V275, P661, DOI 10.1098/rspb.2007.0898; Gregorova S, 2000, FOLIA BIOL-PRAGUE, V46, P31; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; Hurst JL, 2009, BEHAV BRAIN RES, V200, P295, DOI 10.1016/j.bbr.2008.12.020; Johansen JA, 2008, PHYSIOL BEHAV, V95, P425, DOI 10.1016/j.physbeh.2008.07.004; Kavaliers M, 2006, P NATL ACAD SCI USA, V103, P4293, DOI 10.1073/pnas.0600410103; Koide T, 2011, EXP ANIM TOKYO, V60, P347, DOI 10.1538/expanim.60.347; Kozak GM, 2011, P ROY SOC B-BIOL SCI, V278, P2604, DOI 10.1098/rspb.2010.2466; Laukaitis CM, 1997, EVOLUTION, V51, P2000, DOI [10.2307/2411020, 10.1111/j.1558-5646.1997.tb05121.x]; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; MARSDEN HM, 1964, SCIENCE, V144, P1469, DOI 10.1126/science.144.3625.1469; Mavarez J, 2006, NATURE, V441, P868, DOI 10.1038/nature04738; Mendelson TC, 2012, TRENDS ECOL EVOL, V27, P421, DOI 10.1016/j.tree.2012.04.001; Miller GF, 1998, TRENDS COGN SCI, V2, P190, DOI 10.1016/S1364-6613(98)01169-3; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Paredes RG, 1999, BEHAV BRAIN RES, V105, P117, DOI 10.1016/S0166-4328(99)00087-X; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Rundle HD, 1998, EVOLUTION, V52, P200, DOI 10.1111/j.1558-5646.1998.tb05153.x; Schwartz JJ, 2001, BEHAV ECOL SOCIOBIOL, V49, P443, DOI 10.1007/s002650100317; Smadja C, 2005, J EVOLUTION BIOL, V18, P1485, DOI 10.1111/j.1420-9101.2005.00944.x; Smadja C, 2004, J EVOLUTION BIOL, V17, P165, DOI 10.1046/j.1420-9101.2003.00647.x; Smadja C, 2002, BEHAV ECOL, V13, P312, DOI 10.1093/beheco/13.3.312; Storchova R, 2004, MAMM GENOME, V15, P515, DOI 10.1007/s00335-004-2386-0; Teeter KC, 2008, GENOME RES, V18, P67, DOI 10.1101/gr.6757907; Winslow James T, 2003, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0816s22; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847	48	23	23	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66064	10.1371/journal.pone.0066064	http://dx.doi.org/10.1371/journal.pone.0066064			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762466	Green Published, Green Submitted, gold			2022-12-25	WOS:000320440500062
J	Geng, Y; Lin, DJ; Shao, LJ; Yan, F; Ju, HX				Geng, Yao; Lin, Dajie; Shao, Lijia; Yan, Feng; Ju, Huangxian			Cellular Delivery of Quantum Dot-Bound Hybridization Probe for Detection of Intracellular Pre-MicroRNA Using Chitosan/Poly(gamma-Glutamic Acid) Complex as a Carrier	PLOS ONE			English	Article							TRANSFECTION EFFICIENCY; MOLECULAR-WEIGHT; BREAST-CANCER; NANOPARTICLES; EXPRESSION; RNA; CHITOSAN; MECHANISMS; MIRNAS; GENES	A quantum dot (QD)-bound hybridization probe was designed for detection of intracellular pre-miRNA using chitosan (CS)/poly(gamma-glutamic acid) (gamma-PGA) complex as a gene vector. The probe was prepared by assembling thiolated RNA to gold nanoparticle (Au NP) via Au-S bond and then binding 3'- end amine of the RNA to the carboxy group capped on quantum dot surface. The QD-RNA-Au NP probe was assembled on the vector by mixing with aqueous gamma-PGA solution and then CS solution to construct a gene delivery system for highly effective cellular uptake and delivery. After the probe was released from CS/gamma-PGA complex to the cytoplasm by electrostatic repulsion at intracellular pH, it hybridized with pre-miRNA precursor as target. The formed product was then cleaved by RNase III Dicer, leading to the separation of QDs from Au NPs and fluorescence emission of QDs, which could be detected by confocal microscopic imaging to monitor the amount of the intracellular pre-miRNA precursor. The in vitro assays revealed that the QD-RNA-Au NP was a robust, sensitive and selective probe for quantitative detection of target pre-miRNA. Using MDA-MB231 and MCF-7 breast cancer cells as models, the relative amount of pre-miRNA let-7a could be successfully compared. Since the amount of miRNA is related to the progress and prognosis of cancer, this strategy could be expected to hold promising application potential in medical research and clinical diagnostics.	[Geng, Yao; Shao, Lijia; Yan, Feng] Jiangsu Inst Canc Prevent & Cure, Nanjing, Jiangsu, Peoples R China; [Geng, Yao; Lin, Dajie; Ju, Huangxian] Nanjing Univ, Sch Chem & Chem Engn, State Key Lab Analyt Chem Life Sci, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Yan, F (corresponding author), Jiangsu Inst Canc Prevent & Cure, Nanjing, Jiangsu, Peoples R China.	yanfeng2007@sohu.com; hxju@nju.edu.cn	Ju, Huangxian/B-2265-2010	Ju, Huangxian/0000-0002-6741-5302	National Basic Research Program [2010CB732400]; National Natural Science Foundation of China [21075055, 21135002, 21121091]; Department of Health of Jiangsu Province	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Health of Jiangsu Province	This work was financially supported by National Basic Research Program (2010CB732400), National Natural Science Foundation of China (21075055, 21135002, 21121091), and the Leading Medical Talents Program from Department of Health of Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cissell KA, 2008, ANAL CHEM, V80, P2319, DOI 10.1021/ac702577a; Dong HF, 2012, ANGEW CHEM INT EDIT, V51, P4607, DOI 10.1002/anie.201108302; Dong HF, 2011, BIOMATERIALS, V32, P3875, DOI 10.1016/j.biomaterials.2011.02.001; Duceppe N, 2009, BIOMATERIALS, V30, P2625, DOI 10.1016/j.biomaterials.2009.01.017; Fang SP, 2006, J AM CHEM SOC, V128, P14044, DOI 10.1021/ja065223p; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Lavertu M, 2006, BIOMATERIALS, V27, P4815, DOI 10.1016/j.biomaterials.2006.04.029; Li JJ, 2010, BIOMATERIALS, V31, P5996, DOI 10.1016/j.biomaterials.2010.04.014; Liao ZX, 2010, BIOMATERIALS, V31, P8780, DOI 10.1016/j.biomaterials.2010.07.086; Liu WG, 2002, J CONTROL RELEASE, V83, P1; Liu XD, 2007, BIOMATERIALS, V28, P1280, DOI 10.1016/j.biomaterials.2006.11.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Noh SM, 2010, J CONTROL RELEASE, V145, P159, DOI 10.1016/j.jconrel.2010.04.005; Patel PC, 2011, MOL PHARMACEUT, V8, P1285, DOI 10.1021/mp200084y; Peng SF, 2011, BIOMATERIALS, V32, P239, DOI 10.1016/j.biomaterials.2010.08.081; Peng SF, 2009, BIOMATERIALS, V30, P1797, DOI 10.1016/j.biomaterials.2008.12.019; Poehlmann C, 2010, ANAL CHEM, V82, P4434, DOI 10.1021/ac100186p; Rudzinski WE, 2010, INT J PHARMACEUT, V399, P1, DOI 10.1016/j.ijpharm.2010.08.022; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tsay JM, 2004, J AM CHEM SOC, V126, P1926, DOI 10.1021/ja039227v; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Zhang H, 2002, BIOMATERIALS, V23, P2761, DOI 10.1016/S0142-9612(02)00011-X	37	24	24	1	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65540	10.1371/journal.pone.0065540	http://dx.doi.org/10.1371/journal.pone.0065540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762388	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800059
J	Jian, SL; Hsieh, HY; Liao, CT; Yen, TC; Nien, SW; Cheng, AJ; Juang, JL				Jian, Shiou-Ling; Hsieh, Hsin-Yi; Liao, Chun-Ta; Yen, Tzu-Chen; Nien, Shu-Wei; Cheng, Ann-Joy; Juang, Jyh-Lyh			G alpha(12) Drives Invasion of Oral Squamous Cell Carcinoma through Up-Regulation of Proinflammatory Cytokines	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; HETEROTRIMERIC G-PROTEINS; NF-KAPPA-B; NECK-CANCER; EXTRACAPSULAR SPREAD; POTENTIAL BIOMARKERS; LYMPH-NODES; G12 FAMILY; TNF-ALPHA; HEAD	Oral squamous cell carcinoma (OSCC) ranks among the top ten most prevalent cancers worldwide. Like most head and neck squamous cell carcinomas (HNSCCs), OSCC is highly inflammatory and aggressive. However, the signaling pathways triggering the activation of its inflammatory processes remain elusive. G protein-coupled receptor signaling regulates the inflammatory response and invasiveness of cancers, but it remains unclear whether G alpha(12) is a critical player in the inflammatory cytokine pathway during the tumorigenesis of OSCC. This study was undertaken to determine the role of G alpha(12) signaling in the regulation of proinflammatory cytokines in their mediation of OSCC invasion. We found that both the transcription and protein levels of G alpha(12) are up-regulated in OSCC tumors. The elevated G alpha(12) expressions in OSCC patients also correlated with extra-capsular spread, an indicator of tumor invasiveness in HNSCCs. This clinical finding was supported by the studies of overexpression and RNAi knockdown of G alpha(12) in OSCC cells, which demonstrated that G alpha(12) promoted tumor cell migration and invasion. To understand how G alpha(12) modulates OSCC invasiveness, we analyzed key biological processes in microarray data upon depletion of G alpha(12) and found that cytokine- and other immune-related pathways were severely impaired. Importantly, the mRNA levels of IL-6 and IL-8 proinflammatory cytokines in clinical samples were found to be significantly correlated with the increased G alpha(12) levels, suggesting a potential role of G alpha(12) in modulating the IL-6 and IL-8 expressions. Supporting this hypothesis, overexpression or RNAi knockdown of G alpha(12) in OSCC cell lines both showed that G alpha(12) positively regulated the mRNA and protein levels of IL-6 and IL-8. Finally, we demonstrated that the G alpha(12) promotion of tumor cell invasiveness was suppressed by the neutralization of IL-6 and IL-8 in OSCC cells. Together, these findings suggest that G alpha(12) drives OSCC invasion through the up-regulation of IL-6 and IL-8 cytokines.	[Jian, Shiou-Ling; Juang, Jyh-Lyh] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Jian, Shiou-Ling; Hsieh, Hsin-Yi; Nien, Shu-Wei; Juang, Jyh-Lyh] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan; [Liao, Chun-Ta; Yen, Tzu-Chen] Chang Gung Mem Hosp, Head & Neck Oncol Grp, Tao Yuan, Taiwan; [Liao, Chun-Ta; Yen, Tzu-Chen] Chang Gung Univ, Tao Yuan, Taiwan; [Cheng, Ann-Joy] Chang Gung Univ, Grad Sch Med Biotechnol, Tao Yuan, Taiwan; [Juang, Jyh-Lyh] China Med Univ, PhD Program Aging, Taichung, Taiwan	National Defense Medical Center; National Health Research Institutes - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; China Medical University Taiwan	Juang, JL (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	juang@nhri.org.tw	Juang, Jyh-Lyh/E-3944-2010; Cheng, Ann-Joy/AAI-4374-2020		National Health Research Institutes [01A1-MGPP02014]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	Funding was provided by National Health Research Institutes (http://www.nhri.org.tw/NHRI_WEB/nhriw001Action.do), Grant number: 01A1-MGPP02014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki Y, 2008, ARCH ORAL BIOL, V53, P207, DOI 10.1016/j.archoralbio.2007.08.006; Bian D, 2006, ONCOGENE, V25, P2234, DOI 10.1038/sj.onc.1209261; Chen C-J, 2012, PLOS ONE, V7; Chen SU, 2008, J CLIN ENDOCR METAB, V93, P935, DOI 10.1210/jc.2007-1512; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; Chen Z, 1999, CLIN CANCER RES, V5, P1369; Chung CH, 2009, CLIN CANCER RES, V15, P6758, DOI 10.1158/1078-0432.CCR-09-0784; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; Culig Z, 2013, EXPERT OPIN THER TAR, V17, P53, DOI 10.1517/14728222.2013.733368; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Facchinetti MM, 2010, CELLS TISSUES ORGANS, V192, P314, DOI 10.1159/000318173; Fraser CC, 2008, INT REV IMMUNOL, V27, P320, DOI 10.1080/08830180802262765; Freier K, 2008, ORAL ONCOL, V44, P116, DOI 10.1016/j.oraloncology.2007.01.006; Gokhale AS, 2005, ORAL ONCOL, V41, P70, DOI 10.1016/j.oraloncology.2004.06.005; Greenberg JS, 2003, CANCER, V97, P1464, DOI 10.1002/cncr.11202; Ho M K C, 2009, Curr Mol Pharmacol, V2, P19; Hwang YS, 2012, ORAL ONCOL, V48, P40, DOI 10.1016/j.oraloncology.2011.08.022; Juneja J, 2009, BRIT J PHARMACOL, V158, P32, DOI 10.1111/j.1476-5381.2009.00180.x; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Ki SH, 2007, J BIOL CHEM, V282, P1938, DOI 10.1074/jbc.M606080200; Lebman DA, 2008, J LIPID RES, V49, P1388, DOI 10.1194/jlr.R800008-JLR200; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li SY, 2005, INT J ONCOL, V27, P1329; Liao CT, 2011, INT J RADIAT ONCOL, V81, P930, DOI 10.1016/j.ijrobp.2010.07.1988; Lin SC, 2004, J ORAL PATHOL MED, V33, P79, DOI 10.1111/j.1600-0714.2004.00034.x; Liu SC, 2009, CANCER RES, V69, P6122, DOI 10.1158/0008-5472.CAN-08-3435; Lu YC, 2012, CANCER PREV RES, V5, P665, DOI 10.1158/1940-6207.CAPR-11-0358; de Oliveira MVM, 2009, HEAD NECK-J SCI SPEC, V31, P1439, DOI 10.1002/hed.21121; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Pai SI, 2009, ANNU REV PATHOL-MECH, V4, P49, DOI 10.1146/annurev.pathol.4.110807.092158; Peng C-H, 2011, PLOS ONE, V6; Penson RT, 2000, INT J GYNECOL CANCER, V10, P33, DOI 10.1046/j.1525-1438.2000.00003.x; Pries R, 2006, EXPERT REV ANTICANC, V6, P1195, DOI 10.1586/14737140.6.9.1195; Radhika V, 2005, ONCOGENE, V24, P4597, DOI 10.1038/sj.onc.1208665; Ramqvist T, 2010, EMERG INFECT DIS, V16, P1671, DOI 10.3201/eid1611.100452; Rao SK, 2010, J BIOL CHEM, V285, P32512, DOI 10.1074/jbc.M110.150490; Riedel F, 2005, ANTICANCER RES, V25, P2761; SahebJamee M, 2008, MED ORAL PATOL ORAL, V13, pE292; Shaw RJ, 2010, HEAD NECK-J SCI SPEC, V32, P714, DOI 10.1002/hed.21244; Spiegelberg BD, 2007, CURR OPIN GENET DEV, V17, P40, DOI 10.1016/j.gde.2006.12.002; St John MAR, 2004, ARCH OTOLARYNGOL, V130, P929, DOI 10.1001/archotol.130.8.929; Tung CL, 2013, J PHARMACEUT BIOMED, V75, P7, DOI 10.1016/j.jpba.2012.11.017; Wang F, 2009, CURR OPIN PHARMACOL, V9, P389, DOI 10.1016/j.coph.2009.06.005; Wang Y, 2010, CANCER LETT, V295, P110, DOI 10.1016/j.canlet.2010.02.019; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wenzel S, 2004, EUR ARCH OTO-RHINO-L, V261, P270, DOI 10.1007/s00405-003-0678-8; Wu JY, 2010, ORAL ONCOL, V46, P226, DOI 10.1016/j.oraloncology.2010.01.007	50	15	18	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66133	10.1371/journal.pone.0066133	http://dx.doi.org/10.1371/journal.pone.0066133			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762476	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800093
J	Reid, WDK; Sweeting, CJ; Wigham, BD; Zwirglmaier, K; Hawkes, JA; McGill, RAR; Linse, K; Polunin, NVC				Reid, William D. K.; Sweeting, Christopher J.; Wigham, Ben D.; Zwirglmaier, Katrin; Hawkes, Jeffrey A.; McGill, Rona A. R.; Linse, Katrin; Polunin, Nicholas V. C.			Spatial Differences in East Scotia Ridge Hydrothermal Vent Food Webs: Influences of Chemistry, Microbiology and Predation on Trophodynamics	PLOS ONE			English	Article							MID-ATLANTIC RIDGE; NITROGEN ISOTOPIC COMPOSITION; RIFTIA-PACHYPTILA; SEA-FLOOR; BACK-ARC; TROPHIC RELATIONSHIPS; GENUS ALVINICONCHA; STABLE-ISOTOPES; AXIAL-VOLCANO; AMINO-ACIDS	The hydrothermal vents on the East Scotia Ridge are the first to be explored in the Antarctic and are dominated by large peltospiroid gastropods, stalked barnacles (Vulcanolepas sp.) and anomuran crabs (Kiwa sp.) but their food webs are unknown. Vent fluid and macroconsumer samples were collected at three vent sites (E2, E9N and E9S) at distances of tens of metres to hundreds of kilometres apart with contrasting vent fluid chemistries to describe trophic interactions and identify potential carbon fixation pathways using stable isotopes. delta C-13 of dissolved inorganic carbon from vent fluids ranged from 24.6 parts per thousand to 0.8 parts per thousand at E2 and from -4.4 parts per thousand to 1.5 parts per thousand at E9. The lowest macroconsumer delta C-13 was observed in peltospiroid gastropods (-30.0 parts per thousand to -31.1 parts per thousand) and indicated carbon fixation via the Calvin-Benson-Bassham (CBB) cycle by endosymbiotic gamma-Proteobacteria. Highest delta C-13 occurred in Kiwa sp. (-19.0 parts per thousand to -10.5 parts per thousand), similar to that of the epibionts sampled from their ventral setae. Kiwa sp. delta C-13 differed among sites, which were attributed to spatial differences in the epibiont community and the relative contribution of carbon fixed via the reductive tricarboxylic acid (rTCA) and CBB cycles assimilated by Kiwa sp. Site differences in carbon fixation pathways were traced into higher trophic levels e.g. a stichasterid asteroid that predates on Kiwa sp. Sponges and anemones at the periphery of E2 assimilated a proportion of epipelagic photosynthetic primary production but this was not observed at E9N. Differences in the delta C-13 and delta S-34 values of vent macroconsumers between E2 and E9 sites suggest the relative contributions of photosynthetic and chemoautotrophic carbon fixation (rTCA v CBB) entering the hydrothermal vent food webs vary between the sites.	[Reid, William D. K.; Sweeting, Christopher J.; Polunin, Nicholas V. C.] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wigham, Ben D.] Newcastle Univ, Sch Marine Sci & Technol, Dove Marine Lab, Cullercoats, England; [Zwirglmaier, Katrin; Linse, Katrin] British Antarctic Survey, NERC, Cambridge CB3 0ET, England; [Hawkes, Jeffrey A.] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton, Hants, England; [McGill, Rona A. R.] Scottish Univ, Environm Res Ctr, NERC, Life Sci Mass Spectrometry Facil, E Kilbride, Lanark, Scotland	Newcastle University - UK; Newcastle University - UK; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; NERC National Oceanography Centre; University of Southampton; Scottish Universities Research & Reactor Center; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Reid, WDK (corresponding author), Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	wdkreid@gmail.com	McGill, Rona/F-1793-2010; Zwirglmaier, Katrin/H-9799-2014; Reid, William/J-8528-2013	McGill, Rona/0000-0003-0400-7288; Zwirglmaier, Katrin/0000-0001-8598-9572; Reid, William/0000-0003-0190-0425; Polunin, Nick/0000-0002-1480-8794; Wigham, Ben/0000-0001-8408-5600; Linse, Katrin/0000-0003-3477-3047	Natural Environment Research Council (NERC) through ChEsSO consortium [NE/DO1249X/1, NE/F010664/1, NE/H524922]; NERC [LSMSFBRIS043_04/10_R_09/10]; Natural Environment Research Council [bas0100026, lsmsf010002, NE/D01249X/1, NE/D010470/2] Funding Source: researchfish; NERC [lsmsf010002, NE/D010470/2, bas0100026, NE/D01249X/1] Funding Source: UKRI	Natural Environment Research Council (NERC) through ChEsSO consortium(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research was funded by the Natural Environment Research Council (NERC) through ChEsSO consortium grant NE/DO1249X/1 and studentships NE/F010664/1 (WDKR) and NE/H524922 (JAH). Sample analysis was funded via NERC Life Sciences Mass Spectrometry Facilities grant LSMSFBRIS043_04/10_R_09/10. The funders had no role in the study design, data collection and anlaysis, decision to publish, or preparation of the manuscript.	Bergquist DC, 2007, MAR ECOL PROG SER, V330, P49, DOI 10.3354/meps330049; BROOKS JM, 1987, SCIENCE, V238, P1138, DOI 10.1126/science.238.4830.1138; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Campbell BJ, 2004, APPL ENVIRON MICROB, V70, P6282, DOI 10.1128/AEM.70.10.6282-6289.2004; Campbell BJ, 2003, APPL ENVIRON MICROB, V69, P5070, DOI 10.1128/AEM.69.9.5070-5078.2003; CAVANAUGH CM, 1981, SCIENCE, V213, P340, DOI 10.1126/science.213.4505.340; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; CHILDRESS JJ, 1992, OCEANOGR MAR BIOL, V30, P337; Colaco A, 2002, DEEP-SEA RES PT I, V49, P395, DOI 10.1016/S0967-0637(01)00060-7; Cuvelier D, 2011, LIMNOL OCEANOGR, V56, P1624, DOI 10.4319/lo.2011.56.5.1624; De Busserolles F, 2009, DEEP-SEA RES PT II, V56, P1649, DOI 10.1016/j.dsr2.2009.05.011; DESBRUYERES D, 1994, MAR GEOL, V116, P227, DOI 10.1016/0025-3227(94)90178-3; Erickson KL, 2009, DEEP-SEA RES PT II, V56, P1577, DOI 10.1016/j.dsr2.2009.05.002; FISHER CR, 1994, MAR ECOL PROG SER, V103, P45, DOI 10.3354/meps103045; Flores GE, 2011, ENVIRON MICROBIOL, V13, P2158, DOI 10.1111/j.1462-2920.2011.02463.x; German C.R., 2006, TREATISE GEOCHEMISTR, V6, P45, DOI 10.1016/B0-08-043751-6/06109-0; German CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023259; German CR, 2000, EARTH PLANET SC LETT, V184, P241, DOI 10.1016/S0012-821X(00)00319-8; GUY RD, 1993, PLANT PHYSIOL, V101, P37, DOI 10.1104/pp.101.1.37; Herzig PM, 1998, MINER DEPOSITA, V33, P226, DOI 10.1007/s001260050143; House CH, 2003, ORG GEOCHEM, V34, P345, DOI 10.1016/S0146-6380(02)00237-1; Hugler M, 2011, ANNU REV MAR SCI, V3, P261, DOI 10.1146/annurev-marine-120709-142712; Karl DM, 1995, MICR EXTREM UNUSUAL, P35; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Levesque C, 2005, MAR ECOL PROG SER, V289, P43, DOI 10.3354/meps289043; Levesque C, 2003, MAR ECOL PROG SER, V246, P173, DOI 10.3354/meps246173; Levesque C, 2006, DEEP-SEA RES PT I, V53, P726, DOI 10.1016/j.dsr.2006.01.007; Levin LA, 2009, DEEP-SEA RES PT II, V56, P1632, DOI 10.1016/j.dsr2.2009.05.010; Limen H, 2006, CAH BIOL MAR, V47, P449; Luther GW, 2001, NATURE, V410, P813, DOI 10.1038/35071069; Markert S, 2007, SCIENCE, V315, P247, DOI 10.1126/science.1132913; Marsh L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048348; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; McCollom TM, 1997, GEOCHIM COSMOCHIM AC, V61, P4375, DOI 10.1016/S0016-7037(97)00241-X; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Nakagawa S, 2008, FEMS MICROBIOL ECOL, V65, P1, DOI 10.1111/j.1574-6941.2008.00502.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2011, R LANG ENV STAT COMP; RAU GH, 1979, SCIENCE, V203, P648, DOI 10.1126/science.203.4381.648; Reid WDK, 2012, MAR ECOL PROG SER, V463, P89, DOI 10.3354/meps09863; Riou V, 2010, MAR ECOL PROG SER, V405, P187, DOI 10.3354/meps08515; Robinson JJ, 2003, LIMNOL OCEANOGR, V48, P48, DOI 10.4319/lo.2003.48.1.0048; ROESKE CA, 1984, BIOCHEMISTRY-US, V23, P6275, DOI 10.1021/bi00320a058; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Staudigel H, 2006, P NATL ACAD SCI USA, V103, P6448, DOI 10.1073/pnas.0600830103; Suzuki Y, 2006, APPL ENVIRON MICROB, V72, P1388, DOI 10.1128/AEM.72.2.1388-1393.2006; Suzuki Y, 2005, APPL ENVIRON MICROB, V71, P5440, DOI 10.1128/AEM.71.9.5440-5450.2005; Suzuki Y, 2005, FEMS MICROBIOL LETT, V249, P105, DOI 10.1016/j.femsle.2005.06.023; Takai K, 2009, GEOMICROBIOL J, V26, P552, DOI 10.1080/01490450903304949; Thurber AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026243; Trask JL, 1999, LIMNOL OCEANOGR, V44, P334, DOI 10.4319/lo.1999.44.2.0334; Tunnicliffe V, 2003, ECOSY WORLD, V28, P81; Van Dover CL, 2002, MAR BIOL, V141, P761, DOI 10.1007/s00227-002-0865-y; VANDOVER CL, 1989, MAR BIOL, V102, P257, DOI 10.1007/BF00428287; VANDOVER CL, 1994, LIMNOL OCEANOGR, V39, P51, DOI 10.4319/lo.1994.39.1.0051; Vetter RD, 1998, MAR BIOL, V132, P453, DOI 10.1007/s002270050411; Wirsen CO, 2002, APPL ENVIRON MICROB, V68, P316, DOI 10.1128/AEM.68.1.316-325.2002	59	50	51	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65553	10.1371/journal.pone.0065553	http://dx.doi.org/10.1371/journal.pone.0065553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762393	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000321094800064
J	Bienkowski, M; Piaskowski, S; Stoczynska-Fidelus, E; Szybka, M; Banaszczyk, M; Witusik-Perkowska, M; Jesien-Lewandowicz, E; Jaskolski, DJ; Radomiak-Zaluska, A; Jesionek-Kupnicka, D; Sikorska, B; Papierz, W; Rieske, P; Liberski, PP				Bienkowski, Michal; Piaskowski, Sylwester; Stoczynska-Fidelus, Ewelina; Szybka, Malgorzata; Banaszczyk, Mateusz; Witusik-Perkowska, Monika; Jesien-Lewandowicz, Emilia; Jaskolski, Dariusz J.; Radomiak-Zaluska, Anna; Jesionek-Kupnicka, Dorota; Sikorska, Beata; Papierz, Wielislaw; Rieske, Piotr; Liberski, Pawel P.			Screening for EGFR Amplifications with a Novel Method and Their Significance for the Outcome of Glioblastoma Patients	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; COPY NUMBER GAIN; GENE AMPLIFICATION; PROGNOSTIC-SIGNIFICANCE; ADJUVANT TEMOZOLOMIDE; CLINICAL-SIGNIFICANCE; MOLECULAR ANALYSIS; MULTIFORME; SURVIVAL; EXPRESSION	Glioblastoma is a highly aggressive tumour of the central nervous system, characterised by poor prognosis irrespective of the applied treatment. The aim of our study was to analyse whether the molecular markers of glioblastoma (i.e. TP53 and IDH1 mutations, CDKN2A deletion, EGFR amplification, chromosome 7 polysomy and EGFRvIII expression) could be associated with distinct prognosis and/or response to the therapy. Moreover, we describe a method which allows for a reliable, as well as time- and cost-effective, screening for EGFR amplification and chromosome 7 polysomy with quantitative Real-Time PCR at DNA level. In the clinical data, only the patient's age had prognostic significance (continuous: HR = 1.04; p<0.01). At the molecular level, EGFRvIII expression was associated with a better prognosis (HR = 0.37; p = 0.04). Intriguingly, EGFR amplification was associated with a worse outcome in younger patients (HR = 3.75; p<0.01) and in patients treated with radiotherapy (HR = 2.71; p = 0.03). We did not observe any difference between the patients with the amplification treated with radiotherapy and the patients without such a treatment. Next, EGFR amplification was related to a better prognosis in combination with the homozygous CDKN2A deletion (HR = 0.12; p = 0.01), but to a poorer prognosis in combination with chromosome 7 polysomy (HR = 14.88; p = 0.01). Importantly, the results emphasise the necessity to distinguish both mechanisms of the increased EGFR gene copy number (amplification and polysomy). To conclude, although the data presented here require validation in different groups of patients, they strongly advocate the consideration of the patient's tumour molecular characteristics in the selection of the therapy.	[Bienkowski, Michal; Piaskowski, Sylwester; Stoczynska-Fidelus, Ewelina; Szybka, Malgorzata; Banaszczyk, Mateusz; Witusik-Perkowska, Monika; Sikorska, Beata; Rieske, Piotr; Liberski, Pawel P.] Med Univ Lodz, Dept Mol Pathol & Neuropathol, Chair Oncol, Lodz, Poland; [Jesien-Lewandowicz, Emilia] Med Univ Lodz, Dept Radiotherapy, Chair Oncol, Lodz, Poland; [Jaskolski, Dariusz J.] Med Univ Lodz, Dept Neurosurg, Lodz, Poland; [Radomiak-Zaluska, Anna] Maria Sklodowska Curie Hosp Zgierz, Ward Neurosurg, Zgierz, Poland; [Jesionek-Kupnicka, Dorota] Med Univ Lodz, Dept Pathol, Chair Oncol, Lodz, Poland; [Papierz, Wielislaw] Med Univ Lodz, Dept Pathomorphol, Lodz, Poland	Medical University Lodz; Medical University Lodz; Medical University Lodz; Medical University Lodz; Medical University Lodz	Bienkowski, M (corresponding author), Med Univ Lodz, Dept Mol Pathol & Neuropathol, Chair Oncol, Lodz, Poland.	michal.bienkowski@gmail.com	Sikorska, Beata/H-7138-2016; Jaskólski, Dariusz/AAA-7656-2021; Stoczynska-Fidelus, Ewelina/S-9948-2016; Witusik-Perkowska, Monika/S-9942-2016; Jaskólski, Dariusz J/H-8051-2013; Bieńkowski, Michał/H-3046-2019; Rieske, Piotr/M-4821-2015; Stoczynska-Fidelus, Ewelina/M-4871-2015	Sikorska, Beata/0000-0002-6166-0729; Bieńkowski, Michał/0000-0002-9291-3928; Rieske, Piotr/0000-0002-2970-0970; Szybka, Malgorzata/0000-0003-2318-7923; Liberski, Pawel P./0000-0001-6507-4682; Jesionek-Kupnicka, Dorota/0000-0001-9319-9570; Jaskolski, Dariusz/0000-0002-9971-9677; Stoczynska-Fidelus, Ewelina/0000-0002-7779-3075	National Science Centre [N N401 047337]; Polpharma Science Foundation; Polish Ministry of Science and Higher Education	National Science Centre(National Science Centre, Poland); Polpharma Science Foundation; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by grants from: National Science Centre N N401 047337, Polpharma Science Foundation, Polish Ministry of Science and Higher Education "Diamond Grant''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algars A, 2012, BRIT J CANCER, V106, P428, DOI 10.1038/bjc.2011.571; Ang C, 2010, CAN J NEUROL SCI, V37, P625, DOI 10.1017/S0317167100010805; Backlund LM, 2003, CLIN CANCER RES, V9, P4151; Benito R, 2010, NEUROPATHOLOGY, V30, P392, DOI 10.1111/j.1440-1789.2009.01081.x; Eley GD, 2002, NEURO-ONCOLOGY, V4, P86, DOI 10.1093/neuonc/4.2.86; Felsberg J, 2009, CLIN CANCER RES, V15, P6683, DOI 10.1158/1078-0432.CCR-08-2801; Feng JJ, 2012, CANCER-AM CANCER SOC, V118, P232, DOI 10.1002/cncr.26250; Filippini G, 2008, NEURO-ONCOLOGY, V10, P79, DOI 10.1215/15228517-2007-038; Gilbert MR, 2012, J NEURO-ONCOL, V106, P147, DOI 10.1007/s11060-011-0650-1; Hartmann C, 2010, ACTA NEUROPATHOL, V120, P707, DOI 10.1007/s00401-010-0781-z; Hassler M, 2006, CANCER GENET CYTOGEN, V166, P46, DOI 10.1016/j.cancergencyto.2005.08.021; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Heimberger AB, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-38; Houillier C, 2006, CANCER-AM CANCER SOC, V106, P2218, DOI 10.1002/cncr.21819; Kamiryo T, 2002, J NEUROSURG, V96, P815, DOI 10.3171/jns.2002.96.5.0815; Korshunov A, 2005, CANCER-AM CANCER SOC, V104, P825, DOI 10.1002/cncr.21221; Kraus JA, 2000, J NEURO-ONCOL, V48, P89, DOI 10.1023/A:1006402614838; LANG FF, 1994, J NEUROSURG, V81, P427, DOI 10.3171/jns.1994.81.3.0427; Layfield LJ, 2006, APPL IMMUNOHISTO M M, V14, P91, DOI 10.1097/01.pai.0000159772.73775.2e; Lee J, 2007, CANCER-AM CANCER SOC, V109, P1561, DOI 10.1002/cncr.22559; Liu L, 2005, J MOL MED, V83, P917, DOI 10.1007/s00109-005-0700-2; McDonald KL, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00188; Miller CT, 2003, CLIN CANCER RES, V9, P4819; Montano N, 2011, NEOPLASIA, V13, P1113, DOI 10.1593/neo.111338; Nobusawa S, 2009, CLIN CANCER RES, V15, P6002, DOI 10.1158/1078-0432.CCR-09-0715; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rapaport F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012028; Ruano Y, 2009, AM J CLIN PATHOL, V131, P257, DOI 10.1309/AJCP64YBDVCTIRWV; Sauter G, 1996, AM J PATHOL, V148, P1047; Sesboue R, 2012, BRIT J CANCER, V106, P426, DOI 10.1038/bjc.2011.570; Shinojima N, 2003, CANCER RES, V63, P6962; Simmons ML, 2001, CANCER RES, V61, P1122; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; VONDEIMLING A, 1992, J NEUROSURG, V77, P295, DOI 10.3171/jns.1992.77.2.0295; Wang XY, 1998, ONCOGENE, V16, P191, DOI 10.1038/sj.onc.1201476; Wozniak K, 2008, CANCER GENET CYTOGEN, V183, P14, DOI 10.1016/j.cancergencyto.2008.01.020; Yin D, 2009, MOL CANCER RES, V7, P665, DOI 10.1158/1541-7786.MCR-08-0270; Yoshimoto K, 2008, CLIN CANCER RES, V14, P488, DOI 10.1158/1078-0432.CCR-07-1966	42	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65444	10.1371/journal.pone.0065444	http://dx.doi.org/10.1371/journal.pone.0065444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762372	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000067
J	Tsuji, A; Tominaga, K; Nishiyama, N; Yuasa, K				Tsuji, Akihiko; Tominaga, Keiko; Nishiyama, Nami; Yuasa, Keizo			Comprehensive Enzymatic Analysis of the Cellulolytic System in Digestive Fluid of the Sea Hare Aplysia kurodai. Efficient Glucose Release from Sea Lettuce by Synergistic Action of 45 kDa Endoglucanase and 210 kDa beta-Glucosidase	PLOS ONE			English	Article							ACID-SEQUENCE SIMILARITIES; CLAM CORBICULA-JAPONICA; GECARCINID LAND CRAB; TRICHODERMA-REESEI; MOLECULAR-CLONING; GLYCOSYL HYDROLASES; LIGNOCELLULOSIC BIOMASS; COPTOTERMES-FORMOSANUS; GECARCOIDEA-NATALIS; CELLULASE GENES	Although many endo-beta-1,4-glucanases have been isolated in invertebrates, their cellulolytic systems are not fully understood. In particular, gastropod feeding on seaweed is considered an excellent model system for production of bioethanol and renewable bioenergy from third-generation feedstocks (microalgae and seaweeds). In this study, enzymes involved in the conversion of cellulose and other polysaccharides to glucose in digestive fluids of the sea hare (Aplysia kurodai) were screened and characterized to determine how the sea hare obtains glucose from sea lettuce (Ulva pertusa). Four endo-beta-1,4-glucanases (21 K, 45 K, 65 K, and 95 K cellulase) and 2 beta-glucosidases (110 K and 210 K) were purified to a homogeneous state, and the synergistic action of these enzymes during cellulose digestion was analyzed. All cellulases exhibited cellulase and lichenase activities and showed distinct cleavage specificities against cellooligosaccharides and filter paper. Filter paper was digested to cellobiose, cellotriose, and cellotetraose by 21 K cellulase, whereas 45 K and 65 K enzymes hydrolyzed the filter paper to cellobiose and glucose. 210 K beta-glucosidase showed unique substrate specificity against synthetic and natural substrates, and 4-methylumbelliferyl (4MU)-beta-glucoside, 4MU-beta-galactoside, cellooligosaccharides, laminarin, and lichenan were suitable substrates. Furthermore, 210 K beta-glucosidase possesses lactase activity. Although beta-glucosidase and cellulase are necessary for efficient hydrolysis of carboxymethylcellulose to glucose, laminarin is hydrolyzed to glucose only by 210 K beta-glucosidase. Kinetic analysis of the inhibition of 210 K beta-glucosidase by D-glucono-1,5-lactone suggested the presence of 2 active sites similar to those of mammalian lactase-phlorizin hydrolase. Saccharification of sea lettuce was considerably stimulated by the synergistic action of 45 K cellulase and 210 K beta-glucosidase. Our results indicate that 45 K cellulase and 210 K beta-glucosidase are the core components of the sea hare digestive system for efficient production of glucose from sea lettuce. These findings contribute important new insights into the development of biofuel processing biotechnologies from seaweed.	[Tsuji, Akihiko; Tominaga, Keiko; Nishiyama, Nami; Yuasa, Keizo] Univ Tokushima, Grad Sch, Dept Biol Sci & Technol, Tokushima 770, Japan	Tokushima University	Tsuji, A (corresponding author), Univ Tokushima, Grad Sch, Dept Biol Sci & Technol, Tokushima 770, Japan.	tsuji@bio.tokushima-u.ac.jp			University of Tokushima	University of Tokushima	This work was supported by a grant for the promotion of pilot research from The University of Tokushima. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allardyce BJ, 2010, J EXP BIOL, V213, P2950, DOI 10.1242/jeb.041582; ANZAI H, 1984, J BIOCHEM-TOKYO, V96, P1381, DOI 10.1093/oxfordjournals.jbchem.a134966; Asada C, 2012, BIOCHEM ENG J, V60, P25, DOI 10.1016/j.bej.2011.09.013; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Byeon GM, 2005, COMP BIOCHEM PHYS B, V141, P418, DOI 10.1016/j.cbpc.2005.05.001; CHEN HZ, 1992, BIOCHIM BIOPHYS ACTA, V1121, P54, DOI 10.1016/0167-4838(92)90336-C; CHIRICO WJ, 1987, EUR J BIOCHEM, V165, P333, DOI 10.1111/j.1432-1033.1987.tb11446.x; CORNISHB.A, 1974, BIOCHEM J, V137, P143, DOI 10.1042/bj1370143; Dashtban M, 2009, INT J BIOL SCI, V5, P578, DOI 10.7150/ijbs.5.578; FERREIRA C, 1983, BIOCHEM J, V213, P43, DOI 10.1042/bj2130043; Fukuda K, 2002, BIOSCI BIOTECH BIOCH, V66, P2060, DOI 10.1271/bbb.66.2060; Ganner T, 2012, J BIOL CHEM, V287, P43215, DOI 10.1074/jbc.M112.419952; Gnansounou E, 2010, BIORESOURCE TECHNOL, V101, P4980, DOI 10.1016/j.biortech.2010.02.009; Guo R, 2008, J COMP PHYSIOL B, V178, P209, DOI 10.1007/s00360-007-0214-z; Hedge J.E., 1962, METHODS CARBOHYDRATE, P380; Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; Iwamatsu A, 1996, J BIOCHEM-TOKYO, V120, P29; John RP, 2011, BIORESOURCE TECHNOL, V102, P186, DOI 10.1016/j.biortech.2010.06.139; King AJ, 2010, P NATL ACAD SCI USA, V107, P5345, DOI 10.1073/pnas.0914228107; Kobayashi H, 2012, PLOS ONE, V7; Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li YH, 2009, COMP BIOCHEM PHYS B, V153, P149, DOI 10.1016/j.cbpb.2009.02.011; Lin Y, 2006, APPL MICROBIOL BIOT, V69, P627, DOI 10.1007/s00253-005-0229-x; Linton SM, 2011, COMP BIOCHEM PHYS B, V160, P44, DOI 10.1016/j.cbpb.2011.05.007; MANTEI N, 1988, EMBO J, V7, P2705, DOI 10.1002/j.1460-2075.1988.tb03124.x; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Menetrez MY, 2012, ENVIRON SCI TECHNOL, V46, P7073, DOI 10.1021/es300917r; Nagahama T, 2009, NEUROSCI RES, V64, P243, DOI 10.1016/j.neures.2009.03.007; Nakajima N, 2011, APPL MICROBIOL BIOT, DOI [10.1007/s00253-011-3538-2, DOI 10.1007/S00253-011-3538-2]; Nelson N, 1944, J BIOL CHEM, V153, P375; Nishida Y, 2007, BIOCHIMIE, V89, P1002, DOI 10.1016/j.biochi.2007.03.015; Peterson R, 2012, MICROBIOL-SGM, V158, P58, DOI 10.1099/mic.0.054031-0; Pitson SM, 1997, ENZYME MICROB TECH, V21, P182, DOI 10.1016/S0141-0229(96)00263-3; Sakamoto K, 2009, GENE, V435, P72, DOI 10.1016/j.gene.2009.01.011; Sakamoto K, 2009, COMP BIOCHEM PHYS B, V152, P390, DOI 10.1016/j.cbpb.2009.01.010; Scharf ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021709; Scharf ME, 2010, INSECT BIOCHEM MOLEC, V40, P611, DOI 10.1016/j.ibmb.2010.06.002; SKOVBJERG H, 1981, EUR J BIOCHEM, V114, P653, DOI 10.1111/j.1432-1033.1981.tb05193.x; Suzuki K, 2003, EUR J BIOCHEM, V270, P771, DOI 10.1046/j.1432-1033.2003.03443.x; SVENNERHOLM L, 1956, J NEUROCHEM, V1, P42, DOI 10.1111/j.1471-4159.1956.tb12053.x; TANAKA A, 1989, AGR BIOL CHEM TOKYO, V53, P1401, DOI 10.1080/00021369.1989.10869468; Todaka N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008636; Tokuda G, 2002, INSECT BIOCHEM MOLEC, V32, P1681, DOI 10.1016/S0965-1748(02)00108-X; Tokuda G, 2009, INSECT BIOCHEM MOLEC, V39, P931, DOI 10.1016/j.ibmb.2009.11.003; Tsuji A, 2004, J BIOCHEM, V136, P673, DOI 10.1093/jb/mvh163; Tsuji A, 2012, COMP BIOCHEM PHYS B, V163, P324, DOI 10.1016/j.cbpb.2012.08.005; van der Wal H, 2013, BIORESOURCE TECHNOL, V128, P431, DOI 10.1016/j.biortech.2012.10.094; Wacker W, 1992, J BIOL CHEM, V267, P18744; Wu Y, 2012, INSECT MOL BIOL, V21, P604, DOI 10.1111/j.1365-2583.2012.01164.x; Yamashita Y, 2010, J BIOSCI BIOENG, V110, P79, DOI 10.1016/j.jbiosc.2009.12.009; Zhang DH, 2012, J INSECT PHYSIOL, V58, P205, DOI 10.1016/j.jinsphys.2011.11.014; Zhang DH, 2010, INSECT SCI, V17, P245, DOI 10.1111/j.1744-7917.2010.01321.x	57	28	29	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65418	10.1371/journal.pone.0065418	http://dx.doi.org/10.1371/journal.pone.0065418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762366	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000064
J	Mizanur, RM; Frasca, V; Swaminathan, S; Bavari, S; Webb, R; Smith, LA; Ahmed, SA				Mizanur, Rahman M.; Frasca, Verna; Swaminathan, Subramanyam; Bavari, Sina; Webb, Robert; Smith, Leonard A.; Ahmed, S. Ashraf			The C Terminus of the Catalytic Domain of Type A Botulinum Neurotoxin May Facilitate Product Release from the Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-STRUCTURE PIPELINE; LIGHT-CHAIN; SUBSTRATE RECOGNITION; TRYPTOPHAN SYNTHASE; SEROTYPE-A; N-TERMINUS; PROTEOLYTIC ACTIVITY; CRYSTAL-STRUCTURE; PROTEASE ACTIVITY; IDENTIFICATION	Botulinum neurotoxins are the most toxic of all compounds. The toxicity is related to a poor zinc endopeptidase activity located in a 50-kDa domain known as light chain (Lc) of the toxin. The C-terminal tail of Lc is not visible in any of the currently available x-ray structures, and it has no known function but undergoes autocatalytic truncations during purification and storage. By synthesizing C-terminal peptides of various lengths, in this study, we have shown that these peptides competitively inhibit the normal catalytic activity of Lc of serotypeA(LcA) and have defined the length of the mature LcA to consist of the first 444 residues. Two catalytically inactive mutants also inhibited LcA activity. Our results suggested that the C terminus of LcA might interact at or near its own active site. By using synthetic C-terminal peptides from LcB, LcC1, LcD, LcE, and LcF and their respective substrate peptides, we have shown that the inhibition of activity is specific only for LcA. Although a potent inhibitor with a K-i of 4.5 mu M, the largest of our LcA C-terminal peptides stimulated LcA activity when added at near-stoichiometric concentration to three versions of LcA differing in their C-terminal lengths. The result suggested a product removal role of the LcA C terminus. This suggestion is supported by a weak but specific interaction determined by isothermal titration calorimetry between an LcA C-terminal peptide and N-terminal product from a peptide substrate of LcA. Our results also underscore the importance of using a mature LcA as an inhibitor screening target.	[Mizanur, Rahman M.; Bavari, Sina; Webb, Robert; Ahmed, S. Ashraf] US Army, Integrated Toxicol Div, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Frasca, Verna] GE Healthcare Life Sci, Northampton, MA 01060 USA; [Swaminathan, Subramanyam] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Smith, Leonard A.] Off Chief Scientist, Ft Detrick, MD 20854 USA	General Electric; United States Department of Energy (DOE); Brookhaven National Laboratory	Ahmed, SA (corresponding author), US Army, Integrated Toxicol Div, Med Res Inst Infect Dis, 1425 Porter St, Ft Detrick, MD 21702 USA.	syed.ahmed@amedd.army.mil	Bavari, Sina/L-3642-2019	Bavari, Sina/0000-0001-8424-5635	Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense Grant [JSTOCBD3.10012_06_RD_B]; National Research Council	Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense Grant; National Research Council(Consiglio Nazionale delle Ricerche (CNR))	This work was supported in part by Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense Grant JSTOCBD3.10012_06_RD_B (to S. A. A.).; Supported by the National Research Council through the research associateship program.	Ahmed SA, 2008, PROTEIN J, V27, P151, DOI 10.1007/s10930-007-9118-8; AHMED SA, 1986, BIOCHEMISTRY-US, V25, P4233, DOI 10.1021/bi00363a010; Ahmed SA, 2004, PROTEIN J, V23, P445; Ahmed SA, 2003, BIOCHEMISTRY-US, V42, P12539, DOI 10.1021/bi030062c; Ahmed SA, 2001, J PROTEIN CHEM, V20, P221, DOI 10.1023/A:1010952025677; AHMED SA, 1987, BIOCHEMISTRY-US, V26, P5492, DOI 10.1021/bi00391a042; Angelucci F, 2009, J BIOL CHEM, V284, P28977, DOI 10.1074/jbc.M109.020701; Baldwin MR, 2004, PROTEIN EXPRES PURIF, V37, P187, DOI 10.1016/j.pep.2004.05.009; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Burnett JC, 2009, BIOORG MED CHEM LETT, V19, P5811, DOI 10.1016/j.bmcl.2009.01.111; Burnett JC, 2007, J BIOL CHEM, V282, P5004, DOI 10.1074/jbc.M608166200; Chen S, 2006, J BIOL CHEM, V281, P10906, DOI 10.1074/jbc.M513032200; DasGupta BR, 2005, PROTEIN J, V24, P337, DOI 10.1007/s10930-005-7589-z; DASGUPTA BR, 1990, BIOCHIMIE, V72, P661, DOI 10.1016/0300-9084(90)90048-L; Eubanks LM, 2007, P NATL ACAD SCI USA, V104, P2602, DOI 10.1073/pnas.0611213104; FORAN P, 1994, BIOCHEMISTRY-US, V33, P15365, DOI 10.1021/bi00255a017; Gilsdorf J, 2006, PROTEIN EXPRES PURIF, V46, P256, DOI 10.1016/j.pep.2005.09.024; Hale M, 2011, J BIOL CHEM, V286, P1802, DOI 10.1074/jbc.M110.146464; Henkel JS, 2009, BIOCHEMISTRY-US, V48, P2522, DOI 10.1021/bi801686b; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jensen MJ, 2003, TOXICON, V41, P691, DOI 10.1016/S0041-0101(03)00042-4; KRIEGLSTEIN KG, 1994, J PROTEIN CHEM, V13, P49, DOI 10.1007/BF01891992; Kucera NJ, 2011, P NATL ACAD SCI USA, V108, P1308, DOI 10.1073/pnas.1017085108; Kumaran D, 2008, J BIOL CHEM, V283, P18883, DOI 10.1074/jbc.M801240200; Kumaran D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000165; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Liu ZJ, 2005, ACTA CRYSTALLOGR D, V61, P679, DOI 10.1107/S0907444905013132; MacDonald JA, 2012, BIOCHEMISTRY-US, V51, P2694, DOI 10.1021/bi2019018; Mathews C. K., 1990, BIOCHEMISTRY-US, P339; Mizanur Rahman M, 2012, Int J Biochem Mol Biol, V3, P313; Molles B. E., 2010, 40 INT BOT RES COORD; Montecucco C, 1995, Q REV BIOPHYS, V28, P423, DOI 10.1017/S0033583500003292; Nilsson Lisa O, 2002, Biochim Biophys Acta, V1598, P199, DOI 10.1016/S0167-4838(02)00362-X; Peng DG, 2010, BIOCHEMISTRY-US, V49, P5832, DOI 10.1021/bi1000867; Rawat R, 2008, PROTEIN EXPRES PURIF, V60, P165, DOI 10.1016/j.pep.2008.03.010; Rowe B, 2010, ANAL BIOCHEM, V396, P188, DOI 10.1016/j.ab.2009.09.034; Segelke B, 2004, P NATL ACAD SCI USA, V101, P6888, DOI 10.1073/pnas.0400584101; Silhar P, 2013, ACS MED CHEM LETT, V4, P283, DOI 10.1021/ml300428s; Silvaggi NR, 2008, BIOCHEMISTRY-US, V47, P5736, DOI 10.1021/bi8001067; Silvaggi NR, 2007, CHEM BIOL, V14, P533, DOI 10.1016/j.chembiol.2007.03.014; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Sugahara Michihiro, 2008, Journal of Structural and Functional Genomics, V9, P21, DOI 10.1007/s10969-008-9042-y; Thompson AA, 2011, BIOCHEMISTRY-US, V50, P4019, DOI 10.1021/bi2001483; Toth SI, 2009, J PHARM SCI-US, V98, P3302, DOI 10.1002/jps.21676; Velazquez-Campoy Adrian, 2004, Methods Mol Biol, V261, P35; Weber-Ban E, 2001, BIOCHEMISTRY-US, V40, P3497, DOI 10.1021/bi002690p	48	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24223	24233		10.1074/jbc.M113.451286	http://dx.doi.org/10.1074/jbc.M113.451286			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23779108	Green Published, hybrid			2022-12-25	WOS:000330611400060
J	Roche, CJ; Cassera, MB; Dantsker, D; Hirsch, RE; Friedman, JM				Roche, Camille J.; Cassera, Maria B.; Dantsker, David; Hirsch, Rhoda Elison; Friedman, Joel M.			Generating S-Nitrosothiols from Hemoglobin MECHANISMS, CONFORMATIONAL DEPENDENCE, AND PHYSIOLOGICAL RELEVANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRITE REDUCTASE-ACTIVITY; RED-BLOOD-CELLS; HYPOXIC VASODILATION; SUSTAINED-RELEASE; OXYGEN DELIVERY; MET HEMOGLOBIN; T-STATE; OXIDE; DEOXYHEMOGLOBIN; NO	In vitro, ferrous deoxy-hemes in hemoglobin (Hb) react with nitrite to generate nitric oxide (NO) through a nitrite reductase reaction. In vivo studies indicate Hb with nitrite can be a source of NO bioactivity. The nitrite reductase reaction does not appear to account fully for this activity because free NO is short lived especially within the red blood cell. Thus, the exporting of NO bioactivity both out of the RBC and over a large distance requires an additional mechanism. A nitrite anhydrase (NA) reaction in which N2O3, a potent S-nitrosating agent, is produced through the reaction of NO with ferric heme-bound nitrite has been proposed (Basu, S., Grubina, R., Huang, J., Conradie, J., Huang, Z., Jeffers, A., Jiang, A., He, X., Azarov, I., Seibert, R., Mehta, A., Patel, R., King, S. B., Hogg, N., Ghosh, A., Gladwin, M. T., and Kim-Shapiro, D. B. (2007) Nat. Chem. Biol. 3, 785-794) as a possible mechanism. Legitimate concerns, including physiological relevance and the nature of the mechanism, have been raised concerning the NA reaction. This study addresses these concerns demonstrating NO and nitrite with ferric hemes under near physiological conditions yield an intermediate having the properties of the purported NA heme-bound N2O3 intermediate. The results indicate that ferric heme sites, traditionally viewed as a source of potential toxicity, can be functionally significant, especially for partially oxygenated/partially met-R state Hb that arises from the NO dioxygenation reaction. In the presence of low levels of nitrite and either NO or a suitable reductant such as L-cysteine, these ferric heme sites can function as a generator for the formation of S-nitrosothiols such as S-nitrosoglutathione and, as such, should be considered as a source of RBC-derived and exportable bioactive NO.	[Roche, Camille J.; Dantsker, David; Hirsch, Rhoda Elison; Friedman, Joel M.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Cassera, Maria B.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Hirsch, Rhoda Elison] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Hirsch, Rhoda Elison] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Friedman, JM (corresponding author), Albert Einstein Coll Med, Dept Physiol & Biophys, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	joel.friedman@einstein.yu.edu			National Institutes of Health [P01-HL110900-01A1, P01-HL071064, R21HL 106421]; FJC, a foundation of philanthropic funds; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019352] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110900, P01HL071064, R21HL106421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FJC, a foundation of philanthropic funds; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01-HL110900-01A1, P01-HL071064, and R21HL 106421. This work was also supported by FJC, a foundation of philanthropic funds.	Allen BW, 2009, TRENDS MOL MED, V15, P452, DOI 10.1016/j.molmed.2009.08.002; Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; Balazy M, 1998, J BIOL CHEM, V273, P32009, DOI 10.1074/jbc.273.48.32009; Balcerczyk A, 2005, FREE RADICAL BIO MED, V39, P327, DOI 10.1016/j.freeradbiomed.2005.03.017; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; Bonaventura C, 2013, ANTIOXID REDOX SIGN, V18, P2298, DOI 10.1089/ars.2012.4947; Cabrales P, 2005, AM J PHYSIOL-HEART C, V289, pH2392, DOI 10.1152/ajpheart.00225.2005; CABRALES P., 2007, TRANSFUS ALTERN TRAN, V9, P281; Cabrales P, 2013, ANTIOXID REDOX SIGN, V18, P2284, DOI 10.1089/ars.2012.5099; Cabrales P, 2011, AM J PHYSIOL-HEART C, V300, pH49, DOI 10.1152/ajpheart.00665.2010; Cabrales P, 2010, FREE RADICAL BIO MED, V49, P530, DOI 10.1016/j.freeradbiomed.2010.04.034; Cantu-Medellin N, 2011, NITRIC OXIDE-BIOL CH, V25, P59, DOI 10.1016/j.niox.2011.01.006; Chen KJ, 2008, NITRIC OXIDE-BIOL CH, V18, P47, DOI 10.1016/j.niox.2007.09.088; Chen QY, 2012, BLOOD CELL MOL DIS, V48, P91, DOI 10.1016/j.bcmd.2011.12.002; Chen QY, 2004, BLOOD CELL MOL DIS, V33, P303, DOI 10.1016/j.bcmd.2004.07.006; Chen ZZ, 2012, ANAL CHEM, V84, P4687, DOI 10.1021/ac300255n; Cortese-Krott MM, 2012, BLOOD, V120, P4229, DOI 10.1182/blood-2012-07-442277; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Crawford JH, 2006, BLOOD, V107, P566, DOI 10.1182/blood-2005-07-2668; Diesen DL, 2008, CIRC RES, V103, P545, DOI 10.1161/CIRCRESAHA.108.176867; Doctor A, 2005, P NATL ACAD SCI USA, V102, P5709, DOI 10.1073/pnas.0407490102; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Fernandez BO, 2004, INORG CHEM, V43, P5393, DOI 10.1021/ic049532x; Fernandez BO, 2003, J AM CHEM SOC, V125, P10510, DOI 10.1021/ja036693b; Fernandez BO, 2003, INORG CHEM, V42, P2, DOI 10.1021/ic020519r; Ford PC, 2010, INORG CHEM, V49, P6226, DOI 10.1021/ic902073z; Foster MW, 2005, HYPERTENSION, V45, P15, DOI 10.1161/01.HYP.0000150160.41992.71; Foster MW, 2003, TRENDS MOL MED, V9, P160, DOI 10.1016/S1471-4914(03)00028-5; Gaston B, 2006, AM J RESP CRIT CARE, V173, P1186, DOI 10.1164/rccm.200510-1584PP; Gladwin M. T., 2008, ACCOUNTS CHEM RES, V47, P6059; Gladwin MT, 2008, BLOOD, V112, P2636, DOI 10.1182/blood-2008-01-115261; Gladwin MT, 2012, NATURE, V491, P344, DOI 10.1038/nature11640; Gladwin MT, 2009, ACCOUNTS CHEM RES, V42, P157, DOI 10.1021/ar800089j; Gladwin MT, 2005, AM J RESP CELL MOL, V32, P363, DOI 10.1165/rcmb.F294; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; Gladwin MT, 2005, NAT CHEM BIOL, V1, P308, DOI 10.1038/nchembio1105-308; Gow AJ, 1998, NATURE, V391, P169, DOI 10.1038/34402; Gow AJ, 2006, BLOOD, V108, P3224, DOI 10.1182/blood-2006-05-023572; Grubina R, 2008, J BIOL CHEM, V283, P3628, DOI 10.1074/jbc.M705222200; Grubina R, 2007, J BIOL CHEM, V282, P12916, DOI 10.1074/jbc.M700546200; Haldar SM, 2013, J CLIN INVEST, V123, P101, DOI 10.1172/JCI62854; Helms C, 2013, FREE RADICAL BIO MED, V61, P464, DOI 10.1016/j.freeradbiomed.2013.04.028; Hogg N, 2002, ANNU REV PHARMACOL, V42, P585, DOI 10.1146/annurev.pharmtox.42.092501.104328; Hopmann KH, 2011, CHEM-EUR J, V17, P6348, DOI 10.1002/chem.201003578; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Ignarro LJ, 2009, NITRIC OXIDE BIOL PA; Ignarro LJ, 2000, NITRIC OXIDE BIOL PA; Isbell TS, 2007, AM J PHYSIOL-HEART C, V293, pH2565, DOI 10.1152/ajpheart.00759.2007; Itoh Y, 2000, ANAL BIOCHEM, V287, P203, DOI 10.1006/abio.2000.4859; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Khan I, 2001, BIOCHEMISTRY-US, V40, P7581, DOI 10.1021/bi010051o; Khan I, 2000, BIOCHEMISTRY-US, V39, P16099, DOI 10.1021/bi000536x; Kim-Shapiro DB, 2005, J INORG BIOCHEM, V99, P237, DOI 10.1016/j.jinorgbio.2004.10.034; Kim-Shapiro DB, 2006, ARTERIOSCL THROM VAS, V26, P697, DOI 10.1161/01.ATV.0000204350.44226.9a; Kluger R, 2010, CURR OPIN CHEM BIOL, V14, P538, DOI 10.1016/j.cbpa.2010.03.021; LALEZARI I, 1990, BIOCHEMISTRY-US, V29, P1515, DOI 10.1021/bi00458a024; Lima B, 2010, CIRC RES, V106, P633, DOI 10.1161/CIRCRESAHA.109.207381; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Luchsinger BP, 2005, J INORG BIOCHEM, V99, P912, DOI 10.1016/j.jinorgbio.2004.12.010; Lui FE, 2008, BIOCHEMISTRY-US, V47, P10773, DOI 10.1021/bi801116k; Lui FE, 2009, BIOCHEMISTRY-US, V48, P11912, DOI 10.1021/bi9014105; Lundberg JO, 2009, NAT CHEM BIOL, V5, P865, DOI 10.1038/nchembio.260; Mayer B, 2000, NITRIC OXIDE; McMahon TJ, 1999, METHOD ENZYMOL, V301, P99; Nachuraju P, 2011, RESUSCITATION, V82, P607, DOI 10.1016/j.resuscitation.2010.12.025; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; Nagababu E, 2006, NITRIC OXIDE-BIOL CH, V15, P20, DOI 10.1016/j.niox.2006.01.012; Nagababu E, 2007, BIOCHEMISTRY-US, V46, P11650, DOI 10.1021/bi700364e; Namin SM, 2013, NITRIC OXIDE-BIOL CH, V28, P39, DOI 10.1016/j.niox.2012.10.001; Navati MS, 2010, J PHYS CHEM B, V114, P2938, DOI 10.1021/jp909425z; Navati MS, 2009, J AM CHEM SOC, V131, P12273, DOI 10.1021/ja903364h; Olson JS, 2004, FREE RADICAL BIO MED, V36, P685, DOI 10.1016/j.freeradbiomed.2003.11.030; Planchet E, 2006, J EXP BOT, V57, P3043, DOI 10.1093/jxb/erl070; Rifkind JM, 2006, ANTIOXID REDOX SIGN, V8, P1193, DOI 10.1089/ars.2006.8.1193; Rifkind JM, 2011, NITRIC OXIDE-BIOL CH, V24, P102, DOI 10.1016/j.niox.2011.01.001; Roche CJ, 2006, J BIOL CHEM, V281, P36874, DOI 10.1074/jbc.M603914200; Roche CJ, 2012, NITRIC OXIDE-BIOL CH, V27, P32, DOI 10.1016/j.niox.2012.04.002; Roche CJ, 2011, J BIOL CHEM, V286, P23452, DOI 10.1074/jbc.M110.183186; Roche CJ, 2010, NITRIC OXIDE-BIOL CH, V22, P180, DOI 10.1016/j.niox.2009.11.003; Salgado MT, 2011, J AM CHEM SOC, V133, P13010, DOI 10.1021/ja1115088; Salgado MT, 2009, J BIOL CHEM, V284, P12710, DOI 10.1074/jbc.M808647200; Samuni U, 2006, BIOCHEMISTRY-US, V45, P2820, DOI 10.1021/bi050010i; Samuni U, 2004, BIOCHEMISTRY-US, V43, P13674, DOI 10.1021/bi048531d; Samuni U, 2003, BIOCHEMISTRY-US, V42, P8272, DOI 10.1021/bi020648j; Samuni U, 2007, J AM CHEM SOC, V129, P12756, DOI 10.1021/ja072342b; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Stamler J S, 1995, Curr Top Microbiol Immunol, V196, P19; Stamler JS, 2008, NAT MED, V14, P1008, DOI 10.1038/nm1008-1008; Stamler JS, 2003, NEW ENGL J MED, V349, P402; Straub AC, 2012, NATURE, V491, P473, DOI 10.1038/nature11626; Tejero J, 2012, J BIOL CHEM, V287, P18262, DOI 10.1074/jbc.M111.298927; Totzeck M, 2012, CIRCULATION, V126, P325, DOI 10.1161/CIRCULATIONAHA.111.087155; Tsai AG, 2006, BLOOD, V108, P3603, DOI 10.1182/blood-2006-02-005272; Tullett JM, 2001, BIOCHEM PHARMACOL, V62, P1239, DOI 10.1016/S0006-2952(01)00750-X; Wanat A, 2002, J BIOL INORG CHEM, V7, P165, DOI 10.1007/s007750100284; Wang XD, 2004, P NATL ACAD SCI USA, V101, P11477, DOI 10.1073/pnas.0402201101; Yi J, 2008, BIOCHEMISTRY-US, V47, P8247, DOI 10.1021/bi801015c; Yi J, 2009, J AM CHEM SOC, V131, P18119, DOI 10.1021/ja904726q; Yurcisin BM, 2013, ANN SURG, V257, P971, DOI 10.1097/SLA.0b013e3182822c52	101	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22408	22425		10.1074/jbc.M113.482679	http://dx.doi.org/10.1074/jbc.M113.482679			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23775069	hybrid, Green Published			2022-12-25	WOS:000330596300023
J	Perzlmaier, AF; Richter, F; Seufert, W				Perzlmaier, Angelika F.; Richter, Frank; Seufert, Wolfgang			Translation Initiation Requires Cell Division Cycle 123 (Cdcl23) to Facilitate Biogenesis of the Eukaryotic Initiation Factor 2 (elF2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Molecular Biology; Protein Assembly; Protein Synthesis; Protein-Protein Interactions; Translation Initiation Factors; Yeast Genetics; Cdc123; eIF2; Translation Initiation	SACCHAROMYCES-CEREVISIAE; PROTEIN COMPLEXES; EXPRESSION; SEQUENCE; SUBUNIT; ENCODES; ASSOCIATION; INTERACTOME; MECHANISM; SELECTION	The eukaryotic translation initiation factor 2 (eIF2) is central to the onset of protein synthesis and its modulation in response to physiological demands. eIF2, a heterotrimeric G-protein, is activated by guanine nucleotide exchange to deliver the initiator methionyl-tRNA to the ribosome. Here we report that assembly of the eIF2 complex in vivo depends on Cdc123, a cell proliferation protein conserved among eukaryotes. Mutations of CDC123 in budding yeast reduced the association of eIF2 subunits, diminished polysome levels, and increased GCN4 expression indicating that Cdc123 is critical for eIF2 activity. Cdc123 bound the unassembled eIF2 subunit, but not the eIF2 complex, and the C-terminal domain III region of eIF2 was both necessary and sufficient for Cdc123 binding. Alterations of the binding site revealed a strict correlation between Cdc123 binding, the biological function of eIF2, and its ability to assemble with eIF2 and eIF2. Interestingly, high levels of Cdc123 neutralized the assembly defect and restored the biological function of an eIF2 mutant. Moreover, the combined overexpression of eIF2 subunits rescued an otherwise inviable cdc123 deletion mutant. Thus, Cdc123 is a specific eIF2 assembly factor indispensable for the onset of protein synthesis. Human Cdc123 is encoded by a disease risk locus, and, therefore, eIF2 biogenesis control by Cdc123 may prove relevant for normal cell physiology and human health. This work identifies a novel step in the eukaryotic translation initiation pathway and assigns a biochemical function to a protein that is essential for growth and viability of eukaryotic cells.	[Perzlmaier, Angelika F.; Seufert, Wolfgang] Univ Regensburg, Dept Genet, D-93040 Regensburg, Germany; [Richter, Frank] Univ Stuttgart, Inst Ind Genet, D-70569 Stuttgart, Germany	University of Regensburg; University of Stuttgart	Seufert, W (corresponding author), Univ Regensburg, Dept Genet, D-93040 Regensburg, Germany.	Wolfgang.Seufert@ur.de	Seufert, Wolfgang/F-7136-2019	Seufert, Wolfgang/0000-0001-8938-9064				Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Alone PV, 2006, J BIOL CHEM, V281, P12636, DOI 10.1074/jbc.M511700200; Ausubel F.M., 1998, CURRENT PROTOCOLS MO; Bieganowski P, 2004, J BIOL CHEM, V279, P44656, DOI 10.1074/jbc.M406151200; Borck G, 2012, MOL CELL, V48, P641, DOI 10.1016/j.molcel.2012.09.005; BRENNER C, 1988, MOL CELL BIOL, V8, P3556, DOI 10.1128/MCB.8.8.3556; Carr-Schmid A, 1999, MOL CELL BIOL, V19, P5257; CIGAN AM, 1989, P NATL ACAD SCI USA, V86, P2784, DOI 10.1073/pnas.86.8.2784; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; HANICJOYCE PJ, 1987, EXP CELL RES, V172, P134, DOI 10.1016/0014-4827(87)90100-5; HANNIG EM, 1993, MOL CELL BIOL, V13, P506, DOI 10.1128/MCB.13.1.506; Hashimoto NN, 2002, BIOCHEM J, V367, P359, DOI 10.1042/BJ20020556; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; HINNEBUSCH AG, 1985, MOL CELL BIOL, V5, P2349, DOI 10.1128/MCB.5.9.2349; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hinnebusch AG, 2011, MICROBIOL MOL BIOL R, V75, P434, DOI 10.1128/MMBR.00008-11; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hoja MR, 2000, EXP CELL RES, V259, P239, DOI 10.1006/excr.2000.4948; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorsch JR, 2010, J BIOL CHEM, V285, P21203, DOI 10.1074/jbc.R110.119743; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; OHNO K, 1984, INT J QUANTUM CHEM, P1; Okuda A, 1996, EXP CELL RES, V223, P242, DOI 10.1006/excr.1996.0078; Sagliocco F A, 1996, Methods Mol Biol, V53, P297; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Schmitt E, 2002, EMBO J, V21, P1821, DOI 10.1093/emboj/21.7.1821; Schmitt E, 2010, FEBS LETT, V584, P405, DOI 10.1016/j.febslet.2009.11.002; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIKORSKI RS, 1989, GENETICS, V122, P19; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; von der Haar T, 2002, MOL MICROBIOL, V46, P531, DOI 10.1046/j.1365-2958.2002.03172.x; Wegerer A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-2; Wiese A, 2001, APPL MICROBIOL BIOT, V55, P750, DOI 10.1007/s002530000574; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	45	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21537	21546		10.1074/jbc.M113.472290	http://dx.doi.org/10.1074/jbc.M113.472290			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23775072	Green Published, hybrid			2022-12-25	WOS:000328841900007
J	Everett, C				Everett, Caleb			Evidence for Direct Geographic Influences on Linguistic Sounds: The Case of Ejectives	PLOS ONE			English	Article							ALTITUDE; SONORITY; POPULATION; CONSONANTS; LANGUAGES; CLIMATE	We present evidence that the geographic context in which a language is spoken may directly impact its phonological form. We examined the geographic coordinates and elevations of 567 language locations represented in a worldwide phonetic database. Languages with phonemic ejective consonants were found to occur closer to inhabitable regions of high elevation, when contrasted to languages without this class of sounds. In addition, the mean and median elevations of the locations of languages with ejectives were found to be comparatively high. The patterns uncovered surface on all major world landmasses, and are not the result of the influence of particular language families. They reflect a significant and positive worldwide correlation between elevation and the likelihood that a language employs ejective phonemes. In addition to documenting this correlation in detail, we offer two plausible motivations for its existence. We suggest that ejective sounds might be facilitated at higher elevations due to the associated decrease in ambient air pressure, which reduces the physiological effort required for the compression of air in the pharyngeal cavity-a unique articulatory component of ejective sounds. In addition, we hypothesize that ejective sounds may help to mitigate rates of water vapor loss through exhaled air. These explications demonstrate how a reduction of ambient air density could promote the usage of ejective phonemes in a given language. Our results reveal the direct influence of a geographic factor on the basic sound inventories of human languages.	Univ Miami, Dept Anthropol, Coral Gables, FL 33124 USA	University of Miami	Everett, C (corresponding author), Univ Miami, Dept Anthropol, Coral Gables, FL 33124 USA.	caleb@miami.edu			University of Miami	University of Miami	This research was funded by salary from the University of Miami. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, PHONOLOGY COGNITIVE; Atkinson QD, 2011, SCIENCE, V332, P346, DOI 10.1126/science.1199295; Beall CM, 2003, LANCET, V362, pS14, DOI 10.1016/S0140-6736(03)15058-1; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Boersma P., 2013, PRAAT DOING PHONETIC; Brown Cecil H., 2011, WORLD ATLAS LANGUAGE; Catford I, 1974, NATURAL SOUND CHANGE, P21; Cohen JE, 1998, P NATL ACAD SCI USA, V95, P14009, DOI 10.1073/pnas.95.24.14009; Comrie B, 2011, WORLD ATLAS LANGUAGE; Debley JS, 2011, CHEST, V139, P16, DOI 10.1378/chest.10-0101; Demolin D, 2002, PHONOL PHONET, V4-1, P455; Donohue M, 2011, LINGUIST TYPOL, V15, P161, DOI [10.1515/lity.2011.011, DOI 10.1515/LITY.2011.011, DOI 10.1515/LITY.20]; Ember CR, 2007, AM ANTHROPOL, V109, P180, DOI 10.1525/AA.2007.109.1.180; Fallon P., 2002, SYNCHRONIC DIACHRONI; Fought JG, 2004, CROSS-CULT RES, V38, P27, DOI 10.1177/1069397103259439; GREENBERG JH, 1970, INT J AM LINGUIST, V36, P123, DOI 10.1086/465105; Hay J, 2007, LANGUAGE, V83, P388, DOI 10.1353/lan.2007.0071; Javkin H, 1977, BERKELEY LINGUISTICS, V3, P557; Kingston John C., 1985, DISSERTATION; Lewis Paul M., 2009, ETHNOLOGUE; Liberman M, 2008, LANGUAGE LOG PO 0511; Lupyan G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008559; Maddieson, 1996, SOUNDS WORLDS LANGUA; Maddieson I, 2011, WORLD ATLAS LANGUAGE; Munroe RL, 2009, CROSS-CULT RES, V43, P123, DOI 10.1177/1069397109331485; Nettle D, 2012, PHILOS T R SOC B, V367, P1829, DOI 10.1098/rstb.2011.0216; SUSSMAN HM, 1991, J ACOUST SOC AM, V90, P1309, DOI 10.1121/1.401923	27	47	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65275	10.1371/journal.pone.0065275	http://dx.doi.org/10.1371/journal.pone.0065275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	163FW	23776463	gold, Green Published, Green Submitted			2022-12-25	WOS:000320322400013
J	Li, L; Wang, Y; Lin, MK; Yuan, GH; Yang, GB; Zheng, YQ; Chen, YP				Li, Lu; Wang, Ying; Lin, Minkui; Yuan, Guohua; Yang, Guobin; Zheng, Yuqian; Chen, YiPing			Augmented BMPRIA-Mediated BMP Signaling in Cranial Neural Crest Lineage Leads to Cleft Palate Formation and Delayed Tooth Differentiation	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN-RECEPTOR; CELL-PROLIFERATION; JUVENILE POLYPOSIS; SECONDARY PALATE; DENTIN FORMATION; MICE EXHIBIT; EXPRESSION; NOGGIN; MESENCHYME; INDUCTION	The importance of BMP receptor Ia (BMPRIa) mediated signaling in the development of craniofacial organs, including the tooth and palate, has been well illuminated in several mouse models of loss of function, and by its mutations associated with juvenile polyposis syndrome and facial defects in humans. In this study, we took a gain-of-function approach to further address the role of BMPR-IA-mediated signaling in the mesenchymal compartment during tooth and palate development. We generated transgenic mice expressing a constitutively active form of BmprIa (caBmprIa) in cranial neural crest (CNC) cells that contributes to the dental and palatal mesenchyme. Mice bearing enhanced BMPRIa-mediated signaling in CNC cells exhibit complete cleft palate and delayed odontogenic differentiation. We showed that the cleft palate defect in the transgenic animals is attributed to an altered cell proliferation rate in the anterior palatal mesenchyme and to the delayed palatal elevation in the posterior portion associated with ectopic cartilage formation. Despite enhanced activity of BMP signaling in the dental mesenchyme, tooth development and patterning in transgenic mice appeared normal except delayed odontogenic differentiation. These data support the hypothesis that a finely tuned level of BMPRIa-mediated signaling is essential for normal palate and tooth development.	[Li, Lu; Wang, Ying; Lin, Minkui; Yuan, Guohua; Yang, Guobin; Zheng, Yuqian; Chen, YiPing] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Wang, Ying] Fourth Mil Med Univ, Coll Stomatol, Dept Operat Dent & Endodont, Xian 710032, Shaanxi, Peoples R China; [Lin, Minkui; Zheng, Yuqian] Fujian Med Univ, Coll Stomatol, Dept Periodontol, Fuzhou, Fujian Province, Peoples R China; [Yuan, Guohua; Yang, Guobin] Wuhan Univ, Coll Stomatol, Dept Pediat Dent, Wuhan 430072, Hubei Province, Peoples R China	Tulane University; Air Force Military Medical University; Fujian Medical University; Wuhan University	Chen, YP (corresponding author), Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA.	ychen@tulane.edu			China Scholarship Council; Fourth Military Medical University College of Stomatology, P.R. China; Department of Health, Fujian Province, P.R. China; NIH [R01DE14044]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014044] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); Fourth Military Medical University College of Stomatology, P.R. China; Department of Health, Fujian Province, P.R. China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	LL was funded by a China Scholarship Council grant. YW was supported by a fellowship from the Fourth Military Medical University College of Stomatology, P.R. China. ML was supported by a fellowship from the Department of Health, Fujian Province, P.R. China. This work was supported by NIH grant R01DE14044 to YPC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alappat SR, 2005, DEV BIOL, V277, P102, DOI 10.1016/j.ydbio.2004.09.010; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Baek JA, 2011, DEV BIOL, V350, P520, DOI 10.1016/j.ydbio.2010.12.028; Baur ST, 2000, DEVELOPMENT, V127, P605; Bei M, 2009, J EXP ZOOL PART B, V312B, P437, DOI 10.1002/jez.b.21261; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Chen YP, 1996, DEVELOPMENT, V122, P3035; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Delnatte C, 2006, AM J HUM GENET, V78, P1066, DOI 10.1086/504301; Dudas M, 2006, DEV BIOL, V296, P298, DOI 10.1016/j.ydbio.2006.05.030; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; He FL, 2010, DEV BIOL, V347, P109, DOI 10.1016/j.ydbio.2010.08.014; Hilliard SA, 2005, J ANAT, V207, P655, DOI 10.1111/j.1469-7580.2005.00474.x; Hosoya A, 2008, CELL TISSUE RES, V333, P503, DOI 10.1007/s00441-008-0655-z; Hu X, 2012, J DENT RES, V91, P394, DOI 10.1177/0022034511435939; Huang XF, 2010, J BONE MINER RES, V25, P1167, DOI 10.1359/jbmr.091103; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Iwata J, 2012, J BIOL CHEM, V287, P2353, DOI 10.1074/jbc.M111.280974; Jacoby RF, 1997, AM J MED GENET, V70, P361, DOI 10.1002/(SICI)1096-8628(19970627)70:4<361::AID-AJMG6>3.0.CO;2-W; Jernvall J, 1998, DEVELOPMENT, V125, P161; Jussila M, 2013, STEM CELLS IN CRANIOFACIAL DEVELOPMENT AND REGENERATION, P109; Komatsu Y, 2012, J BONE MINER RES, DOI [10.1002/jbmr.1857, DOI 10.1002/JBMR.1857.(EPUB]; Lana-Elola E, 2011, HUM MOL GENET, V20, P4005, DOI 10.1093/hmg/ddr329; Li J, 2011, DEVELOPMENT, V138, P1799; Li L, 2011, DEV BIOL, V349, P451, DOI 10.1016/j.ydbio.2010.10.023; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Lu HB, 2000, ARCH ORAL BIOL, V45, P133, DOI 10.1016/S0003-9969(99)00118-1; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Menko FH, 2008, CLIN GENET, V74, P145, DOI 10.1111/j.1399-0004.2008.01026.x; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; NAKASHIMA M, 1994, J DENT RES, V73, P1515, DOI 10.1177/00220345940730090601; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; Nie XG, 2006, INT J DEV BIOL, V50, P511, DOI 10.1387/ijdb.052101.xn; O'Connell DJ, 2013, STEM CELLS IN CRANIOFACIAL DEVELOPMENT AND REGENERATION, P179; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; RUTHERFORD RB, 1994, ARCH ORAL BIOL, V39, P833, DOI 10.1016/0003-9969(94)90014-0; Saito H, 2012, DIS MODEL MECH, V5, P948, DOI 10.1242/dmm.009274; St Amand TR, 2000, DEV BIOL, V217, P323, DOI 10.1006/dbio.1999.9547; Stottmann RW, 2001, DEV BIOL, V240, P457, DOI 10.1006/dbio.2001.0479; Tucker AS, 1998, SCIENCE, V282, P1136, DOI 10.1126/science.282.5391.1136; Wang XP, 2004, DEV DYNAM, V231, P98, DOI 10.1002/dvdy.20118; Wang Y, 2012, J DENT RES, V91, P690, DOI 10.1177/0022034512448660; Yamashiro T, 2003, J DENT RES, V82, P172, DOI 10.1177/154405910308200305; Yao SM, 2010, CONNECT TISSUE RES, V51, P59, DOI 10.3109/03008200903019703; Yi SE, 2000, DEVELOPMENT, V127, P621; Yu L, 2005, DEVELOPMENT, V132, P4397, DOI 10.1242/dev.02013; Zhang YD, 2000, DEVELOPMENT, V127, P1431; Zhang YD, 2003, DEV DYNAM, V226, P713, DOI 10.1002/dvdy.10274; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zhao X, 2000, MECH DEVELOP, V99, P29, DOI 10.1016/S0925-4773(00)00467-6; Zhou XP, 2001, AM J HUM GENET, V69, P704, DOI 10.1086/323703	51	28	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66107	10.1371/journal.pone.0066107	http://dx.doi.org/10.1371/journal.pone.0066107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776616	Green Submitted, gold, Green Published			2022-12-25	WOS:000320322400081
J	Fiume, G; Rossi, A; de Laurentiis, A; Falcone, C; Pisano, A; Vecchio, E; Pontoriero, M; Scala, I; Scialdone, A; Masci, FF; Mimmi, S; Palmieri, C; Scala, G; Quinto, I				Fiume, Giuseppe; Rossi, Annalisa; de laurentiis, Annamaria; Falcone, Cristina; Pisano, Antonio; Vecchio, Eleonora; Pontoriero, Marilena; Scala, Iris; Scialdone, Annarita; Masci, Francesca Fasanella; Mimmi, Selena; Palmieri, Camillo; Scala, Giuseppe; Quinto, Ileana			Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-kappa B	PLOS ONE			English	Article							NF-KAPPA-B; RNA HELICASE ACTIVITY; TRANSLATION INITIATION; MESSENGER-RNA; KINETIC CHARACTERIZATION; PROTEIN-KINASE; IMMUNE-SYSTEM; PHOSPHORYLATION; INHIBITOR; GROWTH	Protein synthesis is mainly regulated at the initiation step, allowing the fast, reversible and spatial control of gene expression. Initiation of protein synthesis requires at least 13 translation initiation factors to assemble the 80S ribosomal initiation complex. Loss of translation control may result in cell malignant transformation. Here, we asked whether translational initiation factors could be regulated by NF-kappa B transcription factor, a major regulator of genes involved in cell proliferation, survival, and inflammatory response. We show that the p65 subunit of NF-kB activates the transcription of eIF4H gene, which is the regulatory subunit of eIF4A, the most relevant RNA helicase in translation initiation. The p65-dependent transcriptional activation of eIF4H increased the eIF4H protein content augmenting the rate of global protein synthesis. In this context, our results provide novel insights into protein synthesis regulation in response to NF-kB activation signalling, suggesting a transcription-translation coupled mechanism of control.	[Fiume, Giuseppe; Rossi, Annalisa; de laurentiis, Annamaria; Falcone, Cristina; Pisano, Antonio; Vecchio, Eleonora; Pontoriero, Marilena; Scialdone, Annarita; Masci, Francesca Fasanella; Mimmi, Selena; Palmieri, Camillo; Scala, Giuseppe; Quinto, Ileana] Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Catanzaro, Italy; [Scala, Iris] Univ Naples Federico II, Dept Pediat, Naples, Italy; [Quinto, Ileana] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy	Magna Graecia University of Catanzaro; University of Naples Federico II; University of Naples Federico II	Fiume, G (corresponding author), Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Catanzaro, Italy.	fiume@unicz.it; scala@unicz.it; quinto@unicz.it	vecchio, eleonora/AAT-4287-2020; Mimmi, Selena/AAB-9585-2019; Falcone, Cristina/AAP-9529-2020; Mimmi, Selena/J-7860-2016; Palmieri, Camillo/A-3195-2009	Mimmi, Selena/0000-0003-2187-9176; Mimmi, Selena/0000-0003-2187-9176; QUINTO, Ileana/0000-0001-8212-8515; Palmieri, Camillo/0000-0001-6707-4723; Scala, Iris/0000-0003-2725-437X; FIUME, Giuseppe/0000-0002-5414-6190	Ministero dell'Istruzione, dell'Universita e della Ricerca [PON01_02782, PON01_00862]; Ministero della Salute [RF-2010-2306943, GR-2009-1606801]; Associazione Italiana per la Ricerca sul Cancro [IG-2009-9411]; Fondazione Italiana per la Ricerca sul Cancro	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Ministero della Salute(Ministry of Health, Italy); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was granted by Ministero dell'Istruzione, dell'Universita e della Ricerca (PON01_02782 and PON01_00862); Ministero della Salute (RF-2010-2306943 and GR-2009-1606801); Associazione Italiana per la Ricerca sul Cancro (IG-2009-9411). A.R. and E.V. were supported by fellowships from Fondazione Italiana per la Ricerca sul Cancro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON RD, 1988, J BIOL CHEM, V263, P6016; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bilanges B, 2007, ONCOGENE, V26, P5973, DOI 10.1038/sj.onc.1210431; De Laurentiis A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007898; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Duffey DC, 1999, CANCER RES, V59, P3468; Fiume G, 2012, NUCLEIC ACIDS RES, V40, P3548, DOI 10.1093/nar/gkr1224; Fiume G, 2009, COMPUT BIOL CHEM, V33, P434, DOI 10.1016/j.compbiolchem.2009.08.001; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Giordano A, 2008, CARDIOVASC RES, V79, P519, DOI 10.1093/cvr/cvn079; GRIFO JA, 1984, J BIOL CHEM, V259, P8648; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Janda E, 2011, BLOOD, V117, P6520, DOI 10.1182/blood-2010-09-308080; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Meric F, 2002, MOL CANCER THER, V1, P971; Palmieri Camillo, 2004, Retrovirology, V1, P45, DOI 10.1186/1742-4690-1-45; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Puca A, 2007, J BIOL CHEM, V282, P37146, DOI 10.1074/jbc.M705815200; Quinto I, 1999, J BIOL CHEM, V274, P17567, DOI 10.1074/jbc.274.25.17567; RAY BK, 1985, J BIOL CHEM, V260, P7651; Richter NJ, 1999, J BIOL CHEM, V274, P35415, DOI 10.1074/jbc.274.50.35415; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Schiavone M, 2012, INT J MOL SCI, V13, P5674, DOI 10.3390/ijms13055674; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shahbazian D, 2010, MOL CELL BIOL, V30, P1478, DOI 10.1128/MCB.01218-09; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spatuzza C, 2008, NUCLEIC ACIDS RES, V36, P4402, DOI 10.1093/nar/gkn413; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vitagliano L, 2011, BIOCHIMIE, V93, P1592, DOI 10.1016/j.biochi.2011.05.025; Watkins SJ, 2002, BRIT J CANCER, V86, P1023, DOI 10.1038/sj/bjc/6600222; Wu D, 2011, INT J CANCER, V128, P1018, DOI 10.1002/ijc.25419	38	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66087	10.1371/journal.pone.0066087	http://dx.doi.org/10.1371/journal.pone.0066087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776612	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400108
J	Kovacs, K; Polasky, S; Nelson, E; Keeler, BL; Pennington, D; Plantinga, AJ; Taff, SJ				Kovacs, Kent; Polasky, Stephen; Nelson, Erik; Keeler, Bonnie L.; Pennington, Derric; Plantinga, Andrew J.; Taff, Steven J.			Evaluating the Return in Ecosystem Services from Investment in Public Land Acquisitions	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; MAXIMIZING RETURN; BIODIVERSITY CONSERVATION; CARBON SEQUESTRATION; UNITED-STATES; PHOSPHORUS; EFFICIENCY; INVENTORY; POLLUTION; POLICIES	We evaluate the return on investment (ROI) from public land conservation in the state of Minnesota, USA. We use a spatially-explicit modeling tool, the Integrated Valuation of Ecosystem Services and Tradeoffs (InVEST), to estimate how changes in land use and land cover (LULC), including public land acquisitions for conservation, influence the joint provision and value of multiple ecosystem services. We calculate the ROI of a public conservation acquisition as the ratio of the present value of ecosystem services generated by the conservation to the cost of the conservation. For the land scenarios analyzed, carbon sequestration services generated the greatest benefits followed by water quality improvements and recreation opportunities. We found ROI values ranged from 0.21 to 5.28 depending on assumptions about future land use change, service values, and discount rate. Our study suggests conservation is a good investment as long as investments are targeted to areas with low land costs and high service values.	[Kovacs, Kent] Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA; [Polasky, Stephen; Taff, Steven J.] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Nelson, Erik] Bowdoin Coll, Dept Econ, Brunswick, ME 04011 USA; [Keeler, Bonnie L.] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA; [Pennington, Derric] World Wildlife Fund, Washington, DC 20037 USA; [Plantinga, Andrew J.] Oregon State Univ, Dept Agr & Resource Econ, Corvallis, OR 97331 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Minnesota System; University of Minnesota Twin Cities; Bowdoin College; University of Minnesota System; University of Minnesota Twin Cities; World Wildlife Fund; Oregon State University	Kovacs, K (corresponding author), Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA.	kkovacs@uark.edu	Polasky, Stephen/AAC-5341-2019; Nelson, Erik J./J-4192-2019	Nelson, Erik J./0000-0002-7291-5192; Keeler, Bonnie/0000-0001-6269-9425	Direct For Social, Behav & Economic Scie [0814628] Funding Source: National Science Foundation	Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Abbitt RJF, 2000, BIOL CONSERV, V96, P169, DOI 10.1016/S0006-3207(00)00064-1; Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; Armsworth PR, 2006, P NATL ACAD SCI USA, V103, P5403, DOI 10.1073/pnas.0505278103; Blackard JA, 2008, REMOTE SENS ENVIRON, V112, P1658, DOI 10.1016/j.rse.2007.08.021; CARLSON RE, 1977, LIMNOL OCEANOGR, V22, P361, DOI 10.4319/lo.1977.22.2.0361; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; CARSON RT, 1993, WATER RESOUR RES, V29, P2445, DOI 10.1029/93WR00495; Caudill J, 2005, BANKING NATURE 2004; Church RL, 1996, BIOL CONSERV, V76, P105, DOI 10.1016/0006-3207(95)00102-6; Costello C, 2004, RESOUR ENERGY ECON, V26, P157, DOI 10.1016/j.reseneeco.2003.11.005; Dobson AP, 1997, SCIENCE, V275, P550, DOI 10.1126/science.275.5299.550; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Fry J.A., 2009, COMPLETION NATL LAND; Goldstein JH, 2008, CONSERV LETT, V1, P236, DOI 10.1111/j.1755-263X.2008.00031.x; Hill J, 2009, P NATL ACAD SCI USA, V106, P2077, DOI 10.1073/pnas.0812835106; Howarth RB, 2009, LAND ECON, V85, P24, DOI 10.3368/le.85.1.24; Irwin EG, 2002, J ECON GEOGR, V2, P31, DOI 10.1093/jeg/2.1.31; Johnston RJ, 2005, CAN J AGR ECON, V53, P221, DOI 10.1111/j.1744-7976.2005.04018.x; Johnston RJ, 2009, ENV EC WATERSHED RES; Lessard-Sams Outdoor Heritage Council (LSOHC), 2009, STRAT PLANN REC DEV; Lewis DJ, 2007, LAND ECON, V83, P109, DOI 10.3368/le.83.2.109; Lewis DJ, 2011, RESOUR ENERGY ECON, V33, P192, DOI 10.1016/j.reseneeco.2010.04.012; Lewis DJ, 2009, J ENVIRON ECON MANAG, V57, P239, DOI 10.1016/j.jeem.2008.11.001; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Loomis J, 2008, BENEFIT TRANSFER VIS; Loomis J. B., 2005, PNWGTR658 USDA FOR S; Lubowski RN, 2006, J ENVIRON ECON MANAG, V51, P135, DOI 10.1016/j.jeem.2005.08.001; Lubowski RN, 2002, THESIS HARVARD U CAM; Lubowski RN, 2008, LAND ECON, V84, P529, DOI 10.3368/le.84.4.529; Mathews LG, 2002, J AM WATER RESOUR AS, V38, P1217, DOI 10.1111/j.1752-1688.2002.tb04343.x; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Minnesota Department of Administration Office of Geographic and Demographic Analysis State Demographic Center, 2007, MINN POP PROJ 2005 2; Minnesota Department of Natural Resources, 2001, PRES; Minnesota Department of Natural Resources, 2011, MN DNR FEE TITL LAND; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Murdoch W, 2010, P NATL ACAD SCI USA, V107, P20855, DOI 10.1073/pnas.1011851107; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Nelson E, 2008, P NATL ACAD SCI USA, V105, P9471, DOI 10.1073/pnas.0706178105; Newburn DA, 2006, AM J AGR ECON, V88, P28, DOI 10.1111/j.1467-8276.2006.00837.x; Nusser SM, 1997, ENVIRON ECOL STAT, V4, P181, DOI 10.1023/A:1018574412308; Polasky S, 2013, MODELING LAND UNPUB; Polasky S, 2012, OXFORD REV ECON POL, V28, P139, DOI 10.1093/oxrep/grs011; Polasky S, 2011, ENVIRON RESOUR ECON, V48, P219, DOI 10.1007/s10640-010-9407-0; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; Protected areas database (PAD) - US Technical Working Group, 2009, PROT AR DAT US TECHN; Smith JE., 2006, METHODS CALCULATING; Tol RSJ, 2009, J ECON PERSPECT, V23, P29, DOI 10.1257/jep.23.2.29; U.S. Department of Agriculture, 1973, SOIL CONS SERV HDB, V210; U.S. Department of Agriculture Office of the Chief Economist World Agricultural Outlook Board, 2010, OCE20101 USDA WORLD; Underwood EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001515; Vogelmann JE, 2001, PHOTOGRAMM ENG REM S, V67, P650; Wilson KA, 2009, ANN NY ACAD SCI, V1162, P237, DOI 10.1111/j.1749-6632.2009.04149.x; Withey JC, 2012, ECOL LETT, V15, P1249, DOI 10.1111/j.1461-0248.2012.01847.x; Wolny, 2011, INVEST 2 1 BETA USER	55	34	36	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e62202	10.1371/journal.pone.0062202	http://dx.doi.org/10.1371/journal.pone.0062202			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	169CU	23776429	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400001
J	Lim, KJ; Sung, BH; Shin, JR; Lee, YW; Kim, DJ; Yang, KS; Kim, SC				Lim, Ki Jung; Sung, Bong Hyun; Shin, Ju Ri; Lee, Young Woong; Kim, Da Jung; Yang, Kyung Seok; Kim, Sun Chang			A Cancer Specific Cell-Penetrating Peptide, BR2, for the Efficient Delivery of an scFv into Cancer Cells	PLOS ONE			English	Article							LYTIC PEPTIDES; NUCLEIC-ACIDS; MECHANISM; MEMBRANE; PROTEINS; TRANSDUCTION; ANTIBODY	Cell-penetrating peptides (CPPs) have proven very effective as intracellular delivery vehicles for various therapeutics. However, there are some concerns about non-specific penetration and cytotoxicity of CPPs for effective cancer treatments. Herein, based on the cell-penetrating motif of an anticancer peptide, buforin IIb, we designed several CPP derivatives with cancer cell specificity. Among the derivatives, a 17-amino acid peptide (BR2) was found to have cancer-specificity without toxicity to normal cells. After specifically targeting cancer cells through interaction with gangliosides, BR2 entered cells via lipid-mediated macropinocytosis. Moreover, BR2 showed higher membrane translocation efficiency than the well-known CPP Tat (49-57). The capability of BR2 as a cancer-specific drug carrier was demonstrated by fusion of BR2 to a single-chain variable fragment (scFv) directed toward a mutated K-ras (G12V). BR2-fused scFv induced a higher degree of apoptosis than Tat-fused scFv in K-ras mutated HCT116 cells. These results suggest that the novel cell-penetrating peptide BR2 has great potential as a useful drug delivery carrier with cancer cell specificity.	[Lim, Ki Jung; Shin, Ju Ri; Lee, Young Woong; Kim, Da Jung; Yang, Kyung Seok; Kim, Sun Chang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Sung, Bong Hyun] Korea Res Inst Biosci & Biotechnol, Biochem & Synthet Biol Res Ctr, Taejon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kim, SC (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	sunkim@kaist.ac.kr	Kim, Sun/GSN-4867-2022; Kim, Sun Chang/C-2026-2011	Sung, Bong Hyun/0000-0002-8992-1118	Intelligent Synthetic Biology Center of Global Frontier Project; Ministry of Education, Science and Technology [2011-0031955]	Intelligent Synthetic Biology Center of Global Frontier Project; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Education, Science and Technology (2011-0031955). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUDY Y, 1994, INT J PEPT PROT RES, V43, P573; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cappelli G, 1999, TUMORI, V85, pS19, DOI 10.1177/030089169908501s06; Cawthorn TR, 2009, CLIN EXP METASTAS, V26, P935, DOI 10.1007/s10585-009-9284-5; Chen YX, 2005, J BIOL CHEM, V280, P12316, DOI 10.1074/jbc.M413406200; Chiu YL, 2004, CHEM BIOL, V11, P1165, DOI 10.1016/j.chembiol.2004.06.006; Cho JH, 2009, BBA-BIOMEMBRANES, V1788, P1564, DOI 10.1016/j.bbamem.2008.10.025; Cochet O, 1998, CANCER RES, V58, P1170; Crombez L, 2009, MOL THER, V17, P95, DOI 10.1038/mt.2008.215; DESHPANDE AK, 1987, MOL CELL BIOL, V7, P1285, DOI 10.1128/MCB.7.3.1285; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Elmquist A, 2001, EXP CELL RES, V269, P237, DOI 10.1006/excr.2001.5316; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; FOX PL, 1994, ONCOGENE, V9, P3519; Geisler I, 2009, CHEM BIOL DRUG DES, V73, P39, DOI 10.1111/j.1747-0285.2008.00759.x; Gupta Manish S. V., 2011, RES J CHEM SCI, V2, P135; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Hoyer J, 2012, ACCOUNTS CHEM RES, V45, P1048, DOI 10.1021/ar2002304; Huang YB, 2012, INT J MOL SCI, V13, P6849, DOI 10.3390/ijms13066849; JEYAPAUL J, 1990, P NATL ACAD SCI USA, V87, P7030, DOI 10.1073/pnas.87.18.7030; Johnson LN, 2008, MOL THER, V16, P107, DOI 10.1038/sj.mt.6300324; Kamada H, 2007, BIOL PHARM BULL, V30, P218, DOI 10.1248/bpb.30.218; Kersemans V, 2010, PHARMACEUTICALS, V3, P600, DOI 10.3390/ph3030600; Lee HS, 2008, CANCER LETT, V271, P47, DOI 10.1016/j.canlet.2008.05.041; Leuschner C, 2004, CURR PHARM DESIGN, V10, P2299, DOI 10.2174/1381612043383971; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; Lundberg M, 2002, BIOCHEM BIOPH RES CO, V291, P367, DOI 10.1006/bbrc.2002.6450; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Martin I, 2010, PHARMACEUTICALS, V3, P1456, DOI 10.3390/ph3051456; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mussbach F, 2011, J CELL BIOCHEM, V112, P3824, DOI 10.1002/jcb.23313; Papo N, 2003, BIOCHEMISTRY-US, V42, P9346, DOI 10.1021/bi027212o; Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097; Pujals S, 2008, ADV DRUG DELIVER REV, V60, P473, DOI 10.1016/j.addr.2007.09.012; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Rothbard JB, 2000, NAT MED, V6, P1253, DOI 10.1038/81359; Sandvig K, 2011, CURR OPIN CELL BIOL, V23, P413, DOI 10.1016/j.ceb.2011.03.007; Shin SY, 2001, J PEPT RES, V58, P504, DOI 10.1034/j.1399-3011.2001.00934.x; Tanaka T, 2003, EMBO J, V22, P1025, DOI 10.1093/emboj/cdg106; Torchilin V, 2008, EXPERT OPIN DRUG DEL, V5, P1003, DOI [10.1517/17425247.5.9.1003, 10.1517/17425247.5.9.1003 ]; Trabulo S, 2010, PHARMACEUTICALS, V3, P961, DOI 10.3390/ph3040961; Turner JJ, 2005, NUCLEIC ACIDS RES, V33, P6837, DOI 10.1093/nar/gki991; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wang B, 2005, WILEY SER DRUG DISC, P1, DOI 10.1002/0471475734; Yukawa H, 2010, BIOMATERIALS, V31, P4094, DOI 10.1016/j.biomaterials.2010.01.134; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	46	81	87	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66084	10.1371/journal.pone.0066084	http://dx.doi.org/10.1371/journal.pone.0066084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776609	gold, Green Published, Green Submitted			2022-12-25	WOS:000320755400107
J	Miyoshi-Akiyama, T; Hayakawa, K; Ohmagari, N; Shimojima, M; Kirikae, T				Miyoshi-Akiyama, Tohru; Hayakawa, Kayoko; Ohmagari, Norio; Shimojima, Masahiro; Kirikae, Teruo			Multilocus Sequence Typing (MLST) for Characterization of Enterobacter cloacae	PLOS ONE			English	Article							POPULATION-GROWTH; TESTS; POLYMORPHISM; NEUTRALITY; BACTERIA	Enterobacter cloacae is an important emerging pathogen, which sometime causes respiratory infection, surgical site infection, urinary infection, sepsis, and outbreaks at neonatal units. We have developed a multilocus sequence typing (MLST) scheme utilizing seven housekeeping genes and evaluated the performance in 101 clinical isolates. The MLST scheme yielded 83 sequence types (ST) including 78 novel STs found in the clinical isolates. These findings supported the robustness of the MLST scheme developed in this study.	[Miyoshi-Akiyama, Tohru; Kirikae, Teruo] Natl Ctr Global Hlth & Med, Dept Infect Dis, Shinjuku Ku, Tokyo, Japan; [Hayakawa, Kayoko; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Shinjuku Ku, Tokyo, Japan; [Shimojima, Masahiro] BML Inc, Kawagoe, Saitama, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; BML, Inc.	Miyoshi-Akiyama, T (corresponding author), Natl Ctr Global Hlth & Med, Dept Infect Dis, Shinjuku Ku, Tokyo, Japan.	takiyam@ri.ncgm.go.jp	Ohmagari, Norio/GLN-5290-2022; Hayakawa, Kayoko/GNW-2394-2022	Ohmagari, Norio/0000-0002-4622-8970; Hayakawa, Kayoko/0000-0002-5480-4405	Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, the Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labor, and Welfare, Japan [23A301]	Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, the Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.riken.jp/en/research/labs/crnid/). TMA was supported by a Grant for International Health Research (23A301) from the Ministry of Health, Labor, and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; Dai W, 2013, INFECT GENET EVOL, V14, P1, DOI 10.1016/j.meegid.2012.10.010; Dalben M, 2008, J HOSP INFECT, V70, P7, DOI 10.1016/j.jhin.2008.05.003; Fernandez A, 2011, J CLIN MICROBIOL, V49, P822, DOI 10.1128/JCM.01872-10; Fu YX, 1997, GENETICS, V147, P915; Hamada Y, 2012, J INFECT CHEMOTHER; Heller I, 2012, J MED MICROBIOL, V61, P567, DOI 10.1099/jmm.0.038646-0; Huang SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047636; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Paauw A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003018; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rozas J, 1995, COMPUT APPL BIOSCI, V11, P621; Sanders WE, 1997, CLIN MICROBIOL REV, V10, P220, DOI 10.1128/CMR.10.2.220; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; TAJIMA F, 1989, GENETICS, V123, P585	17	124	144	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66358	10.1371/journal.pone.0066358	http://dx.doi.org/10.1371/journal.pone.0066358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776664	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400140
J	Octavia, S; Salim, A; Kurniawan, J; Lam, C; Leung, Q; Ahsan, S; Reeves, PR; Nair, GB; Lan, RT				Octavia, Sophie; Salim, Anna; Kurniawan, Jacob; Lam, Connie; Leung, Queenie; Ahsan, Sunjukta; Reeves, Peter R.; Nair, G. Balakrish; Lan, Ruiting			Population Structure and Evolution of Non-O1/Non-O139 Vibrio cholerae by Multilocus Sequence Typing	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PILUS PROTEIN TCPA; PATHOGENICITY ISLAND; ENVIRONMENTAL STRAINS; COMPARATIVE GENOMICS; NUCLEOTIDE-SEQUENCE; VIRULENCE FACTORS; NON-O1; TOXIN; GENES	Pathogenic non-O1/non-O139 Vibrio cholerae strains can cause sporadic outbreaks of cholera worldwide. In this study, multilocus sequence typing (MLST) of seven housekeeping genes was applied to 55 non-O1/non-O139 isolates from clinical and environmental sources. Data from five published O1 isolates and 17 genomes were also included, giving a total of 77 isolates available for analysis. There were 66 sequence types (STs), with the majority being unique, and only three clonal complexes. The V. cholerae strains can be divided into four subpopulations with evidence of recombination among the subpopulations. Subpopulations I and III contained predominantly clinical strains. PCR screening for virulence factors including Vibrio pathogenicity island (VPI), cholera toxin prophage (CTX Phi), type III secretion system (T3SS), and enterotoxin genes (rtxA and sto/stn) showed that combinations of these factors were present in the clinical isolates with 85.7% having rtxA, 51.4% T3SS, 31.4% VPI, 31.4% sto/stn (NAG-ST) and 11.4% CTX Phi. These factors were also present in environmental isolates but at a lower frequency. Five strains previously mis-identified as V. cholerae serogroups O114 to O117 were also analysed and formed a separate population with V. mimicus. The MLST scheme developed in this study provides a framework to identify sporadic cholera isolates by genetic identity.	[Octavia, Sophie; Kurniawan, Jacob; Lam, Connie; Leung, Queenie; Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Salim, Anna; Ahsan, Sunjukta; Reeves, Peter R.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Nair, G. Balakrish] Translat Hlth Sci & Technol Inst, Gurgaon, Haryana, India	University of New South Wales Sydney; University of Sydney; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Lan, RT (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	r.lan@unsw.edu.au	Reeves, Peter R/A-6064-2008	Reeves, Peter R/0000-0003-4479-7974; Octavia, Sophie/0000-0001-8506-9127; Lan, Ruiting/0000-0001-9834-5258	Australian Research Council	Australian Research Council(Australian Research Council)	This study was supported by an Australian Research Council discovery project grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam A, 2011, INFECT IMMUN, V79, P1728, DOI 10.1128/IAI.01194-10; ARITA M, 1986, INFECT IMMUN, V52, P45, DOI 10.1128/IAI.52.1.45-49.1986; Bag PK, 2008, APPL ENVIRON MICROB, V74, P5635, DOI 10.1128/AEM.00029-08; BAGCHI K, 1993, J CLIN MICROBIOL, V31, P1315, DOI 10.1128/JCM.31.5.1315-1317.1993; Bhowmick TS, 2009, J MED MICROBIOL, V58, P1160, DOI 10.1099/jmm.0.008466-0; BLAKE PA, 1980, ANNU REV MICROBIOL, V34, P341, DOI 10.1146/annurev.mi.34.100180.002013; Boyd EF, 2002, MICROBIOL-SGM, V148, P1655, DOI 10.1099/00221287-148-6-1655; Boyd EF, 2000, J BACTERIOL, V182, P5530, DOI 10.1128/JB.182.19.5530-5538.2000; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Cariri FAMO, 2010, CLIN MICROBIOL INFEC, V16, P62, DOI 10.1111/j.1469-0691.2009.02763.x; Ch'ng SL, 2011, APPL ENVIRON MICROB, V77, P768, DOI 10.1128/AEM.01993-10; Chakraborty S, 2000, APPL ENVIRON MICROB, V66, P4022, DOI 10.1128/AEM.66.9.4022-4028.2000; Chakraborty S, 2001, J MED MICROBIOL, V50, P879, DOI 10.1099/0022-1317-50-10-879; Chatterjee S, 2009, J CLIN MICROBIOL, V47, P1087, DOI 10.1128/JCM.02026-08; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; Dalsgaard A, 1999, EPIDEMIOL INFECT, V122, P217, DOI 10.1017/S0950268899002137; Dalsgaard A, 2001, J CLIN MICROBIOL, V39, P4086, DOI 10.1128/JCM.39.11.4086-4092.2001; DALSGAARD A, 1995, J CLIN MICROBIOL, V33, P2715, DOI 10.1128/JCM.33.10.2715-2722.1995; Didelot X, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002191; Theophilo Grace Nazareth Diogo, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P65, DOI 10.1590/S0036-46652006000200002; Dziejman M, 2005, P NATL ACAD SCI USA, V102, P3465, DOI 10.1073/pnas.0409918102; Faruque SM, 2004, P NATL ACAD SCI USA, V101, P2123, DOI 10.1073/pnas.0308485100; Faruque SM, 2003, INFECT IMMUN, V71, P1020, DOI 10.1128/IAI.71.2.1020-1025.2003; Feil EJ, 2000, GENETICS, V154, P1439; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Fraga SG, 2007, J APPL MICROBIOL, V103, P2448, DOI 10.1111/j.1365-2672.2007.03468.x; Ghosh C, 1997, MICROB PATHOGENESIS, V22, P199, DOI 10.1006/mpat.1996.0105; Glenn Morris J., 1994, VIBRIO CHOLERAE CHOL, P103; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Haley BJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-154; Hasan NA, 2010, P NATL ACAD SCI USA, V107, P21134, DOI 10.1073/pnas.1013825107; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jagadeeshan S, 2009, J BASIC MICROB, V49, P538, DOI 10.1002/jobm.200900085; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Keymer DP, 2011, APPL ENVIRON MICROB, V77, P537, DOI 10.1128/AEM.02062-10; Ko WC, 1998, CLIN INFECT DIS, V27, P774, DOI 10.1086/514947; Lee Ya-Ling, 2007, Journal of Microbiology Immunology and Infection, V40, P474; Li MR, 2003, APPL ENVIRON MICROB, V69, P1728, DOI 10.1128/AEM.69.3.1728-1738.2003; Li MR, 2002, INFECT IMMUN, V70, P2441, DOI 10.1128/IAI.70.5.2441-2453.2002; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; McVean G, 2002, GENETICS, V160, P1231; Mukhopadhyay AK, 2001, J BACTERIOL, V183, P4737, DOI 10.1128/JB.183.16.4737-4746.2001; Nandi B, 2000, INFECT IMMUN, V68, P948, DOI 10.1128/IAI.68.2.948-952.2000; O'Shea YA, 2004, J CLIN MICROBIOL, V42, P4657, DOI 10.1128/JCM.42.10.4657-4671.2004; OGAWA A, 1990, INFECT IMMUN, V58, P3325, DOI 10.1128/IAI.58.10.3325-3329.1990; Onifade TJM, 2011, EUROSURVEILLANCE, V16, P10; Ottaviani D, 2009, INT J FOOD MICROBIOL, V132, P47, DOI 10.1016/j.ijfoodmicro.2009.03.014; Pritchard JK, 2000, GENETICS, V155, P945; Rahman MH, 2008, DNA CELL BIOL, V27, P347, DOI 10.1089/dna.2008.0737; Reeves PR, 1998, BRIT MED BULL, V54, P611, DOI 10.1093/oxfordjournals.bmb.a011714; REEVES PR, 1994, COMPUT APPL BIOSCI, V10, P281; Rivera ING, 2001, APPL ENVIRON MICROB, V67, P2421, DOI 10.1128/AEM.67.6.2421-2429.2001; Safa A, 2010, TRENDS MICROBIOL, V18, P46, DOI 10.1016/j.tim.2009.10.003; Salim A, 2005, EMERG INFECT DIS, V11, P1758, DOI 10.3201/eid1111.041170; Sharma C, 1998, J CLIN MICROBIOL, V36, P756, DOI 10.1128/JCM.36.3.756-763.1998; SHIMADA T, 1994, CURR MICROBIOL, V28, P175, DOI 10.1007/BF01571061; Shin OS, 2011, MBIO, V2, DOI 10.1128/mBio.00106-11; SHIRAI H, 1991, J CLIN MICROBIOL, V29, P2517, DOI 10.1128/JCM.29.11.2517-2521.1991; Spratt Brian G, 2004, Methods Mol Biol, V266, P323; Talkington D, 2011, EMERG INFECT DIS, V17, P2122, DOI 10.3201/eid1711.110805; Tay CY, 2008, FEMS MICROBIOL LETT, V289, P210, DOI 10.1111/j.1574-6968.2008.01385.x; Thompson CC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-258; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobin-D'Angelo M, 2008, CLIN INFECT DIS, V47, P1035, DOI 10.1086/591973; Wang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021299; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	69	42	48	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65342	10.1371/journal.pone.0065342	http://dx.doi.org/10.1371/journal.pone.0065342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776471	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400025
J	Payne, SC; Bartlett, CA; Savigni, DL; Harvey, AR; Dunlop, SA; Fitzgerald, M				Payne, Sophie C.; Bartlett, Carole A.; Savigni, Donna L.; Harvey, Alan R.; Dunlop, Sarah A.; Fitzgerald, Melinda			Early Proliferation Does Not Prevent the Loss of Oligodendrocyte Progenitor Cells during the Chronic Phase of Secondary Degeneration in a CNS White Matter Tract	PLOS ONE			English	Article							SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; TRANSCRIPTION FACTOR OLIG2; OPTIC-NERVE; ADULT CNS; RAT-BRAIN; CHRONIC DEMYELINATION; NG2-EXPRESSING CELLS; MULTIPLE-SCLEROSIS; PRECURSOR CELLS	Partial injury to the central nervous system (CNS) is exacerbated by additional loss of neurons and glia via toxic events known as secondary degeneration. Using partial transection of the rat optic nerve (ON) as a model, we have previously shown that myelin decompaction persists during secondary degeneration. Failure to repair myelin abnormalities during secondary degeneration may be attributed to insufficient OPC proliferation and/or differentiation to compensate for loss of oligodendrocyte lineage cells (oligodendroglia). Following partial ON transection, we found that sub-populations of oligodendroglia and other olig2+ glia were differentially influenced by injury. A high proportion of NG2+/olig2-, NG2+/olig2+ and CC1-/olig2+ cells proliferated (Ki67+) at 3 days, prior to the onset of death (TUNEL+) at 7 days, suggesting injury-related cues triggered proliferation rather than early loss of oligodendroglia. Despite this, a high proportion (20%) of the NG2+/olig2+ OPCs were TUNEL+ at 3 months, and numbers remained chronically lower, indicating that proliferation of these cells was insufficient to maintain population numbers. There was significant death of NG2+/olig2- and NG2-/olig2+ cells at 7 days, however population densities remained stable, suggesting proliferation was sufficient to sustain cell numbers. Relatively few TUNEL+/CC1+ cells were detected at 7 days, and no change in density indicated that mature CC1+ oligodendrocytes were resistant to secondary degeneration in vivo. Mature CC1+/olig2-oligodendrocyte density increased at 3 days, reflecting early oligogenesis, while the appearance of shortened myelin internodes at 3 months suggested remyelination. Taken together, chronic OPC decreases may contribute to the persistent myelin abnormalities and functional loss seen in ON during secondary degeneration.	[Payne, Sophie C.; Bartlett, Carole A.; Savigni, Donna L.; Dunlop, Sarah A.; Fitzgerald, Melinda] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia; [Harvey, Alan R.] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Fitzgerald, M (corresponding author), Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia.	lindy.fitzgerald@uwa.edu.au	Fitzgerald, Melinda/C-4235-2011; Dunlop, Sarah A/G-9357-2013	Fitzgerald, Melinda/0000-0002-4823-8179; , Alan/0000-0002-2590-831X; Dunlop, Sarah/0000-0002-1306-3962	Neurotrauma Research Program (Western Australia); National Health & Medical Research Council [572550]; NHMRC, Australia [APP1002347]	Neurotrauma Research Program (Western Australia); National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NHMRC, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Neurotrauma Research Program (Western Australia) and National Health & Medical Research Council (Grant ID: 572550). Prof. Dunlop is a Principal Research Fellow of the NH&MRC, Australia (Grant ID: APP1002347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SA, 1998, J NEUROSCI, V18, P6241; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; Barrett RD, 2012, BRAIN RES, V1469, P35, DOI 10.1016/j.brainres.2012.06.018; Bhat RV, 1996, GLIA, V17, P169; BLAKEMORE WF, 1974, NATURE, V249, P577, DOI 10.1038/249577a0; Bu J, 2001, GLIA, V34, P296, DOI 10.1002/glia.1063; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; BUNGE MB, 1961, J BIOPHYS BIOCHEM CY, V10, P67, DOI 10.1083/jcb.10.1.67; Butt AM, 1999, GLIA, V26, P84, DOI 10.1002/(SICI)1098-1136(199903)26:1<84::AID-GLIA9>3.3.CO;2-C; Butts BD, 2008, CELL DEATH DIFFER, V15, P1178, DOI 10.1038/cdd.2008.70; Carroll WM, 1998, BRAIN, V121, P293, DOI 10.1093/brain/121.2.293; Chen Y, 2008, J NEUROSCI, V28, P10983, DOI 10.1523/JNEUROSCI.3545-08.2008; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.3.CO;2-E; Deng WB, 2003, P NATL ACAD SCI USA, V100, P6801, DOI 10.1073/pnas.1136624100; Di Bello IC, 1999, J NEUROCYTOL, V28, P365, DOI 10.1023/A:1007069815302; Fancy SPJ, 2004, MOL CELL NEUROSCI, V27, P247, DOI 10.1016/j.mcn.2004.06.015; Fancy SPJ, 2010, EXP NEUROL, V225, P18, DOI 10.1016/j.expneurol.2009.12.020; Fern R, 2000, J NEUROSCI, V20, P34, DOI 10.1523/JNEUROSCI.20-01-00034.2000; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; Franklin RJM, 1997, J NEUROSCI RES, V50, P337, DOI 10.1002/(SICI)1097-4547(19971015)50:2<337::AID-JNR21>3.0.CO;2-3; Frei E, 2000, EXP NEUROL, V163, P373, DOI 10.1006/exnr.2000.7379; Fuss B, 2000, DEV BIOL, V218, P259, DOI 10.1006/dbio.1999.9574; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; GERDES J, 1984, J IMMUNOL, V133, P1710; GLEDHILL RF, 1973, NATURE, V244, P443, DOI 10.1038/244443a0; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Hughes S, 2004, INVEST OPHTH VIS SCI, V45, P2795, DOI 10.1167/iovs.03-1312; Jeffery ND, 1997, BRAIN, V120, P27, DOI 10.1093/brain/120.1.27; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Karadottir R, 2008, NAT NEUROSCI, V11, P450, DOI 10.1038/nn2060; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Keirstead HS, 1998, GLIA, V22, P161, DOI 10.1002/(SICI)1098-1136(199802)22:2<161::AID-GLIA7>3.3.CO;2-Z; Kitada M, 2006, GLIA, V54, P35, DOI 10.1002/glia.20354; Lasiene J, 2008, J NEUROSCI, V28, P3887, DOI 10.1523/JNEUROSCI.4756-07.2008; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Nishiyama A, 2002, J NEUROCYTOL, V31, P437, DOI 10.1023/A:1025783412651; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Payne SC, 2012, INVEST OPHTH VIS SCI, V53, P6093, DOI 10.1167/iovs.12-10080; Payne SC, 2011, J NEUROTRAUM, V28, P1077, DOI 10.1089/neu.2010.1665; Penderis J, 2003, BRAIN, V126, P1382, DOI 10.1093/brain/awg126; Petersen JA, 2012, J NEUROTRAUM, V29, P1556, DOI 10.1089/neu.2011.2027; Polito A, 2005, J ANAT, V207, P707, DOI 10.1111/j.1469-7580.2005.00454.x; Powers BE, 2012, J NEUROSCI, V32, P5120, DOI 10.1523/JNEUROSCI.0002-12.2012; Prineas J, 1997, DEMYELINATING DIS, P813; Psachoulia K, 2009, NEURON GLIA BIOL, V5, P57, DOI 10.1017/S1740925X09990354; Reynolds R, 2002, J NEUROCYTOL, V31, P523, DOI 10.1023/A:1025747832215; Rhodes KE, 2006, NEUROSCIENCE, V140, P87, DOI 10.1016/j.neuroscience.2006.01.055; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Rosenberg PA, 2003, J NEUROSCI RES, V71, P237, DOI 10.1002/jnr.10472; Schonberg DL, 2007, J NEUROPATH EXP NEUR, V66, P1124, DOI 10.1097/nen.0b013e31815c2530; Sim FJ, 2002, J NEUROSCI, V22, P2451, DOI 10.1523/JNEUROSCI.22-07-02451.2002; SMITH KJ, 1979, NATURE, V280, P395, DOI 10.1038/280395a0; STALLCUP WB, 1981, DEV BIOL, V83, P154, DOI 10.1016/S0012-1606(81)80018-8; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Tripathi R, 2007, GLIA, V55, P698, DOI 10.1002/glia.20491; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Watanabe M, 2002, J NEUROSCI RES, V69, P826, DOI 10.1002/jnr.10338; Wolswijk G, 1998, J NEUROSCI, V18, P601; Yang H, 2006, J NEUROSCI, V26, P2157, DOI 10.1523/JNEUROSCI.4070-05.2005; Zai LJ, 2005, GLIA, V50, P247, DOI 10.1002/glia.20176; Zhao JW, 2009, EUR J NEUROSCI, V29, P1853, DOI 10.1111/j.1460-9568.2009.06736.x; Zhu L, 2012, GLIA, V60, P1417, DOI 10.1002/glia.22362	72	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65710	10.1371/journal.pone.0065710	http://dx.doi.org/10.1371/journal.pone.0065710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776532	Green Published, gold			2022-12-25	WOS:000320755400060
J	Teodoro, GS; van den Berg, E; Arruda, R				Teodoro, Grazielle Sales; van den Berg, Eduardo; Arruda, Rafael			Metapopulation Dynamics of the Mistletoe and Its Host in Savanna Areas with Different Fire Occurrence	PLOS ONE			English	Article							COLONIZATION-EXTINCTION DYNAMICS; SCALE SPATIAL DYNAMICS; EPIPHYTE METAPOPULATION; DWARF MISTLETOE; DISPERSAL; PATTERNS; FORESTS; MODELS; PLANTS; LORANTHACEAE	Mistletoes are aerial hemiparasitic plants which occupy patches of favorable habitat (host trees) surrounded by unfavorable habitat and may be possibly modeled as a metapopulation. A metapopulation is defined as a subdivided population that persists due to the balance between colonization and extinction in discrete habitat patches. Our aim was to evaluate the dynamics of the mistletoe Psittacanthus robustus and its host Vochysia thyrsoidea in three Brazilian savanna areas using a metapopulation approach. We also evaluated how the differences in terms of fire occurrence affected the dynamic of those populations (two areas burned during the study and one was fire protected). We monitored the populations at six-month intervals. P. robustus population structure and dynamics met the expected criteria for a metapopulation: i) the suitable habitats for the mistletoe occur in discrete patches; (ii) local populations went extinct during the study and (iii) colonization of previously non-occupied patches occurred. The ratio of occupied patches decreased in all areas with time. Local mistletoe populations went extinct due to two different causes: patch extinction in area with no fire and fire killing in the burned areas. In a burned area, the largest decrease of occupied patch ratios occurred due to a fire event that killed the parasites without, however, killing the host trees. The greatest mortality of V. thyrsoidea occurred in the area without fire. In this area, all the dead trees supported mistletoe individuals and no mortality was observed for parasite-free trees. Because P. robustus is a fire sensitive species and V. thyrsoidea is fire tolerant, P. robustus seems to increase host mortality, but its effect is lessened by periodic burning that reduces the parasite loads.	[Teodoro, Grazielle Sales] Univ Estadual Campinas, Inst Biol, Dept Bot, Campinas, SP, Brazil; [van den Berg, Eduardo] Univ Fed Lavras, Dept Biol, Setor Bot Sistemat, Lavras, Brazil; [Arruda, Rafael] Univ Fed Mato Grosso, Inst Ciencias Nat Humanas & Sociais, Sinop, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Lavras; Universidade Federal de Mato Grosso	Teodoro, GS (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Bot, Campinas, SP, Brazil.	gsales.bio@gmail.com	van den Berg, eduardo/L-9617-2014; Arruda, Rafael/D-4362-2012; Teodoro, Grazielle S/K-2586-2014	van den Berg, eduardo/0000-0002-0843-6437; Arruda, Rafael/0000-0003-2869-5134; Teodoro, Grazielle S/0000-0002-5528-8828	FAPEMIG; FAPEMAT	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPEMAT(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT))	The authors thank FAPEMIG for master fellowships and financial support to Grazielle Sales Teodoro and FAPEMAT for post-doctoral fellowships to Rafael Arruda. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZBUYLLA ER, 1994, AM NAT, V143, P155, DOI 10.1086/285599; Arruda R, 2012, ACTA BOT BRAS, V26, P264, DOI 10.1590/S0102-33062012000200003; Aukema JE, 2004, ECOGRAPHY, V27, P137, DOI 10.1111/j.0906-7590.2004.03640.x; Aukema Juliann E., 2002, P99, DOI 10.1079/9780851995250.0099; Blick R, 2009, PERSPECT PLANT ECOL, V11, P41, DOI 10.1016/j.ppees.2008.10.002; Burns KC, 2010, ECOLOGY, V91, P377, DOI 10.1890/08-2004.1; Burns KC, 2009, OIKOS, V118, P191, DOI 10.1111/j.1600-0706.2008.16816.x; Caires CS, 2010, CATALOGO PLANTAS FUN, V2, P1172; Calvin CL, 2006, FLORA, V201, P51, DOI 10.1016/j.flora.2005.03.001; Caruso A, 2010, OIKOS, V119, P1947, DOI 10.1111/j.1600-0706.2010.18713.x; Ehrlen J, 2003, J ECOL, V91, P316, DOI 10.1046/j.1365-2745.2003.00753.x; Fadini RF, 2012, BIOTROPICA, V44, P27, DOI 10.1111/j.1744-7429.2011.00773.x; Fedrowitz K, 2012, J APPL ECOL, V49, P493, DOI 10.1111/j.1365-2664.2012.02113.x; Freckleton RP, 2002, J ECOL, V90, P419, DOI 10.1046/j.1365-2745.2002.00692.x; Freckleton RP, 2003, J ECOL, V91, P321, DOI 10.1046/j.1365-2745.2003.00769.x; Glatzel G, 2009, BOTANY, V87, P10, DOI 10.1139/B08-096; Guerra TJA, 2010, THESIS U ESTADUAL CA; HANSKI I, 1991, BIOL J LINN SOC, V42, P17, DOI 10.1111/j.1095-8312.1991.tb00549.x; Hanski Ilkka, 1997, P69, DOI 10.1016/B978-012323445-2/50007-9; Hessburg PF, 2008, FOREST ECOL MANAG, V255, P2907, DOI 10.1016/j.foreco.2008.01.066; Hessburg PF, 2000, FOREST ECOL MANAG, V136, P53, DOI 10.1016/S0378-1127(99)00263-7; Jurskis V., 2005, Australian Forestry, V68, P221; Kavanagh PH, 2012, BIOL J LINN SOC, V106, P459, DOI 10.1111/j.1095-8312.2012.01890.x; Kipfmueller KF, 1998, FOREST ECOL MANAG, V108, P77, DOI 10.1016/S0378-1127(98)00217-5; Laube S, 2007, J VEG SCI, V18, P613, DOI 10.1111/j.1654-1103.2007.tb02575.x; Lobel S, 2006, ECOGRAPHY, V29, P169, DOI 10.1111/j.2006.0906-7590.04348.x; Lobel S, 2006, J ECOL, V94, P856, DOI 10.1111/j.1365-2745.2006.01114.x; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; MOILANEN A, 1995, J ANIM ECOL, V64, P141, DOI 10.2307/5836; Moilanen A, 1998, ECOLOGY, V79, P2503, DOI 10.1890/0012-9658(1998)079[2503:MDEOHQ]2.0.CO;2; MONTEIRO RF, 1992, J TROP ECOL, V8, P307, DOI 10.1017/S026646740000657X; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Oliveira Filho A. T., 1999, Cerne, V5, P51; OVERTON JM, 1994, J ECOL, V82, P711, DOI 10.2307/2261437; Press MC, 2005, NEW PHYTOL, V166, P737, DOI 10.1111/j.1469-8137.2005.01358.x; R Core Team, 2012, R LANG ENV STAT COMP; Ribeiro JF, 2008, CERRADO ECOLOGIA FLO, P153, DOI DOI 10.1023/A:1015819219386; Roxburgh L, 2008, PLANT ECOL, V195, P21, DOI 10.1007/s11258-007-9295-8; Salle G., 1983, BIOL MISTLETOES, P145; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Shaw DC, 2004, AUST J BOT, V52, P481, DOI 10.1071/BT03074; Sheil D, 2000, J TROP ECOL, V16, P765, DOI 10.1017/S0266467400001723; SHEIL D, 1995, J ECOL, V83, P331, DOI 10.2307/2261571; Snall T, 2005, OIKOS, V109, P209, DOI 10.1111/j.0030-1299.2005.13616.x; Snall T, 2005, ECOLOGY, V86, P106, DOI 10.1890/04-0531; Snall T, 2004, ECOGRAPHY, V27, P757, DOI 10.1111/j.0906-7590.2004.04026.x; Snall T, 2003, OIKOS, V103, P566, DOI 10.1034/j.1600-0706.2003.12551.x; Teodoro GS, 2010, FLORA, V205, P797, DOI 10.1016/j.flora.2010.04.013; Watson DM, 2007, AUSTRAL ECOL, V32, P359, DOI 10.1111/j.1442-9993.2007.01701.x; Wilson CA, 2006, AM J BOT, V93, P787, DOI 10.3732/ajb.93.5.787	51	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65836	10.1371/journal.pone.0065836	http://dx.doi.org/10.1371/journal.pone.0065836			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776554	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400070
J	Young, SE; Duvernay, MT; Schulte, ML; Lindsley, CW; Hamm, HE				Young, Summer E.; Duvernay, Matthew T.; Schulte, Michael L.; Lindsley, Craig W.; Hamm, Heidi E.			Synthesis of Indole Derived Protease-Activated Receptor 4 Antagonists and Characterization in Human Platelets	PLOS ONE			English	Article							SECONDARY PREVENTION; INTERNAL POOL; THROMBIN; INHIBITION; YD-3; AGGREGATION; VORAPAXAR; DISCOVERY; HEMOSTASIS; PEPTIDE	Protease activated receptor-4 (PAR4) is one of the thrombin receptors on human platelets and is a potential target for the management of thrombotic disorders. We sought to develop potent, selective, and novel PAR4 antagonists to test the role of PAR4 in thrombosis and hemostasis. Development of an expedient three-step synthetic route to access a novel series of indole-based PAR4 antagonists also necessitated the development of a platelet based high-throughput screening assay. Screening and subsequent structure activity relationship analysis yielded several selective PAR4 antagonists as well as possible new scaffolds for future antagonist development.	[Young, Summer E.; Duvernay, Matthew T.; Lindsley, Craig W.; Hamm, Heidi E.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Schulte, Michael L.; Lindsley, Craig W.] Vanderbilt Univ, Sch Med, Dept Chem, Nashville, TN 37212 USA; [Lindsley, Craig W.] Vanderbilt Univ, Sch Med, Vanderbilt Specialized Chem Ctr, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Hamm, HE (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA.	heidi.hamm@vanderbilt.edu	Hamm, Heidi E/G-2374-2014		National Institues of Health, MLPCN [U54MH084659]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081669] Funding Source: NIH RePORTER	National Institues of Health, MLPCN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institues of Health, MLPCN, Grant U54MH084659 (http://mli.nih.gov/mli/mlpcn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2000, BIOCHEM PHARMACOL, V60, P1425, DOI 10.1016/S0006-2952(00)00460-3; Andrade-Gordon P, 1999, P NATL ACAD SCI USA, V96, P12257, DOI 10.1073/pnas.96.22.12257; Bernatowicz MS, 1996, J MED CHEM, V39, P4879, DOI 10.1021/jm960455s; CAVALLINI L, 1995, BIOCHEM J, V310, P449, DOI 10.1042/bj3100449; Chen HS, 2008, BIOORGAN MED CHEM, V16, P1262, DOI 10.1016/j.bmc.2007.10.070; Clasby MC, 2006, BIOORG MED CHEM LETT, V16, P1544, DOI 10.1016/j.bmcl.2005.12.042; Cleator JH, 2006, BLOOD, V107, P2736, DOI 10.1182/blood-2004-07-2698; Dormann D, 2000, BLOOD, V96, P2469, DOI 10.1182/blood.V96.7.2469.h8002469_2469_2478; Duvernay MT, 2013, MOL PHARM; Gawaz M, 2000, THROMB HAEMOSTASIS, V83, P915; Hamilton JR, 2004, J THROMB HAEMOST, V2, P1429, DOI 10.1111/j.1538-7836.2004.00783.x; Holinstat M, 2006, J BIOL CHEM, V281, P26665, DOI 10.1074/jbc.M602174200; Holinstat M, 2011, ARTERIOSCL THROM VAS, V31, P435, DOI 10.1161/ATVBAHA.110.219527; Jardin I, 2007, BIOCHEM J, V401, P167, DOI 10.1042/BJ20060888; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kennedy JP, 2008, J COMB CHEM, V10, P345, DOI 10.1021/cc700187t; KLEIMAN NS, 1995, J AM COLL CARDIOL, V26, P1665, DOI 10.1016/0735-1097(95)00391-6; Kudo N, 2006, ANGEW CHEM INT EDIT, V45, P1282, DOI 10.1002/anie.200503479; Lee FY, 2001, J MED CHEM, V44, P3746, DOI 10.1021/jm010001h; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; MISTRY AG, 1986, TETRAHEDRON LETT, V27, P1051, DOI 10.1016/S0040-4039(86)80045-4; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Peng CY, 2010, SHOCK, V34, P580, DOI 10.1097/SHK.0b013e3181df00a3; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; Scirica BM, 2012, LANCET, V380, P1317, DOI 10.1016/S0140-6736(12)61269-0; Shapiro MJ, 2000, J BIOL CHEM, V275, P25216, DOI 10.1074/jbc.M004589200; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Voss B, 2007, MOL PHARMACOL, V71, P1399, DOI 10.1124/mol.106.033365; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wu CC, 2002, THROMB HAEMOSTASIS, V87, P1026, DOI 10.1055/s-0037-1613128; Wu CC, 2000, BRIT J PHARMACOL, V130, P1289, DOI 10.1038/sj.bjp.0703437; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	34	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65528	10.1371/journal.pone.0065528	http://dx.doi.org/10.1371/journal.pone.0065528			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776495	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400038
J	Salazar, JJ; Gallego-Pinazo, R; de Hoz, R; Pinazo-Duran, MD; Rojas, B; Ramirez, AI; Serrano, M; Ramirez, JM				Salazar, Juan J.; Gallego-Pinazo, Roberto; de Hoz, Rosa; Pinazo-Duran, Maria D.; Rojas, Blanca; Ramirez, Ana I.; Serrano, Manuel; Ramirez, Jose M.			"Super p53'' Mice Display Retinal Astroglial Changes	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; INDUCED CELL-DEATH; OXIDATIVE STRESS; RAT RETINA; MACULAR DEGENERATION; GLIAL-CELLS; DNA-DAMAGE; P53-INDUCED APOPTOSIS; EXPERIMENTAL GLAUCOMA; ANTIOXIDANT FUNCTION	Tumour-suppressor genes, such as the p53 gene, produce proteins that inhibit cell division under adverse conditions, as in the case of DNA damage, radiation, hypoxia, or oxidative stress (OS). The p53 gene can arrest proliferation and trigger death by apoptosis subsequent to several factors. In astrocytes, p53 promotes cell-cycle arrest and is involved in oxidative stress-mediated astrocyte cell death. Increasingly, astrocytic p53 is proving fundamental in orchestrating neurodegenerative disease pathogenesis. In terms of ocular disease, p53 may play a role in hypoxia due to ischaemia and may be involved in the retinal response to oxidative stress (OS). We studied the influence of the p53 gene in the structural and quantitative characteristics of astrocytes in the retina. Adult mice of the C57BL/6 strain (12 months old) were distributed into two groups: 1) mice with two extra copies of p53 ("super p53''; n = 6) and 2) wild-type p53 age-matched control, as the control group (WT; n = 6). Retinas from each group were immunohistochemically processed to locate the glial fibrillary acidic protein (GFAP). GFAP+ astrocytes were manually counted and the mean area occupied for one astrocyte was quantified. Retinal-astrocyte distribution followed established patterns; however, morphological changes were seen through the retinas in relation to p53 availability. The mean GFAP+ area occupied by one astrocyte in "super p53'' eyes was significantly higher (p < 0.05; Student's t-test) than in the WT. In addition, astroglial density was significantly higher in the "super p53'' retinas than in the WT ones, both in the whole-retina (p < 0,01 Student's t-test) and in the intermediate and peripheral concentric areas of the retina (p < 0.05 Student's t-test). This fact might improve the resistance of the retinal cells against OS and its downstream signalling pathways.	[Salazar, Juan J.; de Hoz, Rosa; Rojas, Blanca; Ramirez, Ana I.; Ramirez, Jose M.] Univ Complutense Madrid, Inst Invest Oftalmolo Ramon Castroviejo, Madrid, Spain; [Salazar, Juan J.; de Hoz, Rosa; Ramirez, Ana I.] Univ Complutense Madrid, Fac Opt & Optometria, Madrid, Spain; [Rojas, Blanca; Ramirez, Jose M.] Univ Complutense Madrid, Fac Med, Madrid, Spain; [Serrano, Manuel] Spanish Natl Canc Res Ctr, Madrid, Spain; [Gallego-Pinazo, Roberto] Univ & Polytech Hosp Le Fe, Dept Ophthalmol, Valencia, Spain; [Gallego-Pinazo, Roberto; Pinazo-Duran, Maria D.] Univ Valencia, Santiago Grisolia Fac Med, Ophthalm Res Unit, Valencia, Spain	Complutense University of Madrid; Complutense University of Madrid; Complutense University of Madrid; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Valencia	Ramirez, JM (corresponding author), Univ Complutense Madrid, Inst Invest Oftalmolo Ramon Castroviejo, Madrid, Spain.	ramirezs@med.ucm.es	De Hoz, Rosa/ABF-9295-2020; Salazar, Juan J/L-6887-2014; Serrano, Manuel/H-2634-2015; ROJAS, BLANCA/V-8292-2017; Ramírez, Ana I/ABF-4789-2021	De Hoz, Rosa/0000-0002-1581-087X; Salazar, Juan J/0000-0001-5480-5902; Serrano, Manuel/0000-0001-7177-9312; Ramírez, Ana I/0000-0002-2656-4723; Pinazo-Duran, Maria Dolores/0000-0002-0118-7837	RETICs Patologia Ocular del Envejecimiento, Calidad Visual y Calidad de Vida (Spanish Ministry of Science and Innovation) [ISCIII RD07/0062/0000]; RETICs Prevencion, deteccion precoz y tratamiento de la patologia ocular prevalente degenerative y cronica (Spanish Ministry of Science and Innovation) [ISCIII RD12/0034/0002, ISCIII RD12/0034/0008]; BSCH-UCM [GR35/10-A]; Universidad Complutense de Madrid	RETICs Patologia Ocular del Envejecimiento, Calidad Visual y Calidad de Vida (Spanish Ministry of Science and Innovation); RETICs Prevencion, deteccion precoz y tratamiento de la patologia ocular prevalente degenerative y cronica (Spanish Ministry of Science and Innovation); BSCH-UCM; Universidad Complutense de Madrid	Work at the Institute of Ophthalmic Research "Ramon Castroviejo'' (Madrid) has been funded by RETICs Patologia Ocular del Envejecimiento, Calidad Visual y Calidad de Vida (Grant ISCIII RD07/0062/0000, Spanish Ministry of Science and Innovation); RETICs Prevencion, deteccion precoz y tratamiento de la patologia ocular prevalente degenerative y cronica (Grant ISCIII RD12/0034/0002, Spanish Ministry of Science and Innovation); BSCH-UCM (GR35/10-A Programa de Grupos de Investigacion Santander-UCM); BIG is currently supported by a predoctoral fellowship from the Universidad Complutense de Madrid. Work at the Ophthalmic Research Unit "Santiago Grisolia'' (Valencia) has been funded by RETICs Prevencion, deteccion precoz y tratamiento de la patologia ocular prevalente degenerative y cronica (Grant ISCIII RD12/0034/0008, Spanish Ministry of Science and Innovation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bensaad K, 2005, NAT MED, V11, P1278, DOI 10.1038/nm1205-1278; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bonini P, 2004, J NEUROSCI RES, V75, P83, DOI 10.1002/jnr.10822; Borges HL, 2004, CELL DEATH DIFFER, V11, P494, DOI 10.1038/sj.cdd.4401366; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; BUSSOW H, 1980, CELL TISSUE RES, V206, P367; Carson MJ, 2006, CLIN NEUROSCI RES, V6, P237, DOI 10.1016/j.cnr.2006.09.004; Cavallotti C, 2003, ANAT HISTOL EMBRYOL, V32, P12, DOI 10.1046/j.1439-0264.2003.00431.x; Collado M, 2005, CELL CYCLE, V4, P1722, DOI 10.4161/cc.4.12.2260; COX LS, 1995, BIOESSAYS, V17, P501, DOI 10.1002/bies.950170606; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Dirnagl U, 2004, FOCAL CEREBRAL ISCHE, P520; Djebaili M, 2000, NEUROREPORT, V11, P2973, DOI 10.1097/00001756-200009110-00029; Gallego BI, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-92; Gallego-Pinazo R., 2008, Arch Soc Esp Oftalmol, V83, P105; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Gerdes HH, 2007, FEBS LETT, V581, P2194, DOI 10.1016/j.febslet.2007.03.071; Gu S, 2004, MOL CELL PROTEOMICS, V3, P998, DOI 10.1074/mcp.M400033-MCP200; Harada C, 2010, CELL DEATH DIFFER, V17, P1751, DOI 10.1038/cdd.2010.62; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; Hirrlinger PG, 2010, NEUROSCI LETT, V472, P73, DOI 10.1016/j.neulet.2010.01.062; HOLLANDER H, 1991, J COMP NEUROL, V313, P587, DOI 10.1002/cne.903130405; IKUI H, 1976, OPHTHALMIC RES, V8, P100, DOI 10.1159/000264803; Jebelli JD, 2012, GLIA, V60, P515, DOI 10.1002/glia.22268; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Joo CK, 1999, INVEST OPHTH VIS SCI, V40, P713; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lipton S A, 2001, Prog Brain Res, V131, P712; Ljungman M, 2000, NEOPLASIA, V2, P208, DOI 10.1038/sj.neo.7900073; Llanos S, 2006, CELL CYCLE, V5, P1880, DOI 10.4161/cc.5.16.3140; MADIGAN MC, 1994, RETINA-J RET VIT DIS, V14, P65, DOI 10.1097/00006982-199401000-00014; Malhotra A, 2011, SEMIN ULTRASOUND CT, V32, P2, DOI 10.1053/j.sult.2010.10.009; MALHOTRA SK, 1990, CYTOBIOS, V61, P133; Mancino R, 2011, MOL VIS, V17, P1298; Mansour H, 2008, AGING CELL, V7, P526, DOI 10.1111/j.1474-9726.2008.00402.x; Martin LJ, 2002, J NEUROBIOL, V50, P181, DOI 10.1002/neu.10026; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Miller TJ, 2006, NEUROTOXICOLOGY, V27, P44, DOI 10.1016/j.neuro.2005.06.001; Morgan SE, 1997, ADV CANCER RES, V71, P1, DOI 10.1016/S0065-230X(08)60095-0; Morrison RS, 1996, J NEUROSCI, V16, P1337; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; O'Connor JC, 2008, INVEST OPHTH VIS SCI, V49, P4237, DOI 10.1167/iovs.08-1963; Ohia SE, 2005, MUTAT RES-FUND MOL M, V579, P22, DOI 10.1016/j.mrfmmm.2005.03.025; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pinazo-Duran MD, 2007, ARVO M, V48, P4180; Pluquet O, 2001, CANCER LETT, V174, P1, DOI 10.1016/S0304-3835(01)00698-X; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Qin ZH, 1999, J NEUROSCI, V19, P4023; Ramirez AI, 2006, EXP EYE RES, V83, P1423, DOI 10.1016/j.exer.2006.07.023; Ramirez AI, 2010, INVEST OPHTH VIS SCI, V51, P5690, DOI 10.1167/iovs.10-5248; Ramirez JM, 1996, VISION RES, V36, P2029, DOI 10.1016/0042-6989(95)00322-3; RAMIREZ JM, 1994, VISION RES, V34, P1935, DOI 10.1016/0042-6989(94)90024-8; Ramirez JM, 2001, EXP EYE RES, V73, P601, DOI 10.1006/exer.2001.1061; RAMSON BR, 2005, NEUROGLIA, P177; RIDET JL, 2000, ADV STR BIO, V6, P147; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; SAKHI S, 1994, P NATL ACAD SCI USA, V91, P7525, DOI 10.1073/pnas.91.16.7525; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Suzuki K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/978312; Tacconi MT, 1998, NEUROCHEM RES, V23, P759, DOI 10.1023/A:1022463527474; TRIVINO A, 1992, VISION RES, V32, P1601, DOI 10.1016/0042-6989(92)90153-A; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Ueki Y, 2012, GLIA, V60, P1579, DOI 10.1002/glia.22377; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Villapol S, 2007, J NEUROSCI RES, V85, P3545, DOI 10.1002/jnr.21450; Villasante A, 2011, CELL CYCLE, V10, P1488, DOI 10.4161/cc.10.9.15658; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang MH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-173; Wasylyk C, 2000, MOL CELL BIOL, V20, P5554, DOI 10.1128/MCB.20.15.5554-5570.2000; Watanabe H, 1999, BRAIN RES, V837, P38, DOI 10.1016/S0006-8993(99)01652-2; WIEGAND RD, 1983, INVEST OPHTH VIS SCI, V24, P1433; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3; Yung HW, 2004, J NEUROCHEM, V89, P812, DOI 10.1111/j.1471-4159.2004.02395.x; Zahs KR, 1997, GLIA, V20, P10, DOI 10.1002/(SICI)1098-1136(199705)20:1<10::AID-GLIA2>3.3.CO;2-2; Zanon-Moreno V, 2008, J GLAUCOMA, V17, P263, DOI 10.1097/IJG.0b013e31815c3a7f; Zhang Yan, 2011, Commun Integr Biol, V4, P324, DOI 10.4161/cib.4.3.14855; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	84	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65446	10.1371/journal.pone.0065446	http://dx.doi.org/10.1371/journal.pone.0065446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762373	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000321094800050
J	Verbeek, NE; van der Maas, NAT; Jansen, FE; van Kempen, MJA; Lindhout, D; Brilstra, EH				Verbeek, Nienke E.; van der Maas, Nicoline A. T.; Jansen, Floor E.; van Kempen, Marjan J. A.; Lindhout, Dick; Brilstra, Eva H.			Prevalence of SCN1A-Related Dravet Syndrome among Children Reported with Seizures following Vaccination: A Population-Based Ten-Year Cohort Study	PLOS ONE			English	Article							SEVERE MYOCLONIC EPILEPSY; WHOLE-CELL PERTUSSIS; ACELLULAR PERTUSSIS; FEBRILE SEIZURES; SCN1A MUTATIONS; ADVERSE EVENTS; RISK; MEASLES; MUMPS; SURVEILLANCE	Objectives: To determine the prevalence of Dravet syndrome, an epileptic encephalopathy caused by SCN1A-mutations, often with seizure onset after vaccination, among infants reported with seizures following vaccination. To determine differences in characteristics of reported seizures after vaccination in children with and without SCN1A-related Dravet syndrome. Methods: Data were reviewed of 1,269 children with seizures following immunization in the first two years of life, reported to the safety surveillance system of the Dutch national immunization program between 1 January 1997 and 31 December 2006. Selective, prospective follow-up was performed of children with clinical characteristics compatible with a diagnosis of Dravet syndrome. Results: In 21.9% (n = 279) of children, a diagnosis of Dravet syndrome could not be excluded based on available clinical data (median age at follow-up 16 months). Additional follow-up data were obtained in 83.9% (n = 234) of these children (median age 8.5 years). 15 (1.2% of 1,269; 95%CI:0.6 to 1.8%) children were diagnosed with SCN1A-related Dravet syndrome. Of all reported seizures following vaccinations in the first year of life, 2.5% (95%CI:1.3 to 3.6%) were due to SCN1A-related Dravet syndrome, as were 5.9% of reported seizures (95%CI:3.1 to 8.7%) after 2nd or 3rd DTP-IPV-Hib vaccination. Seizures in children with SCN1A-related Dravet syndrome occurred more often with a body temperature below 38.5 degrees C (57.9% vs. 32.6%, p = 0.020) and reoccurred more often after following vaccinations (26.7% vs. 4.0%, p = 0.003), than in children without a diagnosis of SCN1A-related Dravet Syndrome. Conclusions: Although Dravet syndrome is a rare genetic epilepsy syndrome, 2.5% of reported seizures following vaccinations in the first year of life in our cohort occurred in children with this disorder. Knowledge on the specific characteristics of vaccination-related seizures in this syndrome might promote early diagnosis and indirectly, public faith in vaccination safety.	[Verbeek, Nienke E.; van Kempen, Marjan J. A.; Lindhout, Dick; Brilstra, Eva H.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [van der Maas, Nicoline A. T.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Jansen, Floor E.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Child Neurol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	Verbeek, NE (corresponding author), Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands.	n.verbeek@umcutrecht.nl	Lindhout, Dick/AAH-5765-2019; Brilstra, Eva/AAT-3092-2021	Lindhout, Dick/0000-0001-9580-624X	NutsOhra Fund [0801-064]; Stichting Vrienden UMC Utrecht [10.053]	NutsOhra Fund; Stichting Vrienden UMC Utrecht	The first author was supported by the NutsOhra Fund (grant no. 0801-064)(www.fondsnutsohra.nl) and by the "Stichting Vrienden UMC Utrecht" (project 10.053, www.vriendenumcutrecht.nl) on behalf of the Janivo Stichting (www.janivostichting.nl) to perform this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBINK F, 2006, 210021004 RIVM; Barlow WE, 2001, NEW ENGL J MED, V345, P656, DOI 10.1056/NEJMoa003077; Berkovic SF, 2006, LANCET NEUROL, V5, P488, DOI 10.1016/S1474-4422(06)70446-X; Bonhoeffer J, 2004, VACCINE, V22, P557, DOI 10.1016/j.vaccine.2003.09.008; Brunklaus A, 2012, BRAIN, V135, P2329, DOI 10.1093/brain/aws151; Burgess DC, 2006, VACCINE, V24, P3921, DOI 10.1016/j.vaccine.2006.02.033; Caraballo RH, 2006, EPILEPSY RES, V70, pS231, DOI 10.1016/j.eplepsyres.2005.11.026; Ceulemans B, 2004, J CHILD NEUROL, V19, P516, DOI 10.1177/08830738040190070701; David S, 2008, VACCINE, V26, P5883, DOI 10.1016/j.vaccine.2008.07.105; De Jonghe P, 2011, DEV MED CHILD NEUROL, V53, P7, DOI 10.1111/j.1469-8749.2011.03965.x; Depienne C, 2009, J MED GENET, V46, P183, DOI 10.1136/jmg.2008.062323; Depienne C, 2010, J MED GENET, V47, P404, DOI 10.1136/jmg.2009.074328; Dravet C, 2011, EPILEPSIA, V52, P3, DOI 10.1111/j.1528-1167.2011.02994.x; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; Fountain-Capal JK, 2011, PEDIATR NEUROL, V45, P319, DOI 10.1016/j.pediatrneurol.2011.08.001; Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1; Greco D, 1996, NEW ENGL J MED, V334, P341, DOI 10.1056/NEJM199602083340601; GRIFFIN MR, 1991, PEDIATRICS, V88, P881; Hattori J, 2008, EPILEPSIA, V49, P626, DOI 10.1111/j.1528-1167.2007.01475.x; HURST DL, 1990, EPILEPSIA, V31, P397, DOI 10.1111/j.1528-1157.1990.tb05494.x; Marini C, 2007, EPILEPSIA, V48, P1678, DOI 10.1111/j.1528-1167.2007.01122.x; McIntosh AM, 2010, LANCET NEUROL, V9, P592, DOI 10.1016/S1474-4422(10)70107-1; Mulley JC, 2005, HUM MUTAT, V25, P535, DOI 10.1002/humu.20178; Nieto-Barrera M, 2000, REV NEUROLOGIA, V30, P620, DOI 10.33588/rn.3007.2000016; Ottman R, 2010, EPILEPSIA, V51, P655, DOI 10.1111/j.1528-1167.2009.02429.x; Reyes IS, 2011, PEDIATRICS, V128, pE699, DOI 10.1542/peds.2010-0887; Scheffer IE, 1997, BRAIN, V120, P479, DOI 10.1093/brain/120.3.479; Sun YL, 2012, JAMA-J AM MED ASSOC, V307, P823, DOI 10.1001/jama.2012.165; Tro-Baumann B, 2011, EPILEPSIA, V52, P175, DOI 10.1111/j.1528-1167.2010.02885.x; van der Maas N A T, 2007, Ned Tijdschr Geneeskd, V151, P2732; VANDERMAAS NA, 2007, 240071004 RIVM; VANLIER EA, 2008, 210021007 RIVM; Verbeek NE, 2011, EPILEPSIA, V52, pE23, DOI 10.1111/j.1528-1167.2011.02982.x; VERMEERDEBONDT PE, 2002, 000001006 RIVM; von Spiczak S, 2011, EPILEPSIA, V52, P1506, DOI 10.1111/j.1528-1167.2011.03134.x; Ward KN, 2007, PEDIATRICS, V120, P314, DOI 10.1542/peds.2006-3743; YAKOUB M, 1992, BRAIN DEV-JPN, V14, P299, DOI 10.1016/S0387-7604(12)80147-1	37	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65758	10.1371/journal.pone.0065758	http://dx.doi.org/10.1371/journal.pone.0065758			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762420	Green Submitted, Green Published, gold			2022-12-25	WOS:000321099000102
J	Bezold, KL; Shaffer, JF; Khosa, JK; Hoye, ER; Harris, SP				Bezold, Kristina L.; Shaffer, Justin F.; Khosa, Jaskiran K.; Hoye, Elaine R.; Harris, Samantha P.			A Gain-of-Function Mutation in the M-domain of Cardiac Myosin-binding Protein-C Increases Binding to Actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiac Hypertrophy; Cardiac Muscle; Cardiomyopathy; Contractile Protein; Protein Phosphorylation; Myosin-binding Protein C; Tri-helix Bundle	N-TERMINAL DOMAINS; KINASE-A PHOSPHORYLATION; TROPONIN-I; F-ACTIN; MOTIF; MUSCLE; THICK; IDENTIFICATION; ACCELERATION; CONTRACTION	The M-domain is the major regulatory subunit of cardiac myosin-binding protein-C (cMyBP-C) that modulates actin and myosin interactions to influence muscle contraction. However, the precise mechanism(s) and the specific residues involved in mediating the functional effects of the M-domain are not fully understood. Positively charged residues adjacent to phosphorylation sites in the M-domain are thought to be critical for effects of cMyBP-C on cross-bridge interactions by mediating electrostatic binding with myosin S2 and/or actin. However, recent structural studies revealed that highly conserved sequences downstream of the phosphorylation sites form a compact tri-helix bundle. Here we used site-directed mutagenesis to probe the functional significance of charged residues adjacent to the phosphorylation sites and conserved residues within the tri-helix bundle. Results confirm that charged residues adjacent to phosphorylation sites and residues within the tri-helix bundle are important for mediating effects of the M-domain on contraction. In addition, four missense variants within the tri-helix bundle that are associated with human hypertrophic cardiomyopathy caused either loss-of-function or gain-of-function effects on force. Importantly, the effects of the gain-of-function variant, L348P, increased the affinity of the M-domain for actin. Together, results demonstrate that functional effects of the M-domain are not due solely to interactions with charged residues near phosphorylatable serines and provide the first demonstration that the tri-helix bundle contributes to the functional effects of the M-domain, most likely by binding to actin.	[Bezold, Kristina L.; Shaffer, Justin F.; Khosa, Jaskiran K.; Hoye, Elaine R.; Harris, Samantha P.] Univ Calif Davis, Davis, CA 95618 USA	University of California System; University of California Davis	Harris, SP (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, 1 Shields Ave, Davis, CA 95616 USA.	samharris@ucdavis.edu			National Institutes of Health [HL080367]; Department of Defense National Defense Science and Engineering Graduate (NDSEG); American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense National Defense Science and Engineering Graduate (NDSEG); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL080367 (to S. P. H.) and Department of Defense National Defense Science and Engineering Graduate (NDSEG) and American Heart Association fellowships (to K. L. B.).	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Ababou A, 2008, J MOL BIOL, V384, P615, DOI 10.1016/j.jmb.2008.09.065; Ackermann MA, 2013, FASEB J, V27, P3217, DOI 10.1096/fj.13-228882; [Anonymous], 2010, PYMOL MOL GRAPH SYST; Colson BA, 2008, CIRC RES, V103, P244, DOI 10.1161/CIRCRESAHA.108.178996; Colson BA, 2012, J MOL CELL CARDIOL, V53, P609, DOI 10.1016/j.yjmcc.2012.07.012; Copeland O, 2010, J MOL CELL CARDIOL, V49, P1003, DOI 10.1016/j.yjmcc.2010.09.007; Cuello F, 2011, J BIOL CHEM, V286, P5300, DOI 10.1074/jbc.M110.202713; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P223, DOI 10.1016/j.yjmcc.2007.05.003; FRIEDERICH E, 1992, CELL, V70, P81, DOI 10.1016/0092-8674(92)90535-K; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Govindan S, 2012, J MUSCLE RES CELL M, V33, P17, DOI 10.1007/s10974-012-9292-y; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Hamdani N, 2008, CARDIOVASC RES, V77, P649, DOI 10.1093/cvr/cvm079; Harris SP, 2011, CIRC RES, V108, P751, DOI 10.1161/CIRCRESAHA.110.231670; Harris SP, 2004, CIRC RES, V95, P930, DOI 10.1161/01.RES.0000147312.02673.56; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; Herron TJ, 2006, CIRC RES, V98, P1290, DOI 10.1161/01.RES.0000222059.54917.ef; Howarth JW, 2012, J BIOL CHEM, V287, P8254, DOI 10.1074/jbc.M111.309591; Jia WT, 2010, J PROTEOME RES, V9, P1843, DOI 10.1021/pr901006h; Karsai A, 2011, BIOPHYS J, V101, P1968, DOI 10.1016/j.bpj.2011.08.030; Kensler RW, 2011, J STRUCT BIOL, V174, P44, DOI 10.1016/j.jsb.2010.12.003; Kunst G, 2000, CIRC RES, V86, P51, DOI 10.1161/01.RES.86.1.51; LEVINE BA, 1988, EUR J BIOCHEM, V172, P389, DOI 10.1111/j.1432-1033.1988.tb13899.x; Lu YL, 2012, J BIOL CHEM, V287, P31596, DOI 10.1074/jbc.M112.383299; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Michalek AJ, 2013, BIOPHYS J, V104, P442, DOI [10.1016/j.bpj.2012.10.021, 10.1016/j.bpj.2012.12.021]; Mohamed AS, 1998, ARCH BIOCHEM BIOPHYS, V358, P313, DOI 10.1006/abbi.1998.0857; Mun JY, 2011, J MOL BIOL, V410, P214, DOI 10.1016/j.jmb.2011.05.010; Orlova A, 2011, J MOL BIOL, V412, P379, DOI 10.1016/j.jmb.2011.07.056; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602; Razumova MV, 2006, J BIOL CHEM, V281, P35846, DOI 10.1074/jbc.M606949200; Razumova MV, 2008, J GEN PHYSIOL, V132, P575, DOI 10.1085/jgp.200810013; Regnier M, 1998, BIOPHYS J, V74, P2005, DOI 10.1016/S0006-3495(98)77907-X; Rybakova IN, 2011, J BIOL CHEM, V286, P2008, DOI 10.1074/jbc.M110.170605; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; SCHLENDER KK, 1991, J BIOL CHEM, V266, P2811; Shaffer JF, 2007, FEBS LETT, V581, P1501, DOI 10.1016/j.febslet.2007.03.007; Shaffer JF, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/789798; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; Stelzer JE, 2006, CIRC RES, V99, P884, DOI 10.1161/01.RES.0000245191.34690.66; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Weisberg A, 1996, P NATL ACAD SCI USA, V93, P8999, DOI 10.1073/pnas.93.17.8999; Weith A, 2012, J MOL CELL CARDIOL, V52, P219, DOI 10.1016/j.yjmcc.2011.09.019; Weith AE, 2012, J MUSCLE RES CELL M, V33, P449, DOI 10.1007/s10974-012-9312-y; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e	52	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21496	21505		10.1074/jbc.M113.474346	http://dx.doi.org/10.1074/jbc.M113.474346			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23782699	hybrid, Green Published			2022-12-25	WOS:000328841900003
J	Zhou, X; Hao, Q; Liao, JM; Liao, P; Lu, H				Zhou, Xiang; Hao, Qian; Liao, Jun-ming; Liao, Peng; Lu, Hua			Ribosomal Protein S14 Negatively Regulates c-Myc Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Oncogene; p53; Proliferation; Signal Transduction; Transcription Regulation; 5-q Syndrome; c-Myc; Ribosomal Protein L11; Ribosomal Protein S14	TRANSGENIC MICE; DNA-BINDING; ESSENTIAL COFACTOR; GENE-EXPRESSION; ACTIVATES P53; MDM2; L11; DEGRADATION; ARF; PHOSPHORYLATION	The ribosomal gene RPS14 is associated with the cancer-prone 5q-syndrome, which is caused by an interstitial deletion of the long arm of human chromosome 5. Previously, we found that ribosomal protein S14 (RPS14) binds to and inactivates MDM2, consequently leading to p53-dependent cell-cycle arrest and growth inhibition. However, it remains elusive whether RPS14 regulates cell proliferation in a p53-independent manner. Here, we show that RPS14 interacts with the Myc homology box II (MBII) and the C-terminal basic helix-loop-helix leucine zipper (bHLH-LZ) domains of the oncoprotein c-Myc. Further, RPS14 inhibited c-Myc transcriptional activity by preventing the recruitment of c-Myc and its cofactor, TRRAP, to the target gene promoters, as thus suppressing c-Myc-induced cell proliferation. Also, siRNA-mediated RPS14 depletion elevated c-Myc transcriptional activity determined by its target gene, Nucleolin, expression. Interestingly, RPS14 depletion also resulted in the induction of c-Myc mRNA and subsequent protein levels. Consistent with this, RPS14 promoted c-Myc mRNA turnover through an Argonaute 2 (Ago2)- and microRNA-mediated pathway. Taken together, our study demonstrates that RPS14 negates c-Myc functions by directly inhibiting its transcriptional activity and mediating its mRNA degradation via miRNA.	[Lu, Hua] Tulane Univ, Sch Med, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Lu, Hua] Tulane Univ, Sch Med, Ctr Canc, New Orleans, LA 70112 USA	Tulane University; Tulane University	Lu, H (corresponding author), Tulane Univ, Sch Med, Dept Biochem & Mol Biol, 1430 Tulane Ave, New Orleans, LA 70112 USA.	hlu2@tulane.edu	Liao, Peng/Y-1896-2019; Zhou, Xiang/J-5046-2017	Liao, Peng/0000-0002-8409-5574; Zhou, Xiang/0000-0002-1172-7948	National Institutes of Health-NCI [CA095441, CA 079721, CA129828, CA 172468]; NATIONAL CANCER INSTITUTE [R01CA095441, R01CA129828, R01CA172468, R01CA079721] Funding Source: NIH RePORTER	National Institutes of Health-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in whole or in part by National Institutes of Health-NCI Grants CA095441, CA 079721, CA129828, and CA 172468 (to H.L.).	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; Amente S, 2006, CANCER BIOL THER, V5, P287, DOI 10.4161/cbt.5.3.2389; Barlow JL, 2010, NAT MED, V16, P59, DOI 10.1038/nm.2063; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Bonetti P, 2008, J CELL BIOL, V182, P19, DOI 10.1083/jcb.200711040; Challagundla KB, 2011, MOL CELL BIOL, V31, P4007, DOI 10.1128/MCB.05810-11; Chan SP, 2009, DEV BIOL, V334, P152, DOI 10.1016/j.ydbio.2009.07.011; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Cleveland JL, 2004, CANCER CELL, V6, P309, DOI 10.1016/j.ccr.2004.09.020; Court EL, 2004, LEUKEMIA RES, V28, P743, DOI 10.1016/j.leukres.2003.11.011; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2007, CELL CYCLE, V6, P2735, DOI 10.4161/cc.6.22.4895; Dai MS, 2007, EMBO J, V26, P3332, DOI 10.1038/sj.emboj.7601776; Dai MS, 2006, NEOPLASIA, V8, P630, DOI 10.1593/neo.06334; Dai MS, 2012, J BIOL CHEM, V287, P17120, DOI 10.1074/jbc.M111.311902; Datta A, 2004, J BIOL CHEM, V279, P36698, DOI 10.1074/jbc.M312305200; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Delgado M Dolores, 2010, Genes Cancer, V1, P605, DOI 10.1177/1947601910377495; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Escamilla-Powers JR, 2010, J BIOL CHEM, V285, P4847, DOI 10.1074/jbc.M109.074856; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Honda R, 1999, EMBO J, V18, P22, DOI 10.1093/emboj/18.1.22; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; Li ZL, 2008, P NATL ACAD SCI USA, V105, P18794, DOI 10.1073/pnas.0806879105; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Moberg KH, 2004, CURR BIOL, V14, P965, DOI 10.1016/j.cub.2004.04.040; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Park J, 2001, GENE DEV, V15, P1619, DOI 10.1101/gad.900101; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; SCHOENENBERGER CA, 1988, EMBO J, V7, P169, DOI 10.1002/j.1460-2075.1988.tb02797.x; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; STEWART TA, 1984, CELL, V38, P627, DOI 10.1016/0092-8674(84)90257-5; Tao WK, 1999, P NATL ACAD SCI USA, V96, P6937, DOI 10.1073/pnas.96.12.6937; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; VANDENBERGHE H, 1974, NATURE, V251, P437, DOI 10.1038/251437a0; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zeng SX, 2002, EMBO J, V21, P5487, DOI 10.1093/emboj/cdf540; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhang YP, 1999, MOL CELL, V3, P579, DOI 10.1016/S1097-2765(00)80351-2; Zhou X., ONCOGENE, V32, P388; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	65	50	53	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21793	10.1074/jbc.M112.445122	http://dx.doi.org/10.1074/jbc.M112.445122			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23775087	Green Published, hybrid			2022-12-25	WOS:000328841900029
J	Asanuma, M; Miyazaki, I; Diaz-Corrales, FJ; Higashi, Y; Namba, M; Ogawa, N				Asanuma, Masato; Miyazaki, Ikuko; Diaz-Corrales, Francisco J.; Higashi, Youichirou; Namba, Masayoshi; Ogawa, Norio			Transplantation of Melanocytes Obtained from the Skin Ameliorates Apomorphine-Induced Abnormal Behavior in Rodent Hemi-Parkinsonian Models	PLOS ONE			English	Article							LIPOSOME-ENTRAPPED TYROSINASE; MOUSE EPIDERMAL MELANOCYTES; HUMAN SUBSTANTIA-NIGRA; NEUROTROPHIC FACTOR; RAT MODEL; DISEASE; DOPAMINE; CELLS; MICE; DIFFERENTIATION	Tyrosinase, which catalyzes both the hydroxylation of tyrosine and consequent oxidation of L-DOPA to form melanin in melanocytes, is also expressed in the brain, and oxidizes L-DOPA and dopamine. Replacement of dopamine synthesis by tyrosinase was reported in tyrosine hydroxylase null mice. To examine the potential benefits of autograft cell transplantation for patients with Parkinson's disease, tyrosinase-producing cells including melanocytes, were transplanted into the striatum of hemi-parkinsonian model rats or mice lesioned with 6-hydroxydopamine. Marked improvement in apomorphine-induced rotation was noted at day 40 after intrastriatal melanoma cell transplantation. Transplantation of tyrosinase cDNA-transfected hepatoma cells, which constitutively produce L-DOPA, resulted in marked amelioration of the asymmetric apomorphine-induced rotation in hemi-parkinsonian mice and the effect was present up to 2 months. Moreover, parkinsonian mice transplanted with melanocytes from the back skin of black newborn mice, but not from albino mice, showed marked improvement in the apomorphine-induced rotation behavior up to 3 months after the transplantation. Dopamine-positive signals were seen around the surviving transplants in these experiments. Taken together with previous studies showing dopamine synthesis and metabolism by tyrosinase, these results highlight therapeutic potential of intrastriatal autograft cell transplantation of melanocytes in patients with Parkinson's disease.	[Asanuma, Masato; Miyazaki, Ikuko; Diaz-Corrales, Francisco J.; Higashi, Youichirou; Ogawa, Norio] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Brain Sci, Okayama, Japan; [Namba, Masayoshi] Niimi Coll, Niimi, Japan	Okayama University	Asanuma, M (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Brain Sci, Okayama, Japan.	asachan@cc.okayama-u.ac.jp	Diaz-Corrales, Francisco/L-7559-2014	Diaz-Corrales, Francisco/0000-0002-5752-0205	Japanese Ministry of Education, Culture, Sports, Science and Technology; Japanese Ministry of Health, Labour and Welfare; Grants-in-Aid for Scientific Research [24659431] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in part, by Grants-in-aid for Scientific Research on Innovative Areas "Brain Environment'' (M. A.), for Scientific Research (C) (M. A. and I. M.) and for the Encouragement of Young Scientists () (I. M.) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, and by Health and Labour Sciences Research Grants for Research on Measures for Intractable Diseases (M. A.), for Research on Psychiatric and Neurological Diseases and Mental Health (M. A. and N.O.), and for Comprehensive Research on Aging and Health (M. A. and N.O.) from the Japanese Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection, analyses, decision to prepare or submit the manuscript.	Amicarelli F, 1999, CELL MOL BIOL, V45, P1093; Asanuma M, 1998, NEUROSCIENCE, V85, P907, DOI 10.1016/S0306-4522(97)00665-9; DOI I, 1975, GANN, V66, P385; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; FREED WJ, 1989, BRAIN RES, V485, P349, DOI 10.1016/0006-8993(89)90579-9; Gross RE, 2011, LANCET NEUROL, V10, P509, DOI 10.1016/S1474-4422(11)70097-7; Higashi Y, 2000, J NEUROCHEM, V75, P1771, DOI 10.1046/j.1471-4159.2000.0751771.x; Hirobe T, 1999, PIGM CELL RES, V12, P147, DOI 10.1111/j.1600-0749.1999.tb00508.x; HIROBE T, 1992, J CELL PHYSIOL, V152, P337, DOI 10.1002/jcp.1041520215; Inden M, 2013, J NEUROSCI RES, V91, P62, DOI 10.1002/jnr.23128; Kaneko S, 2000, SCIENCE, V289, P633, DOI 10.1126/science.289.5479.633; Lindvall O, 2011, NEUROTHERAPEUTICS, V8, P539, DOI 10.1007/s13311-011-0069-6; MIRANDA M, 1984, GEN PHARMACOL-VASC S, V15, P541, DOI 10.1016/0306-3623(84)90212-X; MIRANDA M, 1983, GEN PHARMACOL, V14, P231, DOI 10.1016/0306-3623(83)90002-2; MIRANDA M, 1988, BIOCHIM BIOPHYS ACTA, V966, P276, DOI 10.1016/0304-4165(88)90077-3; Miyazaki I, 2006, FASEB J, V20, P571, DOI 10.1096/fj.05-4996fje; Motoori S, 2001, CANCER RES, V61, P5382; Nakao N, 2000, J NEUROSURG, V92, P659, DOI 10.3171/jns.2000.92.4.0659; Ogawa N, 2000, NEUROCHEM RES, V25, P755, DOI 10.1023/A:1007530720544; Olanow CW, 2009, ANN NEUROL, V66, P591, DOI 10.1002/ana.21778; Pawitan JA, 2011, ANAT CELL BIOL, V44, P256, DOI 10.5115/acb.2011.44.4.256; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Pellegrino L. J., 1979, STEREOTAXIC ATLAS RA; PEZZOLI G, 1988, BRAIN RES, V459, P398; Rios M, 1999, J NEUROSCI, V19, P3519; Smith GA, 2012, NEUROPHARMACOLOGY, V63, P818, DOI 10.1016/j.neuropharm.2012.06.011; Tief K, 1998, MOL BRAIN RES, V53, P307, DOI 10.1016/S0169-328X(97)00301-X; Tsuji T, 1998, BIOCHEM BIOPH RES CO, V242, P317, DOI 10.1006/bbrc.1997.7958; Xu YM, 1997, MOL BRAIN RES, V45, P159, DOI 10.1016/S0169-328X(96)00308-7; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F; Yasuhara T, 2005, J NEUROSURG, V102, P80, DOI 10.3171/jns.2005.102.1.0080	31	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65983	10.1371/journal.pone.0065983	http://dx.doi.org/10.1371/journal.pone.0065983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776585	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400068
J	Eerland, A; Engelen, JAA; Zwaan, RA				Eerland, Anita; Engelen, Jan A. A.; Zwaan, Rolf A.			The Influence of Direct and Indirect Speech on Mental Representations	PLOS ONE			English	Article							VOICE-SELECTIVE AREAS; SITUATION MODELS; VERB ASPECT; ACCESSIBILITY; ACTIVATION; MEMORY	Language can be viewed as a set of cues that modulate the comprehender's thought processes. It is a very subtle instrument. For example, the literature suggests that people perceive direct speech (e.g., Joanne said: 'I went out for dinner last night') as more vivid and perceptually engaging than indirect speech (e.g., Joanne said that she went out for dinner last night). But how is this alleged vividness evident in comprehenders' mental representations? We sought to address this question in a series of experiments. Our results do not support the idea that, compared to indirect speech, direct speech enhances the accessibility of information from the communicative or the referential situation during comprehension. Neither do our results support the idea that the hypothesized more vivid experience of direct speech is caused by a switch from the visual to the auditory modality. However, our results do show that direct speech leads to a stronger mental representation of the exact wording of a sentence than does indirect speech. These results show that language has a more subtle influence on memory representations than was previously suggested.	[Eerland, Anita] Open Univ, Dept Psychol, Heerlen, Netherlands; [Engelen, Jan A. A.; Zwaan, Rolf A.] Erasmus Univ, Dept Psychol, Rotterdam, Netherlands	Open University Netherlands; Erasmus University Rotterdam	Eerland, A (corresponding author), Open Univ, Dept Psychol, Heerlen, Netherlands.	anita.eerland@ou.nl		Engelen, Jan/0000-0003-1885-3530; Zwaan, Rolf/0000-0001-9967-7879	Erasmus University Rotterdam	Erasmus University Rotterdam	The authors received no external funding for the studies described in the manuscript. The authors used research money from the Erasmus University Rotterdam to pay the participants. The university played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohan J, 2008, 14 ANN C ARCH MECH L; CLARK HH, 1990, LANGUAGE, V66, P764, DOI 10.2307/414729; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; GLENBERG AM, 1987, J MEM LANG, V26, P69, DOI 10.1016/0749-596X(87)90063-5; Green D. M., 1966, SIGNAL DETECTION THE, DOI DOI 10.1086/405615; JACOBY LL, 1981, J EXP PSYCHOL GEN, V110, P306, DOI 10.1037/0096-3445.110.3.306; Johnson-Laird P. N., 1983, MENTAL MODELS COGNIT; Kaup B, 2003, J EXP PSYCHOL LEARN, V29, P439, DOI 10.1037/0278-7393.29.3.439; Kurby CA, 2009, COGNITION, V112, P457, DOI 10.1016/j.cognition.2009.05.007; LONG DL, 1992, J MEM LANG, V31, P634, DOI 10.1016/0749-596X(92)90032-S; Madden CJ, 2003, MEM COGNITION, V31, P663, DOI 10.3758/BF03196106; Magliano JP, 2000, DISCOURSE PROCESS, V29, P83, DOI 10.1207/S15326950dp2902_1; Masson MEJ, 2011, BEHAV RES METHODS, V43, P679, DOI 10.3758/s13428-010-0049-5; MONSEN RB, 1977, J ACOUST SOC AM, V62, P981, DOI 10.1121/1.381593; MORROW DG, 1987, J MEM LANG, V26, P165, DOI 10.1016/0749-596X(87)90122-7; Pinker Steven, 1994, LANGUAGE INSTINCT; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Schooler LJ, 2005, BEHAV RES METHODS, V37, P3, DOI 10.3758/BF03206393; Spence C, 1998, PERCEPT PSYCHOPHYS, V60, P125, DOI 10.3758/BF03211923; Stites MC, 2013, MEM COGNITION, V41, P137, DOI 10.3758/s13421-012-0248-7; SUH SY, 1993, J MEM LANG, V32, P279, DOI 10.1006/jmla.1993.1015; Sundermeier BA, 2005, MEM COGNITION, V33, P462, DOI 10.3758/BF03193063; van Dijk T., 1983, STRATEGIES DISCOURSE; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wagenmakers EJ, 2012, PERSPECT PSYCHOL SCI, V7, P632, DOI 10.1177/1745691612463078; Westerman DL, 2002, J MEM LANG, V47, P607, DOI 10.1016/S0749-596X(02)00022-0; Yao B, 2012, NEUROIMAGE, V60, P1832, DOI 10.1016/j.neuroimage.2012.01.111; Yao B, 2011, COGNITION, V121, P447, DOI 10.1016/j.cognition.2011.08.007; Yao B, 2011, J COGNITIVE NEUROSCI, V23, P3146, DOI 10.1162/jocn_a_00022; Zwaan RA, 1996, J EXP PSYCHOL LEARN, V22, P1196, DOI 10.1037/0278-7393.22.5.1196; ZWAAN RA, 1994, J EXP PSYCHOL LEARN, V20, P920, DOI 10.1037/0278-7393.20.4.920; Zwaan RA, 1998, PSYCHOL BULL, V123, P162, DOI 10.1037/0033-2909.123.2.162; Zwaan RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051382	35	14	14	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65480	10.1371/journal.pone.0065480	http://dx.doi.org/10.1371/journal.pone.0065480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163FW	23776488	Green Published, gold			2022-12-25	WOS:000320322400028
J	Havland, I; Lundholm, C; Lichtenstein, P; Neiderhiser, JM; Ganiban, JM; Spotts, EL; Walum, H; Reiss, D; Almqvist, C				Havland, Ida; Lundholm, Cecilia; Lichtenstein, Paul; Neiderhiser, Jenae M.; Ganiban, Jody M.; Spotts, Erica L.; Walum, Hasse; Reiss, David; Almqvist, Catarina			The Observed Association between Maternal Anxiety and Adolescent Asthma: Children of Twin Design Suggest Familial Effects	PLOS ONE			English	Article							CHILDHOOD ASTHMA; ENVIRONMENTAL-INFLUENCES; STRESS; BEHAVIOR; MOTHERS; DEPRESSION; RISK	Background: Previous studies indicate that maternal anxiety is associated with asthma in the adolescent child, but mechanisms are unclear. Objective: To investigate the association between maternal anxiety and maternal, self-and register-based report of asthma in the adolescent child, and whether the association remains after control of familial confounding (shared environmental and genetic factors). Method: From the Twin and Offspring Study of Sweden, 1691 mothers (1058 twins) and their adolescent child were included. The association between maternal self-reported anxiety (Beck Anxiety Inventory (BAI) and Karolinska Scales of Personality (KSP) somatic or psychic anxiety) and asthma based on subjective (maternal or child report) or objective (register-based diagnosis and medication) measures were analysed using logistic regression. The children-of-twins design was used to explore whether genes or environment contribute to the association. Results: Maternal BAI anxiety (OR 2.02, CI 1.15-3.55) was significantly associated with adolescent asthma reported by the mother. Maternal KSP somatic anxiety (OR 1.74, CI 1.04-2.91) and psychic anxiety (OR 1.74, CI 1.05-2.86) was significantly associated with breathlessness reported by the adolescent child. In contrast, maternal anxiety was not associated with increased risk for the register-based outcomes of asthma diagnosis or medication. The results remained also after adjusting for covariates and the children-of-twins analyses which indicate that the association was due to familial confounding. Conclusions: We found some associations between maternal anxiety and subjectively reported offspring asthma or breathlessness which may be due to familial effects. A likely candidate for explaining this familial confounding is heritable personality traits associated with both anxiety and subjective measures of asthma.	[Havland, Ida; Lundholm, Cecilia; Lichtenstein, Paul; Walum, Hasse; Almqvist, Catarina] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Neiderhiser, Jenae M.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Ganiban, Jody M.] George Washington Univ, Dept Psychol, Washington, DC 20052 USA; [Spotts, Erica L.] NIA, Div Behav & Social Res, NIH, Bethesda, MD 20892 USA; [Reiss, David] Yale Univ, Sch Med, Yale Child Study Ctr, New Haven, CT USA; [Almqvist, Catarina] Dept Womens & Childrens Hlth, Stockholm, Sweden; [Almqvist, Catarina] Astrid Lindgren Childrens Hosp, Stockholm, Sweden	Karolinska Institutet; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; George Washington University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Yale University	Almqvist, C (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	catarina.almqvist@ki.se		lichtenstein, paul/0000-0003-3037-5287; Neiderhiser, Jenae/0000-0003-4474-5330; Lundholm, Cecilia/0000-0002-6546-3650	National Institute of Mental Health [R01MH54610]; Stockholm County Council; Karolinska Institutet; Swedish Research Council [80748301, 2011-3060]; Swedish Heart and Lung Foundation; Strategic Research Program in Epidemiology at Karolinska Institutet; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054610] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Strategic Research Program in Epidemiology at Karolinska Institutet; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was supported by grant R01MH54610 from the National Institute of Mental Health. Financial support was provided through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, grants from the Swedish Research Council (grant numbers 80748301 and 2011-3060), the Swedish Heart and Lung Foundation and the Strategic Research Program in Epidemiology at Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1979, J CONSULT CLIN PSYCH, V47, P223, DOI 10.1037/0022-006X.47.2.223; Bakkeheim E, 2010, ACTA PAEDIATR, V99, P1705, DOI 10.1111/j.1651-2227.2009.01598.x; Beijers R, 2010, PEDIATRICS, V126, pE401, DOI 10.1542/peds.2009-3226; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; Brown ES, 2006, PEDIATRICS, V118, pE1715, DOI 10.1542/peds.2006-1119; BUTZ AM, 1993, J ASTHMA, V30, P199, DOI 10.3109/02770909309054518; BYRNE DG, 1977, AUST NZ J PSYCHIAT, V11, P179, DOI 10.3109/00048677709159558; Calam R, 2003, J ALLERGY CLIN IMMUN, V112, P499, DOI 10.1067/mai.2003.1639; Cookson H, 2009, J ALLERGY CLIN IMMUN, V123, P847, DOI 10.1016/j.jaci.2009.01.042; D'Onofrio BM, 2003, J CHILD PSYCHOL PSYC, V44, P1130, DOI 10.1111/1469-7610.00196; Dietert RR, 2011, REPROD TOXICOL, V32, P198, DOI 10.1016/j.reprotox.2011.04.007; Dreger LC, 2010, J ALLERGY CLIN IMMUN, V125, P116, DOI 10.1016/j.jaci.2009.09.051; Enns MW, 1998, J AFFECT DISORDERS, V47, P195, DOI 10.1016/S0165-0327(97)00103-1; Fang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027202; Koppelman GH, 1999, EUR RESPIR J, V13, P2, DOI 10.1183/09031936.99.13100299; Kozyrskyj AL, 2008, AM J RESP CRIT CARE, V177, P142, DOI 10.1164/rccm.200703-381OC; Kumar RK, 2009, DIS MODEL MECH, V2, P549, DOI 10.1242/dmm.001719; Magne P., 2012, P IEEE TRANSP EL C E, P1, DOI [10.1109/ITEC.2012.6243469, DOI 10.1109/ITEC.2012.6243469]; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Organization WH, 2002, WHO WAO M PREV ALL A, P14; Ortet G, 2002, EUR J PSYCHOL ASSESS, V18, P139, DOI 10.1027//1015-5759.18.2.139; Reiss D, 2001, FAM PROCESS, V40, P261, DOI 10.1111/j.1545-5300.2001.4030100261.x; Silver EJ, 2005, J ASTHMA, V42, P379, DOI 10.1081/JAS-200062999; Slattery MJ, 2010, J PSYCHIAT RES; von Hertzen LC, 2002, J ALLERGY CLIN IMMUN, V109, P923, DOI 10.1067/mai.2002.124776; WAHLER HJ, 1968, J CLIN PSYCHOL, V24, P207, DOI 10.1002/1097-4679(196804)24:2<207::AID-JCLP2270240223>3.0.CO;2-G; Wright RJ, 2002, AM J RESP CRIT CARE, V165, P358, DOI 10.1164/ajrccm.165.3.2102016; Wright RJ, 2011, IMMUNOL ALLERGY CLIN, V31, P19, DOI 10.1016/j.iac.2010.09.011; Yuksel H, 2007, RESP MED, V101, P2550, DOI 10.1016/j.rmed.2007.07.025	29	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66040	10.1371/journal.pone.0066040	http://dx.doi.org/10.1371/journal.pone.0066040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776601	Green Published, gold			2022-12-25	WOS:000320322400073
J	Kimirei, IA; Nagelkerken, I; Mgaya, YD; Huijbers, CM				Kimirei, Ismael A.; Nagelkerken, Ivan; Mgaya, Yunus D.; Huijbers, Chantal M.			The Mangrove Nursery Paradigm Revisited: Otolith Stable Isotopes Support Nursery-to-Reef Movements by Indo-Pacific Fishes	PLOS ONE			English	Article							SEAGRASS BEDS; CORAL-REEFS; TEMPORAL PATTERNS; FEEDING HABITATS; FRENCH GRUNTS; JUVENILE; CONNECTIVITY; ASSEMBLAGES; ESTUARINE; ZANZIBAR	Mangroves and seagrass beds have long been perceived as important nurseries for many fish species. While there is growing evidence from the Western Atlantic that mangrove habitats are intricately connected to coral reefs through ontogenetic fish migrations, there is an ongoing debate of the value of these coastal ecosystems in the Indo-Pacific. The present study used natural tags, viz. otolith stable carbon and oxygen isotopes, to investigate for the first time the degree to which multiple tropical juvenile habitats subsidize coral reef fish populations in the Indo Pacific (Tanzania). Otoliths of three reef fish species (Lethrinus harak, L. lentjan and Lutjanus fulviflamma) were collected in mangrove, seagrass and coral reef habitats and analyzed for stable isotope ratios in the juvenile and adult otolith zones. delta C-13 signatures were significantly depleted in the juvenile compared to the adult zones, indicative of different habitat use through ontogeny. Maximum likelihood analysis identified that 82% of adult reef L. harak had resided in either mangrove (29%) or seagrass (53%) or reef (18%) habitats as juveniles. Of adult L. fulviflamma caught from offshore reefs, 99% had passed through mangroves habitats as juveniles. In contrast, L. lentjan adults originated predominantly from coral reefs (65-72%) as opposed to inshore vegetated habitats (28-35%). This study presents conclusive evidence for a nursery role of Indo-Pacific mangrove habitats for reef fish populations. It shows that intertidal habitats that are only temporarily available can form an important juvenile habitat for some species, and that reef fish populations are often replenished by multiple coastal habitats. Maintaining connectivity between inshore vegetated habitats and coral reefs, and conserving habitat mosaics rather than single nursery habitats, is a major priority for the sustainability of various Indo Pacific fish populations.	[Kimirei, Ismael A.; Nagelkerken, Ivan; Huijbers, Chantal M.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Anim Ecol & Ecophysiol, NL-6525 ED Nijmegen, Netherlands; [Kimirei, Ismael A.] Tanzania Fisheries Res Inst, Kigoma, Tanzania; [Nagelkerken, Ivan] Univ Adelaide, Sch Earth & Environm Sci, So Seas Ecol Labs, Adelaide, SA, Australia; [Mgaya, Yunus D.] Univ Dar Es Salaam, Dept Aquat Sci & Fisheries, Coll Nat & Appl Sci, Dar Es Salaam, Tanzania; [Huijbers, Chantal M.] Griffith Univ, Australian Rivers Inst Coasts & Estuaries, Southport, Qld 4215, Australia	Radboud University Nijmegen; University of Adelaide; University of Dar es Salaam; Griffith University	Nagelkerken, I (corresponding author), Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Anim Ecol & Ecophysiol, NL-6525 ED Nijmegen, Netherlands.	ivan.nagelkerken@adelaide.edu.au	Huijbers, Chantal/J-5176-2014; Nagelkerken, Ivan/E-1093-2011; Kimirei, Ismael Aaron/F-7385-2012	Huijbers, Chantal/0000-0001-5206-3415; Nagelkerken, Ivan/0000-0003-4499-3940; Kimirei, Ismael Aaron/0000-0002-1101-5262; Mgaya, Yunus/0000-0002-9592-4913	WOTRO Science for Global Development (WOTRO); Netherlands Organization for Scientific Research (NWO); NWO; Schure-Beijerinck-Popping Fonds; Western Indian Ocean Marine Science Association (WIOMSA)	WOTRO Science for Global Development (WOTRO); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO(Netherlands Organization for Scientific Research (NWO)); Schure-Beijerinck-Popping Fonds; Western Indian Ocean Marine Science Association (WIOMSA)	This study was funded through WOTRO Science for Global Development (WOTRO) by the Netherlands Organization for Scientific Research (NWO). I.N. was funded by a Vidi grant from NWO. The field work was supported by a grant from Schure-Beijerinck-Popping Fonds and Western Indian Ocean Marine Science Association (WIOMSA) to I.A.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AJ, 2006, MAR ECOL PROG SER, V318, P287, DOI 10.3354/meps318287; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; BLABER SJM, 2000, FISH AQUATIC RESOURC, V7; Blaber SJM, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P533, DOI 10.1007/978-90-481-2406-0_15; Bouillon S, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 7: FUNCTIONING OF ECOSYSTEMS AT THE LAND-OCEAN INTERFACE, P143; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campana SE, 2005, MAR FRESHWATER RES, V56, P485, DOI 10.1071/MF04147; Chittaro PM, 2004, J EXP MAR BIOL ECOL, V308, P169, DOI 10.1016/j.jembe.2004.02.021; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dorenbosch M, 2004, ENVIRON BIOL FISH, V70, P203, DOI 10.1023/B:EBFI.0000033336.10737.f5; Dorenbosch M, 2007, MAR ECOL PROG SER, V334, P103, DOI 10.3354/meps334103; Dorenbosch M, 2006, HYDROBIOLOGIA, V563, P45, DOI 10.1007/s10750-005-1428-2; Dorenbosch M, 2006, BIOL CONSERV, V129, P277, DOI 10.1016/j.biocon.2005.10.032; Dorenbosch M, 2005, MAR ECOL PROG SER, V302, P63, DOI 10.3354/meps302063; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Elsdon TS, 2008, OCEANOGR MAR BIOL, V46, P297, DOI 10.1201/9781420065756.ch7; Faunce CH, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P401, DOI 10.1007/978-90-481-2406-0_11; Field A., 2009, DISCOVERING STAT USI; Gillanders BM, 2002, MAR ECOL PROG SER, V240, P215, DOI 10.3354/meps240215; Gillanders BM, 1997, ENVIRON BIOL FISH, V49, P153, DOI 10.1023/A:1007315201690; Gillanders BM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P503; Gillanders BM, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P457, DOI 10.1007/978-90-481-2406-0_13; Carman VG, 2012, J EXP MAR BIOL ECOL, V429, P64, DOI 10.1016/j.jembe.2012.06.007; Huijbers CM, 2013, ECOLOGY, V94, P1859, DOI 10.1890/11-1759.1; Kimirei IA, 2013, ECOSYSTEMS, V16, P783, DOI 10.1007/s10021-013-9645-4; Kimirei IA, 2011, ESTUAR COAST SHELF S, V92, P47, DOI 10.1016/j.ecss.2010.12.016; Kruitwagen G, 2010, ESTUAR COAST SHELF S, V88, P464, DOI 10.1016/j.ecss.2010.05.002; Laroche J, 1997, J FISH BIOL, V51, P3, DOI 10.1111/j.1095-8649.1997.tb02509.x; Lugendo BR, 2006, J FISH BIOL, V69, P1639, DOI 10.1111/j.1095-8649.2006.01231.x; Lugendo BR, 2007, B MAR SCI, V80, P497; Lugendo BR, 2005, AQUAT LIVING RESOUR, V18, P149, DOI 10.1051/alr:2005016; Mateo I, 2010, MAR ECOL PROG SER, V402, P197, DOI 10.3354/meps08445; McMahon KW, 2011, CORAL REEFS, V30, P1135, DOI 10.1007/s00338-011-0816-5; MILLAR RB, 1990, CAN J FISH AQUAT SCI, V47, P2235, DOI 10.1139/f90-248; Mumby PJ, 2008, J APPL ECOL, V45, P854, DOI 10.1111/j.1365-2664.2008.01459.x; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Nagelkerken I, 2008, MAR ECOL PROG SER, V368, P155, DOI 10.3354/meps07528; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Nagelkerken I, 2000, MAR ECOL PROG SER, V202, P175, DOI 10.3354/meps202175; Nagelkerken I, 2007, B MAR SCI, V80, P595; Nagelkerken I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036906; Nagelkerken I, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P357, DOI 10.1007/978-90-481-2406-0_10; Nakamura Y, 2008, MAR ECOL PROG SER, V355, P257, DOI 10.3354/meps07234; Nakamura Y, 2008, ESTUAR COAST SHELF S, V76, P345, DOI 10.1016/j.ecss.2007.07.014; Nakamura Y, 2012, MAR BIOL, V159, P1305, DOI 10.1007/s00227-012-1911-z; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Olds AD, 2012, CONSERV LETT, V5, P56, DOI 10.1111/j.1755-263X.2011.00204.x; Sheaves M, 2005, MAR ECOL PROG SER, V302, P293, DOI 10.3354/meps302293; Sheaves M, 2001, MAR ECOL PROG SER, V222, P279, DOI 10.3354/meps222279; Sheaves M, 2009, MAR ECOL PROG SER, V391, P107, DOI 10.3354/meps08121; Sheaves M, 2009, MAR ECOL PROG SER, V385, P245, DOI 10.3354/meps08040; Thollot P, 1992, P 7 INT COR REEF S G, V2, P934; Unsworth RKF, 2008, MAR ECOL PROG SER, V353, P213, DOI 10.3354/meps07199; Unsworth RKF, 2007, J MAR BIOL ASSOC UK, V87, P1287, DOI 10.1017/S002531540705638X; URT, 2009, FISH REG 2009 GNNO 3; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Verweij MC, 2008, LIMNOL OCEANOGR, V53, P1540, DOI 10.4319/lo.2008.53.4.1540; Verweij MC, 2007, HYDROBIOLOGIA, V592, P257, DOI 10.1007/s10750-007-0772-9; Verweij MC, 2006, MAR BIOL, V149, P1291, DOI 10.1007/s00227-006-0305-5; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Yates PM, 2012, MAR ECOL PROG SER, V458, P269, DOI 10.3354/meps09759	62	60	61	3	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66320	10.1371/journal.pone.0066320	http://dx.doi.org/10.1371/journal.pone.0066320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776658	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400096
J	Soto-Azat, C; Valenzuela-Sanchez, A; Collen, B; Rowcliffe, JM; Veloso, A; Cunningham, AA				Soto-Azat, Claudio; Valenzuela-Sanchez, Andres; Collen, Ben; Rowcliffe, J. Marcus; Veloso, Alberto; Cunningham, Andrew A.			The Population Decline and Extinction of Darwin's Frogs	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; RHINODERMA-DARWINII; SIGHTING RECORD; XENOPUS-LAEVIS; RAIN-FORESTS; CONSERVATION; DIVERSITY; CHILE; RANGE; AMPHIBIANS	Darwin's frogs (Rhinoderma darwinii and R. rufum) are two species of mouth-brooding frogs from Chile and Argentina. Here, we present evidence on the extent of declines, current distribution and conservation status of Rhinoderma spp.; including information on abundance, habitat and threats to extant Darwin's frog populations. All known archived Rhinoderma specimens were examined in museums in North America, Europe and South America. Extensive surveys were carried out throughout the historical ranges of R. rufum and R. darwinii from 2008 to 2012. Literature review and location data of 2,244 archived specimens were used to develop historical distribution maps for Rhinoderma spp. Based on records of sightings, optimal linear estimation was used to estimate whether R. rufum can be considered extinct. No extant R. rufum was found and our modelling inferred that this species became extinct in 1982 (95% CI, 1980-2000). Rhinoderma darwinii was found in 36 sites. All populations were within native forest and abundance was highest in Chiloe Island, when compared with Coast, Andes and South populations. Estimated population size and density (five populations) averaged 33.2 frogs/population (range, 10.2-56.3) and 14.9 frogs/100 m(2) (range, 5.3-74.1), respectively. Our results provide further evidence that R. rufum is extinct and indicate that R. darwinii has declined to a much greater degree than previously recognised. Although this species can still be found across a large part of its historical range, remaining populations are small and severely fragmented. Conservation efforts for R. darwinii should be stepped up and the species re-classified as Endangered.	[Soto-Azat, Claudio; Valenzuela-Sanchez, Andres] Univ Andres Bello, Fac Ecol & Recursos Nat, Lab Salud Ecosistemas, Santiago, Chile; [Soto-Azat, Claudio; Rowcliffe, J. Marcus; Cunningham, Andrew A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Collen, Ben] UCL, Ctr Biodivers & Environm Res, London, England; [Veloso, Alberto] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Las Palmeras, Nunoa, Chile	Universidad Andres Bello; Zoological Society of London; University of London; University College London; Universidad de Chile	Soto-Azat, C (corresponding author), Univ Andres Bello, Fac Ecol & Recursos Nat, Lab Salud Ecosistemas, Republ 252, Santiago, Chile.	csoto@unab.cl	Cunningham, Andrew A/E-7536-2010; Rowcliffe, Marcus/G-3713-2018; Collen, Ben/F-2543-2016; Valenzuela-Sánchez, Andrés/AAG-2762-2019	Rowcliffe, Marcus/0000-0002-4286-6887; Collen, Ben/0000-0003-2564-4243; Valenzuela-Sánchez, Andrés/0000-0002-0445-9156; Azat, Claudio/0000-0001-9201-7886	Institute of Zoology, Zoological Society of London (ZSL); ZSL EDGE Fellowship Programme; Direccion General de Investigacion y Doctorados, Universidad Andres Bello; Field Veterinary Programme; Wildlife Health Fund; Wildlife Conservation Society (WCS); Fundacion Futuro Scholarship; Royal Society Wolfson Research Merit Award	Institute of Zoology, Zoological Society of London (ZSL); ZSL EDGE Fellowship Programme; Direccion General de Investigacion y Doctorados, Universidad Andres Bello; Field Veterinary Programme; Wildlife Health Fund; Wildlife Conservation Society (WCS); Fundacion Futuro Scholarship; Royal Society Wolfson Research Merit Award(Royal Society of London)	This research was funded by the Institute of Zoology, Zoological Society of London (ZSL) and the ZSL EDGE Fellowship Programme; the Direccion General de Investigacion y Doctorados, Universidad Andres Bello; the Field Veterinary Programme, Wildlife Health Fund, Wildlife Conservation Society (WCS); and a Fundacion Futuro Scholarship. AAC is supported by a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstrup S, 2005, HANDBOOK OF CAPTURE-RECAPTURE ANALYSIS, P58; Babbitt Kimberly J., 2010, P299; Barros R., 1918, Revista Chilena Santiago, V22, P71; Bell T., 1843, ZOOLOGY VOYAGE HMS B; Bourke J, 2010, DIS AQUAT ORGAN, V92, P217, DOI 10.3354/dao02239; Bourke J, 2012, NORTH-WEST J ZOOL, V8, P99; Bourke J, 2011, J NAT HIST, V45, P2661, DOI 10.1080/00222933.2011.597885; Burger O., 1905, NEOMELIA RHINODERMA; Burgman MA, 2003, ANIM CONSERV, V6, P19, DOI 10.1017/S1367943003003044; Busse K, 2004, CRIA CAUTIVIDAD FAUN, P139; Busse Klaus, 2002, Reptilia (GB), V25, P63; Bustamante RO, 2005, BIOL INVASIONS, V7, P243, DOI 10.1007/s10530-004-0740-5; Butchart S. H. M., 2006, Bulletin of the British Ornithologists' Club, V126, P7; Camus P., 2006, AMBIENTE BOSQUES GES; Carn SA, 2009, T AM GEOPHYS UNION, V90, P205, DOI DOI 10.1029/2009EO240001; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; CEI J.M., 1962, BATRACIOS CHILE; Chancellor G., 2009, C DARWINS NOTEBOOKS; Collen B, 2010, DIVERS DISTRIB, V16, P755, DOI 10.1111/j.1472-4642.2010.00689.x; Crump Martha L., 2002, Herpetological Natural History, V9, P21; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; Delpino, 2011, ACTIVIDAD COMPLEJO V; Donoso-Barros R, 1970, CHILE, V31, P49; Duffy KJ, 2011, CONSERV BIOL, V25, P392, DOI 10.1111/j.1523-1739.2010.01612.x; Dumeril AMC, 1841, LIBRARIE ENVY RORET, V8; Echeverria C, 2006, BIOL CONSERV, V130, P481, DOI 10.1016/j.biocon.2006.01.017; Eterovick Paula C., 2009, South American Journal of Herpetology, V4, P235, DOI 10.2994/057.004.0306; Formas J.R., 1995, DIVERSIDAD BIOL CHIL, P314; FORMAS R, 1975, Physis Seccion C los Continentes y los Organismos Terrestres, V34, P147; Formas R, 1976, EXPERIENTIA, V32, P1000; Frost DR, 2013, AMPHIBIAN SPECIES WO; GOICOECHEA O, 1986, J HERPETOL, V20, P168, DOI 10.2307/1563941; Hamer AJ, 2010, ANIM CONSERV, V13, P275, DOI 10.1111/j.1469-1795.2009.00335.x; Huang CY, 2004, ZOOL STUD, V43, P795; Iriarte JA, 2005, REV CHIL HIST NAT, V78, P143, DOI 10.4067/S0716-078X2005000100010; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Jimenez de la Espada DM, 1872, AN SOC HIST NAT MADR, V1, P139; JORQUERA B, 1982, J HERPETOL, V16, P204, DOI 10.2307/1563714; Jorquera B, 1981, MEDIO AMBIENTE, V5, P58; Kuzmin Sergius L., 2010, Russian Journal of Herpetology, V17, P259; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lobos G, 2005, BIODIVERS CONSERV, V14, P429, DOI 10.1007/s10531-004-6403-0; Lockwood J.P., 2010, VOLCANOES GLOBAL PER; Measey GJ, 2012, BIOL INVASIONS, V14, P2255, DOI 10.1007/s10530-012-0227-8; MENDEZ M, 2005, HIST BIODIVERSIDAD E, P441; Ortiz, 1988, COMUNICACIONES MUSEO, V2, P37; PENNA M, 1990, J HERPETOL, V24, P23, DOI 10.2307/1564285; Philippi, 1902, SUPLEMENTO BATRAQUIO; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Rageot R, 1978, OBSERVACIONES BIOL R; Richardson David M., 1998, P450; Scribner KT, 2001, BIOL CONSERV, V98, P201, DOI 10.1016/S0006-3207(00)00155-5; Seimon TA, 2007, GLOBAL CHANGE BIOL, V13, P288, DOI 10.1111/j.1365-2486.2006.01278.x; Smith-Ramirez C, 2004, BIODIVERS CONSERV, V13, P373, DOI 10.1023/B:BIOC.0000006505.67560.9f; Solis R, 2010, BIOL INVASIONS, V12, P1641, DOI 10.1007/s10530-009-9577-2; Solow AR, 2005, MATH BIOSCI, V195, P47, DOI 10.1016/j.mbs.2005.02.001; Soto-Azat C, 2010, DIVERS DISTRIB, V16, P126, DOI 10.1111/j.1472-4642.2009.00618.x; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tabassum F, 2011, ASIAN HERPETOL RES, V2, P245, DOI 10.3724/SP.J.1245.2011.00245; Torres D, 1973, SANTIAGO, V203-204, P7; Ubeda C, 2010, RHINODERMA DARWINII; Valdovinos C., 2005, HIST BIODIVERSIDAD E, P452; Vallan D, 2002, J TROP ECOL, V18, P725, DOI 10.1017/S026646740200247X; Veloso A, 2010, RHINODERMA RUFUM IUC; Voyles J, 2012, ECOL EVOL, V2, P2241, DOI 10.1002/ece3.334; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804; Werning H, 2009, IRCF REPTILES AMPHIB, V16, P247; Wilhelm O, 1927, B SOC BIOL CONCEPCIO, V1, P11; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x	69	33	36	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66957	10.1371/journal.pone.0066957	http://dx.doi.org/10.1371/journal.pone.0066957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776705	Green Published, Green Submitted, gold			2022-12-25	WOS:000320322400122
J	Suikkanen, S; Pulina, S; Engstrom-Ost, J; Lehtiniemi, M; Lehtinen, S; Brutemark, A				Suikkanen, Sanna; Pulina, Silvia; Engstrom-Ost, Jonna; Lehtiniemi, Maiju; Lehtinen, Sirpa; Brutemark, Andreas			Climate Change and Eutrophication Induced Shifts in Northern Summer Plankton Communities	PLOS ONE			English	Article							LONG-TERM CHANGES; REGIME SHIFTS; BALTIC SEA; PHYTOPLANKTON; DYNAMICS; PHENOLOGY; ECOSYSTEM; TRENDS; BLOOMS; GROWTH	Marine ecosystems are undergoing substantial changes due to human-induced pressures. Analysis of long-term data series is a valuable tool for understanding naturally and anthropogenically induced changes in plankton communities. In the present study, seasonal monitoring data were collected in three sub-basins of the northern Baltic Sea between 1979 and 2011 and statistically analysed for trends and interactions between surface water hydrography, inorganic nutrient concentrations and phyto-and zooplankton community composition. The most conspicuous hydrographic change was a significant increase in late summer surface water temperatures over the study period. In addition, salinity decreased and dissolved inorganic nutrient concentrations increased in some basins. Based on redundancy analysis (RDA), warming was the key environmental factor explaining the observed changes in plankton communities: the general increase in total phytoplankton biomass, Cyanophyceae, Prymnesiophyceae and Chrysophyceae, and decrease in Cryptophyceae throughout the study area, as well as increase in rotifers and decrease in total zooplankton, cladoceran and copepod abundances in some basins. We conclude that the plankton communities in the Baltic Sea have shifted towards a food web structure with smaller sized organisms, leading to decreased energy available for grazing zooplankton and planktivorous fish. The shift is most probably due to complex interactions between warming, eutrophication and increased top-down pressure due to overexploitation of resources, and the resulting trophic cascades.	[Suikkanen, Sanna; Lehtiniemi, Maiju; Lehtinen, Sirpa] Finnish Environm Inst, Ctr Marine Res, Helsinki, Finland; [Pulina, Silvia] Univ Sassari, Dept Sci Nat & Environm Resources, I-07100 Sassari, Italy; [Engstrom-Ost, Jonna; Brutemark, Andreas] Novia Univ Appl Sci, ARONIA Coastal Zone Res Team, Ekenas, Finland; [Engstrom-Ost, Jonna; Brutemark, Andreas] Abo Akad Univ, Ekenas, Finland; [Engstrom-Ost, Jonna; Brutemark, Andreas] Tvarminne Zool Stn, SF-10900 Hango, Finland	Finnish Environment Institute; University of Sassari; Novia University of Applied Sciences; Abo Akademi University	Suikkanen, S (corresponding author), Finnish Environm Inst, Ctr Marine Res, Helsinki, Finland.	sanna.suikkanen@ymparisto.fi	Lehtiniemi, Maiju/AAN-6012-2020; Pulina, Silvia/Q-2684-2017; Engström-Öst, Jonna/C-7373-2008	Pulina, Silvia/0000-0002-4861-4170; Engström-Öst, Jonna/0000-0003-1792-7702; Suikkanen, Sanna/0000-0002-0768-8149; Lehtinen, Sirpa/0000-0001-7784-8497	Finnish Institute of Marine Research; Finnish Environment Institute; Department of Natural Science and Environmental Resources of the University of Sassari; Academy of Finland [259357, 255566]; Walter and Andree de Nottbeck Foundation	Finnish Institute of Marine Research; Finnish Environment Institute; Department of Natural Science and Environmental Resources of the University of Sassari; Academy of Finland(Academy of Finland); Walter and Andree de Nottbeck Foundation	This study was supported by the Finnish Institute of Marine Research, Finnish Environment Institute, Department of Natural Science and Environmental Resources of the University of Sassari, the Academy of Finland (grant numbers 259357 to SS and 255566 to JEO) and Walter and Andree de Nottbeck Foundation (post-doctoral scholarship to AB). The funders had no role in study design and analyses, decision to publish, or in the preparation of the manuscript. The major part of the monitoring data used in the study was collected by personnel of the Finnish Institute of Marine Research and Finnish Environment Institute.	B.A.C.C. Author Team, 2008, ASS CLIM CHANG BALT; Beaugrand G, 2012, MAR ECOL PROG SER, V445, P293, DOI 10.3354/meps09493; Berglund J, 2007, LIMNOL OCEANOGR, V52, P121, DOI 10.4319/lo.2007.52.1.0121; Casini M, 2008, P ROY SOC B-BIOL SCI, V275, P1793, DOI 10.1098/rspb.2007.1752; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Dahl E, 2005, J SEA RES, V54, P15, DOI 10.1016/j.seares.2005.02.004; Dame R, 2000, ESTUARIES, V23, P793, DOI 10.2307/1352999; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DEBERNARDI R, 1990, HYDROBIOLOGIA, V200, P29, DOI 10.1007/BF02530326; Dippner JW, 2012, J MARINE SYST, V105, P115, DOI 10.1016/j.jmarsys.2012.07.001; Domingues CM, 2008, NATURE, V453, P1090, DOI 10.1038/nature07080; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Engstrom-Ost J, 2011, HARMFUL ALGAE, V10, P530, DOI 10.1016/j.hal.2011.04.002; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fleming-Lehtinen V, 2008, AMBIO, V37, P86, DOI 10.1579/0044-7447(2008)37[86:LDOINA]2.0.CO;2; FLINKMAN J, 1992, CAN J FISH AQUAT SCI, V49, P73, DOI 10.1139/f92-008; Graham LP, 2004, AMBIO, V33, P235, DOI 10.1639/0044-7447(2004)033[0235:CCEORF]2.0.CO;2; Grasshoff K, 1999, METHODS SEAWATER ANA; Grubisic LM, 2012, MAR ECOL PROG SER, V453, P37, DOI 10.3354/meps09634; Hallegraeff GM, 2010, J PHYCOL, V46, P220, DOI 10.1111/j.1529-8817.2010.00815.x; Hallfors H, 2013, HYDROBIOLOGIA, V707, P109, DOI 10.1007/s10750-012-1414-4; *HELCOM, 1988, BALT SEA ENV P D, V27; HELGOM, 2009, BALT SEA ENV P B, V115B; Hillebrand H, 2010, GLOBAL CHANGE BIOL, V16, P1181, DOI 10.1111/j.1365-2486.2009.02045.x; Intergovernmental Panel on Climate Change, 2022, CLIM CHANG 2022 IMP, P1; Johansson N, 1999, MAR BIOL, V135, P209, DOI 10.1007/s002270050618; Klais R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021567; Klaveness D., 1988, P105; Koeller P, 2009, SCIENCE, V324, P791, DOI 10.1126/science.1170987; Koroleff F., 1979, MERI, V7, P1; LEGENDRE L, 1995, OPHELIA, V41, P153, DOI 10.1080/00785236.1995.10422042; LEHMAN JT, 1985, LIMNOL OCEANOGR, V30, P34, DOI 10.4319/lo.1985.30.1.0034; Lekve K, 2006, P ROY SOC B-BIOL SCI, V273, P3047, DOI 10.1098/rspb.2006.3656; Lepparanta M, 2009, SPRINGER-PRAX BOOKS, pXI; Ljunggren L, 2010, ICES J MAR SCI, V67, P1587, DOI 10.1093/icesjms/fsq109; McKnight DM, 2000, J PHYCOL, V36, P852, DOI 10.1046/j.1529-8817.2000.00031.x; Mollmann C, 2008, ICES J MAR SCI, V65, P302, DOI 10.1093/icesjms/fsm197; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Ohlberger J, 2011, AM NAT, V177, P211, DOI 10.1086/657925; Ojaveer H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012467; Olenina I., 2006, BALT SEA ENV P, V106; Olli K, 2011, BOREAL ENVIRON RES, V16, P3; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; R Core Team, 2012, R LANG ENV STAT COMP; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Richardson AJ, 2012, BIOL LETTERS, V8, P907, DOI 10.1098/rsbl.2012.0530; Sopanen S, 2008, MAR ECOL PROG SER, V361, P191, DOI 10.3354/meps07374; Suikkanen S, 2007, ESTUAR COAST SHELF S, V71, P580, DOI 10.1016/j.ecss.2006.09.004; ter Braak CJF, 1994, ECOSCIENCE, V1, P127, DOI 10.1080/11956860.1994.11682237; Uitto A, 1997, J PLANKTON RES, V19, P655, DOI 10.1093/plankt/19.6.655; Utermohl H, 1958, MITT INT VER LIMNOL, V9, P1; Wasmund N, 2003, ICES J MAR SCI, V60, P177, DOI 10.1016/S1054-3139(02)00280-1; Wasmund N, 2011, J MARINE SYST, V87, P145, DOI 10.1016/j.jmarsys.2011.03.010; Winder M, 2012, HYDROBIOLOGIA, V698, P5, DOI 10.1007/s10750-012-1149-2	54	139	144	6	204	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66475	10.1371/journal.pone.0066475	http://dx.doi.org/10.1371/journal.pone.0066475			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776676	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400104
J	Vasilopoulou, E; Loubiere, LS; Heuer, H; Trajkovic-Arsic, M; Darras, VM; Visser, TJ; Lash, GE; Whitley, GS; McCabe, CJ; Franklyn, JA; Kilby, MD; Chan, SY				Vasilopoulou, Elisavet; Loubiere, Laurence S.; Heuer, Heike; Trajkovic-Arsic, Marija; Darras, Veerle M.; Visser, Theo J.; Lash, Gendie E.; Whitley, Guy S.; McCabe, Christopher J.; Franklyn, Jayne A.; Kilby, Mark D.; Chan, Shiao Y.			Monocarboxylate Transporter 8 Modulates the Viability and Invasive Capacity of Human Placental Cells and Fetoplacental Growth in Mice	PLOS ONE			English	Article							THYROID-HORMONE TRANSPORT; SUBCLINICAL HYPOTHYROIDISM; DEIODINASE ACTIVITY; EXPRESSION; TRIIODOTHYRONINE; PREGNANCY; PROTEIN; 3,5,3'-TRIIODOTHYRONINE; CYTOTROPHOBLASTS; IDENTIFICATION	Monocarboxylate transporter 8 (MCT8) is a well-established thyroid hormone (TH) transporter. In humans, MCT8 mutations result in changes in circulating TH concentrations and X-linked severe global neurodevelopmental delay. MCT8 is expressed in the human placenta throughout gestation, with increased expression in trophoblast cells from growth-restricted pregnancies. We postulate that MCT8 plays an important role in placental development and transplacental TH transport. We investigated the effect of altering MCT8 expression in human trophoblast in vitro and in a Mct8 knockout mouse model. Silencing of endogenous MCT8 reduced T3 uptake into human extravillous trophoblast-like cells (SGHPL-4; 40%, P<0.05) and primary cytotrophoblast (15%, P<0.05). MCT8 over-expression transiently increased T3 uptake (SGHPL-4: 30%, P<0.05; cytotrophoblast: 15%, P<0.05). Silencing MCT8 did not significantly affect SGHPL-4 invasion, but with MCT8 over-expression T3 treatment promoted invasion compared with no T3 (3.3-fold; P<0.05). Furthermore, MCT8 silencing increased cytotrophoblast viability (similar to 20%, P<0.05) and MCT8 over-expression reduced cytotrophoblast viability independently of T3 (similar to 20%, P<0.05). In vivo, Mct8 knockout reduced fetal: placental weight ratios compared with wild-type controls at gestational day 18 (25%, P<0.05) but absolute fetal and placental weights were not significantly different. The volume fraction of the labyrinthine zone of the placenta, which facilitates maternal-fetal exchange, was reduced in Mct8 knockout placentae (10%, P<0.05). However, there was no effect on mouse placental cell proliferation in vivo. We conclude that MCT8 makes a significant contribution to T3 uptake into human trophoblast cells and has a role in modulating human trophoblast cell invasion and viability. In mice, Mct8 knockout has subtle effects upon fetoplacental growth and does not significantly affect placental cell viability probably due to compensatory mechanisms in vivo.	[Vasilopoulou, Elisavet; Loubiere, Laurence S.; McCabe, Christopher J.; Franklyn, Jayne A.; Kilby, Mark D.; Chan, Shiao Y.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Heuer, Heike; Trajkovic-Arsic, Marija] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Darras, Veerle M.] Katholieke Univ, Lab Comparat Endocrinol, Louvain, Belgium; [Visser, Theo J.] Erasmus MC, Rotterdam, Netherlands; [Lash, Gendie E.] Newcastle Univ, Inst Cellular Med, Reprod & Vasc Biol Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Whitley, Guy S.] St Georges Univ London, Div Biomed Sci, London, England	University of Birmingham; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); KU Leuven; Erasmus University Rotterdam; Erasmus MC; Newcastle University - UK; St Georges University London	Chan, SY (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England.	s.chan@bham.ac.uk	Heuer, Heike/AAF-1515-2020; Lash, Gendie/AAI-4116-2021; Whitley, Guy/N-5070-2019; FRCPI, Mark D Kilby MB BS DSc MD FRCOG/AAW-9704-2020; Vasilopoulou, Elisavet/AHB-3024-2022	Whitley, Guy/0000-0002-9670-3004; FRCPI, Mark D Kilby MB BS DSc MD FRCOG/0000-0001-9987-4223; Vasilopoulou, Elisavet/0000-0002-1940-0333; Lash, Gendie/0000-0002-3606-1361; Chan, Shiao-Yng/0000-0002-3530-3023	Medical Research Council [G0501548, G0600285]; British Thyroid Foundation; Action Medical Research - Henry Smith Charity [SP4335]; Wellbeing of Women [RG/1082/09]; Health Foundation [6462/4335]; Clinician Scientist Fellowship; Academy of Medical Sciences (AMS) [AMS-CSF2-Chan] Funding Source: researchfish; Medical Research Council [MR/J001414/1] Funding Source: researchfish; Wellbeing of Women [RG1082] Funding Source: researchfish; MRC [MR/J001414/1, G0501548] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Thyroid Foundation; Action Medical Research - Henry Smith Charity; Wellbeing of Women(Wellbeing of Women (WoW)); Health Foundation; Clinician Scientist Fellowship; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellbeing of Women(Wellbeing of Women (WoW)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the following grants and fellowships: Medical Research Council (G0501548 to SYC, MDK, JAF, CJM; G0600285 to SYC and MDK), British Thyroid Foundation (to SYC), Action Medical Research - Henry Smith Charity (SP4335 to MDK, SYC, LSL, JAF) and Wellbeing of Women (RG/1082/09 to SYC, MDK, JAF, LSL, GEL). Dr Chan was supported by a Clinician Scientist Fellowship awarded by the Health Foundation (6462/4335). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalovich M, 2002, THYROID, V12, P63, DOI 10.1089/105072502753451986; Angiolini E, 2006, PLACENTA, V27, pS98, DOI 10.1016/j.placenta.2005.12.008; Barber KJ, 2005, J CLIN ENDOCR METAB, V90, P1655, DOI 10.1210/jc.2004-0785; Cartwright JE, 1999, BRIT J PHARMACOL, V128, P181, DOI 10.1038/sj.bjp.0702757; Casey BM, 2005, OBSTET GYNECOL, V105, P239, DOI 10.1097/01.AOG.0000152345.99421.22; Chan S, 2003, J CLIN ENDOCR METAB, V88, P4488, DOI 10.1210/jc.2003-030228; Chan SY, 2006, J ENDOCRINOL, V189, P465, DOI 10.1677/joe.1.06582; Coan PM, 2008, J PHYSIOL-LONDON, V586, P4567, DOI 10.1113/jphysiol.2008.156133; Coan PM, 2004, BIOL REPROD, V70, P1806, DOI 10.1095/biolreprod.103.024166; Dash PR, 2007, EXP CELL RES, V313, P3421, DOI 10.1016/j.yexcr.2007.05.030; Dumitrescu AM, 2006, ENDOCRINOLOGY, V147, P4036, DOI 10.1210/en.2006-0390; Dumitrescu AM, 2004, AM J HUM GENET, V74, P168, DOI 10.1086/380999; EMERSON CH, 1988, ENDOCRINOLOGY, V122, P809, DOI 10.1210/endo-122-3-809; Fowden AL, 2009, J PHYSIOL-LONDON, V587, P3459, DOI 10.1113/jphysiol.2009.173013; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Friesema ECH, 2001, ENDOCRINOLOGY, V142, P4339, DOI 10.1210/en.142.10.4339; Friesema ECH, 2008, MOL ENDOCRINOL, V22, P1357, DOI 10.1210/me.2007-0112; Friesema ECH, 2006, MOL ENDOCRINOL, V20, P2761, DOI 10.1210/me.2005-0256; Friesema ECH, 2010, MOL CELL ENDOCRINOL, V322, P107, DOI 10.1016/j.mce.2010.01.016; Fujiwara K, 2001, ENDOCRINOLOGY, V142, P2005, DOI 10.1210/en.142.5.2005; Greenwood SL, 1996, J PHYSIOL-LONDON, V492, P629, DOI 10.1113/jphysiol.1996.sp021333; Hamilton GS, 1998, EXP CELL RES, V244, P147, DOI 10.1006/excr.1998.4195; Heuer H, 2009, ENDOCRINOLOGY, V150, P1078, DOI 10.1210/en.2008-1518; James SR, 2009, ENDOCRINOLOGY, V150, P1961, DOI 10.1210/en.2008-1031; Kilby MD, 1998, J CLIN ENDOCR METAB, V83, P2964, DOI 10.1210/jc.83.8.2964; Kilby MD, 2005, PLACENTA, V26, P105, DOI 10.1016/j.placenta.2004.08.004; Kinne A, 2010, J BIOL CHEM, V285, P28054, DOI 10.1074/jbc.M110.129577; Kinne A, 2009, J MOL ENDOCRINOL, V43, P263, DOI 10.1677/JME-09-0043; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; KoopdonkKool JM, 1996, J CLIN ENDOCR METAB, V81, P2154, DOI 10.1210/jc.81.6.2154; LaFranchi SH, 2005, THYROID, V15, P60, DOI 10.1089/thy.2005.15.60; LAFRENIERE RG, 1994, HUM MOL GENET, V3, P1133, DOI 10.1093/hmg/3.7.1133; LAGA EM, 1973, BIOL NEONATE, V23, P231; Laoag-Fernandez JB, 2004, J CLIN ENDOCR METAB, V89, P4069, DOI 10.1210/jc.2003-032208; Lash GE, 2010, PLACENTA, V31, P545, DOI 10.1016/j.placenta.2010.02.020; Loubiere LS, 2012, ENDOCRINOLOGY, V153, P6126, DOI 10.1210/en.2012-1753; Loubiere LS, 2010, PLACENTA, V31, P295, DOI 10.1016/j.placenta.2010.01.013; MATSUO H, 1993, ACTA ENDOCRINOL-COP, V128, P225, DOI 10.1530/acta.0.1280225; Mestman JH, 2004, BEST PRACT RES CL EN, V18, P267, DOI 10.1016/j.beem.2004.03.005; Mortimer RH, 1996, J CLIN ENDOCR METAB, V81, P2247, DOI 10.1210/jc.81.6.2247; Oki N, 2004, J CLIN ENDOCR METAB, V89, P5213, DOI 10.1210/jc.2004-0352; Price NT, 1998, BIOCHEM J, V329, P321; Reyns GE, 2002, COMP BIOCHEM PHYS B, V132, P239, DOI 10.1016/S1096-4959(01)00528-0; Schwartz CE, 2005, AM J HUM GENET, V77, P41, DOI 10.1086/431313; Suzuki S, 2007, TRENDS ENDOCRIN MET, V18, P286, DOI 10.1016/j.tem.2007.07.002; Trajkovic M, 2007, J CLIN INVEST, V117, P627, DOI 10.1172/JCI28253; Trajkovic-Arsic M, 2010, ENDOCRINOLOGY, V151, P802, DOI 10.1210/en.2009-1053; Vasilopoulou E, 2010, J CLIN ENDOCR METAB, V95, P4762, DOI 10.1210/jc.2010-0354; Vie MP, 1997, MOL ENDOCRINOL, V11, P1728, DOI 10.1210/me.11.11.1728; Visser WE, 2011, MOL ENDOCRINOL, V25, P1, DOI 10.1210/me.2010-0095; Wirth EK, 2011, EUR J ENDOCRINOL, V165, P555, DOI 10.1530/EJE-11-0369	52	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65402	10.1371/journal.pone.0065402	http://dx.doi.org/10.1371/journal.pone.0065402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776477	Green Published, Green Accepted, gold			2022-12-25	WOS:000320322400022
J	Zacharia, J; Mauban, JRH; Raina, H; Fisher, SA; Wier, WG				Zacharia, Joseph; Mauban, Joseph R. H.; Raina, Hema; Fisher, Steven A.; Wier, Withrow G.			High Vascular Tone of Mouse Femoral Arteries In Vivo Is Determined by Sympathetic Nerve Activity Via alpha(1A)- and alpha(1D)-Adrenoceptor Subtypes	PLOS ONE			English	Article							ALPHA-1B ADRENERGIC-RECEPTOR; ALPHA(1)-ADRENOCEPTOR SUBTYPES; SMOOTH-MUSCLE; SELECTIVE ANTAGONIST; RESISTANCE ARTERIES; BLOOD-PRESSURE; MYOGENIC TONE; CONTRACTION; NORADRENALINE; ACTIVATION	Background and purpose: Determining the role of vascular receptors in vivo is difficult and not readily accomplished by systemic application of antagonists or genetic manipulations. Here we used intravital microscopy to measure the contributions of sympathetic receptors, particularly alpha(1)-adrenoceptor subtypes, to contractile activation of femoral artery in vivo. Experimental approach: Diameter and intracellular calcium ([Ca2+](i)) in femoral arteries were determined by intravital fluorescence microscopy in mice expressing a Myosin Light Chain Kinase (MLCK) based calcium-calmodulin biosensor. Pharmacological agents were applied locally to the femoral artery to determine the contributions of vascular receptors to tonic contraction and [Ca2+](i). Key results: In the anesthetized animal, femoral arteries were constricted to a diameter equal to 54% of their passive diameter (i.e. tone=46%). Of this total basal tone, 16% was blocked by RS79948 (0.1 mu M) and thus attributable to alpha(2)-adrenoceptors. A further 46% was blocked by prazosin (0.1 mu M) and thus attributable to alpha(1)-adrenoceptors. Blockade of P-2X and NPY1 receptors with suramin (0.5 mM) and BIBP3226 (1.0 mu M) respectively, reduced tone by a further 22%, leaving 16% of basal tone unaffected at these concentrations of antagonists. Application of RS100329 (alpha(1A)-selective antagonist) and BMY7378 (alpha(1D)-selective) decreased tone by 29% and 26%, respectively, and reduced [Ca2+](i). Chloroethylclonidine (1 mu M preferential for alpha(1B)-) had no effect. Abolition of sympathetic nerve activity (hexamethonium, i. p.) reduced basal tone by 90%. Conclusion and Implications: Tone of mouse femoral arteries in vivo is almost entirely sympathetic in origin. Activation of alpha(1A)- and alpha(1D)-adrenoceptors elevates [Ca2+](i) and accounts for at least 55% of the tone.	[Zacharia, Joseph; Mauban, Joseph R. H.; Raina, Hema; Fisher, Steven A.; Wier, Withrow G.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Zacharia, J (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.	jzach001@umaryland.edu	Wier, Withrow/AAE-2451-2020		National Heart, Lung, and Blood Institute [1RO1 HL091969]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091969] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, and Blood Institute Grants 1RO1 HL091969 to WGW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Bautista DL, 2006, J CHEM INF MODEL, V46, P334, DOI 10.1021/ci050116k; CAMBRIDGE D, 1977, BRIT J PHARMACOL, V59, pP514; Crassous PA, 2009, BRIT J PHARMACOL, V158, P1344, DOI 10.1111/j.1476-5381.2009.00403.x; Daly CJ, 2002, PHYSIOL GENOMICS, V9, P85, DOI 10.1152/physiolgenomics.00065.2001; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; Docherty JR, 2010, CELL MOL LIFE SCI, V67, P405, DOI 10.1007/s00018-009-0174-4; FLAVAHAN NA, 1986, TRENDS PHARMACOL SCI, V7, P347, DOI 10.1016/0165-6147(86)90383-4; Ford APDW, 1997, BRIT J PHARMACOL, V121, P1127, DOI 10.1038/sj.bjp.0701207; FUJIMOTO S, 1994, CAN J PHYSIOL PHARM, V72, P862, DOI 10.1139/y94-122; Geary GG, 1998, AM J PHYSIOL-HEART C, V275, pH292, DOI 10.1152/ajpheart.1998.275.1.H292; GOETZ AS, 1995, EUR J PHARMACOL, V272, pR5, DOI 10.1016/0014-2999(94)00751-R; HAN C, 1987, NATURE, V329, P333, DOI 10.1038/329333a0; Hieble J P, 1996, Prog Drug Res, V47, P81; Hirasawa A, 1997, MOL PHARMACOL, V52, P764, DOI 10.1124/mol.52.5.764; Hosoda C, 2007, AM J PHYSIOL-HEART C, V293, pH514, DOI 10.1152/ajpheart.00626.2006; Huggett RJ, 2004, HYPERTENSION, V44, P847, DOI 10.1161/01.HYP.0000147893.08533.d8; Ibrahim J, 2006, AM J PHYSIOL-HEART C, V290, pH1081, DOI 10.1152/ajpheart.00752.2005; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; Jarajapu YPR, 2001, EUR J PHARMACOL, V422, P127, DOI 10.1016/S0014-2999(01)01051-2; Kuroki MT, 2012, AM J PHYSIOL-HEART C, V302, pH763, DOI 10.1152/ajpheart.00930.2011; Lopez-Guerrero J. J., 2005, Autonomic & Autacoid Pharmacology, V25, P101, DOI 10.1111/j.1474-8673.2005.00338.x; Lyssand JS, 2008, J BIOL CHEM, V283, P18792, DOI 10.1074/jbc.M801860200; Marti D, 2005, AM J PHYSIOL-HEART C, V289, pH1923, DOI 10.1152/ajpheart.00288.2005; Mauban JRH, 2013, MICROCIRCULATION, V20, P269, DOI 10.1111/micc.12025; Methven L, 2009, BRIT J PHARMACOL, V158, P1663, DOI 10.1111/j.1476-5381.2009.00462.x; Moore AW, 2010, J PHYSIOL-LONDON, V588, P4261, DOI 10.1113/jphysiol.2010.194993; MULVANY MJ, 1977, CIRC RES, V41, P19, DOI 10.1161/01.RES.41.1.19; MURAMATSU I, 1990, BRIT J PHARMACOL, V101, P662, DOI 10.1111/j.1476-5381.1990.tb14137.x; Muramatsu I, 2008, BRIT J PHARMACOL, V155, P1224, DOI 10.1038/bjp.2008.360; MURAMATSU I, 1990, BRIT J PHARMACOL, V99, P197, DOI 10.1111/j.1476-5381.1990.tb14678.x; Parati G, 2012, EUR HEART J, V33, P1058, DOI 10.1093/eurheartj/ehs041; Piascik MT, 1997, J PHARMACOL EXP THER, V283, P854; Reimann K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025659; Rokosh DG, 2002, P NATL ACAD SCI USA, V99, P9474, DOI 10.1073/pnas.132552699; Rummery NM, 2007, J PHYSIOL-LONDON, V582, P745, DOI 10.1113/jphysiol.2007.134825; SCHILD HO, 1949, BRIT J PHARM CHEMOTH, V4, P277, DOI 10.1111/j.1476-5381.1949.tb00548.x; SCHWINN DA, 1991, MOL PHARMACOL, V40, P619; Stam WB, 1999, BRIT J PHARMACOL, V127, P661, DOI 10.1038/sj.bjp.0702598; Taki N, 2004, BRIT J PHARMACOL, V142, P647, DOI 10.1038/sj.bjp.0705817; Tanoue A, 2002, J CLIN INVEST, V109, P765, DOI 10.1172/JCI200214001; Tarasova O, 2003, ACTA PHYSIOL SCAND, V177, P157, DOI 10.1046/j.1365-201X.2003.01057.x; Townsend SA, 2004, HYPERTENSION, V44, P776, DOI 10.1161/01.HYP.0000145405.01113.0e; Tsurumaki T, 2003, J CARDIOVASC PHARM, V42, pS33, DOI 10.1097/00005344-200312001-00009; Wier WG, 2008, J PHYSIOL-LONDON, V586, P2437, DOI 10.1113/jphysiol.2008.151522; Wier WG, 2009, EXP PHYSIOL, V94, P31, DOI 10.1113/expphysiol.2008.043638; Williams TJ, 1999, BRIT J PHARMACOL, V127, P252, DOI 10.1038/sj.bjp.0702541; Yang M, 1998, J PHARMACOL EXP THER, V286, P841; Zacharia J, 2005, BRIT J PHARMACOL, V146, P942, DOI 10.1038/sj.bjp.0706395; Zacharia J, 2004, BRIT J PHARMACOL, V141, P915, DOI 10.1038/sj.bjp.0705690; Zhang HY, 2007, CIRC RES, V100, P730, DOI 10.1161/01.RES.0000260189.38975.35; Zhang J, 2010, AM J PHYSIOL-HEART C, V299, pH946, DOI 10.1152/ajpheart.00359.2010; Ziani K, 2002, AM J PHYSIOL-HEART C, V282, pH475, DOI 10.1152/ajpheart.00411.2001	53	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65969	10.1371/journal.pone.0065969	http://dx.doi.org/10.1371/journal.pone.0065969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776582	Green Submitted, Green Published, gold			2022-12-25	WOS:000320322400067
J	Chen, HY; Chou, MX; Wang, XY; Liu, SS; Zhang, FL; Wei, GH				Chen, Hongyan; Chou, Minxia; Wang, Xinye; Liu, Sisi; Zhang, Feilong; Wei, Gehong			Profiling of Differentially Expressed Genes in Roots of Robinia pseudoacacia during Nodule Development Using Suppressive Subtractive Hybridization	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; TRANSCRIPTION FACTOR; LOTUS-JAPONICUS; ARABIDOPSIS-THALIANA; POTENTIAL REGULATORS; LEAF SENESCENCE; NODULATION; PROTEIN; INFECTION; SYNAPTOTAGMIN	Background: Legume-rhizobium symbiosis is a complex process that is regulated in the host plant cell through gene expression network. Many nodulin genes that are upregulated during different stages of nodulation have been identified in leguminous herbs. However, no nodulin genes in woody legume trees, such as black locust (Robinia pseudoacacia), have yet been reported. Methodology/Principal findings: To identify the nodulin genes involved in R. pseudoacacia-Mesorhizobium amorphae CCNWGS0123 symbiosis, a suppressive subtractive hybridization approach was applied to reveal profiling of differentially expressed genes and two subtracted cDNA libraries each containing 600 clones were constructed. Then, 114 unigenes were identified from forward SSH library by differential screening and the putative functions of these translational products were classified into 13 categories. With a particular interest in regulatory genes, twenty-one upregulated genes encoding potential regulatory proteins were selected based on the result of reverse transcription-polymerase chain reaction (RT-PCR) analysis. They included nine putative transcription genes, eight putative post-translational regulator genes and four membrane protein genes. The expression patterns of these genes were further analyzed by quantitative RT-PCR at different stages of nodule development. Conclusions: The data presented here offer the first insights into the molecular foundation underlying R. pseudoacacia-M. amorphae symbiosis. A number of regulatory genes screened in the present study revealed a high level of regulatory complexity (transcriptional, post-transcriptional, translational and post-translational) that is likely essential to develop symbiosis. In addition, the possible roles of these genes in black locust nodulation are discussed.	[Chen, Hongyan; Chou, Minxia; Wang, Xinye; Liu, Sisi; Zhang, Feilong; Wei, Gehong] Northwest Agr & Forestry Univ, State Key Lab Crop Stress Biol Arid Areas, Coll Life Sci, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Wei, GH (corresponding author), Northwest Agr & Forestry Univ, State Key Lab Crop Stress Biol Arid Areas, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	weigehong@nwsuaf.edu.cn			Special Foundation for Basic Research of Central University of China [QN2009068]; National Science Foundation of China [31125007, 3117225]	Special Foundation for Basic Research of Central University of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by projects from the Special Foundation for Basic Research of Central University of China (QN2009068), and National Science Foundation of China (31125007, 3117225). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r24; Blanco FA, 2009, PLANT CELL, V21, P2797, DOI 10.1105/tpc.108.063420; Asamizu E, 2005, MOL PLANT MICROBE IN, V18, P487, DOI 10.1094/MPMI-18-0487; Baima S, 1995, DEVELOPMENT, V121, P4171; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Bloemberg GV, 2000, MOL PLANT MICROBE IN, V13, P1170, DOI 10.1094/MPMI.2000.13.11.1170; Brechenimacher L, 2008, MOL PLANT MICROBE IN, V21, P631, DOI 10.1094/MPMI-21-5-0631; Capoen W, 2011, P NATL ACAD SCI USA, V108, P14348, DOI 10.1073/pnas.1107912108; Cardenas L, 2000, PLANT PHYSIOL, V123, P443, DOI 10.1104/pp.123.2.443; Catalano CM, 2007, PLANTA, V225, P541, DOI 10.1007/s00425-006-0369-y; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chou MX, 2006, J EXP BOT, V57, P2673, DOI 10.1093/jxb/erl030; Combier JP, 2008, GENE DEV, V22, P1549, DOI 10.1101/gad.461808; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Craxton M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-43; Czarnecka AM, 2006, CELL STRESS CHAPERON, V11, P287, DOI 10.1379/CSC-200.1; de Zelicourt A, 2012, PLANT J, V70, P220, DOI 10.1111/j.1365-313X.2011.04859.x; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; FAHRAEUS G, 1957, J GEN MICROBIOL, V16, P374, DOI 10.1099/00221287-16-2-374; Frugier F, 2000, GENE DEV, V14, P475; Godiard L, 2007, MOL PLANT MICROBE IN, V20, P321, DOI 10.1094/MPMI-20-3-0321; Gronlund M, 2003, PLANT MOL BIOL, V52, P303, DOI 10.1023/A:1023967214199; Guo Y, 2004, PLANT CELL ENVIRON, V27, P521, DOI 10.1111/j.1365-3040.2003.01158.x; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Hao XL, 2012, J BACTERIOL, V194, P736, DOI 10.1128/JB.06475-11; Huang XW, 2007, APPL MICROBIOL BIOT, V76, P753, DOI 10.1007/s00253-007-1076-8; Jorgensen JE, 1999, PLANT MOL BIOL, V40, P65, DOI 10.1023/A:1026463506376; Kang H, 2011, PLANT PHYSIOL, V155, P1312, DOI 10.1104/pp.110.167965; Kondorosi E, 2005, PLANT PHYSIOL, V137, P1197, DOI 10.1104/pp.105.060004; Lee MY, 2005, PLANT PHYSIOL, V139, P1881, DOI 10.1104/pp.105.067884; Libault M, 2009, PLANT PHYSIOL, V151, P1207, DOI 10.1104/pp.109.144030; Lin LY, 2007, PROTEINS, V67, P505, DOI 10.1002/prot.21270; Lohar DP, 2006, PLANT PHYSIOL, V140, P221, DOI 10.1104/pp.105.070326; Lohar DP, 2005, J EXP BOT, V56, P1643, DOI 10.1093/jxb/eri160; Mai HT, 2006, PLANT CELL PHYSIOL, V47, P829, DOI 10.1093/pcp/pcj054; Mbengue M, 2010, PLANT CELL, V22, P3474, DOI 10.1105/tpc.110.075861; Meschini EP, 2008, MOL PLANT MICROBE IN, V21, P459, DOI 10.1094/MPMI-21-4-0459; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Pandey R, 2002, NUCLEIC ACIDS RES, V30, P5036, DOI 10.1093/nar/gkf660; Park S, 2003, TREE PHYSIOL, V23, P815, DOI 10.1093/treephys/23.12.815; PEROTTO S, 1994, MOL PLANT MICROBE IN, V7, P99, DOI 10.1094/MPMI-7-0099; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Schapire AL, 2008, PLANT CELL, V20, P3374, DOI 10.1105/tpc.108.063859; Shaw SL, 2003, PLANT PHYSIOL, V131, P976, DOI 10.1104/pp.005546; Tian L, 2001, P NATL ACAD SCI USA, V98, P200, DOI 10.1073/pnas.011347998; Timmers ACJ, 1999, DEVELOPMENT, V126, P3617; Udvardi MK, 2007, PLANT PHYSIOL, V144, P538, DOI 10.1104/pp.107.098061; van Spronsen PC, 2001, MOL PLANT MICROBE IN, V14, P839, DOI 10.1094/MPMI.2001.14.7.839; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Wei GH, 2009, FEMS MICROBIOL ECOL, V68, P320, DOI 10.1111/j.1574-6941.2009.00673.x; Wizemann TM, 1996, P NATL ACAD SCI USA, V93, P7985, DOI 10.1073/pnas.93.15.7985; Wu KQ, 2000, PLANT MOL BIOL, V44, P167, DOI 10.1023/A:1006498413543; Yang XJ, 2003, CURR OPIN GENET DEV, V13, P143, DOI 10.1016/S0959-437X(03)00015-7; Yano K, 2009, PLANT J, V60, P168, DOI 10.1111/j.1365-313X.2009.03943.x; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	60	11	14	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e63930	10.1371/journal.pone.0063930	http://dx.doi.org/10.1371/journal.pone.0063930			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776436	Green Published, gold			2022-12-25	WOS:000320755400005
J	Horn, KC; Eubanks, MD; Siemann, E				Horn, Katherine C.; Eubanks, Micky D.; Siemann, Evan			The Effect of Diet and Opponent Size on Aggressive Interactions Involving Caribbean Crazy Ants (Nylanderia fulva)	PLOS ONE			English	Article							ARGENTINE ANT; ANOPLOLEPIS-GRACILIPES; NESTMATE RECOGNITION; LINEPITHEMA-HUMILE; INVASIVE ANTS; HYMENOPTERA; CONSEQUENCES; FORMICIDAE; RESOURCES; SUCCESS	Biotic interactions are often important in the establishment and spread of invasive species. In particular, competition between introduced and native species can strongly influence the distribution and spread of exotic species and in some cases competition among introduced species can be important. The Caribbean crazy ant, Nylanderia fulva, was recently introduced to the Gulf Coast of Texas, and appears to be spreading inland. It has been hypothesized that competition with the red imported fire ant, Solenopsis invicta, may be an important factor in the spread of crazy ants. We investigated the potential of interspecific competition among these two introduced ants by measuring interspecific aggression between Caribbean crazy ant workers and workers of Solenopsis invicta. Specifically, we examined the effect of body size and diet on individual-level aggressive interactions among crazy ant workers and fire ants. We found that differences in diet did not alter interactions between crazy ant workers from different nests, but carbohydrate level did play an important role in antagonistic interactions with fire ants: crazy ants on low sugar diets were more aggressive and less likely to be killed in aggressive encounters with fire ants. We found that large fire ants engaged in fewer fights with crazy ants than small fire ants, but fire ant size affected neither fire ant nor crazy ant mortality. Overall, crazy ants experienced higher mortality than fire ants after aggressive encounters. Our findings suggest that fire ant workers might outcompete crazy ant workers on an individual level, providing some biotic resistance to crazy ant range expansion. However, this resistance may be overcome by crazy ants that have a restricted sugar intake, which may occur when crazy ants are excluded from resources by fire ants.	[Horn, Katherine C.; Siemann, Evan] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA; [Eubanks, Micky D.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Rice University; Texas A&M University System; Texas A&M University College Station	Siemann, E (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA.	siemann@rice.edu			Wray-Todd Fellowship;  [NSF-DEB-0315796]	Wray-Todd Fellowship; 	Financial support was provided by a Wray-Todd Fellowship to KH and NSF-DEB-0315796 to ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLOWAY TM, 1991, INSECT SOC, V38, P189, DOI 10.1007/BF01240968; ANDERSEN AN, 1994, OECOLOGIA, V98, P15, DOI 10.1007/BF00326085; [Anonymous], 2004, 100 WORLDS WORST INV; Buczkowski G, 2006, ANIM BEHAV, V71, P327, DOI 10.1016/j.anbehav.2005.04.012; BUREN WF, 1974, J NEW YORK ENTOMOL S, V82, P113; Corin SE, 2007, INSECT SOC, V54, P275, DOI 10.1007/s00040-007-0942-9; Drescher J, 2011, BIOTROPICA, V43, P93, DOI 10.1111/j.1744-7429.2010.00662.x; Gotzek D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045314; Gotzek D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007713; Grover CD, 2007, P ROY SOC B-BIOL SCI, V274, P2951, DOI 10.1098/rspb.2007.1065; Helms KR, 2008, ENVIRON ENTOMOL, V37, P487, DOI 10.1603/0046-225X(2008)37[487:PRACGI]2.0.CO;2; Holldobler B., 1990, pi; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Kaspari M, 1999, FUNCT ECOL, V13, P530, DOI 10.1046/j.1365-2435.1999.00343.x; Liang D, 2001, COMP BIOCHEM PHYS B, V129, P871, DOI 10.1016/S1096-4959(01)00404-3; Lim SP, 2003, SOCIOBIOLOGY, V41, P295; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Menke SB, 2007, ECOLOGY, V88, P3164, DOI 10.1890/07-0122.1; Meyers JM, 2008, THESIS TX A M U COLL; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Ness JH, 2004, BIOL INVASIONS, V6, P445, DOI 10.1023/B:BINV.0000041556.88920.dd; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Ricklefs R.E., 2001, EC NATURE; Roulston TH, 2003, INSECT SOC, V50, P151, DOI 10.1007/s00040-003-0624-1; Savage AM, 2011, AUSTRAL ECOL, V36, P310, DOI 10.1111/j.1442-9993.2010.02152.x; SAVOLAINEN R, 1988, OIKOS, V51, P135, DOI 10.2307/3565636; Silverman J, 2001, NATURWISSENSCHAFTEN, V88, P73, DOI 10.1007/s001140000198; Sorvari J, 2008, BEHAV ECOL, V19, P441, DOI 10.1093/beheco/arm160; Suarez Andrew V., 1999, Biological Invasions, V1, P43, DOI 10.1023/A:1010038413690; Torchin ME, 2004, FRONT ECOL ENVIRON, V2, P183, DOI 10.1890/1540-9295(2004)002[0183:PPAIBP]2.0.CO;2; TRAGER JC, 1984, SOCIOBIOLOGY, V9, P51; Walters AC, 2005, AUSTRAL ECOL, V30, P395, DOI 10.1111/j.1442-9993.2005.01481.x; Williams DF, 1994, EXOTIC ANTS BIOL IMP; Wundrow EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048444; Zhao LM, 2012, ENVIRON ENTOMOL, V41, P1008, DOI 10.1603/EN11287	35	9	9	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66912	10.1371/journal.pone.0066912	http://dx.doi.org/10.1371/journal.pone.0066912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776702	Green Published, gold			2022-12-25	WOS:000320755400157
J	Park, CR; Moon, MJ; Park, S; Kim, DK; Cho, EB; Millar, RP; Hwang, JI; Seong, JY				Park, Cho Rong; Moon, Mi Jin; Park, Sumi; Kim, Dong-Kyu; Cho, Eun Bee; Millar, Robert Peter; Hwang, Jong-Ik; Seong, Jae Young			A Novel Glucagon-Related Peptide (GCRP) and Its Receptor GCRPR Account for Coevolution of Their Family Members in Vertebrates	PLOS ONE			English	Article							DIFFERENTIAL LIGAND SELECTIVITY; GONADOTROPIN-RELEASING-HORMONE; GASTRIC-INHIBITORY POLYPEPTIDE; MOLECULAR COEVOLUTION; EXTRACELLULAR LOOP-3; CRYSTAL-STRUCTURE; GENE-EXPRESSION; GNRH RECEPTORS; BINDING-SITE; GLP-1	The glucagon (GCG) peptide family consists of GCG, glucagon-like peptide 1 (GLP1), and GLP2, which are derived from a common GCG precursor, and the glucose-dependent insulinotropic polypeptide (GIP). These peptides interact with cognate receptors, GCGR, GLP1R, GLP2R, and GIPR, which belong to the secretin-like G protein-coupled receptor (GPCR) family. We used bioinformatics to identify genes encoding a novel GCG-related peptide (GCRP) and its cognate receptor, GCRPR. The GCRP and GCRPR genes were found in representative tetrapod taxa such as anole lizard, chicken, and Xenopus, and in teleosts including medaka, fugu, tetraodon, and stickleback. However, they were not present in mammals and zebrafish. Phylogenetic and genome synteny analyses showed that GCRP emerged through two rounds of whole genome duplication (2R) during early vertebrate evolution. GCRPR appears to have arisen by local tandem gene duplications from a common ancestor of GCRPR, GCGR, and GLP2R after 2R. Biochemical ligand-receptor interaction analyses revealed that GCRP had the highest affinity for GCRPR in comparison to other GCGR family members. Stimulation of chicken, Xenopus, and medaka GCRPRs activated Gas-mediated signaling. In contrast to chicken and Xenopus GCRPRs, medaka GCRPR also induced G alpha(q/11)mediated signaling. Chimeric peptides and receptors showed that the K-16 M-17 K-18 and G(16) Q(17) A(18) motifs in GCRP and GLP1, respectively, may at least in part contribute to specific recognition of their cognate receptors through interaction with the receptor core domain. In conclusion, we present novel data demonstrating that GCRP and GCRPR evolved through gene/genome duplications followed by specific modifications that conferred selective recognition to this ligand-receptor pair.	[Park, Cho Rong; Moon, Mi Jin; Park, Sumi; Kim, Dong-Kyu; Cho, Eun Bee; Hwang, Jong-Ik; Seong, Jae Young] Korea Univ, Grad Sch Med, Lab G Prot Coupled Receptors, Seoul, South Korea; [Millar, Robert Peter] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, Hatfield, South Africa; [Millar, Robert Peter] Univ Cape Town, MRC, Receptor Biol Unit, ZA-7925 Observatory, South Africa; [Millar, Robert Peter] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	Korea University; Korea University Medicine (KU Medicine); University of Pretoria; University of Cape Town; University of Edinburgh	Hwang, JI (corresponding author), Korea Univ, Grad Sch Med, Lab G Prot Coupled Receptors, Seoul, South Korea.	hjibio@korea.ac.kr; jyseong@korea.ac.kr	Seong, Jae Young/A-5794-2012	Seong, Jae Young/0000-0002-3312-6924; Hwang, Jong-Ik/0000-0002-0729-1782; Millar, Robert P/0000-0003-3606-2708	National Research Foundation of Korea [2011-0019205, 2010-0022054, 2012K1A3A1A09033014]; National Research Foundation of South Africa	National Research Foundation of Korea(National Research Foundation of Korea); National Research Foundation of South Africa(National Research Foundation - South Africa)	This work was supported by grants from the Brain Research Program (2011-0019205), Basic Research Program (2010-0022054) and Korea-South Africa Collaboration Program (2012K1A3A1A09033014) of the National Research Foundation of Korea and the National Research Foundation of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharjee S, 2004, J BIOL CHEM, V279, P54445, DOI 10.1074/jbc.M408909200; ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bode HP, 1999, ENDOCRINOLOGY, V140, P3919, DOI 10.1210/en.140.9.3919; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Chen QA, 2010, J BIOL CHEM, V285, P24508, DOI 10.1074/jbc.M110.135749; Chen Q, 2009, J BIOL CHEM, V284, P34135, DOI 10.1074/jbc.M109.038109; de Maturana RL, 2004, PROTEIN PEPTIDE LETT, V11, P15, DOI 10.2174/0929866043478491; de Maturana RL, 2002, FEBS LETT, V530, P244, DOI 10.1016/S0014-5793(02)03492-0; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; Drucker DJ, 1996, P NATL ACAD SCI USA, V93, P7911, DOI 10.1073/pnas.93.15.7911; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; FEHMANN HC, 1995, PANCREAS, V11, P196, DOI 10.1097/00006676-199508000-00014; GALLWITZ B, 1994, EUR J BIOCHEM, V225, P1151, DOI 10.1111/j.1432-1033.1994.1151b.x; Gallwitz B, 1996, REGUL PEPTIDES, V63, P17, DOI 10.1016/0167-0115(96)00019-5; Gault VA, 2007, DIABETOLOGIA, V50, P1752, DOI 10.1007/s00125-007-0710-4; GOKE R, 1993, J BIOL CHEM, V268, P19650; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; Harmar AJ, 2001, GENOME BIOL, V2; Hisadome K, 2010, DIABETES, V59, P1890, DOI 10.2337/db10-0128; Hwang JI, 2013, MOL BIOL EVOL, V30, P1119, DOI 10.1093/molbev/mst031; Irwin DM, 2011, DIABETES OBES METAB, V13, P69, DOI 10.1111/j.1463-1326.2011.01444.x; Irwin DM, 2001, REGUL PEPTIDES, V98, P1, DOI 10.1016/S0167-0115(00)00232-9; Kang GX, 2001, J PHYSIOL-LONDON, V536, P375, DOI 10.1111/j.1469-7793.2001.0375c.xd; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Kim DK, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00003; Kim DK, 2011, GEN COMP ENDOCR, V170, P68, DOI 10.1016/j.ygcen.2010.10.018; Kimple AJ, 2009, J BIOL CHEM, V284, P19402, DOI 10.1074/jbc.M109.024711; Lee YR, 2009, ENDOCRINOLOGY, V150, P2837, DOI 10.1210/en.2008-1679; Li JH, 2005, MOL PHARMACOL, V67, P1099, DOI 10.1124/mol.104.004887; Lin F, 2009, J MOL MODEL, V15, P53, DOI 10.1007/s00894-008-0372-2; Lovshin J, 2001, J BIOL CHEM, V276, P21489, DOI 10.1074/jbc.M009382200; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; Moon Mi Jin, 2012, Front Endocrinol (Lausanne), V3, P141, DOI 10.3389/fendo.2012.00141; Moon MJ, 2012, J BIOL CHEM, V287, P3873, DOI 10.1074/jbc.M111.276808; Moon MJ, 2011, MOL CELLS, V32, P389, DOI 10.1007/s10059-011-0157-9; Moon MJ, 2010, MOL CELLS, V30, P149, DOI 10.1007/s10059-010-0100-5; Nauck MA, 2002, J CLIN ENDOCR METAB, V87, P1239, DOI 10.1210/jc.87.3.1239; NAUCK MA, 1993, J CLIN ENDOCR METAB, V76, P912, DOI 10.1210/jcem.76.4.8473405; Oh DY, 2008, J BIOL CHEM, V283, P21054, DOI 10.1074/jbc.M708908200; Oh DY, 2005, MOL ENDOCRINOL, V19, P722, DOI 10.1210/me.2004-0220; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Perry T, 2007, EXP NEUROL, V203, P293, DOI 10.1016/j.expneurol.2006.09.028; Roch GJ, 2009, GEN COMP ENDOCR, V161, P3, DOI 10.1016/j.ygcen.2008.10.017; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Tang-Christensen M, 2000, NAT MED, V6, P802, DOI 10.1038/77535; Um HN, 2010, ANN NY ACAD SCI, V1200, P67, DOI 10.1111/j.1749-6632.2010.05508.x; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Vrang N, 2007, BRAIN RES, V1149, P118, DOI 10.1016/j.brainres.2007.02.043; Wang CB, 2004, MOL ENDOCRINOL, V18, P105, DOI 10.1210/me.2003-0101; Xiao Q, 2000, J MOL ENDOCRINOL, V25, P321, DOI 10.1677/jme.0.0250321; Yegorov S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032923; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7	57	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65420	10.1371/journal.pone.0065420	http://dx.doi.org/10.1371/journal.pone.0065420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776481	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400030
J	Reveron, I; Rodriguez, H; Campos, G; Curiel, JA; Ascaso, C; Carrascosa, AV; Prieto, A; de Las Rivas, B; Munoz, R; de Felipe, FL				Reveron, Ines; Rodriguez, Hector; Campos, Gema; Curiel, Jose Antonio; Ascaso, Carmen; Carrascosa, Alfonso V.; Prieto, Alicia; de las Rivas, Blanca; Munoz, Rosario; de Felipe, Felix Lopez			Tannic Acid-Dependent Modulation of Selected Lactobacillus plantarum Traits Linked to Gastrointestinal Survival	PLOS ONE			English	Article							INTESTINAL-TRACT; HUMAN ISOLATE; IDENTIFICATION; EXPRESSION; IMPACT; GROWTH; GENES	Background: Owing to its antimicrobial properties dietary tannins may alter the functional efficacy of probiotic lactobacilli in the gastrointestinal (GI)-tract influencing their growth, viability and molecular adaptation to the intestinal environment. Methods and Findings: The effects of tannic acid on Lactobacillus plantarum WCFS1 were studied by in vitro growth monitoring and visualizing the morphological alteration on the cell wall using transmission electron microscopy. Growth upon tannic acid was characterized by dose-dependent reductions of initial viable counts and extended lag phases. Lag phase-cells growing upon 0.5 mM tannic acid were abnormally shaped and experienced disturbance on the cell wall such as roughness, occasional leakage and release of cell debris, but resumed growth later at tannic acid concentrations high as 2.5 mM. To gain insight on how the response to tannic acid influenced the molecular adaptation of L. plantarum to the GI-tract conditions, gene expression of selected biomarkers for GI-survival was assessed by RT-qPCR on cDNA templates synthetized from mRNA samples obtained from cells treated with 0.5 or 2 mM tannic acid. Tannic acid-dependent gene induction was confirmed for selected genes highly expressed in the gut or with confirmed roles in GI-survival. No differential expression was observed for the pbp2A gene, a biomarker negatively related with GI-survival. However PBP2A was not labeled by Bocillin FL, a fluorescent dye-labeled penicillin V derivative, in the presence of tannic acid which suggests for enhanced GI-survival reportedly associated with the inactivation of this function. Conclusions: Probiotic L. plantarum WCFS1 is able to overcome the toxic effects of tannic acid. This dietary constituent modulates molecular traits linked to the adaptation to intestinal environment in ways previously shown to enhance GI-survival.	[Reveron, Ines; Rodriguez, Hector; Campos, Gema; Curiel, Jose Antonio; de las Rivas, Blanca; Munoz, Rosario; de Felipe, Felix Lopez] CSIC, ICTAN, Lab Biotecnol Bacteriana, Madrid, Spain; [Ascaso, Carmen] CSIC, MNCN, Dpto Biol Ambiental, Madrid, Spain; [Carrascosa, Alfonso V.] CSIC, Inst Invest & Ciencias Alimentac, Grp Microbiol & Biocatalisis Alimentos, CIAL, Madrid, Spain; [Prieto, Alicia] CSIC, Ctr Invest Biol, Dpto Biol Medioambiental, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN); Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM - Instituto de Investigacion en Ciencias de la Alimentacion (CIAL); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	de Felipe, FL (corresponding author), CSIC, ICTAN, Lab Biotecnol Bacteriana, Madrid, Spain.	fxlopez@ictan.csic.es	de Felipe Toledano, Felix López/ABF-5849-2021; Muñoz, Rosario/H-8597-2012; de las Rivas, Blanca/K-3899-2014; Rodríguez, Héctor/E-6887-2013; J.A., Curiel/H-8831-2015; Ascaso, Carmen/F-5369-2011; Prieto, Alicia/M-7899-2017	de Felipe Toledano, Felix López/0000-0001-5661-8115; Muñoz, Rosario/0000-0003-4170-9713; de las Rivas, Blanca/0000-0002-8357-5226; Rodríguez, Héctor/0000-0002-9948-2497; J.A., Curiel/0000-0002-0111-1437; Ascaso, Carmen/0000-0001-9665-193X; Prieto, Alicia/0000-0002-5075-4025	CICYT grant [AGL2008-001052, AGL2011-22745]; I3P (CSIC); FPI (MICINN); Consolider INGENIO [CSD2007-00063 FUN-C-FOOD]; CAM grant (ALIBIRD) [S2009/AGR-1469]; MINECO grant [CTM2012-38222-C02-02]	CICYT grant(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); I3P (CSIC); FPI (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider INGENIO(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CAM grant (ALIBIRD); MINECO grant(Spanish Government)	H. Rodriguez and J. A. Curiel acknowledge I3P (CSIC) or FPI (MICINN) PhD grants, respectively. The authors gratefully acknowledge the partial financial support of the CICYT grants AGL2008-001052, AGL2011-22745, Consolider INGENIO 2010 CSD2007-00063 FUN-C-FOOD, the CAM grant S2009/AGR-1469 (ALIBIRD) and the MINECO grant CTM2012-38222-C02-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Curiel JA, 2011, MOL NUTR FOOD RES, V55, P1454, DOI 10.1002/mnfr.201000621; Blanco AR, 2005, ANTIMICROB AGENTS CH, V49, P4339, DOI 10.1128/AAC.49.10.4339-4343.2005; Bossi A, 2007, J APPL MICROBIOL, V102, P787, DOI 10.1111/j.1365-2672.2006.03118.x; Bron PA, 2007, J APPL MICROBIOL, V103, P1424, DOI 10.1111/j.1365-2672.2007.03376.x; Bron PA, 2004, J BACTERIOL, V186, P5721, DOI 10.1128/JB.186.17.5721-5729.2004; Bron PA, 2004, J BACTERIOL, V186, P7829, DOI 10.1128/JB.186.23.7829-7835.2004; Cecconi D, 2009, ELECTROPHORESIS, V30, P957, DOI 10.1002/elps.200800310; Chung KT, 1998, FOOD CHEM TOXICOL, V36, P1053, DOI 10.1016/S0278-6915(98)00086-6; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; de los Rios Asuncion, 2002, P87; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; de Vries M. C, 2006, THESIS WAGENINGEN U; De Vuyst L, 1999, FEMS MICROBIOL REV, V23, P153, DOI 10.1016/S0168-6445(98)00042-4; Dolara P, 2005, MUTAT RES-FUND MOL M, V591, P237, DOI 10.1016/j.mrfmmm.2005.04.022; Groenewald W. H., 2006, SOUTH AFRICAN JOURNAL OF ENOLOGY AND VITICULTURE, V27, P46; Hakenbeck R, 1999, MOL MICROBIOL, V33, P673, DOI 10.1046/j.1365-2958.1999.01521.x; Laine RA, 1972, METHOD ENZYMOL, V28, P159, DOI [10.1016/0076-6879(72)28012-0, DOI 10.1016/0076-6879(72)28012-0]; Lebeer S, 2011, MICROB BIOTECHNOL, V4, P368, DOI 10.1111/j.1751-7915.2010.00199.x; Licandro-Seraut H, 2008, J MOL MICROB BIOTECH, V14, P41, DOI 10.1159/000106081; Marco ML, 2007, APPL ENVIRON MICROB, V73, P124, DOI 10.1128/AEM.01475-06; Marco ML, 2010, ISME J, V4, P1481, DOI 10.1038/ismej.2010.61; Marco ML, 2009, ENVIRON MICROBIOL, V11, P2747, DOI 10.1111/j.1462-2920.2009.02001.x; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; O'Donovan L, 2001, MICROBIOL-SGM, V147, P1025, DOI 10.1099/00221287-147-4-1025; Osawa R, 2000, APPL ENVIRON MICROB, V66, P3093, DOI 10.1128/AEM.66.7.3093-3097.2000; Remus DM, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-149; Reveron I, 2012, MOL NUTR FOOD RES, V56, P1848, DOI 10.1002/mnfr.201200384; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rodriguez H, 2008, INT J FOOD MICROBIOL, V121, P92, DOI 10.1016/j.ijfoodmicro.2007.11.002; Rozes N, 1998, APPL MICROBIOL BIOT, V49, P108, DOI 10.1007/s002530051145; Saulnier DAA, 2007, APPL ENVIRON MICROB, V73, P1753, DOI 10.1128/AEM.01151-06; Saulnier DM, 2009, CURR PHARM DESIGN, V15, P1403, DOI 10.2174/138161209788168128; SCALBERT A, 1991, PHYTOCHEMISTRY, V30, P3875, DOI 10.1016/0031-9422(91)83426-L; Serrano J, 2009, MOL NUTR FOOD RES, V53, pS310, DOI 10.1002/mnfr.200900039; Smith A, 2005, SIGHT SOUND, V15, P50; Smith AH, 2004, APPL ENVIRON MICROB, V70, P1104, DOI 10.1128/AEM.70.2.1104-1115.2004; van Bokhorst-van de Veen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039053; Vesa T, 2000, ALIMENT PHARM THER, V14, P823; WHO and FAO, 2003, WHO TECH REP SER, V916, P1	39	24	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66473	10.1371/journal.pone.0066473	http://dx.doi.org/10.1371/journal.pone.0066473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776675	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400147
J	Tanaka, S; Ikeda, H; Kasahara, K; Kato, R; Tsubomi, H; Sugawara, SK; Mori, M; Hanakawa, T; Sadato, N; Honda, M; Watanabe, K				Tanaka, Satoshi; Ikeda, Hanako; Kasahara, Kazumi; Kato, Ryo; Tsubomi, Hiroyuki; Sugawara, Sho K.; Mori, Makoto; Hanakawa, Takashi; Sadato, Norihiro; Honda, Manabu; Watanabe, Katsumi			Larger Right Posterior Parietal Volume in Action Video Game Experts: A Behavioral and Voxel-Based Morphometry (VBM) Study	PLOS ONE			English	Article							BRAIN STRUCTURE CHANGES; VISUAL WORKING-MEMORY; SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; NEURAL BASIS; ATTENTION; CAPACITY; TIME; NEUROPLASTICITY; PLASTICITY	Recent studies suggest that action video game players exhibit superior performance in visuospatial cognitive tasks compared with non-game players. However, the neural basis underlying this visuospatial cognitive performance advantage remains largely unknown. The present human behavioral and imaging study compared gray matter volume in action video game experts and non-experts using structural magnetic resonance imaging and voxel-based morphometry analysis. The results revealed significantly larger gray matter volume in the right posterior parietal cortex in experts compared with non-experts. Furthermore, the larger gray matter volume in the right posterior parietal cortex significantly correlated with individual performance in a visual working memory task in experts. These results suggest that differences in brain structure may be linked to extensive video game play, leading to superior visuospatial cognitive performance in action video game experts.	[Tanaka, Satoshi] Nagoya Inst Technol, Nagoya, Aichi, Japan; [Ikeda, Hanako] Rikkyo Univ, Tokyo 171, Japan; [Kasahara, Kazumi; Sugawara, Sho K.] Japan Soc Promot Sci, Tokyo, Japan; [Kasahara, Kazumi; Hanakawa, Takashi; Honda, Manabu] Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Kato, Ryo] Waseda Univ, Tokyo, Japan; [Tsubomi, Hiroyuki] Toyama Univ, Toyama 930, Japan; [Mori, Makoto] Chiba Prefectural Board Educ, Chiba, Japan; [Hanakawa, Takashi; Watanabe, Katsumi] Japan Sci & Technol Agcy, Saitama, Japan; [Watanabe, Katsumi] Univ Tokyo, Tokyo, Japan	Nagoya Institute of Technology; Rikkyo University; Japan Society for the Promotion of Science; National Center for Neurology & Psychiatry - Japan; Waseda University; University of Toyama; Japan Science & Technology Agency (JST); University of Tokyo	Tanaka, S (corresponding author), Nagoya Inst Technol, Nagoya, Aichi, Japan.	tanaka.satoshi@nitech.ac.jp	HONDA, Manabu/AAO-1202-2020; Hanakawa, Takashi/AEU-7951-2022	Sadato, Norihiro/0000-0002-9786-3907; Kasahara, Kazumi/0000-0002-1306-3989; Watanabe, Katsumi/0000-0003-1282-9994	Hayao Nakayama Foundation for Science & Technology and Culture; Funds for the Development of Human Resources in Science and Technology; Grants-in-Aid for Scientific Research [24118511] Funding Source: KAKEN	Hayao Nakayama Foundation for Science & Technology and Culture; Funds for the Development of Human Resources in Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Hayao Nakayama Foundation for Science & Technology and Culture, and Funds for the Development of Human Resources in Science and Technology, awarded to Satoshi Tanaka. The funding agencies had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.	Achtman RL, 2008, RESTOR NEUROL NEUROS, V26, P435; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Basak C, 2011, BRAIN COGNITION, V76, P407, DOI 10.1016/j.bandc.2011.03.017; Bavelier D, 2012, VISION RES, V61, P132, DOI 10.1016/j.visres.2011.08.007; Bavelier D, 2011, NAT REV NEUROSCI, V12, P763, DOI 10.1038/nrn3135; Bezzola L, 2011, J NEUROSCI, V31, P12444, DOI 10.1523/JNEUROSCI.1996-11.2011; Boot WR, 2012, ACTA PSYCHOL, V141, P276, DOI 10.1016/j.actpsy.2012.06.011; Boot WR, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00226; Boot WR, 2008, ACTA PSYCHOL, V129, P387, DOI 10.1016/j.actpsy.2008.09.005; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Castel AD, 2005, ACTA PSYCHOL, V119, P217, DOI 10.1016/j.actpsy.2005.02.004; Colzato LS, 2013, PSYCHOL RES-PSYCH FO, V77, P234, DOI 10.1007/s00426-012-0415-2; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Coull JT, 1998, NEUROIMAGE, V8, P176, DOI 10.1006/nimg.1998.0354; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Cusack R, 2009, PSYCHON B REV, V16, P641, DOI 10.3758/PBR.16.4.641; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Dye MWG, 2009, NEUROPSYCHOLOGIA, V47, P1780, DOI 10.1016/j.neuropsychologia.2009.02.002; Dye MWG, 2009, CURR DIR PSYCHOL SCI, V18, P321, DOI 10.1111/j.1467-8721.2009.01660.x; Edgington E.S., 2007, RANDOMIZATION TESTS; Erickson KI, 2010, CEREB CORTEX, V20, P2522, DOI 10.1093/cercor/bhp293; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Fukuda K, 2011, PSYCHOL SCI, V22, P361, DOI 10.1177/0956797611398493; Fukuda K, 2009, J NEUROSCI, V29, P8726, DOI 10.1523/JNEUROSCI.2145-09.2009; Gaser C, 2003, J NEUROSCI, V23, P9240; Good P, 2000, PERMUTATION TESTS PR; Green CS, 2007, PSYCHOL SCI, V18, P88, DOI 10.1111/j.1467-9280.2007.01853.x; Green CS, 2006, COGNITION, V101, P217, DOI 10.1016/j.cognition.2005.10.004; Green CS, 2008, PSYCHOL AGING, V23, P692, DOI 10.1037/a0014345; Green CS, 2006, J EXP PSYCHOL HUMAN, V32, P1465, DOI 10.1037/0096-1523.32.6.1465; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Greenfield PM, 2009, SCIENCE, V323, P69, DOI 10.1126/science.1167190; GRIFFITH JL, 1983, PERCEPT MOTOR SKILL, V57, P155, DOI 10.2466/pms.1983.57.1.155; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Hanggi J, 2010, J COGNITIVE NEUROSCI, V22, P139, DOI 10.1162/jocn.2008.21175; Halligan PW, 2003, TRENDS COGN SCI, V7, P125, DOI 10.1016/S1364-6613(03)00032-9; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Hu YZ, 2011, HUM BRAIN MAPP, V32, P10, DOI 10.1002/hbm.20996; Hubert-Wallander B, 2011, ATTEN PERCEPT PSYCHO, V73, P2399, DOI 10.3758/s13414-011-0194-7; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Karle JW, 2010, ACTA PSYCHOL, V134, P70, DOI 10.1016/j.actpsy.2009.12.007; Kuhn S, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.53; Li RW, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001135; Linke AC, 2011, NEUROPSYCHOLOGIA, V49, P1476, DOI 10.1016/j.neuropsychologia.2010.11.034; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Mishra J, 2011, J NEUROSCI, V31, P992, DOI 10.1523/JNEUROSCI.4834-10.2011; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; Schlickum MK, 2009, WORLD J SURG, V33, P2360, DOI 10.1007/s00268-009-0151-y; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Wei GX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017112, 10.1371/journal.pone.0028309]; West GL, 2008, J VISION, V8, DOI 10.1167/8.16.13; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262	61	44	47	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66998	10.1371/journal.pone.0066998	http://dx.doi.org/10.1371/journal.pone.0066998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	169CU	23776706	Green Submitted, gold, Green Published			2022-12-25	WOS:000320755400159
J	Tseng, JR; Chen, KY; Lee, MH; Huang, CT; Wen, YH; Yen, TC				Tseng, Jing-Ren; Chen, Ke-Yuan; Lee, Ming-Hsun; Huang, Ching-Tai; Wen, Ying-Hao; Yen, Tzu-Chen			Potential Usefulness of FDG PET/CT in Patients with Sepsis of Unknown Origin	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; F-18-FDG PET/CT; METASTATIC INFECTION; LIVER-CIRRHOSIS; SCINTIGRAPHY; INFLAMMATION; TOMOGRAPHY	Purpose: The role of FDG PET in the evaluation of patients with sepsis of unknown origin remains unclear. We sought to assess the value of FDG PET/CT in patients with sepsis of unknown cause and to define its priority in this group of subjects. Methods: A total of 53 patients with sepsis of unknown origin underwent FDG PET/CT within two weeks of diagnosis. All of the patients were followed up for at least 3 months after discharge to determine the clinical outcomes. The impact of FDG PET/CT was assessed according to the number of cases who had their treatment modified on the basis of the imaging results. Logistic regression analysis was used to identify the independent predictors of positive FDG PET/CT findings. Results: Of the 53 study patients, 35 (66%) had positive FDG PET/CT findings, and 13 (25%) had their treatment modified on the basis of the imaging results. Logistic regression analysis identified normal serum aspartate aminotransferase (odds ratio [OR] = 6.134; 95% confidence interval [CI] = 1.443-26.076, P = 0.014) and increased serum alkaline phosphatase levels (OR = 5.813; 95% CI = 1.386-24.376, P = 0.016) at diagnosis as independent predictors of positive FDG PET/CT findings. A scoring system using these two covariates was developed, which defined three distinct priority groups for FDG PET/CT imaging. Conclusion: Our findings suggest that FDG PET/CT may be clinically useful for the detection of occult foci of infection in patients with sepsis of unknown origin.	[Tseng, Jing-Ren; Yen, Tzu-Chen] Chang Gung Mem Hosp Linkou, Nucl Med & Mol Imaging Ctr, Tao Yuan, Taiwan; [Chen, Ke-Yuan; Lee, Ming-Hsun; Huang, Ching-Tai] Chang Gung Mem Hosp Linkou, Dept Internal Med, Div Infect Dis, Tao Yuan, Taiwan; [Wen, Ying-Hao] Chang Gung Mem Hosp Linkou, Dept Pathol, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yen, TC (corresponding author), Chang Gung Mem Hosp Linkou, Nucl Med & Mol Imaging Ctr, Tao Yuan, Taiwan.	yen1110@adm.cgmh.org.tw		Tseng, Jing-Ren/0000-0002-2232-9347				ANTHONY PP, 1978, J CLIN PATHOL, V31, P395, DOI 10.1136/jcp.31.5.395; Bleeker-Rovers CP, 2005, J NUCL MED, V46, P2014; BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Chen WC, 2012, INTERN EMERG MED, V7, P53, DOI 10.1007/s11739-011-0739-8; Cuijpers MLH, 2007, EUR J CLIN MICROBIOL, V26, P105, DOI 10.1007/s10096-006-0238-4; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Fowler VG, 2003, ARCH INTERN MED, V163, P2066, DOI 10.1001/archinte.163.17.2066; Gotthardt M, 2010, J NUCL MED, V51, P1937, DOI 10.2967/jnumed.110.076232; Gratz S, 2002, EUR J NUCL MED MOL I, V29, P516, DOI 10.1007/s00259-001-0719-8; Haroon A, 2012, CLIN INFECT DIS, V54, P1333, DOI 10.1093/cid/cis193; Kalicke T, 2000, EUR J NUCL MED, V27, P524, DOI 10.1007/s002590050538; Lesens O, 2004, J INFECTION, V48, P245, DOI 10.1016/j.jinf.2003.10.010; Lever A, 2007, BMJ-BRIT MED J, V335, P879, DOI 10.1136/bmj.39346.495880.AE; Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Rabkin Z, 2010, J NUCL MED, V51, P1015, DOI 10.2967/jnumed.109.074294; SELBERG O, 1993, J CLIN INVEST, V91, P1897, DOI 10.1172/JCI116407; Tietge UE, 2004, LIVER TRANSPLANT, V10, P1030, DOI 10.1002/lt.20147; VANHOOF VO, 1994, CRIT REV CL LAB SCI, V31, P197, DOI 10.3109/10408369409084677; Vos FJ, 2012, MEDICINE, V91, P86, DOI 10.1097/MD.0b013e31824d7ed2; Vos FJ, 2012, EUR J NUCL MED MOL I, V39, P120, DOI 10.1007/s00259-011-1939-1; Vos FJ, 2010, J NUCL MED, V51, P1234, DOI 10.2967/jnumed.109.072371; WEISDORF DJ, 1982, BLOOD, V60, P888; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865	24	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66132	10.1371/journal.pone.0066132	http://dx.doi.org/10.1371/journal.pone.0066132			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776621	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400113
J	Batty, EM; Wong, THN; Trebes, A; Argoud, K; Attar, M; Buck, D; Ip, CLC; Golubchik, T; Cule, M; Bowden, R; Manganis, C; Klenerman, P; Barnes, E; Walker, AS; Wyllie, DH; Wilson, DJ; Dingle, KE; Peto, TEA; Crook, DW; Piazza, P				Batty, Elizabeth M.; Wong, T. H. Nicholas; Trebes, Amy; Argoud, Karene; Attar, Moustafa; Buck, David; Ip, Camilla L. C.; Golubchik, Tanya; Cule, Madeleine; Bowden, Rory; Manganis, Charis; Klenerman, Paul; Barnes, Eleanor; Walker, A. Sarah; Wyllie, David H.; Wilson, Daniel J.; Dingle, Kate E.; Peto, Tim E. A.; Crook, Derrick W.; Piazza, Paolo			A Modified RNA-Seq Approach for Whole Genome Sequencing of RNA Viruses from Faecal and Blood Samples	PLOS ONE			English	Article							ALGORITHMS; EVOLUTION; TOOL	To date, very large scale sequencing of many clinically important RNA viruses has been complicated by their high population molecular variation, which creates challenges for polymerase chain reaction and sequencing primer design. Many RNA viruses are also difficult or currently not possible to culture, severely limiting the amount and purity of available starting material. Here, we describe a simple, novel, high-throughput approach to Norovirus and Hepatitis C virus whole genome sequence determination based on RNA shotgun sequencing (also known as RNA-Seq). We demonstrate the effectiveness of this method by sequencing three Norovirus samples from faeces and two Hepatitis C virus samples from blood, on an Illumina MiSeq benchtop sequencer. More than 97% of reference genomes were recovered. Compared with Sanger sequencing, our method had no nucleotide differences in 14,019 nucleotides (nt) for Noroviruses (from a total of 2 Norovirus genomes obtained with Sanger sequencing), and 8 variants in 9,542 nt for Hepatitis C virus (1 variant per 1,193 nt). The three Norovirus samples had 2, 3, and 2 distinct positions called as heterozygous, while the two Hepatitis C virus samples had 117 and 131 positions called as heterozygous. To confirm that our sample and library preparation could be scaled to true high-throughput, we prepared and sequenced an additional 77 Norovirus samples in a single batch on an Illumina HiSeq 2000 sequencer, recovering.90% of the reference genome in all but one sample. No discrepancies were observed across 118,757 nt compared between Sanger and our custom RNA-Seq method in 16 samples. By generating viral genomic sequences that are not biased by primer-specific amplification or enrichment, this method offers the prospect of large-scale, affordable studies of RNA viruses which could be adapted to routine diagnostic laboratory workflows in the near future, with the potential to directly characterize within-host viral diversity.	[Batty, Elizabeth M.; Trebes, Amy; Argoud, Karene; Attar, Moustafa; Buck, David; Bowden, Rory; Wilson, Daniel J.; Piazza, Paolo] Wellcome Trust Ctr Human Genet, Oxford, England; [Wong, T. H. Nicholas; Manganis, Charis; Klenerman, Paul; Barnes, Eleanor; Walker, A. Sarah; Wyllie, David H.; Wilson, Daniel J.; Peto, Tim E. A.; Crook, Derrick W.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England; [Wong, T. H. Nicholas; Walker, A. Sarah; Wyllie, David H.; Dingle, Kate E.; Peto, Tim E. A.; Crook, Derrick W.] John Radcliffe Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 9DU, England; [Ip, Camilla L. C.; Golubchik, Tanya; Cule, Madeleine] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Dingle, Kate E.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; University of Oxford; University of Oxford	Wong, THN (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England.	nick.wong@ndm.ox.ac.uk	Golubchik, Tanya/B-4226-2018; Walker, Sarah/HDM-8717-2022; Wilson, Daniel J/AAE-8975-2019	Golubchik, Tanya/0000-0003-2765-9828; Wilson, Daniel J/0000-0002-0940-3311; klenerman, paul/0000-0003-4307-9161; Barnes, Eleanor/0000-0002-0860-0831; peto, tim/0000-0003-3477-8307; Batty, Liz/0000-0001-8559-452X; Piazza, Paolo/0000-0002-3736-1841; Dingle, Kate/0000-0002-2303-5957	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; UKCRC Modernising Medical Microbiology Consortium; UKCRC Translational Infection Research Initiative; Medical Research Council, Biotechnology and Biological Sciences Research Council; NIHR on behalf of the Department of Health [G0800778]; Wellcome Trust [087646/Z/08/Z]; Wellcome Trust core funding [090532/Z/09/Z]; MRC Hub [G0900747 91070]; Medical Research Council [MR/K010239/1, G0800778] Funding Source: researchfish; National Institute for Health Research [ACF-2008-13-003, NF-SI-0510-10204, NF-SI-0512-10047, NF-SI-0508-10279] Funding Source: researchfish; MRC [MR/K010239/1, G0800778] Funding Source: UKRI	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); UKCRC Modernising Medical Microbiology Consortium; UKCRC Translational Infection Research Initiative; Medical Research Council, Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Biotechnology and Biological Sciences Research Council (BBSRC)); NIHR on behalf of the Department of Health; Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust core funding; MRC Hub(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre and the UKCRC Modernising Medical Microbiology Consortium, the latter funded under the UKCRC Translational Infection Research Initiative supported by Medical Research Council, Biotechnology and Biological Sciences Research Council and the NIHR on behalf of the Department of Health (grant G0800778) and the Wellcome Trust (grant 087646/Z/08/Z). The authors acknowledge the support of Wellcome Trust core funding (grant 090532/Z/09/Z) and MRC Hub (grant G0900747 91070). TEAP and DWC are NIHR Senior Investigators. THNW is an NIHR Oxford BRC Doctoral Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrovskaya I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S6-S1; Bailey JR, 2012, J VIROL, V86, P12582, DOI 10.1128/JVI.01440-12; Bull RA, 2011, TRENDS MICROBIOL, V19, P233, DOI 10.1016/j.tim.2011.01.002; Chan JZM, 2012, NAT BIOTECHNOL, V30, P1068, DOI 10.1038/nbt.2410; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Croville G, 2012, J CLIN MICROBIOL, V50, P2881, DOI 10.1128/JCM.01142-12; Daly GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028879; Depledge DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027805; Dingle KE, 2004, J CLIN MICROBIOL, V42, P3950, DOI 10.1128/JCM.42.9.3950-3957.2004; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eisenstein M, 2012, NAT BIOTECHNOL, V30, P295, DOI 10.1038/nbt0412-295; Eyre DW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001124; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Holmes EC, 2002, J VIROL, V76, P460, DOI 10.1128/JVI.76.1.460-462.2002; Humphreys I, 2009, J VIROL, V83, P11456, DOI 10.1128/JVI.00884-09; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Lauck M, 2012, J VIROL, V86, P3952, DOI 10.1128/JVI.06627-11; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Malboeuf CM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks794; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAGALAKSHMI U, 2010, CURR PROTOC MOL BIOL, P1; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Prosperi MCF, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-5; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Simmonds P, 2008, NUCLEIC ACIDS RES, V36, P2530, DOI 10.1093/nar/gkn096; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; van Beek J, 2013, EUROSURVEILLANCE, V18, P8; Vennema H, 2002, J CLIN VIROL, V25, P233, DOI 10.1016/S1386-6532(02)00126-9; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Willerth SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013564; Wilson DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002874; Yang X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-475; Yu Q, 2011, BIOINFORMATICS, V27, P266, DOI 10.1093/bioinformatics/btq624; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	42	46	48	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66129	10.1371/journal.pone.0066129	http://dx.doi.org/10.1371/journal.pone.0066129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762474	Green Published, gold, Green Submitted			2022-12-25	WOS:000320440500064
J	Yang, Y; Igumenova, TI				Yang, Yuan; Igumenova, Tatyana I.			The C-Terminal V5 Domain of Protein Kinase C alpha Is Intrinsically Disordered, with Propensity to Associate with a Membrane Mimetic	PLOS ONE			English	Article							PHOSPHOINOSITIDE-DEPENDENT KINASE; PKC-BETA-II; SECONDARY STRUCTURE; BACKBONE DYNAMICS; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; NMR RELAXATION; CIRCULAR-DICHROISM; GAMMA-SYNUCLEIN; TURN MOTIF	The C-terminal V5 domain is one of the most variable domains in Protein Kinase C isoforms (PKCs). V5 confers isoform specificity on its parent enzyme through interactions with isoform-specific adaptor proteins and possibly through specific intra-molecular interactions with other PKC domains. The structural information about V5 domains in solution is sparse. The objective of this work was to determine the conformational preferences of the V5 domain from the a isoform of PKC (V5 alpha) and evaluate its ability to associate with membrane mimetics. We show that V5 alpha and its phosphorylation-mimicking variant, dmV5 alpha, are intrinsically disordered protein domains. Phosphorylation-mimicking mutations do not alter the overall conformation of the polypeptide backbone, as evidenced by the local nature of chemical shift perturbations and the secondary structure propensity scores. However, the population of the "cis-trans" conformer of the Thr(638)-Pro(639)-Pro(640) turn motif, which has been implicated in the down-regulation of PKC alpha via peptidyl-prolyl isomerase Pin1, increases in dmV5 alpha, along with the conformational flexibility of the region between the turn and hydrophobic motifs. Both wild type and dmV5 alpha associate with micelles made of a zwitterionic detergent, n-dodecylphosphocholine. Upon micelle binding, V5 alpha acquires a higher propensity to form helical structures at the conserved "NFD" motif and the entire C-terminal third of the domain. The ability of V5 alpha to partition into the hydrophobic micellar environment suggests that it may serve as a membrane anchor during the PKC maturation process.	[Yang, Yuan; Igumenova, Tatyana I.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Igumenova, TI (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	tigumenova@tamu.edu		Yang, Yuan/0000-0002-9538-6369	Welch Foundation [A-1784]	Welch Foundation(The Welch Foundation)	This work was supported by the Welch Foundation (http://www.welch1.org, award number A-1784). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen H, 2012, J BIOL CHEM, V287, P13262, DOI 10.1074/jbc.M112.349753; Abrial E, 2011, MOL NEUROBIOL, V44, P407, DOI 10.1007/s12035-011-8210-4; Bai YW, 2001, PROTEIN SCI, V10, P1056, DOI 10.1110/ps.00601; Behn-Krappa A, 1999, CURR BIOL, V9, P728, DOI 10.1016/S0960-9822(99)80332-7; Bornancin F, 1996, CURR BIOL, V6, P1114, DOI 10.1016/S0960-9822(02)70678-7; Bornancin F, 1997, J BIOL CHEM, V272, P3544, DOI 10.1074/jbc.272.6.3544; Churchill E, 2008, ANNU REV PHARMACOL, V48, P569, DOI 10.1146/annurev.pharmtox.48.121806.154902; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Edwards AS, 1997, J BIOL CHEM, V272, P18382, DOI 10.1074/jbc.272.29.18382; Edwards AS, 1999, J BIOL CHEM, V274, P6461, DOI 10.1074/jbc.274.10.6461; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; FARROW NA, 1995, BIOCHEMISTRY-US, V34, P868, DOI 10.1021/bi00003a021; Ferreira JCB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033175; Ferreira JCB, 2011, J MOL CELL CARDIOL, V51, P980, DOI 10.1016/j.yjmcc.2011.08.025; Gao TY, 2001, J BIOL CHEM, V276, P19588, DOI 10.1074/jbc.M101357200; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Grodsky N, 2006, BIOCHEMISTRY-US, V45, P13970, DOI 10.1021/bi061128h; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Kazanietz MG, 2011, STRUCTURE, V19, P144, DOI 10.1016/j.str.2011.01.004; Kheifets V, 2007, PHARMACOL RES, V55, P467, DOI 10.1016/j.phrs.2007.04.014; Kim J, 2011, ONCOGENE, V30, P323, DOI 10.1038/onc.2010.415; Kim JW, 2008, CANCER RES, V68, P6831, DOI 10.1158/0008-5472.CAN-07-6195; KULIOPULOS A, 1994, J AM CHEM SOC, V116, P4599, DOI 10.1021/ja00090a008; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Messerschmidt A, 2005, J MOL BIOL, V352, P918, DOI 10.1016/j.jmb.2005.07.060; MOSIOR M, 1991, BIOPHYS J, V60, P149, DOI 10.1016/S0006-3495(91)82038-0; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Palaniyandi SS, 2011, J CELL MOL MED, V15, P1769, DOI 10.1111/j.1582-4934.2010.01174.x; PENG JW, 1992, BIOCHEMISTRY-US, V31, P8571, DOI 10.1021/bi00151a027; PENG JW, 1992, J MAGN RESON, V98, P308, DOI 10.1016/0022-2364(92)90135-T; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Schutkowski M, 1998, BIOCHEMISTRY-US, V37, P5566, DOI 10.1021/bi973060z; Solodukhin AS, 2007, CELL SIGNAL, V19, P2035, DOI 10.1016/j.cellsig.2007.05.010; Sonnenburg ED, 2001, J BIOL CHEM, V276, P45289, DOI 10.1074/jbc.M107416200; Stebbins EG, 2001, J BIOL CHEM, V276, P29644, DOI 10.1074/jbc.M101044200; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stensman H, 2007, J BIOL CHEM, V282, P28627, DOI 10.1074/jbc.M702248200; Stewart MD, 2011, J MOL BIOL, V408, P949, DOI 10.1016/j.jmb.2011.03.020; Takimura T, 2010, ACTA CRYSTALLOGR D, V66, P577, DOI 10.1107/S0907444910005639; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Wagner J, 2009, J MED CHEM, V52, P6193, DOI 10.1021/jm901108b; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xu ZB, 2004, J BIOL CHEM, V279, P50401, DOI 10.1074/jbc.M409216200	59	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65699	10.1371/journal.pone.0065699	http://dx.doi.org/10.1371/journal.pone.0065699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762412	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000095
J	Oner, SS; Vural, A; Lanier, SM				Oner, Sukru S.; Vural, Ali; Lanier, Stephen M.			Translocation of Activator of G-protein Signaling 3 to the Golgi Apparatus in Response to Receptor Activation and Its Effect on the trans-Golgi Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; HETEROTRIMERIC G-PROTEINS; BETA-GAMMA COMPLEX; HEROIN-SEEKING BEHAVIOR; PLASMA-MEMBRANE; REGULATOR AGS3; INDEPENDENT ACTIVATORS; MEDIATED REGULATION; ALPHA-SUBUNITS; IMAGE-ANALYSIS	Group II activators of G-protein signaling play diverse functional roles through their interaction with G alpha(i), G alpha(t), and G alpha(o) via a G-protein regulatory (GPR) motif that serves as a docking site for G alpha-GDP. We recently reported the regulation of the AGS3-G alpha(i) signaling module by a cell surface, seven-transmembrane receptor. Upon receptor activation, AGS3 reversibly dissociates from the cell cortex, suggesting that it may function as a signal transducer with downstream signaling implications, and this question is addressed in the current report. In HEK-293 and COS-7 cells expressing the alpha(2A/D)-AR and G alpha(i3), receptor activation resulted in the translocation of endogenous AGS3 and AGS3-GFP from the cell cortex to a juxtanuclear region, where it co-localized with markers of the Golgi apparatus (GA). The agonist-induced translocation of AGS3 was reversed by the alpha(2)-AR antagonist rauwolscine. The TPR domain of AGS3 was required for agonist-induced translocation of AGS3 from the cell cortex to the GA, and the translocation was blocked by pertussis toxin pretreatment or by the phospholipase C beta inhibitor U73122. Agonist-induced translocation of AGS3 to the GA altered the functional organization and protein sorting at the trans-Golgi network. The regulated movement of AGS3 between the cell cortex and the GA offers unexpected mechanisms for modulating protein secretion and/or endosome recycling events at the trans-Golgi network.	[Oner, Sukru S.; Vural, Ali; Lanier, Stephen M.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA	Medical University of South Carolina	Lanier, SM (corresponding author), Med Univ S Carolina, Dept Pharmacol, 179 Ashley Ave, Charleston, SC 29425 USA.	lanier@musc.edu	Oner, Sukru/K-8032-2012	Oner, Sukru/0000-0002-8864-7356; Lanier, Stephen/0000-0002-2740-7607	National Institutes of Health [DA025896]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA025896 (to S. M. L.).	Akgoz M, 2004, J BIOL CHEM, V279, P51541, DOI 10.1074/jbc.M410639200; Akgoz M, 2006, CELL SIGNAL, V18, P1758, DOI 10.1016/j.cellsig.2006.01.016; Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Azpiazu I, 2006, CELL SIGNAL, V18, P1190, DOI 10.1016/j.cellsig.2005.09.007; Blumer JB, 2012, ACTA PHYSIOL, V204, P202, DOI 10.1111/j.1748-1716.2011.02327.x; Blumer JB, 2003, J BIOL CHEM, V278, P23217, DOI 10.1074/jbc.C200686200; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Bowers MS, 2008, P NATL ACAD SCI USA, V105, P12533, DOI 10.1073/pnas.0706999105; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Cao XQ, 2004, J BIOL CHEM, V279, P27567, DOI 10.1074/jbc.M312786200; Chatterjee TK, 2000, J BIOL CHEM, V275, P24013, DOI 10.1074/jbc.M002082200; Chauhan S, 2012, BIOCHEM J, V446, P445, DOI 10.1042/BJ20111882; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027; Anel AMD, 2007, BIOCHEM J, V406, P157, DOI 10.1042/BJ20070359; Doherty D, 2012, AM J HUM GENET, V90, P1088, DOI 10.1016/j.ajhg.2012.04.008; Garcia-Marcos M, 2011, MOL BIOL CELL, V22, P673, DOI 10.1091/mbc.E10-08-0738; Garcia-Marcos M, 2012, P NATL ACAD SCI USA, V109, P1961, DOI 10.1073/pnas.1120538109; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Giguere PM, 2012, J BIOL CHEM, V287, P31270, DOI 10.1074/jbc.M112.394379; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Groves B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008877; Hewavitharana T, 2012, CELL SIGNAL, V24, P25, DOI 10.1016/j.cellsig.2011.08.014; Hofler C, 2011, J NEUROSCI, V31, P11553, DOI 10.1523/JNEUROSCI.2072-11.2011; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Irannejad R, 2010, J BIOL CHEM, V285, P32393, DOI 10.1074/jbc.M110.154963; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jamora C, 1997, CELL, V91, P617, DOI 10.1016/S0092-8674(00)80449-3; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Klein RR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191783; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; LEYTE A, 1992, EMBO J, V11, P4795, DOI 10.1002/j.1460-2075.1992.tb05585.x; Nadella R, 2010, J AM SOC NEPHROL, V21, P1275, DOI 10.1681/ASN.2009121224; Oner SS, 2013, J BIOL CHEM, V288, P3003, DOI 10.1074/jbc.M112.418467; Oner SS, 2010, J BIOL CHEM, V285, P33949, DOI 10.1074/jbc.M110.138073; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Pattingre S, 2003, J BIOL CHEM, V278, P20995, DOI 10.1074/jbc.M300917200; Pizzinat N, 2001, J BIOL CHEM, V276, P16601, DOI 10.1074/jbc.M007573200; Ponting CP, 1999, J MOL MED, V77, P695, DOI 10.1007/s001099900054; Regner KR, 2011, FASEB J, V25, P1844, DOI 10.1096/fj.10-169797; Saini DK, 2010, P NATL ACAD SCI USA, V107, P11417, DOI 10.1073/pnas.1003042107; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; Sato M, 2011, J BIOL CHEM, V286, P17766, DOI 10.1074/jbc.M111.219816; Sato M, 2009, J BIOL CHEM, V284, P31431, DOI 10.1074/jbc.M109.014068; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHWANINGER R, 1992, J CELL BIOL, V119, P1077, DOI 10.1083/jcb.119.5.1077; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Thomas CJ, 2008, J BIOL CHEM, V283, P23150, DOI 10.1074/jbc.M802422200; Vellano CP, 2011, J BIOL CHEM, V286, P38659, DOI 10.1074/jbc.M111.274928; Vural A, 2010, MOL CELL BIOL, V30, P1528, DOI 10.1128/MCB.01018-09; Willard FS, 2008, J BIOL CHEM, V283, P36698, DOI 10.1074/jbc.M804936200; WILSON BS, 1993, P NATL ACAD SCI USA, V90, P1681, DOI 10.1073/pnas.90.5.1681; Yamaguchi T, 2000, FEBS LETT, V470, P25, DOI 10.1016/S0014-5793(00)01284-9; Yao L, 2005, P NATL ACAD SCI USA, V102, P8746, DOI 10.1073/pnas.0503419102; Yao LN, 2006, P NATL ACAD SCI USA, V103, P7877, DOI 10.1073/pnas.0602661103; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	63	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24091	24103		10.1074/jbc.M112.444505	http://dx.doi.org/10.1074/jbc.M112.444505			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23770668	Green Published, hybrid			2022-12-25	WOS:000330611400045
J	Zhang, WJ; Zeng, FX; Liu, YW; Zhao, Y; Lv, H; Niu, LW; Teng, MK; Li, X				Zhang, Wenjuan; Zeng, Fuxing; Liu, Yiwei; Zhao, Yan; Lv, Hui; Niu, Liwen; Teng, Maikun; Li, Xu			Crystal Structures and RNA-binding Properties of the RNA Recognition Motifs of Heterogeneous Nuclear Ribonucleoprotein L INSIGHTS INTO ITS ROLES IN ALTERNATIVE SPLICING REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS HNRNP L; MESSENGER-RNA; DOMAINS; GENE; PTB; TRANSLATION; REFINEMENT; ISOFORMS; ELEMENTS; EXPORT	Heterogeneous nuclear ribonucleoprotein L (hnRNP L) is an abundant RNA-binding protein implicated in many bioprocesses, including pre-mRNA processing, mRNA export of intronless genes, internal ribosomal entry site-mediated translation, and chromatin modification. It contains four RNA recognition motifs (RRMs) that bind with CA repeats or CA-rich elements. In this study, surface plasmon resonance spectroscopy assays revealed that all four RRM domains contribute to RNA binding. Furthermore, we elucidated the crystal structures of hnRNP L RRM1 and RRM34 at 2.0 and 1.8 angstrom, respectively. These RRMs all adopt the typical beta 1 alpha 1 beta 2 beta 3 alpha 2 beta 4 topology, except for an unusual fifth beta-strand in RRM3. RRM3 and RRM4 interact intimately with each other mainly through helical surfaces, leading the two beta-sheets to face opposite directions. Structure-based mutations and surface plasmon resonance assay results suggested that the beta-sheets of RRM1 and RRM34 are accessible for RNA binding. FRET-based gel shift assays (FRET-EMSA) and steady-state FRET assays, together with cross-linking and dynamic light scattering assays, demonstrated that hnRNP L RRM34 facilitates RNA looping when binding to two appropriately separated binding sites within the same target pre-mRNA. EMSA and isothermal titration calorimetry binding studies with in vivo target RNA suggested that hnRNP L-mediated RNA looping may occur in vivo. Our study provides a mechanistic explanation for the dual functions of hnRNP L in alternative splicing regulation as an activator or repressor.	[Zhang, Wenjuan; Zeng, Fuxing; Liu, Yiwei; Zhao, Yan; Lv, Hui; Niu, Liwen; Teng, Maikun; Li, Xu] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Zhang, Wenjuan; Zeng, Fuxing; Liu, Yiwei; Zhao, Yan; Lv, Hui; Niu, Liwen; Teng, Maikun; Li, Xu] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Zhang, Wenjuan; Zeng, Fuxing; Liu, Yiwei; Zhao, Yan; Lv, Hui; Niu, Liwen; Teng, Maikun; Li, Xu] Chinese Acad Sci, Key Lab Struct Biol, Hefei 230026, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences	Teng, MK (corresponding author), Univ Sci & Technol China, Sch Life Sci, Rm 419, Hefei 230026, Anhui, Peoples R China.	mkteng@ustc.edu.cn; sachem@ustc.edu.cn		Li, Xu/0000-0001-5221-0817; Zhang, Wenjuan/0000-0002-3011-9956	Chinese Ministry of Science and Technology [2012CB917200, 2009CB825500]; Chinese National Natural Science Foundation [31270014, 31130018, 30900224]; Science and Technological Fund of Anhui Province for Outstanding Youth Grant [10040606Y11]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Science and Technological Fund of Anhui Province for Outstanding Youth Grant	This work was supported by Chinese Ministry of Science and Technology Grants 2012CB917200 and 2009CB825500, Chinese National Natural Science Foundation Grants 31270014, 31130018, and 30900224, and Science and Technological Fund of Anhui Province for Outstanding Youth Grant 10040606Y11.	Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dery KJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.204057; Diaz-Moreno I, 2010, NUCLEIC ACIDS RES, V38, P5193, DOI 10.1093/nar/gkq216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Guang SH, 2005, MOL CELL BIOL, V25, P6303, DOI 10.1128/MCB.25.15.6303-6313.2005; Hamilton BJ, 1999, BIOCHEM BIOPH RES CO, V261, P646, DOI 10.1006/bbrc.1999.1040; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Heiner M, 2010, RNA BIOL, V7, P56, DOI 10.4161/rna.7.1.10402; House AE, 2006, NAT STRUCT MOL BIOL, V13, P937, DOI 10.1038/nsmb1149; Huang Y, 2012, MOL CELL, V45, P459, DOI 10.1016/j.molcel.2011.12.022; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Hui JY, 2003, NAT STRUCT BIOL, V10, P33, DOI 10.1038/nsb875; Hung LH, 2008, RNA, V14, P284, DOI 10.1261/rna.725208; Hwang B, 2009, BIOCHEM BIOPH RES CO, V378, P584, DOI 10.1016/j.bbrc.2008.11.091; Kim JH, 2000, J MOL BIOL, V298, P395, DOI 10.1006/jmbi.2000.3687; Kuninger DT, 2002, NUCLEIC ACIDS RES, V30, P823, DOI 10.1093/nar/30.3.823; Lamichhane R, 2010, P NATL ACAD SCI USA, V107, P4105, DOI 10.1073/pnas.0907072107; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liker E, 2000, EMBO J, V19, P5587, DOI 10.1093/emboj/19.21.5587; Majumder M, 2009, MOL CELL BIOL, V29, P2899, DOI 10.1128/MCB.01774-08; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Motta-Mena LB, 2010, MOL CELL, V37, P223, DOI 10.1016/j.molcel.2009.12.027; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Preussner M, 2012, NUCLEIC ACIDS RES, V40, P5666, DOI 10.1093/nar/gks221; Rossbach O, 2009, MOL CELL BIOL, V29, P1442, DOI 10.1128/MCB.01689-08; Rothrock C, 2003, MOL CELL, V12, P1317, DOI 10.1016/S1097-2765(03)00434-9; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; Rueda D, 2003, BIOCHEMISTRY-US, V42, P9924, DOI 10.1021/bi0347757; Rueda David, 2006, V335, P289; SHAMOO Y, 1995, NUCLEIC ACIDS RES, V23, P725, DOI 10.1093/nar/23.5.725; Shenkerling G, 2010, J CLIN INVEST, V120, P3798, DOI 10.1172/JCI45037; Shih SC, 1999, J BIOL CHEM, V274, P1359, DOI 10.1074/jbc.274.3.1359; Simpson PJ, 2004, STRUCTURE, V12, P1631, DOI 10.1016/j.str.2004.07.008; Skrisovska L, 2008, J MOL BIOL, V375, P151, DOI 10.1016/j.jmb.2007.09.030; Soderberg M, 2007, MOL IMMUNOL, V44, P434, DOI 10.1016/j.molimm.2006.02.019; Teplova M, 2011, STRUCTURE, V19, P930, DOI 10.1016/j.str.2011.05.002; Teplova M, 2008, NAT STRUCT MOL BIOL, V15, P1343, DOI 10.1038/nsmb.1519; Tong A, 2005, J BIOL CHEM, V280, P38297, DOI 10.1074/jbc.M508123200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vitali F, 2006, EMBO J, V25, P150, DOI 10.1038/sj.emboj.7600911; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200	49	27	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22636	22649		10.1074/jbc.M113.463901	http://dx.doi.org/10.1074/jbc.M113.463901			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782695	Green Published, hybrid			2022-12-25	WOS:000330596300043
J	Ninomiya, M; Kondo, Y; Funayama, R; Nagashima, T; Kogure, T; Kakazu, E; Kimura, O; Ueno, Y; Nakayama, K; Shimosegawa, T				Ninomiya, Masashi; Kondo, Yasuteru; Funayama, Ryo; Nagashima, Takeshi; Kogure, Takayuki; Kakazu, Eiji; Kimura, Osamu; Ueno, Yoshiyuki; Nakayama, Keiko; Shimosegawa, Tooru			Distinct MicroRNAs Expression Profile in Primary Biliary Cirrhosis and Evaluation of miR 505-3p and miR197-3p as Novel Biomarkers	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CIRCULATING MICRORNAS; SUSCEPTIBILITY LOCI; SERUM; HLA; ANTIGEN; GENES; IDENTIFICATION; CHOLANGITIS; DIAGNOSIS	Background and Aims: MicroRNAs are small endogenous RNA molecules with specific expression patterns that can serve as biomarkers for numerous diseases. However, little is known about the expression profile of serum miRNAs in PBC. Methods: First, we employed Illumina deep sequencing for the initial screening to indicate the read numbers of miRNA expression in 10 PBC, 5 CH-C, 5 CH-B patients and 5 healthy controls. Comparing the differentially expressed miRNAs in the 4 groups, analysis of variance was performed on the number of sequence reads to evaluate the statistical significance. Hierarchical clustering was performed using an R platform and we have found candidates for specific miRNAs in the PBC patients. Second, a quantitative reverse transcription PCR validation study was conducted in 10 samples in each group. The expression levels of the selected miRNAs were presented as fold-changes (2(-Delta Delta Ct)). Finally, computer analysis was conducted to predict target genes and biological functions with MiRror 2.0 and DAVID v6.7. Results: We obtained about 12 million 32-mer short RNA reads on average per sample and the mapping rates to miRBase were 16.60% and 81.66% to hg19. In the statistical significance testing, the expression levels of 81 miRNAs were found to be differentially expressed in the 4 groups. The heat map and hierarchical clustering demonstrated that the miRNA profiles from PBC clustered with those of CH-B, CH-C and healthy controls. Additionally, the circulating levels of hsa-miR-505-3p, 197-3p, and 500a-3p were significantly decreased in PBC compared with healthy controls and the expression levels of hsa-miR-505-3p, 139-5p and 197-3p were significantly reduced compared with the viral hepatitis group. Conclusions: Our results indicate that sera from patients with PBC have a unique miRNA expression profile and that the down-regulated expression of hsa-miR-505-3p and miR-197-3p can serve as clinical biomarkers of PBC.	[Ninomiya, Masashi; Kondo, Yasuteru; Kogure, Takayuki; Kakazu, Eiji; Kimura, Osamu; Shimosegawa, Tooru] Tohoku Univ Hosp, Div Gastroenterol, Sendai, Miyagi, Japan; [Funayama, Ryo; Nagashima, Takeshi; Nakayama, Keiko] Tohoku Univ, Sch Med, Div Cell Proliferat, Sendai, Miyagi 980, Japan; [Ueno, Yoshiyuki] Yamagata Univ, Fac Med, Dept Gastroenterol, Yamagata 990, Japan	Tohoku University; Tohoku University; Yamagata University	Kondo, Y (corresponding author), Tohoku Univ Hosp, Div Gastroenterol, Sendai, Miyagi, Japan.	yasuteru@ebony.plala.or.jp	Ueno, Yoshiyuki/R-9242-2019; Kondo, Yasuteru/A-6893-2010; Kogure, Takayuki/AAI-3946-2021	Ueno, Yoshiyuki/0000-0001-5623-4250; Kondo, Yasuteru/0000-0001-5935-4346; 	 [23790765]		Financial support for this study was provided by Grant-in-Aid for Young Scientists (B) (23790765). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balaga O, 2012, NUCLEIC ACIDS RES, V40, P9404, DOI 10.1093/nar/gks759; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BEGOVICH AB, 1994, TISSUE ANTIGENS, V43, P71, DOI 10.1111/j.1399-0039.1994.tb02303.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg CP, 2008, APOPTOSIS, V13, P63, DOI 10.1007/s10495-007-0157-6; Bihrer V, 2011, AM J GASTROENTEROL, V106, P1663, DOI 10.1038/ajg.2011.161; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; COPPEL RL, 1988, P NATL ACAD SCI USA, V85, P7317, DOI 10.1073/pnas.85.19.7317; Corpechot C, 2007, HEPATOLOGY, V46, P963, DOI 10.1002/hep.21871; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Donaldson PT, 2006, HEPATOLOGY, V44, P667, DOI 10.1002/hep.21316; Friedman Y, 2010, BIOINFORMATICS, V26, P1920, DOI 10.1093/bioinformatics/btq298; GERSHWIN ME, 1987, J IMMUNOL, V138, P3525; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Hirschfield GM, 2011, SEMIN LIVER DIS, V31, P147, DOI 10.1055/s-0031-1276644; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Juran BD, 2010, J AUTOIMMUN, V35, P181, DOI 10.1016/j.jaut.2010.06.005; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Kong XY, 2011, DIGEST DIS SCI, V56, P602, DOI 10.1007/s10620-010-1285-3; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kyriakou DS, 2003, J HEPATOL, V39, P679, DOI 10.1016/S0168-8278(03)00387-8; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Li M, 2009, WORLD J SURG, V33, P667, DOI 10.1007/s00268-008-9836-x; Liang Y, 2008, CLIN EXP MED, V8, P1, DOI 10.1007/s10238-008-0149-z; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; LUDWIG J, 1978, VIRCHOWS ARCH A, V379, P103, DOI 10.1007/BF00432479; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; Metcalf JV, 1996, LANCET, V348, P1399, DOI 10.1016/S0140-6736(96)04410-8; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morita K, 2011, LIVER INT, V31, P474, DOI 10.1111/j.1478-3231.2010.02433.x; Nakagome Y, 2007, J AUTOIMMUN, V29, P20, DOI 10.1016/j.jaut.2007.03.004; Nakamura M, 2012, AM J HUM GENET, V91, P721, DOI 10.1016/j.ajhg.2012.08.010; NAKANUMA Y, 1979, GASTROENTEROLOGY, V76, P1326; ONISHI S, 1994, J HEPATOL, V21, P1053, DOI 10.1016/S0168-8278(05)80617-8; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; SCHEUER PJ, 1967, P ROY SOC MED, V60, P1257, DOI 10.1177/003591576706001205; Selmi C, 2004, GASTROENTEROLOGY, V127, P485, DOI 10.1053/j.gastro.2004.05.005; Silva J, 2011, EUR RESPIR J, V37, P617, DOI 10.1183/09031936.00029610; Singh R, 2011, CLIN IMMUNOL, V138, P41, DOI 10.1016/j.clim.2010.09.006; Team R. D. C, 2011, R LANG ENV STAT COMP; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	56	68	74	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66086	10.1371/journal.pone.0066086	http://dx.doi.org/10.1371/journal.pone.0066086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776611	Green Submitted, Green Published, gold			2022-12-25	WOS:000320322400079
J	Zhao, XQ; Fitzgerald, M				Zhao, Xiangqian; Fitzgerald, Melissa			Climate Change: Implications for the Yield of Edible	PLOS ONE			English	Article							RICE MILLING QUALITY; ORYZA-SATIVA L.; HIGH-TEMPERATURE; KERNEL DEVELOPMENT; FIELD; PHOTOSYNTHESIS; DIMENSIONS; CHALKY	Global warming affects not only rice yield but also grain quality. A better understanding of the effects of climate factors on rice quality provides information for new breeding strategies to develop varieties of rice adapted to a changing world. Chalkiness is a key trait of physical quality, and along with head rice yield, is used to determine the price of rice in all markets. In the present study, we show that for every, 1% decrease in chalkiness, an increase of, 1% in head rice yield follows, illustrating the dual impact of chalk on amount of marketable rice and its value. Previous studies in controlled growing conditions report that chalkiness is associated with high temperature. From 1980-2009 at IRRI, Los Banos, the Philippines, annual minimum and mean temperatures, and diurnal variation changed significantly. The objective of this study was to determine how climate impacts chalkiness in field conditions over four wet and dry seasons. We show that low relative humidity and a high vapour pressure deficit in the dry season associate with low chalk and high head rice yield in spite of higher maximum temperature, but in the opposite conditions of the wet season, chalk is high and head rice yield is low. The data therefore suggest that transpirational cooling is a key factor affecting chalkiness and head rice yield, and global warming per se might not be the major factor that decreases the amount and quality of rice, but other climate factors in combination, that enable the crop to maintain a cool canopy.	[Zhao, Xiangqian; Fitzgerald, Melissa] IRRI, Grain Qual & Nutr Ctr, Manila, Philippines	CGIAR; International Rice Research Institute (IRRI)	Fitzgerald, M (corresponding author), Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia.	m.fitzgerald@irri.org	Fitzgerald, Melissa/AAP-6672-2020; Zhao, Xiangqian/AAF-9295-2020	Fitzgerald, Melissa/0000-0002-0761-764X; 	Australian Centre for International Agricultural Research [CIM-2006-176]	Australian Centre for International Agricultural Research	Funding was from the Australian Centre for International Agricultural Research (www.aciar.gov.au) under the grant CIM-2006-176. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah Z, 2001, J AGRON CROP SCI, V187, P25, DOI 10.1046/j.1439-037X.2001.00500.x; Ambardekar AA, 2011, FIELD CROP RES, V122, P179, DOI 10.1016/j.fcr.2011.03.012; Cooper NTW, 2008, CEREAL CHEM, V85, P276, DOI 10.1094/CCHEM-85-3-0276; Cooper NTW, 2006, CEREAL CHEM, V83, P447, DOI 10.1094/CC-83-0447; Counce PA, 2005, CEREAL CHEM, V82, P645, DOI 10.1094/CC-82-0645; Ebata M, 1960, JAPANESE J CROP SCI, V29, P93; Fan YP, 1988, CROP RES, V2, P18; Fitzgerald MA, 2009, FUNCT PLANT BIOL, V36, P1037, DOI 10.1071/FP09055; Haefele SM, 2009, FIELD CROP RES, V111, P1, DOI 10.1016/j.fcr.2008.09.008; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hirasawa T, 1999, FIELD CROP RES, V62, P53, DOI 10.1016/S0378-4290(99)00005-2; Lisle AJ, 2000, CEREAL CHEM, V77, P627, DOI 10.1094/CCHEM.2000.77.5.627; Lobell DB, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/1/014002; Matsui T, 2007, PLANT PROD SCI, V10, P57, DOI 10.1626/pps.10.57; Nicholls N, 1995, CLIMATE CHANGE 1995: THE SCIENCE OF CLIMATE CHANGE, P133; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Rosegrant MW, 2003, SCIENCE, V302, P1917, DOI 10.1126/science.1092958; Shi CH, 2002, FIELD CROP RES, V76, P1, DOI 10.1016/S0378-4290(02)00011-4; Tashiro T., 1975, Proceedings of the Crop Science Society of Japan, V44, P86; TASHIRO T, 1991, AUST J AGR RES, V42, P485, DOI 10.1071/AR9910485; Tsukaguchi T, 2008, PLANT PROD SCI, V11, P203, DOI 10.1626/pps.11.203; Wanjura DF, 1997, AGR WATER MANAGE, V34, P217, DOI 10.1016/S0378-3774(97)00024-3; Welch JR, 2010, P NATL ACAD SCI USA, V107, P14562, DOI 10.1073/pnas.1001222107; Yamakawa H, 2007, PLANT PHYSIOL, V144, P258, DOI 10.1104/pp.107.098665; Zhu DeFeng, 2010, Scientia Agricultura Sinica, V43, P474; Ziska LH, 1998, GLOBAL CHANGE BIOL, V4, P637, DOI 10.1046/j.1365-2486.1998.00179.x	26	74	78	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66218	10.1371/journal.pone.0066218	http://dx.doi.org/10.1371/journal.pone.0066218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776635	Green Submitted, gold, Green Published			2022-12-25	WOS:000320322400087
J	Guo, BJ; Chen, YH; Zhang, GP; Xing, JW; Hu, ZR; Feng, WJ; Yao, YY; Peng, HR; Du, JK; Zhang, YR; Ni, ZF; Sun, QX				Guo, Baojian; Chen, Yanhong; Zhang, Guiping; Xing, Jiewen; Hu, Zhaorong; Feng, Wanjun; Yao, Yingyin; Peng, Huiru; Du, Jinkun; Zhang, Yirong; Ni, Zhongfu; Sun, Qixin			Comparative Proteomic Analysis of Embryos between a Maize Hybrid and Its Parental Lines during Early Stages of Seed Germination	PLOS ONE			English	Article							NONADDITIVE PROTEIN ACCUMULATION; DIFFERENTIAL GENE-EXPRESSION; RICE CULTIVAR; INBRED LINES; HETEROSIS; ROOT; IDENTIFICATION; MICROARRAY; DOMINANCE; SEQUENCE	In spite of commercial use of heterosis in agriculture, the molecular basis of heterosis is poorly understood. It was observed that maize hybrid Zong3/87-1 exhibited an earlier onset or heterosis in radicle emergence. To get insights into the underlying mechanism of heterosis in radicle emergence, differential proteomic analysis between hybrid and its parental lines was performed. In total, the number of differentially expressed protein spots between hybrid and its parental lines in dry and 24 h imbibed seed embryos were 134 and 191, respectively, among which 47.01% (63/134) and 34.55% (66/191) protein spots displayed nonadditively expressed pattern. Remarkably, 54.55% of nonadditively accumulated proteins in 24 h imbibed seed embryos displayed above or equal to the level of the higher parent patterns. Moreover, 155 differentially expressed protein spots were identified, which were grouped into eight functional classes, including transcription & translation, energy & metabolism, signal transduction, disease & defense, storage protein, transposable element, cell growth & division and unclassified proteins. In addition, one of the upregulated proteins in F-1 hybrids was ZmACT2, a homolog of Arabidopsis thaliana ACT7 (AtACT7). Expressing ZmACT2 driven by the AtACT7 promoter partially complemented the low germination phenotype in the Atact7 mutant. These results indicated that hybridization between two parental lines can cause changes in the expression of a variety of proteins, and it is concluded that the altered pattern of gene expression at translational level in the hybrid may be responsible for the observed heterosis.	[Guo, Baojian; Chen, Yanhong; Zhang, Guiping; Xing, Jiewen; Hu, Zhaorong; Feng, Wanjun; Yao, Yingyin; Peng, Huiru; Du, Jinkun; Zhang, Yirong; Ni, Zhongfu; Sun, Qixin] China Agr Univ, Beijing Key Lab Crop Genet Improvement, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Guo, Baojian; Chen, Yanhong; Zhang, Guiping; Xing, Jiewen; Hu, Zhaorong; Feng, Wanjun; Yao, Yingyin; Peng, Huiru; Du, Jinkun; Zhang, Yirong; Ni, Zhongfu; Sun, Qixin] China Agr Univ, Beijing Key Lab Crop Genet Improvement, Key Lab Crop Heterosis & Utilizat MOE, Beijing 100094, Peoples R China; [Guo, Baojian; Chen, Yanhong; Zhang, Guiping; Xing, Jiewen; Hu, Zhaorong; Feng, Wanjun; Yao, Yingyin; Peng, Huiru; Du, Jinkun; Zhang, Yirong; Ni, Zhongfu; Sun, Qixin] Natl Plant Gene Res Ctr Beijing, Beijing, Peoples R China	China Agricultural University; China Agricultural University	Ni, ZF (corresponding author), China Agr Univ, Beijing Key Lab Crop Genet Improvement, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	nzhf2002@aliyun.com; qxsun@cau.edu.cn			National Basic Research Program of China (973 Program) [2012CB910900]; National Natural Science Foundation of China [31230054, 30925023]; 863 Project of China [2012AA10A305]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Project of China(National High Technology Research and Development Program of China)	This work was financially supported by the National Basic Research Program of China (973 Program) (2012CB910900), the National Natural Science Foundation of China (31230054 and 30925023) and 863 Project of China (2012AA10A305) (http://www.sciencedirect.com/science/article/pii/S0378111912004131#gts0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andorf S, 2010, THEOR APPL GENET, V120, P249, DOI 10.1007/s00122-009-1214-z; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Dahal D, 2012, PLANT J, V72, P70, DOI 10.1111/j.1365-313X.2012.05056.x; Diaz-Camino C, 2005, J EXP BOT, V56, P557, DOI 10.1093/jxb/eri034; Donnelly BE, 2005, PROTEOMICS, V5, P1624, DOI 10.1002/pmic.200401042; Fu HH, 2002, P NATL ACAD SCI USA, V99, P9573, DOI 10.1073/pnas.132259199; Fu ZY, 2011, PROTEOMICS, V11, P1462, DOI 10.1002/pmic.201000481; Gilliland LU, 2003, PLANT J, V33, P319, DOI 10.1046/j.1365-313X.2003.01626.x; GONELLA JA, 1978, MAYDICA, V23, P55; Guo M, 2006, THEOR APPL GENET, V113, P831, DOI 10.1007/s00122-006-0335-x; HEIDRICHSOBRINHO E, 1975, THEOR APPL GENET, V46, P197, DOI 10.1007/BF00281670; Hoecker N, 2008, PROTEOMICS, V8, P3882, DOI 10.1002/pmic.200800023; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Huang Y, 2006, SCI CHINA SER C, V49, P519, DOI 10.1007/s11427-006-2031-0; HUNTER RB, 1971, CAN J GENET CYTOL, V13, P649, DOI 10.1139/g71-093; Limami AM, 2002, PLANT PHYSIOL, V130, P1860, DOI 10.1104/pp.009647; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Marcon C, 2010, J PROTEOME RES, V9, P6511, DOI 10.1021/pr100718d; Meagher R.B., 2000, ACTIN DYNAMIC FRAMEW, P3; Meagher RB, 1999, TRENDS GENET, V15, P278, DOI 10.1016/S0168-9525(99)01759-X; Meyer S, 2007, PLANT MOL BIOL, V63, P381, DOI 10.1007/s11103-006-9095-x; Morita-Yamamuro C, 2004, PLANT CELL PHYSIOL, V45, P781, DOI 10.1093/pcp/pch093; Morris K, 2011, PLANT PHYSIOL, V155, P1851, DOI 10.1104/pp.110.169706; Niogret MF, 1996, PLANT J, V9, P549, DOI 10.1046/j.1365-313X.1996.09040549.x; Porubleva L, 2001, ELECTROPHORESIS, V22, P1724, DOI 10.1002/1522-2683(200105)22:9&lt;1724::AID-ELPS1724&gt;3.0.CO;2-2; Potokina E, 2002, FUNCT INTEGR GENOMIC, V2, P28, DOI 10.1007/s10142-002-0050-x; Ramagli LS, 1999, METH MOL B, V112, P99; ROMAGNOLI S, 1990, THEOR APPL GENET, V80, P769, DOI 10.1007/BF00224190; SARKISSIAN IV, 1964, P NATL ACAD SCI USA, V51, P212, DOI 10.1073/pnas.51.2.212; Song SH, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-49; Song X, 2009, THEOR APPL GENET, V118, P213, DOI 10.1007/s00122-008-0890-4; Song X, 2007, PROTEOMICS, V7, P3538, DOI 10.1002/pmic.200700147; SOPORY SK, 1980, PLANT CELL PHYSIOL, V21, P649, DOI 10.1093/oxfordjournals.pcp.a076039; STUBER CW, 1992, GENETICS, V132, P823; Stupar RM, 2007, PLANT PHYSIOL, V145, P411, DOI 10.1104/pp.107.101428; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; Wang WW, 2008, PROTEOMICS, V8, P4808, DOI 10.1002/pmic.200701164; XIAO JH, 1995, GENETICS, V140, P745; Xu H, 2004, ACTA BIOCH BIOPH SIN, V36, P169, DOI 10.1093/abbs/36.3.169; Yao YY, 2006, PLANT SCI, V170, P579, DOI 10.1016/j.plantsci.2005.10.012; Yao YY, 2005, PLANT MOL BIOL, V58, P367, DOI 10.1007/s11103-005-5102-x; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226	44	43	45	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65867	10.1371/journal.pone.0065867	http://dx.doi.org/10.1371/journal.pone.0065867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776561	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400077
J	Illuzzi, JL; Harris, NA; Manvilla, BA; Kim, D; Li, MX; Drohat, AC; Wilson, DM				Illuzzi, Jennifer L.; Harris, Nicole A.; Manvilla, Brittney A.; Kim, Daemyung; Li, Mengxia; Drohat, Alexander C.; Wilson, David M., III			Functional Assessment of Population and Tumor-Associated APE1 Protein Variants	PLOS ONE			English	Article							BASE-EXCISION-REPAIR; DNA-POLYMERASE-BETA; HUMAN APURINIC ENDONUCLEASE; MAJOR HUMAN; APURINIC/APYRIMIDINIC ENDONUCLEASE; MECHANISTIC INSIGHTS; CANCER-RISK; SITE; IDENTIFICATION; MICE	Apurinic/apyrimidinic endonuclease 1 (APE1) is the predominant AP site repair enzyme in mammals. APE1 also maintains 3'-5' exonuclease and 3'-repair activities, and regulates transcription factor DNA binding through its REF-1 function. Since complete or severe APE1 deficiency leads to embryonic lethality and cell death, it has been hypothesized that APE1 protein variants with slightly impaired function will contribute to disease etiology. Our data indicate that except for the endometrial cancer-associated APE1 variant R237C, the polymorphic variants Q51H, I64V and D148E, the rare population variants G241R, P311S and A317V, and the tumor-associated variant P112L exhibit normal thermodynamic stability of protein folding; abasic endonuclease, 3'-5' exonuclease and REF-1 activities; coordination during the early steps of base excision repair; and intracellular distribution when expressed exogenously in HeLa cells. The R237C mutant displayed reduced AP-DNA complex stability, 3'-5' exonuclease activity and 3'-damage processing. Re-sequencing of the exonic regions of APE1 uncovered no novel amino acid substitutions in the 60 cancer cell lines of the NCI-60 panel, or in HeLa or T98G cancer cell lines; only the common D148E and Q51H variants were observed. Our results indicate that APE1 missense mutations are seemingly rare and that the cancer-associated R237C variant may represent a reduced-function susceptibility allele.	[Illuzzi, Jennifer L.; Li, Mengxia; Wilson, David M., III] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA; [Harris, Nicole A.] Sanford Burnham Med Res Inst, Dept Cardiopathol, Orlando, FL USA; [Manvilla, Brittney A.; Drohat, Alexander C.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Drohat, Alexander C.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Kim, Daemyung] Cheongju Univ, Dept Genet Engn, Cheongju, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Sanford Burnham Prebys Medical Discovery Institute; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Cheongju University	Wilson, DM (corresponding author), NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA.	wilsonda@mail.nih.gov	Wilson, David M/AAK-5409-2021; Li, Mengxia/AAM-4289-2020	Wilson, David M/0000-0002-8945-0395; Li, Mengxia/0000-0003-4443-740X; Drohat, Alex/0000-0002-7458-8770	National Institutes of Health (NIH), National Institute on Aging; NIH [R01-GM72711, T32GM 066706-07]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706, R01GM072711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000750] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program at the National Institutes of Health (NIH), National Institute on Aging, and an NIH grant to ACD (R01-GM72711). BAM was supported by an NIH training grant (T32GM 066706-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbotts R, 2010, CANCER TREAT REV, V36, P425, DOI 10.1016/j.ctrv.2009.12.006; Barnes T, 2009, NUCLEIC ACIDS RES, V37, P3946, DOI 10.1093/nar/gkp275; BARZILAY G, 1995, NUCLEIC ACIDS RES, V23, P1544, DOI 10.1093/nar/23.9.1544; Berquist BR, 2010, NUCLEIC ACIDS RES, V38, P5023, DOI 10.1093/nar/gkq193; Buetow KH, 1999, NAT GENET, V21, P323, DOI 10.1038/6851; Busso CS, 2010, CELL MOL LIFE SCI, V67, P3609, DOI 10.1007/s00018-010-0487-3; Cabelof DC, 2006, CANCER RES, V66, P7460, DOI 10.1158/0008-5472.CAN-06-1177; Cabelof DC, 2012, CELL MOL LIFE SCI, V69, P727, DOI 10.1007/s00018-011-0839-7; Daviet S, 2007, DNA REPAIR, V6, P8, DOI 10.1016/j.dnarep.2006.08.001; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Erzberger JP, 1998, NUCLEIC ACIDS RES, V26, P2771, DOI 10.1093/nar/26.11.2771; Fortini P, 2007, DNA REPAIR, V6, P398, DOI 10.1016/j.dnarep.2006.10.008; Georgiadis MM, 2008, MUTAT RES-FUND MOL M, V643, P54, DOI 10.1016/j.mrfmmm.2008.04.008; Hadi MZ, 2000, NUCLEIC ACIDS RES, V28, P3871, DOI 10.1093/nar/28.20.3871; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; Hung RJ, 2005, AM J EPIDEMIOL, V162, P925, DOI 10.1093/aje/kwi318; Illuzzi JL, 2012, CURR MED CHEM, V19, P3922; Kelley Mark R, 2012, Curr Mol Pharmacol, V5, P36; Leatherbarrow RJ, 1998, STAINES; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Loeb LA, 2011, NAT REV CANCER, V11, P450, DOI 10.1038/nrc3063; Manyusa S, 1999, BIOCHEMISTRY-US, V38, P9533, DOI 10.1021/bi990550d; McNeill DR, 2011, NUCLEIC ACIDS RES, V39, P7992, DOI 10.1093/nar/gkr280; Nemec AA, 2010, SEMIN CANCER BIOL, V20, P320, DOI 10.1016/j.semcancer.2010.10.010; Nguyen LH, 2000, J MOL BIOL, V298, P447, DOI 10.1006/jmbi.2000.3653; Pieretti M, 2001, MUTAT RES-GENOMICS, V432, P53, DOI 10.1016/S1383-5726(00)00002-9; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SEKI S, 1991, BIOCHIM BIOPHYS ACTA, V1079, P57, DOI 10.1016/0167-4838(91)90024-T; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Sokhansanj BA, 2002, NUCLEIC ACIDS RES, V30, P1817, DOI 10.1093/nar/30.8.1817; Sugo N, 2000, EMBO J, V19, P1397, DOI 10.1093/emboj/19.6.1397; Sweasy JB, 2005, P NATL ACAD SCI USA, V102, P14350, DOI 10.1073/pnas.0505166102; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; Ventrella-Lucente LF, 2010, J BIOL CHEM, V285, P19246, DOI 10.1074/jbc.M109.069807; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Wilson DM, 2011, MUTAT RES-FUND MOL M, V711, P100, DOI 10.1016/j.mrfmmm.2010.12.004; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; Wilson DM, 2003, J MOL BIOL, V330, P1027, DOI 10.1016/S0022-2836(03)00712-5; WILSON DM, 1995, J BIOL CHEM, V270, P16002, DOI 10.1074/jbc.270.27.16002; Wilson DM, 1997, NUCLEIC ACIDS RES, V25, P933, DOI 10.1093/nar/25.5.933; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; XANTHOUDAKIS S, 1994, P NATL ACAD SCI USA, V91, P23, DOI 10.1073/pnas.91.1.23; XANTHOUDAKIS S, 1992, EMBO J, V11, P653, DOI 10.1002/j.1460-2075.1992.tb05097.x; Xi T, 2004, GENOMICS, V83, P970, DOI 10.1016/j.ygeno.2003.12.016; Yamtich J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003052; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317	49	24	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65922	10.1371/journal.pone.0065922	http://dx.doi.org/10.1371/journal.pone.0065922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776569	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400081
J	Margalida, A; Carrete, M; Hegglin, D; Serrano, D; Arenas, R; Donazar, JA				Margalida, Antoni; Carrete, Martina; Hegglin, Daniel; Serrano, David; Arenas, Rafael; Donazar, Jose A.			Uneven Large-Scale Movement Patterns in Wild and Reintroduced Pre-Adult Bearded Vultures: Conservation Implications	PLOS ONE			English	Article							GYPAETUS-BARBATUS; POPULATION VIABILITY; GENETIC-VARIABILITY; DISPERSAL; DEPRESSION; DIVERSITY; SURVIVAL; MODELS	After the quasi-extinction of much of the European vertebrate megafauna during the last few centuries, many reintroduction projects seek to restore decimated populations. However, the future of numerous species depends on the management scenarios of metapopulations where the flow of individuals can be critical to ensure their viability. This is the case of the bearded vulture Gypaetus barbatus, an Old World, large body-sized and long-lived scavenger living in mountain ranges. Although persecution in Western Europe restrained it to the Pyrenees, the species is nowadays present in other mountains thanks to reintroduction projects. We examined the movement patterns of pre-adult non-breeding individuals born in the wild population of the Pyrenees (n = 9) and in the reintroduced populations of the Alps (n = 24) and Andalusia (n = 13). Most birds were equipped with GPS-GSM radio transmitters, which allowed accurate determination of individual dispersal patterns. Two estimators were considered: i) step length (i. e., the distance travelled per day by each individual, calculated considering only successive days); and ii)total dispersal distance (i. e., the distance travelled between each mean daily location and the point of release). Both dispersal estimators showed a positive relationship with age but were also highly dependent on the source population, birds in Andalusia and Alps moving farther than in Pyrenees. Future research should confirm if differences in dispersal distances are the rule, in which case the dynamics of future populations would be strongly influenced. In summary, our findings highlight that inter-population differences can affect the flow of individuals among patches (a key aspect to ensure the viability of the European metapopulation of the endangered bearded vulture), and thus should be taken into account when planning reintroduction programs. This result also raises questions about whether similar scenarios may occur in other restoration projects of European megafauna.	[Margalida, Antoni] Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland; [Margalida, Antoni] Bearded Vulture Study & Protect Grp, El Pont De Suert, Lleida, Spain; [Carrete, Martina] Univ Pablo Olavide, Dept Phys Chem & Nat Syst, Seville, Spain; [Hegglin, Daniel] Stiftung Pro Bartgeier, Zurich, Switzerland; [Hegglin, Daniel] SWILD Urban Ecol & Wildlife Res, Zurich, Switzerland; [Hegglin, Daniel] Vulture Conservat Fdn, Zurich, Switzerland; [Hegglin, Daniel] FSWILD Urban Ecol & Wildlife Res, Zurich, Switzerland; [Serrano, David; Donazar, Jose A.] CSIC, Estn Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Arenas, Rafael] Consejeria Medio Ambiente, Direcc Prov Cordoba, Cordoba, Spain	University of Bern; Fundacion para la Conservacion del Quebranthuesos (FCQ); Universidad Pablo de Olavide; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Margalida, A (corresponding author), Univ Bern, Inst Ecol & Evolut, Div Conservat Biol, Bern, Switzerland.	antoni.margalida@iee.unibe.ch	Carrete, Martina/A-6376-2009; Margalida, Antoni/A-2723-2011; Serrano, David/B-5352-2013; Margalida, Antoni/AAG-5337-2020; Carrete, Martina/D-2618-2017; Margalida, Antoni/A-2723-2011	Carrete, Martina/0000-0002-0491-2950; Margalida, Antoni/0000-0002-0576-3993; Serrano, David/0000-0001-6205-386X; Donazar, Jose Antonio/0000-0002-9433-9755; Margalida, Antoni/0000-0002-3904-6212; Margalida, Antoni/0000-0002-7383-671X	Ministerio de Ciencia e Innovacion [RYC-2009-04860]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	The authors acknowledge Ministerio de Medio Ambiente, Tragsatec, Generalitat de Catalunya, Junta de Andalucia, Fundacion Gypaetus, Gobierno de Navarra, Nationalpark Hohe Tauern, Parc National du Mercantour, Parco Naturale delle Alpi Marittime, Nationalpark Stilfserjoch and Parc naturel regional du Vercors. MC was supported by a Ramon y Cajal research contract from the Ministerio de Ciencia e Innovacion (RYC-2009-04860). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beissinger S. R., 2002, POPULATION VIABILITY; Butler H, 2005, WILDLIFE RES, V32, P157, DOI 10.1071/WR04027; Calvete C, 2004, BIOL CONSERV, V120, P507, DOI 10.1016/j.biocon.2004.03.023; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Carrete M, 2006, BIOL LETTERS, V2, P624, DOI 10.1098/rsbl.2006.0498; Doerr ED, 2005, OECOLOGIA, V142, P1, DOI 10.1007/s00442-004-1707-z; Doligez B, 2009, P R SOC B, V276, P2829, DOI 10.1098/rspb.2009.0454; Donazar JA, 2002, ECOL APPL, V12, P1445, DOI 10.1890/1051-0761(2002)012[1445:EOFAOL]2.0.CO;2; Ellegren H, 1996, P ROY SOC B-BIOL SCI, V263, P1635, DOI 10.1098/rspb.1996.0239; Fave MJ, 2008, CONSERV GENET, V9, P281, DOI 10.1007/s10592-007-9339-6; Flagstad O, 2003, MOL ECOL, V12, P869, DOI 10.1046/j.1365-294X.2003.01784.x; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Fuller MR, 1987, J RAPTOR RES, V21, P126; Gautschi B, 2003, CONSERV GENET, V4, P479, DOI 10.1023/A:1024730128819; Godoy JA, 2004, MOL ECOL, V13, P371, DOI 10.1046/j.1365-294X.2003.02075.x; Grande JM, 2009, OIKOS, V118, P580, DOI 10.1111/j.1600-0706.2009.17218.x; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; HANSKI I, 1991, BIOL J LINN SOC, V42, P17, DOI 10.1111/j.1095-8312.1991.tb00549.x; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; Hiraldo F, 1979, MONOGRAFIAS I CONSER, V22; Hirzel AH, 2004, J APPL ECOL, V41, P1103, DOI 10.1111/j.0021-8901.2004.00980.x; Huff DD, 2011, MOL ECOL, V20, P4246, DOI 10.1111/j.1365-294X.2011.05271.x; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.ecolsys.21.1.449; Kuemmerle T, 2011, J APPL ECOL, V48, P317, DOI 10.1111/j.1365-2664.2010.01954.x; Macdonald David W., 2001, P358; Margalida A, 2010, THESIS U BERN BERN; Margalida A, 2008, BIRD CONSERV INT, V18, P1, DOI 10.1017/S0959270908000026; Margalida A, 2008, IBIS, V150, P242, DOI 10.1111/j.1474-919X.2007.00768.x; Margalida A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00753; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026784; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020248; Mathews F, 2005, BIOL CONSERV, V121, P569, DOI 10.1016/j.biocon.2004.06.007; McPhee ME, 2004, BIOL CONSERV, V115, P71, DOI 10.1016/S0006-3207(03)00095-8; Morris W. F., 2002, QUANTITATIVE CONSERV; Negro JJ, 1999, BIOL CONSERV, V87, P249, DOI 10.1016/S0006-3207(98)00056-1; Nichols J., 2001, DISPERSAL; Oro D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004084; Ortega E, 2009, ORYX, V43, P113, DOI 10.1017/S0030605307991048; Perez I, 2012, FRONT ECOL ENVIRON, V10, P494, DOI 10.1890/110175; Proctor MF, 2012, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.6; Rodriguez A, 2003, BIOL CONSERV, V109, P321, DOI 10.1016/S0006-3207(02)00158-1; SAS Institure Inc, 2008, SAS COMP LANG 9 2; Schaub M, 2009, J APPL ECOL, V46, P92, DOI 10.1111/j.1365-2664.2008.01585.x; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Serrano D, 2003, J ANIM ECOL, V72, P400, DOI 10.1046/j.1365-2656.2003.00707.x; Simon MA, 2005, BIOL CONSERVACION QU, P255; Skjelseth S, 2007, P ROY SOC B-BIOL SCI, V274, P1763, DOI 10.1098/rspb.2007.0338	48	49	51	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65857	10.1371/journal.pone.0065857	http://dx.doi.org/10.1371/journal.pone.0065857			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776559	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400075
J	Wu, CP; Zhou, L; Xie, M; Du, HD; Tian, J; Sun, S; Li, JY				Wu, Chun-Ping; Zhou, Liang; Xie, Ming; Du, Huai-Dong; Tian, Jie; Sun, Shan; Li, Jin-Yan			Identification of Cancer Stem-Like Side Population Cells in Purified Primary Cultured Human Laryngeal Squamous Cell Carcinoma Epithelia	PLOS ONE			English	Article							THERAPEUTIC IMPLICATIONS; INITIATING CELLS; LINES; EXPRESSION; PHENOTYPE; TUMORS; BCRP1; MICE	Cancer stem-like side population (SP) cells have been identified in many solid tumors; however, most of these investigations are performed using established cancer cell lines. Cancer cells in tumor tissue containing fibroblasts and many other types of cells are much more complex than any cancer cell line. Although SP cells were identified in the laryngeal squamous cell carcinoma (LSCC) cell line Hep-2 in our pilot study, it is unknown whether the LSCC tissue contains SP cells. In this study, LSCC cells (LSCCs) were primary cultured and purified from a surgically resected LSCC specimen derived from a well-differentiated epiglottic neoplasm of a Chinese male. This was followed by the verification of epithelium-specific characteristics, such as ultrastructure and biomarkers. A distinct SP subpopulation (4.45 +/- 1.07%) was isolated by Hoechst 33342 efflux analysis from cultured LSCCs by using a flow cytometer. Cancer stem cell (CSC)-associated assays, including expression of self-renewal and CSC marker genes, proliferation, differentiation, spheroid formation, chemotherapy resistance, and tumorigenicity were then conducted between SP and non-SP (NSP) LSCCs. In vitro and in vivo assays revealed that SP cells manifested preferential expression of self-renewal and CSC marker genes, higher capacity for proliferation, differentiation, and spheroid formation; enhanced resistance to chemotherapy; and greater xenograft tumorigenicity in immunodeficient mice compared with NSP cells. These findings suggest that the primary cultured and purified LSCCs contain cancer stem-like SP cells, which may serve as a valuable model for CSC research in LSCC.	[Wu, Chun-Ping; Zhou, Liang; Xie, Ming; Du, Huai-Dong] Fudan Univ, Dept Otolaryngol Head & Neck Surg, Eye Ear Nose & Throat Hosp, Shanghai 200433, Peoples R China; [Tian, Jie; Sun, Shan] Fudan Univ, Cent Lab, Eye Ear Nose & Throat Hosp, Shanghai 200433, Peoples R China; [Sun, Shan] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci Stem Cell & Regenerat Med, Shanghai 200433, Peoples R China; [Li, Jin-Yan] Fudan Univ, Shanghai Med Coll, Dept Cellular & Genet Med, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Zhou, L (corresponding author), Fudan Univ, Dept Otolaryngol Head & Neck Surg, Eye Ear Nose & Throat Hosp, Shanghai 200433, Peoples R China.	zhoulent@126.com	Zhou, Liang/AAJ-4024-2020; Sun, Shan/GLR-2365-2022	Sun, Shan/0000-0003-2142-4307; Wu, Chunping/0000-0002-0712-8715	National Natural Science Foundation of China [30872855]; Shanghai Science and Technology Foundation of China [12JC1402101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Foundation of China	This research was partly supported by the National Natural Science Foundation of China (30872855) and the Shanghai Science and Technology Foundation of China (12JC1402101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addla SK, 2008, AM J PHYSIOL-RENAL, V295, pF680, DOI 10.1152/ajprenal.90286.2008; Albers AE, 2012, CRIT REV ONCOL HEMAT, V81, P224, DOI 10.1016/j.critrevonc.2011.03.004; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Christgen M, 2007, MOL CELL BIOCHEM, V306, P201, DOI 10.1007/s11010-007-9570-y; Fukaya R, 2010, CANCER LETT, V291, P150, DOI 10.1016/j.canlet.2009.10.010; Fukuda K, 2009, INT J ONCOL, V34, P1201, DOI 10.3892/ijo_00000248; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Hayashi S, 2011, PEDIATR SURG INT, V27, P9, DOI 10.1007/s00383-010-2719-x; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; Jonker JW, 2005, STEM CELLS, V23, P1059, DOI 10.1634/stemcells.2005-0150; Kato K, 2012, KAOHSIUNG J MED SCI, V28, P63, DOI 10.1016/j.kjms.2011.06.028; Klonisch T, 2008, TRENDS MOL MED, V14, P450, DOI 10.1016/j.molmed.2008.08.003; Li XX, 2012, BIOCHEM BIOPH RES CO, V419, P728, DOI 10.1016/j.bbrc.2012.02.090; Liu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023311; Luo YC, 2012, J INVEST DERMATOL, V132, P2440, DOI 10.1038/jid.2012.161; Ma YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029170; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Moserle L, 2010, CANCER LETT, V288, P1, DOI 10.1016/j.canlet.2009.05.020; Murase M, 2009, BRIT J CANCER, V101, P1425, DOI 10.1038/sj.bjc.6605330; Nakanishi T, 2010, BRIT J CANCER, V102, P815, DOI 10.1038/sj.bjc.6605553; Nishii T, 2009, CANCER SCI, V100, P1397, DOI 10.1111/j.1349-7006.2009.01211.x; Oates JE, 2009, STEM CELLS DEV, V18, P1515, DOI 10.1089/scd.2008.0302; Shi GM, 2008, J CANCER RES CLIN, V134, P1155, DOI 10.1007/s00432-008-0407-1; Shi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033358; Song Z, 2010, MOL BIOL REP, V37, P4091, DOI 10.1007/s11033-010-0069-3; Tabor MH, 2011, LARYNGOSCOPE, V121, P527, DOI 10.1002/lary.21032; Vathipadiekal V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029079; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wan GL, 2010, HEAD NECK-J SCI SPEC, V32, P1302, DOI 10.1002/hed.21325; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Yanamoto S, 2011, ORAL ONCOL, V47, P855, DOI 10.1016/j.oraloncology.2011.06.501; Yang M, 2011, CANCER SCI, V102, P1774, DOI 10.1111/j.1349-7006.2011.02028.x; Yao J, 2010, ONCOL REP, V23, P1375, DOI 10.3892/or_00000774; Zhang P, 2009, CANCER LETT, V277, P227, DOI 10.1016/j.canlet.2008.12.015; Zhang SN, 2010, TUMORI J, V96, P985, DOI 10.1177/548.6520; Zhang SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038996; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	42	15	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65750	10.1371/journal.pone.0065750	http://dx.doi.org/10.1371/journal.pone.0065750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776540	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400066
J	Busacca, S; Chacko, AD; Klabatsa, A; Arthur, K; Sheaff, M; Gunasekharan, VK; Gorski, JJ; El-Tanani, M; Broaddus, VC; Gaudino, G; Fennell, DA				Busacca, Sara; Chacko, Alex D.; Klabatsa, Astero; Arthur, Kenneth; Sheaff, Michael; Gunasekharan, Vignesh K.; Gorski, Julia J.; El-Tanani, Mohamed; Broaddus, V. Courtney; Gaudino, Giovanni; Fennell, Dean A.			BAK and NOXA Are Critical Determinants of Mitochondrial Apoptosis Induced by Bortezomib in Mesothelioma	PLOS ONE			English	Article							MALIGNANT-PLEURAL-MESOTHELIOMA; RANDOMIZED PHASE-II; PROTEASOME INHIBITORS; BCL-2 FAMILY; C-MYC; MEDIATED APOPTOSIS; MOLECULAR-BASIS; RESISTANCE; CELLS; EXPRESSION	Based on promising preclinical efficacy associated with the 20S proteasome inhibitor bortezomib in malignant pleural mesothelioma (MPM), two phase II clinical trials have been initiated (EORTC 08052 and ICORG 05-10). However, the potential mechanisms underlying resistance to this targeted drug in MPM are still unknown. Functional genetic analyses were conducted to determine the key mitochondrial apoptotic regulators required for bortezomib sensitivity and to establish how their dysregulation may confer resistance. The multidomain proapoptotic protein BAK, but not its orthologue BAX, was found to be essential for bortezomib-induced apoptosis in MPM cell lines. Immunohistochemistry was performed on tissues from the ICORG-05 phase II trial and a TMA of archived mesotheliomas. Loss of BAK was found in 39% of specimens and loss of both BAX/BAK in 37% of samples. However, MPM tissues from patients who failed to respond to bortezomib and MPM cell lines selected for resistance to bortezomib conserved BAK expression. In contrast, c-Myc dependent transactivation of NOXA was abrogated in the resistant cell lines. In summary, the block of mitochondrial apoptosis is a limiting factor for achieving efficacy of bortezomib in MPM, and the observed loss of BAK expression or NOXA transactivation may be relevant mechanisms of resistance in the clinic.	[Busacca, Sara; Fennell, Dean A.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England; [Chacko, Alex D.; Arthur, Kenneth; Gorski, Julia J.; El-Tanani, Mohamed] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Klabatsa, Astero] Kings Coll London, Dept Res Oncol, Div Canc Studies, London WC2R 2LS, England; [Sheaff, Michael] Barts & London NHS Trust, Dept Cellular Pathol, London, England; [Gunasekharan, Vignesh K.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Broaddus, V. Courtney] Univ Calif San Francisco, San Francisco Gen Hosp, Lung Biol Ctr, San Francisco, CA 94143 USA; [Gaudino, Giovanni] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA	University of Leicester; Queens University Belfast; University of London; King's College London; Barts Health NHS Trust; Northwestern University; Feinberg School of Medicine; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Cancer Research Center of Hawaii; University of Hawaii System	Fennell, DA (corresponding author), Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England.	df132@le.ac.uk	Gunasekharan, Vignesh/ABH-5896-2020; Klampatsa, Astero/AAK-4419-2020	Klampatsa, Astero/0000-0003-0572-502X; Gunasekharan, Vignesh Kumar/0000-0002-2471-8485; Arthur, Kenneth/0000-0003-3045-4639; El-Tanani, Mohamed/0000-0002-4735-5445	NCI/NI R&D office joint research project in Cancer; Cancer Research UK Clinician Scientist Fellowship	NCI/NI R&D office joint research project in Cancer; Cancer Research UK Clinician Scientist Fellowship(Cancer Research UK)	SB was supported by an NCI/NI R&D office joint research project in Cancer. DAF was supported by a Cancer Research UK Clinician Scientist Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian C, 2002, CLIN CANCER RES, V8, P2505; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Busse A, 2008, CANCER, V112, P659, DOI 10.1002/cncr.23224; Combaret V, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-50; Du X, 2010, MOL CELL BIOL, V30, P3444, DOI 10.1128/MCB.00813-09; Ehebauer M, 2006, SCIENCE, V314, P1414, DOI 10.1126/science.1134042; Fanucchi MP, 2006, J CLIN ONCOL, V24, P5025, DOI 10.1200/JCO.2006.06.1853; Fennell DA, 2008, ONCOGENE, V27, P1189, DOI 10.1038/sj.onc.1210744; Fennell DA, 2004, LANCET ONCOL, V5, P354, DOI 10.1016/S1470-2045(04)01492-5; Fennell DA, 2008, NAT CLIN PRACT ONCOL, V5, P136, DOI 10.1038/ncponc1039; Fennell DA, 2012, J THORAC ONCOL, V7, P1466, DOI 10.1097/JTO.0b013e318260dfb9; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Fuchs D, 2008, J CELL BIOCHEM, V103, P270, DOI 10.1002/jcb.21405; Gordon GJ, 2008, CANCER CHEMOTH PHARM, V61, P549, DOI 10.1007/s00280-007-0500-1; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Johnson TR, 2003, ONCOGENE, V22, P4953, DOI 10.1038/sj.onc.1206656; Liu WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029466; Lu SQ, 2008, J PHARMACOL EXP THER, V326, P423, DOI 10.1124/jpet.108.138131; Lu SQ, 2008, EXP HEMATOL, V36, P1278, DOI 10.1016/j.exphem.2008.04.013; Lu SQ, 2009, EXP HEMATOL, V37, P831, DOI 10.1016/j.exphem.2009.04.001; MANNING LS, 1991, INT J CANCER, V47, P285, DOI 10.1002/ijc.2910470219; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Nikiforov MA, 2007, P NATL ACAD SCI USA, V104, P19488, DOI 10.1073/pnas.0708380104; O'Kane SL, 2006, ACTA ONCOL, V45, P449, DOI 10.1080/02841860500468927; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oerlemans R, 2008, BLOOD, V112, P2489, DOI 10.1182/blood-2007-08-104950; Pandit B, 2011, AM J PATHOL, V178, P355, DOI 10.1016/j.ajpath.2010.11.010; Pietruska JR, 2007, CANCER RES, V67, P3637, DOI 10.1158/0008-5472.CAN-05-3727; Qin JZ, 2005, CANCER RES, V65, P6282, DOI 10.1158/0008-5472.CAN-05-0676; Ri M, 2008, CANC SCI; Ri M, 2010, LEUKEMIA; Rzymski T, 2009, CELL CYCLE, V8, P3838, DOI 10.4161/cc.8.23.10086; Sartore-Bianchi A, 2007, CLIN CANCER RES, V13, P5942, DOI 10.1158/1078-0432.CCR-07-0536; Scagliotti GV, 2010, LUNG CANCER, V68, P420, DOI 10.1016/j.lungcan.2009.07.011; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; SMYTHE WR, 1994, ANN THORAC SURG, V57, P1395, DOI 10.1016/0003-4975(94)90090-6; Soini Y, 1999, CLIN CANCER RES, V5, P3508; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; van Meerbeeck JP, 2005, J CLIN ONCOL, V23, P6881, DOI 10.1200/JCO.20005.14.589; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Voortman J, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-73; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wolf Jeffrey, 2008, Clin Adv Hematol Oncol, V6, P755; Xiong H, 2009, J CELL MOL MED, V13, P3668, DOI 10.1111/j.1582-4934.2009.00661.x	47	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65489	10.1371/journal.pone.0065489	http://dx.doi.org/10.1371/journal.pone.0065489			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762382	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800055
J	Prashar, A; Yildiz, J; McNicol, JW; Bryan, GJ; Jones, HG				Prashar, Ankush; Yildiz, Jane; McNicol, James W.; Bryan, Glenn J.; Jones, Hamlyn G.			Infra-red Thermography for High Throughput Field Phenotyping in Solanum tuberosum	PLOS ONE			English	Article							HIGHER STOMATAL CONDUCTANCE; GRAIN-YIELD; CANOPY TEMPERATURE; DROUGHT TOLERANCE; PIMA COTTON; ASSOCIATION; GLASSHOUSE; RESPONSES; GENOMICS; PROGRESS	The rapid development of genomic technology has made high throughput genotyping widely accessible but the associated high throughput phenotyping is now the major limiting factor in genetic analysis of traits. This paper evaluates the use of thermal imaging for the high throughput field phenotyping of Solanum tuberosum for differences in stomatal behaviour. A large multi-replicated trial of a potato mapping population was used to investigate the consistency in genotypic rankings across different trials and across measurements made at different times of day and on different days. The results confirmed a high degree of consistency between the genotypic rankings based on relative canopy temperature on different occasions. Genotype discrimination was enhanced both through normalising data by expressing genotype temperatures as differences from image means and through the enhanced replication obtained by using overlapping images. A Monte Carlo simulation approach was used to confirm the magnitude of genotypic differences that it is possible to discriminate. The results showed a clear negative association between canopy temperature and final tuber yield for this population, when grown under ample moisture supply. We have therefore established infrared thermography as an easy, rapid and non-destructive screening method for evaluating large population trials for genetic analysis. We also envisage this approach as having great potential for evaluating plant response to stress under field conditions.	[Prashar, Ankush; Yildiz, Jane; Bryan, Glenn J.] James Hutton Inst, Dundee, Scotland; [McNicol, James W.] James Hutton Inst, Biomath & Stat Scotland, Dundee, Scotland; [Jones, Hamlyn G.] Univ Dundee, James Hutton Inst, Plant Sci Div, Dundee, Scotland; [Jones, Hamlyn G.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia	James Hutton Institute; James Hutton Institute; James Hutton Institute; University of Dundee; University of Western Australia	Prashar, A (corresponding author), James Hutton Inst, Dundee, Scotland.	Ankush.Prashar@hutton.ac.uk	Jones, Hamlyn/F-8014-2011	Jones, Hamlyn/0000-0002-3049-3163; Bryan, Glenn/0000-0002-7752-5740	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS)	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS)	The research work was supported by the Scottish Government Rural and Environment Science and Analytical Services Division (RESAS). Authors have no conflict of interest to declare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amani I, 1996, J AGRON CROP SCI, V176, P119, DOI 10.1111/j.1439-037X.1996.tb00454.x; Aminian R., 2010, Wheat Information Service, P25; Birch ANE, 2007, PEDOBIOLOGIA, V51, P251, DOI 10.1016/j.pedobi.2007.04.008; Cowan I. R., 1986, On the economy of plant form and function, P133; Fischer RA, 1998, CROP SCI, V38, P1467, DOI 10.2135/cropsci1998.0011183X003800060011x; Furbank RT, 2011, TRENDS PLANT SCI, V16, P635, DOI 10.1016/j.tplants.2011.09.005; Graham J, 2011, THEOR APPL GENET, V123, P585, DOI 10.1007/s00122-011-1609-5; Horie T, 2006, PLANT CELL ENVIRON, V29, P653, DOI 10.1111/j.1365-3040.2005.01445.x; Horie T., 2003, Rice science: innovations and impact for livelihood. Proceedings of the International Rice Research Conference, Beijing, China, 16-19 September 2002, P117; Jalink H, 2009, NLP184672; Jones H., 2004, WATER USE EFFICIENCY, P27; Jones H. G., 1992, Plants and microclimate: a quantitative approach to environmental plant physiology.; Jones H. G., 1987, Stomatal Function, P431; Jones HG, 2009, FUNCT PLANT BIOL, V36, P978, DOI 10.1071/FP09123; Jones HG, 2004, J EXP BOT, V55, P2427, DOI 10.1093/jxb/erh213; Jones HG, 2002, J EXP BOT, V53, P2249, DOI 10.1093/jxb/erf083; Jones HG, 1981, MATH PLANT PHYSL, P231; KNAPP SJ, 1990, GENETICS, V126, P769; Limpens J, 2012, NEW PHYTOL, V195, P408, DOI 10.1111/j.1469-8137.2012.04157.x; Lopes MS, 2012, FIELD CROP RES, V128, P129, DOI 10.1016/j.fcr.2011.12.017; LU ZM, 1994, PHYSIOL PLANTARUM, V92, P266, DOI 10.1111/j.1399-3054.1994.tb05336.x; Lu ZM, 1996, AUST J PLANT PHYSIOL, V23, P127, DOI 10.1071/PP9960127; Maes WH, 2012, J EXP BOT, V63, P4671, DOI 10.1093/jxb/ers165; Merlot S, 2002, PLANT J, V30, P601, DOI 10.1046/j.1365-313X.2002.01322.x; Mir RR, 2012, THEOR APPL GENET, V125, P625, DOI 10.1007/s00122-012-1904-9; Montes JM, 2007, TRENDS PLANT SCI, V12, P433, DOI 10.1016/j.tplants.2007.08.006; PATTERSON HD, 1976, BIOMETRIKA, V63, P83, DOI 10.1093/biomet/63.1.83; Poorter H, 2012, FUNCT PLANT BIOL, V39, P839, DOI 10.1071/FP12049; Price AH, 2002, J EXP BOT, V53, P989, DOI 10.1093/jexbot/53.371.989; Rattey AR, 2011, FIELD CROP RES, V124, P195, DOI 10.1016/j.fcr.2011.02.006; Rebetzke GJ, 2013, FUNCT PLANT BIOL, V40, P14, DOI 10.1071/FP12184; Sinclair TR, 2005, J EXP BOT, V56, P2777, DOI 10.1093/jxb/eri297; Stoll M., 2005, XIV International GESCO Viticulture Congress, Geisenheim, Germany, 23-27 August, 2005, P211; Takai T, 2006, FIELD CROP RES, V96, P328, DOI 10.1016/j.fcr.2005.08.001; Tuberosa R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00347; Witt S, 2012, MOL PLANT, V5, P401, DOI 10.1093/mp/ssr102; Zheng TC, 2011, FIELD CROP RES, V122, P225, DOI 10.1016/j.fcr.2011.03.015	37	55	56	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65816	10.1371/journal.pone.0065816	http://dx.doi.org/10.1371/journal.pone.0065816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762433	gold, Green Submitted, Green Published			2022-12-25	WOS:000321094800076
J	Stryjek, R; Modlinska, K; Turlejski, K; Pisula, W				Stryjek, Rafal; Modlinska, Klaudia; Turlejski, Krzysztof; Pisula, Wojciech			Circadian Rhythm of Outside-Nest Activity in Wild (WWCPS), Albino and Pigmented Laboratory Rats	PLOS ONE			English	Article							SOCIAL INTERACTIONS; FOOD-INTAKE; WISTAR RAT; OPEN-FIELD; BEHAVIOR; LIGHT; PLACE; ENVIRONMENT; EXPLORATION; AGGRESSION	The domestication process of the laboratory rat has been going on for several hundred generations in stable environmental conditions, which may have affected their physiological and behavioural functions, including their circadian system. Rats tested in our ethological experiments were laboratory-bred wild Norway rats (WWCPS), two strains of pigmented laboratory rats (Brown Norway and Long Evans), and two strains of albino rats (Sprague-Dawley and Wistar). Rats were placed in purpose-built enclosures and their cycle of activity (time spent actively outside the nest) has been studied for one week in standard light conditions and for the next one in round-the-clock darkness. The analysis of circadian pattern of outside-nest activity revealed differences between wild, pigmented laboratory, and albino laboratory strains. During daytime, albino rats showed lower activity than pigmented rats, greater decrease in activity when the light was turned on and greater increase in activity when the light was switched off, than pigmented rats. Moreover albino rats presented higher activity during the night than wild rats. The magnitude of the change in activity between daytime and nighttime was also more pronounced in albino rats. Additionaly, they slept outside the nest more often during the night than during the day. These results can be interpreted in accordance with the proposition that intense light is an aversive stimulus for albino rats, due to lack of pigment in their iris and choroid, which reduces their ability to adapt to light. Pigmented laboratory rats were more active during lights on, not only in comparison to the albino, but also to the wild rats. Since the difference seems to be independent of light intensity, it is likely to be a result of the domestication process. Cosinor analysis revealed a high rhythmicity of circadian cycles in all groups.	[Stryjek, Rafal; Modlinska, Klaudia; Pisula, Wojciech] Polish Acad Sci, Inst Psychol, Warsaw, Poland; [Stryjek, Rafal; Modlinska, Klaudia] Helena Chodkowska Univ Management & Law, Warsaw, Poland; [Turlejski, Krzysztof] M Nencki Inst Expt Biol, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Institute of Psychology of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Stryjek, R (corresponding author), Polish Acad Sci, Inst Psychol, Warsaw, Poland.	rstryjek@wp.pl	Pisula, Wojciech/AAR-3618-2020	Pisula, Wojciech/0000-0001-5777-0549; Krzysztof, Turlejski/0000-0001-6708-7815; Stryjek, Rafal/0000-0003-3889-9341; Modlinska, Klaudia/0000-0002-2161-9019	Polish Ministry of Science [UMO-2011/01/B/HS6/06442]	Polish Ministry of Science(Ministry of Science and Higher Education, Poland)	This research project was funded by the Polish Ministry of Science #UMO-2011/01/B/HS6/06442. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antle MC, 2005, BEHAV LAB RAT, P183; Barker DJ, 2010, BEHAV BRAIN RES, V214, P402, DOI 10.1016/j.bbr.2010.06.020; BARNETT SA, 1969, J MAMMAL, V50, P321, DOI 10.2307/1378349; BARNETT SA, 1981, AGGRESSIVE BEHAV, V7, P259, DOI 10.1002/1098-2337(1981)7:3<259::AID-AB2480070309>3.0.CO;2-V; BARNETT SA, 1979, AGGRESSIVE BEHAV, V5, P105, DOI 10.1002/1098-2337(1979)5:2<105::AID-AB2480050202>3.0.CO;2-U; BARNETT SA, 1958, BRIT J PSYCHOL, V49, P195, DOI 10.1111/j.2044-8295.1958.tb00657.x; Barnett SA, 2009, RAT STUDY BEHAV; BEACH FA, 1949, P SOC EXP BIOL MED, V72, P78, DOI 10.3181/00379727-72-17337; Benca RM, 1998, SLEEP, V21, P451, DOI 10.1093/sleep/21.5.451; BLANCHARD DC, 1988, ANNU REV PSYCHOL, V39, P43, DOI 10.1146/annurev.ps.39.020188.000355; Blanchard R.J., 1989, ETHOEXPERIMENTAL APP; BLANCHARD RJ, 1986, J COMP PSYCHOL, V100, P101, DOI 10.1037/0735-7036.100.2.101; BLANCHARD RJ, 1984, PHYSIOL BEHAV, V33, P857, DOI 10.1016/0031-9384(84)90219-1; BLANCHARD RJ, 1988, PHYSIOL BEHAV, V43, P1, DOI 10.1016/0031-9384(88)90089-3; Calhoun J. B, 1963, ECOLOGY SOCIOLOGY NO; Campuzano A, 1999, BIOL RHYTHM RES, V30, P497, DOI 10.1076/brhm.30.5.497.1397; Castillo-Ruiz A, 2012, PROG BRAIN RES, V199, P267, DOI 10.1016/B978-0-444-59427-3.00016-2; Challet E, 2007, ENDOCRINOLOGY, V148, P5648, DOI 10.1210/en.2007-0804; COWAN PE, 1977, J COMP PHYSIOL PSYCH, V91, P63, DOI 10.1037/h0077297; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Everts HGJ, 1997, HORM BEHAV, V31, P136, DOI 10.1006/hbeh.1997.1375; Favreau A, 2009, ANIM BEHAV, V77, P983, DOI 10.1016/j.anbehav.2009.01.004; FISHMAN R, 1970, PSYCHOPHYSIOLOGY, V7, P304; Fukuhara C, 2005, NEUROSIGNALS, V14, P117, DOI 10.1159/000086294; Galsworthy MJ, 2005, BEHAV BRAIN RES, V157, P211, DOI 10.1016/j.bbr.2004.06.021; Garner JP, 2002, BEHAV BRAIN RES, V136, P83, DOI 10.1016/S0166-4328(02)00111-0; Gibb R. L., 2005, BEHAV LAB RAT, P321; Goldfarb AH, 1997, SPORTS MED, V24, P8, DOI 10.2165/00007256-199724010-00002; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Harker KT, 2002, BEHAV BRAIN RES, V134, P467; Himmler BT, 2013, J COMP PSYC IN PRESS; HOLLOWAY FA, 1973, BEHAV BIOL, V9, P1, DOI 10.1016/S0091-6773(73)80164-6; HUCK UW, 1975, J COMP PHYSIOL PSYCH, V89, P892, DOI 10.1037/h0077160; Jud C, 2005, BIOL PROCED ONLINE, V7, P101, DOI 10.1251/bpo109; Keeler CE, 1942, J HERED, V33, P371, DOI 10.1093/oxfordjournals.jhered.a105097; Klejbor I, 2012, ACTA NEUROBIOL EXP, V72, P452; LOCKARD RB, 1968, AM PSYCHOL, V23, P734, DOI 10.1037/h0026726; Ma WP, 2007, NEUROSCI RES, V59, P224, DOI 10.1016/j.neures.2007.06.1474; Marc RE, 2008, MOL VIS, V14, P782; Mistlberger RE, 2004, BIOL REV, V79, P533, DOI 10.1017/S1464793103006353; Montaudouin S, 2004, BEHAV PROCESS, V67, P235, DOI 10.1016/j.beproc.2004.02.008; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; NIKULINA EM, 1985, ZH VYSSH NERV DEYAT+, V35, P703; Paul MJ, 2007, COLD SPRING HARB SYM, V72, P615, DOI 10.1101/sqb.2007.72.042; Pisula W, 2012, BEHAV PROCESS, V91, P145, DOI 10.1016/j.beproc.2012.06.010; Plyusnina IZ, 2009, BEHAV GENET, V39, P202, DOI 10.1007/s10519-008-9248-6; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Pruskey G. T, 2005, BEHAV LAB RAT, P49; Prusky GT, 2002, BEHAV BRAIN RES, V136, P339, DOI 10.1016/S0166-4328(02)00126-2; REFINETTI R, 1993, PHYSIOL BEHAV, V54, P869, DOI 10.1016/0031-9384(93)90294-P; RICHTER CP, 1959, AM PSYCHOL, V14, P18, DOI 10.1037/h0043834; ROSENWASSER AM, 1981, PHYSIOL BEHAV, V27, P33, DOI 10.1016/0031-9384(81)90296-1; Sachs BD, 1996, PHYSIOL BEHAV, V60, P803, DOI 10.1016/S0031-9384(96)00158-8; Schmitt U, 1998, PROG NEURO-PSYCHOPH, V22, P1197, DOI 10.1016/S0278-5846(98)00051-7; Sherwin CM, 1998, ANIM BEHAV, V56, P11, DOI 10.1006/anbe.1998.0836; SOKOLOVE PG, 1978, J THEOR BIOL, V72, P131, DOI 10.1016/0022-5193(78)90022-X; Stryjek R, 2008, POL PSYCHOL BULL, V39, P6770; Stryjek R, 2008, ACTA NEUROBIOL EXP, V68, P407; Stryjek R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040642; Stryjek R, 2010, LAB ANIMAL, V39, P279, DOI 10.1038/laban0910-279; Tanas L, 2011, BEHAV PROCESS, V86, P279, DOI 10.1016/j.beproc.2010.12.018; Vidal J, 2011, BEHAV PROCESS, V87, P176, DOI 10.1016/j.beproc.2011.03.004; Whishaw IQ, 2003, BEHAV BRAIN RES, V146, P31, DOI 10.1016/j.bbr.2003.09.027; Wideman CH, 2009, NUTR NEUROSCI, V12, P233, DOI 10.1179/147683009X423436; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193	66	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66055	10.1371/journal.pone.0066055	http://dx.doi.org/10.1371/journal.pone.0066055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762462	Green Published, Green Submitted, gold			2022-12-25	WOS:000321094800086
J	Verga-Gerard, A; Porcherot, M; Meyniel-Schicklin, L; Andre, P; Lotteau, V; Perrin-Cocon, L				Verga-Gerard, Amandine; Porcherot, Marine; Meyniel-Schicklin, Laurene; Andre, Patrice; Lotteau, Vincent; Perrin-Cocon, Laure			Hepatitis C virus/human interactome identifies SMURF2 and the viral protease as critical elements for the control of TGF-beta signaling	FASEB JOURNAL			English	Article						transforming growth factor-; hepatocellular carcinoma; EMT	GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; VIRUS-INFECTION; LIVER-CANCER; EXPRESSION; RECEPTOR; ACTIVATION; TUMOR; PATHWAY; LIGASE	TGF- signaling induces epithelial to mesenchymal transition (EMT) and plays an important role in hepatocellular carcinoma (HCC) development. Clinical observations indicate that hepatitis C virus (HCV) chronic infection, which is a major cause of HCC, induces TGF- signaling perturbations. Here, we investigate the mechanisms by which HCV nonstructural proteins interfere with TGF- signaling, in human hepatoma cell lines expressing HCV subgenomic replicon. A transcriptomic study showed that TGF- stimulation of these cells resulted in a protumoral gene expression profile and in up-regulation of EMT-related genes compared to control interferon-treated cells not expressing HCV proteins. We found that the viral protease NS3-4A interacted with SMURF2, a negative regulator of TGF- signaling. In cells expressing HCV subgenomic replicon or NS3-4A, TGF- stimulation induced an increased expression of SMAD-dependent genes compared to control cells. This enhanced signaling was suppressed by SMURF2 overexpression and mimicked by SMURF2 silencing. In addition, NS3-4A expression resulted in an increased and prolonged TGF--induced phosphorylation of SMAD2/3 that was abrogated by SMURF2 overexpression. Neither NS3-4A protease activity nor SMURF2 ubiquitin-ligase activity was required to affect TGF- signaling. Therefore, by targeting SMURF2, NS3-4A appears to block the negative regulation of TGF- signaling, increasing the responsiveness of cells to TGF-. Verga-Gerard, A., Porcherot, M., Meyniel-Schicklin, L., Andre, P., Lotteau, V., and Perrin-Cocon, L. Hepatitis C virus/human interactome identifies SMURF2 and the viral protease as critical elements for the control of TGF- signaling.	[Verga-Gerard, Amandine; Porcherot, Marine; Meyniel-Schicklin, Laurene; Andre, Patrice; Lotteau, Vincent; Perrin-Cocon, Laure] Univ Lyon, Lyon, France; [Verga-Gerard, Amandine; Porcherot, Marine; Meyniel-Schicklin, Laurene; Andre, Patrice; Lotteau, Vincent; Perrin-Cocon, Laure] Ctr Int Rech Infectiol, INSERM, U1111, F-69007 Lyon, France; [Andre, Patrice] Hosp Civils Lyon, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Perrin-Cocon, L (corresponding author), Ctr Int Rech Infectiol, INSERM, U1111, 21 Av Tony Gamier, F-69007 Lyon, France.	laure.perrin@inserm.fr	Perrin-Cocon, Laure A/M-8099-2014; lotteau, vincent/M-8143-2014; André, Patrice/M-8139-2014	Perrin-Cocon, Laure A/0000-0003-0501-6733; André, Patrice/0000-0002-5834-7395; Lotteau, Vincent/0000-0003-0997-3282	Institut National du Cancer (INCa); Association pour la Recherche contre le Cancer (ARC); Agence Nationale pour la Recherche sur le SIDA et les Hepatites Virales (ANRS) [PAIR-CHC 2009-141]; Ligue Nationale contre le Cancer and the Fondation pour la Recherche Medicale (FRM)	Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Agence Nationale pour la Recherche sur le SIDA et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); Ligue Nationale contre le Cancer and the Fondation pour la Recherche Medicale (FRM)	This work was funded by Institut National du Cancer (INCa), Association pour la Recherche contre le Cancer (ARC), Agence Nationale pour la Recherche sur le SIDA et les Hepatites Virales (ANRS; grant PAIR-CHC 2009-141), and Region Rhone-Alpes (SRESR 2009-cluster X), doctoral fellowship from the Ligue Nationale contre le Cancer and the Fondation pour la Recherche Medicale (FRM) to A.V.G. The authors acknowledge the contribution of the PLATIM platform, the AniRA Level 3 security laboratory and genetic analysis platforms of SFR Biosciences Gerland-Lyon Sud (UMS3444/US8; Lyon, France). The authors gratefully acknowledge the contributions of Dr. Y. Jacob (Institut Pasteur, Paris, France) and Dr. M. F. Bourgeade [Institut National de la Sante et de la Recherche Medicale (INSERM) U785, Paris, France] for helpful discussions and materials. The authors thank Prof. Ralf Bartenschlager (University of Heidelberg, Heidelberg, Germany) for providing Huh9.13 cells, and Prof. D. Lamarre (University of Montreal, Montreal, QC, Canada) for providing BILN2061. The authors also thank Lionel Tafforeau and Thibault Chantier (INSERM U851, Lyon, France), Philippe Mangeot (INSERM U1111, Lyon, France), and Benoit de Chassey (Hospices Civiles de Lyon, Lyon, France) for providing materials and expert technical assistance.	Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Akkari L, 2012, J HEPATOL, V57, P1021, DOI 10.1016/j.jhep.2012.06.027; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Battaglia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004355; Blank M, 2012, NAT MED, V18, P227, DOI 10.1038/nm.2596; Bose SK, 2012, J VIROL, V86, P13621, DOI 10.1128/JVI.02016-12; Brass V, 2008, P NATL ACAD SCI USA, V105, P14545, DOI 10.1073/pnas.0807298105; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Cheng PL, 2004, ONCOGENE, V23, P7821, DOI 10.1038/sj.onc.1208066; Choi SH, 2006, J BIOL CHEM, V281, P7468, DOI 10.1074/jbc.M512438200; Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; de Chassey B, 2012, CURR OPIN VIROL, V2, P606, DOI 10.1016/j.coviro.2012.09.001; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Divella R, 2012, ANTICANCER RES, V32, P141; Drabsch Y, 2012, CANCER METAST REV, V31, P553, DOI 10.1007/s10555-012-9375-7; Eichhorn PJA, 2012, NAT MED, V18, P429, DOI 10.1038/nm.2619; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Giannelli G, 2005, GASTROENTEROLOGY, V129, P1375, DOI 10.1053/j.gastro.2005.09.055; Gotzmann J, 2006, ONCOGENE, V25, P3170, DOI 10.1038/sj.onc.1209083; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang Z, 2010, BIOSCIENCE REP, V30, P383, DOI 10.1042/BSR20090129; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Leivonen SK, 2007, INT J CANCER, V121, P2119, DOI 10.1002/ijc.23113; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Lin ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043593; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Malizia AP, 2009, EXP CELL RES, V315, P1819, DOI 10.1016/j.yexcr.2009.04.001; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, GENE DEV, V14, P627; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Navratil V, 2009, NUCLEIC ACIDS RES, V37, pD661, DOI 10.1093/nar/gkn794; Nishioka M, 2013, MOL CARCINOGEN, V52, P207, DOI 10.1002/mc.21845; Pavio N, 2005, ONCOGENE, V24, P6119, DOI 10.1038/sj.onc.1208749; Pellet J, 2010, NUCLEIC ACIDS RES, V38, pD371, DOI 10.1093/nar/gkp1000; Ray S, 2003, J GASTROEN HEPATOL, V18, P393, DOI 10.1046/j.1440-1746.2003.02985.x; Saitoh T, 2002, INT J MOL MED, V10, P345; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Strizzi L, 2012, CANCER RES, V72, P1915, DOI 10.1158/0008-5472.CAN-11-3419; Tang LY, 2011, EMBO J, V30, P4777, DOI 10.1038/emboj.2011.393; Thibeault D, 2009, BIOCHEMISTRY-US, V48, P744, DOI 10.1021/bi801931e; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Zijl F, 2009, FUTURE ONCOL, V5, P1169, DOI [10.2217/fon.09.91, 10.2217/FON.09.91]; Wilson GK, 2012, J HEPATOL, V56, P803, DOI 10.1016/j.jhep.2011.11.018; Yamazaki K, 2011, DIGEST DIS, V29, P284, DOI 10.1159/000327560; Zhang P, 2012, J BIOL CHEM, V287, P21290, DOI 10.1074/jbc.M112.357202	49	13	13	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4027	4040		10.1096/fj.13-229187	http://dx.doi.org/10.1096/fj.13-229187			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23781096				2022-12-25	WOS:000329747100017
J	Bloem, K; Vuist, IM; van der Plas, AJ; Knippels, LMJ; Garssen, J; Garcia-Vallejo, JJ; van Vliet, SJ; van Kooyk, Y				Bloem, Karien; Vuist, Ilona M.; van der Plas, Arend-Jan; Knippels, Leon M. J.; Garssen, Johan; Garcia-Vallejo, Juan J.; van Vliet, Sandra J.; van Kooyk, Yvette			Ligand Binding and Signaling of Dendritic Cell Immunoreceptor (DCIR) Is Modulated by the Glycosylation of the Carbohydrate Recognition Domain	PLOS ONE			English	Article							C-TYPE LECTIN; VIVO GENE DELIVERY; MANNOSE RECEPTOR; ANTIGEN PRESENTATION; IMMUNE-RESPONSES; INHIBITORY MOTIF; SURFACE-RECEPTOR; CUTTING EDGE; ITIM; HIV-1	C-type lectins are innate receptors expressed on antigen-presenting cells that are involved in the recognition of glycosylated pathogens and self-glycoproteins. Upon ligand binding, internalization and/or signaling often occur. Little is known on the glycan specificity and ligands of the Dendritic Cell Immunoreceptor (DCIR), the only classical C-type lectin that contains an intracellular immunoreceptor tyrosine-based inhibitory motif (ITIM). Here we show that purified DCIR binds the glycan structures Lewis(b) and Man(3). Interestingly, binding could not be detected when DCIR was expressed on cells. Since DCIR has an N-glycosylation site inside its carbohydrate recognition domain (CRD), we investigated the effect of this glycan in ligand recognition. Removing or truncating the glycans present on purified DCIR increased the affinity for DCIR-binding glycans. Nevertheless, altering the glycosylation status of the DCIR expressing cell or mutating the N-glycosylation site of DCIR itself did not increase glycan binding. In contrast, cis and trans interactions with glycans induced DCIR mediated signaling, resulting in a decreased phosphorylation of the ITIM sequence. These results show that glycan binding to DCIR is influenced by the glycosylation of the CRD region in DCIR and that interaction with its ligands result in signaling via its ITIM motif.	[Bloem, Karien; Vuist, Ilona M.; van der Plas, Arend-Jan; Garcia-Vallejo, Juan J.; van Vliet, Sandra J.; van Kooyk, Yvette] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Bloem, Karien; Knippels, Leon M. J.; Garssen, Johan] Danone Res, Ctr Specialized Nutr, Wageningen, Netherlands; [Knippels, Leon M. J.; Garssen, Johan] Univ Utrecht, Dept Pharmacol & Pathophysiol, UIPS, Utrecht, Netherlands	Vrije Universiteit Amsterdam; Danone Nutricia; Utrecht University	van Kooyk, Y (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	y.vankooyk@vumc.nl	Garcia-Vallejo, Juan/H-4162-2012; Van Vliet, Sandra/AAO-9534-2020; Vallejo, Juan Garcia/AAA-3765-2020; garssen, johan/I-7159-2016	Garcia-Vallejo, Juan/0000-0001-6238-7069; Van Kooyk, Yvette/0000-0001-5997-3665; van Vliet, Sandra/0000-0003-1811-2687	Dutch Top Institute Pharma [T1-214]; MS Research; Dutch Asthma Foundation [3.210.040]; Veni grant from the Netherlands organization for Scientific Research (NWO) [863.10.017]	Dutch Top Institute Pharma; MS Research; Dutch Asthma Foundation; Veni grant from the Netherlands organization for Scientific Research (NWO)	K. Bloem was supported by the Dutch Top Institute Pharma, project T1-214, I.M. Vuist was supported by MS Research, J.J. Garcia-Vallejo was supported by the Dutch Asthma Foundation (3.210.040) and S.J. van Vliet was supported by a Veni grant (863.10.017) from the Netherlands organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Barrow AD, 2004, J IMMUNOL, V172, P5838, DOI 10.4049/jimmunol.172.10.5838; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Bates EEM, 1999, J IMMUNOL, V163, P1973; Bax M, 2007, J IMMUNOL, V179, P8216, DOI 10.4049/jimmunol.179.12.8216; Cambi A, 2012, ACS CHEM BIOL, V7, P139, DOI 10.1021/cb200326g; Ceroni A, 2007, SOURCE CODE BIOL MED, V2, DOI 10.1186/1751-0473-2-3; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chen CH, 2006, BLOOD, V107, P1459, DOI 10.1182/blood-2005-08-3264; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Danzer CP, 2003, INT IMMUNOL, V15, P1137, DOI 10.1093/intimm/dxg114; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941; FAWCETT J, 1992, NATURE, V360, P481, DOI 10.1038/360481a0; Fontijn RD, 2008, AM J PHYSIOL-HEART C, V294, pH891, DOI 10.1152/ajpheart.01248.2007; Fujikado N, 2008, NAT MED, V14, P176, DOI 10.1038/nm1697; Garcia-Vallejo JJ, 2009, IMMUNOL REV, V230, P22, DOI 10.1111/j.1600-065X.2009.00786.x; Geijtenbeek TBH, 1999, BLOOD, V94, P754, DOI 10.1182/blood.V94.2.754.414k11_754_764; Geijtenbeek TBH, 2002, J BIOL CHEM, V277, P11314, DOI 10.1074/jbc.M111532200; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Guo JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041228; Hsu TL, 2009, J BIOL CHEM, V284, P34479, DOI 10.1074/jbc.M109.065961; Huang X, 2001, BIOCHEM BIOPH RES CO, V281, P131, DOI 10.1006/bbrc.2001.4322; Iida SI, 1999, J BIOL CHEM, V274, P10697, DOI 10.1074/jbc.274.16.10697; Kajiho Y, 2012, FEBS J, V279, P3010, DOI 10.1111/j.1742-4658.2012.08682.x; Kanazawa N, 2002, J INVEST DERMATOL, V118, P261, DOI 10.1046/j.0022-202x.2001.01633.x; Kawar ZS, 2005, J BIOL CHEM, V280, P12810, DOI 10.1074/jbc.M414273200; Kurihara H, 2010, AM J PHYSIOL-RENAL, V299, pF517, DOI 10.1152/ajprenal.00571.2009; Lambert AA, 2008, BLOOD, V112, P1299, DOI 10.1182/blood-2008-01-136473; Lambert AA, 2011, BLOOD, V117, P6589, DOI 10.1182/blood-2011-01-331363; Lee RT, 2011, GLYCOBIOLOGY, V21, P512, DOI 10.1093/glycob/cwq193; Lorentzen JC, 2007, ARTHRITIS RHEUM-US, V56, P2620, DOI 10.1002/art.22813; Marshall ASJ, 2004, J BIOL CHEM, V279, P14792, DOI 10.1074/jbc.M313127200; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Meyer-Wentrup F, 2009, J LEUKOCYTE BIOL, V85, P518, DOI 10.1189/jlb.0608352; Motegi S, 2003, EMBO J, V22, P2634, DOI 10.1093/emboj/cdg278; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Ohnishi H, 1999, J NEUROCHEM, V72, P1402, DOI 10.1046/j.1471-4159.1999.721402.x; Richard M, 2006, MOL IMMUNOL, V43, P1716, DOI 10.1016/j.molimm.2005.10.006; Richard M, 2003, BIOCHEM BIOPH RES CO, V310, P767, DOI 10.1016/j.bbrc.2003.09.077; STANLEY P, 1983, SOMAT CELL GENET, V9, P593, DOI 10.1007/BF01574260; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Su YP, 2005, J BIOL CHEM, V280, P32811, DOI 10.1074/jbc.M503457200; Taylor PR, 2005, TRENDS IMMUNOL, V26, P104, DOI 10.1016/j.it.2004.12.001; Unkeless JC, 1997, CURR OPIN IMMUNOL, V9, P338, DOI 10.1016/S0952-7915(97)80079-9; van Kooyk Y, 2008, BIOCHEM SOC T, V36, P1478, DOI 10.1042/BST0361478; van Vliet SJ, 2007, EUR J IMMUNOL, V37, P2075, DOI 10.1002/eji.200636838; van Vliet SJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000625; van Vliet SJ, 2005, INT IMMUNOL, V17, P661, DOI 10.1093/intimm/dxh246; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	54	31	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66266	10.1371/journal.pone.0066266	http://dx.doi.org/10.1371/journal.pone.0066266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776650	Green Published, gold			2022-12-25	WOS:000320755400132
J	Choi, HJ; Ebersbacher, CF; Kim, MC; Kang, SM; Montemagno, CD				Choi, Hyo-Jick; Ebersbacher, Charles F.; Kim, Min-Chul; Kang, Sang-Moo; Montemagno, Carlo D.			A Mechanistic Study on the Destabilization of Whole Inactivated Influenza Virus Vaccine in Gastric Environment	PLOS ONE			English	Article							LIGHT-SCATTERING METHOD; OSMOTIC-PRESSURE; UNILAMELLAR VESICLES; EMPTYING TIME; PH OPTIMUM; HEMAGGLUTININ; STABILITY; IMMUNOGENICITY; PROTECTION; IMMUNITY	Oral immunization using whole inactivated influenza virus vaccine promises an efficient vaccination strategy. While oral vaccination was hampered by harsh gastric environment, a systematic understanding about vaccine destabilization mechanisms was not performed. Here, we investigated the separate and combined effects of temperature, retention time, pH, and osmotic stress on the stability of influenza vaccine by monitoring the time-dependent morphological change using stopped-flow light scattering. When exposed to osmotic stress, clustering of vaccine particles was enhanced in an acidic medium (pH 2.0) at >= 25 degrees C. Fluorescence spectroscopic studies showed that hyper-osmotic stress at pH 2.0 and 37 degrees C caused a considerable increase in conformational change of antigenic proteins compared to that in acidic iso-osmotic medium. A structural integrity of membrane was destroyed upon exposure to hyper-osmotic stress, leading to irreversible morphological change, as observed by undulation in stopped-flow light scattering intensity and transmission electron microscopy. Consistent with these analyses, hemagglutination activity decreased more significantly with an increasing magnitude of hyper-osmotic stress than in the presence of the hypo- and iso-osmotic stresses. This study shows that the magnitude and direction of the osmotic gradient has a substantial impact on the stability of orally administrated influenza vaccine.	[Choi, Hyo-Jick; Ebersbacher, Charles F.] Univ Cincinnati, Sch Energy Environm Biol & Med Engn, Cincinnati, OH USA; [Kim, Min-Chul; Kang, Sang-Moo] Georgia State Univ, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA; [Kim, Min-Chul; Kang, Sang-Moo] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Kim, Min-Chul] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA; [Kim, Min-Chul] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Montemagno, Carlo D.] Univ Alberta, Natl Inst Nanotechnol, Edmonton, AB, Canada; [Montemagno, Carlo D.] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB, Canada	University System of Ohio; University of Cincinnati; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Emory University; Emory University; National Research Council Canada; University of Alberta; University of Alberta	Choi, HJ (corresponding author), Univ Cincinnati, Sch Energy Environm Biol & Med Engn, Cincinnati, OH USA.	choihc@ucmail.uc.edu; montemag@ualberta.ca		Tripp, Ralph/0000-0002-2924-9956; Choi, Hyo-Jick/0000-0001-8233-5864	Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative; National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) [AI093772, AI087782, AI105170]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI087782, R01AI105170, R01AI093772] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative; National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded by a grant from the Bill & Melinda Gates Foundation through the Grand Challenges Exploration Initiative (CDM and HJC), and in part by National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) grants AI093772 (SMK), AI087782 (SMK), and AI105170 (SMK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001147; BITTMAN R, 1981, CHEM PHYS LIPIDS, V28, P323, DOI 10.1016/0009-3084(81)90018-9; BLOUGH HA, 1971, J GEN VIROL, V12, P317, DOI 10.1099/0022-1317-12-3-317; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Choi HJ, 2013, J CONTROL RELEASE, V166, P159, DOI 10.1016/j.jconrel.2012.12.002; Choi HJ, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/5/055603; Choi HJ, 2012, BIOMATERIALS, V33, P3756, DOI 10.1016/j.biomaterials.2012.01.054; COLWELL WM, 1975, AVIAN DIS, V19, P781, DOI 10.2307/1589191; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; DANIELS RS, 1984, VIROLOGY, V138, P174, DOI 10.1016/0042-6822(84)90158-2; DANIELS RS, 1983, J GEN VIROL, V64, P1657, DOI 10.1099/0022-1317-64-8-1657; ELLIOTT JR, 1983, BIOCHIM BIOPHYS ACTA, V735, P95, DOI 10.1016/0005-2736(83)90264-X; FARAGMAHMOD FI, 1988, VACCINE, V6, P262, DOI 10.1016/0264-410X(88)90222-8; Fatouros DG, 2002, J COLLOID INTERF SCI, V251, P271, DOI 10.1006/jcis.2002.8432; Fatouros DG, 2001, J DRUG TARGET, V9, P61, DOI 10.3109/10611860108995633; Fauci AS, 2006, CELL, V124, P665, DOI 10.1016/j.cell.2006.02.010; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Giudice EL, 2006, ADV DRUG DELIVER REV, V58, P68, DOI 10.1016/j.addr.2005.12.003; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Hellmig S, 2006, J GASTROEN HEPATOL, V21, P1832, DOI 10.1111/j.1440-1746.2006.04449.x; HUNT JN, 1959, PHYSIOL REV, V39, P491, DOI 10.1152/physrev.1959.39.3.491; KATES M, 1961, BIOCHIM BIOPHYS ACTA, V52, P455, DOI 10.1016/0006-3002(61)90403-6; Keitel WA, 2002, PERSP MED V, V7, P145; Kim CH, 1998, BIOCHEMISTRY-US, V37, P137, DOI 10.1021/bi971982w; KNOWLES CJ, 1971, BIOCHIM BIOPHYS ACTA, V234, P144, DOI 10.1016/0005-2728(71)90139-3; Lammert AM, 1998, FOOD CHEM, V61, P139, DOI 10.1016/S0308-8146(97)00132-5; LAZZELL V, 1984, J BIOL STAND, V12, P315, DOI 10.1016/S0092-1157(84)80012-8; MALMBERG CG, 1950, J RES NAT BUR STAND, V45, P299, DOI 10.6028/jres.045.030; McSwiney BA, 1933, J PHYSIOL-LONDON, V79, P437, DOI 10.1113/jphysiol.1933.sp003057; Miller GL, 1944, J EXP MED, V80, P507, DOI 10.1084/jem.80.6.507; MILON A, 1986, BIOCHIM BIOPHYS ACTA, V859, P1, DOI 10.1016/0005-2736(86)90311-1; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; ONG BY, 1978, CAN ANAESTH SOC J, V25, P36, DOI 10.1007/BF03006781; Palese P, 2006, EMERG INFECT DIS, V12, P61, DOI 10.3201/eid1201.051043; Ponder E, 1944, J GEN PHYSIOL, V27, P273, DOI 10.1085/jgp.27.4.273; Quan FS, 2008, J VIROL, V82, P1350, DOI 10.1128/JVI.01615-07; Quan FS, 2011, VIROLOGY, V417, P196, DOI 10.1016/j.virol.2011.05.014; Quan FS, 2010, J VIROL, V84, P7760, DOI 10.1128/JVI.01849-09; Quan FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007152; RICH GT, 1968, J GEN PHYSIOL, V52, P941, DOI 10.1085/jgp.52.6.941; ROSE EF, 1979, J FORENSIC SCI, V24, P200; SCHEIE PO, 1969, J BACTERIOL, V98, P335, DOI 10.1128/JB.98.2.335-340.1969; Schwarz H, 1995, MICROBIOL-UK, V141, P3161, DOI 10.1099/13500872-141-12-3161; Shastri PN, 2012, J PHARM SCI-US, V101, P3623, DOI 10.1002/jps.23220; SKEHEL JJ, 1982, P NATL ACAD SCI-BIOL, V79, P968, DOI 10.1073/pnas.79.4.968; Skehel JJ, 1995, COLD SPRING HARB SYM, V60, P573, DOI 10.1101/SQB.1995.060.01.061; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; SUN ST, 1986, BIOCHIM BIOPHYS ACTA, V860, P525, DOI 10.1016/0005-2736(86)90549-3; Szarka LA, 2009, AM J PHYSIOL-GASTR L, V296, pG461, DOI 10.1152/ajpgi.90467.2008; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; WAITE MRF, 1968, J VIROL, V2, P759, DOI 10.1128/JVI.2.7.759-760.1968; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WOODLE MC, 1989, METHOD ENZYMOL, V171, P193; YEWDELL JW, 1983, J VIROL, V48, P239, DOI 10.1128/JVI.48.1.239-248.1983	57	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66316	10.1371/journal.pone.0066316	http://dx.doi.org/10.1371/journal.pone.0066316			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776657	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400137
J	Marchi, C; Andersen, LW; Loeschcke, V				Marchi, Chiara; Andersen, Liselotte Wesley; Loeschcke, Volker			Effects of Land Management Strategies on the Dispersal Pattern of a Beneficial Arthropod	PLOS ONE			English	Article							WORKING GROUP PESTICIDES; BEETLES COLEOPTERA; BAYESIAN METHOD; LANDSCAPE; CARABIDAE; POPULATION; ABUNDANCE; INTENSITY; DENSITY; SIZE	Several arthropods are known to be highly beneficial to agricultural production. Consequently it is of great relevance to study the importance of land management and land composition for the conservation of beneficial aphid-predator arthropod species in agricultural areas. Therefore our study focusing on the beneficial arthropod Bembidion lampros had two main purposes: I) identifying the physical barriers to the species' dispersal in the agricultural landscape, and II) assessing the effect of different land management strategies (i.e. use of pesticides and intensiveness) on the dispersal patterns. The study was conducted using genetic analysis (microsatellite markers) applied to samples from two agricultural areas (in Denmark) with different agricultural intensity. Land management effects on dispersal patterns were investigated with particular focus on: physical barriers, use of pesticide and intensity of cultivation. The results showed that Bembidion lampros disperse preferably through hedges rather than fields, which act as physical barriers to gene flow. Moreover the results support the hypothesis that organic fields act as reservoirs for the re-colonization of conventional fields, but only when cultivation intensity is low. These results show the importance of non-cultivated areas and of low intensity organic managed areas within the agricultural landscape as corridors for dispersal (also for a species typically found within fields). Hence, the hypothesis that pesticide use cannot be used as the sole predictor of agriculture's effect on wild species is supported as land structure and agricultural intensity can be just as important.	[Marchi, Chiara; Loeschcke, Volker] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Andersen, Liselotte Wesley] Aarhus Univ, Dept Biosci, Ronde, Denmark	Aarhus University; Aarhus University	Marchi, C (corresponding author), Aarhus Univ, Dept Biosci, Aarhus, Denmark.	chiarapuspa@gmail.com	Loeschcke, Volker/J-2527-2013; Andersen, Liselotte Wesley/O-7115-2019	Loeschcke, Volker/0000-0003-1450-0754; Andersen, Liselotte Wesley/0000-0003-3225-9917	Ministry of Food, Agriculture and Fisheries [24.33.02.10]; AGSoS (Aarhus Graduate School of Science)	Ministry of Food, Agriculture and Fisheries; AGSoS (Aarhus Graduate School of Science)	Funded by the Ministry of Food, Agriculture and Fisheries under the Finance and Appropriation Act, Sections 24.33.02.10. Part of the Ph.D. project is funded by AGSoS (Aarhus Graduate School of Science). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LW, 2004, P ROY SOC B-BIOL SCI, V271, P1293, DOI 10.1098/rspb.2004.2720; Brickle NW, 2000, J APPL ECOL, V37, P742, DOI 10.1046/j.1365-2664.2000.00542.x; Cameron KH, 2012, BIODIVERS CONSERV, V21, P763, DOI 10.1007/s10531-011-0215-9; CHIVERTON PA, 1986, ANN APPL BIOL, V109, P49, DOI 10.1111/j.1744-7348.1986.tb03183.x; EDWARDS CA, 1979, J APPL ECOL, V16, P811, DOI 10.2307/2402855; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Eyre MD, 2009, AGR ECOSYST ENVIRON, V131, P340, DOI 10.1016/j.agee.2009.02.006; Faubet P, 2008, GENETICS, V178, P1491, DOI 10.1534/genetics.107.082560; Faubet P, 2007, MOL ECOL, V16, P1149, DOI 10.1111/j.1365-294X.2007.03218.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; HASSAN SA, 1988, J APPL ENTOMOL, V105, P321, DOI 10.1111/j.1439-0418.1988.tb00194.x; HASSAN SA, 1991, ENTOMOPHAGA, V36, P55, DOI 10.1007/BF02374636; Hendrickx F, 2007, J APPL ECOL, V44, P340, DOI 10.1111/j.1365-2664.2006.01270.x; Honek A, 2000, EUR J ENTOMOL, V97, P517, DOI 10.14411/eje.2000.080; Huusela-Veistola E, 1996, ANN ZOOL FENN, V33, P197; Jansen JP, 2010, PEST MANAG SCI, V66, P650, DOI 10.1002/ps.1924; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Milligan B. G., 1992, Molecular genetic analysis of populations: a practical approach., P59; Ovenden JR, 2007, MOL ECOL, V16, P127, DOI 10.1111/j.1365-294X.2006.03132.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PEDERSEN M, 1990, PEDOBIOLOGIA, V34, P367; Petersen MK, 1999, ENTOMOL EXP APPL, V90, P221, DOI 10.1023/A:1003513706764; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pudovkin AI, 1996, GENETICS, V144, P383; Purvis G, 2002, PEDOBIOLOGIA, V46, P452, DOI 10.1078/0031-4056-00152; PURVIS G, 1984, J APPL ECOL, V21, P271, DOI 10.2307/2403053; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Safner T, 2011, INT J MOL SCI, V12, P865, DOI 10.3390/ijms12020865; Smith HG, 2010, OECOLOGIA, V162, P1071, DOI 10.1007/s00442-010-1588-2; Smith RK, 2005, MAMMAL REV, V35, P1, DOI 10.1111/j.1365-2907.2005.00057.x; Wallin H, 1989, ECOGRAPHY, V12, P193; WAPLES RS, 1989, GENETICS, V121, P379	34	11	11	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66208	10.1371/journal.pone.0066208	http://dx.doi.org/10.1371/journal.pone.0066208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776633	gold, Green Published			2022-12-25	WOS:000320755400122
J	Weber, J; Rose, JD; Vazquez, AC; Winner, D; Margot, N; McColl, DJ; Miller, MD; Quinones-Mateu, ME				Weber, Jan; Rose, Justine D.; Vazquez, Ana C.; Winner, Dane; Margot, Nicolas; McColl, Damian J.; Miller, Michael D.; Quinones-Mateu, Miguel E.			Resistance Mutations outside the Integrase Coding Region Have an Effect on Human Immunodeficiency Virus Replicative Fitness but Do Not Affect Its Susceptibility to Integrase Strand Transfer Inhibitors	PLOS ONE			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; CONNECTION DOMAIN; CROSS-RESISTANCE; DOLUTEGRAVIR S/GSK1349572; DELETERIOUS MUTATIONS; COMBINATION THERAPY; TYPE-1 FITNESS; VIRAL FITNESS; RALTEGRAVIR; ELVITEGRAVIR	Most studies describing phenotypic resistance to integrase strand transfer inhibitors have analyzed viruses carrying only patient-derived HIV-1 integrase genes (INT-recombinant viruses). However, to date, many of the patients on INSTI-based treatment regimes, such as raltegravir (RAL), elvitegravir (EVG), and dolutegravir (DTG) are infected with multidrug-resistant HIV-1 strains. Here we analyzed the effect of drug resistance mutations in Gag (p2/NCp7/p1/p6), protease (PR), reverse transcriptase (RT), and integrase (IN) coding regions on susceptibility to INSTIs and viral replicative fitness using a novel HIV-1 phenotyping assay. Initial characterization based on site-directed mutant INSTI-resistant viruses confirmed the effect of a series of INSTI mutations on reduced susceptibility to EVG and RAL and viral replicative fitness (0.6% to 99% relative to the HIV-1(NL4-3) control). Two sets of recombinant viruses containing a 3,428-bp gag-p2/NCp7/p1/p6/pol-PR/RT/IN (p2-INT) or a 1,088 bp integrase (INT) patient-derived fragment were constructed from plasma samples obtained from 27 virologic failure patients participating in a 48-week dose-ranging study of elvitegravir, GS-US-183-0105. A strong correlation was observed when susceptibility to EVG and RAL was assayed using p2-INT-vs. INT-recombinant viruses (Pearson coefficient correlation 0.869 and 0.918, P<0.0001 for EVG and RAL, respectively), demonstrating that mutations in the protease and RT have limited effect on susceptibility to these INSTIs. On the other hand, the replicative fitness of viruses harboring drug resistance mutations in PR, RT, and IN was generally impaired compared to viruses carrying only INSTI-resistance mutations. Thus, in the absence of drug pressure, drug resistance mutations in the PR and RT contribute to decrease the replicative fitness of the virus already impaired by mutations in the integrase. The use of recombinant viruses containing most or all HIV-1 regions targeted by antiretroviral drugs might be essential to understand the collective effect of epistatic interactions in multidrug-resistant viruses.	[Weber, Jan] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Rose, Justine D.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Vazquez, Ana C.] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Winner, Dane; Quinones-Mateu, Miguel E.] Univ Hosp Case Med Ctr, Univ Hosp Translat Lab, Cleveland, OH USA; [Margot, Nicolas; McColl, Damian J.; Miller, Michael D.] Gilead Sci Inc, Foster City, CA 94404 USA; [Quinones-Mateu, Miguel E.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Case Western Reserve University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Case Western Reserve University; Case Western Reserve University Hospital; Gilead Sciences; Case Western Reserve University	Quinones-Mateu, ME (corresponding author), Univ Hosp Case Med Ctr, Univ Hosp Translat Lab, Cleveland, OH USA.	meq@case.edu	Weber, Jan/B-5405-2013; Quinones-Mateu, Miguel/H-3846-2019	Weber, Jan/0000-0002-2799-7352; Quinones-Mateu, Miguel/0000-0001-9170-5601	Ministry of Education, Youth and Sports of the Czech Republic [LK11207]; State of Ohio; Department of Development; Third Frontier Commission;  [NIH-AI-71747]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071747] Funding Source: NIH RePORTER	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); State of Ohio; Department of Development; Third Frontier Commission; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MEQ-M was supported by research grant NIH-AI-71747. JW was supported by research grant from the Ministry of Education, Youth and Sports of the Czech Republic (LK11207). The authors thank Doug Wylie and Ariel Rhea (Diagnostic Hybrids, Inc., Athens, Ohio) for their involvement in the drug susceptibility assays. Diagnostic Hybrids, Inc. acknowledges the contribution of the State of Ohio, Department of Development and Third Frontier Commission, which provided funding in support of the Platform for Antiviral Resistance Testing and Vaccine Development project. The content reflects the views of Diagnostic Hybrids, Inc. and does not purport to reflect the views of the State of Ohio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram ME, 2012, ANTIVIR THER, V17, pA11; Armenia D, 2012, J INFECT DIS, V205, P557, DOI 10.1093/infdis/jir821; Blanco JL, 2011, J INFECT DIS, V203, P1204, DOI 10.1093/infdis/jir025; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Canducci F, 2011, CLIN MICROBIOL INFEC, V17, P928, DOI 10.1111/j.1469-0691.2010.03375.x; Canducci F, 2011, J INFECT DIS, V204, P1811, DOI 10.1093/infdis/jir636; Ceccherini-Silberstein F, 2010, J ANTIMICROB CHEMOTH, V65, P2305, DOI 10.1093/jac/dkq326; Ceccherini-Silberstein F, 2010, ANTIMICROB AGENTS CH, V54, P3938, DOI 10.1128/AAC.01720-09; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; da SJ, 2010, GENETICS; Dam E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000345; Delelis O, 2009, NUCLEIC ACIDS RES, V37, P1193, DOI 10.1093/nar/gkn1050; Dudley DM, 2009, BIOTECHNIQUES, V46, P458, DOI 10.2144/000113119; Ehteshami M, 2008, J BIOL CHEM, V283, P22222, DOI 10.1074/jbc.M803521200; Ehteshami M, 2008, AIDS REV, V10, P224; Ferns RB, 2009, AIDS, V23, P2159, DOI 10.1097/QAD.0b013e32832ec4ae; Fransen S, 2012, J VIROL, V86, P7249, DOI 10.1128/JVI.06618-11; Fransen S, 2009, J VIROL, V83, P11440, DOI 10.1128/JVI.01168-09; Fransen S, 2009, ANTIMICROB AGENTS CH, V53, P4522, DOI 10.1128/AAC.00651-09; Fun A, 2010, J ANTIMICROB CHEMOTH, V65, P2300, DOI 10.1093/jac/dkq319; Goethals O, 2008, J VIROL, V82, P10366, DOI 10.1128/JVI.00470-08; Goodman D, 2008, 17 INT HIV DRUG RES; Gupta S, 2010, ANTIMICROB AGENTS CH, V54, P1973, DOI 10.1128/AAC.00870-09; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Hinkley T, 2011, NAT GENET, V43, P487, DOI 10.1038/ng.795; Hu ZX, 2010, JAIDS-J ACQ IMM DEF, V55, P148, DOI 10.1097/QAI.0b013e3181e9a87a; Jegede O, 2008, AIDS REV, V10, P172; Buzon MJ, 2010, AIDS, V24, P17, DOI 10.1097/QAD.0b013e328331c81e; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; Kouyos RD, 2007, TRENDS ECOL EVOL, V22, P308, DOI 10.1016/j.tree.2007.02.014; Larrouy L, 2011, ANTIMICROAGENTS CHEM; Larrouy L, 2010, ANTIMICROB AGENTS CH, V54, P2910, DOI 10.1128/AAC.00194-10; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; Malet I, 2009, J ANTIMICROB CHEMOTH, V63, P795, DOI 10.1093/jac/dkp014; Margot NA, 2012, ANTIVIR RES, V93, P288, DOI 10.1016/j.antiviral.2011.12.008; Martinez JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018375; McColl DJ, 2007, ANTIVIR THER, V12, pS11; McColl DJ, 2010, ANTIVIR RES, V85, P101, DOI 10.1016/j.antiviral.2009.11.004; Mesplede T, 2012, J INT AIDS SOC, V15, P8, DOI 10.7448/IAS.15.6.18113; Mesplede T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-22; Nijhuis M, 2001, CURR OPIN INFECT DIS, V14, P23, DOI 10.1097/00001432-200102000-00005; Parera M, 2009, J MOL BIOL, V392, P243, DOI 10.1016/j.jmb.2009.07.015; Quashie PK, 2013, CURR OPIN INFECT DIS, V26, P43, DOI 10.1097/QCO.0b013e32835ba81c; Quashie PK, 2012, J VIROL, V86, P2696, DOI 10.1128/JVI.06591-11; Quercia R, 2009, J VIROL, V83, P10245, DOI 10.1128/JVI.00894-09; Quinones-Mateu ME, 2000, J VIROL, V74, P9222, DOI 10.1128/JVI.74.19.9222-9233.2000; Quinones-Mateu ME, 2006, CURR TOP MICROBIOL, V299, P83; Quinones-Mateu ME, 2002, DRUG RESIST UPDATE, V5, P224, DOI 10.1016/S1368-7646(02)00123-1; Quinones-Mateu ME, 2001, HIV SEQUENCE COMPEND, P134; Raffi F, 2013, LANCET; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rockstroh J, 2012, J INT AIDS SOC, V15, P18220; Sato M, 2006, J MED CHEM, V49, P1506, DOI 10.1021/jm0600139; Selhorst P, 2011, ANTIMICROB AGENTS CH, V55, P1403, DOI 10.1128/AAC.01426-10; Shimura K, 2008, J VIROL, V82, P764, DOI 10.1128/JVI.01534-07; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; van Lunzen J, 2012, LANCET INFECT DIS, V12, P111, DOI 10.1016/S1473-3099(11)70290-0; Van Wesenbeeck L, 2011, ANTIMICROB AGENTS CH, V55, P321, DOI 10.1128/AAC.01733-09; Weber J, 2007, ANTIVIR THER, V12, pS155; Weber J, 2003, J GEN VIROL, V84, P2217, DOI 10.1099/vir.0.19123-0; Weber J, 2003, JAIDS-J ACQ IMM DEF, V33, P448, DOI 10.1097/00126334-200308010-00005; Weber J, 2006, J VIROL METHODS, V136, P102, DOI 10.1016/j.jviromet.2006.04.004; Weber J, 2011, ANTIMICROB AGENTS CH, V55, P3729, DOI 10.1128/AAC.00396-11; Wilkinson TA, 2009, J BIOL CHEM, V284, P7931, DOI 10.1074/jbc.M806241200; Winters MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040514; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335; Zolopa A, 2012, J INT AIDS SOC, V15, P23, DOI 10.7448/IAS.15.6.18219; Zolopa AR, 2010, J INFECT DIS, V201, P814, DOI 10.1086/650698	69	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65631	10.1371/journal.pone.0065631	http://dx.doi.org/10.1371/journal.pone.0065631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776513	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400049
J	Chi, LJ; Galtseva, A; Chen, L; Mo, R; Hui, CC; Rosenblum, ND				Chi, Lijun; Galtseva, Alevtina; Chen, Lin; Mo, Rong; Hui, Chi-chung; Rosenblum, Norman D.			Kif3a Controls Murine Nephron Number Via GLI3 Repressor, Cell Survival, and Gene Expression in a Lineage-Specific Manner	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; PRIMARY CILIUM; INTRAFLAGELLAR TRANSPORT; URETERAL BUD; MUTANT MICE; KINESIN-II; MOUSE; MORPHOGENESIS; WNT11; ORGANOGENESIS	The primary cilium is required during early embryo patterning, epithelial tubulogenesis, and growth factor-dependent signal transduction. The requirement for primary cilia during renal epithelial-mesenchymal tissue interactions that give rise to nephrons is undefined. Here, we used Cre-mediated recombination to generate mice with Kif3a deficiency targeted to the ureteric and/or metanephric mesenchyme cell lineages in the embryonic kidney. Gradual loss of primary cilia in either lineage leads to a phenotype of reduced nephron number. Remarkably, in addition to cyst formation, loss of primary cilia in the ureteric epithelial cell leads to decreased expression of Wnt11 and Ret and reduced ureteric branching. Constitutive expression of GLI3 repressor (Gli3(Delta 699/+)) rescues these abnormalities. In embryonic metanephric mesenchyme cells, Kif3a deficiency limits survival of nephrogenic progenitor cells and expression of genes required for nephron formation. Together, our data demonstrate that Kif3a controls nephron number via distinct cell lineage-specific mechanisms.	[Chi, Lijun; Galtseva, Alevtina; Chen, Lin; Mo, Rong; Hui, Chi-chung; Rosenblum, Norman D.] Univ Toronto, Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Chi, Lijun; Rosenblum, Norman D.] Hosp Sick Children, Div Nephrol, Toronto, ON M5G 1X8, Canada; [Hui, Chi-chung] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Rosenblum, Norman D.] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Rosenblum, Norman D.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Rosenblum, Norman D.] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto	Rosenblum, ND (corresponding author), Univ Toronto, Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada.	norman.rosenblum@sickkids.ca	Rosenblum, Norman D/H-4737-2015	Rosenblum, Norman D/0000-0003-1767-6464	Canadian Institutes of Health Research; Kidney Foundation of Canada; Canada Research Chairs Program; Canadian Cancer Society Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Canada Research Chairs Program(Canada Research Chairs); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported by grants from the Canadian Institutes of Health Research, the Kidney Foundation of Canada and the Canada Research Chairs Program (to NDR) and operating grants from the Canadian Cancer Society Research Institute (to CCH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bose J, 2002, HUM MOL GENET, V11, P1129, DOI 10.1093/hmg/11.9.1129; Bridgewater D, 2008, DEV BIOL, V317, P83, DOI 10.1016/j.ydbio.2008.02.010; Cain JE, 2011, J CLIN INVEST, V121, P1199, DOI 10.1172/JCI45523; Cain JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007313; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Chi LJ, 2006, ENDOCRINOLOGY, V147, P3777, DOI 10.1210/en.2006-0299; Chi Lijun, 2012, Methods Mol Biol, V886, P157, DOI 10.1007/978-1-61779-851-1_14; Chi LJ, 2004, DEVELOPMENT, V131, P3345, DOI 10.1242/dev.01200; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Di Giovanni V, 2011, DEVELOPMENT, V138, P2717, DOI 10.1242/dev.059030; Ding Q, 1998, DEVELOPMENT, V125, P2533; Evans MJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1263, DOI 10.1152/ajplung.00180.2002; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Grieshammer U, 2005, DEVELOPMENT, V132, P3847, DOI 10.1242/dev.01944; Hartwig S, 2008, J AM SOC NEPHROL, V19, P117, DOI 10.1681/ASN.2007010080; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hu MC, 2006, DEVELOPMENT, V133, P569, DOI 10.1242/dev.02220; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137; Kispert A, 1996, DEVELOPMENT, V122, P3627; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; Lancaster MA, 2009, NAT MED, V15, P1046, DOI 10.1038/nm.2010; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Michos O, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000809; Neugebauer JM, 2009, NATURE, V458, P651, DOI 10.1038/nature07753; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Rosenquist TA, 1996, DEV DYNAM, V205, P379, DOI 10.1002/(SICI)1097-0177(199604)205:4<379::AID-AJA2>3.0.CO;2-F; Sainio K, 1997, DEVELOPMENT, V124, P4077; Saxen L., 1987, ORGANOGENESIS KIDNEY; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Schuchardt A, 1996, DEVELOPMENT, V122, P1919; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215; Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002	46	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65448	10.1371/journal.pone.0065448	http://dx.doi.org/10.1371/journal.pone.0065448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762375	gold, Green Submitted, Green Published			2022-12-25	WOS:000321094800051
J	Lai, CH; Lai, CK; Lin, YJ; Hung, CL; Chu, CH; Feng, CL; Chang, CS; Su, HL				Lai, Chih-Ho; Lai, Cheng-Kuo; Lin, Ying-Ju; Hung, Chiu-Lien; Chu, Chia-Han; Feng, Chun-Lung; Chang, Chia-Shuo; Su, Hong-Lin			Characterization of Putative Cholesterol Recognition/Interaction Amino Acid Consensus-Like Motif of Campylobacter jejuni Cytolethal Distending Toxin C	PLOS ONE			English	Article							CELL-CYCLE ARREST; GPI-ANCHORED PROTEIN; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; MEMBRANE CHOLESTEROL; BACTERIAL GENOTOXIN; SIGNAL-TRANSDUCTION; MOLECULAR DOCKING; ENDOCYTOSIS; SUBUNITS; RECOGNITION	Cytolethal distending toxin (CDT) produced by Campylobacter jejuni comprises a heterotrimeric complex formed by CdtA, CdtB, and CdtC. Among these toxin subunits, CdtA and CdtC function as essential proteins that mediate toxin binding to cytoplasmic membranes followed by delivery of CdtB into the nucleus. The binding of CdtA/CdtC to the cell surface is mediated by cholesterol, a major component in lipid rafts. Although the putative cholesterol recognition/interaction amino acid consensus (CRAC) domain of CDT has been reported from several bacterial pathogens, the protein regions contributing to CDT binding to cholesterol in C. jejuni remain unclear. Here, we selected a potential CRAC-like region present in the CdtC from C. jejuni for analysis. Molecular modeling showed that the predicted functional domain had the shape of a hydrophobic groove, facilitating cholesterol localization to this domain. Mutation of a tyrosine residue in the CRAC-like region decreased direct binding of CdtC to cholesterol rather than toxin intermolecular interactions and led to impaired CDT intoxication. These results provide a molecular link between C. jejuni CdtC and membrane-lipid rafts through the CRAC-like region, which contributes to toxin recognition and interaction with cholesterol.	[Lai, Chih-Ho; Lai, Cheng-Kuo; Chang, Chia-Shuo] China Med Univ, Grad Inst Basic Med Sci, Sch Med, Dept Microbiol, Taichung, Taiwan; [Lai, Cheng-Kuo; Su, Hong-Lin] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Dept Life Sci, Taichung 40227, Taiwan; [Lin, Ying-Ju] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Hung, Chiu-Lien] Univ Calif Davis, Dept Biochem & Mol Med, Ctr Comprehens Canc, Sacramento, CA 95817 USA; [Chu, Chia-Han] Natl Tsing Hua Univ, Biomed Sci & Engn Ctr, Hsinchu, Taiwan; [Feng, Chun-Lung] China Med Univ Hosp, Dept Internal Med, Taichung, Taiwan; [Su, Hong-Lin] China Med Univ, Dept Phys Therapy, Taichung, Taiwan	China Medical University Taiwan; National Chung Hsing University; China Medical University Taiwan; University of California System; University of California Davis; National Tsing Hua University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Lai, CH (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Sch Med, Dept Microbiol, Taichung, Taiwan.	chl@mail.cmu.edu.tw; suhonglin@nchu.edu.tw	Chu, Chu/T-6038-2019; Lai, Chih-Ho/M-2433-2013	Lai, Chih-Ho/0000-0001-9229-818X	National Science Council [NSC101-2313-B-039-004-MY3]; China Medical University, Taiwan [CMU101-S-13]; Tomorrow Medicine Foundation	National Science Council(Ministry of Science and Technology, Taiwan); China Medical University, Taiwan(China Medical University); Tomorrow Medicine Foundation	This work was supported by the National Science Council (NSC101-2313-B-039-004-MY3), China Medical University, Taiwan (CMU101-S-13), and Tomorrow Medicine Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Boesze-Battaglia K, 2006, CELL MICROBIOL, V8, P823, DOI 10.1111/j.1462-5822.2005.00669.x; Boesze-Battaglia K, 2009, J BIOL CHEM, V284, P10650, DOI 10.1074/jbc.M809094200; Coconnier MH, 2000, CELL MICROBIOL, V2, P487, DOI 10.1046/j.1462-5822.2000.00073.x; Damek-Poprawa M, 2012, INFECT IMMUN, V80, P2761, DOI 10.1128/IAI.00385-12; Eshraghi A, 2010, J BIOL CHEM, V285, P18199, DOI 10.1074/jbc.M110.112912; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; Guerra L, 2005, CELL MICROBIOL, V7, P921, DOI 10.1111/j.1462-5822.2005.00520.x; Jinadasa RN, 2011, MICROBIOL-SGM, V157, P1851, DOI 10.1099/mic.0.049536-0; Lai CH, 2013, BIOMEDICINE-TAIWAN, V3, P27, DOI 10.1016/j.biomed.2012.12.002; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; Lee RB, 2003, INFECT IMMUN, V71, P4883, DOI 10.1128/IAI.71.9.4883-4890.2003; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Lin CD, 2011, INFECT IMMUN, V79, P3563, DOI 10.1128/IAI.05175-11; Lin CJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/682418; Mao XQ, 2002, CELL MICROBIOL, V4, P245, DOI 10.1046/j.1462-5822.2002.00186.x; McSweeney LA, 2005, INFECT IMMUN, V73, P2051, DOI 10.1128/IAI.73.4.2051-2060.2005; McSweeney LA, 2004, CELL MICROBIOL, V6, P447, DOI 10.1111/j.1462-5822.2004.00373.x; Mise K, 2005, INFECT IMMUN, V73, P4846, DOI 10.1128/IAI.73.8.4846-4852.2005; Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532; Nesic D, 2005, PLOS PATHOG, V1, P214, DOI 10.1371/journal.ppat.0010028; Ricci V, 2000, MOL BIOL CELL, V11, P3897, DOI 10.1091/mbc.11.11.3897; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Smith JL, 2006, CRIT REV MICROBIOL, V32, P227, DOI 10.1080/10408410601023557; Tauxe RV, 1997, EMERG INFECT DIS, V3, P425, DOI 10.3201/eid0304.970403; Wolf AA, 2002, J BIOL CHEM, V277, P16249, DOI 10.1074/jbc.M109834200; Wooldridge KG, 1996, MICROB PATHOGENESIS, V21, P299, DOI 10.1006/mpat.1996.0063; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Yamada T, 2006, PROTEIN SCI, V15, P362, DOI 10.1110/ps.051790506; Yang JM, 2004, PROTEINS, V55, P288, DOI 10.1002/prot.20035; Zhou MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032580; Zitzer A, 2001, J BIOL CHEM, V276, P14628, DOI 10.1074/jbc.M100241200	36	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e66202	10.1371/journal.pone.0066202	http://dx.doi.org/10.1371/journal.pone.0066202			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762481	Green Submitted, gold, Green Published			2022-12-25	WOS:000321099000129
J	Byeon, B; Wang, W; Barski, A; Ranallo, RT; Bao, K; Schones, DE; Zhao, KJ; Wu, C; Wu, WH				Byeon, Boseon; Wang, Wei; Barski, Artem; Ranallo, Ryan T.; Bao, Kan; Schones, Dustin E.; Zhao, Keji; Wu, Carl; Wu, Wei-Hua			The ATP-dependent Chromatin Remodeling Enzyme Fun30 Represses Transcription by Sliding Promoter-proximal Nucleosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; HISTONE H2A.Z; FREE REGIONS; DNA; COMPLEX; YEAST; FAMILY; POSITIONS; BIOLOGY; GENES	The evolutionarily conserved ATP-dependent chromatin remodeling enzyme Fun30 has recently been shown to play important roles in heterochromatin silencing and DNA repair. However, how Fun30 remodels nucleosomes is not clear. Here we report a nucleosome sliding activity of Fun30 and its role in transcriptional repression. We observed that Fun30 repressed the expression of genes involved in amino acid and carbohydrate metabolism, the stress response, and meiosis. In addition, Fun30 was localized at the 5' and 3' ends of genes and within the open reading frames of its targets. Consistent with its role in gene repression, we observed that Fun30 target genes lacked histone modifications often associated with gene activation and showed an increased level of ubiquitinated histone H2B. Furthermore, a genome-wide nucleosome mapping analysis revealed that the length of the nucleosome-free region at the 5' end of a subset of genes was changed in Fun30-depleted cells. In addition, the positions of the -1, +2, and +3 nucleosomes at the 5' end of target genes were shifted significantly, whereas the position of the +1 nucleosome remained largely unchanged in the fun30 Delta mutant. Finally, we demonstrated that affinity-purified, single-component Fun30 exhibited a nucleosome sliding activity in an ATP-dependent manner. These results define a role for Fun30 in the regulation of transcription and indicate that Fun30 remodels chromatin at the 5' end of genes by sliding promoter-proximal nucleosomes.	[Byeon, Boseon; Wang, Wei; Bao, Kan; Wu, Wei-Hua] Georgia Regents Univ, Inst Mol Med & Genet, Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA; [Barski, Artem; Schones, Dustin E.; Zhao, Keji] NHLBI, Syst Biol Ctr, Bethesda, MD 20892 USA; [Ranallo, Ryan T.; Wu, Carl; Wu, Wei-Hua] NCI, Lab Biochem & Mol Biol, NIH, Bethesda, MD 20892 USA	University System of Georgia; Augusta University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wu, WH (corresponding author), Georgia Regents Univ, Inst Mol Med & Genet, Med Coll Georgia, CA-3012,1462 Laney Walker Blvd, Augusta, GA 30912 USA.	wwu@gru.edu		Barski, Artem/0000-0002-1861-5316	NHLBI National Institutes of Health; NCI National Institutes of Health [1K22CA122453]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058, ZIAHL005801] Funding Source: NIH RePORTER	NHLBI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI National Institutes of Health intramural research support (to K. Z.), NCI National Institutes of Health intramural research support (to C. W.), and NCI National Institutes of Health Grant 1K22CA122453 (to W.-H. W.).	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Awad S, 2010, J BIOL CHEM, V285, P9477, DOI 10.1074/jbc.M109.082149; Banaszynski LA, 2010, DEV CELL, V19, P662, DOI 10.1016/j.devcel.2010.10.014; BARTON AB, 1994, J BACTERIOL, V176, P1872, DOI 10.1128/jb.176.7.1872-1880.1994; Batta K, 2011, GENE DEV, V25, P2254, DOI 10.1101/gad.177238.111; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; CAIRNS BR, 1994, P NATL ACAD SCI USA, V91, P1950, DOI 10.1073/pnas.91.5.1950; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Chandrasekharan MB, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12314; Chen KF, 2013, GENOME RES, V23, P312, DOI 10.1101/gr.141952.112; Chen XF, 2012, NATURE, V489, P576, DOI 10.1038/nature11355; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; CLARK MW, 1992, YEAST, V8, P133, DOI 10.1002/yea.320080208; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Costelloe T, 2012, NATURE, V489, P581, DOI 10.1038/nature11353; Cristianini N, 2007, INTRODUCTION TO COMPUTATIONAL GENOMICS: A CASE STUDIES APPROACH, P38; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Durand-Dubief M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002974; Eapen VV, 2012, MOL CELL BIOL, V32, P4727, DOI 10.1128/MCB.00566-12; Fazzio TG, 2005, MOL CELL BIOL, V25, P9165, DOI 10.1128/MCB.25.21.9165-9174.2005; Gkikopoulos T, 2011, SCIENCE, V333, P1758, DOI 10.1126/science.1206097; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hota SK, 2011, BBA-GENE REGUL MECH, V1809, P476, DOI 10.1016/j.bbagrm.2011.05.007; Jansen A, 2011, MICROBIOL MOL BIOL R, V75, P301, DOI 10.1128/MMBR.00046-10; Jiang CZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r109; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luk E, 2010, CELL, V143, P725, DOI 10.1016/j.cell.2010.10.019; Marques M, 2010, EPIGENETICS-US, V5, P267, DOI 10.4161/epi.5.4.11520; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Mizuguchi G, 2012, METHOD ENZYMOL, V512, P275, DOI 10.1016/B978-0-12-391940-3.00012-3; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Narlikar GJ, 2010, CURR OPIN CHEM BIOL, V14, P660, DOI 10.1016/j.cbpa.2010.08.001; Neves-Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008111; Papamichos-Chronakis M, 2011, CELL, V144, P200, DOI 10.1016/j.cell.2010.12.021; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Ray-Gallet D, 2010, ESSAYS BIOCHEM, V48, P75, DOI [10.1042/bse0480075, 10.1042/BSE0480075]; Rowbotham SP, 2011, MOL CELL, V42, P285, DOI 10.1016/j.molcel.2011.02.036; Sadeh R, 2011, CELL, V147, P263, DOI 10.1016/j.cell.2011.09.042; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Seeber A, 2013, CURR OPIN GENET DEV, V23, P174, DOI 10.1016/j.gde.2012.12.008; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Stralfors A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001334; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Thoma F, 1996, METHOD ENZYMOL, V274, P197; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; Udugama M, 2011, MOL CELL BIOL, V31, P662, DOI 10.1128/MCB.01035-10; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Yadon AN, 2010, MOL CELL BIOL, V30, P5110, DOI 10.1128/MCB.00602-10; Yen KY, 2012, CELL, V149, P1461, DOI 10.1016/j.cell.2012.04.036; Yu Q, 2011, J BIOL CHEM, V286, P14659, DOI 10.1074/jbc.M110.183269; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	62	25	25	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23182	23193		10.1074/jbc.M113.471979	http://dx.doi.org/10.1074/jbc.M113.471979			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23779104	Green Published, hybrid			2022-12-25	WOS:000330598200025
J	Stawikowska, R; Cudic, M; Giulianotti, M; Houghten, RA; Fields, GB; Minond, D				Stawikowska, Roma; Cudic, Mare; Giulianotti, Marc; Houghten, Richard A.; Fields, Gregg B.; Minond, Dmitriy			Activity of ADAM17 (a Disintegrin and Metalloprotease 17) Is Regulated by Its Noncatalytic Domains and Secondary Structure of its Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; PEPTIDE EXOSITE INHIBITORS; FACTOR-ALPHA; CONVERTING-ENZYME; FACTOR-VIIA; SPECIFICITY; PROTEINASES; SITE; DISCOVERY; TARGET	ADAM proteases are implicated in multiple diseases, but no drugs based on ADAM inhibition exist. Most of the ADAM inhibitors developed to date feature zinc-binding moieties that target the active site zinc, which leads to a lack of selectivity and off target toxicity. Targeting secondary substrate binding sites (exosites) can potentially work as an alternative strategy for drug discovery; however, there are only a few reports of potential exosites in ADAM protease structures. In the study presented here, we utilized a series of TNF alpha-based substrates to probe ADAM10 and 17 interactions with its canonical substrate to identify the structural features that determine ADAM protease substrate specificity. We found that noncatalytic domains of ADAM17 did not directly bind the substrates used in the study but affected the binding nevertheless, most likely because of steric hindrance. Additionally, noncatalytic domains of ADAM17 affected the size/shape of the carbohydrate-binding pocket contained within the catalytic domain of ADAM17. This suggests that noncatalytic domains of ADAM17 play a role in substrate specificity and might help explain differences in substrate repertoires of ADAM17 and its closest homologue, ADAM10. We also addressed the question of which substrate features can affect ADAM protease specificity. We found that all ADAM proteases tested (i.e., ADAM10,12, and 17) significantly decreased activity when the TNF alpha-derived sequence was induced into alpha-helical conformation, suggesting that conformation plays a role in determining ADAM protease substrate specificity. These findings can help in the discovery of ADAM isoform- and substrate-specific inhibitors.	[Stawikowska, Roma; Cudic, Mare; Giulianotti, Marc; Houghten, Richard A.; Fields, Gregg B.; Minond, Dmitriy] Torrey Pines Inst Mol Studies, Port St Lucie, FL 34987 USA	Torrey Pines Institute for Molecular Studies, Florida	Minond, D (corresponding author), Torrey Pines Inst Mol Studies, 11350 SW Village Pkwy, Port St Lucie, FL 34987 USA.	dminond@tpims.org		Minond, Dmitriy/0000-0003-2473-5944; Giulianotti, Marc/0000-0002-2232-3789	National Institutes of Health [DA033985, CA098799, DA031370]; James and Esther King Biomedical Research Program Grant [2KN05]; Multiple Sclerosis National Research Institute; State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development; NATIONAL CANCER INSTITUTE [R01CA098799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031370, R03DA033985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James and Esther King Biomedical Research Program Grant; Multiple Sclerosis National Research Institute; State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA033985 (to D. M.), CA098799 (to G. B. F.), and DA031370 (to R. A. H.). This work was also supported by James and Esther King Biomedical Research Program Grant 2KN05 (to D. M.), the Multiple Sclerosis National Research Institute (to G. B. F.), and the State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development.	Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Baragi VM, 2009, ARTHRITIS RHEUM-US, V60, P2008, DOI 10.1002/art.24629; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 2003, BIOCHEM SOC SYMP, V70, P39, DOI 10.1042/bss0700039; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Dennis MS, 2000, NATURE, V404, P465, DOI 10.1038/35006574; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Engel CK, 2005, CHEM BIOL, V12, P181, DOI 10.1016/j.chembiol.2004.11.014; Fingleton B, 2007, CURR PHARM DESIGN, V13, P333, DOI 10.2174/138161207779313551; Georgiadis D, 2008, BIOORGAN MED CHEM, V16, P8781, DOI 10.1016/j.bmc.2008.08.058; Gooljarsingh LT, 2008, PROTEIN SCI, V17, P66, DOI 10.1110/ps.073130208; Hall T, 2009, ARCH BIOCHEM BIOPHYS, V491, P106, DOI 10.1016/j.abb.2009.09.005; Hosseini M, 2011, MOL PHARMACOL, V80, P585, DOI 10.1124/mol.111.072280; Izaguirre G, 2009, J BIOL CHEM, V284, P1550, DOI 10.1074/jbc.M807340200; Johnson AR, 2007, J BIOL CHEM, V282, P27781, DOI 10.1074/jbc.M703286200; Kataoka H, 2009, J DERMATOL SCI, V56, P148, DOI 10.1016/j.jdermsci.2009.10.002; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Lauer-Fields JL, 2009, BIOORGAN MED CHEM, V17, P990, DOI 10.1016/j.bmc.2008.03.004; Lee MH, 2002, FEBS LETT, V520, P102, DOI 10.1016/S0014-5793(02)02776-X; Minond D, 2012, J BIOL CHEM, V287, P36473, DOI 10.1074/jbc.M112.389114; Moss ML, 2008, NAT CLIN PRACT RHEUM, V4, P300, DOI 10.1038/ncprheum0797; Moss ML, 2008, CURR PHARM BIOTECHNO, V9, P2, DOI 10.2174/138920108783497613; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; Moss ML, 2010, COMB CHEM HIGH T SCR, V13, P358; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Roberge M, 2002, BIOCHEM J, V363, P387, DOI 10.1042/0264-6021:3630387; Roberge M, 2001, BIOCHEMISTRY-US, V40, P9522, DOI 10.1021/bi010592d; Roth J, 2011, BIOORG MED CHEM LETT, V21, P7180, DOI 10.1016/j.bmcl.2011.09.077; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Takeda S, 2007, FEBS LETT, V581, P5859, DOI 10.1016/j.febslet.2007.11.062; Takeda S, 2009, SEMIN CELL DEV BIOL, V20, P146, DOI 10.1016/j.semcdb.2008.07.009; Tape CJ, 2011, P NATL ACAD SCI USA, V108, P5578, DOI 10.1073/pnas.1017067108; WINGFIELD P, 1987, FEBS LETT, V211, P179, DOI 10.1016/0014-5793(87)81432-1; Wittwer AJ, 2007, BIOCHEMISTRY-US, V46, P6393, DOI 10.1021/bi7000642	38	33	34	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22871	22879		10.1074/jbc.M113.462267	http://dx.doi.org/10.1074/jbc.M113.462267			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23779109	Green Published, hybrid			2022-12-25	WOS:000330596300063
J	Pontes, O; Vitins, A; Ream, TS; Hong, E; Pikaard, CS; Costa-Nunes, P				Pontes, Olga; Vitins, Alexa; Ream, Thomas S.; Hong, Evelyn; Pikaard, Craig S.; Costa-Nunes, Pedro			Intersection of Small RNA Pathways in Arabidopsis thaliana Sub-Nuclear Domains	PLOS ONE			English	Article							TRANS-ACTING SIRNAS; CAJAL BODIES; MESSENGER-RNA; COILED BODIES; ENDOGENOUS SIRNA; POLYMERASE-II; DNA; PROTEINS; GENE; METHYLATION	In Arabidopsis thaliana, functionally diverse small RNA (smRNA) pathways bring about decreased RNA accumulation of target genes via several different mechanisms. Cytological experiments have suggested that the processing of microRNAs (miRNAs) and heterochromatic small interfering RNAs (hc-siRNAs) occurs within a specific nuclear domain that can present Cajal Body (CB) characteristics. It is unclear whether single or multiple smRNA-related domains are found within the same CB and how specialization of the smRNA pathways is determined within this specific sub-compartment. To ascertain whether nuclear smRNA centers are spatially related, we localized key proteins required for siRNA or miRNA biogenesis by immunofluorescence analysis. The intranuclear distribution of the proteins revealed that hc-siRNA, miRNA and trans-acting siRNA (ta-siRNA) pathway proteins accumulate and colocalize within a sub-nuclear structure in the nucleolar periphery. Furthermore, colocalization of miRNA-and siRNA-pathway members with CB markers, and reduced wild-type localization patterns in CB mutants indicates that proper nuclear localization of these proteins requires CB integrity. We hypothesize that these nuclear domains could be important for RNA silencing and may partially explain the functional redundancies and interactions among components of the same protein family. The CB may be the place in the nucleus where Dicer-generated smRNA precursors are processed and assigned to a specific pathway, and where storage, recycling or assembly of RNA interference components takes place.	[Pontes, Olga; Vitins, Alexa; Ream, Thomas S.; Hong, Evelyn; Pikaard, Craig S.; Costa-Nunes, Pedro] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Pontes, Olga; Costa-Nunes, Pedro] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Pikaard, Craig S.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Pikaard, Craig S.] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN USA	University of New Mexico; Washington University (WUSTL); Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Pontes, O (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	opontes@unm.edu	Pikaard, Craig S/K-8772-2012	Pikaard, Craig S/0000-0001-8204-7459	Edward Mallinckrodt, Jr. Foundation award; Monsanto Company; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077590] Funding Source: NIH RePORTER	Edward Mallinckrodt, Jr. Foundation award; Monsanto Company; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	OP, EH and PC-N were supported by an Edward Mallinckrodt, Jr. Foundation award and Monsanto Company. TR is a Gordon and Betty Moore Foundation Fellow of the Life Sciences Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; BEVEN AF, 1995, J CELL SCI, V108, P509; Bies-Etheve N, 2009, EMBO REP, V10, P649, DOI 10.1038/embor.2009.31; Bollman KM, 2003, DEVELOPMENT, V130, P1493, DOI 10.1242/dev.00362; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Boudonck K, 1999, MOL BIOL CELL, V10, P2297, DOI 10.1091/mbc.10.7.2297; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Chen XM, 2002, DEVELOPMENT, V129, P1085; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Collier S, 2006, MOL BIOL CELL, V17, P2942, DOI 10.1091/mbc.E05-12-1157; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; Elmayan T, 2009, FEBS J, V276, P835, DOI 10.1111/j.1742-4658.2008.06828.x; Fang YD, 2007, CURR BIOL, V17, P818, DOI 10.1016/j.cub.2007.04.005; Fujioka Y, 2007, PLANT CELL PHYSIOL, V48, P1243, DOI 10.1093/pcp/pcm099; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; Gao ZH, 2010, NATURE, V465, P106, DOI 10.1038/nature09025; He XJ, 2009, GENE DEV, V23, P318, DOI 10.1101/gad.1765209; Hernandez-Pinzon I, 2007, PLANT J, V50, P140, DOI 10.1111/j.1365-313X.2007.03043.x; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hiraguri A, 2005, PLANT MOL BIOL, V57, P173, DOI 10.1007/s11103-004-6853-5; Hoffer P, 2011, P NATL ACAD SCI USA, V108, P409, DOI 10.1073/pnas.1009805108; Hunter C, 2003, CURR BIOL, V13, P1734, DOI 10.1016/j.cub.2003.09.004; Jauvion V, 2010, PLANT CELL, V22, P2697, DOI 10.1105/tpc.110.076638; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jouannet V, 2012, EMBO J, V31, P1704, DOI 10.1038/emboj.2012.20; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Kanno T, 2008, NAT GENET, V40, P670, DOI 10.1038/ng.119; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Kiss T, 2006, COLD SPRING HARB SYM, V71, P407, DOI 10.1101/sqb.2006.71.025; Kota KP, 2008, J CELL SCI, V121, P1526, DOI 10.1242/jcs.021055; Kumakura N, 2009, FEBS LETT, V583, P1261, DOI 10.1016/j.febslet.2009.03.055; Law JA, 2010, CURR BIOL, V20, P951, DOI 10.1016/j.cub.2010.03.062; Li CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040027; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lukowiak AA, 2001, RNA, V7, P1833; Luo ZH, 2007, PLANT CELL, V19, P943, DOI 10.1105/tpc.106.045724; Lynn K, 1999, DEVELOPMENT, V126, P469; Matera AG, 1998, J CELL BIOCHEM, V70, P181; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; OCHS RL, 1994, J CELL SCI, V107, P385; Ogg SC, 2002, J CELL BIOL, V159, P17, DOI 10.1083/jcb.200206111; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Pontes O, 2008, CURR OPIN GENET DEV, V18, P197, DOI 10.1016/j.gde.2008.01.008; Pontes O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001157; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; Ruiz-Ferrer V, 2019, ANN REV PLANT BIOL, V60, P485; Schott G, 2012, EMBO J, V31, P2553, DOI 10.1038/emboj.2012.92; Scofield DG, 2008, MOL BIOL EVOL, V25, P2255, DOI 10.1093/molbev/msn175; Shaw PJ, 2004, CURR OPIN PLANT BIOL, V7, P614, DOI 10.1016/j.pbi.2004.09.011; Sleeman JE, 2003, J CELL SCI, V116, P2039, DOI 10.1242/jcs.00400; Smith LM, 2007, PLANT CELL, V19, P1507, DOI 10.1105/tpc.107.051540; Song L, 2007, P NATL ACAD SCI USA, V104, P5437, DOI 10.1073/pnas.0701061104; Stanek D, 2008, MOL BIOL CELL, V19, P2534, DOI 10.1091/mbc.E07-12-1259; Stanek D, 2006, CHROMOSOMA, V115, P343, DOI 10.1007/s00412-006-0056-6; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Vaucheret Herve, 2005, Sci STKE, V2005, ppe43, DOI 10.1126/stke.3002005pe43; Verheggen C, 2002, EMBO J, V21, P2736, DOI 10.1093/emboj/21.11.2736; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Wierzbicki AT, 2009, NAT GENET, V41, P630, DOI 10.1038/ng.365; Xie ZD, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-25; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Ye RQ, 2012, MOL CELL, V46, P859, DOI 10.1016/j.molcel.2012.04.013; Yelina NE, 2010, P NATL ACAD SCI USA, V107, P13948, DOI 10.1073/pnas.0911341107; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zheng BL, 2009, GENE DEV, V23, P2850, DOI 10.1101/gad.1868009; Zhu YS, 2004, MOL BIOL CELL, V15, P81, DOI 10.1091/mbc.E03-07-0525; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	78	29	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65652	10.1371/journal.pone.0065652	http://dx.doi.org/10.1371/journal.pone.0065652			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776518	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400040
J	Despars, G; Pandruvada, SNM; Anginot, A; Domenget, C; Jurdic, P; Mazzorana, M				Despars, Genevieve; Pandruvada, Subramanya N. M.; Anginot, Adrienne; Domenget, Chantal; Jurdic, Pierre; Mazzorana, Marlene			DAP12 Overexpression Induces Osteopenia and Impaired Early Hematopoiesis	PLOS ONE			English	Article							DENDRITIC CELL TRANSDIFFERENTIATION; ACTIVATED-T-CELLS; BONE-MARROW; OSTEOCLAST DIFFERENTIATION; ADAPTER PROTEINS; GENE-EXPRESSION; CD34(+) CELLS; MICE; SHIP; PROGENITOR	ITAM-bearing transmembrane signaling adaptors such as DAP12 and FcR gamma are important players in bone homeostasis, but their precise role and functions are still unknown. It has been shown that osteoclast differentiation results from the integration of the RANK and of the DAP12 and FcR gamma signaling pathways. DAP12-deficient mice suffer from a mild osteopetrosis and culture of their bone marrow cells in the presence of M-CSF and RANKL, fails to give rise to multinucleated osteoclasts. Here, we report that mice overexpressing human DAP12 have an osteopenic bone phenotype due to an increased number of osteoclasts on the surface of trabecular and cortical bone. This enhanced number of osteoclasts is associated with an increased number of proliferating myeloid progenitors in Tg-hDAP12 mice. It is concomitant with an arrest of B cell development at the Pre-Pro B/Pre B stage in the bone marrow of Tg-hDAP12 mice and important decrease of follicular and marginal B cells in the spleen of these animals. Our data show that the overexpression of DAP12 results in both increased osteoclastogenesis and impaired hematopoiesis underlining the relationship between bone homeostasis and hematopoiesis.	[Despars, Genevieve; Pandruvada, Subramanya N. M.; Anginot, Adrienne; Domenget, Chantal; Jurdic, Pierre; Mazzorana, Marlene] Univ Lyon 1, Inst Genom Fonct Lyon, Ecole Normale Super Lyon, CNRS, F-69365 Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Mazzorana, M (corresponding author), Univ Lyon 1, Inst Genom Fonct Lyon, Ecole Normale Super Lyon, CNRS, F-69365 Lyon, France.	marlene.mazzorana@ens-lyon.fr	pandruvada, subramanya/AAA-3072-2019; Anginot, Adrienne/N-9299-2017; Pandruvada, Subramanya/E-4373-2012	Pandruvada, Subramanya/0000-0001-9568-7666; MAZZORANA, Marlene/0000-0002-3956-4319	Fondation pour la Recherche Medicale [DEQ20051205752]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work has been supported by grants from the Fondation pour la Recherche Medicale (DEQ20051205752) (http://www.frm.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Anginot A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000585; Barrow AD, 2011, J CLIN INVEST, V121, P3505, DOI 10.1172/JCI45913; Bauer W, 2011, HAEMATOL-HEMATOL J, V96, P1580, DOI 10.3324/haematol.2011.042515; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Cho KA, 2010, INT J MOL MED, V26, P557, DOI 10.3892/ijmm_00000499; David V, 2003, J BONE MINER RES, V18, P1622, DOI 10.1359/jbmr.2003.18.9.1622; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Helgason CD, 2000, J EXP MED, V191, P781, DOI 10.1084/jem.191.5.781; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Hodge JM, 2004, J BONE MINER RES, V19, P190, DOI 10.1359/JBMR.0301232; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Humphrey MB, 2004, J BONE MINER RES, V19, P224, DOI 10.1359/JBMR.0301234; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kiani A, 2004, J LEUKOCYTE BIOL, V76, P1057, DOI 10.1189/jlb.0404259; Kiani A, 2007, EXP HEMATOL, V35, P757, DOI 10.1016/j.exphem.2007.02.001; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kotani M, 2013, J IMMUNOL, V190, P605, DOI 10.4049/jimmunol.1201345; Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Li Y, 2007, BLOOD, V109, P3839, DOI 10.1182/blood-2006-07-037994; Lucas M, 2002, EUR J IMMUNOL, V32, P2653, DOI 10.1002/1521-4141(200209)32:9<2653::AID-IMMU2653>3.0.CO;2-V; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mourcin F, 2011, BLOOD, V117, P6552, DOI 10.1182/blood-2010-12-323113; Muller MR, 2009, P NATL ACAD SCI USA, V106, P7034, DOI 10.1073/pnas.0813296106; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Nakamura K, 2004, J EXP MED, V199, P243, DOI 10.1084/jem.20031193; Nataf S, 2005, AM J PATHOL, V166, P275, DOI 10.1016/S0002-9440(10)62251-1; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Paloneva J, 2001, NEUROLOGY, V56, P1552, DOI 10.1212/WNL.56.11.1552; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Rivollier A, 2004, BLOOD, V104, P4029, DOI 10.1182/blood-2004-01-0041; Schleinitz N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006264; Shinohara M, 2008, CELL, V132, P794, DOI 10.1016/j.cell.2007.12.037; Speziani C, 2007, EUR J IMMUNOL, V37, P747, DOI 10.1002/eji.200636534; Takeshita S, 2002, NAT MED, V8, P943, DOI 10.1038/nm752; Tomasello E, 2005, EUR J IMMUNOL, V35, P1670, DOI 10.1002/eji.200425932; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Wu YL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000586; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	44	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65297	10.1371/journal.pone.0065297	http://dx.doi.org/10.1371/journal.pone.0065297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776468	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400023
J	Sanz, E; Evanoff, R; Quintana, A; Evans, E; Miller, JA; Ko, C; Amieux, PS; Griswold, MD; McKnight, GS				Sanz, Elisenda; Evanoff, Ryan; Quintana, Albert; Evans, Elizabeth; Miller, Jeremy A.; Ko, Chemyong; Amieux, Paul S.; Griswold, Michael D.; McKnight, G. Stanley			RiboTag Analysis of Actively Translated mRNAs in Sertoli and Leydig Cells In Vivo	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; FIBROBLAST GROWTH-FACTORS; GENE-EXPRESSION; PLASMINOGEN-ACTIVATOR; INTERSTITIAL FLUID; TISSUE KALLIKREIN; RECEPTOR; ANDROGEN; GONADOTROPIN; MICE	Male spermatogenesis is a complex biological process that is regulated by hormonal signals from the hypothalamus (GnRH), the pituitary gonadotropins (LH and FSH) and the testis (androgens, inhibin). The two key somatic cell types of the testis, Leydig and Sertoli cells, respond to gonadotropins and androgens and regulate the development and maturation of fertilization competent spermatozoa. Although progress has been made in the identification of specific transcripts that are translated in Sertoli and Leydig cells and their response to hormones, efforts to expand these studies have been restricted by technical hurdles. In order to address this problem we have applied an in vivo ribosome tagging strategy (RiboTag) that allows a detailed and physiologically relevant characterization of the "translatome'' (polysome-associated mRNAs) of Leydig or Sertoli cells in vivo. Our analysis identified all previously characterized Leydig and Sertoli cell-specific markers and identified in a comprehensive manner novel markers of Leydig and Sertoli cells; the translational response of these two cell types to gonadotropins or testosterone was also investigated. Modulation of a small subset of Sertoli cell genes occurred after FSH and testosterone stimulation. However, Leydig cells responded robustly to gonadotropin deprivation and LH restoration with acute changes in polysome-associated mRNAs. These studies identified the transcription factors that are induced by LH stimulation, uncovered novel potential regulators of LH signaling and steroidogenesis, and demonstrate the effects of LH on the translational machinery in vivo in the Leydig cell.	[Sanz, Elisenda; Amieux, Paul S.; McKnight, G. Stanley] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Evanoff, Ryan; Evans, Elizabeth; Griswold, Michael D.] Washington State Univ, Sch Mol Biosci, Ctr Reprod Biol, Pullman, WA 99164 USA; [Quintana, Albert] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Quintana, Albert] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Miller, Jeremy A.] Allen Inst Brain Sci, Seattle, WA USA; [Ko, Chemyong] Univ Illinois, Coll Vet Med, Dept Comparat Biosci, Urbana, IL USA	University of Washington; University of Washington Seattle; Washington State University; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Allen Institute for Brain Science; University of Illinois System; University of Illinois Urbana-Champaign	McKnight, GS (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	mcknight@u.washington.edu	Sanz, Elisenda/I-2765-2015; Quintana, Albert/N-5544-2015; Ko, CheMyong Jay/A-7475-2019; Amieux, Paul/AAG-4102-2021	Sanz, Elisenda/0000-0002-7932-8556; Quintana, Albert/0000-0003-1674-7160; Ko, CheMyong Jay/0000-0002-0963-3731; 	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/National Institutes of Health (NIH) [1R21HD057790-01, 2 R01 HD010808]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/NIH [U54HD12629]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/NIH Contraception Center Research Grant [U54 HD042454, MH086386]; Spanish Ministry of Science and Innovation (MICINN); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD028934, U54HD042454, R01HD010808] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD012629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086386] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/NIH Contraception Center Research Grant; Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/National Institutes of Health (NIH) grant 1R21HD057790-01 (P.S.A.) and 2 R01 HD010808 (M.D.G); the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/NIH through cooperative agreement grant U54HD12629 as part of the Specialized Centers Program in Reproduction and Infertility Research (Project 3, G.S.M.); the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)/NIH Contraception Center Research Grant U54 HD042454 (M.D.G.) and MH086386 to G.S.M. and P.S.A.E.S. and A.Q. were supported by the postdoctoral mobility program of the Spanish Ministry of Science and Innovation (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MH, 2009, J MOL ENDOCRINOL, V42, P291, DOI 10.1677/JME-08-0107; Aitken RJ, 2008, J CLIN INVEST, V118, P1330, DOI 10.1172/JCI33873; Bakker ML, 2008, CIRC RES, V102, P1340, DOI 10.1161/CIRCRESAHA.107.169565; Bartles JR, 1996, J CELL SCI, V109, P1229; Bridges PJ, 2008, GENESIS, V46, P499, DOI 10.1002/dvg.20428; Cancilla B, 2000, J ENDOCRINOL, V164, P149, DOI 10.1677/joe.0.1640149; Canipari R, 2000, BIOL REPROD, V63, P544, DOI 10.1095/biolreprod63.2.544; Clark BJ, 2012, J ENDOCRINOL, V212, P257, DOI 10.1530/JOE-11-0313; Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7; Cotton LM, 2008, ENDOCR REV, V29, P193, DOI 10.1210/er.2007-0028; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Douglas NC, 2012, DEV DYNAM, V241, P365, DOI 10.1002/dvdy.23710; Eacker SM, 2007, MOL ENDOCRINOL, V21, P895, DOI 10.1210/me.2006-0113; GEYER PK, 1982, MOL CELL BIOL, V2, P685, DOI 10.1128/MCB.2.6.685; HALL SH, 1991, ENDOCRINOLOGY, V129, P1243, DOI 10.1210/endo-129-3-1243; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; Hedger MP, 2000, J ANDROL, V21, P747; HETTLE JA, 1986, BIOL REPROD, V34, P895, DOI 10.1095/biolreprod34.5.895; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; Hornstein E, 2001, COLD SPRING HARB SYM, V66, P477, DOI 10.1101/sqb.2001.66.477; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; LASLETT AL, 1995, J STEROID BIOCHEM, V54, P245, DOI 10.1016/0960-0760(95)00138-P; LEVY S, 1991, P NATL ACAD SCI USA, V88, P3319, DOI 10.1073/pnas.88.8.3319; Lin YM, 2010, INT J ANDROL, V33, P545, DOI 10.1111/j.1365-2605.2009.00966.x; Ma XP, 2004, P NATL ACAD SCI USA, V101, P17294, DOI 10.1073/pnas.0404743101; Martinez-Pomares L, 2012, J LEUKOCYTE BIOL, V92, P1177, DOI 10.1189/jlb.0512231; Matsui H, 2000, EUR J BIOCHEM, V267, P6858, DOI 10.1046/j.1432-1033.2000.01786.x; Matsui H, 2005, INT J BIOCHEM CELL B, V37, P2333, DOI 10.1016/j.biocel.2005.05.011; Matsui H, 2001, ENDOCRINOLOGY, V142, P4918, DOI 10.1210/en.142.11.4918; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; McLean DJ, 2002, MOL ENDOCRINOL, V16, P2780, DOI 10.1210/me.2002-0059; Meachem SJ, 2001, EUR J ENDOCRINOL, V145, P561, DOI 10.1530/eje.0.1450561; Midzak AS, 2011, BIOL REPROD, V84, P976, DOI 10.1095/biolreprod.110.087460; Miller JA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-322; Musnier A, 2012, MOL ENDOCRINOL, V26, P669, DOI 10.1210/me.2011-1267; Nalam RL, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001468; NARITA M, 1995, J CLIN INVEST, V96, P1164, DOI 10.1172/JCI118105; Nelson RD, 1998, AM J PHYSIOL-CELL PH, V275, pC216, DOI 10.1152/ajpcell.1998.275.1.C216; O'Shaughnessy PJ, 2009, MOL CELL ENDOCRINOL, V306, P2, DOI 10.1016/j.mce.2008.11.005; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; OTTER M, 1991, J BIOL CHEM, V266, P13931; PAYNE AH, 1990, BIOL REPROD, V42, P399, DOI 10.1095/biolreprod42.3.399; Plant TM, 2008, J NEUROENDOCRINOL, V20, P719, DOI 10.1111/j.1365-2826.2008.01708.x; Ross AJ, 2005, TRENDS ENDOCRIN MET, V16, P19, DOI 10.1016/j.tem.2004.11.004; Roth MY, 2011, CLIN PHARMACOL THER, V89, P133, DOI 10.1038/clpt.2010.103; Sadate-Ngatchou PI, 2004, MOL ENDOCRINOL, V18, P2805, DOI 10.1210/me.2003-0203; Sadate-Ngatchou PI, 2004, MOL ENDOCRINOL, V18, P422, DOI 10.1210/me.2003-0188; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; SHARPE RM, 1979, J REPROD FERTIL, V55, P365, DOI 10.1530/jrf.0.0550365; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Singh M, 2012, NAT BIOTECHNOL, V30, P648, DOI 10.1038/nbt.2286; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; Soccio RE, 2005, J BIOL CHEM, V280, P19410, DOI 10.1074/jbc.M501778200; Song KH, 2001, ENDOCRINOLOGY, V142, P5116, DOI 10.1210/en.142.12.5116; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Stolovich M, 2002, MOL CELL BIOL, V22, P8101, DOI 10.1128/MCB.22.23.8101-8113.2002; SWINNEN JV, 1991, J BIOL CHEM, V266, P18370; Tai P, 2011, MOL ENDOCRINOL, V25, P885, DOI 10.1210/me.2010-0489; Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Ujioka T, 2000, BIOL REPROD, V63, P1513, DOI 10.1095/biolreprod63.5.1513; Vicini E, 1997, MOL ENDOCRINOL, V11, P839, DOI 10.1210/me.11.7.839; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Weinbauer G F, 1995, Adv Exp Med Biol, V377, P55; Weiss RB, 2011, SCIENCE, V334, P1509, DOI 10.1126/science.1216974; Willems A, 2010, INT J ANDROL, V33, P507, DOI 10.1111/j.1365-2605.2009.00964.x; Wu YL, 2008, CHINESE J PHYSIOL, V51, P282; Young EA, 1995, CRIT REV NEUROBIOL, V9, P371; Zhou Q, 2005, BIOL REPROD, V72, P1010, DOI 10.1095/biolreprod.104.035915	73	56	56	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66179	10.1371/journal.pone.0066179	http://dx.doi.org/10.1371/journal.pone.0066179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776628	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400117
J	Karauzum, H; Adhikari, RP; Sarwar, J; Devi, VS; Abaandou, L; Haudenschild, C; Mahmoudieh, M; Boroun, AR; Vu, H; Nguyen, T; Warfield, KL; Shulenin, S; Aman, MJ				Karauzum, Hatice; Adhikari, Rajan P.; Sarwar, Jawad; Devi, V. Sathya; Abaandou, Laura; Haudenschild, Christian; Mahmoudieh, Mahta; Boroun, Atefeh R.; Hong Vu; Tam Nguyen; Warfield, Kelly L.; Shulenin, Sergey; Aman, M. Javad			Structurally Designed Attenuated Subunit Vaccines for S. aureus LukS-PV and LukF-PV Confer Protection in a Mouse Bacteremia Model	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; RESISTANT STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURE; POLYMORPHONUCLEAR LEUKOCYTES; VIRULENCE DETERMINANTS; SKIN INFECTIONS; GAMMA-HEMOLYSIN; PORE FORMATION; COMMUNITY; LEUCOCIDIN	Previous efforts towards S. aureus vaccine development have largely focused on cell surface antigens to induce opsonophagocytic killing aimed at providing sterile immunity, a concept successfully applied to other Gram-positive pathogens such as Streptococcus pneumoniae. However, these approaches have largely failed, possibly in part due to the remarkable diversity of the staphylococcal virulence factors such as secreted immunosuppressive and tissue destructive toxins. S. aureus produces several pore-forming toxins including the single subunit alpha hemolysin as well as bicomponent leukotoxins such as Panton-Valentine leukocidin (PVL), gamma hemolysins (Hlg), and LukED. Here we report the generation of highly attenuated mutants of PVL subunits LukS-PV and LukF-PV that were rationally designed, based on an octameric structural model of the toxin, to be deficient in oligomerization. The attenuated subunit vaccines were highly immunogenic and showed significant protection in a mouse model of S. aureus USA300 sepsis. Protection against sepsis was also demonstrated by passive transfer of rabbit immunoglobulin raised against LukS-PV. Antibodies to LukS-PV inhibited the homologous oligomerization of LukS-PV with LukF-PV as well heterologous oligomerization with HlgB. Importantly, immune sera from mice vaccinated with the LukS mutant not only inhibited the PMN lytic activity produced by the PVL-positive USA300 but also blocked PMN lysis induced by supernatants of PVL-negative strains suggesting a broad protective activity towards other bicomponent toxins. These findings strongly support the novel concept of an anti-virulence, toxin-based vaccine intended for prevention of clinical S. aureus invasive disease, rather than achieving sterile immunity. Such a multivalent vaccine may include attenuated leukotoxins, alpha hemolysin, and superantigens.	[Karauzum, Hatice; Adhikari, Rajan P.; Sarwar, Jawad; Devi, V. Sathya; Abaandou, Laura; Haudenschild, Christian; Mahmoudieh, Mahta; Boroun, Atefeh R.; Hong Vu; Tam Nguyen; Warfield, Kelly L.; Shulenin, Sergey; Aman, M. Javad] Integrated Biotherapeut Inc, Gaithersburg, MD USA		Aman, MJ (corresponding author), Integrated Biotherapeut Inc, Gaithersburg, MD USA.	javad@integratedbiotherapeutics.com	Venkatarmani, Sathyadevi/AAP-1068-2020; Adhikari, Rajan/J-7396-2019	Venkatarmani, Sathyadevi/0000-0003-1242-8162; 	National Institute of Allergy and Infectious Diseases [5R43AI085665]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI085665] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a grant from the National Institute of Allergy and Infectious Diseases (Grant number: 5R43AI085665). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari RP, 2012, J INFECT DIS, V206, P915, DOI 10.1093/infdis/jis462; Adhikari RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038567; Alonzo F, 2012, MOL MICROBIOL, V83, P423, DOI 10.1111/j.1365-2958.2011.07942.x; Aman MJ, 2010, J BIOMOL STRUCT DYN, V28, P1; Brown EL, 2009, CLIN MICROBIOL INFEC, V15, P156, DOI 10.1111/j.1469-0691.2008.02648.x; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Coler RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013677; Cremieux AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007204; Devi VS, 2006, BIOCHEMISTRY-US, V45, P1599, DOI 10.1021/bi052352u; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fattom AI, 1996, INFECT IMMUN, V64, P1659, DOI 10.1128/IAI.64.5.1659-1665.1996; Ferreras M, 1998, BBA-BIOMEMBRANES, V1414, P108, DOI 10.1016/S0005-2736(98)00160-6; FINCKBARBANCON V, 1993, BIOCHIM BIOPHYS ACTA, V1182, P275, DOI 10.1016/0925-4439(93)90069-D; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gravet A, 1998, FEBS LETT, V436, P202, DOI 10.1016/S0014-5793(98)01130-2; Guillet V, 2004, J BIOL CHEM, V279, P41028, DOI 10.1074/jbc.M406904200; He F, 2010, J PHARM SCI-US, V99, P1707, DOI 10.1002/jps.21955; Holzinger D, 2012, J LEUKOCYTE BIOL, V92, P1069, DOI 10.1189/jlb.0112014; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; Kaneko J, 1998, GENE, V215, P57, DOI 10.1016/S0378-1119(98)00278-9; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Malachowa N, 2011, VIRULENCE, V2, P567, DOI 10.4161/viru.2.6.17732; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Meyer R D, 2001, Int J Infect Dis, V5, P163, DOI 10.1016/S1201-9712(01)90093-1; Miles G, 2002, PROTEIN SCI, V11, P894, DOI 10.1110/ps.4360102; Mullen GED, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002940; Narita S, 2001, GENE, V268, P195, DOI 10.1016/S0378-1119(01)00390-0; Nilsson IM, 1999, INFECT IMMUN, V67, P1045, DOI 10.1128/IAI.67.3.1045-1049.1999; Nizet V, 2007, J ALLERGY CLIN IMMUN, V120, P13, DOI 10.1016/j.jaci.2007.06.005; Pedelacq JD, 2000, INT J MED MICROBIOL, V290, P395; Perret M, 2012, CELL MICROBIOL, V14, P1019, DOI 10.1111/j.1462-5822.2012.01772.x; PREVOST G, 1995, INFECT IMMUN, V63, P4121; RomeroSteiner S, 1997, CLIN DIAGN LAB IMMUN, V4, P415, DOI 10.1128/CDLI.4.4.415-422.1997; Schuberth HJ, 2001, VET MICROBIOL, V82, P187, DOI 10.1016/S0378-1135(01)00386-8; Supersac G, 1998, MICROB PATHOGENESIS, V24, P241, DOI 10.1006/mpat.1997.0192; Tristan A, 2007, J HOSP INFECT, V65, P105, DOI 10.1016/S0195-6701(07)60025-5; Varshney AK, 2009, J INFECT DIS; Ventura CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011634; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108	43	37	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65384	10.1371/journal.pone.0065384	http://dx.doi.org/10.1371/journal.pone.0065384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762356	Green Submitted, Green Published, gold			2022-12-25	WOS:000321094800044
J	Suito, H; Iwawaki, Y; Goto, T; Tomotake, Y; Ichikawa, T				Suito, Hideki; Iwawaki, Yuki; Goto, Takaharu; Tomotake, Yoritoki; Ichikawa, Tetsuo			Oral Factors Affecting Titanium Elution and Corrosion: An In Vitro Study Using Simulated Body Fluid	PLOS ONE			English	Article							ION RELEASE; IMPLANT; DISSEMINATION; HIP	Objectives: Ti, which is biocompatible and resistant to corrosion, is widely used for dental implants, particularly in patients allergic to other materials. However, numerous studies have reported on Ti allergy and the in vitro corrosion of Ti. This study investigated the conditions that promote the elution of Ti ions from Ti implants. Methods: Specimens of commercially pure Ti, pure nickel, a magnetic alloy, and a gold alloy were tested. Each specimen was immersed in a simulated body fluid (SBF) whose pH value was controlled (2.0, 3.0, 5.0, 7.4, and 9.0) using either hydrochloric or lactic acid. The parameters investigated were the following: duration of immersion, pH of the SBF, contact with a dissimilar metal, and mechanical stimulus. The amounts of Ti ions eluted were measured using a polarized Zeeman atomic absorption spectrophotometer. Results: Eluted Ti ions were detected after 24 h (pH of 2.0 and 3.0) and after 48 h (pH of 9.0). However, even after 4 weeks, eluted Ti ions were not detected in SBF solutions with pH values of 5.0 and 7.4. Ti elution was affected by immersion time, pH, acid type, mechanical stimulus, and contact with a dissimilar metal. Elution of Ti ions in a Candida albicans culture medium was observed after 72 h. Significance: Elution of Ti ions in the SBF was influenced by its pH and by crevice corrosion. The results of this study elucidate the conditions that lead to the elution of Ti ions in humans, which results in implant corrosion and Ti allergy.	[Suito, Hideki; Iwawaki, Yuki; Goto, Takaharu; Tomotake, Yoritoki; Ichikawa, Tetsuo] Univ Tokushima, Inst Anim Biosci, Dept Oral & Maxillofacial Prosthodont & Oral Impl, Tokushima 770, Japan	Tokushima University	Ichikawa, T (corresponding author), Univ Tokushima, Inst Anim Biosci, Dept Oral & Maxillofacial Prosthodont & Oral Impl, Tokushima 770, Japan.	ichi@tokushima-u.ac.jp	Goto, Takaharu/S-5766-2019	Goto, Takaharu/0000-0003-0962-7304	University of Tokushima	University of Tokushima	This study was supported by the University of Tokushima. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUCHANAN RA, 1987, J BIOMED MATER RES, V21, P367, DOI 10.1002/jbm.820210309; COLLIER JP, 1992, J BONE JOINT SURG BR, V74, P511, DOI 10.1302/0301-620X.74B4.1624507; Danko JC, 1998, MICROSTR SC, V25, P73; Edgar WM, 1996, SALIVA ORAL HLTH, P86; Egusa H, 2008, J PROSTHET DENT, V100, P344, DOI 10.1016/S0022-3913(08)60233-4; Foti B, 1999, J ORAL REHABIL, V26, P495, DOI 10.1046/j.1365-2842.1999.00404.x; Hirayama Teruhisa, 2008, Nihon Hotetsu Shika Gakkai Zasshi, V52, P501; Iimuro F T, 1993, Dent Mater J, V12, P136; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607; Mine Y, 2010, J PROSTHODONT RES, V54, P1, DOI 10.1016/j.jpor.2009.07.003; Mu Y, 2000, J BIOMED MATER RES, V49, P238, DOI 10.1002/(SICI)1097-4636(200002)49:2<238::AID-JBM12>3.0.CO;2-J; Mudali UK, 2003, SADHANA-ACAD P ENG S, V28, P601, DOI 10.1007/bf02706450; Olmedo D, 2002, J MATER SCI-MATER M, V13, P793, DOI 10.1023/A:1016131310025; Olmedo DG, 2008, INT J ORAL MAX SURG, V37, P1032, DOI 10.1016/j.ijom.2008.05.013; POURBAIX M, 1984, BIOMATERIALS, V5, P122, DOI 10.1016/0142-9612(84)90046-2; RECLARU L, 1994, J DENT, V22, P159, DOI 10.1016/0300-5712(94)90200-3; SAMARANAYAKE LP, 1986, J ORAL PATHOL MED, V15, P251, DOI 10.1111/j.1600-0714.1986.tb00617.x; Sicilia A, 2008, CLIN ORAL IMPLAN RES, V19, P823, DOI 10.1111/j.1600-0501.2008.01544.x; Siddiqi A, 2011, CLIN ORAL IMPLAN RES, V22, P673, DOI 10.1111/j.1600-0501.2010.02081.x; Staffolani N, 1999, J DENT, V27, P449, DOI 10.1016/S0300-5712(98)00073-6; Tanji Y, 2002, CORROSION-US, V58, P232, DOI 10.5006/1.3279874; Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002; Watanabe M, 2011, PLOS ONE, V22; Zhang BB, 2009, DENT MATER, V25, P672, DOI 10.1016/j.dental.2008.10.016	25	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66052	10.1371/journal.pone.0066052	http://dx.doi.org/10.1371/journal.pone.0066052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762461	gold, Green Submitted, Green Published			2022-12-25	WOS:000321094800085
J	Sanchez, N; Gallagher, M; Lao, N; Gallagher, C; Clarke, C; Doolan, P; Aherne, S; Blanco, A; Meleady, P; Clynes, M; Barron, N				Sanchez, Noelia; Gallagher, Mark; Lao, Nga; Gallagher, Clair; Clarke, Colin; Doolan, Padraig; Aherne, Sinead; Blanco, Alfonso; Meleady, Paula; Clynes, Martin; Barron, Niall			MiR-7 Triggers Cell Cycle Arrest at the G1/S Transition by Targeting Multiple Genes Including Skp2 and Psme3	PLOS ONE			English	Article							PROTEASOME ACTIVATOR PA28-GAMMA; TRANSCRIPTIONAL REPRESSOR; DNA-REPLICATION; PROTEIN-KINASE; P53; DEGRADATION; MICRORNAS; MYC; RECEPTOR; PROMOTES	MiR-7 acts as a tumour suppressor in many cancers and abrogates proliferation of CHO cells in culture. In this study we demonstrate that miR-7 targets key regulators of the G1 to S phase transition, including Skp2 and Psme3, to promote increased levels of p27(KIP) and temporary growth arrest of CHO cells in the G1 phase. Simultaneously, the down-regulation of DNA repair-specific proteins via miR-7 including Rad54L, and pro-apoptotic regulators such as p53, combined with the up-regulation of anti-apoptotic factors like p-Akt, promoted cell survival while arrested in G1. Thus miR-7 can co-ordinate the levels of multiple genes and proteins to influence G1 to S phase transition and the apoptotic response in order to maintain cellular homeostasis. This work provides further mechanistic insight into the role of miR-7 as a regulator of cell growth in times of cellular stress.	[Sanchez, Noelia; Gallagher, Mark; Gallagher, Clair; Clarke, Colin; Doolan, Padraig; Aherne, Sinead; Meleady, Paula; Clynes, Martin; Barron, Niall] Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin 9, Ireland; [Lao, Nga; Blanco, Alfonso] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland	Dublin City University; University College Dublin	Barron, N (corresponding author), Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin 9, Ireland.	niall.barron@dcu.ie	Meleady, Paula/AAI-4726-2020	Clarke, Colin/0000-0003-2817-9527; Blanco, Alfonso/0000-0003-0439-0838; barron, niall/0000-0003-4602-326X	Science Foundation Ireland [07/IN.I/B1323]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The funding for this study was provided by Science Foundation Ireland Grant No. 07/IN.I/B1323. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Barron N, 2011, J BIOTECHNOL, V151, P204, DOI 10.1016/j.jbiotec.2010.12.005; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Bretones G, 2011, J BIOL CHEM, V286, P9815, DOI 10.1074/jbc.M110.165977; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Cannell IG, 2010, CELL CYCLE, V9, P2726, DOI 10.4161/cc.9.14.12182; Challagundla KB, 2011, MOL CELL BIOL, V31, P4007, DOI 10.1128/MCB.05810-11; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Clarke C, 2011, J BIOTECHNOL, V151, P159, DOI 10.1016/j.jbiotec.2010.11.016; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Fang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018067; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Hu HL, 2011, J MOL CELL BIOL, V3, P151, DOI 10.1093/jmcb/mjq042; Ichimura A, 2011, FEBS J, V278, P1610, DOI 10.1111/j.1742-4658.2011.08087.x; Ikeda Y, 2012, MOL CANCER RES, V10, P259, DOI 10.1158/1541-7786.MCR-11-0035; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Kanaar R, 1996, CURR BIOL, V6, P828, DOI 10.1016/S0960-9822(02)00606-1; Kasof GM, 1999, MOL CELL BIOL, V19, P4390; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kim AH, 2003, J BIOL CHEM, V278, P29830, DOI 10.1074/jbc.M305349200; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kossatz U, 2004, GENE DEV, V18, P2602, DOI 10.1101/gad.321004; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Masson P, 2003, J MOL BIOL, V327, P1001, DOI 10.1016/S0022-2836(03)00188-8; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; McInnes N, 2012, ONCOGENE, V31, P1045, DOI 10.1038/onc.2011.293; Meleady P, 2012, J BIOTECHNOL, V160, P251, DOI 10.1016/j.jbiotec.2012.03.002; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Muller D, 2008, TRENDS BIOTECHNOL, V26, P359, DOI 10.1016/j.tibtech.2008.03.010; Murata S, 1999, J BIOL CHEM, V274, P38211, DOI 10.1074/jbc.274.53.38211; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Rajewsky N, 2011, J MOL BIOL, V409, P70, DOI 10.1016/j.jmb.2011.03.021; Ross HH, 2008, STEM CELLS, V26, P3218, DOI 10.1634/stemcells.2008-0299; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarras H, 2010, THESCIENTIFICWORLDJO, V10, P1450, DOI 10.1100/tsw.2010.132; Shi W, 2000, J CELL BIOL, V148, P591, DOI 10.1083/jcb.148.3.591; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324; ZHANG H, 1995, CELL, V82, P915, DOI 10.1016/0092-8674(95)90271-6; Zhang Z, 2008, EMBO J, V27, P852, DOI 10.1038/emboj.2008.25; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156	60	53	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65671	10.1371/journal.pone.0065671	http://dx.doi.org/10.1371/journal.pone.0065671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762407	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000089
J	Wang, JQ; Chen, JH; Chen, YC; Chen, MY; Hsieh, CY; Teng, SC; Wu, KJ				Wang, Jian-Qiu; Chen, Jian-Hong; Chen, Yen-Chung; Chen, Mei-Yu; Hsieh, Chia-Ying; Teng, Shu-Chun; Wu, Kou-Juey			Interaction between NBS1 and the mTOR/Rictor/SIN1 Complex through Specific Domains	PLOS ONE			English	Article							NIJMEGEN BREAKAGE SYNDROME; DNA-REPAIR; PHOSPHOINOSITIDE 3-KINASE; TARGETED DISRUPTION; ACTIVATION; AKT; PHOSPHORYLATION; OVEREXPRESSION; PROMOTES; PATHWAY	Nijmegen breakage syndrome (NBS) is a chromosomal-instability syndrome. The NBS gene product, NBS1 (p95 or nibrin), is a part of the Mre11-Rad50-NBS1 complex. SIN1 is a component of the mTOR/Rictor/SIN1 complex mediating the activation of Akt. Here we show that NBS1 interacted with mTOR, Rictor, and SIN1. The specific domains of mTOR, Rictor, or SIN1 interacted with the internal domain (a.a. 221-402) of NBS1. Sucrose density gradient showed that NBS1 was located in the same fractions as the mTOR/Rictor/SIN1 complex. Knockdown of NBS1 decreased the levels of phosphorylated Akt and its downstream targets. Ionizing radiation (IR) increased the NBS1 levels and activated Akt activity. These results demonstrate that NBS1 interacts with the mTOR/Rictor/SIN1 complex through the a. a. 221-402 domain and contributes to the activation of Akt activity.	[Wang, Jian-Qiu; Chen, Jian-Hong; Chen, Yen-Chung; Chen, Mei-Yu; Hsieh, Chia-Ying; Wu, Kou-Juey] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Wang, Jian-Qiu] Hangzhou Normal Univ, Sch Med, Dept Basic Med Sci, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China; [Teng, Shu-Chun] Natl Taiwan Univ, Coll Med, Inst Microbiol, Taipei 10764, Taiwan	National Yang Ming Chiao Tung University; Hangzhou Normal University; National Taiwan University	Wu, KJ (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan.	kjwu2@ym.edu.tw	Wu, Kou-Juey/P-4654-2015	TENG, SHU-CHUN/0000-0002-6492-2560; CHEN, MEI-YU/0000-0002-5765-9178	National Research Program for Genomic Medicine [NRPGM-DOH-99-TD-G-111-024, NSC100-3112-B-010-003]; National Science Council [NSC101-2321-B-010-002, NSC98-2320-B-010-023]; National Research Program for Biopharmaceuticals [NSC101-2325-B-010-004]; Ministry of Education, Aim for the Top University Plan [101AC-T505, 102AC-TC13, 102AC-TC15]; center of excellence for cancer research at Taipei Veterans General Hospital [DOH101-TD-C-111-007]; Taichung Veterans General Hospital [TCVGH-YM1000301, TCVGH-YM1010301]; National Health Research Institutes [NHRI-EX101-9931BI, NHRI-EX102-10230SI]	National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); National Research Program for Biopharmaceuticals; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); center of excellence for cancer research at Taipei Veterans General Hospital(Taipei Veterans General Hospital); Taichung Veterans General Hospital; National Health Research Institutes(National Health Research Institutes, Japan)	This work was supported in part to KJW by National Research Program for Genomic Medicine (NRPGM-DOH-99-TD-G-111-024, NSC100-3112-B-010-003), National Science Council Frontier grant (NSC101-2321-B-010-002), National Research Program for Biopharmaceuticals (NSC101-2325-B-010-004), a grant from Ministry of Education, Aim for the Top University Plan (101AC-T505, 102AC-TC13), center of excellence for cancer research at Taipei Veterans General Hospital (DOH101-TD-C-111-007), Taichung Veterans General Hospital (TCVGH-YM1000301, TCVGH-YM1010301), and National Health Research Institutes (NHRI-EX101-9931BI, NHRI-EX102-10230SI); and to MYC by National Science Council (NSC98-2320-B-010-023) and a grant from Ministry of Education, Aim for the Top University Plan (102AC-TC15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoccia A, 2006, GENOME DYN, V1, P191, DOI 10.1159/000092508; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen YC, 2005, J BIOL CHEM, V280, P32505, DOI 10.1074/jbc.M501449200; Chen YC, 2008, J MOL MED, V86, P401, DOI 10.1007/s00109-008-0302-x; Chiang YC, 2003, J BIOL CHEM, V278, P19286, DOI 10.1074/jbc.M212043200; Contessa JN, 2002, ONCOGENE, V21, P4032, DOI 10.1038/sj.onc.1205500; Culjkovic B, 2008, J CELL BIOL, V181, P51, DOI 10.1083/jcb.200707018; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Damaraju S, 2010, ANAL BIOCHEM, V396, P69, DOI 10.1016/j.ab.2009.08.019; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Hematulin A, 2008, CELL SIGNAL, V20, P2276, DOI 10.1016/j.cellsig.2008.08.017; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kang J, 2002, EMBO J, V21, P1447, DOI 10.1093/emboj/21.6.1447; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Saidi A, 2010, MOL CELL BIOL, V30, P5572, DOI 10.1128/MCB.00917-10; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schroder W, 2004, GENE, V339, P17, DOI 10.1016/j.gene.2004.07.001; Suman S, 2012, INT J RADIAT ONCOL, V84, P500, DOI 10.1016/j.ijrobp.2011.12.033; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Toral-Barza L, 2005, BIOCHEM BIOPH RES CO, V332, P304, DOI 10.1016/j.bbrc.2005.04.117; Tsai YP, 2009, CARCINOGENESIS, V30, P1049, DOI 10.1093/carcin/bgp087; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Williams BR, 2002, CURR BIOL, V12, P648, DOI 10.1016/S0960-9822(02)00763-7; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Yang MH, 2007, ONCOGENE, V26, P1459, DOI 10.1038/sj.onc.1209929; Yang MH, 2006, CLIN CANCER RES, V12, P507, DOI 10.1158/1078-0432.CCR-05-1231; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	35	7	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65586	10.1371/journal.pone.0065586	http://dx.doi.org/10.1371/journal.pone.0065586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762398	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000080
J	Quan, H; Zhou, F; Nie, D; Chen, Q; Cai, X; Shan, X; Zhou, Z; Chen, K; Huang, A; Li, S; Tang, N				Quan, H.; Zhou, F.; Nie, D.; Chen, Q.; Cai, X.; Shan, X.; Zhou, Z.; Chen, K.; Huang, A.; Li, S.; Tang, N.			Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition	ONCOGENE			English	Article						hepatitis C virus; epigenetic silencing; SFRP1; Wnt/beta-catenin signaling pathway; methylation	BETA-CATENIN; DNA METHYLATION; EXPRESSION; CANCER; TUMOR; DIFFERENTIATION; TARGET; GENES; CELLS; DNMT1	Hepatocellular carcinoma (HCC) is one of the most deadly cancers. Aberrant oncogenic activation of the Wnt/beta-catenin signaling pathway contributes to hepatocellular carcinogenesis. Various epigenetic modifications of the Wnt antagonist secreted frizzledrelated protein (SFRP) family have been implicated in regulating Wnt signaling. Here, we report that Hepatitis C virus (HCV) core protein downregulates SFRP1 expression when it is expressed in Huh7 and HepG2 cells. SFRP1 expression can be effectively restored by using either a DNA methylation inhibitor alone or in combination with a histone deacetylase inhibitor. DNA methylation analysis of the SFRP1 promoter revealed that cytosine-phosphate-guanine (CpG) islands close to the transcriptional start site (TSS) in the SFRP1 promoter were hypermethylated in core-expressing Huh7 cells, suggesting that HCV core protein may downregulate SFRP1 expression by inducing hypermethylation of the SFRP1 promoter. Chromatin immunoprecipitation revealed that HCV core protein markedly increased the expression level and binding of DNA methyltransferase-1 (Dnmt1) and histone deacetylase-1 (HDAC1) to the TSS of the SFRP1 promoter region, resulting in repression of acetyl-histone H3-binding capacity to SFRP1 promoter and the eventual epigenetic silencing of SFRP1 expression. Furthermore, the core protein-promoted cell proliferation, migration and invasiveness were effectively abrogated either by Dnmt1 knockdown or restoration of SFRP1 expression in hepatoma cells. Dnmt1 knockdown or SFRP1 overexpression also inhibited HCV core-induced epithelial-mesenchymal transition (EMT) and significantly decreased the expression levels of activated b-catenin and Wnt/b-catenin target genes, c-Myc and cyclin D1. We further showed that knockdown of Dnmt1 and restoration of SFRP1 inhibited core-induced in vivo tumor growth and aggressiveness in a xenograft HCC model. Taken together, our results strongly suggest that the HCV core-induced epigenetic silencing of SFRP1 may lead to the activation of the Wnt signaling pathway and thus contribute to HCC aggressiveness through induction of EMT.	[Quan, H.; Zhou, F.; Nie, D.; Chen, Q.; Cai, X.; Shan, X.; Zhou, Z.; Chen, K.; Huang, A.; Li, S.; Tang, N.] Chongqing Med Univ, Affiliated Hosp 2, Chongqing 400010, Peoples R China; [Quan, H.; Zhou, F.; Nie, D.; Chen, Q.; Cai, X.; Shan, X.; Zhou, Z.; Chen, K.; Huang, A.; Li, S.; Tang, N.] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Chinese Minist Educ, Chongqing 400010, Peoples R China	Chongqing Medical University; Chongqing Medical University	Li, S (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Lin Jiang Rd, Chongqing 400010, Peoples R China.	cqlsw@yahoo.com.cn; nitang809@hotmail.com	Tang, Ni/Z-5133-2019	Tang, Ni/0000-0001-5830-8786	Major National S T program [2013ZX10002002, 2012ZX10002005-003-002]; China National Natural Science Foundation [30972586, 31171307, 81171563]; Natural Science Foundation Project of CQMU	Major National S T program; China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQMU	This study was supported by research grants from Major National S&T program (2013ZX10002002, AH; 2012ZX10002005-003-002, NT), China National Natural Science Foundation (# 30972586, # 31171307, NT; # 81171563, ZZ) and Natural Science Foundation Project of CQMU (NT). We thank Dr T-C He of University of Chicago, USA, for kind provision of adenoviruses AdGFP, AdsiDnmt1 and AdSFRP1. We are also grateful for Dr Takaji Wakita (National Institute of Infectious Diseases, Tokyo) for providing the HCV JFH-1 cDNA clone.	Akkari L, 2012, J HEPATOL, V57, P1021, DOI 10.1016/j.jhep.2012.06.027; Arora P, 2008, CANCER LETT, V261, P244, DOI 10.1016/j.canlet.2007.11.033; Austinat M, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-21; Battaglia S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004355; Benegiamo G, 2012, DIGEST DIS SCI, V57, P1598, DOI 10.1007/s10620-012-2160-1; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Bose SK, 2012, J VIROL, V86, P13621, DOI 10.1128/JVI.02016-12; Campbell PM, 2003, CARCINOGENESIS, V24, P17, DOI 10.1093/carcin/24.1.17; Cervoni N, 2001, J BIOL CHEM, V276, P40778, DOI 10.1074/jbc.M103921200; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Chiam K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025634; Clement S, 2010, J HEPATOL, V52, P635, DOI 10.1016/j.jhep.2009.10.035; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Danam RP, 2005, MOL CANCER THER, V4, P61; Easwaran V, 2003, CANCER RES, V63, P3145; Fang S, 2013, CLIN EXP MED, V13, P127, DOI 10.1007/s10238-012-0182-9; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; Gauger KJ, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-25; Gavert N, 2011, MOL CANCER RES, V9, P14, DOI 10.1158/1541-7786.MCR-10-0406; Gong CM, 2012, TOXICOL LETT, V209, P264, DOI 10.1016/j.toxlet.2012.01.007; Gros C, 2012, BIOCHIMIE, V94, P2280, DOI 10.1016/j.biochi.2012.07.025; Guo N, 2012, J CELL BIOCHEM, V113, P3419, DOI 10.1002/jcb.24218; Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Kaneda A, 2012, CANCER RES, V72, P3445, DOI 10.1158/0008-5472.CAN-11-3919; Kato N, 2000, HEPATOLOGY, V32, P405, DOI 10.1053/jhep.2000.9198; Kaur P, 2012, TUMOR BIOL, V33, P325, DOI 10.1007/s13277-012-0331-5; Lee JY, 2012, J AM CHEM SOC, V134, P173, DOI 10.1021/ja210273w; Li KQK, 2013, ANTI-CANCER AGENT ME, V13, P242; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023098; Mao W, 2011, INVEST OPHTH VIS SCI, V53, P7043; Milavetz B, 2012, EPIGENETICS-US, V7, P528, DOI 10.4161/epi.20057; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Shih YL, 2007, INT J CANCER, V121, P1028, DOI 10.1002/ijc.22750; Sturgeon SR, 2012, EPIGENETICS-US, V7, P1258, DOI 10.4161/epi.22220; Su HY, 2010, INT J CANCER, V127, P555, DOI 10.1002/ijc.25083; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Vaid M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023000; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang XB, 2012, ONCOL LETT, V4, P334, DOI 10.3892/ol.2012.713; Wu DW, 2012, AM J PATHOL, V181, P1796, DOI 10.1016/j.ajpath.2012.07.032	44	72	76	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 29	2014	33	22					2826	2835		10.1038/onc.2013.225	http://dx.doi.org/10.1038/onc.2013.225			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EI	23770846				2022-12-25	WOS:000337231800002
J	Liu, L; Xu, HX; Wang, WQ; Wu, CT; Chen, T; Qin, Y; Liu, C; Xu, J; Long, J; Zhang, B; Xu, YF; Ni, QX; Li, M; Yu, XJ				Liu, L.; Xu, H-X; Wang, W-Q; Wu, C-T; Chen, T.; Qin, Y.; Liu, C.; Xu, J.; Long, J.; Zhang, B.; Xu, Y-F; Ni, Q-X; Li, M.; Yu, X-J			Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic cancer	ONCOGENE			English	Article						cavin-1; caveolin-1; pancreatic cancer; metastatic potential; prognostic potency	TRANSCRIPT-RELEASE FACTOR; I OVEREXPRESSION; CELL-MIGRATION; POOR-PROGNOSIS; POLYMERASE-I; EXPRESSION; CARCINOMA; GENE; PROGRESSION; INVASION	Caveolin-1 exhibits a stage-dependent, functional fluctuation during pancreatic cancer development, but the underlying mechanisms remain unclear. Here, we report that cavin-1, a structural protein of caveolae, modulates the oncogenic function of caveolin-1 and cooperates with caveolin-1 to enhance pancreatic cancer aggressiveness. Cavin-1 expression is associated with caveolin-1 in pancreatic cancer tissue samples and cell lines, and predicts the metastatic potential of pancreatic cancer. Interactome analyses further revealed the physical interaction of cavin-1 and caveolin-1 and their colocalization in pancreatic cancer cells. Cavin-1 stabilizes caveolin-1 expression or activity by inhibiting its internalization and subsequent lysosomal degradation. More in-depth functional experiments showed that caveolin-1-enhanced aggressiveness of pancreatic cancer cells is dependent on the presence of cavin-1. In contrast, cavin-1 depletion inhibited the invasion and metastasis of pancreatic cancer cells, which could not be restored by caveolin-1-rescue construct. Tissue microarray analyses in two independent clinic cohorts also supported the augment of cavin-1 on the prognostic potency of caveolin-1, and showed that combination of cavin-1 with caveolin-1 predicted worse survival in pancreatic cancer patients. Of note, the phenotypes because of cavin-1 could not be achieved by other cavins such as cavin-2, and the tumor-promoting role of cavin-1 in pancreatic cancer was found to be largely dependent on caveolin-1 expression, which highlights the critical role of cavin-1/caveoin-1 in pancreatic cancer progression, and suggests that the interruption of cavin-1/caveolin-1 interaction is a promising therapeutic strategy for pancreatic cancer.	[Liu, L.; Xu, H-X; Wang, W-Q; Wu, C-T; Chen, T.; Qin, Y.; Liu, C.; Xu, J.; Long, J.; Zhang, B.; Xu, Y-F; Ni, Q-X; Li, M.; Yu, X-J] Fudan Univ, Pancreat Canc Inst, Shanghai 200032, Peoples R China; [Liu, L.; Xu, H-X; Wang, W-Q; Wu, C-T; Chen, T.; Qin, Y.; Liu, C.; Xu, J.; Long, J.; Zhang, B.; Xu, Y-F; Ni, Q-X; Li, M.; Yu, X-J] Fudan Univ, Dept Pancreat & Hepatobiliary Surg, Shanghai Canc Ctr, Shanghai 200032, Peoples R China; [Liu, L.; Xu, H-X; Wang, W-Q; Wu, C-T; Chen, T.; Qin, Y.; Liu, C.; Xu, J.; Long, J.; Zhang, B.; Xu, Y-F; Ni, Q-X; Li, M.; Yu, X-J] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Li, M.] Univ Texas Houston, Sch Med, Vivian L Smith Dept Neurosurg, Houston, TX USA	Fudan University; Fudan University; Fudan University; University of Texas System; University of Texas Health Science Center Houston	Yu, XJ (corresponding author), Fudan Univ, Pancreat Canc Inst, 270 DongAn Rd, Shanghai 200032, Peoples R China.	Min.Li@uth.tmc.edu; yuxianjun88@hotmail.com		yu, xianjun/0000-0002-6697-7143	National Natural Science Foundation of China [81172005, 81172276]; National Natural Science Foundation of Shanghai [11ZR1407000]; PhD Programs Foundation of Ministry of Education of China [20110071120096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Shanghai; PhD Programs Foundation of Ministry of Education of China(Ministry of Education, China)	We thank Zhi-Qiang Meng for providing the pancreatic cancer cells SW1990HM and Huan-Yu Xia for assistance in collecting the patient data. This research project was supported by grants from the National Natural Science Foundation of China (81172005 and 81172276), the National Natural Science Foundation of Shanghai (11ZR1407000) and PhD Programs Foundation of Ministry of Education of China (20110071120096).	Aung CS, 2011, EUR J CELL BIOL, V90, P136, DOI 10.1016/j.ejcb.2010.06.004; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Bender FC, 2000, CANCER RES, V60, P5870; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Burgermeister E, 2007, CANCER RES, V67, P8519, DOI 10.1158/0008-5472.CAN-07-1125; Chen ST, 2004, INT J MOL MED, V14, P577; Chiu WT, 2011, CANCER RES, V71, P4932, DOI 10.1158/0008-5472.CAN-10-4249; Fong A, 2003, AM J CLIN PATHOL, V120, P93, DOI 10.1309/292NHAYNWAVREJ37; Gamez-Pozo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033752; Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Harris J, 2002, IMMUNOLOGY, V105, P190, DOI 10.1046/j.1365-2567.2002.01362.x; Hasegawa T, 2000, BIOCHEM J, V347, P55, DOI 10.1042/0264-6021:3470055; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Ho CC, 2008, LUNG CANCER, V59, P105, DOI 10.1016/j.lungcan.2007.07.024; Huang C, 2012, CANCER RES, V72, P655, DOI 10.1158/0008-5472.CAN-11-3102; Ito Y, 2002, BRIT J CANCER, V86, P912, DOI 10.1038/sj.bjc.6600172; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Kai WC, 2001, AM J PATHOL, V159, P1635, DOI 10.1016/S0002-9440(10)63010-6; Karam JA, 2007, PROSTATE, V67, P614, DOI 10.1002/pros.20557; Kato K, 2002, CANCER, V94, P929, DOI 10.1002/cncr.10329.abs; Li LK, 2001, CANCER RES, V61, P4386; Lin M, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-21; Liu LA, 2010, CLIN CANCER RES, V16, P2740, DOI 10.1158/1078-0432.CCR-09-2610; Liu L, 2010, CANCER SCI, V101, P120, DOI 10.1111/j.1349-7006.2009.01363.x; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Murakami S, 2003, BRIT J CANCER, V88, P1234, DOI 10.1038/sj.bjc.6600878; Nabi IR, 2009, NAT CELL BIOL, V11, P789, DOI 10.1038/ncb0709-789; Quest AFG, 2008, J CELL MOL MED, V12, P1130, DOI 10.1111/j.1582-4934.2008.00331.x; Rao X, 2013, ONCOGENE, V32, P4519, DOI 10.1038/onc.2012.474; Shi WD, 2009, CANCER LETT, V283, P84, DOI 10.1016/j.canlet.2009.03.030; Terris B, 2002, AM J PATHOL, V160, P1745, DOI 10.1016/S0002-9440(10)61121-2; Thomas S, 2004, MOL IMMUNOL, V41, P399, DOI 10.1016/j.molimm.2004.03.022; Wiechen K, 2001, AM J PATHOL, V158, P833, DOI 10.1016/S0002-9440(10)64031-X	37	45	46	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 22	2014	33	21					2728	2736		10.1038/onc.2013.223	http://dx.doi.org/10.1038/onc.2013.223			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EH	23770857				2022-12-25	WOS:000337231700006
J	Diani-Moore, S; Zhang, S; Ram, P; Rifkind, AB				Diani-Moore, Silvia; Zhang, Sheng; Ram, Payal; Rifkind, Arleen B.			Aryl Hydrocarbon Receptor Activation by Dioxin Targets Phosphoenolpyruvate Carboxykinase (PEPCK) for ADP-ribosylation via 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-inducible Poly(ADP-ribose) Polymerase (TiPARP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP-ribosylation; Aryl Hydrocarbon Receptor; Dioxin; Liver; Phosphoenolpyruvate Carboxykinase; TiPARP	INDEPENDENT GENE BATTERIES; HEPATIC GLUCONEOGENESIS; HEPATOCYTE CULTURES; MASS-SPECTROMETRY; MOUSE-LIVER; RNA LEVELS; EXPRESSION; TCDD; IDENTIFICATION; MITOCHONDRIAL	Effects of the environmental toxin and carcinogen 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin) include a wasting syndrome associated with decreased gluconeogenesis. TCDD is a potent activator of the aryl hydrocarbon receptor (AHR), a ligand activated transcription factor. The relationship between gene activation by the AHR and TCDD toxicities is not well understood. We recently identified a pathway by which the AHR target gene TiPARP (TCDD-inducible poly(ADP-ribose) polymerase) contributes to TCDD suppression of transcription of phosphoenolpyruvate carboxykinase (PEPCK), a key regulator of gluconeogenesis, by consuming NAD(+) and decreasing Sirtuin 1 activation of the peroxisome proliferator-activated receptor coactivator 1 (PGC1), a transcriptional activator of PEPCK. We report here that TCDD-induced TiPARP also targets PEPCK for ADP-ribosylation. Both cytosolic and mitochondrial forms of PEPCK were found to undergo ADP-ribosylation. Unexpectedly, AHR suppression also enhanced ADP-ribosylation and did so by a poly(ADP-ribose) polymerase-independent mechanism. This report 1) identifies ADP-ribosylation as a new posttranslational modification for PEPCK, 2) describes a pathway by which transcriptional induction of TiPARP by the AHR can lead to a downstream posttranslational change in a TCDD target protein (PEPCK), and 3) reveals that the AHR exerts complex, previously unidentified modulatory effects on ADP-ribosylation.	[Diani-Moore, Silvia; Ram, Payal; Rifkind, Arleen B.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Zhang, Sheng] Cornell Univ, Inst Biotechnol & Life Sci Technol, Ithaca, NY 14850 USA	Cornell University; Cornell University	Rifkind, AB (corresponding author), Weill Cornell Med Coll, Dept Pharmacol, 1300 York Ave, New York, NY 10065 USA.	arifkind@med.cornell.edu			National Institutes of Health [ES-03606]; Winston Foundation; Cornell University-Ithaca; Weill Cornell Medical College Faculty; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003606] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Winston Foundation; Cornell University-Ithaca; Weill Cornell Medical College Faculty; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES-03606 (to A. B. R.). This work was also supported by a gift from the Winston Foundation (to A. B. R.) and a Seed Grant for Collaborations between Cornell University-Ithaca and Weill Cornell Medical College Faculty.	Adriouch S, 2008, FASEB J, V22, P861, DOI 10.1096/fj.07-9294com; Agca C, 2002, PHYSIOL GENOMICS, V11, P53, DOI 10.1152/physiolgenomics.00108.2001; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Boutros PC, 2009, TOXICOL SCI, V112, P245, DOI 10.1093/toxsci/kfp191; Boutros PC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-419; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Diani-Moore S, 2006, TOXICOL SCI, V90, P96, DOI 10.1093/toxsci/kfj065; Diani-Moore S, 2011, CHEM-BIOL INTERACT, V193, P119, DOI 10.1016/j.cbi.2011.05.010; Diani-Moore S, 2010, J BIOL CHEM, V285, P38801, DOI 10.1074/jbc.M110.131573; Feijs KLH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-5; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Goyak KMO, 2008, TOXICOL APPL PHARM, V231, P216, DOI 10.1016/j.taap.2008.04.024; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; HAMADA T, 1984, COMP BIOCHEM PHYS B, V77, P547, DOI 10.1016/0305-0491(84)90273-6; Hanson RW, 2009, J BIOL CHEM, V284, P27021, DOI 10.1074/jbc.R109.040519; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hengel SM, 2009, J AM SOC MASS SPECTR, V20, P477, DOI 10.1016/j.jasms.2008.10.025; Herrero-Yraola A, 2001, EMBO J, V20, P2404, DOI 10.1093/emboj/20.10.2404; HOD Y, 1986, ANN NY ACAD SCI, V478, P31, DOI 10.1111/j.1749-6632.1986.tb15519.x; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Jiang H, 2013, ANAL BIOCHEM, V433, P218, DOI 10.1016/j.ab.2012.10.029; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Kawajiri K, 2007, ARCH BIOCHEM BIOPHYS, V464, P207, DOI 10.1016/j.abb.2007.03.038; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Laing S, 2011, AMINO ACIDS, V41, P257, DOI 10.1007/s00726-010-0676-2; LENTNEK M, 1991, BIOCHEM BIOPH RES CO, V174, P1267, DOI 10.1016/0006-291X(91)91558-T; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Q, 2001, BIOCHEM BIOPH RES CO, V289, P499, DOI 10.1006/bbrc.2001.5987; MacPherson L, 2013, NUCLEIC ACIDS RES, V41, P1604, DOI 10.1093/nar/gks1337; Manning GE, 2013, TOXICOL APPL PHARM, V266, P38, DOI 10.1016/j.taap.2012.10.030; Martinez-Zamudio R, 2012, MOL CELL BIOL, V32, P2490, DOI 10.1128/MCB.06667-11; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Mendez-Lucas A, 2013, J HEPATOL, V59, P105, DOI 10.1016/j.jhep.2013.02.020; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Okey AB, 2007, TOXICOL SCI, V98, P5, DOI 10.1093/toxsci/kfm096; Osago H, 2009, ANAL BIOCHEM, V393, P248, DOI 10.1016/j.ab.2009.06.028; Platten M, 2012, ONCOIMMUNOLOGY, V1, P395, DOI 10.4161/onci.19071; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; SAVON S, 1993, BIOL NEONATE, V64, P62; Schwanekamp JA, 2006, BBA-GENE STRUCT EXPR, V1759, P388, DOI 10.1016/j.bbaexp.2006.07.005; STAHL BU, 1993, TOXICOLOGY, V79, P81, DOI 10.1016/0300-483X(93)90207-9; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; UNKILA M, 1994, TOXICOL APPL PHARM, V128, P280, DOI 10.1006/taap.1994.1208; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Walker RP, 2002, PLANT PHYSIOL, V128, P165, DOI 10.1104/pp.010432; WEBER LWD, 1991, ARCH TOXICOL, V65, P119, DOI 10.1007/BF02034937; Yadgary L, 2012, POULTRY SCI, V91, P444, DOI 10.3382/ps.2011-01669; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Yang Y, 2007, ELECTROPHORESIS, V28, P2080, DOI 10.1002/elps.200600524; Yang Y, 2011, J PROTEOME RES, V10, P4647, DOI 10.1021/pr200455s; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	66	22	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21514	21525		10.1074/jbc.M113.458067	http://dx.doi.org/10.1074/jbc.M113.458067			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23770670	hybrid, Green Published			2022-12-25	WOS:000328841900005
J	Safratowich, BD; Lor, C; Bianchi, L; Carvelli, L				Safratowich, Bryan D.; Lor, Chee; Bianchi, Laura; Carvelli, Lucia			Amphetamine Activates an Amine-gated Chloride Channel to Generate Behavioral Effects in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C; elegans; Dopamine Transporters; Electrophysiology; Ion Channels; Membrane Proteins; Amphetamine	DOPAMINE TRANSPORTER; C-ELEGANS; RAT STRIATUM; RECEPTORS; LOCOMOTOR; HYPERACTIVITY; CLEARANCE; COCAINE; PSYCHOSTIMULANTS; INHIBITION	Amphetamine is a highly addictive psychostimulant, which is thought to generate its effects by promoting release of dopamine through reverse activation of dopamine transporters. However, some amphetamine-mediated behaviors persist in dopamine transporter knock-out animals, suggesting the existence of alternative amphetamine targets. Here we demonstrate the identification of a novel amphetamine target by showing that in Caenorhabditis elegans, a large fraction of the behavioral effects of amphetamine is mediated through activation of the amine-gated chloride channel, LGC-55. These findings bring to light alternative pathways engaged by amphetamine, and urge rethinking of the molecular mechanisms underlying the effects of this highly-addictive psychostimulant.	[Safratowich, Bryan D.; Lor, Chee; Carvelli, Lucia] Univ N Dakota, Dept Pharmacol Physiol & Therapeut, Sch Med & Hlth Sci, Grand Forks, ND 58202 USA; [Bianchi, Laura] Univ Miami, Dept Physiol & Biophys, Miller Sch Med, Miami, FL 33136 USA	University of North Dakota Grand Forks; University of Miami	Carvelli, L (corresponding author), Univ N Dakota, Dept Pharmacol Physiol & Therapeut, 504 Hamline St, Grand Forks, ND 58202 USA.	lucia.carvelli@med.und.edu			National Institutes of Health [R21 DA024797, RGS-09-043-01-DDC5, R01 NS070969]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024797] Funding Source: NIH RePORTER; Direct For Biological Sciences [1359243, 0851869] Funding Source: National Science Foundation; EPSCoR [0814442] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 DA024797 (to L. C.) and Grants RGS-09-043-01-DDC5 and R01 NS070969 (to L. B.).	Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; BLANC G, 1994, EUR J NEUROSCI, V6, P293, DOI 10.1111/j.1460-9568.1994.tb00272.x; BRENNER S, 1974, GENETICS, V77, P71; Budygin EA, 2004, P NATL ACAD SCI USA, V101, P7781, DOI 10.1073/pnas.0401418101; Budygin EA, 2000, NEUROSCI LETT, V281, P9, DOI 10.1016/S0304-3940(00)00813-2; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Carboni E, 2001, J NEUROSCI, V21; Carvelli L, 2010, MOL PHARMACOL, V78, P151, DOI 10.1124/mol.109.062703; Chase Daniel L, 2007, WormBook, P1; Darracq L, 1998, J NEUROSCI, V18, P2729; DICKINSON SL, 1988, PSYCHOPHARMACOLOGY, V96, P521, DOI 10.1007/BF02180034; Drouin C, 2002, J NEUROSCI, V22, P2873, DOI 10.1523/JNEUROSCI.22-07-02873.2002; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; McDonald PW, 2007, J NEUROSCI, V27, P14216, DOI 10.1523/JNEUROSCI.2992-07.2007; McDonald PW, 2006, CELL MOL NEUROBIOL, V26, P593, DOI 10.1007/s10571-006-9003-6; Pirri JK, 2009, NEURON, V62, P526, DOI 10.1016/j.neuron.2009.04.013; Revel FG, 2012, NEUROPSYCHOPHARMACOL, V37, P2580, DOI 10.1038/npp.2012.109; Ringstad N, 2009, SCIENCE, V325, P96, DOI 10.1126/science.1169243; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; RITZ MC, 1988, PROG NEURO-PSYCHOPH, V12, P233, DOI 10.1016/0278-5846(88)90040-1; Sabeti J, 2003, J PHARMACOL EXP THER, V305, P180, DOI 10.1124/jpet.102.047258; Salahpour A, 2008, P NATL ACAD SCI USA, V105, P4405, DOI 10.1073/pnas.0707646105; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schafer WR, 2004, NEUROPHARMACOLOGY, V47, P123, DOI 10.1016/j.neuropharm.2004.06.026; Sotnikova TD, 2005, PLOS BIOL, V3, P1488, DOI 10.1371/journal.pbio.0030271; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Talloczy Z, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040028; Tsalik EL, 2003, DEV BIOL, V263, P81, DOI 10.1016/S0012-1606(03)00447-0; ZACZEK R, 1991, J PHARMACOL EXP THER, V257, P830; Zahniser NR, 1999, J PHARMACOL EXP THER, V289, P266; Zhou FC, 2002, BRAIN RES, V942, P109, DOI 10.1016/S0006-8993(02)02709-9	32	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21630	21637		10.1074/jbc.M113.484139	http://dx.doi.org/10.1074/jbc.M113.484139			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23775081	Green Published, hybrid			2022-12-25	WOS:000328841900015
J	Larson, JL; Redmond, CT; Potter, DA				Larson, Jonathan L.; Redmond, Carl T.; Potter, Daniel A.			Assessing Insecticide Hazard to Bumble Bees Foraging on Flowering Weeds in Treated Lawns	PLOS ONE			English	Article							BOMBUS-TERRESTRIS HYMENOPTERA; IMPATIENS HYMENOPTERA; APIDAE; NEONICOTINOIDS; CLOTHIANIDIN; MANAGEMENT; COLONIES; EXPOSURE; SUCCESS; DECLINE	Maintaining bee-friendly habitats in cities and suburbs can help conserve the vital pollination services of declining bee populations. Despite label precautions not to apply them to blooming plants, neonicotinoids and other residual systemic insecticides may be applied for preventive control of lawn insect pests when spring-flowering weeds are present. Dietary exposure to neonicotinoids adversely affects bees, but the extent of hazard from field usage is controversial. We exposed colonies of the bumble bee Bombus impatiens to turf with blooming white clover that had been treated with clothianidin, a neonicotinoid, or with chlorantraniliprole, the first anthranilic diamide labeled for use on lawns. The sprays were applied at label rate and lightly irrigated. After residues had dried, colonies were confined to forage for six days, and then moved to a non-treated rural site to openly forage and develop. Colonies exposed to clothianidin-treated weedy turf had delayed weight gain and produced no new queens whereas those exposed to chlorantraniliprole-treated plots developed normally compared with controls. Neither bumble bees nor honey bees avoided foraging on treated white clover in open plots. Nectar from clover blooms directly contaminated by spray residues contained 171 +/- 44 ppb clothianidin. Notably, neither insecticide adversely impacted bee colonies confined on the treated turf after it had been mown to remove clover blooms present at the time of treatment, and new blooms had formed. Our results validate EPA label precautionary statements not to apply neonicotinoids to blooming nectar-producing plants if bees may visit the treatment area. Whatever systemic hazard through lawn weeds they may pose appears transitory, however, and direct hazard can be mitigated by adhering to label precautions, or if blooms inadvertently are contaminated, by mowing to remove them. Chlorantraniliprole usage on lawns appears non-hazardous to bumble bees.	[Larson, Jonathan L.; Redmond, Carl T.; Potter, Daniel A.] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	University of Kentucky	Potter, DA (corresponding author), Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA.	dapotter@uky.edu	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216; Redmond, Carl/0000-0001-6898-8682	University of Kentucky's B.C.	University of Kentucky's B.C.	This work was supported by the University of Kentucky's B.C. Pass Research Professorship and Graduate Assistantship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Analytical Software, 2008, STAT VERS 9 0 US MAN; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Blaine TW, 2012, ENVIRON MANAGE, V50, P257, DOI 10.1007/s00267-012-9874-x; Bonmatin JM, 2005, ENVIRONMENTAL CHEMISTRY: GREEN CHEMISTRY AND POLLUTANTS IN ECOSYSTEMS, P483; Bonmatin JM, 2003, ANAL CHEM, V75, P2027, DOI 10.1021/ac020600b; Brugger KE, 2010, PEST MANAG SCI, V66, P1075, DOI 10.1002/ps.1977; Byrne FJ, 2012, PEST MANAG SCI, V68, P811, DOI 10.1002/ps.2337; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Cutler GC, 2007, J ECON ENTOMOL, V100, P765, DOI 10.1603/0022-0493(2007)100[765:ETCSCH]2.0.CO;2; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Franklin MT, 2004, J ECON ENTOMOL, V97, P369, DOI 10.1603/0022-0493-97.2.369; Gels JA, 2002, J ECON ENTOMOL, V95, P722, DOI 10.1603/0022-0493-95.4.722; Gerloff CU, 2005, OIKOS, V111, P67, DOI 10.1111/j.0030-1299.2005.13980.x; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Held D, 2012, ANNU REV ENTOMOL, V57, P329, DOI 10.1146/annurev-ento-120710-100542; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hernandez JL, 2009, CITIES ENV, V2, P1, DOI DOI 10.15365/cate.2132009; Hopwood J., 2012, ARE NEONICOTINOIDS K; JAKOBSEN HB, 1994, ANN BOT-LONDON, V74, P327, DOI 10.1006/anbo.1994.1125; Larson JL, 2012, PEST MANAG SCI, V68, P740, DOI 10.1002/ps.2321; Laycock I, 2012, ECOTOXICOLOGY, V21, P1937, DOI 10.1007/s10646-012-0927-y; McFrederick QS, 2006, BIOL CONSERV, V129, P372, DOI 10.1016/j.biocon.2005.11.004; Milesi C, 2005, ENVIRON MANAGE, V36, P426, DOI 10.1007/s00267-004-0316-2; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; MORSE RA, 1990, J ECON ENTOMOL, V83, P81, DOI 10.1093/jee/83.1.81; MULLER CB, 1992, ECOL ENTOMOL, V17, P343, DOI 10.1111/j.1365-2311.1992.tb01068.x; Paya P, 2007, ANAL BIOANAL CHEM, V389, P1697, DOI 10.1007/s00216-007-1610-7; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Schmid-Hempel P, 2001, NATURWISSENSCHAFTEN, V88, P147, DOI 10.1007/s001140100222; Schonherr J, 2001, PEST MANAG SCI, V57, P17, DOI 10.1002/1526-4998(200101)57:1<17::AID-PS266>3.0.CO;2-8; Tasei JN, 2000, PEST MANAG SCI, V56, P784, DOI 10.1002/1526-4998(200009)56:9<784::AID-PS208>3.0.CO;2-T; Tasei JN, 2001, J ECON ENTOMOL, V94, P623, DOI 10.1603/0022-0493-94.3.623; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Tommasi D, 2004, CAN ENTOMOL, V136, P851; U.S. Environmental Protection Agency, 2003, EPA PEST FACT SHEET; Wang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036623; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025	42	89	92	7	187	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66375	10.1371/journal.pone.0066375	http://dx.doi.org/10.1371/journal.pone.0066375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776667	gold, Green Published			2022-12-25	WOS:000320322400100
J	Li, YS; Xu, J; Chen, H; Zhao, Z; Li, SL; Bai, J; Wu, AW; Jiang, CJ; Wang, Y; Su, B; Li, X				Li, Yongsheng; Xu, Juan; Chen, Hong; Zhao, Zheng; Li, Shengli; Bai, Jing; Wu, Aiwei; Jiang, Chunjie; Wang, Yuan; Su, Bin; Li, Xia			Characterizing Genes with Distinct Methylation Patterns in the Context of Protein-Protein Interaction Network: Application to Human Brain Tissues	PLOS ONE			English	Article							DNA METHYLATION; SYSTEMS BIOLOGY; MOUSE; MODULES; EPIGENETICS; PREDICTION; ACTIVATORS; RESOURCE; DATABASE; TARGETS	Background: DNA methylation is an essential epigenetic mechanism involved in transcriptional control. However, how genes with different methylation patterns are assembled in the protein-protein interaction network (PPIN) remains a mystery. Results: In the present study, we systematically dissected the characterization of genes with different methylation patterns in the PPIN. A negative association was detected between the methylation levels in the brain tissues and topological centralities. By focusing on two classes of genes with considerably different methylation levels in the brain tissues, namely the low methylated genes (LMGs) and high methylated genes (HMGs), we found that their organizing principles in the PPIN are distinct. The LMGs tend to be the center of the PPIN, and attacking them causes a more deleterious effect on the network integrity. Furthermore, the LMGs express their functions in a modular pattern and substantial differences in functions are observed between the two types of genes. The LMGs are enriched in the basic biological functions, such as binding activity and regulation of transcription. More importantly, cancer genes, especially recessive cancer genes, essential genes, and aging-related genes were all found more often in the LMGs. Additionally, our analysis presented that the intra-classes communications are enhanced, but inter-classes communications are repressed. Finally, a functional complementation was revealed between methylation and miRNA regulation in the human genome. Conclusions: We have elucidated the assembling principles of genes with different methylation levels in the context of the PPIN, providing key insights into the complex epigenetic regulation mechanisms.	[Li, Yongsheng; Xu, Juan; Chen, Hong; Zhao, Zheng; Li, Shengli; Bai, Jing; Wu, Aiwei; Jiang, Chunjie; Wang, Yuan; Su, Bin; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	Harbin Medical University	Li, X (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	lixia@hrbmu.edu.cn	Jiang, Chunjie/AAU-1775-2020; li, xia/HHZ-7468-2022	Jiang, Chunjie/0000-0002-3033-092X; Wu, Aiwei/0000-0001-8531-4815; Li, Yongsheng/0000-0003-1914-0727; Xu, Juan/0000-0002-3709-4165; Li, Shengli/0000-0001-5430-303X	National Natural Science Foundation of China [81121003, 91129710, 61170154, 3001304, 61203264]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20102307110022]; China Postdoctoral Science Foundation [2012M520764]; Innovation Research Fund for Graduate Students of Heilongjiang province [YJSCX2012-196HLJ]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Innovation Research Fund for Graduate Students of Heilongjiang province	This work was supported by the Funds for Creative Research Groups of The National Natural Science Foundation of China (Grant Nos. 81121003), the National Natural Science Foundation of China (Grant Nos. 91129710, 61170154, 3001304, 61203264), the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant Nos. 20102307110022), China Postdoctoral Science Foundation (Grant Nos. 2012M520764) and The Innovation Research Fund for Graduate Students of Heilongjiang province (YJSCX2012-196HLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Awan A, 2007, IET SYST BIOL, V1, P292, DOI 10.1049/iet-syb:20060068; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Blake JA, 2003, NUCLEIC ACIDS RES, V31, P193, DOI 10.1093/nar/gkg047; Blake JA, 2000, NUCLEIC ACIDS RES, V28, P108, DOI 10.1093/nar/28.1.108; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Bundo M, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-22; Campbell DB, 2009, PEDIATRICS, V123, P1018, DOI 10.1542/peds.2008-0819; de Magalhaes JP, 2004, FEBS LETT, V571, P243, DOI 10.1016/j.febslet.2004.07.006; Deneberg S, 2011, BLOOD, V118, P5573, DOI 10.1182/blood-2011-01-332353; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fernandez AF, 2009, GENOME RES, V19, P438, DOI 10.1101/gr.083550.108; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gronniger E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000971; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97; Hsu CW, 2008, PROTEOMICS, V8, P1975, DOI 10.1002/pmic.200701004; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Jiang CZ, 2007, MOL BIOL EVOL, V24, P1991, DOI 10.1093/molbev/msm128; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kesavapany S, 2004, J NEUROSCI, V24, P4421, DOI 10.1523/JNEUROSCI.0690-04.2004; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Numata S, 2012, AM J HUM GENET, V90, P260, DOI 10.1016/j.ajhg.2011.12.020; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; QUILLIAM LA, 1995, BIOESSAYS, V17, P395, DOI 10.1002/bies.950170507; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Su ZX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S15; Tang P, 1997, J NEURO-ONCOL, V35, P303, DOI 10.1023/A:1005824802617; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Wang JG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000521; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Winnefeld M, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-7-165, 10.1186/gb4033]; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xiao Y, 2012, NUCLEIC ACIDS RES, V40, P7653, DOI 10.1093/nar/gks538; Yang XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002604; Zeng J, 2012, AM J HUM GENET, V91, P455, DOI 10.1016/j.ajhg.2012.07.024; Zhang QC, 2012, NATURE, V490, P556, DOI 10.1038/nature11503	55	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65871	10.1371/journal.pone.0065871	http://dx.doi.org/10.1371/journal.pone.0065871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776563	gold, Green Published, Green Submitted			2022-12-25	WOS:000320322400060
J	Perez-Sanchez, J; Estensoro, I; Redondo, MJ; Calduch-Giner, JA; Kaushik, S; Sitja-Bobadilla, A				Perez-Sanchez, Jaume; Estensoro, Itziar; Redondo, Maria Jose; Calduch-Giner, Josep Alvar; Kaushik, Sadasivam; Sitja-Bobadilla, Ariadna			Mucins as Diagnostic and Prognostic Biomarkers in a Fish-Parasite Model: Transcriptional and Functional Analysis	PLOS ONE			English	Article							GILTHEAD SEA BREAM; ENTEROMYXUM-LEEI MYXOZOA; CELL-SURFACE MUCIN; SPARUS-AURATA; GENE-EXPRESSION; INTESTINAL EPITHELIUM; TRANSMEMBRANE MUCINS; DIGESTIVE-TRACT; IMMUNE-RESPONSE; MUCOUS CELLS	Mucins are O-glycosylated glycoproteins present on the apex of all wet-surfaced epithelia with a well-defined expression pattern, which is disrupted in response to a wide range of injuries or challenges. The aim of this study was to identify mucin gene sequences of gilthead sea bream (GSB), to determine its pattern of distribution in fish tissues and to analyse their transcriptional regulation by dietary and pathogenic factors. Exhaustive search of fish mucins was done in GSB after de novo assembly of next-generation sequencing data hosted in the IATS transcriptome database ( www.nutrigroup-iats.org/seabreamdb). Six sequences, three categorized as putative membrane-bound mucins and three putative secreted-gel forming mucins, were identified. The transcriptional tissue screening revealed that Muc18 was the predominant mucin in skin, gills and stomach of GSB. In contrast, Muc19 was mostly found in the oesophagus and Muc13 was along the entire intestinal tract, although the posterior intestine exhibited a differential pattern with a high expression of an isoform that does not share a clear orthologous in mammals. This mucin was annotated as intestinal mucin (I-Muc). Its RNA expression was highly regulated by the nutritional background, whereas the other mucins, including Muc2 and Muc2-like, were expressed more constitutively and did not respond to high replacement of fish oil (FO) by vegetable oils (VO) in plant protein-based diets. After challenge with the intestinal parasite Enteromyxum leei, the expression of a number of mucins was decreased mainly in the posterior intestine of infected fish. But, interestingly, the highest down-regulation was observed for the I-Muc. Overall, the magnitude of the changes reflected the intensity and progression of the infection, making mucins and I-Muc, in particular, reliable markers of prognostic and diagnostic value of fish intestinal health.	[Perez-Sanchez, Jaume; Calduch-Giner, Josep Alvar] IATS CSIC, Nutrigenom & Fish Growth Endocrinol Grp, Castellon de La Plana, Spain; [Estensoro, Itziar; Redondo, Maria Jose; Sitja-Bobadilla, Ariadna] IATS CSIC, Fish Pathol Grp, Castellon de La Plana, Spain; [Kaushik, Sadasivam] INRA, NuMeA Nutr UR1067, St Pee Sur Nivelle, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); INRAE; Universite de Pau et des Pays de l'Adour	Perez-Sanchez, J (corresponding author), IATS CSIC, Nutrigenom & Fish Growth Endocrinol Grp, Castellon de La Plana, Spain.	jperez@iats.csic.es	Sánchez, Jaume Pérez/AAJ-6628-2021; Sitjà-Bobadilla, Ariadna/J-2715-2014; Calduch-Giner, Josep/K-8253-2014; Calduch-Giner, Josep/AAY-1475-2021; Kaushik, Sadasivam J/B-9824-2009; sanchez, jaume perez/K-3231-2014; estensoro, itziar/AAX-4469-2020	Sánchez, Jaume Pérez/0000-0003-2506-1523; Sitjà-Bobadilla, Ariadna/0000-0002-7473-3413; Calduch-Giner, Josep/0000-0003-3124-5986; Calduch-Giner, Josep/0000-0003-3124-5986; Kaushik, Sadasivam J/0000-0001-7856-8374; sanchez, jaume perez/0000-0003-2506-1523; estensoro, itziar/0000-0002-6218-2191	EU ARRAINA project (Advanced Research Initiatives for Nutrition Aquaculture) [288925]; Spanish Ministry of Science and Innovation (MICINN) [AGL2009-13282-C02-01, CSD2007-00002]; Generalitat Valenciana [PROMETEO 2010/006, ISIC 2011/003]	EU ARRAINA project (Advanced Research Initiatives for Nutrition Aquaculture); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was funded by the EU ARRAINA project (Advanced Research Initiatives for Nutrition & Aquaculture, FP7/2007/2013; grant agreement no. 288925) and by the Spanish Ministry of Science and Innovation (MICINN) through the projects AGL2009-13282-C02-01 and AQUAGENOMICS (CSD2007-00002, Improvement of Aquaculture Production by the Use of Biotechnological Tools). Additional funding was obtained from the "Generalitat Valenciana" (research grants PROMETEO 2010/006, ISIC 2011/003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	alvarez-Pellitero P., 2011, MUCOSAL INTESTINAL I; Andrianifahanana M, 2006, BBA-REV CANCER, V1765, P189, DOI 10.1016/j.bbcan.2006.01.002; Artis D, 2008, MUCOSAL IMMUNOL, V1, P252, DOI 10.1038/mi.2008.21; Bergstrom KSB, 2008, INFECT IMMUN, V76, P796, DOI 10.1128/IAI.00093-07; Bermudez R, 2009, 14 EUR ASS FISH PATH; Bosi G, 2005, DIS AQUAT ORGAN, V64, P45, DOI 10.3354/dao064045; Burger-van Paassen N, 2009, BIOCHEM J, V420, P211, DOI 10.1042/BJ20082222; Calduch-Giner JA, 2003, COMP BIOCHEM PHYS B, V136, P1, DOI 10.1016/S1096-4959(03)00150-7; Calduch-Giner JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-178; Calduch-Giner JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-470; Carraway KL, 2003, BIOESSAYS, V25, P66, DOI 10.1002/bies.10201; Chaturvedi P, 2008, FASEB J, V22, P966, DOI 10.1096/fj.07-9673rev; Chauhan SC, 2009, CANCER RES, V69, P765, DOI 10.1158/0008-5472.CAN-08-0587; Chen Y, 2004, AM J RESP CELL MOL, V30, P155, DOI 10.1165/rcmb.2003-0103OC; Desseyn JL, 2008, GENE, V410, P215, DOI 10.1016/j.gene.2007.12.014; Desseyn JL, 2009, MOL PHYLOGENET EVOL, V52, P284, DOI 10.1016/j.ympev.2009.03.035; Desseyn JL, 2002, EUR J BIOCHEM, V269, P3150, DOI 10.1046/j.1432-1033.2002.02988.x; Desseyn JL, 2000, MOL BIOL EVOL, V17, P1175, DOI 10.1093/oxfordjournals.molbev.a026400; Dezfuli BS, 2010, J FISH DIS, V33, P481, DOI 10.1111/j.1365-2761.2010.01146.x; Duraisamy S, 2006, GENE, V373, P28, DOI 10.1016/j.gene.2005.12.021; Dykstra NS, 2011, PEDIATR RES, V69, P206, DOI 10.1203/PDR.0b013e3182096ff0; Estensoro I, 2013, PARASITOL RES, V112, P567, DOI 10.1007/s00436-012-3168-3; Estensoro I, 2012, DIS AQUAT ORGAN, V100, P29, DOI 10.3354/dao02486; Estensoro I, 2011, VET PARASITOL, V175, P141, DOI 10.1016/j.vetpar.2010.09.015; Estensoro I, 2010, DIS AQUAT ORGAN, V92, P51, DOI 10.3354/dao02267; Fange R., 1979, FISH PHYSIOL, V7, P161, DOI DOI 10.1016/S1546-5098(08)60027-8; Fleurance R, 2008, DIS AQUAT ORGAN, V79, P219, DOI 10.3354/dao01832; FUJINO T, 1993, J HELMINTHOL, V67, P179, DOI 10.1017/S0022149X00013110; Gaudier E, 2004, AM J PHYSIOL-GASTR L, V287, pG1168, DOI 10.1152/ajpgi.00219.2004; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; Gheorghiu C, 2012, DIS AQUAT ORGAN, V98, P143, DOI 10.3354/dao02434; Harikrishnan R, 2011, FISH SHELLFISH IMMUN, V31, P310, DOI 10.1016/j.fsi.2011.05.020; Hino S, 2012, J NUTR, V142, P1429, DOI 10.3945/jn.112.159731; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; LAMBERT ME, 1979, BRIT MED J, V1, P857, DOI 10.1136/bmj.1.6167.857; Lang T, 2004, GLYCOBIOLOGY, V14, P521, DOI 10.1093/glycob/cwh066; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; Lee KD, 2010, J PARASITOL, V96, P58, DOI 10.1645/GE-2195.1; Lee SY, 2012, PHYTOTHER RES, V26, P1082, DOI 10.1002/ptr.3701; Li N, 2012, INT IMMUNOPHARMACOL, V14, P195, DOI 10.1016/j.intimp.2012.07.008; Lien KA, 2001, J ANIM FEED SCI, V10, P223; Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maher DM, 2011, MOL CANCER RES, V9, P531, DOI 10.1158/1541-7786.MCR-10-0443; Mahomed F, 2011, ORAL ONCOL, V47, P797, DOI 10.1016/j.oraloncology.2011.06.008; Martinez-Maqueda D, 2012, J AGR FOOD CHEM, V60, P8600, DOI 10.1021/jf301279k; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Menzies M, 2010, PARASITE IMMUNOL, V32, P36, DOI 10.1111/j.1365-3024.2009.01156.x; Micallef G, 2012, MAR BIOTECHNOL, V14, P559, DOI 10.1007/s10126-012-9447-2; Moncada DM, 2003, TRENDS PARASITOL, V19, P305, DOI 10.1016/S1471-4922(03)00122-3; Moniaux N, 2001, FRONT BIOSCI-LANDMRK, V6, pD1192, DOI 10.2741/Moniaux; Montero D, 2010, FISH SHELLFISH IMMUN, V29, P1073, DOI 10.1016/j.fsi.2010.08.024; Redondo MJ, 2010, PARASITOL INT, V59, P445, DOI 10.1016/j.parint.2010.06.005; Rinaldi M, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-61; Rothberg BEG, 2009, JNCI-J NATL CANCER I, V101, P452, DOI 10.1093/jnci/djp038; SACHDEV HPS, 1993, J PEDIATR GASTR NUTR, V16, P33, DOI 10.1097/00005176-199301000-00006; Sasaki M, 2007, PROG HISTOCHEM CYTO, V42, P61, DOI 10.1016/j.proghi.2007.02.001; Schroers V, 2009, AQUACULTURE, V288, P184, DOI 10.1016/j.aquaculture.2008.12.013; SERS C, 1993, P NATL ACAD SCI USA, V90, P8514, DOI 10.1073/pnas.90.18.8514; Sheng YH, 2012, J GASTROEN HEPATOL, V27, P28, DOI 10.1111/j.1440-1746.2011.06909.x; Sheng YH, 2011, GUT, V60, P1661, DOI 10.1136/gut.2011.239194; Shimamura T, 2005, CANCER SCI, V96, P265, DOI 10.1111/j.1349-7006.2005.00043.x; Sitja-Bobadilla A, 2005, AQUACULTURE, V249, P387, DOI 10.1016/j.aquaculture.2005.03.031; Sitja-Bobadilla A, 2008, FISH SHELLFISH IMMUN, V24, P610, DOI 10.1016/j.fsi.2008.01.014; Sitja-Bobadilla A, 2012, FISH PARASITES: PATHOBIOLOGY AND PROTECTION, P163, DOI 10.1079/9781845938062.0163; Skoog EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036378; Smith AG, 2011, BRIT J NUTR, V105, P669, DOI 10.1017/S0007114510004277; Soga K, 2008, PARASITOL RES, V103, P1427, DOI 10.1007/s00436-008-1152-8; STEINBERG SE, 1975, GASTROENTEROLOGY, V68, P309; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Theodoropoulos G, 2007, J CELL BIOCHEM, V102, P1103, DOI 10.1002/jcb.21539; Torrecillas S, 2011, AQUACULT NUTR, V17, P223, DOI 10.1111/j.1365-2095.2009.00730.x; Valque H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046699; van der Marel M, 2012, FISH SHELLFISH IMMUN, V32, P494, DOI 10.1016/j.fsi.2011.12.008; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Walsh MD, 2007, HUM PATHOL, V38, P883, DOI 10.1016/j.humpath.2006.11.020; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200; Yonezawa S, 2011, PATHOL INT, V61, P697, DOI 10.1111/j.1440-1827.2011.02734.x	79	75	77	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65457	10.1371/journal.pone.0065457	http://dx.doi.org/10.1371/journal.pone.0065457			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776483	Green Submitted, Green Published, gold			2022-12-25	WOS:000320322400027
J	Joyner-Matos, J; Hicks, KA; Cousins, D; Keller, M; Denver, DR; Baer, CF; Estes, S				Joyner-Matos, Joanna; Hicks, Kiley A.; Cousins, Dustin; Keller, Michelle; Denver, Dee R.; Baer, Charles F.; Estes, Suzanne			Evolution of a Higher Intracellular Oxidizing Environment in Caenorhabditis elegans under Relaxed Selection	PLOS ONE			English	Article							BASE-SUBSTITUTION MUTATION; OXIDATIVE DNA-DAMAGE; GENOME-WIDE VIEW; LIFE-SPAN; SOMATIC MOSAICISM; NATURAL VARIATION; PROTEIN CARBONYL; C-ELEGANS; ACCUMULATION; STRESS	We explored the relationship between relaxed selection, oxidative stress, and spontaneous mutation in a set of mutation-accumulation (MA) lines of the nematode Caenorhabditis elegans and in their common ancestor. We measured steady-state levels of free radicals and oxidatively damaged guanosine nucleosides in the somatic tissues of five MA lines for which nuclear genome base substitution and GC-TA transversion frequencies are known. The two markers of oxidative stress are highly correlated and are elevated in the MA lines relative to the ancestor; point estimates of the per-generation rate of mutational decay (DM) of these measures of oxidative stress are similar to those reported for fitness-related traits. Conversely, there is no significant relationship between either marker of oxidative stress and the per-generation frequencies of base substitution or GC-TA transversion. Although these results provide no direct evidence for a causative relationship between oxidative damage and base substitution mutations, to the extent that oxidative damage may be weakly mutagenic in the germline, the case for condition-dependent mutation is advanced.	[Joyner-Matos, Joanna; Cousins, Dustin; Keller, Michelle] Eastern Washington Univ, Dept Biol, Cheney, WA 99004 USA; [Hicks, Kiley A.; Estes, Suzanne] Portland State Univ, Dept Biol, Portland, OR 97207 USA; [Denver, Dee R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Denver, Dee R.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Baer, Charles F.] Univ Florida, Dept Biol, Gainesville, FL USA; [Baer, Charles F.] Univ Florida, Genet Inst, Gainesville, FL USA	Eastern Washington University; Portland State University; Oregon State University; Oregon State University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Joyner-Matos, J (corresponding author), Eastern Washington Univ, Dept Biol, Cheney, WA 99004 USA.	jmatos@ewu.edu		Joyner-Matos, Joanna/0000-0002-0289-5982	Eastern Washington University; National Institutes of Health [R01 GM072639, 5 R01 GM087628-02]; PSU Faculty Enhancement grant; American Heart Association [11PRE4880069]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087628, R01GM072639] Funding Source: NIH RePORTER	Eastern Washington University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PSU Faculty Enhancement grant; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by an Eastern Washington University Start Something Big Grant to JJM (http://sites.ewu.edu/foundation/resources/start-something-big-grant/); National Institutes of Health (http://www.nih.gov/) grant R01 GM072639 to CFB and DRD, National Institutes of Health grant 5 R01 GM087628-02 to DRD and SE; PSU Faculty Enhancement grant to SE (http://www.pdx.edu/oaa/faculty-enhancement-grants) and American Heart Association Predoctoral Fellowship 11PRE4880069 to KAH (http://my.americanheart. org/professional/Research/FundingOpportunities/Funding-Opportunities_UCM_316909_SubHomePage.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 1998, J GERONTOL A-BIOL, V53, pB240, DOI 10.1093/gerona/53A.4.B240; Agrawal AF, 2008, PLOS BIOL, V6, P389, DOI 10.1371/journal.pbio.0060030; Aitlhadj L, 2010, MECH AGEING DEV, V131, P364, DOI 10.1016/j.mad.2010.03.002; Arczewska KD, 2011, DNA REPAIR, V10, P176, DOI 10.1016/j.dnarep.2010.10.009; Baer CF, 2005, P NATL ACAD SCI USA, V102, P5785, DOI 10.1073/pnas.0406056102; Baer CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008750; Berquist BR, 2012, CANCER LETT, V327, P61, DOI 10.1016/j.canlet.2012.02.001; Busuttil RA, 2005, CANCER RES, V65, P11271, DOI 10.1158/0008-5472.CAN-05-2980; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Busuttil RA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000876; Cardoso AR, 2012, FREE RADICAL BIO MED, V52, P2201, DOI 10.1016/j.freeradbiomed.2012.03.008; CHENG KC, 1992, J BIOL CHEM, V267, P166; Cooke MS, 2007, P NATL ACAD SCI USA, V104, P13535, DOI 10.1073/pnas.0706878104; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; DARR D, 1995, FREE RADICAL BIO MED, V18, P195, DOI 10.1016/0891-5849(94)00118-4; Davies SK, 2012, MECH AGEING DEV, V133, P46, DOI 10.1016/j.mad.2011.11.002; Delsite RL, 2003, MUTAGENESIS, V18, P497, DOI 10.1093/mutage/geg027; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Denver DR, 2006, GENETICS, V174, P57, DOI 10.1534/genetics.106.059840; Denver DR, 2012, GENOME BIOL EVOL, V4, P513, DOI 10.1093/gbe/evs028; Denver DR, 2009, P NATL ACAD SCI USA, V106, P16310, DOI 10.1073/pnas.0904895106; Denver DR, 2005, GENETICS, V170, P107, DOI 10.1534/genetics.104.038521; Denver DR, 2003, MOL BIOL EVOL, V20, P1603, DOI 10.1093/molbev/msg177; Dingley S, 2010, MITOCHONDRION, V10, P125, DOI 10.1016/j.mito.2009.11.003; Dolle MET, 2000, P NATL ACAD SCI USA, V97, P8403, DOI 10.1073/pnas.97.15.8403; Drake JW, 1998, GENETICS, V148, P1667; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Estes S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-11; Fortune MT, 2000, HUM MOL GENET, V9, P439, DOI 10.1093/hmg/9.3.439; GANDHI S, 1980, MECH AGEING DEV, V12, P137, DOI 10.1016/0047-6374(80)90090-1; Garcia AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000950; GILLE JJP, 1994, CARCINOGENESIS, V15, P2695, DOI 10.1093/carcin/15.12.2695; Halligan DL, 2009, ANNU REV ECOL EVOL S, V40, P151, DOI 10.1146/annurev.ecolsys.39.110707.173437; Halliwell B., 2007, FREE RADICALS BIOL M; Hartman P, 2004, MECH AGEING DEV, V125, P417, DOI 10.1016/j.mad.2004.02.007; Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288; Hicks KA, 2010, PLOS ONE, V7; Hicks KA, 2013, MITOCHONDRION, V13, P44, DOI 10.1016/j.mito.2012.12.006; Hill KA, 2005, ENVIRON MOL MUTAGEN, V45, P442, DOI 10.1002/em.20119; HSIE AW, 1986, P NATL ACAD SCI USA, V83, P9616, DOI 10.1073/pnas.83.24.9616; Ishii N, 2004, MECH AGEING DEV, V125, P41, DOI 10.1016/j.mad.2003.10.002; ISHII N, 1990, MUTAT RES, V237, P165, DOI 10.1016/0921-8734(90)90022-J; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; ISHIZAWA M, 1991, NUCLEIC ACIDS RES, V19, P5792, DOI 10.1093/nar/19.20.5792; Jeffreys AJ, 1997, HUM MOL GENET, V6, P129, DOI 10.1093/hmg/6.1.129; Keightley PD, 1997, P NATL ACAD SCI USA, V94, P3823, DOI 10.1073/pnas.94.8.3823; Kim SY, 2010, EVOLUTION, V64, P852, DOI 10.1111/j.1558-5646.2009.00862.x; KIMURA M, 1962, GENETICS, V47, P713; KONDRASHOV AS, 1994, P ROY SOC B-BIOL SCI, V258, P221, DOI 10.1098/rspb.1994.0166; Kondrashov FA, 2006, J THEOR BIOL, V240, P616, DOI 10.1016/j.jtbi.2005.10.020; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; Martorell L, 2000, EUR J HUM GENET, V8, P423, DOI 10.1038/sj.ejhg.5200478; Matsuba C, 2012, G3-GENES GENOM GENET, V2, P1497, DOI 10.1534/g3.112.003947; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Noguera JC, 2011, BIOL LETT IN PRESS; Paul C, 2013, NAT REV URO IN PRESS; Roerink SF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002800; Rowe LA, 2003, FREE RADIC BIOL MED, V45, P1167; Sharp NP, 2012, P NATL ACAD SCI USA, V109, P6142, DOI 10.1073/pnas.1118918109; Stiernagle T, 1999, PRACT APPROACH SER, V213, P51; Stoltzfus A, 2008, MUTAT RES-FUND MOL M, V644, P71, DOI 10.1016/j.mrfmmm.2008.05.003; TKESHELASHVILI LK, 1991, J BIOL CHEM, V266, P6401; Tudek B, 2003, J BIOCHEM MOL BIOL, V36, P12; Uehara Y, 2009, MUTAT RES-FUND MOL M, V670, P24, DOI 10.1016/j.mrfmmm.2009.06.018; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Yasuda K, 1999, J GERONTOL A-BIOL, V54, pB47, DOI 10.1093/gerona/54.2.B47; Yasuda K, 2006, MECH AGEING DEV, V127, P763, DOI 10.1016/j.mad.2006.07.002; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028	71	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65604	10.1371/journal.pone.0065604	http://dx.doi.org/10.1371/journal.pone.0065604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776511	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400048
J	Li, YQ; Qin, YG; Yang, N; Sun, YF; Yang, XL; Sun, RF; Wang, QM; Ling, Y				Li, Yongqiang; Qin, Yaoguo; Yang, Na; Sun, Yufeng; Yang, Xinling; Sun, Ranfeng; Wang, Qingmin; Ling, Yun			Studies on Insecticidal Activities and Action Mechanism of Novel Benzoylphenylurea Candidate NK-17	PLOS ONE			English	Article							SULFONYLUREA RECEPTOR; GROWTH-REGULATORS; INHIBITION; DESIGN; DIFLUBENZURON; BIOACTIVITY; PUPAE; MODE	Insecticidal activity of NK-17 was evaluated both in laboratory and in field. It was found that the toxicity of NK-17 against S. exigua was 1.93 times and 2.69 times those of hexaflumuron and chlorfluazuron respectively, and the toxicity of NK-17 against P. xylostella was 1.36 times and 1.90 times those of hexaflumuron and chlorfluazuron respectively, and the toxicity of NK-17 against M. separate was 18.24 times those of hexaflumuron in laboratory, and 5% NK-17 EC at 60 g a.i ha(-1) can control S. exigua and P. xylostella with the best control efficiency of about 89% and over 88% respectively in Changsha and Tianjin in field. The insecticidal mechanism of NK-17 was explored for the first time by utilizing the fluorescence polarization method. NK-17 could bind to sulfonylurea receptor (SUR) of B. germanica with stronger affinity comparing to diflubenzuron and glibenclamide, which suggested that NK-17 may also act on the site of SUR to inhibit the chitin synthesis in insect body and the result can well explain that NK-17 exhibited stronger toxicity against B. germanica than diflubenzuron and glibenclamide in vivo.	[Li, Yongqiang; Qin, Yaoguo; Sun, Yufeng; Yang, Xinling; Ling, Yun] China Agr Univ, Key Lab Pesticide Chem & Applicat, MOA, Dept Appl Chem,Coll Sci, Beijing 100094, Peoples R China; [Li, Yongqiang; Yang, Na; Sun, Ranfeng; Wang, Qingmin] Nankai Univ, Inst Elementoorgan Chem, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China	China Agricultural University; Nankai University	Wang, QM (corresponding author), Nankai Univ, Inst Elementoorgan Chem, State Key Lab Elementoorgan Chem, Tianjin 300071, Peoples R China.	wangqm@nankai.edu.cn; lyun@cau.edu.cn	Yang, xinling/HHC-1621-2022; Yang, Xinling/C-8289-2015		National Key Project for Basic Research [2010CB126100]; National Natural Science Foundation of China [21132003, 21102077, 21072109]; National 12th Five-year Key Technology RD Program [2011BAE06B08-04]	National Key Project for Basic Research(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 12th Five-year Key Technology RD Program	The authors greatly acknowledge financial support for this work from the National Key Project for Basic Research (2010CB126100) and the National Natural Science Foundation of China (21132003, 21102077, 21072109) and the National 12th Five-year Key Technology R&D Program (2011BAE06B08-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Elghar GE, 2004, INSECT BIOCHEM MOLEC, V34, P743, DOI 10.1016/j.ibmb.2004.03.009; [Anonymous], 1925, J ECON ENTOMOL; Burke MA, 2008, CIRC RES, V102, P164, DOI 10.1161/CIRCRESAHA.107.165324; Castellan NJ, 1988, NONPARAMETRIC STAT B; Chen L, 2005, J AGR FOOD CHEM, V53, P38, DOI 10.1021/jf048561n; Chen L, 2007, BIOORGAN MED CHEM, V15, P3678, DOI 10.1016/j.bmc.2007.03.049; Chen L, 2007, J AGR FOOD CHEM, V55, P2659, DOI 10.1021/jf063564g; COHEN E, 1980, PESTIC BIOCHEM PHYS, V13, P129, DOI 10.1016/0048-3575(80)90064-4; DELOACH JR, 1981, PESTIC BIOCHEM PHYS, V15, P172, DOI 10.1016/0048-3575(81)90083-3; FAO, 1979, FAO PLANT PROTECT B, V18, P6; Harris A, 2003, J BIOMOL SCREEN, V8, P410, DOI 10.1177/1087057103256319; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Matsumura F, 2010, PESTIC BIOCHEM PHYS, V97, P133, DOI 10.1016/j.pestbp.2009.10.001; MAYER RT, 1981, EXPERIENTIA, V37, P337, DOI 10.1007/BF01959848; MEOLA SM, 1980, SCIENCE, V207, P985, DOI 10.1126/science.207.4434.985; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Oberlander H, 1998, PESTIC SCI, V54, P300, DOI 10.1002/(SICI)1096-9063(1998110)54:3&lt;300::AID-PS830&gt;3.0.CO;2-8; POST LC, 1973, NATURWISSENSCHAFTEN, V60, P431, DOI 10.1007/BF00623561; Qian XH, 1999, J AGR FOOD CHEM, V47, P4415, DOI 10.1021/jf981174r; Qian XH, 2010, J AGR FOOD CHEM, V58, P2613, DOI 10.1021/jf904098w; Shang J, 2010, J AGR FOOD CHEM, V58, P1834, DOI 10.1021/jf903642s; Sun RF, 2011, J AGR FOOD CHEM, V59, P4851, DOI 10.1021/jf200395g; Sun RF, 2011, J AGR FOOD CHEM, V59, P2471, DOI 10.1021/jf104578j; Sun RF, 2009, J AGR FOOD CHEM, V57, P6356, DOI 10.1021/jf900882c; Sun RF, 2009, J AGR FOOD CHEM, V57, P3661, DOI 10.1021/jf900324a; Sun RF, 2008, J AGR FOOD CHEM, V56, P11376, DOI 10.1021/jf801901h; Sun YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032759; VANDAALEN JJ, 1972, NATURWISSENSCHAFTEN, V59, P312, DOI 10.1007/BF00593360; Xu XY, 2003, J FLUORINE CHEM, V121, P51, DOI 10.1016/S0022-1139(02)00330-5; Yang XL, 1998, PESTIC SCI, V52, P282, DOI 10.1002/(SICI)1096-9063(199803)52:3&lt;282::AID-PS723&gt;3.0.CO;2-J; Yoon C, 2008, J PESTIC SCI, V33, P44, DOI 10.1584/jpestics.G07-09; [No title captured]	32	13	14	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66251	10.1371/journal.pone.0066251	http://dx.doi.org/10.1371/journal.pone.0066251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776644	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400126
J	Marttila, S; Jylhava, J; Nevalainen, T; Nykter, M; Jylha, M; Hervonen, A; Tserel, L; Peterson, P; Hurme, M				Marttila, Saara; Jylhava, Juulia; Nevalainen, Tapio; Nykter, Matti; Jylha, Marja; Hervonen, Antti; Tserel, Liina; Peterson, Part; Hurme, Mikko			Transcriptional Analysis Reveals Gender-Specific Changes in the Aging of the Human Immune System	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; AGE; EXPRESSION	Aging and gender have a strong influence on the functional capacity of the immune system. In general, the immune response in females is stronger than that in males, but there is scant information about the effect of aging on the gender difference in the immune response. To address this question, we performed a transcriptomic analysis of peripheral blood mononuclear cells derived from elderly individuals (nonagenarians, n = 146) and young controls (aged 19-30 years, n = 30). When compared to young controls, we found 339 and 248 genes that were differentially expressed (p < 0.05, fold change >1.5 or <-1.5) in nonagenarian females and males, respectively, 180 of these genes were changed in both genders. An analysis of the affected signaling pathways revealed a clear gender bias: there were 48 pathways that were significantly changed in females, while only 29 were changed in males. There were 24 pathways that were shared between both genders. Our results indicate that female nonagenarians have weaker T cell defenses and a more prominent pro-inflammatory response as compared to males. In males significantly fewer pathways were affected, two of which are known to be regulated by estrogen. These data show that the effects of aging on the human immune system are significantly different in males and females.	[Marttila, Saara; Jylhava, Juulia; Nevalainen, Tapio; Hurme, Mikko] Univ Tampere, Sch Med, Dept Microbiol & Immunol, FIN-33101 Tampere, Finland; [Marttila, Saara; Jylhava, Juulia; Nevalainen, Tapio; Jylha, Marja; Hervonen, Antti; Hurme, Mikko] Gerontol Res Ctr, Tampere, Finland; [Nykter, Matti] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Jylha, Marja; Hervonen, Antti] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Tserel, Liina; Peterson, Part] Univ Tartu, EE-50090 Tartu, Estonia; [Hurme, Mikko] Tampere Univ Hosp, Ctr Lab Med, Tampere, Finland	Tampere University; Tampere University; Tampere University; University of Tartu; Tampere University; Tampere University Hospital	Marttila, S (corresponding author), Univ Tampere, Sch Med, Dept Microbiol & Immunol, FIN-33101 Tampere, Finland.	saara.marttila@uta.fi	Peterson, Pärt/A-5788-2009	Peterson, Pärt/0000-0001-6755-791X; Jylhava, Juulia/0000-0003-0250-4491; Hurme, Mikko/0000-0002-8614-1044; Nykter, Matti/0000-0001-6956-2843; Marttila, Saara/0000-0003-3071-3784; Nevalainen, Tapio/0000-0003-1141-9854	Academy of Finland [132704]; Competitive Research Fund of Pirkanmaa Hospital District [9M017, 9N013]; European Regional Development Fund; Archimedes Foundation; Centre for Translational Genomics of Tartu University; Estonian targeted grant [SF0180021s07]	Academy of Finland(Academy of Finland); Competitive Research Fund of Pirkanmaa Hospital District; European Regional Development Fund(European Commission); Archimedes Foundation; Centre for Translational Genomics of Tartu University; Estonian targeted grant	This work was financially supported by grants from the Academy of Finland (132704) (http://www.aka.fi/eng), the Competitive Research Fund of Pirkanmaa Hospital District (9M017 and 9N013) (http://www.pshp.fi/default.aspx?nodeid = 10066&contentlan = 2) (MH), European Regional Development Fund (http://www.communities.gov.uk/regeneration/regenerationfunding/europeanregionaldevelopment/), Archimedes Foundation (http://archimedes.ee/), Centre for Translational Genomics of Tartu University (http://www.ctg.ut.ee/) and Estonian targeted grant SF0180021s07 (LT, PP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademokun A, 2010, BIOGERONTOLOGY, V11, P125, DOI 10.1007/s10522-009-9256-9; Arnold CR, 2011, J CLIN IMMUNOL, V31, P137, DOI 10.1007/s10875-010-9499-x; Bianchi I, 2012, J AUTOIMMUN, V38, pJ187, DOI 10.1016/j.jaut.2011.11.012; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Brown DM, 2010, CELL IMMUNOL, V262, P89, DOI 10.1016/j.cellimm.2010.02.008; Cao JN, 2010, AGING CELL, V9, P19, DOI 10.1111/j.1474-9726.2009.00534.x; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dunning Mark J, 2008, BMC Res Notes, V1, P18, DOI 10.1186/1756-0500-1-18; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Gangemi S, 2005, MEDIAT INFLAMM, P245, DOI 10.1155/MI.2005.245; Goebeler S, 2003, AGING CLIN EXP RES, V15, P154; Graves BM, 2006, AM J HUM BIOL, V18, P161, DOI 10.1002/ajhb.20488; Harries LW, 2011, AGING CELL, V10, P868, DOI 10.1111/j.1474-9726.2011.00726.x; Hewagama A, 2009, GENES IMMUN, V10, P509, DOI 10.1038/gene.2009.12; Hong MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003024; Horstman AM, 2012, J GERONTOL A-BIOL, V67, P1140, DOI 10.1093/gerona/gls068; Jylhava J, 2010, BIOGERONTOLOGY, V11, P671, DOI 10.1007/s10522-010-9274-7; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Kuparinen T, 2013, EXP GERONTOL, V48, P305, DOI 10.1016/j.exger.2012.12.010; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; McClelland EE, 2011, ARCH IMMUNOL THER EX, V59, P203, DOI 10.1007/s00005-011-0124-3; Mengel-From J, 2012, EUR J HUM GENET, V20, P361, DOI 10.1038/ejhg.2011.215; Nunn CL, 2009, PHILOS T R SOC B, V364, P61, DOI 10.1098/rstb.2008.0148; Passtoors WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027759; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; Pawelec G, 2010, J COMP PATHOL, V141, pS39, DOI 10.1016/j.jcpa.2009.09.005; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Weigel MT, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3191; Zampieri M, 2010, MECH AGEING DEV, V131, P89, DOI 10.1016/j.mad.2009.12.005	32	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66229	10.1371/journal.pone.0066229	http://dx.doi.org/10.1371/journal.pone.0066229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776639	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400124
J	Neu, C; Sedlag, A; Bayer, C; Forster, S; Crauwels, P; Niess, JH; van Zandbergen, G; Frascaroli, G; Riedel, CU				Neu, Caroline; Sedlag, Anne; Bayer, Carina; Foerster, Sabine; Crauwels, Peter; Niess, Jan-Hendrik; van Zandbergen, Ger; Frascaroli, Giada; Riedel, Christian U.			CD14-Dependent Monocyte Isolation Enhances Phagocytosis of Listeria monocytogenes by Proinflammatory, GM-CSF-Derived Macrophages	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INTESTINAL MACROPHAGES; TYPE-2 MACROPHAGES; POLARIZATION; DIFFERENTIATION; CD14; CELLS; INFLAMMATION; EXPRESSION; INFECTION	Macrophages are an important line of defence against invading pathogens. Human macrophages derived by different methods were tested for their suitability as models to investigate Listeria monocytogenes (Lm) infection and compared to macrophage-like THP-1 cells. Human primary monocytes were isolated by either positive or negative immunomagnetic selection and differentiated in the presence of granulocyte macrophage colony-stimulating factor (GM-CSF) or macrophage colony-stimulating factor (M-CSF) into pro- or anti-inflammatory macrophages, respectively. Regardless of the isolation method, GM-CSF-derived macrophages (GM-M phi) stained positive for CD206 and M-CSF-derived macrophages (M-M phi) for CD163. THP-1 cells did not express CD206 or CD163 following incubation with PMA, M-or GM-CSF alone or in combination. Upon infection with Lm, all primary macrophages showed good survival at high multiplicities of infection whereas viability of THP-1 was severely reduced even at lower bacterial numbers. M-M phi generally showed high phagocytosis of Lm. Strikingly, phagocytosis of Lm by GM-M phi was markedly influenced by the method used for isolation of monocytes. GM-M phi derived from negatively isolated monocytes showed low phagocytosis of Lm whereas GM-M phi generated from positively selected monocytes displayed high phagocytosis of Lm. Moreover, incubation with CD14 antibody was sufficient to enhance phagocytosis of Lm by GM-M phi generated from negatively isolated monocytes. By contrast, non-specific phagocytosis of latex beads by GM-M phi was not influenced by treatment with CD14 antibody. Furthermore, phagocytosis of Lactococcus lactis, Escherichia coli, human cytomegalovirus and the protozoan parasite Leishmania major by GM-M phi was not enhanced upon treatment with CD14 antibody indicating that this effect is specific for Lm. Based on these observations, we propose macrophages derived by ex vivo differentiation of negatively selected human primary monocytes as the most suitable model to study Lm infection of macrophages.	[Neu, Caroline; Sedlag, Anne; Riedel, Christian U.] Univ Ulm, Inst Microbiol & Biotechnol, D-89069 Ulm, Germany; [Bayer, Carina; Frascaroli, Giada] Univ Med Ctr Ulm, Inst Virol, Ulm, Germany; [Foerster, Sabine; Crauwels, Peter; van Zandbergen, Ger] Fed Inst Vaccines & Biomed, Paul Ehrlich Inst, Div Immunol, Langen, Germany; [Niess, Jan-Hendrik] Inselspital Bern, Dept Visceral Med & Surg, CH-3010 Bern, Switzerland	Ulm University; Ulm University; Paul Ehrlich Institute; University of Bern; University Hospital of Bern	Riedel, CU (corresponding author), Univ Ulm, Inst Microbiol & Biotechnol, D-89069 Ulm, Germany.	christian.riedel@uni-ulm.de	Niess, Jan/E-8361-2017; van Zandbergen, Ger/M-1571-2013	Niess, Jan/0000-0001-6902-5650; Riedel, Christian U./0000-0001-7134-7085	Carl Zeiss Foundation in the "Programm zur 3 Starkung von Forschungsstrukturen an Universitaten	Carl Zeiss Foundation in the "Programm zur 3 Starkung von Forschungsstrukturen an Universitaten	This study was partially funded by a grant of the Carl Zeiss Foundation in the "Programm zur 3 Starkung von Forschungsstrukturen an Universitaten to GF, GvZ and CUR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akagawa KS, 2002, INT J HEMATOL, V76, P27, DOI 10.1007/BF02982715; Akashi-Takamura S, 2008, CURR OPIN IMMUNOL, V20, P420, DOI 10.1016/j.coi.2008.07.001; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alberti-Segui C, 2007, CELL MICROBIOL, V9, P179, DOI 10.1111/j.1462-5822.2006.00780.x; Bayer C, 2013, J VIROL, V87, P67, DOI 10.1128/JVI.01585-12; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Diget EA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/208412; Edelson BT, 2000, CURR OPIN IMMUNOL, V12, P425, DOI 10.1016/S0952-7915(00)00112-6; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; GRIFFIN JD, 1981, J CLIN INVEST, V68, P932, DOI 10.1172/JCI110348; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Hawley KL, 2012, P NATL ACAD SCI USA, V109, P1228, DOI 10.1073/pnas.1112078109; Janot L, 2008, J INFECT DIS, V198, P115, DOI 10.1086/588815; Jersmann HPA, 2005, IMMUNOL CELL BIOL, V83, P462, DOI 10.1111/j.1440-1711.2005.01370.x; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Misslitz A, 2000, MOL BIOCHEM PARASIT, V107, P251, DOI 10.1016/S0166-6851(00)00195-X; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; MUNN DH, 1995, J EXP MED, V181, P127, DOI 10.1084/jem.181.1.127; Nathan C, 2006, SCIENCE, V312, P1874; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Schenk M, 2007, SEMIN IMMUNOL, V19, P84, DOI 10.1016/j.smim.2006.09.002; Schneemann M, 2002, NAT IMMUNOL, V3, P102, DOI 10.1038/ni0202-102a; SETOGUCHI M, 1989, BIOCHIM BIOPHYS ACTA, V1008, P213, DOI 10.1016/0167-4781(80)90012-3; Sierra-Filardi E, 2011, BLOOD, V117, P5092, DOI 10.1182/blood-2010-09-306993; Smith PD, 2011, MUCOSAL IMMUNOL, V4, P31, DOI 10.1038/mi.2010.66; Smith PD, 2005, IMMUNOL REV, V206, P149, DOI 10.1111/j.0105-2896.2005.00288.x; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Trofimov S, 2004, EUR J ENDOCRINOL, V150, P305, DOI 10.1530/eje.0.1500305; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Wenzel UA, 2012, FASEB J, V26, P29, DOI 10.1096/fj.11-184895; Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090; Xu W, 2013, MOL IMMUNOL, V53, P179, DOI 10.1016/j.molimm.2012.07.005; Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662	44	32	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66898	10.1371/journal.pone.0066898	http://dx.doi.org/10.1371/journal.pone.0066898			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776701	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400156
J	Huq, NL; Seers, CA; Toh, ECY; Dashper, SG; Slakeski, N; Zhang, LY; Ward, BR; Meuric, V; Chen, D; Cross, KJ; Reynolds, EC				Huq, N. Laila; Seers, Christine A.; Toh, Elena C. Y.; Dashper, Stuart G.; Slakeski, Nada; Zhang, Lianyi; Ward, Brent R.; Meuric, Vincent; Chen, Dina; Cross, Keith J.; Reynolds, Eric C.			Propeptide-Mediated Inhibition of Cognate Gingipain Proteinases	PLOS ONE			English	Article							C-TERMINAL-DOMAIN; PORPHYROMONAS-GINGIVALIS; CYSTEINE PROTEINASE; ACTIVE-SITE; PERIODONTAL-DISEASE; ARG-GINGIPAIN; ARGININE; PROTEASES; RGPB; IDENTIFICATION	Porphyromonas gingivalis is a major pathogen associated with chronic periodontitis. The organism's cell-surface cysteine proteinases, the Arg-specific proteinases (RgpA, RgpB) and the Lys-specific proteinase (Kgp), which are known as gingipains have been implicated as major virulence factors. All three gingipain precursors contain a propeptide of around 200 amino acids in length that is removed during maturation. The aim of this study was to characterize the inhibitory potential of the Kgp and RgpB propeptides against the mature cognate enzymes. Mature Kgp was obtained from P. gingivalis mutant ECR368, which produces a recombinant Kgp with an ABM1 motif deleted from the catalytic domain (rKgp) that enables the otherwise membrane bound enzyme to dissociate from adhesins and be released. Mature RgpB was obtained from P. gingivalis HG66. Recombinant propeptides of Kgp and RgpB were produced in Escherichia coli and purified using nickel-affinity chromatography. The Kgp and RgpB propeptides displayed non-competitive inhibition kinetics with K-i values of 2.04 mu M and 12 nM, respectively. Both propeptides exhibited selectivity towards their cognate proteinase. The specificity of both propeptides was demonstrated by their inability to inhibit caspase-3, a closely related cysteine protease, and papain that also has a relatively long propeptide. Both propeptides at 100 mg/L caused a 50% reduction of P. gingivalis growth in a protein-based medium. In summary, this study demonstrates that gingipain propeptides are capable of inhibiting their mature cognate proteinases.	[Huq, N. Laila; Seers, Christine A.; Toh, Elena C. Y.; Dashper, Stuart G.; Slakeski, Nada; Zhang, Lianyi; Ward, Brent R.; Meuric, Vincent; Chen, Dina; Cross, Keith J.; Reynolds, Eric C.] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Melbourne, Vic 3010, Australia	University of Melbourne	Reynolds, EC (corresponding author), Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Melbourne, Vic 3010, Australia.	e.reynolds@unimelb.edu.au	Zhang, Lianyi/H-7491-2014; Cross, Keith J/N-4602-2013; Meuric, Vincent/AAW-7709-2020; Huq, Laila/A-2861-2012	Meuric, Vincent/0000-0001-5411-4001; Huq, Laila/0000-0001-7788-4797; Dashper, Stuart/0000-0003-0106-8691; Slakeski, Nada/0000-0001-9776-6018; Reynolds, Eric/0000-0002-6618-4856; Seers, Christine/0000-0002-7777-443X; Rahma, Indah/0000-0002-6855-1146	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian National Health and Medical Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ally N, 2003, BIOCHEMISTRY-US, V42, P11693, DOI 10.1021/bi0349726; Aravind L, 2002, PROTEINS, V46, P355, DOI 10.1002/prot.10060; Bhogal PS, 1997, MICROBIOL-SGM, V143, P2485, DOI 10.1099/00221287-143-7-2485; Blat Y, 2010, CHEM BIOL DRUG DES, V75, P535, DOI 10.1111/j.1747-0285.2010.00972.x; Chen JM, 1998, FEBS LETT, V441, P361, DOI 10.1016/S0014-5793(98)01574-9; Cruz LJ, 2010, J CONTROL RELEASE, V144, P118, DOI 10.1016/j.jconrel.2010.02.013; Curtis MA, 1999, J PERIODONTAL RES, V34, P464, DOI 10.1111/j.1600-0765.1999.tb02282.x; Dasanayake AP, 2008, MCN-AM J MATERN-CHIL, V33, P45, DOI 10.1097/01.NMC.0000305657.24613.47; Dashper SG, 2012, ANTIMICROB AGENTS CH, V56, P1548, DOI 10.1128/AAC.05100-11; Dashper SG, 2009, J BACTERIOL, V191, P1044, DOI 10.1128/JB.01270-08; de Diego I, 2013, J BIOL CHEM; Demidyuk Ilya V, 2010, Biomol Concepts, V1, P305, DOI 10.1515/bmc.2010.025; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; Fowler J, 1997, PRACTICAL STAT FIELD; Grenier D, 2003, INFECT IMMUN, V71, P4742, DOI 10.1128/IAI.71.8.4742-4748.2003; Grenier D, 2001, INFECT IMMUN, V69, P5166, DOI 10.1128/IAI.69.8.5166-5172.2001; Guay J, 2000, EUR J BIOCHEM, V267, P6311, DOI 10.1046/j.1432-1327.2000.01730.x; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Hondoh T, 2006, PROTEIN SCI, V15, P871, DOI 10.1110/ps.051880406; Hujoel PP, 2003, ANN EPIDEMIOL, V13, P312, DOI 10.1016/S1047-2797(02)00425-8; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Jackson CA, 2000, FEMS MICROBIOL LETT, V186, P133, DOI 10.1111/j.1574-6968.2000.tb09094.x; Kadowaki T, 2007, FRONT BIOSCI-LANDMRK, V12, P4800, DOI 10.2741/2428; Kamer AR, 2008, ALZHEIMERS DEMENT, V4, P242, DOI 10.1016/j.jalz.2007.08.004; Kato D, 2005, NAT CHEM BIOL, V1, P33, DOI 10.1038/nchembio707; Kontani M, 1999, INFECT IMMUN, V67, P4917, DOI 10.1128/IAI.67.9.4917-4920.1999; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Mikolajczyk J, 2003, J BIOL CHEM, V278, P10458, DOI 10.1074/jbc.M210564200; Mikolajczyk-Pawlinska J, 1998, BIOL CHEM, V379, P205, DOI 10.1515/bchm.1998.379.2.205; Nakayama K, 1996, J BACTERIOL, V178, P2818, DOI 10.1128/jb.178.10.2818-2824.1996; O'Brien-Simpson NM, 2005, J IMMUNOL, V175, P3980, DOI 10.4049/jimmunol.175.6.3980; O'Brien-Simpson NM, 2003, CURR PROTEIN PEPT SC, V4, P409, DOI 10.2174/1389203033487009; Oda H, 2007, J PERIODONTAL RES, V42, P438, DOI 10.1111/j.1600-0765.2006.00966.x; Pathirana RD, 2007, INFECT IMMUN, V75; PIKE R, 1994, J BIOL CHEM, V269, P406; Rangarajan M, 1997, BIOCHEM J, V323, P701, DOI 10.1042/bj3230701; Rawlings ND, 2004, NUCLEIC ACIDS RES, V32, pD160, DOI 10.1093/nar/gkp971; Renvert S, 2003, ORAL HLTH PREV DE S1, V1, P358; Renvert Stefan, 2003, Oral Health Prev Dent, V1 Suppl 1, P341; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Seers CA, 2006, J BACTERIOL, V188, P6376, DOI 10.1128/JB.00731-06; Sheets SM, 2006, INFECT IMMUN, V74, P5667, DOI 10.1128/IAI.01140-05; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Shi Y, 1999, J BIOL CHEM, V274, P17955, DOI 10.1074/jbc.274.25.17955; Shi Y, 2000, J BIOL CHEM, V275, P30002, DOI 10.1074/jbc.M001518200; Slakeski N, 1998, MICROBIOL-UK, V144, P1583, DOI 10.1099/00221287-144-6-1583; Slakeski N, 1999, ORAL MICROBIOL IMMUN, V14, P92, DOI 10.1034/j.1399-302X.1999.140203.x; Slakeski N, 2011, J BACTERIOL, V193, P132, DOI 10.1128/JB.00773-10; Sztukowska M, 2012, BIOL CHEM, V393, P971, DOI 10.1515/hsz-2012-0175; Toh ECY, 2011, ANTIMICROB AGENTS CH, V55, P1155, DOI 10.1128/AAC.00466-10; Tripos, 2011, SYBYL X 1 2; Wiederanders B, 2003, CURR PROTEIN PEPT SC, V4, P309, DOI 10.2174/1389203033487081; Wilkens M, 2002, J BIOL CHEM, V277, P9366, DOI 10.1074/jbc.M110848200; Yoshioka M, 2003, CURR MICROBIOL, V47, P1, DOI 10.1007/s00284-002-3916-1; Zar J. H., 2009, BIOSTATISTICAL ANAL	58	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65447	10.1371/journal.pone.0065447	http://dx.doi.org/10.1371/journal.pone.0065447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762374	Green Published, gold			2022-12-25	WOS:000320440500040
J	Sun, LC; Ye, YT; Sun, HB; Yu, J; Zhang, L; Sun, Y; Zhang, DH; Ma, L; Shen, B; Zhu, CL				Sun, Linchun; Ye, Yuting; Sun, Haibo; Yu, Jing; Zhang, Li; Sun, Yan; Zhang, Donghui; Ma, Lei; Shen, Bo; Zhu, Changliang			Identification of Proteasome Subunit Beta Type 6 (PSMB6) Associated with Deltamethrin Resistance in Mosquitoes by Proteomic and Bioassay Analyses	PLOS ONE			English	Article							UBIQUITIN-SPECIFIC PROTEASE; INSECTICIDE RESISTANCE; ANOPHELES-GAMBIAE; EXPRESSION; INHIBITORS; GENES; DEGRADATION; PROTEINS; CLONING; ROLES	Deltamethrin (DM) insecticides are currently being promoted worldwide for mosquito control, because of the high efficacy, low mammalian toxicity and less environmental impact. Widespread and improper use of insecticides induced resistance, which has become a major obstacle for the insect-borne disease management. Resistance development is a complex and dynamic process involving many genes. To better understand the possible molecular mechanisms involved in DM resistance, a proteomic approach was employed for screening of differentially expressed proteins in DM-susceptible and resistant mosquito cells. Twenty-seven differentially expressed proteins were identified by two-dimensional electrophoresis (2-DE) and mass spectrometry (MS). Four members of the ubiquitin-proteasome system were significantly elevated in DM-resistant cells, suggesting that the ubiquitin-proteasome pathway may play an important role in DM resistance. Proteasome subunit beta type 6 (PSMB6) is a member of 20S proteasomal subunit family, which forms the proteolytic core of 26S proteasome. We used pharmaceutical inhibitor and molecular approaches to study the contributions of PSMB6 in DM resistance: the proteasome inhibitor MG-132 and bortezomib were used to suppress the proteasomal activity and siRNA was designed to block the function of PSMB6. The results revealed that both MG-132 and bortezomib increased the susceptibility in DM-resistant cells and resistance larvae. Moreover, PSMB6 knockdown decreased cellular viability under DM treatment. Taken together, our study indicated that PSMB6 is associated with DM resistance in mosquitoes and that proteasome inhibitors such as MG-132 or bortezomib are suitable for use as a DM synergist for vector control.	[Sun, Linchun; Ye, Yuting; Sun, Haibo; Yu, Jing; Zhang, Li; Sun, Yan; Zhang, Donghui; Ma, Lei; Shen, Bo; Zhu, Changliang] Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Sun, Linchun] Nanjing Med Univ, Nanjing Childrens Hosp, Pediat Res Ctr, Nanjing, Jiangsu, Peoples R China; [Zhang, Li] Jiangsu Prov Hosp Integrat Chinese & Western Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing University of Chinese Medicine	Zhu, CL (corresponding author), Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China.	shenbo@njmu.edu.cn; clzhu@njmu.edu.cn	Sun, Haibo/R-1518-2016	Sun, Haibo/0000-0003-3635-7557	National Institutes of Health of US [2R01AI075746-05]; National Science and Technology Major Project of China [2008ZX10004-010]; National Natural Science Foundation of China [30972564, 30901244, 801101279, 81171900]; Natural Science Foundation of Jiangsu province [BK2011768]; Research Fund for the Doctoral Program of Higher Education of China [20113234120007]; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075746] Funding Source: NIH RePORTER	National Institutes of Health of US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science and Technology Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health of US (2R01AI075746-05), National Science and Technology Major Project of China (No. 2008ZX10004-010), National Natural Science Foundation of China (No. 30972564, No. 30901244, No. 801101279 and No. 81171900), Natural Science Foundation of Jiangsu province (No. BK2011768), Research Fund for the Doctoral Program of Higher Education of China (No. 20113234120007), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, World Health Organ Tech Rep Ser, V818, P1; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Boonyuan W, 2011, J VECTOR ECOL, V36, P361, DOI 10.1111/j.1948-7134.2011.00177.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butler D, 2007, NATURE, V450, P144, DOI 10.1038/450144b; Cardozo C, 2002, ARCH BIOCHEM BIOPHYS, V408, P103, DOI 10.1016/S0003-9861(02)00493-9; Casimiro S, 2006, J MED ENTOMOL, V43, P276, DOI 10.1603/0022-2585(2006)043[0276:IRIAAA]2.0.CO;2; Chauhan D, 2004, ONCOGENE, V23, P3597, DOI 10.1038/sj.onc.1207458; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Denholm I, 2002, SCIENCE, V297, P2222, DOI 10.1126/science.1077266; Geng FQ, 2012, P NATL ACAD SCI USA, V109, P6060, DOI 10.1073/pnas.1200854109; Gilchrist CA, 1997, J BIOL CHEM, V272, P32280, DOI 10.1074/jbc.272.51.32280; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Jager S, 1999, J MOL BIOL, V291, P997, DOI 10.1006/jmbi.1999.2995; Kim HM, 2011, BBA-GENE REGUL MECH, V1809, P67, DOI 10.1016/j.bbagrm.2010.08.008; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Liu NN, 2007, GENE, V394, P61, DOI 10.1016/j.gene.2007.01.032; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Ma MY, 2008, J PROTEOME RES, V7, P4821, DOI 10.1021/pr800392s; Mahande AM, 2012, J GLOB INFECT DIS, V4, P114, DOI 10.4103/0974-777X.96776; Munkacsy G, 2010, BRIT J CANCER, V102, P361, DOI 10.1038/sj.bjc.6605478; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Roberts DR, 1998, T ROY SOC TROP MED H, V92, P687, DOI 10.1016/S0035-9203(98)90816-1; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Smith L, 2007, ONCOL RES, V16, P497, DOI 10.3727/096504007783438358; Smith L, 2007, EUR J CANCER, V43, P2330, DOI 10.1016/j.ejca.2007.07.023; Spataro V, 1997, J BIOL CHEM, V272, P30470, DOI 10.1074/jbc.272.48.30470; Stitzel ML, 2001, GENE DEV, V15, P128, DOI 10.1101/gad.863801; Takeuchi J, 1997, Tanpakushitsu Kakusan Koso, V42, P2247; TOBIAS JW, 1991, J BIOL CHEM, V266, P12021; Vais H, 2001, PEST MANAG SCI, V57, P877, DOI 10.1002/ps.392; Verbrugge SE, 2012, J PHARMACOL EXP THER, V341, P174, DOI 10.1124/jpet.111.187542; Walters KJ, 2003, P NATL ACAD SCI USA, V100, P12694, DOI 10.1073/pnas.1634989100; Wilding CS, 2012, INSECT BIOCHEM MOLEC, V42, P699, DOI 10.1016/j.ibmb.2012.06.003; Wu HW, 2004, PESTIC BIOCHEM PHYS, V79, P75, DOI 10.1016/j.pestbp.2004.04.004; Wu J, 2009, CHEM RES TOXICOL, V22, P668, DOI 10.1021/tx800406z; Wu X, 2011, MOL BIOL REP, V38, P5465, DOI 10.1007/s11033-011-0866-3; Zhu YF, 2006, J PROTEOME RES, V5, P2217, DOI 10.1021/pr0600733; Zimmermann J, 2001, J BIOL CHEM, V276, P10759, DOI 10.1074/jbc.M008567200	48	11	13	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65859	10.1371/journal.pone.0065859	http://dx.doi.org/10.1371/journal.pone.0065859			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762443	Green Published, Green Submitted, gold			2022-12-25	WOS:000320440500054
J	Pajak, A; Szafraniec, K; Kubinova, R; Malyutina, S; Peasey, A; Pikhart, H; Nikitin, Y; Marmot, M; Bobak, M				Pajak, Andrzej; Szafraniec, Krystyna; Kubinova, Ruzena; Malyutina, Sofia; Peasey, Anne; Pikhart, Hynek; Nikitin, Yuri; Marmot, Michael; Bobak, Martin			Binge Drinking and Blood Pressure: Cross-Sectional Results of the HAPIEE Study	PLOS ONE			English	Article							REPORTED ALCOHOL-CONSUMPTION; CARDIOVASCULAR-DISEASE; HEART-DISEASE; EASTERN-EUROPE; RISK; HYPERTENSION; PATTERN; ASSOCIATION; SAMPLE; POPULATION	Objectives: To investigate whether binge drinking pattern influences blood pressure independently from drinking volume or whether it modifies the effect of volume of drinking. Methods: We used cross-sectional data from population samples of 7559 men and 7471 women aged 45-69 years in 2002-05, not on antihypertensive medication, from Russia, Poland and Czech Republic. Annual alcohol intake, drinking frequency and binge drinking (>= 100 g in men and >= 60 g in women in one session at least once a month) were estimated from graduated frequency questionnaire. Blood pressure was analysed as continuous variables (systolic and diastolic pressure) and a binary outcome (>= 140/90 mm Hg). Results: In men, annual alcohol intake and drinking frequency were strongly associated with blood pressure. The odds ratio of high blood pressure for binge drinking in men was 1.62 (95% CI 1.45-1.82) after controlling for age, country, body mass index, education and smoking; additional adjustment for annual alcohol intake reduced it to 1.20 (1.03-1.39). In women, the fully adjusted odds ratio of high blood pressure for binge drinking was 1.31 (1.05-1.63). Binge drinking did not modify the effect of annual alcohol intake. Consuming alcohol as wine, beer or spirits had similar effects. Conclusions: The results suggest that the independent long-term effect of binge drinking was modest, that binge drinking did not modify the effect of alcohol intake, and that different alcoholic beverages had similar effects on blood pressure	[Pajak, Andrzej; Szafraniec, Krystyna] Jagiellonian Univ, Coll Med, Inst Publ Hlth, Krakow, Poland; [Kubinova, Ruzena] Natl Inst Publ Hlth, Ctr Hlth Monitoring, Prague, Czech Republic; [Malyutina, Sofia; Nikitin, Yuri] Russian Acad Med Sci, Siberian Branch, Inst Internal Med, Novosibirsk, Russia; [Peasey, Anne; Pikhart, Hynek; Marmot, Michael; Bobak, Martin] UCL, Dept Epidemiol & Publ Hlth, London, England	Jagiellonian University; Collegium Medicum Jagiellonian University; National Institute of Public Health (SZU) - Czech Republic; Russian Academy of Medical Sciences; Russian Academy of Sciences; University of London; University College London	Bobak, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	m.bobak@ucl.ac.uk	Pikhart, Hynek/E-3074-2010; Nikitin, Yuri/D-2774-2018; Marmot, M G/Y-3920-2019; Malyutina, Sofia/J-1651-2018	Pikhart, Hynek/0000-0001-5277-4049; Nikitin, Yuri/0000-0002-3932-2299; Marmot, M G/0000-0002-2431-6419; Malyutina, Sofia/0000-0001-6539-0466; Bobak, Martin/0000-0002-2633-6851; Peasey, Anne/0000-0001-7434-2079	Wellcome Trust [064947/Z, 081081/Z]; US National Institute of Aging [1R01 AG23522]; MacArthur Foundation; ESRC [ES/F02679X/1] Funding Source: UKRI; MRC [G1000616, G0701830, G0601647, G0902037] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [R01AG023522] Funding Source: NIH RePORTER; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Economic and Social Research Council [ES/F02679X/1] Funding Source: researchfish; Medical Research Council [G0100222, G19/35, G0601647, G0902037, G8802774, G1000616, G0701830] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); US National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MacArthur Foundation; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by grants from the Wellcome Trust (064947/Z, 081081/Z), the US National Institute of Aging (1R01 AG23522) and the MacArthur Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson JL, 2010, AM J HYPERTENS, V23, P994, DOI 10.1038/ajh.2010.109; Bobak M, 2004, J EPIDEMIOL COMMUN H, V58, P238, DOI 10.1136/jech.2003.011825; Bobak M, 1999, ADDICTION, V94, P857, DOI 10.1046/j.1360-0443.1999.9468579.x; Britton A, 2000, J EPIDEMIOL COMMUN H, V54, P328, DOI 10.1136/jech.54.5.328; Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052; CLARK LT, 1985, ALCOHOL CLIN EXP RES, V9, P125, DOI 10.1111/j.1530-0277.1985.tb05533.x; CRIQUI MH, 1982, PREV MED, V11, P391, DOI 10.1016/0091-7435(82)90043-3; Djousse L, 2009, REV ESP CARDIOL, V62, P603, DOI 10.1016/S0300-8932(09)71326-0; Fuchs FD, 2001, HYPERTENSION, V37, P1242, DOI 10.1161/01.HYP.37.5.1242; Husemoen LLN, 2008, ALCOHOL CLIN EXP RES, V32, P1984, DOI 10.1111/j.1530-0277.2008.00780.x; Klatsky AL, 2006, J STUD ALCOHOL, V67, P421, DOI 10.15288/jsa.2006.67.421; Laatikainen T, 2002, ALCOHOL ALCOHOLISM, V37, P282, DOI 10.1093/alcalc/37.3.282; MARMOT MG, 1994, BRIT MED J, V308, P1263, DOI 10.1136/bmj.308.6939.1263; Marques-Vidal P, 2001, HYPERTENSION, V38, P1361, DOI 10.1161/hy1101.095328; McKee M, 1998, J ROY SOC MED, V91, P402, DOI 10.1177/014107689809100802; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; NIKITIN YP, 2010, KARDIOLOGIYA, V48, P4; Nunez-Cordoba JM, 2009, REV ESP CARDIOL, V62, P633, DOI 10.1016/S0300-8932(09)71330-2; Peasey A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-255; PHILLIPS AN, 1991, J CLIN EPIDEMIOL, V44, P1223, DOI 10.1016/0895-4356(91)90155-3; Pomerleau J, 2008, ALCOHOL ALCOHOLISM, V43, P351, DOI 10.1093/alcalc/agm167; Puddey IB, 1999, ADDICTION, V94, P649, DOI 10.1046/j.1360-0443.1999.9456493.x; Rakic V, 1998, J HYPERTENS, V16, P165, DOI 10.1097/00004872-199816020-00006; Rehm J, 1998, ALCOHOL CLIN EXP RES, V22, p4S, DOI 10.1111/j.1530-0277.1998.tb04368.x; Rehm J, 2001, EUR ADDICT RES, V7, P138, DOI 10.1159/000050731; Rehm J, 2007, INT J EPIDEMIOL, V36, P458, DOI 10.1093/ije/dyl294; Roerecke M, 2010, AM J EPIDEMIOL, V171, P633, DOI 10.1093/aje/kwp451; Seppa K, 1999, HYPERTENSION, V33, P79, DOI 10.1161/01.HYP.33.1.79; SEPPA K, 1994, AM J HYPERTENS, V7, P249, DOI 10.1093/ajh/7.3.249; Sesso HD, 2008, HYPERTENSION, V51, P1080, DOI 10.1161/HYPERTENSIONAHA.107.104968; Sieri S, 2002, PUBLIC HEALTH NUTR, V5, P1287, DOI 10.1079/PHN2002405; Single E., 1998, DRINKING PATTERNS TH, P7; Steffens AA, 2006, J HYPERTENS, V24, P1489, DOI 10.1097/01.hjh.0000239282.27938.0f; Stranges S, 2004, HYPERTENSION, V44, P813, DOI 10.1161/01.HYP.0000146537.03103.f2; Sundell L, 2008, STROKE, V39, P3179, DOI 10.1161/STROKEAHA.108.520817; TREVISAN M, 1987, INT J EPIDEMIOL, V16, P520, DOI 10.1093/ije/16.4.520; Wakabayashi I, 2008, AM J HYPERTENS, V21, P1310, DOI 10.1038/ajh.2008.299; WANNAMETHEE G, 1991, J HUM HYPERTENS, V5, P59; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424	39	25	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65856	10.1371/journal.pone.0065856	http://dx.doi.org/10.1371/journal.pone.0065856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173QU	23762441	Green Published, gold			2022-12-25	WOS:000321094800080
J	Topping, CJ; Odderskaer, P; Kahlert, J				Topping, Christopher J.; Odderskaer, Peter; Kahlert, Johnny			Modelling Skylarks (Alauda arvensis) to Predict Impacts of Changes in Land Management and Policy: Development and Testing of an Agent-Based Model	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; FARMLAND BIRDS; RISK-ASSESSMENT; POPULATIONS; FRAGMENTATION; DIVERSITY; ABUNDANCE	Agent-based simulation models provide a viable approach for developing applied models of species and systems for predictive management. However, there has been some reluctance to use these models for policy applications due to complexity and the need for improved testing and communication of the models. We present the development and testing of a comprehensive model for Skylark (Alauda arvensis) in Danish agricultural landscapes. The model is part of the ALMaSS system, which considers not only individual skylarks, but also the detailed dynamic environment from which they obtain the information necessary to simulate their behaviour. Population responses emerge from individuals interacting with each other and the environment. Model development and testing was carried out using pattern-oriented modelling. The testing procedure was based on the model's ability to represent detailed real world patterns of distribution and density, reproductive performance and seasonal changes in territory numbers. Data to support this was collected over a 13-year period and comprised detailed field observations of breeding birds and intensive surveys. The model was able to recreate the real world data patterns accurately; it was also able to simultaneously fit a number of other secondary system properties which were not formally a part of the testing procedure. The correspondence of model output to real world data and sensitivity analysis are presented and discussed, and the model's description is provided in ODdox format (a formal description inter-linked to the program code). Detailed and stringent tests for model performance were carried out, and standardised model description and open access to the source code were provided to open development of the skylark model to others. Over and above documenting the utility of the model, this open process is essential to engender the user trust and ensure continued development of these comprehensive systems for applied purposes.	[Topping, Christopher J.; Odderskaer, Peter; Kahlert, Johnny] Univ Aarhus, Dept Biosci, Ronde, Denmark	Aarhus University	Topping, CJ (corresponding author), Univ Aarhus, Dept Biosci, Ronde, Denmark.	cjt@dmu.dk	Topping, Christopher J/A-9167-2009	Topping, Christopher J/0000-0003-0874-7603; Topping, Christopher/0000-0003-2304-1916	'ARLAS' project under the Danish research program 'Jordbrugeren som landskabsforvalter'; Danish Environmental Agency; Danish Nature Agency	'ARLAS' project under the Danish research program 'Jordbrugeren som landskabsforvalter'; Danish Environmental Agency; Danish Nature Agency	This work was supported by the 'ARLAS' project under the Danish research program 'Jordbrugeren som landskabsforvalter' (1998-2000), by the Danish Environmental Agency (1990-1997, 2003-2005) and by the Danish Nature Agency (2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian L, 2000, J ENVIRON MANAGE, V59, P235, DOI 10.1006/jema.2000.0374; Butler SJ, 2007, SCIENCE, V315, P381, DOI 10.1126/science.1136607; Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; Dalgaard T., 2002, GEOGR J, V3, P29; Dalkvist T, 2009, ECOTOX ENVIRON SAFE, V72, P1663, DOI 10.1016/j.ecoenv.2008.10.002; Dietterich T, 1995, ACM COMPUT SURV, V27, P326, DOI 10.1145/212094.212114; Drent R., 1975, AVIAN BIOL, P333; European_Communities,, 2007, 0062007 EUR COMM; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2012, PHILOS T R SOC B, V367, P298, DOI 10.1098/rstb.2011.0180; Hendrichsen Ditte K., 2009, BMC Ecology, V9, P10, DOI 10.1186/1472-6785-9-10; Holling CrawfordS., 1978, ADAPTIVE ENV ASSESSM; Jepsen JU, 2005, AGR ECOSYST ENVIRON, V105, P581, DOI 10.1016/j.agee.2004.08.007; Jepsen JU, 2004, CAN J ZOOL, V82, P1528, DOI 10.1139/Z04-131; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Lenth R., 2019, Journal of Statistical Software, V60, P1; Lorek H, 1998, ECOL MODEL, V108, P77, DOI 10.1016/S0304-3800(98)00020-9; McCarthy MA, 2007, CONSERV BIOL, V21, P956, DOI 10.1111/j.1523-1739.2007.00677.x; Odderskaer P, 1997, AGR ECOSYST ENVIRON, V62, P21, DOI 10.1016/S0167-8809(96)01113-9; Odderskaer P, 2006, 105 BEK MIDD, P127; Odderskar P., 1997, BEKAEMPELSESMIDDELFO, V32; Parry HR, 2013, ENVIRON MODELL SOFTW, V45, P104, DOI 10.1016/j.envsoft.2012.08.006; Siriwardena GM, 1998, J APPL ECOL, V35, P24, DOI 10.1046/j.1365-2664.1998.00275.x; Smith Graham C., 2009, P53, DOI 10.1007/978-4-431-77134-0_4; Thorbek P, 2005, BIOCONTROL, V50, P1, DOI 10.1007/s10526-004-1114-8; Topping C, 2003, ANN ZOOL FENN, V40, P255; Topping C, 2005, VEGETATION GROWTH SI; Topping C, 2012, RELATIONSHIPS INSECT; Topping CJ, 2012, HUM ECOL RISK ASSESS, V18, P168, DOI 10.1080/10807039.2012.632292; Topping CJ, 2010, ECOL MODEL, V221, P245, DOI 10.1016/j.ecolmodel.2009.09.014; Topping CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045872; Topping CJ, 2011, ECOL ENG, V37, P2009, DOI 10.1016/j.ecoleng.2011.08.010; Topping CJ, 2010, ECOL MODEL, V221, P729, DOI 10.1016/j.ecolmodel.2009.11.004; Topping CJ, 2005, ECOTOXICOLOGY, V14, P925, DOI 10.1007/s10646-005-0027-3; Topping CJ, 2004, ENVIRON TOXICOL CHEM, V23, P509, DOI 10.1897/02-524a; Topping CJ, 2003, ECOL MODEL, V167, P65, DOI 10.1016/S0304-3800(03)00173-X; Vickery JA, 2004, BIOL CONSERV, V119, P19, DOI 10.1016/j.biocon.2003.06.004; Zurell D, 2010, OIKOS, V119, P622, DOI 10.1111/j.1600-0706.2009.18284.x; [No title captured]	39	16	16	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65803	10.1371/journal.pone.0065803	http://dx.doi.org/10.1371/journal.pone.0065803			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762430	Green Submitted, Green Published, gold			2022-12-25	WOS:000321099000108
J	Rodriguez-Paredes, M; de Paz, AM; Simo-Riudalbas, L; Sayols, S; Moutinho, C; Moran, S; Villanueva, A; Vazquez-Cedeira, M; Lazo, PA; Carneiro, F; Moura, CS; Vieira, J; Teixeira, MR; Esteller, M				Rodriguez-Paredes, M.; Martinez de Paz, A.; Simo-Riudalbas, L.; Sayols, S.; Moutinho, C.; Moran, S.; Villanueva, A.; Vazquez-Cedeira, M.; Lazo, P. A.; Carneiro, F.; Moura, C. S.; Vieira, J.; Teixeira, M. R.; Esteller, M.			Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis	ONCOGENE			English	Article						SETDB1; gene amplification; overexpression; lung cancer; histone methyltransferase; chemotherapy	COMPARATIVE GENOMIC HYBRIDIZATION; GROUP PROTEIN EZH2; PROSTATE-CANCER; LYSINE METHYLTRANSFERASES; BREAST-CANCER; C-MYC; LEUKEMIA; CELLS; EXPRESSION; POLYCOMB	Disruption of the histone modification patterns is one of the most common features of human tumors. However, few genetic alterations in the histone modifier genes have been described in tumorigenesis. Herein we show that the histone methyltransferase SETDB1 undergoes gene amplification in non-small and small lung cancer cell lines and primary tumors. The existence of additional copies of the SETDB1 gene in these transformed cells is associated with higher levels of the corresponding mRNA and protein. From a functional standpoint, the depletion of SETDB1 expression in amplified cells reduces cancer growth in cell culture and nude mice models, whereas its overexpression increases the tumor invasiveness. The increased gene dosage of SETDB1 is also associated with enhanced sensitivity to the growth inhibitory effect mediated by the SETDB1-interfering drug mithramycin. Overall, the findings identify SETDB1 as a bona fide oncogene undergoing gene amplification-associated activation in lung cancer and suggest its potential for new therapeutic strategies.	[Rodriguez-Paredes, M.; Martinez de Paz, A.; Simo-Riudalbas, L.; Sayols, S.; Moutinho, C.; Moran, S.; Esteller, M.] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Progrm PEBC, Barcelona, Spain; [Villanueva, A.] Inst Catala Oncol, IDIBELL, Translat Res Lab, Barcelona, Spain; [Vazquez-Cedeira, M.; Lazo, P. A.] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Expt Therapeut & Translat Oncol Program, E-37008 Salamanca, Spain; [Vazquez-Cedeira, M.; Lazo, P. A.] Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain; [Carneiro, F.; Moura, C. S.] Univ Porto IPATIMPU, Ctr Hosp Sao Joao, Fac Med, Dept Pathol, P-4100 Oporto, Portugal; [Carneiro, F.; Moura, C. S.] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Vieira, J.; Teixeira, M. R.] Univ Porto, Portuguese Oncol Inst, Dept Genet, P-4100 Oporto, Portugal; [Vieira, J.; Teixeira, M. R.] Univ Porto, Biomed Sci Inst ICBAS, P-4100 Oporto, Portugal; [Esteller, M.] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona, Spain; [Esteller, M.] ICREA, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); Sao Joao Hospital; Universidade do Porto; Universidade do Porto; Portuguese Institute of Oncology; Universidade do Porto; Universidade do Porto; University of Barcelona; ICREA	Esteller, M (corresponding author), Hosp Duran & Reynals, Canc Epigenet & Biol Program PEBC, 3rd Floor,Ave Gran Via 199-203, Barcelona 08907, Spain.	mesteller@idibell.cat	Rodríguez, Manuel/N-2708-2019; Esteller, Manel/L-5956-2014; Lazo, Pedro A./M-6435-2014; Teixeira, Manuel António Rodrigues/E-4885-2011; Carneiro, Fatima/J-6432-2013; Moran, Sebastian/G-5293-2013; Carneiro, Fatima/AAV-8677-2021; Rodríguez Paredes, Manuel/B-1480-2019; Teixeira, Manuel AC/AAZ-7251-2020	Esteller, Manel/0000-0003-4490-6093; Lazo, Pedro A./0000-0001-8997-3025; Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; Carneiro, Fatima/0000-0002-1964-1006; Moran, Sebastian/0000-0003-4192-8983; Carneiro, Fatima/0000-0002-1964-1006; Rodríguez Paredes, Manuel/0000-0001-5471-4277; Teixeira, Manuel AC/0000-0002-1959-0624; Vieira, Joana/0000-0002-0608-2137; Sayols, Sergi/0000-0002-3877-4170	European Community - CURELUNG project [HEALTH-F2-2010-258677]; Institute of Health Carlos III [(ISCIII)-PI10/02992]; Ministerio de Educacion, Ciencia e Innovacion [SAF2010-14935]; Kutxa-Fundacion INBIOMED; Health and Science Departments of the Catalan Government (Generalitat de Catalunya); ICREA Funding Source: Custom	European Community - CURELUNG project; Institute of Health Carlos III(Instituto de Salud Carlos III); Ministerio de Educacion, Ciencia e Innovacion; Kutxa-Fundacion INBIOMED; Health and Science Departments of the Catalan Government (Generalitat de Catalunya); ICREA(ICREA)	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under Grant agreement number HEALTH-F2-2010-258677-CURELUNG project, the Institute of Health Carlos III (ISCIII)-PI10/02992, Ministerio de Educacion, Ciencia e Innovacion Grant SAF2010-14935, Kutxa-Fundacion INBIOMED and the Health and Science Departments of the Catalan Government (Generalitat de Catalunya). ME is an ICREA Research Professor.	Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Balsara BR, 1997, CANCER RES, V57, P2116; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beke L, 2007, ONCOGENE, V26, P4590, DOI 10.1038/sj.onc.1210248; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Berdasco M, 2009, P NATL ACAD SCI USA, V106, P21830, DOI 10.1073/pnas.0906831106; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Canaani E, 2004, BRIT J CANCER, V90, P756, DOI 10.1038/sj.bjc.6601639; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chen H, 2005, J BIOL CHEM, V280, P22437, DOI 10.1074/jbc.M501379200; Cho S, 2011, J BIOL CHEM, V286, P41115, DOI 10.1074/jbc.M111.248534; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Esteller M, 2006, BRIT J CANCER, V94, P179, DOI 10.1038/sj.bjc.6602918; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Fullgrabe J, 2011, ONCOGENE, V30, P3391, DOI 10.1038/onc.2011.121; Goeze A, 2002, J PATHOL, V196, P8, DOI 10.1002/path.1009; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hayashi M, 2005, ONCOL REP, V14, P1429; JONES DE, 1995, ONCOGENE, V10, P2323; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Luk C, 2001, CANCER GENET CYTOGEN, V125, P87, DOI 10.1016/S0165-4608(00)00363-0; MacGregor S, 2011, NAT GENET, V43, P1114, DOI 10.1038/ng.958; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Ryu H, 2006, P NATL ACAD SCI USA, V103, P19176, DOI 10.1073/pnas.0606373103; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Sun P, 2009, STEM CELLS, V27, P1473, DOI 10.1002/stem.89; Sy SMH, 2004, EUR J CANCER, V40, P1082, DOI 10.1016/j.ejca.2004.01.012; Taniguchi H, 2012, ONCOGENE, V31, P1988, DOI 10.1038/onc.2011.387; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Watanabe H, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-15; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Yakut T, 2006, LUNG CANCER, V54, P293, DOI 10.1016/j.lungcan.2006.08.011; Yang L, 2002, ONCOGENE, V21, P148, DOI 10.1038/sj.onc.1204998; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Yoshimi A, 2011, J CELL BIOCHEM, V112, P415, DOI 10.1002/jcb.22972; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	49	96	100	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 22	2014	33	21					2807	2813		10.1038/onc.2013.239	http://dx.doi.org/10.1038/onc.2013.239			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EH	23770855	Green Published, hybrid			2022-12-25	WOS:000337231700014
J	Jiang, CC; Croft, A; Tseng, HY; Guo, ST; Jin, L; Hersey, P; Zhang, XD				Jiang, C. C.; Croft, A.; Tseng, H-Y; Guo, S. T.; Jin, L.; Hersey, P.; Zhang, X. D.			Repression of microRNA-768-3p by MEK/ERK signalling contributes to enhanced mRNA translation in human melanoma	ONCOGENE			English	Article						miR-768-3p; eIF4E; mRNA translation; melanoma; RAF/MEK/ERK	CAP-BINDING PROTEIN; INCREASED EXPRESSION; CYCLIN D1; INITIATION; EIF4E; EIF-4E; CELLS; TRANSFORMATION; INHIBITION; DEREGULATION	Increased global protein synthesis and selective translation of mRNAs encoding proteins contributing to malignancy is common in cancer cells. This is often associated with elevated expression of eukaryotic translation initiation factor 4 (eIF4E), the rate-limiting factor of cap-dependent translation initiation. We report here that in human melanoma downregulation of miR-768-3p as a result of activation of the mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway has an important role in the upregulation of eIF4E and enhancement in protein synthesis. Melanoma cells displayed increased nascent protein production and elevated eIF4E expression, which was associated with the downregulation of miR-768-3p that was predicted to target the 30-untranslated region of the eIF4E mRNA. Overexpression of miR-768-3p led to the downregulation of the endogenous eIF4E protein, reduction in nascent protein synthesis and inhibition of cell survival and proliferation. These effects were efficiently reversed when eIF4E was co-overexpressed in melanoma cells. On the other hand, introduction of anti-miR-768-3p into melanocytes upregulated endogenous eIF4E protein expression and increased global protein synthesis. Downregulation of miR-768-3p appeared to be mediated by activation of the MEK/ERK pathway, in that treatment of BRAFV600E melanoma cells with the mutant BRAF inhibitor PLX4720 or exposure of either BRAFV600E or wild-type BRAF melanoma cells to the MEK inhibitor U0126 resulted in the upregulation of miR-768-3p and inhibition of nascent protein synthesis. This inhibition was partially blocked in cells cointroduced with anti-miR-768-3p. Significantly, miR-768-3p was similarly downregulated, which was inversely associated with the expression levels of eIF4E in fresh melanoma isolates. Taken together, these results identify downregulation of miR-768-3p and subsequent upregulation of eIF4E as an important mechanism in addition to phosphorylation of eIF4E responsible for MEK/ERK-mediated enhancement of protein synthesis in melanoma.	[Jiang, C. C.; Croft, A.; Tseng, H-Y; Zhang, X. D.] Univ Newcastle, Prior Res Ctr Canc Res, Callaghan, NSW 2308, Australia; [Jiang, C. C.; Tseng, H-Y; Zhang, X. D.] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia; [Croft, A.] Calvary Mater Newcastle Hosp, Oncol & Immunol Unit, Waratah, NSW, Australia; [Guo, S. T.; Zhang, X. D.] Shanxi Canc Hosp & Inst, Dept Mol Biol, Taiyuan, Shanxi, Peoples R China; [Jin, L.; Hersey, P.] Univ Sydney, Kolling Inst Med Res, St Leonards, NSW, Australia	University of Newcastle; University of Newcastle; Calvary Mater Newcastle Hospital; University of Sydney; Kolling Institute of Medical Research	Zhang, XD (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Prior Res Ctr Canc Res, LS3-49,Life Sci Bldg, Callaghan, NSW 2308, Australia.	Xu.Zhang@newcastle.edu.au	Tseng, Cindy Hsin-Yi/AAB-8958-2022; Jin, Lei/K-2315-2019; zhang, xu/GYE-3558-2022; zhang, xian/GYA-0290-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GRX-9733-2022; Jin, Lei/J-1896-2019	Tseng, Cindy Hsin-Yi/0000-0002-7499-7515; Jin, Lei/0000-0001-7187-9671; Zhang, Xu Dong/0000-0001-9457-8003	NSW State Cancer Council, Cancer Institute NSW; National Health and Medical Research Council (NHMRC), Australia; NHMRC	NSW State Cancer Council, Cancer Institute NSW(Cancer Council New South Wales); National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the NSW State Cancer Council, Cancer Institute NSW, and National Health and Medical Research Council (NHMRC), Australia. CCJ is a recipient of postdoctoral training Fellowship of NHMRC. XDZ is supported by a senior research fellowship of NHMRC.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912; Bilanges B, 2007, ONCOGENE, V26, P5973, DOI 10.1038/sj.onc.1210431; Bitterman PB, 2012, CELL CYCLE, V11, P1097, DOI 10.4161/cc.11.6.19610; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Bonazzi VF, 2012, MELANOMA RES, V22, P101, DOI 10.1097/CMR.0b013e32834f6fbb; Caramuta S, 2010, J INVEST DERMATOL, V130, P2062, DOI 10.1038/jid.2010.63; Coleman LJ, 2009, BRIT J CANCER, V100, P1393, DOI 10.1038/sj.bjc.6605044; Couts KL, 2013, ONCOGENE, V32, P1959, DOI 10.1038/onc.2012.209; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dong L, 2011, ONCOGENE, V30, P3716, DOI 10.1038/onc.2011.87; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Grzmil M, 2012, CANCER RES, V72, P3891, DOI 10.1158/0008-5472.CAN-12-0026; Guo ST, 2013, ONCOGENE, V32, P1910, DOI 10.1038/onc.2012.214; Haflidadottir BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011574; HE L, 2004, NAT REV GENET, V5, P522; Hong DS, 2011, CLIN CANCER RES, V17, P6582, DOI 10.1158/1078-0432.CCR-11-0430; Hou JQ, 2012, ONCOTARGET, V3, P118; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Ibrahim AF, 2011, CANCER RES, V71, P5214, DOI 10.1158/0008-5472.CAN-10-4645; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jiang CC, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.48; Jin L, 2011, P NATL ACAD SCI USA, V108, P15840, DOI 10.1073/pnas.1019312108; Kiss T, 2004, J CELL SCI, V117, P5949, DOI 10.1242/jcs.01487; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; Larsson O, 2007, CANCER RES, V67, P6814, DOI 10.1158/0008-5472.CAN-07-0752; LAZARISKARATZAS A, 1992, MOL CELL BIOL, V12, P1234, DOI 10.1128/MCB.12.3.1234; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Li SC, 2007, DNA CELL BIOL, V26, P195, DOI 10.1089/dna.2006.0558; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Mamane Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000242; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Miyoshi K, 2010, MOL GENET GENOMICS, V284, P95, DOI 10.1007/s00438-010-0556-1; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Mueller DW, 2010, PIGM CELL MELANOMA R, V23, P620, DOI 10.1111/j.1755-148X.2010.00734.x; Phillips A, 2008, ONCOGENE, V27, P1645, DOI 10.1038/sj.onc.1210785; Platz A, 2008, MOL ONCOL, V1, P395, DOI 10.1016/j.molonc.2007.12.003; ROSENWALD IB, 1993, MOL CELL BIOL, V13, P7358, DOI 10.1128/MCB.13.12.7358; Rosenwald IB, 2004, ONCOGENE, V23, P3230, DOI 10.1038/sj.onc.1207552; ROSENWALD IB, 1993, P NATL ACAD SCI USA, V90, P6175, DOI 10.1073/pnas.90.13.6175; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stumpf CR, 2011, CURR OPIN GENET DEV, V21, P474, DOI 10.1016/j.gde.2011.03.007; Takatsu H, 1998, J BIOL CHEM, V273, P24693, DOI 10.1074/jbc.273.38.24693; Valleron W, 2012, BLOOD, V120, P3997, DOI 10.1182/blood-2012-06-438135; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wilmott JS, 2011, PATHOLOGY, V43, P657, DOI 10.1097/PAT.0b013e32834a7358; Wulfken LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025787; Yanagiya A, 2012, MOL CELL, V46, P847, DOI 10.1016/j.molcel.2012.04.004; Yang SX, 2007, ONCOL REP, V17, P281	54	23	24	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 15	2014	33	20					2577	2588		10.1038/onc.2013.237	http://dx.doi.org/10.1038/onc.2013.237			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH9YT	23770856	Green Submitted			2022-12-25	WOS:000336502700004
J	Cai, YQ; Balli, D; Ustiyan, V; Fulford, L; Hiller, A; Misetic, V; Zhang, YF; Paluch, AM; Waltz, SE; Kasper, S; Kalin, TV				Cai, Yuqi; Balli, David; Ustiyan, Vladimir; Fulford, Logan; Hiller, Andrea; Misetic, Vinko; Zhang, Yufang; Paluch, Andrew M.; Waltz, Susan E.; Kasper, Susan; Kalin, Tanya V.			Foxm1 Expression in Prostate Epithelial Cells Is Essential for Prostate Carcinogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M1 TRANSCRIPTION FACTOR; TRANSGENIC MOUSE; RESPIRATORY EPITHELIUM; LIVER-REGENERATION; CANCER DEVELOPMENT; TUMOR SUPPRESSION; FORKHEAD; PROGRESSION; MICE; ARF	The treatment of advanced prostate cancer (PCa) remains a challenge. Identification of new molecular mechanisms that regulate PCa initiation and progression would provide targets for the development of new cancer treatments. The Foxm1 transcription factor is highly up-regulated in tumor cells, inflammatory cells, and cells of tumor microenvironment. However, its functions in different cell populations of PCa lesions are unknown. To determine the role of Foxm1 in tumor cells during PCa development, we generated two novel transgenic mouse models, one exhibiting Foxm1 gain-of-function and one exhibiting Foxm1 loss-of-function under control of the prostate epithelial-specific Probasin promoter. In the transgenic adenocarcinoma mouse prostate (TRAMP) model of PCa that uses SV40 large T antigen to induce PCa, loss of Foxm1 decreased tumor growth and metastasis. Decreased prostate tumorigenesis was associated with a decrease in tumor cell proliferation and the down-regulation of genes critical for cell proliferation and tumor metastasis, including Cdc25b, Cyclin B1, Plk-1, Lox, and Versican. In addition, tumor-associated angiogenesis was decreased, coinciding with reduced Vegf-A expression. The mRNA and protein levels of 11 beta-Hsd2, an enzyme playing an important role in tumor cell proliferation, were down-regulated in Foxm1-deficient PCa tumors in vivo and in Foxm1-depleted TRAMP C2 cells in vitro. Foxm1 bound to, and increased transcriptional activity of, the mouse 11 beta-Hsd2 promoter through the -892/-879 region, indicating that 11 beta-Hsd2 was a direct transcriptional target of Foxm1. Without TRAMP, overexpression of Foxm1 either alone or in combination with inhibition of a p19(ARF) tumor suppressor caused a robust epithelial hyperplasia, but was insufficient to induce progression from hyperplasia to PCa. Foxm1 expression in prostate epithelial cells is critical for prostate carcinogenesis, suggesting that inhibition of Foxm1 is a promising therapeutic approach for prostate cancer chemotherapy.	[Cai, Yuqi; Balli, David; Ustiyan, Vladimir; Fulford, Logan; Hiller, Andrea; Zhang, Yufang; Kalin, Tanya V.] Cincinnati Childrens Res Fdn, Perinatal Inst, Div Pulm Biol, Cincinnati, OH 45229 USA; [Misetic, Vinko] Univ Lausanne Hosp, CHUV Head & Neck Canc Res Lab Biopole 3 DB11, Dept Otorhinolaryngol & Head & Neck Surg, CH-1066 Epalinges, Switzerland; [Zhang, Yufang; Paluch, Andrew M.] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45229 USA; [Kasper, Susan] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Kalin, TV (corresponding author), 3333 Burnet Ave,MLC 7009, Cincinnati, OH 45229 USA.	Tatiana.kalin@cchmc.org		Waltz, Susan/0000-0003-3572-4642	National Institutes of Health [R01 CA142724]; Department of Defense [PC080478]; NATIONAL CANCER INSTITUTE [R01CA125379, R01CA142724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA142724 (to T. V. K.) and Department of Defense Award PC080478 (to T. V. K.).	Abate-Shen Cory, 2002, Trends Genet, V18, pS1, DOI 10.1016/S0168-9525(02)02683-5; Balli D, 2012, ONCOGENE, V31, P3875, DOI 10.1038/onc.2011.549; Balli D, 2011, CANCER RES, V71, P40, DOI 10.1158/0008-5472.CAN-10-2004; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Berges RR, 1995, CLIN CANCER RES, V1, P473; Costa RH, 2005, CURR OPIN GENET DEV, V15, P42, DOI 10.1016/j.gde.2004.12.007; Datta A, 2002, MOL CELL BIOL, V22, P8398, DOI 10.1128/MCB.22.24.8398-8408.2002; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Edwards IJ, 2012, NAT REV UROL, V9, P196, DOI 10.1038/nrurol.2012.19; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Gingrich JR, 1996, CANCER RES, V56, P4096; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Hundertmark S, 1997, J ENDOCRINOL, V155, P171, DOI 10.1677/joe.0.1550171; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kalin TV, 2008, P NATL ACAD SCI USA, V105, P19330, DOI 10.1073/pnas.0806748105; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kasper S, 2005, J CELL BIOCHEM, V94, P279, DOI 10.1002/jcb.20339; Kelly WK, 2012, J CLIN ONCOL, V30, P1534, DOI 10.1200/JCO.2011.39.4767; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Koyama K, 2001, J STEROID BIOCHEM, V76, P153, DOI 10.1016/S0960-0760(00)00157-6; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Maddison LA, 2000, GENESIS, V26, P154, DOI 10.1002/(SICI)1526-968X(200002)26:2<154::AID-GENE18>3.0.CO;2-2; Major ML, 2004, MOL CELL BIOL, V24, P2649, DOI 10.1128/MCB.24.7.2649-2661.2004; Martelli F, 2001, P NATL ACAD SCI USA, V98, P4455, DOI 10.1073/pnas.081061398; McCormick F, 1999, TRENDS BIOCHEM SCI, V24, pM53, DOI 10.1016/S0968-0004(99)01480-2; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Park HJ, 2011, EMBO MOL MED, V3, P21, DOI 10.1002/emmm.201000107; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; Rabbitt EH, 2003, J STEROID BIOCHEM, V85, P415, DOI 10.1016/S0960-0760(03)00224-3; Richards J, 2012, CANCER RES, V72, P2176, DOI 10.1158/0008-5472.CAN-11-3980; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Stichtenoth DO, 2001, J IMMUNOL, V167, P469, DOI 10.4049/jimmunol.167.1.469; Uzgare AR, 2003, PROSTATE, V55, P128, DOI 10.1002/pros.10212; Wang IC, 2008, ONCOGENE, V27, P4137, DOI 10.1038/onc.2008.60; Wang IC, 2012, MOL CELL BIOL, V32, P3838, DOI 10.1128/MCB.00355-12; Wang IC, 2010, DEV BIOL, V347, P301, DOI 10.1016/j.ydbio.2010.08.027; Wang IC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006609; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299; Wang XH, 2002, J BIOL CHEM, V277, P44310, DOI 10.1074/jbc.M207510200; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Watson PA, 2005, CANCER RES, V65, P11565, DOI 10.1158/0008-5472.CAN-05-3441; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Zhang MZ, 2009, J CLIN INVEST, V119, P876, DOI 10.1172/JCI37398; Zhang MZ, 1999, P NATL ACAD SCI USA, V96, P15280, DOI 10.1073/pnas.96.26.15280; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154	59	46	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22527	22541		10.1074/jbc.M113.455089	http://dx.doi.org/10.1074/jbc.M113.455089			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23775078	hybrid, Green Published			2022-12-25	WOS:000330596300033
J	Cheepala, SB; Bao, J; Nachagari, D; Sun, DX; Wang, Y; Zhong, T; Naren, AP; Zheng, J; Schuetz, JD				Cheepala, Satish B.; Bao, Ju; Nachagari, Deepa; Sun, Daxi; Wang, Yao; Zhong, Tao; Naren, Anjaparavanda P.; Zheng, Jie; Schuetz, John D.			Crucial Role for Phylogenetically Conserved Cytoplasmic Loop 3 in ABCC4 Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; BINDING CASSETTE TRANSPORTERS; CHLORIDE CHANNEL ACTIVITY; MULTIDRUG-RESISTANCE; SECONDARY STRUCTURE; MOLECULAR-MODEL; MRP4; CFTR; GENE; MUTATIONS	The ABC transporter ABCC4 is recognized as an ATP-dependent exporter of endogenous substances as well as an increasing variety of anionic chemotherapeutics. A loss-of-function variant of zebrafish Abcc4 was identified with a single amino acid substitution in the cytoplasmic loop T804M. Because this substituted amino acid is highly conserved among ABCC4 orthologs and is located in cytoplasmic loop 3 (CL3), we investigated the impact of this mutation on human and zebrafish Abcc4 expression. We demonstrate that zebrafish Abcc4 T804M or human ABCC4 T796M exhibit substantially reduced expression, coupled with impaired plasma membrane localization. To understand the molecular basis for the localization defect, we developed a homology model of zebrafish Abcc4. The homology model suggested that the bulky methionine substitution disrupted side-chain contacts. Molecular dynamic simulations of a fragment of human or zebrafish CL3 containing a methionine substitution indicated altered helicity coupled with reduced thermal stability. Trifluoroethanol challenge coupled with circular dichroism revealed that the methionine substitution disrupted the ability of this fragment of CL3 to readily form an alpha-helix. Furthermore, expression and plasma membrane localization of these mutant ABCC4/Abcc4 proteins are mostly rescued by growing cells at subphysiological temperatures. Because the cystic fibrosis transmembrane conductance regulator (ABCC7) is closely related to ABCC4, we extended this by engineering certain pathogenic CFTR-CL3 mutations, and we showed they destabilized human and zebrafish ABCC4. Altogether, our studies provide the first evidence for a conserved domain in CL3 of ABCC4 that is crucial in ensuring its proper plasma membrane localization.	[Cheepala, Satish B.; Nachagari, Deepa; Sun, Daxi; Wang, Yao; Schuetz, John D.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Bao, Ju; Zheng, Jie] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Zhong, Tao] Vanderbilt Univ, Dept Cardiovasc Biol, Nashville, TN 37235 USA; [Naren, Anjaparavanda P.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; Vanderbilt University; University of Tennessee System; University of Tennessee Health Science Center	Schuetz, JD (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	John.Schuetz@stjude.org	Schuetz, John D/N-2692-2018		National Institutes of Health [2R01GM60904, P30CA21745, CA21865, DK080834, DK093045]; ALSAC; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080834, R01DK093045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081492, R01GM100909, R01GM060904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01GM60904, P30CA21745, and CA21865 (to J. D. S.) and DK080834 and DK093045 (to A. P. N.). This work was also supported by ALSAC.	Abla N, 2008, J PHARMACOL EXP THER, V325, P859, DOI 10.1124/jpet.108.136523; Ban H, 2010, J GASTROENTEROL, V45, P1014, DOI 10.1007/s00535-010-0248-y; Banasavadi-Siddegowda YK, 2011, J BIOL CHEM, V286, P43071, DOI 10.1074/jbc.M111.269993; BARBER R, 1980, BIOCHEMISTRY-US, V19, P2560, DOI 10.1021/bi00553a004; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Bertolucci CM, 2005, PROTEIN SCI, V14, P644, DOI 10.1110/ps.041107205; Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNTON LL, 1980, J CYCLIC NUCL PROT, V6, P369; Chang C, 2006, EUR J PHARM SCI, V27, P411, DOI 10.1016/j.ejps.2005.09.013; Cheepala S, 2013, ANNU REV PHARMACOL, V53, P231, DOI 10.1146/annurev-pharmtox-010611-134609; CLAUSTRES M, 1993, HUM MOL GENET, V2, P1209, DOI 10.1093/hmg/2.8.1209; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; El Hiani Y, 2012, BIOCHEMISTRY-US, V51, P3971, DOI 10.1021/bi300065z; Fukuda Y, 2011, J BIOL CHEM, V286, P8481, DOI 10.1074/jbc.M110.174516; Hayashi H, 2007, HEPATOLOGY, V45, P1506, DOI 10.1002/hep.21630; Hazai E, 2008, J STRUCT BIOL, V162, P63, DOI 10.1016/j.jsb.2007.12.001; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Janke D, 2008, HUM MUTAT, V29, P659, DOI 10.1002/humu.20694; Jordan IK, 2008, P NATL ACAD SCI USA, V105, P18865, DOI 10.1073/pnas.0806306105; Kanki K, 2009, APOPTOSIS, V14, P309, DOI 10.1007/s10495-009-0318-x; Kool M, 1997, CANCER RES, V57, P3537; Krishnamurthy P, 2008, CANCER RES, V68, P4983, DOI 10.1158/0008-5472.CAN-07-6790; Kruh GD, 2007, CANCER METAST REV, V26, P5, DOI 10.1007/s10555-007-9039-1; Loo TW, 2012, J BIOL CHEM, V287, P26806, DOI 10.1074/jbc.M112.376202; Ravna AW, 2008, BIOORG MED CHEM LETT, V18, P3481, DOI 10.1016/j.bmcl.2008.05.047; Ravna AW, 2009, MINI-REV MED CHEM, V9, P186, DOI 10.2174/138955709787316065; Ravna AW, 2008, EUR J MED CHEM, V43, P2557, DOI 10.1016/j.ejmech.2008.01.015; Rosenberg MF, 2011, J BIOL CHEM, V286, P42647, DOI 10.1074/jbc.M111.292268; Sauna ZE, 2004, J BIOL CHEM, V279, P48855, DOI 10.1074/jbc.M408849200; Schuetz JD, 1999, NAT MED, V5, P1048, DOI 10.1038/12487; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Seibert FS, 1996, J BIOL CHEM, V271, P27493, DOI 10.1074/jbc.271.44.27493; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Unneberg P, 2001, PROTEINS, V42, P460, DOI 10.1002/1097-0134(20010301)42:4<460::AID-PROT50>3.0.CO;2-U; Vardy E, 2004, PROTEIN SCI, V13, P1832, DOI 10.1110/ps.04657704; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wielinga PR, 2002, MOL PHARMACOL, V62, P1321, DOI 10.1124/mol.62.6.1321; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22207	22218		10.1074/jbc.M113.476218	http://dx.doi.org/10.1074/jbc.M113.476218			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23766510	Green Published, hybrid			2022-12-25	WOS:000330596300003
J	Glockner, C; Kern, J; Broser, M; Zouni, A; Yachandra, V; Yano, J				Gloeckner, Carina; Kern, Jan; Broser, Matthias; Zouni, Athina; Yachandra, Vittal; Yano, Junko			Structural Changes of the Oxygen-evolving Complex in Photosystem II during the Catalytic Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-ABSORPTION; PHOTOSYNTHETIC WATER OXIDATION; MN4CA CLUSTER; CRYSTAL-STRUCTURE; MN CLUSTER; MANGANESE COMPLEX; ELECTRONIC-STRUCTURE; S-2 STATES; THERMOSYNECHOCOCCUS-ELONGATUS; ANGSTROM RESOLUTION	The oxygen-evolving complex (OEC) in the membrane-bound protein complex photosystem II (PSII) catalyzes the water oxidation reaction that takes place in oxygenic photosynthetic organisms. We investigated the structural changes of the Mn4CaO5 cluster in the OEC during the S state transitions using x-ray absorption spectroscopy (XAS). Overall structural changes of the Mn4CaO5 cluster, based on the manganese ligand and Mn-Mn distances obtained from this study, were incorporated into the geometry of the Mn4CaO5 cluster in the OEC obtained from a polarized XAS model and the 1.9-angstrom high resolution crystal structure. Additionally, we compared the S-1 state XAS of the dimeric and monomeric form of PSII from Thermosynechococcus elongatus and spinach PSII. Although the basic structures of the OEC are the same for T. elongatus PSII and spinach PSII, minor electronic structural differences that affect the manganese K-edge XAS between T. elongatus PSII and spinach PSII are found and may originate from differences in the second sphere ligand atom geometry.	[Gloeckner, Carina; Broser, Matthias; Zouni, Athina] Tech Univ Berlin, Inst Chem, Max Volmer Lab Biophys Chem, D-10623 Berlin, Germany; [Kern, Jan; Yachandra, Vittal; Yano, Junko] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Technical University of Berlin; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zouni, A (corresponding author), Tech Univ Berlin, Inst Chem, Max Volmer Lab Biophys Chem, Str 17 Juni 135, D-10623 Berlin, Germany.	zouni@mailbox.tu-berlin.de; vkyachandra@lbl.gov; jyano@lbl.gov	Kern, Jan/G-2586-2013	Kern, Jan/0000-0002-7272-1603	National Institutes of Health; NCCR; Department of Energy, Office of Biological and Environmental Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055302, R56GM055302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCR(Swiss National Science Foundation (SNSF)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Prof. Johannes Messinger for many useful discussions, D. DiFiore for technical assistance with sample preparation and the staff at Stanford Synchrotron Radiation Lightsource, Stanford, CA, for support of the EXAFS measurements. Synchrotron facilities were provided by the Stanford Synchrotron Radiation Lightsource operated by the Department of Energy, Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Lightsource Biomedical Technology program is supported by the National Institutes of Health, the NCCR, and the Department of Energy, Office of Biological and Environmental Research.	Ames W, 2011, J AM CHEM SOC, V133, P19743, DOI 10.1021/ja2041805; BALDWIN MJ, 1994, J AM CHEM SOC, V116, P11349, DOI 10.1021/ja00104a014; BOUSSAC A, 1989, BIOCHEMISTRY-US, V28, P8984, DOI 10.1021/bi00449a005; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; Broser M, 2010, J BIOL CHEM, V285, P26255, DOI 10.1074/jbc.M110.127589; Chu HA, 2004, BIOCHEMISTRY-US, V43, P3152, DOI 10.1021/bi035915f; Cinco RM, 1999, INORG CHEM, V38, P5988, DOI 10.1021/ic991003j; Cinco RM, 2004, BIOCHEMISTRY-US, V43, P13271, DOI 10.1021/bi036308v; Cinco RM, 1998, J PHYS CHEM B, V102, P8248, DOI 10.1021/jp981658q; Cinco RM, 2002, BIOCHEMISTRY-US, V41, P12928, DOI 10.1021/bi026569p; Cox N, 2013, ACCOUNTS CHEM RES, V46, P1588, DOI 10.1021/ar3003249; Cox N, 2011, J AM CHEM SOC, V133, P3635, DOI 10.1021/ja110145v; Dau H, 1997, J PHYS IV, V7, P607, DOI 10.1051/jp4/1997112; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Debus RJ, 2008, COORDIN CHEM REV, V252, P244, DOI 10.1016/j.ccr.2007.09.022; DISMUKES GC, 1981, P NATL ACAD SCI-BIOL, V78, P274, DOI 10.1073/pnas.78.1.274; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Galstyan A, 2012, J AM CHEM SOC, V134, P7442, DOI 10.1021/ja300254n; Grabolle M, 2006, J BIOL CHEM, V281, P4580, DOI 10.1074/jbc.M509724200; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Haddy A, 2007, PHOTOSYNTH RES, V92, P357, DOI 10.1007/s11120-007-9194-9; Haumann M, 2005, BIOCHEMISTRY-US, V44, P1894, DOI 10.1021/bi048697e; Ifuku K, 2011, J PHOTOCH PHOTOBIO B, V104, P158, DOI 10.1016/j.jphotobiol.2011.02.006; Isobe H, 2012, DALTON T, V41, P13727, DOI 10.1039/c2dt31420g; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kanady JS, 2011, SCIENCE, V333, P733, DOI 10.1126/science.1206036; Kern J, 2005, BBA-BIOENERGETICS, V1706, P147, DOI 10.1016/j.bbabio.2004.10.007; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Komenda J, 2012, CURR OPIN PLANT BIOL, V15, P245, DOI 10.1016/j.pbi.2012.01.017; Koua FHM, 2013, P NATL ACAD SCI USA, V110, P3889, DOI 10.1073/pnas.1219922110; Kouril R, 2012, BBA-BIOENERGETICS, V1817, P2, DOI 10.1016/j.bbabio.2011.05.024; Kulik LV, 2007, J AM CHEM SOC, V129, P13421, DOI 10.1021/ja071487f; Kulik LV, 2005, J AM CHEM SOC, V127, P2392, DOI 10.1021/ja043012j; Liang WC, 2000, J AM CHEM SOC, V122, P3399, DOI 10.1021/ja992501u; Lohmiller T, 2012, J BIOL CHEM, V287, P24721, DOI 10.1074/jbc.M112.365288; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Luber S, 2011, BIOCHEMISTRY-US, V50, P6308, DOI 10.1021/bi200681q; Messinger J, 2001, J AM CHEM SOC, V123, P7804, DOI 10.1021/ja004307+; Miqyass M, 2007, PHOTOSYNTH RES, V92, P275, DOI 10.1007/s11120-006-9124-2; Mukherjee S, 2012, P NATL ACAD SCI USA, V109, P2257, DOI 10.1073/pnas.1115290109; Mukhopadhyay S, 2004, CHEM REV, V104, P3981, DOI 10.1021/cr0206014; Newville M, 2001, J SYNCHROTRON RADIAT, V8, P322, DOI 10.1107/S0909049500016964; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Noguchi T, 2008, COORDIN CHEM REV, V252, P336, DOI 10.1016/j.ccr.2007.05.001; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; ONO T, 1988, FEBS LETT, V227, P147, DOI 10.1016/0014-5793(88)80886-X; Pantazis DA, 2012, ANGEW CHEM INT EDIT, V51, P9935, DOI 10.1002/anie.201204705; Peloquin JM, 2000, J AM CHEM SOC, V122, P10926, DOI 10.1021/ja002104f; Peloquin JM, 2001, BBA-BIOENERGETICS, V1503, P96, DOI 10.1016/S0005-2728(00)00219-X; Pizarro SA, 2004, PHYS CHEM CHEM PHYS, V6, P4864, DOI 10.1039/b407513g; Pushkar YL, 2008, P NATL ACAD SCI USA, V105, P1879, DOI 10.1073/pnas.0707092105; Pushkar Y, 2007, J BIOL CHEM, V282, P7198, DOI 10.1074/jbc.M610505200; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Robblee JH, 2002, J AM CHEM SOC, V124, P7459, DOI 10.1021/ja011621a; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; Sauer K, 2008, COORDIN CHEM REV, V252, P318, DOI 10.1016/j.ccr.2007.08.009; Siegbahn PEM, 2011, CHEMPHYSCHEM, V12, P3274, DOI 10.1002/cphc.201100475; Siegbahn PEM, 2011, J PHOTOCH PHOTOBIO B, V104, P94, DOI 10.1016/j.jphotobiol.2011.01.014; Siegbahn PEM, 2009, ACCOUNTS CHEM RES, V42, P1871, DOI 10.1021/ar900117k; Sigfridsson KGV, 2013, J BIOL CHEM, V288, P9648, DOI 10.1074/jbc.M112.438796; Su JH, 2011, BBA-BIOENERGETICS, V1807, P829, DOI 10.1016/j.bbabio.2011.03.002; Suzuki H, 2009, J AM CHEM SOC, V131, P7849, DOI 10.1021/ja901696m; Takahashi T, 2009, J BIOL CHEM, V284, P15598, DOI 10.1074/jbc.M109.000372; Teutloff C, 2009, PHYS CHEM CHEM PHYS, V11, P6715, DOI 10.1039/b908093g; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Watanabe M, 2009, PLANT CELL PHYSIOL, V50, P1674, DOI 10.1093/pcp/pcp112; Wydrzynski T, 2005, PHOTOSYSTEM, DOI [10.1007/1-4020-4254-X_6, DOI 10.1007/1-4020-4254-X_6]; Yano J, 2005, J AM CHEM SOC, V127, P14974, DOI 10.1021/ja054873a; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Yano J, 2008, INORG CHEM, V47, P1711, DOI 10.1021/ic7016837; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186; Yano J, 2011, J BIOL CHEM, V286, P9257, DOI 10.1074/jbc.M110.205740; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	74	125	126	1	77	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22607	22620		10.1074/jbc.M113.476622	http://dx.doi.org/10.1074/jbc.M113.476622			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23766513	hybrid, Green Published			2022-12-25	WOS:000330596300041
J	Tran, KD; Rodriguez-Contreras, D; Vieira, DP; Yates, PA; David, L; Beatty, W; Elferich, J; Landfear, SM				Tran, Khoa D.; Rodriguez-Contreras, Dayana; Vieira, Danielle P.; Yates, Phillip A.; David, Larry; Beatty, Wandy; Elferich, Johannes; Landfear, Scott M.			KHARON1 Mediates Flagellar Targeting of a Glucose Transporter in Leishmania mexicana and Is Critical for Viability of Infectious Intracellular Amastigotes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY MEMBRANE; PRIMARY CILIUM; PROTEIN; GENE; LOCALIZATION; TRAFFICKING; MODULATION; PROTISTS; SEQUENCE; RAFTS	The LmxGT1 glucose transporter is selectively targeted to the flagellum of the kinetoplastid parasite Leishmania mexicana, but the mechanism for targeting this and other flagella-specific membrane proteins among the Kinetoplastida is unknown. To address the mechanism of flagellar targeting, we employed in vivo cross-linking, tandem affinity purification, and mass spectrometry to identify a novel protein, KHARON1 (KH1), which is important for the flagellar trafficking of LmxGT1. Kh1 null mutant parasites are strongly impaired in flagellar targeting of LmxGT1, and trafficking of the permease was arrested in the flagellar pocket. Immunolocalization revealed that KH1 is located at the base of the flagellum, within the flagellar pocket, where it associates with the proximal segment of the flagellar axoneme. We propose that KH1 mediates transit of LmxGT1 from the flagellar pocket into the flagellar membrane via interaction with the proximal portion of the flagellar axoneme. KH1 represents the first component involved in flagellar trafficking of integral membrane proteins among parasitic protozoa. Of considerable interest, Kh1 null mutants are strongly compromised for growth as amastigotes within host macrophages. Thus, KH1 is also important for the disease causing stage of the parasite life cycle.	[Tran, Khoa D.; Rodriguez-Contreras, Dayana; Vieira, Danielle P.; Landfear, Scott M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [Yates, Phillip A.; Elferich, Johannes] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [David, Larry] Oregon Hlth & Sci Univ, Dept Prote Shared Resource, Portland, OR 97239 USA; [Beatty, Wandy] Washington Univ, Sch Med, Mol Microbiol Imaging Facil, St Louis, MO 63110 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Washington University (WUSTL)	Landfear, SM (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR USA.	landfear@ohsu.edu	Vieira, Danielle/N-1254-2014	Elferich, Johannes/0000-0002-9911-706X; Landfear, Scott/0000-0002-1643-6664	National Institutes of Health [AI25920, AI023682]; American Heart Association [11POST7440105]; National Institutes of Health NRSA [1F32AI096854]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Brasil (CNPq); NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025571] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY010572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI096854, R01AI023682, R37AI023682, R01AI025920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institutes of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI25920 (to S. M. L.) and American Heart Association Postdoctoral Fellowship 11POST7440105 and National Institutes of Health NRSA F32 Fellowship 1F32AI096854 (to K. D. T.).; Supported by a fellowship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Brasil (CNPq).; Supported by National Institutes of Health Grant AI023682.	Absalon S, 2008, MOL BIOL CELL, V19, P929, DOI 10.1091/mbc.E07-08-0749; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bloodgood RA, 2010, J CELL SCI, V123, P505, DOI 10.1242/jcs.066308; Buchanan KT, 2005, J BIOL CHEM, V280, P40104, DOI 10.1074/jbc.M505777200; Burchmore RJS, 2003, P NATL ACAD SCI USA, V100, P3901, DOI 10.1073/pnas.0630165100; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; CRUZ A, 1990, NATURE, V348, P171, DOI 10.1038/348171a0; Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017; Denny PW, 2004, MOL MICROBIOL, V53, P725, DOI 10.1111/j.1365-2958.2004.04208.x; Denny PW, 2001, FEBS LETT, V491, P148, DOI 10.1016/S0014-5793(01)02172-X; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Emmer BT, 2010, J CELL SCI, V123, P529, DOI 10.1242/jcs.062968; ENGMAN DM, 1989, J BIOL CHEM, V264, P18627; Figarella K, 2007, MOL MICROBIOL, V65, P1006, DOI 10.1111/j.1365-2958.2007.05845.x; Fridberg A, 2007, PARASITOL RES, V100, P205, DOI 10.1007/s00436-006-0329-2; Fulwiler AL, 2011, MOL BIOCHEM PARASIT, V175, P209, DOI 10.1016/j.molbiopara.2010.10.008; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Ginger ML, 2008, NAT REV MICROBIOL, V6, P838, DOI 10.1038/nrmicro2009; Gluenz E, 2010, FASEB J, V24, P3117, DOI 10.1096/fj.09-151381; Gluenz E, 2010, CURR OPIN MICROBIOL, V13, P473, DOI 10.1016/j.mib.2010.05.008; Godsel LM, 1999, EMBO J, V18, P2057, DOI 10.1093/emboj/18.8.2057; Gourbal B, 2004, J BIOL CHEM, V279, P31010, DOI 10.1074/jbc.M403959200; Gruber M, 2005, NUCLEIC ACIDS RES, V33, pW239, DOI 10.1093/nar/gki405; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Heras SR, 2006, CELL MOL LIFE SCI, V63, P1449, DOI 10.1007/s00018-006-6038-2; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; Liu JF, 2003, NUCLEIC ACIDS RES, V31, P3833, DOI 10.1093/nar/gkg515; Mandal G, 2012, MOL MICROBIOL, V85, P1204, DOI 10.1111/j.1365-2958.2012.08169.x; Maric D, 2011, J BIOL CHEM, V286, P33109, DOI 10.1074/jbc.M111.240895; Maric D, 2010, CURR OPIN MICROBIOL, V13, P466, DOI 10.1016/j.mib.2010.06.001; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; McConville MJ, 2002, MICROBIOL MOL BIOL R, V66, P122, DOI 10.1128/MMBR.66.1.122-154.2002; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nasser MIA, 2004, MOL BIOCHEM PARASIT, V135, P89, DOI 10.1016/j.molbiopara.2004.01.009; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; PAINDAVOINE P, 1992, MOL CELL BIOL, V12, P1218, DOI 10.1128/MCB.12.3.1218; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pazour GJ, 2008, CURR TOP DEV BIOL, V85, P115, DOI 10.1016/S0070-2153(08)00805-3; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Sacks D L, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1902s28; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Tran KD, 2012, J CELL SCI, V125, P3293, DOI 10.1242/jcs.103028; Tran KD, 2010, DEVELOPMENT, V137, P1421, DOI 10.1242/dev.048678; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Tull D, 2004, MOL BIOL CELL, V15, P4775, DOI 10.1091/mbc.E04-06-0457; Valdes R, 2004, BIOCHEMISTRY-US, V43, P6793, DOI 10.1021/bi049873m; WHO, 2013, NEGL TROP DIS; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Wittig I, 2008, PROTEOMICS, V8, P3974, DOI 10.1002/pmic.200800017; Zheng ZF, 2004, J BIOL CHEM, V279, P42106, DOI 10.1074/jbc.M403780200	58	17	17	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22721	22733		10.1074/jbc.M113.483461	http://dx.doi.org/10.1074/jbc.M113.483461			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23766511	Green Published, hybrid			2022-12-25	WOS:000330596300050
J	Banos, G; Wall, E; Coffey, MP; Bagnall, A; Gillespie, S; Russell, GC; McNeilly, TN				Banos, Georgios; Wall, Eileen; Coffey, Michael P.; Bagnall, Ainsley; Gillespie, Sandra; Russell, George C.; McNeilly, Tom N.			Identification of Immune Traits Correlated with Dairy Cow Health, Reproduction and Productivity	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; MULTIPLE IMPLANTATION FAILURES; DIFFERENTIAL LEUKOCYTE COUNTS; RECURRENT PREGNANCY LOSSES; NATURAL-KILLER-CELLS; FLOW-CYTOMETRY; MONOCLONAL-ANTIBODIES; CYTOKINE EXPRESSION; SHORT-COMMUNICATION; GENETIC-PARAMETERS	Detailed biological analyses (e. g. epidemiological, genetic) of animal health and fitness in the field are limited by the lack of large-scale recording of individual animals. An alternative approach is to identify immune traits that are associated with these important functions and can be subsequently used in more detailed studies. We have used an experimental dairy herd with uniquely dense phenotypic data to identify a range of potentially useful immune traits correlated with enhanced (or depressed) health and fitness. Blood samples from 248 dairy cows were collected at two-monthly intervals over a 10-month period and analysed for a number of immune traits, including levels of serum proteins associated with the innate immune response and circulating leukocyte populations. Immune measures were matched to individual cow records related to productivity, fertility and disease. Correlations between traits were calculated using bivariate analyses based on animal repeatability and random regression models with a Bonferroni correction to account for multiple testing. A number of significant correlations were found between immune traits and other recorded traits including: CD4(+): CD8(+) T lymphocyte ratio and subclinical mastitis; % CD8(+) lymphocytes and fertility; % CD335(+) natural killer cells and lameness episodes; and serum haptoglobin levels and clinical mastitis. Importantly these traits were not associated with reduced productivity and, in the case of cellular immune traits, were highly repeatable. Moreover these immune traits displayed significant between-animal variation suggesting that they may be altered by genetic selection. This study represents the largest simultaneous analysis of multiple immune traits in dairy cattle to-date and demonstrates that a number of immune traits are associated with health events. These traits represent useful selection markers for future programmes aimed at improving animal health and fitness.	[Banos, Georgios; Wall, Eileen; Coffey, Michael P.; Bagnall, Ainsley] SRUC, Edinburgh, Midlothian, Scotland; [Banos, Georgios] Aristotle Univ Thessaloniki, Fac Vet Med, GR-54006 Thessaloniki, Greece; [Gillespie, Sandra; Russell, George C.; McNeilly, Tom N.] Moredun Res Inst, Edinburgh EH17 7JH, Midlothian, Scotland	Aristotle University of Thessaloniki; Moredun Research Institute	McNeilly, TN (corresponding author), Moredun Res Inst, 408 Gilmerton Rd, Edinburgh EH17 7JH, Midlothian, Scotland.	Tom.McNeilly@moredun.ac.uk	McNeilly, Tom/AAC-8264-2019	McNeilly, Tom/0000-0001-6469-0512; Russell, George/0000-0002-1951-3215; Banos, Georgios/0000-0002-7674-858X; Coffey, Mike/0000-0003-4890-6218	Rural and Environment Science and Analytical Services (RESAS) Cross-Cutting Theme Fellowship [MRI/102/10]; Scottish Government; Biotechnology and Biological Sciences Research Council [BB/K002260/1] Funding Source: researchfish; BBSRC [BB/K002260/1] Funding Source: UKRI	Rural and Environment Science and Analytical Services (RESAS) Cross-Cutting Theme Fellowship; Scottish Government; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by Rural and Environment Science and Analytical Services (RESAS) Cross-Cutting Theme Fellowship MRI/102/10. EW, MPC, GR and TNM are supported by core funding from the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsemgeest SPM, 1996, VET IMMUNOL IMMUNOP, V53, P179, DOI 10.1016/0165-2427(96)05602-4; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; Bell MJ, 2011, J DAIRY SCI, V94, P3662, DOI 10.3168/jds.2010-4023; BENSAID A, 1991, VET IMMUNOL IMMUNOP, V27, P51, DOI 10.1016/0165-2427(91)90078-Q; Bougarn S, 2011, CYTOKINE, V56, P749, DOI 10.1016/j.cyto.2011.09.020; CASALI P, 1989, IMMUNOL TODAY, V10, P364, DOI 10.1016/0167-5699(89)90268-5; Ceciliani F, 2012, J PROTEOMICS, V75, P4207, DOI 10.1016/j.jprot.2012.04.004; Clapperton M, 2008, ANIMAL, V2, P1575, DOI 10.1017/S1751731108002929; Clapperton M, 2005, VET IMMUNOL IMMUNOP, V104, P131, DOI 10.1016/j.vetimm.2004.10.009; Clapperton M, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-54; Davis WC, 1996, VET IMMUNOL IMMUNOP, V52, P275, DOI 10.1016/0165-2427(96)05578-X; DAVIS WC, 1993, VET IMMUNOL IMMUNOP, V39, P85, DOI 10.1016/0165-2427(93)90167-3; Eckersall PD, 2010, VET J, V185, P23, DOI 10.1016/j.tvjl.2010.04.009; Eckersall PD, 2006, J DAIRY SCI, V89, P1488, DOI 10.3168/jds.S0022-0302(06)72216-0; Eckersall PD, 2001, VET REC, V148, P35, DOI 10.1136/vr.148.2.35; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Ferlazzo G, 2004, J IMMUNOL, V172, P1333, DOI 10.4049/jimmunol.172.3.1333; Ferreira MAR, 2010, AM J HUM GENET, V86, P88, DOI 10.1016/j.ajhg.2009.12.008; Flori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022717; Flori Laurence, 2011, BMC Proc, V5 Suppl 4, pS32, DOI 10.1186/1753-6561-5-S4-S32; Gilmour A., 2006, ASREML USER GUIDE RE; Glass EJ, 2005, INT J PARASITOL, V35, P337, DOI 10.1016/j.ijpara.2004.12.006; Gregory N, 2011, IN PRACTICE, V33, P328, DOI 10.1136/inp.d4505; Hall MA, 2000, GENES IMMUN, V1, P423, DOI 10.1038/sj.gene.6363702; He Y, 2011, J DAIRY RES, P1; Holm S, 1974, SCANDINAVIAN J STAT, V6, P65; JAIN NC, 1991, AM J VET RES, V52, P630; Jenkins C, 2000, FERTIL STERIL, V73, P1206, DOI 10.1016/S0015-0282(00)00517-3; Kushibiki S, 2003, J DAIRY SCI, V86, P819, DOI 10.3168/jds.S0022-0302(03)73664-9; Kushibiki S, 2011, ANIM SCI J, V82, P504, DOI 10.1111/j.1740-0929.2011.00931.x; Kwak-Kim JYH, 2003, HUM REPROD, V18, P767, DOI 10.1093/humrep/deg156; Lun S, 2007, REPROD DOMEST ANIM, V42, P126, DOI 10.1111/j.1439-0531.2006.00741.x; MACHUGH ND, 1991, VET IMMUNOL IMMUNOP, V27, P65, DOI 10.1016/0165-2427(91)90081-M; Maecker HT, 2010, NAT IMMUNOL, V11, P975, DOI 10.1038/ni1110-975; Marzi M, 1996, CLIN EXP IMMUNOL, V106, P127, DOI 10.1046/j.1365-2249.1996.d01-809.x; Miglior F, 2005, J DAIRY SCI, V88, P1255, DOI 10.3168/jds.S0022-0302(05)72792-2; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Moyes KM, 2009, J DAIRY SCI, V92, P4301, DOI 10.3168/jds.2009-2170; Mrode R, 2012, J DAIRY SCI, V95, P4618, DOI 10.3168/jds.2011-4971; Mrode R. A., 1996, Animal Breeding Abstracts, V64, P847; NAESSENS J, 1990, IMMUNOLOGY, V69, P525; Nielsen BH, 2004, VET REC, V154, P361, DOI 10.1136/vr.154.12.361; Ohtsuka H, 2001, J VET MED SCI, V63, P675, DOI 10.1292/jvms.63.675; PARK YH, 1993, VET IMMUNOL IMMUNOP, V36, P137, DOI 10.1016/0165-2427(93)90103-B; Park Yong Ho, 2004, J Vet Sci, V5, P29; Pryce JE, 1999, LIVEST PROD SCI, V57, P193, DOI 10.1016/S0301-6226(98)00180-8; Quesniaux VFJ, 2010, CURR DIR AUTOIMMUN, V11, P157, DOI 10.1159/000289204; Raghupathy R, 2000, HUM REPROD, V15, P713, DOI 10.1093/humrep/15.3.713; Rasmussen M, 2012, VET MICROBIOL, V160, P151, DOI 10.1016/j.vetmic.2012.05.018; RENEAU JK, 1986, J DAIRY SCI, V69, P1708, DOI 10.3168/jds.S0022-0302(86)80590-2; Riollet C, 2001, J DAIRY SCI, V84, P1077, DOI 10.3168/jds.S0022-0302(01)74568-7; SHOOK GE, 1994, J DAIRY SCI, V77, P648, DOI 10.3168/jds.S0022-0302(94)76995-2; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Soltys J, 1999, INFECT IMMUN, V67, P6293; Sopp P, 1997, VET IMMUNOL IMMUNOP, V56, P11, DOI 10.1016/S0165-2427(96)05731-5; Storset AK, 2004, EUR J IMMUNOL, V34, P669, DOI 10.1002/eji.200324504; Suojala L, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-18; Taylor BC, 1997, CELL IMMUNOL, V182, P68, DOI 10.1006/cimm.1997.1215; Thielen MA, 2007, J DAIRY SCI, V90, P1215, DOI 10.3168/jds.S0022-0302(07)71609-0; Thompson-Crispi KA, 2012, J DAIRY SCI, V95, P3888, DOI 10.3168/jds.2011-5201; Thompson-Crispi KA, 2012, J DAIRY SCI, V95, P401, DOI 10.3168/jds.2011-4452; van Knegsel ATM, 2007, J DAIRY SCI, V90, P5490, DOI 10.3168/jds.2007-0289; van Knegsel ATM, 2012, PREV VET MED, V103, P287, DOI 10.1016/j.prevetmed.2011.09.006; WEIL GJ, 1981, BLOOD, V57, P1099; Wilkerson MJ, 2012, VET CLIN N AM-SMALL, V42, P53, DOI 10.1016/j.cvsm.2011.09.012; Wong P, 2003, ANNU REV IMMUNOL, V21, P29, DOI 10.1146/annurev.immunol.21.120601.141114; Yang KM, 2010, AM J REPROD IMMUNOL, V63, P370, DOI 10.1111/j.1600-0897.2010.00811.x; Zitvogel L, 2002, J EXP MED, V195, pf9, DOI 10.1084/jem.20012040	69	58	60	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65766	10.1371/journal.pone.0065766	http://dx.doi.org/10.1371/journal.pone.0065766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776543	Green Submitted, Green Published, gold			2022-12-25	WOS:000320322400052
J	Brown, CJ; Saunders, MI; Possingham, HP; Richardson, AJ				Brown, Christopher J.; Saunders, Megan I.; Possingham, Hugh P.; Richardson, Anthony J.			Managing for Interactions between Local and Global Stressors of Ecosystems	PLOS ONE			English	Article							CLIMATE-CHANGE; CORAL-REEFS; PROTECTED AREAS; RESILIENCE; TEMPERATURE; STRATEGIES; MORTALITY; IMPACTS; RISK; ACIDIFICATION	Global stressors, including climate change, are a major threat to ecosystems, but they cannot be halted by local actions. Ecosystem management is thus attempting to compensate for the impacts of global stressors by reducing local stressors, such as overfishing. This approach assumes that stressors interact additively or synergistically, whereby the combined effect of two stressors is at least the sum of their isolated effects. It is not clear, however, how management should proceed for antagonistic interactions among stressors, where multiple stressors do not have an additive or greater impact. Research to date has focussed on identifying synergisms among stressors, but antagonisms may be just as common. We examined the effectiveness of management when faced with different types of interactions in two systems - seagrass and fish communities - where the global stressor was climate change but the local stressors were different. When there were synergisms, mitigating local stressors delivered greater gains, whereas when there were antagonisms, management of local stressors was ineffective or even degraded ecosystems. These results suggest that reducing a local stressor can compensate for climate change impacts if there is a synergistic interaction. Conversely, if there is an antagonistic interaction, management of local stressors will have the greatest benefits in areas of refuge from climate change. A balanced research agenda, investigating both antagonistic and synergistic interaction types, is needed to inform management priorities.	[Brown, Christopher J.; Saunders, Megan I.] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia; [Brown, Christopher J.; Saunders, Megan I.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Possingham, Hugh P.] Univ Queensland, Australian Res Council, Ctr Excellence Environm Decis, Sch Biol Sci, St Lucia, Qld, Australia; [Richardson, Anthony J.] Commonwealth Sci & Ind Res Org, Climate Adaptat Flagship, Marine & Atmospher Res, Brisbane, Qld, Australia; [Richardson, Anthony J.] Univ Queensland, Ctr Applicat Nat Resource Math, Sch Math & Phys, St Lucia, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Brown, CJ (corresponding author), Univ Queensland, Global Change Inst, St Lucia, Qld, Australia.	c.brown5@uq.edu.au	Saunders, Megan/I-7731-2012; Possingham, Hugh/B-1337-2008; POSSINGHAM, HUGH/R-8310-2019; Brown, Christopher J/G-4287-2011; Richardson, Anthony J/B-3649-2010	Saunders, Megan/0000-0002-8549-5609; Possingham, Hugh/0000-0001-7755-996X; POSSINGHAM, HUGH/0000-0001-7755-996X; Brown, Christopher J/0000-0002-7271-4091; Richardson, Anthony J/0000-0002-9289-7366	Australian Research Council (ARC) Centre of Excellence for Environmental Decisions; ARC; ARC [FT0991722, DP0879365]	Australian Research Council (ARC) Centre of Excellence for Environmental Decisions(Australian Research Council); ARC(Australian Research Council); ARC(Australian Research Council)	CJB's contribution was supported by the Australian Research Council (ARC) Centre of Excellence for Environmental Decisions. MIS was supported by an ARC Super Science Postdoctoral Fellowship. AJR was supported by an ARC Future Fellowship FT0991722. This work forms part of the ARC Discovery Grant DP0879365. ARC: http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba CR, 2013, NAT CLIM CHANGE, V3, P2; Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Ban NC, 2010, MAR POLICY, V34, P876, DOI 10.1016/j.marpol.2010.01.010; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Brown CJ, 2011, GLOBAL CHANGE BIOL, V17, P3697, DOI 10.1111/j.1365-2486.2011.02531.x; Burkholder JM, 2007, J EXP MAR BIOL ECOL, V350, P46, DOI 10.1016/j.jembe.2007.06.024; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Carr JA, 2012, MAR ECOL PROG SER, V448, P289, DOI 10.3354/meps09556; Cote IM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000438; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; Darling ES, 2010, CONSERV LETT, V3, P122, DOI 10.1111/j.1755-263X.2009.00089.x; Ebert TA, 2002, LIMNOL OCEANOGR, V47, P600, DOI 10.4319/lo.2002.47.2.0600; Game ET, 2008, CONSERV BIOL, V22, P1619, DOI 10.1111/j.1523-1739.2008.01037.x; Graham NAJ, 2011, ECOL LETT, V14, P341, DOI 10.1111/j.1461-0248.2011.01592.x; Grantham HS, 2010, FRONT ECOL ENVIRON, V8, P431, DOI 10.1890/080151; Griffith GP, 2012, CONSERV BIOL, V26, P1145, DOI 10.1111/j.1523-1739.2012.01937.x; Griffith GP, 2011, GLOBAL CHANGE BIOL, V17, P3058, DOI 10.1111/j.1365-2486.2011.02453.x; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2010, P NATL ACAD SCI USA, V107, P18312, DOI 10.1073/pnas.0908503107; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Jorda G, 2013, NAT CLIM CHANGE, V3, P3; Jorda G, 2012, NAT CLIM CHANGE, V2, P821, DOI [10.1038/nclimate1533, 10.1038/NCLIMATE1533]; Klein CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012431; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; Mantyka-Pringle CS, 2012, GLOBAL CHANGE BIOL, V18, P1239, DOI 10.1111/j.1365-2486.2011.02593.x; Marba N, 2010, GLOBAL CHANGE BIOL, V16, P2366, DOI 10.1111/j.1365-2486.2009.02130.x; Morgan CL, 2011, LIMITS ADAPTATION RE; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2011, ECOL LETT, V14, P132, DOI 10.1111/j.1461-0248.2010.01562.x; Orth RJ, 2010, ESTUAR COAST, V33, P1144, DOI [10.1007/s12237-009-9234-0, 10.1007/s12237-010-9311-4]; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PARSONS PA, 1991, ANNU REV ECOL SYST, V22, P1, DOI 10.1146/annurev.es.22.110191.000245; Planque B, 2010, J MARINE SYST, V79, P403, DOI 10.1016/j.jmarsys.2008.12.018; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Rasheed MA, 2011, MAR ECOL PROG SER, V422, P93, DOI 10.3354/meps08925; Rietkerk M, 1997, OIKOS, V79, P69, DOI 10.2307/3546091; Saunders DL, 2002, CONSERV BIOL, V16, P30, DOI 10.1046/j.1523-1739.2002.99562.x; Selig ER, 2012, GLOBAL CHANGE BIOL, V18, P1561, DOI 10.1111/j.1365-2486.2012.02658.x; Short FT, 1999, AQUAT BOT, V63, P169, DOI 10.1016/S0304-3770(98)00117-X; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Touchette BW, 2003, ESTUARIES, V26, P142, DOI 10.1007/BF02691701; Vinebrooke RD, 2004, OIKOS, V104, P451, DOI 10.1111/j.0030-1299.2004.13255.x; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009	49	162	163	0	164	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65765	10.1371/journal.pone.0065765	http://dx.doi.org/10.1371/journal.pone.0065765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776542	Green Submitted, Green Published, gold			2022-12-25	WOS:000320322400051
J	Ebina, M; Tsuruta, F; Katoh, MC; Kigoshi, Y; Someya, A; Chiba, T				Ebina, Manato; Tsuruta, Fuminori; Katoh, Megumi C.; Kigoshi, Yu; Someya, Akie; Chiba, Tomoki			Myeloma Overexpressed 2 (Myeov2) Regulates L11 Subnuclear Localization through Nedd8 Modification	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN L11; COP9 SIGNALOSOME; MULTIPLE-MYELOMA; TUMOR-SUPPRESSOR; P53; MDM2; INHIBITION; ARF; ARABIDOPSIS; ACTIVATION	Nucleolus is a dynamic structure that controls biogenesis of ribosomal RNA and senses cellular stresses. Nucleolus contains a number of proteins including ribosomal proteins that conduct cellular stresses to downstream signaling such as p53 pathway. Recently, it has been reported that modification by a ubiquitin-like molecule, Nedd8, regulates subnuclear localization of ribosomal protein L11. Most of L11 is normally localized and neddylated in nucleolus. However, cellular stress triggers deneddylation and redistribution of L11, and subsequent activation of p53. Although Nedd8 modification is thought to be important for L11 localization, the mechanism of how neddylation of L11 is regulated remains largely unknown. Here, we show that Myeloma overexpressed 2 (Myeov2) controls L11 localization through down-regulation of Nedd8 modification. Expression of Myeov2 reduced neddylation of proteins including L11. We also found that Myeov2 associates with L11 and withholds L11 in nucleoplasm. Although Myeov2 interacted with a Nedd8 deconjugation enzyme COP9 signalosome, L11 deneddylation was mediated by another deneddylase Nedp1, independently of Myeov2. Finally, p53 transcriptional activity is upregulated by Myeov2 expression. These data demonstrate that Myeov2 hampers L11 neddylation through their interactions and confines L11 to nucleoplasm to modulate nucleolar integrity. Our findings provide a novel link between oncogenic stress and p53 pathway and may shed light on the protective mechanism against cancer.	[Ebina, Manato; Tsuruta, Fuminori; Katoh, Megumi C.; Kigoshi, Yu; Someya, Akie; Chiba, Tomoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba	Tsuruta, F (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	ftsuruta@gmail.com; tchiba@biol.tsukuba.ac.jp			Ministry of Education, Science, Sports and Culture of Japan; Grants-in-Aid for Scientific Research [23570221] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid from Ministry of Education, Science, Sports and Culture of Japan to FT and TC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Aoki I, 2012, ONCOGENE; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Chan Y, 2008, J CELL SCI, V121, P3218, DOI 10.1242/jcs.030445; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kato JY, 2009, GENES CELLS, V14, P1209, DOI 10.1111/j.1365-2443.2009.01349.x; Kigoshi Y, 2011, J BIOL CHEM, V286, P33613, DOI 10.1074/jbc.M111.245126; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kwok SF, 1996, PLANT PHYSIOL, V110, P731, DOI 10.1104/pp.110.3.731; Lee M. H., 2011, CELL CYCLE, V10, P3057, DOI [DOI 10.4161/CC.10.18, 10.4161/cc.10.18.17320, DOI 10.4161/CC.10.18.17320]; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mahata B, 2012, ONCOGENE, V31, P3060, DOI 10.1038/onc.2011.482; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Nakasone A, 2012, PLANT PHYSIOL, V160, P93, DOI 10.1104/pp.111.188409; Nakasone A, 2009, J PLANT PHYSIOL, V166, P1307, DOI 10.1016/j.jplph.2009.02.005; Ohki Y, 2009, BIOCHEM BIOPH RES CO, V381, P443, DOI 10.1016/j.bbrc.2009.02.090; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Rahman A, 2006, PLANT J, V47, P788, DOI 10.1111/j.1365-313X.2006.02832.x; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; Ruggero D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003477; Sasaki M, 2011, NAT MED, V17, P944, DOI 10.1038/nm.2392; Serino G, 2003, ANNU REV PLANT BIOL, V54, P165, DOI 10.1146/annurev.arplant.54.031902.134847; SMETANA K, 1973, CANCER RES, V33, P2300; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Sundqvist A, 2009, EMBO REP, V10, P1132, DOI 10.1038/embor.2009.178; Suzuki A, 2010, FEBS LETT, V584, P2801, DOI 10.1016/j.febslet.2010.05.020; [汤立军 Tang Lijun], 2003, [中国生物化学与分子生物学报, Chinese Journal of Biochemistry and Molecular Biology], V19, P60; van Marion AMW, 2003, CURR DIAGN PATHOL, V9, P322; Watson IR, 2010, ONCOGENE, V29, P297, DOI 10.1038/onc.2009.314; Watson IR, 2011, CANCER CELL, V19, P168, DOI 10.1016/j.ccr.2011.01.002; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Yanamandra N, 2011, J PHARMACOL EXP THER, V337, P636, DOI 10.1124/jpet.110.172809; Yoneda-Kato N, 2005, EMBO J, V24, P1739, DOI 10.1038/sj.emboj.7600656; YonedaKato N, 1996, ONCOGENE, V12, P265; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	53	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65285	10.1371/journal.pone.0065285	http://dx.doi.org/10.1371/journal.pone.0065285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776465	Green Submitted, gold, Green Published			2022-12-25	WOS:000320322400015
J	Andrisse, S; Patel, GD; Chen, JE; Webber, AM; Spears, LD; Koehler, RM; Robinson-Hill, RM; Ching, JK; Jeong, I; Fisher, JS				Andrisse, Stanley; Patel, Gaytri D.; Chen, Joseph E.; Webber, Andrea M.; Spears, Larry D.; Koehler, Rikki M.; Robinson-Hill, Rona M.; Ching, James K.; Jeong, Imju; Fisher, Jonathan S.			ATM and GLUT1-S490 Phosphorylation Regulate GLUT1 Mediated Transport in Skeletal Muscle	PLOS ONE			English	Article							DEHYDROASCORBIC ACID TRANSPORT; FACTOR-INDEPENDENT SURVIVAL; GROWTH-FACTOR REGULATION; BETA-CELL DYSFUNCTION; GLUCOSE-TRANSPORTER; INSULIN-RESISTANCE; ATAXIA-TELANGIECTASIA; GENE-EXPRESSION; IONIZING-RADIATION; OXIDATIVE STRESS	Objective: The glucose and dehydroascorbic acid (DHA) transporter GLUT1 contains a phosphorylation site, S490, for ataxia telangiectasia mutated (ATM). The objective of this study was to determine whether ATM and GLUT1-S490 regulate GLUT1. Research Design and Methods: L6 myoblasts and mouse skeletal muscles were used to study the effects of ATM inhibition, ATM activation, and S490 mutation on GLUT1 localization, trafficking, and transport activity. Results: In myoblasts, inhibition of ATM significantly diminished cell surface GLUT1, glucose and DHA transport, GLUT1 externalization, and association of GLUT1 with Ga-interacting protein-interacting protein, C-terminus (GIPC1), which has been implicated in recycling of endosomal proteins. In contrast, ATM activation by doxorubicin (DXR) increased DHA transport, cell surface GLUT1, and the GLUT1/GIPC1 association. S490A mutation decreased glucose and DHA transport, cell surface GLUT1, and interaction of GLUT1 with GIPC1, while S490D mutation increased transport, cell surface GLUT1, and the GLUT1/GIPC1 interaction. ATM dysfunction or ATM inhibition reduced DHA transport in extensor digitorum longus (EDL) muscles and decreased glucose transport in EDL and soleus. In contrast, DXR increased DHA transport in EDL. Conclusions: These results provide evidence that ATM and GLUT1-S490 promote cell surface GLUT1 and GLUT1-mediated transport in skeletal muscle associated with upregulation of the GLUT1/GIPC1 interaction.	[Andrisse, Stanley; Patel, Gaytri D.; Chen, Joseph E.; Webber, Andrea M.; Spears, Larry D.; Koehler, Rikki M.; Robinson-Hill, Rona M.; Ching, James K.; Jeong, Imju; Fisher, Jonathan S.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA	Saint Louis University	Fisher, JS (corresponding author), St Louis Univ, Dept Biol, St Louis, MO 63103 USA.	fisherjs@slu.edu	Fisher, Jonathan/A-3095-2008	Fisher, Jonathan/0000-0001-5170-2692; Spears, Larry/0000-0003-2797-684X	National Institute of Diabetes and Digestive and Kidney Diseases [R15DK091904, R15DK080437, R15DK080437-01S2, R15DK080437-01S3]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK080437, R15DK091904] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project was supported by Grant Numbers R15DK091904 and R15DK080437 (through American Recovery and Reinvestment Act supplements R15DK080437-01S2 and R15DK080437-01S3) from the National Institute of Diabetes and Digestive and Kidney Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; BILAN PJ, 1992, BIOCHEM BIOPH RES CO, V186, P1129, DOI 10.1016/0006-291X(92)90864-H; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Carruthers A, 2009, AM J PHYSIOL-ENDOC M, V297, pE836, DOI 10.1152/ajpendo.00496.2009; Cheatham B, 2000, TRENDS ENDOCRIN MET, V11, P356, DOI 10.1016/S1043-2760(00)00308-8; Ching JK, 2013, APPL PHYSL IN PRESS; Ciaraldi TP, 2005, J CLIN ENDOCR METAB, V90, P352, DOI 10.1210/jc.2004-0516; Dauterive R, 1996, J BIOL CHEM, V271, P11414, DOI 10.1074/jbc.271.19.11414; De Rosa S, 2010, CURR VASC PHARMACOL, V8, P259; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; GUILLETDENIAU I, 1994, J CELL SCI, V107, P487; Halaby MJ, 2008, CELL SIGNAL, V20, P1555, DOI 10.1016/j.cellsig.2008.04.011; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hirakawa T, 2003, J BIOL CHEM, V278, P49348, DOI 10.1074/jbc.M306557200; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang J, 2011, CANCER RES, V71, P6310, DOI 10.1158/0008-5472.CAN-10-3397; Im SS, 2007, IUBMB LIFE, V59, P134, DOI 10.1080/15216540701313788; Ishikura S., 2010, CURR PROTOC CELL BIO; Jeong I, 2010, ACTA PHYSIOL, V198, P465, DOI 10.1111/j.1748-1716.2009.02069.x; Ju JS, 2005, AM J PHYSIOL-ENDOC M, V288, pE347, DOI 10.1152/ajpendo.00238.2004; KAHN BB, 1994, J NUTR, V124, pS1289, DOI 10.1093/jn/124.suppl_8.1289S; KAHN BB, 1990, DIABETES CARE, V13, P548, DOI 10.2337/diacare.13.6.548; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kasahara T, 2009, BBA-BIOMEMBRANES, V1788, P1051, DOI 10.1016/j.bbamem.2009.01.014; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; KLIP A, 1992, J CELL BIOCHEM, V48, P51, DOI 10.1002/jcb.240480109; Korcok J, 2003, BRAIN RES, V993, P201, DOI 10.1016/j.brainres.2003.09.016; Krook A, 2004, MED SCI SPORT EXER, V36, P1212, DOI 10.1249/01.MSS.0000132387.25853.3B; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Miles PD, 2007, AM J PHYSIOL-ENDOC M, V293, pE70, DOI 10.1152/ajpendo.00259.2006; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; Murata H, 2000, J BIOL CHEM, V275, P20251, DOI 10.1074/jbc.C000228200; Rainey MD, 2008, CANCER RES, V68, P7466, DOI 10.1158/0008-5472.CAN-08-0763; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; Rudich A, 2003, DIABETOLOGIA, V46, P649, DOI 10.1007/s00125-003-1080-1; Rumsey SC, 1997, J BIOL CHEM, V272, P18982, DOI 10.1074/jbc.272.30.18982; Rumsey SC, 2000, J BIOL CHEM, V275, P28246; Schneider JG, 2006, CELL METAB, V4, P377, DOI 10.1016/j.cmet.2006.10.002; Smith JL, 2004, J APPL PHYSIOL, V97, P2339, DOI 10.1152/japplphysiol.01219.2003; Stiffler MA, 2006, J AM CHEM SOC, V128, P5913, DOI 10.1021/ja060943h; Stuart CA, 2009, J CLIN ENDOCR METAB, V94, P3535, DOI 10.1210/jc.2009-0162; Stumvoll M, 2001, CLIN LAB MED, V21, P31; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; VERHEY KJ, 1993, J CELL BIOL, V123, P137, DOI 10.1083/jcb.123.1.137; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; Wieman HL, 2009, BIOCHEM J, V418, P345, DOI 10.1042/BJ20081422; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wijesekara N, 2006, AM J PHYSIOL-ENDOC M, V290, pE1276, DOI 10.1152/ajpendo.00573.2005; WILSON CM, 1995, FEBS LETT, V368, P19, DOI 10.1016/0014-5793(95)00589-2; Wood IS, 2003, BRIT J NUTR, V89, P3, DOI 10.1079/BJN2002763; Zhang JZ, 2001, AM J PHYSIOL-CELL PH, V280, pC1277, DOI 10.1152/ajpcell.2001.280.5.C1277; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	60	28	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66027	10.1371/journal.pone.0066027	http://dx.doi.org/10.1371/journal.pone.0066027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776597	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400102
J	Bielecki, J; Hoeg, JT; Garm, A				Bielecki, Jan; Hoeg, Jens T.; Garm, Anders			Fixational Eye Movements in the Earliest Stage of Metazoan Evolution	PLOS ONE			English	Article							BOX JELLYFISH; TRIPEDALIA-CYSTOPHORA; LIGHT ADAPTATION; NERVOUS-SYSTEM	All known photoreceptor cells adapt to constant light stimuli, fading the retinal image when exposed to an immobile visual scene. Counter strategies are therefore necessary to prevent blindness, and in mammals this is accomplished by fixational eye movements. Cubomedusae occupy a key position for understanding the evolution of complex visual systems and their eyes are assumedly subject to the same adaptive problems as the vertebrate eye, but lack motor control of their visual system. The morphology of the visual system of cubomedusae ensures a constant orientation of the eyes and a clear division of the visual field, but thereby also a constant retinal image when exposed to stationary visual scenes. Here we show that bell contractions used for swimming in the medusae refresh the retinal image in the upper lens eye of Tripedalia cystophora. This strongly suggests that strategies comparable to fixational eye movements have evolved at the earliest metazoan stage to compensate for the intrinsic property of the photoreceptors. Since the timing and amplitude of the rhopalial movements concur with the spatial and temporal resolution of the eye it circumvents the need for post processing in the central nervous system to remove image blur.	[Bielecki, Jan; Hoeg, Jens T.; Garm, Anders] Univ Copenhagen, Marine Biol Sect, Copenhagen, Denmark	University of Copenhagen	Bielecki, J (corresponding author), Univ Copenhagen, Marine Biol Sect, Copenhagen, Denmark.	jbielecki@bio.ku.dk	Hoeg, Jens Thorvald/D-5784-2015; Garm, Anders/K-4362-2014	Hoeg, Jens Thorvald/0000-0002-3596-1691; Garm, Anders/0000-0002-2080-735X	VILLUM Foundation [VKR022166]	VILLUM Foundation(Villum Fonden)	AG acknowledges the financial support from the VILLUM Foundation (grant# VKR022166). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker A, 2005, DALTON T, P1545, DOI 10.1039/b416246c; BROWN KT, 1968, VISION RES, V8, P633, DOI 10.1016/0042-6989(68)90041-2; Buskey EJ, 2003, MAR BIOL, V142, P225, DOI 10.1007/s00227-002-0938-y; Coates MM, 2003, INTEGR COMP BIOL, V43, P542, DOI 10.1093/icb/43.4.542; DUELLI P, 1978, CELL TISSUE RES, V187, P417; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Fain GL, 2011, MOL NEUROBIOL, V44, P374, DOI 10.1007/s12035-011-8205-1; Fain GL, 2010, CURR BIOL, V20, pR114, DOI 10.1016/j.cub.2009.12.006; Garm A, 2008, J COMP PHYSIOL A, V194, P641, DOI 10.1007/s00359-008-0336-0; Garm A, 2008, VISION RES, V48, P1061, DOI 10.1016/j.visres.2008.01.019; Garm A, 2007, J EXP BIOL, V210, P3616, DOI 10.1242/jeb.004044; Garm A, 2009, J EXP BIOL, V212, P3951, DOI 10.1242/jeb.031559; Garm A, 2011, CURR BIOL, V21, P798, DOI 10.1016/j.cub.2011.03.054; Kaps F, 1996, J EXP BIOL, V199, P2451; Kowler E, 2011, VISION RES, V51, P1457, DOI 10.1016/j.visres.2010.12.014; Koyanagi M, 2008, P NATL ACAD SCI USA, V105, P15576, DOI 10.1073/pnas.0806215105; Laska G., 1982, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V108, P107; LAUGHLIN SB, 1978, J COMP PHYSIOL, V128, P319, DOI 10.1007/BF00657606; MACKIE GO, 1990, AM ZOOL, V30, P907; MAFFEI L, 1981, SCIENCE, V211, P953, DOI 10.1126/science.7466368; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; Nilsson DE, 2009, PHILOS T R SOC B, V364, P2833, DOI 10.1098/rstb.2009.0083; Nilsson DE, 2005, NATURE, V435, P201, DOI 10.1038/nature03484; O'Connor M, 2010, J COMP PHYSIOL A, V196, P213, DOI 10.1007/s00359-010-0506-8; RIGGS LA, 1953, J OPT SOC AM, V43, P495, DOI 10.1364/JOSA.43.000495; Skogh C, 2006, J MORPHOL, V267, P1391, DOI 10.1002/jmor.10472; WEHNER R, 1987, J COMP PHYSIOL A, V161, P511, DOI 10.1007/BF00603659	28	3	3	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66442	10.1371/journal.pone.0066442	http://dx.doi.org/10.1371/journal.pone.0066442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776673	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000320755400146
J	Chen, J; Liu, XJ; Chen, X; Guo, ZH; Liu, J; Hao, JY; Zhang, J				Chen, Jing; Liu, Xinjuan; Chen, Xue; Guo, Zihao; Liu, Juan; Hao, Jianyu; Zhang, Jie			Real-Time Monitoring of miRNA Function in Pancreatic Cell Lines Using Recombinant AAV-Based miRNA Asensors	PLOS ONE			English	Article							MIR-200 FAMILY; MESENCHYMAL TRANSITION; REPRESSORS ZEB1; CANCER; MICRORNA; TELOMERASE; EXPRESSION; MIR-155; ESTABLISHMENT; ASSOCIATION	Background: MicroRNAs (miRNAs) are reportedly involved in pancreatic ductal adenocarcinoma (PDAC) development. Current methods do not allow us to reliably monitor miRNA function. Asensors are adeno-associated virus (AAV) vector miRNA sensors for real-time consecutive functional monitoring of miRNA profiling in living cells. Methods: miR-200a, -200b, -21, -96, -146a, -10a, -155, and -221 in three PDAC cell lines (BxPC-3, CFPAC-1, SW1990), pancreatic epithelioid carcinoma cells (PANC-1), and human pancreatic nestin-expressing cells (hTERT-HPNE) were monitored by Asensors. Subsequently, the real-time consecutive functional profile of all miRNAs was evaluated. Results: Selected miRNAs were detectable in all cell lines with high sensitivity and reproducibility. In the three PDAC cell lines, BxPC-3, CFPAC-1, and SW1990, the calibrated signal unit of the eight miRNAs Asensors was significantly lower than that of the Asensor control. However, in PANC-1 cells, miR-200a and -155 showed upregulation of target gene expression at 24 hours after infection with the sensors; at 48 hours, miR-200b and -155 displayed upregulation of reporter expression; and at 72 hours, reporter gene expression was upregulated by miR-200a and -200b. The result that miRNA could upregulate gene expression was further confirmed in miR-155 of hTERT-HPNE cells. Furthermore, miRNA activity varied among cell/tissue types and time. Conclusion: It is possible that miRNA participates in the pathophysiology of pancreatic cancer, but the current popular methods do not accurately reveal the real-time miRNA function. Thus, this report provided a convenient, accurate, and sensitive approach to miRNA research.	[Chen, Jing; Liu, Xinjuan; Chen, Xue; Guo, Zihao; Hao, Jianyu; Zhang, Jie] Capital Med Univ, Beijing Chaoyang Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Liu, Juan] Zhengzhou Tenth Peoples Hosp, Zhengzhou, Henan, Peoples R China	Capital Medical University	Zhang, J (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Gastroenterol, Beijing, Peoples R China.	zhangjie4155@gmail.com			Wu Jieping Medical Foundation, China [320.6750.09.161, 320.6700.1181]	Wu Jieping Medical Foundation, China	This work is Supported by Wu Jieping Medical Foundation (No. 320.6750.09.161 and 320.6700.1181), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu Aruna, 2011, Genes Cancer, V2, P108, DOI 10.1177/1947601911409212; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Caponi S, 2013, ANN ONCOL, V24, P734, DOI 10.1093/annonc/mds513; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Dong XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013479; du Rieu MC, 2010, CLIN CHEM, V56, P603, DOI 10.1373/clinchem.2009.137364; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Greten FR, 2001, PANCREATOLOGY, V1, P363, DOI 10.1159/000055835; Habbe N, 2009, CANCER BIOL THER, V8, P340, DOI 10.4161/cbt.8.4.7338; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Koorstra JBM, 2008, PANCREATOLOGY, V8, P110, DOI 10.1159/000123838; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee KM, 2005, LAB INVEST, V85, P1003, DOI 10.1038/labinvest.3700298; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li A, 2010, CANCER RES, V70, P5226, DOI 10.1158/0008-5472.CAN-09-4227; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Muckstein U, 2006, BIOINFORMATICS, V22, P1177, DOI 10.1093/bioinformatics/btl024; Negrini M, 2007, J CELL SCI, V120, P1833, DOI 10.1242/jcs.03450; Ouellette MM, 2000, HUM MOL GENET, V9, P403, DOI 10.1093/hmg/9.3.403; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; PARSA I, 1985, CANCER RES, V45, P1285; Qi LQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-163; Qian BY, 2009, BREAST CANCER RES TR, V117, P131, DOI 10.1007/s10549-008-0219-7; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slack FJ, 2008, NEW ENGL J MED, V359, P2720, DOI 10.1056/NEJMe0808667; Tang GL, 2005, TRENDS BIOCHEM SCI, V30, P106, DOI 10.1016/j.tibs.2004.12.007; Tian WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029551; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wagner M, 1998, GASTROENTEROLOGY, V115, P1254, DOI 10.1016/S0016-5085(98)70098-8; Weiss FU, 2009, GASTROENTEROLOGY, V137, P2136, DOI 10.1053/j.gastro.2009.08.065; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141; Yu S, CANC RES, V70, P6015	47	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66315	10.1371/journal.pone.0066315	http://dx.doi.org/10.1371/journal.pone.0066315			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776656	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400136
J	Nikiforuk, A; Kos, T; Fijal, K; Holuj, M; Rafa, D; Popik, P				Nikiforuk, Agnieszka; Kos, Tomasz; Fijal, Katarzyna; Holuj, Malgorzata; Rafa, Dominik; Popik, Piotr			Effects of the Selective 5-HT7 Receptor Antagonist SB-269970 and Amisulpride on Ketamine-Induced Schizophrenia-like Deficits in Rats	PLOS ONE			English	Article							ANIMAL-MODELS; MEMORY; IMPAIRMENT; BLOCKADE; AGONIST; SB-258741; LAUGHTER; CORTEX	A wide body of evidence suggests that 5-HT7 receptors are implicated in a variety of central nervous system functions, including control of learning and memory processes. According to recent preclinical data, the selective blockade of these receptors may be a potential target for cognitive improvement in schizophrenia. The first aim of the present study was to evaluate the effects of the selective 5-HT7 receptor antagonist, SB-269970, and the antipsychotic drug with a high affinity for 5-HT7 receptors, amisulpride, on ketamine-induced deficits in attentional set-shifting and novel object recognition tasks in rats. Because the role of 5-HT7 receptor blockade in ameliorating positive and negative symptoms of schizophrenia remains equivocal, the second aim of these experiments was to examine the effectiveness of SB-269970 and amisulpride in reversing ketamine-induced deficits in prepulse inhibition of the startle reflex and in social interaction test in rats. The study revealed that acute administration of SB-269970 (1 mg/kg) or amisulpride (3 mg/kg) ameliorated ketamine-induced cognitive inflexibility and novel object recognition deficit in rats. Both compounds were also effective in attenuating ketamine-evoked disruption of social interactions. In contrast, neither SB-269970 nor amisulpride affected ketamine-disrupted prepulse inhibition or 50 kHz USVs accompanying social behaviour. In conclusion, antagonism of 5-HT7 receptors may represent a useful pharmacological approach in the treatment of cognitive deficits and some negative symptoms of schizophrenia.	[Nikiforuk, Agnieszka; Kos, Tomasz; Fijal, Katarzyna; Holuj, Malgorzata; Rafa, Dominik; Popik, Piotr] Polish Acad Sci, Inst Pharmacol, Dept Behav Neurosci & Drug Dev, Krakow, Poland	Polish Academy of Sciences	Nikiforuk, A (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Behav Neurosci & Drug Dev, Krakow, Poland.	nikifor@if-pan.krakow.pl	Popik, Piotr/R-5383-2016	Popik, Piotr/0000-0003-0722-1263; Nikiforuk, Agnieszka/0000-0002-2424-8348; Holuj, Malgorzata/0000-0001-7867-0643	Statutory Funds of the Institute of Pharmacology; Polish Academy of Sciences and project "Prokog'' [UDA-POIG.01.03.01-12-063/09-00]; European Union from the European Fund of Regional Development (EFRD)	Statutory Funds of the Institute of Pharmacology; Polish Academy of Sciences and project "Prokog''; European Union from the European Fund of Regional Development (EFRD)	This study was supported by the Statutory Funds of the Institute of Pharmacology, the Polish Academy of Sciences and project "Prokog,'' UDA-POIG.01.03.01-12-063/09-00, co-financed by the European Union from the European Fund of Regional Development (EFRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AI, 2009, PSYCHOPHARMACOLOGY, V205, P119, DOI 10.1007/s00213-009-1521-8; BAKSHI VP, 1994, J PHARMACOL EXP THER, V271, P787; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bonaventure P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020210; Cifariello A, 2008, BEHAV BRAIN RES, V195, P171, DOI 10.1016/j.bbr.2007.12.012; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Forbes IT, 2002, BIOORG MED CHEM LETT, V12, P3341, DOI 10.1016/S0960-894X(02)00690-X; Galici R, 2008, BEHAV PHARMACOL, V19, P153, DOI 10.1097/FBP.0b013e3282f62d8c; Gastambide F, 2013, EUR NEUROPSYCHOPHARM, DOI [10.1016/j.euro-neuro.2013.03.002, DOI 10.1016/J.EUR0-NEUR0.2013.03.002]; Gilmour G, 2013, NEUROSCI BIOBEHAV R, V37, P2125, DOI 10.1016/j.neubiorev.2012.04.006; Hagan JJ, 2000, BRIT J PHARMACOL, V130, P539, DOI 10.1038/sj.bjp.0703357; Hedlund PB, 2009, PSYCHOPHARMACOLOGY, V206, P345, DOI 10.1007/s00213-009-1626-0; Horiguchi M, 2011, J PHARMACOL EXP THER, V338, P605, DOI 10.1124/jpet.111.180638; Horisawa T, 2011, BEHAV BRAIN RES, V220, P83, DOI 10.1016/j.bbr.2011.01.034; Ishibashi T, 2010, J PHARMACOL EXP THER, V334, P171, DOI 10.1124/jpet.110.167346; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Leopoldo M, 2011, PHARMACOL THERAPEUT, V129, P120, DOI 10.1016/j.pharmthera.2010.08.013; Liy-Salmeron G, 2008, HIPPOCAMPUS, V18, P965, DOI 10.1002/hipo.20459; Lopuch S, 2011, J COMP PSYCHOL, V125, P250, DOI 10.1037/a0021532; Mahe C, 2004, EUR J PHARMACOL, V495, P97, DOI 10.1016/j.ejphar.2004.05.033; Matthys A, 2011, MOL NEUROBIOL, V43, P228, DOI 10.1007/s12035-011-8175-3; McLean SL, 2009, PSYCHOPHARMACOLOGY, V206, P403, DOI 10.1007/s00213-009-1618-0; Meneses A, 2004, BEHAV BRAIN RES, V155, P275, DOI 10.1016/j.bbr.2004.04.026; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Neill JC, 2010, PHARMACOL THERAPEUT, V128, P419, DOI 10.1016/j.pharmthera.2010.07.004; Newcomer JW, 1999, NEUROPSYCHOPHARMACOL, V20, P106, DOI 10.1016/S0893-133X(98)00067-0; Nikiforuk A, 2012, BEHAV BRAIN RES, V226, P118, DOI 10.1016/j.bbr.2011.09.006; Nikiforuk A, 2010, EUR NEUROPSYCHOPHARM, V20, P37, DOI 10.1016/j.euroneuro.2009.08.001; Nuechterlein KH, 2004, SCHIZOPHR RES, V72, P29, DOI 10.1016/j.schres.2004.09.007; Panksepp J, 2005, SCIENCE, V308, P62, DOI 10.1126/science.1112066; Panksepp J, 2000, BEHAV BRAIN RES, V115, P25, DOI 10.1016/S0166-4328(00)00238-2; Pouzet B, 2002, PHARMACOL BIOCHEM BE, V71, P655, DOI 10.1016/S0091-3057(01)00744-4; Roberts AJ, 2004, EUR J NEUROSCI, V19, P1913, DOI 10.1111/j.1460-9568.2004.03288.x; Roberts AJ, 2012, HIPPOCAMPUS, V22, P762, DOI 10.1002/hipo.20938; Sarkisyan G, 2009, BEHAV BRAIN RES, V202, P26, DOI 10.1016/j.bbr.2009.03.011; Semenova S, 2008, BIOL PSYCHIAT, V63, P98, DOI 10.1016/j.biopsych.2006.12.011; Slot LAB, 2005, NEUROPHARMACOLOGY, V49, P996, DOI 10.1016/j.neuropharm.2005.05.013; Snigdha S, 2008, BEHAV BRAIN RES, V191, P26, DOI 10.1016/j.bbr.2008.03.018; Varty GB, 1999, NEUROPSYCHOPHARMACOL, V20, P311, DOI 10.1016/S0893-133X(98)00072-4; Waters KA, 2012, BEHAV BRAIN RES, V228, P211, DOI 10.1016/j.bbr.2011.12.009; Watson DJG, 2012, INT J NEUROPSYCHOPH, V15, P471, DOI 10.1017/S1461145711000435; Wesolowska A, 2008, PHARMACOL REP, V60, P464; Wesolowska A, 2006, NEUROPHARMACOLOGY, V51, P578, DOI 10.1016/j.neuropharm.2006.04.017; Willey AR, 2009, BEHAV BRAIN RES, V202, P122, DOI 10.1016/j.bbr.2009.03.025; Wright JM, 2013, PSYCHOPHARMACOLOGY, V225, P853, DOI 10.1007/s00213-012-2871-1; Young JW, 2009, PHARMACOL THERAPEUT, V122, P150, DOI 10.1016/j.pharmthera.2009.02.004	47	77	84	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66695	10.1371/journal.pone.0066695	http://dx.doi.org/10.1371/journal.pone.0066695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776692	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400153
J	Shyamasundar, S; Jadhav, SP; Bay, BH; Tay, SSW; Kumar, SD; Rangasamy, D; Dheen, ST				Shyamasundar, Sukanya; Jadhav, Shweta P.; Bay, Boon Huat; Tay, Samuel Sam Wah; Kumar, S. Dinesh; Rangasamy, Danny; Dheen, S. Thameem			Analysis of Epigenetic Factors in Mouse Embryonic Neural Stem Cells Exposed to Hyperglycemia	PLOS ONE			English	Article							ALTERED GENE-EXPRESSION; NEURONAL MIGRATION; DIABETIC PREGNANCY; DNA METHYLATION; CONGENITAL-ANOMALIES; MICRORNA EXPRESSION; FATE SPECIFICATION; LIS1; MIR-124; MALFORMATIONS	Background: Maternal diabetes alters gene expression leading to neural tube defects (NTDs) in the developing brain. The mechanistic pathways that deregulate the gene expression remain unknown. It is hypothesized that exposure of neural stem cells (NSCs) to high glucose/hyperglycemia results in activation of epigenetic mechanisms which alter gene expression and cell fate during brain development. Methods and Findings: NSCs were isolated from normal pregnancy and streptozotocin induced-diabetic pregnancy and cultured in physiological glucose. In order to examine hyperglycemia induced epigenetic changes in NSCs, chromatin reorganization, global histone status at lysine 9 residue of histone H3 (acetylation and trimethylation) and global DNA methylation were examined and found to be altered by hyperglycemia. In NSCs, hyperglycemia increased the expression of Dcx (Doublecortin) and Pafah1b1 (Platelet activating factor acetyl hydrolase, isoform 1b, subunit 1) proteins concomitant with decreased expression of four microRNAs (mmu-miR-200a, mmu-miR-200b, mmu-miR-466a-3p and mmu-miR-466 d-3p) predicted to target these genes. Knockdown of specific microRNAs in NSCs resulted in increased expression of Dcx and Pafah1b1 proteins confirming target prediction and altered NSC fate by increasing the expression of neuronal and glial lineage markers. Conclusion/Interpretation: This study revealed that hyperglycemia alters the epigenetic mechanisms in NSCs, resulting in altered expression of some development control genes which may form the basis for the NTDs. Since epigenetic changes are reversible, they may be valuable therapeutic targets in order to improve fetal outcomes in diabetic pregnancy.	[Shyamasundar, Sukanya; Jadhav, Shweta P.; Bay, Boon Huat; Tay, Samuel Sam Wah; Dheen, S. Thameem] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore; [Kumar, S. Dinesh] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 639798, Singapore; [Rangasamy, Danny] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Australian National University; John Curtin School of Medical Research	Dheen, ST (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore.	antstd@nus.edu.sg	Dheen, S. Thameem/AAU-8627-2020; Srinivasan, Dinesh Kumar/E-6383-2017; , sukanya/K-2638-2019; Srinivasan, Dinesh Kumar/A-9872-2008; Srinivasan, Dinesh Kumar/P-6528-2019	Srinivasan, Dinesh Kumar/0000-0001-6535-5441; Srinivasan, Dinesh Kumar/0000-0001-6535-5441; Dheen, S. Thameem/0000-0001-9600-6789	NUS bridging fund [R-181-000-130-720]	NUS bridging fund	This study is supported by the NUS bridging fund R-181-000-130-720. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Caspi M, 2000, HUM MOL GENET, V9, P2205, DOI 10.1093/oxfordjournals.hmg.a018911; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Dimitri P, 2005, BIOESSAYS, V27, P29, DOI 10.1002/bies.20158; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; ERIKSSON UJ, 1995, DIABETES METAB REV, V11, P63, DOI 10.1002/dmr.5610110106; Filipovic R, 2012, STEM CELLS, V30, P1852, DOI 10.1002/stem.1162; Fu J, 2006, DIABETOLOGIA, V49, P1027, DOI 10.1007/s00125-006-0153-3; Fu J, 2007, J NEUROCHEM, V103, P1654, DOI 10.1111/j.1471-4159.2007.04880.x; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gambello MJ, 2003, J NEUROSCI, V23, P1719; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Guerrini R, 2008, TRENDS NEUROSCI, V31, P154, DOI 10.1016/j.tins.2007.12.004; HANSON U, 1990, DIABETOLOGIA, V33, P100, DOI 10.1007/BF00401047; Hirotsune S, 1998, NAT GENET, V19, P333, DOI 10.1038/1221; Hsieh J, 2004, CURR OPIN GENET DEV, V14, P461, DOI 10.1016/j.gde.2004.07.006; Hu XL, 2012, PROTEIN CELL, V3, P278, DOI 10.1007/s13238-012-2916-6; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Jiang B, 2008, J NEUROSCI RES, V86, P3481, DOI 10.1002/jnr.21800; Jones PL, 1999, SEMIN CANCER BIOL, V9, P339, DOI 10.1006/scbi.1999.0134; Junien C, 2006, J INHERIT METAB DIS, V29, P359, DOI 10.1007/s10545-006-0299-7; Karali M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-715; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; KITZMILLER JL, 1991, JAMA-J AM MED ASSOC, V265, P731, DOI 10.1001/jama.265.6.731; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; KUCERA J, 1971, J REPROD MED, V7, P73; Liao DM, 2004, DIABETOLOGIA, V47, P523, DOI 10.1007/s00125-004-1351-5; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeken MR, 2005, AM J MED GENET C, V135C, P77, DOI 10.1002/ajmg.c.30056; Maiorano NA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-40; Miao F, 2007, J BIOL CHEM, V282, P13854, DOI 10.1074/jbc.M609446200; MILLS JL, 1979, DIABETES, V28, P292, DOI 10.2337/diabetes.28.4.292; MILLS JL, 1982, TERATOLOGY, V25, P385, DOI 10.1002/tera.1420250316; Morshead CM, 2003, EUR J NEUROSCI, V18, P76, DOI 10.1046/j.1460-9568.2003.02727.x; Namihira M, 2008, PHILOS T R SOC B, V363, P2099, DOI 10.1098/rstb.2008.2262; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Pramparo T, 2010, J NEUROSCI, V30, P3002, DOI 10.1523/JNEUROSCI.4851-09.2010; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; ter Braak EWMT, 2002, DIABETES-METAB RES, V18, P96, DOI 10.1002/dmrr.271; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; Villeneuve LM, 2008, P NATL ACAD SCI USA, V105, P9047, DOI 10.1073/pnas.0803623105; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Waterland RA, 2006, J NUTR, V136, p1706S, DOI 10.1093/jn/136.6.1706S; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576	56	34	37	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65945	10.1371/journal.pone.0065945	http://dx.doi.org/10.1371/journal.pone.0065945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776576	Green Published, gold			2022-12-25	WOS:000320755400087
J	Voncken, F; Gao, F; Wadforth, C; Harley, M; Colasante, C				Voncken, Frank; Gao, Fei; Wadforth, Cath; Harley, Maggie; Colasante, Claudia			The Phosphoarginine Energy-Buffering System of Trypanosoma brucei Involves Multiple Arginine Kinase Isoforms with Different Subcellular Locations	PLOS ONE			English	Article							OXIDATIVE STRESS; BLOOD-STREAM; ADENYLATE KINASE; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL EXPRESSION; ATP DEPLETION; CELL BIOLOGY; GENE FAMILY; CRUZI; PROTEIN	Phosphagen energy-buffering systems play an essential role in regulating the cellular energy homeostasis in periods of high-energy demand or energy supply fluctuations. Here we describe the phosphoarginine/arginine kinase system of the kinetoplastid parasite Trypanosoma brucei, consisting of three highly similar arginine kinase isoforms (TbAK1-3). Immunofluorescence microscopy using myc-tagged protein versions revealed that each isoform is located in a specific subcellular compartment: TbAK1 is exclusively found in the flagellum, TbAK2 in the glycosome, and TbAK3 in the cytosol of T. brucei. The flagellar location of TbAK1 is dependent on a 22 amino acid long N-terminal sequence, which is sufficient for targeting a GFP-fusion protein to the trypanosome flagellum. The glycosomal location of TbAK2 is in agreement with the presence of a conserved peroxisomal targeting signal, the C-terminal tripeptide 'SNL'. TbAK3 lacks any apparent targeting sequences and is accordingly located in the cytosol of the parasite. Northern blot analysis indicated that each TbAK isoform is differentially expressed in bloodstream and procyclic forms of T. brucei, while the total cellular arginine kinase activity was 3-fold higher in bloodstream form trypanosomes. These results suggest a substantial change in the temporal and spatial energy requirements during parasite differentiation. Increased arginine kinase activity improved growth of procyclic form T. brucei during oxidative challenges with hydrogen peroxide. Elimination of the total cellular arginine kinase activity by RNA interference significantly decreased growth (>90%) of procyclic form T. brucei under standard culture conditions and was lethal for this life cycle stage in the presence of hydrogen peroxide. The putative physiological roles of the different TbAK isoforms in T. brucei are further discussed.	[Voncken, Frank; Gao, Fei; Wadforth, Cath; Harley, Maggie; Colasante, Claudia] Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Colasante, Claudia] Univ Giessen, Inst Anat & Zellbiol 2, D-35390 Giessen, Germany	University of Hull; Justus Liebig University Giessen	Voncken, F (corresponding author), Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England.	F.Voncken@hull.ac.uk	Colasante, Claudia/AAO-1230-2021	Voncken, Frank/0000-0002-2929-276X; Colasante, Claudia/0000-0002-5760-4919				Agalakova NI, 2012, ENVIRON TOXICOL PHAR, V34, P334, DOI 10.1016/j.etap.2012.05.006; Amery L, 1998, BIOCHEM J, V336, P367, DOI 10.1042/bj3360367; Azzi A, 2004, PROTEIN SCI, V13, P575, DOI 10.1110/ps.03428304; Benz C, 2005, MOL BIOCHEM PARASIT, V143, P125, DOI 10.1016/j.molbiopara.2005.05.008; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; Binder M, 2001, J IMMUNOL, V167, P5470, DOI 10.4049/jimmunol.167.9.5470; Boscardin SB, 2010, J CELL MOL MED, V14, P1373, DOI 10.1111/j.1582-4934.2010.01007.x; Bouvier LA, 2006, BBA-GEN SUBJECTS, V1760, P913, DOI 10.1016/j.bbagen.2006.02.013; Brems S, 2005, MOL BIOCHEM PARASIT, V139, P163, DOI 10.1016/j.molbiopara.2004.11.004; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Canepa GE, 2011, COMP BIOCHEM PHYS B, V160, P40, DOI 10.1016/j.cbpb.2011.05.006; Canonaco F, 2002, J BIOL CHEM, V277, P31303, DOI 10.1074/jbc.M204052200; Canonaco F, 2003, BIOTECHNOL LETT, V25, P1013, DOI 10.1023/A:1024172518062; Chamberlin ME, 1997, J EXP BIOL, V200, P2789; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Colasante C, 2007, MOL BIOCHEM PARASIT, V151, P193, DOI 10.1016/j.molbiopara.2006.11.003; Colasante C, 2006, PROTEOMICS, V6, P3275, DOI 10.1002/pmic.200500668; Colasante C, 2009, MOL BIOCHEM PARASIT, V167, P104, DOI 10.1016/j.molbiopara.2009.05.004; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; Fenn K, 2007, CURR OPIN MICROBIOL, V10, P539, DOI 10.1016/j.mib.2007.09.014; Fernandez P, 2007, PROTEINS, V69, P209, DOI 10.1002/prot.21557; Fridberg A, 2007, PARASITOL RES, V100, P205, DOI 10.1007/s00436-006-0329-2; Ginger ML, 2005, J BIOL CHEM, V280, P11781, DOI 10.1074/jbc.M413821200; GLOVER JR, 1994, P NATL ACAD SCI USA, V91, P10541, DOI 10.1073/pnas.91.22.10541; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Hart SR, 2009, J AM SOC MASS SPECTR, V20, P167, DOI 10.1016/j.jasms.2008.08.014; HIRD FJR, 1985, COMP BIOCHEM PHYS B, V80, P517, DOI 10.1016/0305-0491(85)90283-4; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hoffman GG, 2011, COMP BIOCHEM PHYS D, V6, P171, DOI 10.1016/j.cbd.2011.02.004; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Lee MS, 1997, PLANT CELL, V9, P185, DOI 10.1105/tpc.9.2.185; Lorenz P, 1998, EMBO J, V17, P3542, DOI 10.1093/emboj/17.13.3542; MacLeod ET, 2007, PARASITOLOGY, V134, P827, DOI 10.1017/S0031182007002247; Macleod ET, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000239; Malvy D, 2011, CLIN MICROBIOL INFEC, V17, P986, DOI 10.1111/j.1469-0691.2011.03536.x; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; MICHELS PAM, 1989, EXP PARASITOL, V69, P310, DOI 10.1016/0014-4894(89)90079-9; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Miranda MR, 2006, EXP PARASITOL, V114, P341, DOI 10.1016/j.exppara.2006.04.004; Miranda MR, 2009, PARASITOLOGY, V136, P1201, DOI 10.1017/S0031182009990448; Mitchell BF, 2005, MOL BIOL CELL, V16, P4509, DOI 10.1091/mbc.E05-04-0347; NEVO AC, 1970, J THEOR BIOL, V26, P11, DOI 10.1016/S0022-5193(70)80027-3; Noguchi M, 2001, J EXP BIOL, V204, P1063; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; OVERATH P, 1986, EUR J BIOCHEM, V160, P175, DOI 10.1111/j.1432-1033.1986.tb09955.x; Pena-Diaz P, 2012, J BIOL CHEM, V287, P41861, DOI 10.1074/jbc.M112.404699; Pereira CA, 2000, J BIOL CHEM, V275, P1495, DOI 10.1074/jbc.275.2.1495; Pereira CA, 2003, FEBS LETT, V554, P201, DOI 10.1016/S0014-5793(03)01171-2; Pereira CA, 2002, J EUKARYOT MICROBIOL, V49, P82, DOI 10.1111/j.1550-7408.2002.tb00346.x; Pereira Claudio A, 2011, Enzyme Res, V2011, P576483, DOI 10.4061/2011/576483; Pullen TJ, 2004, MOL BIOL CELL, V15, P3257, DOI 10.1091/mbc.E04-03-0217; Ralston KS, 2009, ANNU REV MICROBIOL, V63, P335, DOI 10.1146/annurev.micro.091208.073353; RATTO A, 1989, EUR J BIOCHEM, V186, P195, DOI 10.1111/j.1432-1033.1989.tb15195.x; Saleh MA, 2009, VET PARASITOL, V162, P192, DOI 10.1016/j.vetpar.2009.03.035; Snapp EL, 1999, J BIOL CHEM, V274, P29543, DOI 10.1074/jbc.274.41.29543; SOMMER JM, 1994, ANNU REV MICROBIOL, V48, P105, DOI 10.1146/annurev.mi.48.100194.000541; Subramani S, 2002, J CELL BIOL, V156, P415, DOI 10.1083/jcb.200112122; Tiwari BS, 2002, PLANT PHYSIOL, V128, P1271, DOI 10.1104/pp.010999; TOMBES RM, 1985, CELL, V41, P325, DOI 10.1016/0092-8674(85)90085-6; Turrens Julio F., 2004, Molecular Aspects of Medicine, V25, P211, DOI 10.1016/j.mam.2004.02.021; van Hellemond JJ, 2005, BIOCHEM SOC T, V33, P967, DOI 10.1042/BST20050967; Viant MR, 2001, J CHROMATOGR B, V765, P107, DOI 10.1016/S0378-4347(01)00428-5; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Voncken F, 2003, J BIOL CHEM, V278, P35299, DOI 10.1074/jbc.M301811200; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; WATTS DC, 1970, NATURE, V226, P450, DOI 10.1038/226450a0; Wright-Weber B, 2006, BBA-GEN SUBJECTS, V1760, P364, DOI 10.1016/j.bbagen.2005.11.005	69	42	46	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65908	10.1371/journal.pone.0065908	http://dx.doi.org/10.1371/journal.pone.0065908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776565	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400079
J	Del Lama, LS; de Goes, EG; Petchevist, PCD; Moretto, EL; Borges, JC; Covas, DT; de Almeida, A				Del Lama, Lucas Sacchini; de Goes, Evamberto Garcia; Dias Petchevist, Paulo Cesar; Moretto, Edson Lara; Borges, Jose Carlos; Covas, Dimas Tadeu; de Almeida, Adelaide			Prevention of Transfusion-Associated Graft-versus-Host Disease by Irradiation: Technical Aspect of a New Ferrous Sulphate Dosimetric System	PLOS ONE			English	Article							FRICKE XYLENOL GEL; RADIATION-DOSE DISTRIBUTIONS; NUCLEAR-MAGNETIC-RESONANCE; BLOOD IRRADIATION; IMMUNOCOMPETENT PATIENTS; OPTICAL TOMOGRAPHY; QUALITY-CONTROL; T-CELLS; LYMPHOCYTES; VALIDATION	Irradiation of whole blood and blood components before transfusion is currently the only accepted method to prevent Transfusion-Associated Graft-Versus-Host-Disease (TA-GVHD). However, choosing the appropriate technique to determine the dosimetric parameters associated with blood irradiation remains an issue. We propose a dosimetric system based on the standard Fricke Xylenol Gel (FXG) dosimeter and an appropriate phantom. The modified dosimeter was previously calibrated using a Co-60 teletherapy unit and its validation was accomplished with a Cs-137 blood irradiator. An ionization chamber, standard FXG, radiochromic film and thermoluminescent dosimeters (TLDs) were used as reference dosimeters to determine the dose response and dose rate of the Co-60 unit. The dose distributions in a blood irradiator were determined with the modified FXG, the radiochromic film, and measurements by TLD dosimeters. A linear response for absorbed doses up to 54 Gy was obtained with our system. Additionally, the dose rate uncertainties carried out with gel dosimetry were lower than 5% and differences lower than 4% were noted when the absorbed dose responses were compared with ionization chamber, film and TLDs.	[Del Lama, Lucas Sacchini; Dias Petchevist, Paulo Cesar; de Almeida, Adelaide] Univ Sao Paulo FFCLRP USP, Sch Philosophy Sci & Letters Ribeirao Preto, Dept Phys, Ribeirao Preto, SP, Brazil; [de Goes, Evamberto Garcia] Fed Univ Rio Grande IMEF FURG, Math Stat & Phys Inst, Rio Grande, RS, Brazil; [Moretto, Edson Lara; Borges, Jose Carlos; Covas, Dimas Tadeu] Reg Blood Ctr Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Covas, Dimas Tadeu] Univ Sao Paulo, Sch Med Ribeirao Preto, Ctr Cell Based Therapy, BR-14049 Ribeirao Preto, SP, Brazil	Universidade Federal do Rio Grande; Universidade de Sao Paulo	Del Lama, LS (corresponding author), Univ Sao Paulo FFCLRP USP, Sch Philosophy Sci & Letters Ribeirao Preto, Dept Phys, Ribeirao Preto, SP, Brazil.	lucasdellama@gmail.com	Del Lama, Lucas/D-9232-2013; Covas, Dimas T/C-5431-2013; Covas, Dimas/AAL-8499-2021; CTC USP, CEPID 13 18/J-8951-2014	Covas, Dimas T/0000-0002-7364-2595; CTC USP, CEPID 13 18/0000-0002-7123-9524	CAPES; Regional Blood Center of Ribeirao Preto, Brazil	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Regional Blood Center of Ribeirao Preto, Brazil	This study was partially funded by CAPES (http://www.capes.gov.br/) and the Regional Blood Center of Ribeirao Preto, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AABB, 2011, TECHNICAL REPORT; Agbaht K, 2007, TRANSFUSION, V47, P1405, DOI 10.1111/j.1537-2995.2007.01282.x; Ahya R, 1998, HEART, V80, P299, DOI 10.1136/hrt.80.3.299; AKAHOSHI M, 1992, TRANSFUSION, V32, P169, DOI 10.1046/j.1537-2995.1992.32292180149.x; Almond PR, 1999, MED PHYS, V26, P1847, DOI 10.1118/1.598691; Alva M, 2010, J PHYS C SERIES, V250; ANDERSON KC, 1990, NEW ENGL J MED, V323, P315; ANDREWS HL, 1957, REV SCI INSTRUM, V28, P329, DOI 10.1063/1.1715877; [Anonymous], 1983, MED PHYS, V10, P741; [Anonymous], 1993, 50 ICRU; [Anonymous], 1998, PHYSICS; Aoun E, 2003, TRANSFUSION, V43, P1672, DOI 10.1046/j.0041-1132.2003.00578.x; ARSURA EL, 1988, ARCH INTERN MED, V148, P1941, DOI 10.1001/archinte.148.9.1941; Attix F.H., 2008, INTRO RADIOLOGICAL P; AUKETT RJ, 1991, BRIT J RADIOL, V64, P918, DOI 10.1259/0007-1285-64-766-918; BCSH, 2010, TECHNICAL REPORT; Bero M, 2009, J PHYS C SERIES, V164; Bero M. A., 2000, Journal of Radiological Protection, V20, P287, DOI 10.1088/0952-4746/20/3/303; Bero MA, 2001, RADIAT PHYS CHEM, V61, P433, DOI 10.1016/S0969-806X(01)00289-4; Bero MA, 2000, NUCL INSTRUM METH B, V166, P820, DOI 10.1016/S0168-583X(99)00873-3; Bero MA, 2004, J PHYS C SERIES, V3; Bogner L, 1998, STRAHLENTHER ONKOL, V174, P431, DOI 10.1007/BF03038566; BRUBAKER DB, 1983, VOX SANG, V45, P401, DOI 10.1111/j.1423-0410.1983.tb01937.x; BURNS LJ, 1984, ACTA HAEMATOL-BASEL, V71, P270, DOI 10.1159/000206599; Butson MJ, 1999, TRANSFUSION MED, V9, P205; Calcina CSG, 2007, PHYS MED BIOL, V52, P1431, DOI 10.1088/0031-9155/52/5/014; Caldeira AMF, 2007, NUCL INSTRUM METH A, V582, P484, DOI 10.1016/j.nima.2007.09.001; Caldeira AMF, 2007, APPL RADIAT ISOTOPES, V65, P605, DOI 10.1016/j.apradiso.2007.01.012; Cavinato CC, 2010, HELS SUC P 3 EUR IRP; Chapman J, 1996, TRANSFUSION MED, V6, P261, DOI 10.1111/j.1365-3148.1996.tb00078.x; Chen F, 2001, APPL RADIAT ISOTOPES, V55, P13, DOI 10.1016/S0969-8043(00)00379-1; Cheung T, 2001, PHYS MED BIOL, V46, pN241, DOI 10.1088/0031-9155/46/10/402; Council of Europe, 2011, TECHNICAL REPORT; CROWLEY JP, 1974, VOX SANG, V26, P513, DOI 10.1111/j.1423-0410.1974.tb02728.x; Czelusniak C, 2010, J PHYS C SERIES, V250; DAY MJ, 1990, PHYS MED BIOL, V35, P1605, DOI 10.1088/0031-9155/35/12/001; DAY MJ, 1950, NATURE, V166, P146, DOI 10.1038/166146a0; de Oliveiraa LN, 2007, BRAZ J PHYS, V37, P1141, DOI 10.1590/S0103-97332007000700012; Doran SJ, 2001, PHYS MED BIOL, V46, P3191, DOI 10.1088/0031-9155/46/12/309; DROBYSKI W, 1989, BLOOD, V74, P2285; Fainstein C, 2000, APPL RADIAT ISOTOPES, V52, P1195, DOI 10.1016/S0969-8043(00)00070-1; FDA, 1993, TECHNICAL REPORT; FERRARA JLM, 1991, NEW ENGL J MED, V324, P667; Fricke H, 1927, AM J ROENTGENOL RADI, V18, P430; Fricke H., 1966, RADIATION DOSIMETRY, V2, P167; GAMBARINI G, 1994, PHYS MED BIOL, V39, P703, DOI 10.1088/0031-9155/39/4/004; Gambarini G, 2004, NUCL INSTRUM METH B, V213, P321, DOI 10.1016/S0168-583X(03)01636-7; Gambarini G, 1999, NUCL INSTRUM METH A, V422, P643, DOI 10.1016/S0168-9002(98)00975-9; Goes EG, 2006, TRANSFUSION, V46, P34, DOI 10.1111/j.1537-2995.2005.00669.x; GORE JC, 1984, PHYS MED BIOL, V29, P1189, DOI 10.1088/0031-9155/29/10/002; Gorman TE, 2000, AM J CLIN PATHOL, V113, P732, DOI 10.1309/QE5G-N5QX-GQWX-N04M; GRAW RG, 1970, LANCET, V2, P338; GREENBAUM BH, 1991, J CLIN ONCOL, V9, P1889, DOI 10.1200/JCO.1991.9.10.1889; HAYASHI H, 1993, ANESTHESIOLOGY, V79, P1419, DOI 10.1097/00000542-199312000-00034; HAZLE JD, 1991, PHYS MED BIOL, V36, P1117, DOI 10.1088/0031-9155/36/8/007; HILLYER CD, 1993, TRANSFUSION, V33, P898, DOI 10.1046/j.1537-2995.1993.331194082379.x; HOLLAND PV, 1989, ARCH PATHOL LAB MED, V113, P285; IAEA, 2000, TECHNICAL REPORT SER, V398; Ibbott G. S., 2004, Journal of Physics: Conference Series, V3, P58, DOI 10.1088/1742-6596/3/1/007; ICRU, 1989, 44 ICRU; ICRU, 1984, 35 ICRU; ISO/ASTM, 2005, TECHNICAL REPORT; JAMIESON NV, 1991, TRANSPLANT INT, V4, P67, DOI 10.1111/j.1432-2277.1991.tb01950.x; Jenneson PM, 1999, IEEE NUCL SCI CONF R, P538, DOI 10.1109/NSSMIC.1999.842542; Johns HE, 1983, PHYS RADIOLOGY; Joint Committee for Guides in Metrology, 2008, TECHNICAL REPORT; JUJI T, 1989, NEW ENGL J MED, V321, P56; Kelly RG, 1998, MED PHYS, V25, P1741, DOI 10.1118/1.598356; KERNAN NA, 1986, BLOOD, V68, P770; Khan FM, 2009, PHYS RAD THERAPY; Kilic SS, 2010, J INVEST ALLERG CLIN, V20, P153; Klein HG, 2006, TRANSFUSION, V46, P878, DOI 10.1111/j.1537-2995.2006.00853.x; KOBAYASHI H, 1993, AM J HEMATOL, V43, P51, DOI 10.1002/ajh.2830430112; KORNGOLD R, 1993, AM J PEDIAT HEMATOL, V15, P18; Kron T, 1997, MAGN RESON IMAGING, V15, P211, DOI 10.1016/S0730-725X(96)00352-9; Kronholz HL, 1998, INFUSIONSTHERAPIE, V25, P56; Kumar TK, 1997, RADIAT PHYS CHEM, V50, P545, DOI 10.1016/S0969-806X(97)00089-3; LAW J, 1970, PHYS MED BIOL, V15, P741, DOI 10.1088/0031-9155/15/4/016; LEITMAN SF, 1993, TRANSFUSION, V33, P447, DOI 10.1046/j.1537-2995.1993.33693296804.x; LOWENTHAL RM, 1993, TRANSFUSION, V33, P524, DOI 10.1046/j.1537-2995.1993.33693296818.x; Luban NLC, 2000, TRANSFUSION, V40, P348, DOI 10.1046/j.1537-2995.2000.40030348.x; MASTERSON ME, 1992, MED PHYS, V19, P649, DOI 10.1118/1.596809; MATTSSON LO, 1982, ACTA RADIOL ONCOL, V21, P139, DOI 10.3109/02841868209133997; MCLAUGHLIN WL, 1996, APPL RADIAT ISOTOPES, pS67; Moroff G, 1997, TRANSFUS MED REV, V11, P15, DOI 10.1016/S0887-7963(97)80006-5; Moroff G, 1997, TRANSFUSION, V37, P1084, DOI 10.1046/j.1537-2995.1997.371098016450.x; Neves JF, 2010, TRANSFUSION, V50, P2484, DOI 10.1111/j.1537-2995.2010.02705.x; NIST, 2010, XRAY MASS ATT COEFF; Nollet KE, 2003, TRANSFUSION, V43, P1655, DOI 10.1111/j.0041-1132.2003.00635.x; OCONNOR NTJ, 1992, J CLIN PATHOL, V45, P621, DOI 10.1136/jcp.45.7.621; OHTO H, 1992, TRANSFUSION, V32, P691, DOI 10.1046/j.1537-2995.1992.32792391051.x; Ohto H, 1996, TRANSFUS MED REV, V10, P31, DOI 10.1016/S0887-7963(96)80121-0; OLSSON LE, 1989, PHYS MED BIOL, V34, P43, DOI 10.1088/0031-9155/34/1/004; Orlin J B, 1997, Curr Opin Hematol, V4, P442; Oto OA, 2006, EUR J INTERN MED, V17, P151, DOI 10.1016/j.ejim.2005.10.011; PARKMAN R, 1974, NEW ENGL J MED, V290, P359, DOI 10.1056/NEJM197402142900703; Patel KK, 2010, INDIAN J HEMATOL BLO, V26, P92, DOI 10.1007/s12288-010-0028-0; PELSZYNSKI MM, 1994, BLOOD, V83, P1683; PETZ LD, 1993, TRANSFUSION, V33, P742, DOI 10.1046/j.1537-2995.1993.33994025025.x; Podgorsak E.B., 2005, RAD ONCOLOGY PHYS; Przepiorka D, 1996, AM J CLIN PATHOL, V106, P6; ROSEN NR, 1993, TRANSFUSION, V33, P125, DOI 10.1046/j.1537-2995.1993.33293158043.x; Rososhansky S, 1999, VOX SANG, V76, P59, DOI 10.1046/j.1423-0410.1999.7610059.x; Sampaio FGA, 2013, IEEE T NUCL SCI, V60, P810, DOI 10.1109/TNS.2013.2240464; Sampaio FGA, 2011, NUCL INSTRUM METH B, V269, P3141, DOI 10.1016/j.nimb.2011.04.097; Sato R, 2009, NUCL INSTRUM METH B, V267, P842, DOI 10.1016/j.nimb.2008.12.012; Schreiner L. J., 2004, Journal of Physics: Conference Series, V3, P9, DOI 10.1088/1742-6596/3/1/003; Serefhanoglu K, 2005, J NATL MED ASSOC, V97, P418; SHORTT KR, 1989, PHYS MED BIOL, V34, P1923, DOI 10.1088/0031-9155/34/12/014; SPRENT J, 1974, EUR J IMMUNOL, V4, P204, DOI 10.1002/eji.1830040310; SPROUL AM, 1992, BRIT J HAEMATOL, V80, P251, DOI 10.1111/j.1365-2141.1992.tb08908.x; Tahler M, 1989, NEW ENGL J MED, V321, P25; Tarte BJ, 1997, MED PHYS, V24, P1521, DOI 10.1118/1.598041; Taylor ML, 2008, AUSTRALAS PHYS ENG S, V31, P131, DOI 10.1007/BF03178587; THOMAS ED, 1961, ARCH INTERN MED, V107, P829, DOI 10.1001/archinte.1961.03620060029006; Treleaven J, 2011, BRIT J HAEMATOL, V152, P35, DOI 10.1111/j.1365-2141.2010.08444.x; Triulzi D, 2006, TRANSFUSION, V46, P885, DOI 10.1111/j.1537-2995.2006.00819.x; VANDERMAST BJ, 1994, LANCET, V343, P753, DOI 10.1016/S0140-6736(94)91836-8; Vergote K, 2004, PHYS MED BIOL, V49, P287, DOI 10.1088/0031-9155/49/2/008; VONFLIEDNER V, 1982, AM J MED, V72, P951; Wolodzko JG, 1999, MED PHYS, V26, P2508, DOI 10.1118/1.598772	121	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65334	10.1371/journal.pone.0065334	http://dx.doi.org/10.1371/journal.pone.0065334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762345	Green Published, gold			2022-12-25	WOS:000321094800041
J	Lian, H; Hu, W; Huang, R; Du, FK; Liao, LJ; Zhu, ZY; Wang, YP				Lian, Hao; Hu, Wei; Huang, Rong; Du, Fukuan; Liao, Lanjie; Zhu, Zuoyan; Wang, Yaping			Transgenic Common Carp Do Not Have the Ability to Expand Populations	PLOS ONE			English	Article							POSSIBLE ECOLOGICAL RISKS; ATLANTIC SALMON; GROWTH ENHANCEMENT; METABOLIC-RATE; NILE TILAPIA; FISH; PERFORMANCE; FOOD; COMPETE; SPERM	The ecological safety of transgenic organisms is an important issue of international public and political concern. The assessment of ecological risks is also crucial for realizing the beneficial industrial application of transgenic organisms. In this study, reproduction of common carp (Cyprinus carpio, CC) in isolated natural aquatic environments was analyzed. Using the method of paternity testing, a comparative analysis was conducted on the structure of an offspring population of "all-fish" growth hormone gene-transgenic common carp (afgh-CC) and of wild CC to evaluate their fertility and juvenile viability. Experimental results showed that in a natural aquatic environment, the ratio of comparative advantage in mating ability of afgh-CC over wild CC was 1: 1, showing nearly identical mating competitiveness. Juvenile viability of afgh-CC was low, and the average daily survival rate was less than 98.00%. After a possible accidental escape or release of transgenic CC into natural aquatic environments they are unable to monopolize resources from eggs of natural CC populations, leading to the extinction of transgenic CC. Transgenic CC are also unlikely to form dominant populations in natural aquatic environments due to their low juvenile viability. Thus, it is expected that the proportion of afgh-CC in the natural environment would remain low or gradually decline, and ultimately disappear.	[Lian, Hao; Hu, Wei; Huang, Rong; Du, Fukuan; Liao, Lanjie; Zhu, Zuoyan; Wang, Yaping] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Lian, Hao] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, YP (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	Wangyp.ihb@gmail.com			Development Plan of the State Key Fundamental Research of China [2009CB118701]; National Natural Science Foundation of China [30771664]	Development Plan of the State Key Fundamental Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by grants from the Development Plan of the State Key Fundamental Research of China (Grant No. 2009CB118701), and the National Natural Science Foundation of China (Grant No. 30771664). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekkevold D, 2002, MOL ECOL, V11, P91, DOI 10.1046/j.0962-1083.2001.01424.x; Bessey C, 2004, T AM FISH SOC, V133, P1205, DOI 10.1577/T04-010.1; Cook JT, 2000, AQUACULTURE, V188, P15, DOI 10.1016/S0044-8486(00)00331-8; Cook JT, 2000, AQUACULTURE, V188, P33, DOI 10.1016/S0044-8486(00)00332-X; Crooijmans RPMA, 1997, ANIM GENET, V28, P129, DOI 10.1111/j.1365-2052.1997.00097.x; David L, 2001, MOL GENET GENOMICS, V266, P353, DOI 10.1007/s004380100569; Devlin R.H., 1992, TRANSGENIC FISH, P229, DOI DOI 10.1142/1678; Devlin RH, 1999, AQUAC RES, V30, P479, DOI 10.1046/j.1365-2109.1999.00359.x; Devlin RH, 2004, P NATL ACAD SCI USA, V101, P9303, DOI 10.1073/pnas.0400023101; DU SJ, 1992, BIO-TECHNOL, V10, P176, DOI 10.1038/nbt0292-176; Duan M, 2010, J APPL ICHTHYOL, V26, P908, DOI 10.1111/j.1439-0426.2010.01479.x; Duan M, 2009, J FISH BIOL, V75, P1459, DOI 10.1111/j.1095-8649.2009.02393.x; Duan M, 2011, AQUACULTURE, V317, P175, DOI 10.1016/j.aquaculture.2011.04.013; Farrell AP, 1997, CAN J ZOOL, V75, P335, DOI 10.1139/z97-043; Fitzpatrick JL, 2011, AQUACULTURE, V312, P185, DOI 10.1016/j.aquaculture.2010.11.044; Fu C, 2007, J FISH BIOL, V70, P347, DOI 10.1111/j.1095-8649.2007.01301.x; Gage MJG, 1995, PHILOS T R SOC B, V350, P391, DOI 10.1098/rstb.1995.0173; Guan B, 2010, CHINESE SCI BULL, V55, P4032, DOI 10.1007/s11434-010-4165-5; Guan B, 2008, AQUACULTURE, V284, P217, DOI 10.1016/j.aquaculture.2008.06.028; Hallennan EM, 2007, APPL ANIM BEHAV SCI, V104, P265, DOI 10.1016/j.applanim.2006.09.008; Howard RD, 2004, P NATL ACAD SCI USA, V101, P2934, DOI 10.1073/pnas.0306285101; Kobayashi SI, 2007, AQUACULTURE, V270, P427, DOI 10.1016/j.aquaculture.2007.05.016; Lee CG, 2003, J FISH BIOL, V62, P753, DOI 10.1046/j.1095-8649.2003.00057.x; Li D, 2009, J FISH BIOL, V74, P186, DOI 10.1111/j.1095-8649.2008.02128.x; Li DS, 1961, INLAND FISH FARMING, P11; Li MD, 1989, FISH ECOLOGY; Maclean N, 2000, FISH FISH, V1, P146, DOI 10.1046/j.1467-2979.2000.00014.x; McKenzie DJ, 2003, J FISH BIOL, V63, P398, DOI 10.1046/j.1095-8649.2003.00162.x; Muir WM, 2002, TRANSGENIC RES, V11, P101, DOI 10.1023/A:1015203812200; Muir WM, 1999, P NATL ACAD SCI USA, V96, P13853, DOI 10.1073/pnas.96.24.13853; Nam YK, 2001, TRANSGENIC RES, V10, P353, DOI 10.1023/A:1016696104185; Quan Ying-chun, 2005, Zoological Research, V26, P595; Rahman MA, 1998, TRANSGENIC RES, V7, P357, DOI 10.1023/A:1008837105299; Rahman MA, 2001, J FISH BIOL, V59, P62, DOI [10.1111/j.1095-8649.2001.tb02338.x, 10.1006/jfbi.2001.1622]; Rahman MA, 1999, AQUACULTURE, V173, P333, DOI 10.1016/S0044-8486(98)00456-6; Slate J, 2000, MOL ECOL, V9, P801, DOI 10.1046/j.1365-294x.2000.00930.x; Sundstrom LF, 2004, P ROY SOC B-BIOL SCI, V271, pS350, DOI 10.1098/rsbl.2004.0189; TSAI HJ, 1995, CAN J FISH AQUAT SCI, V52, P776, DOI 10.1139/f95-077; Wang YP, 2001, CHINESE SCI BULL, V46, P226; Yang, 1981, FRESHW FISH, V1, P31; Zhang T, 2006, 7 INT C BIOL FISH ST, P18; ZHU Z, 1985, Zeitschrift fuer Angewandte Ichthyologie, V1, P31; Zhu Z, 1986, CHINESE SCI BULL, V31, P387	43	7	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65506	10.1371/journal.pone.0065506	http://dx.doi.org/10.1371/journal.pone.0065506			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762383	Green Submitted, gold, Green Published			2022-12-25	WOS:000321094800056
J	Okumura, LM; Lesch, BJ; Page, DC				Okumura, Leah M.; Lesch, Bluma J.; Page, David C.			The Ligand Binding Domain of GCNF Is Not Required for Repression of Pluripotency Genes in Mouse Fetal Ovarian Germ Cells	PLOS ONE			English	Article							NUCLEAR FACTOR; TRANSCRIPTION FACTOR; PREIMPLANTATION EMBRYOS; MAMMALIAN EMBRYO; OCT4 EXPRESSION; STEM-CELLS; DIFFERENTIATION; NANOG; DYNAMICS; EPIBLAST	In mice, successful development and reproduction require that all cells, including germ cells, transition from a pluripotent to a differentiated state. This transition is associated with silencing of the pluripotency genes Oct4 and Nanog. Interestingly, these genes are repressed at different developmental timepoints in germ and somatic cells. Ovarian germ cells maintain their expression until about embryonic day (E) 14.5, whereas somatic cells silence them much earlier, at about E8.0. In both somatic cells and embryonic stem cells, silencing of Oct4 and Nanog requires the nuclear receptor GCNF. However, expression of the Gcnf gene has not been investigated in fetal ovarian germ cells, and whether it is required for silencing Oct4 and Nanog in that context is not known. Here we demonstrate that Gcnf is expressed in fetal ovarian germ cells, peaking at E14.5, when Oct4 and Nanog are silenced. However, conditional ablation of the ligand-binding domain of Gcnf using a ubiquitous, tamoxifen-inducible Cre indicates that Gcnf is not required for the down-regulation of pluripotency genes in fetal ovarian germ cells, nor is it required for initiation of meiosis and oogenesis. These results suggest that the silencing of Oct4 and Nanog in germ cells occurs via a different mechanism from that operating in somatic cells during gastrulation.	[Okumura, Leah M.; Lesch, Bluma J.; Page, David C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Okumura, Leah M.; Lesch, Bluma J.; Page, David C.] Whitehead Inst, Cambridge, MA 02142 USA; [Okumura, Leah M.; Lesch, Bluma J.; Page, David C.] MIT, Dept Biol, Cambridge, MA USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Lesch, BJ (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	leschb@wi.mit.edu; dcpage@wi.mit.edu			Howard Hughes Medical Institute; National Institutes of Health/National Human Genome Research Institute [2R01HG00257-20]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000257] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health/National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by Howard Hughes Medical Institute and by National Institutes of Health/National Human Genome Research Institute (2R01HG00257-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung ACK, 2001, MOL CELL BIOL, V21, P663, DOI 10.1128/MCB.21.2.663-677.2001; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Gill ME, 2011, P NATL ACAD SCI USA, V108, P7443, DOI 10.1073/pnas.1104501108; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Lan ZJ, 2002, J BIOL CHEM, V277, P50660, DOI 10.1074/jbc.M209586200; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Prieto I, 2004, CHROMOSOME RES, V12, P197, DOI 10.1023/B:CHRO.0000021945.83198.0e; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Susens U, 1997, DEV NEUROSCI-BASEL, V19, P410, DOI 10.1159/000111238; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yamaguchi S, 2009, DEVELOPMENT, V136, P4011, DOI 10.1242/dev.041160; Yan ZJ, 2000, J BIOL CHEM, V275, P35077, DOI 10.1074/jbc.M005566200; Yang JX, 2005, P NATL ACAD SCI USA, V102, P5755, DOI 10.1073/pnas.0408718102; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yu JY, 2001, BIOL REPROD, V65, P1260, DOI 10.1095/biolreprod65.4.1260	27	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66062	10.1371/journal.pone.0066062	http://dx.doi.org/10.1371/journal.pone.0066062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762465	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800087
J	Overvliet, KE; Krampe, RT; Wagemans, J				Overvliet, Krista E.; Krampe, Ralf Th.; Wagemans, Johan			Grouping by Proximity in Haptic Contour Detection	PLOS ONE			English	Article							VISUAL-SEARCH; GESTALT PSYCHOLOGY; SERIAL SEARCH; PERCEPTION; TACTILE; HAND; RECOGNITION; SIMILARITY; MOVEMENTS; STIMULUS	We investigated the applicability of the Gestalt principle of perceptual grouping by proximity in the haptic modality. To do so, we investigated the influence of element proximity on haptic contour detection. In the course of four sessions ten participants performed a haptic contour detection task in which they freely explored a haptic random dot display that contained a contour in 50% of the trials. A contour was defined by a higher density of elements ( raised dots), relative to the background surface. Proximity of the contour elements as well as the average proximity of background elements was systematically varied. We hypothesized that if proximity of contour elements influences haptic contour detection, detection will be more likely when contour elements are in closer proximity. This should be irrespective of the ratio with the proximity of the background elements. Results showed indeed that the closer the contour elements were, the higher the detection rates. Moreover, this was the case independent of the contour/background ratio. We conclude that the Gestalt law of proximity applies to haptic contour detection.	[Overvliet, Krista E.; Krampe, Ralf Th.; Wagemans, Johan] Univ Leuven KU Leuven, Expt Psychol Lab, Louvain, Belgium	KU Leuven	Overvliet, KE (corresponding author), Univ Leuven KU Leuven, Expt Psychol Lab, Louvain, Belgium.	Krista.Overvliet@gmail.com	Wagemans, Johan/M-3878-2019; Overvliet, Krista/J-9214-2014	Overvliet, Krista/0000-0002-3537-8172; Krampe, Ralf/0000-0002-6150-2317; Wagemans, Johan/0000-0002-7970-1541	Flemish government [METH/08/02]; FWO [1.2.610.11.N.00]	Flemish government(European Commission); FWO(FWO)	The authors were supported by a Methusalem grant by the Flemish government (METH/08/02, awarded to JW) and an FWO post-doctoral fellowship (1.2.610.11.N.00, awarded to KO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azanon E, 2010, CURR BIOL, V20, P1304, DOI 10.1016/j.cub.2010.05.063; Chang D., 2007, 8 AUSTR US INT C AUI; Demeyer M, 2012, BEHAV RES METHODS, V44, P439, DOI 10.3758/s13428-011-0167-8; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Harrar V, 2007, PERCEPTION, V36, P1455, DOI 10.1068/p5844; Koffka K, 1922, PSYCHOL BULL, V19, P531, DOI 10.1037/h0072422; LEDERMAN SJ, 1990, PERCEPT PSYCHOPHYS, V47, P54, DOI 10.3758/BF03208164; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Overvliet KE, 2008, ACTA PSYCHOL, V129, P83, DOI 10.1016/j.actpsy.2008.04.011; Overvliet KE, 2008, ACTA PSYCHOL, V127, P51, DOI 10.1016/j.actpsy.2007.01.001; Overvliet KE, 2007, PERCEPT PSYCHOPHYS, V69, P1059, DOI 10.3758/BF03193944; Overvliet KE, 2007, EXP BRAIN RES, V182, P427, DOI 10.1007/s00221-007-0998-9; Overvliet KE, PSYCHOL AGI IN PRESS; Overvliet KE, 2012, J EXP PSYCHOL HUMAN, V38, P817, DOI 10.1037/a0029222; Overvliet KE, 2011, NEUROPSYCHOLOGIA, V49, P3046, DOI 10.1016/j.neuropsychologia.2011.07.005; Overvliet KE, 2010, EXP BRAIN RES, V202, P261, DOI 10.1007/s00221-009-2127-4; Palmer SE, 2003, ACTA PSYCHOL, V114, P311, DOI 10.1016/j.actpsy.2003.06.003; PHILLIPS JR, 1992, J NEUROSCI, V12, P827; TREISMAN A, 1982, J EXP PSYCHOL HUMAN, V8, P194, DOI 10.1037/0096-1523.8.2.194; UTTAL WR, 1970, PERCEPT PSYCHOPHYS, V8, P385, DOI 10.3758/BF03207029; VALLBO AB, 1984, HUM NEUROBIOL, V3, P3; Wagemans J, 2012, PSYCHOL BULL, V138, P1172, DOI 10.1037/a0029333; Wagemans J, 2012, PSYCHOL BULL, V138, P1218, DOI 10.1037/a0029334; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; Wertheimer M, 1912, Z PSYCHOL PHYSIOL SI, V61, P161; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419	26	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65412	10.1371/journal.pone.0065412	http://dx.doi.org/10.1371/journal.pone.0065412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173QU	23762364	Green Submitted, Green Published, gold			2022-12-25	WOS:000321094800046
J	Zheng, J; Rubin, EJ; Bifani, P; Mathys, V; Lim, V; Au, M; Jang, J; Nam, J; Dick, T; Walker, JR; Pethe, K; Camacho, LR				Zheng, Jun; Rubin, Eric J.; Bifani, Pablo; Mathys, Vanessa; Lim, Vivian; Au, Melvin; Jang, Jichan; Nam, Jiyoun; Dick, Thomas; Walker, John R.; Pethe, Kevin; Camacho, Luis R.			para-Aminosalicylic Acid Is a Prodrug Targeting Dihydrofolate Reductase in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROPTEROATE SYNTHASE; CRYSTAL-STRUCTURE; RIBOFLAVIN; EXPRESSION; RESISTANCE; EFFICIENT; REVEALS; WR99210; SCREEN; BCG	para-Aminosalicylic acid (PAS) is one of the antimycobacterial drugs currently used for multidrug-resistant tuberculosis. Although it has been in clinical use for over 60 years, its mechanism(s) of action remains elusive. Here we report that PAS is a prodrug targeting dihydrofolate reductase (DHFR) through an unusual and novel mechanism of action. We provide evidences that PAS is incorporated into the folate pathway by dihydropteroate synthase (DHPS) and dihydrofolate synthase (DHFS) to generate a hydroxyl dihydrofolate antimetabolite, which in turn inhibits DHFR enzymatic activity. Interestingly, PAS is recognized by DHPS as efficiently as its natural substrate para-amino benzoic acid. Chemical inhibition of DHPS or mutation in DHFS prevents the formation of the antimetabolite, thereby conferring resistance to PAS. In addition, we identified a bifunctional enzyme (riboflavin biosynthesis protein (RibD)), a putative functional analog of DHFR in a knock-out strain. This finding is further supported by the identification of PAS-resistant clinical isolates encoding a RibD overexpression mutation displaying cross-resistance to genuine DHFR inhibitors. Our findings reveal that a metabolite of PAS inhibits DHFR in the folate pathway. RibD was shown to act as a functional analog of DHFR, and as for DHFS, both were shown to be associated in PAS resistance in laboratory strains and clinical isolates.	[Zheng, Jun; Bifani, Pablo; Lim, Vivian; Au, Melvin; Dick, Thomas; Camacho, Luis R.] Novartis Inst Trop Dis, Singapore 138670, Singapore; [Rubin, Eric J.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Mathys, Vanessa] Sci Inst Publ Hlth, Inst Pasteur, Lab Mol Pathol TB, B-1050 Brussels, Belgium; [Jang, Jichan; Nam, Jiyoun; Pethe, Kevin] Inst Pasteur Korea, Songnam 463400, South Korea; [Walker, John R.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Novartis; Harvard University; Harvard T.H. Chan School of Public Health; Institut Pasteur Korea; Novartis	Zheng, J (corresponding author), Vela Res Pte Ltd, Singapore 117406, Singapore.	zhjunyy@hotmail.com; camacholuis112@gmail.com	Dick, Thomas/AAC-4824-2019; Zheng, Jun/AAN-4698-2020; Pethe, Kevin/F-9495-2015; Pethe, Kevin/L-1199-2013; Dick, Thomas/AAB-4109-2019	Zheng, Jun/0000-0001-6329-4518; Pethe, Kevin/0000-0003-0297-0150; Dick, Thomas/0000-0002-9604-9452; Pethe, Kevin/0000-0003-0916-8873; Bifani, Pablo/0000-0001-9651-6439; Rubin, Eric/0000-0001-5120-962X	Korean Ministry of Education, Science and Technology	Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We acknowledge several scientists at Novartis: Bryan Yeung, Ravinder Kondreddi, and Ranga Rao for providing NITD344; Boon Heng Lee and Koh Sin for technical help with MIC assays and LC/MS analysis; Whitney Barnes for whole genome sequencing; Veronique Dartois for critical review of the manuscript; and Paul Smith for support and stimulating discussions. The Institute Pasteur-Korea receives support from the Korean Ministry of Education, Science and Technology.	Achari A, 1997, NAT STRUCT BIOL, V4, P490, DOI 10.1038/nsb0697-490; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; BROWN GM, 1982, ADV ENZYMOL RAMB, V53, P345; Chakraborty S, 2013, SCIENCE, V339, P88, DOI 10.1126/science.1228980; Chen SC, 2006, J BIOL CHEM, V281, P7605, DOI 10.1074/jbc.M510254200; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Forgacs P, 2009, ANTIMICROB AGENTS CH, V53, P4789, DOI 10.1128/AAC.01658-08; Freuler F, 2008, PROTEIN EXPRES PURIF, V59, P232, DOI 10.1016/j.pep.2008.02.003; Gengenbacher M, 2008, FEMS MICROBIOL LETT, V287, P128, DOI 10.1111/j.1574-6968.2008.01302.x; Gerum AB, 2002, ANTIMICROB AGENTS CH, V46, P3362, DOI 10.1128/AAC.46.11.3362-3369.2002; Green J. C., 1996, ESCHERICHIA COLI SAL, P665; HekmatNejad M, 1997, EXP PARASITOL, V87, P222, DOI 10.1006/expr.1997.4228; Kurabachew M, 2008, J ANTIMICROB CHEMOTH, V62, P713, DOI 10.1093/jac/dkn269; LEHMANN J, 1946, LANCET, V250, P15; Li RB, 2000, J MOL BIOL, V295, P307, DOI 10.1006/jmbi.1999.3328; Mathieu M, 2005, J BIOL CHEM, V280, P18916, DOI 10.1074/jbc.M413799200; Mathys V, 2009, ANTIMICROB AGENTS CH, V53, P2100, DOI 10.1128/AAC.01197-08; Nopponpunth V, 1999, J BACTERIOL, V181, P6814, DOI 10.1128/JB.181.21.6814-6821.1999; Ong W, 2010, ANTIMICROB AGENTS CH, V54, P2748, DOI 10.1128/AAC.00029-10; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Park SW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002264; Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060; RATLEDGE C, 1972, AM REV RESPIR DIS, V106, P774, DOI 10.1164/arrd.1972.106.5.774; Rengarajan J, 2004, MOL MICROBIOL, V53, P275, DOI 10.1111/j.1365-2958.2004.04120.x; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schmitt EK, 2011, ANGEW CHEM INT EDIT, V50, P5889, DOI 10.1002/anie.201101740; SCHWEITZER BI, 1990, FASEB J, V4, P2441, DOI 10.1096/fasebj.4.8.2185970; SHIOTA T, 1964, J BIOL CHEM, V239, P2259; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108; WHO, 2011, WORLD REPORT ON DISABILITY, P1; YOUMANS GP, 1947, J BACTERIOL, V54, P409, DOI 10.1128/JB.54.4.409-416.1947; Young PG, 2008, ACTA CRYSTALLOGR D, V64, P745, DOI 10.1107/S0907444908012262	33	115	120	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23447	23456		10.1074/jbc.M113.475798	http://dx.doi.org/10.1074/jbc.M113.475798			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23779105	hybrid, Green Published			2022-12-25	WOS:000330598200051
J	Chen, DQ; Fang, L; Li, HJ; Tang, MS; Jin, CY				Chen, Danqi; Fang, Lei; Li, Hongjie; Tang, Moon-shong; Jin, Chunyuan			Cigarette Smoke Component Acrolein Modulates Chromatin Assembly by Inhibiting Histone Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cigarette Smoke; Epigenetics; Histone Modification; Nucleosome; Transcription; Acrolein; Chromatin Assembly	LUNG-CANCER; TRANSCRIPTIONAL RESPONSES; MUTATIONAL HOTSPOTS; GENE-EXPRESSION; DNA-DAMAGE; CELL-CYCLE; REPLICATION; VARIANTS; BINDING; ACTIVATION	Chromatin structure and gene expression are both regulated by nucleosome assembly. How environmental factors influence histone nuclear import and the nucleosome assembly pathway, leading to changes in chromatin organization and transcription, remains unknown. Acrolein (Acr) is an ,-unsaturated aldehyde, which is abundant in the environment, especially in cigarette smoke. It has recently been implicated as a potential major carcinogen of smoking-related lung cancer. Here we show that Acr forms adducts with histone proteins in vitro and in vivo and preferentially reacts with free histones rather than with nucleosomal histones. Cellular fractionation analyses reveal that Acr exposure specifically inhibits acetylations of N-terminal tails of cytosolic histones H3 and H4, modifications that are important for nuclear import and chromatin assembly. Notably, Acr exposure compromises the delivery of histone H3 into chromatin and increases chromatin accessibility. Moreover, changes in nucleosome occupancy at several genomic loci are correlated with transcriptional responses to Acr exposure. Our data provide new insights into mechanisms whereby environmental factors interact with the genome and influence genome function.	NYU, Sch Med, Dept Environm Med, New York, NY 10987 USA; NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10987 USA	New York University; New York University	Jin, CY (corresponding author), 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	Chunyuan.jin@nyumc.org	Chen, Danqi/AAP-1269-2020; Jin, Chunyuan/GRX-9623-2022	Fang, Lei/0000-0002-2582-4845	National Institutes of Health, NIEHS, Center of Excellence Pilot Project [5 P30 ES000260-47]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS, Center of Excellence Pilot Project; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health, NIEHS, Center of Excellence Pilot Project Grant 5 P30 ES000260-47 (to C.J.).	Adkins MW, 2004, J BIOL CHEM, V279, P52069, DOI 10.1074/jbc.M406113200; Aldini G, 2011, MOL NUTR FOOD RES, V55, P1301, DOI 10.1002/mnfr.201100182; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Bein K, 2011, MOL NUTR FOOD RES, V55, P1342, DOI 10.1002/mnfr.201100279; Burcham PC, 2008, MINI-REV MED CHEM, V8, P319, DOI 10.2174/138955708783955953; Burcham PC, 2010, CHEM-BIOL INTERACT, V183, P416, DOI 10.1016/j.cbi.2009.12.006; Burcham PC, 2010, ANTIOXID REDOX SIGN, V12, P337, DOI 10.1089/ars.2009.2817; CHUNG FL, 1984, CANCER RES, V44, P990; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Ejlassi-Lassallette A, 2012, BIOCHEM CELL BIOL, V90, P14, DOI [10.1139/o11-044, 10.1139/O11-044]; Ejlassi-Lassallette A, 2011, MOL BIOL CELL, V22, P245, DOI 10.1091/mbc.E10-07-0633; Faroon O, 2008, TOXICOL IND HEALTH, V24, P447, DOI 10.1177/0748233708094188; Faroon O, 2008, TOXICOL IND HEALTH, V24, P543, DOI 10.1177/0748233708098124; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; Gossett AJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002771; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; HAN M, 1987, CELL, V48, P589, DOI 10.1016/0092-8674(87)90237-6; Hecht SS, 2006, P NATL ACAD SCI USA, V103, P15725, DOI 10.1073/pnas.0607811103; Jin C, 2006, P NATL ACAD SCI USA, V103, P574, DOI 10.1073/pnas.0509974103; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; KIM UJ, 1988, EMBO J, V7, P2211, DOI 10.1002/j.1460-2075.1988.tb03060.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li HJ, 2007, J CLIN INVEST, V117, P1314, DOI 10.1172/JCI31222; Li HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002353; Li Q, 2012, BBA-GENE REGUL MECH, V1819, P238, DOI 10.1016/j.bbagrm.2011.06.013; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Lu K, 2008, CHEM RES TOXICOL, V21, P1586, DOI 10.1021/tx8000576; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luo J, 2007, AM J PHYSIOL-HEART C, V293, pH3673, DOI 10.1152/ajpheart.00284.2007; Mercado C, 2007, CURR HYPERTENS REP, V9, P66, DOI 10.1007/s11906-007-0012-8; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Polo SE, 2006, CURR OPIN GENET DEV, V16, P104, DOI 10.1016/j.gde.2006.02.011; Singh M, 2010, J ALZHEIMERS DIS, V21, P741, DOI 10.3233/JAD-2010-100405; Sithu SD, 2010, TOXICOL APPL PHARM, V248, P100, DOI 10.1016/j.taap.2010.07.013; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Stevens JF, 2011, MOL NUTR FOOD RES, V55, P1275, DOI 10.1002/mnfr.201190034; Tang MS, 2011, MOL NUTR FOOD RES, V55, P1291, DOI 10.1002/mnfr.201100148; Thompson CA, 2008, TOXICOL IN VITRO, V22, P844, DOI 10.1016/j.tiv.2007.12.018; Thompson CA, 2008, CHEM RES TOXICOL, V21, P2245, DOI 10.1021/tx8001934; Tirumalai R, 2002, TOXICOL LETT, V132, P27, DOI 10.1016/S0378-4274(02)00055-3; Valacchi G, 2005, ANTIOXID REDOX SIGN, V7, P25, DOI 10.1089/ars.2005.7.25; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Wang HT, 2013, CARCINOGENESIS, V34, P220, DOI 10.1093/carcin/bgs323; Wang HT, 2012, J BIOL CHEM, V287, P12379, DOI 10.1074/jbc.M111.329623; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Zhang H, 2012, J BIOL CHEM, V287, P6573, DOI 10.1074/jbc.M111.312637; Zhou X, 2009, TOXICOL APPL PHARM, V236, P78, DOI 10.1016/j.taap.2009.01.009; Zhu Y, 2012, BBA-GENE REGUL MECH, V1819, P343, DOI 10.1016/j.bbagrm.2011.07.012	50	54	56	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21678	21687		10.1074/jbc.M113.476630	http://dx.doi.org/10.1074/jbc.M113.476630			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23770671	Green Published, hybrid			2022-12-25	WOS:000328841900020
J	Larabee, JL; Shakir, SM; Barua, S; Ballard, JD				Larabee, Jason L.; Shakir, Salika M.; Barua, Soumitra; Ballard, Jimmy D.			Increased cAMP in Monocytes Augments Notch Signaling Mechanisms by Elevating RBP-J and Transducin-like Enhancer of Split (TLE)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Bacterial Toxins; Cyclic AMP (cAMP); Monocytes; Notch Pathway	ANTHRAX TOXIN; CYCLIC-AMP; MACROPHAGES; TRANSCRIPTION; INHIBITION; ACTIVATION; EXPRESSION; REPRESSION; RESPONSES; PROTEINS	In cells of the innate immune system, pathological increases in intracellular cAMP attenuate immune responses and contribute to infections by bacteria such as Bacillus anthracis. In this work, cAMP from B. anthracis edema toxin (ET) is found to activate the Notch signaling pathway in both mouse macrophages and human monocytes. ET as well as a cell-permeable activator of PKA induce Notch target genes (HES1, HEY1, IL2RA, and IL7R) and are able to significantly enhance the induction of these Notch target genes by a Toll-like receptor ligand. Elevated cAMP also resulted in increased levels of Groucho/transducin-like enhancer of Split (TLE) and led to increased amounts of a transcriptional repressor complex consisting of TLE and the Notch target Hes1. To address the mechanism used by ET to activate Notch signaling, components of Notch signaling were examined, and results revealed that ET increased levels of recombinant recognition sequence binding protein at the J site (RBP-J), a DNA binding protein and principal transcriptional regulator of Notch signaling. Overexpression studies indicated that RBP-J was sufficient to activate Notch signaling and potentiate LPS-induced Notch signaling. Further examination of the mechanism used by ET to activate Notch signaling revealed that C/EBP , a transcription factor activated by cAMP, helped activate Notch signaling and up-regulated RBP-J. These studies demonstrate that cAMP activates Notch signaling and increases the expression of TLE, which could be an important mechanism utilized by cAMP to suppress immune responses.	[Larabee, Jason L.; Shakir, Salika M.; Barua, Soumitra; Ballard, Jimmy D.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Larabee, JL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, BMSB 1062,940 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	jason-larabee@ouhsc.edu		Larabee, Jason/0000-0001-5757-7247	National Institutes of Health [U19 AI 062629]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant U19 AI 062629 (to J.D.B.).	Alvarez Y, 2011, J BIOL CHEM, V286, P16583, DOI 10.1074/jbc.M111.222158; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Caolo V, 2010, J BIOL CHEM, V285, P40681, DOI 10.1074/jbc.M110.176065; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Foldi J, 2010, J IMMUNOL, V185, P5023, DOI 10.4049/jimmunol.1001544; Grbavec D, 1998, EUR J BIOCHEM, V258, P339, DOI 10.1046/j.1432-1327.1998.2580339.x; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; Guichard A, 2010, NATURE, V467, P854, DOI 10.1038/nature09446; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Kim C, 2008, P NATL ACAD SCI USA, V105, P6150, DOI 10.1073/pnas.0800105105; Larabee JL, 2011, INFECT IMMUN, V79, P3302, DOI 10.1128/IAI.05070-11; Larabee JL, 2011, J BIOL CHEM, V286, P19364, DOI 10.1074/jbc.M111.224543; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Lewis Julian, 2009, Journal of Biology (London), V8, P44, DOI 10.1186/jbiol145; Lui SH, 2010, CELL HOST MICROBE, V8, P455, DOI 10.1016/j.chom.2010.10.004; Maillard I, 2003, IMMUNITY, V19, P781, DOI 10.1016/S1074-7613(03)00325-X; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999; Peters-Golden M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275pe37; Serezani CH, 2008, AM J RESP CELL MOL, V39, P127, DOI 10.1165/rcmb.2008-0091TR; Sharif MN, 2006, J EXP MED, V203, P1891, DOI 10.1084/jem.20051725; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Tetsuka T, 2000, J BIOL CHEM, V275, P4383, DOI 10.1074/jbc.275.6.4383; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zhang QH, 2012, J BIOL CHEM, V287, P6208, DOI 10.1074/jbc.M111.310375	28	18	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21526	21536		10.1074/jbc.M113.465120	http://dx.doi.org/10.1074/jbc.M113.465120			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23775085	hybrid, Green Published			2022-12-25	WOS:000328841900006
J	Laugsch, M; Seebach, J; Schnittler, H; Jessberger, R				Laugsch, Magdalena; Seebach, Jochen; Schnittler, Hans; Jessberger, Rolf			Imbalance of SMC1 and SMC3 Cohesins Causes Specific and Distinct Effects	PLOS ONE			English	Article							DE-LANGE-SYNDROME; CHROMATID COHESION; MAMMALIAN-CELLS; DNA-DAMAGE; HINGE; PROTEIN; COMPLEX; EXPRESSION; DIMERIZATION; REPLICATION	SMC1 and SMC3 form a high-affinity heterodimer, which provides an open backbone of the cohesin ring, to be closed by a kleisin protein. RNAi mediated knock-down of either one heterodimer partner, SMC1 or SMC3, is expected to cause very similar if not identical phenotypes. However, we observed highly distinct, protein-specific phenotypes. Upon knock-down of human SMC1, much of SMC3 remains stable, accumulates in the cytoplasm and does not associate with other cohesin proteins. Most of the excess nuclear SMC3 is highly mobile and not or only weakly chromosome-associated. In contrast, human SMC3 knock-down rendered SMC1 instable without cytoplasmic accumulation. As observed by differential protein extraction and in FRAP experiments the remaining SMC1 or SMC3 proteins in the respective SMC1 or SMC3 knock-down experiments constituted a cohesin pool, which is associated with chromatin with highest affinity, likely the least expendable. Expression of bovine EGFP-SMC1 or mouse EGFP-SMC3 in human cells under conditions of human SMC1 or SMC3 knock-down rescued the respective phenotypes, but in untreated cells over-expressed exogenous SMC proteins mis-localized. Paucity of either one of the SMC proteins causes RAD21 degradation. These results argue for great caution in interpreting SMC1 and SMC3 RNAi or over-expression experiments. Under challenged conditions these two proteins unexpectedly behave differently, which may have biological consequences for regulation of cohesin-associated functions and for human cohesin pathologies.	[Laugsch, Magdalena; Jessberger, Rolf] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Physiol Chem, Dresden, Germany; [Seebach, Jochen; Schnittler, Hans] Univ Munster, Dept Anat & Vasc Biol, D-48149 Munster, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Munster	Laugsch, M (corresponding author), Univ Clin Carl Gustav Carus Dresden, Dept Pediat, Dresden, Germany.	Magdalena.Laugsch@uniklinikum-dresden.de; rolf.jessberger@tu-dresden.de	Laugsch, Magdalena/AAH-8170-2021		DFG [SPP1384]; German Cancer Aid Society (Deutsche Krebshilfe e.V.)	DFG(German Research Foundation (DFG)); German Cancer Aid Society (Deutsche Krebshilfe e.V.)	This work was in part funded through a grant by the DFG, SPP1384, to RJ, and by the German Cancer Aid Society (Deutsche Krebshilfe e.V.) to RJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Bauerschmidt C, 2010, NUCLEIC ACIDS RES, V38, P477, DOI 10.1093/nar/gkp976; Behlke-Steinert S, 2009, CELL CYCLE, V8, P2211, DOI 10.4161/cc.8.14.8979; Buheitel J, 2013, EMBO J; Chan KL, 2012, CELL, V150, P961, DOI 10.1016/j.cell.2012.07.028; Chen F, 2002, J BIOL CHEM, V277, P16775, DOI 10.1074/jbc.M201322200; Chiu A, 2004, J BIOL CHEM, V279, P26233, DOI 10.1074/jbc.M402439200; Deardorff MA, 2012, NATURE; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Focarelli ML, 2006, MUTAT RES-FUND MOL M, V595, P23, DOI 10.1016/j.mrfmmm.2005.09.002; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; Ghiselli G, 2000, J BIOL CHEM, V275, P20235, DOI 10.1074/jbc.C000213200; Graumann PL, 1998, J BACTERIOL, V180, P5749, DOI 10.1128/JB.180.21.5749-5755.1998; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Haering CH, 2012, EXP CELL RES; Hirano M, 2002, EMBO J, V21, P5733, DOI 10.1093/emboj/cdf575; Hirano M, 2001, EMBO J, V20, P3238, DOI 10.1093/emboj/20.12.3238; Hirano M, 1998, EMBO J, V17, P7139, DOI 10.1093/emboj/17.23.7139; Jessberger R, 1996, EMBO J, V15, P4061, DOI 10.1002/j.1460-2075.1996.tb00779.x; Jones S, 2001, GENOME BIOL, V2; Kakiuchi S, 2003, MOL CANCER RES, V1, P485; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kurze A, 2011, EMBO J, V30, P364, DOI 10.1038/emboj.2010.315; Liu J, 2009, CLIN GENET, V76, P303, DOI 10.1111/j.1399-0004.2009.01271.x; Mannini L, 2010, HUM MUTAT, V31, P5, DOI 10.1002/humu.21129; McNairn AJ, 2008, MUTAT RES-FUND MOL M, V647, P103, DOI 10.1016/j.mrfmmm.2008.08.010; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Mishra A, 2010, CURR BIOL, V20, P279, DOI 10.1016/j.cub.2009.12.059; Murdoch B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003241; Musio A, 2005, HUM MOL GENET, V14, P525, DOI 10.1093/hmg/ddi049; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; NIKI H, 1992, EMBO J, V11, P5101, DOI 10.1002/j.1460-2075.1992.tb05617.x; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ocampo-Hafalla MT, 2011, J CELL SCI, V124, P685, DOI 10.1242/jcs.073866; Patel CA, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-3; Patel CA, 2005, BIOCHEM BIOPH RES CO, V330, P333, DOI 10.1016/j.bbrc.2005.02.162; Pati D, 2002, MOL CELL BIOL, V22, P8267, DOI 10.1128/MCB.22.23.8267-8277.2002; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Revenkova E, 2009, HUM MOL GENET, V18, P418, DOI 10.1093/hmg/ddn369; Seitan VC, 2012, CURR OPIN GENET DEV, V22, P93, DOI 10.1016/j.gde.2011.11.003; Shintomi K, 2010, CHROMOSOMA, V119, P459, DOI 10.1007/s00412-010-0271-z; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; Stursberg S, 1999, GENE, V228, P1, DOI 10.1016/S0378-1119(99)00021-9; Watrin E, 2009, EMBO J, V28, P2625, DOI 10.1038/emboj.2009.202; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Wong RW, 2008, P NATL ACAD SCI USA, V105, P15441, DOI 10.1073/pnas.0807660105; Xiong B, 2010, ANNU REV BIOCHEM, V79, P131, DOI 10.1146/annurev-biochem-061708-092640; Yang D, 2002, P NATL ACAD SCI USA, V99, P9942, DOI 10.1073/pnas.152327299; Yazdi PT, 2002, GENE DEV, V16, P571, DOI 10.1101/gad.970702	54	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65149	10.1371/journal.pone.0065149	http://dx.doi.org/10.1371/journal.pone.0065149			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776448	Green Published, Green Submitted, gold			2022-12-25	WOS:000320322400009
J	Liu, FF; Huang, B; Dong, XY; Sun, Y				Liu, Fu-Feng; Huang, Bo; Dong, Xiao-Yan; Sun, Yan			Molecular Basis for the Dissociation Dynamics of Protein A-Immunoglobulin G1 Complex	PLOS ONE			English	Article							GRAINED FORCE-FIELD; COMPUTER-SIMULATION; MEMBRANE-PROTEINS; LOW PH; AFFINITY; MODELS; ANTIBODY; CHROMATOGRAPHY; BIOMOLECULES; CURVATURE	Staphylococcus aureus protein A (SpA) is the most popular affinity ligand for immunoglobulin G1 (IgG1). However, the molecular basis for the dissociation dynamics of SpA-IgG1 complex is unclear. Herein, coarse-grained (CG) molecular dynamics (MD) simulations with the Martini force field were used to study the dissociation dynamics of the complex. The CG-MD simulations were first verified by the agreement in the structural and interactional properties of SpA and human IgG1 (hIgG1) in the association process between the CG-MD and all-atom MD at different NaCl concentrations. Then, the CG-MD simulation studies focused on the molecular insight into the dissociation dynamics of SpA-hIgG1 complex at pH 3.0. It is found that there are four steps in the dissociation process of the complex. First, there is a slight conformational adjustment of helix II in SpA. This is followed by the phenomena that the electrostatic interactions provided by the three hot spots (Glu143, Arg146 and Lys154) of helix II of SpA break up, leading to the dissociation of helix II from the binding site of hIgG1. Subsequently, breakup of the hydrophobic interactions between helix I (Phe132, Tyr133 and His137) in SpA and hIgG1 occurs, resulting in the disengagement of helix I from its binding site of hIgG1. Finally, the non-specific interactions between SpA and hIgG1 decrease slowly till disappearance, leading to the complete dissociation of the SpA-hIgG1 complex. This work has revealed that CG-MD coupled with the Martini force field is an effective method for studying the dissociation dynamics of protein-protein complex.	[Sun, Yan] Tianjin Univ, Sch Chem Engn & Technol, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China; Tianjin Univ, Sch Chem Engn & Technol, Dept Biochem Engn, Tianjin 300072, Peoples R China	Tianjin University; Tianjin University	Sun, Y (corresponding author), Tianjin Univ, Sch Chem Engn & Technol, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China.	ysun@tju.edu.cn	Liu, Fufeng/M-9833-2016	Liu, Fufeng/0000-0002-9454-2382; Sun, Yan/0000-0001-5256-9571	Natural Science Foundation of China [21236005, 20906068]; National Basic Research Program of China (973 Program) [2009CB724705]; Natural Science Foundation of Tianjin from Tianjin Municipal Science and Technology Commission [10JCYBJC04500]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of Tianjin from Tianjin Municipal Science and Technology Commission	This work was supported by the Natural Science Foundation of China (Grant Nos. 21236005 and 20906068), the National Basic Research Program of China (973 Program, Grant No. 2009CB724705) and the Natural Science Foundation of Tianjin from Tianjin Municipal Science and Technology Commission (Contract No. 10JCYBJC04500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029628; Avila CL, 2011, CURR PROTEIN PEPT SC, V12, P221; Ayton GS, 2010, BIOPHYS J, V99, P2757, DOI 10.1016/j.bpj.2010.08.018; Barderas R, 2008, P NATL ACAD SCI USA, V105, P9029, DOI 10.1073/pnas.0801221105; Bereau T, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3152842; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boi C, 2009, J CHROMATOGR A, V1216, P8687, DOI 10.1016/j.chroma.2009.05.045; Bond PJ, 2007, J STRUCT BIOL, V157, P593, DOI 10.1016/j.jsb.2006.10.004; Bond PJ, 2006, J AM CHEM SOC, V128, P2697, DOI 10.1021/ja0569104; BOTTOMLEY SP, 1995, J IMMUNOL METHODS, V182, P185, DOI 10.1016/0022-1759(95)00049-G; Braun AR, 2012, J AM CHEM SOC, V134, P2613, DOI 10.1021/ja208316h; Chang CEA, 2007, CHEM BIOL DRUG DES, V69, P5, DOI 10.1111/j.1747-0285.2007.00464.x; Cieplak M, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2939247; Das A, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4705417; de Jong DH, 2012, J CHEM THEORY COMPUT, V8, P1003, DOI 10.1021/ct200599d; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Depa P, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3513365; Di Fenza A, 2009, PROTEINS, V76, P946, DOI 10.1002/prot.22399; Fuhrmans M, 2012, J AM CHEM SOC, V134, P1543, DOI 10.1021/ja207290b; Gattin Z, 2008, CHEMBIOCHEM, V9, P923, DOI 10.1002/cbic.200700434; Hober S, 2007, J CHROMATOGR B, V848, P40, DOI 10.1016/j.jchromb.2006.09.030; Huang B, 2012, J PHYS CHEM B, V116, P424, DOI 10.1021/jp205770p; Huang B, 2011, J PHYS CHEM B, V115, P4168, DOI 10.1021/jp111216g; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hyeon C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1481; Kamerlin SCL, 2011, ANNU REV PHYS CHEM, V62, P41, DOI 10.1146/annurev-physchem-032210-103335; Kamerlin SCL, 2011, PHYS CHEM CHEM PHYS, V13, P10401, DOI 10.1039/c0cp02823a; Karimi-Varzaneh HA, 2012, TOP CURR CHEM, V307, P295, DOI 10.1007/128_2010_122; Karo J, 2012, J BIOL CHEM, V287, P7467, DOI 10.1074/jbc.M111.332320; Khelashvili G, 2012, J AM CHEM SOC, V134, P15858, DOI 10.1021/ja3056485; Kral V, 2008, PROTEINS, V71, P1275, DOI 10.1002/prot.21821; Leguebe M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047332; Liwo A, 2011, PHYS CHEM CHEM PHYS, V13, P16890, DOI 10.1039/c1cp20752k; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; McCue JT, 2003, J CHROMATOGR A, V989, P139, DOI 10.1016/S0021-9673(03)00005-0; Mendez R, 2003, PROTEINS, V52, P51, DOI 10.1002/prot.10393; Moiani D, 2009, J PHYS CHEM B, V113, P16268, DOI 10.1021/jp909405b; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Morriss-Andrews A, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3624929; Niemela PS, 2010, J AM CHEM SOC, V132, P7574, DOI 10.1021/ja101481b; Orsi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028637; Pan YM, 2008, J AM CHEM SOC, V130, P5140, DOI 10.1021/ja077972s; Patra N, 2011, J AM CHEM SOC, V133, P6146, DOI 10.1021/ja2009778; Perezzan R, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4765057; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Perlmutter JD, 2011, J AM CHEM SOC, V133, P6563, DOI 10.1021/ja106626r; Santo KP, 2012, J PHYS CHEM B, V116, P3021, DOI 10.1021/jp212018f; Seo M, 2012, J CHEM THEORY COMPUT, V8, P1774, DOI 10.1021/ct200876v; Shinoda W, 2012, CURR OPIN STRUC BIOL, V22, P175, DOI 10.1016/j.sbi.2012.01.011; Smith LJ, 1999, PROTEINS, V36, P77, DOI 10.1002/(SICI)1097-0134(19990701)36:1<77::AID-PROT7>3.0.CO;2-X; Spiliotopoulos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046902; Takada S, 2012, CURR OPIN STRUC BIOL, V22, P130, DOI 10.1016/j.sbi.2012.01.010; Tozzini V, 2005, CURR OPIN STRUC BIOL, V15, P144, DOI 10.1016/j.sbi.2005.02.005; Tozzini V, 2010, ACCOUNTS CHEM RES, V43, P220, DOI 10.1021/ar9001476; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang YT, 2009, PHYS CHEM CHEM PHYS, V11, P2002, DOI 10.1039/b819182d; Ward AB, 2012, PROTEINS, V80, P2178, DOI 10.1002/prot.24108; Wu Z, 2011, J CHEM THEORY COMPUT, V7, P3793, DOI 10.1021/ct200593t; Yu XA, 2010, BIOPHYS J, V99, P666, DOI 10.1016/j.bpj.2010.05.006; Zhang J, 2009, IUBMB LIFE, V61, P627, DOI 10.1002/iub.223; Zhang L, 2011, J MOL GRAPH MODEL, V29, P906, DOI 10.1016/j.jmgm.2011.02.004	62	6	7	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66935	10.1371/journal.pone.0066935	http://dx.doi.org/10.1371/journal.pone.0066935			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776704	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400121
J	Alsanosy, RM; Mahfouz, MS; Gaffar, AM				Alsanosy, Rashad Mohammed; Mahfouz, Mohamed Salih; Gaffar, Abdelrahim Mutwakel			Khat Chewing Habit among School Students of Jazan Region, Saudi Arabia	PLOS ONE			English	Article							COLLEGE-STUDENTS; SECONDARY-SCHOOL; CATHA-EDULIS; ABUSE; PREVALENCE; PSYCHOSIS	Background: The use of Khat leaves (Catha edulis) in Jazan, southwest of KSA, is prevalent among all segments of the population. Objective: This study was conducted to assess the prevalence and predictors of Khat chewing among intermediate and secondary school students of Jazan region. Methodology: A cross-sectional survey was conducted in late 2011 in Jazan region. A random sample of 3923 students was selected from 72 intermediate and upper secondary schools representing the different educational sectors of the region. A structured self-administered questionnaire was used for data collection. Descriptive statistics, a chi-squared test and logistic regression were performed to examine the prevalence, associations and predictors of Khat chewing. Result: The overall Khat chewing prevalence among students was 20.5% (95% C. I.: 19.27-21.79). The prevalence was significantly higher among males, at 33.1% (95% CI: 31.16-35.08), than among females 4.3% (95% C.I.: 3.39-5.31) (P<0.001). Univariate analysis revealed that gender, age, academic performance, friends' smoking and Khat chewing, and students' smoking status were associated with a significantly high risk of Khat chewing (P<0.001 for all). The multivariate logistic regression analysis suggested that the most important independent predictors of Khat chewing among the students in our sample were students' smoking status (OR = 13.02, P<0.001), friends' use of Khat (OR = 5.65, P<0.001), gender (OR = 4.62, P<0.001), and friend's use of tobacco (OR = 1.43, P<0.001). Conclusion: A significant percentage of students chew Khat. The abuse of Khat is significantly associated with gender, peer influence, and cigarette smoking. Intervention programs are needed to create awareness among school students and to reduce the prevalence of the habit and its unfavorable consequences.	[Alsanosy, Rashad Mohammed; Mahfouz, Mohamed Salih; Gaffar, Abdelrahim Mutwakel] Jazan Univ, Fac Med, Dept Family & Community Med, Jazan, Saudi Arabia; [Alsanosy, Rashad Mohammed] Jazan Univ, Subst Abuse Res Ctr, Jazan, Saudi Arabia	Jazan University; Jazan University	Mahfouz, MS (corresponding author), Jazan Univ, Fac Med, Dept Family & Community Med, Jazan, Saudi Arabia.	mm.mahfouz@gmail.com	Gaffar, Abdelrahim Mutwakel/A-5668-2012; Mahfouz, Mohamed/A-7388-2012	Mahfouz, Mohamed/0000-0002-3155-6381; Gaffar, Abdelrahim/0000-0002-6656-2204; Alsanosy, Rashad/0000-0002-0719-9708	Substance Abuse Research Center, Jazan University, Saudi Arabia	Substance Abuse Research Center, Jazan University, Saudi Arabia	Funding recived from Substance Abuse Research Center, Jazan University, Saudi Arabia (www.Jazanu.edu.sa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2000, SIDAMA, V5, P15; ADUGNA F, 1994, ETHIOPIAN MED J, V32, P161; Ageely HM, 2008, J FAMILY COMMUNITY M, V15; Ageely HM, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-11; Al-Mugahed L, 2008, B WORLD HEALTH ORGAN, V86, P741, DOI 10.2471/BLT.08.011008; Al-Sanosy RM, 2009, J FAM COMMUNITY MED, V16, P89; Alem A, 1999, ACTA PSYCHIAT SCAND, V100, P84, DOI 10.1111/j.1600-0447.1999.tb10699.x; Alem A, 1977, ETHIOPIAN MED J, V35, P137; Arnett JJ, 2005, J DRUG ISSUES, V35, P235, DOI 10.1177/002204260503500202; BAASHER T, 1981, BRIT J ADDICT, V76, P233; Baasher T, 1980, DRUG PROBLEMS SOCIOC; Bani I., 2011, EUR J SCI RES, V63, P122; Department of Statistics and Information KSA, 2010 1431 POP CENS P; DHADPHALE M, 1981, E AFR MED J, V58, P130; Donahue MJ, 1995, J SOC ISSUES, V51, P145, DOI 10.1111/j.1540-4560.1995.tb01328.x; GOUGH SP, 1984, LANCET, V1, P455, DOI 10.1016/S0140-6736(84)91789-6; Griffiths P, 1998, QAT USE LONDON STUDY; HALBACH H, 1972, B WORLD HEALTH ORGAN, V47, P21; HEACOCK RA, 1974, CAN J PHARM SCI, V9, P64; Hes J P, 1970, Harefuah, V78, P283; KALIX P, 1987, BRIT J ADDICT, V82, P47; KENNEDY JG, 1983, SOC SCI MED, V17, P783, DOI 10.1016/0277-9536(83)90029-1; LUQMAN W, 1976, ANN INTERN MED, V85, P246, DOI 10.7326/0003-4819-85-2-246; Milaat AA, 2006, RES REPORT; Mossie A, 2004, ETHIOPIAN MED J, V42, P125; Odenwald M, 2007, PLOS MED, V4, P1959, DOI 10.1371/journal.pmed.0040341; Odenwald M, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-5; PANTELIS C, 1989, PSYCHOL MED, V19, P657, DOI 10.1017/S0033291700024259; Patel S.L., 2005, HOME OFFICE ONLINE R, V47; Rahim BEEA, 2012, LIFE SCI J, V9, P2295; Rapeah M.Y., 2008, ANN DENT, V15, P77, DOI [10.22452/adum.vol15no2.4, DOI 10.22452/ADUM.VOL15NO2.4]; Reda AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033946; Regnerus MD, 2003, J SCI STUD RELIG, V42, P189, DOI 10.1111/1468-5906.00172; Rozi S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-312; Siziya S, 2007, Rural Remote Health, V7, P728; YOUSEF G, 1995, BRIT J HOSP MED, V54, P322	36	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65504	10.1371/journal.pone.0065504	http://dx.doi.org/10.1371/journal.pone.0065504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	169CU	23776490	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400036
J	Li, JM; Andika, IB; Shen, JF; Lv, YD; Ji, YQ; Sun, LY; Chen, JP				Li, Junmin; Andika, Ida Bagus; Shen, Jiangfeng; Lv, Yuanda; Ji, Yongqiang; Sun, Liying; Chen, Jianping			Characterization of Rice Black-Streaked Dwarf Virus- and Rice Stripe Virus-Derived siRNAs in Singly and Doubly Infected Insect Vector Laodelphax striatellus	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; YELLOW-VEIN-VIRUS; ANTIVIRAL IMMUNITY; PLANT-VIRUSES; DROSOPHILA; REPLICATION; GENOME; SYNERGISM; PROTEINS; SUPPRESSION	Replication of RNA viruses in insect cells triggers an antiviral defense that is mediated by RNA interference (RNAi) which generates viral-derived small interfering RNAs (siRNAs). However, it is not known whether an antiviral RNAi response is also induced in insects by reoviruses, whose double-stranded RNA genome replication is thought to occur within core particles. Deep sequencing of small RNAs showed that when the small brown planthopper (Laodelphax striatellus) was infected by Rice black-streaked dwarf virus (RBSDV) (Reoviridae; Fijivirus), more viral-derived siRNAs accumulated than when the vector insect was infected by Rice stripe virus (RSV), a negative single-stranded RNA virus. RBSDV siRNAs were predominantly 21 and 22 nucleotides long and there were almost equal numbers of positive and negative sense. RBSDV siRNAs were frequently generated from hotspots in the 5' -and 3'-terminal regions of viral genome segments but these hotspots were not associated with any predicted RNA secondary structures. Under laboratory condition, L. striatellus can be infected simultaneously with RBSDV and RSV. Double infection enhanced the accumulation of particular genome segments but not viral coat protein of RBSDV and correlated with an increase in the abundance of siRNAs derived from RBSDV. The results of this study suggest that reovirus replication in its insect vector potentially induces an RNAi-mediated antiviral response.	[Li, Junmin; Andika, Ida Bagus; Sun, Liying; Chen, Jianping] Zhejiang Acad Agr Sci, Key Lab Biotechnol Plant Protect, State Key Lab Breeding Base Zhejiang Sustainable, Inst Virol & Biotechnol,Minist Agr, Hangzhou, Zhejiang Provin, Peoples R China; [Shen, Jiangfeng] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Zhejiang Provin, Peoples R China; [Lv, Yuanda] Jiangsu Acad Agr Sci, Prov Key Lab Agrobiol, Nanjing, Jiangsu Provinc, Peoples R China; [Ji, Yongqiang] Yangzhou Univ, Coll Biotechnol & Life Sci, Yangzhou, Jiangsu Provinc, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang Academy of Agricultural Sciences; Zhejiang Normal University; Jiangsu Academy of Agricultural Sciences; Yangzhou University	Sun, LY (corresponding author), Zhejiang Acad Agr Sci, Key Lab Biotechnol Plant Protect, State Key Lab Breeding Base Zhejiang Sustainable, Inst Virol & Biotechnol,Minist Agr, Hangzhou, Zhejiang Provin, Peoples R China.	sunliying255@yahoo.com; jpchen2001@yahoo.com.cn		LV, Yuanda/0000-0001-6576-7999; Li, Junmin/0000-0002-8385-8912; Lv, Yuanda/0000-0002-6640-5989	Project of New Varieties Genetically Modified Wheat of China [2008ZX08002-001]; China Agriculture Research System from the Ministry of Agriculture of the P.R. China [CARS-3-1]; Project of Molecular Mechanism of Plant Defense to Pest and Disease from the Ministry of Science and Technology of the P.R. China [2012CB722504]; Modern Agricultural Biotechnology and Crop Disease Control from Key Subject Construction Program of Zhejiang Province, Zhejiang Provincial Natural Science Foundation of China [Q12C140016]; China Postdoctoral Science Foundation [2012M521200]	Project of New Varieties Genetically Modified Wheat of China; China Agriculture Research System from the Ministry of Agriculture of the P.R. China; Project of Molecular Mechanism of Plant Defense to Pest and Disease from the Ministry of Science and Technology of the P.R. China; Modern Agricultural Biotechnology and Crop Disease Control from Key Subject Construction Program of Zhejiang Province, Zhejiang Provincial Natural Science Foundation of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This study was funded by grants from the Project of New Varieties Genetically Modified Wheat of China (2008ZX08002-001), China Agriculture Research System (CARS-3-1) from the Ministry of Agriculture of the P.R. China, the Project of Molecular Mechanism of Plant Defense to Pest and Disease (2012CB722504) from the Ministry of Science and Technology of the P.R. China, Modern Agricultural Biotechnology and Crop Disease Control from Key Subject Construction Program of Zhejiang Province, Zhejiang Provincial Natural Science Foundation of China (Q12C140016) and China Postdoctoral Science Foundation (2012M521200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2006, NAT REV MICROBIOL, V4, P371, DOI 10.1038/nrmicro1389; Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; Andika IB, 2005, MOL PLANT MICROBE IN, V18, P194, DOI 10.1094/MPMI-18-0194; Andika IB, 2012, J GEN VIROL, V93, P1841, DOI 10.1099/vir.0.043513-0; Attoui H., 2011, VIRUS TAXONOMY, P541; Baulcombe D, 2005, TRENDS BIOCHEM SCI, V30, P290, DOI 10.1016/j.tibs.2005.04.012; Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Chen QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032860; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Du ZG, 2011, MOL PLANT PATHOL, V12, P808, DOI [10.1111/J.1364-3703.2011.00716.X, 10.1111/j.1364-3703.2011.00716.x]; Endo S, 2002, APPL ENTOMOL ZOOL, V37, P79, DOI 10.1303/aez.2002.79; Flynt A, 2009, P NATL ACAD SCI USA, V106, P5270, DOI 10.1073/pnas.0813412106; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Garcia-Cano E, 2006, PHYTOPATHOLOGY, V96, P1263, DOI 10.1094/PHYTO-96-1263; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Hemmes H, 2007, RNA, V13, P1079, DOI 10.1261/rna.444007; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Isogai M, 1998, J GEN VIROL, V79, P1487, DOI 10.1099/0022-1317-79-6-1487; KAKUTANI T, 1991, J GEN VIROL, V72, P465, DOI 10.1099/0022-1317-72-2-465; Llave C, 2010, TRENDS PLANT SCI, V15, P701, DOI 10.1016/j.tplants.2010.09.001; Merkling SH, 2013, J INSECT PHYSIOL, V59, P159, DOI 10.1016/j.jinsphys.2012.07.004; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Myles KM, 2009, RNA BIOL, V6, P387, DOI 10.4161/rna.6.4.8946; Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Patton JT, 2000, VIROLOGY, V277, P217, DOI 10.1006/viro.2000.0645; Peever TL, 1997, PHYTOPATHOLOGY, V87, P1026, DOI 10.1094/PHYTO.1997.87.10.1026; Pirkooh AA, 2012, INTERVIROLOGY, V55, P62, DOI 10.1159/000324033; Pruss G, 1997, PLANT CELL, V9, P859, DOI 10.1105/tpc.9.6.859; RAMIREZ BC, 1994, J GEN VIROL, V75, P467, DOI 10.1099/0022-1317-75-3-467; Sabin LR, 2010, CURR OPIN IMMUNOL, V22, P4, DOI 10.1016/j.coi.2010.01.007; Sherry B, 2009, J INTERF CYTOK RES, V29, P559, DOI 10.1089/jir.2009.0072; Shi XM, 1997, VIROLOGY, V231, P35, DOI 10.1006/viro.1997.8488; Shinkai A, 1962, B NAT I AGR SCI C, V14, P1; Siu RWC, 2011, J VIROL, V85, P2907, DOI 10.1128/JVI.02052-10; Sun LY, 2006, J GEN VIROL, V87, P3703, DOI 10.1099/vir.0.82213-0; Syller J, 2012, MOL PLANT PATHOL, V13, P204, DOI 10.1111/j.1364-3703.2011.00734.x; Taraporewala ZF, 2004, VIRUS RES, V101, P57, DOI 10.1016/j.virusres.2003.12.006; TORIYAMA S, 1986, MICROBIOL SCI, V3, P347; Tsatsralt-Od B, 2006, J MED VIROL, V78, P542, DOI 10.1002/jmv.20574; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Xiong RY, 2009, VIROLOGY, V387, P29, DOI 10.1016/j.virol.2009.01.045; Xu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046238; Zhang HM, 2001, ARCH VIROL, V146, P2331, DOI 10.1007/s007050170006; Zhou T, 2011, RICE SCI, V18, P152, DOI 10.1016/S1672-6308(11)60022-X; ZHU YF, 1991, J GEN VIROL, V72, P763, DOI 10.1099/0022-1317-72-4-763	53	46	54	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66007	10.1371/journal.pone.0066007	http://dx.doi.org/10.1371/journal.pone.0066007			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776591	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400097
J	Clarke, SF; Murphy, EF; O'Sullivan, O; Ross, RP; O'Toole, PW; Shanahan, F; Cotter, PD				Clarke, Siobhan F.; Murphy, Eileen F.; O'Sullivan, Orla; Ross, R. Paul; O'Toole, Paul W.; Shanahan, Fergus; Cotter, Paul D.			Targeting the Microbiota to Address Diet-Induced Obesity: A Time Dependent Challenge	PLOS ONE			English	Article							HUMAN GUT MICROBIOTA; INTESTINAL MICROBIOTA; ANTIBIOTIC-TREATMENT; GENERATION; RESISTANCE; DIVERSITY; CAPACITY; ECOLOGY; IMPACT; TREES	Links between the gut microbiota and host metabolism have provided new perspectives on obesity. We previously showed that the link between the microbiota and fat deposition is age-and time-dependent subject to microbial adaptation to diet over time. We also demonstrated reduced weight gain in diet-induced obese (DIO) mice through manipulation of the gut microbiota with vancomycin or with the bacteriocin-producing probiotic Lactobacillus salivarius UCC118 (Bac(+)), with metabolic improvement achieved in DIO mice in receipt of vancomycin. However, two phases of weight gain were observed with effects most marked early in the intervention phase. Here, we compare the gut microbial populations at the early relative to the late stages of intervention using a high throughput sequencing-based analysis to understand the temporal relationship between the gut microbiota and obesity. This reveals several differences in microbiota composition over the intervening period. Vancomycin dramatically altered the gut microbiota composition, relative to controls, at the early stages of intervention after which time some recovery was evident. It was also revealed that Bac(+) treatment initially resulted in the presence of significantly higher proportions of Peptococcaceae and significantly lower proportions of Rikenellaceae and Porphyromonadaceae relative to the gut microbiota of L. salivarius UCC118 bacteriocin negative (Bac(-)) administered controls. These differences were no longer evident at the later time. The results highlight the resilience of the gut microbiota and suggest that interventions may need to be monitored and continually adjusted to ensure sustained modification of the gut microbiota.	[Clarke, Siobhan F.; Murphy, Eileen F.; Ross, R. Paul; O'Toole, Paul W.; Shanahan, Fergus; Cotter, Paul D.] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Clarke, Siobhan F.; O'Sullivan, Orla; Ross, R. Paul; Cotter, Paul D.] Teagasc Food Res Ctr, Cork, Ireland; [Clarke, Siobhan F.; O'Toole, Paul W.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [Murphy, Eileen F.] Alimentary Hlth Ltd, Cork, Ireland; [Shanahan, Fergus] Natl Univ Ireland Univ Coll Cork, Dept Med, Cork, Ireland	University College Cork; Teagasc; University College Cork; University College Cork	Cotter, PD (corresponding author), Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland.	paul.cotter@teagasc.ie	O'Toole, Paul W/G-1593-2012; Cotter, Paul/B-7781-2008; Ross, Paul/A-7584-2015; O'Sullivan, Orla/ABE-5980-2020; Shanahan, Fergus/ABF-2390-2020; Cotter, Paul/AAX-5449-2021; STANTON, CATHERINE/A-9549-2015	O'Toole, Paul W/0000-0001-5377-0824; Cotter, Paul/0000-0002-5465-9068; Ross, Paul/0000-0003-4876-8839; O'Sullivan, Orla/0000-0002-4332-1109; Shanahan, Fergus/0000-0003-0467-0936; Cotter, Paul/0000-0002-5465-9068; STANTON, CATHERINE/0000-0002-6724-7011; Clarke, Siobhan/0000-0002-7050-3661	Teagasc, Science Foundation Ireland; Alimentary Health Ltd.	Teagasc, Science Foundation Ireland(Science Foundation Ireland); Alimentary Health Ltd.	The authors are supported in part by Teagasc, Science Foundation Ireland (in the form of a research centre grant to the Alimentary Pharmabiotic Centre and PI awards to PWOT and PC) and by Alimentary Health Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BARNA JCJ, 1984, ANNU REV MICROBIOL, V38, P339, DOI 10.1146/annurev.mi.38.100184.002011; Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; Chen VB, 2009, PROTEIN SCI, V18, P2403, DOI 10.1002/pro.250; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Clarke S, 2012, GUT MICROBES, V3; Cotter PD, 2012, DISCOV MED, V13, P193; D'Aimmo MR, 2007, INT J FOOD MICROBIOL, V115, P35, DOI 10.1016/j.ijfoodmicro.2006.10.003; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Flint HJ, 2011, J CLIN GASTROENTEROL, V45, pS128, DOI 10.1097/MCG.0b013e31821f44c4; Flynn S, 2002, MICROBIOL-SGM, V148, P973, DOI 10.1099/00221287-148-4-973; Fouhy F, 2012, ANTIMICROB AGENTS CH, V56, P5811, DOI 10.1128/AAC.00789-12; Greiner T, 2011, TRENDS ENDOCRIN MET, V22, P117, DOI 10.1016/j.tem.2011.01.002; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Howden BP, 2013, INFECT GENET EVOL, pS1567; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Murphy EF, 2013, GUT, V62, P220, DOI 10.1136/gutjnl-2011-300705; O'Mahony L, 2001, ALIMENT PHARM THER, V15, P1219, DOI 10.1046/j.1365-2036.2001.01027.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rea MC, 2011, P NATL ACAD SCI USA, V108, P4639, DOI 10.1073/pnas.1001224107; Salimnia H, 2011, TRANSPL INFECT DIS, V13, P294, DOI 10.1111/j.1399-3062.2010.00586.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27; Zhang H, 2013, J FOOD SAFETY; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	41	104	109	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65790	10.1371/journal.pone.0065790	http://dx.doi.org/10.1371/journal.pone.0065790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762426	Green Submitted, gold, Green Published			2022-12-25	WOS:000321094800072
J	Silveira, KD; Barroso, LC; Vieira, AT; Cisalpino, D; Lima, CX; Bader, M; Arantes, RME; dos Santos, RAS; Simoes-e-Silva, AC; Teixeira, MM				Silveira, Katia Daniela; Barroso, Livia Correa; Vieira, Angelica Thomaz; Cisalpino, Daniel; Lima, Cristiano Xavier; Bader, Michael; Esteves Arantes, Rosa Maria; Souza dos Santos, Robson Augusto; Simoes-e-Silva, Ana Cristina; Teixeira, Mauro Martins			Beneficial Effects of the Activation of the Angiotensin-(1-7) Mas Receptor in a Murine Model of Adriamycin-Induced Nephropathy	PLOS ONE			English	Article							II TYPE-1 RECEPTOR; GROWTH-FACTOR-BETA; 1-7/MAS RECEPTOR; BLOOD-PRESSURE; SYSTEM; RATS; BLOCKADE; PROTEIN; PROGRESSION; TELMISARTAN	Angiotensin-(1-7) [Ang-(1-7)] is a biologically active heptapeptide that may counterbalance the physiological actions of angiotensin II (Ang II) within the renin-angiotensin system (RAS). Here, we evaluated whether activation of the Mas receptor with the oral agonist, AVE 0991, would have renoprotective effects in a model of adriamycin (ADR)-induced nephropathy. We also evaluated whether the Mas receptor contributed for the protective effects of treatment with AT(1) receptor blockers. ADR (10 mg/kg) induced significant renal injury and dysfunction that was maximal at day 14 after injection. Treatment with the Mas receptor agonist AVE 0991 improved renal function parameters, reduced urinary protein loss and attenuated histological changes. Renoprotection was associated with reduction in urinary levels of TGF-beta. Similar renoprotection was observed after treatment with the AT(1) receptor antagonist, Losartan. AT(1) and Mas receptor mRNA levels dropped after ADR administration and treatment with losartan reestablished the expression of Mas receptor and increased the expression of ACE2. ADR-induced nephropathy was similar in wild type (Mas(+/+)) and Mas knockout (Mas(-/-)) mice, suggesting there was no endogenous role for Mas receptor activation. However, treatment with Losartan was able to reduce renal injury only in Mas(+/+) , but not in Mas(-/-) mice. Therefore, these findings suggest that exogenous activation of the Mas receptor protects from ADR-induced nephropathy and contributes to the beneficial effects of AT(1) receptor blockade. Medications which target specifically the ACE2/Ang-(1-7)/Mas axis may offer new therapeutic opportunities to treat human nephropathies.	[Silveira, Katia Daniela; Barroso, Livia Correa; Vieira, Angelica Thomaz; Cisalpino, Daniel; Lima, Cristiano Xavier; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Esteves Arantes, Rosa Maria] Univ Fed Minas Gerais, Dept Patol Geral, Belo Horizonte, MG, Brazil; [Lima, Cristiano Xavier; Simoes-e-Silva, Ana Cristina; Teixeira, Mauro Martins] Univ Fed Minas Gerais, Fac Med, Dept Pediat, Belo Horizonte, MG, Brazil; [Souza dos Santos, Robson Augusto] Univ Fed Minas Gerais, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil; [Bader, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Simoes-e-Silva, AC (corresponding author), Univ Fed Minas Gerais, Fac Med, Dept Pediat, Belo Horizonte, MG, Brazil.	ana@medicina.ufmg.br; mmtex@icb.ufmg.br	Bader, Michael/K-2124-2013; Arantes, Rosa ME/C-5749-2013; LIMA, CRISTIANO/AAH-9402-2021; Santos, Robson A S/C-9336-2011; Vieira, Angelica T/A-6227-2015; Simões e Silva, Ana Cristina/A-4409-2013; Teixeira, Mauro M/A-4587-2008; SILVEIRA, KATIA D/N-3036-2013; Lima, Cristiano/B-1874-2013	Arantes, Rosa ME/0000-0003-1428-9717; Santos, Robson A S/0000-0001-8738-5852; Vieira, Angelica T/0000-0002-4556-7671; Simões e Silva, Ana Cristina/0000-0001-9222-3882; Teixeira, Mauro M/0000-0002-6944-3008; SILVEIRA, KATIA D/0000-0003-4955-3709; Cisalpino, Daniel/0000-0003-1611-0661; XAVIER LIMA, CRISTIANO/0000-0001-7724-890X; Bader, Michael/0000-0003-4780-4164	Coordenacao de Aperfeicoamento de Pessoal de Nivel 445 Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao do Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); European Union [LSHB-CT-2005-518167]; European Community [HEALTH-F4-2011-281608]	Coordenacao de Aperfeicoamento de Pessoal de Nivel 445 Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao do Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); European Union(European Commission); European Community(European Commission)	Coordenacao de Aperfeicoamento de Pessoal de Nivel 445 Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao do Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), the European Union's Sixth Framework Programme (INNOCHEM, project grant LSHB-CT-2005-518167) and the European Community's Seventh Framework Programme [FP7-2007-2013] under grant agreement HEALTH-F4-2011-281608. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averill DB, 2003, CIRCULATION, V108, P2141, DOI 10.1161/01.CIR.0000092888.63239.54; Barroso L. C., 2012, INT J HYPERTENS, V2012, DOI DOI 10.1155/2012/808726; Benter IF, 2008, AM J NEPHROL, V28, P25, DOI 10.1159/000108758; BENTER IF, 1995, AM J PHYSIOL-HEART C, V269, pH313, DOI 10.1152/ajpheart.1995.269.1.H313; BERTANI T, 1982, LAB INVEST, V46, P16; Border WA, 1998, HYPERTENSION, V31, P181, DOI 10.1161/01.HYP.31.1.181; Botelho-Santos GA, 2007, AM J PHYSIOL-HEART C, V292, pH2485, DOI 10.1152/ajpheart.01245.2006; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; Chappell MC, 2004, CONTRIB NEPHROL, V143, P77; Chen A, 1998, NEPHRON, V78, P440, DOI 10.1159/000044974; Crowley SD, 2009, J CLIN INVEST, V119, P943, DOI 10.1172/JCI34862; da Silveira KD, 2010, CLIN SCI, V119, P385, DOI 10.1042/CS20090554; da Silveira KD, 2010, J IMMUNOL, V185, P5569, DOI 10.4049/jimmunol.1000314; Dhaunsi GS, EUR J PHARM, V638, P108; Dilauro M, 2009, THESCIENTIFICWORLDJO, V9, P522, DOI 10.1100/tsw.2009.70; Esteban V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005406; Ferrario CM, 2005, KIDNEY INT, V68, P2189, DOI 10.1111/j.1523-1755.2005.00675.x; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; Gava E, 2009, NEPHROL DIAL TRANSPL, V24, P1766, DOI 10.1093/ndt/gfn736; Giani JF, 2011, AM J PHYSIOL-RENAL, V300, pF272, DOI 10.1152/ajprenal.00278.2010; He JG, 2010, HEART VESSELS, V25, P438, DOI 10.1007/s00380-009-1213-7; Igase Michiya, 2011, Ther Adv Cardiovasc Dis, V5, P297, DOI 10.1177/1753944711429343; Ishiyama Y, 2004, HYPERTENSION, V43, P970, DOI 10.1161/01.HYP.0000124667.34652.1a; Ji ZQ, 2005, CELL MOL IMMUNOL, V2, P150; KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251; Katovich MJ, 2008, CURR HYPERTENS REP, V10, P227, DOI 10.1007/s11906-008-0043-9; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; LAN HY, 1995, KIDNEY INT, V48, P753, DOI 10.1038/ki.1995.347; Lara LS, 2010, ARCH BIOCHEM BIOPHYS, V496, P117, DOI 10.1016/j.abb.2010.02.005; Lee VWS, 2011, NEPHROLOGY, V16, P30, DOI 10.1111/j.1440-1797.2010.01383.x; Li YW, 2009, HYPERTENS RES, V32, P369, DOI 10.1038/hr.2009.25; Magaldi AJ, 2003, PFLUG ARCH EUR J PHY, V447, P223, DOI 10.1007/s00424-003-1173-1; Matsusaka T, 2010, HYPERTENSION, V55, P967, DOI 10.1161/HYPERTENSIONAHA.109.141994; Mihailovic-Stanojevic N, 2009, NEPHROL DIAL TRANSPL, V24, P1142, DOI 10.1093/ndt/gfn596; Naito T, 2010, AM J PHYSIOL-RENAL, V298, pF683, DOI 10.1152/ajprenal.00503.2009; Okada H, 2004, BIOCHEM BIOPH RES CO, V314, P403, DOI 10.1016/j.bbrc.2003.12.105; Pereira RM, 2007, J HEPATOL, V46, P674, DOI 10.1016/j.jhep.2006.10.018; Pinheiro SVB, 2009, KIDNEY INT, V75, P1184, DOI 10.1038/ki.2009.61; Pinheiro SVB, 2004, HYPERTENSION, V44, P490, DOI 10.1161/01.HYP.0000141438.64887.42; Ruilope LM, 2008, CURR MED RES OPIN, V24, P1285, DOI [10.1185/030079908X291921, 10.1185/030079908X291921 ]; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Santos RAS, 2006, HYPERTENSION, V47, P996, DOI 10.1161/01.HYP.0000215289.51180.5c; Santos RAS, 2008, EXP PHYSIOL, V93, P519, DOI 10.1113/expphysiol.2008.042002; Satoh M, 2001, J AM SOC NEPHROL, V12, P317, DOI 10.1681/ASN.V122317; Shao Y, 2008, ACTA PHARMACOL SIN, V29, P829, DOI 10.1111/j.1745-7254.2008.00812.x; Shimizu A, 2012, NEPHROL DIAL TRANSPL, V27, P3169, DOI 10.1093/ndt/gfs033; Silveira KD, 2010, PEDIATR NEPHROL, V25, P1795; Su Z, 2006, KIDNEY INT, V69, P2212, DOI 10.1038/sj.ki.5001509; Sukumaran V, 2012, LIFE SCI, V90, P289, DOI 10.1016/j.lfs.2011.11.018; Sukumaran V, 2011, INT J BIOL SCI, V7, P1077, DOI 10.7150/ijbs.7.1077; Sun Y, 2000, HYPERTENSION, V35, P1078, DOI 10.1161/01.HYP.35.5.1078; Tsakas S, 2006, AM J NEPHROL, V26, P186, DOI 10.1159/000093178; van der Wouden EA, 2005, J RENIN-ANGIO-ALDO S, V6, P96, DOI 10.3317/jraas.2005.016; Velkoska E, 2011, CLIN SCI, V120, P335, DOI 10.1042/CS20100280; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Zhang JD, 2010, AM J PHYSIOL-RENAL, V298, pF579, DOI 10.1152/ajprenal.00548.2009; Zimpelmann J, 2009, AM J PHYSIOL-RENAL, V296, pF337, DOI 10.1152/ajprenal.90437.2008; Zong WN, 2011, ACTA PHARMACOL SIN, V32, P1345, DOI 10.1038/aps.2011.96	58	40	42	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66082	10.1371/journal.pone.0066082	http://dx.doi.org/10.1371/journal.pone.0066082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762470	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800089
J	Williams, PT; Franklin, BA				Williams, Paul T.; Franklin, Barry A.			Reduced Incidence of Cardiac Arrhythmias in Walkers and Runners	PLOS ONE			English	Article							LONE ATRIAL-FIBRILLATION; HEART-DISEASE RISK; OF-SPORTS-MEDICINE; PHYSICAL-ACTIVITY; FOLLOW-UP; VIGOROUS EXERCISE; PUBLIC-HEALTH; OLDER-ADULTS; MEN; WALKING	Purpose: Walking is purported to reduce the risk of atrial fibrillation by 48%, whereas jogging is purported to increase its risk by 53%, suggesting a strong anti-arrhythmic benefit of walking over running. The purpose of these analyses is to compare incident self-reported physician-diagnosed cardiac arrhythmia to baseline energy expenditure (metabolic equivalent hours per day, METhr/d) from walking, running and other exercise. Methods: Proportional hazards analysis of 14,734 walkers and 32,073 runners. Results: There were 1,060 incident cardiac arrhythmias (412 walkers, 648 runners) during 6.2 years of follow-up. The risk for incident cardiac arrhythmias declined 4.4% per baseline METhr/d walked by the walkers, or running in the runners (P = 0.0001). Specifically, the risk declined 14.2% (hazard ratio: 0.858) for 1.8 to 3.6 METhr/d, 26.5% for 3.6 to 5.4 METhr/d, and 31.7% for >= 5.4 METhr/d, relative to <1.8 METhr/d. The risk reduction per METhr/d was significantly greater for walking than running (P < 0.01), but only because walkers were at 34% greater risk than runners who fell below contemporary physical activity guideline recommendations; otherwise the walkers and runners had similar risks for cardiac arrhythmias. Cardiac arrhythmias were unrelated to walking and running intensity, and unrelated to marathon participation and performance. Conclusions: The risk for cardiac arrhythmias was similar in walkers and runners who expended comparable METhr/d during structured exercise. We found no significant risk increase for self-reported cardiac arrhythmias associated with running distance, exercise intensity, or marathon participation. Rhythm abnormalities were based on self-report, precluding definitive categorization of the nature of the rhythm disturbance. However, even if the runners' arrhythmias include sinus bradycardia due to running itself, there was no increase in arrhythmias with greater running distance.	[Williams, Paul T.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Franklin, Barry A.] William Beaumont Hosp, Beaumont Hlth Ctr, Prevent Cardiol & Cardiac Rehabil, Royal Oak, MI 48072 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Beaumont Health	Williams, PT (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	ptwilliams@lbl.gov			National Heart, Lung and Blood Institute [HL094717]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094717] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grant HL094717 from the National Heart, Lung and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Aizer A, 2009, AM J CARDIOL, V103, P1572, DOI 10.1016/j.amjcard.2009.01.374; Baldesberger S, 2008, EUR HEART J, V29, P71, DOI 10.1093/eurheartj/ehm555; Camm AJ, 2012, AM J CARDIOL, V110, P270, DOI 10.1016/j.amjcard.2012.03.021; Elosua R, 2006, INT J CARDIOL, V108, P332, DOI 10.1016/j.ijcard.2005.05.020; Frost L, 2005, OCCUP ENVIRON MED, V62, P49, DOI 10.1136/oem.2004.014266; Furlanello F, 1998, J CARDIOVASC ELECTR, V9, pS63; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI 10.1161/CIRCULATIONAHA.107.185649; Heidbuchel H, 2006, INT J CARDIOL, V107, P67, DOI 10.1016/j.ijcard.2005.02.043; Heidbuchel H, 2006, EUR J CARDIOV PREV R, V13, P475, DOI 10.1097/01.hjr.0000216543.54066.72; Hoogsteen J, 2004, EUROPACE, V6, P222, DOI 10.1016/j.eupc.2004.01.004; Kannel WB, 1998, AM J CARDIOL, V82, p2N, DOI 10.1016/S0002-9149(98)00583-9; Karjalainen J, 1998, BMJ-BRIT MED J, V316, P1784, DOI 10.1136/bmj.316.7147.1784; Lee CD, 2002, MED SCI SPORT EXER, V34, P592; Leitzmann MF, 1998, ANN INTERN MED, V128, P417, DOI 10.7326/0003-4819-128-6-199803150-00001; Leitzmann MF, 1999, NEW ENGL J MED, V341, P777, DOI 10.1056/NEJM199909093411101; Link Mark S, 2002, Curr Sports Med Rep, V1, P75; Molina L, 2008, EUROPACE, V10, P618, DOI 10.1093/europace/eun071; Mont L, 2002, EUR HEART J, V23, P477, DOI 10.1053/euhj.2001.2802; Mont L, 2008, EUROPACE, V10, P15, DOI 10.1093/europace/eum263; Mozaffarian D, 2008, CIRCULATION, V118, P800, DOI 10.1161/CIRCULATIONAHA.108.785626; O'Keefe JH, 2013, HEART, V99, P516, DOI 10.1136/heartjnl-2012-302886; O'Keefe JH, 2012, MAYO CLIN PROC, V87, P587, DOI 10.1016/j.mayocp.2012.04.005; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pelliccia A, 2005, J AM COLL CARDIOL, V46, P690, DOI 10.1016/j.jacc.2005.04.052; Psaty BM, 1997, CIRCULATION, V96, P2455; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Walker J, 2010, AM J MED, V123, P1075, DOI 10.1016/j.amjmed.2010.05.008; Wilhelm M, 2011, AM J CARDIOL, V108, P1489, DOI 10.1016/j.amjcard.2011.06.073; Williams PT, 2008, MED SCI SPORT EXER, V40, P433, DOI 10.1249/MSS.0b013e31815f38f1; Williams PT, 2013, MED SCI SPORT EXER, V45, P706, DOI 10.1249/MSS.0b013e31827b0d0a; Williams PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041906; Williams PT, 2012, MED SCI SPORT EXER, V44, P1728, DOI 10.1249/MSS.0b013e318258af3f; Williams PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036360; Williams PT, 2010, ATHEROSCLEROSIS, V209, P524, DOI 10.1016/j.atherosclerosis.2009.09.018; Williams PT, 2004, INT J OBESITY, V28, P120, DOI 10.1038/sj.ijo.0802480; Williams PT, 2013, MED SCI SPO IN PRESS; Wolf PA, 1998, ARCH INTERN MED, V158, P229, DOI 10.1001/archinte.158.3.229; Zheng H, 2009, EUR J EPIDEMIOL, V24, P181, DOI 10.1007/s10654-009-9328-9	39	17	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65302	10.1371/journal.pone.0065302	http://dx.doi.org/10.1371/journal.pone.0065302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762337	Green Submitted, Green Published, gold			2022-12-25	WOS:000321094800036
J	Gaikwad, NW				Gaikwad, Nilesh W.			Metabolomic Profiling Unravels DNA Adducts in Human Breast That Are Formed from Peroxidase Mediated Activation of Estrogens to Quinone Methides	PLOS ONE			English	Article							CANCER; BIOMARKERS; MECHANISMS; DISEASE; EXPRESSION; ETIOLOGY; OBESITY; DAMAGE; RISK	Currently there are three major hypotheses that have been proposed for estrogen induced carcinogenicity, however exact etiology remains unknown. Based on the chemical logic, studies were undertaken to investigate if estrogens could generate quinone methides in an oxidative environment which then could cause DNA damage in humans. In presence of MnO2 estrogens were oxidized to quinone methides. Surprisingly quinone methides were found to be stable with t(1/2) of 20.8 and 4.5 min respectively. Incubation of estrogens with lactoperoxidase (LPO) and H2O2 resulted in formation of respective quinone methides (E-1(E-2)-QM). Subsequent addition of adenine to the assay mixture lead to trapping of E1(E2)-QM, resulting in formation of adenine adducts of estrogens, E-1(E-2)-9-N-Ade. Targeted ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) based metabolomic analysis of the breast tissue extracts showed the presence of adenine adducts of estrogens, E-1(E-2)-9-N-Ade, along with other estrogen related metabolites. Identity of E-1(E-2)-N-Ade in LPO assay extracts and breast tissue extracts were confirmed by comparing them to pure synthesized E-1(E-2)-9-N-Ade standards. From these results, it is evident that peroxidase enzymes or peroxidase-like activity in human breast tissue could oxidize estrogens to electrophilic and stable quinone methides in a single step that covalently bind to DNA to form adducts. The error prone repair of the damaged DNA can result in mutation of critical genes and subsequently cancer. This article reports evidence for hitherto unknown estrogen metabolic pathway in human breast, catalyzed by peroxidase, which could initiate cancer.	[Gaikwad, Nilesh W.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Gaikwad, Nilesh W.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Gaikwad, NW (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	ngaikwad@ucdavis.edu			Center for Health & Nutrition Research (CHNR), Department of Nutrition, University of California, Davis [CA-D-NTR-2104-H]; Hellman Foundation	Center for Health & Nutrition Research (CHNR), Department of Nutrition, University of California, Davis; Hellman Foundation	This research was supported by grant from Center for Health & Nutrition Research (CHNR), Department of Nutrition, University of California, Davis. # CA-D-NTR-2104-H and grant from Hellman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechlioulis A, 2010, CURR VASC PHARMACOL, V8, P249, DOI 10.2174/157016110790886974; BOYLAND E, 1969, ADV ENZYMOL RAMB, V32, P173; Carruba G, 2006, ANN NY ACAD SCI, V1089, P201, DOI 10.1196/annals.1386.027; Cavalieri E, 2006, BBA-REV CANCER, V1766, P63, DOI 10.1016/j.bbcan.2006.03.001; Chakraborti A, 2007, REV NEUROSCIENCE, V18, P395; Cleary MP, 2009, ENDOCRINOLOGY, V150, P2537, DOI 10.1210/en.2009-0070; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Feigelson HS, 1996, CARCINOGENESIS, V17, P2279, DOI 10.1093/carcin/17.11.2279; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Gaikwad NW, 2008, INT J CANCER, V122, P1949, DOI 10.1002/ijc.23329; Gaikwad NW, 2009, BIOMARKERS, V14, P502, DOI 10.3109/13547500903121715; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Hein A, 2013, EUR J CANCER PREV, V22, P52, DOI 10.1097/CEJ.0b013e328355ec22; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Khosla S, 2010, J CLIN ENDOCR METAB, V95, P3569, DOI 10.1210/jc.2010-0856; Liehr JG, 2000, ENDOCR REV, V21, P40, DOI 10.1210/er.21.1.40; Mayes J S, 2004, Obes Rev, V5, P197, DOI 10.1111/j.1467-789X.2004.00152.x; Persson I, 2000, J STEROID BIOCHEM, V74, P357, DOI 10.1016/S0960-0760(00)00113-8; Russo J, 2006, J STEROID BIOCHEM, V102, P89, DOI 10.1016/j.jsbmb.2006.09.004; Shang YF, 2006, NAT REV CANCER, V6, P360, DOI 10.1038/nrc1879; Simpson ER, 2011, EXPERT REV ENDOCRINO, V6, P383, DOI [10.1586/eem.11.35, 10.1586/EEM.11.35]; SWANECK GE, 1988, P NATL ACAD SCI USA, V85, P7831, DOI 10.1073/pnas.85.21.7831; TELANG NT, 1991, BREAST CANCER RES TR, V18, P155, DOI 10.1007/BF01990031; Williams JA, 2000, CANCER RES, V60, P4667; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yang L, 2009, PROSTATE, V69, P41, DOI 10.1002/pros.20850	26	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65826	10.1371/journal.pone.0065826	http://dx.doi.org/10.1371/journal.pone.0065826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762435	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000109
J	Nan, HW; Liu, Q; Chen, JS; Cheng, XY; Yin, HJ; Yin, CY; Zhao, CZ				Nan, Hongwei; Liu, Qing; Chen, Jinsong; Cheng, Xinying; Yin, Huajun; Yin, Chunying; Zhao, Chunzhang			Effects of Nutrient Heterogeneity and Competition on Root Architecture of Spruce Seedlings: Implications for an Essential Feature of Root Foraging	PLOS ONE			English	Article							NEIGHBORING PLANTS; GROWTH-RATE; RESPONSES; PHOSPHORUS; GRAVITROPISM; ARABIDOPSIS; RESOURCE; SURVIVAL; BEHAVIOR; SYSTEMS	Background: We have limited understanding of root foraging responses when plants were simultaneously exposed to nutrient heterogeneity and competition, and our goal was to determine whether and how plants integrate information about nutrients and neighbors in root foraging processes. Methodology/Principal Findings: The experiment was conducted in split-containers, wherein half of the roots of spruce (Picea asperata) seedlings were subjected to intraspecific root competition (the vegetated half), while the other half experienced no competition (the non-vegetated half). Experimental treatments included fertilization in the vegetated half (FV), the non-vegetated half (FNV), and both compartments (F), as well as no fertilization (NF). The root architecture indicators consisted of the number of root tips over the root surface (RTRS), the length percentage of diameter-based fine root subclasses to total fine root (SRLP), and the length percentage of each root order to total fine root (ROLP). The target plants used novel root foraging behaviors under different combinations of neighboring plant and localized fertilization. In addition, the significant increase in the RTRS of 0-0.2 mm fine roots after fertilization of the vegetated half alone and its significant decrease in fertilizer was applied throughout the plant clearly showed that plant root foraging behavior was regulated by local responses coupled with systemic control mechanisms. Conclusions/Significance: We measured the root foraging ability for woody plants by means of root architecture indicators constructed by the roots possessing essential nutrient uptake ability (i.e., the first three root orders), and provided new evidence that plants integrate multiple forms of environmental information, such as nutrient status and neighboring competitors, in a non-additive manner during the root foraging process. The interplay between the responses of individual root modules (repetitive root units) to localized environmental signals and the systemic control of these responses may well account for the non-additive features of the root foraging process.	[Liu, Qing] Chinese Acad Sci, Inst Biol, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu, Peoples R China; Chinese Acad Sci, Inst Biol, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Chengdu, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS	Liu, Q (corresponding author), Chinese Acad Sci, Inst Biol, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu, Peoples R China.	liuqing@cib.ac.cn			Chinese Academy of Sciences [XDA05050303]; National Key Technology R D Program [2011BAC09B04]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Key Technology R D Program(National Key Technology R&D Program)	This research was supported by grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA05050303) and the National Key Technology R & D Program (2011BAC09B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair Brent C., 1998, Biotropica, V30, P21; Bolte A, 2006, EUR J FOREST RES, V125, P15, DOI 10.1007/s10342-005-0075-5; Cahill JF, 2010, SCIENCE, V328, P1657, DOI 10.1126/science.1189736; Cheng S, 2005, PLANT SOIL, V270, P321, DOI 10.1007/s11104-004-1726-x; Comas LH, 2004, FUNCT ECOL, V18, P388, DOI 10.1111/j.0269-8463.2004.00835.x; Coomes DA, 2000, ECOL MONOGR, V70, P171, DOI 10.1890/0012-9615(2000)070[0171:IORCIF]2.0.CO;2; Day KJ, 2003, FUNCT ECOL, V17, P454, DOI 10.1046/j.1365-2435.2003.00758.x; De Kroon H, 2009, PLANT CELL ENVIRON, V32, P704, DOI 10.1111/j.1365-3040.2009.01936.x; Fang SQ, 2011, PLANT PHYSIOL, V155, P1277, DOI 10.1104/pp.110.167304; Farley RA, 1999, J ECOL, V87, P849, DOI 10.1046/j.1365-2745.1999.00396.x; Farley RA, 1999, J ECOL, V87, P688, DOI 10.1046/j.1365-2745.1999.00390.x; FITTER AH, 1991, NEW PHYTOL, V118, P383, DOI 10.1111/j.1469-8137.1991.tb00019.x; FITTER AH, 1991, NEW PHYTOL, V118, P375, DOI 10.1111/j.1469-8137.1991.tb00018.x; FITTER AH, 1987, NEW PHYTOL, V106, P61, DOI 10.1111/j.1469-8137.1987.tb04683.x; Fletcher EH, 2012, AGROFOREST SYST, V86, P49, DOI 10.1007/s10457-012-9507-7; Fujita H, 1996, PLANT CELL PHYSIOL, V37, P1094, DOI 10.1093/oxfordjournals.pcp.a029059; Garcia AL, 2006, J PLANT NUTR, V29, P2093, DOI 10.1080/01904160600972183; Gersani M, 2001, J ECOL, V89, P660, DOI 10.1046/j.0022-0477.2001.00609.x; Grabov A, 2005, NEW PHYTOL, V165, P641, DOI 10.1111/j.1469-8137.2004.01258.x; Grime JP, 2002, EVOL ECOL, V16, P299, DOI 10.1023/A:1019640813676; Gunaratne AMTA, 2011, FOREST ECOL MANAG, V262, P229, DOI 10.1016/j.foreco.2011.03.027; Guo DL, 2008, NEW PHYTOL, V180, P673, DOI 10.1111/j.1469-8137.2008.02573.x; Guo DL, 2004, OECOLOGIA, V140, P450, DOI 10.1007/s00442-004-1596-1; Hartnett DC, 2004, AFR J ECOL, V42, P328, DOI 10.1111/j.1365-2028.2004.00533.x; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Hodge A, 2009, PLANT CELL ENVIRON, V32, P628, DOI 10.1111/j.1365-3040.2008.01891.x; Hu Rong, 2011, Scientia Silvae Sinicae, V47, P23; Kembel SW, 2008, ANN BOT-LONDON, V101, P1295, DOI 10.1093/aob/mcn044; Lei PF, 2012, FOREST ECOL MANAG, V265, P191, DOI 10.1016/j.foreco.2011.10.033; Leuschner C, 2001, OECOLOGIA, V126, P276, DOI 10.1007/s004420000507; Lucash MS, 2007, TREES-STRUCT FUNCT, V21, P593, DOI 10.1007/s00468-007-0160-0; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Lynch JP, 2005, PLANT SOIL, V269, P45, DOI 10.1007/s11104-004-1096-4; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Messier C, 2009, J ECOL, V97, P548, DOI 10.1111/j.1365-2745.2009.01500.x; Mommer L, 2012, FUNCT ECOL, V26, P66, DOI 10.1111/j.1365-2435.2011.01916.x; Nord EA, 2011, FUNCT PLANT BIOL, V38, P941, DOI 10.1071/FP11130; O'Brien EE, 2008, J ECOL, V96, P438, DOI 10.1111/j.1365-2745.2008.01354.x; Ozier-Lafontaine H, 1999, PLANT SOIL, V209, P167, DOI 10.1023/A:1004461130561; Postma JA, 2012, ANN BOT-LONDON, V110, P521, DOI 10.1093/aob/mcs082; Pregitzer KS, 2002, ECOL MONOGR, V72, P293, DOI 10.1890/0012-9615(2002)072[0293:FRAONN]2.0.CO;2; Rubio G, 2003, CROP SCI, V43, P598, DOI 10.2135/cropsci2003.0598; Rubio G, 2001, ANN BOT-LONDON, V88, P929, DOI 10.1006/anbo.2001.1530; Wells CE, 2002, AM J BOT, V89, P79, DOI 10.3732/ajb.89.1.79; Zheng M, 2012, J ARID ENVIRON, V85, P105, DOI 10.1016/j.jaridenv.2012.05.006; Zhou J, 2012, ANN BOT-LONDON, V109, P813, DOI 10.1093/aob/mcr314	47	13	16	2	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65650	10.1371/journal.pone.0065650	http://dx.doi.org/10.1371/journal.pone.0065650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762405	Green Submitted, Green Published, gold			2022-12-25	WOS:000321099000088
J	Wong, CE; Singh, MB; Bhalla, PL				Wong, Chui E.; Singh, Mohan B.; Bhalla, Prem L.			The Dynamics of Soybean Leaf and Shoot Apical Meristem Transcriptome Undergoing Floral Initiation Process	PLOS ONE			English	Article							FLOWERING-LOCUS-T; GIBBERELLIN 20-OXIDASE GENES; FALSE DISCOVERY RATE; ARABIDOPSIS-THALIANA; PLANT DEVELOPMENT; ABSCISIC-ACID; REPRODUCTIVE DEVELOPMENT; TREHALOSE 6-PHOSPHATE; VEGETATIVE GROWTH; IDENTITY GENES	Flowering process governs seed set and thus affects agricultural productivity. Soybean, a major legume crop, requires short-day photoperiod conditions for flowering. While leaf-derived signal(s) are essential for the photoperiod-induced floral initiation process at the shoot apical meristem, molecular events associated with early floral transition stages in either leaves or shoot apical meristems are not well understood. To provide novel insights into the molecular basis of floral initiation, RNA-Seq was used to characterize the soybean transcriptome of leaf and micro-dissected shoot apical meristem at different time points after short-day treatment. Shoot apical meristem expressed a higher number of transcripts in comparison to that of leaf highlighting greater diversity and abundance of transcripts expressed in the shoot apical meristem. A total of 2951 shoot apical meristem and 13,609 leaf sequences with significant profile changes during the time course examined were identified. Most changes in mRNA level occurred after 1short-day treatment. Transcripts involved in mediating responses to stimulus including hormones or in various metabolic processes represent the top enriched GO functional category for the SAM and leaf dataset, respectively. Transcripts associated with protein degradation were also significantly changing in leaf and SAM implicating their involvement in triggering the developmental switch. RNA-Seq analysis of shoot apical meristem and leaf from soybean undergoing floral transition reveal major reprogramming events in leaves and the SAM that point toward hormones gibberellins (GA) and cytokinin as key regulators in the production of systemic flowering signal(s) in leaves. These hormones may form part of the systemic signals in addition to the established florigen, FLOWERING LOCUS T (FT). Further, evidence is emerging that the conversion of shoot apical meristem to inflorescence meristem is linked with the interplay of auxin, cytokinin and GA creating a low cytokinin and high GA environment.	[Wong, Chui E.; Singh, Mohan B.; Bhalla, Prem L.] Univ Melbourne, Plant Mol Biol & Biotechnol Grp, ARC Ctr Excellence Integrat Legume Res, Melbourne Sch Land & Environm, Parkville, Vic 3052, Australia	University of Melbourne	Bhalla, PL (corresponding author), Univ Melbourne, Plant Mol Biol & Biotechnol Grp, ARC Ctr Excellence Integrat Legume Res, Melbourne Sch Land & Environm, Parkville, Vic 3052, Australia.	premlb@unimelb.edu.au		Bhalla, Prem/0000-0002-2910-0393; WONG, Chui Eng/0000-0003-3006-2176; Singh, Mohan/0000-0001-9427-8975	Australian Research Council in the form of the ARC Centre of Excellence for Integrative Legume Research [CE0348212]	Australian Research Council in the form of the ARC Centre of Excellence for Integrative Legume Research(Australian Research Council)	This work was supported by the Australian Research Council in the form of the ARC Centre of Excellence for Integrative Legume Research (CE0348212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2007, P NATL ACAD SCI USA, V104, P6484, DOI 10.1073/pnas.0610717104; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Avonce N, 2004, PLANT PHYSIOL, V136, P3649, DOI 10.1104/pp.104.052084; Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borner R, 2000, PLANT J, V24, P591, DOI 10.1046/j.1365-313x.2000.00906.x; Carabelli M, 2007, GENE DEV, V21, P1863, DOI 10.1101/gad.432607; Chiang GCK, 2009, P NATL ACAD SCI USA, V106, P11661, DOI 10.1073/pnas.0901367106; Citerne HL, 2003, PLANT PHYSIOL, V131, P1042, DOI 10.1104/pp.102.016311; Coles JP, 1999, PLANT J, V17, P547, DOI 10.1046/j.1365-313X.1999.00410.x; Corbesier L, 2003, J EXP BOT, V54, P2511, DOI 10.1093/jxb/erg276; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; D'Aloia M, 2011, PLANT J, V65, P972, DOI 10.1111/j.1365-313X.2011.04482.x; Das P, 2009, DEVELOPMENT, V136, P1605, DOI 10.1242/dev.035436; Davis SJ, 2009, PLANT CELL ENVIRON, V32, P1201, DOI 10.1111/j.1365-3040.2009.01968.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Eriksson S, 2006, PLANT CELL, V18, P2172, DOI 10.1105/tpc.106.042317; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; Gocal GFW, 2001, PLANT PHYSIOL, V125, P1788, DOI 10.1104/pp.125.4.1788; Gomez LD, 2010, PLANT J, V64, P1, DOI 10.1111/j.1365-313X.2010.04312.x; Gremski K, 2007, DEVELOPMENT, V134, P3593, DOI 10.1242/dev.011510; Haerizadeh F, 2009, PLANT MOL BIOL, V69, P711, DOI 10.1007/s11103-008-9450-1; Harberd NP, 2009, PLANT CELL, V21, P1328, DOI 10.1105/tpc.109.066969; Hisamatsu T, 2005, PLANT PHYSIOL, V138, P1106, DOI 10.1104/pp.104.059055; Hisamatsu T, 2008, J EXP BOT, V59, P3821, DOI 10.1093/jxb/ern232; Iqbal N, 2011, CURR SCI INDIA, V100, P998; Jasinski S, 2005, CURR BIOL, V15, P1560, DOI 10.1016/j.cub.2005.07.023; Jones B, 2010, PLANT CELL, V22, P2956, DOI 10.1105/tpc.110.074856; Jung CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038250; Kania T, 1997, PLANT CELL, V9, P1327, DOI 10.1105/tpc.9.8.1327; Karim MR, 2009, PLANT CELL, V21, P1360, DOI 10.1105/tpc.109.067025; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Laurie RE, 2011, PLANT PHYSIOL, V156, P2207, DOI 10.1104/pp.111.180182; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li YH, 2006, GENOME RES, V16, P414, DOI 10.1101/gr.4237406; Liang D, 2009, J EXP BOT, V60, P4201, DOI 10.1093/jxb/erp254; Lin MK, 2007, PLANT CELL, V19, P1488, DOI 10.1105/tpc.107.051920; Liu BH, 2010, PLANT PHYSIOL, V153, P198, DOI 10.1104/pp.109.150607; Lunn JE, 2006, BIOCHEM J, V397, P139, DOI 10.1042/BJ20060083; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Perilli S, 2010, CURR OPIN PLANT BIOL, V13, P21, DOI 10.1016/j.pbi.2009.09.018; PODOLNYI VZ, 1989, BIOL PLANTARUM, V31, P139, DOI 10.1007/BF02907247; Ramon M, 2007, PLANT MOL BIOL, V63, P195, DOI 10.1007/s11103-006-9082-2; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; Shoemaker RC, 2006, CURR OPIN PLANT BIOL, V9, P104, DOI 10.1016/j.pbi.2006.01.007; Sohlberg JJ, 2006, PLANT J, V47, P112, DOI 10.1111/j.1365-313X.2006.02775.x; Tardif G, 2007, PLANT MOL BIOL, V63, P703, DOI 10.1007/s11103-006-9119-6; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tucker SC, 2003, PLANT PHYSIOL, V131, P911, DOI 10.1104/pp.102.017459; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; van Dijken AJH, 2004, PLANT PHYSIOL, V135, P969, DOI 10.1104/pp.104.039743; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; Weiss D, 2007, PLANT PHYSIOL, V144, P1240, DOI 10.1104/pp.107.100370; Wellmer F, 2006, PLOS GENET, V2, P1012, DOI 10.1371/journal.pgen.0020117; Wilmowicz E, 2008, J PLANT PHYSIOL, V165, P1917, DOI 10.1016/j.jplph.2008.04.009; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403; Wolbang CM, 2004, PLANT PHYSIOL, V134, P769, DOI 10.1104/pp.103.030460; Wolters H, 2009, NAT REV GENET, V10, P305, DOI 10.1038/nrg2558; Wong CE, 2009, PLANT SIGNALING BEHA, V4, P1; Wong CE, 2011, J EXP BOT, V62, P2495, DOI 10.1093/jxb/erq437; Wong CE, 2011, PLANTA, V233, P553, DOI 10.1007/s00425-010-1320-9; Wong CE, 2009, PLANT J, V57, P832, DOI 10.1111/j.1365-313X.2008.03730.x; Xu J, 2010, PLANT CELL, V22, P91, DOI 10.1105/tpc.109.071803; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yoo SD, 2009, TRENDS PLANT SCI, V14, P270, DOI 10.1016/j.tplants.2009.02.007; Yoo SK, 2011, PLANT J, V65, P62, DOI 10.1111/j.1365-313X.2010.04402.x; Zhang QZ, 2008, P NATL ACAD SCI USA, V105, P21028, DOI 10.1073/pnas.0810585105	70	33	35	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65319	10.1371/journal.pone.0065319	http://dx.doi.org/10.1371/journal.pone.0065319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762343	Green Submitted, gold, Green Published			2022-12-25	WOS:000321099000055
J	Lu, X; Mazur, SJ; Lin, T; Appella, E; Xu, Y				Lu, X.; Mazur, S. J.; Lin, T.; Appella, E.; Xu, Y.			The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis	ONCOGENE			English	Article						nanog; breast cancer; tumorigenesis; metastasis	GENE-EXPRESSION; STEM-CELLS; SIGNALING PATHWAYS; OCT4; MIGRATION; INVASION; NETWORK; MICE	Nanog is a transcription factor required for maintaining the pluripotency of embryonic stem cells, and is not expressed in most normal adult tissues. However, recent studies have indicated that Nanog is overexpressed in many types of human cancers, including breast cancer. To elucidate the physiological roles of Nanog in tumorigenesis, we developed an inducible Nanog transgenic mouse model, in which the expression of Nanog in adult tissues can be induced via LoxP/Cre-mediated deletion. Our findings indicate that overexpression of Nanog in the mammary gland is not sufficient to induce mammary tumor. However, when coexpressed with Wnt-1 in the mouse mammary gland, it promotes mammary tumorigenesis and metastasis. In this context, Nanog promotes the migration and invasion of breast cancer cells. Microarray analysis has shown that the ectopic expression of Nanog deregulates the expression of numerous genes associated with tumorigenesis and metastasis, such as the PDGFR alpha gene. Our findings demonstrate the involvement of Nanog in breast cancer metastasis, and provide the basis for the reported correlation between Nanog expression and poor prognosis of human breast cancer patients. As Nanog is not expressed in most adult tissues, these findings identify Nanog as a potential therapeutic target in the treatment of Nanog-expressing metastatic breast cancer.	[Lu, X.; Xu, Y.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Mazur, S. J.; Appella, E.] NCI, Lab Cell Biol, NIH, Bethesda, MD 20892 USA; [Lin, T.] Guangdong Prov Acad Chinese Med Sci, Ctr Regenerat Med & Translat Med, Guangzhou, Guangdong, Peoples R China	University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Guangzhou University of Chinese Medicine	Xu, Y (corresponding author), Univ Calif San Diego, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yangxu@ucsd.edu	Lin, Tongxiang/I-4695-2013	Lin, Tongxiang/0000-0001-7033-6982; Xu, Yang/0000-0001-5574-921X	NIH [CA94254, CA124834]; Intramural Research Program of the National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA094254, R01CA124834, ZIABC005599] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Y Li for providing the Wnt-1 transgenic mice. This work was supported by NIH grants (CA94254 and CA124834) to YX and by the Intramural Research Program of the National Cancer Institute, National Institutes of Health.	Almstrup K, 2004, CANCER RES, V64, P4736, DOI 10.1158/0008-5472.CAN-04-0679; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Esselens C, 2010, J BIOL CHEM, V285, P2463, DOI 10.1074/jbc.M109.055129; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Fields S, 2007, SCIENCE, V316, P1441, DOI 10.1126/science.1144479; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hart AH, 2005, CANCER, V104, P2092, DOI 10.1002/cncr.21435; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Herman JG, 2007, INT J ONCOL, V30, P1231; Ibrahim EE, 2012, STEM CELLS, V30, P2076, DOI 10.1002/stem.1182; Ishiguro T, 2012, BIOCHEM BIOPH RES CO, V418, P199, DOI 10.1016/j.bbrc.2011.10.123; Jechlinger M, 2006, J CLIN INVEST, V116, P1561, DOI 10.1172/JCI24652; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kelleher FC, 2006, ACTA ONCOL, V45, P375, DOI 10.1080/02841860600602946; Kohler EE, 2011, BLOOD, V117, P1761, DOI 10.1182/blood-2010-07-295261; Lee EK, 2010, J PROTEOME RES, V9, P5108, DOI 10.1021/pr100378z; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Liu DP, 2010, ONCOGENE, V29, P949, DOI 10.1038/onc.2009.376; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagata T, 2014, BREAST CANCER-TOKYO, V21, P96, DOI 10.1007/s12282-012-0357-y; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Park SJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S50; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Sharov AA, 2006, DNA RES, V13, P123, DOI 10.1093/dnares/dsl005; Siu MKY, 2013, ONCOGENE, V32, P3500, DOI 10.1038/onc.2012.363; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yeom YI, 1996, DEVELOPMENT, V122, P881; Zhang JY, 2010, ONCOL LETT, V1, P457, DOI 10.3892/ol_00000081	52	100	106	2	29	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 15	2014	33	20					2655	2664		10.1038/onc.2013.209	http://dx.doi.org/10.1038/onc.2013.209			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH9YT	23770853	Green Accepted			2022-12-25	WOS:000336502700011
J	Doshi, R; van Veen, HW				Doshi, Rupak; van Veen, Hendrik W.			Substrate Binding Stabilizes a Pre-translocation Intermediate in the ATP-binding Cassette Transport Protein MsbA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Lipid Transport; Membrane Transport; Multidrug Transporters; Protein Conformation; Substrate-stimulated ATPase	HUMAN P-GLYCOPROTEIN; ABC TRANSPORTER; ALTERNATING ACCESS; DRUG-BINDING; CONFORMATIONAL-CHANGES; MOLECULAR-BASIS; CYCLE; DISSECTION; LMRA	ATP-binding cassette (ABC) transporters belong to one of the largest protein superfamilies that expands from prokaryotes to man. Recent x-ray crystal structures of bacterial and mammalian ABC exporters suggest a common alternating access mechanism of substrate transport, which has also been biochemically substantiated. However, the current model does not yet explain the coupling between substrate binding and ATP hydrolysis that underlies ATP-dependent substrate transport. In our studies on the homodimeric multidrug/lipid A ABC exporter MsbA from Escherichia coli, we performed cysteine cross-linking, fluorescence energy transfer, and cysteine accessibility studies on two reporter positions, near the nucleotide-binding domains and in the membrane domains, for transporter embedded in a biological membrane. Our results suggest for the first time that substrate binding by MsbA stimulates the maximum rate of ATP hydrolysis by facilitating the dimerization of nucleotide-binding domains in a state, which is markedly distinct from the previously described nucleotide-free, inward-facing and nucleotide-bound, outward-facing conformations of ABC exporters and which binds ATP.	[Doshi, Rupak; van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	van Veen, HW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	hwv20@cam.ac.uk	van Veen, Hendrik W./A-4162-2008	van Veen, Hendrik W./0000-0002-9658-8077	Biotechnology and Biological Sciences Research Council; Cambridge Commonwealth and Overseas Trust; Charter studentship; BBSRC [BB/I002383/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I002383/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge Commonwealth and Overseas Trust; Charter studentship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Biotechnology and Biological Sciences Research Council.; Recipient of a Cambridge Commonwealth and Overseas Trust scholarship and a Charter studentship.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; Arnaud O, 2010, J MED CHEM, V53, P6720, DOI 10.1021/jm100839w; Booth IR, 2007, NAT REV MICROBIOL, V5, P431, DOI 10.1038/nrmicro1659; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Cooper RS, 2013, J BIOL CHEM, V288, P20785, DOI 10.1074/jbc.M113.477976; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Doshi R, 2013, J BIOL CHEM, V288, P6801, DOI 10.1074/jbc.M112.430074; Doshi R, 2011, BIOCHEM SOC T, V39, P807, DOI 10.1042/BST0390807; Doshi R, 2010, PROTEINS, V78, P2867, DOI 10.1002/prot.22813; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Hellmich UA, 2012, J AM CHEM SOC, V134, P5857, DOI 10.1021/ja211007t; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Infed N, 2011, BBA-BIOMEMBRANES, V1808, P2313, DOI 10.1016/j.bbamem.2011.05.016; Li-Blatter X, 2009, BBA-BIOMEMBRANES, V1788, P2335, DOI 10.1016/j.bbamem.2009.07.010; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; Loo TW, 2003, J BIOL CHEM, V278, P1575, DOI 10.1074/jbc.M211307200; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Mehmood S, 2012, P NATL ACAD SCI USA, V109, P10832, DOI 10.1073/pnas.1204067109; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; SCARBOROUGH GA, 1995, J BIOENERG BIOMEMBR, V27, P37, DOI 10.1007/BF02110329; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Siarheyeva A, 2009, BIOCHEM J, V419, P317, DOI 10.1042/BJ20081364; Szabo K, 1998, J BIOL CHEM, V273, P10132, DOI 10.1074/jbc.273.17.10132; VanVeen HW, 1996, P NATL ACAD SCI USA, V93, P10668, DOI 10.1073/pnas.93.20.10668; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; Wang GC, 1998, EUR J BIOCHEM, V255, P383, DOI 10.1046/j.1432-1327.1998.2550383.x; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Woebking B, 2008, BIOCHEMISTRY-US, V47, P10904, DOI 10.1021/bi800778d; Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	36	34	34	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21638	21647		10.1074/jbc.M113.485714	http://dx.doi.org/10.1074/jbc.M113.485714			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23766512	Green Published, hybrid			2022-12-25	WOS:000328841900016
J	Ciaramella, A; Salani, F; Bizzoni, F; Pontieri, FE; Stefani, A; Pierantozzi, M; Assogna, F; Caltagirone, C; Spalletta, G; Bossu, P				Ciaramella, Antonio; Salani, Francesca; Bizzoni, Federica; Pontieri, Francesco E.; Stefani, Alessandro; Pierantozzi, Mariangela; Assogna, Francesca; Caltagirone, Carlo; Spalletta, Gianfranco; Bossu, Paola			Blood Dendritic Cell Frequency Declines in Idiopathic Parkinson's Disease and Is Associated with Motor Symptom Severity	PLOS ONE			English	Article							INTERFERON-PRODUCING CELLS; NONMOTOR SYMPTOMS; SUBSETS; IMMUNITY; NEUROINFLAMMATION; NEUROMELANIN; ACTIVATION; DEPRESSION; DOPAMINE	The role of inflammation in Parkinson's Disease (PD) is well appreciated, but its underlying mechanisms are still unclear. Our objective was to determine whether dendritic cells (DC), a unique type of migratory immune cells that regulate immunological response and inflammation have an impact on PD. In a case-control study including 80 PD patients and 80 age- and gender-matched healthy control subjects, the two main blood subsets of plasmacytoid and myeloid DC were defined by flow cytometry analysis. Clinical evaluation of subjects consisting of cognition and depression assessment was performed using the Mini Mental State Examination and the Beck Depression Inventory. The severity of motor symptoms was measured using the Unified Parkinson's Disease Rating Scale-Part III. Comparison between patient and control DC measures and their relationships with clinical assessments were evaluated. The following main results were obtained: 1) the level of circulating DC (mainly the myeloid subset) was significantly reduced in PD patients in comparison with healthy controls; 2) after controlling for depressive and cognitive characteristics, the frequency of myeloid DC was confirmed as one of the independent determinants of PD; 3) the number of both myeloid and plasmacytoid DC was negatively associated with motor symptom severity. Overall, the decline of blood DC, perhaps due to the recruitment of immune cells to the site of disease-specific lesions, can be considered a clue of the immune alteration that characterizes PD, suggesting innovative exploitations of DC monitoring as a clinically significant tool for PD treatment. Indeed, this study suggests that reduced peripheral blood DC are a pathologically-relevant factor of PD and also displays the urgency to better understand DC role in PD for unraveling the immune system contribution to disease progression and thus favoring the development of innovative therapies ideally based on immunomodulation.	[Ciaramella, Antonio; Salani, Francesca; Bizzoni, Federica; Assogna, Francesca; Caltagirone, Carlo; Spalletta, Gianfranco; Bossu, Paola] IRCCS Fdn Santa Lucia, Rome, Italy; [Pontieri, Francesco E.] Univ Roma La Sapienza, Dept Neurol & Psychiat, Movement Disorder Unit, St Andrea Hosp, I-00185 Rome, Italy; [Stefani, Alessandro; Pierantozzi, Mariangela] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy	IRCCS Santa Lucia; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; University of Rome Tor Vergata	Bossu, P (corresponding author), IRCCS Fdn Santa Lucia, Rome, Italy.	p.bossu@hsantalucia.it	Bossù, Paola/E-4832-2014; Pierantozzi, Mariangela/J-6905-2018; Nacmias, Benedetta/J-5084-2018; Spalletta, Gianfranco/K-3828-2018; Assogna, Francesca/J-9968-2016; SALANI, FRANCESCA/I-1314-2012; ciaramella, antonio/F-1170-2011; ciaramella, antonio/P-9009-2019; PONTIERI, FRANCESCO ERNESTO/K-4232-2018	Bossù, Paola/0000-0002-1432-0078; Nacmias, Benedetta/0000-0001-9338-9040; Spalletta, Gianfranco/0000-0002-7432-4249; Assogna, Francesca/0000-0003-4315-7879; SALANI, FRANCESCA/0000-0002-6901-6057; ciaramella, antonio/0000-0001-9888-8156; ciaramella, antonio/0000-0001-9888-8156; PIERANTOZZI, MARIANGELA/0000-0002-4507-4666; STEFANI, ALESSANDRO/0000-0002-1806-8922; PONTIERI, FRANCESCO ERNESTO/0000-0002-8693-8432	Italian Ministry of Health [RF07-08, RC-08-09-10-11]	Italian Ministry of Health(Ministry of Health, Italy)	This study is not industry-sponsored and it received financial support from Italian Ministry of Health, Grant RF07-08 and RC-08-09-10-11 (PB and GS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anderson G, 2012, MED HYPOTHESES, V78, P752, DOI 10.1016/j.mehy.2012.02.023; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barnum CJ, 2012, CURR NEUROL NEUROSCI, V12, P350, DOI 10.1007/s11910-012-0283-6; Beck AT., 1996, BECK DEPRESSION INVE; Ciaramella A, 2010, J ALZHEIMERS DIS, V19, P559, DOI 10.3233/JAD-2010-1257; Dillon SM, 2008, JAIDS-J ACQ IMM DEF, V48, P1, DOI 10.1097/QAI.0b013e3181664b60; Fahn S.E., 1987, RECENT DEV PARKINSON, V153, P293; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Funk N, 2013, MOVEMENT DISORD, V28, P392, DOI 10.1002/mds.25300; Garbe K, 2012, HUM IMMUNOL, V73, P493, DOI 10.1016/j.humimm.2012.02.007; GOTHAM AM, 1986, J NEUROL NEUROSUR PS, V49, P381, DOI 10.1136/jnnp.49.4.381; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hughes AJ, 2001, NEUROLOGY, V57, P1497, DOI 10.1212/WNL.57.8.1497; Iribarren P, 2002, ARCH IMMUNOL THER EX, V50, P187; Koutsilieri E, 2013, J NEURAL TRANSM, V120, P75, DOI 10.1007/s00702-012-0842-7; Kunitani H, 2002, J HEPATOL, V36, P734, DOI 10.1016/S0168-8278(02)00062-4; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Mabbott NA, 2000, NAT MED, V6, P719, DOI 10.1038/77401; Menza M, 2010, PSYCHOSOMATICS, V51, P474, DOI 10.1176/appi.psy.51.6.474; Oberlander U, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-116; Olweus J, 1997, P NATL ACAD SCI USA, V94, P12551, DOI 10.1073/pnas.94.23.12551; Pacheco R, 2009, J NEUROIMMUNOL, V216, P8, DOI 10.1016/j.jneuroim.2009.07.018; Prado C, 2012, J IMMUNOL, V188, P3062, DOI 10.4049/jimmunol.1103096; Reynolds AD, 2009, J IMMUNOL, V182, P4137, DOI 10.4049/jimmunol.0803982; Rezai-Zadeh K, 2009, J NEUROIMMUNE PHARM, V4, P462, DOI 10.1007/s11481-009-9166-2; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Uehira K, 2002, CLIN IMMUNOL, V105, P296, DOI 10.1006/clim.2002.5287; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; Wilms H, 2003, FASEB J, V17, P500, DOI 10.1096/fj.02-0314fje; Yilmaz A, 2010, CLIN SCI, V118, P147, DOI 10.1042/CS20090154	34	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65352	10.1371/journal.pone.0065352	http://dx.doi.org/10.1371/journal.pone.0065352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776473	gold, Green Published, Green Submitted			2022-12-25	WOS:000320755400027
J	McKimm-Breschkin, JL; Barrett, S; Pudjiatmoko; Azhar, M; Wong, FYK; Selleck, P; Mohr, PG; McGrane, J; Kim, M				McKimm-Breschkin, Jennifer L.; Barrett, Susan; Pudjiatmoko; Azhar, Muhammad; Wong, Frank Y. K.; Selleck, Paul; Mohr, Peter G.; McGrane, James; Kim, Mia			I222 Neuraminidase Mutations Further Reduce Oseltamivir Susceptibility of Indonesian Clade 2.1 Highly Pathogenic Avian Influenza A(H5N1) Viruses	PLOS ONE			English	Article							A H5N1 VIRUSES; SIALIC-ACID; H1N1 VIRUS; 2.2-A RESOLUTION; A(H1N1) VIRUS; DRUG DESIGN; B VIRUSES; IN-VITRO; RESISTANT; INHIBITORS	We have tested the susceptibility to neuraminidase inhibitors of 155 clade 2.1 H5N1 viruses from Indonesia, isolated between 2006-2008 as well as 12 clade 1 isolates from Thailand and Cambodia from 2004-2007 using a fluorometric MUNANA-based enzyme inhibition assay. The Thailand and Cambodian clade 1 isolates tested here were all susceptible to oseltamivir and zanamivir, and sequence comparison indicated that reduced oseltamivir susceptibility we observed previously with clade 1 Cambodian isolates correlated with an S246G neuraminidase mutation. Eight Indonesian viruses (5%), all bearing I222 neuraminidase mutations, were identified as mild to extreme outliers for oseltamivir based on statistical analysis by box plots. IC(50)s were from 50 to 500-fold higher than the reference clade 1 virus from Viet Nam, ranging from 43-75 nM for I222T/V mutants and from 268-349 nM for I222M mutants. All eight viruses were from different geographic locales; all I222M variants were from central Sumatra. None of the H5N1 isolates tested demonstrated reduced susceptibility to zanamivir (IC(50)s all <5 nM). All I222 mutants showed loss of slow binding specifically for oseltamivir in an IC50 kinetics assay. We identified four other Indonesian isolates with higher IC(50)s which also demonstrated loss of slow binding, including one virus with an I117V mutation. There was a minimal effect on the binding of zanamivir and peramivir for all isolates tested. As H5N1 remains a potential pandemic threat, the incidence of mutations conferring reduced oseltamivir susceptibility is concerning and emphasizes the need for greater surveillance of drug susceptibility.	[McKimm-Breschkin, Jennifer L.; Barrett, Susan] Commonwealth Sci & Ind Res Org, Parkville, Vic, Australia; [McKimm-Breschkin, Jennifer L.; Barrett, Susan; Wong, Frank Y. K.; Selleck, Paul; Mohr, Peter G.] Commonwealth Sci & Ind Res Org, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Pudjiatmoko; Azhar, Muhammad] Minist Agr, Directorate Anim Hlth, Directorate Gen Livestock, Jakarta, Indonesia; [Pudjiatmoko; Azhar, Muhammad] Minist Agr, Anim Hlth Serv, Jakarta, Indonesia; [McGrane, James; Kim, Mia] UN, Food & Agr Org, Emergency Ctr Transboundary Anim Dis, Jakarta, Indonesia; [Kim, Mia] World Org Anim Hlth & Food, Paris, France; [Kim, Mia] United Nations Global Network Expertise Anim Infl, Agr Org, OFFLU, Paris, France; [Kim, Mia] World Org Anim Hlth & Food, Rome, Italy; [Kim, Mia] United Nations Global Network Expertise Anim Infl, Agr Org, OFFLU, Rome, Italy; [Kim, Mia] USDA, Natl Vet Serv Labs, Ames, IA 50010 USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Ministry of Agricultire & Rural Development; Ministry of Agricultire & Rural Development; Food & Agriculture Organization of the United Nations (FAO); United States Department of Agriculture (USDA)	McKimm-Breschkin, JL (corresponding author), Commonwealth Sci & Ind Res Org, Parkville, Vic, Australia.	mck245@csiro.au	Wong, Frank/H-1950-2013; McKimm-Breschkin, Jennifer L/D-1880-2013	Wong, Frank/0000-0003-2471-9549; McKimm-Breschkin, Jennifer/0000-0002-2345-6786; Mohr, Peter/0000-0002-2402-3843; Barrett, Susan/0000-0003-1132-5268	Australian Department of Agriculture, Forestry and Fisheries	Australian Department of Agriculture, Forestry and Fisheries(Australian GovernmentDepartment of Agriculture and Water Resources)	Parts of this work were supported by the Australian Department of Agriculture, Forestry and Fisheries. No additional external funding was received for this study. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abed Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002431; Babu YS, 2000, J MED CHEM, V43, P3482, DOI 10.1021/jm0002679; Barrett S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023627; Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Boltz DA, 2010, J GEN VIROL, V91, P949, DOI 10.1099/vir.0.017459-0; BURMEISTER WP, 1992, EMBO J, V11, P49, DOI 10.1002/j.1460-2075.1992.tb05026.x; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P969; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Deyde VM, 2009, ANTIMICROB AGENTS CH, V53, P1039, DOI 10.1128/AAC.01446-08; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Eshaghi A, 2011, EMERG INFECT DIS, V17, P1472, DOI 10.3201/eid1708.102004; FAO, 2012, FAOAIDE NEWS AN INFL; Govorkova EA, 2010, J VIROL, V84, P8042, DOI 10.1128/JVI.00689-10; Govorkova EA, 2009, ANTIMICROB AGENTS CH, V53, P3088, DOI 10.1128/AAC.01667-08; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hatakeyama S, 2011, CLIN MICROBIOL INFEC, V17, P1332, DOI 10.1111/j.1469-0691.2010.03313.x; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; Hill AW, 2009, INFECT GENET EVOL, V9, P169, DOI 10.1016/j.meegid.2008.10.006; Hurt AC, 2007, ANTIVIR RES, V73, P228, DOI 10.1016/j.antiviral.2006.10.004; Hurt AC, 2012, EMERG INFECT DIS, V18, P109, DOI 10.3201/eid1801.111079; Hurt AC, 2009, ANTIMICROB AGENTS CH, V53, P4433, DOI 10.1128/AAC.00334-09; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Ilyushina NA, 2008, ANTIMICROB AGENTS CH, V52, P3889, DOI 10.1128/AAC.01579-07; Ilyushina NA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000933; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Landon MR, 2008, CHEM BIOL DRUG DES, V71, P106, DOI 10.1111/j.1747-0285.2007.00614.x; Mai TQL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003339; Matsuzaki Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-53; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; McKimm-Breschkin JL, 2007, EMERG INFECT DIS, V13, P1354, DOI 10.3201/eid1309.070164; McKimm-Breschkin JL, 2012, J ANTIMICROB CHEMOTH, V67, P1874, DOI 10.1093/jac/dks150; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Monto AS, 2006, ANTIMICROB AGENTS CH, V50, P2395, DOI 10.1128/AAC.01339-05; Morrison D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001305; Naughtin M, 2011, ANTIMICROB AGENTS CH, V55, P2004, DOI 10.1128/AAC.01773-10; Nguyen HT, 2012, ANTIVIR THER, V17, P159, DOI 10.3851/IMP2067; Nguyen HT, 2010, CLIN INFECT DIS, V51, P983, DOI 10.1086/656439; Oakley AJ, 2010, J MED CHEM, V53, P6421, DOI 10.1021/jm100621s; Oo C, 2001, Paediatr Drugs, V3, P229, DOI 10.2165/00128072-200103030-00005; Pizzorno A, 2011, J INFECT DIS, V203, P25, DOI 10.1093/infdis/jiq010; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Rameix-Welti MA, 2006, ANTIMICROB AGENTS CH, V50, P3809, DOI 10.1128/AAC.00645-06; Rayner JM, 2007, NATURALLY OCCURING A, V68, P48; Sleeman K, 2011, EMERG INFECT DIS, V17, P2043, DOI 10.3201/eid1711.110787; Smith BJ, 2002, J MED CHEM, V45, P2207, DOI 10.1021/jm010528u; Takano R, 2012, J INFECT DIS; Takano R, 2013, J INFECT DIS, V207, P89, DOI 10.1093/infdis/jis633; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302; Varghese JN, 1998, STRUCT FOLD DES, V6, P735, DOI 10.1016/S0969-2126(98)00075-6; VARGHESE JN, 1991, J MOL BIOL, V221, P473, DOI 10.1016/0022-2836(91)80068-6; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wattanagoon Y, 2009, ANTIMICROB AGENTS CH, V53, P945, DOI 10.1128/AAC.00588-08; Wetherall NT, 2003, J CLIN MICROBIOL, V41, P742, DOI 10.1128/JCM.41.2.742-750.2003; WHO, 2013, CUM NUMB CONF HUM CA; Wibawa H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-425	57	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66105	10.1371/journal.pone.0066105	http://dx.doi.org/10.1371/journal.pone.0066105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776615	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400110
J	van Beest, FM; Milner, JM				van Beest, Floris M.; Milner, Jos M.			Behavioural Responses to Thermal Conditions Affect Seasonal Mass Change in a Heat-Sensitive Northern Ungulate	PLOS ONE			English	Article							DEPENDENT REPRODUCTIVE SUCCESS; MOOSE ALCES-ALCES; CLIMATE-CHANGE; HABITAT SELECTION; RESOURCE SELECTION; PHENOTYPIC PLASTICITY; ACTIVITY PATTERNS; LARGE HERBIVORES; TAILED DEER; BODY-MASS	Background: Empirical tests that link temperature-mediated changes in behaviour (activity and resource selection) to individual fitness or condition are currently lacking for endotherms yet may be critical to understanding the effect of climate change on population dynamics. Moose (Alces alces) are thought to suffer from heat stress in all seasons so provide a good biological model to test whether exposure to non-optimal ambient temperatures influence seasonal changes in body mass. Seasonal mass change is an important fitness correlate of large herbivores and affects reproductive success of female moose. Methodology/Principal Findings: Using GPS-collared adult female moose from two populations in southern Norway we quantified individual differences in seasonal activity budget and resource selection patterns as a function of seasonal temperatures thought to induce heat stress in moose. Individual body mass was recorded in early and late winter, and autumn to calculate seasonal mass changes (n = 52 over winter, n = 47 over summer). We found large individual differences in temperature-dependent resource selection patterns as well as within and between season variability in thermoregulatory strategies. As expected, individuals using an optimal strategy, selecting young successional forest (foraging habitat) at low ambient temperatures and mature coniferous forest (thermal shelter) during thermally stressful conditions, lost less mass in winter and gained more mass in summer. Conclusions/Significance: This study provides evidence that behavioural responses to temperature have important consequences for seasonal mass change in moose living in the south of their distribution in Norway, and may be a contributing factor to recently observed declines in moose demographic performance. Although the mechanisms that underlie the observed temperature mediated habitat-fitness relationship remain to be tested, physiological state and individual variation in thermal tolerance are likely contributory factors. Climate-related effects on animal behaviour, and subsequently fitness, are expected to intensify as global warming continues.	[van Beest, Floris M.] Univ Saskatchewan, Dept Anim & Poultry Sci, Coll Agr & Bioresources, Saskatoon, SK S7N 0W0, Canada; [van Beest, Floris M.; Milner, Jos M.] Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Evenstad, Norway	University of Saskatchewan; Inland Norway University of Applied Sciences	van Beest, FM (corresponding author), Univ Saskatchewan, Dept Anim & Poultry Sci, Coll Agr & Bioresources, Saskatoon, SK S7N 0W0, Canada.	floris.vanbeest@usask.ca	Milner, Jos M./G-7722-2012; van Beest, Floris M./C-6745-2019	Milner, Jos M./0000-0003-0229-3655; van Beest, Floris M./0000-0002-5701-4927	Norwegian Research Council [173868/AREAL]; Innovation Norway, Telemark County, Hedmark County and municipalities in Telemark, Vestfold, and Hedmark	Norwegian Research Council(Research Council of NorwayEuropean Commission); Innovation Norway, Telemark County, Hedmark County and municipalities in Telemark, Vestfold, and Hedmark	Funding was provided by Norwegian Research Council (173868/AREAL), Innovation Norway, Telemark County, Hedmark County and municipalities in Telemark, Vestfold, and Hedmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnemo Jon M., 2003, Alces, V39, P243; Aublet JF, 2009, OECOLOGIA, V159, P237, DOI 10.1007/s00442-008-1198-4; AVERY RA, 1978, J ANIM ECOL, V47, P143, DOI 10.2307/3928; Bertolo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018603; Bourgoin G, 2011, CAN J ZOOL, V89, P765, DOI [10.1139/Z11-046, 10.1139/z11-046]; Bowyer RT, 2009, CALIF FISH GAME, V95, P128; Boyce MS, 2006, DIVERS DISTRIB, V12, P269, DOI 10.1111/j.1366-9516.2006.00243.x; Boyles JG, 2011, INTEGR COMP BIOL, V51, P676, DOI 10.1093/icb/icr053; Burthe S, 2011, J ANIM ECOL, V80, P1134, DOI 10.1111/j.1365-2656.2011.01865.x; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; CluttonBrock TH, 1996, J ANIM ECOL, V65, P675, DOI 10.2307/5667; CLUTTONBROCK TH, 1989, NATURE, V337, P260, DOI 10.1038/337260a0; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Dussault C, 2004, ECOSCIENCE, V11, P321, DOI 10.1080/11956860.2004.11682839; Edwards LJ, 2008, STAT MED, V27, P6137, DOI 10.1002/sim.3429; Festa-Bianchet M, 1998, ECOL LETT, V1, P91; Festa-Bianchet M, 1998, AM NAT, V152, P367, DOI 10.1086/286175; FestaBianchet M, 1996, CAN J ZOOL, V74, P330, DOI 10.1139/z96-041; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Galanthay TE, 2012, AM NAT, V179, P475, DOI 10.1086/664625; Garel M, 2004, P ROY SOC B-BIOL SCI, V271, pS471, DOI 10.1098/rsbl.2004.0219; Grotan V, 2009, OECOLOGIA, V161, P685, DOI 10.1007/s00442-009-1419-5; Hansen BB, 2011, ECOLOGY, V92, P1917, DOI 10.1890/11-0095.1; Henry RC, 2013, J THEOR BIOL, V321, P1, DOI 10.1016/j.jtbi.2012.12.004; Herfindal I, 2009, ECOGRAPHY, V32, P849, DOI 10.1111/j.1600-0587.2009.05783.x; HUEY RB, 1991, AM NAT, V137, pS91, DOI 10.1086/285141; Knowlton JL, 2010, BIOL CONSERV, V143, P1342, DOI 10.1016/j.biocon.2010.03.011; Leblond M, 2010, ECOGRAPHY, V33, P1102, DOI 10.1111/j.1600-0587.2009.06104.x; Lenarz MS, 2009, J WILDLIFE MANAGE, V73, P503, DOI 10.2193/2008-265; Lowe SJ, 2010, CAN J ZOOL, V88, P1032, DOI 10.1139/Z10-071; LUNDMARK C, 2008, THESIS SWEDISH U AGR; Manly B.F.J., 2002, RESOURCE SELECTION A; McLoughlin PD, 2006, P ROY SOC B-BIOL SCI, V273, P1449, DOI 10.1098/rspb.2006.3486; Milner JM, 2013, OECOLOGIA IN PRESS, DOI [10.1007/s00442-012-2547-x, DOI 10.1007/S00442-012-2547-X]; Moen R, 1997, ECOLOGY, V78, P505; Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x; Mysterud A, 1999, WILDLIFE SOC B, V27, P385; Mysterud A, 2008, PHILOS T R SOC B, V363, P2359, DOI 10.1098/rstb.2007.2206; Mysterud Atle, 2011, P349; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pelletier F, 2007, EVOLUTION, V61, P1969, DOI 10.1111/j.1558-5646.2007.00160.x; Post E, 2009, BIOSCIENCE, V59, P489, DOI 10.1525/bio.2009.59.6.7; Putman RJ, 2004, MAMMAL REV, V34, P285, DOI 10.1111/j.1365-2907.2004.00044.x; RENECKER LA, 1986, CAN J ZOOL, V64, P322, DOI 10.1139/z86-052; Renecker Lyle A., 1990, Alces, V26, P66; RISENHOOVER KL, 1986, J WILDLIFE MANAGE, V50, P727, DOI 10.2307/3800990; Rughetti M, 2012, J MAMMAL, V93, P1301, DOI 10.1644/11-MAMM-A-402.1; Sand H, 1998, CAN J ZOOL, V76, P187, DOI 10.1139/cjz-76-1-187; SCHMITZ OJ, 1991, HOLARCTIC ECOL, V14, P104; Schoener TW, 1971, REV ECOL SYST, V2, P369; SCHWAB FE, 1991, CAN J ZOOL, V69, P3071, DOI 10.1139/z91-431; Stien A, 2010, ECOLOGY, V91, P915, DOI 10.1890/09-0056.1; van Beest FM, 2012, ANIM BEHAV, V84, P723, DOI 10.1016/j.anbehav.2012.06.032; van Beest FM, 2011, J ANIM ECOL, V80, P771, DOI 10.1111/j.1365-2656.2011.01829.x; van Beest FM, 2010, J ANIM ECOL, V79, P910, DOI 10.1111/j.1365-2656.2010.01701.x; van Beest FM, 2010, J WILDLIFE MANAGE, V74, P219, DOI 10.2193/2009-109; Van Moorter B, 2009, OECOLOGIA, V159, P669, DOI 10.1007/s00442-008-1245-1; Van Moorter B, 2010, J WILDLIFE MANAGE, V74, P588, DOI 10.2193/2009-155	60	57	58	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65972	10.1371/journal.pone.0065972	http://dx.doi.org/10.1371/journal.pone.0065972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776584	Green Published, gold			2022-12-25	WOS:000320755400092
J	Argunhan, B; Farmer, S; Leung, WK; Terentyev, Y; Humphryes, N; Tsubouchi, T; Toyoizumi, H; Tsubouchi, H				Argunhan, Bilge; Farmer, Sarah; Leung, Wing-Kit; Terentyev, Yaroslav; Humphryes, Neil; Tsubouchi, Tomomi; Toyoizumi, Hiroshi; Tsubouchi, Hideo			Direct and Indirect Control of the Initiation of Meiotic Recombination by DNA Damage Checkpoint Mechanisms in Budding Yeast	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; MEIOSIS; PHOSPHORYLATION; LANDSCAPE; PACHYTENE; ATM	Meiotic recombination plays an essential role in the proper segregation of chromosomes at meiosis I in many sexually reproducing organisms. Meiotic recombination is initiated by the scheduled formation of genome-wide DNA double-strand breaks (DSBs). The timing of DSB formation is strictly controlled because unscheduled DSB formation is detrimental to genome integrity. Here, we investigated the role of DNA damage checkpoint mechanisms in the control of meiotic DSB formation using budding yeast. By using recombination defective mutants in which meiotic DSBs are not repaired, the effect of DNA damage checkpoint mutations on DSB formation was evaluated. The Tel1 (ATM) pathway mainly responds to unresected DSB ends, thus the sae2 mutant background in which DSB ends remain intact was employed. On the other hand, the Mec1 (ATR) pathway is primarily used when DSB ends are resected, thus the rad51 dmc1 double mutant background was employed in which highly resected DSBs accumulate. In order to separate the effect caused by unscheduled cell cycle progression, which is often associated with DNA damage checkpoint defects, we also employed the ndt80 mutation which permanently arrests the meiotic cell cycle at prophase I. In the absence of Tel1, DSB formation was reduced in larger chromosomes (IV, VII, II and XI) whereas no significant reduction was found in smaller chromosomes (III and VI). On the other hand, the absence of Rad17 (a critical component of the ATR pathway) lead to an increase in DSB formation (chromosomes VII and II were tested). We propose that, within prophase I, the Tel1 pathway facilitates DSB formation, especially in bigger chromosomes, while the Mec1 pathway negatively regulates DSB formation. We also identified prophase I exit, which is under the control of the DNA damage checkpoint machinery, to be a critical event associated with down-regulating meiotic DSB formation.	[Argunhan, Bilge; Farmer, Sarah; Leung, Wing-Kit; Terentyev, Yaroslav; Humphryes, Neil; Tsubouchi, Tomomi; Tsubouchi, Hideo] Univ Sussex, MRC Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Toyoizumi, Hiroshi] Waseda Univ, Grad Sch Accounting, Tokyo, Japan; [Toyoizumi, Hiroshi] Waseda Univ, Dept Appl Math, Tokyo, Japan	University of Sussex; Waseda University; Waseda University	Tsubouchi, H (corresponding author), Univ Sussex, MRC Genome Damage & Stabil Ctr, Brighton, E Sussex, England.	h.tsubouchi@sussex.ac.uk		Tsubouchi, Tomomi/0000-0001-9960-3888; Leung, Wing-Kit/0000-0003-3039-4904; Tsubouchi, Hideo/0000-0003-0814-8432	Marie Curie Cancer Care; Biotechnology and Biological Sciences Research Council; BBSRC [BB/I009159/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I009159/1] Funding Source: researchfish; Medical Research Council [G0801130B, 1094901] Funding Source: researchfish	Marie Curie Cancer Care; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Tsubouchi laboratory is supported by Marie Curie Cancer Care and the Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blitzblau HG, 2011, METHODS MOL BIOL, V745, P47, DOI 10.1007/978-1-61779-129-1_4; Bonilla CY, 2008, MOL CELL, V30, P267, DOI 10.1016/j.molcel.2008.03.023; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Farmer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039724; Farmer S, 2011, METHODS MOL BIOL, V745, P33, DOI 10.1007/978-1-61779-129-1_3; Gerton JL, 2005, NAT REV GENET, V6, P477, DOI 10.1038/nrg1614; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Ho HC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002351; Joyce EF, 2011, J CELL BIOL, V195, P359, DOI 10.1083/jcb.201104121; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Lange J, 2011, NATURE, V479, P237, DOI 10.1038/nature10508; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lichten M, 2011, CELL, V147, P267, DOI 10.1016/j.cell.2011.09.038; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lydall D, 1996, MEIOTIC RECOMBINATIO; MacQueen AJ, 2011, TRENDS CELL BIOL, V21, P393, DOI 10.1016/j.tcb.2011.03.004; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Sasanuma H, 2008, GENE DEV, V22, P398, DOI 10.1101/gad.1626608; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; Toyoizumi H, 2012, J COMPUT BIOL, V19, P1277, DOI 10.1089/cmb.2012.0209; Tsubouchi H, 2006, GENE DEV, V20, P1766, DOI 10.1101/gad.1422506; Tung KS, 2000, P NATL ACAD SCI USA, V97, P12187, DOI 10.1073/pnas.220464597; Vader G, 2011, NATURE, V477, P115, DOI 10.1038/nature10331; Wan L, 2008, GENE DEV, V22, P386, DOI 10.1101/gad.1626408; Wu HY, 2006, CURR BIOL, V16, P2473, DOI 10.1016/j.cub.2006.10.069; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	33	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65875	10.1371/journal.pone.0065875	http://dx.doi.org/10.1371/journal.pone.0065875			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762445	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000320440500055
J	Stettner, M; Wolffram, K; Mausberg, AK; Albrecht, P; Derksen, A; Methner, A; Dehmel, T; Hartung, HP; Dietrich, H; Kieseier, BC				Stettner, Mark; Wolffram, Kathleen; Mausberg, Anne K.; Albrecht, Philipp; Derksen, Angelika; Methner, Axel; Dehmel, Thomas; Hartung, Hans-Peter; Dietrich, Helmut; Kieseier, Bernd C.			Promoting Myelination in an In Vitro Mouse Model of the Peripheral Nerve System: The Effect of Wine Ingredients	PLOS ONE			English	Article							CONCORD GRAPE JUICE; SCHWANN-CELLS INVITRO; RED WINE; ANTIOXIDANT STATUS; OXIDATIVE STRESS; BLOOD-PRESSURE; RESVERATROL; SUPPLEMENTATION; CONSUMPTION; POLYPHENOLS	Protective properties of moderate wine consumption against cancers, cardiovascular, metabolic and degenerative diseases have been reported in various clinical studies. Here, we analysed the effect of red wine (RW) and white wine (WW) on myelination using an in vitro embryonic co-culture mouse model. The total amount of myelin was found to be significantly increased after RW and WW treatment, while only RW significantly increased the number of internodes. Both types of wine increased rat Schwann cell- (rSC) expression of the NAD+-dependent deacetylase sirtuin-two-homolog 2 (Sirt2), a protein known to be involved in myelination. Detailed chemical analysis of RW revealed a broad spectrum of anthocyanins, piceids, and phenolics, including resveratrol (RSV). In our assay system RSV in low concentrations induced myelination. Furthermore RSV raised intracellular glutathione concentrations in rSCs and in co-cultures and therefore augmented antioxidant capacity. We conclude that wine promotes myelination in a rodent in vitro model by controlling intracellular metabolism and SC plasticity. During this process, RSV exhibits protective properties; however, the fostering effect on myelinaton during exposure to wine appears to be a complex interaction of various compounds.	[Stettner, Mark; Wolffram, Kathleen; Mausberg, Anne K.; Albrecht, Philipp; Derksen, Angelika; Methner, Axel; Dehmel, Thomas; Hartung, Hans-Peter; Kieseier, Bernd C.] Univ Dusseldorf, Dept Neurol, Res Grp Clin & Expt Neuroimmunol, Fac Med, Dusseldorf, Germany; [Dietrich, Helmut] Geisenheim Res Ctr, Dept Wine Anal & Beverage Technol, Geisenheim, Germany	Heinrich Heine University Dusseldorf	Stettner, M (corresponding author), Univ Dusseldorf, Dept Neurol, Res Grp Clin & Expt Neuroimmunol, Fac Med, Dusseldorf, Germany.	mark.stettner@med.uni-duesseldorf.de	Stettner, Mark/GQY-7516-2022	Methner, Axel/0000-0002-8774-0057; Mausberg, Anne K/0000-0001-9026-1703				Albrecht P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-163; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Beirowski B, 2011, P NATL ACAD SCI USA, V108, pE952, DOI 10.1073/pnas.1104969108; Block G, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-30; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Castilla P, 2008, AM J CLIN NUTR, V87, P1053, DOI 10.1093/ajcn/87.4.1053; Chopra K, 2012, BRIT J CLIN PHARMACO, V73, P348, DOI 10.1111/j.1365-2125.2011.04111.x; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; ELDRIDGE CF, 1987, J CELL BIOL, V105, P1023, DOI 10.1083/jcb.105.2.1023; ELDRIDGE CF, 1989, J NEUROSCI, V9, P625; Estruch R, 2011, NUTR METAB CARDIOVAS, V21, P46, DOI 10.1016/j.numecd.2009.07.006; Freedman JE, 2001, CIRCULATION, V103, P2792, DOI 10.1161/01.CIR.103.23.2792; FUHRMAN B, 1995, AM J CLIN NUTR, V61, P549, DOI 10.1093/ajcn/61.3.549; Goldberg DA, 2003, CLIN BIOCHEM, V36, P79, DOI 10.1016/S0009-9120(02)00397-1; Hansen AS, 2005, EUR J CLIN NUTR, V59, P449, DOI 10.1038/sj.ejcn.1602107; Hayek T, 1997, ARTERIOSCL THROM VAS, V17, P2744, DOI 10.1161/01.ATV.17.11.2744; Hollis JH, 2009, J AM COLL NUTR, V28, P574, DOI 10.1080/07315724.2009.10719789; Jessen K.R., 2010, F1000 BIOL REP, V2; Josuttis M, 2010, DEUT LEBENSM-RUNDSCH, V106, P254; Keevil JG, 2000, J NUTR, V130, P53; Kiviniemi TO, 2007, ATHEROSCLEROSIS, V195, pE176, DOI 10.1016/j.atherosclerosis.2007.06.004; Koike H, 2006, CURR OPIN NEUROL, V19, P481, DOI 10.1097/01.wco.0000245371.89941.eb; Krikorian R, 2010, BRIT J NUTR, V103, P730, DOI 10.1017/S0007114509992364; Kumar A, 2007, PHARMACOLOGY, V79, P17, DOI 10.1159/000097511; Kumar P, 2006, BEHAV PHARMACOL, V17, P485, DOI 10.1097/00008877-200609000-00014; Lehmann HC, 2009, GLIA, V57, P479, DOI 10.1002/glia.20774; Lewerenz J, 2009, J NEUROCHEM, V111, P332, DOI 10.1111/j.1471-4159.2009.06347.x; MCLANE JA, 1987, ALCOHOL, V4, P385, DOI 10.1016/0741-8329(87)90071-1; Medina-Remon A, 2011, NUTR METAB CARDIOVAS, V21, P323, DOI 10.1016/j.numecd.2009.10.019; Mellion M, 2011, MUSCLE NERVE, V43, P309, DOI 10.1002/mus.21946; Mladenka P, 2010, FREE RADICAL BIO MED, V49, P963, DOI 10.1016/j.freeradbiomed.2010.06.010; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Park YK, 2004, BIOFACTORS, V22, P145, DOI 10.1002/biof.5520220128; Patz CD, 2004, ANAL CHIM ACTA, V513, P81, DOI 10.1016/j.aca.2004.02.051; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Podratz JL, 2004, GLIA, V45, P54, DOI 10.1002/glia.10302; Podratz JL, 2001, GLIA, V35, P35, DOI 10.1002/glia.1068; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Rechner A, 1998, DEUT LEBENSM-RUNDSCH, V94, P363; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Spaak J, 2010, AM J PHYSIOL-HEART C, V298, pH2226, DOI 10.1152/ajpheart.00700.2009; Stettner M, 2011, J PERIPHER NERV SYST, V16, P250, DOI 10.1111/j.1529-8027.2011.00355.x; Trapp J, 2006, CURR DRUG TARGETS, V7, P1553, DOI 10.2174/1389450110607011553; Tsang C, 2005, BRIT J NUTR, V93, P233, DOI 10.1079/BJN20041311; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang Q, 2002, BRAIN RES, V958, P439, DOI 10.1016/S0006-8993(02)03543-6; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Yamagata K, 2009, BIOCHEM BIOPH RES CO, V390, P1355, DOI 10.1016/j.bbrc.2009.10.156; Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525	50	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66079	10.1371/journal.pone.0066079	http://dx.doi.org/10.1371/journal.pone.0066079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762469	Green Submitted, Green Published, gold			2022-12-25	WOS:000321094800088
J	Nishimura, T; Uratani, Y; Okayasu, T; Nakagawa, S; Hosoi, H				Nishimura, Tadashi; Uratani, Yuka; Okayasu, Tadao; Nakagawa, Seiji; Hosoi, Hiroshi			Magnetoencephalographic Study on Forward Suppression by Ipsilateral, Contralateral, and Binaural Maskers	PLOS ONE			English	Article							BONE-CONDUCTED ULTRASOUND; PRIMARY AUDITORY-CORTEX; N1M AMPLITUDE; MASKING; STIMULATION; MECHANISMS; RESPONSES; DURATION; BURSTS; GROWTH	When two tones are presented in a short time interval, the response to the second tone is suppressed. This phenomenon is referred to as forward suppression. To address the effect of the masker laterality on forward suppression, magnetoencephalographic responses were investigated for eight subjects with normal hearing when the preceding maskers were presented ipsilaterally, contralaterally, and binaurally. We employed three masker intensity conditions: the ipsilateral-strong, left-right-balanced, and contralateral-strong conditions. Regarding the responses to the maskers without signal, the N1m amplitude evoked by the left and binaural maskers was significantly larger than that evoked by the right masker for the left-strong and left-right-balanced conditions. No significant difference was observed for the right-strong condition. Regarding the subsequent N1m amplitudes, they were attenuated by the presence of the left, binaural, and right maskers for all conditions. For the left-and right-strong conditions, the subsequent N1m amplitude in the presence of the left masker was smaller than those of the binaural and right maskers. No difference was observed between the binaural and right masker presentation. For left-right-balanced condition, the subsequent N1m amplitude decreased in the presence of the right, binaural, and left maskers in that order. If the preceding activity reflected the ability to suppress the subsequent activity, the forward suppression by the left masker would be superior to that by the right masker for the left-strong and left-right-balanced conditions. Furthermore, the forward suppression by the binaural masker would be expected to be superior to that by the left masker owing to additional afferent activity from the right ear. Thus, the current results suggest that the forward suppression by ipsilateral maskers is superior to that by contralateral maskers although both maskers evoked the N1m amplitudes to the same degree. Additional masker at the contralateral ear can attenuate the forward suppression by the ipsilateral masker.	[Nishimura, Tadashi; Uratani, Yuka; Okayasu, Tadao; Hosoi, Hiroshi] Nara Med Univ, Dept Otolaryngol Head & Neck Surg, Nara, Japan; [Nakagawa, Seiji] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Ikeda, Osaka, Japan	Nara Medical University; National Institute of Advanced Industrial Science & Technology (AIST)	Nishimura, T (corresponding author), Nara Med Univ, Dept Otolaryngol Head & Neck Surg, Nara, Japan.	t-nishim@naramed-u.ac.jp		Okayasu, Tadao/0000-0002-0811-1405				Aran JM, 2000, AUDIOLOGY, V39, P311; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Devlin JT, 2003, J NEUROSCI, V23, P11516; Jancke L, 2002, HEARING RES, V170, P166, DOI 10.1016/S0378-5955(02)00488-4; JOUTSINIEMI SL, 1989, AUDIOLOGY, V28, P325; Neukirch M, 2002, NEUROPSYCHOBIOLOGY, V45, P41, DOI 10.1159/000048672; Nishimura T, 2003, NEUROREPORT, V14, P891, DOI 10.1097/00001756-200305060-00024; Nishimura T, 2002, NEUROSCI LETT, V327, P119, DOI 10.1016/S0304-3940(02)00409-3; Nishimura T, 2009, ACTA OTO-LARYNGOL, V129, P28, DOI 10.1080/00016480902915707; ONISHI S, 1968, J ACOUST SOC AM, V44, P582, DOI 10.1121/1.1911124; Ozmeral EJ, 2012, J ACOUST SOC AM, V132, P1152, DOI 10.1121/1.4730976; Pantev C, 1998, AUDIOL NEURO-OTOL, V3, P183, DOI 10.1159/000013789; Razak KA, 2012, HEARING RES, V290, P1, DOI 10.1016/j.heares.2012.05.008; RELKIN EM, 1988, J ACOUST SOC AM, V84, P584, DOI 10.1121/1.396836; Soeta Y, 2009, NEUROREPORT, V20, P548, DOI 10.1097/WNR.0b013e32832a6f15; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Woldorff MG, 1999, HUM BRAIN MAPP, V7, P49, DOI 10.1002/(SICI)1097-0193(1999)7:1<49::AID-HBM5>3.3.CO;2-A	18	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e66225	10.1371/journal.pone.0066225	http://dx.doi.org/10.1371/journal.pone.0066225			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762482	Green Submitted, gold, Green Published			2022-12-25	WOS:000321099000130
J	Gossing, M; Chidambaram, S; von Mollard, GF				Gossing, Michael; Chidambaram, Subbulakshmi; von Mollard, Gabriele Fischer			Importance of the N-Terminal Domain of the Qb-SNARE Vti1p for Different Membrane Transport Steps in the Yeast Endosomal System	PLOS ONE			English	Article							EPSIN-RELATED PROTEINS; SACCHAROMYCES-CEREVISIAE; LATE GOLGI; ENDOPLASMIC-RETICULUM; TETHERING COMPLEX; R-SNARE; VESICLE TRAFFICKING; VACUOLE FUSION; PATHWAYS; HOMOLOG	SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) on transport vesicles and target membranes are crucial for vesicle targeting and fusion. They form SNARE complexes, which contain four a-helical SNARE motifs contributed by three or four different SNAREs. Most SNAREs function only in a single transport step. The yeast SNARE Vti1p participates in four distinct SNARE complexes in transport from the trans Golgi network to late endosomes, in transport to the vacuole, in retrograde transport from endosomes to the trans Golgi network and in retrograde transport within the Golgi. So far, all vti1 mutants investigated had mutations within the SNARE motif. Little is known about the function of the N-terminal domain of Vti1p, which forms a three helix bundle called H-abc domain. Here we generated a temperature-sensitive mutant of this domain to study the effects on different transport steps. The secondary structure of wild type and vti1-3 H-abc domain was analyzed by circular dichroism spectroscopy. The amino acid exchanges identified in the temperature-sensitive vti1-3 mutant caused unfolding of the H-abc domain. Transport pathways were investigated by immunoprecipitation of newly synthesized proteins after pulse-chase labeling and by fluorescence microscopy of a GFP-tagged protein cycling between plasma membrane, early endosomes and Golgi. In vti1-3 cells transport to the late endosome and assembly of the late endosomal SNARE complex was blocked at 37 degrees C. Retrograde transport to the trans Golgi network was affected while fusion with the vacuole was possible but slower. Steady state levels of SNARE complexes mediating these steps were less affected than that of the late endosomal SNARE complex. As different transport steps were affected our data demonstrate the importance of a folded Vti1p H-abc domain for transport.	[Gossing, Michael; Chidambaram, Subbulakshmi; von Mollard, Gabriele Fischer] Univ Bielefeld, Fac Chem, Bielefeld, Germany	University of Bielefeld	von Mollard, GF (corresponding author), Univ Bielefeld, Fac Chem, Bielefeld, Germany.	gabriele.mollard@uni-bielefeld.de	von Mollard, Gabriele Fischer/O-9778-2019; von Mollard, Gabriele Fischer/A-3935-2012	von Mollard, Gabriele Fischer/0000-0003-3236-1401; von Mollard, Gabriele Fischer/0000-0003-3236-1401; Chidambaram, Subbulakshmi/0000-0002-3180-4429	Deutsche Forschungsgemeinschaft (DFG) [FI 583/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grant FI 583/5-1 from the Deutsche Forschungsgemeinschaft (DFG, website: http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Antonin W, 2002, J BIOL CHEM, V277, P36449, DOI 10.1074/jbc.M204369200; BANFIELD DK, 1995, NATURE, V375, P806, DOI 10.1038/375806a0; Becherer KA, 1996, MOL BIOL CELL, V7, P579, DOI 10.1091/mbc.7.4.579; Boeke JD, 1984, MOL GEN GENET, V197; Brickner JH, 2001, J CELL BIOL, V155, P969, DOI 10.1083/jcb.200104093; Burd CG, 1997, MOL BIOL CELL, V8, P1089, DOI 10.1091/mbc.8.6.1089; Chidambaram S, 2004, J BIOL CHEM, V279, P4175, DOI 10.1074/jbc.M308667200; Chidambaram S, 2008, J CELL SCI, V121, P329, DOI 10.1242/jcs.012708; Conibear E, 2003, MOL BIOL CELL, V14, P1610, DOI 10.1091/mbc.E02-10-0654; Conibear E, 2000, MOL BIOL CELL, V11, P305, DOI 10.1091/mbc.11.1.305; Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Dilcher M, 2003, EMBO J, V22, P3664, DOI 10.1093/emboj/cdg339; Dilcher M, 2001, J BIOL CHEM, V276, P34537, DOI 10.1074/jbc.M101551200; Dulubova I, 2002, EMBO J, V21, P3620, DOI 10.1093/emboj/cdf381; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; Duncan MC, 2003, NAT CELL BIOL, V5, P77, DOI 10.1038/ncb901; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Fridmann-Sirkis Y, 2006, TRAFFIC, V7, P182, DOI 10.1111/j.1600-0854.2005.00374.x; Holthuis JCM, 1998, EMBO J, V17, P113, DOI 10.1093/emboj/17.1.113; HOLTZER ME, 1992, BIOPOLYMERS, V32, P1675, DOI 10.1002/bip.360321209; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jun Y, 2007, EMBO J, V26, P4935, DOI 10.1038/sj.emboj.7601915; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Kramer L, 2011, MOL BIOL CELL, V22, P2601, DOI 10.1091/mbc.E11-02-0104; Kweon Y, 2003, MOL BIOL CELL, V14, P1868, DOI 10.1091/mbc.E02-10-0687; Laage R, 2001, MOL BIOL CELL, V12, P3375, DOI 10.1091/mbc.12.11.3375; Lewis MJ, 1997, EMBO J, V16, P3017, DOI 10.1093/emboj/16.11.3017; Lewis MJ, 2002, TRAFFIC, V3, P922, DOI 10.1034/j.1600-0854.2002.31207.x; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Luo L, 2011, MOL BIOL CELL, V22, P2564, DOI 10.1091/mbc.E10-06-0493; Lupashin VV, 1997, MOL BIOL CELL, V8, P2659, DOI 10.1091/mbc.8.12.2659; McNew JA, 1997, J BIOL CHEM, V272, P17776, DOI 10.1074/jbc.272.28.17776; Meiringer CTA, 2011, J BIOL CHEM, V286, P25039, DOI 10.1074/jbc.M110.215327; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; NOTHWEHR SF, 1993, J CELL BIOL, V121, P1197, DOI 10.1083/jcb.121.6.1197; NOTHWEHR SF, 1995, J CELL BIOL, V129, P35, DOI 10.1083/jcb.129.1.35; Perez-Victoria FJ, 2010, MOL BIOL CELL, V21, P3386, DOI 10.1091/mbc.E10-05-0392; Pieren M, 2010, NAT STRUCT MOL BIOL, V17, P710, DOI 10.1038/nsmb.1809; Proszynski TJ, 2005, P NATL ACAD SCI USA, V102, P17981, DOI 10.1073/pnas.0509107102; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; Reggiori F, 2003, J BIOL CHEM, V278, P5009, DOI 10.1074/jbc.M210436200; Ren Y, 2009, CELL, V139, P1119, DOI 10.1016/j.cell.2009.11.002; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Sato TK, 2000, MOL CELL, V6, P661, DOI 10.1016/S1097-2765(00)00064-2; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 2002, J BIOL CHEM, V277, P48318, DOI 10.1074/jbc.M209428200; Starai VJ, 2007, P NATL ACAD SCI USA, V104, P13551, DOI 10.1073/pnas.0704741104; Stein IS, 2009, BIOCHEM J, V419, P229, DOI 10.1042/BJ20081973; Tishgarten T, 1999, PROTEIN SCI, V8, P2465; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Ungermann C, 1999, J CELL BIOL, V145, P1435, DOI 10.1083/jcb.145.7.1435; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; VATER CA, 1992, J CELL BIOL, V119, P773, DOI 10.1083/jcb.119.4.773; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; von Mollard GF, 1998, J BIOL CHEM, V273, P2624, DOI 10.1074/jbc.273.5.2624; von Mollard GF, 1999, MOL BIOL CELL, V10, P1719, DOI 10.1091/mbc.10.6.1719; vonMollard GF, 1997, J CELL BIOL, V137, P1511, DOI 10.1083/jcb.137.7.1511; Wang J, 2011, P NATL ACAD SCI USA, V108, P12277, DOI 10.1073/pnas.1013101108; Yamaguchi T, 2002, DEV CELL, V2, P295, DOI 10.1016/S1534-5807(02)00125-9	62	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66304	10.1371/journal.pone.0066304	http://dx.doi.org/10.1371/journal.pone.0066304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776654	Green Submitted, Green Published, gold			2022-12-25	WOS:000320322400095
J	Koldso, H; Autzen, HE; Grouleff, J; Schiott, B				Koldso, Heidi; Autzen, Henriette Elisabeth; Grouleff, Julie; Schiott, Birgit			Ligand Induced Conformational Changes of the Human Serotonin Transporter Revealed by Molecular Dynamics Simulations	PLOS ONE			English	Article							ANTIDEPRESSANT BINDING-SITE; BACTERIAL HOMOLOG; NEUROTRANSMITTER TRANSPORTERS; SUBSTRATE; LEUT; DOPAMINE; IBOGAINE; INHIBITOR; COCAINE; STATE	The competitive inhibitor cocaine and the non-competitive inhibitor ibogaine induce different conformational states of the human serotonin transporter. It has been shown from accessibility experiments that cocaine mainly induces an outward-facing conformation, while the non-competitive inhibitor ibogaine, and its active metabolite noribogaine, have been proposed to induce an inward-facing conformation of the human serotonin transporter similar to what has been observed for the endogenous substrate, serotonin. The ligand induced conformational changes within the human serotonin transporter caused by these three different types of ligands, substrate, non-competitive and competitive inhibitors, are studied from multiple atomistic molecular dynamics simulations initiated from a homology model of the human serotonin transporter. The results reveal that diverse conformations of the human serotonin transporter are captured from the molecular dynamics simulations depending on the type of the ligand bound. The inward-facing conformation of the human serotonin transporter is reached with noribogaine bound, and this state resembles a previously identified inward-facing conformation of the human serotonin transporter obtained from molecular dynamics simulation with bound substrate, but also a recently published inward-facing conformation of a bacterial homolog, the leucine transporter from Aquifex Aoelicus. The differences observed in ligand induced behavior are found to originate from different interaction patterns between the ligands and the protein. Such atomic-level understanding of how an inhibitor can dictate the conformational response of a transporter by ligand binding may be of great importance for future drug design.	[Koldso, Heidi; Schiott, Birgit] Aarhus Univ, Ctr Insoluble Prot Struct inSPIN, Aarhus, Denmark; [Koldso, Heidi; Schiott, Birgit] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark; [Koldso, Heidi; Autzen, Henriette Elisabeth; Grouleff, Julie; Schiott, Birgit] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Schiott, B (corresponding author), Aarhus Univ, Ctr Insoluble Prot Struct inSPIN, Aarhus, Denmark.	birgit@chem.au.dk	Autzen, Henriette Elisabeth/AAI-1084-2019; Schiott, Birgit/F-5067-2011	Autzen, Henriette Elisabeth/0000-0003-3691-5010; Schiott, Birgit/0000-0001-9937-1562	Danish Council for Independent Research \ Natural Sciences, The Danish Research Foundation [DNRF59]; Lundbeck Foundation	Danish Council for Independent Research \ Natural Sciences, The Danish Research Foundation; Lundbeck Foundation(Lundbeckfonden)	The work was supported by grants from the Danish Council for Independent Research vertical bar Natural Sciences, The Danish Research Foundation (DNRF59), and the Lundbeck Foundation. Computations were made possible through support from the Danish Center for Scientific Computing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittoniemi J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000762; Alper KR, 1999, AM J ADDICTION, V8, P234; Andersen J, 2010, J BIOL CHEM, V285, P2051, DOI 10.1074/jbc.M109.072587; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; [Anonymous], 2010, SCHROD SUIT 2010 PRO; [Anonymous], 2010, SCHROD SUIT 2010 IND; [Anonymous], 2010, MAESTR VERS 9 1; [Anonymous], 2005, IMP VERS 5 6; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Baumann MH, 2001, ALKALOIDS CHEM BIOL, V56, P76; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Bisgaard H, 2011, NEUROPHARMACOLOGY, V60, P182, DOI 10.1016/j.neuropharm.2010.08.021; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; Celik L, 2008, BIOPHYS J, V94, P1600, DOI 10.1529/biophysj.107.117580; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fjorback AW, 2009, BIOCHEM BIOPH RES CO, V380, P724, DOI 10.1016/j.bbrc.2009.01.128; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; GABE EJ, 1963, ACTA CRYSTALLOGR, V16, P796, DOI 10.1107/S0365110X6300205X; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Indarte M, 2008, PROTEINS, V70, P1033, DOI 10.1002/prot.21598; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jorgensen AM, 2007, CHEMMEDCHEM, V2, P827, DOI 10.1002/cmdc.200600243; Jorgensen AM, 2007, CHEMMEDCHEM, V2, P815, DOI 10.1002/cmdc.200600242; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Koldso H, 2013, ACS CHEM NEUROSCI, V4, P295, DOI 10.1021/cn300148r; Koldso H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002246; Koldso H, 2010, J AM CHEM SOC, V132, P1311, DOI 10.1021/ja906923j; Kolossvary I, 1996, J AM CHEM SOC, V118, P5011, DOI 10.1021/ja952478m; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Kroncke BM, 2010, BIOCHEMISTRY-US, V49, P10045, DOI 10.1021/bi101148w; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Martens PF, ORIENTATION AN UNPUB; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mash D C, 2001, Alkaloids Chem Biol, V56, P155, DOI 10.1016/S0099-9598(01)56012-5; MASH DC, 1995, LIFE SCI, V57, pPL45, DOI 10.1016/0024-3205(95)00273-9; NELSON PJ, 1979, J BIOL CHEM, V254, P84; Nnadi Charles U, 2005, J Natl Med Assoc, V97, P1504; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plenge P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371765; POPIK P, 1995, PHARMACOL REV, V47, P235; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrodinger LLC, 2010, EP VERS 2 1; Schrodinger LLC, 2010, MACROMODEL VERS 9 8; Severinsen K, 2012, ACS CHEM NEUROSCI, V3, P693, DOI 10.1021/cn300040f; Shaikh SA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000905; Shan JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016350; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; SHEPPARD SG, 1994, J SUBST ABUSE TREAT, V11, P379, DOI 10.1016/0740-5472(94)90049-3; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sofuoglu Mehmet, 2006, Expert Opin Emerg Drugs, V11, P91, DOI 10.1517/14728214.11.1.91; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhao CF, 2011, BIOCHEMISTRY-US, V50, P1848, DOI 10.1021/bi101454f; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	75	39	39	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e63635	10.1371/journal.pone.0063635	http://dx.doi.org/10.1371/journal.pone.0063635			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776432	Green Published, Green Submitted, gold			2022-12-25	WOS:000320322400001
J	Mansouri, D; McMillan, DC; Grant, Y; Crighton, EM; Horgan, PG				Mansouri, David; McMillan, Donald C.; Grant, Yasmin; Crighton, Emilia M.; Horgan, Paul G.			The Impact of Age, Sex and Socioeconomic Deprivation on Outcomes in a Colorectal Cancer Screening Programme	PLOS ONE			English	Article							FECAL-OCCULT-BLOOD; RANDOMIZED CONTROLLED-TRIAL; SURVIVAL; GENDER	Background: Population-based colorectal cancer screening has been shown to reduce cancer specific mortality and is used across the UK. Despite evidence that older age, male sex and deprivation are associated with an increased incidence of colorectal cancer, uptake of bowel cancer screening varies across demographic groups. The aim of this study was to assess the impact of age, sex and deprivation on outcomes throughout the screening process. Methods: A prospectively maintained database, encompassing the first screening round of a faecal occult blood test screening programme in a single geographical area, was analysed. Results: Overall, 395 096 individuals were invited to screening, 204 139 (52%) participated and 6 079 (3%) tested positive. Of the positive tests, 4 625 (76%) attended for colonoscopy and cancer was detected in 396 individuals (9%). Lower uptake of screening was associated with younger age, male sex and deprivation (all p<0.001). Only deprivation was associated with failure to proceed to colonoscopy following a positive test (p<0.001). Despite higher positivity rates in those that were more deprived (p<0.001), the likelihood of detecting cancer in those attending for colonoscopy was lower (8% most deprived vs 10% least deprived, p = 0.003). Conclusion: Individuals who are deprived are less likely to participate in screening, less likely to undergo colonoscopy and less likely to have cancer identified as a result of a positive test. Therefore, this study suggests that strategies aimed at improving participation of deprived individuals in colorectal cancer screening should be directed at all stages of the screening process and not just uptake of the test.	[Mansouri, David; McMillan, Donald C.; Grant, Yasmin; Horgan, Paul G.] Univ Glasgow, Glasgow Royal Infirm, Sch Med, Acad Surg Unit, Glasgow G31 2ER, Lanark, Scotland; [Crighton, Emilia M.] Gartnaval Royal Hosp, NHS Greater Glasgow & Clyde, Publ Hlth Directorate, Glasgow, Lanark, Scotland	University of Glasgow; Gartnavel Royal Hospital	Mansouri, D (corresponding author), Univ Glasgow, Glasgow Royal Infirm, Sch Med, Acad Surg Unit, Glasgow G31 2ER, Lanark, Scotland.	David.Mansouri@glasgow.ac.uk		McMillan, Donald/0000-0003-4260-5334				Allard J, 2010, CAN J GASTROENTEROL, V24, P113, DOI 10.1155/2010/516363; Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; Atkin WS, 2002, GUT, V51, pV6, DOI 10.1136/gut.51.suppl_5.v6; Bretthauer M, 2011, J INTERN MED, V270, P87, DOI 10.1111/j.1365-2796.2011.02399.x; DUKES CE, 1958, BRIT J CANCER, V12, P309, DOI 10.1038/bjc.1958.37; Fraser CG, 2012, J MED SCREEN, V19, P8, DOI 10.1258/jms.2011.011098; Harmston C, 2010, COLORECTAL DIS, V12, P416, DOI 10.1111/j.1463-1318.2009.01804.x; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Hole DJ, 2002, BRIT J SURG, V89, P586, DOI 10.1046/j.1365-2168.2002.02073.x; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Libby G, 2011, J MED SCREEN, V18, P24, DOI 10.1258/jms.2011.011002; Logan RFA, 2012, GUT, V61, P1439, DOI 10.1136/gutjnl-2011-300843; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mansouri D, 2013, CRIT REV ONCOL HEMAT, V85, P342, DOI 10.1016/j.critrevonc.2012.08.006; Morris S, 2012, BRIT J CANCER, V107, P765, DOI 10.1038/bjc.2012.303; Oliphant R, 2011, BRIT J CANCER, V104, P1791, DOI 10.1038/bjc.2011.149; Rockey DC, 1999, AM J GASTROENTEROL, V94, P344, DOI 10.1111/j.1572-0241.1999.855_r.x; Scottish Government Publication, 2009, SCOTTISH INDEX MULTI; Steele RJC, 2012, GUT, V61, P576, DOI 10.1136/gutjnl-2011-300535; Steele RJC, 2010, J MED SCREEN, V17, P68, DOI 10.1258/jms.2010.009120; Steele RJC, 2009, GUT, V58, P530, DOI 10.1136/gut.2008.162883; TURNBULL RB, 1967, ANN SURG, V166, P420; von Wagner C, 2011, INT J EPIDEMIOL, V40, P712, DOI 10.1093/ije/dyr008; Whynes DK, 2003, PUBLIC HEALTH, V117, P389, DOI 10.1016/S0033-3506(03)00146-X; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	27	41	42	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66063	10.1371/journal.pone.0066063	http://dx.doi.org/10.1371/journal.pone.0066063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776606	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000320322400075
J	Roth, LSV; Lind, O				Roth, Lina S. V.; Lind, Olle			The Impact of Domestication on the Chicken Optical Apparatus	PLOS ONE			English	Article							RED JUNGLEFOWL; GALLUS-GALLUS; SIZE; EYE	Domestication processes tend to release animals from natural selection and favour traits desired by humans, such as food-production and co-operative behaviour. A side effect of such selective breeding is the alteration of unintended traits. In this paper, we investigate how active selection for egg production in chickens has affected the visual system, in particular the optical sensitivity that relates to the ability of chickens to see in dim light. We measured eye dimensions as well as the pupil diameter at different light intensities (the steady state pupil dynamics), in adult male and female White Leghorns and the closest relatives to their ancestor, the Red Junglefowls. With this information, we calculated the focal length and optical sensitivity (f-number) of the eyes. Males have larger eyes than females in both breeds and White Leghorn eyes are larger than those of Red Junglefowls in both sexes. The steady state pupil dynamics is less variable, however, the combination of pupil dynamics and eye size gives a higher optical sensitivity in Red Junglefowl eyes than in White Leghorns at light intensities below approximately 10 cd/m(2). While eye size and focal length match the larger body size in White Leghorns compared to Red Junglefowls, the steady state pupil dynamics do not. The reason for this is likely to be that eye morphology and the neuro-muscular control of the pupil have been affected differently by the strong selection for egg production and the simultaneous release of the selection pressure for high performing vision. This study is the first description of how optical sensitivity has changed in a domesticated species and our results demonstrate important considerations regarding domestication processes and sensory ability.	[Roth, Lina S. V.] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Lind, Olle] Lund Univ, Dept Biol, Lund, Sweden	Linkoping University; Lund University	Roth, LSV (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden.	linaroth@ifm.liu.se	Roth, Lina S.V./J-6272-2019	Roth, Lina S V/0000-0002-3297-1130				Al-Nasser A, 2007, WORLD POULTRY SCI J, V63, P285, DOI 10.1017/S004393390700147X; Clutton-Brook J, 1981, DOMESTICATED ANIMALS; Evans KE, 2007, ANAT HISTOL EMBRYOL, V36, P151, DOI 10.1111/j.1439-0264.2006.00749.x; Howland HC, 2004, VISION RES, V44, P2043, DOI 10.1016/j.visres.2004.03.023; Jarvis JR, 2002, VISION RES, V42, P99, DOI 10.1016/S0042-6989(01)00268-1; Kerje S, 2003, ANIM GENET, V34, P264, DOI 10.1046/j.1365-2052.2003.01000.x; Land MF, 2002, ANIMAL EYES; LILJEDAHL LE, 1979, ACTA AGR SCAND, V29, P273, DOI 10.1080/00015127909435238; Lind O, 2009, J EXP BIOL, V212, P3693, DOI 10.1242/jeb.035477; Lisney TJ, 2012, J COMP PHYSIOL A, V198, P717, DOI 10.1007/s00359-012-0742-1; Lisney TJ, 2011, VISION RES, V51, P1324, DOI 10.1016/j.visres.2011.04.009; MARTIN GR, 1982, J COMP PHYSIOL, V145, P341, DOI 10.1007/BF00619338; McGreevy P, 2004, BRAIN BEHAV EVOLUT, V63, P13, DOI 10.1159/000073756; Rubene D, 2010, J EXP BIOL, V213, P3357, DOI 10.1242/jeb.042424; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schutz KE, 2001, ETHOLOGY, V107, P753, DOI 10.1046/j.1439-0310.2001.00703.x; Trut LN, 1999, AM SCI, V87, P160, DOI 10.1511/1999.20.813; WEST B, 1988, J ARCHAEOL SCI, V15, P515, DOI 10.1016/0305-4403(88)90080-5	18	12	12	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65509	10.1371/journal.pone.0065509	http://dx.doi.org/10.1371/journal.pone.0065509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776492	gold, Green Published, Green Submitted			2022-12-25	WOS:000320322400030
J	Zhang, ZH; Lu, YY; Yue, JB				Zhang, Zhe-Hao; Lu, Ying-Ying; Yue, Jianbo			Two Pore Channel 2 Differentially Modulates Neural Differentiation of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; CYCLIC ADP-RIBOSE; NEURONAL DIFFERENTIATION; 2-PORE CHANNELS; CA2+ STORES; IN-VITRO; PARKINSONS-DISEASE; RELEASE CHANNEL; BETA-CELLS; ES CELLS	Nicotinic acid adenine dinucleotide phosphate (NAADP) is an endogenous Ca2+ mobilizing nucleotide presented in various species. NAADP mobilizes Ca2+ from acidic organelles through two pore channel 2 (TPC2) in many cell types and it has been previously shown that NAADP can potently induce neuronal differentiation in PC12 cells. Here we examined the role of TPC2 signaling in the neural differentiation of mouse embryonic stem (ES) cells. We found that the expression of TPC2 was markedly decreased during the initial ES cell entry into neural progenitors, and the levels of TPC2 gradually rebounded during the late stages of neurogenesis. Correspondingly, TPC2 knockdown accelerated mouse ES cell differentiation into neural progenitors but inhibited these neural progenitors from committing to neurons. Overexpression of TPC2, on the other hand, inhibited mouse ES cell from entering the early neural lineage. Interestingly, TPC2 knockdown had no effect on the differentiation of astrocytes and oligodendrocytes of mouse ES cells. Taken together, our data indicate that TPC2 signaling plays a temporal and differential role in modulating the neural lineage entry of mouse ES cells, in that TPC2 signaling inhibits ES cell entry to early neural progenitors, but is required for late neuronal differentiation.	[Zhang, Zhe-Hao; Lu, Ying-Ying; Yue, Jianbo] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Yue, JB (corresponding author), Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.	jyue@hku.hk	Yue, Jianbo/AAC-4588-2019; Yue, Jianbo/K-8002-2015	Lu, Yingying/0000-0002-5423-9522; Yue, Jianbo/0000-0001-6384-5447	Research Grant Council (RGC) [HKU 782709M, HKU 785911M]; Leukemia and Lymphoma Society of America	Research Grant Council (RGC)(Hong Kong Research Grants Council); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society)	This work was supported by Research Grant Council (RGC) grants (HKU 782709M and HKU 785911M), and a Special Fellow Award from the Leukemia and Lymphoma Society of America (J.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aley PK, 2010, P NATL ACAD SCI USA, V107, P19927, DOI 10.1073/pnas.1007381107; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Bain G., 2000, Functional and Integrative Genomics, V1, P127, DOI 10.1007/s101420000014; Bak J, 1999, CURR BIOL, V9, P751, DOI 10.1016/S0960-9822(99)80335-2; Beck A, 2006, FASEB J, V20, P962, DOI 10.1096/fj.05-5538fje; Berg I, 2000, J CELL BIOL, V150, P581, DOI 10.1083/jcb.150.3.581; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; Bezin S, 2006, J PHYSIOLOGY-PARIS, V99, P111, DOI 10.1016/j.jphysparis.2005.12.007; Bezin S, 2008, J BIOL CHEM, V283, P27859, DOI 10.1074/jbc.M804701200; Brailoiu E, 2005, J BIOL CHEM, V280, P5646, DOI 10.1074/jbc.M408746200; Brailoiu E, 2006, J BIOL CHEM, V281, P15923, DOI 10.1074/jbc.M602249200; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Brailoiu GC, 2010, J BIOL CHEM, V285, P37133, DOI 10.1074/jbc.C110.169763; Brailoiu GC, 2009, BIOCHEM J, V419, P91, DOI 10.1042/BJ20081138; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Chan YS, 2011, PROG DRUG RES, V67, P239, DOI 10.1007/978-3-7643-8989-5_12; Churamani D, 2012, BIOCHEM J, V441, P317, DOI 10.1042/BJ20111617; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Dammermann W, 2009, P NATL ACAD SCI USA, V106, P10678, DOI 10.1073/pnas.0809997106; Davis LC, 2012, CURR BIOL; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Galione A, 2002, CELL CALCIUM, V32, P343, DOI 10.1016/S0143416002001902; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gaspard N, 2009, NAT PROTOC, V4, P1454, DOI 10.1038/nprot.2009.157; Guse AH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002890; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; Harr MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005579; Heidemann AC, 2005, J BIOL CHEM, V280, P35630, DOI 10.1074/jbc.M507338200; Hooper R, 2011, J BIOL CHEM, V286, P9141, DOI 10.1074/jbc.M110.189985; Kagalwala MN, 2008, COLD SH Q B, V73, P227, DOI 10.1101/sqb.2008.73.042; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kawasaki H, 2002, Methods Mol Biol, V185, P217; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Li HW, 2009, BMC NEUROSCI, V10, DOI [10.1186/1471-2202-10-122, 10.1186/1471-2105-10-418]; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031905; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Lopez JJ, 2006, CELL SIGNAL, V18, P373, DOI 10.1016/j.cellsig.2005.05.006; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; MALTSEV VA, 1994, CIRC RES, V75, P233, DOI 10.1161/01.RES.75.2.233; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; Moccia F, 2004, CELL CALCIUM, V36, P515, DOI 10.1016/j.ceca.2004.05.004; Pandey V, 2009, BIOCHEM J, V422, P503, DOI 10.1042/BJ20090194; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Resende RR, 2008, CELL CALCIUM, V43, P107, DOI 10.1016/j.ceca.2007.04.007; Resende RR, 2010, STEM CELLS DEV, V19, P379, DOI 10.1089/scd.2008.0289; Rietdorf K, 2011, J BIOL CHEM; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Shi FX, 2007, EUR J NEUROSCI, V26, P3016, DOI 10.1111/j.1460-9568.2007.05909.x; Walseth TF, 2012, J BIOL CHEM, V287, P2308, DOI 10.1074/jbc.M111.306563; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Wei WJ, 2012, J BIOL CHEM, V287, P35599, DOI 10.1074/jbc.M112.392530; Wong CK, 2012, J CELL PHYSIOL, V227, P2519, DOI 10.1002/jcp.22990; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Yu PL, 2012, J BIOL CHEM, V287, P24774, DOI 10.1074/jbc.M111.329854; Yu PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051028; Yue JB, 2006, MOL CELL BIOL, V26, P5300, DOI 10.1128/MCB.00273-06; Yue JB, 2009, J BIOL CHEM, V284, P29335, DOI 10.1074/jbc.M109.049767; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zhang F, 2009, J CELL MOL MED, V13, P3174, DOI 10.1111/j.1582-4934.2008.00486.x; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	69	33	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66077	10.1371/journal.pone.0066077	http://dx.doi.org/10.1371/journal.pone.0066077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776607	Green Submitted, Green Published, gold			2022-12-25	WOS:000320322400076
J	Gao, Y; Chen, G; Tian, HM; Lin, LX; Lu, JM; Weng, JP; Jia, WP; Ji, LN; Xiao, JZ; Zhou, ZG; Ran, XW; Ren, Y; Chen, T; Yang, WY				Gao, Yun; Chen, Gang; Tian, Haoming; Lin, Lixiang; Lu, Juming; Weng, Jianping; Jia, Weiping; Ji, Linong; Xiao, Jianzhong; Zhou, Zhiguang; Ran, Xingwu; Ren, Yan; Chen, Tao; Yang, Wenying		China Natl Diabet Metab Disorders	Prevalence of Hypertension in China: A Cross-Sectional Study	PLOS ONE			English	Article							OBESITY; NUTRITION; AWARENESS; OVERWEIGHT; HEALTH; TRENDS; WOMEN; MEN	Aims: The present study aimed to assess the prevalence of hypertension among Chinese adults. Methods: Data were obtained from sphygmomanometer measurements and a questionnaire administered to 46239 Chinese adults >= 20 years of age who participated in the 2007-2008 China National Diabetes and Metabolic Disorders Study. Hypertension was defined as blood pressure >= 140/90 mm Hg or use of antihypertensive medication. Results: A total of 26.6% of Chinese adults had hypertension, and a significantly greater number of men were hypertensive than women (29.2% vs 24.1%, p<0.001). The age-specific prevalence of hypertension was 13.0%, 36.7%, and 56.5% among persons aged 20 to 44 years (young people), 45 to 64 years (middle-aged people), and >= 65 years (elderly people), respectively. In economically developed regions, the prevalence of hypertension was significantly higher among rural residents than among urban residents (31.3% vs 29.2%, p = 0.001). Among women or individuals who lived in the northern region, the disparity in the prevalence of hypertension between urban and rural areas disappeared (women: 24.0% vs. 24.0%, p = 0.942; northern region: 31.6% vs. 31.2%, p = 0.505). Among hypertensive patients, 45.0% were aware of their condition, 36.2% were treated, and 11.1% were adequately controlled. Conclusions: The prevalence of hypertension in China is increasing. The trend of an increase in prevalence is striking in young people and rural populations. Hypertension awareness, treatment, and control are poor. Public health efforts for further improving awareness and enhancing effective control are urgently needed in China, especially in emerging populations.	[Gao, Yun; Tian, Haoming; Ran, Xingwu; Ren, Yan; Chen, Tao] Sichuan Univ, Dept Endocrinol, West China Hosp, Chengdu 610064, Peoples R China; [Chen, Gang; Lin, Lixiang] Fujian Prov Hosp, Dept Endocrinol, Fuzhou, Peoples R China; [Lu, Juming] Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China; [Weng, Jianping] Sun Yat Sen Univ, Hosp 3, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China; [Jia, Weiping] Shanghai Jiao Tong Univ, Dept Endocrinol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol, Beijing 100871, Peoples R China; [Xiao, Jianzhong; Yang, Wenying] China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China; [Zhou, Zhiguang] Xiangya Second Hosp, Dept Endocrinol, Changsha, Hunan, Peoples R China	Sichuan University; Fujian Provincial Hospital; Chinese People's Liberation Army General Hospital; Sun Yat Sen University; Shanghai Jiao Tong University; Peking University; China-Japan Friendship Hospital; Central South University	Yang, WY (corresponding author), China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China.	ywy_1010@yahoo.com.cn	Linong, Ji/AAB-6543-2020	Weng, Jianping/0000-0002-7889-1697; Zhou, Zhiguang/0000-0002-0374-1838	Chinese Medical Association Foundation; Chinese Diabetes Society [07020470055]	Chinese Medical Association Foundation; Chinese Diabetes Society	This project was Supported by grants from the Chinese Medical Association Foundation and Chinese Diabetes Society (No. 07020470055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Cheung Bernard M Y, 2006, J Clin Hypertens (Greenwich), V8, P93, DOI 10.1111/j.1524-6175.2006.04895.x; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dahlof B, 2007, AM J CARDIOL, V100, p17J, DOI 10.1016/j.amjcard.2007.05.010; Department of Noncommunicable Disease Surveillance, 1999, DEF DIAGN CLASS DI 1; Guo FJ, 2012, J AM COLL CARDIOL, V60, P599, DOI 10.1016/j.jacc.2012.04.026; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; He J, 1996, AM J HYPERTENS, V9, p74A, DOI DOI 10.1016/0895-7061(96)81695-5; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Ji Cheng-ye, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P103; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Levine JA, 2008, CHINESE MED J-PEKING, V121, P1043, DOI 10.1097/00029330-200806010-00015; Luepker R. V., 2004, Cardiovascular survey methods; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Messerli FH, 2007, LANCET, V370, P591, DOI 10.1016/S0140-6736(07)61299-9; National Bureau of Statistics of China, 2006, CHIN STAT YB 2006; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Reynolds K, 2003, J HYPERTENS, V21, P1273, DOI 10.1097/00004872-200307000-00014; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Toft I, 1998, METABOLISM, V47, P848, DOI 10.1016/S0026-0495(98)90125-1; Uauy R., 2004, OBES REV S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Wang Zhihong, 2008, Wei Sheng Yan Jiu, V37, P62; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	26	170	200	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65938	10.1371/journal.pone.0065938	http://dx.doi.org/10.1371/journal.pone.0065938			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776574	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400085
J	Sabbatini, ME; Williams, JA				Sabbatini, Maria Eugenia; Williams, John A.			Cholecystokinin-Mediated RhoGDI Phosphorylation via PKC alpha Promotes both RhoA and Rac1 Signaling	PLOS ONE			English	Article							PROTEIN-KINASE-C; GDP-DISSOCIATION INHIBITOR; PANCREATIC ACINAR-CELLS; INDUCED AMYLASE RELEASE; ACTIVATION; EXOCYTOSIS; DELTA; GTPASE; TRANSLOCATION; G-ALPHA(13)	RhoA and Rac1 have been implicated in the mechanism of CCK-induced amylase secretion from pancreatic acini. In all cell types studied to date, inactive Rho GTPases are present in the cytosol bound to the guanine nucleotide dissociation inhibitor RhoGDI. Here, we identified the switch mechanism regulating RhoGDI1-Rho GTPase dissociation and RhoA translocation upon CCK stimulation in pancreatic acini. We found that both G alpha 13 and PKC, independently, regulate CCK-induced RhoA translocation and that the PKC isoform involved is PKC alpha. Both RhoGDI1 and RhoGDI3, but not RhoGDI2, are expressed in pancreatic acini. Cytosolic RhoA and Rac1 are associated with RhoGDI1, and CCK-stimulated PKC alpha activation releases the complex. Overexpression of RhoGDI1, by binding RhoA, inhibits its activation, and thereby, CCK-induced apical amylase secretion. RhoA translocation is also inhibited by RhoGDI1. Inactive Rac1 influences CCK-induced RhoA activation by preventing RhoGDI1 from binding RhoA. By mutational analysis we found that CCK-induced PKC alpha phosphorylation on RhoGDI1 at Ser96 releases RhoA and Rac1 from RhoGDI1 to facilitate Rho GTPases signaling.	[Sabbatini, Maria Eugenia; Williams, John A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Sabbatini, ME (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	mesabba@umich.edu		Williams, John/0000-0002-6063-7615; Sabbatini, Maria Eugenia/0000-0001-7100-2482	NIH [R37 DK-041122]; Protein Identification and Localization Core of the Michigan Gastrointestinal Peptide Center [P30 DK-34933]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, R37DK041122, P30DK020572] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Protein Identification and Localization Core of the Michigan Gastrointestinal Peptide Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grant R37 DK-041122 to JAW and by the Protein Identification and Localization Core of the Michigan Gastrointestinal Peptide Center (P30 DK-34933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra CN, 1997, P NATL ACAD SCI USA, V94, P4279, DOI 10.1073/pnas.94.9.4279; [Anonymous], 2012, PHYSL GASTROINTESTIN; Bi Y, 2005, AM J PHYSIOL-GASTR L, V289, pG561, DOI 10.1152/ajpgi.00508.2004; Bi Y, 2005, AM J PHYSIOL-CELL PH, V289, pC22, DOI 10.1152/ajpcell.00395.2004; Braz JC, 2002, J CELL BIOL, V156, P905, DOI 10.1083/jcb.200108062; Brunet N, 2002, TRAFFIC, V3, P342, DOI 10.1034/j.1600-0854.2002.30504.x; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chen YC, 2005, EXP BIOL MED, V230, P731, DOI 10.1177/153537020523001006; Chen Z, 2003, J BIOL CHEM, V278, P9912, DOI 10.1074/jbc.M212695200; Chianale F, 2010, P NATL ACAD SCI USA, V107, P4182, DOI 10.1073/pnas.0908326107; Cosen-Binker LI, 2007, J BIOL CHEM, V282, P13047, DOI 10.1074/jbc.M611132200; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; DerMardirossian CM, 2006, METHOD ENZYMOL, V406, P80, DOI 10.1016/S0076-6879(06)06007-1; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Dovas A, 2010, J BIOL CHEM, V285, P23294, DOI 10.1074/jbc.M109.098129; Elfenbein A, 2009, J CELL BIOL, V186, P75, DOI 10.1083/jcb.200810179; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Guilluy C, 2008, CIRC RES, V102, P1265, DOI 10.1161/CIRCRESAHA.107.164764; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HORI Y, 1991, ONCOGENE, V6, P515; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Knezevic N, 2007, MOL CELL BIOL, V27, P6323, DOI 10.1128/MCB.00523-07; Kuribayashi K, 2007, J CELL BIOL, V176, P1049, DOI 10.1083/jcb.200607019; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Li CW, 2004, AM J PHYSIOL-GASTR L, V287, pG764, DOI 10.1152/ajpgi.00111.2004; Li QW, 2003, J PHYSIOL-LONDON, V550, P431, DOI 10.1113/jphysiol.2003.039073; Mariot P, 1996, EMBO J, V15, P6476, DOI 10.1002/j.1460-2075.1996.tb01038.x; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Nemoto T, 2004, J BIOL CHEM, V279, P37544, DOI 10.1074/jbc.M403976200; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Qiao J, 2003, AM J PHYSIOL-LUNG C, V284, pL972, DOI 10.1152/ajplung.00429.2002; Qiao J, 2008, AM J PHYSIOL-CELL PH, V295, pC1161, DOI 10.1152/ajpcell.00139.2008; Sabbatini ME, 2010, AM J PHYSIOL-CELL PH, V298, pC592, DOI 10.1152/ajpcell.00448.2009; Satoh A, 2004, AM J PHYSIOL-GASTR L, V287, pG582, DOI 10.1152/ajpgi.00087.2004; Sauzeau V, 2000, J BIOL CHEM, V275, P21722, DOI 10.1074/jbc.M000753200; Thrower EC, 2009, PANCREAS, V38, P930, DOI 10.1097/MPA.0b013e3181b8476a; Wang ZX, 2010, J BIOL CHEM, V285, P6186, DOI 10.1074/jbc.M109.072421	40	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66029	10.1371/journal.pone.0066029	http://dx.doi.org/10.1371/journal.pone.0066029			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776598	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400103
J	Sanoja, C; Carbajosa, S; Fresno, M; Girones, N				Sanoja, Cristina; Carbajosa, Sofia; Fresno, Manuel; Girones, Nuria			Analysis of the Dynamics of Infiltrating CD4(+) T Cell Subsets in the Heart during Experimental Trypanosoma cruzi Infection	PLOS ONE			English	Article							HUMAN CHAGAS-DISEASE; NITRIC-OXIDE SYNTHASE; IMMUNE-RESPONSES; BLOOD-SAMPLES; LIMITED ROLE; ACUTE-PHASE; MICE; RESISTANCE; DEFICIENT; MECHANISM	Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, affects several million people in Latin America. Myocarditis, observed during both the acute and chronic phases of the disease, is characterized by an inammatory mononuclear cell infiltrate that includes CD4(+) T cells. It is known that Th1 cytokines help to control infection. The role that T-reg and Th17 cells may play in disease outcome, however, has not been completely elucidated. We performed a comparative study of the dynamics of CD4(+) T cell subsets after infection with the T. cruzi Y strain during both the acute and chronic phases of the disease using susceptible BALB/c and non-susceptible C57BL/6 mice infected with high or low parasite inocula. During the acute phase, infected C57BL/6 mice showed high levels of CD4(+) T cell infiltration and expression of Th1 cytokines in the heart associated with the presence of T-reg cells. In contrast, infected BALB/c mice had a high heart parasite burden, low heart CD4(+) T cell infiltration and low levels of Th1 and inflammatory cytokines, but with an increased presence of Th17 cells. Moreover, an increase in the expression of IL-6 in susceptible mice was associated with lethality upon infection with a high parasite load. Chronically infected BALB/c mice continued to present higher parasite burdens than C57BL/6 mice and also higher levels of IFN-gamma, TNF, IL-10 and TGF-beta. Thus, the regulation of the Th1 response by T-reg cells in the acute phase may play a protective role in non-susceptible mice irrespective of parasite numbers. On the other hand, Th17 cells may protect susceptible mice at low levels of infection, but could, in association with IL-6, be pathogenic at high parasite loads.	[Sanoja, Cristina] Cent Univ Venezuela, Inst Expt Biol, Caracas, Venezuela; [Carbajosa, Sofia; Fresno, Manuel; Girones, Nuria] Univ Autonoma Madrid, CBMSO, CSIC, Madrid, Spain; [Fresno, Manuel; Girones, Nuria] Inst Invest Sanitaria Princesa IP, Madrid, Spain	University of Central Venezuela; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Girones, N (corresponding author), Univ Autonoma Madrid, CBMSO, CSIC, Madrid, Spain.	ngirones@cbm.uam.es	Gironès, Núria/AAR-7436-2020; Carbajosa, Sofía/AAB-1554-2020; Girones, Nuria/L-7865-2017	Gironès, Núria/0000-0002-8130-2750; Girones, Nuria/0000-0002-8130-2750; Carbajosa Gonzalez, Sofia/0000-0002-0133-8287; Girones Pujol, Nuria/0000-0002-0932-5018; Fresno Escudero, Manuel/0000-0002-9223-5477	Ministerio de Ciencia y Tecnologia [SAF2007-61716, SAF2005-02220]; Fondo de Investigaciones Sanitarias [PS09/00538]; Red Tematica de Investigacion en Enfermedades cardiovasculares [RECAVA RD06/0014/1013]; Red de Investigacion de Centros de Enfermedades Tropicales [RICET RD06/0021/0016]; European Union [HEALTH-FE-2008-22303]; Universidad Autonoma de Madrid; Comunidad de Madrid [CC08-UAM/SAL-4440/08]; AECID cooperation with Argentine [A/025417/09]; Fundacion Ramon Areces; "Consejo de Desarrollo Cientifico y Humanistico" de la Universidad Central de Venezuela; Spanish "Ministerio de Ciencia y Tecnologia"	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Red Tematica de Investigacion en Enfermedades cardiovasculares; Red de Investigacion de Centros de Enfermedades Tropicales; European Union(European Commission); Universidad Autonoma de Madrid; Comunidad de Madrid(Comunidad de Madrid); AECID cooperation with Argentine; Fundacion Ramon Areces; "Consejo de Desarrollo Cientifico y Humanistico" de la Universidad Central de Venezuela; Spanish "Ministerio de Ciencia y Tecnologia"(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by "Ministerio de Ciencia y Tecnologia" (SAF2007-61716; SAF2005-02220); "Fondo de Investigaciones Sanitarias" (PS09/00538); "Red Tematica de Investigacion en Enfermedades cardiovasculares" (RECAVA RD06/0014/1013); "Red de Investigacion de Centros de Enfermedades Tropicales" (RICET RD06/0021/0016); European Union (HEALTH-FE-2008-22303, ChagasEpiNet); "Universidad Autonoma de Madrid" and "Comunidad de Madrid" (CC08-UAM/SAL-4440/08); AECID cooperation with Argentine (A/025417/09) and "Fundacion Ramon Areces". M. Fresno and N. Girones are professors at the "Biologia Molecular" Department ("Universidad Autonoma de Madrid"). C. Sanoja was recipient of a fellowship financed by "Consejo de Desarrollo Cientifico y Humanistico" de la Universidad Central de Venezuela. S. Carbajosa was recipient of an FPI fellowship financed by Spanish "Ministerio de Ciencia y Tecnologia". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsohn IA, 2000, INFECT IMMUN, V68, P1975, DOI 10.1128/IAI.68.4.1975-1979.2000; AGUS DB, 1991, J EXP MED, V173, P1039, DOI 10.1084/jem.173.5.1039; Aliberti JCS, 2001, AM J PATHOL, V158, P1433, DOI 10.1016/S0002-9440(10)64094-1; Andrade LO, 2002, EXP PARASITOL, V100, P269, DOI 10.1016/S0014-4894(02)00024-3; ANDRADE V, 1985, BRAZ J MED BIOL RES, V18, P499; [Anonymous], 1986, COUNC DIR CONV PROT; Antonio CSE, 2008, MOL IMMUNOL, V45, P3580, DOI 10.1016/j.molimm.2008.05.004; Araujo FF, 2007, FRONT BIOSCI-LANDMRK, V12, P2797, DOI 10.2741/2273; Baldeviano GC, 2010, CIRC RES, V106, P1646, DOI 10.1161/CIRCRESAHA.109.213157; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389; Cuervo H, 2008, J INFECT DIS, V197, P1772, DOI 10.1086/529527; Cuervo H, 2011, J IMMUNOL, V187, P2656, DOI 10.4049/jimmunol.1002928; Guedes PMD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000604; de Araujo FF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000992; de Meis J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000417; Dutra WO, 2009, MEM I OSWALDO CRUZ, V104, P208, DOI 10.1590/S0074-02762009000900027; Gao WD, 2002, INT J PARASITOL, V32, P167, DOI 10.1016/S0020-7519(01)00322-8; GAZZINELLI RT, 1992, EUR J IMMUNOL, V22, P2501, DOI 10.1002/eji.1830221006; Girones N, 2005, CURR TOP MICROBIOL, V296, P89; Girones N, 2003, TRENDS PARASITOL, V19, P19, DOI 10.1016/S1471-4922(02)00006-5; Holscher C, 1998, INFECT IMMUN, V66, P1208; Jager A, 2010, SCAND J IMMUNOL, V72, P173, DOI 10.1111/j.1365-3083.2010.02432.x; Kotner J, 2007, INFECT IMMUN, V75, P861, DOI 10.1128/IAI.01500-06; Laucella SA, 2004, J INFECT DIS, V189, P909, DOI 10.1086/381682; Legault J, 2012, J IMMUNOL, V188; Marcon GEB, 2002, DIAGN MICR INFEC DIS, V43, P39, DOI 10.1016/S0732-8893(02)00366-8; Mariano FS, 2008, MICROBES INFECT, V10, P825, DOI 10.1016/j.micinf.2008.04.009; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Guedes PMM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001630; MICHIE SA, 1988, J EXP MED, V168, P1929, DOI 10.1084/jem.168.5.1929; Miyazaki Y, 2010, J IMMUNOL, V185, P1150, DOI 10.4049/jimmunol.0900047; MUNOZFERNANDEZ MA, 1992, EUR J IMMUNOL, V22, P301, DOI 10.1002/eji.1830220203; Perez AR, 2005, LIFE SCI, V77, P1945, DOI 10.1016/j.lfs.2005.01.025; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; Perez AR, 2011, NEUROIMMUNOMODULAT, V18, P328, DOI 10.1159/000329494; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sales-Junior PA, 2008, MICROBES INFECT, V10, P680, DOI 10.1016/j.micinf.2008.03.008; Savino W, 2006, PLOS PATHOG, V2, P472, DOI 10.1371/journal.ppat.0020062; Stephens LA, 2000, J IMMUNOL, V165, P3105, DOI 10.4049/jimmunol.165.6.3105; Telleria J, 2010, AM TRYPANOSOMIASIS C, P848; Boari JT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002658; TRISCHMANN TM, 1982, INFECT IMMUN, V35, P546, DOI 10.1128/IAI.35.2.546-551.1982; Vitelli-Avelar DM, 2005, SCAND J IMMUNOL, V62, P297, DOI 10.1111/j.1365-3083.2005.01668.x; Wynn TA, 2005, NAT IMMUNOL, V6, P1069, DOI 10.1038/ni1105-1069; Yamaguchi T, 2007, IMMUNITY, V27, P145, DOI 10.1016/j.immuni.2007.04.017	46	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65820	10.1371/journal.pone.0065820	http://dx.doi.org/10.1371/journal.pone.0065820			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776551	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400069
J	Xu, L; Zahid, KR; He, LR; Zhang, WW; He, X; Zhang, XL; Yang, XY; Zhu, LF				Xu, Lian; Zahid, Kashif Rafiq; He, Liangrong; Zhang, Wenwen; He, Xin; Zhang, Xianlong; Yang, Xiyan; Zhu, Longfu			GhCAX3 Gene, a Novel Ca2+/H+ Exchanger from Cotton, Confers Regulation of Cold Response and ABA Induced Signal Transduction	PLOS ONE			English	Article							OSMOTIC-STRESS; CATION/H+ EXCHANGERS; ARABIDOPSIS CAX1; LOW-TEMPERATURE; PROTEIN-KINASE; ABSCISIC-ACID; EXPRESSION; CALCIUM; TOLERANCE; TOBACCO	As a second messenger, Ca2+ plays a major role in cold induced transduction via stimulus-specific increases in [Ca2+](cyt), which is called calcium signature. During this process, CAXs (Ca2+/H+ exchangers) play critical role. For the first time, a putative Ca2+/H+ exchanger GhCAX3 gene from upland cotton (Gossypium hirsutum cv. 'YZ-1') was isolated and characterized. It was highly expressed in all tissues of cotton except roots and fibers. This gene may act as a regulator in cotton's response to abiotic stresses as it could be up-regulated by Ca2+, NaCl, ABA and cold stress. Similar to other CAXs, it was proved that GhCAX3 also had Ca2+ transport activity and the N-terminal regulatory region (NRR) through yeast complementation assay. Over-expression of GhCAX3 in tobacco showed less sensitivity to ABA during seed germination and seedling stages, and the phenotypic difference between wild type (WT) and transgenic plants was more significant when the NRR was truncated. Furthermore, GhCAX3 conferred cold tolerance in yeast as well as in tobacco seedlings based on physiological and molecular studies. However, transgenic plant seeds showed more sensitivity to cold stress compared to WT during seed germination, especially when expressed in N-terminal truncated version. Finally, the extent of sensitivity in transgenic lines was more severe than that in WT line under sodium tungstate treatment (an ABA repressor), indicating that ABA could alleviate cold sensitivity of GhCAX3 seeds, especially in short of its NRR. Meanwhile, we also found that overexpression of GhCAX3 could enhance some cold and ABA responsive marker genes. Taken together, these results suggested that GhCAX3 plays important roles in the cross-talk of ABA and cold signal transduction, and compared to full-length of GhCAX3, the absence of NRR could enhance the tolerance or sensitivity to cold stress, depending on seedling's developmental stages.	[Xu, Lian; Zahid, Kashif Rafiq; He, Liangrong; Zhang, Wenwen; He, Xin; Zhang, Xianlong; Yang, Xiyan; Zhu, Longfu] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; [He, Liangrong] Tarim Univ, Coll Plant Sci, Alaer, Xinjiang, Peoples R China	Huazhong Agricultural University; Tarim University	Zhu, LF (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	lfzhu@mail.hzau.edu.cn	He, Xin/C-4371-2017	He, Xin/0000-0002-8602-5166; Zhu, Longfu/0000-0002-4947-8609	Fundamental Research Funds for the Central Universities of China [2010QC034]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was founded by the Department of Science and Technology of China and the Fundamental Research Funds for the Central Universities of China (2010QC034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GJ, 2000, SCIENCE, V289, P2338, DOI 10.1126/science.289.5488.2338; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Barkla BJ, 2008, PLANT SIGNAL BEHAV, V3, P354, DOI 10.4161/psb.3.5.5600; Catala R, 2003, PLANT CELL, V15, P2940, DOI 10.1105/tpc.015248; Chen H, 2008, P NATL ACAD SCI USA, V105, P4495, DOI 10.1073/pnas.0710778105; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chung MY, 2010, PLANT BIOTECHNOL REP, V4, P15, DOI 10.1007/s11816-009-0112-9; CORBISIER P, 1987, ANAL BIOCHEM, V164, P240, DOI 10.1016/0003-2697(87)90392-7; Helliwell CA, 2002, FUNCT PLANT BIOL, V29, P1217, DOI 10.1071/FP02033; Hirschi KD, 1999, PLANT CELL, V11, P2113, DOI 10.1105/tpc.11.11.2113; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hu XL, 2010, J PLANT PHYSIOL, V167, P1307, DOI 10.1016/j.jplph.2010.04.014; Kamiya T, 2006, PLANT CELL PHYSIOL, V47, P96, DOI 10.1093/pcp/pci227; Kamiya T, 2005, PLANT CELL PHYSIOL, V46, P1735, DOI 10.1093/pcp/pci173; Kim KN, 2003, PLANT CELL, V15, P411, DOI 10.1105/tpc.006858; Knight H, 1999, PLANT CELL, V11, P875, DOI 10.1105/tpc.11.5.875; Knight H, 2001, TRENDS PLANT SCI, V6, P262, DOI 10.1016/S1360-1385(01)01946-X; Kong XP, 2011, PLANT CELL REP, V30, P2097, DOI 10.1007/s00299-011-1116-9; Luo GZ, 2005, PLANT MOL BIOL, V59, P809, DOI 10.1007/s11103-005-1386-0; Manohar M, 2011, PLANT BIOLOGY, V13, P561, DOI 10.1111/j.1438-8677.2011.00466.x; Manohar M, 2011, BIOCHEMISTRY-US, V50, P6189, DOI 10.1021/bi2003839; Matteucci M, 2011, J EXP BOT, V62, P3403, DOI 10.1093/jxb/err013; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; Mei H, 2007, J EXP BOT, V58, P3419, DOI 10.1093/jxb/erm190; Mei H, 2009, NEW PHYTOL, V183, P95, DOI 10.1111/j.1469-8137.2009.02831.x; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Park S, 2005, PLANT PHYSIOL, V139, P1194, DOI 10.1104/pp.105.066266; Pittman JK, 2001, PLANT PHYSIOL, V127, P1020, DOI 10.1104/pp.010409; Pittman JK, 2009, J BIOL CHEM, V284, P525, DOI 10.1074/jbc.M807173200; POLLE A, 1994, PLANT PHYSIOL, V106, P53, DOI 10.1104/pp.106.1.53; Ruelland E, 2010, ENVIRON EXP BOT, V69, P225, DOI 10.1016/j.envexpbot.2010.05.011; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Seo PJ, 2010, PLANT J, V61, P661, DOI 10.1111/j.1365-313X.2009.04091.x; Shigaki T, 2006, J MOL EVOL, V63, P815, DOI 10.1007/s00239-006-0048-4; Shigaki T, 2006, PLANT BIOLOGY, V8, P419, DOI 10.1055/s-2006-923950; Shigaki T, 2010, PLANT BIOLOGY, V12, P935, DOI 10.1111/j.1438-8677.2010.00368.x; Suzuki K, 2008, PLANT CELL PHYSIOL, V49, P433, DOI 10.1093/pcp/pcn020; Tamura T, 2003, PLANT PHYSIOL, V131, P454, DOI 10.1104/pp.102.011007; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tu LL, 2007, PLANT CELL REP, V26, P1309, DOI 10.1007/s00299-007-0337-4; Ueoka-Nakanishi H, 2000, EUR J BIOCHEM, V267, P3090, DOI 10.1046/j.1432-1033.2000.01343.x; Verlues PE, 2005, PLANT J, V45, P523; Wang YuCheng, 2006, Bulletin of Botanical Research, V26, P84; Wu HC, 2012, PLANT CELL ENVIRON, V35, P1543, DOI 10.1111/j.1365-3040.2012.02508.x; Yang GP, 1996, AUST J PLANT PHYSIOL, V23, P437, DOI 10.1071/PP9960437; Zhang MY, 2012, J PLANT PHYSIOL, V169, P1501, DOI 10.1016/j.jplph.2012.06.008; Zhu LF, 2011, AGR SCI CHINA, V10, P499, DOI 10.1016/S1671-2927(11)60030-8; Zhu LongFu, 2005, Acta Agronomica Sinica, V31, P1657	48	14	21	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66303	10.1371/journal.pone.0066303	http://dx.doi.org/10.1371/journal.pone.0066303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776653	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400134
J	Liu, CF; Breidenbach, A; Aschbacher-Smith, L; Butler, D; Wylie, C				Liu, Chia-Feng; Breidenbach, Andrew; Aschbacher-Smith, Lindsey; Butler, David; Wylie, Christopher			A Role for Hedgehog Signaling in the Differentiation of the Insertion Site of the Patellar Tendon in the Mouse	PLOS ONE			English	Article							INDIAN-HEDGEHOG; ARTICULAR-CARTILAGE; ACHILLES-TENDON; GENE-EXPRESSION; CELL-MIGRATION; GROWTH; BONE; PATHWAY; OSTEOARTHRITIS; CHONDROCYTES	Tendons are typically composed of two histologically different regions: the midsubstance and insertion site. We previously showed that Gli1, a downstream effector of the hedgehog (Hh) signaling pathway, is expressed only in the insertion site of the mouse patellar tendon during its differentiation. To test for a functional role of Hh signaling, we targeted the Smoothened (Smo) gene in vivo using a Cre/Lox system. Constitutive activation of the Hh pathway in the mid-substance caused molecular markers of the insertion site, e. g. type II collagen, to be ectopically expressed or up-regulated in the midsubstance. This was confirmed using a novel organ culture method in vitro. Conversely, when Smo was excised in the scleraxis-positive cell population, the development of the fibrocartilaginous insertion site was affected. Whole transcriptome analysis revealed that the expression of genes involved in chondrogenesis and mineralization was down-regulated in the insertion site, and expression of insertion site markers was decreased. Biomechanical testing of murine adult patellar tendon, which developed in the absence of Hh signaling, showed impairment of tendon structural properties (lower linear stiffness and greater displacement) and material properties (greater strain), although the linear modulus of the mutant group was not significantly lower than controls. These studies provide new insights into the role of Hh signaling during tendon development.	[Liu, Chia-Feng; Aschbacher-Smith, Lindsey; Wylie, Christopher] Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH USA; [Breidenbach, Andrew; Butler, David] Univ Cincinnati, Biomed Engn Program, Sch Energy Environm Biol & Med Engn, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Wylie, C (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH USA.	christopher.wylie@cchmc.org			National Institute of Health [AR056943]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056943] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study is supported by the National Institute of Health (AR056943)(http://www.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Bai CB, 2002, DEVELOPMENT, V129, P4753; Benjamin M, 2000, INT REV CYTOL, V196, P85; Benjamin M, 2009, SCAND J MED SCI SPOR, V19, P520, DOI 10.1111/j.1600-0838.2009.00906.x; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Blitz E, 2009, DEV CELL, V17, P861, DOI 10.1016/j.devcel.2009.10.010; Brunskill EW, 2012, DEV BIOL, V368, P4, DOI 10.1016/j.ydbio.2012.05.030; BUTLER DL, 1990, J BIOMECH ENG-T ASME, V112, P38, DOI 10.1115/1.2891124; Chang CF, 2012, OSTEOARTHR CARTILAGE, V20, P152, DOI 10.1016/j.joca.2011.11.009; Chiquet-Ehrismann R, 2004, INT J BIOCHEM CELL B, V36, P1085, DOI 10.1016/j.biocel.2004.01.007; Dahia CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035944; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Dyment NA, 2012, J ORTHOP RES, V30, P28, DOI 10.1002/jor.21484; Ehlen Harald W. A., 2006, Birth Defects Research, V78, P267, DOI 10.1002/bdrc.20076; Eliasson P, 2009, J APPL PHYSIOL, V107, P399, DOI 10.1152/japplphysiol.91563.2008; Gu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025984; Gu Y, 2009, DEVELOPMENT, V136, P1295, DOI 10.1242/dev.030619; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Karp SJ, 2000, DEVELOPMENT, V127, P543; Koyama E, 1996, DEV DYNAM, V207, P344, DOI 10.1002/(SICI)1097-0177(199611)207:3<344::AID-AJA11>3.0.CO;2-4; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Krull CE, 1998, CURR TOP DEV BIOL, V36, P145; Kwan KM, 2002, GENESIS, V32, P49, DOI 10.1002/gene.10068; Lazarenko OP, 2006, BONE, V38, P74, DOI 10.1016/j.bone.2005.07.008; Levangie PK, 2005, JOINT STRUCTURE FUNC, V4th; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Liu CF, 2012, TISSUE ENG PT A, V18, P598, DOI [10.1089/ten.tea.2011.0338, 10.1089/ten.TEA.2011.0338]; Liu CF, 2011, TISSUE ENG PART B-RE, V17, P165, DOI 10.1089/ten.teb.2010.0662; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; PACIFICI M, 1993, DEV DYNAM, V198, P123, DOI 10.1002/aja.1001980206; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; ROUGHLEY PJ, 1994, MATRIX BIOL, V14, P51, DOI 10.1016/0945-053X(94)90029-9; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Steinert AF, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3921; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Waggett AD, 1998, MATRIX BIOL, V16, P457, DOI 10.1016/S0945-053X(98)90017-8; Wang M, 2012, J BONE MINERAL RES O; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	40	38	38	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65411	10.1371/journal.pone.0065411	http://dx.doi.org/10.1371/journal.pone.0065411			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762363	Green Submitted, gold, Green Published			2022-12-25	WOS:000320440500037
J	Prentice, JR; Clark, MJ; Hoggard, N; Morton, AC; Tooth, C; Paley, MN; Stockley, I; Hadjivassiliou, M; Wilkinson, JM				Prentice, Jennifer R.; Clark, Matthew J.; Hoggard, Nigel; Morton, Allison C.; Tooth, Claire; Paley, Martyn N.; Stockley, Ian; Hadjivassiliou, Marios; Wilkinson, J. Mark			Metal-on-Metal Hip Prostheses and Systemic Health: A Cross-Sectional Association Study 8 Years after Implantation	PLOS ONE			English	Article							RESURFACING ARTHROPLASTY; ION LEVELS; INSULIN SENSITIVITY; IN-VIVO; CHROMIUM; COBALT; FAILURE; SINGLE; BLOOD; SIGHT	There is public concern over the long term systemic health effects of metal released from hip replacement prostheses that use large-diameter metal-on-metal bearings. However, to date there has been no systematic study to determine which organs may be at risk, or the magnitude of any effect. We undertook a detailed cross-sectional health screen at a mean of 8 years after surgery in 35 asymptomatic patients who had previously received a metal-on-metal hip resurfacing (MoMHR) versus 35 individually age and sex matched asymptomatic patients who had received a conventional hip replacement. Total body bone mineral density was 5% higher (mean difference 0.05 g/cm(2), P = 0.02) and bone turnover was 14% lower (TRAP 5b, mean difference -0.56IU/L, P = 0.006; osteocalcin, mean difference -3.08 ng/mL, P = 0.03) in the hip resurfacing versus conventional hip replacement group. Cardiac ejection fraction was 7% lower (mean absolute difference -5%, P = 0.04) and left ventricular end-diastolic diameter was 6% larger (mean difference 2.7 mm, P = 0.007) in the hip resurfacing group versus those patients who received a conventional hip replacement. The urinary fractional excretion of metal was low (cobalt 5%, chromium 1.5%) in patients with MoMHR, but creatinine clearance was normal. Diuretic prescription was associated with a 40% increase in the fractional excretion of chromium (mean difference 0.5%, P = 0.03). There was no evidence of difference in neuropsychological, renal tubular, hepatic or endocrine function between groups (P. 0.05). Our findings of differences in bone and cardiac function between patient groups suggest that chronic exposure to low elevated metal concentrations in patients with well-functioning MoMHR prostheses may have systemic effects. Long-term epidemiological studies in patients with well-functioning metal on metal hip prostheses should include musculoskeletal and cardiac endpoints to quantitate the risk of clinical disease.	[Prentice, Jennifer R.; Clark, Matthew J.; Hoggard, Nigel; Paley, Martyn N.; Wilkinson, J. Mark] Univ Sheffield, Dept Human Metab, Sheffield, S Yorkshire, England; [Morton, Allison C.] Sheffield Teaching Hosp NHS Fdn Trust, Dept Cardiol, Sheffield, S Yorkshire, England; [Tooth, Claire; Hadjivassiliou, Marios] Sheffield Teaching Hosp NHS Fdn Trust, Dept Neurol, Sheffield, S Yorkshire, England; [Stockley, Ian; Wilkinson, J. Mark] Sheffield Teaching Hosp NHS Fdn Trust, Dept Orthopaed, Sheffield, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield; University of Sheffield	Wilkinson, JM (corresponding author), Univ Sheffield, Dept Human Metab, Sheffield, S Yorkshire, England.	j.m.wilkinson@sheffield.ac.uk		Clark, Matthew/0000-0003-2152-2257	Sheffield Musculoskeletal Biomedical Research Unit; National Institute of Health Research in the United Kingdom (NIHR)	Sheffield Musculoskeletal Biomedical Research Unit; National Institute of Health Research in the United Kingdom (NIHR)	This study was funded by Sheffield Musculoskeletal Biomedical Research Unit through its core grant from the National Institute of Health Research in the United Kingdom (NIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2000, DIABETIC MED, V17, P124, DOI 10.1046/j.1464-5491.2000.00234.x; ANDREWS RE, 2011, BONE; Back DL, 2005, CLIN ORTHOP RELAT R, P177, DOI 10.1097/01.blo.0000166901.85323.5d; Blake GM, 2007, J CLIN DENSITOM, V10, P259, DOI 10.1016/j.jocd.2007.03.102; CARTWRIGHT GE, 1955, AM J CLIN NUTR, V3, P11, DOI 10.1093/ajcn/3.1.11; Cohen D, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1410; Costa ML, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2147; Daniel J, 2007, J BONE JOINT SURG BR, V89B, P169, DOI 10.1302/0301-620X.89B2.18519; Daniel J, 2009, J BONE JOINT SURG BR, V91B, P176, DOI 10.1302/0301-620X.91B2.21654; Davda K, 2011, J BONE JOINT SURG BR, V93B, P738, DOI 10.1302/0301-620X.93B6.25804; de Smet K, 2008, J BONE JOINT SURG AM, V90A, P202, DOI 10.2106/JBJS.H.00672; Fassett RG, 2011, KIDNEY INT, V80, P806, DOI 10.1038/ki.2011.198; Hart AJ, 2011, J BONE JOINT SURG BR, V93B, P1308, DOI 10.1302/0301-620X.93B10.26249; HARTMANN A, 2012, CLIN ORTHOP RELAT RE; Heisel C, 2008, J BONE JOINT SURG AM, V90A, P125, DOI 10.2106/JBJS.H.00437; Holland JP, 2012, J BONE JOINT SURG BR, V94B, P471, DOI 10.1302/0301-620X.94B4.27895; Hua Y, 2012, J NUTR BIOCHEM, V23, P313, DOI 10.1016/j.jnutbio.2011.11.001; Ikeda T, 2010, MUSCLE NERVE, V42, P140, DOI 10.1002/mus.21638; Kwon YM, 2011, J ARTHROPLASTY, V26, P511, DOI 10.1016/j.arth.2010.05.030; Langton DJ, 2010, J BONE JOINT SURG BR, V92B, P38, DOI 10.1302/0301-620X.92B1.22770; Legro RS, 1998, J CLIN ENDOCR METAB, V83, P2694, DOI 10.1210/jc.83.8.2694; Linna A, 2004, OCCUP ENVIRON MED, V61, P877, DOI 10.1136/oem.2003.009605; Marker M, 2008, ARCH ORTHOP TRAUM SU, V128, P915, DOI 10.1007/s00402-007-0466-9; MCCARTY MF, 1995, MED HYPOTHESES, V45, P241, DOI 10.1016/0306-9877(95)90112-4; MORIN YL, 1967, CAN MED ASSOC J, V97, P881; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; OLDENBURG M, 2009, J ARTHROPLASTY, V24, P52820; PENNY JO, 2013, ACTA ORTHOP; Quinteros FA, 2007, TOXICOL APPL PHARM, V218, P79, DOI 10.1016/j.taap.2006.10.017; Rising JP, 2012, NEW ENGL J MED, V367, DOI 10.1056/NEJMp1206794; Rizzetti MC, 2009, LANCET, V373, P1052, DOI 10.1016/S0140-6736(09)60490-6; Russell RGG, 1999, BONE, V25, P97, DOI 10.1016/S8756-3282(99)00116-7; Steens W, 2006, ACTA ORTHOP, V77, P830, DOI 10.1080/17453670610013079; Tower SS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e430; WEDEEN RP, 1991, ENVIRON HEALTH PERSP, V92, P71, DOI 10.2307/3431139; Wilkinson JM, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7792	36	46	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66186	10.1371/journal.pone.0066186	http://dx.doi.org/10.1371/journal.pone.0066186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762480	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000320440500066
J	Aouida, M; Kim, K; Shaikh, AR; Pardo, JM; Eppinger, J; Yun, DJ; Bressan, RA; Narasimhan, ML				Aouida, Mustapha; Kim, Kangchang; Shaikh, Abdul Rajjak; Pardo, Jose M.; Eppinger, Joerg; Yun, Dae-Jin; Bressan, Ray A.; Narasimhan, Meena L.			A Saccharomyces cerevisiae Assay System to Investigate Ligand/AdipoR1 Interactions That Lead to Cellular Signaling	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; ISCHEMIA-REPERFUSION INJURY; ADIPONECTIN RECEPTORS; CRYSTAL-STRUCTURE; THAUMATIN-LIKE; ANTIFUNGAL PROTEIN; ENERGY-METABOLISM; FORCE-FIELD; YEAST; OSMOTIN	Adiponectin is a mammalian hormone that exerts anti-diabetic, anti-cancer and cardioprotective effects through interaction with its major ubiquitously expressed plasma membrane localized receptors, AdipoR1 and AdipoR2. Here, we report a Saccharomyces cerevisiae based method for investigating agonist-AdipoR interactions that is amenable for high-throughput scale-up and can be used to study both AdipoRs separately. Agonist-AdipoR1 interactions are detected using a split firefly luciferase assay based on reconstitution of firefly luciferase (Luc) activity due to juxtaposition of its N- and C-terminal fragments, NLuc and CLuc, by ligand induced interaction of the chimeric proteins CLuc-AdipoR1 and APPL1-NLuc (adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif 1-NLuc) in a S. cerevisiae strain lacking the yeast homolog of AdipoRs (Izh2p). The assay monitors the earliest known step in the adiponectin-AdipoR anti-diabetic signaling cascade. We demonstrate that reconstituted Luc activity can be detected in colonies or cells using a CCD camera and quantified in cell suspensions using a microplate reader. AdipoR1-APPL1 interaction occurs in absence of ligand but can be stimulated specifically by agonists such as adiponectin and the tobacco protein osmotin that was shown to have AdipoR-dependent adiponectin-like biological activity in mammalian cells. To further validate this assay, we have modeled the three dimensional structures of receptor-ligand complexes of membrane-embedded AdipoR1 with cyclic peptides derived from osmotin or osmotin-like plant proteins. We demonstrate that the calculated AdipoR1-peptide binding energies correlate with the peptides' ability to behave as AdipoR1 agonists in the split luciferase assay. Further, we demonstrate agonist-AdipoR dependent activation of protein kinase A (PKA) signaling and AMP activated protein kinase (AMPK) phosphorylation in S. cerevisiae, which are homologous to important mammalian adiponectin-AdipoR1 signaling pathways. This system should facilitate the development of therapeutic inventions targeting adiponectin and/or AdipoR physiology.	[Aouida, Mustapha; Bressan, Ray A.; Narasimhan, Meena L.] King Abdullah Univ Sci & Technol, Plant Stress Genom Res Ctr, Thuwal, Saudi Arabia; [Kim, Kangchang; Yun, Dae-Jin] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Div Appl Life Sci, Brain Korea Program 21, Jinju, South Korea; [Shaikh, Abdul Rajjak; Eppinger, Joerg] King Abdullah Univ Sci & Technol, Div Phys Sci & Engn, KAUST Catalysis Ctr, Thuwal, Saudi Arabia; [Pardo, Jose M.] CSIC, Inst Recursos Nat & Agrobiol, E-41080 Seville, Spain; [Bressan, Ray A.] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA	King Abdullah University of Science & Technology; Gyeongsang National University; King Abdullah University of Science & Technology; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Narasimhan, ML (corresponding author), Biowrite LLC, W Lafayette, IN USA.	biowrite.mln@gmail.com	Eppinger, Jörg/AAJ-6924-2020; Eppinger, Jörg/F-2348-2010; Pardo, Jose M./B-4652-2009; Pardo, Jose M/AAB-5866-2022; Aouida, Mustapha/AEJ-4513-2022; Shaikh, Abdul Rajjak/C-5624-2012	Eppinger, Jörg/0000-0001-7886-7059; Eppinger, Jörg/0000-0001-7886-7059; Pardo, Jose M./0000-0003-4510-8624; Pardo, Jose M/0000-0003-4510-8624; Aouida, Mustapha/0000-0001-7945-5320; Shaikh, Abdul Rajjak/0000-0003-4444-0684; Bressan, Ray/0000-0002-8754-606X; Yun, Dae-Jin/0000-0002-3638-6043	King Abullah University of Science and Technology, KAUST-GCR [FIC/2010/07]; Rural Development Administration for the Next-Generation BioGreen 21 Program (Systems and Synthetic Agrobiotech Center), Republic of South Korea [PJ008025]; Ministry of Education, Science and Technology for the World Class University (WCU) program, Republic of South Korea [R32-10148]	King Abullah University of Science and Technology, KAUST-GCR; Rural Development Administration for the Next-Generation BioGreen 21 Program (Systems and Synthetic Agrobiotech Center), Republic of South Korea; Ministry of Education, Science and Technology for the World Class University (WCU) program, Republic of South Korea	This research was supported in part by funds from King Abullah University of Science and Technology, KAUST-GCR (stipend A.R.S.: FIC/2010/07), the Rural Development Administration for the Next-Generation BioGreen 21 Program (Systems and Synthetic Agrobiotech Center, no. PJ008025), Republic of South Korea, and the Ministry of Education, Science and Technology for the World Class University (WCU) program (R32-10148), Republic of South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batalia MA, 1996, NAT STRUCT BIOL, V3, P19, DOI 10.1038/nsb0196-19; BECKER DM, 1991, METHOD ENZYMOL, V194, P182; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen HM, 2008, PLANT PHYSIOL, V146, P368, DOI 10.1104/pp.107.111740; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; Dieudonne MN, 2006, BIOCHEM BIOPH RES CO, V345, P271, DOI 10.1016/j.bbrc.2006.04.076; Edman K, 2002, STRUCTURE, V10, P473, DOI 10.1016/S0969-2126(02)00736-0; Fang WL, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/401537; Fang X, 2006, BIOCHEM SOC T, V34, P798, DOI 10.1042/BST0340798; Fujikawa Y, 2007, PLANT J, V52, P185, DOI 10.1111/j.1365-313X.2007.03214.x; Garitaonandia I, 2009, J RECEPT SIG TRANSD, V29, P67, DOI 10.1080/10799890902729456; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Goldstein BJ, 2009, NAT CLIN PRACT CARD, V6, P27, DOI 10.1038/ncpcardio1398; GRAHAM JS, 1992, PLANT PHYSIOL, V98, P163, DOI 10.1104/pp.98.1.163; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; Ishikawa M, 2007, CANCER SCI, V98, P1120, DOI 10.1111/j.1349-7006.2007.00486.x; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Jortay J, 2012, AM J PATHOL, V181, P245, DOI 10.1016/j.ajpath.2012.03.035; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; KO TP, 1994, ACTA CRYSTALLOGR D, V50, P813, DOI 10.1107/S0907444994005512; Kondo H, 2002, DIABETES, V51, P2325, DOI 10.2337/diabetes.51.7.2325; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kupchak BR, 2008, BIOCHEM BIOPH RES CO, V374, P210, DOI 10.1016/j.bbrc.2008.07.002; Kupchak BR, 2007, BBA-MOL CELL RES, V1773, P1124, DOI 10.1016/j.bbamcr.2007.04.003; Lee H, 2010, EUKARYOT CELL, V9, P558, DOI 10.1128/EC.00316-09; Leone P, 2006, BIOCHIMIE, V88, P45, DOI 10.1016/j.biochi.2005.07.001; LESAGE P, 1994, NUCLEIC ACIDS RES, V22, P597, DOI 10.1093/nar/22.4.597; Liu X, 2012, GUT; Lou Y, 2010, J BIOL CHEM, V285, P19384, DOI 10.1074/jbc.M110.125377; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Masson JY, 1997, MOL MICROBIOL, V24, P711, DOI 10.1046/j.1365-2958.1997.3841748.x; Matsuda M, 2002, J BIOL CHEM, V277, P37487, DOI 10.1074/jbc.M206083200; Matsuzawa Y, 2010, CURR PHARM DESIGN, V16, P1896, DOI 10.2174/138161210791208893; Miele M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016690; Min K, 2004, PROTEINS, V54, P170, DOI 10.1002/prot.10571; Min XS, 2012, FEBS LETT, V586, P912, DOI 10.1016/j.febslet.2012.02.024; Narasimhan ML, 2005, MOL CELL, V17, P171, DOI 10.1016/j.molcel.2004.11.050; Narasimhan ML, 2001, MOL CELL, V8, P921, DOI 10.1016/S1097-2765(01)00365-3; Neumeier M, 2006, J LEUKOCYTE BIOL, V79, P803, DOI 10.1189/jlb.0905521; Ohashi K, 2011, AM J HYPERTENS, V24, P263, DOI 10.1038/ajh.2010.216; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Palacin A, 2008, CLIN EXP ALLERGY, V38, P1220, DOI 10.1111/j.1365-2222.2007.02927.x; Paulmurugan R, 2005, ANAL CHEM, V77, P1295, DOI 10.1021/ac0484777; Petranovic D, 2010, FEMS YEAST RES, V10, P1046, DOI 10.1111/j.1567-1364.2010.00689.x; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shklyaev S, 2003, P NATL ACAD SCI USA, V100, P14217, DOI 10.1073/pnas.2333912100; Tang YT, 2005, J MOL EVOL, V61, P372, DOI 10.1007/s00239-004-0375-2; Veronese P, 2003, PLANT PHYSIOL, V131, P1580, DOI 10.1104/pp.102.013417; Villa NY, 2009, MOL PHARMACOL, V75, P866, DOI 10.1124/mol.108.049809; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang YJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE663, DOI 10.1152/ajpendo.00663.2009; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357	61	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65454	10.1371/journal.pone.0065454	http://dx.doi.org/10.1371/journal.pone.0065454			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762377	Green Published, Green Submitted, gold			2022-12-25	WOS:000321094800052
J	Haikarainen, T; Venkannagari, H; Narwal, M; Obaji, E; Lee, HW; Nkizinkiko, Y; Lehtio, L				Haikarainen, Teemu; Venkannagari, Harikanth; Narwal, Mohit; Obaji, Ezeogo; Lee, Hao-Wei; Nkizinkiko, Yves; Lehtio, Lari			Structural Basis and Selectivity of Tankyrase Inhibition by a Wnt Signaling Inhibitor WIKI4	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE-1 PARP-1; CRYSTAL-STRUCTURE; ASSAY; ANTAGONISTS; POCKET; SAR	Recently a novel inhibitor of Wnt signaling was discovered. The compound, WIKI4, was found to act through tankyrase inhibition and regulate beta-catenin levels in many cancer cell lines and human embryonic stem cells. Here we confirm that WIKI4 is a high potency tankyrase inhibitor and that it selectively inhibits tankyrases over other ARTD enzymes tested. The binding mode of the compound to tankyrase 2 was determined by protein X-ray crystallography to 2.4 A degrees resolution. The structure revealed a novel binding mode to the adenosine subsite of the donor NAD(+) binding groove of the catalytic domain. Our results form a structural basis for further development of potent and selective tankyrase inhibitors based on the WIKI4 scaffold.	[Haikarainen, Teemu; Venkannagari, Harikanth; Narwal, Mohit; Obaji, Ezeogo; Lee, Hao-Wei; Lehtio, Lari] Univ Oulu, Dept Biochem, Bioctr Oulu, Oulu, Finland; [Narwal, Mohit; Nkizinkiko, Yves] Abo Akad Univ, Dept Biosci, Turku, Finland	Finland National Institute for Health & Welfare; University of Oulu; Abo Akademi University	Lehtio, L (corresponding author), Univ Oulu, Dept Biochem, Bioctr Oulu, Oulu, Finland.	lari.lehtio@oulu.fi	Venkannagari, Harikanth/AAX-6211-2021	Obaji, Ezeogo/0000-0001-9880-5664; Lehtio, Lari/0000-0001-7250-832X	Biocenter Oulu; Sigrid Juselius foundation; European Community under BioStruct-X [283570]	Biocenter Oulu; Sigrid Juselius foundation(Sigrid Juselius Foundation); European Community under BioStruct-X	The work was funded by Biocenter Oulu (http://www.oulu.fi/biocenter/) and by Sigrid Juselius foundation (http://www.sigridjuselius.fi/). MN and HV are members of the National Doctoral Programme of Informational and Structural Biology. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (grant agreement No283570). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Bell CE, 1996, BIOCHEMISTRY-US, V35, P1137, DOI 10.1021/bi9520848; Bregman H, 2013, J MED CHEM, V56, P1341, DOI 10.1021/jm301607v; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Dynek JN, 2004, SCIENCE, V304, P97, DOI 10.1126/science.1094754; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferraris DV, 2010, J MED CHEM, V53, P4561, DOI 10.1021/jm100012m; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Hsiao SJ, 2009, J CELL BIOL, V184, P515, DOI 10.1083/jcb.200810132; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; James RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050457; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karlberg T, 2010, J MED CHEM, V53, P5352, DOI 10.1021/jm100249w; Karlberg T, 2010, BIOCHEMISTRY-US, V49, P1056, DOI 10.1021/bi902079y; Lehtio L, 2009, J MED CHEM, V52, P3108, DOI 10.1021/jm900052j; Miyashiro J, 2009, BIOORG MED CHEM LETT, V19, P4050, DOI 10.1016/j.bmcl.2009.06.016; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narwal M, 2012, J BIOMOL SCREEN, V17, P593, DOI 10.1177/1087057112436558; Narwal M, 2012, J MED CHEM, V55, P1360, DOI 10.1021/jm201510p; Putt KS, 2004, ANAL BIOCHEM, V326, P78, DOI 10.1016/j.ab.2003.11.015; Riffell JL, 2012, NAT REV DRUG DISCOV, V11, P923, DOI 10.1038/nrd3868; Sbodio JI, 2002, BIOCHEM J, V361, P451, DOI 10.1042/0264-6021:3610451; Shultz MD, 2012, J MED CHEM, V55, P1127, DOI 10.1021/jm2011222; Smith S, 2000, CURR BIOL, V10, P1299, DOI 10.1016/S0960-9822(00)00752-1; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Venkannagari H, 2013, EUR J PHARM SCI, V49, P148, DOI 10.1016/j.ejps.2013.02.012; Voronkov A, 2013, J MED CHEM, V56, P3012, DOI 10.1021/jm4000566; Waaler J, 2011, CANCER RES, V71, P197, DOI 10.1158/0008-5472.CAN-10-1282	30	25	27	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65404	10.1371/journal.pone.0065404	http://dx.doi.org/10.1371/journal.pone.0065404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762361	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000063
J	Damiano, L; Stewart, KM; Cohet, N; Mouw, JK; Lakins, JN; Debnath, J; Reisman, D; Nickerson, JA; Imbalzano, AN; Weaver, VM				Damiano, L.; Stewart, K. M.; Cohet, N.; Mouw, J. K.; Lakins, J. N.; Debnath, J.; Reisman, D.; Nickerson, J. A.; Imbalzano, A. N.; Weaver, V. M.			Oncogenic targeting of BRM drives malignancy through C/EBP beta-dependent induction of alpha 5 integrin	ONCOGENE			English	Article						alpha 5 integrin; Brahma; breast cancer; C/EBP beta; ECM-cell interactions; c-Myc	EPITHELIAL-SPECIFIC DISRUPTION; TRANSGENIC MOUSE MODEL; CELL-PROLIFERATION; SWI/SNF COMPLEX; 3-DIMENSIONAL CULTURE; TRANSCRIPTION FACTOR; MAMMARY-GLAND; CANCER; EXPRESSION; BRG1	Integrin expression and activity are altered in tumors, and aberrant integrin signaling promotes malignancy. However, how integrins become altered in tumors remains poorly understood. We discovered that oncogenic activation of MEK signaling induces cell growth and survival, and promotes the malignant phenotype of mammary epithelial cells (MECs) by increasing alpha 5 integrin expression. We determined that MEK activates c-Myc to reduce the transcription of the SWI/SNF chromatin remodeling enzyme Brahma (BRM). Our studies revealed that reduced BRM expression and/or activity drives the malignant behavior of MECs by epigenetically promoting C/EBP beta expression to directly induce alpha 5 integrin transcription. Consistently, we could show that restoring BRM levels normalized the malignant behavior of transformed MECs in culture and in vivo by preventing C/EBP beta-dependent alpha 5 integrin transcription. Our findings identify a novel mechanism whereby oncogenic signaling promotes malignant transformation by regulating transcription of a key chromatin remodeling molecule that regulates integrin-dependent stromal-epithelial interactions.	[Damiano, L.; Stewart, K. M.; Mouw, J. K.; Lakins, J. N.; Weaver, V. M.] Univ Calif San Francisco, Dept Surg, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA; [Cohet, N.; Nickerson, J. A.; Imbalzano, A. N.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA USA; [Debnath, J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Reisman, D.] Univ Florida, Dept Med, Div Hematol Oncol, Gainesville, FL USA; [Weaver, V. M.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Anat Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; State University System of Florida; University of Florida; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Weaver, VM (corresponding author), Univ Calif San Francisco, Dept Surg, Ctr Bioengn & Tissue Regenerat, 513 Parnassus Ave,HSE 565,Box 0465, San Francisco, CA 94143 USA.	Valerie.Weaver@ucsfmedctr.org		Weaver, Valerie marie/0000-0003-4786-6752; Mouw, Janna K/0000-0002-9846-8466; Debnath, Jayanta/0000-0002-8745-4069	DOD [BC044791, W81XWH-05-1-0330, BC062562]; NIH/NCI [R01 CA138818, R01 CA085492]; NIEHS [U01ES019458]; NATIONAL CANCER INSTITUTE [R01CA085492, P01CA082834, U54CA163155, R01CA138818, U54CA143836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019458] Funding Source: NIH RePORTER	DOD(United States Department of Defense); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank R Bainer for analyzing the BRM promoter, MP Marinkovich for the BM165 antibody and C Damsky for the AIIB2 antibody. This work was supported by DOD BC044791 (W81XWH-05-1-0330), and NIH/NCI R01 CA138818 (to VMW), NIH/NCI R01 CA085492 (to HLM and VMW), DOD BC062562 (to JKM), and NIEHS U01ES019458 (to ZW).	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Adeyinka A, 2002, CLIN CANCER RES, V8, P1747; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bock VL, 2011, BRIT J DERMATOL, V164, P1221, DOI 10.1111/j.1365-2133.2011.10267.x; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Cohet N, 2010, J CELL PHYSIOL, V223, P667, DOI 10.1002/jcp.22072; Corbi AL, 2000, FEBS LETT, V474, P201, DOI 10.1016/S0014-5793(00)01591-X; Dawson PJ, 1996, AM J PATHOL, V148, P313; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dingemans AMC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-152; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Gilbert PM, 2010, J CLIN INVEST, V120, P1535, DOI 10.1172/JCI39534; Glaros S, 2007, ONCOGENE, V26, P7058, DOI 10.1038/sj.onc.1210514; Gramling S, 2011, ONCOGENE, V30, P3289, DOI 10.1038/onc.2011.80; Grimm SL, 2003, J MAMMARY GLAND BIOL, V8, P191, DOI 10.1023/A:1025900908026; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Haenssen KK, 2010, J CELL SCI, V123, P1373, DOI 10.1242/jcs.050906; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herkert Barbara, 2010, Genes Cancer, V1, P580, DOI 10.1177/1947601910379012; Hill DA, 2004, J CELL SCI, V117, P5847, DOI 10.1242/jcs.01502; Huck L, 2010, P NATL ACAD SCI USA, V107, P15559, DOI 10.1073/pnas.1003034107; Kahali B, 2014, ONCOGENE, V33, P653, DOI 10.1038/onc.2012.613; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liu G, 2011, ONCOGENE, V30, P3295, DOI 10.1038/onc.2011.81; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Maschler S, 2005, ONCOGENE, V24, P2032, DOI 10.1038/sj.onc.1208423; Muchardt C, 1998, EMBO J, V17, P223, DOI 10.1093/emboj/17.1.223; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Nam JM, 2010, CANCER RES, V70, P5238, DOI 10.1158/0008-5472.CAN-09-2319; Park J, 2004, ONCOGENE, V23, P3474, DOI 10.1038/sj.onc.1207470; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Provenzano PP, 2008, AM J PATHOL, V173, P1551, DOI 10.2353/ajpath.2008.080308; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Reisman DN, 2003, CANCER RES, V63, P560; Reisman DN, 2002, ONCOGENE, V21, P1196, DOI 10.1038/sj.onc.1205188; Shen H, 2008, CANCER RES, V68, P10154, DOI 10.1158/0008-5472.CAN-08-1794; Sun A, 2007, PROSTATE, V67, P203, DOI 10.1002/pros.20521; Tabaries S, 2011, ONCOGENE, V30, P1318, DOI 10.1038/onc.2010.518; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Yang XF, 2009, J CELL SCI, V122, P2473, DOI 10.1242/jcs.049148; Yao ES, 2007, CANCER RES, V67, P659, DOI 10.1158/0008-5472.CAN-06-2768; Yarnamichi N, 2007, CANCER RES, V67, P10727, DOI 10.1158/0008-5472.CAN-07-2601; Yu M, 2012, NATURE, V487, P510, DOI 10.1038/nature11217; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887	58	12	12	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2014	33	19					2441	2453		10.1038/onc.2013.220	http://dx.doi.org/10.1038/onc.2013.220			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH3OK	23770848	Green Accepted, Green Published			2022-12-25	WOS:000336033600004
J	Schmid, CL; Streicher, JM; Groer, CE; Munro, TA; Zhou, L; Bohn, LM				Schmid, Cullen L.; Streicher, John M.; Groer, Chad E.; Munro, Thomas A.; Zhou, Lei; Bohn, Laura M.			Functional Selectivity of 6 '-Guanidinonaltrindole (6 '-GNTI) at kappa-Opioid Receptors in Striatal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEROTONIN 2A RECEPTOR; G-PROTEIN; BETA-ARRESTIN; IN-VIVO; NOR-BINALTORPHIMINE; AGONIST SALVINORIN; REGULATED KINASE; DRUG-SEEKING; RATS; ACTIVATION	There is considerable evidence to suggest that drug actions at the kappa-opioid receptor (KOR) may represent a means to control pain perception and modulate reward thresholds. As a G protein-coupled receptor (GPCR), the activation of KOR promotes G alpha(i/o) protein coupling and the recruitment of beta-arrestins. It has become increasingly evident that GPCRs can transduce signals that originate independently via G protein pathways and beta-arrestin pathways; the ligand-dependent bifurcation of such signaling is referred to as "functional selectivity" or "signaling bias." Recently, a KOR agonist, 6'-guanidinonaltrindole (6'-GNTI), was shown to display bias toward the activation of G protein-mediated signaling over beta-arrestin2 recruitment. Therefore, we investigated whether such ligand bias was preserved in striatal neurons. Although the reference KOR agonist U69,593 induces the phosphorylation of ERK1/2 and Akt, 6'-GNTI only activates the Akt pathway in striatal neurons. Using pharmacological tools and beta-arrestin2 knock-out mice, we show that KOR-mediated ERK1/2 phosphorylation in striatal neurons requires beta-arrestin2, whereas Akt activation depends upon G protein signaling. These findings reveal a point of KOR signal bifurcation that can be observed in an endogenous neuronal setting and may prove to be an important indicator when developing biased agonists at the KOR.	[Schmid, Cullen L.; Streicher, John M.; Groer, Chad E.; Zhou, Lei; Bohn, Laura M.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Schmid, Cullen L.; Streicher, John M.; Groer, Chad E.; Zhou, Lei; Bohn, Laura M.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Munro, Thomas A.] McLean Hosp, Mailman Res Ctr, Belmont, MA 02478 USA; [Munro, Thomas A.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02215 USA	Scripps Research Institute; Scripps Research Institute; Harvard University; McLean Hospital; Harvard University; Harvard Medical School	Bohn, LM (corresponding author), Scripps Inst, Dept Mol Therapeut, 130 Scripps Way,Rm 2A2, Jupiter, FL 33458 USA.	lbohn@scripps.edu	Bohn, Laura M/A-7483-2014; Munro, Thomas Anthony/B-2712-2009	Bohn, Laura M/0000-0002-6474-8179; Munro, Thomas Anthony/0000-0002-3366-7149; Schmid Mason, Cullen/0000-0002-2882-1842; Streicher, John/0000-0002-4173-7362	National Institutes of Health [R01 DA031927]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DA031927 (to L. M. B.).	Aldrich JV, 2009, P NATL ACAD SCI USA, V106, P18396, DOI 10.1073/pnas.0910180106; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; BODKIN JA, 1995, J CLIN PSYCHOPHARM, V15, P49, DOI 10.1097/00004714-199502000-00008; Bohn Laura M, 2010, Drug Discov Today Technol, V7, pe37, DOI 10.1016/j.ddtec.2010.06.005; Bohn Laura M., 2009, P71, DOI 10.1007/978-1-60327-335-0_5; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2004, MOL PHARMACOL, V66, P106, DOI 10.1124/mol.66.1.106; BROADBEAR JH, 1994, PSYCHOPHARMACOLOGY, V115, P311, DOI 10.1007/BF02245071; Bruchas MR, 2007, J BIOL CHEM, V282, P29803, DOI 10.1074/jbc.M705540200; Carlezon WA, 2006, J PHARMACOL EXP THER, V316, P440, DOI 10.1124/jpet.105.092304; Cohen BM, 2008, INT J NEUROPSYCHOPH, V11, P243, DOI 10.1017/S1461145707008073; Cowen DS, 2005, J NEUROCHEM, V93, P910, DOI 10.1111/j.1471-4159.2005.03107.x; Evans BA, 2011, MOL PHARMACOL, V79, P298, DOI 10.1124/mol.110.067454; GLICK SD, 1995, BRAIN RES, V681, P147, DOI 10.1016/0006-8993(95)00306-B; Groer CE, 2007, MOL PHARMACOL, V71, P549, DOI 10.1124/mol.106.028258; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2012, ACS CHEM NEUROSCI, V3, P193, DOI 10.1021/cn200111m; Knoll AT, 2011, BIOL PSYCHIAT, V70, P425, DOI 10.1016/j.biopsych.2011.03.017; Ko MCH, 2003, BRAIN RES, V982, P38, DOI 10.1016/S0006-8993(03)02938-X; Kostenis E, 2001, TRENDS PHARMACOL SCI, V22, P560, DOI 10.1016/S0165-6147(00)01810-1; Land BB, 2009, P NATL ACAD SCI USA, V106, P19168, DOI 10.1073/pnas.0910705106; Li JG, 1999, J BIOL CHEM, V274, P12087, DOI 10.1074/jbc.274.17.12087; Mague SD, 2003, J PHARMACOL EXP THER, V305, P323, DOI 10.1124/jpet.102.046433; Mailman RB, 2007, TRENDS PHARMACOL SCI, V28, P390, DOI 10.1016/j.tips.2007.06.002; McLennan GP, 2008, J NEUROCHEM, V107, P1753, DOI 10.1111/j.1471-4159.2008.05745.x; Negri A, 2013, J CHEM INF MODEL, V53, P521, DOI 10.1021/ci400019t; Negus SS, 1997, J PHARMACOL EXP THER, V282, P44; Potter DN, 2011, BIOL PSYCHIAT, V70, P744, DOI 10.1016/j.biopsych.2011.05.021; Raehal KM, 2011, PHARMACOL REV, V63, P1001, DOI 10.1124/pr.111.004598; Rives ML, 2012, J BIOL CHEM, V287, P27050, DOI 10.1074/jbc.C112.387332; Schenk S, 1999, PSYCHOPHARMACOLOGY, V144, P339, DOI 10.1007/s002130051016; Schmid CL, 2008, P NATL ACAD SCI USA, V105, P1079, DOI 10.1073/pnas.0708862105; Schmid CL, 2010, J NEUROSCI, V30, P13513, DOI 10.1523/JNEUROSCI.1665-10.2010; Sharma SK, 2001, J MED CHEM, V44, P2073, DOI 10.1021/jm010095v; Spetea M., 2013, CURR PHARM IN PRESS; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Van't Veer A, 2013, NEUROPSYCHOPHARMACOL, V38, P1585, DOI 10.1038/npp.2013.58; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; Walsh SL, 2001, J PHARMACOL EXP THER, V299, P147; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	41	65	69	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22387	22398		10.1074/jbc.M113.476234	http://dx.doi.org/10.1074/jbc.M113.476234			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23775075	Green Published, hybrid			2022-12-25	WOS:000330596300020
J	Ensign, SPF; Mathews, LT; Eschbacher, JM; Loftus, JC; Symons, MH; Tran, NL				Ensign, Shannon P. Fortin; Mathews, Lan T.; Eschbacher, Jennifer M.; Loftus, Joseph C.; Symons, Marc H.; Tran, Nhan L.			The Src Homology 3 Domain-containing Guanine Nucleotide Exchange Factor Is Overexpressed in High-grade Gliomas and Promotes Tumor Necrosis Factor-like Weak Inducer of Apoptosis-Fibroblast Growth Factor-inducible 14-induced Cell Migration and Invasion via Tumor Necrosis Factor Receptor-associated Factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Invasion; Cell Signaling; Glioblastoma; Guanine Nucleotide Exchange Factor (GEF); Rho GTPases	NF-KAPPA-B; ACTIN STRESS FIBERS; ACTIVATES RAC1; RHO GTPASES; GLIOBLASTOMA; PROTEINS; SURVIVAL; TRAF2; PHOSPHORYLATION; MOLECULES	Glioblastoma (GB) is the highest grade of primary adult brain tumors, characterized by a poorly defined and highly invasive cell population. Importantly, these invading cells are attributed with having a decreased sensitivity to radiation and chemotherapy. TNF-like weak inducer of apoptosis (TWEAK)-Fn14 ligand-receptor signaling is one mechanism in GB that promotes cell invasiveness and survival and is dependent upon the activity of multiple Rho GTPases, including Rac1. Here we report that Src homology 3 domain-containing guanine nucleotide exchange factor (SGEF), a RhoG-specific guanine nucleotide exchange factor, is overexpressed in GB tumors and promotes TWEAK-Fn14-mediated glioma invasion. Importantly, levels of SGEF expression in GB tumors inversely correlate with patient survival. SGEF mRNA expression is increased in GB cells at the invasive rim relative to those in the tumor core, and knockdown of SGEF expression by shRNA decreases glioma cell migration in vitro and invasion ex vivo. Furthermore, we showed that, upon TWEAK stimulation, SGEF is recruited to the Fn14 cytoplasmic tail via TRAF2. Mutation of the Fn14-TRAF domain site or depletion of TNF receptor-associated factor 2 (TRAF2) expression by siRNA oligonucleotides blocked SGEF recruitment to Fn14 and inhibited SGEF activity and subsequent GB cell migration. We also showed that knockdown of either SGEF or RhoG diminished TWEAK activation of Rac1 and subsequent lamellipodia formation. Together, these results indicate that SGEF-RhoG is an important downstream regulator of TWEAK-Fn14-driven GB cell migration and invasion.	[Ensign, Shannon P. Fortin; Mathews, Lan T.; Tran, Nhan L.] Translat Genom Res Inst, Canc & Cell Biol Div, Phoenix, AZ 85004 USA; [Ensign, Shannon P. Fortin] Univ Arizona, Canc Biol Grad Interdisciplinary Program, Tucson, AZ 85724 USA; [Eschbacher, Jennifer M.] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Loftus, Joseph C.] Mayo Clin, Scottsdale, AZ 85259 USA; [Symons, Marc H.] North Shore Long Isl Jewish, Ctr Oncol & Cell Biol, Feinstein Inst Med Res, Manhasset, NY 11030 USA	Translational Genomics Research Institute; University of Arizona; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Mayo Clinic; Mayo Clinic Phoenix; Northwell Health	Tran, NL (corresponding author), Translat Genom Res Inst, Canc & Cell Biol Div, 445 N 5th St, Phoenix, AZ 85004 USA.	ntran@tgen.org		Fortin Ensign, Shannon/0000-0002-7433-528X; Mathews, Ian/0000-0003-4773-7985	National Institutes of Health [R01 CA130940]; Achievement Reward for College Scientists Foundation Eller scholarship; Science Foundation Arizona fellowship; NATIONAL CANCER INSTITUTE [P50CA108961, R01CA130940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Achievement Reward for College Scientists Foundation Eller scholarship; Science Foundation Arizona fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA130940 (to N. L. T.). This work was also supported by an Achievement Reward for College Scientists Foundation Eller scholarship and a Science Foundation Arizona fellowship (to S. P. F. E.).	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; ANDO S, 1992, J BIOL CHEM, V267, P25709; BERENS ME, 1994, CLIN EXP METASTAS, V12, P405, DOI 10.1007/BF01755884; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Brown SAN, 2003, BIOCHEM J, V371, P395, DOI 10.1042/BJ20021730; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; BURGER PC, 1988, J NEUROSURG, V68, P698, DOI 10.3171/jns.1988.68.5.0698; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; Ellerbroek SM, 2004, MOL BIOL CELL, V15, P3309, DOI 10.1091/mbc.E04-02-0146; Fortin SP, 2012, MOL CANCER RES, V10, P958, DOI 10.1158/1541-7786.MCR-11-0616; Fortin SP, 2009, MOL CANCER RES, V7, P1871, DOI 10.1158/1541-7786.MCR-09-0194; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Gauthier-Rouviere C, 1998, MOL BIOL CELL, V9, P1379, DOI 10.1091/mbc.9.6.1379; Hiramoto K, 2006, EXP CELL RES, V312, P4205, DOI 10.1016/j.yexcr.2006.09.006; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Jang KW, 2011, J CELL BIOCHEM, V112, P3612, DOI 10.1002/jcb.23292; Jarzynka NJ, 2007, CANCER RES, V67, P7203, DOI 10.1158/0008-5472.CAN-07-0473; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Kislin KL, 2009, NEOPLASIA, V11, P377, DOI 10.1593/neo.81572; Kwiatkowska A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-65; Lin WJ, 2011, P NATL ACAD SCI USA, V108, P18354, DOI 10.1073/pnas.1109427108; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Mariani L, 2001, J NEURO-ONCOL, V53, P161, DOI 10.1023/A:1012253317934; Munson JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003016; Murga C, 2002, ONCOGENE, V21, P207, DOI 10.1038/sj.onc.1205036; Nakada M, 2004, CANCER RES, V64, P3179, DOI 10.1158/0008-5472.CAN-03-3667; Natoli G, 1998, J BIOL CHEM, V273, P31262, DOI 10.1074/jbc.273.47.31262; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144; Prieto-Sanchez RM, 2003, J BIOL CHEM, V278, P37916, DOI 10.1074/jbc.M301437200; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Sampetrean O, 2011, NEOPLASIA, V13, P784, DOI 10.1593/neo.11624; Samson T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055202; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Subbaiah VK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002543; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; Tran NL, 2003, AM J PATHOL, V162, P1313, DOI 10.1016/S0002-9440(10)63927-2; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; Wennerberg K, 2002, J BIOL CHEM, V277, P47810, DOI 10.1074/jbc.M203816200; Yang HJ, 2013, J BIOL CHEM, V288, P2965, DOI 10.1074/jbc.M112.385989; Zheng M, 2008, CANCER RES, V68, P7570, DOI 10.1158/0008-5472.CAN-08-0632	52	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21887	10.1074/jbc.M113.468686	http://dx.doi.org/10.1074/jbc.M113.468686			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23775076	Green Published, hybrid			2022-12-25	WOS:000328841900037
J	Yamamoto, K; Matsuoka, T; Kawashima, S; Takebe, S; Kubo, N; Miyatsuka, T; Kaneto, H; Shimomura, I				Yamamoto, Kaoru; Matsuoka, Taka-aki; Kawashima, Satoshi; Takebe, Satomi; Kubo, Noriyo; Miyatsuka, Takeshi; Kaneto, Hideaki; Shimomura, Iichiro			A Novel Function of Onecut1 Protein as a Negative Regulator of MafA Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Diabetes; Insulin Synthesis; Islet; Transcription Factors	PANCREATIC BETA-CELLS; INSULIN GENE; TRANSCRIPTION FACTOR; HOMEODOMAIN PROTEIN; PDX-1 GENE; DIFFERENTIATION; SEQUENCES; ENDODERM; HNF-6; IDENTIFICATION	The transcription factor MafA is a key regulator of insulin gene expression and maturation of islet cells. Despite its importance, the regulatory mechanism of MafA gene expression is still unclear. To identify the transcriptional regulators of MafA, we examined various transcription factors, which are potentially involved in cell differentiation. An adenovirus-mediated overexpression study clearly demonstrated that Onecut1 suppresses the promoter activity of MafA through the Foxa2-binding cis-element on the MafA enhancer region (named area A). However, ChIP analysis showed that Foxa2 but not Onecut1 could directly bind to area A. Furthermore, overexpression of Onecut1 inhibited the binding of Foxa2 onto area A upon ChIP analysis. Importantly, insertion of a mutation in the Foxa2-binding site of area A significantly decreased the promoter activity of MafA. These findings suggest that Onecut1 suppresses MafA gene expression through the Foxa2-binding site. In the mouse pancreas, MafA expression was first detected at the latest stage of cell differentiation and was scarcely observed in Onecut1-positive cells during pancreas development. In addition, Onecut1 expression was significantly increased in the islets of diabetic db/db mice, whereas MafA expression was markedly decreased. The improved glucose levels of db/db mice with insulin injections significantly reduced Onecut1 expression and rescued the reduction of MafA expression. These in vivo experiments also suggest that Onecut1 is a negative regulator of MafA gene expression. This study implicates the novel role of Onecut1 in the control of normal cell differentiation and its involvement in cell dysfunction under diabetic conditions by suppressing MafA gene expression.	[Yamamoto, Kaoru; Matsuoka, Taka-aki; Kawashima, Satoshi; Takebe, Satomi; Kubo, Noriyo; Miyatsuka, Takeshi; Kaneto, Hideaki; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 5650871, Japan	Osaka University	Matsuoka, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	matsuoka@endmet.med.osaka-u.ac.jp			Juvenile Diabetes Research Foundation [2-2005-946]; KAKENHI [10379258]; Grants-in-Aid for Scientific Research [24591328] Funding Source: KAKEN	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Juvenile Diabetes Research Foundation Career Development Award 2-2005-946 (to T. M.) and KAKENHI Grant 10379258 (to T. M.).	ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; CROWE DT, 1989, MOL CELL BIOL, V9, P1784, DOI 10.1128/MCB.9.4.1784; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; Gannon M, 2000, DEVELOPMENT, V127, P2883; Gerrish K, 2004, MOL ENDOCRINOL, V18, P533, DOI 10.1210/me.2003-0371; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; Kaneto H, 2005, J BIOL CHEM, V280, P15047, DOI 10.1074/jbc.M412013200; KARLSSON O, 1987, P NATL ACAD SCI USA, V84, P8819, DOI 10.1073/pnas.84.24.8819; Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200; Kawashima S, 2011, BIOCHEM BIOPH RES CO, V404, P534, DOI 10.1016/j.bbrc.2010.12.021; Landry C, 1997, DEV BIOL, V192, P247, DOI 10.1006/dbio.1997.8757; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; Matsuoka TA, 2007, MOL ENDOCRINOL, V21, P2764, DOI 10.1210/me.2007-0028; Matsuoka T, 2010, DIABETES, V59, P1709, DOI 10.2337/db08-0693; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Nishimura W, 2009, DEV BIOL, V333, P108, DOI 10.1016/j.ydbio.2009.06.029; Nock A, 2009, J BIOL CHEM, V284, P19915, DOI 10.1074/jbc.M109.016295; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; PESHAVARIA M, 1994, MOL ENDOCRINOL, V8, P806, DOI 10.1210/me.8.6.806; PETERSEN HV, 1994, P NATL ACAD SCI USA, V91, P10465, DOI 10.1073/pnas.91.22.10465; Raum JC, 2006, MOL CELL BIOL, V26, P5735, DOI 10.1128/MCB.00249-06; Rausa F, 1997, DEV BIOL, V192, P228, DOI 10.1006/dbio.1997.8744; Tweedie E, 2006, DIABETES, V55, P3264, DOI 10.2337/db06-0090; Villasenor A, 2008, DEV DYNAM, V237, P3270, DOI 10.1002/dvdy.21740; WHELAN J, 1989, MOL CELL BIOL, V9, P3253, DOI 10.1128/MCB.9.8.3253; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhang HJ, 2009, MECH DEVELOP, V126, P958, DOI 10.1016/j.mod.2009.09.006	37	13	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21648	21658		10.1074/jbc.M113.481424	http://dx.doi.org/10.1074/jbc.M113.481424			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23775071	hybrid, Green Published			2022-12-25	WOS:000328841900017
J	Borgmann, KL; Conway, CJ; Morrison, ML				Borgmann, Kathi L.; Conway, Courtney J.; Morrison, Michael L.			Breeding Phenology of Birds: Mechanisms Underlying Seasonal Declines in the Risk of Nest Predation	PLOS ONE			English	Article							REPRODUCTIVE-PERFORMANCE; CLUTCH SIZE; BEHAVIORAL INDICATORS; DUSKY FLYCATCHER; SITE SELECTION; GREAT TIT; SPACE USE; SUCCESS; FOREST; FITNESS	Seasonal declines in avian clutch size are well documented, but seasonal variation in other reproductive parameters has received less attention. For example, the probability of complete brood mortality typically explains much of the variation in reproductive success and often varies seasonally, but we know little about the underlying cause of that variation. This oversight is surprising given that nest predation influences many other life-history traits and varies throughout the breeding season in many songbirds. To determine the underlying causes of observed seasonal decreases in risk of nest predation, we modeled nest predation of Dusky Flycatchers (Empidonax oberholseri) in northern California as a function of foliage phenology, energetic demand, developmental stage, conspecific nest density, food availability for nest predators, and nest predator abundance. Seasonal variation in the risk of nest predation was not associated with seasonal changes in energetic demand, conspecific nest density, or predator abundance. Instead, seasonal variation in the risk of nest predation was associated with foliage density (early, but not late, in the breeding season) and seasonal changes in food available to nest predators. Supplemental food provided to nest predators resulted in a numerical response by nest predators, increasing the risk of nest predation at nests that were near supplemental feeders. Our results suggest that seasonal changes in foliage density and factors associated with changes in food availability for nest predators are important drivers of temporal patterns in risk of avian nest predation.	[Borgmann, Kathi L.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA; [Conway, Courtney J.] Univ Idaho, US Geol Survey, Idaho Cooperat Fish & Wildlife Res Unit, Coll Nat Resources, Moscow, ID 83843 USA; [Morrison, Michael L.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA	University of Arizona; Idaho; University of Idaho; United States Department of the Interior; United States Geological Survey; Texas A&M University System; Texas A&M University College Station	Borgmann, KL (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ 85721 USA.	klborgmann@gmail.com		Chiaradia, Andre/0000-0002-6178-4211	United States Department of Agriculture Forest Service Lake Tahoe Basin Management Unit, Cooper Ornithological Society; University of Arizona's Silliman Research Grant; Biosphere 2 at the University of Arizona; NSF GK-12 BioME teaching fellowship at the University of Arizona	United States Department of Agriculture Forest Service Lake Tahoe Basin Management Unit, Cooper Ornithological Society; University of Arizona's Silliman Research Grant; Biosphere 2 at the University of Arizona; NSF GK-12 BioME teaching fellowship at the University of Arizona	Support was provided by contributions from United States Department of Agriculture Forest Service Lake Tahoe Basin Management Unit, Cooper Ornithological Society (Mewaldt-King Research Award), The University of Arizona's Silliman Research Grant, Biosphere 2 at the University of Arizona, and NSF GK-12 BioME teaching fellowship at the University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldredge MW, 2007, ECOL APPL, V17, P948, DOI 10.1890/06-0685; Anderson D.R., 2008, MODEL BASED INFERENC; ANDREN H, 1992, ECOLOGY, V73, P794, DOI 10.2307/1940158; ANGELSTAM P, 1986, OIKOS, V47, P365, DOI 10.2307/3565450; Blums P, 2002, J ANIM ECOL, V71, P280, DOI 10.1046/j.1365-2656.2002.00598.x; Borgmann KL, 2010, MECH UNDERLYING INTR; Brinkhof MWG, 1997, P ROY SOC B-BIOL SCI, V264, P291, DOI 10.1098/rspb.1997.0041; Brown CR, 1999, CONDOR, V101, P230, DOI 10.2307/1369986; Brown WP, 2002, ECOLOGY, V83, P958, DOI 10.2307/3071905; Burhans DE, 2002, J WILDLIFE MANAGE, V66, P240, DOI 10.2307/3802890; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cain JW, 2003, J WILDLIFE MANAGE, V67, P600; Chalfoun AD, 2010, CONDOR, V112, P701, DOI 10.1525/cond.2010.090242; Choi SW, 2008, ZOOL SCI, V25, P53, DOI 10.2108/zsj.25.53; Christians JK, 2001, J ANIM ECOL, V70, P1080, DOI 10.1046/j.0021-8790.2001.00566.x; CLUTTONBROCK TH, 1987, J ANIM ECOL, V56, P53, DOI 10.2307/4799; CONNER RN, 1986, AUK, V103, P23, DOI 10.1093/auk/103.1.23; Conway CJ, 2000, EVOLUTION, V54, P670; Conway CJ, 2000, BEHAV ECOL, V11, P178, DOI 10.1093/beheco/11.2.178; CUSHMAN JH, 1994, OECOLOGIA, V99, P194, DOI 10.1007/BF00317101; Davis SK, 2005, CONDOR, V107, P605, DOI 10.1650/0010-5422(2005)107[0605:NSPATI]2.0.CO;2; Dinsmore SJ, 2002, ECOLOGY, V83, P3476, DOI 10.1890/0012-9658(2002)083[3476:ATFMAN]2.0.CO;2; Emery RB, 2005, J WILDLIFE MANAGE, V69, P1181, DOI 10.2193/0022-541X(2005)069[1181:SVIWNS]2.0.CO;2; Farnsworth GL, 1999, AUK, V116, P1075, DOI 10.2307/4089686; FILLIATER TS, 1994, CONDOR, V96, P761, DOI 10.2307/1369479; Fontaine JJ, 2006, AM NAT, V168, P811, DOI 10.1086/508297; Garrison BA, 2005, CALIF FISH GAME, V91, P1; Grant TA, 2005, AUK, V122, P661, DOI 10.1642/0004-8038(2005)122[0661:TVIPNS]2.0.CO;2; Gruebler MU, 2010, J AVIAN BIOL, V41, P282, DOI 10.1111/j.1600-048X.2009.04865.x; HAFTORN S, 1985, AUK, V102, P470, DOI 10.1093/auk/102.3.470; HARTLEY IR, 1994, ARDEA, V82, P173; HOCHACHKA W, 1990, ECOLOGY, V71, P1279, DOI 10.2307/1938265; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Kroll AJ, 2009, J ORNITHOL, V150, P409, DOI 10.1007/s10336-008-0353-3; LANDA K, 1992, EVOLUTION, V46, P121, DOI [10.1111/j.1558-5646.1992.tb01989.x, 10.2307/2409809]; Liebezeit JR, 2002, CONDOR, V104, P507, DOI 10.1650/0010-5422(2002)104[0507:NPNSSA]2.0.CO;2; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; Lorenz TJ, 2009, CONDOR, V111, P326, DOI 10.1525/cond.2009.080070; Lozano GA, 1996, J AVIAN BIOL, V27, P164, DOI 10.2307/3677146; Luginbuhl JM, 2001, J FIELD ORNITHOL, V72, P556, DOI 10.1648/0273-8570-72.4.556; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MARTIN TE, 1988, P NATL ACAD SCI USA, V85, P2196, DOI 10.1073/pnas.85.7.2196; MARTIN TE, 1992, ECOLOGY AND CONSERVATION OF NEOTROPICAL MIGRANT LANDBIRDS, P455; MARTIN TE, 1993, J FIELD ORNITHOL, V64, P507; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Mermoz ME, 1998, AUK, V115, P871, DOI 10.2307/4089506; Messaoud Y, 2007, AM J BOT, V94, P746, DOI 10.3732/ajb.94.5.746; Muller M, 2005, OECOLOGIA, V143, P37, DOI 10.1007/s00442-004-1770-5; MURPHY MT, 1986, ECOLOGY, V67, P1483, DOI 10.2307/1939079; NAGER RG, 1995, AM NAT, V146, P454, DOI 10.1086/285809; Nams VO, 1997, OECOLOGIA, V110, P440, DOI 10.1007/s004420050179; NOLAN V, 1963, ECOLOGY, V44, P305, DOI 10.2307/1932177; Pacifici K, 2008, AUK, V125, P600, DOI 10.1525/auk.2008.07078; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; PERRINS CM, 1965, J ANIM ECOL, V34, P601, DOI 10.2307/2453; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; Rangen SA, 1999, CAN J ZOOL, V77, P1676, DOI 10.1139/cjz-77-11-1676; REITSMA LR, 1990, OIKOS, V57, P375, DOI 10.2307/3565967; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; Rodewald AD, 2001, AUK, V118, P1018, DOI 10.1642/0004-8038(2001)118[1018:ANSIFL]2.0.CO;2; Rodewald AD, 2010, BIOL INVASIONS, V12, P33, DOI 10.1007/s10530-009-9426-3; Roper JJ, 1997, J AVIAN BIOL, V28, P111, DOI 10.2307/3677304; ROSEBERRY JL, 1970, WILSON BULL, V82, P243; Rotella J. J., 2004, Animal Biodiversity and Conservation, V27, P187; SAS Institute, 2008, SAS VERS 9 2; Schmidt KA, 2001, ECOLOGY, V82, P2937, DOI 10.1890/0012-9658(2001)082[2937:INPISB]2.0.CO;2; Schmidt KA, 2007, ISR J ECOL EVOL, V53, P389, DOI 10.1560/IJEE.53.3.389; SCHULTZ ET, 1993, EVOLUTION, V47, P520, DOI 10.1111/j.1558-5646.1993.tb02111.x; Shaffer Terry L., 2007, Studies in Avian Biology, V34, P84; Shaffer TL, 2004, AUK, V121, P526, DOI 10.1642/0004-8038(2004)121[0526:AUATAN]2.0.CO;2; Sieving KE, 1999, CAN J ZOOL, V77, P1829, DOI 10.1139/cjz-77-11-1829; Sieving KE, 1998, ECOLOGY, V79, P2391, DOI 10.1890/0012-9658(1998)079[2391:NPAASD]2.0.CO;2; Skagen SK, 2010, CONDOR, V112, P8, DOI 10.1525/cond.2010.090155; SKUTCH AF, 1949, IBIS, V91, P430, DOI 10.1111/j.1474-919X.1949.tb02293.x; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; Soderstrom B, 1998, OECOLOGIA, V117, P108, DOI 10.1007/s004420050638; Stearns S.C., 1992, pi; Stephens D.W., 1986, pi; Svensson E, 1997, EVOLUTION, V51, P1276, DOI 10.1111/j.1558-5646.1997.tb03974.x; TINBERGEN L., 1960, ARCH NEERLAND ZOOL, V13, P265; Tomback DF, 1998, CLARKS NUTCRACKER NU; VERHULST S, 1995, ECOLOGY, V76, P2392, DOI 10.2307/2265815; Verhulst S, 2008, PHILOS T R SOC B, V363, P399, DOI 10.1098/rstb.2007.2146; Wiebe KL, 2003, OIKOS, V100, P291, DOI 10.1034/j.1600-0706.2003.12046.x; Wilson S, 2007, CONDOR, V109, P377, DOI 10.1650/0010-5422(2007)109[377:NSPIWP]2.0.CO;2; Winter M, 2005, J WILDLIFE MANAGE, V69, P185, DOI 10.2193/0022-541X(2005)069&lt;0185:VIVEOD&gt;2.0.CO;2; Winter M, 2005, J FIELD ORNITHOL, V76, P61, DOI 10.1648/0273-8570-76.1.61; WOODWARD A, 1994, CAN J FOREST RES, V24, P1133, DOI 10.1139/x94-150; Yunger JA, 2002, J MAMMAL, V83, P267, DOI 10.1644/1545-1542(2002)083<0267:ROTLDP>2.0.CO;2	89	37	38	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65909	10.1371/journal.pone.0065909	http://dx.doi.org/10.1371/journal.pone.0065909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776566	Green Submitted, gold, Green Published			2022-12-25	WOS:000320322400062
J	Mathieu, A; Delmont, TO; Vogel, TM; Robe, P; Nalin, R; Simonet, P				Mathieu, Alban; Delmont, Tom O.; Vogel, Timothy M.; Robe, Patrick; Nalin, Renaud; Simonet, Pascal			Life on Human Surfaces: Skin Metagenomics	PLOS ONE			English	Article							DIVERSITY	The human skin microbiome could provide another example, after the gut, of the strong positive or negative impact that human colonizing bacteria can have on health. Deciphering functional diversity and dynamics within human skin microbial communities is critical for understanding their involvement and for developing the appropriate substances for improving or correcting their action. We present a direct PCR-free high throughput sequencing approach to unravel the human skin microbiota specificities through metagenomic dataset analysis and inter-environmental comparison. The approach provided access to the functions carried out by dominant skin colonizing taxa, including Corynebacterium, Staphylococcus and Propionibacterium, revealing their specific capabilities to interact with and exploit compounds from the human skin. These functions, which clearly illustrate the unique life style of the skin microbial communities, stand as invaluable investigation targets for understanding and potentially modifying bacterial interactions with the human host with the objective of increasing health and well being.	[Mathieu, Alban; Delmont, Tom O.; Vogel, Timothy M.; Simonet, Pascal] Univ Lyon, Ecole Cent Lyon, Lab Ampere, Environm Microbial Genom Grp, Ecully, France; [Mathieu, Alban; Robe, Patrick; Nalin, Renaud] LibraGen, Toulouse, France	Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon	Simonet, P (corresponding author), Univ Lyon, Ecole Cent Lyon, Lab Ampere, Environm Microbial Genom Grp, Ecully, France.	pascal.simonet@ec-lyon.fr	Delmont, Tom/A-4331-2018	Delmont, Tom/0000-0001-7053-7848; Vogel, Timothy/0000-0002-9542-3246	company Libragen	company Libragen	AM, PR and RN are affiliated to the commercial company Libragen. The phD thesis of the first author is financed by the company Libragen but not the research developed in the article. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	CASIANOCOLON A, 1988, APPL ENVIRON MICROB, V54, P1318; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Delmont TO, 2011, ISME J, V5, P1837, DOI 10.1038/ismej.2011.61; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fitz-Gibbon S, 2013, J INVEST DERMATOL, V133, P2152, DOI 10.1038/jid.2013.21; Fredricks DN, 2001, J INVEST DERM SYMP P, V6, P167, DOI 10.1046/j.0022-202x.2001.00039.x; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Radner FPW, 2011, DERM-ENDOCRINOL, V3, P77, DOI 10.4161/derm.3.2.15472; Wilson M, 2004, MICROBIAL INHABITANT	17	34	37	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65288	10.1371/journal.pone.0065288	http://dx.doi.org/10.1371/journal.pone.0065288			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776466	Green Published, Green Submitted, gold			2022-12-25	WOS:000320322400016
J	Warfe, DM; Jardine, TD; Pettit, NE; Hamilton, SK; Pusey, BJ; Bunn, SE; Davies, PM; Douglas, MM				Warfe, Danielle M. y; Jardine, Timothy D.; Pettit, Neil E.; Hamilton, Stephen K.; Pusey, Bradley J.; Bunn, Stuart E.; Davies, Peter M.; Douglas, Michael M.			Productivity, Disturbance and Ecosystem Size Have No Influence on Food Chain Length in Seasonally Connected Rivers	PLOS ONE			English	Article							DRY TROPICAL RIVERS; WEB STRUCTURE; FLOODPLAIN RIVER; NORTHERN AUSTRALIA; TROPHIC POSITION; STABLE-ISOTOPE; LITTORAL-ZONE; SPATIAL SCALE; BODY-SIZE; COMMUNITY	The food web is one of the oldest and most central organising concepts in ecology and for decades, food chain length has been hypothesised to be controlled by productivity, disturbance, and/or ecosystem size; each of which may be mediated by the functional trophic role of the top predator. We characterised aquatic food webs using carbon and nitrogen stable isotopes from 66 river and floodplain sites across the wet-dry tropics of northern Australia to determine the relative importance of productivity (indicated by nutrient concentrations), disturbance (indicated by hydrological isolation) and ecosystem size, and how they may be affected by food web architecture. We show that variation in food chain length was unrelated to these classic environmental determinants, and unrelated to the trophic role of the top predator. This finding is a striking exception to the literature and is the first published example of food chain length being unaffected by any of these determinants. We suggest the distinctive seasonal hydrology of northern Australia allows the movement of fish predators, linking isolated food webs and potentially creating a regional food web that overrides local effects of productivity, disturbance and ecosystem size. This finding supports ecological theory suggesting that mobile consumers promote more stable food webs. It also illustrates how food webs, and energy transfer, may function in the absence of the human modifications to landscape hydrological connectivity that are ubiquitous in more populated regions.	[Warfe, Danielle M. y; Douglas, Michael M.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Jardine, Timothy D.] Univ Saskatchewan, Toxicol Ctr, Saskatoon, SK, Canada; [Jardine, Timothy D.; Pusey, Bradley J.; Bunn, Stuart E.] Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia; [Pettit, Neil E.; Pusey, Bradley J.; Davies, Peter M.] Univ Western Australia, Ctr Excellence Nat Resource Management, Albany, WA, Australia; [Hamilton, Stephen K.] Michigan State Univ, Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Hamilton, Stephen K.] Michigan State Univ, Dept Zool, Hickory Corners, MI USA	Charles Darwin University; University of Saskatchewan; Griffith University; University of Western Australia; Michigan State University; Michigan State University	Warfe, DM (corresponding author), Univ Western Australia, Ctr Excellence Nat Resource Management, Albany, WA, Australia.	danielle.warfe@uwa.edu.au	Pettit, Neil E/D-4309-2013; Warfe, Danielle M/C-2426-2013; Bunn, Stuart E/B-9065-2008; Jardine, Timothy Donald/AFZ-4837-2022; Hamilton, Stephen K/N-2979-2014; Douglas, Michael M/I-3149-2012	Bunn, Stuart E/0000-0002-6540-3586; Hamilton, Stephen K/0000-0002-4702-9017; Douglas, Michael M/0000-0003-3650-3374; Jardine, Timothy/0000-0002-5917-9792; Pettit, Neil/0000-0001-6126-8914	Australian Government's Commonwealth Environment Research Facilities initiative; Australian Government; Land and Water Australia; Fisheries Research and Development Corporation; Queensland Government	Australian Government's Commonwealth Environment Research Facilities initiative(Australian Government); Australian Government(Australian GovernmentCGIAR); Land and Water Australia; Fisheries Research and Development Corporation; Queensland Government	This project forms part of the Tropical Rivers and Coastal Knowledge (TRaCK) Program. TRaCK received major funding for its research through the Australian Government's Commonwealth Environment Research Facilities initiative (http://www.environment.gov.au/about/programs/cerf/); the Australian Government's Raising National Water Standards Program (http://archive.nwc.gov.au/rnws); Land and Water Australia (http://lwa.gov.au); the Fisheries Research and Development Corporation (http://www.frdc.com.au) and the Queensland Government's Smart State Innovation Fund (http://www.qld.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrington DA, 2006, J N AM BENTHOL SOC, V25, P126, DOI 10.1899/0887-3593(2006)25[126:HATSFP]2.0.CO;2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRIAND F, 1987, SCIENCE, V238, P956, DOI 10.1126/science.3672136; Brodie JE, 2005, MAR FRESHWATER RES, V56, P279, DOI 10.1071/MF04081; Bunn SE, 2006, RIVER RES APPL, V22, P179, DOI 10.1002/rra.904; Bunn SE, 2003, FRESHWATER BIOL, V48, P619, DOI 10.1046/j.1365-2427.2003.01031.x; Burford MA, 2011, MAR FRESHWATER RES, V62, P141, DOI 10.1071/MF10224; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CABANA G, 1994, NATURE, V372, P255, DOI 10.1038/372255a0; Calcagno V, 2011, P ROY SOC B-BIOL SCI, V278, P3042, DOI 10.1098/rspb.2011.0112; CARPENTER SR, 1987, ECOLOGY, V68, P1863, DOI 10.2307/1939878; COHEN JE, 1991, AM NAT, V138, P1542, DOI 10.1086/285299; Davis AM, 2010, J FISH BIOL, V76, P862, DOI 10.1111/j.1095-8649.2010.02541.x; DEANGELIS DL, 1989, AM NAT, V134, P778, DOI 10.1086/285011; DEATH RG, 1994, J N AM BENTHOL SOC, V13, P125, DOI 10.2307/1467232; Doi H, 2009, OIKOS, V118, P138, DOI 10.1111/j.1600-0706.2008.17171.x; Douglas MM, 2005, MAR FRESHWATER RES, V56, P329, DOI 10.1071/MF04084; Elton C. S., 1927, ANIMAL ECOLOGY; Francoeur SN, 2001, J N AM BENTHOL SOC, V20, P358, DOI 10.2307/1468034; Ganf GG, 2007, MAR FRESHWATER RES, V58, P315, DOI 10.1071/MF06161; Gooderham J., 2002, WATERBUG BOOK; HAIRSTON NG, 1993, AM NAT, V142, P379, DOI 10.1086/285546; Hoeinghaus DJ, 2008, OIKOS, V117, P984, DOI 10.1111/j.0030-1299.2008.16459.x; Holt RD, 2002, ECOL RES, V17, P261, DOI 10.1046/j.1440-1703.2002.00485.x; Hunt RJ, 2012, FRESHWATER BIOL, V57, P435, DOI 10.1111/j.1365-2427.2011.02708.x; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jardine TD, RIVER RES A IN PRESS; Jardine TD, 2012, OECOLOGIA, V168, P829, DOI 10.1007/s00442-011-2148-0; Jardine TD, 2012, J ANIM ECOL, V81, P310, DOI 10.1111/j.1365-2656.2011.01925.x; Jardine TD, 2011, MAR FRESHWATER RES, V62, P83, DOI 10.1071/MF10211; JENKINS B, 1992, OIKOS, V65, P249, DOI 10.2307/3545016; Jennings S, 2003, P ROY SOC B-BIOL SCI, V270, P1413, DOI 10.1098/rspb.2003.2392; Jepsen DB, 2002, OIKOS, V96, P46, DOI 10.1034/j.1600-0706.2002.960105.x; Kaunzinger CMK, 1998, NATURE, V395, P495, DOI 10.1038/26741; Kennard MJ, 2010, FRESHWATER BIOL, V55, P171, DOI 10.1111/j.1365-2427.2009.02307.x; Lake PS, 2003, FRESHWATER BIOL, V48, P1161, DOI 10.1046/j.1365-2427.2003.01086.x; Layman CA, 2005, ECOLOGY, V86, P2530, DOI 10.1890/04-1098; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leigh C, 2010, MAR FRESHWATER RES, V61, P357, DOI 10.1071/MF09107; Levin SA, 1998, ECOSYSTEMS, V1, P431, DOI 10.1007/s100219900037; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; McCann KS, 2009, PHILOS T R SOC B, V364, P1789, DOI 10.1098/rstb.2008.0273; McCann KS, 2005, ECOL LETT, V8, P513, DOI 10.1111/j.1461-0248.2005.00742.x; McHugh PA, 2010, ECOL LETT, V13, P881, DOI 10.1111/j.1461-0248.2010.01484.x; Moliere DR, 2009, J HYDROL, V367, P1, DOI 10.1016/j.jhydrol.2008.12.015; Pettit NE, 2012, MAR FRESHWATER RES, V63, P788, DOI 10.1071/MF12114; PIMM SL, 1987, OIKOS, V50, P302, DOI 10.2307/3565490; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; Polis GA, 1998, NATURE, V395, P744, DOI 10.1038/27323; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Post DM, 2007, OIKOS, V116, P775, DOI 10.1111/j.2007.0030-1299.15552.x; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; Pusey B., 2004, FRESHWATER FISHES N, DOI DOI 10.1071/9780643092082; Reid MA, 2012, RIVER RES APPL, V28, P827, DOI 10.1002/rra.1491; Sabo JL, 2010, SCIENCE, V330, P965, DOI 10.1126/science.1196005; Sabo JL, 2009, ANN NY ACAD SCI, V1162, P187, DOI 10.1111/j.1749-6632.2009.04445.x; Schindler DE, 1997, SCIENCE, V277, P248, DOI 10.1126/science.277.5323.248; Schneider DW, 1997, OECOLOGIA, V110, P567, DOI 10.1007/s004420050197; SCHOENER TW, 1989, ECOLOGY, V70, P1559, DOI 10.2307/1938088; Spencer M, 1996, OIKOS, V75, P419, DOI 10.2307/3545882; Stein JL, 2002, LANDSCAPE URBAN PLAN, V60, P1, DOI 10.1016/S0169-2046(02)00048-8; Stein JL, 2009, ECOHYDROLOGICAL CLAS; Stenroth P, 2008, OECOLOGIA, V156, P681, DOI 10.1007/s00442-008-1019-9; Sterner RW, 1997, ECOLOGY, V78, P2258, DOI 10.1890/0012-9658(1997)078[2258:TEOFCL]2.0.CO;2; Takimoto G, ECOL RES IN PRESS; Takimoto G, 2012, ECOL RES, V27, P481, DOI 10.1007/s11284-012-0929-5; Takimoto G, 2008, ECOLOGY, V89, P3001, DOI 10.1890/07-1990.1; Thompson RM, 2005, OIKOS, V108, P137, DOI 10.1111/j.0030-1299.2005.11600.x; Townsend CR, 1998, ECOL LETT, V1, P200; Townsend SA, 2008, FRESHWATER BIOL, V53, P509, DOI 10.1111/j.1365-2427.2007.01916.x; Townsend SA, 2011, J N AM BENTHOL SOC, V30, P603, DOI 10.1899/10-066.1; Van de Koppel J, 2005, ECOSYSTEMS, V8, P801, DOI 10.1007/s10021-005-0134-2; Vander Zanden MJ, 2007, OIKOS, V116, P1378, DOI 10.1111/j.2007.0030-1299.16036.x; Vander Zanden MJ, 1999, AM NAT, V154, P406, DOI 10.1086/303250; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Walters AW, 2008, ECOLOGY, V89, P3261, DOI 10.1890/08-0273.1; Ward DP, 2013, ECOHYDROLOGY, V6, P312, DOI 10.1002/eco.1270; Warfe DM, 2011, FRESHWATER BIOL, V56, P2169, DOI 10.1111/j.1365-2427.2011.02660.x; Warfe DM, 2013, FRESHWATER BIOL, V58, P292, DOI 10.1111/fwb.12058; Warren PH, 1996, OIKOS, V75, P407, DOI 10.2307/3545881; Webster IT, 2005, MAR FRESHWATER RES, V56, P303, DOI 10.1071/MF04083; Williams AJ, 2006, HYDROBIOLOGIA, V569, P493, DOI 10.1007/s10750-006-0151-y; WINEMILLER KO, 1990, ECOL MONOGR, V60, P331, DOI 10.2307/1943061; Winemiller KO, 1998, J FISH BIOL, V53, P267, DOI 10.1111/j.1095-8649.1998.tb01032.x	86	33	34	0	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66240	10.1371/journal.pone.0066240	http://dx.doi.org/10.1371/journal.pone.0066240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776641	Green Published, gold			2022-12-25	WOS:000320322400092
J	Chiu, TY; Chen, PH; Chang, CL; Yang, DM				Chiu, Tai-Yu; Chen, Po-Hsun; Chang, Cha-Ling; Yang, De-Ming			Live-Cell Dynamic Sensing of Cd2+ with a FRET-Based Indicator	PLOS ONE			English	Article							DIVALENT METAL TRANSPORTER-1; FLUORESCENT INDICATORS; CADMIUM RESISTANCE; IONIC MIMICRY; MERR FAMILY; MECHANISMS; CYTOTOXICITY; TOXICITY; CHLORIDE; MUSCLE	Cd2+ causes damages to several human tissues. Although the toxicological and carcinogenetic mechanisms of Cd2+ have been previously established, some basic questions on this toxicant remain unclear. In this study, we constructed Met-cad 1.57, a new fluorescent resonance energy transfer (FRET)-based Cd2+ indicator, which contains a portion of a Cd2+-binding protein (CadR) obtained from Pseudomonas putida as the Cd2+ sensing key. We produced a human embryonic kidney cell line HEK-MCD157 which stably expresses the Met-cad 1.57 for further investigations. Both fluorescence spectroscopy and FRET microscopic ratio imaging were used to monitor the Cd2+ concentration within the living HEK-MCD157 cells. The dissociation constant of Met-cad 1.57 was approximately 271 nM. The function of Ca2+ channels as a potential Cd2+ entry gateway was further confirmed in the HEK-MCD157 cells. The organelle-targeted property of the protein-based Cd2+ indicator directly reveals the nucleus accumulation phenomena. In summary, a human kidney cell line that stably expresses the FRET-based Cd2+ indicator Met-cad 1.57 was constructed for reliable and convenient investigations to determine the Cd2+ concentration within living cells, including the identification of the entry pathway of Cd2+ and sub-cellular sequestration.	[Chiu, Tai-Yu; Chen, Po-Hsun; Chang, Cha-Ling; Yang, De-Ming] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chiu, Tai-Yu; Chen, Po-Hsun; Yang, De-Ming] Sch Med Technol & Engn, Inst Biophoton, Taipei, Taiwan; [Yang, De-Ming] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Yang, DM (corresponding author), Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan.	yang.deming@gmail.com	Yang, De-Ming/AAW-9886-2020	Yang, De-Ming/0000-0002-6923-4855; Dague, Etienne/0000-0003-3290-9166	National Science Council of the Republic of China, Taiwan [NSC-100-2320-B-075-004]; Taipei Veterans General Hospital [V100C1-032, V101C1-072, V102C-163]; UTVGH (University System of Taiwan) [VGHUST100-G1-1-2, VGHUST102-G7-1-2E]; National Yang-Ming University (Ministry of Education, Aim for the Top University Plan); Biophotonics and Molecular Imaging Research Center; UTVGH (Taipei Veterans General Hospital) [VGHUST100-G1-1-2, VGHUST102-G7-1-2E]	National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); UTVGH (University System of Taiwan); National Yang-Ming University (Ministry of Education, Aim for the Top University Plan)(Ministry of Education, Taiwan); Biophotonics and Molecular Imaging Research Center; UTVGH (Taipei Veterans General Hospital)(Taipei Veterans General Hospital)	This work is supported by grants from the National Science Council of the Republic of China, Taiwan (Grants NSC-100-2320-B-075-004), Taipei Veterans General Hospital (V100C1-032, V101C1-072, V102C-163), the Joint Projects of UTVGH (University System of Taiwan together with Taipei Veterans General Hospital: VGHUST100-G1-1-2, VGHUST102-G7-1-2E), and National Yang-Ming University (Ministry of Education, Aim for the Top University Plan) and Biophotonics and Molecular Imaging Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry (ATSDR), 2005, CERCLA PRIOR LIST HA; Bannon DI, 2002, BIOCHEM BIOPH RES CO, V295, P978, DOI 10.1016/S0006-291X(02)00756-8; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Bressler JP, 2004, ANN NY ACAD SCI, V1012, P142, DOI 10.1196/annals.1306.011; Bridges CC, 2005, TOXICOL APPL PHARM, V204, P274, DOI 10.1016/j.taap.2004.09.007; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Cheng TY, 2008, J AM CHEM SOC, V130, P16160, DOI 10.1021/ja806928n; Chiu TY, 2012, TOXICOL SCI, V126, P436, DOI 10.1093/toxsci/kfs007; CLARKSON TW, 1993, ANNU REV PHARMACOL, V33, P545, DOI 10.1146/annurev.pa.33.040193.002553; Dalton TP, 2005, P NATL ACAD SCI USA, V102, P3401, DOI 10.1073/pnas.0406085102; Dean KM, 2012, BBA-MOL CELL RES, V1823, P1406, DOI 10.1016/j.bbamcr.2012.04.001; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; FUKUDA J, 1977, SCIENCE, V196, P309, DOI 10.1126/science.847472; Goyer RA, 2008, CASARETT DOULLS TOXI; He L, 2009, TOXICOL APPL PHARM, V238, P250, DOI 10.1016/j.taap.2009.02.017; Joseph P, 2009, TOXICOL APPL PHARM, V238, P272, DOI 10.1016/j.taap.2009.01.011; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Lee SW, 2001, APPL ENVIRON MICROB, V67, P1437, DOI 10.1128/AEM.67.4.1437-1444.2001; Leslie EM, 2006, MOL PHARMACOL, V69, P629, DOI 10.1124/mol.105.014241; Li IT, 2006, BIOTECHNOL LETT, V28, P1971, DOI 10.1007/s10529-006-9193-5; LIN CJ, 1995, TOXICOL APPL PHARM, V133, P20, DOI 10.1006/taap.1995.1122; Martineau C, 2010, TOXICOL LETT, V199, P357, DOI 10.1016/j.toxlet.2010.09.019; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Moulis JM, 2010, BIOMETALS, V23, P877, DOI 10.1007/s10534-010-9336-y; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nishimura Y, 2006, TOXICOL IN VITRO, V20, P211, DOI 10.1016/j.tiv.2005.06.006; Peng XJ, 2007, J AM CHEM SOC, V129, P1500, DOI 10.1021/ja0643319; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Taki M, 2008, J AM CHEM SOC, V130, P12564, DOI 10.1021/ja803429z; Thevenod F, 2010, BIOMETALS, V23, P857, DOI 10.1007/s10534-010-9309-1; Tvermoes BE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020542; Vesey DA, 2010, TOXICOL LETT, V198, P13, DOI 10.1016/j.toxlet.2010.05.004; Vinkenborg JL, 2010, CURR OPIN CHEM BIOL, V14, P231, DOI 10.1016/j.cbpa.2009.11.022; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; Wegner SV, 2010, J AM CHEM SOC, V132, P2567, DOI 10.1021/ja9097324; Weidner WJ, 1997, ARCH TOXICOL, V71, P455, DOI 10.1007/s002040050411	39	28	28	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65853	10.1371/journal.pone.0065853	http://dx.doi.org/10.1371/journal.pone.0065853			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776557	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400073
J	Cunningham, CJ; Pitschi, V; Anderson, P; Barry, DA; Patterson, C; Peshkur, TA				Cunningham, Colin J.; Pitschi, Vanessa; Anderson, Peter; Barry, D. A.; Patterson, Colin; Peshkur, Tanya A.			Field Application of a Rapid Spectrophotometric Method for Determination of Persulfate in Soil	PLOS ONE			English	Article							OXIDATION	Remediation of hydrocarbon contaminated soils can be performed both in situ and ex situ using chemical oxidants such as sodium persulfate. Standard methods for quantifying persulfate require either centrifugation or prolonged settling times. An optimized soil extraction procedure was developed for persulfate involving simple water extraction using a modified disposable syringe. This allows considerable saving of time and removes the need for centrifugation. The extraction time was reduced to only 5 min compared to 15 min for the standard approach. A comparison of the two approaches demonstrated that each provides comparable results. Comparisons were made using high (93 g kg(-1) soil) and low (9.3 g kg(-1) soil) additions of sodium persulfate to a petroleum hydrocarbon-contaminated soil, as well as sand spiked with diesel. Recoveries of 95 +/- 1% and 96 +/- 10% were observed with the higher application rate in the contaminated soil and spiked sand, respectively. Corresponding recoveries of 86 +/- 5% and 117 +/- 19% were measured for the lower application rate. Results were obtained in only 25 min and the method is well suited to batch analyses. In addition, it is suitable for application in a small field laboratory or even a mobile, vehicle-based system, as it requires minimal equipment and reagents.	[Cunningham, Colin J.; Anderson, Peter; Patterson, Colin; Peshkur, Tanya A.] Univ Strathclyde, Fac Engn, Scottish Environm Technol Network, Glasgow, Lanark, Scotland; [Pitschi, Vanessa; Barry, D. A.] Ecole Polytech Fed Lausanne, Fac Environm Nat Architectural & Construit ENAC, Inst Sci & Technol Environm, Lab Technol Ecol, Lausanne, Switzerland	University of Strathclyde; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Cunningham, CJ (corresponding author), Univ Strathclyde, Fac Engn, Scottish Environm Technol Network, Glasgow, Lanark, Scotland.	colin.cunningham@strath.ac.uk	Barry, D. Andrew/C-6077-2008	Barry, D. Andrew/0000-0002-8621-0425	Contaminated Land Assessment and Remediation Research Centre (CLARRC)	Contaminated Land Assessment and Remediation Research Centre (CLARRC)	The work was funded by Contaminated Land Assessment and Remediation Research Centre (CLARRC). The funders undertook the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Grimshaw H.M., 1989, CHEM ANAL ECOLOGICAL, V2nd, P81; Huang KC, 2002, CHEMOSPHERE, V49, P413, DOI 10.1016/S0045-6535(02)00330-2; Ko S, 2012, J ENVIRON MANAGE, V108, P42, DOI 10.1016/j.jenvman.2012.04.034; Liang CJ, 2008, WATER RES, V42, P4091, DOI 10.1016/j.watres.2008.06.022; Liang CJ, 2008, CHEMOSPHERE, V73, P1540, DOI 10.1016/j.chemosphere.2008.08.043; Liang CJ, 2003, SOIL SEDIMENT CONTAM, V12, P207, DOI 10.1080/713610970; Rivas FJ, 2006, J HAZARD MATER, V138, P234, DOI 10.1016/j.jhazmat.2006.07.048; Schumb WC, 1940, J AM CHEM SOC, V62, P3416, DOI 10.1021/ja01869a036; SHIUNDU PM, 1990, CAN J CHEM, V68, P1750, DOI 10.1139/v90-272; Walker A, 2000, TECHN PRAT, P173; Yazgan MS, 2005, CHEMOSPHERE, V60, P1325, DOI 10.1016/j.chemosphere.2005.01.075; Yen CH, 2011, J HAZARD MATER, V186, P2097, DOI 10.1016/j.jhazmat.2010.12.129	12	27	27	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65106	10.1371/journal.pone.0065106	http://dx.doi.org/10.1371/journal.pone.0065106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776446	gold, Green Published, Green Submitted			2022-12-25	WOS:000320755400010
J	Hutchison, MR				Hutchison, Michele R.			Mice with a Conditional Deletion of the Neurotrophin Receptor TrkB Are Dwarfed, and Are Similar to Mice with a MAPK14 Deletion	PLOS ONE			English	Article							SRY-RELATED GENE; LONGITUDINAL BONE-GROWTH; AUTOSOMAL SEX REVERSAL; ATDC5 IN-VITRO; CHONDROCYTE DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; OSTEOBLAST DIFFERENTIATION; CAMPOMELIC DYSPLASIA; TARGETED DISRUPTION; KINASE PATHWAYS	Long bone growth results from ordered chondrocyte development within the cartilagenous growth plate. Chondrocytes are recruited from a resting pool to proliferate along the long axis of the bone, until various signals trigger differentiation and hypertrophy. We have shown previously that the neurotrophin receptor TrkB is expressed in growth plate chondrocytes, where the tyrosine kinase receptor regulates the pace of hypertrophic differentiation by modulating the activities of ERK and p38 MAP kinases. To investigate the physiological relevance of TrkB to bone growth in vivo, we generated mice with a targeted disruption of the receptor, and compared them to mice targeted for MAPK14, the gene for p38 alpha. The TrkB mutant and p38 alpha mutant mice showed a similar degree of dwarfism and delayed hypertrophic differentiation. To extend these findings, we showed that both the TrkB and p38 alpha mutant mice have altered expression of Runx2 and Sox9, two key transcription factors required for skeletogenesis. The data provides in vivo evidence for the role of TrkB in bone growth, supports the role of p38 downstream of TrkB, and suggests that Runx2 and Sox9 expression is regulated by this pathway at the growth plate.	Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Hutchison, MR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.	Michele.hutchison@utsw.edu			National Institutes of Health [K08DK073447, R03DK089151]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK089151, K08DK073447] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health Grants K08DK073447 and R03DK089151 to MRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; ALLEN SJ, 1994, NEUROSCIENCE, V60, P825, DOI 10.1016/0306-4522(94)90507-X; ARMANINI MP, 1995, EUR J NEUROSCI, V7, P1403, DOI 10.1111/j.1460-9568.1995.tb01132.x; Asaumi K, 2000, BONE, V26, P625, DOI 10.1016/S8756-3282(00)00281-7; Baxter GT, 1997, J NEUROSCI, V17, P2683; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eide FF, 1996, J NEUROSCI, V16, P3123; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; HUNZIKER EB, 1994, MICROSC RES TECHNIQ, V28, P505, DOI 10.1002/jemt.1070280606; Hutchison MR, 2010, MOL ENDOCRINOL, V24, P193, DOI 10.1210/me.2009-0228; Hutchison MR, 2012, MOL ENDOCRINOL; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Kajiya M, 2008, J BIOL CHEM, V283, P16259, DOI 10.1074/jbc.M800668200; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kurihara H, 2003, J PERIODONTOL, V74, P76, DOI 10.1902/jop.2003.74.1.76; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Luikart BW, 2003, NEUROSCIENCE, V117, P847, DOI 10.1016/S0306-4522(02)00719-4; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; NILSSON A, 1994, EUR J CLIN NUTR, V48, pS150; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pinski J, 2002, CANCER RES, V62, P986; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shukunami C, 1997, J BONE MINER RES, V12, P1174, DOI 10.1359/jbmr.1997.12.8.1174; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Yamashiro T, 2001, BONE, V28, P404, DOI 10.1016/S8756-3282(01)00405-7; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Yoshimura S, 2010, MULT SCLER J, V16, P1178, DOI 10.1177/1352458510375706; Zhang R, 2006, P NATL ACAD SCI USA, V103, P365, DOI 10.1073/pnas.0507979103; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	47	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66206	10.1371/journal.pone.0066206	http://dx.doi.org/10.1371/journal.pone.0066206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776632	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400121
J	Schneider, D; Arp, G; Reimer, A; Reitner, J; Daniel, R				Schneider, Dominik; Arp, Gernot; Reimer, Andreas; Reitner, Joachim; Daniel, Rolf			Phylogenetic Analysis of a Microbialite-Forming Microbial Mat from a Hypersaline Lake of the Kiritimati Atoll, Central Pacific	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIUM; SP-NOV.; GEN. NOV.; EUKARYOTIC DIVERSITY; HYDROTHERMAL VENT; CHRISTMAS ISLAND; ARCHAEA; COMMUNITY; STROMATOLITES; COMPLEXITY	On the Kiritimati atoll, several lakes exhibit microbial mat-formation under different hydrochemical conditions. Some of these lakes trigger microbialite formation such as Lake 21, which is an evaporitic, hypersaline lake (salinity of approximately 170%). Lake 21 is completely covered with a thick multilayered microbial mat. This mat is associated with the formation of decimeter-thick highly porous microbialites, which are composed of aragonite and gypsum crystals. We assessed the bacterial and archaeal community composition and its alteration along the vertical stratification by large-scale analysis of 16S rRNA gene sequences of the nine different mat layers. The surface layers are dominated by aerobic, phototrophic, and halotolerant microbes. The bacterial community of these layers harbored Cyanobacteria (Halothece cluster), which were accompanied with known phototrophic members of the Bacteroidetes and Alphaproteobacteria. In deeper anaerobic layers more diverse communities than in the upper layers were present. The deeper layers were dominated by Spirochaetes, sulfate-reducing bacteria (Deltaproteobacteria), Chloroflexi (Anaerolineae and Caldilineae), purple non-sulfur bacteria (Alphaproteobacteria), purple sulfur bacteria (Chromatiales), anaerobic Bacteroidetes (Marinilabiacae), Nitrospirae (OPB95), Planctomycetes and several candidate divisions. The archaeal community, including numerous uncultured taxonomic lineages, generally changed from Euryarchaeota (mainly Halobacteria and Thermoplasmata) to uncultured members of the Thaumarchaeota (mainly Marine Benthic Group B) with increasing depth.	[Schneider, Dominik; Daniel, Rolf] Univ Gottingen, Dept Genom & Appl Microbiol, Inst Microbiol & Genet, D-37073 Gottingen, Germany; [Schneider, Dominik; Daniel, Rolf] Univ Gottingen, Gottingen Genom Lab, Inst Microbiol & Genet, D-37073 Gottingen, Germany; [Arp, Gernot; Reimer, Andreas; Reitner, Joachim] Univ Gottingen, Geosci Ctr, D-37073 Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Daniel, R (corresponding author), Univ Gottingen, Dept Genom & Appl Microbiol, Inst Microbiol & Genet, D-37073 Gottingen, Germany.	rdaniel@gwdg.de	Daniel, Rolf/AAQ-5933-2021	Daniel, Rolf/0000-0002-8646-7925; Schneider, Dominik/0000-0002-1134-5026	Deutsche Forschungsgemeinschaft [DFG-FOR 571, DA 374/5-2, AR335/5-3]; Courant Center Geobiology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Courant Center Geobiology	This study has been supported by the Deutsche Forschungsgemeinschaft (DFG-FOR 571 "Geobiology of Organo- and Biofilms"; DA 374/5-2, AR335/5-3, publication 61) and the Courant Center Geobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfreider A, 2002, SYST APPL MICROBIOL, V25, P232, DOI 10.1078/0723-2020-00111; Allen MA, 2009, GEOBIOLOGY, V7, P82, DOI 10.1111/j.1472-4669.2008.00187.x; Allwood AC, 2006, NATURE, V441, P714, DOI 10.1038/nature04764; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anton Josefa, 2008, Saline Syst, V4, P15, DOI 10.1186/1746-1448-4-15; Arp G, 2003, J SEDIMENT RES, V73, P105, DOI 10.1306/071002730105; Arp G, 2001, FACIES, V44, P1, DOI 10.1007/BF02668163; Arp G, 2012, GEOMICROBIOL J, V29, P29, DOI 10.1080/01490451.2010.521436; Atanasova NS, 2012, ENVIRON MICROBIOL, V14, P426, DOI 10.1111/j.1462-2920.2011.02603.x; Bardavid RE, 2012, EXTREMOPHILES, V16, P567, DOI 10.1007/s00792-012-0455-y; Baumgartner LK, 2006, SEDIMENT GEOL, V185, P131, DOI 10.1016/j.sedgeo.2005.12.008; Bebout BM, 2002, ASTROBIOLOGY, V2, P383, DOI 10.1089/153110702762470491; Blumenberg M, 2013, ORG GEOCHEM, V55, P55, DOI 10.1016/j.orggeochem.2012.11.004; Bontognali TRR, 2012, P NATL ACAD SCI USA, V109, P15146, DOI 10.1073/pnas.1207491109; Breitbart M, 2009, ENVIRON MICROBIOL, V11, P16, DOI 10.1111/j.1462-2920.2008.01725.x; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Buhring SI, 2009, GEOBIOLOGY, V7, P308, DOI 10.1111/j.1472-4669.2009.00198.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cohen Y, 1984, MICROBIAL MATS STROM, P498; Daffonchio D, 2006, NATURE, V440, P203, DOI 10.1038/nature04418; DeLong EE, 2001, SYST BIOL, V50, P470, DOI 10.1080/106351501750435040; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dupraz C, 2005, TRENDS MICROBIOL, V13, P429, DOI 10.1016/j.tim.2005.07.008; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Feazel LM, 2008, APPL ENVIRON MICROB, V74, P329, DOI 10.1128/AEM.01448-07; Ferrer M, 2011, MICROB ECOL, V62, P824, DOI 10.1007/s00248-011-9903-y; Gantner S, 2011, J MICROBIOL METH, V84, P12, DOI 10.1016/j.mimet.2010.10.001; Garcia-Pichel F, 1998, ARCH MICROBIOL, V169, P469, DOI 10.1007/s002030050599; Garrity GM, 2005, GAMMAPROTEOBACTERI B, P1006; Garrity GM, 2001, ARCHAEA DEEPLY BRANC, P721; Garrity GM, 2005, ALPHA BETA DELTA E C, P1388; Goh F, 2009, ISME J, V3, P383, DOI 10.1038/ismej.2008.114; Harris JK, 2013, ISME J, V7, P50, DOI 10.1038/ismej.2012.79; HIRSCH P, 1989, SYST APPL MICROBIOL, V11, P291; Hoehler TM, 2001, NATURE, V412, P324, DOI 10.1038/35085554; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Isenbarger TA, 2008, APPL ENVIRON MICROB, V74, P840, DOI 10.1128/AEM.01933-07; Jahnke LL, 2008, GEOBIOLOGY, V6, P394, DOI 10.1111/j.1472-4669.2008.00165.x; Jakobsen TF, 2006, INT J SYST EVOL MICR, V56, P2063, DOI 10.1099/ijs.0.64323-0; Kempe S., 1990, FACETS MODERN BIOGEO, P255, DOI DOI 10.1007/978-3-642-73978-1_21; Knittel K, 2005, APPL ENVIRON MICROB, V71, P467, DOI 10.1128/AEM.71.1.467-479.2005; Krekeler D, 1997, ARCH MICROBIOL, V167, P369, DOI 10.1007/s002030050457; KREKELER D, 1995, FEMS MICROBIOL ECOL, V17, P271; Kunin Victor, 2008, Mol Syst Biol, V4, P198, DOI 10.1038/msb.2008.35; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Lloyd KG, 2013, NATURE, V496, P215, DOI 10.1038/nature12033; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Miroshnichenko ML, 2010, INT J SYST EVOL MICR, V60, P2120, DOI 10.1099/ijs.0.016667-0; Miroshnichenko ML, 2003, INT J SYST EVOL MICR, V53, P323, DOI 10.1099/ijs.0.02390-0; Mobberley JM, 2012, ENVIRON MICROBIOL, V14, P82, DOI 10.1111/j.1462-2920.2011.02509.x; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; Myshrall KL, 2010, GEOBIOLOGY, V8, P337, DOI 10.1111/j.1472-4669.2010.00245.x; Papineau D, 2005, APPL ENVIRON MICROB, V71, P4822, DOI 10.1128/AEM.71.8.4822-4832.2005; Parkhurst D.L., 1999, 994259 US GEOL SURV, VVolume 312, P99; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pynaert K, 2003, APPL ENVIRON MICROB, V69, P3626, DOI 10.1128/AEM.69.6.3626-3635.2003; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Robertson CE, 2009, APPL ENVIRON MICROB, V75, P1801, DOI 10.1128/AEM.01811-08; Saenger Casey, 2006, Saline Syst, V2, P8, DOI 10.1186/1746-1448-2-8; Sahl JW, 2008, APPL ENVIRON MICROB, V74, P6444, DOI 10.1128/AEM.00879-08; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Seckbach J., 2010, MICROBIAL MATS MODER, P606; Sorensen KB, 2005, APPL ENVIRON MICROB, V71, P7352, DOI 10.1128/AEM.71.11.7352-7365.2005; Spear JR, 2003, BIOL BULL-US, V204, P168, DOI 10.2307/1543553; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P2657, DOI 10.1128/AEM.69.5.2657-2663.2003; Sun H, 2010, STAND GENOMIC SCI, V3, P276, DOI 10.4056/sigs.1243258; Takai K, 1999, GENETICS, V152, P1285; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; Trichet J, 2001, SEDIMENT GEOL, V140, P177, DOI 10.1016/S0037-0738(00)00177-9; Trichet J., 1995, NONBIOLOGICALLY SUPP, P203; Turova T P, 2002, Mikrobiologiia, V71, P230; Vaisman N, 2009, INT J SYST EVOL MICR, V59, P2571, DOI 10.1099/ijs.0.010892-0; Van Kranendonk MJ, 2008, PRECAMBRIAN RES, V167, P93, DOI 10.1016/j.precamres.2008.07.003; VANGEMERDEN H, 1993, MAR GEOL, V113, P3, DOI 10.1016/0025-3227(93)90146-M; Vetriani C, 1999, APPL ENVIRON MICROB, V65, P4375; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Woodroffe CD, 1998, CORAL REEFS, V17, P235, DOI 10.1007/s003380050124; Yamada T, 2006, INT J SYST EVOL MICR, V56, P1331, DOI 10.1099/ijs.0.64169-0; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108	84	80	82	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66662	10.1371/journal.pone.0066662	http://dx.doi.org/10.1371/journal.pone.0066662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762495	gold, Green Submitted, Green Published			2022-12-25	WOS:000320440500068
J	Cavassani, KA; Moreira, AP; Habiel, D; Ito, T; Coelho, AL; Allen, RM; Hu, B; Raphelson, J; Carson, WF; Schaller, MA; Lukacs, NW; Omary, MB; Hogaboam, CM; Kunkel, SL				Cavassani, Karen A.; Moreira, Ana Paula; Habiel, David; Ito, Toshihiro; Coelho, Ana Lucia; Allen, Ron M.; Hu, Bin; Raphelson, Janna; Carson, William F.; Schaller, Matthew A.; Lukacs, Nicholas W.; Omary, M. Bishr; Hogaboam, Cory M.; Kunkel, Steven L.			Toll Like Receptor 3 Plays a Critical Role in the Progression and Severity of Acetaminophen-Induced Hepatotoxicity	PLOS ONE			English	Article							INDUCED LIVER-INJURY; NECROSIS-FACTOR-ALPHA; TERMINAL KINASE; SUBCELLULAR-LOCALIZATION; EXPRESSION; TLR3; ACTIVATION; CELLS; MICE; RNA	Toll-like receptor (TLR) activation has been implicated in acetaminophen (APAP)-induced hepatotoxicity. Herein, we hypothesize that TLR3 activation significantly contributed to APAP-induced liver injury. In fasted wildtype (WT) mice, APAP caused significant cellular necrosis, edema, and inflammation in the liver, and the de novo expression and activation of TLR3 was found to be necessary for APAP-induced liver failure. Specifically, liver tissues from similarly fasted TLR3-deficient (tlr3(-/-)) mice exhibited significantly less histological and biochemical evidence of injury after APAP challenge. Similar protective effects were observed in WT mice in which TLR3 was targeted through immunoneutralization at 3 h post-APAP challenge. Among three important death ligands (i.e. TNF alpha, TRAIL, and FASL) known to promote hepatocyte death after APAP challenge, TNF alpha was the only ligand that was significantly reduced in APAP-challenged tlr3(-/-) mice compared with APAP-challenged WT controls. In vivo studies demonstrated that TLR3 activation contributed to TNFa production in the liver presumably via F4/80(+) and CD11c(+) immune cells. In vitro studies indicated that there was cooperation between TNF alpha and TLR3 in the activation of JNK signaling in isolated and cultured liver epithelial cells (i.e. nMuLi). Moreover, TLR3 activation enhanced the expression of phosphorylated JNK in APAP injured livers. Thus, the current study demonstrates that TLR3 activation contributes to APAP-induced hepatotoxicity.	[Cavassani, Karen A.; Moreira, Ana Paula; Habiel, David; Ito, Toshihiro; Coelho, Ana Lucia; Allen, Ron M.; Raphelson, Janna; Carson, William F.; Schaller, Matthew A.; Lukacs, Nicholas W.; Hogaboam, Cory M.; Kunkel, Steven L.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Hu, Bin] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Omary, M. Bishr] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cavassani, KA (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	kcavassa@med.umich.edu; slkunkel@med.umich.edu	Hogaboam, Cory M./AAI-1433-2021; Schaller, Matthew/AAL-7640-2020; hogaboam, cory/M-3578-2014; Lukacs, Nicholas W/ABH-5583-2020	Hogaboam, Cory M./0000-0003-3366-4850; Carson, William F/0000-0001-9459-3924; Omary, Bishr/0000-0002-8624-2347	National Institutes of Health [HL089216, HL31237, HL92845]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031237, R33HL092845, R01HL089216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047918, R01DK052951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported through grant support from the National Institutes of Health (HL089216, HL31237, HL92845). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begon E, 2007, EUR J DERMATOL, V17, P497; Bernard J.J., 2012, NAT MED; Blazka ME, 1996, RES COMMUN MOL PATH, V92, P259; BLAZKA ME, 1995, TOXICOL APPL PHARM, V133, P43, DOI 10.1006/taap.1995.1125; Bone-Larson CL, 2001, J IMMUNOL, V167, P7077, DOI 10.4049/jimmunol.167.12.7077; Bourdi M, 2011, CHEM RES TOXICOL, V24, P794, DOI 10.1021/tx200143x; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Cho WG, 2009, P NATL ACAD SCI USA, V106, P7137, DOI 10.1073/pnas.0812317106; Czaja MJ, 2003, AM J PHYSIOL-GASTR L, V284, pG875, DOI 10.1152/ajpgi.00549.2002; DAHLBERG JE, 2007, SCI STKE, pPE25; Farina C, 2005, J NEUROIMMUNOL, V159, P12, DOI 10.1016/j.jneuroim.2004.09.009; Ghaffari AA, 2011, HEPATOLOGY, V53, P2042, DOI 10.1002/hep.24316; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Henderson NC, 2007, GUT, V56, P982, DOI 10.1136/gut.2006.104372; Hogaboam CM, 2000, AM J PATHOL, V156, P1245, DOI 10.1016/S0002-9440(10)64995-4; Hu B, 2008, AM J PHYSIOL-GASTR L, V295, pG45, DOI 10.1152/ajpgi.00024.2008; Huys L, 2009, J EXP MED, V206, P1873, DOI 10.1084/jem.20090213; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Ishida Y, 2004, J LEUKOCYTE BIOL, V75, P59, DOI 10.1189/jlb.0403152; Jiang W, 2005, P NATL ACAD SCI USA, V102, P17077, DOI 10.1073/pnas.0504570102; Kaplowitz N, 2004, HEPATOLOGY, V40, P23, DOI 10.1002/hep.20312; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lee H, 2006, BIOCHEM BIOPH RES CO, V350, P742, DOI 10.1016/j.bbrc.2006.09.108; Lee WM, 2007, HEPATOLOGY, V46, P966, DOI 10.1002/hep.21926; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Liu ZX, 2006, HEPATOLOGY, V43, P1220, DOI 10.1002/hep.21175; Liu ZX, 2004, GASTROENTEROLOGY, V127, P1760, DOI 10.1053/j.gastro.2004.08.053; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Matsumura T, 2000, J INTERF CYTOK RES, V20, P915, DOI 10.1089/10799900050163299; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755; Mencin A, 2009, GUT, V58, P704, DOI 10.1136/gut.2008.156307; Murray LA, 2008, AM J RESP CRIT CARE, V178, P1227, DOI 10.1164/rccm.200807-1020OC; Neff SB, 2003, EXP MOL PATHOL, V75, P187, DOI 10.1016/S0014-4800(03)00096-0; Papa S, 2009, BIOL CHEM, V390, P965, DOI 10.1515/BC.2009.111; Patole PS, 2006, NEPHROL DIAL TRANSPL, V21, P3062, DOI 10.1093/ndt/gfl336; Patole PS, 2005, J AM SOC NEPHROL, V16, P1326, DOI 10.1681/ASN.2004100820; Rudd BD, 2005, J VIROL, V79, P3350, DOI 10.1128/JVI.79.6.3350-3357.2005; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Simpson KJ, 2000, J PATHOL, V190, P489; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Wullaert A, 2006, BIOCHEM PHARMACOL, V72, P1090, DOI 10.1016/j.bcp.2006.07.003; Yin S, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/750904; Yohe HC, 2006, AM J PHYSIOL-GASTR L, V290, pG1269, DOI 10.1152/ajpgi.00239.2005; Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004	53	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65899	10.1371/journal.pone.0065899	http://dx.doi.org/10.1371/journal.pone.0065899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762449	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800081
J	Klenke, C; Widera, D; Engelen, T; Muller, J; Noll, T; Niehaus, K; Schmitz, ML; Kaltschmidt, B; Kaltschmidt, C				Klenke, Christin; Widera, Darius; Engelen, Thomas; Mueller, Janine; Noll, Thomas; Niehaus, Karsten; Schmitz, M. Lienhard; Kaltschmidt, Barbara; Kaltschmidt, Christian			Hsc70 Is a Novel Interactor of NF-kappaB p65 in Living Hippocampal Neurons	PLOS ONE			English	Article							RETROGRADE TRANSPORT; B ACTIVITY; IN-VIVO; EXPRESSION; COMPLEX; HSP90; BRAIN; HSP70; ACTIVATION; PLASTICITY	Signaling via NF-kappa B in neurons depends on complex formation with interactors such as dynein/dynactin motor complex and can be triggered by synaptic activation. However, so far a detailed interaction map for the neuronal NF-kappa B is missing. In this study we used mass spectrometry to identify novel interactors of NF-kappa B p65 within the brain. Hsc70 was identified as a novel neuronal interactor of NF-kappa B p65. In HEK293 cells, a direct physical interaction was shown by co-immunoprecipitation and verified via in situ proximity ligation in healthy rat neurons. Pharmacological blockade of Hsc70 by deoxyspergualin (DSG) strongly decreased nuclear translocation of NF-kappa B p65 and transcriptional activity shown by reporter gene assays in neurons after stimulation with glutamate. In addition, knock down of Hsc70 via siRNA significantly reduced neuronal NF-kappa B activity. Taken together these data provide evidence for Hsc70 as a novel neuronal interactor of NF-kappa B p65.	[Klenke, Christin; Widera, Darius; Engelen, Thomas; Mueller, Janine; Niehaus, Karsten; Kaltschmidt, Barbara; Kaltschmidt, Christian] Univ Bielefeld, D-33615 Bielefeld, Germany; [Noll, Thomas] Univ Bielefeld, Cell Culture Technol, D-33615 Bielefeld, Germany; [Schmitz, M. Lienhard] Univ Giessen, Inst Biochem, Fac Med, D-35390 Giessen, Germany	University of Bielefeld; University of Bielefeld; Justus Liebig University Giessen	Kaltschmidt, C (corresponding author), Univ Bielefeld, D-33615 Bielefeld, Germany.	c.kaltschmidt@uni-bielefeld.de	Noll, Thomas/A-3539-2012; Widera, Darius/J-4237-2012; Schmitz, M. Lienhard/D-9328-2017	Noll, Thomas/0000-0003-0748-3423; Widera, Darius/0000-0003-1686-130X; Schmitz, M. Lienhard/0000-0002-6984-7192	Deutsche Forschungsgemeinschaft (DFG); Bielefeld University Library	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bielefeld University Library	This study was supported by the grant of the Deutsche Forschungsgemeinschaft (DFG) to CK. The authors acknowledge the support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft (DFG) and the Open Access Publication Funds of Bielefeld University Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharadwaj S, 1999, MOL CELL BIOL, V19, P8033; D'Souza SM, 1998, CELL STRESS CHAPERON, V3, P188, DOI 10.1379/1466-1268(1998)003<0188:CEOHSP>2.3.CO;2; DEWAEGH S, 1989, J NEUROSCI RES, V23, P433, DOI 10.1002/jnr.490230409; Dokladny K, 2010, CELL STRESS CHAPERON, V15, P153, DOI 10.1007/s12192-009-0129-6; Fridmacher V, 2003, J NEUROSCI, V23, P9403; Galigniana MD, 2004, MOL BRAIN RES, V123, P27, DOI 10.1016/j.molbrainres.2003.12.015; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; KALTSCHMIDT C, 1993, MECH DEVELOP, V43, P135, DOI 10.1016/0925-4773(93)90031-R; KALTSCHMIDT C, 1994, MOL CELL BIOL, V14, P3981, DOI 10.1128/MCB.14.6.3981; Marcora E, 2010, HUM MOL GENET, V19, P4373, DOI 10.1093/hmg/ddq358; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Mikenberg I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000589; Morishima Y, 2001, BIOCHEMISTRY-US, V40, P1109, DOI 10.1021/bi002399+; Nadler SG, 1998, BIOCHEM BIOPH RES CO, V253, P176, DOI 10.1006/bbrc.1998.9775; Shrum CK, 2009, P NATL ACAD SCI USA, V106, P2647, DOI 10.1073/pnas.0806677106; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stetler RA, 2010, PROG NEUROBIOL, V92, P184, DOI 10.1016/j.pneurobio.2010.05.002; Sugawara A, 2009, CELL STRESS CHAPERON, V14, P133, DOI 10.1007/s12192-008-0064-y; Suzuki T, 1999, BRAIN RES, V816, P99, DOI 10.1016/S0006-8993(98)01083-X; TEPPER MA, 1995, J IMMUNOL, V155, P2427; Wellmann H, 2001, J BIOL CHEM, V276, P11821, DOI 10.1074/jbc.M009253200	25	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65280	10.1371/journal.pone.0065280	http://dx.doi.org/10.1371/journal.pone.0065280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762333	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000321094800033
J	Vickers, DAL; Chory, EJ; Harless, MC; Murthy, SK				Vickers, Dwayne A. L.; Chory, Emma J.; Harless, Megan C.; Murthy, Shashi K.			p38 Signaling and Receptor Recycling Events in a Microfluidic Endothelial Cell Adhesion Assay	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FLUID SHEAR-STRESS; SMOOTH-MUSCLE; INHIBITOR; ENDOCYTOSIS; DEPLETION; FLOW; PHOSPHORYLATION; INTERNALIZATION; STIMULATION	Adhesion-based microfluidic cell separation has proven to be very useful in applications ranging from cancer diagnostics to tissue engineering. This process involves functionalizing microchannel surfaces with a capture molecule. High specificity and purity capture can be achieved using this method. Despite these advances, little is known about the mechanisms that govern cell capture within these devices and their relationships to basic process parameters such as fluid shear stress and the presence of soluble factors. This work examines how the adhesion of human endothelial cells (ECs) is influenced by a soluble tetrapeptide, Arg-Glu-Asp-Val (REDV) and fluidic shear stress. The ability of these ECs to bind within microchannels coated with REDV is shown to be governed by shear-and soluble-factor mediated changes in p38 mitogen-activated protein kinase expression together with recycling of adhesion receptors from the endosome.	[Vickers, Dwayne A. L.; Chory, Emma J.; Harless, Megan C.; Murthy, Shashi K.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Murthy, Shashi K.] Northeastern Univ, Barnett Inst Chem & Biol Anal, Boston, MA 02115 USA	Northeastern University; Northeastern University	Murthy, SK (corresponding author), Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.	smurthy@coe.neu.edu	Vickers, Dwayne/I-5819-2012	Vickers, Dwayne/0000-0002-9218-7348; Chory, Emma/0000-0001-8541-9289	U.S. National Science Foundation [CBET-0747166]; Directorate For Engineering [0747166] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The authors gratefully acknowledge financial support from the U.S. National Science Foundation through grant CBET-0747166 (CAREER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Azenabor AA, 2011, IMMUNOBIOLOGY, V216, P1248, DOI 10.1016/j.imbio.2011.07.002; Azuma N, 2000, J VASC SURG, V32, P789, DOI 10.1067/mva.2000.107989; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BOEYNAEMS JM, 1993, EUR J PHARMACOL, V233, P13, DOI 10.1016/0014-2999(93)90343-G; BORRAS M, 1994, J STEROID BIOCHEM, V48, P325, DOI 10.1016/0960-0760(94)90072-8; Byron A, 2009, J CELL SCI, V122, P4009, DOI 10.1242/jcs.056770; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Cheng XH, 2009, LAB CHIP, V9, P1357, DOI 10.1039/b818813k; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; GEIGER RV, 1992, AM J PHYSIOL, V262, pC1411, DOI 10.1152/ajpcell.1992.262.6.C1411; Hatch A, 2011, LANGMUIR, V27, P4257, DOI 10.1021/la105016a; Hendriks BS, 2003, BIOPHYS J, V85, P2732, DOI 10.1016/S0006-3495(03)74696-7; Humphries MJ, 2003, TRENDS BIOCHEM SCI, V28, P313, DOI 10.1016/S0968-0004(03)00112-9; Jin H, 2010, BLOOD COAGUL FIBRIN, V21, P420, DOI 10.1097/MBC.0b013e328337b475; Kurata S, 2000, J BIOL CHEM, V275, P23413, DOI 10.1074/jbc.C000308200; Kwan HY, 2003, CIRC RES, V92, P286, DOI 10.1161/01.RES.0000054625.24468.08; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; MAGNUSSON S, 1993, EXP CELL RES, V205, P118, DOI 10.1006/excr.1993.1065; Manthey CL, 1998, J LEUKOCYTE BIOL, V64, P409, DOI 10.1002/jlb.64.3.409; Murthy SK, 2004, LANGMUIR, V20, P11649, DOI 10.1021/la048047b; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Okuda M, 1999, J BIOL CHEM, V274, P26803, DOI 10.1074/jbc.274.38.26803; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Plouffe BD, 2008, LAB CHIP, V8, P462, DOI 10.1039/b715707j; Plouffe BD, 2007, LANGMUIR, V23, P5050, DOI 10.1021/la0700220; Plouffe BD, 2009, FASEB J, V23, P3309, DOI 10.1096/fj.09-130260; Pratt ED, 2011, CHEM ENG SCI, V66, P1508, DOI 10.1016/j.ces.2010.09.012; Ptasinska A, 2007, FASEB J, V21, P950, DOI 10.1096/fj.06-6822com; Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4; Russom A, 2008, CLIN CHEM, V54, P891, DOI 10.1373/clinchem.2007.099150; Serge A, 2011, INTEGR BIOL-UK, V3, P675, DOI 10.1039/c0ib00121j; Shen KK, 2012, BIOCHEM PHARMACOL, V84, P784, DOI 10.1016/j.bcp.2012.05.024; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Spangler JB, 2010, P NATL ACAD SCI USA, V107, P13252, DOI 10.1073/pnas.0913476107; Stone MK, 2008, INFECT IMMUN, V76, P1115, DOI 10.1128/IAI.01300-07; Sumpio BE, 2005, J BIOL CHEM, V280, P11185, DOI 10.1074/jbc.M414631200; Surapisitchat J, 2001, P NATL ACAD SCI USA, V98, P6476, DOI 10.1073/pnas.101134098; SYMS AJ, 1985, J BIOL CHEM, V260, P455; Tandon V, 2012, BIOTECHNOLOGY ADV; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; TSAVALER L, 1986, J CELL PHYSIOL, V128, P1, DOI 10.1002/jcp.1041280102; Tzima E, 2002, EMBO J, V21, P6791, DOI 10.1093/emboj/cdf688; Wankhede SP, 2006, BIOTECHNOL PROGR, V22, P1426, DOI 10.1021/bp060127d; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020; Young EWK, 2010, LAB CHIP, V10, P143, DOI 10.1039/b913390a; Zhang BY, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494003; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	53	2	2	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65828	10.1371/journal.pone.0065828	http://dx.doi.org/10.1371/journal.pone.0065828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762436	Green Submitted, gold, Green Published			2022-12-25	WOS:000321094800077
J	Wu, AC; Morell, MK; Gilbert, RG				Wu, Alex Chi; Morell, Matthew K.; Gilbert, Robert G.			A Parameterized Model of Amylopectin Synthesis Provides Key Insights into the Synthesis of Granular Starch	PLOS ONE			English	Article							ASSISTED CARBOHYDRATE ELECTROPHORESIS; BRANCHING-ENZYME; RICE ENDOSPERM; DISPROPORTIONATING ENZYME; DEBRANCHING ENZYMES; INTERNAL STRUCTURE; FINE-STRUCTURE; ARABIDOPSIS; BIOSYNTHESIS; MUTANTS	A core set of genes involved in starch synthesis has been defined by genetic studies, but the complexity of starch biosynthesis has frustrated attempts to elucidate the precise functional roles of the enzymes encoded. The chain-length distribution (CLD) of amylopectin in cereal endosperm is modeled here on the basis that the CLD is produced by concerted actions of three enzyme types: starch synthases, branching and debranching enzymes, including their respective isoforms. The model, together with fitting to experiment, provides four key insights. (1) To generate crystalline starch, defined restrictions on particular ratios of enzymatic activities apply. (2) An independent confirmation of the conclusion, previously reached solely from genetic studies, of the absolute requirement for debranching enzyme in crystalline amylopectin synthesis. (3) The model provides a mechanistic basis for understanding how successive arrays of crystalline lamellae are formed, based on the identification of two independent types of long amylopectin chains, one type remaining in the amorphous lamella, while the other propagates into, and is integral to the formation of, an adjacent crystalline lamella. (4) The model provides a means by which a small number of key parameters defining the core enzymatic activities can be derived from the amylopectin CLD, providing the basis for focusing studies on the enzymatic requirements for generating starches of a particular structure. The modeling approach provides both a new tool to accelerate efforts to understand granular starch biosynthesis and a basis for focusing efforts to manipulate starch structure and functionality using a series of testable predictions based on a robust mechanistic framework.	[Wu, Alex Chi; Gilbert, Robert G.] Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei Province, Peoples R China; [Wu, Alex Chi; Gilbert, Robert G.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Ctr Nutr & Food Sci, Brisbane, Qld, Australia; [Morell, Matthew K.] CSIRO, Food Futures Natl Res Flagship, Canberra, ACT, Australia; [Morell, Matthew K.] CSIRO, Canberra, ACT, Australia	Huazhong University of Science & Technology; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Gilbert, RG (corresponding author), Huazhong Univ Sci & Technol, Tongji Sch Pharm, Wuhan 430074, Hubei Province, Peoples R China.	b.gilbert@uq.edu.au	Morell, Matthew/AAQ-5368-2021; Wu, Alex/C-3513-2017; Gilbert, Robert G/C-5660-2009	Morell, Matthew/0000-0003-4467-1626; Wu, Alex/0000-0002-6612-7691; Gilbert, Robert G/0000-0001-6988-114X	Australian Postgraduate Award; CSIRO Food Future Flagship Postgraduate scholarship	Australian Postgraduate Award(Australian Government); CSIRO Food Future Flagship Postgraduate scholarship	This work is supported by an Australian Postgraduate Award (http://www.innovation.gov.au/research/researchblockgrants/pages/australianpostgraduateawards.aspx) and CSIRO Food Future Flagship Postgraduate scholarship (http://www.csiro.au/Organisation-Structure/Flagships/Food-Futures-Flagship/Future-Grains-Theme.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao ZH, 2007, CARBOHYD POLYM, V67, P46, DOI 10.1016/j.carbpol.2006.04.013; ASAOKA M, 1985, AGR BIOL CHEM TOKYO, V49, P1973, DOI 10.1080/00021369.1985.10867028; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Benmoussa M, 2007, J AGR FOOD CHEM, V55, P1475, DOI 10.1021/jf062349x; BOYER CD, 1978, CARBOHYD RES, V61, P321, DOI 10.1016/S0008-6215(00)84492-4; Bresolin NS, 2006, PLANTA, V224, P20, DOI 10.1007/s00425-005-0187-7; Burton RA, 2002, PLANT J, V31, P97, DOI 10.1046/j.1365-313X.2002.01339.x; Butardo VM, 2011, J EXP BOT, V62, P4927, DOI 10.1093/jxb/err188; Colleoni C, 1999, PLANT PHYSIOL, V120, P993, DOI 10.1104/pp.120.4.993; Commuri PD, 2001, PLANT J, V25, P475, DOI 10.1046/j.1365-313x.2001.00955.x; Critchley JH, 2001, PLANT J, V26, P89, DOI 10.1046/j.1365-313x.2001.01012.x; Delatte T, 2005, PLANT J, V41, P815, DOI 10.1111/j.1365-313X.2005.02348.x; Edner C, 2007, PLANT PHYSIOL, V145, P17, DOI 10.1104/pp.107.104224; Fujita N, 2006, PLANT PHYSIOL, V140, P1070, DOI 10.1104/pp.105.071845; Fujita N, 2007, PLANT PHYSIOL, V144, P2009, DOI 10.1104/pp.107.102533; Guan HP, 1997, ARCH BIOCHEM BIOPHYS, V342, P92, DOI 10.1006/abbi.1997.0115; HIZUKURI S, 1986, CARBOHYD RES, V147, P342, DOI 10.1016/S0008-6215(00)90643-8; INOUCHI N, 1983, STARKE, V35, P371, DOI 10.1002/star.19830351102; JAMES MG, 1995, PLANT CELL, V7, P417, DOI 10.1105/tpc.7.4.417; JANE JL, 1993, CARBOHYD RES, V247, P279, DOI 10.1016/0008-6215(93)84260-D; JENKINS JPJ, 1993, STARCH-STARKE, V45, P417; Jeon JS, 2010, PLANT PHYSIOL BIOCH, V48, P383, DOI 10.1016/j.plaphy.2010.03.006; Konik-Rose C, 2007, THEOR APPL GENET, V115, P1053, DOI 10.1007/s00122-007-0631-0; Lehmann U, 2007, TRENDS FOOD SCI TECH, V18, P346, DOI 10.1016/j.tifs.2007.02.009; Li L, 2007, CARBOHYD POLYM, V67, P630, DOI 10.1016/j.carbpol.2006.08.013; Morell MK, 1998, ELECTROPHORESIS, V19, P2603, DOI 10.1002/elps.1150191507; Mouille G, 1996, PLANT CELL, V8, P1353; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; Nakamura Y, 2010, PLANT CELL PHYSIOL, V51, P776, DOI 10.1093/pcp/pcq035; Nielsen TH, 2002, J BIOL CHEM, V277, P20249, DOI 10.1074/jbc.M201866200; O'Shea MG, 1998, CARBOHYD RES, V307, P1, DOI 10.1016/S0008-6215(97)10085-4; Pan DD, 2000, BIOMACROMOLECULES, V1, P126, DOI 10.1021/bm990016l; Rahman S, 2001, PLANT PHYSIOL, V125, P1314, DOI 10.1104/pp.125.3.1314; Roldan I, 2007, PLANT J, V49, P492, DOI 10.1111/j.1365-313X.2006.02968.x; Rydberg U, 2001, EUR J BIOCHEM, V268, P6140, DOI 10.1046/j.0014-2956.2001.02568.x; Sharma A, 2008, FOOD REV INT, V24, P193, DOI 10.1080/87559120801926237; Streb S, 2008, PLANT CELL, V20, P3448, DOI 10.1105/tpc.108.063487; Szydlowski N, 2009, PLANT CELL, V21, P2443, DOI 10.1105/tpc.109.066522; Tetlow IJ, 2011, SEED SCI RES, V21, P5, DOI 10.1017/S0960258510000292; Tomlinson KL, 1997, PLANT J, V11, P31, DOI 10.1046/j.1365-313X.1997.11010031.x; Umemoto T, 2002, THEOR APPL GENET, V104, P1, DOI 10.1007/s001220200000; Vermeylen R, 2004, BIOMACROMOLECULES, V5, P1775, DOI 10.1021/bm0499132; Waters DLE, 2006, PLANT BIOTECHNOL J, V4, P115, DOI 10.1111/j.1467-7652.2005.00162.x; Wattebled F, 2008, PLANT PHYSIOL, V148, P1309, DOI 10.1104/pp.108.129379; Witt T, 2013, RELATIONS MOL UNPUB; Wu AC, 2013, PROGRAM APCLDFIT; Wu AC, 2010, BIOMACROMOLECULES, V11, P3539, DOI 10.1021/bm1010189; Yoo SH, 2002, CARBOHYD POLYM, V49, P307, DOI 10.1016/S0144-8617(01)00339-3; Zeeman SC, 1998, PLANT J, V15, P357, DOI 10.1046/j.1365-313X.1998.00213.x	50	88	89	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65768	10.1371/journal.pone.0065768	http://dx.doi.org/10.1371/journal.pone.0065768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762422	gold, Green Submitted, Green Published			2022-12-25	WOS:000321094800070
J	Grum, D; Franke, S; Kraff, O; Heider, D; Schramm, A; Hoffmann, D; Bayer, P				Grum, Daniel; Franke, Stefan; Kraff, Oliver; Heider, Dominik; Schramm, Alexander; Hoffmann, Daniel; Bayer, Peter			Design of a Modular Protein-Based MRI Contrast Agent for Targeted Application	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; HIGHLY EFFICIENT; CARCINOMA-CELLS; BINDING; FLUORESCENCE; SIMULATION; GADOLINIUM; DOMAIN; FIELD; EGF	Magnetic resonance imaging (MRI) offers a non-radioactive alternative for the non-invasive detection of tumours. Low molecular weight MRI contrast agents currently in clinical use suffer either from a lack of specificity for tumour tissue or from low relaxivity and thus low contrast amplification. In this study, we present the newly designed two domain fusion protein Zarvin, which is able to bind to therapeutic IgG antibodies suitable for targeting, while facilitating contrast enhancement through high affinity binding sites for Gd3+. We show that the Zarvin fold is stable under serum conditions, specifically targets a cancer cell-line when bound to the Cetuximab IgG, and allows for imaging with high relaxivity, a property that would be advantageous for the detection of small tumours and metastases at 1.5 or 3 T.	[Grum, Daniel; Bayer, Peter] Univ Duisburg Essen, Res Grp Struct & Med Biochem, Ctr Med Biotechnol, Essen, Germany; [Franke, Stefan; Heider, Dominik; Hoffmann, Daniel] Univ Duisburg Essen, Res Grp Bioinformat, Ctr Med Biotechnol, Essen, Germany; [Kraff, Oliver] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Schramm, Alexander] Univ Childrens Hosp, Dept Pediat Hematol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hoffmann, D (corresponding author), Univ Duisburg Essen, Res Grp Bioinformat, Ctr Med Biotechnol, Essen, Germany.	Daniel.Hoffmann@uni-due.de; Peter.Bayer@uni-due.de	Schramm, Alexander/G-5688-2010; Hoffmann, Daniel/P-5624-2019; Hoffmann, Daniel/B-1314-2018; Heider, Dominik/F-8545-2010; Bayer, Peter/B-8803-2009; Kraff, Oliver/AAE-2238-2020	Schramm, Alexander/0000-0001-7670-7529; Hoffmann, Daniel/0000-0003-2973-7869; Hoffmann, Daniel/0000-0003-2973-7869; Heider, Dominik/0000-0002-3108-8311; Bayer, Peter/0000-0003-0435-7202; Kraff, Oliver/0000-0002-6006-8934	"Bundesministerium fur Bildung und Forschung" (BMBF) [01EZ093 1-4]	"Bundesministerium fur Bildung und Forschung" (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the "Bundesministerium fur Bildung und Forschung" (BMBF; 01EZ093 1-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES DW, 1982, J CELL BIOL, V93, P1, DOI 10.1083/jcb.93.1.1; Basu G, 2003, J BIOL INORG CHEM, V8, P721, DOI 10.1007/s00775-003-0470-7; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Bernstein MA, 2004, HDB MRI PULSE SEQUEN, P608; Brucher E, 2002, TOP CURR CHEM, V221, P103; Caravan P, 2006, CHEM SOC REV, V35, P512, DOI 10.1039/b510982p; Caravan P, 2009, CONTRAST MEDIA MOL I, V4, P89, DOI 10.1002/cmmi.267; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Daura X, 1998, J COMPUT CHEM, V19, P535, DOI 10.1002/(SICI)1096-987X(19980415)19:5<535::AID-JCC6>3.0.CO;2-N; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Fasman G.D., 1976, HDB BIOCH MOL BIOL P, V1; Flacke S, 2001, CIRCULATION, V104, P1280, DOI 10.1161/hc3601.094303; Guenoun J, 2012, CELL TRANSPLANT, V21, P191, DOI 10.3727/096368911X593118; HAIGLER H, 1978, P NATL ACAD SCI USA, V75, P3317, DOI 10.1073/pnas.75.7.3317; Han LA, 2011, BIOMATERIALS, V32, P2989, DOI 10.1016/j.biomaterials.2011.01.005; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Histed SN, 2012, NUCL MED COMMUN, V33, P349, DOI 10.1097/MNM.0b013e32834ec8a5; HORROCKS WD, 1979, J AM CHEM SOC, V101, P334, DOI 10.1021/ja00496a010; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim BH, 2011, J AM CHEM SOC, V133, P12624, DOI 10.1021/ja203340u; KWOK TT, 1991, BRIT J CANCER, V64, P251, DOI 10.1038/bjc.1991.286; Lee YH, 2004, BIOCHEMISTRY-US, V43, P10008, DOI 10.1021/bi0492915; Lide D. R., 1995, CRC HDB CHEM PHYS; MARTELL AE, 1993, NIST STANDARD REFERE; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MASUI H, 1993, J CELL BIOL, V120, P85, DOI 10.1083/jcb.120.1.85; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; Plazinski W, 2012, APPL SURF SCI, V262, P153, DOI 10.1016/j.apsusc.2012.03.151; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Winter PM, 2003, CANCER RES, V63, P5838; Yang JJ, 2008, J AM CHEM SOC, V130, P9260, DOI 10.1021/ja800736h; Zheng DY, 2004, PROTEIN SCI, V13, P549, DOI 10.1110/ps.03351704	33	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65346	10.1371/journal.pone.0065346	http://dx.doi.org/10.1371/journal.pone.0065346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762349	Green Submitted, gold, Green Published			2022-12-25	WOS:000321099000059
J	Nikam, A; Patankar, JV; Lackner, C; Schock, E; Kratky, D; Zatloukal, K; Abuja, PM				Nikam, Aniket; Patankar, Jay V.; Lackner, Carolin; Schoeck, Elisabeth; Kratky, Dagmar; Zatloukal, Kurt; Abuja, Peter M.			Transition between Acute and Chronic Hepatotoxicity in Mice Is Associated with Impaired Energy Metabolism and Induction of Mitochondrial Heme Oxygenase-1	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; HEPATIC FERROCHELATASE; RESPIRATORY-CHAIN; ENZYME-ACTIVITIES; ATP HOMEOSTASIS; MALLORY BODIES; LIVER; INHIBITION; DYSFUNCTION; MECHANISM	The formation of protein inclusions is frequently associated with chronic metabolic diseases. In mice, short-term intoxication with 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) leads to hepatocellular damage indicated by elevated serum liver enzyme activities, whereas only minor morphological changes are observed. Conversely, chronic administration of DDC for several weeks results in severe morphological damage, characterized by hepatocellular ballooning, disruption of the intermediate filament cytoskeleton, and formation of Mallory-Denk bodies consisting predominantly of misfolded keratins, Sqstm1/p62, and heat shock proteins. To evaluate the mechanistic underpinnings for this dichotomy we dissected the time-course of DDC intoxication for up to 10 weeks. We determined body weight change, serum liver enzyme activities, morphologic alterations, induction of antioxidant response (heme oxygenase-1, HO-1), oxidative damage and ATP content in livers as well as respiration, oxidative damage and the presence and activity of HO-1 in endoplasmic reticulum and mitochondria (mtHO-1). Elevated serum liver enzyme activity and oxidative liver damage were already present at early intoxication stages without further subsequent increase. After 2 weeks of intoxication, mice had transiently lost 9% of their body weight, liver ATP-content was reduced to 58% of controls, succinate-driven respiration was uncoupled from ATP-production and antioxidant response was associated with the appearance of catalytically active mtHO-1. Oxidative damage was associated with both acute and chronic DDC toxicity whereas the onset of chronic intoxication was specifically associated with mitochondrial dysfunction which was maximal after 2 weeks of intoxication. At this transition stage, adaptive responses involving mtHO-1 were induced, indirectly leading to improved respiration and preventing further drop of ATP levels. Our observations clearly demonstrate principally different mechanisms for acute and chronic toxic damage.	[Nikam, Aniket; Lackner, Carolin; Schoeck, Elisabeth; Zatloukal, Kurt; Abuja, Peter M.] Med Univ Graz, Inst Pathol, Graz, Austria; [Patankar, Jay V.; Kratky, Dagmar] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria	Medical University of Graz; Medical University of Graz	Abuja, PM (corresponding author), Med Univ Graz, Inst Pathol, Graz, Austria.	peter.abuja@medunigraz.at	Kratky, Dagmar/ABF-5699-2021	Kratky, Dagmar/0000-0003-1357-7573; Patankar, Jay/0000-0002-1884-7424; Abuja, Peter Michael/0000-0003-1957-4066	Austrian GenAu program, project GATiB II; FWF Austrian Science Fund [P22382, SFB F30]; PhD-program of the Medical University of Graz, Austria; Austrian Science Fund (FWF) [F 3004] Funding Source: researchfish	Austrian GenAu program, project GATiB II; FWF Austrian Science Fund(Austrian Science Fund (FWF)); PhD-program of the Medical University of Graz, Austria; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work has been supported by the Austrian GenAu program (www.genau.at), project GATiB II (to KZ and PMA), by the FWF Austrian Science Fund (www.fwf.ac.at), projects P22382 and SFB F30 (to DK), and the PhD-program of the Medical University of Graz, Austria (www.medunigraz.at) (to AN/PMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLEGATE LA, 1991, CANCER RES, V51, P974; Atamna H, 2002, P NATL ACAD SCI USA, V99, P14807, DOI 10.1073/pnas.192585799; Atamna H, 2001, J BIOL CHEM, V276, P48410, DOI 10.1074/jbc.M108362200; Beer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002493; Berson A, 1998, GASTROENTEROLOGY, V114, P764, DOI 10.1016/S0016-5085(98)70590-6; Bindu S, 2011, J BIOL CHEM, V286, P39387, DOI 10.1074/jbc.M111.279893; Converso DP, 2006, FASEB J, V20, P1236, DOI 10.1096/fj.05-4204fje; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Frezza C, 2011, J MOL MED, V89, P213, DOI 10.1007/s00109-011-0728-4; FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Hanada S, 2010, GASTROENTEROLOGY, V138, P1607, DOI 10.1053/j.gastro.2009.12.055; HUBERWJ, 2007, BIOCHEMISTRY-US, V46, P12212, DOI DOI 10.1021/BI701496Z; Ishii T, 2002, METHOD ENZYMOL, V348, P182, DOI 10.1016/S0076-6879(02)48637-5; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Lancel S, 2009, J PHARMACOL EXP THER, V329, P641, DOI 10.1124/jpet.108.148049; Lickteig AJ, 2007, J BIOCHEM MOL TOXIC, V21, P216, DOI 10.1002/jbt.20177; Long JG, 2006, LIFE SCI, V79, P1466, DOI 10.1016/j.lfs.2006.04.024; MCCLUSKEY SA, 1989, MOL PHARMACOL, V36, P608; MCCLUSKEY SA, 1988, MOL PHARMACOL, V34, P80; Nan YM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-124; Navarro S, 2005, EXP DERMATOL, V14, P26, DOI 10.1111/j.0906-6705.2005.00248.x; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Serviddio G, 2008, EUR J CLIN INVEST, V38, P245, DOI 10.1111/j.1365-2362.2008.01936.x; Singla A, 2012, HEPATOLOGY; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Stumptner C, 2001, J HEPATOL, V34, P665, DOI 10.1016/S0168-8278(00)00099-4; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; YOKOO H, 1982, GASTROENTEROLOGY, V83, P109; YOSHIDA T, 1991, EUR J BIOCHEM, V199, P729, DOI 10.1111/j.1432-1033.1991.tb16177.x; Yu J, 2009, GASTROENTEROLOGY, V138, p[694, 704, e691]; ZATLOUKAL K, 1990, LAB INVEST, V62, P427; Zatloukal K, 2004, METHOD CELL BIOL, V78, P205; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zatloukal K, 2007, EXP CELL RES, V313, P2033, DOI 10.1016/j.yexcr.2007.04.024	42	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e66094	10.1371/journal.pone.0066094	http://dx.doi.org/10.1371/journal.pone.0066094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762471	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000126
J	Zagaceta, J; Zulueta, JJ; Bastarrika, G; Colina, I; Alcaide, AB; Campo, A; Celli, BR; de Torres, JP				Zagaceta, Jorge; Zulueta, Javier J.; Bastarrika, Gorka; Colina, Inmaculada; Alcaide, Ana B.; Campo, Arantza; Celli, Bartolome R.; de Torres, Juan P.			Epicardial Adipose Tissue in Patients with Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							VISCERAL ABDOMINAL FAT; AIR-FLOW OBSTRUCTION; PERICARDIAL FAT; COMPUTED-TOMOGRAPHY; LUNG-CANCER; SLEEP-APNEA; RISK; MORTALITY; ASSOCIATION; ATHEROSCLEROSIS	Rationale: Epicardial Adipose Tissue (EAT) volume as determined by chest computed tomography (CT) is an independent marker of cardiovascular events in the general population. COPD patients have an increased risk of cardiovascular disease, however nothing is known about the EAT volume in this population. Objectives: To assess EAT volume in COPD and explore its association with clinical and physiological variables of disease severity. Methods: We measured EAT using low-dose CT in 171 stable COPD patients and 70 controls matched by age, smoking history and BMI. We determined blood pressure, cholesterol, glucose and HbA1c levels, microalbuminuria, lung function, BODE index, co-morbidity index and coronary artery calcium score (CAC). EAT volume were compared between groups. Uni and multivariate analyses explored the relationship between EAT volume and the COPD related variables. Results: COPD patients had a higher EAT volume [143.7 (P25-75, 108.3-196.6) vs 129.1 (P25-75, 91.3-170.8) cm(3), p = 0.02)] and the EAT volume was significantly associated with CAC (r = 0.38, p<0.001) and CRP (r = 0.32, p<0.001) but not with microalbuminuria (r = 0.12, p = 0.13). In COPD patients, EAT volume was associated with: age, pack-years, BMI, gender, FEV1%, 6 MWD, MMRC and HTN. Multivariate analysis showed that only pack-years (B = 0.6, 95% CI: 0.5-1.3), BMI (B = 7.8, 95% CI: 5.7-9.9) and 6 MWD (B = -0.2, 95% CI: -0.3--0.1), predicted EAT volume. Conclusions: EAT volume is increased in COPD patients and is independently associated with smoking history, BMI and exercise capacity, all modifiable risk factors of future cardiovascular events. EAT volume could be a non-invasive marker of COPD patients at high risk for future cardiovascular events.	[Zagaceta, Jorge; Zulueta, Javier J.; Alcaide, Ana B.; Campo, Arantza; de Torres, Juan P.] Univ Navarra Clin, Dept Pulm, Pamplona, Spain; [Bastarrika, Gorka] Univ Navarra Clin, Dept Radiol, Pamplona, Spain; [Colina, Inmaculada] Univ Navarra Clin, Dept Internal Med, Pamplona, Spain; [Celli, Bartolome R.] Brigham & Womens Hosp, Div Pulm, Boston, MA 02115 USA	University of Navarra; University of Navarra; University of Navarra; Harvard University; Brigham & Women's Hospital	de Torres, JP (corresponding author), Univ Navarra Clin, Dept Pulm, Pamplona, Spain.	jupa65@hotmail.com	Campo, Arantza/F-9487-2017; Zulueta, Javier J/H-5127-2011; Zulueta, Javier J/GXZ-5810-2022	Campo, Arantza/0000-0001-9700-4355; Zulueta, Javier J/0000-0003-3182-3555; de Torres, Juan Pablo/0000-0003-1231-4894	ISC III (Ministry of Health, Government of Spain) [PI070792, RD12/0036/0040, RD12/0036/0062]; Ramon Areces Foundation	ISC III (Ministry of Health, Government of Spain); Ramon Areces Foundation	Financially supported by ISC III (Ministry of Health, Government of Spain) research grants noPI070792, RD12/0036/0040, RD12/0036/0062 and a grant from the Ramon Areces Foundation. The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbara S, 2006, EUR J RADIOL, V57, P417, DOI 10.1016/j.ejrad.2005.12.030; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Agusti A, 2012, THORAX; Almendros I, 2011, SLEEP, V34, P1127, DOI 10.5665/SLEEP.1176; Martinez-Garcia MA, 2011, CHEST, V140, P1130, DOI 10.1378/chest.10-1758; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Barr RG, 2012, EUR RESPIR J, V39, P846, DOI 10.1183/09031936.00165410; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Casanova C, 2010, AM J RESP CRIT CARE, V182, P1004, DOI 10.1164/rccm.201003-0360OC; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dagvasumberel M, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-106; de Torres JP, 2011, AM J RESP CRIT CARE, V184, P913, DOI 10.1164/rccm.201103-0430OC; Diercks GFH, 2002, CAN J CARDIOL, V18, P525; Ding JZ, 2009, AM J CLIN NUTR, V90, P499, DOI 10.3945/ajcn.2008.27358; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Furutate R, 2011, INT J CHRONIC OBSTR, V6, P423, DOI 10.2147/COPD.S22885; Iacobellis G, 2005, J CLIN ENDOCR METAB, V90, P6300, DOI 10.1210/jc.2005-1087; Iacobellis G, 2003, J CLIN ENDOCR METAB, V88, P5163, DOI 10.1210/jc.2003-030698; Iacobellis G, 2011, INT J BIOCHEM CELL B, V43, P1651, DOI 10.1016/j.biocel.2011.09.006; Iwamoto H, 2009, AM J RESP CRIT CARE, V179, P35, DOI 10.1164/rccm.200804-560OC; Kessels K, 2006, Heart, V92, P962, DOI 10.1136/hrt.2005.074872; Kim MK, 2009, J APPL PHYSIOL, V106, P5, DOI 10.1152/japplphysiol.90756.2008; Klimcakova E, 2011, DIABETOLOGIA, V54, P876, DOI 10.1007/s00125-010-2014-3; Mahabadi AA, 2009, EUR HEART J, V30, P850, DOI 10.1093/eurheartj/ehn573; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; McAllister DA, 2007, AM J RESP CRIT CARE, V176, P1208, DOI 10.1164/rccm.200707-1080OC; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nakagawa Y, 2011, J ATHEROSCLER THROMB, V18, P240, DOI 10.5551/jat.6593; Nakazato R, 2012, ATHEROSCLEROSIS, V220, P139, DOI 10.1016/j.atherosclerosis.2011.10.014; Nishimura M, 2012, AM J RESP CRIT CARE, V185, P44, DOI 10.1164/rccm.201106-0992OC; Pitta F, 2005, AM J RESP CRIT CARE, V171, P972, DOI 10.1164/rccm.200407-855OC; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Samaras K, 2010, OBES SURG, V20, P108, DOI 10.1007/s11695-009-9952-1; Shemesh J, 2010, RADIOLOGY, V257, P541, DOI 10.1148/radiol.10100383; Sin DD, 2006, EUR RESPIR J, V28, P1245, DOI 10.1183/09031936.00133805; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Sin Don D, 2005, Proc Am Thorac Soc, V2, P8, DOI 10.1513/pats.200404-032MS; U.S. Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute, 2003, NIH PUBLICATION; van den Borst B, 2013, AM J RESP CRIT CARE, V187, P8, DOI 10.1164/rccm.201208-1441OE; van den Borst B, 2012, AM J CLIN NUTR, V96, P516, DOI 10.3945/ajcn.112.040774; van Gestel YRBM, 2010, RESP MED, V104, P712, DOI 10.1016/j.rmed.2009.10.027; Vestbo J, 2012, AM J RESP CRIT CARE; Wells JM, 2012, NEW ENGL J MED, V367, P913, DOI 10.1056/NEJMoa1203830; Willens HJ, 2007, AM J CARDIOL, V99, P1242, DOI 10.1016/j.amjcard.2006.12.042	48	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65593	10.1371/journal.pone.0065593	http://dx.doi.org/10.1371/journal.pone.0065593			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762399	Green Submitted, Green Published, gold			2022-12-25	WOS:000321099000081
J	Abelein, A; Kaspersen, JD; Nielsen, SB; Jensen, GV; Christiansen, G; Pedersen, JS; Danielsson, J; Otzen, DE; Graslund, A				Abelein, Axel; Kaspersen, Jorn Dovling; Nielsen, Soren Bang; Jensen, Grethe Vestergaard; Christiansen, Gunna; Pedersen, Jan Skov; Danielsson, Jens; Otzen, Daniel E.; Graslund, Astrid			Formation of Dynamic Soluble Surfactant-induced Amyloid beta Peptide Aggregation Intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; ANGLE NEUTRON-SCATTERING; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; PROTEIN AGGREGATION; CONGO RED; FIBRILS; MICELLES; FIBRILLATION; PROBES	Intermediate amyloidogenic states along the amyloid beta peptide (A beta) aggregation pathway have been shown to be linked to neurotoxicity. To shed more light on the different structures that may arise during A beta aggregation, we here investigate surfactant-induced A beta aggregation. This process leads to co-aggregates featuring a beta-structure motif that is characteristic for mature amyloid-like structures. Surfactants induce secondary structure in A beta in a concentration-dependent manner, from predominantly random coil at low surfactant concentration, via beta-structure to the fully formed beta-helical state at high surfactant concentration. The beta-rich state is the most aggregation-prone as monitored by thioflavin T fluorescence. Small angle x-ray scattering reveals initial globular structures of surfactant-A beta co-aggregated oligomers and formation of elongated fibrils during a slow aggregation process. Alongside this slow (minutes to hours time scale) fibrillation process, much faster dynamic exchange (k(ex) similar to 1100 s(-1)) takes place between free and co-aggregate-bound peptide. The two hydrophobic segments of the peptide are directly involved in the chemical exchange and interact with the hydrophobic part of the co-aggregates. Our findings suggest a model for surfactant-induced aggregation where free peptide and surfactant initially co-aggregate to dynamic globular oligomers and eventually form elongated fibrils. When interacting with beta-structure promoting substances, such as surfactants, A beta is kinetically driven toward an aggregation-prone state.	[Abelein, Axel; Danielsson, Jens; Graslund, Astrid] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Kaspersen, Jorn Dovling; Jensen, Grethe Vestergaard; Pedersen, Jan Skov] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark; [Kaspersen, Jorn Dovling; Jensen, Grethe Vestergaard; Pedersen, Jan Skov] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark; [Nielsen, Soren Bang; Otzen, Daniel E.] Aarhus Univ, Ctr Insoluble Prot Struct InSPIN, DK-8000 Aarhus, Denmark; [Christiansen, Gunna] Aarhus Univ, Dept Biomed Med Microbiol & Immunol, DK-8000 Aarhus, Denmark	Stockholm University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Graslund, A (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Svante Arrhenius Vag 16, SE-10691 Stockholm, Sweden.	astrid@dbb.su.se	Danielsson, Jens/AAG-6915-2021; Kaspersen, Jørn Døvling/O-6317-2015; Nielsen, Søren B/D-5936-2011; Pedersen, Jan Skov/A-8346-2008; Jensen, Grethe V./D-9079-2015	Pedersen, Jan Skov/0000-0002-7768-0206; Jensen, Grethe V./0000-0002-0625-0620; Abelein, Axel/0000-0002-8079-3017; Danielsson, Jens/0000-0002-6048-6896; Otzen, Daniel/0000-0002-2918-8989; Christiansen, Gunna/0000-0003-0540-1367	Swedish Research Council; Swedish Brain Foundation; EMBO; Danish Research Foundation (inSPIN); Lundbeck Foundation (BioNet 2); Danish Research Council, Natural Sciences	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Foundation; EMBO(European Molecular Biology Organization (EMBO)); Danish Research Foundation (inSPIN); Lundbeck Foundation (BioNet 2); Danish Research Council, Natural Sciences	This work was supported by the Swedish Research Council (to A. G.), the Swedish Brain Foundation (to A. G.), EMBO (to A. A.), the Danish Research Foundation (inSPIN) (to D. E. O.), the Lundbeck Foundation (BioNet 2) (to J. D. K., S. B. N., J. S. P., and D. E. O.), and the Danish Research Council, Natural Sciences (to J. S. P., S. B. N., and D. E. O.).	Abelein A, 2012, FEBS LETT, V586, P3991, DOI 10.1016/j.febslet.2012.09.035; Abelein A, 2012, BIOCHEMISTRY-US, V51, P126, DOI 10.1021/bi201745g; ANANTHAPADMANABHAN KP, 1985, LANGMUIR, V1, P352, DOI 10.1021/la00063a015; Andersen KK, 2009, J MOL BIOL, V391, P207, DOI 10.1016/j.jmb.2009.06.019; Andreasen M, 2012, J BIOL CHEM, V287, P34730, DOI 10.1074/jbc.M112.379552; Antzutkin ON, 2000, P NATL ACAD SCI USA, V97, P13045, DOI 10.1073/pnas.230315097; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bergstrom M, 1999, J PHYS CHEM B, V103, P8502, DOI 10.1021/jp990535i; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; CARVER JP, 1972, J MAGN RESON, V6, P89, DOI 10.1016/0022-2364(72)90090-X; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P333, DOI 10.1016/B978-012164491-8/50007-5; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Danielsson J, 2005, FEBS J, V272, P3938, DOI 10.1111/j.1742-4658.2005.04812.x; Danielsson J, 2006, MAGN RESON CHEM, V44, pS114, DOI 10.1002/mrc.1814; DAVIS DG, 1994, J MAGN RESON SER B, V104, P266, DOI 10.1006/jmrb.1994.1084; Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Fandrich M, 2011, TRENDS BIOCHEM SCI, V36, P338, DOI 10.1016/j.tibs.2011.02.002; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Fawzi NL, 2010, J AM CHEM SOC, V132, P9948, DOI 10.1021/ja1048253; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Giehm L, 2010, J MOL BIOL, V401, P115, DOI 10.1016/j.jmb.2010.05.060; GLATTER O, 1979, J APPL CRYSTALLOGR, V12, P166, DOI 10.1107/S0021889879012139; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Halle B, 2003, P NATL ACAD SCI USA, V100, P12135, DOI 10.1073/pnas.2033320100; Hard T, 2012, J MOL BIOL, V421, P441, DOI 10.1016/j.jmb.2011.12.062; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Jarvet J, 2007, J BIOMOL NMR, V39, P63, DOI 10.1007/s10858-007-9176-4; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; KALYANASUNDARAM K, 1977, J AM CHEM SOC, V99, P2039, DOI 10.1021/ja00449a004; Khan JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029694; KINNING DJ, 1984, MACROMOLECULES, V17, P1712, DOI 10.1021/ma00139a013; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kowalewski J., 2006, NUCL SPIN RELAXATION, P243; Kuzyk A, 2010, J BIOL CHEM, V285, P31202, DOI 10.1074/jbc.M110.142174; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lang LS, 2012, P NATL ACAD SCI USA, V109, P17868, DOI 10.1073/pnas.1201795109; Lendel C, 2010, BIOCHEMISTRY-US, V49, P1358, DOI 10.1021/bi902005t; Liao CR, 2013, ANALYST, V138, P3991, DOI 10.1039/c3an00295k; Lin JM, 2009, SOFT MATTER, V5, P3913, DOI 10.1039/b908203d; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P631, DOI 10.1021/bi201435d; Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; MUKERJEE P, 1967, J PHYS CHEM-US, V71, P4166, DOI 10.1021/j100872a702; Neugebauer T., 1943, ANN PHYS LPZ, V434, P509; Oliveira CLP, 2009, J MOL BIOL, V387, P147, DOI 10.1016/j.jmb.2009.01.020; OSTER G, 1952, ACTA CRYSTALLOGR, V5, P272, DOI 10.1107/S0365110X5200071X; Otzen D, 2011, BBA-PROTEINS PROTEOM, V1814, P562, DOI 10.1016/j.bbapap.2011.03.003; Otzen DE, 2010, CURR PROTEIN PEPT SC, V11, P355; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Palmer AG, 2001, ANNU REV BIOPH BIOM, V30, P129, DOI 10.1146/annurev.biophys.30.1.129; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170; PEDERSEN JS, 1994, EUR BIOPHYS J BIOPHY, V22, P379, DOI 10.1007/BF00180159; Pedersen JS, 1996, J APPL CRYSTALLOGR, V29, P646, DOI 10.1107/S0021889896006589; Pertinhez TA, 2002, FEBS LETT, V529, P193, DOI 10.1016/S0014-5793(02)03333-1; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Wahlstrom A, 2008, FEBS J, V275, P5117, DOI 10.1111/j.1742-4658.2008.06643.x	65	39	40	1	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23518	23528		10.1074/jbc.M113.470450	http://dx.doi.org/10.1074/jbc.M113.470450			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23775077	Green Published, hybrid			2022-12-25	WOS:000330598200056
J	Liebminger, E; Grass, J; Altmann, F; Mach, L; Strasser, R				Liebminger, Eva; Grass, Josephine; Altmann, Friedrich; Mach, Lukas; Strasser, Richard			Characterizing the Link between Glycosylation State and Enzymatic Activity of the Endo-beta 1,4-glucanase KORRIGAN1 from Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX N-GLYCANS; MEMBRANE-BOUND ENDO-1,4-BETA-GLUCANASE; ER QUALITY-CONTROL; CELLULOSE BIOSYNTHESIS; ENDOPLASMIC-RETICULUM; GLUCOSIDASE-II; CELL-WALL; MOLECULAR-CLONING; GOLGI-APPARATUS; INNATE IMMUNITY	Defects in N-glycosylation and N-glycan processing frequently cause alterations in plant cell wall architecture, including changes in the structure of cellulose, which is the most abundant plant polysaccharide. KORRIGAN1 (KOR1) is a glycoprotein enzyme with an essential function during cellulose biosynthesis in Arabidopsis thaliana. KOR1 is a membrane-anchored endo-beta 1,4-glucanase and contains eight potential N-glycosylation sites in its extracellular domain. Here, we expressed A. thaliana KOR1 as a soluble, enzymatically active protein in insect cells and analyzed its N-glycosylation state. Structural analysis revealed that all eight potential N-glycosylation sites are utilized. Individual elimination of evolutionarily conserved N-glycosylation sites did not abolish proper KOR1 folding, but mutations of Asn-216, Asn-324, Asn-345, and Asn-567 resulted in considerably lower enzymatic activity. In contrast, production of wild-type KOR1 in the presence of the class I alpha-mannosidase inhibitor kifunensine, which abolished the conversion of KOR1 N-glycans into complex structures, did not affect the activity of the enzyme. To address N-glycosylation site occupancy and N-glycan composition of KOR1 under more natural conditions, we expressed a chimeric KOR1-Fc-GFP fusion protein in leaves of Nicotiana benthamiana. Although Asn-108 and Asn-133 carried oligomannosidic N-linked oligosaccharides, the six other glycosylation sites were modified with complex N-glycans. Interestingly, the partially functional KOR1 G429R mutant encoded by the A. thaliana rsw2-1 allele displayed only oligomannosidic structures when expressed in N. benthamiana, indicating its retention in the endoplasmic reticulum. In summary, our data indicate that utilization of several N-glycosylation sites is important for KOR1 activity, whereas the structure of the attached N-glycans is not critical.	[Liebminger, Eva; Mach, Lukas; Strasser, Richard] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, A-1190 Vienna, Austria; [Grass, Josephine; Altmann, Friedrich] Univ Nat Resources & Life Sci, Dept Chem, BOKU, A-1190 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Strasser, R (corresponding author), Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Muthgasse 18, A-1190 Vienna, Austria.	richard.strasser@boku.ac.at	Strasser, Richard/AAD-2916-2020	Strasser, Richard/0000-0001-8764-6530; Mach, Lukas/0000-0001-9013-5408; Altmann, Friedrich/0000-0002-0112-7877	Austria Science Fund [P23906-B20, P20817]; Austrian Science Fund (FWF) [P 23906, P 20817] Funding Source: researchfish	Austria Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austria Science Fund Grants P23906-B20 and P20817.	Bencur P, 2005, BIOCHEM J, V388, P515, DOI 10.1042/BJ20042091; Boisson M, 2001, EMBO J, V20, P1010, DOI 10.1093/emboj/20.5.1010; Burn JE, 2002, PLANT J, V32, P949, DOI 10.1046/j.1365-313X.2002.01483.x; Delmer DP, 1999, ANNU REV PLANT PHYS, V50, P245, DOI 10.1146/annurev.arplant.50.1.245; Endler A, 2011, MOL PLANT, V4, P199, DOI 10.1093/mp/ssq079; Fanata WID, 2013, PLANT J, V73, P966, DOI 10.1111/tpj.12087; Farid A, 2013, PLANT PHYSIOL, V162, P24, DOI 10.1104/pp.113.215509; Farid A, 2011, PLANT J, V68, P314, DOI 10.1111/j.1365-313X.2011.04688.x; Gillmor CS, 2002, J CELL BIOL, V156, P1003, DOI 10.1083/jcb.200111093; Guerriero G, 2010, J INTEGR PLANT BIOL, V52, P161, DOI 10.1111/j.1744-7909.2010.00935.x; Haweker H, 2010, J BIOL CHEM, V285, P4629, DOI 10.1074/jbc.M109.063073; His I, 2001, PLANTA, V212, P348, DOI 10.1007/s004250000437; Jin H, 2009, P NATL ACAD SCI USA, V106, P13612, DOI 10.1073/pnas.0906144106; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; Kolarich D, 2012, NAT PROTOC, V7, P1285, DOI 10.1038/nprot.2012.062; Lane DR, 2001, PLANT PHYSIOL, V126, P278, DOI 10.1104/pp.126.1.278; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Liebminger E, 2012, PHYTOCHEMISTRY, V84, P24, DOI 10.1016/j.phytochem.2012.08.023; Liebminger E, 2009, PLANT CELL, V21, P3850, DOI 10.1105/tpc.109.072363; Lu X, 2009, P NATL ACAD SCI USA, V106, P22522, DOI 10.1073/pnas.0907711106; Lukowitz W, 2001, P NATL ACAD SCI USA, V98, P2262, DOI 10.1073/pnas.051625798; Maloney VJ, 2012, NEW PHYTOL, V193, P1076, DOI 10.1111/j.1469-8137.2011.03998.x; Maloney VJ, 2010, PLANT BIOTECHNOL J, V8, P294, DOI 10.1111/j.1467-7652.2009.00483.x; Master ER, 2004, BIOCHEMISTRY-US, V43, P10080, DOI 10.1021/bi049453x; Molhoj M, 2001, PLANT PHYSIOL, V127, P674, DOI 10.1104/pp.010269; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Pattison RJ, 2009, TRENDS PLANT SCI, V14, P92, DOI 10.1016/j.tplants.2008.11.008; Peng LC, 2000, PLANTA, V211, P406, DOI 10.1007/s004250000301; Ruiz-May E, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00117; Saijo Y, 2009, EMBO J, V28, P3439, DOI 10.1038/emboj.2009.263; Saint-Jore CM, 2002, PLANT J, V29, P661, DOI 10.1046/j.0960-7412.2002.01252.x; Sarkar M, 1998, GLYCOCONJUGATE J, V15, P193, DOI 10.1023/A:1006928624913; Sato S, 2001, PLANT CELL PHYSIOL, V42, P251, DOI 10.1093/pcp/pce045; Schoberer J, 2011, MOL PLANT, V4, P220, DOI 10.1093/mp/ssq082; Schoberer J, 2009, TRAFFIC, V10, P101, DOI 10.1111/j.1600-0854.2008.00841.x; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Strasser R, 2006, PLANT J, V45, P789, DOI 10.1111/j.1365-313X.2005.02648.x; Strasser R, 2005, BIOCHEM J, V387, P385, DOI 10.1042/BJ20041686; Strasser R, 1999, GLYCOBIOLOGY, V9, P779, DOI 10.1093/glycob/9.8.779; Strasser R, 2004, FEBS LETT, V561, P132, DOI 10.1016/S0014-5793(04)00150-4; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Strasser R, 2007, PLANT CELL, V19, P2278, DOI 10.1105/tpc.107.052985; Strasser R, 2007, PLANT PHYSIOL, V145, P5, DOI 10.1104/pp.107.101162; Szyjanowicz PMJ, 2004, PLANT J, V37, P730, DOI 10.1111/j.1365-313X.2003.02000.x; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; von Numers N, 2010, MOL PLANT, V3, P740, DOI 10.1093/mp/ssq017; von Schaewen A, 2008, PLANT SIGNAL BEHAV, V3, P871, DOI 10.4161/psb.3.10.6227; VONSCHAEWEN A, 1993, PLANT PHYSIOL, V102, P1109, DOI 10.1104/pp.102.4.1109; Zhang Y, 2011, PHYTOCHEMISTRY, V72, P1109, DOI 10.1016/j.phytochem.2010.10.019; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031; Zuo JR, 2000, PLANT CELL, V12, P1137, DOI 10.1105/tpc.12.7.1137	55	35	36	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22270	22280		10.1074/jbc.M113.475558	http://dx.doi.org/10.1074/jbc.M113.475558			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782689	hybrid, Green Published			2022-12-25	WOS:000330596300009
J	Hwang, MS; Yu, N; Stinson, SY; Yue, P; Newman, RJ; Allan, BB; Dornan, D				Hwang, Michael S.; Yu, Nancy; Stinson, Susanna Y.; Yue, Peng; Newman, Robert J.; Allan, Bernard B.; Dornan, David			miR-221/222 Targets Adiponectin Receptor 1 to Promote the Epithelial-to-Mesenchymal Transition in Breast Cancer	PLOS ONE			English	Article							NF-KAPPA-B; SIGNALING PATHWAY; TUMOR-METASTASIS; SELF-RENEWAL; CELLS; INHIBITION; PROGRESSION; EXPRESSION; INVASION; CADHERIN	The epithelial-to-mesenchymal transition (EMT) is a highly conserved physiological program involved in development and tissue repair; however, its aberrant activation has been implicated in accelerating the progression of a variety of cancers. In breast cancer, the microRNAs (miRNAs) miR-221 and miR-222 (miR-221/222) are differentially expressed in the clinically more aggressive basal-like subtype compared to luminal subtype of breast cancer and upregulation of miR-221/222 induces the EMT by targeting the 39 untranslated region (3'UTR) of the GATA family transcriptional repressor TRPS1 (tricho-rhinophalangeal syndrome type 1). The complete mechanism through which miR-221/222 promotes the EMT, however, is not fully understood. We identified adiponectin receptor 1 (ADIPOR1), a receptor for the adipocytokine adiponectin, as a direct target of miR-221/222. ADIPOR1 is expressed at higher levels in the luminal compared to the basal-like subtype of breast cancer cell lines, which can be reduced by miR-221/222 targeting of its 3' UTR. In addition, miR-221/222 were negatively correlated with ADIPOR1 expression across breast cancer cell lines and tumors. ADIPOR1 depletion by siRNA in MCF10A cells induced the EMT and increased cell invasion. Depletion of ADIPOR1 by siRNA induced activation of the canonical nuclear factor-kappaB (NF-kappa B) and subsequent phosphorylation of signal transducer and activator of transcription 3 (STAT3) in an interleukin 6 (IL6)-dependent manner. Finally, overexpression of ADIPOR1 in the basal-like cell line, MDA-MB-231, attenuated cell invasion and promoted the mesenchymal-to-epithelial transition (MET). We conclude that ADIPOR1 negatively regulates EMT in breast cancer and provides an additional node by which miR-221/222 induces the EMT. These results suggest that ADIPOR1 may play an important role in breast cancer progression and metastasis, and could potentially offer an alternative therapeutic strategy for basal-like breast cancer patients.	[Hwang, Michael S.; Yu, Nancy; Stinson, Susanna Y.; Dornan, David] Genentech Inc, Dept Mol Diagnost & Canc Cell Biol, San Francisco, CA 94080 USA; [Yue, Peng] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Newman, Robert J.; Allan, Bernard B.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Dornan, D (corresponding author), Genentech Inc, Dept Mol Diagnost & Canc Cell Biol, San Francisco, CA 94080 USA.	david.dornan@gilead.com						Andrews JL, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3065; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Blaskovich MA, 2003, CANCER RES, V63, P1270; Cilloni D, 2006, LEUKEMIA, V20, P61, DOI 10.1038/sj.leu.2403998; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Droebner K, 2008, J VIROL, V82, P11461, DOI 10.1128/JVI.01071-08; Duggan C, 2011, J CLIN ONCOL, V29, P32, DOI 10.1200/JCO.2009.26.4473; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Fang X, 2011, ONCOGENE, V30, P4707, DOI 10.1038/onc.2011.181; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Hutchinson L, 2010, NAT REV CLIN ONCOL, V7, P669, DOI 10.1038/nrclinonc.2010.192; Kaklamani VG, 2008, CANCER RES, V68, P3178, DOI 10.1158/0008-5472.CAN-08-0533; Landskroner-Eiger S, 2009, CLIN CANCER RES, V15, P3265, DOI 10.1158/1078-0432.CCR-08-2649; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mantzoros C, J CLIN ENDOCRINOL ME, V89, P1102; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Miyoshi Y, 2003, CLIN CANCER RES, V9, P5699; Nefedova Y, 2005, CANCER RES, V65, P9525, DOI 10.1158/0008-5472.CAN-05-0529; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; SOMMERS CL, 1992, CANCER RES, V52, P5190; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stinson S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001538; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Taliaferro-Smith L, 2009, ONCOGENE, V28, P2621, DOI 10.1038/onc.2009.129; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thike AA, 2010, MODERN PATHOL, V23, P123, DOI 10.1038/modpathol.2009.145; Tobar N, 2010, MOL CELL BIOCHEM, V340, P195, DOI 10.1007/s11010-010-0418-5; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Xie GZ, 2012, INT J ONCOL, V40, P1171, DOI 10.3892/ijo.2011.1275; Xiong H, 2012, J BIOL CHEM, V287, P5819, DOI 10.1074/jbc.M111.295964; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	46	108	113	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66502	10.1371/journal.pone.0066502	http://dx.doi.org/10.1371/journal.pone.0066502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776679	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400149
J	Morales, JM; Garcia, D; Martinez, D; Rodriguez-Perez, J; Herrera, JM				Manuel Morales, Juan; Garcia, Daniel; Martinez, Daniel; Rodriguez-Perez, Javier; Manuel Herrera, Jose			Frugivore Behavioural Details Matter for Seed Dispersal: A Multi-Species Model for Cantabrian Thrushes and Trees	PLOS ONE			English	Article							POPULATION-DYNAMICS; TEMPORAL VARIATION; BIRDS; FRUIT; LANDSCAPE; PATTERNS; CONSEQUENCES; DISTANCE; ESTABLISHMENT; ENVIRONMENT	Animal movement and behaviour is fundamental for ecosystem functioning. The process of seed dispersal by frugivorous animals is a showcase for this paradigm since their behaviour shapes the spatial patterns of the earliest stage of plant regeneration. However, we still lack a general understanding of how intrinsic (frugivore and plant species traits) and extrinsic (landscape features) factors interact to determine how seeds of a given species are more likely to be deposited in some places more than in others. We develop a multi-species mechanistic model of seed dispersal based on frugivore behavioural responses to landscape heterogeneity. The model was fitted to data from three-years of spatially-explicit field observations on the behaviour of six frugivorous thrushes and the fruiting patterns of three fleshy-fruited trees in a secondary forest of the Cantabrian range (N Spain). With such model we explore how seed rain patterns arise from the interaction between animal behaviour and landscape heterogeneity. We show that different species of thrushes respond differently to landscape heterogeneity even though they belong to the same genus, and that provide complementary seed dispersal functions. Simulated seed rain patterns are only realistic when at least some landscape heterogeneity (forest cover and fruit abundance) is taken into account. The common and simple approach of re-sampling movement data to quantify seed dispersal produces biases in both the distance and the habitat at which seeds arrive. Movement behaviour not only affects dispersal distance and seed rain patterns but also can affect frugivore diet composition even if there is no built-in preference for fruiting species. In summary, the fate of seeds produced by a given plant species is strongly affected by both the composition of the frugivore assemblage and the landscape-scale context of the plant location, including the presence of fruits from other plants (from the same or different species).	[Manuel Morales, Juan] Univ Nacl Comahue, INIBIOMA CONICET, Lab Ecotono, Black River, Argentina; [Garcia, Daniel; Martinez, Daniel; Rodriguez-Perez, Javier; Manuel Herrera, Jose] Univ Oviedo, Dept Biol Organismos & Sistemas, Oviedo, Spain; [Garcia, Daniel; Martinez, Daniel; Rodriguez-Perez, Javier; Manuel Herrera, Jose] CSIC UO PA, UMIB, Unidad Mixta Invest Biodiversidad, Oviedo, Spain	Universidad Nacional del Comahue; University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC)	Morales, JM (corresponding author), Univ Nacl Comahue, INIBIOMA CONICET, Lab Ecotono, Black River, Argentina.	jm.morales@conicet.gov.ar	Morales, Juan/B-6316-2009; Herrera, José M./L-7432-2013; García, Daniel/A-1236-2011; Javier Rodríguez-Pérez, Ph.D. Biology/C-9773-2009	Morales, Juan/0000-0001-7269-7490; Herrera, José M./0000-0001-7968-3438; García, Daniel/0000-0002-7334-7836; Javier Rodríguez-Pérez, Ph.D. Biology/0000-0002-1292-9090	European Social Fund; Spanish Ministry of Science [CGL2008-01275, CGL2011-28430]; CONICET; FONCYT [PIP 114-200801-00276]	European Social Fund(European Social Fund (ESF)); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCYT(FONCyT)	Research was supported by the European Social Fund and Spanish Ministry of Science (FPI grants to DM and JMH; CGL2008-01275 and CGL2011-28430 grants to DG), and CONICET and FONCYT (PIP 114-200801-00276 grant to JMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JT, 2011, P ROY SOC B-BIOL SCI, V278, P3329, DOI 10.1098/rspb.2011.0155; Blendinger PG, 2011, OECOLOGIA, V167, P61, DOI 10.1007/s00442-011-1956-6; Breitbach N, 2012, J ECOLOGY; Carlo T. A., 2007, Seed dispersal: theory and its application in a changing world, P369, DOI 10.1079/9781845931650.0369; Carlo TA, 2008, J ECOL, V96, P609, DOI 10.1111/j.1365-2745.2008.01379.x; Cousens RD, 2010, FUNCT ECOL, V24, P1163, DOI 10.1111/j.1365-2435.2010.01747.x; Dennis AJ, 2007, ESTIMATING DISPERSAL; Dennis AJ, 2006, OECOLOGIA, V149, P620, DOI 10.1007/s00442-006-0475-3; Donatti CI, 2011, ECOLOGY LETT, V14; Garcia D, 2005, J ECOL, V93, P693, DOI 10.1111/j.1365-2745.2005.01004.x; Garcia D, 2012, P ROYAL SOC B, V279; Garcia D, 2011, ECOL MONOGR, V81, P123; Garcia D, 2012, ECOGRAPHY IN PRESS; GUITIAN J., 2000, ZORZALES ESPINOS SER; HERRERA CM, 1984, ECOLOGY, V65, P609, DOI 10.2307/1941423; Herrera JM, 2010, CONSERVATION BIOL, V24; Herrera JM, 2011, J ECOL, V99, P1100, DOI 10.1111/j.1365-2745.2011.01861.x; Hickey JR, 1999, OIKOS, V87, P499, DOI 10.2307/3546814; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Jordano P., 2000, Seeds: the ecology of regeneration in plant communities, P125, DOI 10.1079/9780851994321.0125; Keitt TH, 2002, ECOGRAPHY, V25, P616, DOI 10.1034/j.1600-0587.2002.250509.x; Lehouck V, 2009, J VEGETATION SCI, V20; Lenz J, 2011, P ROY SOC B-BIOL SCI, V278, P2257, DOI 10.1098/rspb.2010.2383; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; LEVEY DJ, 1988, ECOL MONOGR, V58, P251, DOI 10.2307/1942539; Levine JM, 2003, ANNU REV ECOL EVOL S, V34, P549, DOI 10.1146/annurev.ecolsys.34.011802.132400; LOISELLE BA, 1991, ECOLOGY, V72, P180, DOI 10.2307/1938913; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; Marcum HA, 1998, ECOL MODEL, V106, P161, DOI 10.1016/S0304-3800(97)00190-7; Martinez I, 2008, ECOSCIENCE, V15, P189, DOI 10.2980/15-2-3096; Morales JM, 2008, OIKOS, V117, P1362, DOI 10.1111/j.0030-1299.2008.16737.x; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Morales JM, 2006, ECOLOGY, V87, P1489, DOI 10.1890/0012-9658(2006)87[1489:TEOPDA]2.0.CO;2; Morales LM, 1999, ECOL LETT, V2, P228; Moran C, 2004, OECOLOGIA, V141, P584, DOI 10.1007/s00442-004-1685-1; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19050, DOI 10.1073/pnas.0808918105; Perry JN, 1995, J ANIMAL ECOLOGY, V64; Rodriguez-Perez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033246; Sasal Y, 2012, OIKOS IN PRESS; Sasal Y, 2013, OIKOS, V122, P95, DOI 10.1111/j.1600-0706.2012.20669.x; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; Spiegel O, 2007, ECOL LETT, V10, P718, DOI 10.1111/j.1461-0248.2007.01062.x; Telleria JL, 2008, ECOGRAPHY, V31, P381, DOI 10.1111/j.0906-7590.2008.05283.x; Uriarte M, 2011, ECOLOGY, V92, P924, DOI 10.1890/10-0709.1; Westcott DA, 2005, OECOLOGIA, V146, P57, DOI 10.1007/s00442-005-0178-1	45	71	72	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65216	10.1371/journal.pone.0065216	http://dx.doi.org/10.1371/journal.pone.0065216			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776452	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400015
J	Zitomersky, NL; Atkinson, BJ; Franklin, SW; Mitchell, PD; Snapper, SB; Comstock, LE; Bousvaros, A				Zitomersky, Naamah L.; Atkinson, Benjamin J.; Franklin, Sarah W.; Mitchell, Paul D.; Snapper, Scott B.; Comstock, Laurie E.; Bousvaros, Athos			Characterization of Adherent Bacteroidales from Intestinal Biopsies of Children and Young Adults with Inflammatory Bowel Disease	PLOS ONE			English	Article							MUCOSAL FLORA; SYMBIOTIC BACTERIA; CROHNS-DISEASE; IGA RESPONSE; MICROBIOTA; FRAGILIS; DIVERSITY; COLITIS; COMMENSAL; GENE	There is extensive evidence implicating the intestinal microbiota in inflammatory bowel disease [IBD], but no microbial agent has been identified as a sole causative agent. Bacteroidales are numerically dominant intestinal organisms that associate with the mucosal surface and have properties that both positively and negatively affect the host. To determine precise numbers and species of Bacteroidales adherent to the mucosal surface in IBD patients, we performed a comprehensive culture based analysis of intestinal biopsies from pediatric Crohn's disease [CD], ulcerative colitis [UC], and control subjects. We obtained biopsies from 94 patients and used multiplex PCR or 16S rDNA sequencing of Bacteroidales isolates for species identification. Eighteen different Bacteroidales species were identified in the study group, with up to ten different species per biopsy, a number higher than demonstrated using 16S rRNA gene sequencing methods. Species diversity was decreased in IBD compared to controls and with increasingly inflamed tissue. There were significant differences in predominant Bacteroidales species between biopsies from the three groups and from inflamed and uninflamed sites. Parabacteroides distasonis significantly decreased in inflamed tissue. All 373 Bacteroidales isolates collected in this study grew with mucin as the only utilizable carbon source suggesting this is a non-pathogenic feature of this bacterial order. Bacteroides fragilis isolates with the enterotoxin gene [bft], previously associated with flares of colitis, were not found more often at inflamed colonic sites or within IBD subjects. B. fragilis isolates with the ability to synthesize the immunomodulatory polysaccharide A [PSA], previously shown to be protective in murine models of colitis, were not detected more often from healthy versus inflamed tissue.	[Zitomersky, Naamah L.; Atkinson, Benjamin J.; Franklin, Sarah W.; Snapper, Scott B.; Bousvaros, Athos] Harvard Univ, Sch Med, Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Mitchell, Paul D.] Boston Childrens Hosp, Clin Res Ctr, Boston, MA USA; [Snapper, Scott B.] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Comstock, Laurie E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zitomersky, NL (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02114 USA.	naamah.zitomersky@childrens.harvard.edu		Zitomersky, Naamah/0000-0002-4047-1048	Children's Hospital Boston Career Development Award; Thrasher Research Fund: Early Career Award; Rasmussen Family Fund; Wolpow Family Chair in IBD Treatment and Research; NIH/NIAID [R01AI081843]; NASPGHAN-CDHNF; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081843] Funding Source: NIH RePORTER	Children's Hospital Boston Career Development Award; Thrasher Research Fund: Early Career Award; Rasmussen Family Fund; Wolpow Family Chair in IBD Treatment and Research; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NASPGHAN-CDHNF; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by the Children's Hospital Boston Career Development Award (http://www.childrenshospital.org/cfapps/research/data_admin/Site2209/mainpageS2209P0.html); NASPGHAN-CDHNF Fellow to Faculty Transition Award (http://www.naspghan.org/wmspage.cfm?parm1=665); Thrasher Research Fund: Early Career Award (www.thrasherresearch.org) to NLZ; Rasmussen Family Fund to B.J.A, S. W. F. and A. B.; Wolpow Family Chair in IBD Treatment and Research to S. B. S.; and NIH/NIAID R01AI081843 to L.E.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basset C, 2004, DIGEST DIS SCI, V49, P1425, DOI 10.1023/B:DDAS.0000042241.13489.88; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Chatzidaki-Livanis M, 2010, P NATL ACAD SCI USA, V107, P11976, DOI 10.1073/pnas.1005039107; Chung GT, 1999, INFECT IMMUN, V67, P4945, DOI 10.1128/IAI.67.9.4945-4949.1999; Comelli EM, 2008, GENOMICS, V91, P70, DOI 10.1016/j.ygeno.2007.09.006; Comstock LE, 2000, INFECT IMMUN, V68, P6182, DOI 10.1128/IAI.68.11.6182-6188.2000; Conte MP, 2006, GUT, V55, P1760, DOI 10.1136/gut.2005.078824; Coyne MJ, 2001, INFECT IMMUN, V69, P4342, DOI 10.1128/IAI.69.7.4342-4350.2001; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Gosiewski T, 2012, J PEDIATR GASTR NUTR, V54, P20, DOI 10.1097/MPG.0b013e31822d53e5; HARPER PH, 1985, GUT, V26, P279, DOI 10.1136/gut.26.3.279; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hoentjen F, 2003, GUT, V52, P1721, DOI 10.1136/gut.52.12.1721; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; HYAMS JS, 1991, J PEDIATR GASTR NUTR, V12, P439, DOI 10.1097/00005176-199105000-00005; Kaufman J, 2009, INFLAMM BOWEL DIS, V15, P985, DOI 10.1002/ibd.20876; Kellermayer R, 2012, J PEDIATR GASTR NUTR, V55, P243, DOI 10.1097/MPG.0b013e3182617c16; Khan KJ, 2011, AM J GASTROENTEROL, V106, P661, DOI 10.1038/ajg.2011.72; Krinos CM, 2001, NATURE, V414, P555, DOI 10.1038/35107092; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Liu CX, 2003, FEMS MICROBIOL LETT, V222, P9, DOI 10.1016/S0378-1097(03)00296-9; Lucke K, 2006, J MED MICROBIOL, V55, P617, DOI 10.1099/jmm.0.46198-0; Malaty HM, 2010, J PEDIATR GASTR NUTR, V50, P27, DOI 10.1097/MPG.0b013e3181b99baa; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403; Neut C, 2002, AM J GASTROENTEROL, V97, P939, DOI 10.1111/j.1572-0241.2002.05613.x; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; PANTOSTI A, 1995, J CLIN MICROBIOL, V33, P2647, DOI 10.1128/JCM.33.10.2647-2652.1995; Papa E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039242; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Prindiville TP, 2000, EMERG INFECT DIS, V6, P171, DOI 10.3201/eid0602.000210; Rath HC, 1999, INFECT IMMUN, V67, P2969, DOI 10.1128/IAI.67.6.2969-2974.1999; Rehman A, 2010, J MED MICROBIOL, V59, P1114, DOI 10.1099/jmm.0.021170-0; Rhee KJ, 2009, INFECT IMMUN, V77, P1708, DOI 10.1128/IAI.00814-08; RUTGEERTS P, 1995, GASTROENTEROLOGY, V108, P1617, DOI 10.1016/0016-5085(95)90121-3; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Sears CL, 2009, CLIN MICROBIOL REV, V22, P349, DOI 10.1128/CMR.00053-08; Sheng YH, 2012, J GASTROEN HEPATOL, V27, P28, DOI 10.1111/j.1440-1746.2011.06909.x; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Swidsinski A, 2007, INFLAMM BOWEL DIS, V13, P51, DOI 10.1002/ibd.20003; TSAI HH, 1992, CLIN SCI, V82, P447, DOI 10.1042/cs0820447; Turner D, 2007, GASTROENTEROLOGY, V133, P423, DOI 10.1053/j.gastro.2007.05.029; VAREL VH, 1974, APPL MICROBIOL, V28, P251, DOI 10.1128/AEM.28.2.251-257.1974; Verma R, 2010, J CLIN MICROBIOL, V48, P4279, DOI 10.1128/JCM.01360-10; Walker AW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-7; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zitomersky NL, 2011, INFECT IMMUN, V79, P2012, DOI 10.1128/IAI.01348-10; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	53	61	84	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e63686	10.1371/journal.pone.0063686	http://dx.doi.org/10.1371/journal.pone.0063686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776434	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400004
J	Blackburn, MB; Martin, PAW; Kuhar, D; Farrar, RR; Gundersen-Rindal, DE				Blackburn, Michael B.; Martin, Phyllis A. W.; Kuhar, Daniel; Farrar, Robert R., Jr.; Gundersen-Rindal, Dawn E.			Phylogenetic Distribution of Phenotypic Traits in Bacillus thuringiensis Determined by Multilocus Sequence Analysis	PLOS ONE			English	Article							POPULATION-STRUCTURE; CEREUS; EVOLUTION	Diverse isolates from a world-wide collection of Bacillus thuringiensis were classified based on phenotypic profiles resulting from six biochemical tests; production of amylase (T), lecithinase (L), urease (U), acid from sucrose (S) and salicin (A), and the hydrolysis of esculin (E). Eighty two isolates representing the 15 most common phenotypic profiles were subjected to phylogenetic analysis by multilocus sequence typing; these were found to be distributed among 19 sequence types, 8 of which were novel. Approximately 70% of the isolates belonged to sequence types corresponding to the classical B. thuringiensis varieties kurstaki (20 isolates), finitimus (15 isolates), morrisoni (11 isolates) and israelensis (11 isolates). Generally, there was little apparent correlation between phenotypic traits and phylogenetic position, and phenotypic variation was often substantial within a sequence type. Isolates of the sequence type corresponding to kurstaki displayed the greatest apparent phenotypic variation with 6 of the 15 phenotypic profiles represented. Despite the phenotypic variation often observed within a given sequence type, certain phenotypes appeared highly correlated with particular sequence types. Isolates with the phenotypic profiles TLUAE and LSAE were found to be exclusively associated with sequence types associated with varieties kurstaki and finitimus, respectively, and 7 of 8 TS isolates were found to be associated with the morrisoni sequence type. Our results suggest that the B. thuringiensis varieties israelensis and kurstaki represent the most abundant varieties of Bt in soil.	[Blackburn, Michael B.; Martin, Phyllis A. W.; Kuhar, Daniel; Farrar, Robert R., Jr.; Gundersen-Rindal, Dawn E.] USDA, Invas Insect Biocontrol & Behav Lab, Agr Res Serv, Henry A Wallace Beltsville Agr Res Ctr, Beltsville, MD 20705 USA	United States Department of Agriculture (USDA)	Blackburn, MB (corresponding author), USDA, Invas Insect Biocontrol & Behav Lab, Agr Res Serv, Henry A Wallace Beltsville Agr Res Ctr, Beltsville, MD 20705 USA.	mike.blackburn@ars.usda.gov		Blackburn, Michael/0000-0001-5541-4831	Agricultural Research Service [1245-22000-273-00]	Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Research funded by the Agricultural Research Service, Project Number: 1245-22000-273-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blackburn MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018122; DE BARJAC H., 1962, Entomophaga, V7, P5, DOI 10.1007/BF02375988; DEBARJAC H, 1981, MICROBIAL CONTROL PE, P35; Didelot X, 2009, SYST APPL MICROBIOL, V32, P81, DOI 10.1016/j.syapm.2009.01.001; Guinebretiere MH, 2008, ENVIRON MICROBIOL, V10, P851, DOI 10.1111/j.1462-2920.2007.01495.x; HEIMPEL AM, 1967, J INVERTEBR PATHOL, V9, P364, DOI 10.1016/0022-2011(67)90072-9; HEIMPEL AM, 1958, CAN J MICROBIOL, V4, P531, DOI 10.1139/m58-058; Helgason E, 2004, APPL ENVIRON MICROB, V70, P191, DOI 10.1128/AEM.70.1.191-201.2004; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Martin PAW, 2008, BIOCONTROL SCI TECHN, V18, P291, DOI 10.1080/09583150801899716; Martin PAW, 2010, SYST APPL MICROBIOL, V33, P204, DOI 10.1016/j.syapm.2010.04.002; Martin PAW, 2009, BIOL CONTROL, V51, P147, DOI 10.1016/j.biocontrol.2009.03.020; Mols M, 2008, APPL ENVIRON MICROB, V74, P2370, DOI 10.1128/AEM.02737-07; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Sorokin A, 2006, APPL ENVIRON MICROB, V72, P1569, DOI 10.1128/AEM.72.2.1569-1578.2006; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tourasse NJ, 2011, FOOD MICROBIOL, V28, P236, DOI 10.1016/j.fm.2010.06.014; TRAVERS RS, 1987, APPL ENVIRON MICROB, V53, P1263, DOI 10.1128/AEM.53.6.1263-1266.1987; Xu D, 2008, APPL ENVIRON MICROB, V74, P5524, DOI 10.1128/AEM.00951-08	20	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66061	10.1371/journal.pone.0066061	http://dx.doi.org/10.1371/journal.pone.0066061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762464	Green Submitted, Green Published, gold			2022-12-25	WOS:000320440500061
J	Ledee, D; Portman, MA; Kajimoto, M; Isern, N; Olson, AK				Ledee, Dolena; Portman, Michael A.; Kajimoto, Masaki; Isern, Nancy; Olson, Aaron K.			Thyroid Hormone Reverses Aging-Induced Myocardial Fatty Acid Oxidation Defects and Improves the Response to Acutely Increased Afterload	PLOS ONE			English	Article							C-13 ISOTOPOMER ANALYSIS; SUBSTRATE METABOLISM; HEART-FAILURE; RAT-HEART; CARDIAC-FUNCTION; FAILING HEART; ACETYL-COA; DYSFUNCTION; DISEASE; CARDIOMYOPATHY	Background: Subclinical hypothyroidism occurs during aging in humans and mice and may contribute to the development of heart failure. Aging also impairs myocardial fatty acid oxidation, causing increased reliance on flux through pyruvate dehydrogenase (PDH) to maintain function. We hypothesize that the metabolic changes in aged hearts make them less tolerant to acutely increased work and that thyroid hormone supplementation reverses these defects. Methods: Studies were performed on young (Young, 4-6 months) and aged (Old, 22-24 months) C57/BL6 mice at standard (50 mmHg) and high afterload (80 mmHg). Another aged group received thyroid hormone for 3 weeks (Old-TH, high afterload only). Function was measured in isolated working hearts along with substrate fractional contributions (Fc) to the citric acid cycle (CAC) using perfusate with C-13 labeled lactate, pyruvate, glucose and unlabeled palmitate and insulin. Results: Old mice maintained cardiac function under standard workload conditions, despite a marked decrease in unlabeled (presumably palmitate) Fc and relatively similar individual carbohydrate contributions. However, old mice exhibited reduced palmitate oxidation with diastolic dysfunction exemplified by lower -dP/dT. Thyroid hormone abrogated the functional and substrate flux abnormalities in aged mice. Conclusion: The aged heart shows diminished ability to increase cardiac work due to substrate limitations, primarily impaired fatty acid oxidation. The heart accommodates slightly by increasing efficiency through oxidation of carbohydrate substrates. Thyroid hormone supplementation in aged mice significantly improves cardiac function potentially through restoration of fatty acid oxidation.	[Ledee, Dolena; Portman, Michael A.; Kajimoto, Masaki; Olson, Aaron K.] Seattle Childrens Res Inst, Seattle, WA USA; [Portman, Michael A.; Olson, Aaron K.] Univ Washington, Dept Pediat, Div Cardiol, Seattle, WA 98195 USA; [Isern, Nancy] Pacific NW Natl Lab, EMSL, Richland, WA 99352 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Olson, AK (corresponding author), Seattle Childrens Res Inst, Seattle, WA USA.	Aaron.olson@seattlechildrens.org	Kajimoto, Masaki/GPJ-9489-2022; Isern, Nancy/J-8016-2013	Kajimoto, Masaki/0000-0001-9377-1354; Isern, Nancy/0000-0001-9571-8864; Ledee, Dolena/0000-0003-1041-4795; Olson, Aaron/0000-0002-5237-400X	National Heart, Lung, and Blood Institute [K08-HL-092333]; National Institute of Aging [R21-AG-033815]; Department of Energy's Office of Biological and Environmental Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007828, K08HL092333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033815] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Energy's Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Heart, Lung, and Blood Institute Grant K08-HL-092333 to A.K.O. and National Institute of Aging R21-AG-033815 to M.A.P. A portion of the research was performed using EMSL, a national scientific user facility sponsored by the Department of Energy's Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUERREISH GM, 1977, AM J PHYSIOL, V232, pE258, DOI 10.1152/ajpendo.1977.232.3.E258; Biondi B, 2002, ANN INTERN MED, V137, P904, DOI 10.7326/0003-4819-137-11-200212030-00011; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Biondi B, 2012, EUR J ENDOCRINOL, V167, P609, DOI 10.1530/EJE-12-0627; Chen YF, 2008, J MOL CELL CARDIOL, V44, P180, DOI 10.1016/j.yjmcc.2007.09.009; Fazio S, 2004, RECENT PROG HORM RES, V59, P31, DOI 10.1210/rp.59.1.31; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Gencer B, 2012, CIRCULATION, V126, P1040, DOI 10.1161/CIRCULATIONAHA.112.096024; Hyland KA, 2012, J CLIN ENDOCRINOL ME; Hyyti OM, 2006, AM J PHYSIOL-ENDOC M, V290, pE372, DOI 10.1152/ajpendo.00288.2005; Hyyti OM, 2008, AM J PHYSIOL-ENDOC M, V295, pE420, DOI 10.1152/ajpendo.90329.2008; Hyyti OM, 2010, AM J PHYSIOL-HEART C, V299, pH868, DOI 10.1152/ajpheart.00931.2009; Jeffrey FMH, 1996, AM J PHYSIOL-ENDOC M, V271, pE788, DOI 10.1152/ajpendo.1996.271.4.E788; Kates AM, 2003, J AM COLL CARDIOL, V41, P293, DOI 10.1016/S0735-1097(02)02714-6; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; Kolwicz SC, 2012, CIRC RES, V111, P728, DOI 10.1161/CIRCRESAHA.112.268128; Koonen DPY, 2007, CIRCULATION, V116, P2139, DOI 10.1161/CIRCULATIONAHA.107.712901; Krueger JJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE983, DOI 10.1152/ajpendo.2001.281.5.E983; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lehman JJ, 2002, CLIN EXP PHARMACOL P, V29, P339, DOI 10.1046/j.1440-1681.2002.03655.x; Lloyd S, 2003, AM J PHYSIOL-HEART C, V285, pH163, DOI 10.1152/ajpheart.01117.2002; Malloy CR, 1996, MAGN RESON MATER PHY, V4, P35, DOI 10.1007/BF01759778; MCMILLIN JB, 1993, CARDIOVASC RES, V27, P2222, DOI 10.1093/cvr/27.12.2222; Monzani F, 2001, J CLIN ENDOCR METAB, V86, P1110, DOI 10.1210/jc.86.3.1110; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Olson AK, 2012, J MOL CELL CARDIOL; Pantos C, 2009, J PHYSIOL PHARMACOL, V60, P49; ROHRER D, 1988, J BIOL CHEM, V263, P6941; SHIRANI J, 1993, AM J CARDIOL, V72, P365, DOI 10.1016/0002-9149(93)90691-5; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	31	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65532	10.1371/journal.pone.0065532	http://dx.doi.org/10.1371/journal.pone.0065532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762386	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800058
J	Lehti, S; Kakela, R; Horkko, S; Kummu, O; Helske-Suihko, S; Kupari, M; Werkkala, K; Kovanen, PT; Oorni, K				Lehti, Satu; Kakela, Reijo; Horkko, Sohvi; Kummu, Outi; Helske-Suihko, Satu; Kupari, Markku; Werkkala, Kalervo; Kovanen, Petri T.; Oorni, Katariina			Modified Lipoprotein-Derived Lipid Particles Accumulate in Human Stenotic Aortic Valves	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; PHOSPHOLIPASE A(2); ATHEROSCLEROTIC LESIONS; LDL PARTICLES; ATHEROGENIC LIPOPROTEINS; OXIDATIVE MODIFICATION; CARDIAC VALVES; OXIDIZED LDL; RETENTION; HEART	In aortic stenosis plasma lipoprotein-derived lipids accumulate in aortic valves. Here, we first compared the lipid compositions of stenotic aortic valves and atherosclerotic plaque cores. Both pathological tissues were found to be enriched in cholesteryl linoleate, a marker of extracellularly accumulated lipoproteins. In addition, a large proportion of the phospholipids were found to contain arachidonic acid, the common precursor of a number of proinflammatory lipid mediators. Next, we isolated and characterized extracellular lipid particles from human stenotic and non-stenotic control valves, and compared them to plasma lipoproteins from the same subjects. The extracellular valvular lipid particles were isolated from 15 stenotic and 14 non-stenotic aortic valves. Significantly more apoB-100-containing lipid particles were found in the stenotic than in the non-stenotic valves. The majority of the lipid particles isolated from the non-stenotic valves had sizes (23 +/- 6.2 nm in diameter) similar to those of plasma low density lipoprotein (LDL) (22 +/- 1.5 nm), while the lipid particles from stenotic valves were not of uniform size, their sizes ranging from 18 to more than 500 nm. The lipid particles showed signs of oxidative modifications, and when compared to isolated plasma LDL particles, the lipid particles isolated from the stenotic valves had a higher sphingomyelin/phosphatidylcholine -ratio, and also higher contents of lysophosphatidylcholine and unesterified cholesterol. The findings of the present study reveal, for the first time, that in stenotic human aortic valves, infiltrated plasma lipoproteins have undergone oxidative and lipolytic modifications, and become fused and aggregated. The generated large lipid particles may contribute to the pathogenesis of human aortic stenosis.	[Lehti, Satu; Helske-Suihko, Satu; Kovanen, Petri T.; Oorni, Katariina] Wihuri Res Inst, SF-00140 Helsinki, Finland; [Kakela, Reijo] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Helske-Suihko, Satu; Kupari, Markku] Univ Helsinki, Cent Hosp, Div Cardiol, Helsinki, Finland; [Werkkala, Kalervo] Univ Helsinki, Cent Hosp, Div Cardiothorac Surg, Helsinki, Finland; [Horkko, Sohvi; Kummu, Outi] Univ Oulu, Dept Med Microbiol & Immunol, Inst Diagnost, Oulu, Finland; [Horkko, Sohvi; Kummu, Outi] Oulu Univ Hosp, Clin Res Ctr, Oulu, Finland; [Horkko, Sohvi] Oulu Univ Hosp, NordLab Oulu, Oulu, Finland	Wihuri Research Institute; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Oulu; University of Oulu	Oorni, K (corresponding author), Wihuri Res Inst, SF-00140 Helsinki, Finland.	kati.oorni@wri.fi	Oorni, Katariina/G-2484-2011	Oorni, Katariina/0000-0002-9525-0250; Kummu, Outi/0000-0003-0327-3496				BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Boren J, 2000, CURR OPIN LIPIDOL, V11, P451, DOI 10.1097/00041433-200010000-00002; Butcher JT, 2008, J HEART VALVE DIS, V17, P62; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Camejo G, 2002, ATHEROSCLEROSIS SUPP, V3, P3, DOI 10.1016/S1567-5688(01)00005-8; CHAO FF, 1990, AM J PATHOL, V136, P169; Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876; Dichlberger A, 2007, J LIPID RES, V48, P1451, DOI 10.1194/jlr.C600026-JLR200; Dichlberger A, 2011, J LIPID RES, V52, P2198, DOI 10.1194/jlr.M019737; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; DYLEWSKI DP, 1984, EUR J CELL BIOL, V35, P99; Edep ME, 2000, CARDIOVASC PATHOL, V9, P281, DOI 10.1016/S1054-8807(00)00043-0; ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F; FILIP DA, 1987, ATHEROSCLEROSIS, V67, P199, DOI 10.1016/0021-9150(87)90280-2; Fogelstrand P, 2012, NUTR METAB CARDIOVAS, V22, P1, DOI 10.1016/j.numecd.2011.09.007; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forte T, 1972, Adv Lipid Res, V10, P1; Gazi I, 2005, CLIN CHEM, V51, P2264, DOI 10.1373/clinchem.2005.058404; GOLDSTEIN JL, 1975, J BIOL CHEM, V250, P8487; Goncalves I, 2012, ARTERIOSCL THROM VAS, V32, P1505, DOI 10.1161/ATVBAHA.112.249854; GUYTON JR, 1994, ARTERIOSCLER THROMB, V14, P1305, DOI 10.1161/01.ATV.14.8.1305; Haimi P, 2006, ANAL CHEM, V78, P8324, DOI 10.1021/ac061390w; Hakala JK, 2003, ARTERIOSCL THROM VAS, V23, P1430, DOI 10.1161/01.ATV.0000077207.49221.06; Hakala JK, 2001, ARTERIOSCL THROM VAS, V21, P1053, DOI 10.1161/01.ATV.21.6.1053; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Helske S, 2004, J AM COLL CARDIOL, V44, P1859, DOI 10.1016/j.jacc.2004.07.054; Helske S, 2009, CIRCULATION, V119, P2653, DOI 10.1161/CIRCULATIONAHA.109.864421; Hurt-Camejo E, 2000, CURR OPIN LIPIDOL, V11, P465, DOI 10.1097/00041433-200010000-00004; Kolasa-Trela R, 2012, CLIN CHEM LAB MED, V50, P1825, DOI 10.1515/cclm-2012-0015; Kovanen PT, 1999, TRENDS CARDIOVAS MED, V9, P86, DOI 10.1016/S1050-1738(99)00013-4; Kupreishvili K, 2011, J HEART VALVE DIS, V20, P29; Li CM, 2005, INVEST OPHTH VIS SCI, V46, P2576, DOI 10.1167/iovs.05-0034; Lommi JI, 2011, ATHEROSCLEROSIS, V219, P538, DOI 10.1016/j.atherosclerosis.2011.08.027; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maskrey BH, 2011, ARTERIOSCL THROM VAS, V31, P1001, DOI 10.1161/ATVBAHA.110.213850; MCMURRAY HF, 1993, J CLIN INVEST, V92, P1004, DOI 10.1172/JCI116605; Miller JD, 2009, CIRCULATION, V119, P2693, DOI 10.1161/CIRCULATIONAHA.108.834614; Mohty D, 2008, ARTERIOSCL THROM VAS, V28, P187, DOI 10.1161/ATVBAHA.107.154989; Nakashima Y, 2007, ARTERIOSCL THROM VAS, V27, P1159, DOI 10.1161/ATVBAHA.106.134080; NIEVELSTEINPOST P, 1994, ARTERIOSCLER THROMB, V14, P1151, DOI 10.1161/01.ATV.14.7.1151; O'Brien KD, 1995, CIRCULATION, V92, pI; OBrien KD, 1996, ARTERIOSCL THROM VAS, V16, P523, DOI 10.1161/01.ATV.16.4.523; OLSSON M, 1994, J AM COLL CARDIOL, V23, P1162, DOI 10.1016/0735-1097(94)90606-8; Olsson M, 1999, ARTERIOSCL THROM VAS, V19, P1218, DOI 10.1161/01.ATV.19.5.1218; Oorni K, 2000, J LIPID RES, V41, P1703; Oorni K, 2005, ARTERIOSCL THROM VAS, V25, P1678, DOI 10.1161/01.ATV.0000168912.42941.60; Oorni K, 2004, J BIOL CHEM, V279, P34776, DOI 10.1074/jbc.M310814200; Oorni K, 1997, J BIOL CHEM, V272, P21303, DOI 10.1074/jbc.272.34.21303; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Pentikainen MO, 1997, J BIOL CHEM, V272, P25283, DOI 10.1074/jbc.272.40.25283; Pentikainen MO, 2000, J INTERN MED, V247, P359, DOI 10.1046/j.1365-2796.2000.00655.x; Pentikainen MO, 2001, ARTERIOSCL THROM VAS, V21, P1902, DOI 10.1161/hq1201.099423; Plihtari R, 2010, J LIPID RES, V51, P1801, DOI 10.1194/jlr.M003103; QUINN MT, 1988, P NATL ACAD SCI USA, V85, P2805, DOI 10.1073/pnas.85.8.2805; RADDING CM, 1960, J CLIN INVEST, V39, P1560, DOI 10.1172/JCI104177; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; Rajamannan NM, 2009, ARTERIOSCL THROM VAS, V29, P162, DOI 10.1161/ATVBAHA.107.156752; Rajamannan NM, 2002, CIRCULATION, V105, P2660, DOI 10.1161/01.CIR.0000017435.87463.72; Robenek H, 2005, J BIOL CHEM, V280, P5789, DOI 10.1074/jbc.M407194200; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Sacks MS, 2007, PHILOS T R SOC B, V362, P1369, DOI 10.1098/rstb.2007.2122; Sartipy P, 1996, J BIOL CHEM, V271, P26307, DOI 10.1074/jbc.271.42.26307; SIMIONESCU N, 1986, AM J PATHOL, V123, P109; Skalen K, 2002, NATURE, V417, P750, DOI 10.1038/nature00804; Stephens EH, 2008, ACTA BIOMATER, V4, P1148, DOI 10.1016/j.actbio.2008.03.014; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Turunen SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034910; Veneskoski M, 2011, FREE RADICAL BIO MED, V51, P834, DOI 10.1016/j.freeradbiomed.2011.05.029; Vickers KC, 2010, ATHEROSCLEROSIS, V211, P122, DOI 10.1016/j.atherosclerosis.2010.04.005; WILLIAMS KJ, 1995, ARTERIOSCL THROM VAS, V15, P551, DOI 10.1161/01.ATV.15.5.551; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499; Zeng Z, 2007, AM J PHYSIOL-HEART C, V292, pH2687, DOI 10.1152/ajpheart.00606.2006	75	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65810	10.1371/journal.pone.0065810	http://dx.doi.org/10.1371/journal.pone.0065810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762432	Green Published, Green Submitted, gold			2022-12-25	WOS:000321094800075
J	Remon, N; Galan, P; Vila, M; Arribas, O; Naveira, H				Remon, Nuria; Galan, Pedro; Vila, Marta; Arribas, Oscar; Naveira, Horacio			Causes and Evolutionary Consequences of Population Subdivision of an Iberian Mountain Lizard, Iberolacerta monticola	PLOS ONE			English	Article							MITOCHONDRIAL GENETIC DIVERSITY; CYRENI-MARTINEZRICAI ARRIBAS; ROCK-LIZARDS; INBREEDING DEPRESSION; SOCIAL RELATIONSHIPS; MAXIMUM-LIKELIHOOD; COMPUTER-PROGRAM; F-STATISTICS; ICE AGES; DISPERSAL	Aim<bold>: </bold>The study of the factors that influence population connectivity and spatial distribution of genetic variation is crucial for understanding speciation and for predicting the effects of landscape modification and habitat fragmentation, which are considered severe threats to global biodiversity. This dual perspective is obtained from analyses of subalpine mountain species, whose present distribution may have been shaped both by cyclical climate changes over ice ages and anthropogenic perturbations of their habitats. Here, we examine the phylogeography, population structure and genetic diversity of the lacertid lizard Iberolacerta monticola, an endemism considered to be facing a high risk of extinction in several populations. Location<bold>: </bold>Northwestern quadrant of the Iberian Peninsula. Methods<bold>: </bold>We analyzed the mtDNA variation at the control region (454 bp) and the cytochrome b (598 bp) loci, as well as at 10 nuclear microsatellite loci from 17 populations throughout the distribution range of the species. Results<bold>: </bold>According to nuclear markers, most sampling sites are defined as distinct, genetically differentiated populations, and many of them show traces of recent bottlenecks. Mitochondrial data identify a relatively old, geographically restricted lineage, and four to six younger geographically vicariant sister clades, whose origin may be traced back to the mid-Pleistocene revolution, with several subclades possibly associated to the mid-Bruhnes transition. Geographic range fragmentation of one of these clades, which includes lowland sites, is very recent, and most likely due to the accelerated loss of Atlantic forests by human intervention. Main Conclusions<bold>: </bold>Altogether, the data fit a "refugia within refugia" model, some lack of pattern uniformity notwithstanding, and suggest that these mountains might be the cradles of new species of Iberolacerta. However, the changes operated during the Holocene severely compromise the long-term survival of those genetic lineages more exposed to the anthropogenic perturbations of their habitats.	[Remon, Nuria; Galan, Pedro] Univ A Coruna, Fac Ciencias, Dept Biol Anim Biol Vexetal & Ecol, La Coruna, Spain; [Vila, Marta; Naveira, Horacio] Univ A Coruna, Fac Ciencias, Dept Biol Celular & Mol, La Coruna, Spain	Universidade da Coruna; Universidade da Coruna	Naveira, H (corresponding author), Univ A Coruna, Fac Ciencias, Dept Biol Celular & Mol, La Coruna, Spain.	horacio.naveira.fachal@udc.es	Vila Taboada, Marta/F-6118-2016; Naveira, Horacio/H-7249-2014; Galán, Pedro/L-7002-2014; Naveira, Horacio/I-7802-2019	Vila Taboada, Marta/0000-0002-8803-9174; Naveira, Horacio/0000-0002-3840-1569; Galán, Pedro/0000-0002-1681-3343; Naveira, Horacio/0000-0002-3840-1569	(Ministerio de Ciencia y Tecnologia, Spain [REN2003-02931/GLO]; Xunta de Galicia, Spain [PGIDIT03RFO10301PR, PGIDIT06RFO10301PR]; Ministerio de Ciencia y Tecnologia, Spain [PTA2008-1366-P]	(Ministerio de Ciencia y Tecnologia, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia, Spain(Xunta de Galicia); Ministerio de Ciencia y Tecnologia, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants REN2003-02931/GLO (Ministerio de Ciencia y Tecnologia, Spain), PGIDIT03RFO10301PR and PGIDIT06RFO10301PR (Xunta de Galicia, Spain), awarded to Horacio Naveira. Nuria Remon was also funded by grant PTA2008-1366-P (Ministerio de Ciencia y Tecnologia, Spain), awarded to Marta Vila. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AP, 2002, J ZOOL SYST EVOL RES, V40, P57, DOI 10.1046/j.1439-0469.2002.00174.x; Aragon P, 2004, ETHOLOGY, V110, P1001, DOI 10.1111/j.1439-0310.2004.01046.x; Aragon P, 2001, CAN J ZOOL, V79, P1965, DOI 10.1139/cjz-79-11-1965; Arnold E.N., 1981, P217; Arnold EN, 2007, ZOOTAXA, P1, DOI 10.11646/zootaxa.1430.1.1; Arribas O, 2004, ZOOTAXA, P1; Arribas OJ, 2004, AMPHIBIA-REPTILIA, V25, P359, DOI 10.1163/1568538042788942; Arribas O, 2006, ZOOTAXA, P1; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Balloux F, 2004, MOL ECOL, V13, P3021, DOI 10.1111/j.1365-294X.2004.02318.x; Baselga A, 2008, ANN ENTOMOL SOC AM, V101, P402, DOI 10.1603/0013-8746(2008)101[402:CIARFO]2.0.CO;2; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; Blomqvist D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-33; Boudjemadi K, 1999, J ANIM ECOL, V68, P1207, DOI 10.1046/j.1365-2656.1999.00363.x; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Campos JL, 2007, FRESHWATER BIOL, V52, P510, DOI 10.1111/j.1365-2427.2006.01721.x; Carranza S., 2004, Systematics and Biodiversity, V2, P57, DOI 10.1017/S1477200004001355; Carrion Y, 2010, HOLOCENE, V20, P53, DOI 10.1177/0959683609348849; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Coltman DW, 2003, EVOLUTION, V57, P971, DOI 10.1111/j.0014-3820.2003.tb00309.x; COOPE GR, 1994, PHILOS T ROY SOC B, V344, P19, DOI 10.1098/rstb.1994.0046; Crochet PA, 2004, MOL PHYLOGENET EVOL, V30, P860, DOI 10.1016/j.ympev.2003.07.016; Crowley TJ, 1999, PALEOCLIMATOLOGY; Deffontaine V, 2005, MOL ECOL, V14, P1727, DOI 10.1111/j.1365-294X.2005.02506.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Eckstein RL, 2006, MOL ECOL, V15, P2367, DOI 10.1111/j.1365-294X.2006.02944.x; Ersts P.J, 2007, GEOGRAPHIC DISTANCE; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Felsenstein J., 2005, PHYLIP PHYLOGENETIC; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fitze PS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-347; Forsdyke Donald R., 2001, ORIGIN SPECIES REVIS; Galan P., 2000, Galemys, V12, P41; Galan P, 2007, MUNIBE S, V25, P34; Galan P., 2005, RECURSOS RURAIS SERI, V2, P51; Galan Pedro, 1999, Boletin de la Asociacion Herpetologica Espanola, V10, P47; Galan P, 2010, AMPHIBIA-REPTILIA, V31, P144, DOI 10.1163/156853810790457858; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Glemin S, 2003, GENETICS, V165, P2193; Glez-Pena D, 2010, NUCLEIC ACIDS RES, V38, pW14, DOI 10.1093/nar/gkq321; Godinho R, 2008, MOL ECOL, V17, P4670, DOI 10.1111/j.1365-294X.2008.03929.x; Godinho R, 2006, HEREDITY, V96, P454, DOI 10.1038/sj.hdy.6800823; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Gu X, 1997, MOL BIOL EVOL, V14, P1106, DOI 10.1093/oxfordjournals.molbev.a025720; Helaers R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-379; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt Godfrey M, 2004, Front Zool, V1, P4; Hipsley CA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-151; Hoffman JI, 2007, NATURE, V445, P912, DOI 10.1038/nature05558; Howard D.J., 1998, ENDLESS FORMS SPECIE; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaquiery J, 2009, CONSERV BIOL, V23, P207, DOI 10.1111/j.1523-1739.2008.01052.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Johansson H, 2008, MOL ECOL, V17, P4425, DOI 10.1111/j.1365-294X.2008.03923.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kawamura K, 2007, CONSERV GENET, V8, P1163, DOI 10.1007/s10592-006-9271-1; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kropf M, 2003, MOL ECOL, V12, P931, DOI 10.1046/j.1365-294X.2003.01781.x; Lande R, 1998, RES POPUL ECOL, V40, P259, DOI 10.1007/BF02763457; Lee-Yaw JA, 2009, MOL ECOL, V18, P1863, DOI 10.1111/j.1365-294X.2009.04152.x; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; MANTEL N, 1967, CANCER RES, V27, P209; Martinez Fernandez Aquilino, 2008, Boletin BIGA, V4, P87; Martinez-Solano I, 2006, MOL ECOL, V15, P3375, DOI 10.1111/j.1365-294X.2006.03013.x; Mayer W, 2003, J ZOOL SYST EVOL RES, V41, P157, DOI 10.1046/j.1439-0469.2003.00223.x; Mayer Werner, 1996, Herpetozoa, V9, P57; MICKEVICH MF, 1981, SYST ZOOL, V30, P351, DOI 10.2307/2413255; Monasterio C, 2009, J BIOGEOGR, V36, P1673, DOI 10.1111/j.1365-2699.2009.02113.x; Mosquera DF, 2000, NUCL INSTRUM METH B, V172, P832; Mouret V, 2011, J BIOGEOGR, V38, P1717, DOI 10.1111/j.1365-2699.2011.02514.x; Olsson M, 2003, BIOL J LINN SOC, V79, P277, DOI 10.1046/j.1095-8312.2003.00116.x; Park S.D.E., 2001, THESIS; Perez-Mellado V., 2009, IUCN RED LIST THREAT, V2009, pe.T17795A7481971, DOI [10.2305/IUCN.UK.2009.RLTS.T17795A7481971.en, DOI 10.2305/IUCN.UK.2009.RLTS.T17795A7481971.EN]; Pino Perez J.J., 2009, Boletin BIGA, V6, P125; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A., 2006, FIGTREE TREE FIGURE; Raymo ME, 2008, NATURE, V451, P284, DOI 10.1038/nature06589; Recuero E, 2011, MOL PHYLOGENET EVOL, V60, P170, DOI 10.1016/j.ympev.2011.04.006; Remon N, 2008, MOL ECOL RESOUR, V8, P1351, DOI 10.1111/j.1755-0998.2008.02271.x; Remon N, 2012, CONSERV GENET, V13, P131, DOI 10.1007/s10592-011-0272-3; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rodriguez T, 1997, J BIOGEOGR, V24, P893, DOI 10.1046/j.1365-2699.1997.00112.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rowe G, 2000, OIKOS, V88, P641, DOI 10.1034/j.1600-0706.2000.880321.x; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schmitt T, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-9; Sinervo B, 2003, SCIENCE, V300, P1949, DOI 10.1126/science.1083109; Sobrino CM, 2007, VEG HIST ARCHAEOBOT, V16, P223, DOI 10.1007/s00334-006-0083-5; Sobrino CM, 2005, BOREAS, V34, P381, DOI 10.1080/03009480510013006; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Takezaki N, 1996, GENETICS, V144, P389; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Theodorou K, 2006, HEREDITY, V96, P69, DOI 10.1038/sj.hdy.6800762; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Vidal-Romani JR, 1994, CUATERNARIO GEOMORFO, V8, P33; Waldman Bruce, 1993, P250; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whitlock MC, 2002, GENETICS, V160, P1191; Zamudio KR, 2003, LIZARD SOCIAL BEHAVIOR, P83	118	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66034	10.1371/journal.pone.0066034	http://dx.doi.org/10.1371/journal.pone.0066034			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762459	Green Published, Green Submitted, gold			2022-12-25	WOS:000321094800083
J	Higgins, PC; Prigerson, HG				Higgins, Philip C.; Prigerson, Holly G.			Caregiver Evaluation of the Quality of End-Of-Life Care (CEQUEL) Scale: The Caregiver's Perception of Patient Care Near Death	PLOS ONE			English	Article							EXPLORATORY FACTOR-ANALYSIS; BEREAVED FAMILY-MEMBERS; INITIAL VALIDATION; TERMINAL ILLNESS; CANCER-PATIENTS; MENTAL-HEALTH; MEDICAL-CARE; COMMUNICATION; PROVIDERS; PERSPECTIVES	Purpose: End-of-life (EOL) measures are limited in capturing caregiver assessment of the quality of EOL care. Because none include caregiver perception of patient suffering or prolongation of death, we sought to develop and validate the Caregiver Evaluation of Quality of End-of-Life Care (CEQUEL) scale to include these dimensions of caregiver-perceived quality of EOL care. Patients and Methods: Data were derived from Coping with Cancer (CwC), a multisite, prospective, longitudinal study of advanced cancer patients and their caregivers (N = 275 dyads). Caregivers were assessed before and after patient deaths. CEQUEL's factor structure was examined; reliability was evaluated using Cronbach's alpha, and convergent validity by the strength of associations between CEQUEL scores and key EOL outcomes. Results: Factor analysis revealed four distinct factors: Prolongation of Death, Perceived Suffering, Shared Decision-Making, and Preparation for the Death. Each item loaded strongly on only a single factor. The 13-item CEQUEL and its subscales showed moderate to acceptable Cronbach's alpha (range: 0.52-0.78). 53% of caregivers reported patients suffering more than expected. Higher CEQUEL scores were positively associated with therapeutic alliance (rho =. 13; p <=.05) and hospice enrollment (z = -2.09; p <=.05), and negatively associated with bereaved caregiver regret (rho = -.36, p <=.001) and a diagnosis of Posttraumatic Stress Disorder (z = -2.06; p <=.05). Conclusion: CEQUEL is a brief, valid measure of quality of EOL care from the caregiver's perspective. It is the first scale to include perceived suffering and prolongation of death. If validated in future work, it may prove a useful quality indicator for the delivery of EOL care and a risk indicator for poor bereavement adjustment.	[Higgins, Philip C.] Boston Coll, Grad Sch Social Work, Chestnut Hill, MA 02167 USA; [Higgins, Philip C.] Dana Farber Canc Inst, Dept Psychosocial Oncol & Palliat Care, Boston, MA 02115 USA; [Higgins, Philip C.; Prigerson, Holly G.] Dana Farber Canc Inst, Ctr Psychosocial Epidemiol & Outcomes Res, Boston, MA 02115 USA; [Prigerson, Holly G.] Dana Farber Canc Inst, Dept Med Oncol, Div Populat Sci, Boston, MA 02115 USA; [Prigerson, Holly G.] Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA; [Prigerson, Holly G.] Harvard Univ, Sch Med, Boston, MA USA	Boston College; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Prigerson, HG (corresponding author), Dana Farber Canc Inst, Ctr Psychosocial Epidemiol & Outcomes Res, Boston, MA 02115 USA.	holly_prigerson@dfci.harvard.edu	Prigerson, Holly/GWV-3283-2022; Prigerson, Holly/L-3800-2019	Prigerson, Holly/0000-0002-7075-4268	American Cancer Society [DSW1009403SW]; National Institute of Mental Health [MH63892]; National Cancer Institute [CA106370, CA156732]; Center for Psychosocial Epidemiology and Outcomes Research, Dana-Farber Cancer Institute; NATIONAL CANCER INSTITUTE [U54CA156732, R01CA106370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063892] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Psychosocial Epidemiology and Outcomes Research, Dana-Farber Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported in part by the following grants to PCH: DSW1009403SW from the American Cancer Society; and to HGP: MH63892 from the National Institute of Mental Health and CA106370 and CA156732 from the National Cancer Institute; and the Center for Psychosocial Epidemiology and Outcomes Research, Dana-Farber Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington-Hall J, 2001, J PAIN SYMPTOM MANAG, V22, P784, DOI 10.1016/S0885-3924(01)00330-X; Akiyama A, 2010, ARCH GERONTOL GERIAT, V50, P175, DOI 10.1016/j.archger.2009.03.006; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Barry LC, 2002, AM J GERIAT PSYCHIAT, V10, P447; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; Byock IR, 1998, PALLIATIVE MED, V12, P231, DOI 10.1191/026921698670234618; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cherlin E, 2005, J PALLIAT MED, V8, P1176, DOI 10.1089/jpm.2005.8.1176; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Curtis JR, 2002, J PAIN SYMPTOM MANAG, V24, P17, DOI 10.1016/S0885-3924(02)00419-0; DeCoster J, 2005, SCALE CONSTRUCTION N; Emanuel L L, 2001, J Palliat Med, V4, P465, DOI 10.1089/109662101753381601; Emanuel L L, 2000, J Palliat Med, V3, P419, DOI 10.1089/jpm.2000.3.4.419; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; First M. B., 2002, STRUCTURED CLIN INTE; Fowler FJ, 1999, J PAIN SYMPTOM MANAG, V17, P114, DOI 10.1016/S0885-3924(98)00133-X; Fried TR, 2003, J AM GERIATR SOC, V51, P1398, DOI 10.1046/j.1532-5415.2003.51457.x; Ganzini L, 2009, J PAIN SYMPTOM MANAG, V38, P807, DOI 10.1016/j.jpainsymman.2009.04.026; Gries CJ, 2008, CHEST, V133, P704, DOI 10.1378/chest.07-1773; Hales S, 2010, PALLIATIVE MED, V24, P127, DOI 10.1177/0269216309351783; Hanson LC, 1997, J AM GERIATR SOC, V45, P1339, DOI 10.1111/j.1532-5415.1997.tb02933.x; Hayton JC, 2004, ORGAN RES METHODS, V7, P191, DOI 10.1177/1094428104263675; Hebert RS, 2008, J PALLIAT MED, V11, P476, DOI 10.1089/jpm.2007.0165; Heyland DK, 2006, CMAJ, V174; Hinton J, 1996, SOC SCI MED, V43, P1229, DOI 10.1016/0277-9536(95)00437-8; HOUTS P S, 1989, Journal of Psychosocial Oncology, V7, P113, DOI 10.1300/J077v07n03_08; Hudson PL, 2010, PALLIATIVE MED, V24, P656, DOI 10.1177/0269216310373167; Koop Priscilla M, 2003, Clin Nurs Res, V12, P127; Kris AE, 2006, AM J GERIAT PSYCHIAT, V14, P264, DOI 10.1097/01.JGP.0000194642.86116.ce; Latham AE, 2004, SUICIDE LIFE-THREAT, V34, P350, DOI 10.1521/suli.34.4.350.53737; Loggers ET, 2013, NEW ENGL J MED, V368, P1417, DOI 10.1056/NEJMsa1213398; Mack JW, 2009, CANCER-AM CANCER SOC, V115, P3302, DOI 10.1002/cncr.24360; McDonagh JR, 2004, CRIT CARE MED, V32, P1484, DOI 10.1097/01.CCM.0000127262.16690.65; Muthen B., 1997, ROBUST INFERENCE USI; Muthen LK, 2011, BINARY DATA FACTOR A; National Hospice and Palliative Care Organization, 2012, NHPCO FACTS FIG HOSP; Norton SA, 2003, AM J CRIT CARE, V12, P548, DOI 10.4037/ajcc2003.12.6.548; Ott CH, 2007, J NERV MENT DIS, V195, P332, DOI 10.1097/01.nmd.0000243890.93992.1e; Pargament KI, 2000, J CLIN PSYCHOL, V56, P519, DOI 10.1002/(SICI)1097-4679(200004)56:4<519::AID-JCLP6>3.3.CO;2-T; Pargament KI, 1998, J SCI STUD RELIG, V37, P710, DOI 10.2307/1388152; Patrick DL, 2001, J PAIN SYMPTOM MANAG, V22, P717, DOI 10.1016/S0885-3924(01)00333-5; Pearce MJ, 2006, J HEALTH PSYCHOL, V11, P743, DOI 10.1177/1359105306066629; Prigerson HG, 2003, AM J GERIAT PSYCHIAT, V11, P309, DOI 10.1176/appi.ajgp.11.3.309; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Russ AJ, 2005, CULT MED PSYCHIAT, V29, P103, DOI 10.1007/s11013-005-4625-6; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Steinhauser Karen E, 2002, J Palliat Med, V5, P829, DOI 10.1089/10966210260499014; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Steinhauser KE, 2001, J PAIN SYMPTOM MANAG, V22, P727, DOI 10.1016/S0885-3924(01)00334-7; Teno JM, 2001, J PAIN SYMPTOM MANAG, V22, P752, DOI 10.1016/S0885-3924(01)00331-1; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Teno JM, 2001, J PAIN SYMPTOM MANAG, V22, P738, DOI 10.1016/S0885-3924(01)00335-9; Tilden Virginia P, 2002, Gerontologist, V42 Spec No 3, P71; Torges CM, 2008, PSYCHOL AGING, V23, P169, DOI 10.1037/0882-7974.23.1.169; Wendler D, 2011, ANN INTERN MED, V154, P336, DOI 10.7326/0003-4819-154-5-201103010-00008; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Wright AA, 2010, J CLIN ONCOL, V28, P4457, DOI 10.1200/JCO.2009.26.3863; Wright AA, 2010, CANCER-AM CANCER SOC, V116, P4656, DOI 10.1002/cncr.25217; Yu CY, 2002, EVALUATING CUTOFF CR; Zhang BH, 2012, ARCH INTERN MED, V172, P1133, DOI 10.1001/archinternmed.2012.2364	62	29	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e66066	10.1371/journal.pone.0066066	http://dx.doi.org/10.1371/journal.pone.0066066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173SK	23762467	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000125
J	Yu, Q; Sali, A; Van der Meulen, J; Creeden, BK; Gordish-Dressman, H; Rutkowski, A; Rayavarapu, S; Uaesoontrachoon, K; Huynh, T; Nagaraju, K; Spurney, CF				Yu, Qing; Sali, Arpana; Van der Meulen, Jack; Creeden, Brittany K.; Gordish-Dressman, Heather; Rutkowski, Anne; Rayavarapu, Sree; Uaesoontrachoon, Kitipong; Tony Huynh; Nagaraju, Kanneboyina; Spurney, Christopher F.			Omigapil Treatment Decreases Fibrosis and Improves Respiratory Rate in dy(2J) Mouse Model of Congenital Muscular Dystrophy	PLOS ONE			English	Article							ALPHA-GLUCOSIDASE GENE; TARGETED DISRUPTION; CGP 3466B; DISEASE; MICE; DEFICIENT; TCH346; TRIAL; DRUG	Introduction: Congenital muscular dystrophy is a distinct group of diseases presenting with weakness in infancy or childhood and no current therapy. One form, MDC1A, is the result of laminin alpha-2 deficiency and results in significant weakness, respiratory insufficiency and early death. Modification of apoptosis is one potential pathway for therapy in these patients. Methods: dy(2J) mice were treated with vehicle, 0.1 mg/kg or 1 mg/kg of omigapil daily via oral gavage over 17.5 weeks. Untreated age matched BL6 mice were used as controls. Functional, behavioral and histological measurements were collected. Results: dy(2J) mice treated with omigapil showed improved respiratory rates compared to vehicle treated dy(2J) mice (396 to 402 vs. 371 breaths per minute, p<0.03) and similar to control mice. There were no statistical differences in normalized forelimb grip strength between dy(2J) and controls at baseline or after 17.5 weeks and no significant differences seen among the dy(2J) treatment groups. At 30-33 weeks of age, dy(2J) mice treated with 0.1 mg/kg omigapil showed significantly more movement time and less rest time compared to vehicle treated. dy(2J) mice showed normal cardiac systolic function throughout the trial. dy(2J) mice had significantly lower hindlimb maximal (p<0.001) and specific force (p<0.002) compared to the control group at the end of the trial. There were no statistically significant differences in maximal or specific force among treatments. dy(2J) mice treated with 0.1 mg/kg/day omigapil showed decreased percent fibrosis in both gastrocnemius (p<0.03) and diaphragm (p<0.001) compared to vehicle, and in diaphragm (p<0.013) when compared to 1 mg/kg/day omigapil treated mice. Omigapil treated dy(2J) mice demonstrated decreased apoptosis. Conclusion: Omigapil therapy (0.1 mg/kg) improved respiratory rate and decreased skeletal and respiratory muscle fibrosis in dy(2J) mice. These results support a putative role for the use of omigapil in laminin deficient congenital muscular dystrophy patients.	[Yu, Qing; Sali, Arpana; Van der Meulen, Jack; Creeden, Brittany K.; Gordish-Dressman, Heather; Rayavarapu, Sree; Uaesoontrachoon, Kitipong; Tony Huynh; Nagaraju, Kanneboyina; Spurney, Christopher F.] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Spurney, Christopher F.] Childrens Natl Med Ctr, Div Cardiol, Washington, DC 20010 USA; [Rutkowski, Anne] Kaiser SCPMG, Cure CMD, Olathe, KS USA	Children's National Health System; Children's National Health System; Kaiser Permanente; Southern California Permanente Medical Group (SCPMG)	Spurney, CF (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	cspurney@childrensnational.org	Nagaraju, Kanneboyina/AAV-7684-2021; Nagaraju, Kanneboyina/ABA-6525-2021; Huynh, Tony/AAU-9811-2020; Huynh, Tony/J-6783-2014	Huynh, Tony/0000-0002-7909-3670; Huynh, Tony/0000-0002-7909-3670	National Institutes of Health National Center for Research Resources [UL1TR000075]; Department of Defense USAMRAA [W81XWH-05-1-0616]; National Institutes of Health [K26RR032082, R01-AR050478, 1U54HD053177-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD053177] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000075] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR032082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050478] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD011171] Funding Source: NIH RePORTER	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Defense USAMRAA(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by Award Number UL1TR000075 from the National Institutes of Health National Center for Research Resources. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health; Department of Defense USAMRAA grant W81XWH-05-1-0616 (Mouse Drug Screening Core); W81XWH-11-1-0782; National Institutes of Health grants K26RR032082; R01-AR050478; 1U54HD053177-01A1 (Wellstone Muscular Dystrophy Center); 2R24HD050846-06 (Integrated Molecular Core for Rehabilitation Medicine); CureCMD (curecmd.org) and Muscular Dystrophy Association (mda.org). Co-Author, Dr. A Rutkowski, is a member of CureCMD and assisted with study design and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Collins J, 2010, CURR NEUROL NEUROSCI, V10, P83, DOI 10.1007/s11910-010-0092-8; Dominov JA, 2005, HUM MOL GENET, V14, P1029, DOI 10.1093/hmg/ddi095; Erb M, 2009, J PHARMACOL EXP THER, V331, P787, DOI 10.1124/jpet.109.160754; Girgenrath M, 2004, J CLIN INVEST, V114, P1635, DOI 10.1172/JCI200422928; Hayashi YK, 2001, NEUROMUSCULAR DISORD, V11, P350, DOI 10.1016/S0960-8966(00)00203-0; Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705; Miller R, 2007, NEUROLOGY, V69, P776, DOI 10.1212/01.wnl.0000269676.07319.09; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Muntoni F, 2004, NEUROMUSCULAR DISORD, V14, P635, DOI 10.1016/j.nmd.2004.06.009; Nagaraju K, 2000, P NATL ACAD SCI USA, V97, P9209, DOI 10.1073/pnas.97.16.9209; Olanow CW, 2006, LANCET NEUROL, V5, P1013, DOI 10.1016/S1474-4422(06)70602-0; Raben N, 1998, J BIOL CHEM, V273, P19086, DOI 10.1074/jbc.273.30.19086; Raben N, 2000, NEUROMUSCULAR DISORD, V10, P283, DOI 10.1016/S0960-8966(99)00117-0; Sagot Y, 2000, BRIT J PHARMACOL, V131, P721, DOI 10.1038/sj.bjp.0703633; Spurney CF, 2011, J CARDIOVASC PHARM T, V16, P87, DOI 10.1177/1074248410381757; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; Waldmeier PC, 2000, ADV RES NEURODEGENER, V8, P197; XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297	19	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65468	10.1371/journal.pone.0065468	http://dx.doi.org/10.1371/journal.pone.0065468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762378	gold, Green Submitted, Green Published			2022-12-25	WOS:000321099000071
J	Luo, M; Velikovsky, CA; Yang, XB; Siddiqui, MA; Hong, X; Barchi, JJ; Gildersleeve, JC; Pancer, Z; Mariuzza, RA				Luo, Ming; Velikovsky, C. Alejandro; Yang, Xinbo; Siddiqui, Maqbool A.; Hong, Xia; Barchi, Joseph J., Jr.; Gildersleeve, Jeffrey C.; Pancer, Zeev; Mariuzza, Roy A.			Recognition of the Thomsen-Friedenreich Pancarcinoma Carbohydrate Antigen by a Lamprey Variable Lymphocyte Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR RECOGNITION; STRUCTURAL INSIGHTS; BINDING; EVOLUTION; ANTIBODY; THERMODYNAMICS; GLYCOSYLATION; SPECIFICITY; SITES	Variable lymphocyte receptors (VLRs) are leucine-rich repeat proteins that mediate adaptive immunity in jawless vertebrates. VLRs were recently shown to recognize glycans, such as the tumor-associated Thomsen-Friedenreich antigen (TF alpha; Gal beta 1-3GalNAc alpha), with a selectivity rivaling or exceeding that of lectins and antibodies. To understand the basis for TF alpha recognition by one such VLR (VLRB.aGPA.23), we measured thermodynamic parameters for the binding interaction and determined the structure of the VLRB.aGPA.23-TF alpha complex to 2.2 angstrom resolution. In the structure, four tryptophan residues form a tight hydrophobic cage encasing the TF alpha disaccharide that completely excludes buried water molecules. This cage together with hydrogen bonding of sugar hydroxyls to polar side chains explains the exquisite selectivity of VLRB.aGPA.23. The topology of the glycan-binding site of VLRB.aGPA.23 differs markedly from those of lectins or antibodies, which typically consist of long, convex grooves for accommodating the oligosaccharide. Instead, the TF alpha disaccharide is sandwiched between a variable loop and the concave surface of the VLR formed by the beta-strands of the leucine-rich repeat modules. Longer oligosaccharides are predicted to extend perpendicularly across the beta-strands, requiring them to bend to match the concavity of the VLR solenoid.	[Luo, Ming; Velikovsky, C. Alejandro; Yang, Xinbo; Mariuzza, Roy A.] Univ Maryland, Inst Biosci & Biotechnol Res, WM Keck Lab Struct Biol, Rockville, MD 20850 USA; [Luo, Ming] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Luo, Ming] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Velikovsky, C. Alejandro; Yang, Xinbo; Mariuzza, Roy A.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Siddiqui, Maqbool A.; Barchi, Joseph J., Jr.; Gildersleeve, Jeffrey C.] NCI, Biol Chem Lab, Ctr Canc Res, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Hong, Xia; Pancer, Zeev] Univ Maryland, Sch Med, Inst Marine & Environm Technol, Baltimore, MD 21202 USA; [Hong, Xia; Pancer, Zeev] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21202 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; University System of Maryland; University of Maryland Baltimore	Mariuzza, RA (corresponding author), Univ Maryland, Inst Biosci & Biotechnol Res, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	rmariuzz@umd.edu	Gildersleeve, Jeffrey/N-3392-2014; Barchi, Joseph J/N-3784-2014	Gildersleeve, Jeffrey/0000-0002-3744-6423; Barchi, Joseph/0000-0001-9906-0799	National Institutes of Health (NIH) [AI036900, AI083892]; NIH, NCI; National Science Foundation [MCB-0614672]; China Scholarship Council; NATIONAL CANCER INSTITUTE [ZIABC010740, ZIABC011232, ZIABC010451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036900, R21AI083892, R01AI036900] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants AI036900 (to R. A. M.) and AI083892 (to Z. P.) and by the intramural research program of the NIH, NCI (to J. J. B. and J. C. G.). This work was also supported by National Science Foundation Grant MCB-0614672 (to Z. P.).; Supported by the Joint Supervision Ph.D. Project of the China Scholarship Council.	Akke M, 2012, BIOCHEM SOC T, V40, P419, DOI 10.1042/BST20110750; Almogren Adel, 2012, Front Biosci (Schol Ed), V4, P840; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Boehm T, 2012, ANNU REV IMMUNOL, V30, P203, DOI 10.1146/annurev-immunol-020711-075038; Boehm T, 2011, NAT REV IMMUNOL, V11, P307, DOI 10.1038/nri2944; Boltz KW, 2009, ANALYST, V134, P650, DOI 10.1039/b823156g; BRUMMELL DA, 1993, BIOCHEMISTRY-US, V32, P1180, DOI 10.1021/bi00055a024; BUNDLE DR, 1994, BIOCHEMISTRY-US, V33, P5172, DOI 10.1021/bi00183a022; Corzana F, 2007, J AM CHEM SOC, V129, P9458, DOI 10.1021/ja072181b; Dam TK, 2002, CHEM REV, V102, P387, DOI 10.1021/cr000401x; Deng L, 2013, ANNU REV BIOPHYS, V42, P191, DOI 10.1146/annurev-biophys-083012-130422; Deng L, 2010, P NATL ACAD SCI USA, V107, P13408, DOI 10.1073/pnas.1005475107; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Han BW, 2008, SCIENCE, V321, P1834, DOI 10.1126/science.1162484; Hong X, 2013, ACS CHEM BIOL, V8, P152, DOI 10.1021/cb300399s; Hu D, 2012, J BIOL CHEM, V287, P20313, DOI 10.1074/jbc.M112.351965; Imberty A, 2005, CURR OPIN STRUC BIOL, V15, P525, DOI 10.1016/j.sbi.2005.08.003; Julien JP, 2012, IMMUNOL REV, V250, P180, DOI 10.1111/imr.12005; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Kirchdoerfer RN, 2012, STRUCTURE, V20, P479, DOI 10.1016/j.str.2012.01.009; Li Q, 2010, INT J CANCER, V126, P459, DOI 10.1002/ijc.24716; Mallajosyula SS, 2011, J PHYS CHEM B, V115, P11215, DOI 10.1021/jp203695t; Manimala JC, 2007, GLYCOBIOLOGY, V17, p17C, DOI 10.1093/glycob/cwm047; Manimala JC, 2006, ANGEW CHEM INT EDIT, V45, P3607, DOI 10.1002/anie.200600591; Moulaei T, 2010, STRUCTURE, V18, P1104, DOI 10.1016/j.str.2010.05.016; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PISANO A, 1993, GLYCOBIOLOGY, V3, P429, DOI 10.1093/glycob/3.5.429; Powlesland AS, 2009, GLYCOBIOLOGY, V19, P899, DOI 10.1093/glycob/cwp065; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; Sakai K, 2010, J BIOCHEM, V147, P809, DOI 10.1093/jb/mvq014; SIGURSKJOLD BW, 1992, J BIOL CHEM, V267, P8371; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sun W, 2010, CURR PHARM DESIGN, V16, P2269, DOI 10.2174/138161210791792877; Tasumi S, 2009, P NATL ACAD SCI USA, V106, P12891, DOI 10.1073/pnas.0904443106; Varki A., 2009, ESSENTIALS GLYCOBIOL; Velikovsky CA, 2009, NAT STRUCT MOL BIOL, V16, P725, DOI 10.1038/nsmb.1619; Vyas NK, 2002, BIOCHEMISTRY-US, V41, P13575, DOI 10.1021/bi0261387	37	30	32	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23597	23606		10.1074/jbc.M113.480467	http://dx.doi.org/10.1074/jbc.M113.480467			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23782692	hybrid, Green Published			2022-12-25	WOS:000330598200063
J	Djokic, J; Fagotto-Kaufmann, C; Bartels, R; Nelea, V; Reinhardt, DP				Djokic, Jelena; Fagotto-Kaufmann, Christine; Bartels, Rainer; Nelea, Valentin; Reinhardt, Dieter P.			Fibulin-3,-4, and-5 Are Highly Susceptible to Proteolysis, Interact with Cells and Heparin, and Form Multimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASES; MACULAR DEGENERATION; PROTEIN; FIBRILLIN-1; EXPRESSION; ELASTOGENESIS; BINDING; FIBULIN-5/DANCE; MUTATIONS; MOLECULES	Extracellular short fibulins, fibulin-3, -4, and -5, are components of the elastic fiber/microfibril system and are implicated in the formation and homeostasis of elastic tissues. In this study, we report new structural and functional properties of the short fibulins. Full-length human short fibulins were recombinantly expressed in human embryonic kidney cells and purified by immobilized metal ion affinity chromatography. All three fibulins showed various levels of degradation after the purification procedure. N-terminal sequencing revealed that all three fibulins are highly susceptible to proteolysis within the N-terminal linker region of the first calcium-binding epidermal growth factor domain. Proteolytic susceptibility of the linker correlated with its length. Exposure of these fibulins to matrix metalloproteinase (MMP)-1, -2, -3, -7, -9, and -12 resulted in similar proteolytic fragments with MMP-7 and -12 being the most potent proteases. Fibulin-3 proteolysis was almost completely inhibited in cell culture by the addition of 25 mu M doxycycline (a broad spectrum MMP inhibitor). Reducible fibulin-4 dimerization and multimerization were consistently observed by SDS-PAGE, Western blotting, and mass spectrometry. Atomic force microscopy identified monomers, dimers, and multimers in purified fibulin-4 preparations with sizes of similar to 10-15, similar to 20-25, and similar to 30-50 nm, respectively. All short fibulins strongly adhered to human fibroblasts and smooth muscle cells. Although only fibulin-5 has an RGD integrin binding site, all short fibulins adhere at a similar level to the respective cells. Solid phase binding assays detected strong calcium-dependent binding of the short fibulins to immobilized heparin, suggesting that these fibulins may bind cell surface-located heparan sulfate.	[Djokic, Jelena; Nelea, Valentin; Reinhardt, Dieter P.] McGill Univ, Div Biomed Sci, Fac Dent, Montreal, PQ H3A 0C7, Canada; [Fagotto-Kaufmann, Christine; Reinhardt, Dieter P.] McGill Univ, Dept Anat & Cell Biol, Fac Med, Montreal, PQ H3A 0C7, Canada; [Bartels, Rainer] Airway Res Ctr North, Res Ctr Borstel, Div Struct Biochem, Leibniz Ctr Med & Biosci, D-23845 Borstel, Germany	McGill University; McGill University; Forschungszentrum Borstel	Reinhardt, DP (corresponding author), McGill Univ, Dept Anat & Cell Biol, 3640 Univ St, Montreal, PQ H3A 0C7, Canada.	dieter.reinhardt@mcgill.ca	Reinhardt, Dieter P/A-3102-2008	Reinhardt, Dieter P/0000-0001-6535-9872	Natural Sciences and Engineering Research Council of Canada [RGPIN 375738-09]; Canadian Institutes of Health Research [MOP-106494]; Network for Oral and Bone Health Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Network for Oral and Bone Health Research	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant RGPIN 375738-09, Canadian Institutes of Health Research Grant MOP-106494, and the Network for Oral and Bone Health Research.	ALBIN RJ, 1987, AM REV RESPIR DIS, V135, P1281; Ashworth JL, 1999, BIOCHEM J, V340, P171, DOI 10.1042/0264-6021:3400171; Boyle MJ, 2010, BLOOD, V115, P4559, DOI 10.1182/blood-2009-09-243725; BRUNE DC, 1992, ANAL BIOCHEM, V207, P285, DOI 10.1016/0003-2697(92)90013-W; Budatha M, 2011, J CLIN INVEST, V121, P2048, DOI 10.1172/JCI45636; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Choudhury R, 2009, J BIOL CHEM, V284, P24553, DOI 10.1074/jbc.M109.019364; Cooley MA, 2011, BIOL EXTRACELL MATR, P337, DOI 10.1007/978-3-642-16555-9_10; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; El-Hallous E, 2007, J BIOL CHEM, V282, P8935, DOI 10.1074/jbc.M608204200; Franco C, 2006, AM J PATHOL, V168, P1697, DOI 10.2353/ajpath.2006.050613; Freeman LJ, 2005, BIOCHEM J, V388, P1, DOI 10.1042/BJ20050368; Giltay R, 1999, MATRIX BIOL, V18, P469, DOI 10.1016/S0945-053X(99)00038-4; Gu W, 2011, EUR J DERMATOL, V21, P717, DOI 10.1684/ejd.2011.1449; Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026; Horiguchi M, 2009, P NATL ACAD SCI USA, V106, P19029, DOI 10.1073/pnas.0908268106; Hubmacher D, 2010, J BIOL CHEM, V285, P1188, DOI 10.1074/jbc.M109.021246; Hucthagowder V, 2006, AM J HUM GENET, V78, P1075, DOI 10.1086/504304; Jackson V, 2012, J THORAC CARDIOV SUR, V144, P459, DOI 10.1016/j.jtcvs.2011.08.043; Jones RPO, 2010, INVEST OPHTH VIS SCI, V51, P2356, DOI 10.1167/iovs.09-4620; Jones RPO, 2009, J BIOL CHEM, V284, P25938, DOI 10.1074/jbc.M109.011627; Kaijzel EL, 2010, CIRC-CARDIOVASC IMAG, V3, P567, DOI 10.1161/CIRCIMAGING.109.933093; Kapustin A, 2012, BIOCHEM J, V443, P491, DOI 10.1042/BJ20110348; Kett WC, 2005, ANAL BIOCHEM, V339, P206, DOI 10.1016/j.ab.2005.01.054; Kirschner R, 2011, J BIOL CHEM, V286, P32810, DOI 10.1074/jbc.M111.221804; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; Koullias GJ, 2004, ANN THORAC SURG, V78, P2106, DOI 10.1016/j.athoracsur.2004.05.088; Kridel SJ, 2001, J BIOL CHEM, V276, P20572, DOI 10.1074/jbc.M100900200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LECKACZERNIK B, 1995, MOL CELL BIOL, V15, P120, DOI 10.1128/MCB.15.1.120; Li DQ, 2000, INVEST OPHTH VIS SCI, V41, P404; Lin GQ, 2002, J BIOL CHEM, V277, P50795, DOI 10.1074/jbc.M210611200; Lomas AC, 2007, BIOCHEM J, V405, P417, DOI 10.1042/BJ20070400; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; McLaughlin PJ, 2007, HUM MOL GENET, V16, P3059, DOI 10.1093/hmg/ddm264; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Sekhon BS, 2010, RES REP BIOL, V1, P1, DOI 10.2147/RRB.S12043; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200; VINE N, 1991, CLIN SCI, V81, P233, DOI 10.1042/cs0810233; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Xin X, 2011, BIOL PHARM BULL, V34, P480, DOI 10.1248/bpb.34.480; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yue W, 2009, CANCER RES, V69, P6339, DOI 10.1158/0008-5472.CAN-09-0398; Zheng Q, 2007, MOL CELL BIOL, V27, P1083, DOI 10.1128/MCB.01330-06	47	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22821	22835		10.1074/jbc.M112.439158	http://dx.doi.org/10.1074/jbc.M112.439158			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782690	Green Published, hybrid			2022-12-25	WOS:000330596300059
J	Sunahori, K; Nagpal, K; Hedrich, CM; Mizui, M; Fitzgerald, LM; Tsokos, GC				Sunahori, Katsue; Nagpal, Kamalpreet; Hedrich, Christian M.; Mizui, Masayuki; Fitzgerald, Lisa M.; Tsokos, George C.			The Catalytic Subunit of Protein Phosphatase 2A (PP2Ac) Promotes DNA Hypomethylation by Suppressing the Phosphorylated Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (ERK) Kinase (MEK)/Phosphorylated ERK/DNMT1 Protein Pathway in T-cells from Controls and Systemic Lupus Erythematosus Patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Methylation; Epigenetics; ERK; Protein Phosphatase; T-cell; SLE	EPIGENETIC MECHANISMS; CHROMATIN-STRUCTURE; GENE-EXPRESSION; METHYLATION; DEMETHYLATION; LYMPHOCYTES; DETERMINES; DISEASE; TARGETS; ENZYMES	DNA hypomethylation is a characteristic feature of systemic lupus erythematosus (SLE) immune cells. Numerous reports have implicated the involvement of the MEK/ERK pathway in the reduction of DNA methyltransferase (DNMT) expression, hence inducing the transcription of methylation-sensitive genes in SLE patients. However, the molecular mechanisms involved remain unclear. Here, we investigated whether the catalytic subunit of protein phosphatase 2A (PP2Ac), which is overexpressed in SLE T-cells, contributes to reduced DNA methylation. We show that both chemical suppression and siRNA silencing of PP2Ac in T-cells resulted in sustained phosphorylation of MEK and ERK following stimulation with phorbol 12-myristate 13-acetate and ionomycin. Furthermore, PP2Ac suppression resulted in increased DNMT enzyme activity, DNA hypermethylation, and decreased expression of methylation-sensitive genes. Similarly, in SLE T-cells, suppression of PP2Ac resulted in increased MEK/ERK phosphorylation, enhanced DNMT1 expression and suppressed expression of the methylation-sensitive CD70 gene. Our results demonstrate that PP2A regulates DNA methylation by influencing the phosphorylation of MEK/ERK. We propose that enhanced PP2Ac in SLE T-cells may dephosphorylate and activate the signaling pathway upstream of DNMT1, thus disturbing the tight control of methylation-sensitive genes, which are involved in SLE pathogenesis.	[Sunahori, Katsue; Nagpal, Kamalpreet; Hedrich, Christian M.; Mizui, Masayuki; Fitzgerald, Lisa M.; Tsokos, George C.] Harvard Univ, Sch Med, Dept Med, Div Rheumatol,Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Nagpal, K (corresponding author), Harvard Univ, Sch Med, Dept Med, Div Rheumatol,Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	knagpal@bidmc.harvard.edu; gtsokos@bidmc.harvard.edu	Hedrich, Christian/AAW-3958-2020; Hedrich, Christian/AAD-6855-2019; Mizui, Masayuki/AAD-1432-2019; tsokos, george C/O-3360-2013	Mizui, Masayuki/0000-0003-2543-8108; tsokos, george C/0000-0001-9589-2360; Hedrich, Christian/0000-0002-1295-6179	NIAID NIH HHS [R01 AI068787] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068787] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ballestar E, 2006, J IMMUNOL, V176, P7143, DOI 10.4049/jimmunol.176.12.7143; Clements EG, 2012, NUCLEIC ACIDS RES, V40, P4334, DOI 10.1093/nar/gks031; Crispin JC, 2007, ANN RHEUM DIS, V66, P65, DOI 10.1136/ard.2007.078493; Crispin JC, 2011, P NATL ACAD SCI USA, V108, P12443, DOI 10.1073/pnas.1103915108; Crispin JC, 2010, NAT REV RHEUMATOL, V6, P317, DOI 10.1038/nrrheum.2010.60; Deng C, 2001, ARTHRITIS RHEUM, V44, P397, DOI 10.1002/1529-0131(200102)44:2<397::AID-ANR59>3.3.CO;2-E; Gorelik G, 2007, J IMMUNOL, V179, P5553, DOI 10.4049/jimmunol.179.8.5553; Gorelik G, 2009, AUTOIMMUN REV, V8, P196, DOI 10.1016/j.autrev.2008.07.043; Hedrich CM, 2012, P NATL ACAD SCI USA, V109, P16606, DOI 10.1073/pnas.1210129109; Hedrich CM, 2012, J BIOL CHEM, V287, P4715, DOI 10.1074/jbc.M111.323261; Hedrich CM, 2011, TRENDS MOL MED, V17, P714, DOI 10.1016/j.molmed.2011.07.005; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Juang YT, 2008, J IMMUNOL, V181, P3658, DOI 10.4049/jimmunol.181.5.3658; Juang YT, 2011, J BIOL CHEM, V286, P1795, DOI 10.1074/jbc.M110.166785; Katsiari CG, 2005, J CLIN INVEST, V115, P3193, DOI 10.1172/JCI24895; Lavoie G, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-31; Liu Y, 2009, CLIN IMMUNOL, V132, P257, DOI 10.1016/j.clim.2009.03.529; Lu Q, 2007, J IMMUNOL, V179, P6352, DOI 10.4049/jimmunol.179.9.6352; Lu QJ, 2005, J IMMUNOL, V174, P6212, DOI 10.4049/jimmunol.174.10.6212; Lu QJ, 2002, BLOOD, V99, P4503, DOI 10.1182/blood.V99.12.4503; Lu QJ, 2002, ARTHRITIS RHEUM, V46, P1282, DOI 10.1002/art.10234; Moulton VR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3251; Patel DR, 2010, CURR OPIN RHEUMATOL, V22, P478, DOI 10.1097/BOR.0b013e32833ae915; RICHARDSON B, 1990, ARTHRITIS RHEUM, V33, P1665, DOI 10.1002/art.1780331109; Richardson B, 2003, CLIN IMMUNOL, V109, P72, DOI 10.1016/S1521-6616(03)00206-7; Richardson B, 2007, NAT CLIN PRACT RHEUM, V3, P521, DOI 10.1038/ncprheum0573; Singer NG, 1996, IMMUNOLOGY, V88, P537; Sunahori K, 2011, J IMMUNOL, V186, P4508, DOI 10.4049/jimmunol.1000340; Sunahori K, 2009, J IMMUNOL, V182, P1500, DOI 10.4049/jimmunol.182.3.1500; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Zhao M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/931018; Zhao M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3214	33	68	72	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21936	10.1074/jbc.M113.467266	http://dx.doi.org/10.1074/jbc.M113.467266			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23775084	hybrid, Green Published			2022-12-25	WOS:000328841900041
J	Baptista, FI; Pinto, MJ; Elvas, F; Almeida, RD; Ambrosio, AF				Baptista, Filipa I.; Pinto, Maria J.; Elvas, Filipe; Almeida, Ramiro D.; Ambrosio, Antonio F.			Diabetes Alters KIF1A and KIF5B Motor Proteins in the Hippocampus	PLOS ONE			English	Article							RETROGRADE AXONAL-TRANSPORT; NERVE GROWTH-FACTOR; VESICLE PRECURSOR TRANSPORT; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; NEURODEGENERATIVE DISEASES; EXOCYTOTIC PROTEINS; SIGNALING PATHWAY; OXIDATIVE STRESS; GENE-EXPRESSION	Diabetes mellitus is the most common metabolic disorder in humans. Diabetic encephalopathy is characterized by cognitive and memory impairments, which have been associated with changes in the hippocampus, but the mechanisms underlying those impairments triggered by diabetes, are far from being elucidated. The disruption of axonal transport is associated with several neurodegenerative diseases and might also play a role in diabetes-associated disorders affecting nervous system. We investigated the effect of diabetes (2 and 8 weeks duration) on KIF1A, KIF5B and dynein motor proteins, which are important for axonal transport, in the hippocampus. The mRNA expression of motor proteins was assessed by qRT-PCR, and also their protein levels by immunohistochemistry in hippocampal slices and immunoblotting in total extracts of hippocampus from streptozotocin-induced diabetic and age-matched control animals. Diabetes increased the expression and immunoreactivity of KIF1A and KIF5B in the hippocampus, but no alterations in dynein were detected. Since hyperglycemia is considered a major player in diabetic complications, the effect of a prolonged exposure to high glucose on motor proteins, mitochondria and synaptic proteins in hippocampal neurons was also studied, giving particular attention to changes in axons. Hippocampal cell cultures were exposed to high glucose (50 mM) or mannitol (osmotic control; 25 mM plus 25 mM glucose) for 7 days. In hippocampal cultures incubated with high glucose no changes were detected in the fluorescence intensity or number of accumulations related with mitochondria in the axons of hippocampal neurons. Nevertheless, high glucose increased the number of fluorescent accumulations of KIF1A and synaptotagmin-1 and decreased KIF5B, SNAP-25 and synaptophysin immunoreactivity specifically in axons of hippocampal neurons. These changes suggest that anterograde axonal transport mediated by these kinesins may be impaired in hippocampal neurons, which may lead to changes in synaptic proteins, thus contributing to changes in hippocampal neurotransmission and to cognitive and memory impairments.	[Baptista, Filipa I.; Elvas, Filipe; Ambrosio, Antonio F.] Univ Coimbra, Ctr Ophthalmol & Vis Sci, IBILI, Fac Med, Coimbra, Portugal; [Baptista, Filipa I.; Elvas, Filipe; Ambrosio, Antonio F.] Univ Coimbra, IBILI, Fac Med, Coimbra, Portugal; [Pinto, Maria J.; Almeida, Ramiro D.; Ambrosio, Antonio F.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Pinto, Maria J.] Univ Coimbra, Ctr Neurosci & Cell Biol, PhD Programme Expt Biol & Biomed PDBEB, Coimbra, Portugal; [Ambrosio, Antonio F.] AIBILI, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Ambrosio, AF (corresponding author), Univ Coimbra, Ctr Ophthalmol & Vis Sci, IBILI, Fac Med, Coimbra, Portugal.	afambrosio@fmed.uc.pt	Almeida, Ramiro D./J-2656-2013; Baptista, Filipa/E-2828-2012; Pinto, Maria Joana MJ Guimarães/L-8990-2016; Ambrósio, António F/I-3722-2012	Almeida, Ramiro D./0000-0001-5830-2595; Baptista, Filipa/0000-0001-7972-640X; Pinto, Maria Joana MJ Guimarães/0000-0001-9730-5772; Ambrósio, António F/0000-0002-0477-1641	FCT, Portugal [PEst-C/SAU/UI3282/2011, PEst-/SAU/LA0001/2011]; COMPETE [PEst-C/SAU/UI3282/2011, PEst-/SAU/LA0001/2011, PTDC/SAU-NEU/104100/2008]; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/35961/2007, SFRH/BD/51196/2010]; FCT; Marie Curie Actions, 7th Famework programme	FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); COMPETE; Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Marie Curie Actions, 7th Famework programme	This work was supported by PEst-C/SAU/UI3282/2011 and PEst-/SAU/LA0001/2011 (FCT, Portugal, and COMPETE). Filipa I. Baptista and Maria J. Pinto acknowledge fellowships from Fundacao para a Ciencia e a Tecnologia, Portugal (SFRH/BD/35961/2007 and SFRH/BD/51196/2010, respectively). Ramiro D. Almeida is supported by FCT and COMPETE (PTDC/SAU-NEU/104100/2008) and by Marie Curie Actions, 7th Famework programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBATE SL, 1991, DIABETES, V40, P111, DOI 10.2337/diabetes.40.1.111; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baptista FI, 2011, BRAIN RES, V1383, P257, DOI 10.1016/j.brainres.2011.01.071; Biessels GJ, 1998, BRAIN RES, V800, P125, DOI 10.1016/S0006-8993(98)00510-1; Biessels GJ, 1996, DIABETES, V45, P1259, DOI 10.2337/diabetes.45.9.1259; Bronk P, 2007, J NEUROPHYSIOL, V98, P794, DOI 10.1152/jn.00226.2007; Brownlees J, 2002, HUM MOL GENET, V11, P2837, DOI 10.1093/hmg/11.23.2837; CALCUTT NA, 1990, J NEUROL SCI, V96, P283, DOI 10.1016/0022-510X(90)90139-E; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Chung CY, 2009, J NEUROSCI, V29, P3365, DOI 10.1523/JNEUROSCI.5427-08.2009; De Vos K, 1998, J BIOL CHEM, V273, P9673, DOI 10.1074/jbc.273.16.9673; De Vos K, 2000, J CELL BIOL, V149, P1207, DOI 10.1083/jcb.149.6.1207; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Delcroix JD, 1998, DIABETES, V47, P1779, DOI 10.2337/diabetes.47.11.1779; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Falzone TL, 2010, HUM MOL GENET, V19, P4399, DOI 10.1093/hmg/ddq363; Falzone TL, 2009, J NEUROSCI, V29, P5758, DOI 10.1523/JNEUROSCI.0780-09.2009; Fang C, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-29; Fernandez DC, 2012, AM J PATHOL, V180, P303, DOI 10.1016/j.ajpath.2011.09.018; Fernyhough Paul, 2010, Expert Rev Endocrinol Metab, V5, P39; Gaspar JM, 2010, NEUROSCIENCE, V171, P981, DOI 10.1016/j.neuroscience.2010.10.019; Gaspar JM, 2010, NEUROSCIENCE, V169, P1589, DOI 10.1016/j.neuroscience.2010.06.021; Grillo CA, 2005, NEUROSCIENCE, V136, P477, DOI 10.1016/j.neuroscience.2005.08.019; HELLWEG R, 1994, EXP NEUROL, V130, P24, DOI 10.1006/exnr.1994.1181; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Ino-ue M, 2000, INVEST OPHTH VIS SCI, V41, P4055; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; JAKOBSEN J, 1981, DIABETES, V30, P797, DOI 10.2337/diab.30.10.797; Kamal A, 1999, NEUROSCIENCE, V90, P737, DOI 10.1016/S0306-4522(98)00485-0; Karle KN, 2012, NEUROGENETICS, V13, P169, DOI 10.1007/s10048-012-0324-y; Kim B, 2009, ENDOCRINOLOGY, V150, P5294, DOI 10.1210/en.2009-0695; Kondo M, 2012, NEURON, V73, P743, DOI 10.1016/j.neuron.2011.12.020; Kuhad A, 2009, PHARMACOL BIOCHEM BE, V92, P251, DOI 10.1016/j.pbb.2008.12.012; Lee JR, 2003, J BIOL CHEM, V278, P2624, DOI 10.1074/jbc.M211152200; Lee PG, 2002, BRAIN RES, V941, P127, DOI 10.1016/S0006-8993(02)02645-8; Lee PG, 2001, EXP NEUROL, V170, P149, DOI 10.1006/exnr.2001.7673; Li ZG, 2005, BRAIN RES, V1037, P12, DOI 10.1016/j.brainres.2004.11.063; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo KY, 2011, NEUROSCI LETT, V491, P168, DOI 10.1016/j.neulet.2011.01.018; McLean WG, 1997, NEUROCHEM RES, V22, P951, DOI 10.1023/A:1022466624223; MEDORI R, 1985, P NATL ACAD SCI USA, V82, P7716, DOI 10.1073/pnas.82.22.7716; Obulesu M, 2011, NEUROCHEM RES, V36, P1329, DOI 10.1007/s11064-011-0475-5; Qu ZS, 2011, BRAIN RES, V1383, P300, DOI 10.1016/j.brainres.2011.01.084; Reddy PH, 2011, BRAIN RES, V1415, P136, DOI 10.1016/j.brainres.2011.07.052; Sharma R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013463; Sima AAF, 2005, DIABETES, V54, P1497, DOI 10.2337/diabetes.54.5.1497; Sima Anders A F, 2009, Rev Diabet Stud, V6, P37, DOI 10.1900/RDS.2009.6.37; Stagi M, 2005, J NEUROSCI, V25, P352, DOI 10.1523/JNEUROSCI.3887-04.2005; Stagi M, 2006, FASEB J, V20, P2573, DOI 10.1096/fj.06-6679fje; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; YAGIHASHI S, 1990, AM J PATHOL, V136, P1365; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zhang LX, 2000, CURR EYE RES, V20, P131, DOI 10.1076/0271-3683(200002)20:2;1-D;FT131	54	35	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65515	10.1371/journal.pone.0065515	http://dx.doi.org/10.1371/journal.pone.0065515			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776493	Green Published, Green Submitted, gold			2022-12-25	WOS:000320322400031
J	Kulesskaya, N; Voikar, V; Peltola, M; Yegutkin, GG; Salmi, M; Jalkanen, S; Rauvala, H				Kulesskaya, Natalia; Voikar, Vootele; Peltola, Marjaana; Yegutkin, Gennady G.; Salmi, Marko; Jalkanen, Sirpa; Rauvala, Heikki			CD73 Is a Major Regulator of Adenosinergic Signalling in Mouse Brain	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ADULT-RATS; RECEPTOR INTERACTIONS; MALLEABLE SYNAPSES; LOCOMOTOR-ACTIVITY; TRANSGENIC MICE; SOCIAL APPROACH; A(1) RECEPTOR; ANIMAL-MODELS; GLIAL-CELLS	CD73 (ecto-5'-nucleotidase) is a cell surface enzyme that regulates purinergic signalling by desphosphorylating extracellular AMP to adenosine. 59-nucleotidases are known to be expressed in brain, but the expression of CD73 and its putative physiological functions at this location remain elusive. Here we found, using immunohistochemistry of wild-type and CD73 deficient mice, that CD73 is prominently expressed in the basal ganglia core comprised of striatum (caudate nucleus and putamen) and globus pallidus. Furthermore, meninges and the olfactory tubercle were found to specifically express CD73. Analysis of wild type (wt) and CD73 deficient mice revealed that CD73 confers the majority of 5'-nucleotidase activity in several areas of the brain. In a battery of behavioural tests and in IntelliCage studies, the CD73 deficient mice demonstrated significantly enhanced exploratory locomotor activity, which probably reflects the prominent expression of CD73 in striatum and globus pallidus that are known to control locomotion. Furthermore, the CD73 deficient mice displayed altered social behaviour. Overall, our data provide a novel mechanistic insight into adenosinergic signalling in brain, which is implicated in the regulation of normal and pathological behaviour.	[Kulesskaya, Natalia; Voikar, Vootele; Peltola, Marjaana; Rauvala, Heikki] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Kulesskaya, Natalia; Voikar, Vootele] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Yegutkin, Gennady G.; Salmi, Marko; Jalkanen, Sirpa] Univ Turku, MediCity, Turku, Finland; [Yegutkin, Gennady G.; Salmi, Marko; Jalkanen, Sirpa] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland; [Yegutkin, Gennady G.; Salmi, Marko; Jalkanen, Sirpa] Natl Inst Hlth & Welf, Turku, Finland; [Salmi, Marko] Univ Turku, Dept Med Biochem & Genet, Turku, Finland	University of Helsinki; University of Helsinki; University of Turku; University of Turku; Finland National Institute for Health & Welfare; University of Turku	Voikar, V (corresponding author), Univ Helsinki, Ctr Neurosci, Helsinki, Finland.	vootele.voikar@gmail.com; heikki.rauvala@helsinki.fi	Yegutkin, Gennady G./K-3815-2014; Voikar, Vootele/V-4542-2019	Yegutkin, Gennady G./0000-0001-6684-7982; Voikar, Vootele/0000-0003-4201-8666; Rauvala, Heikki/0000-0001-7809-9811; Kulesskaya, Natalia/0000-0001-5517-8525	Finnish Academy; Biocenter Finland; Sigrid JusA(C)lius Foundation	Finnish Academy(Academy of Finland); Biocenter Finland; Sigrid JusA(C)lius Foundation	This work was supported by the Finnish Academy, Biocenter Finland and the Sigrid JusA (c) lius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boison D, 2010, CELL DEATH DIFFER, V17, P1071, DOI 10.1038/cdd.2009.131; Bonan CD, 2000, BRAIN RES, V854, P253, DOI 10.1016/S0006-8993(99)02300-8; Bonan CD, 1998, NEUROCHEM RES, V23, P977, DOI 10.1023/A:1021084422228; Burnstock G, 2011, PROG NEUROBIOL, V95, P229, DOI 10.1016/j.pneurobio.2011.08.006; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Ferre S, 1997, TRENDS NEUROSCI, V20, P482, DOI 10.1016/S0166-2236(97)01096-5; Florio C, 1997, LIFE SCI, V60, P1477, DOI 10.1016/S0024-3205(97)00099-4; Gammie SC, 2007, GENES BRAIN BEHAV, V6, P432, DOI 10.1111/j.1601-183X.2006.00271.x; Gimenez-Llort L, 2002, EUR J NEUROSCI, V16, P547, DOI 10.1046/j.1460-9568.2002.02122.x; Gotoh L, 2009, PSYCHIAT GENET, V19, P328, DOI 10.1097/YPG.0b013e3283328e26; Gould TD, 2006, GENES BRAIN BEHAV, V5, P113, DOI 10.1111/j.1601-183X.2005.00186.x; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jones BE, 2009, NEURON, V61, P156, DOI 10.1016/j.neuron.2009.01.005; Kalueff AV, 2006, BEHAV PROCESS, V71, P8, DOI 10.1016/j.beproc.2005.09.004; Karpa MJ, 2010, J AGING HEALTH, V22, P154, DOI 10.1177/0898264309353066; Kiss J, 2008, EUR J IMMUNOL, V38, P3041, DOI 10.1002/eji.200838651; Koszalka P, 2004, CIRC RES, V95, P814, DOI 10.1161/01.RES.0000144796.82787.6f; Krackow S, 2010, GENES BRAIN BEHAV, V9, P722, DOI 10.1111/j.1601-183X.2010.00606.x; Langer D, 2008, CELL TISSUE RES, V334, P199, DOI 10.1007/s00441-008-0681-x; Lazic SE, 2007, BRAIN RES, V1151, P219, DOI 10.1016/j.brainres.2007.03.018; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; MESSERI P, 1975, PHYSIOL BEHAV, V14, P53, DOI 10.1016/0031-9384(75)90141-9; Mills JH, 2008, P NATL ACAD SCI USA, V105, P9325, DOI 10.1073/pnas.0711175105; Moy SS, 2009, GENES BRAIN BEHAV, V8, P129, DOI 10.1111/j.1601-183X.2008.00452.x; Murphy C, 2009, ANN NY ACAD SCI, V1170, P647, DOI 10.1111/j.1749-6632.2009.04486.x; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Niemela J, 2008, EUR J IMMUNOL, V38, P2718, DOI 10.1002/eji.200838437; Oka H, 2010, J NEUROL, V257, P969, DOI 10.1007/s00415-009-5447-1; Powell CM, 2006, BIOL PSYCHIAT, V59, P1198, DOI 10.1016/j.biopsych.2006.05.008; Ribeiro JA, 2002, PROG NEUROBIOL, V68, P377, DOI 10.1016/S0301-0082(02)00155-7; Salamone John D, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS130, DOI 10.1016/j.parkreldis.2008.04.017; Salmi P, 2005, J MOL NEUROSCI, V26, P239, DOI 10.1385/JMN:26:2-3:239; Sanchez-Andrade G, 2009, BEHAV BRAIN RES, V200, P323, DOI 10.1016/j.bbr.2008.12.021; SCHOEN SW, 1995, NEUROSCIENCE, V65, P37, DOI 10.1016/0306-4522(94)00469-L; Schoen SW, 1997, BRAIN RES PROTOC, V1, P33, DOI 10.1016/S1385-299X(96)00006-2; Sebastiao AM, 2009, CURR NEUROPHARMACOL, V7, P180, DOI 10.2174/157015909789152128; Shen HY, 2009, CURR NEUROPHARMACOL, V7, P195, DOI 10.2174/157015909789152191; Sowa NA, 2010, J NEUROSCI, V30, P2235, DOI 10.1523/JNEUROSCI.5324-09.2010; Stork O, 1997, EUR J NEUROSCI, V9, P1117, DOI 10.1111/j.1460-9568.1997.tb01464.x; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Vinkers CH, 2009, NEUROSCIENCE, V159, P39, DOI 10.1016/j.neuroscience.2008.12.009; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Voikar V, 2005, GENES BRAIN BEHAV, V4, P240, DOI 10.1111/j.1601-183X.2004.00103.x; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; Wrenn CC, 2003, BEHAV NEUROSCI, V117, P21, DOI 10.1037/0735-7044.117.1.21; Xie XB, 2007, COMPARATIVE MED, V57, P538; Yaar R, 2005, J CELL PHYSIOL, V202, P9, DOI 10.1002/jcp.20138; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yegutkin GG, 2001, FASEB J, V15, P251, DOI 10.1096/fj.00-0268com; Zimmermann H, 1996, PROG NEUROBIOL, V49, P589, DOI 10.1016/0301-0082(96)00026-3; Zlomuzica A, 2012, PURINERGIS IN PRESS	54	38	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66896	10.1371/journal.pone.0066896	http://dx.doi.org/10.1371/journal.pone.0066896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776700	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400120
J	Pesce, A; Tilleman, L; Donne, J; Aste, E; Ascenzi, P; Ciaccio, C; Coletta, M; Moens, L; Viappiani, C; Dewilde, S; Bolognesi, M; Nardini, M				Pesce, Alessandra; Tilleman, Lesley; Donne, Joke; Aste, Elisa; Ascenzi, Paolo; Ciaccio, Chiara; Coletta, Massimo; Moens, Luc; Viappiani, Cristiano; Dewilde, Sylvia; Bolognesi, Martino; Nardini, Marco			Structure and Haem-Distal Site Plasticity in Methanosarcina acetivorans Protoglobin	PLOS ONE			English	Article							GLOBIN-COUPLED SENSORS; BINDING; HEMOGLOBINS; MYOGLOBIN; PROTEINS; CAVITIES; AFFINITY; MODEL; LIFE	Protoglobin from Methanosarcina acetivorans C2A (MaPgb), a strictly anaerobic methanogenic Archaea, is a dimeric haem-protein whose biological role is still unknown. As other globins, protoglobin can bind O-2, CO and NO reversibly in vitro, but it displays specific functional and structural properties within members of the hemoglobin superfamily. CO binding to and dissociation from the haem occurs through biphasic kinetics, which arise from binding to (and dissociation from) two distinct tertiary states in a ligation-dependent equilibrium. From the structural viewpoint, protoglobin-specific loops and a N-terminal extension of 20 residues completely bury the haem within the protein matrix. Thus, access of small ligand molecules to the haem is granted by two apolar tunnels, not common to other globins, which reach the haem distal site from locations at the B/G and B/E helix interfaces. Here, the roles played by residues Trp(60)B9, Tyr(61)B10 and Phe(93)E11 in ligand recognition and stabilization are analyzed, through crystallographic investigations on the ferric protein and on selected mutants. Specifically, protein structures are reported for protoglobin complexes with cyanide, with azide (also in the presence of Xenon), and with more bulky ligands, such as imidazole and nicotinamide. Values of the rate constant for cyanide dissociation from ferric MaPgb-cyanide complexes have been correlated to hydrogen bonds provided by Trp(60)B9 and Tyr(61)B10 that stabilize the haem-Fe(III)-bound cyanide. We show that protoglobin can strikingly reshape, in a ligand-dependent way, the haem distal site, where Phe(93)E11 acts as ligand sensor and controls accessibility to the haem through the tunnel system by modifying the conformation of Trp(60)B9.	[Pesce, Alessandra; Aste, Elisa] Univ Genoa, Dept Phys, Genoa, Italy; [Tilleman, Lesley; Donne, Joke; Moens, Luc; Dewilde, Sylvia] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Ascenzi, Paolo] Univ Roma Tre, Interdept Lab Electron Microscopy, Rome, Italy; [Ascenzi, Paolo] Natl Res Council CNR, Inst Prot Biochem, Naples, Italy; [Ciaccio, Chiara; Coletta, Massimo] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy; [Ciaccio, Chiara; Coletta, Massimo] Interunivers Consortium Res Chem Met Biol Syst, Bari, Italy; [Viappiani, Cristiano] Univ Parma, Dept Phys & Earth Sci, I-43100 Parma, Italy; [Bolognesi, Martino; Nardini, Marco] Univ Milan, Dept Biosci, Milan, Italy; [Bolognesi, Martino] Univ Milan, Natl Res Council Biophys Inst CNR IBF, Milan, Italy; [Bolognesi, Martino] Univ Milan, Interdisciplinary Ctr Nanostruct Mat & Interfaces, Milan, Italy	University of Genoa; University of Antwerp; Roma Tre University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); University of Rome Tor Vergata; University of Parma; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan; University of Milan	Nardini, M (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	marco.nardini@unimi.it	Viappiani, Cristiano/AAC-7579-2019; Nardini, Marco/B-7842-2017; Bolognesi, Martino/B-7924-2017; Pesce, Alessandra/A-3660-2015; Coletta, Massimiliano/GSN-5927-2022; Coletta, Massimo/N-9049-2015	Viappiani, Cristiano/0000-0001-7470-4770; Nardini, Marco/0000-0002-3718-2165; Bolognesi, Martino/0000-0002-9253-5170; COLETTA, Massimiliano/0000-0002-5489-9467	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca [2008BFJ34R]; Azioni Integrate Italia Spagna [IT10L1M59M]; Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese [20112013]; University of Antwerp; Fund for Scientific Research, Flanders, Belgium [G.0247.09]; Ministry for University; Research of Italy (University Roma Tre, Roma, Italy; University of Milano	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Azioni Integrate Italia Spagna; Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese; University of Antwerp; Fund for Scientific Research, Flanders, Belgium(FWO); Ministry for University; Research of Italy (University Roma Tre, Roma, Italy; University of Milano	The authors acknowledge the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN 2008, 2008BFJ34R, and Azioni Integrate Italia Spagna 2009, IT10L1M59M), and Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese (Progetti di Grande Rilevanza, Italia-Argentina 20112013), the University of Antwerp and the Fund for Scientific Research, Flanders, Belgium (Grant No G.0247.09) for financial support. This work was partially supported by grants from the Ministry for University and Research of Italy (University Roma Tre, Roma, Italy, "CLAR 2012''.) and by institutional funds from University of Milano (FIRST-2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzetti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033614; APPLEBY CA, 1973, P NATL ACAD SCI USA, V70, P564, DOI 10.1073/pnas.70.2.564; Ascenzi P, 2013, BIOCHEM BIOPH RES CO, V430, P1301, DOI 10.1016/j.bbrc.2012.11.122; Ascenzi P, 2010, BIOCHEM BIOPH RES CO, V393, P196, DOI 10.1016/j.bbrc.2010.01.092; Bikiel DE, 2010, J PHYS CHEM B, V114, P8536, DOI 10.1021/jp102135p; Bolognesi M, 1997, PROG BIOPHYS MOL BIO, V68, P29, DOI 10.1016/S0079-6107(97)00017-5; Bolognesi M, 1999, BIOPHYS J, V77, P1093, DOI 10.1016/S0006-3495(99)76959-6; Ciaccio C, 2013, BIOCH BIOPH IN PRESS, DOI [10.1016/j.bbapap.2013.02.026, DOI 10.1016/J.BBAPAP.2013.02.026.IN]; de Sanctis D, 2004, BIOCHEM BIOPH RES CO, V316, P1217, DOI 10.1016/j.bbrc.2004.03.007; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS PR, 1993, P CCP4 STUD WEEK DAT; Ferry JG, 2006, MOL BIOL EVOL, V23, P1286, DOI 10.1093/molbev/msk014; Freitas TAK, 2005, J INORG BIOCHEM, V99, P23, DOI 10.1016/j.jinorgbio.2004.10.024; Freitas TAK, 2004, P NATL ACAD SCI USA, V101, P6675, DOI 10.1073/pnas.0308657101; Freitas TAK, 2003, FEBS LETT, V552, P99, DOI 10.1016/S0014-5793(03)00923-2; Hou SB, 2001, P NATL ACAD SCI USA, V98, P9353, DOI 10.1073/pnas.161185598; Knapp JE, 2009, STRUCTURE, V17, P1494, DOI 10.1016/j.str.2009.09.004; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGM, 2003, MOSFLM USER GUIDE MO; Marti MA, 2006, J INORG BIOCHEM, V100, P761, DOI 10.1016/j.jinorgbio.2005.12.009; Milani M, 2004, J BIOL CHEM, V279, P21520, DOI 10.1074/jbc.M401320200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nardini M, 2008, EMBO REP, V9, P157, DOI 10.1038/sj.embor.7401153; Pesce A, 2011, IUBMB LIFE, V63, P287, DOI 10.1002/iub.484; Pesce A, 2009, J MOL BIOL, V386, P246, DOI 10.1016/j.jmb.2008.12.023; Rother M, 2004, P NATL ACAD SCI USA, V101, P16929, DOI 10.1073/pnas.0407486101; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Vinogradov SN, 2007, GENE, V398, P132, DOI 10.1016/j.gene.2007.02.041; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2	31	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66144	10.1371/journal.pone.0066144	http://dx.doi.org/10.1371/journal.pone.0066144			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776624	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400084
J	Hsieh, MH; Chou, PC; Chou, CL; Ho, SC; Joa, WC; Chen, LF; Sheng, TF; Lin, HC; Wang, TY; Chang, PJ; Wang, CH; Kuo, HP				Hsieh, Meng-Heng; Chou, Pai-Chien; Chou, Chun-Liang; Ho, Shu-Chuan; Joa, Wen-Ching; Chen, Li-Fei; Sheng, Te-Fang; Lin, Horng-Chyuan; Wang, Tsai-Yu; Chang, Po-Jui; Wang, Chun-Hua; Kuo, Han-Pin			Matrix Metalloproteinase-1 Polymorphism (-1607G) and Disease Severity in Non-Cystic Fibrosis Bronchiectasis in Taiwan	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; IDIOPATHIC PULMONARY-FIBROSIS; MYCOBACTERIUM-TUBERCULOSIS; TISSUE INHIBITOR; EPITHELIAL-CELLS; GENE-EXPRESSION; PROMOTER POLYMORPHISM; DERMAL FIBROBLASTS; MMP-1 PROMOTER; MELANOMA-CELLS	Objectives: Bronchiectasis is characterized by an irreversible dilatation of bronchi and is associated with lung fibrosis. MMP-1 polymorphism may alter its transcriptional activity, and differentially modulate bronchial destruction and lung fibrosis. Design: To investigate the association of MMP-1 polymorphisms with disease severity in non-cystic fibrosis (CF) bronchiectasis patients, 51 normal subjects and 113 patients with bronchiectasis were studied. The associations between MMP-1 polymorphisms, lung function, and disease severity evaluated by high resolution computed tomography (HRCT) were analyzed. Results: The frequency of MMP-1(-1607G) allele was significantly higher in patients with bronchiectasis than normal subjects (70.8% vs 45.1%, p < 0.01). Forced expiratory volume in 1 second (FEV1) was decreased in bronchiectasis patients with 1G/1G (1.2 +/- 0.1 L, n = 14) and 1G/2G (1.3 +/- 0.1 L, n = 66) genotypes compared to the 2G/2G genotype (1.7 +/- 0.1 L, n = 33, p < 0.01). Six minute walking distance was decreased in bronchiectasis patients with 1G/1G and 1G/2G compared to that of 2G/2G genotype. Disease severity evaluated by HRCT score significantly increased in bronchiectasis patients with 1G/1G and 1G/2G genotypes compared to that of 2G/2G genotype. Bronchiectasis patients with at least one MMP-1 (-1607G) allele showed increased tendency for hospitalization. Serum levels of pro-MMP-1, active MMP-1 and TGF-beta 1 were significantly increased in patients with bronchiectasis with 1G/1G and 1G/2G genotype compared with 2G/2G genotype or normal subjects. Under IL-1 beta stimulation, peripheral blood monocytes from subjects with 1G/2G or 1G/1G genotype secreted higher levels of TGF-beta 1compared to subjects with 2G/2G genotype. Conclusion: This is the first report to address the influence of MMP-1 polymorphisms on lung function and airway destruction in non-CF bronchiectasis patients. Bronchiectasis patients with MMP-1(-1607G) polymorphism may be more vulnerable to permanent lung fibrosis or airway destruction due to the enhanced MMP-1 and TGF-beta 1 activity. Upregulated MMP-1 activity results in proteolytic destruction of matrix, and leads to subsequent fibrosis.	[Hsieh, Meng-Heng; Chou, Pai-Chien; Chou, Chun-Liang; Ho, Shu-Chuan; Joa, Wen-Ching; Chen, Li-Fei; Sheng, Te-Fang; Lin, Horng-Chyuan; Wang, Tsai-Yu; Chang, Po-Jui; Wang, Chun-Hua; Kuo, Han-Pin] Chang Gung Med Fdn, Dept Thorac Med, Taipei, Taiwan; [Ho, Shu-Chuan] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan	Chang Gung Memorial Hospital; Taipei Medical University	Wang, CH (corresponding author), Chang Gung Med Fdn, Dept Thorac Med, Taipei, Taiwan.	wchunhua@ms7.hinet.net	Wang, Chun-Hua/C-1488-2016; Wang, Chun-Hua/V-9861-2019	Wang, Chun-Hua/0000-0002-3514-9353	Chang Gung Medical foundation, Chang Gung University, Taiwan [CMRPG370961]	Chang Gung Medical foundation, Chang Gung University, Taiwan	This work was supported by CMRPG370961 from the Chang Gung Medical foundation, Chang Gung University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELAZIZ MM, 1995, AM J RESP CELL MOL, V13, P728, DOI 10.1165/ajrcmb.13.6.7576711; Agarwal AR, 2003, ALLERGY ASTHMA PROC, V24, P35; Benbow U, 2002, J CELL BIOCHEM, V86, P307, DOI 10.1002/jcb.10225; CAMPBELL EJ, 1991, J IMMUNOL, V146, P1286; Cataldo DD, 2004, LAB INVEST, V84, P418, DOI 10.1038/labinvest.3700063; Chen HJ, 2003, AM J PHYSIOL-HEART C, V284, pH1612, DOI 10.1152/ajpheart.00992.2002; Cole P J, 1986, Eur J Respir Dis Suppl, V147, P6; Dunsmore SE, 1996, AM J PHYSIOL-LUNG C, V270, pL3, DOI 10.1152/ajplung.1996.270.1.L3; Eickelberg O, 1999, AM J PHYSIOL-LUNG C, V276, pL814, DOI 10.1152/ajplung.1999.276.5.L814; Elkington P, 2011, J CLIN INVEST, V121, P1827, DOI 10.1172/JCI45666; Elkington PTG, 2005, J IMMUNOL, V175, P5333, DOI 10.4049/jimmunol.175.8.5333; Fineschi S, 2006, FASEB J, V20, P562, DOI 10.1096/fj.05-4870fje; Friedland JS, 2002, MATRIX BIOL, V21, P103, DOI 10.1016/S0945-053X(01)00175-5; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Ghilardi G, 2001, CLIN CANCER RES, V7, P2344; Green JA, 2010, J IMMUNOL, V184, P6492, DOI 10.4049/jimmunol.0903811; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Henry MT, 2002, EUR RESPIR J, V20, P1220, DOI 10.1183/09031936.02.00022302; Honda A, 2008, J DERMATOL SCI, V49, P63, DOI 10.1016/j.jdermsci.2007.09.007; Joos L, 2002, HUM MOL GENET, V11, P569, DOI 10.1093/hmg/11.5.569; Kanamori Y, 1999, CANCER RES, V59, P4225; Keistinen T, 1997, EUR RESPIR J, V10, P2784, DOI 10.1183/09031936.97.10122784; Kuo HP, 2008, TUBERCULOSIS, V88, P262, DOI 10.1016/j.tube.2007.08.010; Loukides S, 2002, CHEST, V121, P81, DOI 10.1378/chest.121.1.81; Morris DG, 2003, NATURE, V422, P169, DOI 10.1038/nature01413; Ninomiya S, 2004, SARCOIDOSIS VASC DIF, V21, P19; Nishioka Y, 2003, CANCER LETT, V200, P49, DOI 10.1016/S0304-3835(03)00411-7; Okuno T, 2002, SCAND J GASTROENTERO, V37, P317, DOI 10.1080/003655202317284228; Pardo A, 2005, INT J BIOCHEM CELL B, V37, P283, DOI 10.1016/j.biocel.2004.06.017; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Rutter JL, 1998, CANCER RES, V58, P5321; Selman M, 2000, AM J PHYSIOL-LUNG C, V279, pL562, DOI 10.1152/ajplung.2000.279.3.L562; SEPPER R, 1995, CHEST, V107, P1641, DOI 10.1378/chest.107.6.1641; SEPPER R, 1994, CHEST, V106, P1129, DOI 10.1378/chest.106.4.1129; Shi J, 2004, INFLAMM RES, V53, P377, DOI 10.1007/s00011-004-1271-3; Stankovic M, 2009, J INVEST MED, V57, P500, DOI 10.2310/JIM.0b013e318198277c; Todorova L, 2010, RESP MED, V104, P1799, DOI 10.1016/j.rmed.2010.06.015; Tower GB, 2002, BBA-MOL BASIS DIS, V1586, P265, DOI 10.1016/S0925-4439(01)00105-3; Vairaktaris E, 2007, ANTICANCER RES, V27, P459; Wang CH, 2010, INT J TUBERC LUNG D, V14, P627; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Yamamoto T, 2000, J IMMUNOL, V164, P6174, DOI 10.4049/jimmunol.164.12.6174; Zhu Y, 2001, CANCER RES, V61, P7825; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	44	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66265	10.1371/journal.pone.0066265	http://dx.doi.org/10.1371/journal.pone.0066265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776649	gold, Green Published, Green Submitted			2022-12-25	WOS:000320755400131
J	Jones, KH; Ford, DV; Jones, PA; John, A; Middleton, RM; Lockhart-Jones, H; Peng, J; Osborne, LA; Noble, JG				Jones, Kerina H.; Ford, David V.; Jones, Philip A.; John, Ann; Middleton, Rodden M.; Lockhart-Jones, Hazel; Peng, Jeffrey; Osborne, Lisa A.; Noble, J. Gareth			How People with Multiple Sclerosis Rate Their Quality of Life: An EQ-5D Survey via the UK MS Register	PLOS ONE			English	Article							DRIVES	Introduction: The EQ-5D is a widely-used, standardised, quality of life measure producing health profiles, indices and states. The aims of this study were to assess the role of various factors in how people with Multiple Sclerosis rate their quality of life, based on responses to the EQ-5D received via the web portal of the UK MS Register. Methods: The 4516 responses to the EQ-5D (between May 2011 and April 2012) were collated with basic demographic and descriptive MS data and the resulting dataset was analysed in SPSS (v. 20). Results: The mean health state for people with MS was 59.73 (SD 22.4, median 61), compared to the UK population mean of 82.48 (which is approximately 1SD above the cohort mean). The characteristics of respondents with high health states (at or above + 1SD) were: better health profiles (most predictive dimension: Usual Activities), higher health indices, younger age, shorter durations of MS, female gender, relapsing-remitting MS, higher educational attainment and being in paid employment (all p-values<0.001). Conversely, the characteristics of respondents with low health states (at or below -1SD) were: poorer health profiles (most predictive dimension: Mobility), lower health indices, older age, longer durations of MS, male gender, progressive MS, lower educational attainment and having an employment status of sick/disabled (p = 0.0014 for age, all other p-values<0.001). Particular living arrangements were not associated with either the high or low health status groups. Conclusions: This large-scale study has enabled in-depth analyses on how people with MS rate their quality of life, and it provides new knowledge on the various factors that contribute to their self-assessed health status. These findings demonstrate the impact of MS on quality of life, and they can be used to inform care provision and further research, to work towards enhancing the quality of life of people with MS.	[Jones, Kerina H.; Ford, David V.; Jones, Philip A.; John, Ann; Middleton, Rodden M.; Lockhart-Jones, Hazel; Peng, Jeffrey; Noble, J. Gareth] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Osborne, Lisa A.] Swansea Univ, Coll Human & Hlth Sci, Long Term & Chron Condit Ctr, Swansea, W Glam, Wales	Swansea University; Swansea University	Jones, KH (corresponding author), Swansea Univ, Coll Med, Swansea, W Glam, Wales.	k.h.jones@swansea.ac.uk		Ford, David/0000-0001-6551-721X; Middleton, Rodden/0000-0002-2130-4420; Noble, Gareth/0000-0002-4588-049X; Jones, Kerina/0000-0001-8164-3718; John, Ann/0000-0002-5657-6995	MS Society of Great Britain and Northern Ireland; Economic and Social Research Council [ES/L007444/1] Funding Source: researchfish; Medical Research Council [MR/K006525/1] Funding Source: researchfish; ESRC [ES/L007444/1] Funding Source: UKRI; MRC [MR/K006525/1] Funding Source: UKRI	MS Society of Great Britain and Northern Ireland; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study is funded by the MS Society of Great Britain and Northern Ireland http://www.mssociety.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ETH REV RES DAT; Boot CRL, 2010, HEALTH INFORM J, V16, P145, DOI 10.1177/1460458210364786; Carr AJ, 2001, BMJ-BRIT MED J, V322, P1240, DOI 10.1136/bmj.322.7296.1240; Cheung K, 2009, EQ 5D USER GUIDE BAS; European Medicines Agency, 2012, EMACHMP771852011; Ford DV, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-73; Ford DV, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-157; Gallacher J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054331; Good Alice, 2007, J Healthc Inf Manag, V21, P72; Hemmett L, 2004, QJM-INT J MED, V97, P671, DOI 10.1093/qjmed/hch105; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; Jones KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055422; Jones KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041910; Juniper EF, 2004, EUR RESPIR J, V23, P287, DOI 10.1183/09031936.04.00064204; Kind P, 1999, 172 U YORK; Lyons RA, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-3; Noble JG, 2012, MULTIPLE SCLEROSIS J, V18; Office for National Statistics, NOM OFF LAB MARK STA; Osborne LA, 2013, INT J HEALT IN PRESS; Osborne LA, 2013, INT J MED I IN PRESS; Osborne LA, 2012, INT J HEALTHC INF SY, V7, P27, DOI 10.4018/jhisi.2012070103; Osborne LA, 2012, CHRONIC ILLN, V8, P112, DOI 10.1177/1742395312436747; Popham F, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001342; Sullivan PW, 2011, MED DECIS MAKING, V31, P800, DOI 10.1177/0272989X11401031; Szende A., 2004, MEASURING SELF REPOR; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	28	49	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65640	10.1371/journal.pone.0065640	http://dx.doi.org/10.1371/journal.pone.0065640			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776516	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400051
J	Zhao, TC; Du, JF; Zhuang, SG; Liu, P; Zhang, LX				Zhao, Ting C.; Du, Jianfeng; Zhuang, Shugang; Liu, Paul; Zhang, Ling X.			HDAC Inhibition Elicits Myocardial Protective Effect through Modulation of MKK3/Akt-1	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITION; MESENCHYMAL STEM-CELLS; P38 MAP KINASE; NF-KAPPA-B; CARDIAC-HYPERTROPHY; INFARCTED HEARTS; IN-VITRO; AKT; ACTIVATION; ISCHEMIA	We and others have demonstrated that HDAC inhibition protects the heart against myocardial injury. It is known that Akt-1 and MAP kinase play an essential role in modulation of myocardial protection and cardiac preconditioning. Our recent observations have shown that Akt-1 was activated in post-myocardial infarction following HDAC inhibition. However, it remains unknown whether MKK3 and Akt-1 are involved in HDAC inhibition-induced myocardial protection in acute myocardial ischemia and reperfusion injury. We sought to investigate whether the genetic disruption of Akt-1 and MKK3 eliminate cardioprotection elicited by HDAC inhibition and whether Akt-1 is associated with MKK3 to ultimately achieve protective effects. Adult wild type and MKK3(-/-), Akt-1(-/-) mice received intraperitoneal injections of trichostatin A (0.1mg/kg), a potent inhibitor of HDACs. The hearts were subjected to 30 min myocardial ischemia/30 min reperfusion in the Langendorff perfused heart after twenty four hours to elicit pharmacologic preconditioning. Left ventricular function was measured, and infarct size was determined. Acetylation and phosphorylation of MKK3 were detected and disruption of Akt1 abolished both acetylation and phosphorylation of MKK3. HDAC inhibition produces an improvement in left ventricular functional recovery, but these effects were abrogated by disruption of either Akt-1 or MKK3. Disruption of Akt-1 or MKK3 abolished the effects of HDAC inhibition-induced reduction of infarct size. Trichostatin A treatment resulted in an increase in MKK3 phosphorylation or acetylation in myocardium. Taken together, these results indicate that stimulation of the MKK3 and Akt-1 pathway is a novel approach to HDAC inhibition -induced cardioprotection.	[Zhao, Ting C.; Du, Jianfeng] Boston Univ, Sch Med, Roger Williams Med Ctr, Dept Surg,Cardiovasc Res Lab, Providence, RI USA; [Zhuang, Shugang; Zhang, Ling X.] Brown Univ, Rhode Isl Hosp, Brown Med Sch, Dept Med, Providence, RI 02903 USA; [Liu, Paul] Brown Univ, Rhode Isl Hosp, Brown Med Sch, Dept Plast Surg, Providence, RI 02903 USA	Boston University; Roger Williams Medical Center; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Zhao, TC (corresponding author), Boston Univ, Sch Med, Roger Williams Med Ctr, Dept Surg,Cardiovasc Res Lab, Providence, RI USA.	tzhao@bu.edu			National Heart, Lung, and Blood Institute [R01 HL089405]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089405] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute Grant (R01 HL089405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; CANO E, 1995, TRENDS BIOCHEM SCI, V20, P117, DOI 10.1016/S0968-0004(00)88978-1; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Dana A, 2000, CIRC RES, V86, P989, DOI 10.1161/01.RES.86.9.989; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Lochner A, 2003, CARDIOVASC DRUG THER, V17, P217, DOI 10.1023/A:1026116022552; Loubani Mahmoud, 2002, BMC Physiol, V2, P10, DOI 10.1186/1472-6793-2-10; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Martindale JJ, 2005, J BIOL CHEM, V280, P669, DOI 10.1074/jbc.M406690200; Matsui T, 2001, CIRCULATION, V104, P330; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; Schieven GL, 2005, CURR TOP MED CHEM, V5, P921, DOI 10.2174/1568026054985902; Schulz R, 2002, CARDIOVASC RES, V55, P690, DOI 10.1016/S0008-6363(02)00319-X; Shiojima I, 2002, J BIOL CHEM, V277, P37670, DOI 10.1074/jbc.M204572200; Shiraishi I, 2004, CIRC RES, V94, P884, DOI 10.1161/01.RES.0000124394.01180.BE; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Tseng A, 2010, CARDIOVASC RES, V87, P704, DOI 10.1093/cvr/cvq110; Tseng YT, 2005, AM J PHYSIOL-HEART C, V289, pH1834, DOI 10.1152/ajpheart.00435.2005; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Vigushin DM, 2004, CURR CANCER DRUG TAR, V4, P205, DOI 10.2174/1568009043481560; Wang AH, 1999, MOL CELL BIOL, V19, P7816; Wang YG, 2004, J MOL CELL CARDIOL, V37, P1041, DOI 10.1016/j.yjmcc.2004.09.004; Zhang L, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.379115; Zhang L, 2012, J PHARMACOL EXP THER, V341, P285, DOI 10.1124/jpet.111.189910; Zhao TC, 2003, AM J PHYSIOL-HEART C, V285, pH434, DOI 10.1152/ajpheart.00095.2003; Zhao TC, 2002, J MOL CELL CARDIOL, V34, P263, DOI 10.1006/jmcc.2001.1510; Zhao TC, 2001, CIRC RES, V89, P915, DOI 10.1161/hh2201.099452; Zhao TC, 2001, AM J PHYSIOL-HEART C, V280, pH1278, DOI 10.1152/ajpheart.2001.280.3.H1278; Zhao TC, 2007, CARDIOVASC RES, V76, P473, DOI 10.1016/j.cardiores.2007.08.010; Zhao TC, 2010, BBA-MOL CELL RES, V1803, P872, DOI 10.1016/j.bbamcr.2010.04.007; Zhao TC, 2006, J PHARMACOL EXP THER, V317, P1106, DOI 10.1124/jpet.106.100982	42	22	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65474	10.1371/journal.pone.0065474	http://dx.doi.org/10.1371/journal.pone.0065474			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762381	Green Submitted, Green Published, gold			2022-12-25	WOS:000320440500041
J	Fritz, S; Capitan, A; Djari, A; Rodriguez, SC; Barbat, A; Baur, A; Grohs, C; Weiss, B; Boussaha, M; Esquerre, D; Klopp, C; Rocha, D; Boichard, D				Fritz, Sebastien; Capitan, Aurelien; Djari, Anis; Rodriguez, Sabrina C.; Barbat, Anne; Baur, Aurelia; Grohs, Cecile; Weiss, Bernard; Boussaha, Mekki; Esquerre, Diane; Klopp, Christophe; Rocha, Dominique; Boichard, Didier			Detection of Haplotypes Associated with Prenatal Death in Dairy Cattle and Identification of Deleterious Mutations in GART, SHBG and SLC37A2	PLOS ONE			English	Article							MOUSE; DISRUPTION; DEFICIENCY; FERTILITY; DEFECTS; MODEL; GENE; DNA	The regular decrease of female fertility over time is a major concern in modern dairy cattle industry. Only half of this decrease is explained by indirect response to selection on milk production, suggesting the existence of other factors such as embryonic lethal genetic defects. Genomic regions harboring recessive deleterious mutations were detected in three dairy cattle breeds by identifying frequent haplotypes (>1%) showing a deficit in homozygotes among Illumina Bovine 50k Beadchip haplotyping data from the French genomic selection database (47,878 Holstein, 16,833 Montbeliarde, and 11,466 Normande animals). Thirty-four candidate haplotypes (p<10(-4)) including previously reported regions associated with Brachyspina, CVM, HH1, and HH3 in Holstein breed were identified. Haplotype length varied from 1 to 4.8 Mb and frequencies from 1.7 up to 9%. A significant negative effect on calving rate, consistent in heifers and in lactating cows, was observed for 9 of these haplotypes in matings between carrier bulls and daughters of carrier sires, confirming their association with embryonic lethal mutations. Eight regions were further investigated using whole genome sequencing data from heterozygous bull carriers and control animals (45 animals in total). Six strong candidate causative mutations including polymorphisms previously reported in FANCI (Brachyspina), SLC35A3 (CVM), APAF1 (HH1) and three novel mutations with very damaging effect on the protein structure, according to SIFT and Polyphen-2, were detected in GART, SHBG and SLC37A2 genes. In conclusion, this study reveals a yet hidden consequence of the important inbreeding rate observed in intensively selected and specialized cattle breeds. Counter-selection of these mutations and management of matings will have positive consequences on female fertility in dairy cattle.	[Fritz, Sebastien; Capitan, Aurelien; Baur, Aurelia] UNCEIA, Genet Team, Paris, France; [Fritz, Sebastien; Capitan, Aurelien; Rodriguez, Sabrina C.; Barbat, Anne; Baur, Aurelia; Grohs, Cecile; Weiss, Bernard; Boussaha, Mekki; Rocha, Dominique; Boichard, Didier] INRA, Anim Genet & Integrat Biol UMR1313, Jouy En Josas, France; [Djari, Anis; Rodriguez, Sabrina C.; Klopp, Christophe] INRA, Sigenae, Biometrie & Intelligence Artificielle UR875, F-31326 Castanet Tolosan, France; [Esquerre, Diane] INRA, GeT Genom Facil, Lab Genet Cellulaire UMR444, F-31326 Castanet Tolosan, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; INRAE	Boichard, D (corresponding author), INRA, Anim Genet & Integrat Biol UMR1313, Jouy En Josas, France.	didier.boichard@jouy.inra.fr	Rocha, Dominique/R-5546-2019; Capitan, Aurélien/M-3732-2015; Klopp, Christophe/J-3164-2019; Boichard, Didier/AAD-8675-2020	Rocha, Dominique/0000-0003-4998-9641; Klopp, Christophe/0000-0001-7126-5477; Boichard, Didier/0000-0003-0361-2961; boussaha, mekki/0000-0002-5432-4604; FRITZ, Sebastien/0000-0002-3378-1048	ANR (French National Research Agency) [ANR-05-GENANIMAL-007, ANR-08-GENM-030-01, ANR-08-GANI-034]; Creavia; Amelis; Genes Diffusion; Midatest; Umotest; Jura Betail; Interselection Normande; ANR [ANR-10-GENM-0018]; ApisGene [ANR-10-GENM-0018]	ANR (French National Research Agency)(French National Research Agency (ANR)); Creavia; Amelis; Genes Diffusion; Midatest; Umotest; Jura Betail; Interselection Normande; ANR(French National Research Agency (ANR)); ApisGene	Genotypes originated from the Cartofine (ANR-05-GENANIMAL-007), Amasgen (ANR-08-GENM-030-01) and Lactoscan (ANR-08-GANI-034) projects funded by ANR (French National Research Agency) and ApisGene, and from genomic selection activity generated by seven French cattle breeding companies (Creavia, Amelis, Genes Diffusion, Midatest, Umotest, Jura Betail, Interselection Normande). The whole genome sequence data originated from the CartoSeq (ANR-10-GENM-0018) project funded by ANR and ApisGene. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HA, 2012, PLANT AN GEN M JUN 1; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Agerholm Jorgen S, 2007, BMC Vet Res, V3, P8, DOI 10.1186/1746-6148-3-8; Agerholm JS, 2007, APMIS, V115, P1, DOI 10.1111/j.1600-0463.2007.apm_v115_s122.x; Agerholm JS, 2001, J VET DIAGN INVEST, V13, P283, DOI 10.1177/104063870101300401; Bair SR, 2004, MOL CELL BIOL, V24, P5383, DOI 10.1128/MCB.24.12.5383-5390.2004; BALI D, 1995, J BIOL CHEM, V270, P21464, DOI 10.1074/jbc.270.37.21464; Barbat A, 2010, J REPROD DEVELOP, V56, pS15, DOI 10.1262/jrd.1056S15; Boichard D, 2012, ANIM PROD SCI, V52, P115, DOI 10.1071/AN11119; Boichard D, 1996, PROD ANIM, V9, P323; Burstyn-Cohen T, 2009, J CLIN INVEST, V119, P2942, DOI 10.1172/JCI39325; Capel C, 2010, B TECHNIQUE INSEMINA, V132, P40; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Charlier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043085; DeYoung RA, 2003, J BIOL CHEM, V278, P47104, DOI 10.1074/jbc.M307496200; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; Duchesne A, 2006, GENOMICS, V88, P610, DOI 10.1016/j.ygeno.2006.05.007; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Kim IS, 2012, MOL CELL, V46, P260, DOI 10.1016/j.molcel.2012.03.021; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Longo L, 2002, EMBO J, V21, P4229, DOI 10.1093/emboj/cdf426; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miglior F., 2000, P 10 WORLD HOLST FRI, P108; Near RI, 2009, MOL VIS, V15, P685; Pan CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023157; PEARCE SR, 1995, MAMM GENOME, V6, P858, DOI 10.1007/BF00292435; Rantakari P, 2008, MOL ENDOCRINOL, V22, P665, DOI 10.1210/me.2007-0257; Rozen S, 2000, Methods Mol Biol, V132, P365; SHUSTER DE, 1992, P NATL ACAD SCI USA, V89, P9225, DOI 10.1073/pnas.89.19.9225; Sonstegard TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054872; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; VanRaden PM, 2011, J DAIRY SCI, V94, P6153, DOI 10.3168/jds.2011-4624; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	37	114	125	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65550	10.1371/journal.pone.0065550	http://dx.doi.org/10.1371/journal.pone.0065550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762392	Green Published, Green Submitted, gold			2022-12-25	WOS:000321094800063
J	Cho, YW; Hong, CJ; Hou, A; Gent, PM; Zhang, KX; Won, KJ; Hamilton, BA				Cho, Young-Wook; Hong, Chen-Jei; Hou, Aiju; Gent, Peter M.; Zhang, Kuixing; Won, Kyoung-Jae; Hamilton, Bruce A.			Zfp423 Binds Autoregulatory Sites in P19 Cell Culture Model	PLOS ONE			English	Article							GENE-EXPRESSION; CEREBELLAR DEVELOPMENT; TRANSCRIPTION FACTORS; FINGER PROTEIN; DNA; DIFFERENTIATION; NEUROBLASTOMA; ESTABLISHMENT; MUTATIONS; INTERACTS	Zfp423 is a 30 zinc finger transcription factor that forms regulatory complexes with EBF family members and factors targeted by canonical signaling pathways. Zfp423 mutations produce a range of developmental abnormalities in mice and humans related to the ciliopathies. Surprisingly, computational analysis of clustered Zfp423 and partner motifs in conserved genomic sequences predicts enrichment in Zfp423 and Ebf genes. In cell culture models selected for Zfp423 and EBF expression, we identify strong and reproducible occupancy of two Zfp423 intronic sites using chromatin immunoprecipitation with multiple independent antibodies. Both sites are significantly enriched in either quantitative PCR or massively parallel sequencing assays. A site in intron 5 acts as a classical enhancer in transient assays, but does not require the consensus motif for activity, suggesting a redundant or modulatory role for Zfp423 binding in this context. We speculate that Zfp423 may repress this enhancer as part of a developmental ratchet.	[Cho, Young-Wook; Hong, Chen-Jei; Hou, Aiju; Gent, Peter M.; Zhang, Kuixing; Hamilton, Bruce A.] Univ Calif San Diego, Sch Med, Inst Genom Med & Moores, UCSD Canc Ctr,Dept Med, La Jolla, CA 92093 USA; [Cho, Young-Wook; Hong, Chen-Jei; Hou, Aiju; Gent, Peter M.; Zhang, Kuixing; Hamilton, Bruce A.] Univ Calif San Diego, Sch Med, Inst Genom Med & Moores, UCSD Canc Ctr,Dept cellular & Mol Med, La Jolla, CA 92093 USA; [Won, Kyoung-Jae] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Dept Genet, Philadelphia, PA 19104 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Pennsylvania	Hamilton, BA (corresponding author), Univ Calif San Diego, Sch Med, Inst Genom Med & Moores, UCSD Canc Ctr,Dept Med, La Jolla, CA 92093 USA.	bah@ucsd.edu	Gent, Peter/AAI-1540-2021	Gent, Peter/0000-0002-5519-8654; Hamilton, Bruce/0000-0001-5599-9139; Won, Kyoung Jae/0000-0002-2924-9630	National Institute for Neurological Disorders and Stroke [NS054871, NS010909]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010909, R01NS060109, R01NS054871] Funding Source: NIH RePORTER	National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute for Neurological Disorders and Stroke to B. A. H. (NS054871, NS010909). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz WA, 2006, P NATL ACAD SCI USA, V103, P19424, DOI 10.1073/pnas.0609184103; Alcaraz WA, 2011, HUM MOL GENET, V20, P3822, DOI 10.1093/hmg/ddr300; Chaki M, 2012, CELL IN PRESS; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Cheng LE, 2007, DEV BIOL, V307, P43, DOI 10.1016/j.ydbio.2007.04.005; Cheng LE, 2007, NEURON, V54, P547, DOI 10.1016/j.neuron.2007.04.029; Floyd JA, 2003, NAT GENET, V35, P221, DOI 10.1038/ng1247; FRIEDMAN HS, 1985, J NEUROPATH EXP NEUR, V44, P592, DOI 10.1097/00005072-198511000-00005; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Ku MC, 2003, BIOCHEM BIOPH RES CO, V311, P702, DOI 10.1016/j.bbrc.2003.10.053; Masserdotti G, 2010, J BIOL CHEM, V285, P30814, DOI 10.1074/jbc.M110.142869; MCBURNEY MW, 1982, DEV BIOL, V89, P503, DOI 10.1016/0012-1606(82)90338-4; Miyazaki K, 2009, BLOOD; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; PONTEN J, 1968, ACTA PATHOL MIC SC, V74, P465; Rozen S, 2000, Methods Mol Biol, V132, P365; Tsai RYL, 1998, MOL CELL BIOL, V18, P6447, DOI 10.1128/MCB.18.11.6447; Tsai RYL, 1997, J NEUROSCI, V17, P4159; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; WANG MM, 1993, MOL CELL BIOL, V13, P5805, DOI 10.1128/MCB.13.9.5805; Warming S, 2004, ONCOGENE, V23, P2727, DOI 10.1038/sj.onc.1207452; Warming S, 2006, MOL CELL BIOL, V26, P6913, DOI 10.1128/MCB.02255-05; Wen G, 2007, HUM MOL GENET, V16, P1752, DOI 10.1093/hmg/ddm123; WESTERMARK B, 1973, ACTA PATH MICRO IM A, VA 81, P791	28	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e66514	10.1371/journal.pone.0066514	http://dx.doi.org/10.1371/journal.pone.0066514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762491	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000133
J	Eskici, G; Gur, M				Eskici, Gozde; Gur, Mert			Computational Design of New Peptide Inhibitors for Amyloid Beta (A beta) Aggregation in Alzheimer's Disease: Application of a Novel Methodology	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; FREE-ENERGY DIFFERENCES; FIBRIL FORMATION; MEAN FORCE; TOXICITY; LIGAND; PROTEIN; OLIGOMERIZATION; RECOGNITION; POTENTIALS	Alzheimer's disease is the most common form of dementia. It is a neurodegenerative and incurable disease that is associated with the tight packing of amyloid fibrils. This packing is facilitated by the compatibility of the ridges and grooves on the amyloid surface. The GxMxG motif is the major factor creating the compatibility between two amyloid surfaces, making it an important target for the design of amyloid aggregation inhibitors. In this study, a peptide, experimentally proven to bind A beta 40 fibrils at the GxMxG motif, was mutated by a novel methodology that systematically replaces amino acids with residues that share similar chemical characteristics and subsequently assesses the energetic favorability of these mutations by docking. Successive mutations are combined and reassessed via docking to a desired level of refinement. This methodology is both fast and efficient in providing potential inhibitors. Its efficiency lies in the fact that it does not perform all possible combinations of mutations, therefore decreasing the computational time drastically. The binding free energies of the experimentally studied reference peptide and its three top scoring derivatives were evaluated as a final assessment/valuation. The potential of mean forces (PMFs) were calculated by applying the Jarzynski's equality to results of steered molecular dynamics simulations. For all of the top scoring derivatives, the PMFs showed higher binding free energies than the reference peptide substantiating the usage of the introduced methodology to drug design.	[Eskici, Gozde; Gur, Mert] Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey	Koc University	Gur, M (corresponding author), Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA.	MEG78@pitt.edu	Gur, Mert/P-6408-2014; Gur, Mert/O-5304-2015	Gur, Mert/0000-0003-0983-4397				Austen BM, 2008, BIOCHEMISTRY-US, V47, P1984, DOI 10.1021/bi701415b; Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078; Cannon MJ, 2004, ANAL BIOCHEM, V328, P67, DOI 10.1016/j.ab.2004.01.014; Chang WLE, 2010, BIOPHYS J, V98, P2662, DOI 10.1016/j.bpj.2010.02.031; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Ghanta J, 1996, J BIOL CHEM, V271, P29525, DOI 10.1074/jbc.271.47.29525; Gibson TJ, 2005, BIOCHEMISTRY-US, V44, P8898, DOI 10.1021/bi050225s; Giordano C, 2009, EUR J MED CHEM, V44, P179, DOI 10.1016/j.ejmech.2008.03.036; Hard T, 2012, J MOL BIOL, V421, P441, DOI 10.1016/j.jmb.2011.12.062; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Jarzynski C, 1997, PHYS REV E, V56, P5018, DOI 10.1103/PhysRevE.56.5018; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lemkul JA, 2010, BIOCHEMISTRY-US, V49, P3935, DOI 10.1021/bi1000855; Liu R, 2012, CURR MED CHEM, V19, P4157, DOI 10.2174/092986712802430018; Liu W, 2005, BIOCHEMISTRY-US, V44, P3591, DOI 10.1021/bi047827g; Lowe TL, 2001, BIOCHEMISTRY-US, V40, P7882, DOI 10.1021/bi002734u; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473; Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a; Raman EP, 2009, BIOPHYS J, V97, P2070, DOI 10.1016/j.bpj.2009.07.032; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Sciarretta KL, 2006, METHOD ENZYMOL, V413, P273, DOI 10.1016/S0076-6879(06)13015-3; Shen ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033500; Takeda T, 2009, BIOPHYS J, V96, P442, DOI 10.1016/j.bpj.2008.10.008; TAN SY, 1995, AM J KIDNEY DIS, V26, P267, DOI 10.1016/0272-6386(95)90647-9; Taylor M, 2010, BIOCHEMISTRY-US, V49, P3261, DOI 10.1021/bi100144m; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Tycko R, 2004, CURR OPIN STRUC BIOL, V14, P96, DOI 10.1016/j.sbi.2003.12.002; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Vashisth H, 2008, BIOPHYS J, V95, P4193, DOI 10.1529/biophysj.108.139675; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wiesehan K, 2008, PROTEIN ENG DES SEL, V21, P241, DOI 10.1093/protein/gzm054; Zhang DQ, 2006, J AM CHEM SOC, V128, P3019, DOI 10.1021/ja057292u; Zhao JH, 2013, J MOL MODEL, V19, P151, DOI 10.1007/s00894-012-1532-y	39	34	34	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e66178	10.1371/journal.pone.0066178	http://dx.doi.org/10.1371/journal.pone.0066178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762479	Green Published, gold			2022-12-25	WOS:000321099000128
J	Tie, XX; Han, S; Meng, LX; Wang, YJ; Wu, AH				Tie, Xinxin; Han, Sheng; Meng, Lingxuan; Wang, Yunjie; Wu, Anhua			NFAT1 Is Highly Expressed in, and Regulates the Invasion of, Glioblastoma Multiforme Cells	PLOS ONE			English	Article							ACTIVATED T-CELLS; TRANSCRIPTION FACTOR; NUCLEAR FACTOR; BREAST-CANCER; STEM-CELLS; TUMOR; CYCLOOXYGENASE-2; INDUCTION; CARCINOMA; GLIOMA	Members of the nuclear factor of activated T cells (NFAT) family have been identified as regulators of oncogenic transformation in several human malignancies. A prominent member of this family, NFAT1, is associated with tumor cell survival, apoptosis, migration and invasion. Here, we investigated the role of NFAT1 in glioma cells. In 111 clinical samples, microarray analysis demonstrated that NFAT1 was over-expressed in glioblastoma multiforme (GBM), compared with low-grade gliomas, a result confirmed by RT-PCR in 24 clinical samples and in the U87 and U251 cell lines. Immunohistochemistry and immunofluorescence stain indicated that over-expressed NFAT1 was mainly located in the nucleus, where it acted as a transcription factor. After treatment with the NFAT antagonist cyclosporin A (CsA) and FK506, levels of NFAT1 in the nuclei of U87 GBM cells were dramatically reduced. The invasive potential of U87 cells was reduced by the same treatment, as well as by inhibition of NFAT1 expression using small hairpin RNA. Proliferation of U87 cells was unaffected by CsA, FK506 and NFAT1 shRNA transfection. Clustering analysis and Pearson correlation analysis of microarray data showed that the expression of NFAT1 correlated with the expression of the invasion-related genes cyclooxygenase-2 (COX-2), matrix metalloproteinase-7 (MMP-7) and MMP-9, a result confirmed by in vitro analysis. These findings demonstrate that NFAT1 contributes to the invasive potential but not the proliferation of GBM cells, and suggest that CsA may find application as an adjuvant in combined treatment strategies for GBM.	[Tie, Xinxin; Han, Sheng; Meng, Lingxuan; Wang, Yunjie; Wu, Anhua] China Med Univ, Hosp 1, Dept Neurosurg, Shenyang, Peoples R China	China Medical University	Wu, AH (corresponding author), China Med Univ, Hosp 1, Dept Neurosurg, Shenyang, Peoples R China.	cmuwuanhua@yahoo.com.cn			National High Technology Research and Development Program of China (863) [2012AA02A508]; National Natural Science Foundation of China [81172409]; Science and Technology Department of Liaoning Province [2011225034]	National High Technology Research and Development Program of China (863)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Liaoning Province	This work was supported by grants from the National High Technology Research and Development Program of China (863) (No.2012AA02A508), National Natural Science Foundation of China (No.81172409) and Science and Technology Department of Liaoning Province (No.2011225034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir M, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-152; Chen LC, 2012, CARCINOGENESIS, V33, P2276, DOI 10.1093/carcin/bgs261; Crabtree GR, 2009, CELL, V138, DOI 10.1016/j.cell.2009.06.026; De Rosa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052113; Dikshit B, 2012, ONCOGENE, DOI [10.1038/onc.2012.393, DOI 10.1038/0NC.2012.393]; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; Faget DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047868; Flockhart RJ, 2008, FASEB J, V22, P4218, DOI 10.1096/fj.08-113076; Iniguez MA, 2000, J BIOL CHEM, V275, P23627, DOI 10.1074/jbc.M001381200; Jacobs VL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037955; Jacobs VL, 2012, NEURO-ONCOLOGY, V14, P119, DOI 10.1093/neuonc/nor194; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; John Anitha, 2001, Pathology and Oncology Research, V7, P14; Joseph JV, 2013, BIOCHEM PHARMACOL, V85, P478, DOI 10.1016/j.bcp.2012.11.005; Kim KH, 2013, NEURO-ONCOLOGY, V15, P161, DOI 10.1093/neuonc/nos299; Lee YS, 2009, EXP MOL MED, V41, P259, DOI 10.3858/emm.2009.41.4.029; Liao Q, 2012, NAN FANG YI KE DA XU, V32, P789; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ma J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037297; Muellenhoff MW, 2012, J DERMATOL TREAT, V23, P290, DOI 10.3109/09546634.2011.590792; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Najbauer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035150; Oh MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047846; Qian XM, 2012, MOL PHARMACEUT, V9, P2636, DOI 10.1021/mp3002039; Rafferty P, 2012, J IMMUNOTOXICOL, V9, P43, DOI 10.3109/1547691X.2011.614646; Rath BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054752; Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08; Schnell O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030429; Soroceanu L, 2012, CANC RES; Stechishin OD, 2013, NEURO-ONCOLOGY, V15, P198, DOI 10.1093/neuonc/nos302; Tsuda Masumi, 2012, Genes Cancer, V3, P334, DOI 10.1177/1947601912458687; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Vazquez-Cedeira M, 2012, J BIOL CHEM, V287, P42739, DOI 10.1074/jbc.M112.404285; Wu AH, 2010, CELL ONCOL, V32, P313, DOI 10.3233/CLO-2010-0524; Yiu GK, 2006, J BIOL CHEM, V281, P12210, DOI 10.1074/jbc.M600184200; Zhang CY, 2012, MAR DRUGS, V10, P119, DOI 10.3390/md10010119; Zheng JM, 2011, MOL ENDOCRINOL, V25, P2054, DOI 10.1210/me.2011-1141	37	45	46	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e66008	10.1371/journal.pone.0066008	http://dx.doi.org/10.1371/journal.pone.0066008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762456	Green Submitted, Green Published, gold			2022-12-25	WOS:000321099000124
J	Sampath, V; Liu, BS; Tafrov, S; Srinivasan, M; Rieger, R; Chen, EI; Sternglanz, R				Sampath, Vinaya; Liu, Bingsheng; Tafrov, Stefan; Srinivasan, Madhusudhan; Rieger, Robert; Chen, Emily I.; Sternglanz, Rolf			Biochemical Characterization of Hpa2 and Hpa3, Two Small Closely Related Acetyltransferases from Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Histone Acetylase; Histone Modification; Mass Spectrometry (MS); Polyamines; Translation; Acetyltransferase	ACID-N-ACETYLTRANSFERASE; D-AMINO ACIDS; HISTONE ACETYLTRANSFERASE; HAT COMPLEX; YEAST; PROTEIN; ACETYLATION; METABOLISM; EXPRESSION; GENES	Based on their sequences, the Saccharomyces cerevisiae Hpa2 and Hpa3 proteins are annotated as two closely related members of the Gcn5 acetyltransferase family. Here, we describe the biochemical characterization of Hpa2 and Hpa3 as bona fide acetyltransferases with different substrate specificities. Mutational and MALDI-TOF analyses showed that Hpa3 translation initiates primarily from Met-19 rather than the annotated start site, Met-1, with a minor product starting at Met-27. When expressed in Escherichia coli and assayed in vitro, Hpa2 and Hpa3 (from Met-19) acetylated histones and polyamines. Whereas Hpa2 acetylated histones H3 and H4 (at H3 Lys-14, H4 Lys-5, and H4 Lys-12), Hpa3 acetylated only histone H4 (at Lys-8). Additionally, Hpa2, but not Hpa3, acetylated certain small basic proteins. Hpa3, but not Hpa2, has been reported to acetylate d-amino acids, and we present results consistent with that. Overexpression of Hpa2 or Hpa3 is toxic to yeast cells. However, their deletions do not show any standard phenotypic defects. These results suggest that Hpa2 and Hpa3 are similar but distinct acetyltransferases that might have overlapping roles with other known acetyltransferases in vivo in acetylating histones and other small proteins.	[Sampath, Vinaya; Liu, Bingsheng; Tafrov, Stefan; Srinivasan, Madhusudhan; Sternglanz, Rolf] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Chen, Emily I.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Rieger, Robert; Chen, Emily I.] SUNY Stony Brook, Prote Ctr, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sternglanz, R (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	rolf@life.bio.sunysb.edu			National Institutes of Health [R01 GM55641]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM55641 (to R.S.).	Angus-Hill ML, 1999, J MOL BIOL, V294, P1311, DOI 10.1006/jmbi.1999.3338; Ausubel FM., 1988, CURRENT PROTOCOLS MO; Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Bartel P.L., 1993, CELLULAR INTERACTION; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; CASERO RA, 1993, FASEB J, V7, P653, DOI 10.1096/fasebj.7.8.8500690; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Guthrie C, 1991, GUIDE YEAST GENETICS; John S, 2000, GENE DEV, V14, P1196; KLEFF S, 1995, J BIOL CHEM, V270, P24674, DOI 10.1074/jbc.270.42.24674; LIBBY PR, 1978, J BIOL CHEM, V253, P233; Liu BS, 2005, J BIOL CHEM, V280, P16659, DOI 10.1074/jbc.M414008200; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Parthun MR, 2007, ONCOGENE, V26, P5319, DOI 10.1038/sj.onc.1210602; Pollard KJ, 1997, MOL CELL BIOL, V17, P6212, DOI 10.1128/MCB.17.11.6212; RYTKA J, 1975, J BACTERIOL, V121, P562, DOI 10.1128/JB.121.2.562-570.1975; Soutourina J, 2000, J BIOL CHEM, V275, P11626, DOI 10.1074/jbc.275.16.11626; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Sutton A, 2001, MOL CELL BIOL, V21, P3514, DOI 10.1128/MCB.21.10.3514-3522.2001; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Yow GY, 2006, ARCH MICROBIOL, V185, P39, DOI 10.1007/s00203-005-0060-x; Yow GY, 2004, ARCH MICROBIOL, V182, P396, DOI 10.1007/s00203-004-0724-y; Yuan H, 2013, BIOPOLYMERS, V99, P98, DOI 10.1002/bip.22128	29	15	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21506	21513		10.1074/jbc.M113.486274	http://dx.doi.org/10.1074/jbc.M113.486274			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23775086	Green Published, hybrid			2022-12-25	WOS:000328841900004
J	Le, DT; Tarrago, L; Watanabe, Y; Kaya, A; Lee, BC; Tran, U; Nishiyama, R; Fomenko, DE; Gladyshev, VN; Tran, LSP				Dung Tien Le; Tarrago, Lionel; Watanabe, Yasuko; Kaya, Alaattin; Lee, Byung Cheon; Uyen Tran; Nishiyama, Rie; Fomenko, Dmitri E.; Gladyshev, Vadim N.; Lam-Son Phan Tran			Diversity of Plant Methionine Sulfoxide Reductases B and Evolution of a Form Specific for Free Methionine Sulfoxide	PLOS ONE			English	Article							R-SULFOXIDE; AMINO-ACID; OXIDIZED PROTEINS; LIFE-SPAN; OXIDATION; RESIDUES; EXPRESSION; GLUTAREDOXINS; THIOREDOXIN; REDUCTION	Methionine can be reversibly oxidized to methionine sulfoxide (MetO) under physiological conditions. Organisms evolved two distinct methionine sulfoxide reductase families (MSRA & MSRB) to repair oxidized methionine residues. We found that 5 MSRB genes exist in the soybean genome, including GmMSRB1 and two segmentally duplicated gene pairs (GmMSRB2 and GmMSRB5, GmMSRB3 and GmMSRB4). GmMSRB2 and GmMSRB4 proteins showed MSRB activity toward protein-based MetO with either DTT or thioredoxin (TRX) as reductants, whereas GmMSRB1 was active only with DTT. GmMSRB2 had a typical MSRB mechanism with Cys121 and Cys 68 as catalytic and resolving residues, respectively. Surprisingly, this enzyme also possessed the MSRB activity toward free Met-R-O with kinetic parameters similar to those reported for fRMSR from Escherichia coli, an enzyme specific for free Met-R-O. Overexpression of GmMSRB2 or GmMSRB4 in the yeast cytosol supported the growth of the triple MSRA/MSRB/fRMSR (Delta 3MSRs) mutant on MetO and protected cells against H2O2-induced stress. Taken together, our data reveal an unexpected diversity of MSRBs in plants and indicate that, in contrast to mammals that cannot reduce free Met-R-O and microorganisms that use fRMSR for this purpose, plants evolved MSRBs for the reduction of both free and protein-based MetO.	[Dung Tien Le; Watanabe, Yasuko; Uyen Tran; Nishiyama, Rie; Lam-Son Phan Tran] RIKEN Ctr Sustainable Resource Sci, Signaling Pathway Res Unit, Yokohama, Kanagawa, Japan; [Dung Tien Le; Tarrago, Lionel; Kaya, Alaattin; Lee, Byung Cheon; Gladyshev, Vadim N.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Dung Tien Le; Tarrago, Lionel; Kaya, Alaattin; Lee, Byung Cheon; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA USA; [Dung Tien Le] Vietnamese Acad Agr Sci, Natl Key Lab Plant Cell & Biotechnol, Hanoi, Vietnam; [Dung Tien Le] Vietnamese Acad Agr Sci, Agr Genet Inst, Hanoi, Vietnam; [Fomenko, Dmitri E.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Fomenko, Dmitri E.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE USA	RIKEN; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Le, DT (corresponding author), RIKEN Ctr Sustainable Resource Sci, Signaling Pathway Res Unit, Yokohama, Kanagawa, Japan.	tiendung.le@riken.jp; vgladyshev@rics.bwh.harvard.edu; tran@psc.riken.jp	Tarrago, Lionel/CAH-1308-2022; Tarrago, Lionel/N-3534-2016; Kaya, Alaattin/T-6427-2017; Tran, Lam-Son P/A-1346-2009; Le, Dung Tien/A-7276-2008; Gladyshev, Vadim N/J-6187-2013	Tarrago, Lionel/0000-0001-7115-8137; Tarrago, Lionel/0000-0001-7115-8137; Kaya, Alaattin/0000-0002-6132-5197; Tran, Lam-Son P/0000-0001-9883-9768; Le, Dung Tien/0000-0002-5117-3476; Gladyshev, Vadim/0000-0002-0372-7016; Lee, Byung Cheon/0000-0003-1467-1940	RIKEN; JSPS; RIKEN [AP24-1-0076]; NIH [AG021518]; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	RIKEN; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by a RIKEN postdoctoral fellowship to DTL, a grant from JSPS Institutional Program for Young Researcher Overseas Visits to DTL, a grant (AP24-1-0076) from the RIKEN Strategic Research Program for R & D to L-SPT & DTL and a NIH grant (AG021518) to VNG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Couturier J, 2012, FEBS LETT, V586, P3894, DOI 10.1016/j.febslet.2012.09.020; Ding D, 2007, BIOCHEM BIOPH RES CO, V361, P629, DOI 10.1016/j.bbrc.2007.07.072; Dos Santos CV, 2007, FEBS LETT, V581, P4371, DOI 10.1016/j.febslet.2007.07.081; Dos Santos CV, 2005, PLANT PHYSIOL, V138, P909, DOI 10.1104/pp.105.062430; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049522; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042411; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Grimaud R, 2001, J BIOL CHEM, V276, P48915, DOI 10.1074/jbc.M105509200; Kim HY, 2008, BIOCHEM BIOPH RES CO, V371, P490, DOI 10.1016/j.bbrc.2008.04.101; Kim HY, 2012, ACTA BIOCH BIOPH SIN, V44, P623, DOI 10.1093/abbs/gms038; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Kryukov GV, 2002, P NATL ACAD SCI USA, V99, P4245, DOI 10.1073/pnas.072603099; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kumar RA, 2002, J BIOL CHEM, V277, P37527, DOI 10.1074/jbc.M203496200; Kwak GH, 2012, ARCH BIOCHEM BIOPHYS, V527, P1, DOI 10.1016/j.abb.2012.07.009; Laugier E, 2010, PLANT J, V61, P271, DOI 10.1111/j.1365-313X.2009.04053.x; Le DT, 2005, BBA-PROTEINS PROTEOM, V1749, P103, DOI 10.1016/j.bbapap.2005.02.012; Le DT, 2008, BIOCHEMISTRY-US, V47, P6685, DOI 10.1021/bi800422s; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Le DT, 2011, DNA RES, V18, P17, DOI 10.1093/dnares/dsq032; Le DT, 2009, J BIOL CHEM, V284, P4354, DOI 10.1074/jbc.M805891200; Lee BC, 2008, J BIOL CHEM, V283, P28361, DOI 10.1074/jbc.M805059200; Lee BC, 2011, FREE RADICAL BIO MED, V50, P221, DOI 10.1016/j.freeradbiomed.2010.11.008; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Lin ZD, 2007, P NATL ACAD SCI USA, V104, P9597, DOI 10.1073/pnas.0703774104; Lowther WT, 2000, P NATL ACAD SCI USA, V97, P6463, DOI 10.1073/pnas.97.12.6463; Moskovitz J, 2001, P NATL ACAD SCI USA, V98, P12920, DOI 10.1073/pnas.231472998; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Romero HM, 2004, PLANT PHYSIOL, V136, P3784, DOI 10.1104/pp.104.046656; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; SANCHEZ J, 1983, PLANT PHYSIOL, V73, P619, DOI 10.1104/pp.73.3.619; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Stadtman ER, 2003, ANTIOXID REDOX SIGN, V5, P577, DOI 10.1089/152308603770310239; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarrago L, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1097, DOI 10.1134/S0006297912100021; Tarrago L, 2012, J BIOL CHEM, V287, P24448, DOI 10.1074/jbc.M112.374520; Tarrago L, 2010, J BIOL CHEM, V285, P14964, DOI 10.1074/jbc.M110.108373; Tarrago L, 2009, J BIOL CHEM, V284, P18963, DOI 10.1074/jbc.M109.015487; Tarrago L, 2009, MOL PLANT, V2, P202, DOI 10.1093/mp/ssn067; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G	41	24	25	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65637	10.1371/journal.pone.0065637	http://dx.doi.org/10.1371/journal.pone.0065637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776515	Green Published, Green Submitted, gold			2022-12-25	WOS:000320322400039
J	Kirkpatrick, S; Locock, L; Giles, MF; Lasserson, DS				Kirkpatrick, Susan; Locock, Louise; Giles, Matthew F.; Lasserson, Daniel S.			Non-Focal Neurological Symptoms Associated with Classical Presentations of Transient Ischaemic Attack: Qualitative Analysis of Interviews with Patients	PLOS ONE			English	Article							MINOR STROKE; GENERAL-PRACTITIONER; PRIMARY-CARE; POPULATION; DIAGNOSIS; RECOGNITION; TIA; PHYSICIANS; AGREEMENT; DISEASE	Background: Improving the recognition of transient ischaemic attack (TIA) at initial healthcare contact is essential as urgent specialist assessment and treatment reduces stroke risk. Accurate TIA detection could be achieved with clinical prediction rules but none have been validated in primary care. An alternative approach using qualitative analysis of patients' experiences of TIA may identify novel features of the TIA phenotype that are not detected routinely, as such techniques have revealed novel early features of other important conditions such as meningococcaemia. We sought to determine whether the patient's experience of TIA would reveal additional deficits that can be tested prospectively in cohort studies to determine their additional diagnostic and prognostic utility at the first healthcare contact. Methodology and Findings: Qualitative semi-structured interviews with 25 patients who had experienced definite TIA as determined by a stroke specialist; framework analysis to map symptoms and key words or descriptive phrases used against each individual, with close attention to the detail of the language used. All interview transcripts were reviewed by a specialist clinician with experience in TIA/minor stroke. Patients described non-focal symptoms consistent with higher function deficits in spatial perception and awareness of deficit, as well as feelings of disconnection with their immediate surroundings. Of the classical features, weakness and speech disturbance were described in ways that did not meet the readily recognisable phenotype. Conclusion/Significance: Analysis of patients' narrative accounts reveals a set of overlooked features of the experience of TIA which may provide additional diagnostic utility so that providers of first contact healthcare can recognise TIA more easily. Future research is required in a prospective cohort of patients presenting with transient neurological symptoms to determine how frequent these features are, what they add to diagnostic information and whether they can refine measures to predict stroke risk.	[Kirkpatrick, Susan; Locock, Louise] Univ Oxford, Dept Primary Care Hlth Sci, Hlth Experiences Res Grp, Oxford, England; [Giles, Matthew F.] Univ Oxford, Nuffield Dept Clin Neurosci, Stroke Prevent Unit, Oxford, England; [Lasserson, Daniel S.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England	University of Oxford; University of Oxford; University of Oxford	Lasserson, DS (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England.	daniel.lasserson@phc.ox.ac.uk	Lasserson, Daniel S/T-8978-2017	Lasserson, Daniel/0000-0001-8274-5580	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme; National Institute for Health Research [CL-2007-13-007] Funding Source: researchfish	National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The research was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel E.K., 1998, PRAGMATIC WOMEN BODY, P310; Bots ML, 1997, STROKE, V28, P768, DOI 10.1161/01.STR.28.4.768; Castle J, 2010, STROKE, V41, P1367, DOI 10.1161/STROKEAHA.109.577650; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; Dawson J, 2009, QJM-INT J MED, V102, P43, DOI 10.1093/qjmed/hcn139; DENNIS MS, 1989, LANCET, V1, P185; Donders RCJM, 1999, J NEUROL, V246, P1145, DOI 10.1007/s004150050533; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; Gibson J, 2012, J ADV NURS, V68, P1707, DOI 10.1111/j.1365-2648.2011.05849.x; Harbison J, 2003, STROKE, V34, P71, DOI 10.1161/01.STR.0000044170.46643.5E; Kamara Stania, 2012, Prim Health Care Res Dev, V13, P165, DOI 10.1017/S146342361100051X; KOUDSTAAL PJ, 1986, STROKE, V17, P723, DOI 10.1161/01.STR.17.4.723; Lasserson DS, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1569; Lavallee PC, 2007, LANCET NEUROL, V6, P953, DOI 10.1016/S1474-4422(07)70248-X; Manawadu D, 2010, EMERG MED J, V27, P364, DOI 10.1136/emj.2009.074831; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Murray S, 2007, SCOT MED J, V52, P4, DOI 10.1258/rsmsmj.52.1.4; Nor AM, 2005, LANCET NEUROL, V4, P727, DOI 10.1016/S1474-4422(05)70201-5; Patton M. Q., 1990, QUALITATIVE EVALUATI; QUIKVANMILLIGEN MLT, 1992, CEREBROVASC DIS, V2, P102, DOI 10.1159/000108996; Ritchie J, 1993, ANAL QUALITATIVE DAT, P173, DOI DOI 10.1016/J.JPSYCHORES.2008.12.001; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Spurgeon L, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/486261; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; Tomasik T, 2003, FAM PRACT, V20, P464, DOI 10.1093/fampra/cmg423; Visintin Cristina, 2010, BMJ, V340, pc3209, DOI 10.1136/bmj.c3209; Wong JN, 2012, AGE AGEING, V41, P115, DOI 10.1093/ageing/afr134	27	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66351	10.1371/journal.pone.0066351	http://dx.doi.org/10.1371/journal.pone.0066351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776662	Green Published, gold			2022-12-25	WOS:000320322400098
J	Kobayashi, GS; Alvizi, L; Sunaga, DY; Francis-West, P; Kuta, A; Almada, BVP; Ferreira, SG; de Andrade-Lima, LC; Bueno, DF; Raposo-Amaral, CE; Menck, CF; Passos-Bueno, MR				Kobayashi, Gerson Shigeru; Alvizi, Lucas; Sunaga, Daniele Yumi; Francis-West, Philippa; Kuta, Anna; Pimenta Almada, Bruno Vinicius; Ferreira, Simone Gomes; de Andrade-Lima, Leonardo Carmo; Bueno, Daniela Franco; Raposo-Amaral, Cassio Eduardo; Menck, Carlos Frederico; Passos-Bueno, Maria Rita			Susceptibility to DNA Damage as a Molecular Mechanism for Non-Syndromic Cleft Lip and Palate	PLOS ONE			English	Article							STRAND BREAK REPAIR; CELL-CYCLE CONTROL; OXIDATIVE STRESS; GENE-EXPRESSION; HOMOLOGOUS RECOMBINATION; TRANSCRIPTION FACTORS; INDUCED REPLICATION; OROFACIAL CLEFTS; CANCER-RISK; ORAL CLEFTS	Non-syndromic cleft lip/palate (NSCL/P) is a complex, frequent congenital malformation, determined by the interplay between genetic and environmental factors during embryonic development. Previous findings have appointed an aetiological overlap between NSCL/P and cancer, and alterations in similar biological pathways may underpin both conditions. Here, using a combination of transcriptomic profiling and functional approaches, we report that NSCL/P dental pulp stem cells exhibit dysregulation of a co-expressed gene network mainly associated with DNA double-strand break repair and cell cycle control (p = 2.88 x 10(-2)-5.02 x 10(-9)). This network included important genes for these cellular processes, such as BRCA1, RAD51, and MSH2, which are predicted to be regulated by transcription factor E2F1. Functional assays support these findings, revealing that NSCL/P cells accumulate DNA double-strand breaks upon exposure to H2O2. Furthermore, we show that E2f1, Brca1 and Rad51 are co-expressed in the developing embryonic orofacial primordia, and may act as a molecular hub playing a role in lip and palate morphogenesis. In conclusion, we show for the first time that cellular defences against DNA damage may take part in determining the susceptibility to NSCL/P. These results are in accordance with the hypothesis of aetiological overlap between this malformation and cancer, and suggest a new pathogenic mechanism for the disease.	[Kobayashi, Gerson Shigeru; Alvizi, Lucas; Sunaga, Daniele Yumi; Pimenta Almada, Bruno Vinicius; Ferreira, Simone Gomes; Bueno, Daniela Franco; Passos-Bueno, Maria Rita] Univ Sao Paulo, Inst Biosci, Human Genome Res Ctr, Sao Paulo, Brazil; [Francis-West, Philippa; Kuta, Anna] Kings Coll London, Inst Dent, Dept Craniofacial Dev & Stem Cell Biol, London WC2R 2LS, England; [de Andrade-Lima, Leonardo Carmo; Menck, Carlos Frederico] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil; [Bueno, Daniela Franco; Raposo-Amaral, Cassio Eduardo] SOBRAPAR Inst, Campinas, SP, Brazil	Universidade de Sao Paulo; University of London; King's College London; Universidade de Sao Paulo	Passos-Bueno, MR (corresponding author), Univ Sao Paulo, Inst Biosci, Human Genome Res Ctr, Sao Paulo, Brazil.	passos@ib.usp.br	Raposo-Amaral, Cassio/D-1397-2013; Kobayashi, Gerson/H-4017-2013; Alvizi, Lucas/F-9043-2012; Passos-Bueno, Maria Rita/I-6796-2016; Francis-West, Philippa/AAR-5607-2020; Menck, Carlos FM/G-6321-2011; Bueno, Daniela/AAK-2926-2020; Kobayashi, Gerson Shigeru/AAB-9113-2019; Bueno, Daniela F/K-9977-2018	Raposo-Amaral, Cassio/0000-0001-6201-0827; Kobayashi, Gerson/0000-0002-6520-5774; Passos-Bueno, Maria Rita/0000-0002-9248-3008; Menck, Carlos FM/0000-0003-1941-0694; Kobayashi, Gerson Shigeru/0000-0002-6520-5774; Bueno, Daniela F/0000-0001-5932-6134; Sunaga-Franze, Daniele Yumi/0000-0002-6851-9162	CNPq (National Counsel of Technological and Scientific Development); FAPESP (Sao Paulo Research Foundation); CAPES (Higher Education Co-Ordination Agency); MCT (Ministry of Science, Technology and Innovation); BBSRC [BB/G021074/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G021074/1] Funding Source: researchfish	CNPq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Higher Education Co-Ordination Agency); MCT (Ministry of Science, Technology and Innovation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is funded by CNPq (National Counsel of Technological and Scientific Development), FAPESP (Sao Paulo Research Foundation), CAPES (Higher Education Co-Ordination Agency) and MCT (Ministry of Science, Technology and Innovation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albino D, 2011, INT J DEV BIOL, V55, P65, DOI 10.1387/ijdb.092970da; Alsdorf Rachel, 2005, Expert Opin Drug Saf, V4, P345, DOI 10.1517/14740338.4.2.345; Bahado-Singh RO, 2011, J MATERN-FETAL NEO M, V24, P687, DOI 10.3109/14767058.2010.529970; Baroni T, 2010, J CELL PHYSIOL, V222, P748, DOI 10.1002/jcp.22006; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bille C, 2005, AM J EPIDEMIOL, V161, P1047, DOI 10.1093/aje/kwi132; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Biswas AK, 2012, CANCER RES, V72, P13, DOI 10.1158/0008-5472.CAN-11-2196; Bliek BJB, 2008, BIRTH DEFECTS RES A, V82, P627, DOI 10.1002/bdra.20488; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brito LA, 2011, AM J MED GENET A, V155A, P1581, DOI 10.1002/ajmg.a.34036; Bueno DF, 2011, STEM CELL REV REP, V7, P446, DOI 10.1007/s12015-010-9197-3; Calin G, 1998, CANCER RES, V58, P3777; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cordero DR, 2011, AM J MED GENET A, V155A, P270, DOI 10.1002/ajmg.a.33702; Costa AD, 2008, J CRANIOFAC SURG, V19, P204, DOI 10.1097/scs.0b013e31815c8a54; Dastjerdi A, 2007, DEV DYNAM, V236, P353, DOI 10.1002/dvdy.21010; Deroo LA, 2008, AM J EPIDEMIOL, V168, P638, DOI 10.1093/aje/kwn186; Dixon K, 2004, SEMIN CANCER BIOL, V14, P441, DOI 10.1016/j.semcancer.2004.06.007; Feng WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008066; Ferone G, 2012, EMBO MOL MED, V4, P192, DOI 10.1002/emmm.201100199; Gao LB, 2011, BREAST CANCER RES TR, V125, P827, DOI 10.1007/s10549-010-0995-8; Gliszczynska-Swiglo A, 2007, J AGR FOOD CHEM, V55, P8237, DOI 10.1021/jf070986x; Grant SFA, 2009, J PEDIATR-US, V155, P909, DOI 10.1016/j.jpeds.2009.06.020; Greene RM, 2010, BIRTH DEFECTS RES C, V90, P133, DOI 10.1002/bdrc.20180; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Huang Xuan, 2006, Methods Mol Biol, V314, P73; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Janebodin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027526; Jiang RL, 2006, DEV DYNAM, V235, P1152, DOI 10.1002/dvdy.20646; Joshi R, 2001, FREE RADICAL BIO MED, V30, P1390, DOI 10.1016/S0891-5849(01)00543-3; Kachhap SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011208; Komada M, 2012, CONGENIT ANOM, V52, P72, DOI 10.1111/j.1741-4520.2012.00368.x; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Krenzlin H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002557; Kusek JC, 2000, INT J DEV BIOL, V44, P267; Langerak P, 2011, PHILOS T R SOC B, V366, P3562, DOI 10.1098/rstb.2011.0070; Lee WY, 1999, HISTOPATHOLOGY, V34, P106; Leite Isabel Cristina Gonçalves, 2009, Braz. oral res., V23, P31, DOI 10.1590/S1806-83242009000100006; Letauayova L, 2006, DNA REPAIR, V5, P602, DOI 10.1016/j.dnarep.2006.01.004; Letra A, 2012, J DENT RES, V91, P473, DOI 10.1177/0022034512440578; Li HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007091; Linger RJ, 2010, FEBS J, V277, P3086, DOI 10.1111/j.1742-4658.2010.07735.x; Llorente B, 2008, CELL CYCLE, V7, P859, DOI 10.4161/cc.7.7.5613; Lydeard JR, 2010, GENE DEV, V24, P1133, DOI 10.1101/gad.1922610; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Marinucci L, 2009, TOXICOLOGY, V257, P10, DOI 10.1016/j.tox.2008.12.002; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Mueller CR, 2003, BREAST CANCER RES, V5, P45, DOI 10.1186/bcr557; Nulman I, 1997, AM J MED GENET, V68, P18, DOI 10.1002/(SICI)1096-8628(19970110)68:1<18::AID-AJMG4>3.0.CO;2-U; Pardo B, 2009, CELL MOL LIFE SCI, V66, P1039, DOI 10.1007/s00018-009-8740-3; Park SC, 2012, MOL MED REP, V5, P1027, DOI 10.3892/mmr.2012.754; Pezzetti F, 2009, PATHOLOGY, V41, P261, DOI 10.1080/00313020902756899; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Restivo G, 2011, EMBO J, V30, P4571, DOI 10.1038/emboj.2011.325; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Rocha CR, 2012, MUTAT RES; Rosen EM, 2006, CANCER LETT, V236, P175, DOI 10.1016/j.canlet.2005.04.037; Saha T, 2010, J BIOL CHEM, V285, P19092, DOI 10.1074/jbc.M110.104430; Seifert M, 2006, J MOL HISTOL, V37, P301, DOI 10.1007/s10735-006-9062-5; Severin J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r39; Sha K, 2010, BIRTH DEFECTS RES B, V89, P124, DOI 10.1002/bdrb.20236; Sharma R, 2004, ANTIOXID REDOX SIGN, V6, P289, DOI 10.1089/152308604322899350; Taioli E, 2010, CANCER INVEST, V28, P958, DOI 10.3109/07357907.2010.483510; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; Tung EWY, 2011, MOL PHARMACOL, V80, P979, DOI 10.1124/mol.111.072314; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uno S, 2011, GENES CELLS, V16, P842, DOI 10.1111/j.1365-2443.2011.01535.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vieira AR, 2012, AM J MED GENET A, V158A, P1503, DOI 10.1002/ajmg.a.35359; Vogelaar IP, 2013, HUM MOL GENET, V22, P919, DOI 10.1093/hmg/dds497; Wang Y, 2000, GENE DEV, V14, P927; Washbourne BJ, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-18; Wehby GL, 2010, ORAL DIS, V16, P11, DOI 10.1111/j.1601-0825.2009.01587.x; Wells PG, 2009, TOXICOL SCI, V108, P4, DOI 10.1093/toxsci/kfn263; Weyemi U, 2012, MUTAT RES-REV MUTAT, V751, P77, DOI 10.1016/j.mrrev.2012.04.002; Winn LM, 2003, J PHARMACOL EXP THER, V306, P523, DOI 10.1124/jpet.103.052639; Yarden RI, 2006, MOL CANCER THER, V5, P1396, DOI 10.1158/1535-7163.MCT-05-0471; Yata K, 2009, DNA REPAIR, V8, P6, DOI 10.1016/j.dnarep.2008.09.002; Yu HM, 2012, NEUROSCI LETT, V529, P166, DOI 10.1016/j.neulet.2012.09.013; Yu WL, 2009, INDIAN J PLAST SURG, V42, pS35, DOI 10.4103/0970-0358.57185; Zhu JL, 2002, BRIT J CANCER, V87, P524, DOI 10.1038/sj.bjc.6600488	88	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65677	10.1371/journal.pone.0065677	http://dx.doi.org/10.1371/journal.pone.0065677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776525	gold, Green Published, Green Submitted			2022-12-25	WOS:000320322400045
J	Silva-Santisteban, MC; Westwood, IM; Boxall, K; Brown, N; Peacock, S; McAndrew, C; Barrie, E; Richards, M; Mirza, A; Oliver, AW; Burke, R; Hoelder, S; Jones, K; Aherne, GW; Blagg, J; Collins, I; Garrett, MD; van Montfort, RLM				Silva-Santisteban, M. Cris; Westwood, Isaac M.; Boxall, Kathy; Brown, Nathan; Peacock, Sam; McAndrew, Craig; Barrie, Elaine; Richards, Meirion; Mirza, Amin; Oliver, Antony W.; Burke, Rosemary; Hoelder, Swen; Jones, Keith; Aherne, G. Wynne; Blagg, Julian; Collins, Ian; Garrett, Michelle D.; van Montfort, Rob L. M.			Fragment-Based Screening Maps Inhibitor Interactions in the ATP-Binding Site of Checkpoint Kinase 2	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; CHK2 PROTEIN-KINASE; SELECTIVE INHIBITOR; CRYSTAL-STRUCTURE; POTENT INHIBITOR; P53; PHOSPHORYLATION; IDENTIFICATION; CANCER; ACTIVATION	Checkpoint kinase 2 (CHK2) is an important serine/threonine kinase in the cellular response to DNA damage. A fragment-based screening campaign using a combination of a high-concentration AlphaScreen (TM) kinase assay and a biophysical thermal shift assay, followed by X-ray crystallography, identified a number of chemically different ligand-efficient CHK2 hinge-binding scaffolds that have not been exploited in known CHK2 inhibitors. In addition, it showed that the use of these orthogonal techniques allowed efficient discrimination between genuine hit matter and false positives from each individual assay technology. Furthermore, the CHK2 crystal structures with a quinoxaline-based fragment and its follow-up compound highlight a hydrophobic area above the hinge region not previously explored in rational CHK2 inhibitor design, but which might be exploited to enhance both potency and selectivity of CHK2 inhibitors.	[Silva-Santisteban, M. Cris; Westwood, Isaac M.; Boxall, Kathy; Brown, Nathan; Peacock, Sam; McAndrew, Craig; Barrie, Elaine; Richards, Meirion; Mirza, Amin; Burke, Rosemary; Hoelder, Swen; Jones, Keith; Aherne, G. Wynne; Blagg, Julian; Collins, Ian; Garrett, Michelle D.; van Montfort, Rob L. M.] Canc Res UK, Canc Therapeut Unit, Div Canc Therapeut, Inst Canc Res,Haddow Labs, Sutton, Surrey, England; [Silva-Santisteban, M. Cris; Westwood, Isaac M.; Oliver, Antony W.; van Montfort, Rob L. M.] Inst Canc Res, Chester Beatty Labs, Div Struct Biol, London SW3 6JB, England	Cancer Research UK; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	van Montfort, RLM (corresponding author), Canc Res UK, Canc Therapeut Unit, Div Canc Therapeut, Inst Canc Res,Haddow Labs, Sutton, Surrey, England.	Rob.vanMontfort@icr.ac.uk	Brown, Nathan/I-7711-2016; Jones, Keith/R-7629-2016; Oliver, Antony W./O-5165-2019	Brown, Nathan/0000-0001-9243-8699; Jones, Keith/0000-0002-9440-4094; Oliver, Antony W./0000-0002-2912-8273	Cancer Research United Kingdom [C309/A8274]; Institute of Cancer Research; National Health Service; Wellcome Trust; Cancer Research UK [11566, 14532] Funding Source: researchfish	Cancer Research United Kingdom(Cancer Research UK); Institute of Cancer Research; National Health Service; Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research United Kingdom (http://www.cancerresearchuk.org/) program grant number C309/A8274, The Institute of Cancer Research (www.icr.ac.uk), and National Health Service funding to the National Institute for Health Biomedical Research Centre (http://www.nihr.ac.uk/). MCSS is supported by a Wellcome Trust (www.wellcome.ac.uk) doctoral training program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addie M, 2013, J MED CHEM, V56, P2059, DOI 10.1021/jm301762v; Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; Ahn JY, 2000, CANCER RES, V60, P5934; Anderson VE, 2011, CANCER RES, V71, P463, DOI 10.1158/0008-5472.CAN-10-1252; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Arienti KL, 2005, J MED CHEM, V48, P1873, DOI 10.1021/jm0495935; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Blanc E., 2011, BUSTER VERSION 2 11; Blasina A, 2008, MOL CANCER THER, V7, P2394, DOI 10.1158/1535-7163.MCT-07-2391; Boettcher A, 2010, J BIOMOL SCREEN, V15, P1029, DOI 10.1177/1087057110380455; Bruno IJ, 2004, J CHEM INF COMP SCI, V44, P2133, DOI 10.1021/ci049780b; Bruno IJ, 1997, J COMPUT AID MOL DES, V11, P525, DOI 10.1023/A:1007934413448; Busby EC, 2000, CANCER RES, V60, P2108; Caldwell JJ, 2011, J MED CHEM, V54, P580, DOI 10.1021/jm101150b; Carlessi L, 2007, MOL CANCER THER, V6, P935, DOI 10.1158/1535-7163.MCT-06-0567; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Congreve M, 2003, DRUG DISCOV TODAY, V8, P876, DOI 10.1016/S1359-6446(03)02831-9; Congreve M, 2008, J MED CHEM, V51, P3661, DOI 10.1021/jm8000373; Davis BJ, 2013, BIOORG MED CHEM LETT, DOI DOI 10.1016/J.BMCL.2013.1003.1028; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; editor Group CC, 2011, MOE201010 CHEM COMP; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; Hilton S, 2010, BIOORGAN MED CHEM, V18, P4591, DOI 10.1016/j.bmc.2010.05.014; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Howard S, 2009, J MED CHEM, V52, P379, DOI 10.1021/jm800984v; Hubbard RE, 2011, METHOD ENZYMOL, V493, P509, DOI 10.1016/B978-0-12-381274-2.00020-0; Jobson AG, 2007, MOL PHARMACOL, V72, P876, DOI 10.1124/mol.107.035832; Jobson AG, 2009, J PHARMACOL EXP THER, V331, P816, DOI 10.1124/jpet.109.154997; Kamenecka T, 2009, J BIOL CHEM, V284, P12853, DOI 10.1074/jbc.M809430200; Koster H, 2011, J MED CHEM, V54, P7784, DOI 10.1021/jm200642w; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Larson G, 2007, BIOORG MED CHEM LETT, V17, P172, DOI 10.1016/j.bmcl.2006.09.067; Lee JT, 2010, PIGM CELL MELANOMA R, V23, P820, DOI 10.1111/j.1755-148X.2010.00763.x; Levesque AA, 2007, CARCINOGENESIS, V28, P13, DOI 10.1093/carcin/bgl214; Liddle J, 2009, BIOORG MED CHEM LETT, V19, P2504, DOI 10.1016/j.bmcl.2009.03.034; Lountos GT, 2011, J STRUCT BIOL, V176, P292, DOI 10.1016/j.jsb.2011.09.008; Lountos GT, 2009, PROTEIN SCI, V18, P92, DOI 10.1002/pro.16; Matijssen C, 2012, BIOORGAN MED CHEM, V20, P6630, DOI 10.1016/j.bmc.2012.09.024; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matthews TP, 2009, J MED CHEM, V52, P4810, DOI 10.1021/jm900314j; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNeely SC, 2011, MOL CANC THER S1, V10; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Murray CW, 2009, NAT CHEM, V1, P187, DOI [10.1038/NCHEM.217, 10.1038/nchem.217]; Neff DK, 2007, BIOORG MED CHEM LETT, V17, P6467, DOI 10.1016/j.bmcl.2007.09.098; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Orita M, 2011, METHOD ENZYMOL, V493, P383, DOI 10.1016/B978-0-12-381274-2.00015-7; Oza V, 2012, J MED CHEM, V55, P5130, DOI 10.1021/jm300025r; Pollack SJ, 2011, J COMPUT AID MOL DES, V25, P677, DOI 10.1007/s10822-011-9454-9; Pommier Y, 2006, CLIN CANCER RES, V12, P2657, DOI 10.1158/1078-0432.CCR-06-0743; Pommier Y, 2005, CURR PHARM DESIGN, V11, P2855, DOI 10.2174/1381612054546716; Rees DC, 2004, NAT REV DRUG DISCOV, V3, P660, DOI 10.1038/nrd1467; Riesterer O, 2011, INVEST NEW DRUG, V29, P514, DOI 10.1007/s10637-009-9361-2; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Saleem RSZ, 2012, BIOORGAN MED CHEM, V20, P1475, DOI 10.1016/j.bmc.2011.12.054; Saxty G, 2007, J MED CHEM, V50, P2293, DOI 10.1021/jm070091b; Schulz MN, 2009, CURR OPIN PHARMACOL, V9, P615, DOI 10.1016/j.coph.2009.04.009; Schwarz JK, 2003, MOL CANCER RES, V1, P598; Sharma V, 2004, BIOORG MED CHEM LETT, V14, P4319, DOI 10.1016/j.bmcl.2004.05.079; Smart O. S., 2011, GRADE VERSION 1 1 1; Soussi T, 2000, HUM MUTAT, V15, P105, DOI 10.1002/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO;2-G; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Takai H, 2002, EMBO J, V21, P5195, DOI 10.1093/emboj/cdf506; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Tanimoto T.T., 1957, NOV, V17, P1957; Villasenor AG, 2009, CHEM BIOL DRUG DES, V73, P466, DOI 10.1111/j.1747-0285.2009.00785.x; VISWANADHAN VN, 1989, J CHEM INF COMP SCI, V29, P163, DOI 10.1021/ci00063a006; von Leoprechting A, 2004, J BIOMOL SCREEN, V9, P719, DOI 10.1177/1087057104268805; Wielens J, 2013, J BIOMOL SCREEN, V18, P147, DOI 10.1177/1087057112465979; Wu W, 2012, CANC RES S1, V72; Wu XL, 2003, J BIOL CHEM, V278, P36163, DOI 10.1074/jbc.M303795200; Wyatt PG, 2008, J MED CHEM, V51, P4986, DOI 10.1021/jm800382h; Yu Q, 2002, CANCER RES, V62, P5743; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004	83	14	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65689	10.1371/journal.pone.0065689	http://dx.doi.org/10.1371/journal.pone.0065689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776527	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000320322400046
J	Chang, AN; Huang, J; Battiprolu, PK; Hill, JA; Kamm, KE; Stull, JT				Chang, Audrey N.; Huang, Jian; Battiprolu, Pavan K.; Hill, Joseph A.; Kamm, Kristine E.; Stull, James T.			The Effects of Neuregulin on Cardiac Myosin Light Chain Kinase Gene-Ablated Hearts	PLOS ONE			English	Article							CARDIOMYOCYTE PROLIFERATION; PHOSPHORYLATION; HYPERTROPHY; FAILURE; CAMKII; MICE; ACTIVATION; KINETICS; DISEASE; MODELS	Background: Activation of ErbB2/4 receptor tyrosine kinases in cardiomyocytes by neuregulin treatment is associated with improvement in cardiac function, supporting its use in human patients with heart failure despite the lack of a specific mechanism. Neuregulin infusion in rodents increases cardiac myosin light chain kinase (cMLCK) expression and cardiac myosin regulatory light chain (RLC) phosphorylation which may improve actin-myosin interactions for contraction. We generated a cMLCK knockout mouse to test the hypothesis that cMLCK is necessary for neuregulin-induced improvement in cardiac function by increasing RLC phosphorylation. Principal Findings: The cMLCK knockout mice have attenuated RLC phosphorylation and decreased cardiac performance measured as fractional shortening. Neuregulin infusion for seven days in wildtype mice increased cardiac cMLCK protein expression and RLC phosphorylation while increasing Akt phosphorylation and decreasing phospholamban phosphorylation. There was no change in fractional shortening. In contrast, neuregulin infusion in cMLCK knockout animals increased cardiac performance in the absence of cMLCK without increasing RLC phosphorylation. In addition, CaMKII signaling appeared to be enhanced in neuregulin-treated knockout mice. Conclusions: Thus, Neuregulin may improve cardiac performance in the failing heart without increasing cMLCK and RLC phosphorylation by activating other signaling pathways.	[Chang, Audrey N.; Huang, Jian; Kamm, Kristine E.; Stull, James T.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Battiprolu, Pavan K.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA; [Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chang, AN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	audreyn.chang@utsouthwestern.edu			National Institutes of Health [HL080536, HL026043, HL007360-31]; Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; American Heart Association; American Diabetes Association Mentor-Based Postdoctoral Fellowship [7-08-MN-21-ADA];  [HL-075173];  [HL-080144];  [HL-090842]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL026043, R37HL026043, T32HL007360, R01HL090842, R01HL075173, R01HL080144, R01HL080536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; American Heart Association(American Heart Association); American Diabetes Association Mentor-Based Postdoctoral Fellowship(American Diabetes Association); ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL080536 and HL026043, grants from the Moss Heart Fund and the Fouad A. and Val Imm Bashour Distinguished Chair in Physiology (J. T. Stull.); National Institutes of Health Postdoctoral Fellowship HL007360-31 and a postdoctoral fellowship from the American Heart Association (A. N. Chang); HL-075173, HL-080144, and HL-090842 (J.A. Hill); and American Diabetes Association Mentor-Based Postdoctoral Fellowship 7-08-MN-21-ADA (J.A. Hill and P.K. Battiprolu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bian Y, 2009, AM J PHYSIOL-HEART C, V297, pH1974, DOI 10.1152/ajpheart.01010.2008; Chaanine AH, 2011, EUR J HEART FAIL, V13, P825, DOI 10.1093/eurjhf/hfr080; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Collins KA, 2001, AM J PHYSIOL-HEART C, V280, pH1954, DOI 10.1152/ajpheart.2001.280.5.H1954; Ding PG, 2010, J BIOL CHEM, V285, P40819, DOI 10.1074/jbc.M110.160499; Gu XH, 2010, CARDIOVASC RES, V88, P334, DOI 10.1093/cvr/cvq223; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; KAMM KE, 1989, J BIOL CHEM, V264, P21223; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kamm KE, 2011, J BIOL CHEM, V286, P9941, DOI 10.1074/jbc.R110.198697; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Kuramochi Y, 2006, J MOL CELL CARDIOL, V41, P228, DOI 10.1016/j.yjmcc.2006.04.007; Lemmens K, 2007, CIRCULATION, V116, P954, DOI 10.1161/CIRCULATIONAHA.107.690487; Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057; Mattiazzi A, 2005, CARDIOVASC RES, V68, P366, DOI 10.1016/j.cardiores.2005.08.010; Mishra S, 2011, CIRC RES, V109, P1354, DOI 10.1161/CIRCRESAHA.111.248401; Olsson MC, 2004, AM J PHYSIOL-HEART C, V287, pH2712, DOI 10.1152/ajpheart.01067.2003; Pentassuglia L, 2009, EXP CELL RES, V315, P627, DOI 10.1016/j.yexcr.2008.08.015; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; Sheikh F, 2012, J CLIN INVEST, V122, P1209, DOI 10.1172/JCI61134; Stelzer JE, 2006, J GEN PHYSIOL, V128, P261, DOI 10.1085/jgp.200609547; Wadugu B, 2012, AM J PHYSIOL-HEART C, V302, pH2139, DOI 10.1152/ajpheart.00063.2012; Warren SA, 2012, CIRCULATION, V126, P2575, DOI 10.1161/CIRCULATIONAHA.112.116202; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5	31	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66720	10.1371/journal.pone.0066720	http://dx.doi.org/10.1371/journal.pone.0066720			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776695	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400154
J	Ghatak, A; Willocquet, L; Savary, S; Kumar, J				Ghatak, Abhijeet; Willocquet, Laetitia; Savary, Serge; Kumar, Jatinder			Variability in Aggressiveness of Rice Blast (Magnaporthe oryzae) Isolates Originating from Rice Leaves and Necks: A Case of Pathogen Specialization?	PLOS ONE			English	Article							PYRICULARIA-ORYZAE; PARTIAL RESISTANCE; DYNAMICS; LEAF	Rice blast, caused by Magnaporthe oryzae, causes yield losses associated with injuries on leaves and necks, the latter being in general far more important than the former. Many questions remain on the relationships between leaf and neck blast, including questions related to the population biology of the pathogen. Our objective was to test the hypothesis of adaptation of M. oryzae isolates to the type of organ they infect. To that aim, the components of aggressiveness of isolates originating from leaves and necks were measured. Infection efficiency, latent period, sporulation intensity, and lesion size were measured on both leaves and necks. Univariate and multivariate analyses indicated that isolates originating from leaves were less aggressive than isolates originating from necks, when aggressiveness components were measured on leaves as well as on necks, indicating that there is no specialization within the pathogen population with respect to the type of organ infected. This result suggests that the more aggressive isolates involved in epidemics on leaves during the vegetative stage of the crop cycle have a higher probability to infect necks, and that a population shift may occur during disease transmission from leaves to necks. Implications for disease management are discussed.	[Ghatak, Abhijeet; Willocquet, Laetitia; Savary, Serge] Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Los Banos, Philippines; [Ghatak, Abhijeet; Kumar, Jatinder] GBPUAT, Dept Plant Pathol, Pantnagar, Uttarakhand, India; [Willocquet, Laetitia; Savary, Serge] INRA, Unite Mixte Rech Agrosyst & Agr Gest Ressources I, F-31326 Castanet Tolosan, France; [Willocquet, Laetitia; Savary, Serge] INPT, Castanet Tolosan, France	CGIAR; International Rice Research Institute (IRRI); Govind Ballabh Pant University of Agriculture Technology; INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse	Willocquet, L (corresponding author), Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Los Banos, Philippines.	Laetitia.Willocquet@toulouse.inra.fr		Ghatak, Abhijeet/0000-0001-8684-7402	IRRI core budget; Bill and Melinda Gates Foundation under the Cereal System Initiative for South Asia Project	IRRI core budget; Bill and Melinda Gates Foundation under the Cereal System Initiative for South Asia Project	This work was partly supported by IRRI core budget. Additional funds were provided by the Bill and Melinda Gates Foundation under the Cereal System Initiative for South Asia Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1979, EPIDEMIOLOGY PLANT D; BONMAN JM, 1992, EUPHYTICA, V63, P115, DOI 10.1007/BF00023917; BONMAN JM, 1989, PLANT DIS, V73, P388, DOI 10.1094/PD-73-0388; Couch BC, 2002, MYCOLOGIA, V94, P683, DOI 10.2307/3761719; Flier WG, 1999, EUR J PLANT PATHOL, V105, P381, DOI 10.1023/A:1008737222830; French R, 2003, ANNU REV PHYTOPATHOL, V41, P199, DOI 10.1146/annurev.phyto.41.052002.095559; GREGORY PH, 1948, ANN APPL BIOL, V35, P412, DOI 10.1111/j.1744-7348.1948.tb07385.x; KATO H, 1970, PHYTOPATHOLOGY, V60, P608, DOI 10.1094/Phyto-60-608; KATO H, 1974, PHYTOPATHOLOGY, V64, P828, DOI 10.1094/Phyto-64-828; Kim C. K., 1983, Korean Journal of Plant Protection, V22, P287; Kumar J, 1999, GENETICS, V152, P971; Ou S H, 1987, RICE DIS; PINNSCHMIDT HO, 1994, RICE BLAST DISEASE, P381; ROUMEN EC, 1992, EUPHYTICA, V64, P173, DOI 10.1007/BF00046046; ROUMEN EC, 1993, EUPHYTICA, V69, P185, DOI 10.1007/BF00022364; ROYER MH, 1984, PHYTOPATHOLOGY, V74, P1001, DOI 10.1094/Phyto-74-1001; Sacristan S, 2011, J VIROL, V85, P4974, DOI 10.1128/JVI.00057-11; Savary S, 2000, PLANT DIS, V84, P357, DOI 10.1094/PDIS.2000.84.3.357; Savary S, 2009, PHYTOPATHOLOGY, V99, P930, DOI 10.1094/PHYTO-99-8-0930; YEH WH, 1986, PLANT PATHOL, V35, P319, DOI 10.1111/j.1365-3059.1986.tb02021.x	21	23	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66180	10.1371/journal.pone.0066180	http://dx.doi.org/10.1371/journal.pone.0066180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776629	Green Submitted, gold, Green Published			2022-12-25	WOS:000320755400118
J	Li, S; Zhang, YJ; Sack, L; Scoffoni, C; Ishida, A; Chen, YJ; Cao, KF				Li, Shuai; Zhang, Yong-Jiang; Sack, Lawren; Scoffoni, Christine; Ishida, Atsushi; Chen, Ya-Jun; Cao, Kun-Fang			The Heterogeneity and Spatial Patterning of Structure and Physiology across the Leaf Surface in Giant Leaves of Alocasia macrorrhiza	PLOS ONE			English	Article							GAS-EXCHANGE; HYDRAULIC ARCHITECTURE; STOMATAL DENSITY; VENATION ARCHITECTURE; HIGH-TEMPERATURE; BANANA LEAVES; WATER-FLOW; EVOLUTION; SIZE; PHOTOINHIBITION	Leaf physiology determines the carbon acquisition of the whole plant, but there can be considerable variation in physiology and carbon acquisition within individual leaves. Alocasia macrorrhiza (L.) Schott is an herbaceous species that can develop very large leaves of up to 1 m in length. However, little is known about the hydraulic and photosynthetic design of such giant leaves. Based on previous studies of smaller leaves, and on the greater surface area for trait variation in large leaves, we hypothesized that A. macrorrhiza leaves would exhibit significant heterogeneity in structure and function. We found evidence of reduced hydraulic supply and demand in the outer leaf regions; leaf mass per area, chlorophyll concentration, and guard cell length decreased, as did stomatal conductance, net photosynthetic rate and quantum efficiency of photosystem II. This heterogeneity in physiology was opposite to that expected from a thinner boundary layer at the leaf edge, which would have led to greater rates of gas exchange. Leaf temperature was 8.8 degrees C higher in the outer than in the central region in the afternoon, consistent with reduced stomatal conductance and transpiration caused by a hydraulic limitation to the outer lamina. The reduced stomatal conductance in the outer regions would explain the observed homogeneous distribution of leaf water potential across the leaf surface. These findings indicate substantial heterogeneity in gas exchange across the leaf surface in large leaves, greater than that reported for smaller-leafed species, though the observed structural differences across the lamina were within the range reported for smaller-leafed species. Future work will determine whether the challenge of transporting water to the outer regions can limit leaf size for plants experiencing drought, and whether the heterogeneity of function across the leaf surface represents a particular disadvantage for large simple leaves that might explain their global rarity, even in resource-rich environments.	[Li, Shuai] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui Province, Peoples R China; [Li, Shuai; Zhang, Yong-Jiang; Chen, Ya-Jun; Cao, Kun-Fang] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan Province, Peoples R China; [Zhang, Yong-Jiang] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Sack, Lawren; Scoffoni, Christine] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Ishida, Atsushi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Chen, Ya-Jun] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Cao, Kun-Fang] Guangxi Univ, Key Lab, Minist Educ Microbial & Plant Genet Engn, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Guangxi Provinc, Peoples R China; [Cao, Kun-Fang] Guangxi Univ, Coll Forestry, Nanning 530004, Guangxi Provinc, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Harvard University; University of California System; University of California Los Angeles; Kyoto University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Guangxi University; Guangxi University	Cao, KF (corresponding author), Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Yunnan Province, Peoples R China.	caokf@xtbg.ac.cn	Cao, Kun-Fang/D-2157-2009; Sack, Lawren/A-5492-2008	Cao, Kun-Fang/0000-0002-2253-7189; Sack, Lawren/0000-0002-7009-7202; Zhang, Yongjiang/0000-0001-5637-3015; Ishida, Atsushi/0000-0003-0620-5819; Li, Shuai/0000-0003-2545-7763	National Natural Science Foundation of China [31170399]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant NO.31170399). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affek HP, 2006, NEW PHYTOL, V169, P321, DOI 10.1111/j.1469-8137.2005.01603.x; Aldea M, 2005, PLANT CELL ENVIRON, V28, P402, DOI 10.1111/j.1365-3040.2005.01279.x; Aldea M, 2006, OECOLOGIA, V149, P221, DOI 10.1007/s00442-006-0444-x; BIMOVA A, 1992, BIOL PLANTARUM, V34, P475, DOI 10.1007/BF02923606; Boyce CK, 2005, PALEOBIOLOGY, V31, P117, DOI 10.1666/0094-8373(2005)031&lt;0117:POSACI&gt;2.0.CO;2; Boyce CK, 2002, PALEOBIOLOGY, V28, P70, DOI 10.1666/0094-8373(2002)028&lt;0070:EODPAT&gt;2.0.CO;2; Bragg JG, 2002, FUNCT ECOL, V16, P633, DOI 10.1046/j.1365-2435.2002.00661.x; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; Brodribb TJ, 2010, FUNCT PLANT BIOL, V37, P488, DOI 10.1071/FP10010; Brodribb TJ, 2003, NEW PHYTOL, V158, P295, DOI 10.1046/j.1469-8137.2003.00736.x; BROWN VK, 1991, PHILOS T R SOC B, V333, P265, DOI 10.1098/rstb.1991.0076; Buckley TN, 2011, PLANT PHYSIOL, V156, P962, DOI 10.1104/pp.111.175638; Cochard H, 2004, PLANT CELL ENVIRON, V27, P1257, DOI 10.1111/j.1365-3040.2004.01233.x; Coomes DA, 2007, BIOL LETTERS, V3, P86, DOI 10.1098/rsbl.2006.0551; Crafts-Brandner SJ, 2000, P NATL ACAD SCI USA, V97, P13430, DOI 10.1073/pnas.230451497; Delaney KJ, 2006, PLANT CELL ENVIRON, V29, P1245, DOI 10.1111/j.1365-3040.2006.01504.x; Dunbar-Co S, 2009, INT J PLANT SCI, V170, P61, DOI 10.1086/593111; GAMON JA, 1990, PLANT CELL ENVIRON, V13, P267, DOI 10.1111/j.1365-3040.1990.tb01311.x; Guilioni L, 2008, AGR FOREST METEOROL, V148, P1908, DOI 10.1016/j.agrformet.2008.07.009; Hohmann-Marriott MF, 2011, ANNU REV PLANT BIOL, V62, P515, DOI 10.1146/annurev-arplant-042110-103811; Inoue N, 2001, PLANT CELL PHYSIOL, V42, P1140, DOI 10.1093/pcp/pce147; Ishida A, 1999, TREE PHYSIOL, V19, P117; Ishida A, 2001, TREE PHYSIOL, V21, P497, DOI 10.1093/treephys/21.8.497; KATOH S, 1967, ARCH BIOCHEM BIOPHYS, V122, P144, DOI 10.1016/0003-9861(67)90133-6; Koch GW, 2004, NATURE, V428, P851, DOI 10.1038/nature02417; Koniger M, 1998, PLANTA, V205, P214, DOI 10.1007/s004250050314; Lawson T, 1999, J EXP BOT, V50, P1381, DOI 10.1093/jexbot/50.337.1381; Martre P, 2000, NEW PHYTOL, V146, P235, DOI 10.1046/j.1469-8137.2000.00641.x; Martre P, 2001, PLANT CELL ENVIRON, V24, P65, DOI 10.1046/j.1365-3040.2001.00657.x; Martre P, 2001, INT J PLANT SCI, V162, P755, DOI 10.1086/320786; McKown AD, 2010, AM NAT, V175, P447, DOI 10.1086/650721; MIRANDA V, 1981, NEW PHYTOL, V89, P179, DOI 10.1111/j.1469-8137.1981.tb07481.x; Moller M, 2007, J EXP BOT, V58, P827, DOI 10.1093/jxb/erl115; MULKEY SS, 1992, FUNCT ECOL, V6, P719, DOI 10.2307/2389969; Nardini A, 2008, PLANT CELL ENVIRON, V31, P804, DOI 10.1111/j.1365-3040.2008.01798.x; Nardini A, 2010, PLANT CELL ENVIRON, V33, P1091, DOI 10.1111/j.1365-3040.2010.02131.x; Nicotra AB, 2011, FUNCT PLANT BIOL, V38, P535, DOI 10.1071/FP11057; Niinemets U, 2007, FUNCT ECOL, V21, P28, DOI 10.1111/j.1365-2435.2006.01221.x; Niinemets U, 2006, NEW PHYTOL, V171, P91, DOI 10.1111/j.1469-8137.2006.01741.x; NOBEL PS, 1975, J EXP BOT, V26, P120, DOI 10.1093/jxb/26.1.120; Ocheltree TW, 2012, PLANT CELL ENVIRON, V35, P1040, DOI 10.1111/j.1365-3040.2011.02470.x; PARKHURST DF, 1972, J ECOL, V60, P505, DOI 10.2307/2258359; Peppe DJ, 2011, NEW PHYTOL, V190, P724, DOI 10.1111/j.1469-8137.2010.03615.x; Poole I, 1996, PLANT CELL ENVIRON, V19, P705, DOI 10.1111/j.1365-3040.1996.tb00405.x; Powles JE, 2006, PLANT CELL ENVIRON, V29, P981, DOI 10.1111/j.1365-3040.2005.01491.x; Raven JA, 2009, FUNCT PLANT BIOL, V36, P505, DOI 10.1071/FP09087; RAWSON HM, 1987, AUST J PLANT PHYSIOL, V14, P287, DOI 10.1071/PP9870287; ROWLANDBAMFORD AJ, 1990, ENVIRON EXP BOT, V30, P175, DOI 10.1016/0098-8472(90)90062-9; Sack L, 2003, PLANT CELL ENVIRON, V26, P1343, DOI 10.1046/j.0016-8025.2003.01058.x; Sack L, 2006, ECOLOGY, V87, P483, DOI 10.1890/05-0710; Sack L, 2004, PLANT PHYSIOL, V134, P1824, DOI 10.1104/pp.103.031203; Sack L, 2003, PLANT ECOL, V168, P139, DOI 10.1023/A:1024423820136; Sack L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1835; Sack L, 2013, NEW PHYTOL, V198, P983, DOI 10.1111/nph.12253; Salisbury EJ, 1928, PHILOS T R SOC LON B, V216, P1, DOI 10.1098/rstb.1928.0001; SCHUEPP PH, 1993, NEW PHYTOL, V125, P477, DOI 10.1111/j.1469-8137.1993.tb03898.x; Scoffoni C, 2011, PLANT PHYSIOL, V156, P832, DOI 10.1104/pp.111.173856; Shapira O, 2013, PLANT CELL ENVIRON, V36, P275, DOI 10.1111/j.1365-3040.2012.02572.x; Shapira O, 2009, PLANT CELL ENVIRON, V32, P476, DOI 10.1111/j.1365-3040.2009.01941.x; SLAVIK B, 1963, BIOL PLANTARUM, V5, P143, DOI 10.1007/BF02933646; Sperdouli I, 2012, PLANT BIOLOGY, V14, P118, DOI 10.1111/j.1438-8677.2011.00473.x; Sperry JS, 2003, INT J PLANT SCI, V164, pS115, DOI 10.1086/368398; TERASHIMA I, 1992, PHOTOSYNTH RES, V31, P195, DOI 10.1007/BF00035537; Trifilo P, 2003, PHYSIOL PLANTARUM, V119, P409, DOI 10.1034/j.1399-3054.2003.00154.x; Vogel S, 2009, NEW PHYTOL, V183, P13, DOI 10.1111/j.1469-8137.2009.02854.x; White JW, 2005, FIELD CROP RES, V91, P7, DOI 10.1016/j.fcr.2004.05.001; WIEBE HH, 1977, PLANT PHYSIOL, V59, P256, DOI 10.1104/pp.59.2.256; Woodruff DR, 2009, TREE PHYSIOL, V29, P261, DOI 10.1093/treephys/tpn024; Yamane Y, 1998, PHOTOSYNTH RES, V57, P51, DOI 10.1023/A:1006019102619; Zhang YJ, 2009, PLANT CELL ENVIRON, V32, P1456, DOI 10.1111/j.1365-3040.2009.02012.x; Zwieniecki MA, 2004, PLANT CELL ENVIRON, V27, P357, DOI 10.1111/j.1365-3040.2003.01153.x	71	23	25	8	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66016	10.1371/journal.pone.0066016	http://dx.doi.org/10.1371/journal.pone.0066016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776594	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400100
J	Wang, Y; Yang, X; Zheng, Y; Wu, ZH; Zhang, XA; Li, QP; He, XY; Wang, CZ; Feng, ZC				Wang, Yan; Yang, Xiao; Zheng, Yong; Wu, Zhi-Hao; Zhang, Xiao-Ai; Li, Qiu-Ping; He, Xi-Yu; Wang, Chun-Zhi; Feng, Zhi-Chun			The SEPS1 G-105A Polymorphism Is Associated with Risk of Spontaneous Preterm Birth in a Chinese Population	PLOS ONE			English	Article							PREMATURE RUPTURE; DISEASE; MEMBRANES	Inflammation plays an important role in the etiology and pathophysiology of spontaneous preterm birth (SPTB), and selenoprotein S (SEPS1) is involved in regulating the inflammatory response. Recently the G-105A promoter polymorphism in SEPS1 was shown to increase pro-inflammatory cytokine expression. We examined whether this functional polymorphism was related to the risk of SPTB in a Chinese population. We also examined the impact of premature rupture of membranes (PROM) on susceptibility to SPTB. The SEPS1 G-105A polymorphism was genotyped in 569 preterm singleton neonates and 673 term neonates by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. chi(2) tests and logistic regression analyses were used to calculate the odds ratios (ORs) and 95% confidence intervals (95% CIs). We observed that, compared with the GG genotype, -105A positive genotypes (GA + AA genotypes) were associated with significantly increased susceptibility to SPTB (adjusted OR, 1.87; 95% CI, 1.36-2.57; P<0.001). The -105A positive genotypes were also significantly associated with increased susceptibility to SPTB, both in the patients with PROM (adjusted OR, 2.65; 95% CI, 1.73-4.03; P<0.001) and in those without PROM (adjusted OR, 1.56; 95% CI, 1.09-2.24; P = 0.015). The -105A positive genotypes were also significantly associated with increased susceptibility to SPTB between extremely preterm neonates and controls (adjusted OR, 4.46; 95% CI, 1.86-10.73; P = 0.002) and between moderately preterm neonates and controls (adjusted OR, 1.76; 95% CI, 1.25-2.47; P = 0.001). Our findings suggest that the SEPS1 G-105A polymorphism contributes to the risk of developing SPTB in a Chinese population.	[Wang, Yan; Yang, Xiao; Li, Qiu-Ping; He, Xi-Yu; Wang, Chun-Zhi; Feng, Zhi-Chun] Gen Mil Hosp Beijing PLA, BaYi Childrens Hosp, Beijing, Peoples R China; [Wu, Zhi-Hao] Beijing Inst Dis Control & Prevent, Dept Infect Dis Control, Beijing, Peoples R China; [Zhang, Xiao-Ai] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Wang, CZ (corresponding author), Gen Mil Hosp Beijing PLA, BaYi Childrens Hosp, Beijing, Peoples R China.	wczzy@126.com; zhichunfeng81@163.com		Liu, Wei/0000-0002-9302-8170	National Natural Science Foundation of China [30973210, 81170602]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30973210 and 81170602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanne M, 2007, HUM GENET, V122, P355, DOI 10.1007/s00439-007-0402-7; Anum EA, 2009, PEDIATR RES, V65, P1, DOI 10.1203/PDR.0b013e31818912e7; Chim SSC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034328; Curran JE, 2005, NAT GENET, V37, P1234, DOI 10.1038/ng1655; Day LJ, 2011, REPROD SCI, V18, P286, DOI 10.1177/1933719110391277; Engel SAM, 2005, EPIDEMIOLOGY, V16, P469, DOI 10.1097/01.ede.0000164539.09250.31; Goepfert AR, 2004, OBSTET GYNECOL, V104, P777, DOI 10.1097/01.AOG.0000139836.47777.6d; Graves SW, 2011, AM J OBSTET GYNECOL, V204, pS46, DOI 10.1016/j.ajog.2010.09.021; Gulati S, 2012, J MATERN-FETAL NEO M, V25, P1428, DOI 10.3109/14767058.2011.638952; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kim KW, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.040; Krediet TG, 2007, PEDIATR RES, V62, P474, DOI 10.1203/PDR.0b013e31813c9401; Lee SY, 2011, J IMMUNOL, V186, P3226, DOI 10.4049/jimmunol.1003587; Meplan C, 2010, CARCINOGENESIS, V31, P1074, DOI 10.1093/carcin/bgq076; Moses EK, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.024; Moura E, 2009, J REPROD IMMUNOL, V80, P115, DOI 10.1016/j.jri.2008.11.007; Nold C, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.036; Olsson M, 2011, METABOLISM, V60, P114, DOI 10.1016/j.metabol.2010.05.011; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Pereyra Silvana, 2012, BMC Res Notes, V5, P69, DOI 10.1186/1756-0500-5-69; Rey G, 2008, MOL HUM REPROD, V14, P555, DOI 10.1093/molehr/gan049; Ruiz RJ, 2012, J PERINATOL, V32, P483, DOI 10.1038/jp.2011.193; Sata F, 2009, MOL HUM REPROD, V15, P121, DOI 10.1093/molehr/gan078; Shibata T, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-2; Sutherland A, 2010, GENES NUTR, V5, P215, DOI 10.1007/s12263-010-0176-8; Varner MW, 2005, BJOG-INT J OBSTET GY, V112, P28, DOI 10.1111/j.1471-0528.2005.00581.x; Weiner CP, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.034; Winkvist A, 1998, INT J EPIDEMIOL, V27, P248, DOI 10.1093/ije/27.2.248; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yilmaz Y, 2012, DNA CELL BIOL, V31, P92, DOI 10.1089/dna.2010.1169; Zhao XL, 2012, LANCET, V380, P1144, DOI 10.1016/S0140-6736(12)61661-4	31	5	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65657	10.1371/journal.pone.0065657	http://dx.doi.org/10.1371/journal.pone.0065657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776519	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400053
J	Lacharite, M; Metaxas, A				Lacharite, Myriam; Metaxas, Anna			Early Life History of Deep-Water Gorgonian Corals May Limit Their Abundance	PLOS ONE			English	Article							PRIMNOA-RESEDAEFORMIS; NORTHEAST CHANNEL; CONTINENTAL-SLOPE; SEA CORALS; GENE FLOW; RECRUITMENT; HABITAT; GROWTH; ECOLOGY; REPRODUCTION	Deep-water gorgonian corals are long-lived organisms found worldwide off continental margins and seamounts, usually occurring at depths of similar to 200-1,000 m. Most corals undergo sexual reproduction by releasing a planktonic larval stage that disperses; however, recruitment rates and the environmental and biological factors influencing recruitment in deep-sea species are poorly known. Here, we present results from a 4-year field experiment conducted in the Gulf of Maine (northwest Atlantic) at depths >650 m that document recruitment for 2 species of deep-water gorgonian corals, Primnoa resedaeformis and Paragorgia arborea. The abundance of P. resedaeformis recruits was high, and influenced by the structural complexity of the recipient habitat, but very few recruits of P. arborea were found. We suggest that divergent reproductive modes (P. resedaeformis as a broadcast spawner and P. arborea as a brooder) may explain this pattern. Despite the high recruitment of P. resedaeformis, severe mortality early on in the benthic stage of this species may limit the abundance of adult colonies. Most recruits of this species (similar to 80%) were at the primary polyp stage, and less than 1% of recruits were at stage of 4 polyps or more. We propose that biological disturbance, possibly by the presence of suspension-feeding brittle stars, and limited food supply in the deep sea may cause this mortality. Our findings reinforce the vulnerability of these corals to anthropogenic disturbances, such as trawling with mobile gear, and the importance of incorporating knowledge on processes during the early life history stages in conservation decisions.	[Lacharite, Myriam; Metaxas, Anna] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada	Dalhousie University	Lacharite, M (corresponding author), Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada.	myriam.lacharite@dal.ca			National Science and Engineering Research Council (NSERC) [222932-06, 372526-09]; Canadian Healthy Oceans Network [340843-06]; Canada Graduate Scholarship (NSERC); Dalhousie University	National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Healthy Oceans Network; Canada Graduate Scholarship (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dalhousie University	This study was funded by the National Science and Engineering Research Council (NSERC) through a Discovery Grant - ship time to AM (222932-06,372526-09) and the Canadian Healthy Oceans Network (340843-06). ML is the recipient of a Canada Graduate Scholarship (NSERC) and a fellowship from Dalhousie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AH, 2002, HYDROBIOLOGIA, V471, P101, DOI 10.1023/A:1016501320206; Auster PJ, 2005, ERLANGEN EARTH C SER, P747, DOI 10.1007/3-540-27673-4_39; Ayre DJ, 2000, EVOLUTION, V54, P1590; Breeze H, 1997, DISTRIBUTION STATUS; Bryan TL, 2006, DEEP-SEA RES PT I, V53, P1865, DOI 10.1016/j.dsr.2006.09.006; Buhl-Mortensen L, 2005, ERLANGEN EARTH C SER, P849, DOI 10.1007/3-540-27673-4_44; Buhl-Mortensen L, 2004, J NAT HIST, V38, P1233, DOI 10.1080/0022293031000155205; Canals M, 2006, NATURE, V444, P354, DOI 10.1038/nature05271; Cordes EE, 2001, MAR BIOL, V138, P491, DOI 10.1007/s002270000470; Du Preez C, 2011, MAR ECOL PROG SER, V425, P217, DOI 10.3354/meps09005; Edinger EN, 2011, CONT SHELF RES, V31, pS69, DOI 10.1016/j.csr.2010.07.004; ESSIM Planning Office, 2006, 200601 ESSIM PLANN O; Etnoyer P, 2005, ERLANGEN EARTH C SER, P331, DOI 10.1007/3-540-27673-4_16; Gass SE, 2005, ERLANGEN EARTH C SER, P223, DOI 10.1007/3-540-27673-4_11; Gass SE, 2006, MAR POLLUT BULL, V52, P549, DOI 10.1016/j.marpolbul.2005.10.002; GENIN A, 1986, NATURE, V322, P59, DOI 10.1038/322059a0; GRASSLE JF, 1977, NATURE, V265, P618, DOI 10.1038/265618a0; GRIGG RW, 1988, MAR ECOL PROG SER, V45, P121, DOI 10.3354/meps045121; Harrison P.L., 1990, ECOSYSTEMS WORLD, V25, P133; Heifetz J, 2009, MAR ECOL PROG SER, V397, P295, DOI 10.3354/meps08304; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Hunt HL, 1997, MAR ECOL PROG SER, V155, P269, DOI 10.3354/meps155269; Huvenne VAI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028755; Kahng SE, 2011, MAR ECOL PROG SER, V443, P265, DOI 10.3354/meps09414; Kelly N, 2007, AQUAT BIOL, V1, P1, DOI 10.3354/ab00001; Kovalenko KE, 2012, HYDROBIOLOGIA, V685, P1, DOI 10.1007/s10750-011-0974-z; Krieger KJ, 2001, P 1 INT S DEEP SEA C, P106; Levin LA, 2012, ANNU REV MAR SCI, V4, P79, DOI 10.1146/annurev-marine-120709-142714; Mercier A, 2011, CORAL REEFS, V30, P337, DOI 10.1007/s00338-011-0724-8; Metaxas A, 2004, DEEP-SEA RES PT I, V51, P1307, DOI 10.1016/j.dsr.2004.06.001; Mortensen P, 2005, MAR BIOL, V147, P775, DOI 10.1007/s00227-005-1604-y; Mortensen PB, 2004, MAR BIOL, V144, P1223, DOI 10.1007/s00227-003-1280-8; Mullineaux LS, 1998, DEEP-SEA RES PT II, V45, P441, DOI 10.1016/S0967-0645(97)00045-3; Murillo FJ, 2011, ICES J MAR SCI, V68, P319, DOI 10.1093/icesjms/fsq071; Nishikawa A, 2003, MAR ECOL PROG SER, V256, P87, DOI 10.3354/meps256087; Orejas C, 2002, MAR ECOL PROG SER, V231, P101, DOI 10.3354/meps231101; Orejas C, 2007, MAR BIOL, V150, P551, DOI 10.1007/s00227-006-0370-9; RAMP SR, 1985, J PHYS OCEANOGR, V15, P1790, DOI 10.1175/1520-0485(1985)015<1790:TDFTTN>2.0.CO;2; Richmond RH, 1997, LIFE DEATH CORAL REE, P1; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Rowden AA, 2010, MAR ECOL-EVOL PERSP, V31, P95, DOI 10.1111/j.1439-0485.2010.00369.x; SANDERS HL, 1979, SARSIA, V64, P1; Sherwood OA, 2008, DEEP-SEA RES PT I, V55, P1392, DOI 10.1016/j.dsr.2008.05.013; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; SNELGROVE PVR, 1994, J MAR RES, V52, P345, DOI 10.1357/0022240943077082; Sun Z, 2010, MAR BIOL, V157, P863, DOI 10.1007/s00227-009-1369-9; Thresher RE, 2011, CORAL REEFS, V30, P1063, DOI 10.1007/s00338-011-0806-7; Tong RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043534; Vermeij MJA, 2008, ECOLOGY, V89, P1994, DOI 10.1890/07-1296.1; Waller RG, 2005, ERLANGEN EARTH C SER, P691, DOI 10.1007/3-540-27673-4_35; Wareham VE, 2007, CONSERVATION AND ADAPTIVE MANAGEMENT OF SEAMOUNT AND DEEP-SEA CORAL ECOSYSTEMS, P289; Watanabe S, 2009, DEEP-SEA RES PT I, V56, P2235, DOI 10.1016/j.dsr.2009.09.003; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; Young CM, 2003, ECOSY WORLD, V28, P381	55	36	38	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65394	10.1371/journal.pone.0065394	http://dx.doi.org/10.1371/journal.pone.0065394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762358	Green Published, gold, Green Submitted			2022-12-25	WOS:000320440500035
J	Song, DQ; Li, YM; Cao, JT; Han, ZH; Gao, L; Xu, ZJ; Yin, ZF; Wang, GF; Fan, YQ; Wang, CQ				Song, Dongqiang; Li, Yuanmin; Cao, Jiatian; Han, Zhihua; Gao, Lin; Xu, Zuojun; Yin, Zhaofang; Wang, Guifang; Fan, Yuqi; Wang, Changqian			Effect of Iron Deficiency on c-kit(+) Cardiac Stem Cells In Vitro	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; REGENERATE INFARCTED MYOCARDIUM; MECHANISMS; EXPRESSION; CHELATION; ANEMIA; GROWTH; DIFFERENTIATION; DESFERRIOXAMINE; PROLIFERATION	Aim: Iron deficiency is a common comorbidity in chronic heart failure (CHF) which may exacerbate CHF. The c-kit(+) cardiac stem cells (CSCs) play a vital role in cardiac function repair. However, much is unknown regarding the role of iron deficiency in regulating c-kit(+) CSCs function. In this study, we investigated whether iron deficiency regulates c-kit(+) CSCs proliferation, migration, apoptosis, and differentiation in vitro. Method: All c-kit(+) CSCs were isolated from adult C57BL/6 mice. The c-kit(+) CSCs were cultured with deferoxamine (DFO, an iron chelator), mimosine (MIM, another iron chelator), or a complex of DFO and iron (Fe(III)), respectively. Cell migration was assayed using a 48-well chamber system. Proliferation, cell cycle, and apoptosis of c-kit(+) CSCs were analyzed with BrdU labeling, population doubling time assay, CCK-8 assay, and flow cytometry. Caspase-3 protein level and activity were examined with Western blotting and spectrophotometric detection. The changes in the expression of cardiac-specific proteins (GATA-4, TNI, and beta-MHC) and cell cycle-related proteins (cyclin D1, RB, and pRB) were detected with Western blotting. Result: DFO and MIM suppressed c-kit(+) CSCs proliferation and differentiation. They also modulated cell cycle and cardiac-specific protein expression. Iron chelators down-regulated the expression and phosphorylation of cell cycle-related proteins. Iron reversed those suppressive effects of DFO. DFO and MIM didn't affect c-kit(+) CSCs migration and apoptosis. Conclusion: Iron deficiency suppressed proliferation and differentiation of c-kit(+) CSCs. This may partly explain how iron deficiency affects CHF prognosis.	[Song, Dongqiang; Li, Yuanmin; Cao, Jiatian; Han, Zhihua; Gao, Lin; Xu, Zuojun; Yin, Zhaofang; Fan, Yuqi; Wang, Changqian] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Cardiol, Shanghai 200030, Peoples R China; [Wang, Guifang] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Shanghai Key Lab Stomatol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Fan, YQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Cardiol, Shanghai 200030, Peoples R China.	moricizine@gmail.com; changqianwang@hotmail.com			Chinese National Natural Science Foundation [81270376, 31201010, 30971436]; Shanghai Jiaotong University Interdisciplinary Cooperation Grant [YG2011MS50, YG2012MS24]; Shanghai Jiaotong University School of Medicine Science Foundation [11XJ21025]; Shanghai Committee of Science and Technology of China [10JC1408900, 12401905200]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Jiaotong University Interdisciplinary Cooperation Grant; Shanghai Jiaotong University School of Medicine Science Foundation; Shanghai Committee of Science and Technology of China	This work was supported by the Chinese National Natural Science Foundation Grants 81270376, 31201010 and 30971436, the Shanghai Jiaotong University Interdisciplinary Cooperation Grant YG2011MS50 and YG2012MS24, the Shanghai Jiaotong University School of Medicine Science Foundation Grant 11XJ21025, and the Shanghai Committee of Science and Technology of China Grant 10JC1408900 and 12401905200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Chamuleau SAF, 2009, NETH HEART J, V17, P199, DOI 10.1007/BF03086247; Coma S, 2011, CELL ADHES MIGR, V5, P266, DOI 10.4161/cam.5.3.16294; Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102; Dayani PN, 2004, J NEURO-ONCOL, V67, P367, DOI 10.1023/B:NEON.0000024238.21349.37; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Ge Y, 2011, TRENDS CARDIOVAS MED, V21, P105, DOI 10.1016/j.tcm.2012.03.007; Gharagozloo M, 2008, EUR J PHARMACOL, V589, P1, DOI 10.1016/j.ejphar.2008.03.059; Guo JL, 2009, INT J EXP PATHOL, V90, P355, DOI 10.1111/j.1365-2613.2009.00659.x; Gutzwiller FS, 2012, EUR J HEART FAIL, V14, P782, DOI 10.1093/eurjhf/hfs083; Jankowska EA, 2010, EUR HEART J, V31, P1872, DOI 10.1093/eurheartj/ehq158; Jia Peng, 2012, Zhonghua Yi Xue Za Zhi, V92, P2214; Kajstura J, 2010, CIRC RES, V107, P1374, DOI 10.1161/CIRCRESAHA.110.231498; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee S, 2012, J NEUROSCI RES, V90, P540, DOI 10.1002/jnr.22779; Li LX, 2009, ARTERIOSCL THROM VAS, V29, P732, DOI 10.1161/ATVBAHA.108.183210; Li M, 2008, CIRC RES, V102, P677, DOI 10.1161/CIRCRESAHA.107.161737; Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Naito Y, 2009, AM J PHYSIOL-HEART C, V296, pH585, DOI 10.1152/ajpheart.00463.2008; Nanas JN, 2006, J AM COLL CARDIOL, V48, P2485, DOI 10.1016/j.jacc.2006.08.034; Nurtjahja-Tjendraputra E, 2007, BLOOD, V109, P4045, DOI 10.1182/blood-2006-10-047753; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Pahl PMB, 2000, J BIOL CHEM, V275, P17821, DOI 10.1074/jbc.M909918199; Pan YJ, 2004, BBA-MOL CELL RES, V1691, P41, DOI 10.1016/j.bbamcr.2003.12.003; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Saletta F, 2011, J BIOL CHEM, V286, P35396, DOI 10.1074/jbc.M111.273060; Silverberg D, 2011, HYPERTENSION, V57, P381, DOI 10.1161/HYPERTENSIONAHA.110.166868; Tang JM, 2009, EXP CELL RES, V315, P3521, DOI 10.1016/j.yexcr.2009.09.026; Terrovitis JV, 2012, J AM COLL CARDIOL, V60, P2255, DOI 10.1016/j.jacc.2012.05.065; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; van Veldhuisen DJ, 2011, NAT REV CARDIOL, V8, P485, DOI 10.1038/nrcardio.2011.77; Zeng HL, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-32	35	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65721	10.1371/journal.pone.0065721	http://dx.doi.org/10.1371/journal.pone.0065721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762416	Green Published, Green Submitted, gold			2022-12-25	WOS:000320440500048
J	Chen, L; Ge, Q; Black, JL; Deng, LH; Burgess, JK; Oliver, BGG				Chen, Ling; Ge, Qi; Black, Judith L.; Deng, Linhong; Burgess, Janette K.; Oliver, Brian G. G.			Differential Regulation of Extracellular Matrix and Soluble Fibulin-1 Levels by TGF-beta(1) in Airway Smooth Muscle Cells	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GROWTH-FACTOR-BETA; EXPRESSION; PROLIFERATION; PROTEINS; LOCALIZATION; MECHANISMS; DEPOSITION; FIBROSIS; ASTHMA	Fibulin-1 (FBLN-1) is a secreted glycoprotein that is associated with extracellular matrix (ECM) formation and rebuilding. Abnormal and exaggerated deposition of ECM proteins is a hallmark of many fibrotic diseases, such as chronic obstructive pulmonary disease (COPD) where small airway fibrosis occurs. The aim of this study was to investigate the regulation of FBLN-1 by transforming growth factor beta 1 (TGF-beta(1)) (a pro-fibrotic stimulus) in primary human airway smooth muscle (ASM) cells from volunteers with and without COPD. Human ASM cells were seeded at a density of 1 x 10(4) cells/cm(2), and stimulated with or without TGF-beta(1) (10 ng/ml) for 72 hours before FBLN-1 deposition and soluble FBLN-1 were measured. Fold change in FBLN-1 mRNA was measured at 4, 8, 24, 48, 72 hours. In some experiments, cycloheximide (0.5 mu g/ml) was used to assess the regulation of FBLN-1 production. TGF-beta(1) decreased the amount of soluble FBLN-1 both from COPD and non-COPD ASM cells. In contrast, the deposition of FBLN-1 into the ECM was increased in ASM cells obtained from both groups. TGF-beta(1) did not increase FBLN-1 gene expression at any of the time points. There were no differences in the TGF-beta(1) induced FBLN-1 levels between cells from people with or without COPD. Cycloheximide treatment, which inhibits protein synthesis, decreased both the constitutive release of soluble FBLN-1, and TGF-beta(1) induced ECM FBLN-1 deposition. Furthermore, in cycloheximide treated cells addition of soluble FBLN-1 resulted in incorporation of FBLN-1 into the ECM. Therefore the increased deposition of FBLN-1 by ASM cells into the ECM following treatment with TGF-beta(1) is likely due to incorporation of soluble FBLN-1 rather than de-novo synthesis.	[Chen, Ling; Deng, Linhong] Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing, Peoples R China; [Chen, Ling; Ge, Qi; Black, Judith L.; Burgess, Janette K.; Oliver, Brian G. G.] Woolcock Inst Med Res, Sydney, NSW, Australia; [Ge, Qi; Black, Judith L.; Burgess, Janette K.; Oliver, Brian G. G.] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Deng, Linhong] Changzhou Univ, Inst Biomed Engn & Hlth Sci, Changzhou, Jiangsu, Peoples R China	Chongqing University; University of Sydney; Woolcock Institute of Medical Research; University of Sydney; Changzhou University	Deng, LH (corresponding author), Chongqing Univ, Bioengn Coll, Minist Educ, Key Lab Biorheol Sci & Technol, Chongqing, Peoples R China.	dlh@cczu.edu.cn	Burgess, Janette K/A-3597-2010; Ge, Qi/D-3988-2013; Oliver, Brian/E-7939-2010; Black, Judith L/C-6559-2008; Deng, Linhong/O-3218-2019; Deng, Linhong/C-1485-2009; Burgess, Janette/M-7117-2019	Oliver, Brian/0000-0002-7122-9262; Deng, Linhong/0000-0003-1970-8239; Burgess, Janette/0000-0001-9868-9966	National Health and Medical Research Council (NHMRC), Australia [570867]; Chinese State Scholarship Fund [2011605038]; NHMRC [571098, 1032695, 1026880]	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); Chinese State Scholarship Fund; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council (NHMRC) Project grant number 570867, Australia (http://www.nhmrc.gov.au/). L. Chen is supported by a Chinese State Scholarship Fund number 2011605038, China (http://www.csc.edu.cn). J. L. Black is supported by a NHMRC senior Principal Research Fellowship number 571098. J. K. Burgess is supported by a NHMRC Career Development Fellowship number 1032695. B. Oliver is supported by a NHMRC Career Development Fellowship number 1026880. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annoni R, 2012, EUR RESP J; Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Carlin S, 1999, AM J PHYSIOL-LUNG C, V276, pL506, DOI 10.1152/ajplung.1999.276.3.L506; de Boer WI, 1998, AM J RESP CRIT CARE, V158, P1951, DOI 10.1164/ajrccm.158.6.9803053; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2013, GLOB STRAT DIAGN MAN; GODYNA S, 1995, MATRIX BIOL, V14, P467, DOI 10.1016/0945-053X(95)90004-7; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Ichimaru Y, 2012, AM J PHYSIOL-LUNG C, V302, pL325, DOI 10.1152/ajplung.00453.2010; Johnson PRA, 2000, AM J RESP CRIT CARE, V162, P2145, DOI 10.1164/ajrccm.162.6.9909111; Johnson PRA, 2006, AM J RESP CRIT CARE, V173, P32, DOI 10.1164/rccm.200406-703OC; Johnson PRA, 2004, J ALLERGY CLIN IMMUN, V113, P690, DOI 10.1016/j.jaci.2003.12.312; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; KHALIL N, 1991, AM J RESP CELL MOL, V5, P155, DOI 10.1165/ajrcmb/5.2.155; Kranenburg AR, 2006, AM J CLIN PATHOL, V126, P725, DOI 10.1309/JC477FAEL1YKV54W; Lalor DJ, 2004, AM J PHYSIOL-LUNG C, V287, pL1007, DOI 10.1152/ajplung.00126.2004; Lau JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013360; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mak JCW, 2009, RESP MED, V103, P1083, DOI 10.1016/j.rmed.2009.01.005; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Moir LM, 2008, J ALLERGY CLIN IMMUN, V121, P1034, DOI 10.1016/j.jaci.2007.12.1159; ROMAN J, 1993, AM J RESP CELL MOL, V8, P538, DOI 10.1165/ajrcmb/8.5.538; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; SASAKI T, 1995, J MOL BIOL, V245, P241, DOI 10.1006/jmbi.1994.0020; Sturton G, 2008, TRENDS PHARMACOL SCI, V29, P340, DOI 10.1016/j.tips.2008.04.003; TIDDENS HAWM, 1995, AM J RESP CRIT CARE, V152, P260, DOI 10.1164/ajrccm.152.1.7599833; Timpl R, 2000, MATRIX BIOL, V19, P309, DOI 10.1016/S0945-053X(00)00072-X; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; ZHANG K, 1995, AM J PATHOL, V147, P352	28	9	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65544	10.1371/journal.pone.0065544	http://dx.doi.org/10.1371/journal.pone.0065544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762390	gold, Green Submitted, Green Published			2022-12-25	WOS:000321094800061
J	Cornman, RS; Lopez, D; Evans, JD				Cornman, Robert Scott; Lopez, Dawn; Evans, Jay D.			Transcriptional Response of Honey Bee Larvae Infected with the Bacterial Pathogen Paenibacillus larvae	PLOS ONE			English	Article							AMERICAN FOULBROOD; APIS-MELLIFERA; DROSOPHILA-MELANOGASTER; EXTRACELLULAR-MATRIX; ANOPHELES-GAMBIAE; IMMUNE-RESPONSE; ZP DOMAIN; PROTEINS; DISEASE; GENES	American foulbrood disease of honey bees is caused by the bacterium Paenibacillus larvae. Infection occurs per os in larvae and systemic infection requires a breaching of the host peritrophic matrix and midgut epithelium. Genetic variation exists for both bacterial virulence and host resistance, and a general immunity is achieved by larvae as they age, the basis of which has not been identified. To quickly identify a pool of candidate genes responsive to P. larvae infection, we sequenced transcripts from larvae inoculated with P. larvae at 12 hours post-emergence and incubated for 72 hours, and compared expression levels to a control cohort. We identified 75 genes with significantly higher expression and six genes with significantly lower expression. In addition to several antimicrobial peptides, two genes encoding peritrophic-matrix domains were also up-regulated. Extracellular matrix proteins, proteases/protease inhibitors, and members of the Osiris gene family were prevalent among differentially regulated genes. However, analysis of Drosophila homologs of differentially expressed genes revealed spatial and temporal patterns consistent with developmental asynchrony as a likely confounder of our results. We therefore used qPCR to measure the consistency of gene expression changes for a subset of differentially expressed genes. A replicate experiment sampled at both 48 and 72 hours post infection allowed further discrimination of genes likely to be involved in host response. The consistently responsive genes in our test set included a hymenopteran-specific protein tyrosine kinase, a hymenopteran specific serine endopeptidase, a cytochrome P450 (CYP9Q1), and a homolog of trynity, a zona pellucida domain protein. Of the known honey bee antimicrobial peptides, apidaecin was responsive at both time-points studied whereas hymenoptaecin was more consistent in its level of change between biological replicates and had the greatest increase in expression by RNA-seq analysis.	[Cornman, Robert Scott; Lopez, Dawn; Evans, Jay D.] USDA ARS, Bee Res Lab, Beltsville, MD USA	United States Department of Agriculture (USDA)	Cornman, RS (corresponding author), USDA ARS, Bee Res Lab, Beltsville, MD USA.	scott.cornman@gmail.com	Evans, Jay D/C-8408-2012	Evans, Jay D/0000-0002-0036-4651	Coordinate Agricultural Project on Pollinator Health (USDA National Institute of Food and Agriculture)	Coordinate Agricultural Project on Pollinator Health (USDA National Institute of Food and Agriculture)	This project was supported by the Coordinate Agricultural Project on Pollinator Health (USDA National Institute of Food and Agriculture). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, GENOME BIOL, V11, pR106; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cornman RS, 2009, INSECT MOL BIOL, V18, P607, DOI 10.1111/j.1365-2583.2009.00902.x; Cornman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012536; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Dorer DR, 2003, GENETICS, V165, P613; Eddy Sean R, 2009, Genome Inform, V23, P205; Emerson KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009574; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Evans JD, 2005, EVOLUTION, V59, P2270, DOI 10.1111/j.0014-3820.2005.tb00935.x; Evans JD, 2004, J INVERTEBR PATHOL, V85, P105, DOI 10.1016/j.jip.2004.02.004; Evans JD, 2004, J ECON ENTOMOL, V97, P752, DOI 10.1603/0022-0493(2004)097[0752:BPIAIR]2.0.CO;2; Gallot A, 2010, INSECT BIOCHEM MOLEC, V40, P235, DOI 10.1016/j.ibmb.2009.12.001; Genersch E, 2005, APPL ENVIRON MICROB, V71, P7551, DOI 10.1128/AEM.71.11.7551-7555.2005; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jazwinska A, 2004, GENE EXPR PATTERNS, V4, P413, DOI 10.1016/j.modgep.2004.01.003; Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Nelson JA, 1924, J AGRIC RES, V28, P1167; Ortiz de Montellano P.R., 2004, CYTOCHROME P450 STRU, V3rd; Rauch S, 2009, APPL ENVIRON MICROB, V75, P3344, DOI 10.1128/AEM.02839-08; Robertson CW, 1936, J MORPHOL, V59, P351, DOI 10.1002/jmor.1050590207; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roch F, 2003, J CELL SCI, V116, P1199, DOI 10.1242/jcs.00298; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHIMANUKI H, 1990, HONEY BEE PESTS PRED, P27; Spivak M, 1998, BEE WORLD, V79, P124, DOI 10.1080/0005772X.1998.11099394; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Terra WR, 2001, ARCH INSECT BIOCHEM, V47, P47, DOI 10.1002/arch.1036; Togawa T, 2008, INSECT BIOCHEM MOLEC, V38, P508, DOI 10.1016/j.ibmb.2007.12.008; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VERCELLOTTI GM, 1985, AM J PATHOL, V120, P13; Vontas J, 2007, INSECT MOL BIOL, V16, P315, DOI 10.1111/j.1365-2583.2007.00728.x; WESTERLUND B, 1993, MOL MICROBIOL, V9, P687, DOI 10.1111/j.1365-2958.1993.tb01729.x; Willis JH, 2010, INSECT BIOCHEM MOLEC, V40, P189, DOI 10.1016/j.ibmb.2010.02.001; Winston M. L. L., 1991, BIOL HONEY BEE; Yue D, 2008, ENVIRON MICROBIOL, V10, P1612, DOI 10.1111/j.1462-2920.2008.01579.x	47	31	36	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65424	10.1371/journal.pone.0065424	http://dx.doi.org/10.1371/journal.pone.0065424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762370	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000066
J	Lee, D; Lee, GK; Yoon, KA; Lee, JS				Lee, Donghoon; Lee, Geon Kook; Yoon, Kyong-Ah; Lee, Jin Soo			Pathway-Based Analysis Using Genome-wide Association Data from a Korean Non-Small Cell Lung Cancer Study	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; SUSCEPTIBILITY LOCUS; VARIANTS; 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; CARCINOGEN; MORTALITY; DISEASE; GENES; POWER; SNPS	Pathway-based analysis, used in conjunction with genome-wide association study (GWAS) techniques, is a powerful tool to detect subtle but systematic patterns in genome that can help elucidate complex diseases, like cancers. Here, we stepped back from genetic polymorphisms at a single locus and examined how multiple association signals can be orchestrated to find pathways related to lung cancer susceptibility. We used single-nucleotide polymorphism (SNP) array data from 869 non-small cell lung cancer (NSCLC) cases from a previous GWAS at the National Cancer Center and 1,533 controls from the Korean Association Resource project for the pathway-based analysis. After mapping single-nucleotide polymorphisms to genes, considering their coding region and regulatory elements (+/- 20 kbp), multivariate logistic regression of additive and dominant genetic models were fitted against disease status, with adjustments for age, gender, and smoking status. Pathway statistics were evaluated using Gene Set Enrichment Analysis (GSEA) and Adaptive Rank Truncated Product (ARTP) methods. Among 880 pathways, 11 showed relatively significant statistics compared to our positive controls (P-GSEA <= 0.025, false discovery rate <= 0.25). Candidate pathways were validated using the ARTP method and similarities between pathways were computed against each other. The top-ranked pathways were ABC Transporters (PGSEA, < 0.001, P-ARTP = 0.001), VEGF Signaling Pathway (PG(SEA), 0.001, P-ARTP = 0.008), G1/S Check Point (P-GSEA = 0.004, P-ARTP = 0.013), and NRAGE Signals Death through JNK (P-GSEA = 0.006, P-ARTP = 0.001). Our results demonstrate that pathway analysis can shed light on post-GWAS research and help identify potential targets for cancer susceptibility.	[Lee, Donghoon; Lee, Geon Kook; Yoon, Kyong-Ah; Lee, Jin Soo] Natl Canc Ctr, Res Inst & Hosp, Lung Canc Branch, Gyeonggi, South Korea	National Cancer Center - Korea (NCC)	Yoon, KA (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Lung Canc Branch, Gyeonggi, South Korea.	kayoon@ncc.re.kr	Lee, Donghoon/I-9967-2017; Lee, Donghoon/AAQ-9786-2021; Lee, Donghoon/AAH-2252-2020	Lee, Donghoon/0000-0003-0453-6059; Lee, Donghoon/0000-0003-0453-6059	National Cancer Center [1210360]	National Cancer Center	The research was supported by National Cancer Center research grant 1210360. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; CORREA E, 1990, CANCER RES, V50, P3435; Falvella FS, 2008, ONCOGENE, V27, P1650, DOI 10.1038/sj.onc.1210775; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Gauderman WJ, 2007, GENET EPIDEMIOL, V31, P383, DOI 10.1002/gepi.20219; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Guo YF, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-429; Han JY, 2011, CANCER-AM CANCER SOC, V117, P3201, DOI 10.1002/cncr.25863; Holden M, 2008, BIOINFORMATICS, V24, P2784, DOI 10.1093/bioinformatics/btn516; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; In KH, 2009, LUNG CANCER, V64, P232, DOI 10.1016/j.lungcan.2008.08.005; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jung KW, 2012, CANCER RES TREAT, V44, P25, DOI 10.4143/crt.2012.44.1.25; Kwee LC, 2008, AM J HUM GENET, V82, P386, DOI 10.1016/j.ajhg.2007.10.010; Lee SJ, 2005, CANCER EPIDEM BIOMAR, V14, P571, DOI 10.1158/1055-9965.EPI-04-0472; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Marugame T, 2009, JPN J CLIN ONCOL, V39, P696, DOI 10.1093/jjco/hyp138; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Miki D, 2010, NAT GENET, V42, P893, DOI 10.1038/ng.667; Nam D, 2010, NUCLEIC ACIDS RES, V38, pW749, DOI 10.1093/nar/gkq428; Pao W, 2012, NAT MED, V18, P349, DOI 10.1038/nm.2697; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; SCHULLER HM, 1990, CANCER RES, V50, P1960; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Truong T, 2010, CARCINOGENESIS, V31, P625, DOI 10.1093/carcin/bgq001; Wang HJ, 2009, CANCER-AM CANCER SOC, V115, P595, DOI 10.1002/cncr.24042; Wang K, 2008, GENET EPIDEMIOL, V32, P108, DOI 10.1002/gepi.20266; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Wang T, 2007, AM J HUM GENET, V80, P353, DOI 10.1086/511312; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002; Yoon KA, 2010, HUM MOL GENET, V19, P4948, DOI 10.1093/hmg/ddq421; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zhang KL, 2010, NUCLEIC ACIDS RES, V38, pW90, DOI 10.1093/nar/gkq324	45	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65396	10.1371/journal.pone.0065396	http://dx.doi.org/10.1371/journal.pone.0065396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762359	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000062
J	Devine, DJ; Rostas, JW; Metge, BJ; Das, S; Mulekar, MS; Tucker, JA; Grizzle, WE; Buchsbaum, DJ; Shevde, LA; Samant, RS				Devine, D. J.; Rostas, J. W.; Metge, B. J.; Das, S.; Mulekar, M. S.; Tucker, J. A.; Grizzle, W. E.; Buchsbaum, D. J.; Shevde, L. A.; Samant, R. S.			Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-beta/SMAD signaling	ONCOGENE			English	Article						N-Myc interactor; epithelial-mesenchymal transition; SMAD; breast cancer	GROWTH-FACTOR-BETA; CANCER STEM-CELLS; INTERFERON-GAMMA; BREAST; EMT; NMI; METASTASIS; SMAD7; TRANSCRIPTION; PROGRESSION	Epithelial-mesenchymal transition is one of the critical cellular programs that facilitate the progression of breast cancer to an invasive disease. We have observed that the expression of N-myc interactor (NMI) decreases significantly during progression of breast cancer, specifically in invasive and metastatic stages. Recapitulation of this loss in breast cell lines with epithelial morphology (MCF10A (non-tumorigenic) and T47D (tumorigenic)) by silencing NMI expression causes mesenchymal-like morphological changes in 3D growth, accompanied by upregulation of SLUG and ZEB2 and increased invasive properties. Conversely, we found that restoring NMI expression attenuated the mesenchymal attributes of metastatic breast cancer cells, accompanied by distinctly circumscribed 3D growth with basement membrane deposition and decreased invasion. Further investigations into the downstream signaling modulated by NMI revealed that NMI expression negatively regulates SMAD signaling, which is a key regulator of cellular plasticity. We demonstrate that NMI blocks TGF-beta/SMAD signaling via upregulation of SMAD7, a negative feedback regulator of the pathway. We also provide evidence that NMI activates STAT signaling, which negatively modulates TGF-beta/SMAD signaling. Taken together, our findings suggest that loss of NMI during breast cancer progression could be one of the driving factors that enhance the invasive ability of breast cancer by aberrant activation of TGF-beta/SMAD signaling.	[Devine, D. J.; Rostas, J. W.] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 35294 USA; [Rostas, J. W.] Univ S Alabama, Dept Surg, Mobile, AL 35294 USA; [Metge, B. J.; Das, S.; Grizzle, W. E.; Shevde, L. A.; Samant, R. S.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Metge, B. J.; Das, S.; Shevde, L. A.; Samant, R. S.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Mulekar, M. S.] Univ S Alabama, Dept Math & Stat, Mobile, AL 35294 USA; [Tucker, J. A.] Univ S Alabama, Dept Pathol, Mobile, AL 35294 USA; [Buchsbaum, D. J.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL USA	University of South Alabama; University of South Alabama; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of South Alabama; University of South Alabama; University of Alabama System; University of Alabama Birmingham	Samant, RS (corresponding author), Univ S Alabama, Dept Pathol, WTI 320E,1720,Second Ave S, Mobile, AL 35294 USA.	rsamant@uab.edu		Samant, Rajeev/0000-0001-5681-4976; Buchsbaum, Donald/0000-0003-2797-5847	USPHS [CA140472, CA138850]; American Medical Association Seed Grant; NATIONAL CANCER INSTITUTE [R01CA140472, R01CA138850] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); American Medical Association Seed Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant support: USPHS grants CA140472 and Mayer Mitchell Award (RSS) and CA138850 (LAS). J. Rostas is a recipient of the American Medical Association Seed Grant 2011. We thank Dr Charles V. Clevenger (Northwestern University, Chicago, IL) for the gift of the beta-casein and lactogenic hormone response element reporters and Dr Robert Weinberg (Whitehead Institute, MA) for the gift of HME and HMEC cell lines.	Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Bao JX, 1996, ONCOGENE, V12, P2171; Baxley SE, 2010, CURR DRUG TARGETS, V11, P1089; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Cano C, 2010, THESCIENTIFICWORLDJO, V10, P1947, DOI 10.1100/tsw.2010.183; Cocolakis E, 2008, J BIOL CHEM, V283, P1293, DOI 10.1074/jbc.M707492200; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Drasin DJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3037; Fillmore RA, 2009, INT J CANCER, V125, P556, DOI 10.1002/ijc.24276; Fuxe J, 2010, CELL CYCLE, V9, P2363, DOI 10.4161/cc.9.12.12050; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; Gunasinghe NPAD, 2012, CANCER METAST REV, V31, P469, DOI 10.1007/s10555-012-9377-5; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Iwamoto T, 2002, HISTOL HISTOPATHOL, V17, P887, DOI 10.14670/HH-17.887; Joseph MJ, 2009, J CELL BIOCHEM, V108, P726, DOI 10.1002/jcb.22309; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Kang YB, 2006, J CELL BIOCHEM, V98, P1380, DOI 10.1002/jcb.20928; Krantz SB, 2012, J SURG RES, V173, P105, DOI 10.1016/j.jss.2011.09.020; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li HC, 2002, J BIOL CHEM, V277, P20965, DOI 10.1074/jbc.M112231200; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Papageorgis P, CANC RES, V70, P968; Piek E, 1999, J CELL SCI, V112, P4557; Postigo AA, 2003, EMBO J, V22, P2443, DOI 10.1093/emboj/cdg225; PRICE JE, 1990, CANCER-AM CANCER SOC, V66, P1313, DOI 10.1002/1097-0142(19900915)66:14+<1313::AID-CNCR2820661403>3.0.CO;2-4; Saika S, 2004, LAB INVEST, V84, P1259, DOI 10.1038/labinvest.3700151; SCHMITT E, 1994, EUR J IMMUNOL, V24, P793, DOI 10.1002/eji.1830240403; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Takebe N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2876; Taylor MA, 2010, J MAMMARY GLAND BIOL, V15, P169, DOI 10.1007/s10911-010-9181-1; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tian F, 2004, CANCER RES, V64, P4523, DOI 10.1158/0008-5472.CAN-04-0030; Tian YC, 2003, AM J PHYSIOL-RENAL, V285, pF130, DOI 10.1152/ajprenal.00408.2002; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Vincent-Salomon A, 2003, BREAST CANCER RES, V5, P101, DOI 10.1186/bcr578; Wakefield LM, 2001, J MAMMARY GLAND BIOL, V6, P67, DOI 10.1023/A:1009568532177; Wang ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI 10.1038/nrgastro.2010.188; Weng HL, 2007, J HEPATOL, V46, P295, DOI 10.1016/j.jhep.2006.09.014; Xiao BG, 1996, CLIN EXP IMMUNOL, V103, P475; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yan XH, 2011, BIOCHEM J, V434, P1, DOI 10.1042/BJ20101827; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yao DB, 2011, MOL CANCER RES, V9, P1608, DOI 10.1158/1541-7786.MCR-10-0568; Yates C, 2012, ADV EXP MED BIOL, V720, P81, DOI 10.1007/978-1-4614-0254-1_7; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhu MH, 1999, CELL, V96, P121, DOI 10.1016/S0092-8674(00)80965-4	57	22	23	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 15	2014	33	20					2620	2628		10.1038/onc.2013.215	http://dx.doi.org/10.1038/onc.2013.215			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH9YT	23770854	Green Accepted			2022-12-25	WOS:000336502700008
J	Chen, JR; Zhang, J; Lazarenko, OP; Cao, JJ; Blackburn, ML; Badger, TM; Ronis, MJJ				Chen, Jin-Ran; Zhang, Jian; Lazarenko, Oxana P.; Cao, Jay J.; Blackburn, Michael L.; Badger, Thomas M.; Ronis, Martin J. J.			Soy protein isolates prevent loss of bone quantity associated with obesity in rats through regulation of insulin signaling in osteoblasts	FASEB JOURNAL			English	Article						high-fat diet; free fatty acid; isoflavone; osteocalcin	VOLUNTARY WEIGHT-LOSS; MINERAL DENSITY; DIETARY PHYTOESTROGENS; FAT; MASS; INHIBITION; ISOFLAVONE; CELL; INTERVENTION; ACQUISITION	In both rodents and humans, excessive consumption of a typical Western diet high in saturated fats and cholesterol is known to result in disruption of energy metabolism and development of obesity and insulin resistance. However, how these high-fat, energy-dense diets affect bone development, morphology, and modeling is poorly understood. Here we show that male weanling rats fed a high-fat (HF) diet containing 45% fat and 0.5% cholesterol made with casein (HF-Cas) for 6 wk displayed a significant increase in bone marrow adiposity and insulin resistance. Substitution of casein with soy protein isolate (SPI) in the HF diet (HF-SPI) prevented these effects. Maintenance of bone quantity in the SPI-fed rats was associated with increased undercarboxylated osteocalcin secretion and altered JNK/IRS1/Akt insulin signaling in osteoblasts. The HF-Cas group had significantly greater serum nonesterified free fatty acid (NEFA) concentrations than controls, whereas the HF-SPI prevented this increase. In vitro treatment of osteoblasts or mesenchymal stromal ST2 cells with NEFAs significantly decreased insulin signaling. An isoflavone mixture similar to that found in serum of HF-SPI rats significantly increased in vitro osteoblast proliferation and blocked significantly reduced NEFA-induced insulin resistance. Finally, insulin/IGF1 was able to increase both osteoblast activity and differentiation in a set of in vitro studies. These results suggest that high-fat feeding may disrupt bone development and modeling; high concentrations of NEFAs and insulin resistance occurring with high fat intake are mediators of reduced osteoblast activity and differentiation; diets high in soy protein may help prevent high dietary fat-induced bone impairments; and the molecular mechanisms underlying the SPI-protective effects involve isoflavone-induced normalization of insulin signaling in bone.Chen, J.-R., Zhang, J., Lazarenko, O. P., Cao, J. J., Blackburn, M. L., Badger, T. M., Ronis, M. J. J. Soy protein isolates prevent loss of bone quantity associated with obesity in rats through regulation of insulin signaling in osteoblasts.	[Chen, Jin-Ran; Zhang, Jian; Lazarenko, Oxana P.; Blackburn, Michael L.; Badger, Thomas M.; Ronis, Martin J. J.] Arkansas Childrens Nutr Ctr, Little Rock, AR 72202 USA; [Chen, Jin-Ran; Zhang, Jian; Badger, Thomas M.; Ronis, Martin J. J.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Lazarenko, Oxana P.; Blackburn, Michael L.; Badger, Thomas M.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; [Ronis, Martin J. J.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Cao, Jay J.] USDA ARS, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58202 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; United States Department of Agriculture (USDA)	Chen, JR (corresponding author), Arkansas Childrens Nutr Ctr, 15 Childrens Way,Slot 512-20B, Little Rock, AR 72202 USA.	chenjinran@uams.edu			U.S. Department of Agriculture (USDA)/Agricultural Research Service (ARS) [CRIS 6251-51000-003, CRIS 5450-51000-046-00D]	U.S. Department of Agriculture (USDA)/Agricultural Research Service (ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported in part by U.S. Department of Agriculture (USDA)/Agricultural Research Service (ARS) grant CRIS 6251-51000-003 to the Arkansas Children's Nutrition Center and CRIS 5450-51000-046-00D to the Grand Forks Human Nutrition Research Center (J.J.C.).	Badger TM, 2008, EXP BIOL MED, V233, P1242, DOI 10.3181/0802-RM-60; Baile CA, 2011, ANN NY ACAD SCI, V1215, P40, DOI 10.1111/j.1749-6632.2010.05845.x; Bhathena SJ, 2002, AM J CLIN NUTR, V76, P1191, DOI 10.1093/ajcn/76.6.1191; Blake C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-28; Botolin S, 2007, ENDOCRINOLOGY, V148, P198, DOI 10.1210/en.2006-1006; Cao JJ, 2009, BONE, V44, P1097, DOI 10.1016/j.bone.2009.02.017; Cederroth CR, 2008, DIABETES, V57, P1176, DOI 10.2337/db07-0630; Chan ME, 2012, FASEB J, V26, P4855, DOI 10.1096/fj.12-209841; Chao D, 2000, J AM GERIATR SOC, V48, P753, DOI 10.1111/j.1532-5415.2000.tb04749.x; Chen JR, 2008, EXP BIOL MED, V233, P1348, DOI 10.3181/0802-RM-63; Chen JR, 2012, FASEB J, V26, P1131, DOI 10.1096/fj.11-197822; Chen JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013704; Chen JR, 2010, J BONE MINER RES, V25, P1117, DOI 10.1002/jbmr.7; Chen JR, 2009, J NUTR, V139, P1839, DOI 10.3945/jn.109.109041; Chen JR, 2009, J BONE MINER RES, V24, P221, DOI 10.1359/JBMR.081011; Chen XW, 2003, J NUTR BIOCHEM, V14, P342, DOI 10.1016/S0955-2863(03)00056-1; Cimino CO, 1999, CLIN CHIM ACTA, V287, P69, DOI 10.1016/S0009-8981(99)00124-2; Clemens TL, 2011, J BONE MINER RES, V26, P677, DOI 10.1002/jbmr.321; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; Davies JH, 2005, ARCH DIS CHILD, V90, P373, DOI 10.1136/adc.2004.053553; Elbaz A, 2010, J CELL MOL MED, V14, P982, DOI 10.1111/j.1582-4934.2009.00751.x; Fazeli PK, 2013, J CLIN ENDOCR METAB, V98, P935, DOI 10.1210/jc.2012-3634; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Gu LW, 2005, J AGR FOOD CHEM, V53, P6858, DOI 10.1021/jf050802j; He JN, 2006, BONE, V38, P826, DOI 10.1016/j.bone.2005.11.021; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; JENSEN LB, 1994, J BONE MINER RES, V9, P459; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Kim MS, 2005, J MED FOOD, V8, P439, DOI 10.1089/jmf.2005.8.439; Nagata C, 2002, OSTEOPOROSIS INT, V13, P200, DOI 10.1007/s001980200014; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; Palacios C, 2006, CRIT REV FOOD SCI, V46, P621, DOI 10.1080/10408390500466174; Pollock NK, 2011, J PEDIATR-US, V158, P727, DOI 10.1016/j.jpeds.2010.11.052; Reid IR, 2008, OSTEOPOROSIS INT, V19, P595, DOI 10.1007/s00198-007-0492-z; Ronis MJ, 2009, J NUTR, V139, P1431, DOI 10.3945/jn.109.107029; Schwartz AV, 2012, J BONE MINER RES, V27, P619, DOI 10.1002/jbmr.1483; Shea MK, 2009, AM J CLIN NUTR, V90, P1230, DOI 10.3945/ajcn.2009.28151; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Spallarossa P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015583; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Taylor ED, 2006, PEDIATRICS, V117, P2167, DOI 10.1542/peds.2005-1832; Torre-Villalvazo I, 2009, J NUTR, V139, P2237, DOI 10.3945/jn.109.109769; Villareal DT, 2011, NEW ENGL J MED, V364, P1218, DOI 10.1056/NEJMoa1008234; Watkins BA, 2005, J NUTR BIOCHEM, V16, P479, DOI 10.1016/j.jnutbio.2005.01.019; Wu J, 2004, METABOLISM, V53, P942, DOI 10.1016/j.metabol.2004.01.019; Zhang JT, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030355, 10.1371/journal.pone.0041657]	49	32	34	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2013	27	9					3514	3523		10.1096/fj.12-226464	http://dx.doi.org/10.1096/fj.12-226464			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	277SV	23776073				2022-12-25	WOS:000328840500012
J	Al-Huseini, LMA; Yeang, HXA; Sethu, S; Alhumeed, N; Hamdam, JM; Tingle, Y; Djouhri, L; Kitteringham, N; Park, BK; Goldring, CE; Sathish, JG				Al-Huseini, Laith M. A.; Yeang, Han Xian Aw; Sethu, Swaminathan; Alhumeed, Naif; Hamdam, Junnat M.; Tingle, Yulia; Djouhri, Laiche; Kitteringham, Neil; Park, B. Kevin; Goldring, Christopher E.; Sathish, Jean G.			Nuclear Factor-erythroid 2 (NF-E2) p45-related Factor-2 (Nrf2) Modulates Dendritic Cell Immune Function through Regulation of p38 MAPK-cAMP-responsive Element Binding Protein/Activating Transcription Factor 1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; N-TERMINAL KINASE; HEME OXYGENASE-1; TNF-ALPHA; T-CELLS; MATURATION; CREB; EXPRESSION; IL-10; LIPOPOLYSACCHARIDE	Nrf2 is a redox-responsive transcription factor that has been implicated in the regulation of DC immune function. Loss of Nrf2 results in increased co-stimulatory molecule expression, enhanced T cell stimulatory capacity, and increased reactive oxygen species (ROS) levels in murine immature DCs (iDCs). It is unknown whether altered immune function of Nrf2-deficient DCs (Nrf2(-/-) iDCs) is due to elevated ROS levels. Furthermore, it is unclear which intracellular signaling pathways are involved in Nrf2-mediated regulation of DC function. Using antioxidant vitamins to reset ROS levels in Nrf2(-/-) iDCs, we show that elevated ROS is not responsible for the altered phenotype and function of these DCs. Pharmacological inhibitors were used to explore the role of key MAPKs in mediating the altered phenotype and function in Nrf2(-/-) iDCs. We demonstrate that the increased co-stimulatory molecule expression (MHC II and CD86) and antigen-specific T cell activation capacity observed in Nrf2(-/-) iDCs was reversed by inhibition of p38 MAPK but not JNK. Importantly, we provide evidence for increased phosphorylation of cAMP-responsive element binding protein (CREB) and activating transcription factor 1 (ATF1), transcription factors that are downstream of p38 MAPK. The increased phosphorylation of CREB/ATF1 in Nrf2(-/-) iDCs was sensitive to p38 MAPK inhibition. We also show data to implicate heme oxygenase-1 as a potential molecular link between Nrf2 and CREB/ATF1. These results indicate that dysregulation of p38 MAPK-CREB/ATF1 signaling axis underlies the altered function and phenotype in Nrf2-deficient DCs. Our findings provide new insights into the mechanisms by which Nrf2 mediates regulation of DC function.	[Al-Huseini, Laith M. A.; Yeang, Han Xian Aw; Sethu, Swaminathan; Alhumeed, Naif; Hamdam, Junnat M.; Tingle, Yulia; Djouhri, Laiche; Kitteringham, Neil; Park, B. Kevin; Goldring, Christopher E.; Sathish, Jean G.] Univ Liverpool, MRC, Ctr Drug Safety Sci, Liverpool L69 3GE, Merseyside, England; [Al-Huseini, Laith M. A.; Yeang, Han Xian Aw; Sethu, Swaminathan; Alhumeed, Naif; Hamdam, Junnat M.; Tingle, Yulia; Djouhri, Laiche; Kitteringham, Neil; Park, B. Kevin; Goldring, Christopher E.; Sathish, Jean G.] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3GE, Merseyside, England; [Al-Huseini, Laith M. A.] Al Qadisiyah Univ, Coll Med, Dept Pharmacol & Therapeut, Diwaniyah, Iraq	University of Liverpool; University of Liverpool; University of Al-Qadisiyah	Sathish, JG (corresponding author), Univ Liverpool, MRC, Ctr Drug Safety Sci, Sherrington Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England.	Jean.Sathish@liv.ac.uk	Alhumeed, Naif/AAR-7956-2021; Sethu, Swaminathan/R-8577-2019; Al-Huseini, Laith M Abbas/S-6613-2019	Alhumeed, Naif/0000-0001-5221-3073; Al-Huseini, Laith M Abbas/0000-0002-5170-1865; Sethu, Swaminathan/0000-0001-9210-2554; Sathish, Jean/0000-0002-5605-6957	Iraqi Ministry of Higher Education and Scientific Research; Saudi Ministry of Higher Education; Biotechnology and Biological Sciences Research Council; King Abdullah Scholarships Program; Medical Research Council [G0700654B] Funding Source: researchfish	Iraqi Ministry of Higher Education and Scientific Research; Saudi Ministry of Higher Education; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); King Abdullah Scholarships Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in whole or in part by studentships from the Iraqi Ministry of Higher Education and Scientific Research (to L. M. A. A), the Saudi Ministry of Higher Education and King Abdullah Scholarships Program (to N. A), and the Biotechnology and Biological Sciences Research Council (to J. H.).	Aiba S, 2003, J INVEST DERMATOL, V120, P390, DOI 10.1046/j.1523-1747.2003.12065.x; Alvarez Y, 2009, J IMMUNOL, V183, P1471, DOI 10.4049/jimmunol.0900312; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Avni D, 2010, MOL IMMUNOL, V47, P1396, DOI 10.1016/j.molimm.2010.02.015; Bergamo P, 2008, IMMUNOL LETT, V117, P181, DOI 10.1016/j.imlet.2008.02.001; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chauveau C, 2005, BLOOD, V106, P1694, DOI 10.1182/blood-2005-02-0494; Cheng C, 2010, CIRC RES, V106, P1656, DOI 10.1161/CIRCRESAHA.110.216945; Copple Ian M, 2010, Handb Exp Pharmacol, P233, DOI 10.1007/978-3-642-00663-0_9; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Go YM, 2004, J BIOL CHEM, V279, P5837, DOI 10.1074/jbc.M307547200; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jeong YJ, 2011, CELL IMMUNOL, V266, P192, DOI 10.1016/j.cellimm.2010.10.005; Jin W, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/725174; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Johnson KG, 1999, J IMMUNOL, V162, P3802; Kantengwa S, 2003, AM J RESP CRIT CARE, V167, P431, DOI 10.1164/rccm.200205-425OC; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kim SS, 2013, J CELL BIOCHEM, V114, P1115, DOI 10.1002/jcb.24452; Li N, 2004, J IMMUNOL, V173, P3467, DOI 10.4049/jimmunol.173.5.3467; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MAMALAKI C, 1992, P NATL ACAD SCI USA, V89, P11342, DOI 10.1073/pnas.89.23.11342; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nakahara T, 2006, J DERMATOL SCI, V42, P1, DOI 10.1016/j.jdermsci.2005.11.004; Nakahara T, 2004, INT IMMUNOL, V16, P1701, DOI 10.1093/intimm/dxh171; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Platzer C, 1999, EUR J IMMUNOL, V29, P3098, DOI 10.1002/(SICI)1521-4141(199910)29:10<3098::AID-IMMU3098>3.0.CO;2-H; Rangasamy T, 2010, AM J RESP CELL MOL, V43, P276, DOI 10.1165/rcmb.2008-0438OC; Riemann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022445; Roche M, 2009, CELL BIOL TOXICOL, V25, P635, DOI 10.1007/s10565-008-9118-2; Rutault K, 1999, FREE RADICAL BIO MED, V26, P232, DOI 10.1016/S0891-5849(98)00194-4; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Sato K, 1999, J IMMUNOL, V162, P3865; Schumacher A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042301; Shanware NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012173; Silva G, 2006, J IMMUNOL, V177, P1894, DOI 10.4049/jimmunol.177.3.1894; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Steinman RM, 2003, APMIS, V111, P675, DOI 10.1034/j.1600-0463.2003.11107802.x; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Vaishnav D, 2003, BIOCHEM BIOPH RES CO, V307, P855, DOI 10.1016/S0006-291X(03)01287-7; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Williams MA, 2008, J IMMUNOL, V181, P4545, DOI 10.4049/jimmunol.181.7.4545; Wu BJ, 2006, J EXP MED, V203, P1117, DOI 10.1084/jem.20052321; Yeang HXA, 2012, J BIOL CHEM, V287, P10556, DOI 10.1074/jbc.M111.322420; Yet SF, 2002, METHOD ENZYMOL, V353, P163; Zakkar M, 2009, ARTERIOSCL THROM VAS, V29, P1851, DOI 10.1161/ATVBAHA.109.193375	54	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22281	22288		10.1074/jbc.M113.483420	http://dx.doi.org/10.1074/jbc.M113.483420			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23775080	Green Published, hybrid			2022-12-25	WOS:000330596300010
J	Henle, SJ; Carlstrom, LP; Cheever, TR; Henley, JR				Henle, Steven J.; Carlstrom, Lucas P.; Cheever, Thomas R.; Henley, John R.			Differential Role of PTEN Phosphatase in Chemotactic Growth Cone Guidance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE GROWTH; ADHESIONS; CALCIUM; KINASE; INHIBITOR; PTEN/MTOR; INTEGRIN; 3-KINASE; ACT	Negatively targeting the tumor suppressor and phosphoinositide phosphatase PTEN (phosphatase and tensin homologue) promotes axon regrowth after injury. How PTEN functions in axon guidance has remained unknown. Here we report the differential role of PTEN in chemotactic guidance of axonal growth cones. Down-regulating PTEN expression in Xenopus laevis spinal neurons selectively abolished growth cone chemorepulsion but permitted chemoattraction. These findings persisted during cAMP-dependent switching of turning behaviors. Live cell imaging using a GFP biosensor revealed rapid PTEN-dependent depression of phosphatidylinositol 3,4,5-trisphosphate levels in the growth cone induced by the repellent myelin-associated glycoprotein. Moreover, down-regulating PTEN expression blocked negative remodeling of beta 1-integrin adhesions triggered by myelin-associated glycoprotein, yet permitted integrin clustering by a positive chemotropic treatment. Thus, PTEN negatively regulates growth cone phosphatidylinositol 3,4,5-trisphosphate levels and mediates chemorepulsion, whereas chemoattraction is PTEN-independent. Regenerative therapies targeting PTEN may therefore suppress growth cone repulsion to soluble cues while permitting attractive guidance, an essential feature for re-forming functional neural circuits.	[Henle, Steven J.; Cheever, Thomas R.] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA; [Carlstrom, Lucas P.] Mayo Clin, Med Scientist Training Program, Rochester, MN 55905 USA; [Henley, John R.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Henley, JR (corresponding author), Mayo Clin, Coll Med, 200 1st St SW, Rochester, MN 55905 USA.	Henley.john@mayo.edu		Henle, Steven/0000-0002-8007-1030; Henley, John/0000-0003-1846-5941	National Institutes of Health Grants [NS067311, NS080322]; John M. Nasseff, Sr., Career Development Award in Neurologic Surgery Research (Mayo Clinic); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS080322, R01NS067311] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John M. Nasseff, Sr., Career Development Award in Neurologic Surgery Research (Mayo Clinic); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS067311 (to J. R. H.) and NS080322 (to T. R. C.). This work was also supported by a John M. Nasseff, Sr., Career Development Award in Neurologic Surgery Research (Mayo Clinic) (to J. R. H.).	Akiyama H, 2010, J BIOL CHEM, V285, P41740, DOI 10.1074/jbc.M110.156489; Carlstrom LP, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-82; Drinjakovic J, 2010, NEURON, V65, P341, DOI 10.1016/j.neuron.2010.01.017; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Giger RJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001867; Gomez TM, 2003, METHOD CELL BIOL, V71, P129, DOI 10.1016/S0091-679X(03)01008-2; Gu JG, 1998, J CELL BIOL, V143, P1375, DOI 10.1083/jcb.143.5.1375; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Henle SJ, 2011, J NEUROSCI, V31, P7016, DOI 10.1523/JNEUROSCI.0216-11.2011; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hines JH, 2010, NAT NEUROSCI, V13, P829, DOI 10.1038/nn.2554; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Huberman AD, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001743; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Keizer-Gunnink I, 2007, J CELL BIOL, V177, P579, DOI 10.1083/jcb.200611046; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Myers JP, 2011, J NEUROSCI, V31, P13585, DOI 10.1523/JNEUROSCI.2381-11.2011; Nicol X, 2011, P NATL ACAD SCI USA, V108, P13776, DOI 10.1073/pnas.1100247108; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Perdigoto AL, 2011, MOL CELL NEUROSCI, V46, P235, DOI 10.1016/j.mcn.2010.09.006; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633; Tojima T, 2011, NAT REV NEUROSCI, V12, P191, DOI 10.1038/nrn2996; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	32	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20837	20842		10.1074/jbc.C113.487066	http://dx.doi.org/10.1074/jbc.C113.487066			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23775074	Green Published, hybrid			2022-12-25	WOS:000322014400008
J	Marras, S; Domenici, P				Marras, Stefano; Domenici, Paolo			Schooling Fish Under Attack Are Not All Equal: Some Lead, Others Follow	PLOS ONE			English	Article							FAST-START PERFORMANCE; EUROPEAN SEA BASS; ESCAPE RESPONSE; DICENTRARCHUS-LABRAX; INFORMATION-TRANSFER; INDIVIDUAL VARIATION; PREDATOR AVOIDANCE; DECISION-MAKING; CLUPEA-HARENGUS; ANIMAL GROUPS	Animal groups such as fish schools, bird flocks and insect swarms appear to move so synchronously that they have long been considered egalitarian, leaderless units. In schooling fish, video observations of their spatial-temporal organization have, however, shown that anti-predator manoeuvres are not perfectly synchronous and that individuals have spatial preferences within the school. Nonetheless, when facing life-or-death situations, it is not known whether schooling fish react to a threat following a random or a hierarchically-based order. Using high-speed video analysis, here we show that schooling fish (Golden grey mullet, Liza aurata) evade a threat in a non-random order, therefore individuals that are first or last to react tend to do so repeatedly over sequential stimulations. Furthermore, startle order is strongly correlated with individual positional preferences. Because school members are known to follow individuals that initiate a manoeuvre, early responders are likely to exert the strongest influence on the escape strategy of the whole school. Our results present new evidence of the intrinsic heterogeneity among school members and provide new rules governing the collective motion of gregarious animals under predator attack.	[Marras, Stefano; Domenici, Paolo] IAMC CNR, Torregrande, Oristano, Italy	Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Marras, S (corresponding author), IAMC CNR, Torregrande, Oristano, Italy.	stefano.marras@iamc.cnr.it	Marras, Stefano/AAX-6549-2020; Domenici, Paolo/F-6958-2010	Marras, Stefano/0000-0002-8386-7608; 	CNR (Consiglio Nazionale delle Ricerche)	CNR (Consiglio Nazionale delle Ricerche)(Consiglio Nazionale delle Ricerche (CNR))	Funding was provided by the authors' institution, CNR (Consiglio Nazionale delle Ricerche). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barelli C, 2008, BEHAVIOUR, V145, P965, DOI 10.1163/156853908784089243; Bisazza A, 2005, P ROY SOC B-BIOL SCI, V272, P1677, DOI 10.1098/rspb.2005.3145; Bumann D, 1997, BEHAVIOUR, V134, P1063, DOI 10.1163/156853997X00403; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Cosolo M, 2010, MAR BIOL, V157, P2533, DOI 10.1007/s00227-010-1517-2; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Dadda M, 2010, BIOL LETTERS, V6, P414, DOI 10.1098/rsbl.2009.0904; de Carvalho CD, 2007, NEOTROP ICHTHYOL, V5, P81, DOI 10.1590/S1679-62252007000100012; DILL LM, 1990, ENVIRON BIOL FISH, V27, P147, DOI 10.1007/BF00001944; Domenici P, 1997, MAR BIOL, V128, P29, DOI 10.1007/s002270050065; Domenici P, 1997, J EXP BIOL, V200, P1165; DOMENICI P, 1994, J FISH BIOL, V45, P97, DOI 10.1111/j.1095-8649.1994.tb01086.x; Domenici P., 2009, FISH LOCOMOTION ECO; Domenici P, 2010, J EXP ZOOL PART A, V313A, P59, DOI 10.1002/jez.580; Eaton RC, 2001, PROG NEUROBIOL, V63, P467, DOI 10.1016/S0301-0082(00)00047-2; Eaton RC., 1984, NEURAL MECH STARTLE, DOI [10.1007/978-1-4899-2286-1, DOI 10.1007/978-1-4899-2286-1]; Fuiman LA, 2006, ANIM BEHAV, V71, P1389, DOI 10.1016/j.anbehav.2005.11.013; GODIN JGJ, 1985, BEHAV ECOL SOCIOBIOL, V16, P105, DOI 10.1007/BF00295142; Harcourt JL, 2010, CURR BIOL, V20, P156, DOI 10.1016/j.cub.2009.11.045; Herbert-Read JE, 2011, P NATL ACAD SCI USA, V108, P18726, DOI 10.1073/pnas.1109355108; Herskin J, 1998, J FISH BIOL, V53, P366, DOI 10.1006/jfbi.1998.0708; HUNTER JR, 1969, ANIM BEHAV, V17, P507, DOI 10.1016/0003-3472(69)90154-7; HUTH A, 1992, J THEOR BIOL, V156, P365, DOI 10.1016/S0022-5193(05)80681-2; Jones KA, 2010, P ROY SOC B-BIOL SCI, V277, P625, DOI 10.1098/rspb.2009.1607; Killen SS, 2012, P ROY SOC B-BIOL SCI, V279, P357, DOI 10.1098/rspb.2011.1006; Kohashi T, 2008, J NEUROSCI, V28, P10641, DOI 10.1523/JNEUROSCI.1435-08.2008; Krause J, 2000, P ROY SOC B-BIOL SCI, V267, P2011, DOI 10.1098/rspb.2000.1243; KRAUSE J, 1992, BEHAV ECOL SOCIOBIOL, V30, P177, DOI 10.1007/BF00166700; Krause J, 2002, LIVING GROUPS; Langerhans RB, 2010, INTEGR COMP BIOL, V50, P1167, DOI 10.1093/icb/icq117; Lefrancois C, 2005, J FISH BIOL, V67, P1711, DOI 10.1111/j.1095-8649.2005.00884.x; Lefrancois C, 2006, MAR BIOL, V149, P969, DOI 10.1007/s00227-006-0261-0; Makris NC, 2009, SCIENCE, V323, P1734, DOI 10.1126/science.1169441; Marras S, 2010, J EXP BIOL, V213, P26, DOI 10.1242/jeb.032136; Marras S, 2012, ADAPT BEHAV, V20, P44, DOI 10.1177/1059712311426799; Marras S, 2011, J EXP BIOL, V214, P3102, DOI 10.1242/jeb.056648; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Nespolo RF, 2007, J EXP BIOL, V210, P2000, DOI 10.1242/jeb.02780; Parrish JK, 2002, BIOL BULL-US, V202, P296, DOI 10.2307/1543482; Pitcher TJ., 1993, Behaviour of teleost fishes, P363, DOI 10.1007/978-94-011-1578-0_12; PYKE GH, 1978, ANIM BEHAV, V26, P241, DOI 10.1016/0003-3472(78)90024-6; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Robert M, 2013, J EXP MAR BIOL ECOL, V440, P238, DOI 10.1016/j.jembe.2013.01.005; SEGHERS BH, 1981, ENVIRON BIOL FISH, V6, P21, DOI 10.1007/BF00001795; STEFANELLI A, 1980, Atti della Accademia Nazionale dei Lincei Memorie Classe di Scienze Fisiche Matematiche e Naturali Sezione IIIA, V16, P1; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; TREHERNE JE, 1981, ANIM BEHAV, V29, P911, DOI 10.1016/S0003-3472(81)80028-0; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; WEBB PW, 1978, J EXP BIOL, V74, P211; WEBB PW, 1976, J EXP BIOL, V65, P157; WILSON DS, 1989, J THEOR BIOL, V136, P337, DOI 10.1016/S0022-5193(89)80169-9	52	25	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65784	10.1371/journal.pone.0065784	http://dx.doi.org/10.1371/journal.pone.0065784			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776547	gold, Green Submitted, Green Published			2022-12-25	WOS:000320322400056
J	Naranjo, V; Ayllon, N; de la Lastra, JMP; Galindo, RC; Kocan, KM; Blouin, EF; Mitra, R; Alberdi, P; Villar, M; de la Fuente, J				Naranjo, Victoria; Ayllon, Nieves; Perez de la Lastra, Jose M.; Galindo, Ruth C.; Kocan, Katherine M.; Blouin, Edmour F.; Mitra, Ruchira; Alberdi, Pilar; Villar, Margarita; de la Fuente, Jose			Reciprocal Regulation of NF-kB (Relish) and Subolesin in the Tick Vector, Ixodes scapularis	PLOS ONE			English	Article							GRANULOCYTIC EHRLICHIOSIS AGENT; PROTECTIVE ANTIGEN SUBOLESIN; ANAPLASMA-MARGINALE; PATHOGEN INFECTION; A-PHAGOCYTOPHILUM; GENETIC DIVERSITY; EXPRESSION; INFESTATIONS; PROTEINS; DROSOPHILA	Background: Tick Subolesin and its ortholog in insects and vertebrates, Akirin, have been suggested to play a role in the immune response through regulation of nuclear factor-kappa B (NF-kB)-dependent and independent gene expression via interaction with intermediate proteins that interact with NF-kB and other regulatory proteins, bind DNA or remodel chromatin to regulate gene expression. The objective of this study was to characterize the structure and regulation of subolesin in Ixodes scapularis. I. scapularis is a vector of emerging pathogens such as Borrelia burgdorferi, Anaplasma phagocytophilum and Babesia microti that cause in humans Lyme disease, anaplasmosis and babesiosis, respectively. The genome of I. scapularis was recently sequenced, and this tick serves as a model organism for the study of vector-host-pathogen interactions. However, basic biological questions such as gene organization and regulation are largely unknown in ticks and other arthropod vectors. Principal Findings: The results presented here provide evidence that subolesin/akirin are evolutionarily conserved at several levels (primary sequence, gene organization and function), thus supporting their crucial biological function in metazoans. These results showed that NF-kB (Relish) is involved in the regulation of subolesin expression in ticks, suggesting that as in other organisms, different NF-kB integral subunits and/or unknown interacting proteins regulate the specificity of the NF-kB-mediated gene expression. These results suggested a regulatory network involving cross-regulation between NF-kB (Relish) and Subolesin and Subolesin auto-regulation with possible implications in tick immune response to bacterial infection. Significance: These results advance our understanding of gene organization and regulation in I. scapularis and have important implications for arthropod vectors genetics and immunology highlighting the possible role of NF-kB and Subolesin/Akirin in vector-pathogen interactions and for designing new strategies for the control of vector infestations and pathogen transmission.	[Naranjo, Victoria; Galindo, Ruth C.; Kocan, Katherine M.; Blouin, Edmour F.; Mitra, Ruchira; de la Fuente, Jose] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA; [Naranjo, Victoria; Ayllon, Nieves; Perez de la Lastra, Jose M.; Galindo, Ruth C.; Alberdi, Pilar; Villar, Margarita; de la Fuente, Jose] SaBio, Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, Ciudad Real, Spain	Oklahoma State University System; Oklahoma State University - Stillwater; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	de la Fuente, J (corresponding author), Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA.	jose_delafuente@yahoo.com	de la Fuente, José/AAU-1197-2020; Pérez de la Lastra, José/F-9184-2013; Villar-Rayo, Marga M/J-4155-2012; de la Lastra, José Manuel Pérez/M-4397-2019; Alberdi, Pilar/K-7788-2014	de la Fuente, José/0000-0001-7383-9649; Pérez de la Lastra, José/0000-0003-4663-5565; Villar-Rayo, Marga M/0000-0003-4172-9079; de la Lastra, José Manuel Pérez/0000-0003-4663-5565; Alberdi, Pilar/0000-0002-6999-9735	Oklahoma Agricultural Experimental [1669]; Walter R. Sitlington Endowed Chair for Food Animal Research; EU [278976]; European Social Fund; Junta de Comunidades de Castilla-La Mancha, Spain; Ministerio de Educacion y Ciencia (MEC), Spain;  [BFU2008-01244/BMC];  [BFU2011-23896]	Oklahoma Agricultural Experimental; Walter R. Sitlington Endowed Chair for Food Animal Research; EU(European Commission); European Social Fund(European Social Fund (ESF)); Junta de Comunidades de Castilla-La Mancha, Spain(Junta de Comunidades de Castilla-La Mancha); Ministerio de Educacion y Ciencia (MEC), Spain(Spanish Government); ; 	This research was supported by grants BFU2008-01244/BMC and BFU2011-23896 to JF, the Oklahoma Agricultural Experimental Grant 1669 and the Walter R. Sitlington Endowed Chair for Food Animal Research to KMK, and the EU FP7 ANTIGONE project number 278976. V. Naranjo was funded by the European Social Fund and the Junta de Comunidades de Castilla-La Mancha (Program FSE 2007-2013), Spain. N. Ayllon was funded by Ministerio de Educacion y Ciencia (MEC), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almazan C, 2005, VACCINE, V23, P4403, DOI 10.1016/j.vaccine.2005.04.012; Almazan C, 2003, VACCINE, V21, P1492, DOI 10.1016/S0264-410X(02)00683-7; Barker SC, 2004, PARASITOLOGY, V129, pS15, DOI 10.1017/S0031182004005207; Bensaci M, 2012, VACCINE, V30, P6040, DOI 10.1016/j.vaccine.2012.07.053; Beuder B, 2008, NAT IMMUNOL, V9, P7, DOI 10.1038/ni0108-7; Blouin EF, 2003, VET PARASITOL, V111, P247, DOI 10.1016/S0304-4017(02)00378-3; Busby AT, 2012, MED VET ENTOMOL, V26, P92, DOI 10.1111/j.1365-2915.2011.00973.x; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; De la Fuente J, 2006, BIOCHEM BIOPH RES CO, V344, P332, DOI 10.1016/j.bbrc.2006.03.109; de la Fuente J, 2005, EXP PARASITOL, V109, P16, DOI 10.1016/j.exppara.2004.10.004; de la Fuente J, 2008, FRONT BIOSCI-LANDMRK, V13, P6938, DOI 10.2741/3200; de la Fuente J, 2007, GENOMICS, V90, P712, DOI 10.1016/j.ygeno.2007.08.009; de la Fuente J, 2007, TRENDS PARASITOL, V23, P427, DOI 10.1016/j.pt.2007.07.002; de la Fuente J, 2006, PARASITOL RES, V100, P85, DOI 10.1007/s00436-006-0244-6; de la Fuente J, 2006, VACCINE, V24, P4082, DOI 10.1016/j.vaccine.2006.02.046; de la Fuente J, 2006, PARASITOL RES, V99, P108, DOI 10.1007/s00436-006-0132-0; de la Fuente J, 2011, VET PARASITOL, V181, P17, DOI 10.1016/j.vetpar.2011.04.018; de la Fuente J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-372; de la Fuente J, 2008, ANN NY ACAD SCI, V1149, P27, DOI 10.1196/annals.1428.056; Estrada-Fena A, 1999, EXP APPL ACAROL, V2, P583; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; Galindo RC, 2009, DEV COMP IMMUNOL, V33, P612, DOI 10.1016/j.dci.2008.11.002; Goto A, 2008, NAT IMMUNOL, V9, P97, DOI 10.1038/ni1543; Havlikova S, 2013, VACCINE, V31, P1582, DOI 10.1016/j.vaccine.2013.01.017; Hill CA, 2005, TRENDS PARASITOL, V21, P151, DOI 10.1016/j.pt.2005.02.004; Iwasaki H, 2002, J BIOL CHEM, V277, P2763, DOI 10.1074/jbc.M108839200; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jongejan F, 2007, TRENDS PARASITOL, V23, P391, DOI 10.1016/j.pt.2007.07.004; Kocan KM, 2007, PARASITOL RES, V100, P1411, DOI 10.1007/s00436-007-0483-1; Kocan KM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-42; Koutna I, 2012, FLOW CYTOMETRY RECEN, P421; Krakowetz CN, 2011, TICKS TICK-BORNE DIS, V2, P143, DOI 10.1016/j.ttbdis.2011.05.003; Labruna MB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-46; LAN Q, 1990, AM J TROP MED HYG, V43, P669, DOI 10.4269/ajtmh.1990.43.669; Lemaitre B, 2004, NAT REV IMMUNOL, V4, P521, DOI 10.1038/nri1390; Lloyd AL, 2005, J MICROBIOL METH, V60, P291, DOI 10.1016/j.mimet.2004.10.009; Macqueen DJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-34; Mangold AJ, 2009, DEV COMP IMMUNOL, V33, P878, DOI 10.1016/j.dci.2009.02.010; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Megy K, 2009, INFECT GENET EVOL, V9, P308, DOI 10.1016/j.meegid.2007.12.007; Merino O, 2011, VACCINE, V29, P8575, DOI 10.1016/j.vaccine.2011.09.023; Merino O, 2011, VACCINE, V29, P2248, DOI 10.1016/j.vaccine.2011.01.050; Munderloh UG, 1996, J CLIN MICROBIOL, V34, P664, DOI 10.1128/JCM.34.3.664-670.1996; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; Nene V, 2009, FRONT BIOSCI-LANDMRK, V14, P2666, DOI 10.2741/3404; Nijhof AM, 2007, INT J PARASITOL, V37, P653, DOI 10.1016/j.ijpara.2006.11.005; Nowak SJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002547; PAHL HL, 1995, EMBO J, V14, P2580, DOI 10.1002/j.1460-2075.1995.tb07256.x; Pena-Rangel MT, 2002, GENETICS, V160, P1035; Sadusky T, 2004, CURR BIOL, V14, P505, DOI 10.1016/j.cub.2004.02.063; Sutterwala FS, 2008, NATURE, V451, P254, DOI 10.1038/451254a; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zivkovic Z, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-7	56	34	36	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65915	10.1371/journal.pone.0065915	http://dx.doi.org/10.1371/journal.pone.0065915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776567	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400063
J	Gish, LA; Gagne, JM; Han, LQ; DeYoung, BJ; Clark, SE				Gish, Lindsey A.; Gagne, Jennifer M.; Han, Linqu; DeYoung, Brody J.; Clark, Steven E.			WUSCHEL-Responsive At5g65480 Interacts with CLAVATA Components In Vitro and in Transient Expression	PLOS ONE			English	Article							DETERGENT-RESISTANT MEMBRANES; STEM-CELL HOMEOSTASIS; ARABIDOPSIS SHOOT; LIPID RAFTS; ORGAN DEVELOPMENT; PROTEIN; RECEPTOR; MICRODOMAINS; MERISTEM; POLTERGEIST	The CLAVATA (CLV) signaling pathway is essential for shoot meristem homeostasis in Arabidopsis. CLV acts to limit the expression domain of the stem cell-promoting gene WUSCHEL (WUS). The closely related receptor-kinases CLV1 and BAM1 are key components in this pathway; however, the downstream factors that link the receptors to WUS regulation are poorly understood. The Arabidopsis gene At5g65480 was recently identified as a direct transcriptional target up-regulated by WUS. We have independently identified this gene which we term CCI1 as a CLV1 and BAM1 interacting protein in vitro and in transient expression. CCI1 has phosphatidylinositide-binding activity in vitro and localizes to the plasma membrane in transient expression. Furthermore, CLV signaling components and CCI1 both partition to detergent-resistant membrane microdomains characterized as lipid rafts.	[Gish, Lindsey A.; Gagne, Jennifer M.; Han, Linqu; DeYoung, Brody J.; Clark, Steven E.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Clark, SE (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	clarks@umich.edu	Gagne, Jennifer M/B-2866-2009	Gagne, Jennifer M/0000-0003-2563-087X	National Institutes of Health [R01GM62962]; U.S. Department of Agriculture National Research Initiative [2006-35304-17403]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (grant no. R01GM62962 to SEC) and the U.S. Department of Agriculture National Research Initiative Competitive Grants Program(grant no. 2006-35304-17403 to SEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Bleckmann A, 2010, PLANT PHYSIOL, V152, P166, DOI 10.1104/pp.109.149930; Borner GHH, 2005, PLANT PHYSIOL, V137, P104, DOI 10.1104/pp.104.053041; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Busch W, 2010, DEV CELL, V18, P849, DOI 10.1016/j.devcel.2010.03.012; DeYoung BJ, 2006, PLANT J, V45, P1, DOI 10.1111/j.1365-313X.2005.02592.x; DeYoung BJ, 2008, GENETICS, V180, P895, DOI 10.1534/genetics.108.091108; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Dunn R, 2004, J CELL BIOL, V165, P135, DOI 10.1083/jcb.200309026; Furt F, 2010, PLANT PHYSIOL, V152, P2173, DOI 10.1104/pp.109.149823; Furt F, 2007, PLANT SIGNAL BEHAV, V2, P508, DOI 10.4161/psb.2.6.4636; Gagne JM, 2010, PLANT CELL, V22, P729, DOI 10.1105/tpc.109.068734; Guo YF, 2010, PLANT SIGNAL BEHAV, V5, P1442, DOI [10.4161/psb.5.11.13359, 10.1111/j.1365-313X.2010.04295]; Guo YF, 2010, PLANT J, V63, P889, DOI 10.1111/j.1365-313X.2010.04295.x; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hong Z, 2008, PLANT CELL, V20, P3418, DOI 10.1105/tpc.108.061879; Hord CLH, 2006, PLANT CELL, V18, P1667, DOI 10.1105/tpc.105.036871; Kleinboelting N, 2012, NUCLEIC ACIDS RES, V40, pD1211, DOI 10.1093/nar/gkr1047; Krugel U, 2012, MOL PLANT, V5, P43, DOI 10.1093/mp/ssr048; Marmagne Anne, 2006, V323, P403; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Meijer HJG, 2003, ANNU REV PLANT BIOL, V54, P265, DOI 10.1146/annurev.arplant.54.031902.134748; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; Nimchuk ZL, 2011, CURR BIOL, V21, P345, DOI 10.1016/j.cub.2011.01.039; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Peskan T, 2000, EUR J BIOCHEM, V267, P6989, DOI 10.1046/j.1432-1327.2000.01776.x; Premkumar L, 2010, J BIOL CHEM, V285, P13211, DOI 10.1074/jbc.M110.102517; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Shahollari B, 2004, PHYSIOL PLANTARUM, V122, P397, DOI 10.1111/j.1399-3054.2004.00414.x; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Song SK, 2006, DEVELOPMENT, V133, P4691, DOI 10.1242/dev.02652; Song SK, 2005, DEV BIOL, V285, P272, DOI 10.1016/j.ydbio.2005.06.020; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Tissier AF, 1999, PLANT CELL, V11, P1841, DOI 10.1105/tpc.11.10.1841; Titapiwatanakun B, 2009, PLANT J, V57, P27, DOI 10.1111/j.1365-313X.2008.03668.x; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Yadav RK, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.8; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Yadav RK, 2010, DEVELOPMENT, V137, P3581, DOI 10.1242/dev.054973; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Yu LP, 2000, DEVELOPMENT, V127, P1661; Yu LP, 2003, CURR BIOL, V13, P179, DOI 10.1016/S0960-9822(03)00042-3; Zhu YF, 2010, PLANT J, V61, P223, DOI 10.1111/j.1365-313X.2009.04049.x	46	3	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66345	10.1371/journal.pone.0066345	http://dx.doi.org/10.1371/journal.pone.0066345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776660	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400138
J	Morey, JS; Van Dolah, FM				Morey, Jeanine S.; Van Dolah, Frances M.			Global Analysis of mRNA Half-Lives and de novo Transcription in a Dinoflagellate, Karenia brevis	PLOS ONE			English	Article							RED-TIDE DINOFLAGELLATE; PENTATRICOPEPTIDE REPEAT PROTEINS; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; MICROARRAY ANALYSIS; URACIL PHOSPHORIBOSYLTRANSFERASE; POSTTRANSCRIPTIONAL REGULATION; CIRCADIAN REGULATION; DECAY-RATES; GONYAULAX	Dinoflagellates possess many physiological processes that appear to be under post-transcriptional control. However, the extent to which their genes are regulated post-transcriptionally remains unresolved. To gain insight into the roles of differential mRNA stability and de novo transcription in dinoflagellates, we biosynthetically labeled RNA with 4-thiouracil to isolate newly transcribed and pre-existing RNA pools in Karenia brevis. These isolated fractions were then used for analysis of global mRNA stability and de novo transcription by hybridization to a K. brevis microarray. Global K. brevis mRNA half-lives were calculated from the ratio of newly transcribed to pre-existing RNA for 7086 array features using the online software HALO (Half-life Organizer). Overall, mRNA half-lives were substantially longer than reported in other organisms studied at the global level, ranging from 42 minutes to greater than 144 h, with a median of 33 hours. Consistent with well-documented trends observed in other organisms, housekeeping processes, including energy metabolism and transport, were significantly enriched in the most highly stable messages. Shorter-lived transcripts included a higher proportion of transcriptional regulation, stress response, and other response/regulatory processes. One such family of proteins involved in post-transcriptional regulation in chloroplasts and mitochondria, the pentatricopeptide repeat (PPR) proteins, had dramatically shorter half-lives when compared to the arrayed transcriptome. As transcript abundances for PPR proteins were previously observed to rapidly increase in response to nutrient addition, we queried the newly synthesized RNA pools at 1 and 4 h following nitrate addition to N-depleted cultures. Transcriptome-wide there was little evidence of increases in the rate of de novo transcription during the first 4 h, relative to that in N-depleted cells, and no evidence for increased PPR protein transcription. These results lend support to the growing consensus of post-transcriptional control of gene expression in dinoflagellates.	[Morey, Jeanine S.; Van Dolah, Frances M.] NOAA, Marine Biotoxins Program, Natl Ocean Serv, Ctr Coastal Environm Hlth & Biomol Res, Charleston, SC USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA	Van Dolah, FM (corresponding author), NOAA, Marine Biotoxins Program, Natl Ocean Serv, Ctr Coastal Environm Hlth & Biomol Res, Charleston, SC USA.	fran.vandolah@noaa.gov			NOAA	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported by NOAA programmatic funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Beauchemin M, 2012, P NATL ACAD SCI USA, V109, P15793, DOI 10.1073/pnas.1206683109; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Brunelle SA, 2011, J EUKARYOT MICROBIOL, V58, P373, DOI 10.1111/j.1550-7408.2011.00560.x; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Cleary MD, 2005, NAT BIOTECHNOL, V23, P232, DOI 10.1038/nbt1061; Conesa A, 2005, BIOINFORMATICS; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; EHLERS B, 1987, MOL CELL BIOL, V7, P1242, DOI 10.1128/MCB.7.3.1242; Fagan T, 1999, BIOCHEMISTRY-US, V38, P7689, DOI 10.1021/bi9826005; Friedel CC, 2010, BIOINFORMATICS, V26, P1264, DOI 10.1093/bioinformatics/btq117; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Friedel CC, 2009, MOL BIOSYST, V5, P1271, DOI 10.1039/b911233b; GREENBERG JR, 1975, J CELL BIOL, V64, P269; Hou YB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006978; Islam MR, 2007, PLANT MOL BIOL, V63, P465, DOI 10.1007/s11103-006-9101-3; Johnson JG, 2012, MAR GENOM, V5, P15, DOI 10.1016/j.margen.2011.08.005; Kenzelmann M, 2007, P NATL ACAD SCI USA, V104, P6164, DOI 10.1073/pnas.0610439104; Le QH, 2001, BIOL RHYTHM RES, V32, P579, DOI 10.1076/brhm.32.5.579.1290; Lidie KB, 2005, MAR BIOTECHNOL, V7, P481, DOI 10.1007/s10126-004-4110-6; Lidie KB, 2007, THESIS MED U S CAROL, P249; Lidie KB, 2007, J EUKARYOT MICROBIOL, V54, P427, DOI 10.1111/j.1550-7408.2007.00282.x; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Magana HA, 2006, HARMFUL ALGAE, V5, P192, DOI 10.1016/j.hal.2005.07.003; Manful T, 2011, RNA, V17, P2039, DOI 10.1261/rna.2837311; Miller MR, 2009, NAT METHODS, V6, P439, DOI [10.1038/nmeth.1329, 10.1038/NMETH.1329]; Mittag M, 1998, CHRONOBIOL INT, V15, P93, DOI 10.3109/07420529808998673; Monroe EA, 2010, J PHYCOL, V46, P541, DOI 10.1111/j.1529-8817.2010.00837.x; Morey JS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-346; MORSE D, 1989, P NATL ACAD SCI USA, V86, P172, DOI 10.1073/pnas.86.1.172; Moustafa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009688; MURPHY WJ, 1986, CELL, V47, P517, DOI 10.1016/0092-8674(86)90616-1; Narsai R, 2007, PLANT CELL, V19, P3418, DOI 10.1105/tpc.107.055046; Okamoto OK, 2001, J BIOL CHEM, V276, P19989, DOI 10.1074/jbc.M101169200; Palenchar JB, 2006, MOL BIOCHEM PARASIT, V146, P135, DOI 10.1016/j.molbiopara.2005.12.008; Pelechano V, 2008, YEAST, V25, P85, DOI 10.1002/yea.1548; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Rossini C, 2003, CHRONOBIOL INT, V20, P963, DOI 10.1081/CBI-120025248; Saha D, 2007, PLANT PHYSIOL BIOCH, V45, P521, DOI 10.1016/j.plaphy.2007.03.026; SCHRODERLORENZ A, 1987, PLANTA, V170, P7, DOI 10.1007/BF00392374; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Song XL, 2012, J BIOL CHEM, V287, P12520, DOI 10.1074/jbc.M111.338079; Steglich C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r54; Steidinger KA, 1998, PHYSL ECOLOGY HARMFU, P113; Striepen B, 2004, P NATL ACAD SCI USA, V101, P3154, DOI 10.1073/pnas.0304686101; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Van Dolah FM, 2007, J PHYCOL, V43, P741, DOI 10.1111/j.1529-8817.2007.00354.x; Van Dolah FM, 2009, HARMFUL ALGAE, V8, P562, DOI 10.1016/j.hal.2008.11.004; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Wisecaver JH, 2011, ANNU REV MICROBIOL, V65, P369, DOI 10.1146/annurev-micro-090110-102841; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Yang I, 2011, HARMFUL ALGAE, V12, P55, DOI 10.1016/j.hal.2011.08.012; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104	57	22	22	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66347	10.1371/journal.pone.0066347	http://dx.doi.org/10.1371/journal.pone.0066347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776661	Green Submitted, gold, Green Published			2022-12-25	WOS:000320755400139
J	Skerry, C; Pokkali, S; Pinn, M; Be, NA; Harper, J; Karakousis, PC; Jain, SK				Skerry, Ciaran; Pokkali, Supriya; Pinn, Michael; Be, Nicholas A.; Harper, Jamie; Karakousis, Petros C.; Jain, Sanjay K.			Vaccination with Recombinant Mycobacterium tuberculosis PknD Attenuates Bacterial Dissemination to the Brain in Guinea Pigs	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; BCG VACCINATION; IMMUNE-RESPONSE; CHILDHOOD TUBERCULOSIS; AEROSOL CHALLENGE; PROTEIN-KINASE; MURINE MODEL; MENINGITIS; PATHOGENESIS	Background: We have previously identified Mycobacterium tuberculosis PknD to be an important virulence factor required for the pathogenesis of central nervous system (CNS) tuberculosis (TB). Specifically, PknD mediates bacillary invasion of the blood-brain barrier, which can be neutralized by specific antisera, suggesting its potential role as a therapeutic target against TB meningitis. Methodology/Principal Findings: We utilized an aerosol challenge guinea pig model of CNS TB and compared the protective efficacy of recombinant M. tuberculosis PknD subunit protein with that of M. bovis BCG against bacillary dissemination to the brain. BCG vaccination limited the pulmonary bacillary burden after aerosol challenge with virulent M. tuberculosis in guinea pigs and also reduced bacillary dissemination to the brain (P = 0.01). PknD vaccination also offered significant protection against bacterial dissemination to the brain, which was no different from BCG (P > 0.24), even though PknD vaccinated animals had almost 100-fold higher pulmonary bacterial burdens. Higher levels of PknD-specific IgG were noted in animals immunized with PknD, but not in BCG-vaccinated or control animals. Furthermore, pre-incubation of M. tuberculosis with sera from PknD-vaccinated animals, but not with sera from BCG-vaccinated or control animals, significantly reduced bacterial invasion in a human blood-brain barrier model (P < 0.01). Conclusion: Current recommendations for administering BCG at birth are based on protection gained against severe disease, such as TB meningitis, during infancy. We demonstrate that vaccination with recombinant M. tuberculosis PknD subunit offers a novel strategy to protect against TB meningitis, which is equivalent to BCG in a guinea pig model. Moreover, since BCG lacks the PknD sensor, BCG could also be boosted to develop a more effective vaccine against TB meningitis, a devastating disease that disproportionately affects young children.	[Skerry, Ciaran; Pokkali, Supriya; Pinn, Michael; Be, Nicholas A.; Harper, Jamie; Karakousis, Petros C.; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA; [Skerry, Ciaran; Pokkali, Supriya; Be, Nicholas A.; Harper, Jamie; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Pinn, Michael; Karakousis, Petros C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Be, Nicholas A.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA; [Harper, Jamie; Jain, Sanjay K.] Johns Hopkins Univ, Sch Med, Ctr Infect & Inflammat Imaging Res, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Johns Hopkins University	Jain, SK (corresponding author), Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD 21218 USA.	sjain5@jhmi.edu	Pokkali, Supriya/T-2825-2017; Pokkali, Supriya/H-4773-2013; Karakousis, Petros Constantine/AAR-7899-2020; Skerry, Ciaran/AAX-8291-2020	Pokkali, Supriya/0000-0002-6209-1679; Pokkali, Supriya/0000-0002-6209-1679; Jain, Sanjay/0000-0001-9620-7070	NIH [OD006492, AI083125]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083125] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the NIH Director's New Innovator Award OD006492 (SKJ) and NIH grant AI083125 to PCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2011, J ANTIMICROB CHEMOTH, V66, P1560, DOI 10.1093/jac/dkr188; Be NA, 2008, J INFECT DIS, V198, P1520, DOI 10.1086/592447; Be NA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-7; Be NA, 2011, TUBERCULOSIS, V91, P386, DOI 10.1016/j.tube.2011.07.003; BERENGUER J, 1992, NEW ENGL J MED, V326, P668, DOI 10.1056/NEJM199203053261004; BOUNOUS DI, 1992, AVIAN DIS, V36, P1022, DOI 10.2307/1591566; Campuzano J, 2007, VACCINE, V25, P3722, DOI 10.1016/j.vaccine.2006.12.042; Cisneros-Lira J, 2003, AM J PHYSIOL-LUNG C, V285, pL949, DOI 10.1152/ajplung.00074.2003; Girgis NI, 1998, AM J TROP MED HYG, V58, P28, DOI 10.4269/ajtmh.1998.58.28; Glatman-Freedman A, 1998, CLIN MICROBIOL REV, V11, P514, DOI 10.1128/CMR.11.3.514; Good MC, 2004, J MOL BIOL, V339, P459, DOI 10.1016/j.jmb.2004.03.063; Hiraishi Y, 2011, VACCINE, V29, P2626, DOI 10.1016/j.vaccine.2011.01.042; Jacobs RF, 2003, PRINCIPLES PRACTICE, P796; Jain SK, 2005, CLIN PEDIATR, V44, P443, DOI 10.1177/000992280504400510; Katrak SM, 2000, J NEUROL SCI, V181, P118, DOI 10.1016/S0022-510X(00)00440-8; LINCOLN EM, 1960, J PEDIATR-US, V57, P807, DOI 10.1016/S0022-3476(60)80132-1; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Mawuenyega KG, 2005, MOL BIOL CELL, V16, P396, DOI 10.1091/mbc.e04-04-0329; Ordway D, 2008, CLIN VACCINE IMMUNOL, V15, P1248, DOI 10.1128/CVI.00019-08; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Padayatchi NI, 2006, PEDIATR INFECT DIS J, V25, P147, DOI 10.1097/01.inf.0000199314.88063.4c; PADUNGCHAN S, 1986, B WORLD HEALTH ORGAN, V64, P247; Parra M, 2004, INFECT IMMUN, V72, P6799, DOI 10.1128/IAI.72.12.6799-6805.2004; Peirs P, 2000, FEMS MICROBIOL LETT, V188, P135; Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23; Rich AR, 1933, B JOHNS HOPKINS HOSP, V52, P5; Ritz N, 2012, AM J RESP CRIT CARE, V185, P213, DOI 10.1164/rccm.201104-0714OC; ROMANUS V, 1987, PEDIATR INFECT DIS J, V6, P272, DOI 10.1097/00006454-198703000-00014; ROSENTHAL S, 1961, AM REV RESPIR DIS, V84, P690; ROSENTHAL S, 1961, PEDIATRICS, V28, P622; Roy E, 2005, INFECT IMMUN, V73, P6101, DOI 10.1128/IAI.73.9.6101-6109.2005; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Sofia M, 2001, INT J TUBERC LUNG D, V5, P551; Takahashi K, 1999, COMP BIOCHEM PHYS C, V124, P309, DOI 10.1016/S0742-8413(99)00078-X; Teitelbaum R, 1998, P NATL ACAD SCI USA, V95, P15688, DOI 10.1073/pnas.95.26.15688; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites GE, 2005, LANCET NEUROL, V4, P160, DOI 10.1016/S1474-4422(05)01013-6; TIDJANI O, 1986, TUBERCLE, V67, P269, DOI 10.1016/0041-3879(86)90016-4; Udwadia ZF, 2012, THORAX, V67, P286, DOI 10.1136/thoraxjnl-2012-201663; Wang BL, 2007, CLIN VACCINE IMMUNOL, V14, P902, DOI 10.1128/CDLI.00077-07; World Health Organization (WHO), 1993, IMM BAS IMM SER MOD; YOUNG TK, 1986, AM J PUBLIC HEALTH, V76, P783, DOI 10.2105/AJPH.76.7.783	42	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66310	10.1371/journal.pone.0066310	http://dx.doi.org/10.1371/journal.pone.0066310			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776655	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400135
J	Tytgat, TOG; Verhoeven, KJF; Jansen, JJ; Raaijmakers, CE; Bakx-Schotman, T; McIntyre, LM; van der Putten, WH; Biere, A; van Dam, NM				Tytgat, Tom O. G.; Verhoeven, Koen J. F.; Jansen, Jeroen J.; Raaijmakers, Ciska E.; Bakx-Schotman, Tanja; McIntyre, Lauren M.; van der Putten, Wim H.; Biere, Arjen; van Dam, Nicole M.			Plants Know Where It Hurts: Root and Shoot Jasmonic Acid Induction Elicit Differential Responses in Brassica olracea	PLOS ONE			English	Article							GENE-EXPRESSION; ARABIDOPSIS-THALIANA; JAZ REPRESSORS; MULTITROPHIC INTERACTIONS; 12-OXO-PHYTODIENOIC ACID; STRESS RESPONSES; HERBIVORY; DYNAMICS; DEFENSES; CARBON	Plants respond to herbivore attack by rapidly inducing defenses that are mainly regulated by jasmonic acid (JA). Due to the systemic nature of induced defenses, attack by root herbivores can also result in a shoot response and vice versa, causing interactions between above-and belowground herbivores. However, little is known about the molecular mechanisms underlying these interactions. We investigated whether plants respond differently when roots or shoots are induced. We mimicked herbivore attack by applying JA to the roots or shoots of Brassica oleracea and analyzed molecular and chemical responses in both organs. In shoots, an immediate and massive change in primary and secondary metabolism was observed. In roots, the JA-induced response was less extensive and qualitatively different from that in the shoots. Strikingly, in both roots and shoots we also observed differential responses in primary metabolism, development as well as defense specific traits depending on whether the JA induction had been below-or aboveground. We conclude that the JA response is not only tissue-specific but also dependent on the organ that was induced. Already very early in the JA signaling pathway the differential response was observed. This indicates that both organs have a different JA signaling cascade, and that the signal eliciting systemic responses contains information about the site of induction, thus providing plants with a mechanism to tailor their responses specifically to the organ that is damaged.	[Tytgat, Tom O. G.; van Dam, Nicole M.] Radboud Univ Nijmegen, Dept Ecogen, Inst Water & Wetland Res, NL-6525 ED Nijmegen, Netherlands; [Verhoeven, Koen J. F.; Raaijmakers, Ciska E.; Bakx-Schotman, Tanja; van der Putten, Wim H.; Biere, Arjen] Netherlands Inst Ecol, Dept Terr Ecol, Wageningen, Netherlands; [Jansen, Jeroen J.] Radboud Univ Nijmegen, Dept Chemometr, NL-6525 ED Nijmegen, Netherlands; [McIntyre, Lauren M.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [van der Putten, Wim H.] Wageningen Univ, Nematol Lab, NL-6700 AP Wageningen, Netherlands	Radboud University Nijmegen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Radboud University Nijmegen; State University System of Florida; University of Florida; Wageningen University & Research	Tytgat, TOG (corresponding author), Radboud Univ Nijmegen, Dept Ecogen, Inst Water & Wetland Res, NL-6525 ED Nijmegen, Netherlands.	t.tytgat@science.ru.nl	Jansen, Jeroen/D-6120-2012; van Dam, Nicole M./B-3281-2008; van der Putten, Wim H/C-3707-2011; Verhoeven, Koen JF/C-9920-2010; Biere, Arjen/B-8079-2008; KNAW, NIOO-KNAW/A-4320-2012	van Dam, Nicole M./0000-0003-2622-5446; van der Putten, Wim H/0000-0002-9341-4442; Verhoeven, Koen JF/0000-0003-3002-4102; Biere, Arjen/0000-0002-9006-3448; KNAW, NIOO-KNAW/0000-0002-3835-159X; McIntyre, Lauren/0000-0002-0077-3359				Abdel-Farid IB, 2010, BIOCHEM SYST ECOL, V38, P612, DOI 10.1016/j.bse.2010.07.008; Arimura G, 2009, PLANT CELL PHYSIOL, V50, P911, DOI 10.1093/pcp/pcp030; Balbi V, 2008, NEW PHYTOL, V177, P301, DOI 10.1111/j.1469-8137.2007.02292.x; Baldwin IT, 1996, ENTOMOL EXP APPL, V80, P213, DOI 10.1007/BF00194760; Ballare CL, 2011, TRENDS PLANT SCI, V16, P249, DOI 10.1016/j.tplants.2010.12.001; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Bottcher C, 2009, FEBS J, V276, P4693, DOI 10.1111/j.1742-4658.2009.07195.x; Broekgaarden C, 2008, PLANT CELL ENVIRON, V31, P1592, DOI 10.1111/j.1365-3040.2008.01871.x; Broekgaarden C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-239; Bruinsma M, 2008, ENTOMOL EXP APPL, V128, P109, DOI 10.1111/j.1570-7458.2008.00695.x; Cheng ZW, 2011, MOL PLANT, V4, P279, DOI 10.1093/mp/ssq073; Chico JM, 2008, CURR OPIN PLANT BIOL, V11, P486, DOI 10.1016/j.pbi.2008.06.003; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2010, PLANT J, V63, P613, DOI 10.1111/j.1365-313X.2010.04265.x; Chung HS, 2009, PHYTOCHEMISTRY, V70, P1547, DOI 10.1016/j.phytochem.2009.08.022; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Chung KM, 2008, MOL CELLS, V26, P107; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dicke M, 2009, NAT CHEM BIOL, V5, P317, DOI 10.1038/nchembio.169; Erb M, 2012, TRENDS PLANT SCI, V17, P250, DOI 10.1016/j.tplants.2012.01.003; Erb M, 2009, TRENDS PLANT SCI, V14, P653, DOI 10.1016/j.tplants.2009.08.006; Glauser G, 2008, J BIOL CHEM, V283, P16400, DOI 10.1074/jbc.M801760200; Gomez S, 2010, NEW PHYTOL, V188, P835, DOI 10.1111/j.1469-8137.2010.03414.x; Grini PE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007817; Hasegawa S, 2011, PLANT CELL ENVIRON, V34, P705, DOI 10.1111/j.1365-3040.2011.02274.x; Henkes GJ, 2008, PLANT CELL ENVIRON, V31, P1229, DOI 10.1111/j.1365-3040.2008.01828.x; Ishikawa M, 2006, PLANT J, V46, P736, DOI 10.1111/j.1365-313X.2006.02737.x; Jansen JJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-425; Jansen JJ, 2009, METABOLOMICS, V5, P150, DOI 10.1007/s11306-008-0124-4; Kaplan I, 2008, ECOLOGY, V89, P392, DOI 10.1890/07-0471.1; Karban R, 1999, TRENDS ECOL EVOL, V14, P443, DOI 10.1016/S0169-5347(99)01678-X; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kazan K, 2012, TRENDS PLANT SCI, V17, P22, DOI 10.1016/j.tplants.2011.10.006; Koornneef A, 2008, PLANT PHYSIOL, V147, P1358, DOI 10.1104/pp.108.121392; Lee HS, 2004, PLANT BIOTECHNOL J, V2, P45, DOI 10.1046/j.1467-7652.2003.00048.x; Matsuura H, 2012, PHYTOCHEMISTRY, V83, P25, DOI 10.1016/j.phytochem.2012.06.009; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Niu YJ, 2011, J EXP BOT, V62, P2143, DOI 10.1093/jxb/erq408; Pauwels L, 2009, TRENDS PLANT SCI, V14, P87, DOI 10.1016/j.tplants.2008.11.005; Pierre PS, 2011, J CHEM ECOL, V37, P368, DOI 10.1007/s10886-011-9934-3; Qiu BL, 2009, FUNCT ECOL, V23, P496, DOI 10.1111/j.1365-2435.2008.01516.x; Rasmann S, 2008, PLANT PHYSIOL, V146, P875, DOI 10.1104/pp.107.112045; Rasmann S, 2007, ECOL LETT, V10, P926, DOI 10.1111/j.1461-0248.2007.01084.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schilmiller AL, 2005, CURR OPIN PLANT BIOL, V8, P369, DOI 10.1016/j.pbi.2005.05.008; Schwachtje J, 2006, P NATL ACAD SCI USA, V103, P12935, DOI 10.1073/pnas.0602316103; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Soler R, 2007, OIKOS, V116, P367, DOI 10.1111/j.0030-1299.2007.15501.x; Soppe WJJ, 1999, DEVELOPMENT, V126, P4763; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Usadel B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-535; van Dam NM, 2008, PLANT SIGNAL BEHAV, V3, P91, DOI 10.4161/psb.3.2.5220; van Dam NM, 2011, ANNU PLANT REV, V43, P87, DOI 10.1002/9781444339956.ch4; van Dam NM, 2011, J ECOL, V99, P77, DOI 10.1111/j.1365-2745.2010.01761.x; van Dam NM, 2010, J CHEM ECOL, V36, P1006, DOI 10.1007/s10886-010-9844-9; van Dam NM, 2009, PHYTOCHEM REV, V8, P171, DOI 10.1007/s11101-008-9101-9; van Dam NM, 2004, NEW PHYTOL, V161, P801, DOI 10.1111/j.1469-8137.2004.00984.x; Van der Putten WH, 2001, TRENDS ECOL EVOL, V16, P547, DOI 10.1016/S0169-5347(01)02265-0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Wasternack C, 2010, ACS CHEM BIOL, V5, P63, DOI 10.1021/cb900269u; Zhou LC, 2012, OMICS, V16, P208, DOI 10.1089/omi.2011.0111	66	59	60	3	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65502	10.1371/journal.pone.0065502	http://dx.doi.org/10.1371/journal.pone.0065502			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776489	Green Published, gold			2022-12-25	WOS:000320755400035
J	Jiao, QJ; Huang, Y; Liu, W; Wang, XF; Chen, XS; Shen, HB				Jiao, Qing-Ju; Huang, Yan; Liu, Wei; Wang, Xiao-Fan; Chen, Xiao-Shuang; Shen, Hong-Bin			Revealing the Hidden Relationship by Sparse Modules in Complex Networks with a Large-Scale Analysis	PLOS ONE			English	Article							COMMUNITY STRUCTURE; GENE-COEXPRESSION; IDENTIFICATION; ORGANIZATION; MODULARITY; ONTOLOGY; TOOL	One of the remarkable features of networks is module that can provide useful insights into not only network organizations but also functional behaviors between their components. Comprehensive efforts have been devoted to investigating cohesive modules in the past decade. However, it is still not clear whether there are important structural characteristics of the nodes that do not belong to any cohesive module. In order to answer this question, we performed a large-scale analysis on 25 complex networks with different types and scales using our recently developed BTS (bintree seeking) algorithm, which is able to detect both cohesive and sparse modules in the network. Our results reveal that the sparse modules composed by the cohesively isolated nodes widely co-exist with the cohesive modules. Detailed analysis shows that both types of modules provide better characterization for the division of a network into functional units than merely cohesive modules, because the sparse modules possibly re-organize the nodes in the so-called cohesive modules, which lack obvious modular significance, into meaningful groups. Compared with cohesive modules, the sizes of sparse ones are generally smaller. Sparse modules are also found to have preferences in social and biological networks than others.	[Jiao, Qing-Ju; Liu, Wei; Wang, Xiao-Fan; Shen, Hong-Bin] Shanghai Jiao Tong Univ, Dept Automat, Shanghai 200030, Peoples R China; [Jiao, Qing-Ju; Liu, Wei; Wang, Xiao-Fan; Shen, Hong-Bin] Minist Educ China, Key Lab Syst Control & Informat Proc, Shanghai, Peoples R China; [Huang, Yan; Chen, Xiao-Shuang] Chinese Acad Sci, Natl Lab Infrared Phys, Shanghai Inst Tech Phys, Shanghai, Peoples R China	Shanghai Jiao Tong University; Ministry of Education, China; Chinese Academy of Sciences; Shanghai Institute of Technical Physics, CAS	Shen, HB (corresponding author), Shanghai Jiao Tong Univ, Dept Automat, Shanghai 200030, Peoples R China.	xfwang@sjtu.edu.cn; xschen@mail.sitp.ac.cn; hbshen@sjtu.edu.cn			National Natural Science Foundation of China [91130033, 61175024]; Shanghai Science and Technology Commission [11JC1404800]; A Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201048]; Program for New Century Excellent Talents in University [NCET-11-0330]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); A Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (No. 91130033, 61175024), Shanghai Science and Technology Commission (No. 11JC1404800), A Foundation for the Author of National Excellent Doctoral Dissertation of PR China (No. 201048), and Program for New Century Excellent Talents in University (NCET-11-0330). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Airoldi EM, 2008, J MACH LEARN RES, V9, P1981; [Anonymous], [No title captured]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Bu DB, 2003, NUCLEIC ACIDS RES, V31, P2443, DOI 10.1093/nar/gkg340; Burt RS, 2005, BROKERAGE CLOSURE IN; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Coleman J. S., 1964, INTRO MATH SOCIOLOGY; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Davis A., 1941, DEEP S; De Nooy W., 2011, EXPLORATORY SOCIAL N, V2; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Flake GW, 2002, COMPUTER, V35, P66, DOI 10.1109/2.989932; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fukushima A, 2012, PLANT PHYSIOL, V158, P1487, DOI 10.1104/pp.111.188367; Garfield E, 2001, S HON CAS BORK U PIT; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Jiao QJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027646; Knuth DE., 1993, STANFORD GRAPH BASE; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Leskovec J., 2008, P 17 INT C WORLD WID, P695, DOI DOI 10.1145/1367497.1367591; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Moody J, 2003, AM SOCIOL REV, V68, P103, DOI 10.2307/3088904; Newman MEJ, 2007, P NATL ACAD SCI USA, V104, P9564, DOI 10.1073/pnas.0610537104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Obayashi T, 2011, PLANT CELL PHYSIOL, V52, P213, DOI 10.1093/pcp/pcq203; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Park YS, 2004, SCI TOTAL ENVIRON, V327, P105, DOI 10.1016/j.scitotenv.2004.01.014; Pinkert S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000659; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reitz JM, 2010, ONLINE DICT LIB INFO; Richardson T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036111; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Scott J, 1980, ANATOMY SCOTTISH CAP; Small Mario Luis, 2009, UNANTICIPATED GAINS; Spangler JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045041; Srinivasasainagendra V, 2008, PLANT PHYSIOL, V147, P1004, DOI 10.1104/pp.107.115535; Stovel K, 2012, ANNU REV SOCIOL, V38, P139, DOI 10.1146/annurev-soc-081309-150054; Stovel K, 2011, P NATL ACAD SCI USA, V108, P21326, DOI 10.1073/pnas.1100920108; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Subelj L, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2011-20448-7; Subelj L, 2011, PHYSICA A, V390, P2968, DOI 10.1016/j.physa.2011.03.036; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Taube V., 2004, CONNECTIONS, V26, P29; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wei HR, 2006, PLANT PHYSIOL, V142, P762, DOI 10.1104/pp.106.080358; Weiss RS, 1955, AM SOCIOL REV, V20, P661, DOI 10.2307/2088670; Ye ZQ, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046115; Zhang XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043092	63	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66020	10.1371/journal.pone.0066020	http://dx.doi.org/10.1371/journal.pone.0066020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762457	Green Submitted, Green Published, gold			2022-12-25	WOS:000320440500058
J	Abu El-Asrar, AM; Mohammad, G; De Hertogh, G; Nawaz, MI; Van Den Eynde, K; Siddiquei, MM; Struyf, S; Opdenakker, G; Geboes, K				Abu El-Asrar, Ahmed M.; Mohammad, Ghulam; De Hertogh, Gert; Nawaz, Mohd Imtiaz; Van Den Eynde, Kathleen; Siddiquei, Mohammad Mairaj; Struyf, Sofie; Opdenakker, Ghislain; Geboes, Karel			Neurotrophins and Neurotrophin Receptors in Proliferative Diabetic Retinopathy	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ENDOTHELIAL-CELLS; EXPRESSION; TRKA; SKIN; PATHOGENESIS; ACTIVATION; MIGRATION; SURVIVAL; CANCER	Neurotrophins (NTs) are emerging as important mediators of angiogenesis and fibrosis. We investigated the expression of the NTs nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4) and their receptors TrkA, TrkB, and TrkC in proliferative diabetic retinopathy (PDR). As a comparison, we examined the expression of NTs and their receptors in the retinas of diabetic rats. Vitreous samples from 16 PDR and 15 nondiabetic patients were studied by Western blot analysis and enzyme-linked immunosorbent assay (ELISA). Epiretinal membranes from 17 patients with PDR were studied by immunohistochemistry. Rats were made diabetic with a single high dose of streptozotocin and retinas of rats were examined by Western blot analysis. Western blot analysis revealed a significant increase in the expression of NT-3 and NT-4 and the shedding of receptors TrkA and TrkB in vitreous samples from PDR patients compared to nondiabetic controls, whereas NGF and BDNF and the receptor TrkC were not detected with the use of Western blot analysis and ELISA. In epiretinal membranes, vascular endothelial cells and myofibroblasts expressed NT-3 and the receptors TrkA, TrkB and TrkC in situ, whereas NT-4 was not detected. The expression levels of NT-3 and NT-4 and the receptors TrkA and TrkB, both in intact and solubilized forms, were upregulated in the retinas of diabetic rats, whereas the receptor TrkC was not detected. Co-immunoprecipitation studies revealed binding between NT-3 and the receptors TrkA and TrkB in the retinas of diabetic rats. Our findings in diabetic eyes from humans and rats suggest that the increased expression levels within the NT-3 and NT-4/Trk axis are associated with the progression of PDR.	[Abu El-Asrar, Ahmed M.; Mohammad, Ghulam; Nawaz, Mohd Imtiaz; Siddiquei, Mohammad Mairaj] King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh 11461, Saudi Arabia; [De Hertogh, Gert; Van Den Eynde, Kathleen; Geboes, Karel] Univ Louvain, KU Leuven, Lab Histochem & Cytochem, Louvain, Belgium; [Struyf, Sofie; Opdenakker, Ghislain] Univ Louvain, KU Leuven, Rega Inst Med Res, Lab Mol Immunol, Louvain, Belgium; [Struyf, Sofie; Opdenakker, Ghislain] Univ Louvain, KU Leuven, Immunobiol Lab, Louvain, Belgium	King Saud University; KU Leuven; KU Leuven; KU Leuven	Abu El-Asrar, AM (corresponding author), King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh 11461, Saudi Arabia.	abuasrar@KSU.edu.sa	NAWAZ, MOHD IMTIAZ/G-5193-2011; Abu El-Asrar, Ahmed/AAX-5055-2021; Opdenakker, Ghislain/Q-3130-2017; Mohammad, Ghulam/F-5623-2011; Struyf, Sofie/U-2455-2017; Opdenakker, Ghislain/V-8562-2019	NAWAZ, MOHD IMTIAZ/0000-0002-7040-9405; Opdenakker, Ghislain/0000-0003-1714-2294; Mohammad, Ghulam/0000-0002-6418-4772; Struyf, Sofie/0000-0003-4558-0769; Opdenakker, Ghislain/0000-0003-1714-2294; GHULAM, MOHAMMAD/0000-0001-7264-230X	Dr. Nasser Al-Rashid Research Chair in Ophthalmology; Fund for Scientific Research of Flanders (FWO-Vlaanderen, Belgium); Concerted Research Actions (G.O.A.) of the Regional Government of Flanders	Dr. Nasser Al-Rashid Research Chair in Ophthalmology; Fund for Scientific Research of Flanders (FWO-Vlaanderen, Belgium)(FWO); Concerted Research Actions (G.O.A.) of the Regional Government of Flanders	This work was supported by the Dr. Nasser Al-Rashid Research Chair in Ophthalmology. Research at the KU Leuven was supported by the Fund for Scientific Research of Flanders (FWO-Vlaanderen, Belgium) and the Concerted Research Actions (G.O.A.) of the Regional Government of Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2006, EUR CYTOKINE NETW, V17, P155, DOI 10.1684/ecn.2006.0033; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Ali TK, 2008, DIABETES, V57, P889, DOI 10.2337/db07-1669; Avcuoglu S, 2011, AM J RESP CELL MOL, V45, P768, DOI 10.1165/rcmb.2010-0195OC; Birnbaum T, 2007, J NEURO-ONCOL, V83, P241, DOI 10.1007/s11060-007-9332-4; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Cai F, 1999, NEUROSCI LETT, V263, P81, DOI 10.1016/S0304-3940(99)00124-X; Chen Y, 2007, J ANDROL, V28, P306, DOI 10.2164/jandrol.106.000794; Cristofaro B, 2010, ARTERIOSCL THROM VAS, V30, P1143, DOI 10.1161/ATVBAHA.109.205468; Dagnell C, 2007, TRANSL RES, V150, P303, DOI 10.1016/j.trsl.2007.05.001; Dagnell C, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-156; Diaz-Rodriguez E, 1999, EUR J NEUROSCI, V11, P1421, DOI 10.1046/j.1460-9568.1999.00552.x; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; Fragiadaki M, 2012, DIABETES, V61, P2280, DOI 10.2337/db11-1138; HAMMES HP, 1995, MOL MED, V1, P527, DOI 10.1007/BF03401589; Iannetti L, 2011, INVEST OPHTH VIS SCI, V52, P5786, DOI 10.1167/iovs.10-7116; Kennedy AJ, 1998, J NEUROL NEUROSUR PS, V65, P393, DOI 10.1136/jnnp.65.3.393; Kermani P, 2005, J CLIN INVEST, V115, P653, DOI 10.1172/JCI200522655; Kim H, 2004, J BIOL CHEM, V279, P33538, DOI 10.1074/jbc.M404115200; Kohyama T, 2002, J LAB CLIN MED, V140, P329, DOI 10.1067/mlc.2002.128347; Lagadec C, 2009, ONCOGENE, V28, P1960, DOI 10.1038/onc.2009.61; Lecht S, 2010, MOL CELL BIOCHEM, V339, P201, DOI 10.1007/s11010-010-0386-9; Micera A, 2001, P NATL ACAD SCI USA, V98, P6162, DOI 10.1073/pnas.101130898; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Nakamura K, 2011, MOL CELL NEUROSCI, V46, P498, DOI 10.1016/j.mcn.2010.12.002; Nawaz MI, 2013, EXP EYE RES, V109, P67, DOI 10.1016/j.exer.2013.01.008; Nico B, 2008, MICROVASC RES, V75, P135, DOI 10.1016/j.mvr.2007.07.004; Palazzo E, 2012, J CELL PHYSIOL, V227, P1017, DOI 10.1002/jcp.22811; Park KS, 2008, AM J OPHTHALMOL, V145, P432, DOI 10.1016/j.ajo.2007.11.011; Ricci A, 2001, AM J RESP CELL MOL, V25, P439, DOI 10.1165/ajrcmb.25.4.4470; Spranger J, 2001, EXP CLIN ENDOCR DIAB, V109, pS438, DOI 10.1055/s-2001-18601; Takeo C, 2003, BIOCHEM BIOPH RES CO, V305, P400, DOI 10.1016/S0006-291X(03)00770-8; Terenghi G, 1997, NEUROSCI LETT, V228, P33, DOI 10.1016/S0304-3940(97)00350-9; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	34	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65472	10.1371/journal.pone.0065472	http://dx.doi.org/10.1371/journal.pone.0065472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762379	Green Published, Green Submitted, gold			2022-12-25	WOS:000321094800053
J	Gao, MM; Bu, L; Ma, YJ; Liu, DX				Gao, Mingming; Bu, Le; Ma, Yongjie; Liu, Dexi			Concurrent Activation of Liver X Receptor and Peroxisome Proliferator-Activated Receptor Alpha Exacerbates Hepatic Steatosis in High Fat Diet-Induced Obese Mice	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; PPAR-ALPHA; LIPID-METABOLISM; INSULIN-RESISTANCE; CROSS-TALK; NUTRITIONAL REGULATION; ACID-METABOLISM; GENE-EXPRESSION; DIABETIC MICE; LXR	Liver X receptor (LXR) activation improves glucose homeostasis in obesity. This improvement, however, is associated with several side effects including hyperlipidemia and hepatic steatosis. Activation of peroxisome proliferator-activated receptor alpha (PPAR alpha), on the other hand, increases fatty acid oxidation, leading to a reduction of hyperlipidemia. The objective of this study was to investigate whether concurrent activation of LXR/PPAR alpha can produce synergistic benefits in treating obesity-associated metabolic disorders. Treatment of high fat diet-induced obese mice with T0901317, an LXR activator, or fenofibrate, the PPAR alpha agonist, or in combination alleviated insulin resistance and improved glucose tolerance. The combined treatment dramatically exacerbated hepatic steatosis. Gene expression analysis in the liver showed that combined treatment increased the expression of genes involved in lipogenesis and fatty acid transport, including srebp-1c, chrebp, acc1, fas, scd1 and cd36. Histochemistry and ex vivo glycerol releasing assay showed that combined treatment accelerated lipid mobilization in adipose tissue. Combined treatment also increased the transcription of glut4, hsl, atgl and adiponectin, and decreased that of plin1, cd11c, ifnc and leptin. Combined treatment markedly elevated the transcription of fgf21 in liver but not in adipose tissue. These results suggest that concurrent activation of LXR and PPAR alpha as a strategy to control glucose and lipid metabolism in obesity is beneficial but could lead to elevation of lipid accumulation in the liver.	[Gao, Mingming; Bu, Le; Ma, Yongjie; Liu, Dexi] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Liu, DX (corresponding author), Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	dliu@uga.edu	Gao, Mingming/F-4317-2016; MA, YONGJIE/O-3861-2015		National Institutes of Health (NIH) [RO1EB007357, RO1HL098295]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007357] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The work was supported in part by National Institutes of Health (NIH) (RO1EB007357, RO1HL098295) and no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer A, 2012, MOL ENDOCRINOL, V26, P1980, DOI 10.1210/me.2012-1151; Arsov T, 2006, BIOCHEM BIOPH RES CO, V342, P1152, DOI 10.1016/j.bbrc.2006.02.032; Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Carmona MC, 2005, INT J OBESITY, V29, P864, DOI 10.1038/sj.ijo.0802943; Chisholm JW, 2003, J LIPID RES, V44, P2039, DOI 10.1194/jlr.M300135-JLR200; Colin S, 2008, ENDOCRINOLOGY, V149, P5128, DOI 10.1210/en.2008-0637; Darimont C, 2006, BIOCHIMIE, V88, P309, DOI 10.1016/j.biochi.2005.08.010; Ducheix S, 2013, BIOCHIMIE, V95, P556, DOI 10.1016/j.biochi.2012.09.028; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Fernandez-Veledo S, 2006, DIABETOLOGIA, V49, P3038, DOI 10.1007/s00125-006-0472-4; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Gao MM, 2013, AAPS J, V15, P258, DOI 10.1208/s12248-012-9429-3; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Hirata A, 2009, CARDIOVASC RES, V84, P164, DOI 10.1093/cvr/cvp191; Ide T, 2003, MOL ENDOCRINOL, V17, P1255, DOI 10.1210/me.2002-0191; Im SS, 2011, CIRC RES, V108, P996, DOI 10.1161/CIRCRESAHA.110.226878; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Jeong S, 2009, EXP MOL MED, V41, P397, DOI 10.3858/emm.2009.41.6.045; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Juvet LK, 2003, MOL ENDOCRINOL, V17, P172, DOI 10.1210/me.2001-0210; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kidani Y, 2012, IMMUNOL REV, V249, P72, DOI 10.1111/j.1600-065X.2012.01153.x; Korach-Andre M, 2011, P NATL ACAD SCI USA, V108, P403, DOI 10.1073/pnas.1017884108; Kratzer A, 2009, J LIPID RES, V50, P312, DOI 10.1194/jlr.M800376-JLR200; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Larter CZ, 2012, J GASTROEN HEPATOL, V27, P341, DOI 10.1111/j.1440-1746.2011.06939.x; Lenhard JM, 1999, DIABETOLOGIA, V42, P545, DOI 10.1007/s001250051193; Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Minnich A, 2001, AM J PHYSIOL-ENDOC M, V280, pE270, DOI 10.1152/ajpendo.2001.280.2.E270; Mitro N, 2007, FEBS LETT, V581, P1721, DOI 10.1016/j.febslet.2007.03.047; Oosterveer MH, 2009, J BIOL CHEM, V284, P34036, DOI 10.1074/jbc.M109.051052; Rosenson Robert S, 2008, Expert Rev Cardiovasc Ther, V6, P1319, DOI 10.1586/14779072.6.10.1319; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Sekiya M, 2007, J LIPID RES, V48, P1581, DOI 10.1194/jlr.M700033-JLR200; Stenson BM, 2011, J BIOL CHEM, V286, P370, DOI 10.1074/jbc.M110.179499; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190; Yue LD, 2005, PROTEIN SCI, V14, P812, DOI 10.1110/ps.04951405; Fokko ZA, 2007, BBA-MOL CELL BIOL L, V1771, P972, DOI 10.1016/j.bbalip.2007.04.021	48	43	43	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65641	10.1371/journal.pone.0065641	http://dx.doi.org/10.1371/journal.pone.0065641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762402	gold, Green Submitted, Green Published			2022-12-25	WOS:000321094800067
J	Kramer, K; Bente, G; Luo, SY; Pfeiffer, UJ; Han, SH; Vogeley, K				Kraemer, Katharina; Bente, Gary; Luo, Siyang; Pfeiffer, Ulrich J.; Han, Shihui; Vogeley, Kai			Influence of Ethnic Group-Membership and Gaze Direction on the Perception of Emotions. A Cross-Cultural Study between Germany and China	PLOS ONE			English	Article							DOMINANCE; RESPONSES; DISPLAYS; BEHAVIOR; MIMICRY; OTHERS; PEOPLE; FACES; SMILE; SELF	Emotional facial expressions provide important nonverbal cues in human interactions. The perception of emotions is not only influenced by a person's ethnic background but also depends on whether a person is engaged with the emotion-encoder. Although these factors are known to affect emotion perception, their impact has only been studied in isolation before. The aim of the present study was to investigate their combined influence. Thus, in order to study the influence of engagement on emotion perception between persons from different ethnicities, we compared participants from China and Germany. Asian-looking and European-looking virtual agents expressed anger and happiness while gazing at the participant or at another person. Participants had to assess the perceived valence of the emotional expressions. Results indicate that indeed two factors that are known to have a considerable influence on emotion perception interacted in their combined influence: We found that the perceived intensity of an emotion expressed by ethnic in-group members was in most cases independent of gaze direction, whereas gaze direction had an influence on the emotion perception of ethnic out-group members. Additionally, participants from the ethnic out-group tended to perceive emotions as more pronounced than participants from the ethnic in-group when they were directly gazed at. These findings suggest that gaze direction has a differential influence on ethnic in-group and ethnic out-group dynamics during emotion perception.	[Kraemer, Katharina; Pfeiffer, Ulrich J.; Vogeley, Kai] Univ Hosp Cologne, Dept Psychiat, Neuroimaging Grp, Cologne, Germany; [Bente, Gary] Univ Cologne, Dept Psychol, D-50931 Cologne, Germany; [Luo, Siyang; Han, Shihui] Beijing Univ, Dept Psychol, Culture & Social Cognit Neurosci Lab, Beijing 100871, Peoples R China; [Vogeley, Kai] Res Ctr Juelich, Inst Neurosci & Med Cognit Neurosci INM3, Julich, Germany	University of Cologne; University of Cologne; Peking University; Helmholtz Association; Research Center Julich	Kramer, K (corresponding author), Univ Hosp Cologne, Dept Psychiat, Neuroimaging Grp, Cologne, Germany.	katharina.kraemer@uk-koeln.de	Vogeley, K/E-4860-2012	Vogeley, K/0000-0002-5891-5831	VolkswagenStiftung; Studienstiftung des deutschen Volkes	VolkswagenStiftung(Volkswagen); Studienstiftung des deutschen Volkes	This research has been funded by a grant of the VolkswagenStiftung (http://www.volkswagenstiftung.de/nc/de.html) and a grant of the Studienstiftung des deutschen Volkes (http://www.studienstiftung.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2003, PSYCHOL SCI, V14, P644, DOI 10.1046/j.0956-7976.2003.psci_1479.x; Auvray M, 2009, NEW IDEAS PSYCHOL, V27, P32, DOI 10.1016/j.newideapsych.2007.12.002; Bailenson JN, 2005, PSYCHOL SCI, V16, P814, DOI 10.1111/j.1467-9280.2005.01619.x; Bailenson JN, 2003, PERS SOC PSYCHOL B, V29, P819, DOI 10.1177/0146167203029007002; BAVELAS JB, 1986, J PERS SOC PSYCHOL, V50, P322, DOI 10.1037/0022-3514.50.2.322; Bente G, 2001, BEHAV RES METH INS C, V33, P303, DOI 10.3758/BF03195383; Bente G, 2010, CONSCIOUS COGN, V19, P762, DOI 10.1016/j.concog.2010.06.006; Biele C, 2006, EXP BRAIN RES, V171, P1, DOI 10.1007/s00221-005-0254-0; Blascovich J, 2002, PSYCHOL INQ, V13, P103, DOI 10.1207/S15327965PLI1302_01; Brown LM, 2006, BIOL PSYCHOL, V71, P303, DOI 10.1016/j.biopsycho.2005.06.003; CHOVIL N, 1991, J NONVERBAL BEHAV, V15, P141, DOI 10.1007/BF01672216; De Jaegher H, 2010, TRENDS COGN SCI, V14, P441, DOI 10.1016/j.tics.2010.06.009; Dyck M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003628; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; EKMAN P., 1969, SEMIOTICA, V1, P49, DOI DOI 10.1515/SEMI.1969.1.1.49; Field A., 2009, DISCOVERING STAT USI; FRIDLUND AJ, 1990, J NONVERBAL BEHAV, V14, P113, DOI 10.1007/BF01670438; Frith C, 2009, PHILOS T R SOC B, V364, P3453, DOI 10.1098/rstb.2009.0142; Garau M, 2005, PRESENCE-TELEOP VIRT, V14, P104, DOI 10.1162/1054746053890242; Hess U, 2000, J NONVERBAL BEHAV, V24, P265, DOI 10.1023/A:1006623213355; Hess U, 2005, COGNITION EMOTION, V19, P515, DOI 10.1080/02699930441000364; Hewstone M, 2002, ANNU REV PSYCHOL, V53, P575, DOI 10.1146/annurev.psych.53.100901.135109; Hofstede G., 2016, CULTURES CONSEQUENCE, V34, P108; Hofstede G, 1984, CULTURES CONSEQUENCE; Kramer NC, 2008, HUMAN BEHAV MILITARY; Likowski KU, 2008, J EXP SOC PSYCHOL, V44, P1065, DOI 10.1016/j.jesp.2007.10.007; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; MATSUMOTO D, 1990, MOTIV EMOTION, V14, P195, DOI 10.1007/BF00995569; Matsumoto D., 2006, SAGE HDB NONVERBAL C, P219; MESQUITA B, 1992, PSYCHOL BULL, V112, P179, DOI 10.1037/0033-2909.112.2.179; Ouellette M, 2009, CYBERPSYCHOL BEHAV, V12, P215, DOI 10.1089/cpb.2008.0089; Pfeiffer UJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027591; Recio G, 2011, BRAIN RES, V1376, P66, DOI 10.1016/j.brainres.2010.12.041; Rymarczyk K, 2011, INT J PSYCHOPHYSIOL, V79, P330, DOI 10.1016/j.ijpsycho.2010.11.001; Schilbach L, 2006, NEUROPSYCHOLOGIA, V44, P718, DOI 10.1016/j.neuropsychologia.2005.07.017; Schilbach L, 2012, BEHAV BRAIN SCI; Schilbach L, 2008, SOC NEUROSCI-UK, V3, P37, DOI 10.1080/17470910701563228; Schonbrodt FD, 2012, J PERS, V80, P429, DOI 10.1111/j.1467-6494.2011.00736.x; Schrammel F, 2009, PSYCHOPHYSIOLOGY, V46, P922, DOI 10.1111/j.1469-8986.2009.00831.x; SINGELIS TM, 1994, PERS SOC PSYCHOL B, V20, P580, DOI 10.1177/0146167294205014; Smoski MJ, 2003, COGNITION EMOTION, V17, P327, DOI 10.1080/02699930302296; Vogeley K, NEURAL NETW IN PRESS; Weyers P, 2006, PSYCHOPHYSIOLOGY, V43, P450, DOI 10.1111/j.1469-8986.2006.00451.x; Wieser MJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00471	44	7	7	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66335	10.1371/journal.pone.0066335	http://dx.doi.org/10.1371/journal.pone.0066335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	173QU	23762487	Green Published, gold			2022-12-25	WOS:000321094800096
J	Yang, B; Zhang, WC; Zhang, ZY; Fan, Y; Xie, XH; Ai, HS; Ma, JW; Xiao, SJ; Huang, LS; Ren, J				Yang, Bin; Zhang, Wanchang; Zhang, Zhiyan; Fan, Yin; Xie, Xianhua; Ai, Huashui; Ma, Junwu; Xiao, Shijun; Huang, Lusheng; Ren, Jun			Genome-Wide Association Analyses for Fatty Acid Composition in Porcine Muscle and Abdominal Fat Tissues	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PHENOTYPE NETWORKS; MELTING-POINT; MEAT QUALITY; QTL; EXPRESSION; ELONGASE	Fatty acid composition is an important phenotypic trait in pigs as it affects nutritional, technical and sensory quality of pork. Here, we reported a genome-wide association study (GWAS) for fatty acid composition in the longissimus muscle and abdominal fat tissues of 591 White Duroc x Erhualian F-2 animals and in muscle samples of 282 Chinese Sutai pigs. A total of 46 loci surpassing the suggestive significance level were identified on 15 pig chromosomes (SSC) for 12 fatty acids, revealing the complex genetic architecture of fatty acid composition in pigs. Of the 46 loci, 15 on SSC5, 7, 14 and 16 reached the genome-wide significance level. The two most significant SNPs were ss131535508 (P = 2.48 x 10(-25)) at 41.39 Mb on SSC16 for C20:0 in abdominal fat and ss478935891 (P = 3.29 x 10(-13)) at 121.31 Mb on SSC14 for muscle C18:0. A meta-analysis of GWAS identified 4 novel loci and enhanced the association strength at 6 loci compared to those evidenced in a single population, suggesting the presence of common underlying variants. The longissimus muscle and abdominal fat showed consistent association profiles at most of the identified loci and distinct association signals at several loci. All loci have specific effects on fatty acid composition, except for two loci on SSC4 and SSC7 affecting multiple fatness traits. Several promising candidate genes were found in the neighboring regions of the lead SNPs at the genome-wide significant loci, such as SCD for C18:0 and C16:1 on SSC14 and ELOVL7 for C20:0 on SSC16. The findings provide insights into the molecular basis of fatty acid composition in pigs, and would benefit the final identification of the underlying mutations.	[Huang, Lusheng] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China; Jiangxi Agr Univ, Minist Agr China, Nanchang, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs	Huang, LS (corresponding author), Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China.	lushenghuang@hotmail.com; renjunjxau@hotmail.com	Ren, Jun/H-9793-2019		Program for Changjiang Scholars and Innovative Research Team in University [IRT1136]; National Natural Science Foundation of China [31230069]; National 973 Program [2012CB722502]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Program(National Basic Research Program of China)	This work was supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT1136), National Natural Science Foundation of China (31230069) and National 973 Program (2012CB722502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; BORKMAN M, 1993, NEW ENGL J MED, V328, P238, DOI 10.1056/NEJM199301283280404; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; FOLCH J, 1957, J BIOL CHEM, V226, P497; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Guo T, 2009, ANIM GENET, V40, P185, DOI 10.1111/j.1365-2052.2008.01819.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Li RH, 2006, PLOS GENET, V2, P1046, DOI 10.1371/journal.pgen.0020114; Ma J, 2009, ANIM GENET, V40, P637, DOI 10.1111/j.1365-2052.2009.01892.x; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Naganuma T, 2011, FEBS LETT, V585, P3337, DOI 10.1016/j.febslet.2011.09.024; Neto EC, 2008, GENETICS, V179, P1089, DOI 10.1534/genetics.107.085167; Nii M, 2006, ANIM GENET, V37, P342, DOI 10.1111/j.1365-2052.2006.01485.x; Perez-Enciso M, 2000, J ANIM SCI, V78, P2525; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramayo-Caldas Y, 2012, J ANIM SCI, V90, P2883, DOI 10.2527/jas.2011-4900; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Ren J, 2011, HEREDITY, V106, P862, DOI 10.1038/hdy.2010.129; Ren J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002043; Rothschild MF, 2011, GENETICS OF THE PIG, 2ND EDITION, P1, DOI 10.1079/9781845937560.0000; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Steinberg SJ, 2000, J BIOL CHEM, V275, P35162, DOI 10.1074/jbc.M006403200; Uemoto Y, 2012, ANIM GENET, V43, P225, DOI 10.1111/j.1365-2052.2011.02236.x; Uemoto Y, 2012, ANIM GENET, V43, P27, DOI 10.1111/j.1365-2052.2011.02218.x; Webb EC, 2008, MEAT SCI, V80, P28, DOI 10.1016/j.meatsci.2008.05.029; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Yang B, 2011, J ANIM BREED GENET, V128, P329, DOI 10.1111/j.1439-0388.2011.00928.x; Yang KX, 2010, J ANIM SCI, V88, P3538, DOI 10.2527/jas.2009-2602; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167	38	35	44	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65554	10.1371/journal.pone.0065554	http://dx.doi.org/10.1371/journal.pone.0065554			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762394	Green Published, Green Submitted, gold			2022-12-25	WOS:000321094800065
J	Tonga, C; Kimbi, HK; Anchang-Kimbi, JK; Nyabeyeu, HN; Bissemou, ZB; Lehman, LG				Tonga, Calvin; Kimbi, Helen Kuokuo; Anchang-Kimbi, Judith Kuoh; Nyabeyeu, Herve Nyabeyeu; Bissemou, Zacharie Bissemou; Lehman, Leopold G.			Malaria Risk Factors in Women on Intermittent Preventive Treatment at Delivery and Their Effects on Pregnancy Outcome in Sanaga-Maritime, Cameroon	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; SULFADOXINE-PYRIMETHAMINE; INFECTION; HIV; PREVALENCE; DIAGNOSIS; CHILDREN; BURDEN; BLOOD; AREA	Malaria is known to have a negative impact on pregnant women and their foetuses. The efficacy of Sulfadoxine-Pyrimethamine (SP) used for intermittent preventive treatment (IPT) is being threatened by increasing levels of resistance. This study assessed malaria risk factors in women on intermittent preventive treatment with SP (IPTp-SP) at delivery and their effects on pregnancy outcome in Sanaga-Maritime Division, Cameroon. Socio-economic and obstetrical data of mothers and neonate birth weights were documented. Peripheral blood from 201 mothers and newborns as well as placental and cord blood were used to prepare thick and thin blood films. Maternal haemoglobin concentration was measured. The overall malaria parasite prevalence was 22.9% and 6.0% in mothers and newborns respectively. Monthly income lower than 28000 FCFA and young age were significantly associated with higher prevalence of placental malaria infection (p = 0.0048 and p = 0.019 respectively). Maternal infection significantly increased the risk of infection in newborns (OR = 48.4; p<0.0001). Haemoglobin concentration and birth weight were lower in infected mothers, although not significant. HIV infection was recorded in 6.0% of mothers and increased by 5-folds the risk of malaria parasite infection (OR = 5.38, p = 0.007). Attendance at antenatal clinic and level of education significantly influenced the utilisation of IPTp-SP (p<0.0001 and p = 0.018 respectively). Use of SP and mosquito net resulted in improved pregnancy outcome especially in primiparous, though the difference was not significant. Malaria infection in pregnancy is common and increases the risk of neonatal malaria infection. Preventive strategies are poorly implemented and their utilization has overall reasonable effect on malaria infection and pregnancy outcome.	[Tonga, Calvin; Kimbi, Helen Kuokuo; Anchang-Kimbi, Judith Kuoh] Univ Buea, Dept Zool & Anim Physiol, Buea, South West Regi, Cameroon; [Nyabeyeu, Herve Nyabeyeu; Lehman, Leopold G.] Univ Douala, Dept Anim Biol, Douala, Littoral Region, Cameroon; [Bissemou, Zacharie Bissemou] Pouma Hlth Dist, Pouma Dist Hosp, Pouma, Littoral Region, Cameroon		Kimbi, HK (corresponding author), Univ Buea, Dept Zool & Anim Physiol, Buea, South West Regi, Cameroon.	hkimbi@yahoo.co.uk	Anchang-Kimbi, Judith/AAE-9802-2020; Calvin, TONGA/AAF-7496-2019	Calvin, TONGA/0000-0003-3157-8326				Achidi AE, 2005, J OBSTET GYNAECOL, V25, P235; Adebami OJ, 2007, AM J TROP MED HYG, V77, P209, DOI 10.4269/ajtmh.2007.77.209; Akum AE, 2005, ACTA PAEDIATR, V94, P917, DOI 10.1080/08035250510028605; Akum AE, 2005, J TROP PEDIATRICS, V51, P182, DOI 10.1093/tropej/fmi028; ALLEN SJ, 1992, T ROY SOC TROP MED H, V86, P494, DOI 10.1016/0035-9203(92)90083-O; Anchang-Kimbi JK, 2010, THESIS U BUEA; Anchang-Kimbi JK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-126; Barduagni P, 2003, TROP MED INT HEALTH, V8, P615, DOI 10.1046/j.1365-3156.2003.01062.x; Brabin BJ, 2004, PLACENTA, V25, P359, DOI 10.1016/j.placenta.2003.10.019; Cheesbrough M, 2000, PARASITOLOGICAL TE 2; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Falade CO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-88; Fievet N, 2002, MALAR J, V1; Flateau C, 2011, LANCET INFECT DIS, V11, P541, DOI 10.1016/S1473-3099(11)70031-7; Gonzalez R, 2012, EXPERT REV ANTI-INFE, V10, P153, DOI [10.1586/ERI.11.167, 10.1586/eri.11.167]; Harrington WE, 2011, CLIN INFECT DIS, V53, P224, DOI 10.1093/cid/cir376; Iriemenam NC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-134; Leke RFG, 2010, AM J TROP MED HYG, V83, P996, DOI 10.4269/ajtmh.2010.10-0249; Lin TL, 2012, TROP MED IN IN PRESS; Manirakiza A, 2011, J TROP MED-US, V2011, DOI 10.1155/2011/434816; Marchesini P, 2004, REDUCING BURDEN MALA; Mbacham WF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-34; Mbu ER, 2008, REPROD HLTH, V5; Mockenhaupt FP, 2002, J CLIN MICROBIOL, V40, P306, DOI 10.1128/JCM.40.1.306-308.2002; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P332, DOI 10.1128/AAC.00856-06; Mokuolu OA, 2009, INFECT DIS OBSTET GY; Monebenimp F, 2011, PAN AFRICAN MED J, V8; Mosha JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008707; Mount AM, 2004, LANCET, V363, P1860, DOI 10.1016/S0140-6736(04)16354-X; Napoleon R. P., 2011, Southern Sudan Medical Journal, V4, P33; National Institute of Statistics, 2011, ENQ DEM SANT IND MUL; Omalu ICJ, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/274142; Osungbade KO, 2012, J TROP MED, V2012; Ouedraogo A, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/109705; Ringwald P, 2011, TMIH, V5, P620; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Takem EN, 2009, ACTA TROP, V112, P54, DOI 10.1016/j.actatropica.2009.06.007; Tako EA, 2005, AM J TROP MED HYG, V72, P236, DOI 10.4269/ajtmh.2005.72.236; Tutterrow Yeung Lo, 2012, PLoS One, V7, pe40049, DOI 10.1371/journal.pone.0040049; Tutu EO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-385; Umeh UA, 2012, TROPICAL DOCTOR, P1; Uneke Chigozie J, 2007, Yale J Biol Med, V80, P39; Uneke Chigozie J, 2007, Yale J Biol Med, V80, P95; Uneke Chigozie J, 2008, Yale J Biol Med, V81, P1; Vallely A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-16; Walker-Abbey A, 2005, AM J TROP MED HYG, V72, P229, DOI 10.4269/ajtmh.2005.72.229; WHO, 2004, AFRMALO401 WHO REG O; WHO, 2020, REP ANT DRUG EFF RES; Xi GL, 2003, INFECT IMMUN, V71, P1242, DOI 10.1128/IAI.71.3.1242-1246.2003	50	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65876	10.1371/journal.pone.0065876	http://dx.doi.org/10.1371/journal.pone.0065876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762446	gold, Green Published			2022-12-25	WOS:000321099000115
J	Sun, T; Wang, X; He, HH; Sweeney, CJ; Liu, SX; Brown, M; Balk, S; Lee, GSM; Kantoff, PW				Sun, T.; Wang, X.; He, H. H.; Sweeney, C. J.; Liu, S. X.; Brown, M.; Balk, S.; Lee, G-S M.; Kantoff, P. W.			MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A	ONCOGENE			English	Article						microRNA; miR-221; castration resistant prostate cancer; androgen receptor signaling	BREAST-CANCER; MESENCHYMAL TRANSITION; TAMOXIFEN RESISTANCE; RECEPTOR; EXPRESSION; GENES; PROGRESSION; CASTRATION; MICRORNAS; PROTEINS	Hormone-sensitive prostate cancer typically progresses to castration resistant prostate cancer (CRPC) after the androgen deprivation therapy. We investigated the impact of microRNAs (miRs) in the transition of prostate cancer to CRPC. MiR-221/-222 was highly expressed in bone metastatic CRPC tumor specimens. We previously demonstrated that transient overexpression of miR-221/-222 in LNCaP promoted the development of the CRPC phenotype. In current study, we show that stably overexpressing miR-221 confers androgen independent (AI) cell growth in LNCaP by rescuing LNCaP cells from growth arrest at G1 phase due to the lack of androgen. Overexpressing of miR-221 in LNCaP reduced the transcription of a subgroup of androgen-responsive genes without affecting the androgen receptor (AR) or AR-androgen integrity. By performing systematic biochemical and bioinformatical analyses, we identified two miR-221 targets, HECTD2 and RAB1A, which could mediate the development of CRPC phenotype in multiple prostate cancer cell lines. Downregulation of HECTD2 significantly affected the androgen-induced and AR-mediated transcription, and downregulation of HECTD2 or RAB1A enhances AI cell growth. As a result of the elevated expression of miR-221, expression of many cell cycle genes was altered and pathways promoting epithelial to mesenchymal transition/tumor metastasis were activated. We hypothesize that a major biological consequence of upregulation of miR-221 is reprogramming of AR signaling, which in turn may mediate the transition to the CRPC phenotype.	[Sun, T.; Wang, X.; He, H. H.; Sweeney, C. J.; Brown, M.; Lee, G-S M.; Kantoff, P. W.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [He, H. H.; Liu, S. X.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Balk, S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Canc Biol Program,Dept Med, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Lee, GSM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	Gwo-shu_lee@dfci.harvard.edu; philip_kantoff@dfci.harvard.edu	He, Hansen/ABD-8439-2020; Brown, Myles/AAX-5332-2021; Brown, Myles/B-6906-2008	He, Hansen/0000-0003-2898-3363; Brown, Myles/0000-0002-8213-1658; Kantoff, Philip/0000-0001-7275-0597	SPORE in Prostate Cancer [2 P50 CA090381-06]; Department of Defense (DoD) Prostate Cancer Training [W81XWH-09-1-0372]; NATIONAL CANCER INSTITUTE [P50CA090381, P01CA163227] Funding Source: NIH RePORTER	SPORE in Prostate Cancer; Department of Defense (DoD) Prostate Cancer Training; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a SPORE in Prostate Cancer 2 P50 CA090381-06 and TS was supported by a Department of Defense (DoD) Prostate Cancer Training Award W81XWH-09-1-0372. We thank Dr Peter T Nelson at University of Kentucky and Dr Zissimos Mourelatos at University of Pennsylvania for kindly providing us the anti-AGO antibody. We also thank Dr Wang-xia Wang for technical suggestions on AGO-RIP-Chip experiments.	American Cancer Society, 2012, CANC FACTS FIGS 2012; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bohrer LR, 2010, ENDOCRINOLOGY, V151, P5136, DOI 10.1210/en.2010-0436; Chen Z, 2011, EMBO J, V30, P2405, DOI 10.1038/emboj.2011.154; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; HE L, 2004, NAT REV GENET, V5, P522; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jia L, 2003, MOL CANCER RES, V1, P385; Jiang F, 2004, PROSTATE, V59, P426, DOI 10.1002/pros.20000; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Love HD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008384; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Mizuno H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-137; Nelson PT, 2007, RNA, V13, P1787, DOI 10.1261/rna.646007; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Pfeil K, 2004, PROSTATE, V58, P259, DOI 10.1002/pros.10332; Rao X, 2011, ONCOGENE, V30, P1082, DOI 10.1038/onc.2010.487; Rini Brian I, 2002, Curr Treat Options Oncol, V3, P437, DOI 10.1007/s11864-002-0008-1; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Stinson S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001538; Sun T, 2012, PROSTATE, V72, P1093, DOI 10.1002/pros.22456; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Taneja SS, 2002, J CELL BIOCHEM, V84, P188, DOI 10.1002/jcb.1278; Terasawa K, 2009, FEBS J, V276, P3269, DOI 10.1111/j.1742-4658.2009.07041.x; Vitelli F, 1999, GENOMICS, V55, P335, DOI 10.1006/geno.1998.5666; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Watahiki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024950; Weide T, 2003, BIOCHEM BIOPH RES CO, V306, P79, DOI 10.1016/S0006-291X(03)00918-5; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; Zhang CZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-229; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200	50	107	111	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 22	2014	33	21					2790	2800		10.1038/onc.2013.230	http://dx.doi.org/10.1038/onc.2013.230			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EH	23770851	Green Accepted			2022-12-25	WOS:000337231700012
J	Wald, T; Osickova, A; Sulc, M; Benada, O; Semeradtova, A; Rezabkova, L; Veverka, V; Bednarova, L; Maly, J; Macek, P; Sebo, P; Slaby, I; Vondrasek, J; Osicka, R				Wald, Tomas; Osickova, Adriana; Sulc, Miroslav; Benada, Oldrich; Semeradtova, Alena; Rezabkova, Lenka; Veverka, Vaclav; Bednarova, Lucie; Maly, Jan; Macek, Pavel; Sebo, Peter; Slaby, Ivan; Vondrasek, Jiri; Osicka, Radim			Intrinsically Disordered Enamel Matrix Protein Ameloblastin Forms Ribbon-like Supramolecular Structures via an N-terminal Segment Encoded by Exon 5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING; AMELOGENIN NANOSPHERES; UNSTRUCTURED PROTEINS; MINERALIZED TISSUE; SHEATH PROTEINS; TOOTH ENAMEL; GENE; BIOMINERALIZATION; CLONING; REGION	Tooth enamel, the hardest tissue in the body, is formed by the evolutionarily highly conserved biomineralization process that is controlled by extracellular matrix proteins. The intrinsically disordered matrix protein ameloblastin (AMBN) is the most abundant nonamelogenin protein of the developing enamel and a key element for correct enamel formation. AMBN was suggested to be a cell adhesion molecule that regulates proliferation and differentiation of ameloblasts. Nevertheless, detailed structural and functional studies on AMBN have been substantially limited by the paucity of the purified nondegraded protein. With this study, we have developed a procedure for production of a highly purified form of recombinant human AMBN in quantities that allowed its structural characterization. Using size exclusion chromatography, analytical ultracentrifugation, transmission electron, and atomic force microscopy techniques, we show that AMBN self-associates into ribbon-like supramolecular structures with average widths and thicknesses of 18 and 0.34 nm, respectively. The AMBN ribbons exhibited lengths ranging from tens to hundreds of nm. Deletion analysis and NMR spectroscopy revealed that an N-terminal segment encoded by exon 5 comprises two short independently structured regions and plays a key role in self-assembly of AMBN.	[Wald, Tomas; Osickova, Adriana; Sulc, Miroslav; Benada, Oldrich; Macek, Pavel; Sebo, Peter; Osicka, Radim] Acad Sci Czech Republic, Inst Microbiol, CR-14220 Prague, Czech Republic; [Rezabkova, Lenka] Acad Sci Czech Republic, Inst Physiol, CR-14220 Prague, Czech Republic; [Slaby, Ivan; Vondrasek, Jiri] Acad Sci Czech Republic, Inst Biotechnol, CR-14220 Prague, Czech Republic; [Wald, Tomas] Prague Inst Chem Technol, Dept Biochem & Microbiol, CR-16628 Prague, Czech Republic; [Sulc, Miroslav; Rezabkova, Lenka] Charles Univ Prague, Fac Sci, Prague 12843, Czech Republic; [Semeradtova, Alena; Maly, Jan] Univ JE Purkyne, Fac Sci, Usti Nad Labem 40096, Czech Republic; [Veverka, Vaclav; Bednarova, Lucie; Vondrasek, Jiri] Acad Sci Czech Republic, Inst Organ Chem & Biochem, CR-16610 Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; University of Chemistry & Technology, Prague; Charles University Prague; University of Jan Evangelista Purkyne; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Osicka, R (corresponding author), Acad Sci Czech Republic, Inst Microbiol, Vvi, Videnska 1083, CR-14220 Prague, Czech Republic.	osicka@biomed.cas.cz	Veverka, Vaclav/P-5251-2019; Osicka, Radim/H-6776-2014; Osickova, Adriana/H-6841-2014; SEBO, Peter/N-2043-2019; Veverka, Vaclav/G-9174-2014; Wald, Tomas/J-6894-2014; Sulc, Miroslav/K-1029-2014; Bednarova, Lucie/E-7622-2012; SEBO, Peter/F-7423-2011; Vondrasek, JIri/A-4244-2008; Benada, Oldřich/H-2437-2014; Maly, Jan/B-6434-2011; Rezabkova, Lenka/O-8229-2017	Veverka, Vaclav/0000-0003-3782-5279; Osicka, Radim/0000-0003-2626-5456; Osickova, Adriana/0000-0002-5739-1183; SEBO, Peter/0000-0002-9755-7715; Veverka, Vaclav/0000-0003-3782-5279; Wald, Tomas/0000-0002-6569-5339; Sulc, Miroslav/0000-0002-2659-0489; SEBO, Peter/0000-0002-9755-7715; Benada, Oldřich/0000-0002-4592-6216; Maly, Jan/0000-0002-7022-2157; Rezabkova, Lenka/0000-0002-7274-8080; Macek, Pavel/0000-0003-3774-7717	Czech Science Foundation [P302/10/0427]; Czech National Cost Project [OC10053]; Internal Grant Agency of Jan Evangelista Purkyne University; Academy of Sciences of the Czech Republic [RVO61388971]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech National Cost Project; Internal Grant Agency of Jan Evangelista Purkyne University; Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This work was supported by Grant P302/10/0427 from the Czech Science Foundation (to R. O. and J. V.), Czech National Cost Project OC10053 (to J. M.), Internal Grant Agency of Jan Evangelista Purkyne University (to J. M.), and Academy of Sciences of the Czech Republic Grant RVO61388971.	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Bartlett JD, 1996, GENE, V183, P123, DOI 10.1016/S0378-1119(96)00525-2; Bartlett JD, 2006, CURR TOP DEV BIOL, V74, P57, DOI 10.1016/S0070-2153(06)74003-0; BENADA O, 1990, J ELECTRON MICR TECH, V16, P235, DOI 10.1002/jemt.1060160304; Benseny-Cases N, 2012, CURR ALZHEIMER RES, V9, P962, DOI 10.2174/156720512803251129; Beyeler M, 2010, EXP CELL RES, V316, P1202, DOI 10.1016/j.yexcr.2009.12.019; Cerny R, 1996, J BONE MINER RES, V11, P883; Chun YHP, 2010, J DENT RES, V89, P785, DOI 10.1177/0022034510366903; Dawson R, 2003, J MOL BIOL, V332, P1131, DOI 10.1016/j.jmb.2003.08.008; Delak K, 2009, BIOCHEMISTRY-US, V48, P2272, DOI 10.1021/bi802175a; Dhamija S, 2001, J BIOL CHEM, V276, P35159, DOI 10.1074/jbc.M010719200; Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108; FINCHAM AG, 1995, J STRUCT BIOL, V115, P50, DOI 10.1006/jsbi.1995.1029; FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011; Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130; Fong C D, 1996, Adv Dent Res, V10, P195; Fukae M, 2006, EUR J ORAL SCI, V114, P212, DOI 10.1111/j.1600-0722.2006.00309.x; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; GUNTERT P, 1991, Journal of Biomolecular NMR, V1, P447, DOI 10.1007/BF02192866; Hansma HG, 2010, J THEOR BIOL, V266, P175, DOI 10.1016/j.jtbi.2010.06.016; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hu CC, 1997, J DENT RES, V76, P648, DOI 10.1177/00220345970760020501; Iizuka S, 2011, MOL CELL BIOL, V31, P783, DOI 10.1128/MCB.00912-10; Iwata T, 2007, J DENT RES, V86, P153, DOI 10.1177/154405910708600209; Kalmar L, 2012, BONE, V51, P528, DOI 10.1016/j.bone.2012.05.009; Kawasaki K, 2004, P NATL ACAD SCI USA, V101, P11356, DOI 10.1073/pnas.0404279101; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Khan F, 2006, ANAL CHEM, V78, P3072, DOI 10.1021/ac060184l; Klinov D, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/22/225102; Kobayashi K, 2007, J DENT RES, V86, P962, DOI 10.1177/154405910708601009; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krebsbach PH, 1996, J BIOL CHEM, V271, P4431; Lakshminarayanan R, 2007, BIOPHYS J, V93, P3664, DOI 10.1529/biophysj.107.113936; Makin OS, 2006, CURR OPIN CHEM BIOL, V10, P417, DOI 10.1016/j.cbpa.2006.08.009; Matthews JM, 2012, ADV EXP MED BIOL, V747, P1, DOI 10.1007/978-1-4614-3229-6_1; MORADIANOLDAK J, 1994, ARCH ORAL BIOL, V39, P647, DOI 10.1016/0003-9969(94)90090-6; Murakami C, 1997, HISTOCHEM CELL BIOL, V107, P485, DOI 10.1007/s004180050136; Namba K, 2001, GENES CELLS, V6, P1, DOI 10.1046/j.1365-2443.2001.00384.x; Nanci A, 1998, J HISTOCHEM CYTOCHEM, V46, P911, DOI 10.1177/002215549804600806; Paine ML, 1998, J DENT RES, V77, P496, DOI 10.1177/00220345980770030901; Paine ML, 1996, CONNECT TISSUE RES, V35, P157, DOI 10.3109/03008209609029187; Paine ML, 2000, J STRUCT BIOL, V132, P191, DOI 10.1006/jsbi.2000.4324; Sambrook J., 2002, MOL CLONING LAB MANU; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shapiro JL, 2007, CELL MOL LIFE SCI, V64, P244, DOI 10.1007/s00018-006-6429-4; SIMMER JP, 1994, CALCIFIED TISSUE INT, V54, P312, DOI 10.1007/BF00295956; Simmer JP, 1998, J DENT RES, V77, P377, DOI 10.1177/00220345980770020601; Simmer JP, 2002, CONNECT TISSUE RES, V43, P441, DOI 10.1080/03008200290001159; Sonoda A, 2009, J BIOL CHEM, V284, P27176, DOI 10.1074/jbc.M109.033464; STRAWICH E, 1985, FEBS LETT, V184, P188, DOI 10.1016/0014-5793(85)80604-9; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uchida T, 1997, J HISTOCHEM CYTOCHEM, V45, P1329, DOI 10.1177/002215549704501002; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Vymetal J, 2008, EUR J ORAL SCI, V116, P124, DOI 10.1111/j.1600-0722.2008.00526.x; Wald T, 2011, EUR J ORAL SCI, V119, P261, DOI 10.1111/j.1600-0722.2011.00913.x; Wazen RM, 2009, MATRIX BIOL, V28, P292, DOI 10.1016/j.matbio.2009.04.004; Whitehouse C, 2005, ANGEW CHEM INT EDIT, V44, P1965, DOI 10.1002/anie.200462160; Wojtas M, 2012, ADVANCED TOPICS IN BIOMINERALIZATION, P3; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Yamakoshi Y, 2001, ARCH ORAL BIOL, V46, P1005, DOI 10.1016/S0003-9969(01)00070-X	63	27	27	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22333	22345		10.1074/jbc.M113.456012	http://dx.doi.org/10.1074/jbc.M113.456012			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23782691	Green Published, hybrid			2022-12-25	WOS:000330596300015
J	Yadav, T; Carrasco, B; Hejna, J; Suzuki, Y; Takeyasu, K; Alonso, JC				Yadav, Tribhuwan; Carrasco, Begona; Hejna, James; Suzuki, Yuki; Takeyasu, Kunio; Alonso, Juan C.			Bacillus subtilis DprA Recruits RecA onto Single-stranded DNA and Mediates Annealing of Complementary Strands Coated by SsbB and SsbA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC-RECOMBINATION; GENOME MAINTENANCE; BINDING PROTEIN; REPAIR; TRANSFORMATION; NUCLEATION; MACHINERY; FILAMENTS; SSDNA	Naturally transformable bacteria recombine internalized ssDNA with a homologous resident duplex (chromosomal transformation) or complementary internalized ssDNAs (plasmid or viral transformation). Bacillus subtilis competence-induced DprA, RecA, SsbB, and SsbA proteins are involved in the early processing of the internalized ssDNA, with DprA physically interacting with RecA. SsbB and SsbA bind and melt secondary structures in ssDNA but limit RecA loading onto ssDNA. DprA binds to ssDNA and facilitates partial dislodging of both single-stranded binding (SSB) proteins from ssDNA. In the absence of homologous duplex DNA, DprA does not significantly increase RecA nucleation onto protein-free ssDNA. DprA facilitates RecA nucleation and filament extension onto SsbB-coated or SsbB plus SsbA-coated ssDNA. DprA facilitates RecA-mediated DNA strand exchange in the presence of both SSB proteins. DprA, which plays a crucial role in plasmid transformation, anneals complementary strands preferentially coated by SsbB to form duplex circular plasmid molecules. Our results provide a mechanistic framework for conceptualizing the coordinated events modulated by SsbB in concert with SsbA and DprA that are crucial for RecA-dependent chromosomal transformation and RecA-independent plasmid transformation.	[Yadav, Tribhuwan; Carrasco, Begona; Alonso, Juan C.] CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, E-28049 Madrid, Spain; [Hejna, James; Suzuki, Yuki; Takeyasu, Kunio] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Kyoto University	Alonso, JC (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Biotecnol Microbiana, Plaza Murillo 2, E-28049 Madrid, Spain.	jcalonso@cnb.cisc.es	Alonso, Juan Carlos/D-2595-2009; Suzuki, Yuki/H-9950-2015	Alonso, Juan Carlos/0000-0002-5178-7179; Suzuki, Yuki/0000-0003-1848-0105; Carrasco, Begona/0000-0002-5671-1296; Yadav, Tribhuwan/0000-0003-3571-9907	Ministerio de Economia y Competitividad, Direccion General de Investigacion [BFU2012-39879-C02-01]; Comunidad de Madrid [S2009MAT-1507]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [24115003]; Japan-Spain Bilateral Joint Project Award JSPC-CSIC [2010JP0017]; Grants-in-Aid for Scientific Research [24115003] Funding Source: KAKEN	Ministerio de Economia y Competitividad, Direccion General de Investigacion; Comunidad de Madrid(Comunidad de Madrid); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan-Spain Bilateral Joint Project Award JSPC-CSIC; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Ministerio de Economia y Competitividad, Direccion General de Investigacion, Grant BFU2012-39879-C02-01; Comunidad de Madrid Grant S2009MAT-1507 (to J. C. A); Grant-in-aid for Scientific Research on Innovative Areas "Virus-Host Cell Competency" (24115003) of the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to K. T.); and Japan-Spain Bilateral Joint Project Award JSPC-CSIC 2010JP0017 (to K. T. and J. C. A.).	Alonso JC, 2013, DNA REPAIR, V12, P162, DOI 10.1016/j.dnarep.2012.12.005; Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; Attaiech L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002156; Ayora S, 2002, J BIOL CHEM, V277, P35969, DOI 10.1074/jbc.M204467200; Ayora S, 2002, J MOL BIOL, V316, P35, DOI 10.1006/jmbi.2001.5336; Ayora S, 2011, FEMS MICROBIOL REV, V35, P1055, DOI 10.1111/j.1574-6976.2011.00272.x; Bell JC, 2012, NATURE, V491, P274, DOI 10.1038/nature11598; Cardenas PP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003126; Carrasco B, 2005, NUCLEIC ACIDS RES, V33, P3942, DOI 10.1093/nar/gki713; Carrasco B, 2008, DNA REPAIR, V7, P990, DOI 10.1016/j.dnarep.2008.03.019; CEGLOWSKI P, 1990, MOL GEN GENET, V222, P441, DOI 10.1007/BF00633853; Chan KW, 2009, J MOL BIOL, V388, P508, DOI 10.1016/j.jmb.2009.03.022; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Chiesa M, 2012, NANO LETT, V12, P1275, DOI 10.1021/nl2037547; Claverys JP, 2009, FEMS MICROBIOL REV, V33, P643, DOI 10.1111/j.1574-6976.2009.00164.x; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Deschenes LA, 2000, J AM CHEM SOC, V122, P9567, DOI 10.1021/ja004761d; Fernandez S, 1999, MOL GEN GENET, V261, P567, DOI 10.1007/s004380051002; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Galletto R, 2007, CURR BIOL, V17, pR395, DOI 10.1016/j.cub.2007.03.009; Ha T, 2012, ANNU REV BIOPHYS, V41, P295, DOI 10.1146/annurev-biophys-042910-155351; Hamon L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm147; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Kidane D, 2012, CRIT REV BIOCHEM MOL, V47, P531, DOI 10.3109/10409238.2012.729562; Kidane D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000630; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kramer N, 2007, MOL MICROBIOL, V65, P454, DOI 10.1111/j.1365-2958.2007.05799.x; Lenhart JS, 2012, MICROBIOL MOL BIOL R, V76, P530, DOI 10.1128/MMBR.05020-11; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; LOHMAN TM, 1986, J MOL BIOL, V187, P603, DOI 10.1016/0022-2836(86)90338-4; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Manfredi C, 2008, J BIOL CHEM, V283, P24837, DOI 10.1074/jbc.M802002200; Manfredi C, 2010, NUCLEIC ACIDS RES, V38, P6920, DOI 10.1093/nar/gkq533; Masuda T, 2009, J BIOL CHEM, V284, P30230, DOI 10.1074/jbc.M109.043810; Mortier-Barriere I, 2007, CELL, V130, P824, DOI 10.1016/j.cell.2007.07.038; Pratto F, 2009, J BIOL CHEM, V284, P30298, DOI 10.1074/jbc.M109.035410; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Sanchez H., 2007, MOL GENETICS RECOMBI, V17, P27; Sanchez H, 2008, NUCLEIC ACIDS RES, V36, P110, DOI 10.1093/nar/gkm759; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Tadesse S, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-105; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; Yadav T, 2012, NUCLEIC ACIDS RES, V40, P5546, DOI 10.1093/nar/gks173	46	41	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22437	22450		10.1074/jbc.M113.478347	http://dx.doi.org/10.1074/jbc.M113.478347			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23779106	Green Published, hybrid			2022-12-25	WOS:000330596300025
J	Maszczak-Seneczko, D; Sosicka, P; Olczak, T; Jakimowicz, P; Majkowski, M; Olczak, M				Maszczak-Seneczko, Dorota; Sosicka, Paulina; Olczak, Teresa; Jakimowicz, Piotr; Majkowski, Michal; Olczak, Mariusz			UDP-N-acetylglucosamine Transporter (SLC35A3) Regulates Biosynthesis of Highly Branched N-Glycans and Keratan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycosylation; Glycosyltransferases; Golgi; Keratan; Proteoglycan; UDP-N-Acetylglucosamine Transporter; Branched N-Glycans	NUCLEOTIDE-SUGAR TRANSPORTER; GDP-MANNOSE TRANSPORTER; GALACTOSE TRANSPORTER; MOLECULAR-CLONING; GOLGI MEMBRANE; SIALIC-ACID; ACETYLGALACTOSAMINE TRANSPORTER; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; GAL TRANSPORTER	SLC35A3 is considered the main UDP-N-acetylglucosamine transporter (NGT) in mammals. Detailed analysis of NGT is restricted because mammalian mutant cells defective in this activity have not been isolated. Therefore, using the siRNA approach, we developed and characterized several NGT-deficient mammalian cell lines. CHO, CHO-Lec8, and HeLa cells deficient in NGT activity displayed a decrease in the amount of highly branched tri- and tetraantennary N-glycans, whereas monoantennary and diantennary ones remained unchanged or even were accumulated. Silencing the expression of NGT in Madin-Darby canine kidney II cells resulted in a dramatic decrease in the keratan sulfate content, whereas no changes in biosynthesis of heparan sulfate were observed. We also demonstrated for the first time close proximity between NGT and mannosyl (-1,6-)-glycoprotein -1,6-N-acetylglucosaminyltransferase (Mgat5) in the Golgi membrane. We conclude that NGT may be important for the biosynthesis of highly branched, multiantennary complex N-glycans and keratan sulfate. We hypothesize that NGT may specifically supply -1,3-N-acetylglucosaminyl-transferase 7 (3GnT7), Mgat5, and possibly mannosyl (-1,3-)-glycoprotein -1,4-N-acetylglucosaminyltransferase (Mgat4) with UDP-GlcNAc.	[Maszczak-Seneczko, Dorota; Sosicka, Paulina; Olczak, Teresa; Olczak, Mariusz] Univ Wroclaw, Lab Biochem, Fac Biotechnol, PL-50137 Wroclaw, Poland; [Jakimowicz, Piotr] Univ Wroclaw, Lab Biotechnol, Fac Biotechnol, PL-50137 Wroclaw, Poland; [Majkowski, Michal] Univ Wroclaw, Lab Cytobiochem, Fac Biotechnol, PL-51148 Wroclaw, Poland	University of Wroclaw; University of Wroclaw; University of Wroclaw	Olczak, M (corresponding author), Univ Wroclaw, Lab Biochem, Fac Biotechnol, 2 Tamka St, PL-50137 Wroclaw, Poland.	Mariusz.Olczak@biotech.uni.wroc.pl			National Science Center (NCN), Krakow, Poland [2011/03/B/NZ1/02084]	National Science Center (NCN), Krakow, Poland	This work was supported by Grant 2011/03/B/NZ1/02084 from the National Science Center (NCN), Krakow, Poland.	BRANDLI AW, 1988, J BIOL CHEM, V263, P16283; BRILES EB, 1977, J BIOL CHEM, V252, P1107; Caffaro CE, 2006, ACCOUNTS CHEM RES, V39, P805, DOI 10.1021/ar0400239; COATES SW, 1980, J BIOL CHEM, V255, P9225; Eckhardt M, 1999, J BIOL CHEM, V274, P8779, DOI 10.1074/jbc.274.13.8779; Gao XD, 2000, J BIOL CHEM, V275, P17718, DOI 10.1074/jbc.M909946199; Gerardy-Schahn R, 2001, BIOCHIMIE, V83, P775, DOI 10.1016/S0300-9084(01)01322-0; Guillen E, 1998, P NATL ACAD SCI USA, V95, P7888, DOI 10.1073/pnas.95.14.7888; HARA T, 1989, J BIOCHEM-TOKYO, V106, P236, DOI 10.1093/oxfordjournals.jbchem.a122838; Hong KJ, 2000, BIOCHEMISTRY-US, V39, P2013, DOI 10.1021/bi992363l; Ishida N, 1996, J BIOCHEM, V120, P1074; Ishida N, 1999, J BIOCHEM, V126, P1107, DOI 10.1093/oxfordjournals.jbchem.a022556; Ishida N, 2005, GENOMICS, V85, P106, DOI 10.1016/j.ygeno.2004.09.010; Ishida N, 1999, J BIOCHEM, V126, P68, DOI 10.1093/oxfordjournals.jbchem.a022437; Kitayama K, 2007, J BIOL CHEM, V282, P30085, DOI 10.1074/jbc.M703695200; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Liu L, 2010, SEMIN CELL DEV BIOL, V21, P600, DOI 10.1016/j.semcdb.2010.02.002; Martinez-Duncker I, 2003, BIOCHIMIE, V85, P245, DOI 10.1016/S0300-9084(03)00046-4; Maszczak-Seneczko D, 2012, FEBS LETT, V586, P4082, DOI 10.1016/j.febslet.2012.10.016; Maszczak-Seneczko D, 2011, ACTA BIOCHIM POL, V58, P413; Maszczak-Seneczko D, 2011, GLYCOCONJUGATE J, V28, P481, DOI 10.1007/s10719-011-9348-z; Maszczak-Seneczko D, 2011, FEBS LETT, V585, P3090, DOI 10.1016/j.febslet.2011.08.038; Miera N, 1996, J BIOCHEM-TOKYO, V120, P236; Munster AK, 1998, P NATL ACAD SCI USA, V95, P9140, DOI 10.1073/pnas.95.16.9140; Muraoka M, 2001, FEBS LETT, V495, P87, DOI 10.1016/S0014-5793(01)02358-4; Oelmann S, 2001, J BIOL CHEM, V276, P26291, DOI 10.1074/jbc.M011124200; Olczak M, 2006, BBA-MOL CELL RES, V1763, P82, DOI 10.1016/j.bbamcr.2005.12.006; Olczak M, 2002, BIOCHEM BIOPH RES CO, V293, P213, DOI 10.1016/S0006-291X(02)00201-2; Olczak M, 2013, BIOCHEM BIOPH RES CO, V434, P473, DOI 10.1016/j.bbrc.2013.03.098; Puglielli L, 1999, J BIOL CHEM, V274, P35596, DOI 10.1074/jbc.274.50.35596; Puglielli L, 1999, J BIOL CHEM, V274, P4474, DOI 10.1074/jbc.274.7.4474; Sprong H, 2003, MOL BIOL CELL, V14, DOI 10.1091/mbc.E03-03-0130; STANLEY P, 1983, SOMAT CELL GENET, V9, P593, DOI 10.1007/BF01574260; Suda T, 2004, J BIOL CHEM, V279, P26469, DOI 10.1074/jbc.M311353200; Thomsen B, 2006, GENOME RES, V16, P97, DOI 10.1101/gr.3690506; Toma L, 1996, J BIOL CHEM, V271, P3897; Yoshioka S, 1997, J BIOCHEM, V122, P691	38	38	38	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21850	10.1074/jbc.M113.460543	http://dx.doi.org/10.1074/jbc.M113.460543			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23766508	Green Published, hybrid			2022-12-25	WOS:000328841900034
J	Eusebio, N; Pinheiro, T; Amorim, AA; Gamboa, F; Saraiva, L; Gusmao, L; Amorim, A; Araujo, R				Eusebio, Nadia; Pinheiro, Tiago; Amorim, Adelina A.; Gamboa, Fernanda; Saraiva, Lucilia; Gusmao, Leonor; Amorim, Antonio; Araujo, Ricardo			SNaPaer. A Practical Single Nucleotide Polymorphism Multiplex Assay for Genotyping of Pseudomonas aeruginosa	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; PRIMER-EXTENSION ASSAY; CLOSTRIDIUM-DIFFICILE; POPULATION-STRUCTURE; NITRATE-RESPIRATION; PCR ASSAYS; IDENTIFICATION; BACTERIA; CLONES; EVOLUTION	Multilocus sequence typing (MLST) represents the gold standard genotyping method in studies concerning microbial population structure, being particularly helpful in the detection of clonal relatedness. However, its applicability on large-scale genotyping is limited due to the high cost and time spent on the task. The selection of the most informative nucleotide positions simplifies genomic characterization of bacteria. A simple and informative multiplex, SNaPaer assay, was developed and genotyping of Pseudomonas aeruginosa was obtained after a single reaction of multiplex PCR amplification and mini-sequencing. This cost-effective technique allowed the analysis of a Portuguese set of isolates (n = 111) collected from three distinct hospitals and the genotyping data could be obtained in less than six hours. Point mutations were shown to be the most frequent event responsible for diversification of the Portuguese population sample. The Portuguese isolates corroborated the epidemic hypothesis for P. aeruginosa population. SNaPaer genotyping assay provided a discriminatory power of 0.9993 for P. aeruginosa, by testing in silico several hundreds of MLST profiles available online. The newly proposed assay targets less than 0.01% of the total MLST length and guarantees reproducibility, unambiguous analysis and the possibility of comparing and transferring data between different laboratories. The plasticity of the method still supports the addition of extra molecular markers targeting specific purposes/populations. SNaPaer can be of great value to clinical laboratories by facilitating routine genotyping of P. aeruginosa.	[Eusebio, Nadia; Pinheiro, Tiago; Gusmao, Leonor; Amorim, Antonio; Araujo, Ricardo] Univ Porto, Inst Mol Pathol & Immunol, IPATIMUP, P-4100 Oporto, Portugal; [Eusebio, Nadia; Amorim, Antonio; Araujo, Ricardo] Univ Porto, Fac Sci, P-4100 Oporto, Portugal; [Amorim, Adelina A.] Univ Porto, Fac Med, Dept Pneumol, P-4100 Oporto, Portugal; [Amorim, Adelina A.] Hosp Sao Joao, Oporto, Portugal; [Gamboa, Fernanda] Hosp Univ Coimbra CHUC, EPE, Serv Pneumol, Coimbra, Portugal; [Saraiva, Lucilia] Univ Porto, Fac Farm, Dept Ciencias Biol, REQUIMTE,Lab Microbiol, P-4100 Oporto, Portugal; [Gusmao, Leonor] Fed Univ Para, Med & Human Genet Lab, BR-66059 Belem, Para, Brazil	Universidade do Porto; Universidade do Porto; Universidade do Porto; Sao Joao Hospital; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade do Porto; Universidade Federal do Para	Araujo, R (corresponding author), Univ Porto, Inst Mol Pathol & Immunol, IPATIMUP, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	ricjparaujo@yahoo.com	Gusmão, Leonor/L-8931-2019; Gusmao, Leonor/B-3122-2013; Amorim, Antonio/A-7938-2008; Araujo, Ricardo/H-2297-2018; Saraiva, Lucília/D-4897-2013; Araujo, Ricardo/C-3908-2009	Gusmão, Leonor/0000-0003-0432-6481; Gusmao, Leonor/0000-0003-0432-6481; Amorim, Antonio/0000-0002-7518-6247; Araujo, Ricardo/0000-0001-7382-4834; Saraiva, Lucília/0000-0002-9531-4939; Amorim, Adelina/0000-0003-0357-8900; Eusebio, Nadia/0000-0003-2653-8370	Fundacao Calouste Gulbenkian [35-9924-S/2009]; REQUIMTE [PEst-C/EQB/LA0006/2011]; University of Porto; Santander Totta; Fundacao para a Ciencia e a Tecnologia (FCT) Ciencia; European Social Fund; CAPES/Brazil; FCT	Fundacao Calouste Gulbenkian(European Commission); REQUIMTE; University of Porto; Santander Totta; Fundacao para a Ciencia e a Tecnologia (FCT) Ciencia; European Social Fund(European Social Fund (ESF)); CAPES/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by grants from Fundacao Calouste Gulbenkian (no. 35-9924-S/2009), REQUIMTE (PEst-C/EQB/LA0006/2011), University of Porto and Santander Totta. RA is supported by Fundacao para a Ciencia e a Tecnologia (FCT) Ciencia 2007 and by the European Social Fund. LG is supported by an Invited Professor grant from CAPES/Brazil. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuj SN, 2011, CLIN MICROBIOL INFEC, V17, P1403, DOI 10.1111/j.1469-0691.2010.03439.x; Aydin A, 2001, BIOTECHNIQUES, V31, P920, DOI 10.2144/01314rr03; Ben-Darif E, 2010, J CLIN MICROBIOL, V48, P1055, DOI 10.1128/JCM.01566-09; Boers SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039630; Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075; Cheng HR, 2006, BIOTECHNOL LETT, V28, P55, DOI 10.1007/s10529-005-4688-z; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Cuttelod M, 2011, CLIN MICROBIOL INFEC, V17, P57, DOI 10.1111/j.1469-0691.2010.03164.x; Dalmasso A, 2009, INT J FOOD MICROBIOL, V129, P21, DOI 10.1016/j.ijfoodmicro.2008.10.029; Evans SA, 1996, EUR RESPIR J, V9, P1601, DOI 10.1183/09031936.96.09081601; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FAVERO MS, 1971, SCIENCE, V173, P836, DOI 10.1126/science.173.3999.836; Feil EJ, 1999, MOL BIOL EVOL, V16, P1496, DOI 10.1093/oxfordjournals.molbev.a026061; Green DM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-140; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Hansen SK, 2012, ISME J, V6, P31, DOI 10.1038/ismej.2011.83; HIGASHI T, 1960, J BIOCHEM-TOKYO, V47, P326, DOI 10.1093/oxfordjournals.jbchem.a127070; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jones AM, 2001, LANCET, V358, P557, DOI 10.1016/S0140-6736(01)05714-2; Kerem Eitan, 2005, J Cyst Fibros, V4, P7, DOI 10.1016/j.jcf.2004.12.002; Kidd TJ, 2011, J CLIN MICROBIOL, V49, P263, DOI 10.1128/JCM.01421-10; Lemee L, 2004, J CLIN MICROBIOL, V42, P2609, DOI 10.1128/JCM.42.6.2609-2617.2004; Lomonaco S, 2011, APPL ENVIRON MICROB, V77, P6290, DOI 10.1128/AEM.00429-11; Maatallah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025617; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Morales G, 2004, J BACTERIOL, V186, P4228, DOI 10.1128/JB.186.13.4228-4237.2004; Ou LJ, 2005, ELECTROPHORESIS, V26, P99, DOI 10.1002/elps.200406177; Pirnay JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007740; Pollack M., 2000, PRINCIPLES PRACTICE; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Rozen S, 2000, Methods Mol Biol, V132, P365; Schreiber K, 2007, J BACTERIOL, V189, P4310, DOI 10.1128/JB.00240-07; Scott FW, 2004, J MED MICROBIOL, V53, P609, DOI 10.1099/jmm.0.45620-0; SELANDER RK, 1990, INFECT IMMUN, V58, P1891, DOI 10.1128/IAI.58.6.1891-1901.1990; Stuart B, 2010, PAEDIATR RESPIR REV, V11, P177, DOI 10.1016/j.prrv.2010.05.003; Syrmis MW, 2004, J MED MICROBIOL, V53, P1089, DOI 10.1099/jmm.0.45611-0; Vallone PM, 2004, BIOTECHNIQUES, V37, P226, DOI 10.2144/04372ST03; Vernez I, 2005, FEMS IMMUNOL MED MIC, V43, P29, DOI 10.1016/j.femsim.2004.06.024; Vezenegho SB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-282; Vonberg RP, 2005, INFECT CONT HOSP EP, V26, P401, DOI 10.1086/502558; Waters V, 2012, EUR J CLIN MICROBIOL, P1; Woo PCY, 2011, DIAGN MICR INFEC DIS, V70, P316, DOI 10.1016/j.diagmicrobio.2011.03.006	44	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66083	10.1371/journal.pone.0066083	http://dx.doi.org/10.1371/journal.pone.0066083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776608	Green Published, Green Submitted, gold			2022-12-25	WOS:000320322400077
J	Lambert, AE; Smyth, FL; Beadel, JR; Teachman, BA				Lambert, Ann E.; Smyth, Frederick L.; Beadel, Jessica R.; Teachman, Bethany A.			Aging and Repeated Thought Suppression Success	PLOS ONE			English	Article							MINI-MENTAL-STATE; SELF-CONTROL; PREFRONTAL FUNCTION; EXECUTIVE FUNCTION; COGNITIVE CONTROL; AGE-DIFFERENCES; LIFE-SPAN; ATTENTION; RESOURCE; EMOTION	Intrusive thoughts and attempts to suppress them are common, but while suppression may be effective in the short-term, it can increase thought recurrence in the long-term. Because intentional suppression involves controlled processing, and many aspects of controlled processing decline with age, age differences in thought suppression outcomes may emerge, especially over repeated thought suppression attempts as cognitive resources are expended. Using multilevel modeling, we examined age differences in reactions to thought suppression attempts across four thought suppression sequences in 40 older and 42 younger adults. As expected, age differences were more prevalent during suppression than during free monitoring periods, with younger adults indicating longer, more frequent thought recurrences and greater suppression difficulty. Further, younger adults' thought suppression outcomes changed over time, while trajectories for older adults' were relatively stable. Results are discussed in terms of older adults' reduced thought recurrence, which was potentially afforded by age-related changes in reactive control and distractibility.	[Lambert, Ann E.; Smyth, Frederick L.; Beadel, Jessica R.; Teachman, Bethany A.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA	University of Virginia	Lambert, AE (corresponding author), Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA.	ael4n@hscmail.mcc.virginia.edu			National Institute on Aging (NIA) [R01AG033033]; NATIONAL INSTITUTE ON AGING [R01AG033033] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by a National Institute on Aging (NIA) R01AG033033 grant to BAT. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitz JS, 2001, CLIN PSYCHOL REV, V21, P683, DOI 10.1016/S0272-7358(00)00057-X; Balota D. A., 2000, OXFORD HDB MEMORY, P395, DOI DOI 10.1037/A0015086; Bauml K.-H., 2008, LEARNING MEMORY COMP, P195, DOI DOI 10.1016/B978-012370509-9.00155-8; Beadel JR, J ANXIETY D IN PRESS; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Blanchard-Fields F, 2004, J GERONTOL B-PSYCHOL, V59, pP261, DOI 10.1093/geronb/59.6.P261; BOWLES NL, 1994, PSYCHOL AGING, V9, P414, DOI 10.1037/0882-7974.9.3.414; Braver T. S., 2007, VARIATION WORKING ME, P76, DOI DOI 10.1093/ACPROF:OSO/9780195168648.003.0004; Brewin CR, 2002, BEHAV RES THER, V40, P923, DOI 10.1016/S0005-7967(01)00127-9; Campbell KL, 2010, PSYCHOL SCI, V21, P399, DOI 10.1177/0956797609359910; Carstensen LL, 2003, MOTIV EMOTION, V27, P103, DOI 10.1023/A:1024569803230; Cepeda NJ, 2001, DEV PSYCHOL, V37, P715, DOI 10.1037/0012-1649.37.5.715; Craik F. I., 1982, AGING COGNITIVE PROC, P191, DOI DOI 10.1007/978-1-4684-4178-9_11; Delis DC, 2001, D KEFS EXAMINERS MAN, DOI DOI 10.1037/T15082-000; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Erskine JAK, 2007, PERS INDIV DIFFER, V42, P1047, DOI 10.1016/j.paid.2006.09.016; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gailliot MT, 2007, J PERS SOC PSYCHOL, V92, P325, DOI 10.1037/0022-3514.92.2.325; Hasher L, 1999, ATTENTION PERFORM, V17, P653; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI [10.1016/S0079-7421(08)60041-9, DOI 10.1016/S0079-7421(08)60041-9]; HOWARD DV, 1986, J GERONTOL, V41, P195, DOI 10.1093/geronj/41.2.195; Kahneman D., 1973, ATTENTION EFFORT; Kim S, 2007, PSYCHON B REV, V14, P301, DOI 10.3758/BF03194068; Kray J, 2004, ACTA PSYCHOL, V115, P143, DOI 10.1016/j.actpsy.2003.12.001; Madden DJ, 2003, PSYCHOL AGING, V18, P54, DOI 10.1037/0882-7974.18.1.54; Magee JC, 2012, CLIN PSYCHOL REV, V32, P189, DOI 10.1016/j.cpr.2012.01.001; Magee JC, 2012, PSYCHOL AGING, V27, P199, DOI 10.1037/a0024249; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; McDaniel M. A., 2008, HDB AGING COGNITION, V3rd, P251, DOI DOI 10.1037/0278-7393.30.3.605; Mitchell JP, 2007, PSYCHOL SCI, V18, P292, DOI 10.1111/j.1467-9280.2007.01891.x; Muraven M, 2002, PSYCHOL ADDICT BEHAV, V16, P113, DOI 10.1037//0893-164X.16.2.113; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Paxton JL, 2008, CEREB CORTEX, V18, P1010, DOI 10.1093/cercor/bhm135; RACHMAN S, 1978, BEHAV RES THER, V16, P233, DOI 10.1016/0005-7967(78)90022-0; Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608; Reich DA, 2008, PERS SOC PSYCHOL B, V34, P706, DOI 10.1177/0146167207313732; Reuter-Lorenz PA, 2002, TRENDS COGN SCI, V6, P394, DOI 10.1016/S1364-6613(02)01957-5; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Richter M, 2008, PSYCHOPHYSIOLOGY, V45, P869, DOI 10.1111/j.1469-8986.2008.00688.x; Romine CB, 2005, APPL NEUROPSYCHOL, V12, P190, DOI 10.1207/s15324826an1204_2; SALKOVSKIS PM, 1984, BEHAV RES THER, V22, P549, DOI 10.1016/0005-7967(84)90057-3; SALTHOUSE TA, 1988, DEV REV, V8, P238, DOI 10.1016/0273-2297(88)90006-8; Shunk AW, 2006, APPL NEUROPSYCHOLOGY, V13; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Thomas RC, 2012, J EXP PSYCHOL LEARN, V38, P30, DOI 10.1037/a0024882; Thorpe S.J., 1997, PHOBIAS HDB THEORY R, P81; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Verhaeghen P, 1997, PSYCHOL BULL, V122, P231, DOI 10.1037/0033-2909.122.3.231; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WEGNER DM, 1987, J PERS SOC PSYCHOL, V53, P5, DOI 10.1037/0022-3514.53.1.5; WEGNER DM, 1994, PSYCHOL REV, V101, P34, DOI 10.1037/0033-295X.101.1.34; WEGNER DM, 1994, J PERS, V62, P615, DOI 10.1111/j.1467-6494.1994.tb00311.x; Wenzlaff EM, 2000, ANNU REV PSYCHOL, V51, P59, DOI 10.1146/annurev.psych.51.1.59; Wenzlaff RM, 2003, COGNITIVE THER RES, V27, P293, DOI 10.1023/A:1023966400540; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Wyland CL, 2003, NEUROPSYCHOLOGIA, V41, P1863, DOI 10.1016/j.neuropsychologia.2003.08.001; Zelazo PD, 2004, ACTA PSYCHOL, V115, P167, DOI 10.1016/j.actpsy.2003.12.005	58	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65009	10.1371/journal.pone.0065009	http://dx.doi.org/10.1371/journal.pone.0065009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163FW	23776442	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400005
J	Radulovic, K; Rossini, V; Manta, C; Holzmann, K; Kestler, HA; Niess, JH				Radulovic, Katarina; Rossini, Valerio; Manta, Calin; Holzmann, Karlheinz; Kestler, Hans A.; Niess, Jan Hendrik			The Early Activation Marker CD69 Regulates the Expression of Chemokines and CD4 T Cell Accumulation in Intestine	PLOS ONE			English	Article							GENE-DEFICIENT MICE; DENDRITIC CELLS; LYMPHOCYTE EGRESS; CUTTING EDGE; INFLAMMATORY CONDITIONS; IMMUNE-RESPONSES; LAMINA PROPRIA; GUT; COLITIS; PROTECTION	Migration of naive and activated lymphocytes is regulated by the expression of various molecules such as chemokine receptors and ligands. CD69, the early activation marker of C-type lectin domain family, is also shown to regulate the lymphocyte migration by affecting their egress from the thymus and secondary lymphoid organs. Here, we aimed to investigate the role of CD69 in accumulation of CD4 T cells in intestine using murine models of inflammatory bowel disease. We found that genetic deletion of CD69 in mice increases the expression of the chemokines CCL-1, CXCL-10 and CCL-19 in CD4(+) T cells and/or CD4 2 cells. Efficient in vitro migration of CD69-deficient CD4 T cells toward the chemokine stimuli was the result of increased expression and/or affinity of chemokine receptors. In vivo CD69(-/-) CD4 T cells accumulate in the intestine in higher numbers than B6 CD4 T cells as observed in competitive homing assay, dextran sodium sulphate (DSS)-induced colitis and antigen-specific transfer colitis. In DSS colitis CD69(-/-) CD4 T cell accumulation in colonic lamina propria (cLP) was associated with increased expression of CCL-1, CXCL-10 and CCL-19 genes. Furthermore, treatment of DSS-administrated CD69(-/-) mice with the mixture of CCL-1, CXCL-10 and CCL-19 neutralizing Abs significantly decreased the histopathological signs of colitis. Transfer of OT-II6CD69(-/-) CD45RB(high) CD4 T cells into RAG(-/-) hosts induced CD4 T cell accumulation in cLP. This study showed CD69 as negative regulator of inflammatory responses in intestine as it decreases the expression of chemotactic receptors and ligands and reduces the accumulation of CD4 T cells in cLP during colitis.	[Radulovic, Katarina; Rossini, Valerio; Manta, Calin; Niess, Jan Hendrik] Univ Ulm, Dept Internal Med, D-89069 Ulm, Germany; [Radulovic, Katarina] Univ Ulm, Inst Microbiol & Biotechnol, D-89069 Ulm, Germany; [Holzmann, Karlheinz] Univ Ulm, Microarray Core Facil, D-89069 Ulm, Germany; [Kestler, Hans A.] Univ Ulm, Res Grp Bioinformat & Syst Biol, Inst Neural Informat Proc, D-89069 Ulm, Germany; [Niess, Jan Hendrik] Univ Bern, Inselspital, Dept Visceral Surg & Med, CH-3010 Bern, Switzerland	Ulm University; Ulm University; Ulm University; Ulm University; University of Bern; University Hospital of Bern	Radulovic, K (corresponding author), Univ Ulm, Dept Internal Med, D-89069 Ulm, Germany.	katarina.radulovic@uni-ulm.de	Kestler, Hans A./D-5799-2012; Niess, Jan/E-8361-2017; Rossini, Valerio/AAH-1338-2020	Kestler, Hans A./0000-0002-4759-5254; Niess, Jan/0000-0001-6902-5650; Rossini, Valerio/0000-0003-2792-0360	Deutsche Forschungsgemeinschaft (DFG) [Ni575/6-2, Ni575/7-1]; International Graduate School of Molecular Medicine of Ulm University [GSC270]; European Mucosal Immunology Group (EMIG); German Gastroenterology Association (DGVS)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); International Graduate School of Molecular Medicine of Ulm University; European Mucosal Immunology Group (EMIG); German Gastroenterology Association (DGVS)	This work was supported by grants Ni575/6-2 and Ni575/7-1 from the Deutsche Forschungsgemeinschaft (DFG) to J.H.N., the International Graduate School of Molecular Medicine of Ulm University (GSC270) to V. R. and a young investigator travel awards to K. R. by the European Mucosal Immunology Group (EMIG) and by the German Gastroenterology Association (DGVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; Bromley SK, 2013, J IMMUNOL, V190, P970, DOI 10.4049/jimmunol.1202805; Casazza JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000646; Cassani B, 2011, GASTROENTEROLOGY, V141, P2109, DOI 10.1053/j.gastro.2011.09.015; Cauley LS, 2013, MUCOSAL IMMUNOL, V6, P14, DOI 10.1038/mi.2012.96; Cauley LS, 2002, J IMMUNOL, V169, P6655, DOI 10.4049/jimmunol.169.12.6655; CLARK MA, 1993, J HISTOCHEM CYTOCHEM, V41, P1679, DOI 10.1177/41.11.7691933; Cruz-Adalia A, 2010, CIRCULATION, V122, P1396, DOI 10.1161/CIRCULATIONAHA.110.952820; De Calisto J, 2011, METHODS MOL BIOL, V757, P411, DOI 10.1007/978-1-61779-166-6_24; Deguchi Y, 2006, ONCOL REP, V16, P699; Elgueta R, 2008, J IMMUNOL, V180, P6501, DOI 10.4049/jimmunol.180.10.6501; Esplugues E, 2005, BLOOD, V105, P4399, DOI 10.1182/blood-2004-10-3854; Esplugues E, 2003, J EXP MED, V197, P1093, DOI 10.1084/jem.20021337; Feng CG, 2002, INT IMMUNOL, V14, P535, DOI 10.1093/intimm/dxf020; Grigorova IL, 2010, P NATL ACAD SCI USA, V107, P20447, DOI 10.1073/pnas.1009968107; Grigorova IL, 2009, NAT IMMUNOL, V10, P58, DOI 10.1038/ni.1682; Hammerschmidt SI, 2011, J CLIN INVEST, V121, P3051, DOI 10.1172/JCI44262; Han YM, 2009, J IMMUNOL, V182, P111, DOI 10.4049/jimmunol.182.1.111; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Lamana A, 2011, J INVEST DERMATOL, V131, P1503, DOI 10.1038/jid.2011.54; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lu SY, 2012, CLIN TRANSPLANT, V26, pE158, DOI 10.1111/j.1399-0012.2012.01630.x; Mackay CR, 2008, NAT IMMUNOL, V9, P988, DOI 10.1038/ni.f.210; Martin P, 2010, MOL CELL BIOL, V30, P4877, DOI 10.1128/MCB.00456-10; Martin P, 2010, J ALLERGY CLIN IMMUN, V126, P355, DOI 10.1016/j.jaci.2010.05.010; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McLoughlin RM, 2006, P NATL ACAD SCI USA, V103, P10408, DOI 10.1073/pnas.0508961103; Miki-Hosokawa T, 2009, J IMMUNOL, V183, P8203, DOI 10.4049/jimmunol.0900646; Mizushima T, 2004, INFLAMM BOWEL DIS, V10, P182, DOI 10.1097/00054725-200405000-00002; Mora JR, 2008, INFLAMM BOWEL DIS, V14, P275, DOI 10.1002/ibd.20280; Murata K, 2003, INT IMMUNOL, V15, P987, DOI 10.1093/intimm/dxg102; Nakayama T, 2002, J IMMUNOL, V168, P87, DOI 10.4049/jimmunol.168.1.87; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; Niess JH, 2008, J IMMUNOL, V180, P559, DOI 10.4049/jimmunol.180.1.559; Niess JH, 2010, J IMMUNOL, V184, P2026, DOI 10.4049/jimmunol.0901936; Radulovic K, 2012, J IMMUNOL, V188, P2001, DOI 10.4049/jimmunol.1100765; Roman E, 2010, J IMMUNOL, V185, P3819, DOI 10.4049/jimmunol.0900665; Sanada Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023933; Sancho D, 2003, J CLIN INVEST, V112, P872, DOI 10.1172/JCI200319112; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Soler D, 2006, J IMMUNOL, V177, P6940, DOI 10.4049/jimmunol.177.10.6940; Song J, 2008, J PHARMACOL EXP THER, V324, P276, DOI 10.1124/jpet.106.119172; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Vega-Ramos J, 2010, IMMUNOL CELL BIOL, V88, P707, DOI 10.1038/icb.2010.62; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wang C, 2009, MUCOSAL IMMUNOL, V2, P173, DOI 10.1038/mi.2008.84; Wurbel MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016442; Yuan YH, 2001, INFLAMM BOWEL DIS, V7, P281, DOI 10.1097/00054725-200111000-00001; Zhao QY, 2012, J IMMUNOL, V188, P1117, DOI 10.4049/jimmunol.1100164	50	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65413	10.1371/journal.pone.0065413	http://dx.doi.org/10.1371/journal.pone.0065413			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776480	Green Published, Green Submitted, gold			2022-12-25	WOS:000320322400023
J	Shi, L; Yu, XM; Yang, HL; Wu, XY				Shi, Long; Yu, Xiaoming; Yang, Hongling; Wu, Xinyi			Advanced Glycation End Products Induce Human Corneal Epithelial Cells Apoptosis through Generation of Reactive Oxygen Species and Activation of JNK and p38 MAPK Pathways	PLOS ONE			English	Article							N-EPSILON-CARBOXYMETHYLLYSINE; OXIDATIVE STRESS; NADPH OXIDASE; IN-VITRO; RECEPTOR; RAGE; EXPRESSION; AGES; MECHANISMS; DISEASE	Advanced Glycation End Products (AGEs) has been implicated in the progression of diabetic keratopathy. However, details regarding their function are not well understood. In the present study, we investigated the effects of intracellular reactive oxygen species (ROS) and JNK, p38 MAPK on AGE-modified bovine serum albumin (BSA) induced Human telomerase-immortalized corneal epithelial cells (HUCLs) apoptosis. We found that AGE-BSA induced HUCLs apoptosis and increased Bax protein expression, decreased Bcl-2 protein expression. AGE-BSA also induced the expression of receptor for advanced glycation end product (RAGE). AGE-BSA-RAGE interaction induced intracellular ROS generation through activated NADPH oxidase and increased the phosphorylation of p47phox. AGE-BSA induced HUCLs apoptosis was inhibited by pretreatment with NADPH oxidase inhibitors, ROS quencher N-acetylcysteine (NAC) or neutralizing anti-RAGE antibodies. We also found that AGE-BSA induced JNK and p38 MAPK phosphorylation. JNK and p38 MAPK inhibitor effectively blocked AGE-BSA-induced HUCLs apoptosis. In addition, NAC completely blocked phosphorylation of JNK and p38 MAPK induced by AGE-BSA. Our results indicate that AGE-BSA induced HUCLs apoptosis through generation of intracellular ROS and activation of JNK and p38 MAPK pathways.	[Shi, Long; Yu, Xiaoming; Yang, Hongling; Wu, Xinyi] Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan 250100, Peoples R China; [Shi, Long; Yu, Xiaoming] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Peoples R China; [Shi, Long; Yu, Xiaoming] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Wu, XY (corresponding author), Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan 250100, Peoples R China.	xywu8868@163.com			Education Ministry Fund of China [20070422081]; Natural Science Foundation of Shandong Province, China [2007GG20002031]	Education Ministry Fund of China; Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province)	This work was supported by the Education Ministry Fund of China (No. 20070422081) and Natural Science Foundation of Shandong Province, China (No. 2007GG20002031). The URL of the Education Ministry Fund of China website: http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm. The URL of Natural Science Foundation of Shandong Province website: http://jihlx.sdstc.gov.cn/stdpms/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Azayzih A, 2012, BIOCHEM BIOPH RES CO, V427, P165, DOI 10.1016/j.bbrc.2012.09.035; Alikhani M, 2007, AM J PHYSIOL-CELL PH, V292, pC850, DOI 10.1152/ajpcell.00356.2006; Alikhani M, 2007, BONE, V40, P345, DOI 10.1016/j.bone.2006.09.011; Alves M, 2005, DIABETOLOGIA, V48, P2675, DOI 10.1007/s00125-005-0010-9; Barlovic DP, 2011, CLIN SCI, V121, P43, DOI 10.1042/CS20100501; Basta G, 2005, ARTERIOSCL THROM VAS, V25, P1401, DOI 10.1161/01.ATV.0000167522.48370.5e; Belambri SA, 2012, AM J BLOOD RES, V2, P187; Busch M, 2008, NEPHRON CLIN PRACT, V108, pC291, DOI 10.1159/000127838; Busch M, 2006, AM J KIDNEY DIS, V48, P571, DOI 10.1053/j.ajkd.2006.07.009; Chen LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046744; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; Guimaraes ELM, 2010, J HEPATOL, V52, P389, DOI 10.1016/j.jhep.2009.12.007; Gul M, 2008, CORNEA, V27, P795, DOI 10.1097/ICO.0b013e318169d67c; Guo WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046018; Hsu WH, 2007, ARCH TOXICOL, V81, P719, DOI 10.1007/s00204-006-0169-y; Huo YA, 2009, EXP EYE RES, V89, P876, DOI 10.1016/j.exer.2009.07.012; Ishibashi Y, 2012, METABOLISM, V61, P1067, DOI 10.1016/j.metabol.2012.01.006; Jendrysik MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028198; Kaji Y, 2000, INVEST OPHTH VIS SCI, V41, P362; Kim J, 2012, FREE RADICAL BIO MED, V53, P357, DOI 10.1016/j.freeradbiomed.2012.04.030; Kim J, 2011, J PHARM PHARMACOL, V63, P524, DOI 10.1111/j.2042-7158.2010.01206.x; Kim J, 2011, GRAEF ARCH CLIN EXP, V249, P529, DOI 10.1007/s00417-010-1573-9; Klenovics KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053056; Kumar A, 2006, MICROBES INFECT, V8, P380, DOI 10.1016/j.micinf.2005.07.006; Liu JP, 2012, PLANTA MED, V78, P1757, DOI 10.1055/s-0032-1315257; Liu Y, 2011, ANTIOXID REDOX SIGN, V15, P1769, DOI 10.1089/ars.2010.3764; Malla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013731; Niiya Y, 2012, J STROKE CEREBROVASC, V21, P293, DOI 10.1016/j.jstrokecerebrovasdis.2010.09.002; Octavia Y, 2012, FREE RADICAL BIO MED, V52, P291, DOI 10.1016/j.freeradbiomed.2011.10.482; Park S, 2011, FRONT BIOSCI-LANDMRK, V16, P486, DOI 10.2741/3700; Patel R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035143; Prasad A, 2012, CARDIOL REV, V20, P177, DOI 10.1097/CRD.0b013e318244e57c; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Riemann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022445; Schulze SD, 2006, AM J OPHTHALMOL, V142, P207, DOI 10.1016/j.ajo.2006.04.017; Sheikpranbabu S, 2011, DIABETES METAB, V37, P505, DOI 10.1016/j.diabet.2011.03.006; Shi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032128; Sorci G, 2013, BBA-MOL CELL RES, V1833, P101, DOI 10.1016/j.bbamcr.2012.10.021; Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004; Sukkar MB, 2012, BRIT J PHARMACOL, V167, P1161, DOI 10.1111/j.1476-5381.2012.01984.x; van Zoelen Marieke A D, 2011, Front Biosci (Schol Ed), V3, P1119; Xu KP, 2009, DIABETES, V58, P1077, DOI 10.2337/db08-0997; Xu KP, 2011, INVEST OPHTH VIS SCI, V52, P3301, DOI 10.1167/iovs.10-5670; Xue J, 2011, STRUCTURE, V19, P722, DOI 10.1016/j.str.2011.02.013; Yamagishi S, 2006, J BIOL CHEM, V281, P20213, DOI 10.1074/jbc.M602110200; Yamagishi S, 2011, CURR PHARM BIOTECHNO, V12, P362, DOI 10.2174/138920111794480534; Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148; Yan SF, 2008, NAT CLIN PRACT ENDOC, V4, P285, DOI 10.1038/ncpendmet0786; Yang QS, 2010, EUR J PHARMACOL, V649, P108, DOI 10.1016/j.ejphar.2010.09.025; Yin J, 2010, INVEST OPHTH VIS SCI, V51, P1891, DOI 10.1167/iovs.09-3904; Yuan HP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015726; Yucel I, 2006, CAN J OPHTHALMOL, V41, P60, DOI 10.1016/S0008-4182(06)80068-2; Zhan Y, 2012, MED SCI MONITOR, V18, pBR286, DOI 10.12659/MSM.883207; Zhao ZJ, 2010, MOL VIS, V16, P1576; Zong HL, 2011, CURR DIABETES REP, V11, P244, DOI 10.1007/s11892-011-0198-7; Zou CL, 2012, CORNEA, V31, P1455, DOI 10.1097/ICO.0b013e3182490907	57	77	83	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66781	10.1371/journal.pone.0066781	http://dx.doi.org/10.1371/journal.pone.0066781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776698	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400118
J	Shishido, SN; Prasain, K; Beck, A; Nguyen, TDT; Hua, DH; Nguyen, TA				Shishido, Stephanie N.; Prasain, Keshar; Beck, Amanda; Nguyen, Thi D. T.; Hua, Duy H.; Thu Annelise Nguyen			Bioavailability and Efficacy of a Gap Junction Enhancer (PQ7) in a Mouse Mammary Tumor Model	PLOS ONE			English	Article							INTERCELLULAR COMMUNICATION; GENE-THERAPY; SUBSTITUTED QUINOLINES; IN-VIVO; CANCER; INDUCTION; PHOSPHORYLATION; MODULATION; PROTEIN; INHIBITION	The loss of gap junctional intercellular communication is characteristic of neoplastic cells, suggesting that the restoration with a gap junction enhancer may be a new therapeutic treatment option with less detrimental effects than traditional antineoplastic drugs. A gap junction enhancer, 6-methoxy-8-[(2-furanylmethyl) amino]-4-methyl-5-(3-trifluoromethylphenyloxy) quinoline (PQ7), on the normal tissue was evaluated in healthy C57BL/6J mice in a systemic drug distribution study. Immunoblot analysis of the vital organs indicates a reduction in Cx43 expression in PQ7-treated animals with no observable change in morphology. Next the transgenic strain FVB/N-Tg(MMTV-PyVT) 634Mul/J (also known as PyVT) was used as a spontaneous mammary tumor mouse model to determine the biological and histological effects of PQ7 on tumorigenesis and metastasis at three stages of development: Pre tumor, Early tumor, and Late tumor formation. PQ7 was assessed to have a low toxicity through intraperitoneal administration, with the majority of the compound being detected in the heart, liver, and lungs six hours post injection. The treatment of tumor bearing animals with PQ7 had a 98% reduction in tumor growth, while also decreasing the total tumor burden compared to control mice during the Pre stage of development. PQ7 treatment increased Cx43 expression in the neoplastic tissue during Pre-tumor formation; however, this effect was not observed in Late stage tumor formation. This study shows that the gap junction enhancer, PQ7, has low toxicity to normal tissue in healthy C57BL/6J mice, while having clinical efficacy in the treatment of spontaneous mammary tumors of PyVT mice. Additionally, gap junctional intercellular communication and neoplastic cellular growth are shown to be inversely related, while treatment with PQ7 inhibits tumor growth through targeting gap junction expression.	[Shishido, Stephanie N.; Beck, Amanda; Thu Annelise Nguyen] Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA; [Prasain, Keshar; Nguyen, Thi D. T.; Hua, Duy H.] Kansas State Univ, Dept Chem, Manhattan, KS 66506 USA	Kansas State University; Kansas State University	Nguyen, TA (corresponding author), Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.	tnguyen@vet.ksu-edu	Beck, Amanda P/H-9573-2017	Beck, Amanda P/0000-0003-1867-4110	National Institute of Health [P30RR030926, 1R15CA152922]; NATIONAL CANCER INSTITUTE [R15CA152922] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P30RR030926] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors would like to thank the financial support of National Institute of Health, P30RR030926 and 1R15CA152922. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au JLS, 2001, J CONTROL RELEASE, V74, P31, DOI 10.1016/S0168-3659(01)00308-X; Banerjee D, 2010, INT J CANCER, V127, P839, DOI 10.1002/ijc.25107; BUDUNOVA IV, 1994, CELL BIOL TOXICOL, V10, P71, DOI 10.1007/BF00756491; Burr DB, 2011, EXP EYE RES, V92, P251, DOI 10.1016/j.exer.2011.02.003; Carystinos GD, 1999, CLIN CANCER RES, V5, P61; Ding Y, 2012, ANTI-CANCER DRUG, V23, P897, DOI 10.1097/CAD.0b013e328354ac71; Gakhar G, 2008, DRUG DEVELOP RES, V69, P526, DOI 10.1002/ddr.20281; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hawat G, 2008, PFLUG ARCH EUR J PHY, V456, P519, DOI 10.1007/s00424-007-0426-9; Heiniger B, 2010, ANTICANCER RES, V30, P3927; Huang RP, 2001, INT J CANCER, V92, P130, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1165>3.3.CO;2-7; KLAUNIG JE, 1990, LAB INVEST, V62, P135; Kunishige I, 1998, ANTICANCER RES, V18, P3411; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu JL, 2011, J BIOL CHEM, V286, P16914, DOI 10.1074/jbc.M111.218735; Maglione JE, 2001, CANCER RES, V61, P8298; Mesnil M, 2005, BBA-BIOMEMBRANES, V1719, P125, DOI 10.1016/j.bbamem.2005.11.004; MUSIL LS, 1991, J CELL BIOL, V115, P1357, DOI 10.1083/jcb.115.5.1357; Nagasawa H, 1999, RADIAT RES, V152, P552, DOI 10.2307/3580153; Park JY, 1997, GENE THER, V4, P909, DOI 10.1038/sj.gt.3300477; PITOT HC, 1994, DRUG METAB REV, V26, P209, DOI 10.3109/03602539409029792; Robe PA, 2000, BIOCHEM PHARMACOL, V60, P241, DOI 10.1016/S0006-2952(00)00315-4; Rosenkranz HS, 2000, CARCINOGENESIS, V21, P1007, DOI 10.1093/carcin/21.5.1007; Saunders MM, 2001, CANCER RES, V61, P1765; Shi AB, 2008, BIOORG MED CHEM LETT, V18, P3364, DOI 10.1016/j.bmcl.2008.04.024; Shishido SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044963; Tanaka M, 2001, HUM GENE THER, V12, P2225, DOI 10.1089/10430340152710568; Touraine RL, 1998, HUM GENE THER, V9, P2385, DOI 10.1089/hum.1998.9.16-2385; Trosko James E., 1998, Frontiers in Bioscience, V3, pD208; Upham BL, 1998, ENVIRON HEALTH PERSP, V106, P975, DOI 10.2307/3434140; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Zhou HN, 2000, P NATL ACAD SCI USA, V97, P2099, DOI 10.1073/pnas.030420797	33	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e67174	10.1371/journal.pone.0067174	http://dx.doi.org/10.1371/journal.pone.0067174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776708	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400124
J	Solomon, AJ; Hills, W; Chen, ZQ; Rosenbaum, J; Bourdette, D; Whitham, R				Solomon, Andrew J.; Hills, William; Chen, Zunqiu; Rosenbaum, James; Bourdette, Dennis; Whitham, Ruth			Autoantibodies and Sjogren's Syndrome in Multiple Sclerosis, a Reappraisal	PLOS ONE			English	Article							ANTICARDIOLIPIN ANTIBODIES; ANTINUCLEAR ANTIBODIES; ANTIPHOSPHOLIPID ANTIBODIES; FOLLOW-UP; CLINICAL-SIGNIFICANCE; NEUROMYELITIS-OPTICA; DIAGNOSTIC-CRITERIA; PREVALENCE; DISEASES; FREQUENCY	Background: Rheumatologic diseases may cause neurologic disorders that mimic multiple sclerosis (MS). A panel of serum autoantibodies is often obtained as part of the evaluation of patients suspected of having MS. Objectives: To determine, in light of recently revised diagnostic criteria for MS, neuromyelitis optica, and Sjogren's Syndrome, if testing for autoantibodies in patients with a confirmed diagnosis of MS would reveal a frequency or demonstrate a clinical utility divergent from previous reports or lead to identification of undiagnosed cases of Sjogren's Syndrome. Methods: Convenience sample cross-sectional study of MS patients recruited from the OHSU Multiple Sclerosis Center. Results: Autoantibodies were detected in 38% (35/91) of patients with MS and were not significantly associated with disease characteristics or severity. While four patients had SSA antibodies, none met diagnostic criteria for Sjogren's Syndrome. Conclusions: Rheumatologic autoantibodies are frequently found in MS patients and are not associated with disease severity or systemic rheumatologic disease. Our demonstration of the low specificity of these autoantibodies suggests that the diagnostic utility and cost-effectiveness of testing is not supported when there is strong clinical suspicion of MS and low clinical suspicion of rheumatologic disease.	[Solomon, Andrew J.] Univ Vermont, Dept Neurol Sci, Coll Med, Burlington, VT 05405 USA; [Hills, William; Rosenbaum, James] Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA; [Chen, Zunqiu] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Rosenbaum, James] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Rosenbaum, James] Oregon Hlth & Sci Univ, Dept Cell Biol, Portland, OR 97201 USA; [Hills, William; Bourdette, Dennis; Whitham, Ruth] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Bourdette, Dennis; Whitham, Ruth] Portland VA Med Ctr, MS Ctr Excellence West, Portland, OR USA	University of Vermont; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center	Solomon, AJ (corresponding author), Univ Vermont, Dept Neurol Sci, Coll Med, Burlington, VT 05405 USA.	andrew.solomon@uvm.edu			Partners Multiple Sclerosis Fellowship Award; Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000128] Funding Source: NIH RePORTER	Partners Multiple Sclerosis Fellowship Award; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was funded by the Partners Multiple Sclerosis Fellowship Award and the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNED S, 1995, NEUROLOGY, V45, P384, DOI 10.1212/WNL.45.2.384; Bowen J, 2001, MULT SCLER, V7, P201, DOI 10.1191/135245801678438447; Chapman J, 2004, THROMB RES, V114, P477, DOI 10.1016/j.thromres.2004.06.016; Ciccarelli O, 2000, MULT SCLER J, V6, P137; Collard RC, 1997, NEUROLOGY, V49, P857, DOI 10.1212/WNL.49.3.857; D'Olhaberriague L, 1998, NEUROLOGY, V51, P1376, DOI 10.1212/WNL.51.5.1376; de Andres C, 2001, ACTA NEUROL SCAND, V104, P83, DOI 10.1034/j.1600-0404.2001.104002083.x; de Seze J, 2001, NEUROLOGY, V57, P1359, DOI 10.1212/WNL.57.8.1359; DEKEYSER J, 1988, NEUROLOGY, V38, P371; Delalande S, 2004, MEDICINE, V83, P280, DOI 10.1097/01.md.0000141099.53742.16; DOREDUFFY P, 1982, ARCH NEUROL-CHICAGO, V39, P504, DOI 10.1001/archneur.1982.00510200046008; Garg N, 2007, J NEUROIMMUNOL, V187, P159, DOI 10.1016/j.jneuroim.2007.04.008; Heinzlef O, 2002, J NEUROL NEUROSUR PS, V72, P647, DOI 10.1136/jnnp.72.5.647; Karussis D, 1998, ANN NEUROL, V44, P629, DOI 10.1002/ana.410440408; Liedorp M, 2007, J NEUROL NEUROSUR PS, V78, P1146, DOI 10.1136/jnnp.2007.117713; Miller DH, 2008, MULT SCLER J, V14, P1157, DOI 10.1177/1352458508096878; NOSEWORTHY JH, 1989, ANN NEUROL, V25, P95, DOI 10.1002/ana.410250117; Pericot I, 2003, MULT SCLER, V9, P256, DOI 10.1191/1352458503ms905oa; Petri M, 2000, J AUTOIMMUN, V15, P145, DOI 10.1006/jaut.2000.0409; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Roussel V, 2000, J AUTOIMMUN, V14, P259, DOI 10.1006/jaut.2000.0367; Sanchez-Guerrero J, 2006, J RHEUMATOL, V33, P907; SANDBERGWOLLHEIM M, 1992, NEUROLOGY, V42, P845, DOI 10.1212/WNL.42.4.845; Sastre-Garriga J, 2001, ANN NEUROL, V49, P408, DOI 10.1002/ana.81; SEYFERT S, 1990, ACTA NEUROL SCAND, V81, P37; SHI W, 1990, AUST NZ J MED, V20, P231, DOI 10.1111/j.1445-5994.1990.tb01025.x; Spadaro M, 1999, MULT SCLER, V5, P121, DOI 10.1191/135245899678847211; Stosic M, 2010, J NEUROL, V257, P63, DOI 10.1007/s00415-009-5264-6; Szmyrka-Kaczmarek M, 2012, LUPUS, V21, P412, DOI 10.1177/0961203311427550; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; Tourbah A, 1998, ARCH NEUROL-CHICAGO, V55, P517, DOI 10.1001/archneur.55.4.517; Verdun E, 2002, J INTERF CYTOK RES, V22, P245, DOI 10.1089/107999002753536220; VILA P, 1994, THROMB HAEMOSTASIS, V72, P209; Vilisaar J, 2005, MULT SCLER J, V11, P378, DOI 10.1191/1352458505ms1208oa; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2012, MULT SCLER J, V18, P5, DOI 10.1177/1352458511431077	38	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65385	10.1371/journal.pone.0065385	http://dx.doi.org/10.1371/journal.pone.0065385			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776474	Green Published, Green Submitted, gold			2022-12-25	WOS:000320322400019
J	Van Royen, K; Lachat, C; Holdsworth, M; Smit, K; Kinabo, J; Roberfroid, D; Nago, E; Orach, CG; Kolsteren, P				Van Royen, Kathleen; Lachat, Carl; Holdsworth, Michelle; Smit, Karlien; Kinabo, Joyce; Roberfroid, Dominique; Nago, Eunice; Orach, Christopher Garimoi; Kolsteren, Patrick			How Can the Operating Environment for Nutrition Research Be Improved in Sub-Saharan Africa? The Views of African Researchers	PLOS ONE			English	Article							PUBLIC-HEALTH NUTRITION; CHILD UNDERNUTRITION; DEVELOPING-COUNTRIES; PROGRESS	Optimal nutrition is critical for human development and economic growth. Sub-Saharan Africa is facing high levels of food insecurity and only few sub-Saharan African countries are on track to eradicate extreme poverty and hunger by 2015. Effective research capacity is crucial for addressing emerging challenges and designing appropriate mitigation strategies in sub-Saharan Africa. A clear understanding of the operating environment for nutrition research in sub-Saharan Africa is a much needed prerequisite. We collected data on the barriers and requirements for conducting nutrition research in sub-Saharan Africa through semi-structured interviews with 144 participants involved in nutrition research in 35 countries in sub-Saharan Africa. A total of 133 interviews were retained for coding. The main barriers identified for effective nutrition research were the lack of funding due to poor recognition by policymakers of the importance of nutrition research and under-utilisation of research findings for developing policy, as well as an absence of research priority setting from within Africa. Current research topics were perceived to be mainly determined by funding bodies from outside Africa. Nutrition researchers argued for more commitment from policymakers at national level. The low capacity for nutrition research was mainly seen as a consequence of insufficient numbers of nutrition researchers, limited skills and a poor research infrastructure. In conclusion, African nutrition researchers argued how research priorities need to be identified by African stakeholders, accompanied by consensus building to enable creating a problem-driven national research agenda. In addition, it was considered necessary to promote interactions among researchers, and between researchers and policymakers. Multidisciplinary research and international and cross-African collaboration were seen as crucial to build capacity in sub-Saharan nutrition research.	[Van Royen, Kathleen; Lachat, Carl; Kolsteren, Patrick] Univ Ghent, Dept Food Safety & Food Qual, B-9000 Ghent, Belgium; [Van Royen, Kathleen; Lachat, Carl; Roberfroid, Dominique; Kolsteren, Patrick] Inst Trop Med, Unit Nutr & Child Hlth, B-2000 Antwerp, Belgium; [Holdsworth, Michelle] Univ Sheffield, ScHARR Sect Publ Hlth, Sheffield, S Yorkshire, England; [Smit, Karlien] North West Univ, Africa Unit Transdisciplinary Hlth Res, Potchefstroom, South Africa; [Kinabo, Joyce] Sokoine Univ, Dept Food Sci & Technol, Morogoro, Tanzania; [Nago, Eunice] Univ Abomey Calavi, Fac Agr Sci, Abomey Calavi, Benin; [Orach, Christopher Garimoi] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	Ghent University; Institute of Tropical Medicine (ITM); University of Sheffield; North West University - South Africa; Sokoine University of Agriculture; University of Abomey Calavi; Makerere University	Kolsteren, P (corresponding author), Univ Ghent, Dept Food Safety & Food Qual, B-9000 Ghent, Belgium.	pkolsteren@itg.be	Van Royen, Kathleen/E-9669-2018; holdsworth, michelle/AAH-5400-2020; lachat, carl/AAH-9764-2020	Van Royen, Kathleen/0000-0001-8182-7971; holdsworth, michelle/0000-0001-6028-885X; lachat, carl/0000-0002-1389-8855; van Schalkwyk, Karlien/0000-0001-9444-2288	European Union [266080]	European Union(European Commission)	This work was supported by the European Union as a Coordination and Support Action of the FP7 KBBE programme under grant agreement number 266080. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron GJ, 2010, GLOB PUBLIC HEALTH, V5, pS42, DOI 10.1080/17441692.2010.526128; Adams J., 2010, GLOBAL RES REPORT; Batista R, 2006, 3 COHRED; BEATTIE P, 1999, STRENGTHENING HLTH R; Benson T.D., 2008, IMPROVING NUTR DEV P; Bill & Melinda Gates Foundation, 2011, NUTR STRAT OV; Borregaard N, 2002, DRIVERS KNOWLEDGE PR; Brown KH, 2010, GLOB PUBLIC HEALTH, V5, pS1, DOI 10.1080/17441692.2010.526126; Brownson RC, 2006, AM J PREV MED, V30, P164, DOI 10.1016/j.amepre.2005.10.004; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Department for International Development, 2010, NEGL CRIS UND DFIDS; Food and Agriculture Organisation (FAO), 2003, STAT FOOD INS WORLD; G8 Camp David Summit, 2012, FACT SHEET G 8 ACT F; GAIN, 2012, FAINS NUTR PROGR; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Leroy JL, 2007, AM J PUBLIC HEALTH, V97, P219, DOI 10.2105/AJPH.2005.083287; Mckee M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001209; Meerman J, 2008, MAKING NUTR NATL PRI; Morris SS, 2008, LANCET, V371, P608, DOI 10.1016/S0140-6736(07)61695-X; Pelletier DL, 2012, HEALTH POLICY PLANN, V27, P19, DOI 10.1093/heapol/czr011; Sawyerr A., 2004, J HIGHER ED AREA, V2, P211; Scaling-Up nutrition Roadmap task team, 2010, ROAD MAP SCAL UP NUT; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; UNDP, 2012, AFR HUM DEV REP FOOD; UNDP UNECA AU AfDB, 2011, ASS PROGR AFR MILL D; United Nations Standing Committee on Nutrition (UNSCN), 2010, 6 UNSCN ACC; Vincent R, 2006, FINDINGS, P6; Vorster HH, 1999, NUTR REV, V57, P341, DOI 10.1111/j.1753-4887.1999.tb06911.x; Weber R. P., 1990, BASIC CONTENT ANAL, V2nd; Williams JR, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5287; World Bank, 2010, WORLD DEV IND; World Bank, 2006, REP NUTR CENTR DEV S; World Health Organization, 2008, 2008 2013 ACT PLAN G; World Health Organization, 2010, REV NUTR PO IN PRESS; World Health Organization, 2004, GLOB STRAT DIET PHYS	35	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66355	10.1371/journal.pone.0066355	http://dx.doi.org/10.1371/journal.pone.0066355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776663	Green Published, gold, Green Accepted			2022-12-25	WOS:000320322400099
J	Wang, XY; Xue, LN; Yang, Y; Xu, LJ; Zhang, GX				Wang, Xiaoyong; Xue, Lening; Yang, Yang; Xu, Lijuan; Zhang, Guoxin			TLR9 Promoter Polymorphism Is Associated with Both an Increased Susceptibility to Gastric Carcinoma and Poor Prognosis	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; HELICOBACTER-PYLORI INFECTION; THR399ILE POLYMORPHISMS; GENE POLYMORPHISMS; INNATE IMMUNITY; INCREASED RISK; CANCER; TOLL-LIKE-RECEPTOR-4; CHINESE	Objective: Genetic polymorphisms of Toll-like receptors (TLRs) may influence the effects of H. pylori infection and play important roles in gastric carcinogenesis. The aim of this study was to determine whether the polymorphisms of TLR4 and TLR9 are associated with susceptibility to gastric carcinoma and its prognosis. Methods: This study consisted of 314 patients with gastric cancer and 314 healthy controls. The polymorphisms were assessed using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Survival was analyzed by Kaplan-Meier survival curves. Results: No variant genotypes of TLR4+896A/G, TLR4+1196C/T, or TLR9 -1237T/C were detected. For TLR9 -1486 T/C, multiple logistic regression analyses revealed that compared with the TT homozygote, patients with both the TC variant (adjusted odds ratio (OR) = 1.47, 95% confidence interval (CI) = 1.04-2.10) and the CC variant (adjusted OR = 1.63, 95% CI = 1.01-2.64) had higher risks of gastric cancer. Further stratification analyses revealed that an increased risk of gastric cancer associated with C carriers was evident among females (adjusted OR = 1.84, 95% CI = 1.02-3.33), in younger subjects aged less than 60 years old (adjusted OR = 1.86, 95% CI = 1.15-3.00), and subjects with H. pylori infection (adjusted OR = 1.53, 95% CI = 1.03-2.27). We also observed a significant association between C carriers and noncardia gastric cancer (adjusted OR = 1.51, 95% CI = 1.03-2.20). In addition, we demonstrated that the C carrier genotype and H. pylori infection may have a synergistic effect and conferred an OR of 2.44 for developing gastric cancer. TLR9 -1486C was also identified as an independent marker of poor survival of carcinoma. Conclusions: Our results suggest that TLR9 -1486C carriers are associated with an increased risk and poor prognosis of gastric carcinoma in the Chinese population.	[Wang, Xiaoyong; Xue, Lening] Nanjing Med Univ, Changzhou Hosp 2, Dept Gastroenterol, Changzhou, Peoples R China; [Yang, Yang; Xu, Lijuan; Zhang, Guoxin] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Xue, LN (corresponding author), Nanjing Med Univ, Changzhou Hosp 2, Dept Gastroenterol, Changzhou, Peoples R China.	wujia19811007@126.com; guoxinz@njmu.edu.cn			Natural Science Funds of Jiangsu Province, China [BK2010194]	Natural Science Funds of Jiangsu Province, China	This work was supported by a grant from the Natural Science Funds of Jiangsu Province, China (No. BK2010194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyut BR, 2007, HUM IMMUNOL, V68, P901, DOI 10.1016/j.humimm.2007.10.006; Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anderson AE, 2007, EUR J IMMUNOL, V37, P1548, DOI 10.1002/eji.200636562; Armant MA, 2002, GENOME BIOL, V3; Burns E A, 2000, Cancer Control, V7, P513; Demirci FYK, 2007, J RHEUMATOL, V34, P1708; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Fukata M, 2008, ONCOGENE, V27, P234, DOI 10.1038/sj.onc.1210908; Garza-Gonzalez E, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-70; Hamajima Nobuyuki, 2003, Nagoya J Med Sci, V66, P103; Hamann L, 2006, CLIN CHIM ACTA, V364, P303, DOI 10.1016/j.cca.2005.07.017; Hang JQ, 2004, J ENDOTOXIN RES, V10, P238, DOI 10.1177/09680519040100040601; Hold GL, 2007, GASTROENTEROLOGY, V132, P905, DOI 10.1053/j.gastro.2006.12.026; Hur JW, 2005, TISSUE ANTIGENS, V65, P266, DOI 10.1111/j.1399-0039.2005.00374.x; Ishihara S, 2004, J IMMUNOL, V173, P1406, DOI 10.4049/jimmunol.173.2.1406; Kawahara T, 2001, INFECT IMMUN, V69, P4382, DOI 10.1128/IAI.69.7.4382-4389.2001; Kawahara Tsukasa, 2001, Journal of Medical Investigation, V48, P190; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lawrence T, 2007, TRENDS PHARMACOL SCI, V28, P162, DOI 10.1016/j.tips.2007.02.003; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lochhead P, 2007, BEST PRACT RES CL GA, V21, P281, DOI 10.1016/j.bpg.2007.02.002; Lorenz E, 2001, BIOTECHNIQUES, V31, P22, DOI 10.2144/01311bm01; Mandell L, 2004, INFECT IMMUN, V72, P6446, DOI 10.1128/IAI.72.11.6446-6454.2004; Maslov AY, 2009, BBA-GEN SUBJECTS, V1790, P963, DOI 10.1016/j.bbagen.2009.03.020; Ng MTH, 2010, INFECT IMMUN, V78, P1345, DOI 10.1128/IAI.01226-09; Ng MW, 2005, RHEUMATOLOGY, V44, P1456, DOI 10.1093/rheumatology/kei120; Novak N, 2007, ALLERGY, V62, P766, DOI 10.1111/j.1398-9995.2007.01358.x; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Santini D, 2008, CLIN EXP IMMUNOL, V154, P360, DOI 10.1111/j.1365-2249.2008.03776.x; Schmausser B, 2005, INT J MED MICROBIOL, V295, P179, DOI 10.1016/j.ijmm.2005.02.009; Schmausser B, 2004, CLIN EXP IMMUNOL, V136, P521, DOI 10.1111/j.1365-2249.2004.02464.x; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tahara T, 2007, J CLIN BIOCHEM NUTR, V40, P62, DOI 10.3164/jcbn.40.62; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Tao K, 2007, ANN RHEUM DIS, V66, P905, DOI 10.1136/ard.2006.065961; Wang XY, 2008, HELICOBACTER, V13, P49, DOI 10.1111/j.1523-5378.2008.00578.x; Wu MS, 2006, HEPATO-GASTROENTEROL, V53, P807; Wu MS, 2005, CANCER EPIDEM BIOMAR, V14, P1878, DOI 10.1158/1055-9965.EPI-04-0792; Zeng Hong-Mei, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P588	46	25	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65731	10.1371/journal.pone.0065731	http://dx.doi.org/10.1371/journal.pone.0065731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776537	gold, Green Published, Green Submitted			2022-12-25	WOS:000320322400049
J	Barra, GN; Araya, PA; Fernandez, JO; Gabastou, JM; Hormazabal, JC; Seoane, M; Pidal, PC; Valenzuela, MT; Ibarz-Pavon, AB				Barra, Gisselle N.; Araya, Pamela A.; Fernandez, Jorge O.; Gabastou, Jean-Marc; Carlos Hormazabal, Juan; Seoane, Mabel; Pidal, Paola C.; Valenzuela, Maria T.; Ibarz-Pavon, Ana Belen			Molecular Characterization of Invasive Neisseria meningitidis Strains Isolated in Chile during 2010-2011	PLOS ONE			English	Article							PORA GENE; VACCINE; SURVEILLANCE; MENINGOCOCCI; PREVALENCE; SEROGROUPS; PROTEIN; DISEASE; TARGET; CLONE	Background: With the upcoming licensure of Outer Membrane Protein-based vaccines against meningococcal disease, data on disease incidence and molecular characteristic of circulating N. meningitidis strains in Latin American countries is needed. Chile is, to date, one of the few countries in the region that has performed this type of work in a comprehensive collection of disease-associated strains from two consecutive years, 2010-2011. Methods: A total of 119 N. meningitidis strains isolated from patients with invasive disease in Chile in 2010-2011 were characterized by the National Reference Laboratory. Serogroup determination, MLST and porA typing were performed. Results: Serogroup B was predominant in both study years, but W135 experienced a noticeable increase in 2011 compared to 2010. ST-11 complex, ST-41/44 complex ST-32 complex were the most prevalent among the isolates, and were strongly associated with serogroups W135 (ST-11 Complex) and B (ST-41/44 and ST-32 complexes). Likewise, the major porA types detected were strongly associated with these three clonal complexes: P1.5,2 was found exclusively among W135: ST-11 isolates, whereas P1.7, 2-3 was only detected in C: ST-11. ST-41/44 isolates mainly had P1.10-8, and ST-32 complex were associated with a P1.18-8 porA. Conclusions: Our data show disease-associated N. meningitidis circulating in Chile are similar to those found in other parts of the world. The increase on W135: ST-11 isolates observed in 2011 foretold the unusual epidemiological situation experienced in the country in 2012, and MLST data show that this strain is indistinguishable from the one linked to the global Hajj 2000-related outbreak that occurred in 2001. Finally, this work demonstrates the importance of maintaining a strong national surveillance program integrating clinical, epidemiological and laboratory data and incorporating gold standard diagnostic and characterization techniques that allow the data to be compared all over the world.	[Barra, Gisselle N.; Fernandez, Jorge O.] Inst Publ Hlth, Subdept Mol Genet, Santiago, Chile; [Araya, Pamela A.; Carlos Hormazabal, Juan; Seoane, Mabel] Inst Publ Hlth, Bacteriol Sect, Santiago, Chile; [Gabastou, Jean-Marc; Ibarz-Pavon, Ana Belen] Pan Amer Hlth Org, Washington, DC USA; [Pidal, Paola C.; Valenzuela, Maria T.] Inst Publ Hlth, Biomed Lab Dept, Santiago, Chile	Pan American Health Organization	Fernandez, JO (corresponding author), Inst Publ Hlth, Subdept Mol Genet, Santiago, Chile.	jfernand@ispch.cl; ibarzpav@paho.org		Valenzuela, M Teresa/0000-0002-9433-6423	Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF)	Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF)	Funding was provided by Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad R, 2009, J INFECTION, V59, P104, DOI 10.1016/j.jinf.2009.06.001; [Anonymous], MMWR MORB MORTAL WKL, V50, P221; [Anonymous], 2012, BOLETIN, V2; Brehony C, 2007, FEMS MICROBIOL REV, V31, P15, DOI 10.1111/j.1574-6976.2006.00056.x; Brehony C, 2009, MICROBIOL-SGM, V155, P4155, DOI 10.1099/mic.0.027995-0; Chiavetta L., 2007, Rev. argent. microbiol., V39, P21; Claus H, 2004, MOL MICROBIOL, V51, P227, DOI 10.1046/j.1365-2958.2003.03819.x; Elias J, 2007, J CLIN MICROBIOL, V45, P159, DOI 10.1128/JCM.01322-06; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Gobierno de Chile. Ministerio de Salud. Division de Planificacion Sanitaria. Departamento de Epidemiologia, 2007, B VIGILIANCIA SALUD, V13, P59; Gorla MC, ENFERM INFECC MICROB, V30, P56; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Ibarz-Pavon AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044102; [Instituto de Salud publica de Chile Ministerio de Salud.], ORD B, V51; Jacobsson S, 2009, VACCINE, V27, P1579, DOI 10.1016/j.vaccine.2008.12.052; Jelfs J, 2000, CLIN DIAGN LAB IMMUN, V7, P390, DOI 10.1128/CDLI.7.3.390-395.2000; Jolley KA, 2007, FEMS MICROBIOL REV, V31, P89, DOI 10.1111/j.1574-6976.2006.00057.x; Kugelberg E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009413; Lucidarme J, 2011, CLIN VACCINE IMMUNOL, V18, P194, DOI 10.1128/CVI.00401-10; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Martin DR, 2006, CLIN VACCINE IMMUNOL, V13, P486, DOI 10.1128/CVI.13.4.486-491.2006; Moriel DG, 2008, HUM VACCINES, V4, P184, DOI 10.4161/hv.4.3.6313; Newcombe J, 1998, MOL MICROBIOL, V30, P453, DOI 10.1046/j.1365-2958.1998.01056.x; Panatto D, 2011, EXPERT REV VACCINES, V10, P1337, DOI [10.1586/ERV.11.103, 10.1586/erv.11.103]; Russell JE, 2004, EMERG INFECT DIS, V10, P674, DOI 10.3201/eid1004.030247; Sorhouet-Pereira C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058065; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111/j.1574-6976.2006.00051.x; Taha MK, 2000, LANCET, V356, P2159, DOI 10.1016/S0140-6736(00)03502-9; Thompson EAL, 2003, MICROBIOL-SGM, V149, P1849, DOI 10.1099/mic.0.26131-0; Urwin R, 2004, INFECT IMMUN, V72, P5955, DOI 10.1128/IAI.72.10.5955-5962.2004; Weidlich L, 2008, J INFECTION, V57, P324, DOI 10.1016/j.jinf.2008.07.014; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004; Yogev R, HUM VACCIN, V7, P828	34	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66006	10.1371/journal.pone.0066006	http://dx.doi.org/10.1371/journal.pone.0066006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776590	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400096
J	Bouix, S; Pasternak, O; Rathi, Y; Pelavin, PE; Zafonte, R; Shenton, ME				Bouix, Sylvain; Pasternak, Ofer; Rathi, Yogesh; Pelavin, Paula E.; Zafonte, Ross; Shenton, Martha E.			Increased Gray Matter Diffusion Anisotropy in Patients with Persistent Post-Concussive Symptoms following Mild Traumatic Brain Injury	PLOS ONE			English	Article							PRINCIPAL EIGENVECTOR MEASUREMENTS; TENSOR IMAGING FINDINGS; FRACTIONAL ANISOTROPY; MEAN DIFFUSIVITY; HEAD-INJURY; REPRODUCIBILITY; DEGENERATION; DTI	A significant percentage of individuals diagnosed with mild traumatic brain injury (mTBI) experience persistent post-concussive symptoms (PPCS). Little is known about the pathology of these symptoms and there is often no radiological evidence based on conventional clinical imaging. We aimed to utilize methods to evaluate microstructural tissue changes and to determine whether or not a link with PPCS was present. A novel analysis method was developed to identify abnormalities in high-resolution diffusion tensor imaging (DTI) when the location of brain injury is heterogeneous across subjects. A normative atlas with 145 brain regions of interest (ROI) was built from 47 normal controls. Comparing each subject's diffusion measures to the atlas generated subject-specific profiles of injury. Abnormal ROIs were defined by absolute z-score values above a given threshold. The method was applied to 11 PPCS patients following mTBI and 11 matched controls. Z-score information for each individual was summarized with two location-independent measures: "load'' (number of abnormal regions) and "severity'' (largest absolute z-score). Group differences were then computed using Wilcoxon rank sum tests. Results showed statistically significantly higher load (p = 0.018) and severity (p = 0.006) for fractional anisotropy (FA) in patients compared with controls. Subject-specific profiles of injury evinced abnormally high FA regions in gray matter (30 occurrences over 11 patients), and abnormally low FA in white matter (3 occurrences over 11 subjects). Subject-specific profiles provide important information regarding the pathology associated with PPCS. Increased gray matter (GM) anisotropy is a novel in-vivo finding, which is consistent with an animal model of brain trauma that associates increased FA in GM with pathologies such as gliosis. In addition, the individualized analysis shows promise for enhancing the clinical care of PPCS patients as it could play a role in the diagnosis of brain injury not revealed using conventional imaging.	[Bouix, Sylvain; Pasternak, Ofer; Rathi, Yogesh; Pelavin, Paula E.; Shenton, Martha E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Shenton, Martha E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Zafonte, Ross] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA USA; [Zafonte, Ross] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Shenton, Martha E.] Vet Affairs Boston Healthcare Syst, Dept Psychiat, Brockton Div, Brockton, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Bouix, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Psychiat, Boston, MA 02115 USA.	sylvain@bwh.harvard.edu	Shenton, Martha/V-8780-2019	Bouix, Sylvain/0000-0003-1326-6054	Center for Integration of Medicine and Innovative Technology Soldier in Medicine Award; National Institute of Health [R01 MH082918, R01 NS078337, NAMIC-U54 EB005149]; INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium; Department of Defense Psychological Health/Traumatic Brain Injury Research Program [X81XWH-07-CC-CSDoD]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB005149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078337] Funding Source: NIH RePORTER	Center for Integration of Medicine and Innovative Technology Soldier in Medicine Award; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium; Department of Defense Psychological Health/Traumatic Brain Injury Research Program; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Center for Integration of Medicine and Innovative Technology Soldier in Medicine Award [to S.B.], by the National Institute of Health [R01 MH082918 to S.B., R01 NS078337 to M.E.S., NAMIC-U54 EB005149 to M.E.S.] and by the INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium funded by the Department of Defense Psychological Health/Traumatic Brain Injury Research Program [X81XWH-07-CC-CSDoD to M.E.S., S.B., O.P., Y.R. and R.Z.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; ARNETT JA, 1995, PSYCHOL ASSESSMENT, V7, P220; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benton LA, MULTILINGUAL APHASIA; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Blumenfeld-Katzir T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020678; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Delis DC, CALIFORNIA VERBAL LE; Dobson AJ, 2008, INTRO GEN LINEAR MOD; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; Hannoun S, 2012, AM J NEURORADIOL, V33, P1363, DOI 10.3174/ajnr.A2983; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Irimia Andrei, 2012, Front Neurol, V3, P10, DOI 10.3389/fneur.2012.00010; Jones DK, 2008, CORTEX, V44, P936, DOI 10.1016/j.cortex.2008.05.002; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kaufman L., 2005, FINDING GROUPS DATA; Landman BA, 2007, NEUROIMAGE, V36, P1123, DOI 10.1016/j.neuroimage.2007.02.056; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Peled S, 2009, J MAGN RESON IMAGING, V30, P243, DOI 10.1002/jmri.21808; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Seber G.A.F., 2004, MULTIVARIATE OBSERVA; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Takayama H, 2000, CLIN NEUROL NEUROSUR, V102, P135, DOI 10.1016/S0303-8467(00)00079-2; Taylor MJ, 2001, J INT NEUROPSYCH SOC, V7, P867, DOI 10.1017/S1355617701777107; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280	41	77	77	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66205	10.1371/journal.pone.0066205	http://dx.doi.org/10.1371/journal.pone.0066205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776631	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400120
J	Shan, ZH; Shakoori, A; Bodaghi, S; Goldsmith, P; Jin, J; Wiest, JS				Shan, Zhihong; Shakoori, Abbas; Bodaghi, Sohrab; Goldsmith, Paul; Jin, Jen; Wiest, Jonathan S.			TUSC1, a Putative Tumor Suppressor Gene, Reduces Tumor Cell Growth In Vitro and Tumor Growth In Vivo	PLOS ONE			English	Article							HOMOZYGOUS DELETIONS; CHROMOSOME 9P; LUNG-CANCER; MELANOMA; HETEROZYGOSITY; REGION; IDENTIFICATION; CARCINOMA; PROTEINS; IDENTIFY	We previously reported the identification of TUSC1 (Tumor Suppressor Candidate 1), as a novel intronless gene isolated from a region of homozygous deletion at D9S126 on chromosome 9p in human lung cancer. In this study, we examine the differential expression of TUSC1 in human lung cancer cell lines by western blot and in a primary human lung cancer tissue microarray by immunohistochemical analysis. We also tested the functional activities and mechanisms of TUSC1 as a tumor suppressor gene through growth suppression in vitro and in vivo. The results showed no expression of TUSC1 in TUSC1 homozygously deleted cells and diminished expression in some tumor cell lines without TUSC1 deletion. Interestingly, the results from a primary human lung cancer tissue microarray suggested that higher expression of TUSC1 was correlated with increased survival times for lung cancer patients. Our data demonstrated that growth curves of tumor cell lines transfected with TUSC1 grew slower in vitro than those transfected with the empty vector. More importantly, xenograph tumors in nude mice grew significantly slower in vivo in cells stably transfected with TUSC1 than those transfected with empty vector. In addition, results from confocal microscopy and immunohistochemical analyses show distribution of TUSC1 in the cytoplasm and nucleus in tumor cell lines and in normal and tumor cells in the lung cancer tissue microarray. Taken together, our results support TUSC1 has tumor suppressor activity as a candidate tumor suppressor gene located on chromosome 9p.	[Shan, Zhihong; Bodaghi, Sohrab; Wiest, Jonathan S.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Shakoori, Abbas; Jin, Jen] Mayo Clin & Mayo Fdn, Adv Genome Technol Ctr, Rochester, MN 55905 USA; [Goldsmith, Paul] NCI, Basic Res Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wiest, JS (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA.	wiestj@mail.nih.gov		shakoori, abbas/0000-0002-4363-1967	Intramural Research Program of the National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010448] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2012, CANC FACTS FIG 2012; An HX, 1996, GENE CHROMOSOME CANC, V17, P14, DOI 10.1002/(SICI)1098-2264(199609)17:1<14::AID-GCC3>3.3.CO;2-Y; CAIRNS P, 1995, NAT GENET, V11, P210, DOI 10.1038/ng1095-210; CARNEY DN, 1985, CANCER RES, V45, P2913; Castellano M, 1997, CANCER RES, V57, P4868; CHENG JQ, 1993, CANCER RES, V53, P4761; COLEMAN A, 1994, CANCER RES, V54, P344; Fogh J., 1975, HUMAN TUMOR CELLS IN, VVolume 1, P115, DOI [10.1007/978-1-4757-1647-4_5, DOI 10.1007/978-1-4757-1647-4_5]; Fukuoka J, 2004, CLIN CANCER RES, V10, P4314, DOI 10.1158/1078-0432.CCR-03-0489; GOLDSMITH P, 1987, J BIOL CHEM, V262, P14683; Hamada K, 1998, GENE CHROMOSOME CANC, V22, P232, DOI 10.1002/(SICI)1098-2264(199807)22:3<232::AID-GCC9>3.0.CO;2-X; Hamada K, 2000, GENE CHROMOSOME CANC, V27, P308, DOI 10.1002/(SICI)1098-2264(200003)27:3<308::AID-GCC12>3.3.CO;2-N; HOLLAND EA, 1994, ONCOGENE, V9, P1361; Howlader N, 2012, SEER CANC STAT REV 1; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; La Rochelle J, 2010, CANCER-AM CANCER SOC, V116, P4696, DOI 10.1002/cncr.25279; Mead LJ, 1997, INT J CANCER, V71, P213; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; PETTIJOHN DE, 1988, P NATL ACAD SCI USA, V85, P802, DOI 10.1073/pnas.85.3.802; Ploussard G, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.03.037; Pollock PM, 2001, CANCER RES, V61, P1154; QUELLE DE, 1995, CELL, V83, P993; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Shan ZH, 2004, ONCOGENE, V23, P6612, DOI 10.1038/sj.onc.1207857; Sheu JC, 1999, BRIT J CANCER, V80, P468, DOI 10.1038/sj.bjc.6690380; Takeuchi S, 1997, LEUKEMIA, V11, P1636, DOI 10.1038/sj.leu.2400817; Wiest JS, 1997, CANCER RES, V57, P1; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; XIAO S, 1995, CANCER RES, V55, P2968; Yang XR, 2010, FAM CANCER, V9, P625, DOI 10.1007/s10689-010-9356-3; Zochbauer-Muller S, 2002, ANNU REV PHYSIOL, V64, P681, DOI 10.1146/annurev.physiol.64.081501.155828	34	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66114	10.1371/journal.pone.0066114	http://dx.doi.org/10.1371/journal.pone.0066114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776618	Green Submitted, gold, Green Published			2022-12-25	WOS:000320755400111
J	Xu, J; Zhao, XQ; Wang, YL; Wang, CX; Liu, LP; Sun, BY; Wang, AX; Wang, YJ				Xu, Jie; Zhao, Xingquan; Wang, Yilong; Wang, Chunxue; Liu, Liping; Sun, Baoying; Wang, Anxin; Wang, Yongjun			Impact of a Better Persistence with Antihypertensive Agents on Ischemic Stroke Outcomes for Secondary Prevention	PLOS ONE			English	Article							MEDICATION ADHERENCE; THERAPY; EVENTS	Background: The efficacy of antihypertensive (AH) treatment after stroke has been investigated in several randomized clinical trials. However, non-adherence to AH medication is common for stroke patients in "real world" setting. The purpose of this study was to assess the impact of persistence with AH agents on ischemic stroke (IS) outcomes. Methods and Results: Using the China National Stroke Registry, we analyzed data from 8409 IS patients with hypertension. Persistence with AH therapy (high persistence >= 75%, low persistence <75%) was measured by patient self-report at 3, 6, and 12 months after stroke. Multivariate logistic regression model was used to assess the relationship between persistence and IS outcomes (stroke recurrence, combined vascular events and death) at 12 months. Of the 8409 patients in this study, 40.0% were female and the mean age at study entry was 66.7 years. 31.6% of patients had high persistence with AH drugs, and 68.4% had low persistence during 1 year after stroke onset. High persistence with AH drugs significantly decreased the risk of stroke recurrence (odds ratio, 0.78; 95% CI, 0.68 to 0.89), combined vascular events (0.71; 0.63-0.81) and death (0.44; 0.36-0.53) compared with low persistence. Conclusions: Our study reinforces the benefits of AH medications in routine clinical practice and highlights the importance of persistence with AH therapy among IS patients known to be hypertensive within the first year of an event.	[Xu, Jie; Zhao, Xingquan; Wang, Yilong; Wang, Chunxue; Liu, Liping; Wang, Anxin; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Sun, Baoying] Shandong Univ, Jinan Cent Hosp, Jinan 250100, Shandong, Peoples R China	Capital Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Wang, YJ (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China.	yongjunwang1962@gmail.com	liu, li/HGC-0900-2022		Ministry of Sciences and Technology; Ministry of Health of the People's Republic of China [2006BA101A11, 2009CB521905, 200902004]; National Science Foundation [81071115]	Ministry of Sciences and Technology; Ministry of Health of the People's Republic of China; National Science Foundation(National Science Foundation (NSF))	The China National Stroke Registry was funded by the Ministry of Sciences and Technology and the Ministry of Health of the People's Republic of China (grants 2006BA101A11, 2009CB521905 and 200902004) and the National Science Foundation (grant 81071115). The current analysis of the CNSR data was supported by Beijing Novartis Pharma Co., Ltd. In compliance with the Uniform Requirements for Manuscripts, established by the International Committee of Medical Journal Editors, Novartis did not impose any impediment, directly or indirectly, on the publication of the study's results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, STROKE, V20, P1407; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Bushnell CD, 2011, NEUROLOGY, V77, P1182, DOI 10.1212/WNL.0b013e31822f0423; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Colivicchi F, 2007, STROKE, V38, P2652, DOI 10.1161/STROKEAHA.107.487017; Gehi AK, 2007, ARCH INTERN MED, V167, P1798, DOI 10.1001/archinte.167.16.1798; Gerstein HC, 2000, LANCET, V355, P253; Graves JW, 2012, J HYPERTENS, V30, P1233, DOI 10.1097/HJH.0b013e328353968d; HAYNES RB, 1980, HYPERTENSION, V2, P757, DOI 10.1161/01.HYP.2.6.757; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Kettani FZ, 2009, STROKE, V40, P213, DOI 10.1161/STROKEAHA.108.522193; LIU LS, 1995, CHINESE MED J-PEKING, V108, P710; Muntner P, 2011, J CLIN HYPERTENS, V13, P479, DOI 10.1111/j.1751-7176.2011.00464.x; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Ovbiagele B, 2010, CEREBROVASC DIS, V29, P146, DOI 10.1159/000262311; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Rashid P, 2003, STROKE, V34, P2741, DOI 10.1161/01.STR.0000092488.40085.15; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; Walsh JC, 2002, AIDS, V16, P269, DOI 10.1097/00002030-200201250-00017; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x; Yusuf S, 2008, NEW ENGL J MED, V359, P1225, DOI 10.1056/NEJMoa0804593	22	13	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65233	10.1371/journal.pone.0065233	http://dx.doi.org/10.1371/journal.pone.0065233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776454	Green Submitted, gold, Green Published			2022-12-25	WOS:000320755400017
J	Xiao, CT; Gimenez-Lirola, LG; Jiang, YH; Halbur, PG; Opriessnig, T				Xiao, Chao-Ting; Gimenez-Lirola, Luis G.; Jiang, Yong-Hou; Halbur, Patrick G.; Opriessnig, Tanja			Characterization of a Novel Porcine Parvovirus Tentatively Designated PPV5	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS; VIRAL EVOLUTION; CAPSID PROTEIN; DNA VIRUSES; IDENTIFICATION; BOCAVIRUSES; PREVALENCE; SWINE; TYPE-2; REPLICATION	A new porcine parvovirus (PPV), provisionally designated as PPV5, was identified in U. S. pigs. Cloning and sequencing from a circular or head-to-tail concatemeric array revealed that the PPV5 possesses the typical genomic organization of parvoviruses with two major predicted open reading frames (ORF1 and ORF2), and is most closely related to PPV4 with overall genomic identities of 64.1-67.3%. The amino acid identities between PPV5 and PPV4 were 84.6%-85.1% for ORF1 and 54.0%-54.3% for ORF2. Unlike PPV4, but similar to bovine parvovirus 2 (BPV2), PPV5 lacks the additional ORF3 and has a much longer ORF2. Moreover, the amino acid sequences of ORF1 and ORF2 of BPV2 showed higher homologies to PPV5 than to PPV4. The conserved motifs of the Ca2+ binding loop (YXGXG) and the catalytic center (HDXXY) of phospholipase A(2) (PLA(2)) were identified in VP1 (ORF2) of PPV5, as well as in BPV2, but were not present in PPV4. Phylogenetic analyses revealed that PPV5, PPV4 and BPV2 form a separate clade different from the genera Parvovirus and Bocavirus. Further epidemiologic investigations of PPV4 and PPV5 in U. S. pigs of different ages indicated a slightly higher prevalence for PPV5 (6.6%; 32/483) compared to PPV4 (4.1%; 20/483), with detection of concurrent PPV4 and PPV5 in 15.6% (7/45) of lungs of infected pigs. Evidence for potential vertical transmission or association with reproductive failure was minimal for both PPV4 and PPV5. The high similarity to PPV4 and the lack of ORF3 may suggest PPV5 is an intermediate of PPV4 during the evolution of parvoviruses in pigs.	[Xiao, Chao-Ting; Gimenez-Lirola, Luis G.; Jiang, Yong-Hou; Halbur, Patrick G.; Opriessnig, Tanja] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA	Iowa State University	Opriessnig, T (corresponding author), Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA.	tanjaopr@iastate.edu	Opriessnig, Tanja/F-2984-2012; jiang, yonghou/GVS-6462-2022; , xiaocht/H-3997-2014	Opriessnig, Tanja/0000-0001-9642-0904; , xiaocht/0000-0001-5299-5650; Jiang, Yonghou/0000-0002-6669-2367	National Pork Board Checkoff Dollars	National Pork Board Checkoff Dollars	Funding for this study was provided by the National Pork Board Checkoff Dollars. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABINANTI FR, 1961, VIROLOGY, V14, P288, DOI 10.1016/0042-6822(61)90206-9; Adlhoch C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-171; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Arthur JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000391; Belyi VA, 2010, J VIROL, V84, P12458, DOI 10.1128/JVI.01789-10; BERNS KI, 1990, MICROBIOL REV, V54, P316, DOI 10.1128/MMBR.54.3.316-329.1990; Blomstrom AL, 2009, VIRUS RES, V146, P125, DOI 10.1016/j.virusres.2009.09.006; Blomstrom AL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-192; CARTWRIGHT SF, 1967, VET REC, V81, P196; Cheng WX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013583; Cheung AK, 2010, ARCH VIROL, V155, P801, DOI 10.1007/s00705-010-0646-8; Cotmore SF, 2000, J VIROL, V74, P1332, DOI 10.1128/JVI.74.3.1332-1341.2000; Csagola A, 2012, ARCH VIROL, V157, P1003, DOI 10.1007/s00705-012-1257-3; Dorsch S, 2002, J VIROL, V76, P2014, DOI 10.1128/JVI.76.4.2014-2018.2002; Duan DS, 1998, J VIROL, V72, P8568, DOI 10.1128/JVI.72.11.8568-8577.1998; Duan DS, 1999, VIROLOGY, V261, P8, DOI 10.1006/viro.1999.9821; Gimenez-Lirola LG, 2012, J MICROBIOL METH, V91, P191, DOI 10.1016/j.mimet.2012.06.011; Girod A, 2002, J GEN VIROL, V83, P973, DOI 10.1099/0022-1317-83-5-973; Hijikata M, 2001, JPN J INFECT DIS, V54, P244; Huang L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-333; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Kapoor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021362; Kapoor A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011948; KOCZOT FJ, 1973, P NATL ACAD SCI USA, V70, P215, DOI 10.1073/pnas.70.1.215; Lau SKP, 2008, J GEN VIROL, V89, P1840, DOI 10.1099/vir.0.2008/000380-0; Lau SKP, 2012, J GEN VIROL, V93, P1573, DOI 10.1099/vir.0.042531-0; Lau SKP, 2011, J GEN VIROL, V92, P2047, DOI 10.1099/vir.0.033688-0; Lusebrink J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019457; Manteufel J, 2008, INTERVIROLOGY, V51, P328, DOI 10.1159/000173734; McKillen J, 2011, VET MICROBIOL, V152, P39, DOI 10.1016/j.vetmic.2011.04.013; Mengeling WL, 2000, ANIM REPROD SCI, V60, P199, DOI 10.1016/S0378-4320(00)00135-4; MENGELING WL, 1988, J GEN VIROL, V69, P825, DOI 10.1099/0022-1317-69-4-825; O'Neill KC, 2011, CLIN VACCINE IMMUNOL, V18, P1865, DOI 10.1128/CVI.05318-11; Opriessnig T, 2013, VACCINE, V31, P487, DOI 10.1016/j.vaccine.2012.11.030; Schnepp BC, 2005, J VIROL, V79, P14793, DOI 10.1128/JVI.79.23.14793-14803.2005; Shackelton LA, 2006, J VIROL, V80, P3666, DOI 10.1128/JVI.80.7.3666-3669.2006; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Shan TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017292; Streck AF, 2011, J GEN VIROL, V92, P2628, DOI 10.1099/vir.0.033662-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TATTERSALL P, 1976, NATURE, V263, P106, DOI 10.1038/263106a0; Tijssen P., 2011, VIRUS TAXONOMY, P405; Tse H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025619; Wang F, 2010, VIRUS GENES, V41, P305, DOI 10.1007/s11262-010-0506-3; Xiao CT, 2013, VET MICROBIOL, V161, P325, DOI 10.1016/j.vetmic.2012.07.038; Xiao CT, 2012, VET MICROBIOL, V160, P290, DOI 10.1016/j.vetmic.2012.05.038; Xiao CT, 2012, J VIROL METHODS, V183, P40, DOI 10.1016/j.jviromet.2012.03.026; Xiao CT, 2013, GENOME ANNOUNC, V1; Yang WZ, 2012, ARCH VIROL, V157, P2125, DOI 10.1007/s00705-012-1407-7; Zadori Z, 2001, DEV CELL, V1, P291, DOI 10.1016/S1534-5807(01)00031-4; Zeng SL, 2011, J GEN VIROL, V92, P784, DOI 10.1099/vir.0.028340-0; Zhai SL, 2010, ARCH VIROL, V155, P1313, DOI 10.1007/s00705-010-0698-9; Zhang HB, 2011, EPIDEMIOL INFECT, V139, P1581, DOI 10.1017/S0950268811000847; Zhao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048980	55	47	58	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65312	10.1371/journal.pone.0065312	http://dx.doi.org/10.1371/journal.pone.0065312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762339	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800038
J	Zhang, Z; Zhang, XM; Sun, ZZ; Dong, HB; Qiu, LL; Gu, J; Zhou, JP; Wang, XR; Wang, SL				Zhang, Zhan; Zhang, Xiaoming; Sun, Zhenzhen; Dong, Huibin; Qiu, Lianglin; Gu, Jun; Zhou, Jingping; Wang, Xinru; Wang, Shou-Lin			Cytochrome P450 3A1 Mediates 2,2 ',4,4 '-Tetrabromodiphenyl Ether-Induced Reduction of Spermatogenesis in Adult Rats	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; BROMINATED FLAME RETARDANTS; DEVELOPMENTAL EXPOSURE; HUMAN HEPATOCYTES; SOUTH CHINA; IN-VIVO; BDE-47; CELLS; METABOLITES; APOPTOSIS	Background: 2,2',4,4'-tetrabromodiphenyl ether (BDE47) is the dominant PBDE congener in humans, wildlife, and the environment. It has been reported to be metabolized by cytochrome P450 (CYP) enzymes. Still, the effects of BDE47 on spermatogenesis failure are attracting an increasing amount of attention. However, it is unclear whether CYP-mediated metabolism contributes to BDE47-induced reproductive toxicity. Methodology and Principal Findings: The role of cytochrome P450 3A1 (CYP3A1) in the formation of oxidative metabolites of BDE47 and its induced spermatogenesis failure was investigated in SD rats. BDE47 significantly increased the expression and activity of CYP3A1 in rat liver, and 3-OH-BDE47, the major oxidative metabolite of BDE47, dose-dependently increased in rat liver, serum, and testis, which was aggravated by dexamethasone (DEX), an inducer of CYP3A1. Additionally, testicular 3-OH-BDE47 and reactive oxygen species (ROS) in seminiferous tubules increased especially when BDE47 was administered in combination with DEX, which was confirmed in GC-1 and GC-2 cells that 3-OH-BDE47 induced more ROS production and cell apoptosis via the upregulation of FAS/FASL, p-p53 and caspase 3. As a result, daily sperm production dose-dependently decreased, consistent with histological observations in giant cells and vacuolar spaces and increase in TUNEL-positive apoptotic germ cells. Conclusion: CYP3A1-mediated metabolic activation of BDE47 and the active metabolite 3-OH-BDE47 and consequent ROS played an important role in reduction of spermatogenesis by germ cell apoptosis. Our study helps provide new insights into the mechanism of reproductive toxicity of environmental chemicals.	[Zhang, Zhan; Zhang, Xiaoming; Sun, Zhenzhen; Qiu, Lianglin; Wang, Xinru; Wang, Shou-Lin] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhan; Zhang, Xiaoming; Sun, Zhenzhen; Dong, Huibin; Qiu, Lianglin; Gu, Jun; Zhou, Jingping; Wang, Xinru; Wang, Shou-Lin] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Wang, SL (corresponding author), Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	wangshl@njmu.edu.cn	Zhang, Zhan/AAR-6278-2020; Wang, Xin/AAN-8435-2021	Zhang, Zhan/0000-0002-9685-5753; Wang, Xin/0000-0002-4457-7376	National 973 program [2009CB941701]; National Natural Science Foundation of China [30972508, 81172695]; Environmental protection research special funds for public welfare projects [200909054]; Doctoral Fund of Ministry of Education of China [20093234110002]; Six talents peak project of Jiangsu province [DG216D5047]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), China	National 973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Environmental protection research special funds for public welfare projects; Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Six talents peak project of Jiangsu province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), China	This work was supported by National 973 program (2009CB941701), National Natural Science Foundation of China (30972508, 81172695), Environmental protection research special funds for public welfare projects (200909054), Doctoral Fund of Ministry of Education of China (20093234110002), Six talents peak project of Jiangsu province (DG216D5047), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelouahab N, 2011, REPROD TOXICOL, V31, P546, DOI 10.1016/j.reprotox.2011.02.005; Akutsu K, 2008, B ENVIRON CONTAM TOX, V80, P345, DOI 10.1007/s00128-008-9370-4; An J, 2011, ENVIRON TOXICOL, V26, P591, DOI 10.1002/tox.20582; Athanasiadou M, 2008, ENVIRON HEALTH PERSP, V116, P400, DOI 10.1289/ehp.10713; Chen SJ, 2010, J HAZARD MATER, V176, P979, DOI 10.1016/j.jhazmat.2009.11.138; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Emond C, 2010, TOXICOL APPL PHARM, V242, P290, DOI 10.1016/j.taap.2009.10.019; Erratico CA, 2011, TOXICOL SCI, V123, P37, DOI 10.1093/toxsci/kfr155; Fornari F, 2012, J PATHOL, V227, P275, DOI 10.1002/path.3995; Garcia PC, 2012, REPROD FERT DEVELOP, V24, P559, DOI 10.1071/RD10063; GRAY TJB, 1983, TOXICOL APPL PHARM, V67, P15, DOI 10.1016/0041-008X(83)90240-5; Hamers T, 2008, MOL NUTR FOOD RES, V52, P284, DOI 10.1002/mnfr.200700104; Han XM, 2012, TOXICOLOGY, V302, P44, DOI 10.1016/j.tox.2012.07.010; Jazirehi AR, 2012, AM J CANCER RES, V2, P178; Jin SW, 2010, TOXICOL IN VITRO, V24, P1190, DOI 10.1016/j.tiv.2010.02.012; Kamdem LK, 2006, CHEM RES TOXICOL, V19, P577, DOI 10.1021/tx050358e; Koster R, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.33; Lacorte S, 2010, J CHROMATOGR A, V1217, P337, DOI 10.1016/j.chroma.2009.11.024; Li QZ, 2010, MAR POLLUT BULL, V60, P464, DOI 10.1016/j.marpolbul.2010.01.011; Lilienthal H, 2006, ENVIRON HEALTH PERSP, V114, P194, DOI 10.1289/ehp.8391; Mai BX, 2005, ENVIRON SCI TECHNOL, V39, P3521; Marsh G, 2006, CHEMOSPHERE, V63, P690, DOI 10.1016/j.chemosphere.2005.07.072; Marteau C, 2012, RAPID COMMUN MASS SP, V26, P599, DOI 10.1002/rcm.6136; Nair R, 2003, J BIOL CHEM, V278, P6470, DOI 10.1074/jbc.M209319200; Naomi D., 2010, TOXICOL SCI, V117, P439; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Orn U, 1998, XENOBIOTICA, V28, P199, DOI 10.1080/004982598239687; Sanders JM, 2005, TOXICOL SCI, V88, P127, DOI 10.1093/toxsci/kfi288; Shao J, 2008, MAR ENVIRON RES, V66, P7, DOI 10.1016/j.marenvres.2008.02.007; Shao J, 2008, TOXICOL SCI, V101, P81, DOI 10.1093/toxsci/kfm256; Stapleton HM, 2009, ENVIRON HEALTH PERSP, V117, P197, DOI 10.1289/ehp.11807; Staskal DF, 2005, TOXICOL SCI, V84, P225, DOI 10.1093/toxsci/kfi090; Suvorov A, 2010, ENVIRON HEALTH PERSP, V118, P97, DOI 10.1289/ehp.0901031; Vurusaner B, 2012, FREE RADICAL BIO MED, V52, P7, DOI 10.1016/j.freeradbiomed.2011.09.035; Wong EWP, 2011, TRENDS PHARMACOL SCI, V32, P290, DOI 10.1016/j.tips.2011.01.001; Yan C, 2011, EXP TOXICOL PATHOL, V63, P413, DOI 10.1016/j.etp.2010.02.018; Yang XJ, 2012, TOXICOLOGY, V300, P138, DOI 10.1016/j.tox.2012.06.010; Yoshihara A, 2012, THYROID, V22, P1054, DOI 10.1089/thy.2012.0003; Yuan HP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015726	39	62	67	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66301	10.1371/journal.pone.0066301	http://dx.doi.org/10.1371/journal.pone.0066301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762486	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800095
J	Bradley, CK; Norton, CR; Chen, Y; Han, XH; Booth, CJ; Yoon, JK; Krebs, LT; Gridley, T				Bradley, Cara K.; Norton, Christine R.; Chen, Ying; Han, Xianghua; Booth, Carmen J.; Yoon, Jeong Kyo; Krebs, Luke T.; Gridley, Thomas			The Snail Family Gene Snai3 Is Not Essential for Embryogenesis in Mice	PLOS ONE			English	Article							EXPRESSION; TRANSCRIPTION; DIFFERENTIATION; MYOGENESIS; SMUC; MYOD	The Snail gene family encodes zinc finger-containing transcriptional repressor proteins. Three members of the Snail gene family have been described in mammals, encoded by the Snai1, Snai2, and Snai3 genes. The function of the Snai1 and Snai2 genes have been studied extensively during both vertebrate embryogenesis and tumor progression and metastasis, and play critically important roles during these processes. However, little is known about the function of the Snai3 gene and protein. We describe here generation and analysis of Snai3 conditional and null mutant mice. We also generated an EYFP-tagged Snai3 null allele that accurately reflects endogenous Snai3 gene expression, with the highest levels of expression detected in thymus and skeletal muscle. Snai3 null mutant homozygous mice are viable and fertile, and exhibit no obvious phenotypic defects. These results demonstrate that Snai3 gene function is not essential for embryogenesis in mice.	[Bradley, Cara K.; Norton, Christine R.; Chen, Ying; Han, Xianghua; Yoon, Jeong Kyo; Krebs, Luke T.; Gridley, Thomas] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME USA; [Chen, Ying] Univ Maine, Grad Sch Biomed Sci, Orono, ME USA; [Booth, Carmen J.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA	Maine Medical Center; University of Maine System; University of Maine Orono; Yale University	Gridley, T (corresponding author), Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME USA.	gridlt@mmc.org		Bradley, Cara/0000-0001-9677-3363	NIH [R01AR055278, R01HD034883, P20GM103465, P30GM103392]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD034883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103465, P30GM103392] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH to JKY (R01AR055278) and TG (R01HD034883). In addition, the Molecular Phenotyping Core Facility was supported by NIH grant P20GM103465, and the Histopathology Core Facility was supported by NIH grants P20GM103465 and P30GM103392. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Barrallo-Gimeno A, 2009, TRENDS GENET, V25, P248, DOI 10.1016/j.tig.2009.04.001; Chen Y, 2013, J BONE MINE IN PRESS; Chiang C, 2012, CYTOKINE GROWTH FACT; Dahlem T, 2012, EUR J IMMUNOL, V42, P1038, DOI 10.1002/eji.201142193; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Kataoka H, 2000, NUCLEIC ACIDS RES, V28, P626, DOI 10.1093/nar/28.2.626; Katoh M, 2003, INT J MOL MED, V11, P383; Katoh M, 2005, ONCOL REP, V14, P1083; Krebs LT, 2012, GENESIS, V50, P366, DOI 10.1002/dvg.20813; Liedtke D, 2011, GENE EXPR PATTERNS, V11, P181, DOI 10.1016/j.gep.2010.11.003; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; Murray SA, 2006, P NATL ACAD SCI USA, V103, P10300, DOI 10.1073/pnas.0602234103; Soleimani VD, 2012, MOL CELL, V47, P457, DOI 10.1016/j.molcel.2012.05.046; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Yokoyama S, 2009, DEV CELL, V17, P836, DOI 10.1016/j.devcel.2009.10.011; Zhao P, 2002, J BIOL CHEM, V277, P30091, DOI 10.1074/jbc.M202668200; Zhuge X, 2005, INT J MOL MED, V15, P945	19	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65344	10.1371/journal.pone.0065344	http://dx.doi.org/10.1371/journal.pone.0065344			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762348	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000058
J	Yin, H; Park, SY; Wang, XJ; Misawa, R; Grossman, EJ; Tao, J; Zhong, R; Witkowski, P; Bell, GI; Chong, AS				Yin, Hao; Park, Soo-Young; Wang, Xiao-Jun; Misawa, Ryosuke; Grossman, Eric J.; Tao, Jing; Zhong, Rong; Witkowski, Piotr; Bell, Graeme I.; Chong, Anita S.			Enhancing Pancreatic Beta-Cell Regeneration In Vivo with Pioglitazone and Alogliptin	PLOS ONE			English	Article							CLINICAL ISLET TRANSPLANTATION; DEPENDENT DIABETES-MELLITUS; NOD MICE; GLYCEMIC CONTROL; DB/DB MICE; ANTILYMPHOCYTE-SERUM; ALLOGRAFT SURVIVAL; INSULIN-SECRETION; MOUSE MODEL; MASS	Aims/Hypothesis: Pancreatic beta-cells retain limited ability to regenerate and proliferate after various physiologic triggers. Identifying therapies that are able to enhance beta-cell regeneration may therefore be useful for the treatment of both type 1 and type 2 diabetes. Methods: In this study we investigated endogenous and transplanted beta-cell regeneration by serially quantifying changes in bioluminescence from beta-cells from transgenic mice expressing firefly luciferase under the control of the mouse insulin I promoter. We tested the ability of pioglitazone and alogliptin, two drugs developed for the treatment of type 2 diabetes, to enhance beta-cell regeneration, and also defined the effect of the immunosuppression with rapamycin and tacrolimus on transplanted islet beta mass. Results: Pioglitazone is a stimulator of nuclear receptor peroxisome proliferator-activated receptor gamma while alogliptin is a selective dipeptidyl peptidase IV inhibitor. Pioglitazone alone, or in combination with alogliptin, enhanced endogenous beta-cell regeneration in streptozotocin-treated mice, while alogliptin alone had modest effects. In a model of syngeneic islet transplantation, immunosuppression with rapamycin and tacrolimus induced an early loss of beta-cell mass, while treatment with insulin implants to maintain normoglycemia and pioglitazone plus alogliptin was able to partially promote beta-cell mass recovery. Conclusions/Interpretation: These data highlight the utility of bioluminescence for serially quantifying functional beta-cell mass in living mice. They also demonstrate the ability of pioglitazone, used either alone or in combination with alogliptin, to enhance regeneration of endogenous islet beta-cells as well as transplanted islets into recipients treated with rapamycin and tacrolimus.	[Yin, Hao; Wang, Xiao-Jun; Misawa, Ryosuke; Grossman, Eric J.; Tao, Jing; Zhong, Rong; Witkowski, Piotr; Chong, Anita S.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Park, Soo-Young; Bell, Graeme I.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Yin, Hao] Shanghai Changzheng Hosp, Transplant Ctr, Dept Surg, Shanghai, Peoples R China; [Wang, Xiao-Jun] Third Mil Med Univ, Southwest Hosp, Inst Hepatobiliary Surg, Chongqing, Peoples R China; [Misawa, Ryosuke] Univ Miami, Dept Cellular Transplantat, Coral Gables, FL 33124 USA; [Grossman, Eric J.] Northwestern Univ, Med Ctr, Chicago, IL 60611 USA; [Tao, Jing] First Peoples Hosp Yunnan Prov, Kunming, Peoples R China	University of Chicago; University of Chicago; Naval Medical University; Army Medical University; University of Miami; Northwestern University	Chong, AS (corresponding author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	achong@uchicago.edu			Takeda Pharmaceuticals United States of America [P60DK020595]; National Institute of Diabetes and Digestive And Kidney Diseases; State of Illinois Islet Transplantation; Cinkate Pharmaceutical Corp; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595] Funding Source: NIH RePORTER	Takeda Pharmaceuticals United States of America; National Institute of Diabetes and Digestive And Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); State of Illinois Islet Transplantation; Cinkate Pharmaceutical Corp; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from Takeda Pharmaceuticals United States of America to ASC and P60DK020595 (University of Chicago Diabetes Research and Training Center), the National Institute of Diabetes and Digestive And Kidney Diseases to GIB, the State of Illinois Islet Transplantation (PW) and an international visiting fellowship from Cinkate Pharmaceutical Corp (HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjaneyulu M, 2003, METHOD FIND EXP CLIN, V25, P205, DOI 10.1358/mf.2003.25.3.769641; Baetta R, 2011, DRUGS, V71, P1441, DOI 10.2165/11591400-000000000-00000; Baggio LL, 2006, ANNU REV MED, V57, P265, DOI 10.1146/annurev.med.57.110104.115624; Barnett A, 2006, INT J CLIN PRACT, V60, P1454, DOI 10.1111/j.1742-1241.2006.01178.x; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Barton FB, 2009, CELL TRANSPLANT, V18, P753, DOI 10.3727/096368909X470874; Bertera S, 2003, DIABETES, V52, P387, DOI 10.2337/diabetes.52.2.387; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Chen XJ, 2008, TRANSPLANTATION, V85, P1246, DOI 10.1097/TP.0b013e31816b66b0; Chia CW, 2008, J CLIN ENDOCR METAB, V93, P3703, DOI 10.1210/jc.2007-2109; Chong AS, 2006, SCIENCE, V311, P1774, DOI 10.1126/science.1123510; Diani AR, 2004, AM J PHYSIOL-ENDOC M, V286, pE116, DOI 10.1152/ajpendo.00331.2003; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Faradji RN, 2009, CELL TRANSPLANT, V18, P1247, DOI 10.3727/096368909X474456; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Fosgerau K, 2012, DIABETES OBES METAB; Fowler M, 2005, TRANSPLANTATION, V79, P768, DOI 10.1097/01.TP.0000152798.03204.5C; Grossman EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008749; Guz Y, 2001, ENDOCRINOLOGY, V142, P4956, DOI 10.1210/en.142.11.4956; Ishida H, 2004, METABOLISM, V53, P488, DOI 10.1016/j.metabol.2003.11.021; Kaku K, 2011, DIABETES OBES METAB, V13, P1028, DOI 10.1111/j.1463-1326.2011.01460.x; Karges B, 2004, DIABETES CARE, V27, P1207, DOI 10.2337/diacare.27.5.1207; Kawasaki F, 2005, AM J PHYSIOL-ENDOC M, V288, pE510, DOI 10.1152/ajpendo.00128.2004; Kawashima S, 2011, BIOCHEM BIOPH RES CO, V404, P534, DOI 10.1016/j.bbrc.2010.12.021; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Kushner JA, 2010, CELL METAB, V11, P2, DOI 10.1016/j.cmet.2009.12.005; LEE HC, 1989, ENDOCRINOLOGY, V124, P1571, DOI 10.1210/endo-124-3-1571; Li WC, 2010, J CELL SCI, V123, P2792, DOI 10.1242/jcs.065268; LOHR M, 1987, DIABETOLOGIA, V30, P757; Matsui J, 2004, DIABETES, V53, P2844, DOI 10.2337/diabetes.53.11.2844; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; Molano RD, 2003, TRANSPLANTATION, V75, P1812, DOI 10.1097/01.TP.0000064622.54799.0E; Montanya E, 2000, DIABETES, V49, P1341, DOI 10.2337/diabetes.49.8.1341; Mooradian Arshag D, 2002, Treat Endocrinol, V1, P13, DOI 10.2165/00024677-200201010-00002; Moritoh Y, 2009, BRIT J PHARMACOL, V157, P415, DOI 10.1111/j.1476-5381.2009.00145.x; NAKANISHI K, 1993, METABOLISM, V42, P196, DOI 10.1016/0026-0495(93)90035-M; Nishio J, 2006, SCIENCE, V311, P1775, DOI 10.1126/science.1124004; Ogawa N, 2004, DIABETES, V53, P1700, DOI 10.2337/diabetes.53.7.1700; Park SY, 2009, HORM METAB RES, V41, P1, DOI 10.1055/s-0028-1087209; Park SY, 2005, GENESIS, V43, P80, DOI 10.1002/gene.20157; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Pileggi A, 2001, DIABETES, V50, P1983, DOI 10.2337/diabetes.50.9.1983; Pospisilik JA, 2003, DIABETES, V52, P741, DOI 10.2337/diabetes.52.3.741; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Rother KI, 2004, J CLIN INVEST, V114, P877, DOI 10.1172/JC1200423235; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Ryu S, 2001, J CLIN INVEST, V108, P63, DOI 10.1172/JCI200112335; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Smith SJ, 2006, MOL IMAGING, V5, P65, DOI 10.2310/7290.2006.00007; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Suarez-Pinzon WL, 2005, DIABETES, V54, P2596, DOI 10.2337/diabetes.54.9.2596; Suri A, 2006, SCIENCE, V311, P1778, DOI 10.1126/science.1123500; Takamura T, 1999, DIABETES RES CLIN PR, V44, P107, DOI 10.1016/S0168-8227(99)00030-3; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Virostko J, 2004, MOL IMAGING, V3, P333, DOI 10.1162/1535350042973508; Virostko J, 2010, MOL IMAGING BIOL, V12, P42, DOI 10.1007/s11307-009-0240-1; Wang M, 2012, SCI TRANSL MED, V4; Weir GC, 2004, NAT BIOTECHNOL, V22, P1095, DOI 10.1038/nbt0904-1095; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wu T, 2002, TRANSPLANTATION, V74, P22, DOI 10.1097/00007890-200207150-00005; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Yang ZD, 2006, BIOCHEM BIOPH RES CO, V344, P1017, DOI 10.1016/j.bbrc.2006.03.177; Yin D, 2006, AM J TRANSPLANT, V6, P60, DOI 10.1111/j.1600-6143.2005.01157.x; Yin DP, 2006, DIABETES, V55, P3256, DOI 10.2337/db05-1275; Zhao YF, 2006, INT J BIOCHEM CELL B, V38, P804, DOI 10.1016/j.biocel.2005.11.008	68	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65777	10.1371/journal.pone.0065777	http://dx.doi.org/10.1371/journal.pone.0065777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762423	Green Submitted, gold, Green Published			2022-12-25	WOS:000321099000104
J	Zhang, Y; Jiang, G; Sauler, M; Lee, PJ				Zhang, Yi; Jiang, Ge; Sauler, Maor; Lee, Patty J.			Lung endothelial HO-1 targeting in vivo using lentiviral miRNA regulates apoptosis and autophagy during oxidant injury	FASEB JOURNAL			English	Article						cell death; VE-cadherin; heat-shock protein	HEME OXYGENASE-1; CONFERS SUSCEPTIBILITY; GENE-TRANSCRIPTION; PROTECTIVE ROLE; CELL-DEATH; EXPRESSION; FISSION; FUSION; SIRNA; RNAS	The lung endothelium is a major target for inflammatory and oxidative stress. Heme oxygenase-1 (HO-1) induction is a crucial defense mechanism during oxidant challenges, such as hyperoxia. The role of lung endothelial HO-1during hyperoxia in vivo is not well defined. We engineered lentiviral vectors with microRNA (miRNA) sequences controlled by vascular endothelium cadherin (VE-cad) to study the specific role of lung endothelial HO-1. Wild-type (WT) murine lung endothelial cells (MLECs) or WT mice were treated with lentivirus and exposed to hyperoxia (95% oxygen). We detected HO-1 knockdown (approximate to 55%) specifically in the lung endothelium. MLECs and lungs showed approximately a 2-fold increase in apoptosis and ROS generation after HO-1 silencing. We also demonstrate for the first time that silencing endothelial HO-1 has the same effect on lung injury and survival as silencing HO-1 in multiple lung cell types and that HO-1 regulates caspase 3 activation and autophagy in endothelium during hyperoxia. These studies demonstrate the utility of endothelial-targeted gene silencing in vivo using lentiviral miRNA constructs to assess gene function and that endothelial HO-1 is an important determinant of survival during hyperoxia.Zhang, Y., Jiang, G., Sauler, M., Lee, P. J. Lung endothelial HO-1 targeting in vivo using lentiviral miRNA regulates apoptosis and autophagy during oxidant injury.	[Zhang, Yi; Sauler, Maor; Lee, Patty J.] Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT 06520 USA; [Jiang, Ge] Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, Shanghai, Peoples R China	Yale University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Lee, PJ (corresponding author), Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep Med, POB 208057, New Haven, CT 06520 USA.	patty.lee@yale.edu			U.S. National Institutes of Health [HL 071595, HL 090660, FAMRI 82384]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090660, R01HL071595] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	P.J.L. was supported by U.S. National Institutes of Health grants HL 071595, HL 090660, and FAMRI 82384. The authors thank Dr. Robert Homer (Department of Pathology, Yale University School of Medicine) for his assistance with describing pathology methodology.	Agarwal A, 2000, J AM SOC NEPHROL, V11, P965, DOI 10.1681/ASN.V115965; Banerjee P, 2012, J BIOL CHEM, V287, P32113, DOI 10.1074/jbc.M112.393140; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cao JA, 2011, HUM GENE THER, V22, P271, DOI 10.1089/hum.2010.059; Carchman EH, 2011, HEPATOLOGY, V53, P2053, DOI 10.1002/hep.24324; Constantin M, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/859235; Dib M, 2009, AM J PHYSIOL-LUNG C, V297, pL687, DOI 10.1152/ajplung.90509.2008; Dorn Ii G. W., 2013, CIRC J, V77, P1370; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Jin Y, 2012, AUTOPHAGY, V8, P426, DOI 10.4161/auto.19258; Joza S, 2012, AM J PATHOL, V181, P2003, DOI 10.1016/j.ajpath.2012.08.037; Kawamoto S, 2011, TISSUE ENG PT A, V17, P1605, DOI 10.1089/ten.tea.2010.0447; Ke BB, 2009, HUM GENE THER, V20, P1133, DOI 10.1089/hum.2009.049; Kim HP, 2008, AUTOPHAGY, V4, P887, DOI 10.4161/auto.6767; Kissler S, 2006, NAT GENET, V38, P479, DOI 10.1038/ng1766; Kosmider B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026059; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Lee PJ, 1996, AM J RESP CELL MOL, V14, P556, DOI 10.1165/ajrcmb.14.6.8652184; Lee PJ, 2000, AM J PHYSIOL-LUNG C, V279, pL175, DOI 10.1152/ajplung.2000.279.1.L175; Lian XM, 2005, J IMMUNOL, V174, P7250, DOI 10.4049/jimmunol.174.11.7250; Liu K, 2012, J CARDIOVASC PHARM T, V17, P395, DOI 10.1177/1074248412442002; Liu RL, 2012, CELL BIOL INT, V36, P863, DOI 10.1042/CBI20110662; Lo S, 2013, ANN SURG, V257, P352, DOI 10.1097/SLA.0b013e318269d0e2; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mattart L, 2012, CELL SIGNAL, V24, P199, DOI 10.1016/j.cellsig.2011.09.002; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Morse D, 2003, AM J PHYSIOL-LUNG C, V285, pL250, DOI 10.1152/ajplung.00387.2002; Novak I, 2012, ANTIOXID REDOX SIGN, V17, P794, DOI 10.1089/ars.2011.4407; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Park F, 2007, PHYSIOL GENOMICS, V31, P159, DOI 10.1152/physiolgenomics.00069.2007; Peer D, 2008, SCIENCE, V319, P627, DOI 10.1126/science.1149859; Pushparaj PN, 2008, J DENT RES, V87, P992, DOI 10.1177/154405910808701109; Raval CM, 2010, CURR DRUG TARGETS, V11, P1532; Ryter SW, 2013, CURR PHARM DESIGN, V19, P2747; Sass G, 2012, Z GASTROENTEROL, V50, P34, DOI 10.1055/s-0031-1282046; Schmeckpeper J, 2009, DIFFERENTIATION, V78, P169, DOI 10.1016/j.diff.2009.01.002; Scott JR, 2005, CRIT CARE MED, V33, P2563, DOI 10.1097/01.CCM.0000186765.61268.FC; Shen XD, 2012, AM J TRANSPLANT, V12, P1730, DOI 10.1111/j.1600-6143.2012.04021.x; Siner JM, 2007, FASEB J, V21, P1422, DOI 10.1096/fj.06-6661com; Snove O, 2006, NAT METHODS, V3, P689, DOI 10.1038/NMETH927; Sun MW, 2013, CARDIOVASC RES, V97, P686, DOI 10.1093/cvr/cvs423; Tanimoto T, 2009, FREE RADICAL BIO MED, V46, P1119, DOI 10.1016/j.freeradbiomed.2009.01.017; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Unuma K, 2013, HEPATOL RES, V43, P91, DOI 10.1111/j.1872-034X.2012.01049.x; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang J, 2013, J SURG RES, V182, pE79, DOI 10.1016/j.jss.2012.11.014; Zhang XC, 2005, J IMMUNOL, V175, P4834, DOI 10.4049/jimmunol.175.8.4834; Zhang XC, 2004, J BIOL CHEM, V279, P10677, DOI 10.1074/jbc.M312941200; Zhang XC, 2003, AM J RESP CELL MOL, V28, P305, DOI 10.1165/rcmb.2002-0156OC; Zhang XC, 2002, AM J PHYSIOL-LUNG C, V283, pL815, DOI 10.1152/ajplung.00485.2001; Zhang XC, 2006, FASEB J, V20, P2156, DOI 10.1096/fj.06-5668fje; Zungu M, 2011, CIRC J, V75, P2513, DOI 10.1253/circj.CJ-11-0967	58	41	42	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2013	27	10					4041	4058		10.1096/fj.13-231225	http://dx.doi.org/10.1096/fj.13-231225			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	290IC	23771928	Bronze, Green Published			2022-12-25	WOS:000329747100018
J	Krupnik, T; Kotabova, E; van Bezouwen, LS; Mazur, R; Garstka, M; Nixon, PJ; Barber, J; Kana, R; Boekema, EJ; Kargul, J				Krupnik, Tomasz; Kotabova, Eva; van Bezouwen, Laura S.; Mazur, Radoslaw; Garstka, Maciej; Nixon, Peter J.; Barber, James; Kana, Radek; Boekema, Egbert J.; Kargul, Joanna			A Reaction Center-dependent Photoprotection Mechanism in a Highly Robust Photosystem II from an Extremophilic Red Alga, Cyanidioschyzon merolae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING ANTENNA; OXYGEN-EVOLVING CENTER; CHLOROPHYLL FLUORESCENCE; EXTRINSIC PROTEINS; PHOTOSYNTHETIC ACCLIMATION; PORPHYRIDIUM-CRUENTUM; CYANIDIUM-CALDARIUM; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; CORE COMPLEXES	Members of the rhodophytan order Cyanidiales are unique among phototrophs in their ability to live in extremely low pH levels and moderately high temperatures. The photosynthetic apparatus of the red alga Cyanidioschyzon merolae represents an intermediate type between cyanobacteria and higher plants, suggesting that this alga may provide the evolutionary link between prokaryotic and eukaryotic phototrophs. Although we now have a detailed structural model of photosystem II (PSII) from cyanobacteria at an atomic resolution, no corresponding structure of the eukaryotic PSII complex has been published to date. Here we report the isolation and characterization of a highly active and robust dimeric PSII complex from C. merolae. We show that this complex is highly stable across a range of extreme light, temperature, and pH conditions. By measuring fluorescence quenching properties of the isolated C. merolae PSII complex, we provide the first direct evidence of pH-dependent non-photochemical quenching in the red algal PSII reaction center. This type of quenching, together with high zeaxanthin content, appears to underlie photoprotection mechanisms that are efficiently employed by this robust natural water-splitting complex under excess irradiance. In order to provide structural details of this eukaryotic form of PSII, we have employed electron microscopy and single particle analyses to obtain a 17 angstrom map of the C. merolae PSII dimer in which we locate the position of the protein mass corresponding to the additional extrinsic protein stabilizing the oxygen-evolving complex, PsbQ'. We conclude that this lumenal subunit is present in the vicinity of the CP43 protein, close to the membrane plane.	[Krupnik, Tomasz; Kargul, Joanna] Univ Warsaw, Fac Biol, Dept Plant Mol Physiol, PL-02096 Warsaw, Poland; [Kotabova, Eva; Kana, Radek] Acad Sci Czech Republ, Inst Microbiol, Lab Photosynthesis, CZ-37981 Trebon, Czech Republic; [Kotabova, Eva; Kana, Radek] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [van Bezouwen, Laura S.; Boekema, Egbert J.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Electron Microscopy Grp, NL-9747 AG Groningen, Netherlands; [Mazur, Radoslaw; Garstka, Maciej] Univ Warsaw, Fac Biol, Dept Metab Regulat, PL-02096 Warsaw, Poland; [Nixon, Peter J.; Barber, James] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England	University of Warsaw; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of Groningen; University of Warsaw; Imperial College London	Kargul, J (corresponding author), Univ Warsaw, Fac Biol, Dept Plant Mol Physiol, Miecznikowa 1, PL-02096 Warsaw, Poland.	j.kargul@biol.uw.edu.pl	Kaňa, Radek/A-6434-2009; Kotabova, Eva/E-4560-2011; Krupnik, Tomasz/Q-3056-2016; Mazur, Radosław/P-3283-2019; Kargul, Joanna/AGD-9163-2022; Garstka, Maciej Z/T-4962-2018; Kargul, Joanna/AAN-4227-2021	Kaňa, Radek/0000-0001-5768-6902; Kotabova, Eva/0000-0003-1092-3020; Mazur, Radosław/0000-0003-3615-1911; Kargul, Joanna/0000-0003-1410-1905; Garstka, Maciej Z/0000-0001-7141-505X; Krupnik, Tomasz/0000-0001-6107-7667; Nixon, Peter/0000-0003-1952-6937	Polish Ministry of Science and Higher Education; European Science Foundation [844/N-ESFEuroSolarFuels/10/2011/0]; European Union; Czech Republic Academy of Sciences [GACR P501-120304, CZ.1.05/2.1.00/03.0110]; BBSRC [BB/I00937X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C507037/1, BB/I00937X/1] Funding Source: researchfish	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Science Foundation(European Science Foundation (ESF)European Commission); European Union(European Commission); Czech Republic Academy of Sciences; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Polish Ministry of Science and Higher Education and by European Science Foundation Grant 844/N-ESFEuroSolarFuels/10/2011/0 (to J. K.) and was partially performed with the use of CePT infrastructure financed by the European Union (European Regional Development Fund within the Operational Program "Innovative Economy" for 2007-2013) (to R. M. and M. G.).; Supported by Czech Republic Academy of Sciences Project GACR P501-120304 and Project Algatech (CZ.1.05/2.1.00/03.0110).	Adachi H, 2009, BBA-BIOENERGETICS, V1787, P121, DOI 10.1016/j.bbabio.2008.11.004; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Arteni AA, 2005, J STRUCT BIOL, V149, P325, DOI 10.1016/j.jsb.2004.12.002; Badura A, 2006, PHOTOCHEM PHOTOBIOL, V82, P1385, DOI 10.1562/2006-07-14-RC-969; Barber J, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0984; Boussac A, 2004, J BIOL CHEM, V279, P22809, DOI 10.1074/jbc.M401677200; Boussac A, 2011, BBA-BIOENERGETICS, V1807, P119, DOI 10.1016/j.bbabio.2010.10.004; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; Bruce D, 1997, BIOCHEMISTRY-US, V36, P749, DOI 10.1021/bi962216c; Bumba L, 2004, EUR J BIOCHEM, V271, P2967, DOI 10.1111/j.1432-1033.2004.04226.x; Busch A, 2010, PLANT J, V62, P886, DOI 10.1111/j.1365-313X.2010.04202.x; Ciniglia C, 2004, MOL ECOL, V13, P1827, DOI 10.1111/j.1365-294X.2004.02180.x; Cox N., 2013, BIOCH BIOPH IN PRESS; Cser K, 2007, BBA-BIOENERGETICS, V1767, P233, DOI 10.1016/j.bbabio.2007.01.022; Cullen M, 2007, PHOTOCH PHOTOBIO SCI, V6, P1177, DOI 10.1039/b708611n; Cunningham FX, 2007, EUKARYOT CELL, V6, P533, DOI 10.1128/EC.00265-06; CUNNINGHAM FX, 1989, PLANT PHYSIOL, V91, P1179, DOI 10.1104/pp.91.3.1179; Cunningham FX, 2005, PLANT J, V41, P478, DOI 10.1111/j.1365-313X.2004.02309.x; Dall'Osto L, 2012, J BIOL CHEM, V287, P41820, DOI 10.1074/jbc.M112.405498; Dau H, 2008, PHILOS T R SOC B, V363, P1237, DOI 10.1098/rstb.2007.2220; de Groot HJM, 2010, APPL MAGN RESON, V37, P497, DOI 10.1007/s00723-009-0097-0; Delphin E, 1998, PLANT PHYSIOL, V118, P103, DOI 10.1104/pp.118.1.103; Delphin E, 1996, BIOCHEMISTRY-US, V35, P9435, DOI 10.1021/bi960528+; DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170; Enami I, 1998, BIOCHEMISTRY-US, V37, P2787, DOI 10.1021/bi9724624; Enami I, 2010, CELL ORIG LIFE EXTRE, V13, P373, DOI 10.1007/978-90-481-3795-4_20; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Frank H. A., 1993, CAROTENOIDS PHOTOSYN, P252, DOI [10.1007/978-94-011-2124-8_8, DOI 10.1007/978-94-011-2124-8_8]; Gardian Z, 2007, BBA-BIOENERGETICS, V1767, P725, DOI 10.1016/j.bbabio.2007.01.021; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Havaux M, 1998, TRENDS PLANT SCI, V3, P147, DOI 10.1016/S1360-1385(98)01200-X; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horton P, 2008, FEBS J, V275, P1069, DOI 10.1111/j.1742-4658.2008.06263.x; Ivanov AG, 2008, PHOTOSYNTH RES, V98, P565, DOI 10.1007/s11120-008-9365-3; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; Kaminskaya O, 2005, BBA-BIOENERGETICS, V1708, P333, DOI 10.1016/j.bbabio.2005.05.002; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kana R, 2012, BBA-BIOENERGETICS, V1817, P1237, DOI 10.1016/j.bbabio.2012.02.024; Kargul J., 2012, PHOTSYNTHESIS RES FO, P59; Kargul J, 2008, FEBS J, V275, P1056, DOI 10.1111/j.1742-4658.2008.06262.x; Kargul J, 2007, BBA-BIOENERGETICS, V1767, P404, DOI 10.1016/j.bbabio.2007.01.007; Kato M, 2012, J AM CHEM SOC, V134, P8332, DOI 10.1021/ja301488d; Kirilovsky D., 2013, NONPHOTOCHEMICAL QUE; Koblizek M, 1999, PHOTOSYNTHETICA, V37, P307, DOI 10.1023/A:1007120424769; KOK B, 1956, BIOCHIM BIOPHYS ACTA, V21, P234, DOI 10.1016/0006-3002(56)90003-8; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Koua FHM, 2013, P NATL ACAD SCI USA, V110, P3889, DOI 10.1073/pnas.1219922110; KRIEGER A, 1992, BIOCHIM BIOPHYS ACTA, V1102, P167, DOI 10.1016/0167-4838(92)90507-A; Kuhl H, 1999, EUR J BIOCHEM, V266, P453, DOI 10.1046/j.1432-1327.1999.00877.x; LAVERGNE J, 1982, BIOCHIM BIOPHYS ACTA, V682, P345, DOI 10.1016/0005-2728(82)90048-2; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Minoda A, 2004, PLANT CELL PHYSIOL, V45, P667, DOI 10.1093/pcp/pch087; Murray JW, 2008, PHOTOSYNTH RES, V98, P523, DOI 10.1007/s11120-008-9366-2; Murray JW, 2008, ENERG ENVIRON SCI, V1, P161, DOI 10.1039/b810067p; Nocera DG, 2012, ACCOUNTS CHEM RES, V45, P767, DOI 10.1021/ar2003013; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Nozaki H, 2003, J MOL EVOL, V56, P485, DOI 10.1007/s00239-002-2419-9; Ohta H, 2003, EUR J BIOCHEM, V270, P4156, DOI 10.1046/j.1432-1033.2003.03810.x; Oostergetel GT, 1998, ULTRAMICROSCOPY, V74, P47, DOI 10.1016/S0304-3991(98)00022-9; Oren A, 1995, MAR ECOL PROG SER, V128, P151, DOI 10.3354/meps128151; Pagliano C, 2011, PHOTOSYNTH RES, V108, P33, DOI 10.1007/s11120-011-9650-4; Quigg A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047036; Roose JL, 2007, P NATL ACAD SCI USA, V104, P2548, DOI 10.1073/pnas.0609337104; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; Rudowska L, 2012, BBA-BIOENERGETICS, V1817, P1380, DOI 10.1016/j.bbabio.2012.03.013; Santabarbara S, 2013, PLANT PHYSIOL, V161, P535, DOI 10.1104/pp.112.205260; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shen JR, 2000, BIOCHEMISTRY-US, V39, P14739, DOI 10.1021/bi001402m; Shi LX, 2000, J BIOL CHEM, V275, P37945, DOI 10.1074/jbc.M006300200; Siegbahn P. E., 2013, BIOCH BIOPH IN PRESS; Sozer O, 2010, PLANT CELL PHYSIOL, V51, P823, DOI 10.1093/pcp/pcq031; Sproviero EM, 2008, PHILOS T R SOC B, V363, P1149, DOI 10.1098/rstb.2007.2210; Szabo I, 2005, EMBO REP, V6, P629, DOI 10.1038/sj.embor.7400460; Telfer A, 2005, PHOTOCH PHOTOBIO SCI, V4, P950, DOI 10.1039/b507888c; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; Vass I, 2009, TRENDS PLANT SCI, V14, P200, DOI 10.1016/j.tplants.2009.01.009; Vittadello M, 2010, CHEMSUSCHEM, V3, P471, DOI 10.1002/cssc.200900255; Wang ZG, 2010, J INTEGR PLANT BIOL, V52, P793, DOI 10.1111/j.1744-7909.2010.00971.x; WOLFE GR, 1994, NATURE, V367, P566, DOI 10.1038/367566a0; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186	85	46	46	0	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23529	23542		10.1074/jbc.M113.484659	http://dx.doi.org/10.1074/jbc.M113.484659			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23775073	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000330598200057
J	Rosen, O; Weil, S; Manor, R; Roth, Z; Khalaila, I; Sagi, A				Rosen, Ohad; Weil, Simy; Manor, Rivka; Roth, Ziv; Khalaila, Isam; Sagi, Amir			A Crayfish Insulin-like-binding Protein ANOTHER PIECE IN THE ANDROGENIC GLAND INSULIN-LIKE HORMONE PUZZLE IS REVEALED	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHERAX-QUADRICARINATUS; IGF-I; GROWTH; RECEPTOR; GENE; IMPLANTATION; PEPTIDE; MEMBER; INTERSEXUALITY; EXPRESSION	Across the animal kingdom, the involvement of insulin-like peptide (ILP) signaling in sex-related differentiation processes is attracting increasing attention. Recently, a gender-specific ILP was identified as the androgenic sex hormone in Crustacea. However, moieties modulating the actions of this androgenic insulin-like growth factor were yet to be revealed. Through molecular screening of an androgenic gland (AG) cDNA library prepared from the crayfish Cherax quadricarinatus, we have identified a novel insulin-like growth factor-binding protein (IGFBP) termed Cq-IGFBP. Based on bioinformatics analyses, the deduced Cq-IGFBP was shown to share high sequence homology with IGFBP family members from both invertebrates and vertebrates. The protein also includes a sequence determinant proven crucial for ligand binding, which according to three-dimensional modeling is assigned to the exposed outer surface of the protein. Recombinant Cq-IGFBP (rCq-IGFBP) protein was produced and, using a "pulldown" methodology, was shown to specifically interact with the insulin-like AG hormone of the crayfish (Cq-IAG). Particularly, using both mass spectral analysis and an immunological tool, rCq-IGFBP was shown to bind the Cq-IAG prohormone. Furthermore, a peptide corresponding to residues 23-38 of the Cq-IAG A-chain was found sufficient for in vitro recognition by rCq-IGFBP. Cq-IGFBP is the first IGFBP family member shown to specifically interact with a gender-specific ILP. Unlike their ILP ligands, IGFBPs are highly conserved across evolution, from ancient arthropods, like crustaceans, to humans. Such conservation places ILP signaling at the center of sex-related phenomena in early animal development.	[Rosen, Ohad; Weil, Simy; Manor, Rivka; Roth, Ziv; Sagi, Amir] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Rosen, Ohad; Weil, Simy; Manor, Rivka; Sagi, Amir] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Roth, Ziv; Khalaila, Isam] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University	Sagi, A (corresponding author), POB 653, IL-84105 Beer Sheva, Israel.	sagia@bgu.ac.il	khalaila, Isam/F-1498-2012	khalaila, Isam/0000-0003-3250-5778; Sagi, Amir/0000-0002-4229-1059	BARD of the United States-Israel Binational Agricultural Research and Development Fund [QB-9308-06]	BARD of the United States-Israel Binational Agricultural Research and Development Fund	This work was supported by Research Grant QB-9308-06 from BARD of the United States-Israel Binational Agricultural Research and Development Fund.	Alic N, 2011, AGING CELL, V10, P137, DOI 10.1111/j.1474-9726.2010.00653.x; Andersen AS, 2000, J BIOL CHEM, V275, P16948, DOI 10.1074/jbc.M001578200; Arnott D, 1998, ANAL BIOCHEM, V258, P1, DOI 10.1006/abio.1998.2566; Bach Leon A, 2004, Clin Biochem Rev, V25, P155; Barki A, 2003, J EXP BIOL, V206, P1791, DOI 10.1242/jeb.00335; Barki A, 2006, HORM BEHAV, V50, P322, DOI 10.1016/j.yhbeh.2006.03.017; Baxter RC, 2000, AM J PHYSIOL-ENDOC M, V278, pE967, DOI 10.1152/ajpendo.2000.278.6.E967; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Capoluongo E, 2011, AM J PATHOL, V178, P26, DOI 10.1016/j.ajpath.2010.11.004; Castellanos M, 2008, COMP BIOCHEM PHYS D, V3, P270, DOI 10.1016/j.cbd.2008.07.002; Chan SJ, 2000, AM ZOOL, V40, P213; Cheng LY, 2011, CELL, V146, P435, DOI 10.1016/j.cell.2011.06.040; Daza DO, 2011, ENDOCRINOLOGY, V152, P2278, DOI 10.1210/en.2011-0047; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; Eigenbrot C, 2012, STRUCTURE, V20, P1040, DOI 10.1016/j.str.2012.03.021; Emlen DJ, 2012, SCIENCE, V337, P860, DOI 10.1126/science.1224286; Fedina TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049799; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Forbes B. E., 2012, FRONT ENDOCRINOL, V3, P1; Gai YC, 2010, FISH SHELLFISH IMMUN, V28, P10, DOI 10.1016/j.fsi.2009.09.013; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Glazer L, 2010, J BIOL CHEM, V285, P12831, DOI 10.1074/jbc.M109.071068; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401; Holzenberger M, 1997, J NEUROSCI, V17, P6974; Honegger Basil, 2008, J Biol, V7, P10, DOI 10.1186/jbiol72; Hong J, 2002, J BIOL CHEM, V277, P10489, DOI 10.1074/jbc.M109604200; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Imai Y, 2000, J BIOL CHEM, V275, P18188, DOI 10.1074/jbc.M000070200; Kawamura K, 2004, P NATL ACAD SCI USA, V101, P7323, DOI 10.1073/pnas.0307061101; Kelley KM, 2002, J ENDOCRINOL, V175, P3, DOI 10.1677/joe.0.1750003; Khalaila I, 2002, GEN COMP ENDOCR, V127, P147, DOI 10.1016/S0016-6480(02)00031-X; Khalaila I, 2001, GEN COMP ENDOCR, V121, P242, DOI 10.1006/gcen.2001.7607; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Laron Z, 2001, J CLIN PATHOL-MOL PA, V54, P311; Li N, 2012, FISH SHELLFISH IMMUN, V33, P229, DOI 10.1016/j.fsi.2012.04.016; Manor R, 2004, INVERTEBR REPROD DEV, V45, P151, DOI 10.1080/07924259.2004.9652584; Manor R, 2007, GEN COMP ENDOCR, V150, P326, DOI 10.1016/j.ygcen.2006.09.006; Martin G, 1999, EUR J BIOCHEM, V262, P727, DOI 10.1046/j.1432-1327.1999.00442.x; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; Okamoto N, 2009, FEBS J, V276, P1221, DOI 10.1111/j.1742-4658.2008.06859.x; Okamoto N, 2013, GENE DEV, V27, P87, DOI 10.1101/gad.204479.112; Okuno A, 2002, PEPTIDES, V23, P567, DOI 10.1016/S0196-9781(01)00635-0; Pavelic J, 2007, INDIAN J MED RES, V125, P511; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Rosen O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015281; Roth Z, 2010, GLYCOCONJUGATE J, V27, P159, DOI 10.1007/s10719-009-9268-3; Sagi A, 2002, INVERTEBR REPROD DEV, V41, P27, DOI 10.1080/07924259.2002.9652732; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; STEINER DF, 1978, DIABETES, V27, P145, DOI 10.2337/diab.27.1.S145; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ventura T, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097261; Ventura T, 2011, GEN COMP ENDOCR, V173, P381, DOI 10.1016/j.ygcen.2011.05.018; Ventura T, 2009, ENDOCRINOLOGY, V150, P1278, DOI 10.1210/en.2008-0906; Walossek D., 1998, CRUSTACEANS BIODIVER, P3; Yamanaka Y, 1997, J BIOL CHEM, V272, P30729, DOI 10.1074/jbc.272.49.30729; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046513	58	41	42	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22289	22298		10.1074/jbc.M113.484279	http://dx.doi.org/10.1074/jbc.M113.484279			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23775079	Green Published, hybrid			2022-12-25	WOS:000330596300011
J	He, Y; Lazaridis, T				He, Yi; Lazaridis, Themis			Activity Determinants of Helical Antimicrobial Peptides: A Large-Scale Computational Study	PLOS ONE			English	Article							POTENT ANTIBACTERIAL PEPTIDES; EFFECTIVE ENERGY FUNCTION; LIPID-BILAYER DISRUPTION; MAGAININ 2; PHOSPHOLIPID-MEMBRANES; PORE FORMATION; HOST-DEFENSE; ESCHERICHIA-COLI; NMR-SPECTROSCOPY; MAMMALIAN-CELLS	Antimicrobial peptides (AMPs), produced by a wide range of organisms, have attracted attention due to their potential use as novel antibiotics. The majority of these peptides are cationic and are thought to function by permeabilizing the bacterial membrane, either by making pores or by dissolving it ('carpet' model). A key hypothesis in the literature is that antimicrobial and hemolytic activity correlate with binding affinity to anionic and zwitterionic membranes, respectively. Here we test this hypothesis by using binding free energy data collected from the literature and theoretical binding energies calculated from implicit membrane models for 53 helical AMPs. We indeed find a correlation between binding energy and biological activity, depending on membrane anionic content: antibacterial activity correlates best with transfer energy to membranes with anionic lipid fraction higher than 30% and hemolytic activity correlates best with transfer energy to a 10% anionic membrane. However, the correlations are weak, with correlation coefficient up to 0.4. Weak correlations of the biological activities have also been found with other physical descriptors of the peptides, such as surface area occupation, which correlates significantly with antibacterial activity; insertion depth, which correlates significantly with hemolytic activity; and structural fluctuation, which correlates significantly with both activities. The membrane surface coverage by many peptides at the MIC is estimated to be much lower than would be required for the 'carpet' mechanism. Those peptides that are active at low surface coverage tend to be those identified in the literature as pore-forming. The transfer energy from planar membrane to cylindrical and toroidal pores was also calculated for these peptides. The transfer energy to toroidal pores is negative in almost all cases while that to cylindrical pores is more favorable in neutral than in anionic membranes. The transfer energy to pores correlates with the deviation from predictions of the 'carpet' model.	[He, Yi; Lazaridis, Themis] CUNY City Coll, Dept Chem, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Lazaridis, T (corresponding author), CUNY City Coll, Dept Chem, New York, NY 10031 USA.	tlazaridis@ccny.cuny.edu			NIH [SC1 GM087190]; RCMI from NIH [2G12RR03060-26A1/8G12MD007603-27]; NSF [CNS-0855217, CNS-0958379]; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RCMI from NIH; NSF(National Science Foundation (NSF)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIH grant SC1 GM087190. Infrastructure support was provided by RCMI grant 2G12RR03060-26A1/8G12MD007603-27 from NIH. Computational resources were provided by the City University of New York High Performance Computing Center, supported under NSF Grants CNS-0855217 and CNS-0958379. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende D, 2005, BIOPHYS J, V88, P1828, DOI 10.1529/biophysj.104.049817; Allende D, 2003, CHEM PHYS LIPIDS, V122, P65, DOI 10.1016/S0009-3084(02)00179-2; Almeida PF, 2009, BIOCHEMISTRY-US, V48, P8083, DOI 10.1021/bi900914g; Bastos M, 2008, BIOPHYS J, V94, P2128, DOI 10.1529/biophysj.107.119032; Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001; Ben-Tal N, 2000, BIOPHYS J, V79, P1180, DOI 10.1016/S0006-3495(00)76372-7; BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P52, DOI 10.1021/bi00453a007; Bhonsle JB, 2007, J MED CHEM, V50, P6545, DOI 10.1021/jm070884y; BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI [10.1104/pp.108.4.1353, 10.1016/j.chiabu.2021.105188]; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bulai T, 2003, FEBS LETT, V534, P185, DOI 10.1016/S0014-5793(02)03838-3; Cherkasov A, 2009, ACS CHEM BIOL, V4, P65, DOI 10.1021/cb800240j; Clark KS, 2011, BIOCHEMISTRY-US, V50, P7919, DOI 10.1021/bi200873u; Crandall YM, 2008, BIOPOLYMERS, V89, P197, DOI 10.1002/bip.20891; da Silva A, 2003, BBA-MOL CELL RES, V1643, P95, DOI 10.1016/j.bbamcr.2003.10.001; Dathe M, 2002, BBA-BIOMEMBRANES, V1558, P171, DOI 10.1016/S0005-2736(01)00429-1; Dathe M, 1997, FEBS LETT, V403, P208, DOI 10.1016/S0014-5793(97)00055-0; EISENBERG D, 1982, FARADAY SYMP CHEM S, P109, DOI 10.1039/fs9821700109; Fernandez-Vidall M, 2007, J MOL BIOL, V370, P459, DOI 10.1016/j.jmb.2007.05.016; Fjell CD, 2011, CHEM BIOL DRUG DES, V77, P48, DOI 10.1111/j.1747-0285.2010.01044.x; Frecer V, 2006, BIOORGAN MED CHEM, V14, P6065, DOI 10.1016/j.bmc.2006.05.005; Gable JE, 2009, BIOCHEMISTRY-US, V48, P11264, DOI 10.1021/bi900996q; Ganz T, 1998, CURR OPIN IMMUNOL, V10, P41, DOI 10.1016/S0952-7915(98)80029-0; GLASER RW, 1988, BIOCHIM BIOPHYS ACTA, V940, P275, DOI 10.1016/0005-2736(88)90202-7; Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200; Gregory SM, 2009, BIOPHYS J, V96, P116, DOI 10.1016/j.bpj.2008.09.017; Hall BA, 2011, BIOPHYS J, V100, P1940, DOI 10.1016/j.bpj.2011.02.041; Hallock KJ, 2002, BIOPHYS J, V83, P1004, DOI 10.1016/S0006-3495(02)75226-0; He Y, 2013, J COMPUT CHEM, V34, P1463, DOI 10.1002/jcc.23282; Hilpert K, 2006, CHEM BIOL, V13, P1101, DOI 10.1016/j.chembiol.2006.08.014; Hincha DK, 1996, BBA-BIOMEMBRANES, V1284, P162, DOI 10.1016/S0005-2736(96)00122-8; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Imura Y, 2008, BIOPHYS J, V95, P5757, DOI 10.1529/biophysj.108.133488; Jenssen H, 2008, J PEPT SCI, V14, P110, DOI 10.1002/psc.908; Jenssen H, 2007, CHEM BIOL DRUG DES, V70, P134, DOI 10.1111/j.1747-0285.2007.00543.x; JOHN E, 1992, BIOPHYS J, V63, P1536, DOI 10.1016/S0006-3495(92)81737-X; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Lazaridis T, 2005, J CHEM THEORY COMPUT, V1, P716, DOI 10.1021/ct050055x; Lazaridis T, 2005, PROTEINS, V58, P518, DOI 10.1002/prot.20358; Lazaridis T, 2003, PROTEINS, V52, P176, DOI 10.1002/prot.10410; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Lee CC, 2011, BIOPHYS J, V100, P1688, DOI 10.1016/j.bpj.2011.02.018; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Lewis JR, 1999, BIOCHEMISTRY-US, V38, P5932, DOI 10.1021/bi9828167; Liu ZG, 2007, ANTIMICROB AGENTS CH, V51, P597, DOI 10.1128/AAC.00828-06; Loose C, 2006, NATURE, V443, P867, DOI 10.1038/nature05233; Lorian V., 2005, ANTIBIOTICS LAB MED; Mani R, 2004, BIOCHEMISTRY-US, V43, P13839, DOI 10.1021/bi048650t; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Matsuzaki K, 1997, BBA-BIOMEMBRANES, V1327, P119, DOI 10.1016/S0005-2736(97)00051-5; Matsuzaki K, 2009, BBA-BIOMEMBRANES, V1788, P1687, DOI 10.1016/j.bbamem.2008.09.013; Mei H, 2005, BIOPOLYMERS, V80, P775, DOI 10.1002/bip.20296; Melo MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028549; Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095; Mihajlovic M, 2010, BBA-BIOMEMBRANES, V1798, P1494, DOI 10.1016/j.bbamem.2010.02.023; Mowery BP, 2007, J AM CHEM SOC, V129, P15474, DOI 10.1021/ja077288d; Oren Z, 1996, EUR J BIOCHEM, V237, P303, DOI 10.1111/j.1432-1033.1996.0303n.x; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Oren Z, 1997, BIOCHEMISTRY-US, V36, P1826, DOI 10.1021/bi962507l; Oren Z, 1997, J BIOL CHEM, V272, P14643, DOI 10.1074/jbc.272.23.14643; Oren Z, 1999, EUR J BIOCHEM, V259, P360, DOI 10.1046/j.1432-1327.1999.00047.x; Papo N, 2003, PEPTIDES, V24, P1693, DOI 10.1016/j.peptides.2003.09.013; PATHAK N, 1995, PROTEINS, V22, P182, DOI 10.1002/prot.340220210; Porcelli F, 2008, BIOCHEMISTRY-US, V47, P5565, DOI 10.1021/bi702036s; Ramamoorthy A, 2010, BBA-BIOMEMBRANES, V1798, P223, DOI 10.1016/j.bbamem.2009.08.012; Ramamoorthy A, 2009, SOLID STATE NUCL MAG, V35, P201, DOI 10.1016/j.ssnmr.2009.03.003; RAPAPORT D, 1991, J BIOL CHEM, V266, P23769; RAPAPORT D, 1992, J BIOL CHEM, V267, P6502; Rivas L, 2009, BBA-BIOMEMBRANES, V1788, P1570, DOI 10.1016/j.bbamem.2008.11.002; Sato H, 2006, BIOCHEMISTRY-US, V45, P9997, DOI 10.1021/bi060979m; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shai Y, 1996, J BIOL CHEM, V271, P7305, DOI 10.1074/jbc.271.13.7305; Song C, 2013, P NATL ACAD SCI USA, V110, P4586, DOI 10.1073/pnas.1214739110; Sood R, 2008, BBA-BIOMEMBRANES, V1778, P983, DOI 10.1016/j.bbamem.2007.11.016; Takahashi D, 2010, BIOCHIMIE, V92, P1236, DOI 10.1016/j.biochi.2010.02.023; Tamba Y, 2010, J PHYS CHEM B, V114, P12018, DOI 10.1021/jp104527y; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; Tziakas DN, 2010, INT J CARDIOL, V142, P2, DOI 10.1016/j.ijcard.2009.10.031; Vad BS, 2010, BIOPHYS J, V98, P576, DOI 10.1016/j.bpj.2009.08.063; Verly RM, 2008, PEPTIDES, V29, P15, DOI 10.1016/j.peptides.2007.10.028; Verly RM, 2009, BIOPHYS J, V96, P2194, DOI 10.1016/j.bpj.2008.11.063; Vermeer LS, 2012, J BIOL CHEM, V287, P34120, DOI 10.1074/jbc.M112.359067; Virtanen JA, 1998, P NATL ACAD SCI USA, V95, P4964, DOI 10.1073/pnas.95.9.4964; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wieprecht T, 2000, BIOCHEMISTRY-US, V39, P442, DOI 10.1021/bi992146k; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P6124, DOI 10.1021/bi9619987; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0; Yang L, 1999, BIOPHYS J, V77, P2648, DOI 10.1016/S0006-3495(99)77099-2; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; ZASLOFF M, 1988, P NATL ACAD SCI USA, V85, P910, DOI 10.1073/pnas.85.3.910; Zhang LJ, 1999, BIOCHEMISTRY-US, V38, P8102, DOI 10.1021/bi9904104	94	28	29	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66440	10.1371/journal.pone.0066440	http://dx.doi.org/10.1371/journal.pone.0066440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776672	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400102
J	Kanakogi, Y; Okumura, Y; Inoue, Y; Kitazaki, M; Itakura, S				Kanakogi, Yasuhiro; Okumura, Yuko; Inoue, Yasuyuki; Kitazaki, Michiteru; Itakura, Shoji			Rudimentary Sympathy in Preverbal Infants: Preference for Others in Distress	PLOS ONE			English	Article							PROSOCIAL BEHAVIOR; SOCIAL-DOMINANCE; TODDLERS; ATTRIBUTION; CAUSALITY; CHILDREN; AGENTS	Despite its essential role in human coexistence, the developmental origins and progression of sympathy in infancy are not yet fully understood. We show that preverbal 10-month-olds manifest sympathetic responses, evinced in their preference for attacked others according to their evaluations of the respective roles of victim, aggressor, and neutral party. In Experiment 1, infants viewing an aggressive social interaction between a victim and an aggressor exhibited preference for the victim. In Experiment 2, when comparing the victim and the aggressor to a neutral object, infants preferred the victim and avoided the aggressor. These findings indicate that 10-month-olds not only evaluate the roles of victims and aggressors in interactions but also show rudimentary sympathy toward others in distress based on that evaluation. This simple preference may function as a foundation for full-fledged sympathetic behavior later on.	[Kanakogi, Yasuhiro; Okumura, Yuko; Itakura, Shoji] Kyoto Univ, Dept Psychol, Grad Sch Letters, Sakyo Ku, Kyoto, Japan; [Inoue, Yasuyuki; Kitazaki, Michiteru] Toyohashi Univ Technol, Dept Comp Sci & Engn, Toyohashi, Aichi, Japan	Kyoto University; Toyohashi University of Technology	Kanakogi, Y (corresponding author), Kyoto Univ, Dept Psychol, Grad Sch Letters, Sakyo Ku, Yoshidahonmachi, Kyoto, Japan.	yakanakogi@gmail.com	Kitazaki, Mitchiteru/AAI-6554-2020	Kitazaki, Mitchiteru/0000-0003-0966-4842; Okumura, Yuko/0000-0002-2389-5818	Japan Society for the Promotion of Science; JSPS [21220005, 20220002, 20220004]; MEXT [21118005]; Nissan Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nissan Science Foundation	This work was supported by a grant to Yasuhiro Kanakogi from the Japan Society for the Promotion of Science Research Fellowships for Young Scientists and grants to Shoji Itakura from JSPS (21220005, 20220002 and 20220004), MEXT (21118005) and the Nissan Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Csibra G, 2008, COGNITION, V107, P705, DOI 10.1016/j.cognition.2007.08.001; de Waal FBM, 2012, SO NEUROSCI SER, P87; de Wall, 2009, AGE EMPATHY; Dunfield K, 2011, INFANCY, V16, P227, DOI 10.1111/j.1532-7078.2010.00041.x; Eisenberg N, 2006, HANDBOOK OF MORAL DEVELOPMENT, P517; GERGELY G, 1995, COGNITION, V56, P165, DOI 10.1016/0010-0277(95)00661-H; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hamlin JK, 2011, P NATL ACAD SCI USA, V108, P19931, DOI 10.1073/pnas.1110306108; Hamlin JK, 2010, DEVELOPMENTAL SCI, V13, P923, DOI 10.1111/j.1467-7687.2010.00951.x; Hepach R, 2012, PSYCHOL SCI, V23, P967, DOI 10.1177/0956797612440571; Hoffman M. L., 2001, EMPATHY MORAL DEV IM; Houston-Price C, 2004, INFANT CHILD DEV, V13, P341, DOI 10.1002/icd.364; Kanakogi Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1342; Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104; Kuhlmeier V, 2003, PSYCHOL SCI, V14, P402, DOI 10.1111/1467-9280.01454; LESLIE AM, 1982, PERCEPTION, V11, P173, DOI 10.1068/p110173; LESLIE AM, 1987, COGNITION, V25, P265, DOI 10.1016/S0010-0277(87)80006-9; Mascaro O, 2012, P NATL ACAD SCI USA, V109, P6862, DOI 10.1073/pnas.1113194109; Okumura Y, POWER HUMAN IN PRESS; Premack D, 1997, J COGNITIVE NEUROSCI, V9, P848, DOI 10.1162/jocn.1997.9.6.848; SAGI A, 1976, DEV PSYCHOL, V12, P175, DOI 10.1037/0012-1649.12.2.175; Saxe R, 2005, PSYCHOL SCI, V16, P995, DOI 10.1111/j.1467-9280.2005.01649.x; Scarf D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042698; SIMNER ML, 1971, DEV PSYCHOL, V5, P136, DOI 10.1037/h0031066; Smith A., 1984, THEORY MORAL SENTIME; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; Svetlova M, 2010, CHILD DEV, V81, P1814, DOI 10.1111/j.1467-8624.2010.01512.x; Thomsen L, 2011, SCIENCE, V331, P477, DOI 10.1126/science.1199198; Vaish A, 2011, BRIT J DEV PSYCHOL, V29, P124, DOI 10.1348/026151010X532888; Vaish A, 2009, DEV PSYCHOL, V45, P534, DOI 10.1037/a0014322; Yang CY, 2009, BRAIN RES, V1251, P176, DOI 10.1016/j.brainres.2008.11.062; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126	32	46	46	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65292	10.1371/journal.pone.0065292	http://dx.doi.org/10.1371/journal.pone.0065292			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	163FW	23776467	Green Published, Green Submitted, gold			2022-12-25	WOS:000320322400017
J	Muthayya, S; Rah, JH; Sugimoto, JD; Roos, FF; Kraemer, K; Black, RE				Muthayya, Sumithra; Rah, Jee Hyun; Sugimoto, Jonathan D.; Roos, Franz F.; Kraemer, Klaus; Black, Robert E.			The Global Hidden Hunger Indices and Maps: An Advocacy Tool for Action	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; IRON-DEFICIENCY ANEMIA; DEVELOPING-COUNTRIES; VITAMIN-A; CHILDREN; SUPPLEMENTATION; ZINC; CONSEQUENCES; METAANALYSIS; PREGNANCY	The unified global efforts to mitigate the high burden of vitamin and mineral deficiency, known as hidden hunger, in populations around the world are crucial to the achievement of most of the Millennium Development Goals (MDGs). We developed indices and maps of global hidden hunger to help prioritize program assistance, and to serve as an evidence-based global advocacy tool. Two types of hidden hunger indices and maps were created based on i) national prevalence data on stunting, anemia due to iron deficiency, and low serum retinol levels among preschool-aged children in 149 countries; and ii) estimates of Disability Adjusted Life Years (DALYs) attributed to micronutrient deficiencies in 136 countries. A number of countries in sub-Saharan Africa, as well as India and Afghanistan, had an alarmingly high level of hidden hunger, with stunting, iron deficiency anemia, and vitamin A deficiency all being highly prevalent. The total DALY rates per 100,000 population, attributed to micronutrient deficiencies, were generally the highest in sub-Saharan African countries. In 36 countries, home to 90% of the world's stunted children, deficiencies of micronutrients were responsible for 1.5-12% of the total DALYs. The pattern and magnitude of iodine deficiency did not conform to that of other micronutrients. The greatest proportions of children with iodine deficiency were in the Eastern Mediterranean (46.6%), European (44.2%), and African (40.4%) regions. The current indices and maps provide crucial data to optimize the prioritization of program assistance addressing global multiple micronutrient deficiencies. Moreover, the indices and maps serve as a useful advocacy tool in the call for increased commitments to scale up effective nutrition interventions.	[Muthayya, Sumithra] Sax Inst, Sydney, NSW, Australia; [Rah, Jee Hyun] United Nations Childrens Fund UNICEF India, New Delhi, India; [Sugimoto, Jonathan D.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL USA; [Sugimoto, Jonathan D.] Univ Florida, Coll Med, Gainesville, FL USA; [Sugimoto, Jonathan D.] Fred Hutchinson Canc Res Ctr, Vaccine Infect Dis Div, Seattle, WA 98104 USA; [Roos, Franz F.] DSM Nutr Prod Ltd, Kaiseraugst, Switzerland; [Kraemer, Klaus] Sight & Life, Kaiseraugst, Switzerland; [Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	University of Sydney; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Fred Hutchinson Cancer Center; DSM NV; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kraemer, K (corresponding author), Sight & Life, Kaiseraugst, Switzerland.	klaus.kraemer@sightandlife.org		Black, Robert/0000-0001-9926-7984; Sugimoto, Jonathan/0000-0002-1761-328X	Sight and Life	Sight and Life	The technical consultations were supported by Sight and Life (www.sightandlife.org). There was no funding involved in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 2009, J NUTR, V139, P1022, DOI 10.3945/jn.107.086199; Andersson M, 2012, J NUTR, V142, P744, DOI 10.3945/jn.111.149393; [Anonymous], 2012, POL POL AN NUTR GOV; [Anonymous], 2012, SCALING NUTR SUN MOV; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Black RE, 1998, AM J CLIN NUTR, V68, p476S, DOI 10.1093/ajcn/68.2.476S; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bloem MW, 2010, J NUTR, V140, p132S, DOI 10.3945/jn.109.112094; Brown KH, 2002, AM J CLIN NUTR, V75, P1062, DOI 10.1093/ajcn/75.6.1062; Christian P, 2000, AM J EPIDEMIOL, V152, P542, DOI 10.1093/aje/152.6.542; Costello AMD, 2003, J NUTR, V133, p1757S, DOI 10.1093/jn/133.5.1757S; Ezzati M, 2004, COMP QUANTIFICATION; FAO, 2008, PREV UND TOT POP 200; FAWZI WW, 1993, JAMA-J AM MED ASSOC, V269, P898, DOI 10.1001/jama.269.7.898; Food and Agriculture Organization, 2002, FOOD INS PEOPL MUST; Haas JD, 2001, J NUTR, V131, p676S, DOI 10.1093/jn/131.2.676S; Horton S., 2008, FOOD FORTIFICATION I; International Food Policy Research Institute, 2010, HUNG GLOB IND CHALL; International Food Policy Research Institute /Welthungerhilfe/Concern, 2007, CHALL HUNG 2007 GLOB; LOZOFF B, 1991, NEW ENGL J MED, V325, P687, DOI 10.1056/NEJM199109053251004; Micronutrient Initiative, 2009, INV FUT UN CALL ACT; Pollitt E, 2001, J NUTR, V131, p669S, DOI 10.1093/jn/131.2.669S; Rastogi R, 2000, GLOBAL BURDEN IRON D; SAXENA NC, 2008, HUNGER UNDER NUTR FO; Sommer A., 1996, VITAMIN DEFICIENCY H; Stoltzfus RJ, 2001, J NUTR, V131, p565S, DOI 10.1093/jn/131.2.565S; UNDP (United Nations Development Programme), 2007, HUM DEV REP; United Nations Standing Committee on Nutrition, 2008, IMP HIGH FOOD PRIC M; WHO, 2009, GLOB PREV VIT A DEF, P55; WHO, 2006, WHO CHILD GROWTH STA; World Health Organization, 2008, WORLD PREV AN 1993 2; World Health Organization, 2009, GLOB HLTH RISKS MORT; World Health Organization, 2002, WHO REP 2002 RED RIS; World Health Organization (WHO), 2004, WHO GLOB DAT IOD DEF; Zimmermann MB, 2008, LANCET, V372, P1251, DOI 10.1016/S0140-6736(08)61005-3	35	245	252	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e67860	10.1371/journal.pone.0067860	http://dx.doi.org/10.1371/journal.pone.0067860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776712	gold, Green Published, Green Submitted			2022-12-25	WOS:000320322400128
J	Probst, AJ; Auerbach, AK; Moissl-Eichinger, C				Probst, Alexander J.; Auerbach, Anna K.; Moissl-Eichinger, Christine			Archaea on Human Skin	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; METHANOGENIC ARCHAEA; NATURAL COMMUNITIES; BACTERIAL; DIVERSITY; SEQUENCES; ALIGNMENT; PROBES	The recent era of exploring the human microbiome has provided valuable information on microbial inhabitants, beneficials and pathogens. Screening efforts based on DNA sequencing identified thousands of bacterial lineages associated with human skin but provided only incomplete and crude information on Archaea. Here, we report for the first time the quantification and visualization of Archaea from human skin. Based on 16 S rRNA gene copies Archaea comprised up to 4.2% of the prokaryotic skin microbiome. Most of the gene signatures analyzed belonged to the Thaumarchaeota, a group of Archaea we also found in hospitals and clean room facilities. The metabolic potential for ammonia oxidation of the skin-associated Archaea was supported by the successful detection of thaumarchaeal amoA genes in human skin samples. However, the activity and possible interaction with human epithelial cells of these associated Archaea remains an open question. Nevertheless, in this study we provide evidence that Archaea are part of the human skin microbiome and discuss their potential for ammonia turnover on human skin.	[Moissl-Eichinger, Christine] Univ Regensburg, Inst Microbiol, D-93053 Regensburg, Germany; Univ Regensburg, Archaea Ctr, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg	Moissl-Eichinger, C (corresponding author), Univ Regensburg, Inst Microbiol, D-93053 Regensburg, Germany.	christine.moissl-eichinger@ur.de	Probst, Alexander J/K-2813-2016; Moissl-Eichinger, Christine/A-6682-2015	Moissl-Eichinger, Christine/0000-0001-6755-6263; Probst, Alexander/0000-0002-9392-6544	Institute for Microbiology and Archaea Center; University of Regensburg; European Space Agency [4000103794/11/NL/PA]; DLR [D/316/67130713]; National German Academic Foundation (Studienstiftung des deutschen Volkes)	Institute for Microbiology and Archaea Center; University of Regensburg; European Space Agency(European Space AgencyEuropean Commission); DLR(Helmholtz AssociationGerman Aerospace Centre (DLR)); National German Academic Foundation (Studienstiftung des deutschen Volkes)	Funding provided by the Institute for Microbiology and Archaea Center (Michael Thomm), the University of Regensburg and the European Space Agency (Contract No. 4000103794/11/NL/PA under subcontract with DLR (D/316/67130713)) is acknowledged. AJP was supported by the National German Academic Foundation (Studienstiftung des deutschen Volkes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Brunk CF, 1998, APPL ENVIRON MICROB, V64, P5064; BURGGRAF S, 1991, SYST APPL MICROBIOL, V14, P346, DOI 10.1016/S0723-2020(11)80308-5; Burggraf S, 1997, INT J SYST BACTERIOL, V47, P657, DOI 10.1099/00207713-47-3-657; BURGGRAF S, 1992, SYST APPL MICROBIOL, V15, P352, DOI 10.1016/S0723-2020(11)80207-9; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Casamayor EO, 2002, ENVIRON MICROBIOL, V4, P338, DOI 10.1046/j.1462-2920.2002.00297.x; de Macario EC, 2009, INT J MED MICROBIOL, V299, P99, DOI 10.1016/j.ijmm.2008.06.011; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; EMBLEY TM, 1992, J GEN MICROBIOL, V138, P1479, DOI 10.1099/00221287-138-7-1479; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Gantner S, 2011, J MICROBIOL METH, V84, P12, DOI 10.1016/j.mimet.2010.10.001; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Huber H, 2002, NATURE, V417, P63, DOI 10.1038/417063a; Hulcr J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047712; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kwan K, 2011, APPL ENVIRON MICROB, V77, P2943, DOI 10.1128/AEM.02978-10; La Duc MT, 2012, APPL ENVIRON MICROB, V78, P5912, DOI 10.1128/AEM.01435-12; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lehtovirta-Morley LE, 2011, P NATL ACAD SCI USA, V108, P15892, DOI 10.1073/pnas.1107196108; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Moissl C, 2002, APPL ENVIRON MICROB, V68, P933, DOI 10.1128/AEM.68.2.933-937.2002; Moissl C, 2008, ISME J, V2, P115, DOI 10.1038/ismej.2007.98; Moissl-Eichinger C, 2011, ISME J, V5, P209, DOI 10.1038/ismej.2010.124; Muhl H, 2010, DIAGN MICR INFEC DIS, V66, P41, DOI 10.1016/j.diagmicrobio.2008.07.011; Mussmann M, 2011, P NATL ACAD SCI USA, V108, P16771, DOI 10.1073/pnas.1106427108; Nocker A, 2007, APPL ENVIRON MICROB, V73, P5111, DOI 10.1128/AEM.02987-06; Nose K, 2005, ANAL SCI, V21, P1471, DOI 10.2116/analsci.21.1471; Oxley APA, 2010, ENVIRON MICROBIOL, V12, P2398, DOI 10.1111/j.1462-2920.2010.02212.x; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Probst A, 2011, APPL ENVIRON MICROB, V77, P1628, DOI 10.1128/AEM.02037-10; Probst A, 2010, APPL ENVIRON MICROB, V76, P5148, DOI 10.1128/AEM.00399-10; Probst AJ, 2013, ISME J, V7, P635, DOI 10.1038/ismej.2012.133; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994; Sauder LA, 2012, ENVIRON MICROBIOL, V14, P2589, DOI 10.1111/j.1462-2920.2012.02786.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stahl D.A., 1991, NUCL ACID TECHNIQUES, P205; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x	48	117	120	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65388	10.1371/journal.pone.0065388	http://dx.doi.org/10.1371/journal.pone.0065388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776475	Green Published, Green Submitted, gold			2022-12-25	WOS:000320322400020
J	Thammasri, K; Rauhamaki, S; Wang, LP; Filippou, A; Kivovich, V; Marjomaki, V; Naides, SJ; Gilbert, L				Thammasri, Kanoktip; Rauhamaki, Sanna; Wang, Liping; Filippou, Artemis; Kivovich, Violetta; Marjomaki, Varpu; Naides, Stanley J.; Gilbert, Leona			Human Parvovirus B19 Induced Apoptotic Bodies Contain Altered Self-Antigens that are Phagocytosed by Antigen Presenting Cells	PLOS ONE			English	Article							NONSTRUCTURAL NS1 PROTEIN; AUTOIMMUNE HEPATITIS; INFECTION; VIRUS; DISEASE; LIVER; DNA; MECHANISMS; ANTIBODIES; SURFACE	Human parvovirus B19 (B19V) from the erythrovirus genus is known to be a pathogenic virus in humans. Prevalence of B19V infection has been reported worldwide in all seasons, with a high incidence in the spring. B19V is responsible for erythema infectiosum (fifth disease) commonly seen in children. Its other clinical presentations include arthralgia, arthritis, transient aplastic crisis, chronic anemia, congenital anemia, and hydrops fetalis. In addition, B19V infection has been reported to trigger autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. However, the mechanisms of B19V participation in autoimmunity are not fully understood. B19V induced chronic disease and persistent infection suggests B19V can serve as a model for viral host interactions and the role of viruses in the pathogenesis of autoimmune diseases. Here we investigate the involvement of B19V in the breakdown of immune tolerance. Previously, we demonstrated that the non-structural protein 1 (NS 1) of B19V induces apoptosis in non-permissive cells lines and that this protein can cleave host DNA as well as form NS1-DNA adducts. Here we provide evidence that through programmed cell death, apoptotic bodies (ApoBods) are generated by B19V NS1 expression in a non-permissive cell line. Characterization of purified ApoBods identified potential self-antigens within them. In particular, signature self-antigens such as Smith, ApoH, DNA, histone H4 and phosphatidylserine associated with autoimmunity were present in these ApoBods. In addition, when purified ApoBods were introduced to differentiated macrophages, recognition, engulfment and uptake occurred. This suggests that B19V can produce a source of self-antigens for immune cell processing. The results support our hypothesis that B19V NS1-DNA adducts, and nucleosomal and lysosomal antigens present in ApoBods created in non-permissive cell lines, are a source of self-antigens.	[Thammasri, Kanoktip; Rauhamaki, Sanna; Wang, Liping; Filippou, Artemis; Marjomaki, Varpu; Gilbert, Leona] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Thammasri, Kanoktip; Rauhamaki, Sanna; Wang, Liping; Filippou, Artemis; Marjomaki, Varpu; Gilbert, Leona] Univ Jyvaskyla, Ctr Neurosci, Jyvaskyla, Finland; [Kivovich, Violetta] Penn State Coll Med, Milton S Hershey Med Ctr, Hershey, PA USA; [Naides, Stanley J.] Quest Diagnost Nichols Inst, San Juan Capistrano, CA USA	University of Jyvaskyla; University of Jyvaskyla; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Nichols Institute	Gilbert, L (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	leona.k.gilbert@jyu.fi	Filippou, Artemis/O-8944-2016; Gilbert, Leona/AAF-4258-2021	Filippou, Artemis/0000-0002-4106-1059; Marjomaki, Varpu/0000-0002-4592-5926; Rauhamaki, Sanna/0000-0002-3014-3120; Gilbert, Leona/0000-0002-7470-5770	Academy of Finland [122061]	Academy of Finland(Academy of Finland)	This study was supported by the Academy of Finland Contract Number 122061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Kenji, 2007, Int J Med Sci, V4, P105; Alcami A, 2003, NAT REV IMMUNOL, V3, P36, DOI 10.1038/nri980; ANDERSON MJ, 1985, J INFECT DIS, V152, P257, DOI 10.1093/infdis/152.2.257; ANDERSON MJ, 1987, LANCET, V1, P738; ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223; Arista S, 2003, J HEPATOL, V38, P375, DOI 10.1016/S0168-8278(02)00416-6; Baens M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000054; Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; Bonvicini F, 2008, J GEN VIROL, V89, P3034, DOI 10.1099/vir.0.2008/004341-0; Bruggeman LA, 2007, CLIN J AM SOC NEPHRO, V2, pS13, DOI 10.2215/CJN.04311206; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; CLEWLEY JP, 1984, J GEN VIROL, V65, P241, DOI 10.1099/0022-1317-65-1-241; Cline AM, 2004, CLIN IMMUNOL, V112, P175, DOI 10.1016/j.clim.2004.02.017; Cline AM, 2004, AUTOIMMUNITY, V37, P85, DOI 10.1080/0891693042000196219; Cocca BA, 2002, J IMMUNOL, V169, P159, DOI 10.4049/jimmunol.169.1.159; Corcoran A, 2004, J MED MICROBIOL, V53, P459, DOI 10.1099/jmm.0.05485-0; COSSART YE, 1975, LANCET, V1, P72; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Dame C, 2002, PEDIATR PATHOL MOL M, V21, P25, DOI 10.1080/15227950252774138; Diaz F, 2000, J Infect Chemother, V6, P63, DOI 10.1007/s101560050052; Dorsch S, 2002, J VIROL, V76, P2014, DOI 10.1128/JVI.76.4.2014-2018.2002; Drago F, 1999, BRIT J DERMATOL, V141, P160; FADOK VA, 1992, J IMMUNOL, V148, P2207; Frisoni L, 2005, J IMMUNOL, V175, P2692, DOI 10.4049/jimmunol.175.4.2692; Fu Y, 2002, J VIROL, V76, P5395, DOI 10.1128/JVI.76.11.5395-5403.2002; Heegaard ED, 2002, CLIN MICROBIOL REV, V15, P485, DOI 10.1128/CMR.15.3.485-505.2002; Hemauer A, 1999, J CLIN VIROL, V14, P73, DOI 10.1016/S1386-6532(99)00038-4; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Karetnyi YV, 1999, ARCH VIROL, V144, P1713, DOI 10.1007/s007050050699; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kerr JR, 1996, EUR J CLIN MICROBIOL, V15, P10, DOI 10.1007/BF01586181; Kerr S, 1999, J MED VIROL, V57, P179, DOI 10.1002/(SICI)1096-9071(199902)57:2&lt;179::AID-JMV16&gt;3.0.CO;2-T; Kivovich V, 2012, INT J BIOL SCI, V8, P79, DOI 10.7150/ijbs.8.79; Kivovich V, 2010, INT J MED SCI, V7, P110; Kordes U, 2011, PEDIATR BLOOD CANCER, V56, P323, DOI 10.1002/pbc.22820; Krygier DS, 2009, WORLD J GASTROENTERO, V15, P4067, DOI 10.3748/wjg.15.4067; Krysko DV, 2006, CELL DEATH DIFFER, V13, P2011, DOI 10.1038/sj.cdd.4401900; LAWSON CM, 1992, IMMUNOLOGY, V75, P513; Lehmann HW, 2003, AUTOIMMUN REV, V2, P218, DOI 10.1016/S1568-9972(03)00014-4; Liu HS, 1999, BIOCHEM BIOPH RES CO, V260, P712, DOI 10.1006/bbrc.1999.0954; Lunardi C, 1998, EUR J IMMUNOL, V28, P936, DOI 10.1002/(SICI)1521-4141(199803)28:03<936::AID-IMMU936>3.3.CO;2-O; Lunardi C, 2008, AUTOIMMUN REV, V8, P116, DOI 10.1016/j.autrev.2008.07.005; Meyer O, 2003, JOINT BONE SPINE, V70, P6, DOI 10.1016/S1297-319X(02)00004-0; Mitchell LA, 2002, J MED VIROL, V67, P267, DOI 10.1002/jmv.2217; Moffatt S, 1996, J VIROL, V70, P8485, DOI 10.1128/JVI.70.12.8485-8491.1996; Moffatt S, 1998, J VIROL, V72, P3018, DOI 10.1128/JVI.72.4.3018-3028.1998; Mogensen TH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-246; MUNSHI NC, 1993, J VIROL, V67, P562, DOI 10.1128/JVI.67.1.562-566.1993; MURPHY K, 2008, JANEWAYS IMMUNOBIOUL; Murphy PM, 2001, NAT IMMUNOL, V2, P116, DOI 10.1038/84214; Nobili V, 2004, PEDIATR INFECT DIS J, V23, P184, DOI 10.1097/01.inf.0000110270.38240.51; OZAWA K, 1988, J VIROL, V62, P2884, DOI 10.1128/JVI.62.8.2884-2889.1988; OZAWA K, 1987, BLOOD, V70, P384, DOI 10.1182/blood.V70.2.384.384; Panoutsakopoulou V, 2001, IMMUNITY, V15, P137, DOI 10.1016/S1074-7613(01)00172-8; Pinho JRR, 2001, BRAZ J MED BIOL RES, V34, P1131, DOI 10.1590/S0100-879X2001000900005; Poole BD, 2006, J VIROL, V80, P4114, DOI 10.1128/JVI.80.8.4114-4121.2006; Poole BD, 2004, J VIROL, V78, P7775, DOI 10.1128/JVI.78.14.7775-7783.2004; Poole BD, 2011, INT J MED SCI, V8, P88, DOI 10.7150/ijms.8.88; POTTER CG, 1987, J CLIN INVEST, V79, P1486, DOI 10.1172/JCI112978; Raab U, 2002, VIROLOGY, V293, P86, DOI 10.1006/viro.2001.1285; Radic M, 2004, J IMMUNOL, V172, P6692, DOI 10.4049/jimmunol.172.11.6692; Schiller M, 2008, CELL DEATH DIFFER, V15, P183, DOI 10.1038/sj.cdd.4402239; SHADE RO, 1986, J VIROL, V58, P921, DOI 10.1128/JVI.58.3.921-936.1986; Sol N, 1999, J VIROL, V73, P8762, DOI 10.1128/JVI.73.10.8762-8770.1999; SRIVASTAVA A, 1990, BLOOD, V76, P1997; Sun L, 2012, HEPATOLOGY, V55, P329, DOI 10.1002/hep.24720; Takahashi Y, 1998, P NATL ACAD SCI USA, V95, P8227, DOI 10.1073/pnas.95.14.8227; VENTO S, 1995, LANCET, V346, P608, DOI 10.1016/S0140-6736(95)91438-2; von Landenberg P, 2003, ARTHRITIS RHEUM-US, V48, P1939, DOI 10.1002/art.11038; von Landenberg P, 2007, AUTOIMMUN REV, V6, P278, DOI 10.1016/j.autrev.2006.09.006; vonHerrath MG, 1996, CURR OPIN IMMUNOL, V8, P878, DOI 10.1016/S0952-7915(96)80019-7; Wagner B, 1996, BRIT MED J, V312, P640; Wraith DC, 2003, LANCET, V362, P1659, DOI 10.1016/S0140-6736(03)14802-7; Yang SH, 2012, ANN HEMATOL, V91, P291, DOI 10.1007/s00277-011-1238-8; YOUNG N, 1984, J CLIN INVEST, V74, P2024, DOI 10.1172/JCI111625; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840; Zadori Z, 2001, DEV CELL, V1, P291, DOI 10.1016/S1534-5807(01)00031-4	77	25	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e67179	10.1371/journal.pone.0067179	http://dx.doi.org/10.1371/journal.pone.0067179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776709	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400125
J	Zafon, C; Ciudin, A; Valladares, S; Mesa, J; Simo, R				Zafon, Carles; Ciudin, Andreea; Valladares, Silvia; Mesa, Jordi; Simo, Rafael			Variables Involved in the Discordance between HbA1c and Fructosamine: The Glycation Gap Revisited	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; DIABETIC-PATIENTS; HEMOGLOBIN GLYCATION; GLYCOSYLATION GAP; GLYCEMIC CONTROL; RENAL-DISEASE; METFORMIN; COMPLICATIONS; A1C; ERYTHROCYTES	Aims: Glycation gap (GG) is defined as the difference between the measured level of HbA1c and the level that would be predicted from its regression on the fructosamine level. The aims of the study were: 1) To determine the reproducibility and consistency of GC; 2) To discover factors related to GG value. Given that metformin might increase glucose transport through the erythrocyte membrane, this treatment was also considered in the analyses of the results. Methods: GG was calculated in two blood samples separated 30.6 (SD 7.3) weeks, obtained in 508 type 2 diabetic patients. The following variables were considered: HbA1c, fructosamine, glucose, creatinine, hematological parameters and treatment with metformin. Multivariate and logistic regression analyses were performed to explore the variables independently related to CG. Results: GG was reproducible and consistent over time. Creatinine, mean corpuscular hemoglobin concentration (MCHC), and glycemia (inverse relationship); and HbA1c and treatment with metformin (direct relationship) were independently related to GG. Patients treated with metformin showed higher HbA1c values, despite similar fructosamine concentrations, than patients not treated with the drug. Conclusions: GG is independently related to serum levels of creatinine, MCHC and treatment with metformin. The spurious effect of metformin on Hb glycation could have serious clinical implications and should be considered when interpreting the results of clinical trials.	[Zafon, Carles; Ciudin, Andreea; Valladares, Silvia; Mesa, Jordi; Simo, Rafael] Hosp Valle De Hebron, Diabet & Metab Res Unit VHIR, Barcelona, Spain; [Zafon, Carles; Ciudin, Andreea; Valladares, Silvia; Mesa, Jordi; Simo, Rafael] Hosp Valle De Hebron, Dept Endocrinol, Barcelona, Spain; [Zafon, Carles; Ciudin, Andreea; Valladares, Silvia; Mesa, Jordi; Simo, Rafael] Univ Autonoma Barcelona, E-08193 Barcelona, Spain	Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona	Zafon, C (corresponding author), Hosp Valle De Hebron, Diabet & Metab Res Unit VHIR, Barcelona, Spain.	26276czl@comb.cat	CIUDIN, ANDREEA/O-5250-2016	CIUDIN, ANDREEA/0000-0001-5622-0203; Zafon, Carles/0000-0003-1554-1451; Simo Canonge, Rafael/0000-0003-0475-3096				[Anonymous], 2009, DIABETES CARE, V32, P1327; ARMBRUSTER DA, 1987, CLIN CHEM, V33, P2153; Bailey CJ, 2008, CARDIOVASC DRUG THER, V22, P215, DOI 10.1007/s10557-008-6092-0; Bennett Wendy L, 2012, J Manag Care Pharm, V18, P1; Bloomgarden Zachary T, 2009, Diabetes Care, V32, pe141, DOI 10.2337/dc09-zb12; BROOKS AP, 1980, LANCET, V2, P141; Chalew SA, 2005, J DIABETES COMPLICAT, V19, P218, DOI 10.1016/j.jdiacomp.2005.01.004; COCKRAM CS, 1990, DIABETES RES CLIN PR, V9, P43, DOI 10.1016/0168-8227(90)90007-G; Cohen RM, 2003, DIABETES CARE, V26, P163, DOI 10.2337/diacare.26.1.163; Cohen RM, 2007, DIABETES CARE, V30, P2756, DOI 10.2337/dc07-1301; Cohen RM, 2006, DIABETES CARE, V29, P1739, DOI 10.2337/dc06-0286; Cosson E, 2012, DIABETES METAB; El-Agouza I, 2002, CLIN LAB HAEMATOL, V24, P285, DOI 10.1046/j.1365-2257.2002.00464.x; Ford ES, 2011, J DIABETES, V3, P67, DOI 10.1111/j.1753-0407.2010.00100.x; Hare MJL, 2012, J INTERN MED, V271, P227, DOI 10.1111/j.1365-2796.2012.02513.x; Khera PK, 2008, DIABETES, V57, P2445, DOI 10.2337/db07-1820; Kim C, 2010, DIABETES CARE, V33, P780, DOI 10.2337/dc09-0836; KOSKINEN P, 1992, SCAND J CLIN LAB INV, V52, P863, DOI 10.3109/00365519209088392; Lachin JM, 2007, DIABETES, V56, P1913, DOI 10.2337/db07-0028; Leslie R David G, 2009, J Diabetes Sci Technol, V3, P635; Narbonne H, 2001, DIABETES METAB, V27, P598; Nayak AU, 2011, DIABETES CARE, V34, P1712, DOI 10.2337/dc10-1767; RAPIN JR, 1991, DIABETES METAB, V17, P164; RIZKALLA SW, 1986, DIABETES METAB, V12, P219; Rodriguez-Segade S, 2012, DIABETES CARE, V35, P2447, DOI 10.2337/dc11-2450; Rodriguez-Segade S, 2011, CLIN CHEM, V57, P264, DOI 10.1373/clinchem.2010.144949; Santos RF, 1997, DIABETES METAB, V23, P143; Selvin E, 2008, ARCH INTERN MED, V168, P2070, DOI 10.1001/archinte.168.19.2070; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sharif A, 2010, J AM SOC NEPHROL, V21, P383, DOI 10.1681/ASN.2010010031; Shima K, 2012, ANN CLIN BIOCHEM, V49, P68, DOI 10.1258/acb.2011.011161; SMART LM, 1988, DIABETES CARE, V11, P433, DOI 10.2337/diacare.11.5.433; Soranzo N, 2011, CURR DIABETES REP, V11, P562, DOI 10.1007/s11892-011-0232-9; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; YOA RG, 1993, CLIN EXP PHARMACOL P, V20, P563, DOI 10.1111/j.1440-1681.1993.tb01742.x	35	13	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66696	10.1371/journal.pone.0066696	http://dx.doi.org/10.1371/journal.pone.0066696			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776693	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400115
J	Lu, RM; Chen, MS; Chang, DK; Chiu, CY; Lin, WC; Yan, SL; Wang, YP; Kuo, YS; Yeh, CY; Lo, A; Wu, HC				Lu, Ruei-Min; Chen, Min-Shan; Chang, De-Kuan; Chiu, Chien-Yu; Lin, Wei-Chuan; Yan, Shin-Long; Wang, Yi-Ping; Kuo, Yuan-Sung; Yeh, Chen-Yun; Lo, Albert; Wu, Han-Chung			Targeted Drug Delivery Systems Mediated by a Novel Peptide in Breast Cancer Therapy and Imaging	PLOS ONE			English	Article							SINGLE-CHAIN FV; MACROMOLECULAR THERAPEUTICS; EFFICACY; PENETRATION; LIPOSOMES; IMMUNOLIPOSOMES; NANOTECHNOLOGY; MECHANISM; CARCINOMA; AFFINITY	Targeted delivery of drugs to tumors represents a significant advance in cancer diagnosis and therapy. Therefore, development of novel tumor-specific ligands or pharmaceutical nanocarriers is highly desirable. In this study, we utilized phage display to identify a new targeting peptide, SP90, which specifically binds to breast cancer cells, and recognizes tumor tissues from breast cancer patients. We used confocal and electron microscopy to reveal that conjugation of SP90 with liposomes enables efficient delivery of drugs into cancer cells through endocytosis. Furthermore, in vivo fluorescent imaging demonstrated that SP90-conjugated quantum dots possess tumor-targeting properties. In tumor xenograft and orthotopic models, SP90-conjugated liposomal doxorubicin was found to improve the therapeutic index of the chemotherapeutic drug by selectively increasing its accumulation in tumors. We conclude that the targeting peptide SP90 has significant potential in improving the clinical benefits of chemotherapy in the treatment and the diagnosis of breast cancer.	[Lu, Ruei-Min; Chen, Min-Shan; Chang, De-Kuan; Chiu, Chien-Yu; Lin, Wei-Chuan; Yan, Shin-Long; Wang, Yi-Ping; Yeh, Chen-Yun; Lo, Albert; Wu, Han-Chung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Chen, Min-Shan; Wu, Han-Chung] Natl Taiwan Univ, Coll Med, Grad Inst Oral Biol, Taipei, Taiwan; [Kuo, Yuan-Sung] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Surg, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Wu, HC (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	hcw0928@gate.sinica.edu.tw	Wu, Han-Chung/B-1209-2011; Lu, Ruei-Min/ABF-4388-2021	Wu, Han-Chung/0000-0002-5185-1169; Lu, Ruei-Min/0000-0003-3792-5499; Wang, Yi-Ping/0000-0001-9574-2194	Academia Sinica; National Science Council, Taiwan [NSC-100-2325-B-001-011, NSC-100-2321-B-001-038]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Funding provided by Academia Sinica and National Science Council (NSC-100-2325-B-001-011 and NSC-100-2321-B-001-038), Taiwan (HCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 2001, CANCER RES, V61, P4750; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/NMAT2992, 10.1038/nmat2992]; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Bosslet K, 1998, CANCER RES, V58, P1195; Cai WB, 2008, NAT PROTOC, V3, P89, DOI 10.1038/nprot.2007.478; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chang DK, 2009, J BIOL CHEM, V284, P12905, DOI 10.1074/jbc.M900280200; Chang DK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004171; Cheng WW, 2010, EXPERT OPIN DRUG DEL, V7, P461, DOI 10.1517/17425240903579963; Cho HJ, 2012, BIOMATERIALS, V33, P1190, DOI 10.1016/j.biomaterials.2011.10.064; Cobleigh MA, 2011, SEMIN ONCOL, V38, pS11, DOI 10.1053/j.seminoncol.2011.04.005; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m; Hambley TW, 2009, CANCER RES, V69, P1259, DOI 10.1158/0008-5472.CAN-08-3786; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; IBER FL, 1958, J CLIN INVEST, V37, P1442, DOI 10.1172/JCI103735; Kohschutter J, 2008, EXPERT OPIN DRUG DEL, V5, P653, DOI [10.1517/17425240802145320, 10.1517/17425247.5.6.653 ]; Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010; Lee CMY, 2007, NAT PROTOC, V2, P3001, DOI 10.1038/nprot.2007.448; Lee TY, 2007, CANCER RES, V67, P10958, DOI 10.1158/0008-5472.CAN-07-2233; Lee TY, 2004, CANCER RES, V64, P8002, DOI 10.1158/0008-5472.CAN-04-1948; Lo A, 2008, MOL CANCER THER, V7, P579, DOI 10.1158/1535-7163.MCT-07-2359; Lu RM, 2011, BIOMATERIALS, V32, P3265, DOI 10.1016/j.biomaterials.2010.12.061; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Nellis DF, 2005, BIOTECHNOL PROGR, V21, P205, DOI 10.1021/bp049840y; O'Brien MER, 2004, ANN ONCOL, V15, P440, DOI 10.1093/annonc/mdh097; O'Shaughnessy JA, 2012, ONCOLOGIST, V17, P476, DOI 10.1634/theoncologist.2011-0281; Park JH, 2009, SMALL, V5, P694, DOI 10.1002/smll.200801789; Park JW, 2002, CLIN CANCER RES, V8, P1172; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shadidi M, 2002, FASEB J, V16, P256, DOI 10.1096/fj.02-0280fje; Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slingerland M, 2012, DRUG DISCOV TODAY, V17, P160, DOI 10.1016/j.drudis.2011.09.015; Svensen N, 2012, TRENDS PHARMACOL SCI, V33, P186, DOI 10.1016/j.tips.2012.02.002; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Torchilin V, 2008, EXPERT OPIN DRUG DEL, V5, P1003, DOI [10.1517/17425247.5.9.1003, 10.1517/17425247.5.9.1003 ]; Wagner V, 2006, NAT BIOTECHNOL, V24, P1211, DOI 10.1038/nbt1006-1211; Wang T, 2010, NANOMEDICINE-UK, V5, P563, DOI [10.2217/nnm.10.30, 10.2217/NNM.10.30]; Wu H, 2006, J CANC MOL, V2, P57; Wu HC, 2010, J ONCOL, V2010, DOI 10.1155/2010/723798	47	55	59	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66128	10.1371/journal.pone.0066128	http://dx.doi.org/10.1371/journal.pone.0066128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776619	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400112
J	Lysenko, O; Schulte, D; Mittelbronn, M; Steinle, A				Lysenko, Olga; Schulte, Dorothea; Mittelbronn, Michel; Steinle, Alexander			BACL Is a Novel Brain-Associated, Non-NKC-Encoded Mammalian C-Type Lectin-Like Receptor of the CLEC2 Family	PLOS ONE			English	Article							MHC CLASS-I; HUMAN NKR-P1A; UNEXPECTED ROLE; CUTTING EDGE; LIGAND; RECOGNITION; EXPRESSION; PROTEINS; SUBSET; CELLS	Natural Killer Gene Complex (NKC)-encoded C-type lectin-like receptors (CTLRs) are expressed on various immune cells including T cells, NK cells and myeloid cells and thereby contribute to the orchestration of cellular immune responses. Some NKC-encoded CTLRs are grouped into the C-type lectin family 2 (CLEC2 family) and interact with genetically linked CTLRs of the NKRP1 family. While many CLEC2 family members are expressed by hematopoietic cells (e.g. CD69 (CLEC2C)), others such as the keratinocyte-associated KACL (CLEC2A) are specifically expressed by other tissues. Here we provide the first characterization of the orphan gene CLEC2L. In contrast to other CLEC2 family members, CLEC2L is conserved among mammals and located outside of the NKC. We show that CLEC2L-encoded CTLRs are expressed as non-glycosylated, disulfide-linked homodimers at the cell surface. CLEC2L expression is fairly tissue-restricted with a predominant expression in the brain. Thus CLEC2L-encoded CTLRs were designated BACL (brain-associated C-type lectin). Combining in situ hybridization and immunohistochemistry, we show that BACL is expressed by neurons in the CNS, with a pronounced expression by Purkinje cells. Notably, the CLEC2L locus is adjacent to another orphan CTLR gene (KLRG2), but reporter cell assays did neither indicate interaction of BACL with the KLRG2 ectodomain nor with human NK cell lines or lymphocytes. Along these lines, growth of BACL-expressing tumor cell lines in immunocompetent mice did not provide evidence for an immune-related function of BACL. Altogether, the CLEC2L gene encodes a homodimeric cell surface CTLR that stands out among CLEC2 family members by its conservation in mammals, its biochemical properties and the predominant expression in the brain. Future studies will have to reveal insights into the functional relevance of BACL in the context of its neuronal expression.	[Lysenko, Olga; Steinle, Alexander] Goethe Univ Frankfurt, Inst Mol Med, D-60054 Frankfurt, Germany; [Schulte, Dorothea; Mittelbronn, Michel] Goethe Univ Frankfurt, Inst Neurol, Edinger Inst, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Steinle, A (corresponding author), Goethe Univ Frankfurt, Inst Mol Med, D-60054 Frankfurt, Germany.	alexander.steinle@kgu.de		Mittelbronn, Michel/0000-0002-2998-052X; Steinle, Alexander/0000-0001-5081-8503; Schulte, Dorothea/0000-0002-7243-6319	Deutsche Forschungsgemeinschaft [STE 828/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (STE 828/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Aust JG, 2009, J IMMUNOL, V183, P106, DOI 10.4049/jimmunol.0804281; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Chen P, 2011, IMMUNOGENETICS, V63, P627, DOI 10.1007/s00251-011-0542-8; Diefenbach A, 2001, NATURE, V413, P165, DOI 10.1038/35093109; Elmer BM, 2012, TRENDS NEUROSCI, V35, P660, DOI 10.1016/j.tins.2012.08.001; Garay Paula A, 2010, Front Synaptic Neurosci, V2, P136, DOI 10.3389/fnsyn.2010.00136; HAWKES R, 1991, PROG NEUROBIOL, V36, P309, DOI 10.1016/0301-0082(91)90004-K; Heine P, 2008, DEVELOPMENT, V135, P805, DOI 10.1242/dev.012088; Hirata Y, 2012, CEREBELLUM, V11, P455, DOI 10.1007/s12311-012-0385-3; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Kristensson K, 2011, NAT REV NEUROSCI, V12, P345, DOI 10.1038/nrn3029; Kuttruff S, 2009, BLOOD, V113, P358, DOI [10.1182/blood-2008-04-145615, 10.1182/blood-2008-03-145615]; Kveberg L, 2011, IMMUNOGENETICS, V63, P429, DOI 10.1007/s00251-011-0520-1; LANIER LL, 1994, J IMMUNOL, V153, P2417; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Spreu J, 2010, P NATL ACAD SCI USA, V107, P5100, DOI 10.1073/pnas.0913108107; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Vitale M, 2001, EUR J IMMUNOL, V31, P233, DOI 10.1002/1521-4141(200101)31:1<233::AID-IMMU233>3.0.CO;2-4; Vogler I, 2011, J INNATE IMMUN, V3, P227, DOI 10.1159/000324112; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.iy.11.040193.003145; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zhang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050561	32	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65345	10.1371/journal.pone.0065345	http://dx.doi.org/10.1371/journal.pone.0065345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776472	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400026
J	Mackiewicz, D; de Oliveira, PMC; de Oliveira, SM; Cebrat, S				Mackiewicz, Dorota; Castro de Oliveira, Paulo Murilo; de Oliveira, Suzana Moss; Cebrat, Stanislaw			Distribution of Recombination Hotspots in the Human Genome - A Comparison of Computer Simulations with Real Data	PLOS ONE			English	Article							MEIOTIC RECOMBINATION; HOT-SPOTS; CONVERSION PARADOX; HAPLOTYPE MAP; EVOLUTION; PRDM9; RATES; REPLICATION; POPULATIONS; PATTERNS	Recombination is the main cause of genetic diversity. Thus, errors in this process can lead to chromosomal abnormalities. Recombination events are confined to narrow chromosome regions called hotspots in which characteristic DNA motifs are found. Genomic analyses have shown that both recombination hotspots and DNA motifs are distributed unevenly along human chromosomes and are much more frequent in the subtelomeric regions of chromosomes than in their central parts. Clusters of motifs roughly follow the distribution of recombination hotspots whereas single motifs show a negative correlation with the hotspot distribution. To model the phenomena related to recombination, we carried out computer Monte Carlo simulations of genome evolution. Computer simulations generated uneven distribution of hotspots with their domination in the subtelomeric regions of chromosomes. They also revealed that purifying selection eliminating defective alleles is strong enough to cause such hotspot distribution. After sufficiently long time of simulations, the structure of chromosomes reached a dynamic equilibrium, in which number and global distribution of both hotspots and defective alleles remained statistically unchanged, while their precise positions were shifted. This resembles the dynamic structure of human and chimpanzee genomes, where hotspots change their exact locations but the global distributions of recombination events are very similar.	[Mackiewicz, Dorota; Cebrat, Stanislaw] Univ Wroclaw, Fac Biotechnol, Dept Genom, PL-50138 Wroclaw, Poland; [Castro de Oliveira, Paulo Murilo; de Oliveira, Suzana Moss] Univ Fed Fluminense, Inst Fis, Rio De Janeiro, Brazil; [Castro de Oliveira, Paulo Murilo; de Oliveira, Suzana Moss] Natl Inst Sci & Technol Complex Syst, Rio De Janeiro, Brazil	University of Wroclaw; Universidade Federal Fluminense	Mackiewicz, D (corresponding author), Univ Wroclaw, Fac Biotechnol, Dept Genom, PL-50138 Wroclaw, Poland.	dorota@smorfland.uni.wroc.pl	Mackiewicz, Dorota/AAJ-8963-2020	Mackiewicz, Dorota/0000-0001-8922-8615	University of Wroclaw	University of Wroclaw	This research was supported by a grant from the University of Wroclaw (http://www.uni.wroc.pl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Azbel' MY, 1999, PHYSICA A, V273, P75, DOI 10.1016/S0378-4371(99)00342-8; Backstrom N, 2010, GENOME RES, V20, P485, DOI 10.1101/gr.101410.109; Barton AB, 2008, GENETICS, V179, P1221, DOI 10.1534/genetics.107.083493; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Cebrat S, 2012, ACS, V1; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; de Massy B, 2003, TRENDS GENET, V19, P514, DOI 10.1016/S0168-9525(03)00201-4; de Oliveira PMC, 2011, PHYSICA A, V390, P492, DOI 10.1016/j.physa.2010.10.010; de Villena FPM, 2001, MAMM GENOME, V12, P318, DOI 10.1007/s003350020005; Drake JW, 1998, GENETICS, V148, P1667; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friberg U, 2008, GENETICS, V179, P2229, DOI 10.1534/genetics.107.085563; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2009, NAT GENET, V41, P625, DOI 10.1038/ng.346; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Mackiewicz D, 2010, J THEOR BIOL, V267, P186, DOI 10.1016/j.jtbi.2010.08.022; Mackiewicz P, 2004, NUCLEIC ACIDS RES, V32, P3781, DOI 10.1093/nar/gkh699; Mahtani MM, 1998, GENOME RES, V8, P100, DOI 10.1101/gr.8.2.100; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; McVean G, 2010, PHILOS T R SOC B, V365, P1213, DOI 10.1098/rstb.2009.0299; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Ogawa T, 2002, MOL MICROBIOL, V44, P1367, DOI 10.1046/j.1365-2958.2002.02969.x; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; Payseur BA, 2000, GENETICS, V156, P1285; Peters AD, 2008, GENETICS, V178, P1579, DOI 10.1534/genetics.107.084061; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Pineda-Krch M, 2005, GENETICS, V169, P2319, DOI 10.1534/genetics.104.034363; Prachumwat A, 2004, GENETICS, V166, P1585, DOI 10.1534/genetics.166.3.1585; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Segurel L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001211; Serre D, 2005, GENOME RES, V15, P1547, DOI 10.1101/gr.4211905; Ubeda F, 2011, J EVOLUTION BIOL, V24, P541, DOI 10.1111/j.1420-9101.2010.02187.x; Waga W, 2007, THEOR BIOSCI, V126, P53, DOI 10.1007/s12064-007-0010-z; Westphal T, 2002, GENETICS, V160, P609; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; Zawierta M, 2008, INT J MOD PHYS C, V19, P917, DOI 10.1142/S0129183108012595	53	9	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65272	10.1371/journal.pone.0065272	http://dx.doi.org/10.1371/journal.pone.0065272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776462	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400022
J	Martinez, C; Cornejo, VH; Lois, P; Ellis, T; Solis, NP; Wainwright, BJ; Palma, V				Martinez, Constanza; Hugo Cornejo, Victor; Lois, Pablo; Ellis, Tammy; Solis, Natalia P.; Wainwright, Brandon J.; Palma, Veronica			Proliferation of Murine Midbrain Neural Stem Cells Depends upon an Endogenous Sonic Hedgehog (Shh) Source	PLOS ONE			English	Article							PROGENITOR CELLS; BRAIN; CEREBELLUM; NEOCORTEX; BEHAVIOR; GROWTH; TECTUM; MICE	The Sonic Hedgehog (Shh) pathway is responsible for critical patterning events early in development and for regulating the delicate balance between proliferation and differentiation in the developing and adult vertebrate brain. Currently, our knowledge of the potential role of Shh in regulating neural stem cells (NSC) is largely derived from analyses of the mammalian forebrain, but for dorsal midbrain development it is mostly unknown. For a detailed understanding of the role of Shh pathway for midbrain development in vivo, we took advantage of mouse embryos with cell autonomously activated Hedgehog (Hh) signaling in a conditional Patched 1 (Ptc1) mutant mouse model. This animal model shows an extensive embryonic tectal hypertrophy as a result of Hh pathway activation. In order to reveal the cellular and molecular origin of this in vivo phenotype, we established a novel culture system to evaluate neurospheres (nsps) viability, proliferation and differentiation. By recreating the three-dimensional (3-D) microenvironment we highlight the pivotal role of endogenous Shh in maintaining the stem cell potential of tectal radial glial cells (RGC) and progenitors by modulating their Ptc1 expression. We demonstrate that during late embryogenesis Shh enhances proliferation of NSC, whereas blockage of endogenous Shh signaling using cyclopamine, a potent Hh pathway inhibitor, produces the opposite effect. We propose that canonical Shh signaling plays a central role in the control of NSC behavior in the developing dorsal midbrain by acting as a niche factor by partially mediating the response of NSC to epidermal growth factor (EGF) and fibroblast growth factor (FGF) signaling. We conclude that endogenous Shh signaling is a critical mechanism regulating the proliferation of stem cell lineages in the embryonic dorsal tissue.	[Martinez, Constanza; Hugo Cornejo, Victor; Lois, Pablo; Solis, Natalia P.; Palma, Veronica] Univ Chile, Fac Sci, FONDAP Ctr Genome Regulat, Lab Stem Cells & Dev, Santiago, Chile; [Ellis, Tammy; Wainwright, Brandon J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	Universidad de Chile; University of Queensland	Wainwright, BJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	b.wainwright@imb.uq.edu.au; vpalma@uchile.cl	Cornejo, Victor Hugo/ABD-8410-2021	Palma, Veronica/0000-0002-4320-7525; Wainwright, Brandon/0000-0003-0406-2092; Palma, Veronica/0000-0002-3907-9436	Pew Foundation; FONDECYT [1070248, 1110237]; CONICYT	Pew Foundation; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	The authors give a special thanks to the Pew Foundation for their support. This work was supported by FONDECYT grants 1070248 and 1110237 (VP) and PhD CONICYT fellowship (CM, VHC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphe C, 2006, CANCER RES, V66, P2081, DOI 10.1158/0008-5472.CAN-05-2146; Blaess S, 2006, DEVELOPMENT, V133, P1799, DOI 10.1242/dev.02339; Briscoe J, 2009, EMBO J, V28, P457, DOI 10.1038/emboj.2009.12; Ciemerych MA, 2002, GENE DEV, V16, P3277, DOI 10.1101/gad.1023602; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Dave RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014680; Douet V, 2013, CELL PROLIFERAT, V46, P137, DOI 10.1111/cpr.12023; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Feijoo CG, 2011, EUR J NEUROSCI, V33, P589, DOI 10.1111/j.1460-9568.2010.07560.x; Garcia-Parra P, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-48; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Ko HC, 2007, DENT MATER, V23, P1349, DOI 10.1016/j.dental.2006.11.023; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396; Liu Y, 2013, TISSUE ENG PT A, V19, P135, DOI [10.1089/ten.tea.2012.0209, 10.1089/ten.TEA.2012.0209]; Ma W, 2008, TISSUE ENG PT A, V14, P1673, DOI 10.1089/ten.tea.2007.0357; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Palma V, 2004, DEVELOPMENT, V131, P337, DOI 10.1242/dev.00930; Palma V, 2011, BIOL RES, V44, P63, DOI 10.4067/S0716-97602011000100008; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Rapacioli M, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-117; Serban MA, 2008, METHODS, V45, P93, DOI 10.1016/j.ymeth.2008.01.010; Stecca B, 2009, EMBO J, V28, P663, DOI 10.1038/emboj.2009.16; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x; Traiffort E, 1998, J NEUROCHEM, V70, P1327; Ulloa F, 2007, CELL CYCLE, V6, P2640, DOI 10.4161/cc.6.21.4822; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0	35	17	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65818	10.1371/journal.pone.0065818	http://dx.doi.org/10.1371/journal.pone.0065818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776550	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400068
J	Rende, D; Baysal, N; Kirdar, B				Rende, Deniz; Baysal, Nihat; Kirdar, Betul			Complex Disease Interventions from a Network Model for Type 2 Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FUNCTIONAL MODULES; BETA-CELL; GENE-EXPRESSION; CIRCADIAN-RHYTHM; RETINOIC ACID; IDENTIFICATION; TOPOLOGY; CARDIOTROPHIN-1; CLASSIFICATION	There is accumulating evidence that the proteins encoded by the genes associated with a common disorder interact with each other, participate in similar pathways and share GO terms. It has been anticipated that the functional modules in a disease related functional linkage network are informative to reveal significant metabolic processes and disease's associations with other complex disorders. In the current study, Type 2 diabetes associated functional linkage network (T2DFN) containing 2770 proteins and 15041 linkages was constructed. The functional modules in this network were scored and evaluated in terms of shared pathways, co-localization, co-expression and associations with similar diseases. The assembly of top scoring overlapping members in the functional modules revealed that, along with the well known biological pathways, circadian rhythm, diverse actions of nuclear receptors in steroid and retinoic acid metabolisms have significant occurrence in the pathophysiology of the disease. The disease's association with other metabolic and neuromuscular disorders was established through shared proteins. Nuclear receptor NRIP1 has a pivotal role in lipid and carbohydrate metabolism, indicating the need to investigate subsequent effects of NRIP1 on Type 2 diabetes. Our study also revealed that CREB binding protein (CREBBP) and cardiotrophin-1 (CTF1) have suggestive roles in linking Type 2 diabetes and neuromuscular diseases.	[Rende, Deniz] Rensselaer Polytech Inst, Dept Mat Sci & Engn, Troy, NY 12180 USA; [Rende, Deniz; Baysal, Nihat] Rensselaer Polytech Inst, Rensselaer Nanotechnol Ctr, Troy, NY USA; [Baysal, Nihat] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY USA; [Kirdar, Betul] Bogazici Univ, Dept Chem Engn, Istanbul, Turkey	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Bogazici University	Rende, D (corresponding author), Rensselaer Polytech Inst, Dept Mat Sci & Engn, Troy, NY 12180 USA.	rended3@rpi.edu	Kirdar, Betul/ABI-7250-2020		Bogazici University Research Fund [09HA502D]; Scientific and Technological Research Council of Turkey 2219 Program;  [DPT-09K120520]	Bogazici University Research Fund(Bogazici University); Scientific and Technological Research Council of Turkey 2219 Program(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); 	The work was supported by Bogazici University Research Fund through project 09HA502D and by DPT-09K120520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DR is supported by The Scientific and Technological Research Council of Turkey 2219 Program.	Andersen H, 2004, DIABETES, V53, P1543, DOI 10.2337/diabetes.53.6.1543; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Barabasi AL, 2000, PHYSICA A, V281, P69, DOI 10.1016/S0378-4371(00)00018-2; Barbieri M, 2008, ATHEROSCLEROSIS, V201, P117, DOI 10.1016/j.atherosclerosis.2008.01.005; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; BAUM D, 2003, FINDING ALL MAXIMAL; Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x; Bonnefond A, 2010, TRENDS MOL MED, V16, P407, DOI 10.1016/j.molmed.2010.06.004; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Brown AC, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-12; Butte AJ, 2006, NAT BIOTECHNOL, V24, P55, DOI 10.1038/nbt1150; Camacho J, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.030901; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Catalan V, 2009, OBES SURG, V19, P771, DOI 10.1007/s11695-009-9834-6; Cermakian N, 2003, BRAIN RES REV, V42, P204, DOI 10.1016/S0165-0173(03)00171-1; Chen CL, 2008, J CELL PHYSIOL, V215, P223, DOI 10.1002/jcp.21303; Chen JC, 2006, BIOINFORMATICS, V22, P2283, DOI 10.1093/bioinformatics/btl370; Christian M, 2006, TRENDS ENDOCRIN MET, V17, P243, DOI 10.1016/j.tem.2006.06.008; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Cvekl A, 2009, EXP EYE RES, V89, P280, DOI 10.1016/j.exer.2009.04.012; Dani C, 2012, INT J OBESITY; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Ekestern E, 2004, NEURODEGENER DIS, V1, P88, DOI 10.1159/000080049; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Ergun A, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100125; Fritah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032520; Gaspin C., 2001, Constraints, V6, P201, DOI 10.1023/A:1011433605905; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gloyn AL, 2001, BEST PRACT RES CL EN, V15, P293, DOI 10.1053/beem.2001.0147; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hakonarson H, 2011, DIABETES-METAB RES, V27, P685, DOI 10.1002/dmrr.1221; Hussain A, 2007, DIABETES RES CLIN PR, V76, P317, DOI 10.1016/j.diabres.2006.09.020; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; Hwang S, 2008, J THEOR BIOL, V252, P722, DOI 10.1016/j.jtbi.2008.02.011; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karimpour-Fard A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-313; Kelly MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032670; Lai SW, 2012, AM J GASTROENTEROL, V107, P46, DOI 10.1038/ajg.2011.384; Lecker SH, 1999, J CLIN INVEST, V104, P1411, DOI 10.1172/JCI7300; Lesbordes JC, 2003, HUM MOL GENET, V12, P1233, DOI 10.1093/hmg/ddg143; Li L, 2007, BRAIN RES REV, V56, P384, DOI 10.1016/j.brainresrev.2007.09.001; Libby P, 2006, AM J CLIN NUTR, V83, p456S; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Liu M, 2007, PLOS GENET, V3, P958, DOI 10.1371/journal.pgen.0030096; LOWE HJ, 1994, JAMA-J AM MED ASSOC, V271, P1103, DOI 10.1001/jama.271.14.1103; Lozano MA, 2006, PATTERN RECOGN, V39, P539, DOI 10.1016/j.patcog.2005.10.008; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Marfella R, 2006, DIABETES, V55, P622, DOI 10.2337/diabetes.55.03.06.db05-0832; Mayer B, 2007, CLIN RES CARDIOL, V96, P1, DOI 10.1007/s00392-006-0447-y; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; McCarthy MI, 2002, AM J PHYSIOL-ENDOC M, V283, pE217, DOI 10.1152/ajpendo.00099.2002; McKusick V.A., 1998, MENDELIAN INHERITANC; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Mejhert N, 2010, BMC ENDOCR DISORD, V10, DOI 10.1186/1472-6823-10-1; Nair S, 2005, DIABETOLOGIA, V48, P1784, DOI 10.1007/s00125-005-1868-2; Nakayama S, 2008, DIABETOLOGIA, V51, P1883, DOI 10.1007/s00125-008-1080-2; Natal C, 2008, AM J PHYSIOL-ENDOC M, V294, pE52, DOI 10.1152/ajpendo.00506.2007; Nibbe RK, 2009, MOL CELL PROTEOMICS, V8, P827, DOI 10.1074/mcp.M800428-MCP200; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Oliveira S, 2007, INT J COMPUT MATH, V84, P683, DOI 10.1080/00207160701332382; Onnela JP, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/179; Owen KR, 2007, CURR OPIN GENET DEV, V17, P239, DOI 10.1016/j.gde.2007.04.003; Palmer ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029202; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Pihlajamaki J, 2009, J CLIN ENDOCR METAB, V94, P3521, DOI 10.1210/jc.2009-0212; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006; Ray M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r148; Rende D, 2011, MOL BIOSYST, V7, P2205, DOI 10.1039/c1mb05064h; Richard AJ, 2011, TRENDS ENDOCRIN MET, V22, P325, DOI 10.1016/j.tem.2011.03.007; Ridderstrale M, 2009, MOL CELL ENDOCRINOL, V297, P10, DOI 10.1016/j.mce.2008.10.002; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sanghera DK, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.1000198; Sengupta U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008100; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Sprenger J, 2008, NUCLEIC ACIDS RES, V36, pD230, DOI 10.1093/nar/gkm950; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; Stix V, 2004, COMPUT OPTIM APPL, V27, P173, DOI 10.1023/B:COAP.0000008651.28952.b6; Su W, 2008, AM J PHYSIOL-HEART C, V295, pH1634, DOI 10.1152/ajpheart.00257.2008; Thomas MK, 2000, DIABETES, V49, P2039, DOI 10.2337/diabetes.49.12.2039; Tsankov AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100106; Ulitsky I, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-8; Wang JG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000521; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wang XW, 2008, CURR OPIN BIOTECH, V19, P482, DOI 10.1016/j.copbio.2008.07.011; Welters HJ, 2008, TRENDS ENDOCRIN MET, V19, P349, DOI 10.1016/j.tem.2008.08.004; Wheeler E, 2011, BRIEF FUNCT GENOMICS, V10, P52, DOI 10.1093/bfgp/elr008; Wheelock CE, 2009, MOL BIOSYST, V5, P588, DOI 10.1039/b902356a; White R, 2008, FEBS LETT, V582, P39, DOI 10.1016/j.febslet.2007.11.017; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zelezniak A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000729; Zhang C, 2006, J PROTEOME RES, V5, P801, DOI 10.1021/pr050366g; Zhang SH, 2006, COMPUT BIOL CHEM, V30, P445, DOI 10.1016/j.compbiolchem.2006.10.001; Zucman-Rossi J, 2010, DIGEST LIVER DIS, V42, pS235, DOI 10.1016/S1590-8658(10)60511-7	102	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65854	10.1371/journal.pone.0065854	http://dx.doi.org/10.1371/journal.pone.0065854			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776558	gold, Green Submitted, Green Published			2022-12-25	WOS:000320755400074
J	Shiu, J; Czinn, SJ; Kobayashi, KS; Sun, YZ; Blanchard, TG				Shiu, Jessica; Czinn, Steven J.; Kobayashi, Koichi S.; Sun, Yezhou; Blanchard, Thomas G.			IRAK-M Expression Limits Dendritic Cell Activation and Proinflammatory Cytokine Production in Response to Helicobacter pylori	PLOS ONE			English	Article							REGULATORY T-CELLS; KINASE-M; GASTRIC INFLAMMATION; NEGATIVE REGULATOR; IMMUNE-RESPONSES; HOST-DEFENSE; INFECTION; FELIS; POLYMORPHISMS; COLONIZATION	Helicobacter pylori (H. pylori) infects the gastric mucosa and persists for the life of the host. Bacterial persistence may be due to the induction of regulatory T cells (T-regs) which may have protective effects against other diseases such as asthma. It has been shown that H. pylori modulates the T cell response through dendritic cell reprogramming but the molecular pathways involved are relatively unknown. The goal of this study was to identify critical elements of dendritic cell (DC) activation and evaluate potential influence on immune activation. Microarray analysis was used to demonstrate limited gene expression changes in H. pylori stimulated bone marrow derived DCs (BMDCs) compared to the BMDCs stimulated with E. coli. IRAK-M, a negative regulator of TLR signaling, was upregulated and we selectedit for investigation of its role in modulating the DC and T cell responses. IRAK-M-/- and wild type BMDC were compared for their response to H. pylori. Cells lacking IRAK-M produced significantly greater amounts of proinflammatory MIP-2 and reduced amounts of immunomodulatory IL-10 than wild type BMDC. IRAK-M-/- cells also demonstrated increased MHC II expression upon activation. However, IRAK-M-/- BMDCs were comparable to wild type BMDCs in inducing T-helper 17 (T(H)17) and T-reg responses as demonstrated in vitro using BMDC CD4+ T cells co-culture assays, and in vivo though the adoptive transfer of CD4(+) FoxP3-GFP T cells into H. pylori infected IRAK-M-/- mice. These results suggest that H. pylori infection leads to the upregulation of anti-inflammatory molecules like IRAK-M and that IRAK-M has a direct impact on innate functions in DCs such as cytokine and costimulation molecule upregulation but may not affect T cell skewing.	[Shiu, Jessica; Czinn, Steven J.; Blanchard, Thomas G.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Kobayashi, Koichi S.] Texas A&M Coll Med, College Stn, TX USA; [Sun, Yezhou] Univ Maryland, Sch Med, Inst Genom Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University System of Maryland; University of Maryland Baltimore	Blanchard, TG (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.	tblanchard@peds.umaryland.edu		Shiu, Jessica/0000-0002-2264-8372; Kobayashi, Koichi/0000-0003-2930-0114	National Institutes of Health [AI-055710, DK-46461]; Canadian Institutes of Health Research [DFSA-236840]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI055710, R01AI055710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046461, R01DK046461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants AI-055710, and DK-46461, and Canadian Institutes of Health Research grant DFSA-236840. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Anderson KM, 2006, J IMMUNOL, V176, P5306, DOI 10.4049/jimmunol.176.9.5306; Arnold IC, 2011, J CLIN INVEST, V121, P3088, DOI 10.1172/JCI45041; Arnold IC, 2011, GASTROENTEROLOGY, V140, P199, DOI 10.1053/j.gastro.2010.06.047; Balaci L, 2007, AM J HUM GENET, V80, P1103, DOI 10.1086/518259; Bamford KB, 1998, GASTROENTEROLOGY, V114, P482, DOI 10.1016/S0016-5085(98)70531-1; Beygo J, 2009, MOL CELL PROBE, V23, P16, DOI 10.1016/j.mcp.2008.10.002; Biswas A, 2011, EUR J IMMUNOL, V41, P182, DOI 10.1002/eji.201040479; Blaser MJ, 2010, GASTROENTEROLOGY, V139, P1819, DOI 10.1053/j.gastro.2010.10.037; Cole TS, 2012, IMMUNOL LETT, V144, P49, DOI 10.1016/j.imlet.2012.03.006; Delyria ES, 2009, GASTROENTEROLOGY, V136, P247, DOI 10.1053/j.gastro.2008.09.017; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; DOOLEY CP, 1989, NEW ENGL J MED, V321, P1562, DOI 10.1056/NEJM198912073212302; Drakes ML, 2006, INFECT IMMUN, V74, P4624, DOI 10.1128/IAI.00289-06; Eaton KA, 2001, J IMMUNOL, V166, P7456, DOI 10.4049/jimmunol.166.12.7456; FAN XJ, 1994, GUT, V35, P1379, DOI 10.1136/gut.35.10.1379; GENTA RM, 1993, HUM PATHOL, V24, P577, DOI 10.1016/0046-8177(93)90235-9; Hitzler I, 2011, GASTROENTEROLOGY, V141, P186, DOI 10.1053/j.gastro.2011.04.009; Holster IL, 2012, HELICOBACTER, V17, P232, DOI 10.1111/j.1523-5378.2012.00934.x; Hoogerwerf JJ, 2012, MOL MED, V18, P1067, DOI 10.2119/molmed.2011.00450; Horvath DJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00056; Kao JY, 2010, GASTROENTEROLOGY, V138, P1046, DOI 10.1053/j.gastro.2009.11.043; Karttunen RA, 1997, SCAND J GASTROENTERO, V32, P22, DOI 10.3109/00365529709025058; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; Lundgren A, 2005, INFECT IMMUN, V73, P523, DOI 10.1128/IAI.73.1.523-531.2005; Mandell L, 2004, INFECT IMMUN, V72, P6446, DOI 10.1128/IAI.72.11.6446-6454.2004; MARSHALL BJ, 1995, JAMA-J AM MED ASSOC, V274, P1064, DOI 10.1001/jama.274.13.1064; MARSHALL BJ, 1984, LANCET, V1, P1311; Nakashima K, 2006, J HUM GENET, V51, P284, DOI 10.1007/s10038-005-0358-1; Oertli M, 2012, J CLIN INVEST, V122, P1082, DOI 10.1172/JCI61029; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Rad R, 2007, GASTROENTEROLOGY, V133, P150, DOI 10.1053/j.gastro.2007.04.071; Rad R, 2006, GASTROENTEROLOGY, V131, P525, DOI 10.1053/j.gastro.2006.05.001; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; Raghavan S, 2004, SCAND J IMMUNOL, V60, P82, DOI 10.1111/j.0300-9475.2004.01447.x; Raghavan S, 2003, CLIN EXP IMMUNOL, V132, P393, DOI 10.1046/j.1365-2249.2003.02177.x; Rahn W, 2004, VACCINE, V23, P807, DOI 10.1016/j.vaccine.2004.06.051; Roth KA, 1999, J IMMUNOL, V163, P1490; Seki M, 2010, J IMMUNOL, V184, P1410, DOI 10.4049/jimmunol.0901709; Shiomi S, 2008, HELICOBACTER, V13, P518, DOI 10.1111/j.1523-5378.2008.00629.x; Skupsky J, 2010, MOL THER, V18, P1527, DOI 10.1038/mt.2010.95; Smith SM, 2011, J IMMUNOL, V186, P2462, DOI 10.4049/jimmunol.1000864; Sonnenberg A, 2010, GASTROENTEROLOGY, V139, P1894, DOI 10.1053/j.gastro.2010.08.018; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Suda Y, 1997, J BIOCHEM-TOKYO, V121, P1129; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Takahashi N, 2010, J PERIODONTAL RES, V45, P512, DOI 10.1111/j.1600-0765.2009.01266.x; Tran AX, 2005, J ENDOTOXIN RES, V11, P161, DOI 10.1179/096805105X37349; Turnis ME, 2010, J IMMUNOL, V185, P4223, DOI 10.4049/jimmunol.0903507; van der Windt GJW, 2012, J INFECT DIS, V205, P1849, DOI 10.1093/infdis/jis290; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Velin D, 2009, GASTROENTEROLOGY, V136, P2237, DOI 10.1053/j.gastro.2009.02.077; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; World Health Organization, 1994, IARC MON EV CARC RIS, P177; WOTHERSPOON AC, 1991, LANCET, V338, P1175, DOI 10.1016/0140-6736(91)92035-Z; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65	59	19	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66914	10.1371/journal.pone.0066914	http://dx.doi.org/10.1371/journal.pone.0066914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776703	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400158
J	Zhang, C; Suckow, AT; Chessler, SD				Zhang, Charles; Suckow, Arthur T.; Chessler, Steven D.			Altered Pancreatic Islet Function and Morphology in Mice Lacking the Beta-Cell Surface Protein Neuroligin-2	PLOS ONE			English	Article							INSULIN-SECRETION; GLUCOSE; RAT; EXPRESSION; NEUREXIN; SENSITIVITY; DEFICIENCY; MATURATION; MUTATIONS; PATHWAYS	Neuroligin-2 is a transmembrane, cell-surface protein originally identified as an inhibitory synapse-associated protein in the central nervous system. Neuroligin-2 is also present on the pancreatic beta-cell surface, and there it engages in transcellular interactions that drive functional maturation of the insulin secretory machinery; these are necessary for normal insulin secretion. The effects of neuroligin-2 deficiency on brain and neuronal function and morphology and on behavior and coordination have been extensively characterized using neuroligin-2 knockout mice. The effects of absent neuroligin-2 expression on islet development and function, however, are unknown. Here, to help test whether neuroligin-2 is necessary for normal islet development, we characterized islet morphology in mice lacking neuroligin-2. To test whether-as predicted by our earlier co-culture studies-absence of neuroligin-2 impairs beta cell function, we compared glucose-stimulated insulin secretion by islets from mutant and wild-type mice. Our results show that while islets from neuroligin-2-deficient mice do not to appear to differ architecturally from wild-type islets, they are smaller, fewer in number, and contain beta cells with lower insulin content. Evaluation of transcript levels suggests that upregulation of neuroligin-1 helps compensate for loss of neuroligin-2. Surprisingly, under both basal and stimulating glucose levels, isolated islets from the knockout mice secreted more of their intracellular insulin content. Rat islets with shRNA-mediated neuroligin-2 knockdown also exhibited increased insulin secretion. Neurexin transcript levels were lower in the knockout mice and, consistent with our prior finding that neurexin is a key constituent of the insulin granule docking machinery, insulin granule docking was reduced. These results indicate that neuroligin-2 is not necessary for the formation of pancreatic islets but that neuroligin-2 influences islet size and number. Neuroligin-2-perhaps through its effects on the expression and/or activity of its binding partner neurexin-promotes insulin granule docking, a known constraint on insulin secretion.	[Zhang, Charles; Chessler, Steven D.] Univ Calif Irvine, Sch Med, Dept Med, Irvine, CA 92717 USA; [Suckow, Arthur T.] Univ Calif San Diego, Pediat Diabet Res Ctr, La Jolla, CA 92093 USA	University of California System; University of California Irvine; University of California System; University of California San Diego	Chessler, SD (corresponding author), Univ Calif Irvine, Sch Med, Dept Med, Irvine, CA 92717 USA.	s.chessler@uci.edu			National Institutes of Health [R01DK080971]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080971, P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant R01DK080971 (to S. D. C; nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaneya Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012486; Blundell J, 2009, GENES BRAIN BEHAV, V8, P114, DOI 10.1111/j.1601-183X.2008.00455.x; Bosco D, 2011, PHYSIOL REV, V91, P1393, DOI 10.1152/physrev.00027.2010; Calabrese A, 2004, EXP CELL RES, V294, P379, DOI 10.1016/j.yexcr.2003.12.007; Chessler SD, 2000, GABA IN THE NERVOUS SYSTEM: THE VIEW AT FIFTY YEARS, P471; Chessler SD, 2002, DIABETES, V51, P1763, DOI 10.2337/diabetes.51.6.1763; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; CIRULLI V, 1994, J CELL SCI, V107, P1429; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dean C, 2005, TRENDS NEUROSCI; Efanov AM, 2004, DIABETES, V53, pS75, DOI 10.2337/diabetes.53.suppl_3.S75; Esni F, 1999, J CELL BIOL, V144, P325, DOI 10.1083/jcb.144.2.325; Etherton MR, 2011, EMBO J, V30, P2908, DOI 10.1038/emboj.2011.182; Gomi H, 2005, J CELL BIOL, V171, P99, DOI 10.1083/jcb.200505179; Grouwels G, 2012, DIABETOLOGIA, V55, P2016, DOI 10.1007/s00125-012-2542-0; Hoon M, 2009, J NEUROSCI, V29, P8039, DOI 10.1523/JNEUROSCI.0534-09.2009; Huang HH, 2011, ISLETS, V3, P6, DOI 10.4161/isl.3.1.14132; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Jain R, 2009, DIABETES OBES METAB, V11, P159, DOI 10.1111/j.1463-1326.2009.01102.x; Jaques F, 2008, ENDOCRINOLOGY, V149, P2494, DOI 10.1210/en.2007-0974; Jedlicka P, 2011, CEREB CORTEX, V21, P357, DOI 10.1093/cercor/bhq100; Kasai K, 2008, TRAFFIC, V9, P1191, DOI 10.1111/j.1600-0854.2008.00744.x; Kelly C, 2011, ISLETS, V3, P41, DOI 10.4161/isl.3.2.14805; Khaldi MZ, 2004, AM J PHYSIOL-ENDOC M, V287, pE207, DOI 10.1152/ajpendo.00426.2003; KIM J, 1993, DIABETES, V42, P1799, DOI 10.2337/diabetes.42.12.1799; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Kwan EP, 2006, DIABETES, V55, P1421, DOI 10.2337/db05-1263; Larrieta E, 2012, J NUTR BIOCHEM, V23, P392, DOI 10.1016/j.jnutbio.2011.01.003; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Lips ES, 2012, MOL PSYCHIATR, V17, P996, DOI 10.1038/mp.2011.117; Morton GJ, 2011, PHYSIOL REV, V91, P389, DOI 10.1152/physrev.00007.2010; Mosedale M, 2012, J BIOL CHEM, V287, P6350, DOI 10.1074/jbc.M111.299081; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Preitner F, 2004, J CLIN INVEST, V113, P635, DOI 10.1172/JCI200420518; Satin LS, 1998, ENDOCRINE, V8, P213, DOI 10.1385/ENDO:8:3:213; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; STEINKE J, 1972, METABOLISM, V21, P465, DOI 10.1016/0026-0495(72)90058-3; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Suckow AT, 2012, J BIOL CHEM, V287, P19816, DOI 10.1074/jbc.M111.280537; Suckow AT, 2010, AM J PHYSIOL-ENDOC M, V299, pE23, DOI 10.1152/ajpendo.00664.2009; Suckow AT, 2008, ENDOCRINOLOGY, V149, P6006, DOI 10.1210/en.2008-0274; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sun CC, 2011, HUM MOL GENET, V20, P3042, DOI 10.1093/hmg/ddr208; Sweet IR, 2006, DIABETES, V55, P3509, DOI 10.2337/db06-0400; Sweet IR, 2004, DIABETES, V53, P401, DOI 10.2337/diabetes.53.2.401; Thorens B, 2010, DIABETES METAB, V36, pS45, DOI 10.1016/S1262-3636(10)70466-3; Tsimikas S, 2011, J AM COLL CARDIOL, V58, P1715, DOI 10.1016/j.jacc.2011.07.017; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Wohr M, 2012, BEHAV BRAIN RES; Zhao AZ, 2010, DIABETES, V59, P2522, DOI 10.2337/db09-1719	52	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65711	10.1371/journal.pone.0065711	http://dx.doi.org/10.1371/journal.pone.0065711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776533	Green Published, gold			2022-12-25	WOS:000320755400061
J	Zhang, J; Xie, PH; Lascoux, M; Meagher, TR; Liu, JQ				Zhang, Jian; Xie, Penghui; Lascoux, Martin; Meagher, Thomas R.; Liu, Jianquan			Rapidly Evolving Genes and Stress Adaptation of Two Desert Poplars, Populus euphratica and P. pruinosa	PLOS ONE			English	Article							COMPARATIVE GENOMICS; SELECTION; SUBSTITUTION; EVOLUTION; TOOL; TRANSCRIPTOMES; EXPRESSION; RESISTANCE; UBIQUITIN; SYSTEM	Understanding which genes have evolved rapidly with the recent tree speciation in arid habitats can provide valuable insights into different adaptation mechanisms. We employed a comparative evolutionary analysis of expressed sequence tags (ESTs) from two desert poplars, Populus pruinosa and P. euphratica, which diverged in the recent past. Following an approach taken previously with P. euphratica, we conducted a deep transcriptomic analysis of P. pruinosa. To maximize representation of conditional transcripts, mRNA was obtained from living tissues of two types of callus and desert-grown trees. De novo assembly generated 114,866 high-quality unique sequences using Solexa sequence data. Following assembly we were able to identify, with high confidence, 2859 orthologous sequence pairs between the two species. Based on the ratio of nonsynonymous (Ka) to synonymous (Ks) substitutions, we identified a total of 84 (2.9%) ortholog pairs exhibiting rapid evolution with signs of strong selection (Ka/Ks>1). Genes homologous to these ortholog pairs in model species are mainly involved in 'responses to stress', 'ubiquitin-dependent protein catabolic processes', and 'biological regulation'. Finally, we examined the expression patterns of candidate genes with rapid evolution in response to salt stress. Only one pair of orthologs up-regulated their expression in both species while three and four genes were found to up-regulated in P. pruinosa and in P. euphratica respectively. Our findings together suggest that the genes at the same category or network but with differentiated expressions or functions may have evolved rapidly during adaptive divergence of the two species to differentiated salty desert habitats.	[Zhang, Jian; Xie, Penghui; Liu, Jianquan] Lanzhou Univ, Sch Life Sci, Mol Ecol Grp, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Gansu, Peoples R China; [Lascoux, Martin] Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Lab Evolutionary Genom, Shanghai, Peoples R China; [Lascoux, Martin] Uppsala Univ, Evolutionary Biol Ctr, Program Evolutionary Funct Genom, Uppsala, Sweden; [Meagher, Thomas R.] Univ St Andrews, Sch Biol, St Andrews KY16 9AJ, Fife, Scotland	Lanzhou University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Uppsala University; University of St Andrews	Liu, JQ (corresponding author), Lanzhou Univ, Sch Life Sci, Mol Ecol Grp, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Gansu, Peoples R China.	liujq@nwipb.ac.cn		Lascoux, Martin/0000-0003-1699-9042; Zhang, Jian/0000-0002-0790-4462	Ministry of Science and Technology (National Key Project for Basic Research) [2012CB114504]; Ministry of Science and Technology (National High Technology Research and Development Program of China) [2013AA102605]; International Collaboration 111 Projects of China; Fundamental Research Funds for the Central Universities [lzujbky-2009-k05]	Ministry of Science and Technology (National Key Project for Basic Research); Ministry of Science and Technology (National High Technology Research and Development Program of China); International Collaboration 111 Projects of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Financial support was provided by the Ministry of Science and Technology (National Key Project for Basic Research 2012CB114504 and the National High Technology Research and Development Program of China No. 2013AA102605), the International Collaboration 111 Projects of China and the Fundamental Research Funds for the Central Universities (lzujbky-2009-k05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barakat A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-38; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen SF, 2011, MAR GENOM, V4, P129, DOI 10.1016/j.margen.2011.03.005; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Eckenwalder James E., 1996, P7; Ellegren H, 2008, MOL ECOL, V17, P4586, DOI 10.1111/j.1365-294X.2008.03954.x; Elmer KR, 2010, MOL ECOL, V19, P197, DOI 10.1111/j.1365-294X.2009.04488.x; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guo YS, 2010, PLANTA, V232, P1499, DOI 10.1007/s00425-010-1271-1; Heras J, 2011, MAR GENOM, V4, P93, DOI 10.1016/j.margen.2011.02.001; Huang JZ, 2012, DNA RES, V19, P195, DOI 10.1093/dnares/dss004; Hughes AL, 1999, ADAPTIVE EVOLUTION G, p[ix, 270]; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kunstner A, 2010, MOL ECOL, V19, P266, DOI 10.1111/j.1365-294X.2009.04487.x; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu JianPing, 2004, Scientia Silvae Sinicae, V40, P165; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; MIYATA T, 1979, J MOL EVOL, V12, P219, DOI 10.1007/BF01732340; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NEI M, 1986, MOL BIOL EVOL, V3, P418; Oh DH, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-3-241, 10.1186/gb4003]; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Ottow EA, 2005, PLANT PHYSIOL, V139, P1762, DOI 10.1104/pp.105.069971; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qiu Q, 2011, TREE PHYSIOL, V31, P452, DOI 10.1093/treephys/tpr015; Rokas A, 2009, TRENDS ECOL EVOL, V24, P192, DOI 10.1016/j.tree.2008.11.004; Schranz ME, 2007, CURR OPIN PLANT BIOL, V10, P168, DOI 10.1016/j.pbi.2007.01.014; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Sutton KA, 1997, J MOL EVOL, V45, P579, DOI 10.1007/PL00006262; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; [王海珍 WANG Haizhen], 2007, [干旱地区农业研究, Agricultural Research in the Arid Areas], V25, P125; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026530; Wang S, 1995, ADV POPLAR RES 1991; Wolf JBW, 2010, MOL ECOL, V19, P162, DOI 10.1111/j.1365-294X.2009.04471.x; Wu YX, 2007, PLANT MOL BIOL, V65, P1, DOI 10.1007/s11103-007-9170-y; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2000, GENETICS, V155, P431; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang F, 2004, IN VITRO CELL DEV-PL, V40, P491, DOI 10.1079/IVP2004546; Zhang F, 2007, PLANT CELL ENVIRON, V30, P775, DOI 10.1111/j.1365-3040.2007.01667.x; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	49	34	35	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66370	10.1371/journal.pone.0066370	http://dx.doi.org/10.1371/journal.pone.0066370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776666	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400142
J	Gavalda, S; Gallardo, M; Luna, R; Aguilera, A				Gavalda, Sandra; Gallardo, Mercedes; Luna, Rosa; Aguilera, Andres			R-Loop Mediated Transcription-Associated Recombination in trf4 Delta Mutants Reveals New Links between RNA Surveillance and Genome Integrity	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; TOPOISOMERASE-I; YEAST GENE; QUALITY-CONTROL; INSTABILITY; ELONGATION; COMPLEX; REPLICATION; POLYADENYLATION	To get further insight into the factors involved in the maintenance of genome integrity we performed a screening of Saccharomyces cerevisiae deletion strains inducing hyperrecombination. We have identified trf4, a gene encoding a non-canonical polyA-polymerase involved in RNA surveillance, as a factor that prevents recombination between DNA repeats. We show that trf4 Delta confers a transcription-associated recombination phenotype that is mediated by the nascent mRNA. In addition, trf4 Delta also leads to an increase in the mutation frequency. Both genetic instability phenotypes can be suppressed by overexpression of RNase H and are exacerbated by overexpression of the human cytidine deaminase AID. These results suggest that in the absence of Trf4 R-loops accumulate co-transcriptionally increasing the recombination and mutation frequencies. Altogether our data indicate that Trf4 is necessary for both mRNA surveillance and maintenance of genome integrity, serving as a link between RNA and DNA metabolism in S. cerevisiae.	[Gavalda, Sandra; Luna, Rosa; Aguilera, Andres] Univ Seville, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Dept Biol Mol, Seville, Spain; [Gallardo, Mercedes; Luna, Rosa; Aguilera, Andres] Univ Seville, Dept Genet, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); University of Sevilla	Aguilera, A (corresponding author), Univ Seville, Ctr Andaluz Biol Mol & Med Regenerat CABIMER, Dept Biol Mol, Seville, Spain.	aguilo@us.es	Aguilera, Andres/L-1825-2014; LUNA, ROSA/F-3974-2016	Aguilera, Andres/0000-0003-4782-1714; LUNA, ROSA/0000-0002-6131-6610	Spanish Ministry of Science and Research [BFU2010-16372, 2010 CSD2007-00015]; Junta de Andalucia [CVI-4567]; European Union (FEDER); Spanish Ministry of Health	Spanish Ministry of Science and Research(Spanish Government); Junta de Andalucia(Junta de Andalucia); European Union (FEDER)(European Commission); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	This work was supported by grants from the Spanish Ministry of Science and Research (BFU2010-16372 and Consolider Ingenio 2010 CSD2007-00015), Junta de Andalucia (CVI-4567) and European Union (FEDER). SG was the recipient of a predoctoral training grant from the Spanish Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILERA A, 1988, GENETICS, V119, P779; AGUILERA A, 1990, MOL CELL BIOL, V10, P1439, DOI 10.1128/MCB.10.4.1439; Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; Bermejo R, 2012, MOL CELL, V45, P710, DOI 10.1016/j.molcel.2012.03.001; Castano IB, 1996, GENE DEV, V10, P2564, DOI 10.1101/gad.10.20.2564; Chavez S, 1997, GENE DEV, V11, P3459, DOI 10.1101/gad.11.24.3459; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Dominguez-Sanchez MS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002386; Edwards S, 2003, MOL CELL BIOL, V23, P2733, DOI 10.1128/MCB.23.8.2733-2748.2003; Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Gallardo M, 2001, GENETICS, V157, P79; Gan WJ, 2011, GENE DEV, V25, P2041, DOI 10.1101/gad.17010011; Garcia-Rubio M, 2003, GENETICS, V165, P457; Gomez-Gonzalez B, 2007, P NATL ACAD SCI USA, V104, P8409, DOI 10.1073/pnas.0702836104; Gomez-Gonzalez B, 2011, EMBO J, V30, P3106, DOI 10.1038/emboj.2011.206; Gonzalez-Aguilera C, 2008, MOL BIOL CELL, V19, P4310, DOI 10.1091/mbc.E08-04-0355; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kallstrom G, 2003, MOL CELL BIOL, V23, P4344, DOI 10.1128/MCB.23.12.4344-4355.2003; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Luna R, 2005, MOL CELL, V18, P711, DOI 10.1016/j.molcel.2005.05.001; Luna R, 2008, CHROMOSOMA, V117, P319, DOI 10.1007/s00412-008-0158-4; Mischo HE, 2011, MOL CELL, V41, P21, DOI 10.1016/j.molcel.2010.12.007; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Paolo SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000555; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Piruat JI, 1998, EMBO J, V17, P4859, DOI 10.1093/emboj/17.16.4859; Planta RJ, 1998, YEAST, V14, P471, DOI 10.1002/(SICI)1097-0061(19980330)14:5<471::AID-YEA241>3.0.CO;2-U; Poltoratsky VP, 2004, J IMMUNOL, V172, P4308, DOI 10.4049/jimmunol.172.7.4308; PRADO F, 1995, GENETICS, V139, P109; Rondon AG, 2003, J BIOL CHEM, V278, P39037, DOI 10.1074/jbc.M305718200; Rougemaille M, 2007, EMBO J, V26, P2317, DOI 10.1038/sj.emboj.7601669; SADOFF BU, 1995, GENETICS, V141, P465; SANTOSROSA H, 1994, MOL GEN GENET, V245, P224, DOI 10.1007/BF00283271; Schmid M, 2008, CHROMOSOMA, V117, P419, DOI 10.1007/s00412-008-0166-4; Schmidt KH, 2006, MOL MICROBIOL, V60, P1251, DOI 10.1111/j.1365-2958.2006.05166.x; Stirling PC, 2012, GENE DEV, V26, P163, DOI 10.1101/gad.179721.111; Tous C, 2011, EMBO J, V30, P1953, DOI 10.1038/emboj.2011.109; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; Tutucci E, 2011, NAT REV MOL CELL BIO, V12, P376, DOI 10.1038/nrm3119; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wahba L, 2011, MOL CELL, V44, P978, DOI 10.1016/j.molcel.2011.10.017; Wang ZH, 2002, GENETICS, V160, P381; Wellinger RE, 2006, MOL CELL BIOL, V26, P3327, DOI 10.1128/MCB.26.8.3327-3334.2006; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039	64	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65541	10.1371/journal.pone.0065541	http://dx.doi.org/10.1371/journal.pone.0065541			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762389	gold, Green Submitted, Green Published			2022-12-25	WOS:000321094800060
J	Jia, YX; Tao, FQ; Li, WQ				Jia, Yanxia; Tao, Faqing; Li, Weiqi			Lipid Profiling Demonstrates That Suppressing Arabidopsis Phospholipase D delta Retards ABA-Promoted Leaf Senescence by Attenuating Lipid Degradation	PLOS ONE			English	Article							PHOSPHATIDIC-ACID; D-ALPHA; MICROSOMAL-MEMBRANES; D ACTIVATION; PLD-DELTA; METABOLISM; STRESS; EXPRESSION; ORGANIZATION; INHIBITION	Senescence is the last phase of the plant life cycle and has an important role in plant development. Degradation of membrane lipids is an essential process during leaf senescence. Several studies have reported fundamental changes in membrane lipids and phospholipase D (PLD) activity as leaves senesce. Suppression of phospholipase D alpha 1 (PLD alpha 1) retards abscisic acid (ABA)-promoted senescence. However, given the absence of studies that have profiled changes in the compositions of membrane lipid molecules during leaf senescence, there is no direct evidence that PLD affects lipid composition during the process. Here, we show that application of n-butanol, an inhibitor of PLD, and N-Acylethanolamine (NAE) 12:0, a specific inhibitor of PLD alpha 1, retarded ABA-promoted senescence to different extents. Furthermore, phospholipase D delta (PLD delta) was induced in leaves treated with ABA, and suppression of PLD delta retarded ABA-promoted senescence in Arabidopsis. Lipid profiling revealed that detachment-induced senescence had different effects on plastidic and extraplastidic lipids. The accelerated degradation of plastidic lipids during ABA-induced senescence in wild-type plants was attenuated in PLD delta-knockout (PLD delta-KO) plants. Dramatic increases in phosphatidic acid (PA) and decreases in phosphatidylcholine (PC) during ABA-induced senescence were also suppressed in PLD delta-KO plants. Our results suggest that PLD delta-mediated hydrolysis of PC to PA plays a positive role in ABA-promoted senescence. The attenuation of PA formation resulting from suppression of PLD delta blocks the degradation of membrane lipids, which retards ABA-promoted senescence.	[Jia, Yanxia; Li, Weiqi] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China; [Tao, Faqing; Li, Weiqi] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming, Peoples R China; [Jia, Yanxia] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, WQ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China.	weiqili@mail.kib.ac.cn			National Natural Science Foundation of China [NSFC 30670474, 30870571, 31070262]; Fund of State Key Laboratory of Phytochemistry and Plant Resources in West China [0807B01211, 097C1211Z1]; Kunming Institute of Botany [KSCX2-EW-J-24]; Germplasm Bank of Wild Species; CAS Innovation Program of Kunming Institute, 100-Talents Program of CAS [540806321211]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund of State Key Laboratory of Phytochemistry and Plant Resources in West China; Kunming Institute of Botany; Germplasm Bank of Wild Species; CAS Innovation Program of Kunming Institute, 100-Talents Program of CAS	The research was supported by grants from the National Natural Science Foundation of China (NSFC 30670474, 30870571, and 31070262), Fund of State Key Laboratory of Phytochemistry and Plant Resources in West China (0807B01211 and 097C1211Z1), Kunming Institute of Botany (KSCX2-EW-J-24), Germplasm Bank of Wild Species, and CAS Innovation Program of Kunming Institute (540806321211), 100-Talents Program of CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin-Brown SL, 2002, PLANT PHYSIOL, V129, P1892, DOI 10.1104/pp.001974; Bargmann BOR, 2009, PLANT CELL PHYSIOL, V50, P78, DOI 10.1093/pcp/pcn173; Bonfig KB, 2006, PLANTA, V225, P1, DOI 10.1007/s00425-006-0303-3; BOROCHOV A, 1982, PLANT PHYSIOL, V69, P296, DOI 10.1104/pp.69.2.296; BROWN JH, 1987, PLANT PHYSIOL, V85, P679, DOI 10.1104/pp.85.3.679; Buchanan B, 2002, BIOCH MOL BIOL PLANT, p[480, 491]; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; BuchananWollaston V, 1997, J EXP BOT, V48, P181, DOI 10.1093/jxb/48.2.181; Dhonukshe P, 2003, PLANT CELL, V15, P2666, DOI 10.1105/tpc.014977; Espinoza C, 2007, J EXP BOT, V58, P3197, DOI 10.1093/jxb/erm165; Fan L, 1997, PLANT CELL, V9, P2183, DOI 10.1105/tpc.9.12.2183; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; Gardiner J, 2003, PLANT CELL PHYSIOL, V44, P687, DOI 10.1093/pcp/pcg095; Gardiner JC, 2001, PLANT CELL, V13, P2143, DOI 10.1105/tpc.13.9.2143; Guo YF, 2005, CURR TOP DEV BIOL, V71, P83, DOI 10.1016/S0070-2153(05)71003-6; He YH, 2002, PLANT CELL, V14, P805, DOI 10.1105/tpc.010422; Hong YY, 2010, PLANT CELL ENVIRON, V33, P627, DOI 10.1111/j.1365-3040.2009.02087.x; Hong YY, 2008, MOL PLANT, V1, P262, DOI 10.1093/mp/ssm025; Jing HC, 2002, PLANT J, V32, P51, DOI 10.1046/j.1365-313X.2002.01400.x; Katagiri T, 2001, PLANT J, V26, P595, DOI 10.1046/j.1365-313x.2001.01060.x; Kim JI, 2011, J EXP BOT, V62, P3981, DOI 10.1093/jxb/err094; KOIWAI A, 1981, PLANT CELL PHYSIOL, V22, P1059; Krinke O, 2009, PLANT PHYSIOL, V150, P424, DOI 10.1104/pp.108.133595; Li MY, 2009, BBA-MOL CELL BIOL L, V1791, P927, DOI 10.1016/j.bbalip.2009.02.017; Li W, 2008, J BIOL CHEM, V283, P461, DOI 10.1074/jbc.M706692200; Li WQ, 2004, NAT BIOTECHNOL, V22, P427, DOI 10.1038/nbt949; Lim PO, 2005, CURR TOP DEV BIOL, V67, P49, DOI 10.1016/S0070-2153(05)67002-0; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Marechal E, 1997, PHYSIOL PLANTARUM, V100, P65, DOI 10.1034/j.1399-3054.1997.1000106.x; Martinez DE, 2008, PLANT J, V56, P196, DOI 10.1111/j.1365-313X.2008.03585.x; Motes CM, 2005, PROTOPLASMA, V226, P109, DOI 10.1007/s00709-005-0124-4; Munnik T, 1995, PLANT CELL, V7, P2197, DOI 10.1105/tpc.7.12.2197; Murphy DJ, 2005, BIOL SCI SER, P1; Page T, 2001, PLANT PHYSIOL, V125, P718, DOI 10.1104/pp.125.2.718; PALIYATH G, 1987, PLANT PHYSIOL, V83, P63, DOI 10.1104/pp.83.1.63; Potocky M, 2003, PLANTA, V217, P122, DOI 10.1007/s00425-002-0965-4; Qin CB, 2002, PLANT PHYSIOL, V128, P1057, DOI 10.1104/pp.010928; Quirino BF, 2000, TRENDS PLANT SCI, V5, P278, DOI 10.1016/S1360-1385(00)01655-1; Rea G, 2004, PLANT PHYSIOL, V134, P1414, DOI 10.1104/pp.103.036764; SMART CM, 1991, PLANT CELL, V3, P647, DOI 10.1105/tpc.3.7.647; Thompson J, 2000, BIOCHEM SOC T, V28, P775, DOI 10.1042/BST0280775; THOMPSON JE, 1982, PLANT PHYSIOL, V69, P859, DOI 10.1104/pp.69.4.859; Thompson JE, 1998, PROG LIPID RES, V37, P119, DOI 10.1016/S0163-7827(98)00006-X; Tocquin Pierre, 2003, BMC Plant Biology, V3, P2, DOI 10.1186/1471-2229-3-2; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; Uraji M, 2012, PLANT PHYSIOL, V159, P450, DOI 10.1104/pp.112.195578; VERKLEIJ AJ, 1982, BIOCHIM BIOPHYS ACTA, V684, P255, DOI 10.1016/0005-2736(82)90014-1; Wang CX, 2001, PLANT PHYSIOL, V127, P1102, DOI 10.1104/pp.010444; Wang XM, 2002, CURR OPIN PLANT BIOL, V5, P408, DOI 10.1016/S1369-5266(02)00283-2; WANNER L, 1991, PLANT SCI, V78, P199, DOI 10.1016/0168-9452(91)90199-I; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; WOOLHOUSE HW, 1984, CAN J BOT, V62, P2934, DOI 10.1139/b84-392; Yamaoka Y, 2011, PLANT J, V67, P648, DOI 10.1111/j.1365-313X.2011.04624.x; YANG SF, 1967, J BIOL CHEM, V242, P477; Zhang WH, 2003, PLANT CELL, V15, P2285, DOI 10.1105/tpc.013961	56	41	48	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65687	10.1371/journal.pone.0065687	http://dx.doi.org/10.1371/journal.pone.0065687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762411	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800069
J	West, PA; Protopopoff, N; Rowland, M; Cumming, E; Rand, A; Drakeley, C; Wright, A; Kivaju, Z; Kirby, MJ; Mosha, FW; Kisinza, W; Kleinschmidt, I				West, Philippa A.; Protopopoff, Natacha; Rowland, Mark; Cumming, Emma; Rand, Alison; Drakeley, Chris; Wright, Alexandra; Kivaju, Zuhura; Kirby, Matthew J.; Mosha, Franklin W.; Kisinza, William; Kleinschmidt, Immo			Malaria Risk Factors in North West Tanzania: The Effect of Spraying, Nets and Wealth	PLOS ONE			English	Article							VECTOR-CONTROL INTERVENTIONS; BIOKO ISLAND; INSECTICIDE; TRANSMISSION; INFECTION; AREA; PREVALENCE; DISEASE	Malaria prevalence remains high in many African countries despite massive scaling-up of insecticide treated nets (ITN) and indoor residual spraying (IRS). This paper evaluates the protective effect of pyrethroid IRS and ITNs in relation to risk factors for malaria based on a study conducted in North-West Tanzania, where IRS has been conducted since 2007 and universal coverage of ITNs has been carried out recently. In 2011 community-based cross-sectional surveys were conducted in the two main malaria transmission periods that occur after the short and long rainy seasons. These included 5,152 and 4,325 children aged 0.5-14 years, respectively. Data on IRS and ITN coverage, household demographics and socio-economic status were collected using an adapted version of the Malaria Indicator Survey. Children were screened for malaria by rapid diagnostic test. In the second survey, haemoglobin density was measured and filter paper blood spots were collected to determine age-specific sero-prevalence in each community surveyed. Plasmodium falciparum infection prevalence in children 0.5-14 years old was 9.3% (95% CI: 5.9-14.5) and 22.8% (95% CI: 17.3-29.4) in the two surveys. Risk factors for infection after the short rains included households not being sprayed (OR = 0.39; 95% CI: 0.20-0.75); low community net ownership (OR = 0.45; 95% CI: 0.21-0.95); and low community SES (least poor vs. poorest tertile: OR = 0.13, 95% CI: 0.05-0.34). Risk factors after the long rains included household poverty (per quintile increase: OR = 0.89; 95% CI: 0.82-0.97) and community poverty (least poor vs. poorest tertile: OR = 0.26, 95% CI: 0.15-0.44); household IRS or high community ITN ownership were not protective. Despite high IRS coverage and equitable LLIN distribution, poverty was an important risk factor for malaria suggesting it could be beneficial to target additional malaria control activities to poor households and communities. High malaria prevalence in some clusters and the limited protection given by pyrethroid IRS and LLINs suggest that it may be necessary to enhance established vector control activities and consider additional interventions.	[West, Philippa A.; Cumming, Emma] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England; [Protopopoff, Natacha; Rowland, Mark; Wright, Alexandra; Kirby, Matthew J.] Univ London London Sch Hyg & Trop Med, Dept Dis Control, London WC1E 7HT, England; [Rand, Alison; Drakeley, Chris] Univ London London Sch Hyg & Trop Med, Immunol & Infect Dept, London WC1E 7HT, England; [Kivaju, Zuhura; Kirby, Matthew J.; Kisinza, William] Amani Med Res Ctr, Natl Inst Med Res, Muheza, Tanzania; [Mosha, Franklin W.] Tumaini Univ, Kilimanjaro Christian Med Coll, Moshi, Tanzania; [Kleinschmidt, Immo] Univ London London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; University of London; London School of Hygiene & Tropical Medicine	West, PA (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.	philippa.west@lshtm.ac.uk		Protopopoff, Natacha/0000-0001-6698-4936	Malaria Centre at the London School of Hygiene and Tropical Medicine; United States Agency for International Development under Translating Research into Action [GHS-A-00-09-00015-00]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Malaria Centre at the London School of Hygiene and Tropical Medicine; United States Agency for International Development under Translating Research into Action(United States Agency for International Development (USAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	PW is funded by a Thorpe legacy studentship from the Malaria Centre at the London School of Hygiene and Tropical Medicine. This study was funded by the United States Agency for International Development under Translating Research into Action, Cooperative Agreement No. GHS-A-00-09-00015-00. This study was made possible by the support of the American people through the United States Agency for International Development (USAID). The findings of this study are the sole responsibility of the authors, and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], J R SOC INTERFACE; [Anonymous], HIST WEATH DAT BUK; [Anonymous], MAL IND SURV HH QUES; [Anonymous], WHO REC INS IND RES; Bonner K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-73; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; BRADLEY DJ, 1991, DIS MORTALITY SUBSAH; Bradley J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-242; Carlstedt A, 1997, LANCET, V350, P1180, DOI 10.1016/S0140-6736(05)63830-5; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P400; Chitnis N, 2010, AM J TROP MED HYG, V83, P230, DOI 10.4269/ajtmh.2010.09-0179; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6; Damien GB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-380; Dickinson KL, 2012, GLOB PUBLIC HEALTH, V7, P384, DOI 10.1080/17441692.2010.539573; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; DRAPER C. C, 1960, TRANS ROY SOC TROP MED AND HYG, V54, P342, DOI 10.1016/0035-9203(60)90115-2; DRAPER CC, 1972, T ROY SOC TROP MED H, V66, P905, DOI 10.1016/0035-9203(72)90126-5; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Graves PM, 2008, TROP MED INT HEALTH, V13, P218, DOI 10.1111/j.1365-3156.2007.01993.x; Graves PM, 2009, T ROY SOC TROP MED H, V103, P1211, DOI 10.1016/j.trstmh.2008.11.016; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Kirkwood BR, 2003, ESSENTIAL MED STAT, P449; Kleinschmidt I, 2006, AM J TROP MED HYG, V74, P972, DOI 10.4269/ajtmh.2006.74.972; Kleinschmidt I, 2007, AM J TROP MED HYG, V76, P1027, DOI 10.4269/ajtmh.2007.76.1027; Kleinschmidt I, 2009, AM J TROP MED HYG, V81, P519, DOI 10.4269/ajtmh.2009.81.519; Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-264; Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-26; Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x; Mboera L E, 2001, Afr J Health Sci, V8, P17; Molineaux L, 2020, GARKI PROJECT RES EP, V8; N'Guessan R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-44; National Bureau of Statistics (NBS) Tanzania Measure DHS, 2012, TANZ HIV AIDS MAL IN; National Bureau of Statistics (NBS) Tanzania TCfAT Zanzibar AIDS Gommission (ZAG) Office of the Chief Government Statistician (OCGS) Macro Inc, 2008, TANZ HIV AIDS MAL IN; *NBS TANZ, 2005, TANZ DEM HLTH SURV 2; Over M, 2004, AM J TROP MED HYG, V71, P214, DOI 10.4269/ajtmh.2004.71.214; Pardo G, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-10; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Presidents Malaria Initiative, 2009, MAL OP PLAN TANZ FY2; Presidents Malaria Initiative USAID, 2011, PRES MAL IN 5 ANN RE; Protopopoff N, 2013, MALARIA J IN PRESS; Protopopoff N, 2012, AM J TROP MED HYG, P200; Protopopoff N, 2008, AM J TROP MED HYG, V79, P12, DOI 10.4269/ajtmh.2008.79.12; Roll Back Malaria Partnership, 2000, AB DECL PLAN ACT; Rozendaal JA, 1997, HOUSE SPRAYING RESID, P357; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Tanzania NBoS, 2006, TANZ CENS 2002 AN RE; Temu EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031409; THOMSON MC, 1994, T ROY SOC TROP MED H, V88, P638, DOI 10.1016/0035-9203(94)90204-6; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; West PA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-273; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2007, MAL EL FEILD MAN LOW; WHO, 2001, IRON DEFICIENCY ANAE; Williams GS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-168; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; World Health Organization Global Malaria Programme, 2007, INS TREAT MOSQ NETS; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x	63	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65787	10.1371/journal.pone.0065787	http://dx.doi.org/10.1371/journal.pone.0065787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762425	gold, Green Published, Green Accepted			2022-12-25	WOS:000321094800071
J	Borssen, M; Palmqvist, L; Karrman, K; Abrahamsson, J; Behrendtz, M; Heldrup, J; Forestier, E; Roos, G; Degerman, S				Borssen, Magnus; Palmqvist, Lars; Karrman, Kristina; Abrahamsson, Jonas; Behrendtz, Mikael; Heldrup, Jesper; Forestier, Erik; Roos, Goran; Degerman, Sofie			Promoter DNA Methylation Pattern Identifies Prognostic Subgroups in Childhood T-Cell Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							POLYCOMB; GENE; CANCER; EXPRESSION; PHENOTYPE; PROTEINS; THERAPY; NOTCH1; LINES	Background: Treatment of pediatric T-cell acute lymphoblastic leukemia (T-ALL) has improved, but there is a considerable fraction of patients experiencing a poor outcome. There is a need for better prognostic markers and aberrant DNA methylation is a candidate in other malignancies, but its potential prognostic significance in T-ALL is hitherto undecided. Design and Methods: Genome wide promoter DNA methylation analysis was performed in pediatric T-ALL samples (n = 43) using arrays covering >27000 CpG sites. Clinical outcome was evaluated in relation to methylation status and compared with a contemporary T-ALL group not tested for methylation (n = 32). Results: Based on CpG island methylator phenotype (CIMP), T-ALL samples were subgrouped as CIMP+ (high methylation) and CIMP- (low methylation). CIMP- T-ALL patients had significantly worse overall and event free survival (p = 0.02 and p = 0.001, respectively) compared to CIMP+ cases. CIMP status was an independent factor for survival in multivariate analysis including age, gender and white blood cell count. Analysis of differently methylated genes in the CIMP subgroups showed an overrepresentation of transcription factors, ligands and polycomb target genes. Conclusions: We identified global promoter methylation profiling as being of relevance for subgrouping and prognostication of pediatric T-ALL.	[Borssen, Magnus; Forestier, Erik; Roos, Goran; Degerman, Sofie] Umea Univ, Dept Med Biosci, Umea, Sweden; [Palmqvist, Lars] Univ Gothenburg, Sahlgrenska Univ Hosp, Dept Clin Chem & Transfus Med, Gothenburg, Sweden; [Karrman, Kristina] Lund Univ, Skane Univ Hosp, Univ & Reg Labs, Dept Clin Genet, Lund, Sweden; [Abrahamsson, Jonas] Sahlgrens Univ Hosp, Dept Pediat, Inst Clin Sci, Gothenburg, Sweden; [Behrendtz, Mikael] Linkoping Univ Hosp, Dept Pediat, S-58185 Linkoping, Sweden; [Heldrup, Jesper] Skane Univ Hosp, Dept Pediat, Lund, Sweden	Umea University; Sahlgrenska University Hospital; University of Gothenburg; Lund University; Skane University Hospital; Sahlgrenska University Hospital; Linkoping University; Lund University; Skane University Hospital	Degerman, S (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	sofie.degerman@medbio.umu.se	Heldrup, Jesper/AAW-6836-2020; Abrahamsson, Jonas/I-5786-2012	Abrahamsson, Jonas/0000-0002-9240-3522; Heldrup, Jesper/0000-0002-6211-1967; Degerman, Sofie/0000-0002-2783-0712	Swedish Cancer Society; Swedish Research Council; Swedish Childhood Cancer Foundation; Medical Faculty, Umea University; Lion's Cancer Research Foundation, Umea; European Community [200950]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Childhood Cancer Foundation(European Commission); Medical Faculty, Umea University; Lion's Cancer Research Foundation, Umea; European Community(European Commission)	This work was supported by grants from the Swedish Cancer Society (GR), the Swedish Research Council (GR), the Swedish Childhood Cancer Foundation (GR, EF), the Medical Faculty, Umea University (GR) and Lion's Cancer Research Foundation, Umea (SD, MBo, GR). The research leading to these results has received funding from the European Community's Seventh Framework Programme FP7/2007-2011 under grant agreement no. 200950 (GR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecassis I, 2008, LEUKEMIA, V22, P511, DOI 10.1038/sj.leu.2405071; Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Ang PW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-227; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bibikova M, 2011, GENOMICS; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI 10.2217/EPI.09.14; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Coustan-Smith E, 2009, LANCET ONCOL, V10, P147, DOI 10.1016/S1470-2045(08)70314-0; Degerman S, 2010, AGING CELL; Deneberg S, 2011, BLOOD, V118, P5573, DOI 10.1182/blood-2011-01-332353; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Gustafsson G, 2000, LEUKEMIA, V14, P2267, DOI 10.1038/sj.leu.2401961; Gutierrez A, 2010, J CLIN ONCOL, V28, P3816, DOI 10.1200/JCO.2010.28.3390; Gutierrez MI, 2003, LEUKEMIA, V17, P1845, DOI 10.1038/sj.leu.2403060; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jung S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052626; Karrman K, 2009, GENE CHROMOSOME CANC, V48, P795, DOI 10.1002/gcc.20684; Kraszewska MD, 2012, LEUKEMIA, V26, P367, DOI 10.1038/leu.2011.208; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lucchi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020785; Ma JX, 2012, MOL BIOL REP, V39, P6095, DOI 10.1007/s11033-011-1424-8; Martin-Perez D, 2010, BLOOD, V116, P5465, DOI 10.1182/blood-2010-05-267096; Martin-Subero JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006986; Milani L, 2010, BLOOD, V115, P1214, DOI 10.1182/blood-2009-04-214668; Milani L, 2009, GENOME RES, V19, P1, DOI 10.1101/gr.083931.108; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Prasad VVSR, 2011, EUR J PHARM SCI, V43, P217, DOI 10.1016/j.ejps.2011.04.010; Quintas-Cardama A, 2010, NAT REV CLIN ONCOL, V7, P433, DOI 10.1038/nrclinonc.2010.87; Roman-Gomez J, 2006, LEUKEMIA, V20, P1445, DOI 10.1038/sj.leu.2404257; Sanders YY, 2012, AM J RESP CRIT CARE, V186, P525, DOI 10.1164/rccm.201201-0077OC; Sandoval J, 2013, BRIT J HAEMATOL, V160, P406, DOI 10.1111/bjh.12113; Schmiegelow K, 2010, LEUKEMIA, V24, P345, DOI 10.1038/leu.2009.251; Shen LL, 2010, J CLIN ONCOL, V28, P605, DOI 10.1200/JCO.2009.23.4781; Simon C., 2012, GENES DEV; Siwicki JK, 2000, EXP GERONTOL, V35, P375, DOI 10.1016/S0531-5565(00)00088-7; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Van der Auwera I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012616; van Eijk KR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-636; Weisenberger DJ, 2008, NUCLEIC ACIDS RES, V36, P4689, DOI 10.1093/nar/gkn455; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	48	47	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65373	10.1371/journal.pone.0065373	http://dx.doi.org/10.1371/journal.pone.0065373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762353	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000061
J	Mandal, P; Bhattacharjee, B; Das Ghosh, D; Mondal, NR; Chowdhury, RR; Roy, S; Sengupta, S				Mandal, Paramita; Bhattacharjee, Bornali; Das Ghosh, Damayanti; Mondal, Nidhu Ranjan; Chowdhury, Rahul Roy; Roy, Sudipta; Sengupta, Sharmila			Differential Expression of HPV16 L2 Gene in Cervical Cancers Harboring Episomal HPV16 Genomes: Influence of Synonymous and Non-Coding Region Variations	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; MESSENGER-RNAS; CAPSID PROTEIN; INDIAN WOMEN; PREVALENCE; INFECTION; IDENTIFICATION; CARCINOMA; MICRORNAS; E2	We tested the hypothesis that (i) synonymous variations within the coding regions, and (ii) variations within the non-coding regions of HPV, influence cervical cancer (CaCx) pathogenesis under the impact of intact HPV16 genomes. Whole genome sequence analysis of HPV16 isolates within 70 CaCx cases and 25 non-malignant samples revealed that synonymous variations were significantly higher within the E6 (p = 0.014), E5 (p = 0.001) and L2 (p = 0.0002) genes of HPV16 isolates within cases, compared to isolates within non-malignant samples. All of the 25 (100%) humanized codons identified within L2 ORF of the samples analyzed, were harbored by CaCx cases, while 8 out of 25 (32%) were harbored by HPV16 positive non-malignant samples (p = 3.87105E-07). L2 (mRNA and protein) expression was evident only among cases with episomal viral genomes and L2 mRNA expression correlated significantly with E2 gene copy numbers suggesting expression from all episomal genomes. Among such cases, Asian American (AA) isolates portrayed all of the humanized codons (100%; 4-6/sample) recorded within L2, which was significantly higher (p = 2.02E-7) compared to the European (E) isolates (22.8%; none or 1-2/sample). Additionally, majority of E variant isolates within cases (54/57; 94.7%) portrayed a variation (T4228C) within the short non-coding region (NCR2) between E5 and L2 genes, which portrays a weak promoter activity specific for L2 mRNA expression. This resulted in loss of 9 out of 14 miRNA binding sites (hsa-miR-548 family), despite the significant overexpression of miR548a-5p and miR548d-5p among such cases (28.64 and 36.25 folds, respectively), in comparison to HPV negative control samples. The findings exemplify the biological relevance of sequence variations in HPV16 genomes and highlight that episomal HPV16 in CaCx cases employ multiple mechanisms to sustain L2 expression, thereby justifying the potential role of L2 in such cancers, as opposed to those harboring viral integration.	[Mandal, Paramita; Sengupta, Sharmila] Natl Inst Biomed Genom, Kalyani, W Bengal, India; [Bhattacharjee, Bornali; Das Ghosh, Damayanti] Indian Stat Inst, Human Genet Unit, Kolkata, India; [Mondal, Nidhu Ranjan; Chowdhury, Rahul Roy] Saroj Gupta Canc Ctr & Res Inst, Dept Gynecol, Kolkata, India; [Roy, Sudipta] Kothari Med Ctr, Dept Pathol, Kolkata, India	Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG); Indian Statistical Institute; Indian Statistical Institute Kolkata	Sengupta, S (corresponding author), Natl Inst Biomed Genom, Kalyani, W Bengal, India.	ssg1@nibmg.ac.in	Mandal, Paramita/ABC-3253-2021	Bhattacharjee, Bornali/0000-0002-0801-1543; MANDAL, PARAMITA/0000-0001-9971-342X; Roy Chowdhury, Rahul/0000-0002-4124-1017	Department of Biotechnology, Government of India [BT/PR8014/Med/14/1220/2006]; Indian Statistical Institute; National Institute of Biomedical Genomics	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Statistical Institute; National Institute of Biomedical Genomics	This work was supported partially by Department of Biotechnology (Grant No. BT/PR8014/Med/14/1220/2006), Government of India, and partially by Indian Statistical Institute (Intramural), and National Institute of Biomedical Genomics (Core Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER CC, 1987, EMBO J, V6, P1027, DOI 10.1002/j.1460-2075.1987.tb04855.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharjee B, 2006, GYNECOL ONCOL, V100, P372, DOI 10.1016/j.ygyno.2005.09.016; Bhattacharjee B, 2008, VIROLOGY, V377, P143, DOI 10.1016/j.virol.2008.04.007; Bhattacharjee B, 2006, VIROLOGY, V354, P280, DOI 10.1016/j.virol.2006.06.018; Bhattacharya P, 2007, TISSUE ANTIGENS, V70, P283, DOI 10.1111/j.1399-0039.2007.00894.x; Bogovac Z, 2011, ACTA DERMATOVEN ALP, V20, P135; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; CHOW LT, 1987, J VIROL, V61, P1913, DOI 10.1128/JVI.61.6.1913-1918.1987; CHOW LT, 1987, J VIROL, V61, P2581, DOI 10.1128/JVI.61.8.2581-2588.1987; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; CROMME FV, 1993, BRIT J CANCER, V67, P1372, DOI 10.1038/bjc.1993.254; Cumming SA, 2008, BIOCHEM SOC T, V36, P522, DOI 10.1042/BST0360522; Darshan MS, 2004, J VIROL, V78, P12179, DOI 10.1128/JVI.78.22.12179-12188.2004; Das BC, 2000, CURR SCI INDIA, V78, P52; Das D, 2010, VIROLOGY, V402, P197, DOI 10.1016/j.virol.2010.03.030; Das Ghosh D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044678; Day PM, 2004, P NATL ACAD SCI USA, V101, P14252, DOI 10.1073/pnas.0404229101; Day PM, 2003, VIROLOGY, V307, P1, DOI 10.1016/S0042-6822(02)00143-5; De Andrea M, 2007, VIRUS RES, V124, P220, DOI 10.1016/j.virusres.2006.09.010; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Fahey LM, 2009, J IMMUNOL, V183, P6151, DOI 10.4049/jimmunol.0902145; Franceschi S, 2005, BRIT J CANCER, V92, P601, DOI 10.1038/sj.bjc.6602348; Gornemann J, 2002, VIROLOGY, V303, P69, DOI 10.1006/viro.2002.1670; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; HAWLEYNELSON P, 1989, EMBO J, V8, P3905, DOI 10.1002/j.1460-2075.1989.tb08570.x; Johansson C, 2012, EMBO J, V31, P3212, DOI 10.1038/emboj.2012.147; Kalantari M, 2001, DIAGN MOL PATHOL, V10, P46, DOI 10.1097/00019606-200103000-00008; Kim SH, 2010, J VIROL, V84, P2629, DOI 10.1128/JVI.02049-09; Klaes R, 1999, CANCER RES, V59, P6132; Laikangbam P, 2007, INT J GYNECOL CANCER, V17, P107, DOI 10.1111/j.1525-1438.2007.00827.x; Leifer Immanuel, 2011, BMC Res Notes, V4, P521, DOI 10.1186/1756-0500-4-521; Levy JP, 1996, NAT BIOTECHNOL, V14, P610, DOI 10.1038/nbt0596-610; Li YK, 2013, PROTEIN CELL, V4, P130, DOI 10.1007/s13238-012-2081-y; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Maki H, 1996, J GEN VIROL, V77, P453, DOI 10.1099/0022-1317-77-3-453; Milligan SG, 2007, VIROLOGY, V360, P172, DOI 10.1016/j.virol.2006.10.012; MUNGER K, 1989, J VIROL, V63, P4417; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Myers G, 1997, THEORETICAL BIOL BIO; O'Brien PM, 2003, TRENDS MICROBIOL, V11, P300, DOI 10.1016/S0966-842X(03)00145-8; Qian WF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002603; ROHLFS M, 1991, VIROLOGY, V183, P331, DOI 10.1016/0042-6822(91)90146-3; Sabol I, 2008, J MED VIROL, V80, P2134, DOI 10.1002/jmv.21304; Sathish N, 2004, GYNECOL ONCOL, V95, P363, DOI 10.1016/j.ygyno.2004.08.025; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; Singh RK, 2006, INT J GYNECOL CANCER, V16, P1048, DOI 10.1111/j.1525-1438.2006.00550.x; Sowjanya AP, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-116; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Sun M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036577; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Wells KD, 1999, TRANSGENIC RES, V8, P371, DOI 10.1023/A:1008952302539; Wentzensen N, 2004, CANCER RES, V64, P3878, DOI 10.1158/0008-5472.CAN-04-0009; YAMADA T, 1995, J VIROL, V69, P7743, DOI 10.1128/JVI.69.12.7743-7753.1995; Zhou J, 1999, J VIROL, V73, P4972, DOI 10.1128/JVI.73.6.4972-4982.1999; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	59	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65647	10.1371/journal.pone.0065647	http://dx.doi.org/10.1371/journal.pone.0065647			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762404	Green Submitted, Green Published, gold			2022-12-25	WOS:000321099000087
J	Wang, X; Sun, Y; Wong, J; Conklin, DS				Wang, X.; Sun, Y.; Wong, J.; Conklin, D. S.			PPAR gamma maintains ERBB2-positive breast cancer stem cells	ONCOGENE			English	Article						PPAR gamma; HER2/neu positive; stem cells	ACTIVATED-RECEPTOR-GAMMA; FATTY-ACID SYNTHASE; INHIBIT GROWTH; EXPRESSION; RESISTANCE; ERBB2; HER2; CARCINOMA; SURVIVAL; LIGAND	Overexpression of the adverse prognostic marker ERBB2 occurs in 30% of breast cancers and is associated with aggressive disease and poor outcomes. Our recent findings have shown that NR1D1 and the peroxisome proliferator-activated receptor-gamma (PPAR gamma)-binding protein (PBP) act through a common pathway in upregulating several genes in the de novo fatty acid synthesis network, which is highly active in ERBB2-positive breast cancer cells. NR1D1 and PBP are functionally related to PPARg, a well-established positive regulator of adipogenesis and lipid storage. Here, we report that inhibition of the PPARg pathway reduces the aldehyde dehydrogenase (ALDH)-positive population in ERBB2-positive breast cancer cells. Results from in vitro tumorsphere formation assays demonstrate that the PPARg antagonists GW9662 and T0070907 decrease tumorsphere formation in ERBB2-positive cells, but not other breast cells. We show that the mechanism by which GW9662 treatment causes a reduction in ALDH-positive population cells is partially due to ROS, as it can be rescued by treatment with N-acetyl-cysteine. Furthermore, global gene expression analyses show that GW9662 treatment suppresses the expression of several lipogenic genes, including ACLY, MIG12, FASN and NR1D1, and the stem-cell related genes KLF4 and ALDH in BT474 cells. Antagonist treatment also decreases the level of acetylation in histone 3 and histone 4 in BT474 cells, compared with MCF7 cells. In vivo, GW9662 pre-treatment inhibits the tumor-seeding ability of BT474 cells. Together, these results show that the PPARg pathway is critical for the cancer stem cell properties of ERBB2-positive breast cancer cells.	[Wang, X.; Sun, Y.; Wong, J.; Conklin, D. S.] SUNY Albany, Canc Res Ctr, Dept Biomed Sci, Rensselaer, NY 12144 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany	Conklin, DS (corresponding author), SUNY Albany, Canc Res Ctr, Dept Biomed Sci, CRC 305,1 Discovery Dr, Rensselaer, NY 12144 USA.	dconklin@albany.edu		Conklin, Douglas/0000-0003-4922-4307	NCI [1R01CA136658]; NATIONAL CANCER INSTITUTE [R01CA136658] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Jan Baumann and other members of the UAlbany CRC for helpful suggestions. This work was supported by NCI 1R01CA136658 to DSC.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; [Anonymous], 2011, PHARMACOGENOMICS, V12, P12; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Baumann J., 2012, BREAST CANC RECENT A, P17; Bedard PL, 2009, J MAMMARY GLAND BIOL, V14, P55, DOI 10.1007/s10911-009-9116-x; Bertucci F, 2004, ONCOGENE, V23, P2564, DOI 10.1038/sj.onc.1207361; Burton JD, 2008, PPAR RES, V2008, DOI 10.1155/2008/494161; Chearwae W, 2008, BRIT J CANCER, V99, P2044, DOI 10.1038/sj.bjc.6604786; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Christgen Matthias, 2012, Methods Mol Biol, V878, P201, DOI 10.1007/978-1-61779-854-2_13; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Dressman MA, 2003, CANCER RES, V63, P2194; Elstner E, 2002, BREAST CANCER RES TR, V74, P155, DOI 10.1023/A:1016114026769; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Ferguson EM, 2006, MOL REPROD DEV, V73, P1195, DOI 10.1002/mrd.20494; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Glazer RI, 2008, PPAR RES, V2008, DOI 10.1155/2008/247379; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; He X, 2012, ANN ONCOL, V23, P1771, DOI 10.1093/annonc/mdr534; Kauraniemi P, 2006, ENDOCR-RELAT CANCER, V13, P39, DOI 10.1677/erc.1.01147; Kim KY, 2006, BIOCHEM PHARMACOL, V72, P530, DOI 10.1016/j.bcp.2006.05.009; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Kourtidis A, 2010, CANCER RES, V70, P1783, DOI 10.1158/0008-5472.CAN-09-1550; Kourtidis A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2240; Kumar-Sinha C, 2003, CANCER RES, V63, P132; Kuniyasu H, 2008, PPAR RES, V2008, DOI 10.1155/2008/529720; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee JJ, 2012, ONCOGENE, V31, P3818, DOI 10.1038/onc.2011.543; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu H, 2003, BREAST CANCER RES TR, V79, P63, DOI 10.1023/A:1023366117157; Mehta RG, 2000, J NATL CANCER I, V92, P418, DOI 10.1093/jnci/92.5.418; Menard S, 2001, ONCOLOGY-BASEL, V61, P67, DOI 10.1159/000055404; Menendez JA, 2004, P NATL ACAD SCI USA, V101, P10715, DOI 10.1073/pnas.0403390101; Michalik L, 2004, NAT REV CANCER, V4, P61, DOI 10.1038/nrc1254; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Oliveras-Ferraros C, 2010, BIOCHEM BIOPH RES CO, V397, P27, DOI 10.1016/j.bbrc.2010.05.041; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Pignatelli M, 2001, J CELL SCI, V114, P4117; Rageul J, 2009, INT J CANCER, V125, P2802, DOI 10.1002/ijc.24683; Reka AK, 2010, MOL CANCER THER, V9, P3221, DOI 10.1158/1535-7163.MCT-10-0570; Robbins GT, 2012, FRONT BIOSCI-LANDMRK, V17, P1816, DOI 10.2741/4021; Sebastiani V, 2006, ANTICANCER RES, V26, P2983; Silva SD, 2004, ORAL ONCOL, V40, P688, DOI 10.1016/j.oraloncology.2004.01.004; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Sutton-McDowall ML, 2012, THERIOGENOLOGY, V77, P1632, DOI 10.1016/j.theriogenology.2011.12.008; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tian LF, 2009, CANCER RES, V69, P9236, DOI 10.1158/0008-5472.CAN-09-2067; Tsao T, 2010, CANCER RES, V70, P4949, DOI 10.1158/0008-5472.CAN-09-1962; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Wang X, 2011, ONCOGENE, V30, P1901, DOI 10.1038/onc.2010.563; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wu L, 2012, BLOOD, V119, P115, DOI 10.1182/blood-2011-06-363093; Yang ZB, 2003, CLIN CANCER RES, V9, P3198; Yin F, 2001, BIOCHEM BIOPH RES CO, V286, P916, DOI 10.1006/bbrc.2001.5491; Yuan HY, 2012, ONCOTARGET, V3, P345; Zhu YJ, 1999, P NATL ACAD SCI USA, V96, P10848, DOI 10.1073/pnas.96.19.10848; Zu XY, 2012, RECENT PAT ANTI-CANC, V7, P154, DOI 10.2174/157489212799972954	61	51	55	2	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 5	2013	32	49					5512	5521		10.1038/onc.2013.217	http://dx.doi.org/10.1038/onc.2013.217			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	269XF	23770845	Green Published			2022-12-25	WOS:000328276400002
J	Balderas-Martinez, YI; Savageau, M; Salgado, H; Perez-Rueda, E; Morett, E; Collado-Vides, J				Itzel Balderas-Martinez, Yalbi; Savageau, Michael; Salgado, Heladia; Perez-Rueda, Ernesto; Morett, Enrique; Collado-Vides, Julio			Transcription Factors in Escherichia coli Prefer the Holo Conformation	PLOS ONE			English	Article							RESPONSIVE REGULATORY PROTEIN; GENE-REGULATION; DEMAND THEORY; BINDING-SITE; EXPRESSION; BACTERIA; MECHANISMS; NETWORKS; DESIGN	The transcriptional regulatory network of Escherichia coli K-12 is among the best studied gene networks of any living cell. Transcription factors bind to DNA either with their effector bound (holo conformation), or as a free protein (apo conformation) regulating transcription initiation. By using RegulonDB, the functional conformations (holo or apo) of transcription factors, and their mode of regulation (activator, repressor, or dual) were exhaustively analyzed. We report a striking discovery in the architecture of the regulatory network, finding a strong under-representation of the apo conformation (without allosteric metabolite) of transcription factors when binding to their DNA sites to activate transcription. This observation is supported at the level of individual regulatory interactions on promoters, even if we exclude the promoters regulated by global transcription factors, where three-quarters of the known promoters are regulated by a transcription factor in holo conformation. This genome-scale analysis enables us to ask what are the implications of these observations for the physiology and for our understanding of the ecology of E. coli. We discuss these ideas within the framework of the demand theory of gene regulation.	[Itzel Balderas-Martinez, Yalbi; Salgado, Heladia; Collado-Vides, Julio] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Programa Genom Computac, Cuernavaca 62191, Morelos, Mexico; [Savageau, Michael] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Perez-Rueda, Ernesto; Morett, Enrique] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; University of California System; University of California Davis; Universidad Nacional Autonoma de Mexico	Balderas-Martinez, YI (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Programa Genom Computac, Cuernavaca 62191, Morelos, Mexico.	balderas@ccg.unam.mx; collado@ccg.unam.mx	Balderas-Martinez, Yalbi Itzel/J-4848-2014; Perez-Rueda, Ernesto/D-7468-2016	Balderas-Martinez, Yalbi Itzel/0000-0001-6400-0526; Collado-Vides, Julio/0000-0001-8780-7664; Perez-Rueda, Ernesto/0000-0002-6879-0673; Morett, Enrique/0000-0001-5723-0032	CONACyT-Mexico [228320]; National Institute of General Medical Sciences, National Institutes of Health, USA [5R01GM071962-08, RO1GM030054-23]; DGAPA [IN209511]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071962, R01GM030054] Funding Source: NIH RePORTER	CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institute of General Medical Sciences, National Institutes of Health, USA; DGAPA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	YIB-M acknowledges the PDCB of CCG-UNAM and her support by a PhD fellowship (228320) from CONACyT-Mexico. This research was supported in part by grants 5R01GM071962-08 to JC-V and RO1GM030054-23 to MS from the National Institute of General Medical Sciences, National Institutes of Health, USA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. EP-R was partially supported by DGAPA grant IN209511. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, INTRO SYSTEMS BIOL D, Vxvi; Ansaldi M, 2000, J BACTERIOL, V182, P961, DOI 10.1128/JB.182.4.961-966.2000; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chen SL, 2005, J MOL BIOL, V345, P251, DOI 10.1016/j.jmb.2004.10.047; COLLADOVIDES J, 1991, MICROBIOL REV, V55, P371, DOI 10.1128/MMBR.55.3.371-394.1991; de Lima Morais DA, 2011, NUCLEIC ACIDS RES, V39, pD427; Engelen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020938; Freyre-Gonzalez JA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r154; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Gerland U, 2009, P NATL ACAD SCI USA, V106, P8841, DOI 10.1073/pnas.0808500106; Giedroc DP, 2007, DALTON T, P3107, DOI 10.1039/b706769k; GOTTESMAN S, 1984, ANNU REV GENET, V18, P415; Gutierrez-Rios RM, 2003, GENOME RES, V13, P2435, DOI 10.1101/gr.1387003; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Merino E, 2005, TRENDS GENET, V21, P260, DOI 10.1016/j.tig.2005.03.002; NEWMAN EB, 1995, ANNU REV MICROBIOL, V49, P747, DOI 10.1146/annurev.mi.49.100195.003531; PRIBNOW D, 1975, P NATL ACAD SCI USA, V72, P784, DOI 10.1073/pnas.72.3.784; R Development Core Team, 2011, R LANG ENV STAT COMP; Ray JCJ, 2011, NAT REV MICROBIOL, V9, P817, DOI 10.1038/nrmicro2667; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; SAVAGEAU MA, 1977, P NATL ACAD SCI USA, V74, P5647, DOI 10.1073/pnas.74.12.5647; Savageau MA, 1998, GENETICS, V149, P1677; SAVAGEAU MA, 1989, THEORETICAL BIOLOGY, P42; Savageau MA, 1998, GENETICS, V149, P1665; SAVAGEAU MA, 1983, P NATL ACAD SCI-BIOL, V80, P1411, DOI 10.1073/pnas.80.5.1411; SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168; Savageau MA, 1976, BIOCH SYSTEMS ANAL S, Vxvii; Savageau MA, 1979, BIOL REGUL DEV, P57; Serres Margrethe Hauge, 2000, Microbial and Comparative Genomics, V5, P205, DOI 10.1089/mcg.2000.5.205; Stec E, 2006, J MOL BIOL, V364, P309, DOI 10.1016/j.jmb.2006.06.033; Swint-Kruse L, 2009, CURR OPIN MICROBIOL, V12, P129, DOI 10.1016/j.mib.2009.01.009; Wall ME, 2004, NAT REV GENET, V5, P34, DOI 10.1038/nrg1244	33	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65723	10.1371/journal.pone.0065723	http://dx.doi.org/10.1371/journal.pone.0065723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776535	gold, Green Published			2022-12-25	WOS:000320322400048
J	Kalembo, FW; Zgambo, M; Mulaga, AN; Du, YK; Ahmed, NI				Kalembo, Fatch W.; Zgambo, Maggie; Mulaga, Atupele N.; Du Yukai; Ahmed, Niman I.			Association between Male Partner Involvement and the Uptake of Prevention of Mother-to-Child Transmission of HIV (PMTCT) Interventions in Mwanza District, Malawi: A Retrospective Cohort Study	PLOS ONE			English	Article								Objective: The main objective of this study was to examine the association between male partner involvement and the uptake of prevention of mother-to-child transmission of HIV (PMTCT) interventions. Methods: A retrospective cohort study was used to collect data on women, their male partners and their children who were enrolled in a PMTCT program from January 2004 to December 2006 at Mwanza District Hospital. HIV infected women and their children were followed-up over the 18 months postnatal period. Data were analyzed using descriptive statistics, chi-square test and logistic regression. Results: A total of 476 HIV positive women were enrolled in a PMTCT program and were followed-up in the study. Of those followed-up in the study, 65 (13.7%) had a male partner involvement while 411 (86.3%) had no male partner involvement. Male partner involvement was significantly associated with condom use (Adjusted odds ratio [AOR] = 5.6, 95% confidence interval [CI]: 2.3-13.5, P<0.001), hospital delivery (AOR = 25.9, 95% CI: 10.6-63.6, P<0.001), and completion of follow-up in the program (AOR = 16.8, 95% CI: 8.5-33.4, P<0.001). Conclusion: Male partner involvement increases the uptake of some PMTCT interventions by HIV positive women. Multi-strategic, culturally tailored public health care models are needed to increase the rate of male partner involvement in the program.	[Kalembo, Fatch W.; Du Yukai; Ahmed, Niman I.] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Child Adolescence & Woman Hlth Care, Wuhan 430074, Peoples R China; [Zgambo, Maggie] Cent S Univ, Xiangya Med Coll, Dept Nursing, Changsha, Hunan, Peoples R China; [Mulaga, Atupele N.] Univ Malawi, Dept Math & Stat, The Polytech, Blantyre, Malawi	Huazhong University of Science & Technology; Central South University; University of Malawi	Du, YK (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Child Adolescence & Woman Hlth Care, Wuhan 430074, Peoples R China.	duyukai100@yahoo.com.cn		Kalembo, Fatch W./0000-0003-3032-3495; Zgambo, Maggie/0000-0001-8667-795X	Tongji Medical College of Huazhong University of Science and Technology	Tongji Medical College of Huazhong University of Science and Technology	The study was funded by Tongji Medical College of Huazhong University of Science and Technology. Below is the URL of the funder (http://english.hust.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDALLAH A, 2006, 2006 HIV AIDS IMPL M; Akarro R, 2011, ASSJ, V20; Aluisio A, 2011, JAIDS-J ACQ IMM DEF, V56, P76, DOI 10.1097/QAI.0b013e3181fdb4c4; Bolu OO, 2007, AM J OBSTET GYNECOL, V197, pS83, DOI 10.1016/j.ajog.2007.03.006; Byamugisha R, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-12; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; HALLISSEY M, 2006, 2006 HIV AIDS IMPL M; Homsy J, 2006, JAIDS-J ACQ IMM DEF, V42, P149, DOI 10.1097/01.qai.0000225032.52766.c2; Kakimoto K, 2007, BIOSCI TRENDS, V1, P97; Kalembo F. W., 2012, Open Journal of Preventive Medicine, V2, P35, DOI 10.4236/ojpm.2012.21006; Katz DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007602; Malawi Ministry of Health, 2008, PMTCT HIV PED HIV CA; Malawi Ministry of Health, 2007, PMTCT TRAIN MOD; Medley M, 2004, B WORLD HEALTH ORGAN, P299; Msuya SE, 2008, AIDS CARE, V20, P700, DOI 10.1080/09540120701687059; Njunga J, 2010, INT BREASTFEED J, V5, DOI 10.1186/1746-4358-5-14; Orne-Gliemann J, 2008, AIDS, V22, P2555, DOI 10.1097/QAD.0b013e32831c54d5; Painter TM, 2001, SOC SCI MED, V53, P1397, DOI 10.1016/S0277-9536(00)00427-5; Pignatelli S, 2006, TROP MED INT HEALTH, V11, P350, DOI 10.1111/j.1365-3156.2006.01564.x; Tweheyo R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-53; UNAIDS, 2010, REP GLOB AIDS EP 201; UNICEF, 2011, MAL PMTCT FACTSH 201; WHO, 2010, MOTH TO CHILD TRANSM; ZULU EM, 2003, DEMOGRAPHIC RES S, V0001	24	92	93	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66517	10.1371/journal.pone.0066517	http://dx.doi.org/10.1371/journal.pone.0066517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776683	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400108
J	Moreau, C; Lefebvre, JF; Jomphe, M; Bherer, C; Ruiz-Linares, A; Vezina, H; Roy-Gagnon, MH; Labuda, D				Moreau, Claudia; Lefebvre, Jean-Francois; Jomphe, Michele; Bherer, Claude; Ruiz-Linares, Andres; Vezina, Helene; Roy-Gagnon, Marie-Helene; Labuda, Damian			Native American Admixture in the Quebec Founder Population	PLOS ONE			English	Article							GENETICS; ANCESTRY; IMPACT; ASSOCIATION; MUTATIONS; LINEAGES; HISTORY; AGE; MAP	For years, studies of founder populations and genetic isolates represented the mainstream of genetic mapping in the effort to target genetic defects causing Mendelian disorders. The genetic homogeneity of such populations as well as relatively homogeneous environmental exposures were also seen as primary advantages in studies of genetic susceptibility loci that underlie complex diseases. European colonization of the St-Lawrence Valley by a small number of settlers, mainly from France, resulted in a founder effect reflected by the appearance of a number of population-specific disease-causing mutations in Quebec. The purported genetic homogeneity of this population was recently challenged by genealogical and genetic analyses. We studied one of the contributing factors to genetic heterogeneity, early Native American admixture that was never investigated in this population before. Consistent admixture estimates, in the order of one per cent, were obtained from genome-wide autosomal data using the ADMIXTURE and HAPMIX software, as well as with the fastIBD software evaluating the degree of the identity-by-descent between Quebec individuals and Native American populations. These genomic results correlated well with the genealogical estimates. Correlations are imperfect most likely because of incomplete records of Native founders' origin in genealogical data. Although the overall degree of admixture is modest, it contributed to the enrichment of the population diversity and to its demographic stratification. Because admixture greatly varies among regions of Quebec and among individuals, it could have significantly affected the homogeneity of the population, which is of importance in mapping studies, especially when rare genetic susceptibility variants are in play.	[Moreau, Claudia; Lefebvre, Jean-Francois; Bherer, Claude; Roy-Gagnon, Marie-Helene; Labuda, Damian] Univ Montreal, Ctr Rech, CHU St Justine, Montreal, PQ, Canada; [Jomphe, Michele; Vezina, Helene] Univ Quebec Chicoutimi, Projet BALSAC, Chicoutimi, PQ, Canada; [Ruiz-Linares, Andres] UCL, Dept Genet Evolut & Environm, London, England; [Roy-Gagnon, Marie-Helene] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Labuda, Damian] Univ Montreal, Dept Pediat, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Quebec; University of Quebec Chicoutimi; University of London; University College London; University of Ottawa; Universite de Montreal	Roy-Gagnon, MH (corresponding author), Univ Montreal, Ctr Rech, CHU St Justine, Montreal, PQ, Canada.	mroygagn@uottawa.ca; damian.labuda@umontreal.ca	Ruiz-Linares, Andres/AAR-1104-2021	Ruiz-Linares, Andres/0000-0001-8372-1011; Roy-Gagnon, Marie-Helene/0000-0001-8747-0846	Reseau de Medecine Genetique Appliquee of Fonds de Recherche en Sante du Quebec (FRSQ); FRSQ grant	Reseau de Medecine Genetique Appliquee of Fonds de Recherche en Sante du Quebec (FRSQ); FRSQ grant	This research was supported by Reseau de Medecine Genetique Appliquee of Fonds de Recherche en Sante du Quebec (FRSQ) (HV and DL) and by FRSQ grant (MHRG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Atzmon G, 2010, AM J HUM GENET, V86, P850, DOI 10.1016/j.ajhg.2010.04.015; BEAUREGARD Y, 1993, HUBERT CHARBONNEAU C, V34, P38; Bedoya G, 2006, P NATL ACAD SCI USA, V103, P7234, DOI 10.1073/pnas.0508716103; Bherer C, 2011, AM J PHYS ANTHROPOL, V144, P432, DOI 10.1002/ajpa.21424; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; BOUCHARD G, 1990, HIST SOC/SOC HIST, V23, P325; Bray SM, 2010, P NATL ACAD SCI USA, V107, P16222, DOI 10.1073/pnas.1004381107; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Campbell DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033570; CHARBONNEAU H, 1988, ACTION NATIONALE, V78, P220; Charbonneau H., 2000, POPULATION HIST N AM, P99; Chong JX, 2012, AM J HUM GENET, V91, P608, DOI 10.1016/j.ajhg.2012.08.007; Desjardins B, 1990, Cah Que Demogr, V19, P63; Gagnon A, 2001, AM J PHYS ANTHROPOL, V114, P30, DOI 10.1002/1096-8644(200101)114:1<30::AID-AJPA1003>3.0.CO;2-L; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Heutink P, 2002, HUM MOL GENET, V11, P2507, DOI 10.1093/hmg/11.20.2507; Kidd JM, 2012, AM J HUM GENET, V91, P660, DOI 10.1016/j.ajhg.2012.08.025; Laberge AM, 2005, CLIN GENET, V68, P287, DOI 10.1111/j.1399-0004.2005.00497.x; Labuda D, 1997, AM J HUM GENET, V61, P768, DOI 10.1016/S0002-9297(07)64341-9; Loh PR, 2013, GENETICS, V193, P1233, DOI 10.1534/genetics.112.147330; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Moorjani P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001373; Moreau C, 2007, M S-MED SCI, V23, P1008, DOI 10.1051/medsci/200723111008; Moreau C, 2011, ANN HUM GENET, V75, P247, DOI 10.1111/j.1469-1809.2010.00617.x; Moreau C, 2009, AM J PHYS ANTHROPOL, V139, P512, DOI 10.1002/ajpa.21012; Morera B, 2004, REV BIOL TROP, V52, P629; Ostrer H, 2001, NAT REV GENET, V2, P891, DOI 10.1038/35098506; PALAMARA PF, 2012, AM J HUM GENET, pR1; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Peltonen L, 1999, HUM MOL GENET, V8, P1913, DOI 10.1093/hmg/8.10.1913; Price AL, 2007, AM J HUM GENET, V80, P1024, DOI 10.1086/518313; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team R, 2022, R LANG ENV STAT COMP; Rahman P, 2003, HUM MOL GENET, V12, pR167, DOI 10.1093/hmg/ddg257; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Roy-Gagnon MH, 2011, HUM GENET, V129, P521, DOI 10.1007/s00439-010-0945-x; Sarkissian CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003296; Scriver CR, 2001, ANNU REV GENOM HUM G, V2, P69, DOI 10.1146/annurev.genom.2.1.69; Seldin MF, 2007, AM J PHYS ANTHROPOL, V132, P455, DOI 10.1002/ajpa.20534; Shah AM, 2011, AM J HUM GENET, V89, P154, DOI 10.1016/j.ajhg.2011.05.030; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Torkamani Ali, 2012, Frontiers in Genetics, V3, P211, DOI 10.3389/fgene.2012.00211; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; Velez C, 2012, HUM GENET, V131, P251, DOI 10.1007/s00439-011-1072-z; VEZMA H, 2012, CAHIERS QUEBECOIS DE, V41, P87; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Yotova V, 2005, HUM GENET, V117, P177, DOI 10.1007/s00439-005-1298-8; Zeegers MPA, 2004, EUR J HUM GENET, V12, P591, DOI 10.1038/sj.ejhg.5201151	54	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65507	10.1371/journal.pone.0065507	http://dx.doi.org/10.1371/journal.pone.0065507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	163FW	23776491	Green Submitted, Green Published, gold			2022-12-25	WOS:000320322400029
J	Tang, ZP; Dong, QZ; Cui, QZ; Papavassiliou, P; Wang, ED; Wang, EH				Tang, Zhong-Ping; Dong, Qian-Ze; Cui, Quan-Zhe; Papavassiliou, Paulie; Wang, En-Di; Wang, En-Hua			Ataxia-Telangiectasia Group D Complementing Gene (ATDC) Promotes Lung Cancer Cell Proliferation by Activating NF-kappa B Pathway	PLOS ONE			English	Article							PROSTATE-CANCER; CYCLIN D1; C-MYC; PANCREATIC-CANCER; IN-SITU; EXPRESSION; PROFILES; OVEREXPRESSION; IDENTIFICATION; RESISTANCE	Previous studies suggested Ataxia-telangiectasia group D complementing gene (ATDC) as an oncogene in many types of cancer. However, its expression and biological functions in non-small cell lung cancer (NSCLC) remain unclear. Herein, we investigated its expression pattern in 109 cases of human NSCLC samples by immunohistochemistry and found that ATDC was overexpressed in 62 of 109 NSCLC samples (56.88%). ATDC overexpression correlated with histological type (p<0.0001), tumor status (p = 0.0227) and histological differentiation (p = 0.0002). Next, we overexpressed ATDC in normal human bronchial epithelial cell line HBE and depleted its expression in NSCLC cell lines A549 and H1299. MTT and colony formation assay showed that ATDC overexpression promoted cell proliferation while its depletion inhibited cell growth. Furthermore, cell cycle analysis showed that ATDC overexpression decreased the percentage of cells in G1 phase and increased the percentage of cells in S phase, while ATDC siRNA treatment increased the G1 phase percentage and decreased the S phase percentage. Further study revealed that ATDC overexpression could up-regulate cyclin D1 and c-Myc expression in HBE cells while its depletion down-regulated cyclin D1 and c-Myc expression in A549 and H1299 cells. In addition, ATDC overexpression was also associated with an increased proliferation index, cyclin D1 and c-Myc expression in human NSCLC samples. Further experiments demonstrated that ATDC up-regulated cyclin D1 and c-Myc expression independent of wnt/beta-catenin or p53 signaling pathway. Interestingly, ATDC overexpression increased NF-kappa B reporter luciferase activity and p-I kappa B protein level. Correspondingly, NF-kappa B inhibitor blocked the effect of ATDC on up-regulation of cyclin D1 and c-Myc. In conclusion, we demonstrated that ATDC could promote lung cancer proliferation through NF-kappa B induced up-regulation of cyclin D1 and c-Myc.	[Tang, Zhong-Ping; Dong, Qian-Ze; Cui, Quan-Zhe; Wang, En-Hua] China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Peoples R China; [Tang, Zhong-Ping; Dong, Qian-Ze; Cui, Quan-Zhe; Wang, En-Hua] China Med Univ, Coll Basic Med Sci, Shenyang, Peoples R China; [Papavassiliou, Paulie; Wang, En-Di] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	China Medical University; China Medical University; Duke University	Wang, EH (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Peoples R China.	wangeh@hotmail.com			National Natural Science Foundation of China [81071905, 81272606]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grants 81071905 and 81272606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Ames BN, 1998, BIOTHERAPY, V11, P205, DOI 10.1023/A:1007971204469; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; BRZOSKA PM, 1995, P NATL ACAD SCI USA, V92, P7824, DOI 10.1073/pnas.92.17.7824; Burke L, 2005, CLIN CANCER RES, V11, P232; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Fernandez-Majada V, 2007, P NATL ACAD SCI USA, V104, P276, DOI 10.1073/pnas.0606476104; Glebov OK, 2006, CANCER EPIDEM BIOMAR, V15, P2253, DOI 10.1158/1055-9965.EPI-05-0694; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hawthorn L, 2006, LUNG CANCER, V53, P129, DOI 10.1016/j.lungcan.2006.04.015; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; KAPP LN, 1992, AM J HUM GENET, V51, P45; KARN J, 1989, ONCOGENE, V4, P773; Keum JS, 1999, BRIT J CANCER, V81, P127, DOI 10.1038/sj.bjc.6690661; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Kosaka Y, 2007, ANN SURG ONCOL, V14, P2543, DOI 10.1245/s10434-007-9461-1; LaTulippe E, 2002, CANCER RES, V62, P4499; Li Q, 2011, P NATL ACAD SCI USA, V108, P19341, DOI 10.1073/pnas.1110946108; Li YJ, 2005, WORLD J GASTROENTERO, V11, P2117, DOI 10.3748/wjg.v11.i14.2117; Liu XL, ZHONGHUA SHI YAN HE, V25, P60; Luo J, 2001, CANCER RES, V61, P4683; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Mutter GL, 2001, GYNECOL ONCOL, V83, P177, DOI 10.1006/gyno.2001.6352; Nacht M, 1999, CANCER RES, V59, P5464; Noguchi K, 2011, CARCINOGENESIS, V32, P995, DOI 10.1093/carcin/bgr068; Ohmachi T, 2006, CLIN CANCER RES, V12, P3057, DOI 10.1158/1078-0432.CCR-05-1961; Oliveira NMM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-81; POSTE G, 1980, NATURE, V283, P139, DOI 10.1038/283139a0; Rahman KMW, 2007, MOL CANCER THER, V6, P2757, DOI 10.1158/1535-7163.MCT-07-0336; Ratschiller D, 2003, J CLIN ONCOL, V21, P2085, DOI 10.1200/JCO.2003.03.103; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Santin AD, 2004, INT J CANCER, V112, P14, DOI 10.1002/ijc.20408; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; SHICHIRI M, 1993, CELL GROWTH DIFFER, V4, P93; Sho T, 1813, BIOCH BIOPHYS ACTA, P1245; Smith AP, 2005, CANCER BIOL THER, V4, P1018, DOI 10.4161/cbt.4.9.2165; Tew GW, 2008, J BIOL CHEM, V283, P963, DOI 10.1074/jbc.M707526200; Tung JN, 2010, MOL VIS, V16, P2733; Udhayakumar G, 2007, MOL CARCINOGEN, V46, P807, DOI 10.1002/mc.20311; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018; Yu S, BIOCH BIOPHYS RES CO, V410, P247; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Yuan Z, J BIOL CHEM, V285, P39329; Yuan Z, MOL CELL BIOL, V30, P3004; Zhan FH, 2002, BLOOD, V99, P1745, DOI 10.1182/blood.V99.5.1745; Zhang P, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-224; Zhao G, PLOS PATHOG, V7	49	25	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e63676	10.1371/journal.pone.0063676	http://dx.doi.org/10.1371/journal.pone.0063676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776433	gold, Green Published, Green Submitted			2022-12-25	WOS:000320322400002
J	Galban, S; Jeon, YH; Bowman, BM; Stevenson, J; Sebolt, KA; Sharkey, LM; Lafferty, M; Hoff, BA; Butler, BL; Wigdal, SS; Binkowski, BF; Otto, P; Zimmerman, K; Vidugiris, G; Encell, LP; Fan, F; Wood, KV; Galban, CJ; Ross, BD; Rehemtulla, A				Galban, Stefanie; Jeon, Yong Hyun; Bowman, Brittany M.; Stevenson, James; Sebolt, Katrina A.; Sharkey, Lisa M.; Lafferty, Michael; Hoff, Benjamin A.; Butler, Braeden L.; Wigdal, Susan S.; Binkowski, Brock F.; Otto, Paul; Zimmerman, Kris; Vidugiris, Gediminas; Encell, Lance P.; Fan, Frank; Wood, Keith V.; Galban, Craig J.; Ross, Brian D.; Rehemtulla, Alnawaz			Imaging Proteolytic Activity in Live Cells and Animal Models	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; INDUCED ACUTE-PANCREATITIS; CANCER STEM-CELLS; FIREFLY LUCIFERASE; CASPASE ACTIVATION; APOPTOSIS; ASSAYS; COMPLEMENTATION; CHEMORESISTANCE; THERAPY	In addition to their degradative role in protein turnover, proteases play a key role as positive or negative regulators of signal transduction pathways and therefore their dysregulation contributes to many disease states. Regulatory roles of proteases include their hormone-like role in triggering G protein-coupled signaling (Protease-Activated-Receptors); their role in shedding of ligands such as EGF, Notch and Fas; and their role in signaling events that lead to apoptotic cell death. Dysregulated activation of apoptosis by the caspase family of proteases has been linked to diseases such as cancer, autoimmunity and inflammation. In an effort to better understand the role of proteases in health and disease, a luciferase biosensor is described which can quantitatively report proteolytic activity in live cells and mouse models. The biosensor, hereafter referred to as GloSensor Caspase 3/7 has a robust signal to noise (50-100 fold) and dynamic range such that it can be used to screen for pharmacologically active compounds in high throughput campaigns as well as to study cell signaling in rare cell populations such as isolated cancer stem cells. The biosensor can also be used in the context of genetically engineered mouse models of human disease wherein conditional expression using the Cre/loxP technology can be implemented to investigate the role of a specific protease in living subjects. While the regulation of apoptosis by caspase's was used as an example in these studies, biosensors to study additional proteases involved in the regulation of normal and pathological cellular processes can be designed using the concepts presented herein.	[Galban, Stefanie; Jeon, Yong Hyun; Bowman, Brittany M.; Stevenson, James; Sebolt, Katrina A.; Sharkey, Lisa M.; Lafferty, Michael; Hoff, Benjamin A.; Galban, Craig J.; Ross, Brian D.; Rehemtulla, Alnawaz] Univ Michigan, Sch Med, Ctr Mol Imaging, Ann Arbor, MI 48109 USA; [Galban, Stefanie; Jeon, Yong Hyun; Sebolt, Katrina A.; Sharkey, Lisa M.; Lafferty, Michael; Rehemtulla, Alnawaz] Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI USA; [Rehemtulla, Alnawaz] Univ Michigan, Sch Med, Cellular & Mol Biol Program, Ann Arbor, MI USA; [Bowman, Brittany M.; Ross, Brian D.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Hoff, Benjamin A.; Galban, Craig J.; Ross, Brian D.] Univ Michigan, Sch Med, Dept Radiol, Ann Arbor, MI USA; [Butler, Braeden L.; Wigdal, Susan S.; Binkowski, Brock F.; Otto, Paul; Zimmerman, Kris; Vidugiris, Gediminas; Encell, Lance P.; Fan, Frank; Wood, Keith V.] Promega, Madison, WI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Promega Corporation	Rehemtulla, A (corresponding author), Univ Michigan, Sch Med, Ctr Mol Imaging, Ann Arbor, MI 48109 USA.	alnawaz@umich.edu	Jeon, Yong hyun/N-6910-2019	Jeon, Yong hyun/0000-0003-3161-7698; Lafferty, Michael/0000-0002-1000-0480; Bowman, Brittany/0000-0003-2054-6169	University of Michigan Cancer Center, NIH [CA46592]; National Institutes of Health [P01CA085878, P50CA093990, R01CA136892]; NATIONAL CANCER INSTITUTE [P30CA046592, R01CA136892, R01CA136829, P50CA093990, P01CA085878] Funding Source: NIH RePORTER	University of Michigan Cancer Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Core support was provided by the University of Michigan Cancer Center, NIH grant number CA46592. Financial support was provided by the National Institutes of Health grants P01CA085878, P50CA093990 and R01CA136892. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan SL, 2003, J BIOL CHEM, V278, P20453, DOI 10.1074/jbc.C300138200; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Chinnaiyan AM, 2000, P NATL ACAD SCI USA, V97, P1754, DOI 10.1073/pnas.030545097; Coppola JM, 2008, CLIN CANCER RES, V14, P2492, DOI 10.1158/1078-0432.CCR-07-0782; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Ding SQ, 2010, HEPATOB PANCREAT DIS, V9, P645; Edgington LE, 2009, NAT MED, V15, P967, DOI 10.1038/nm.1938; Fan F, 2008, ACS CHEM BIOL, V3, P346, DOI 10.1021/cb8000414; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Hall M, 1998, BIOLUMINESCENCE CHEM, P392; Kanno A, 2007, ANGEW CHEM INT EDIT, V46, P7595, DOI 10.1002/anie.200700538; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kim H, 2008, GUT LIVER, V2, P74, DOI 10.5009/gnl.2008.2.2.74; Kuehl WM, 2012, BLOOD, V120, P238, DOI 10.1182/blood-2012-04-422501; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu Y, 2013, MOL MED REP, V7, P725, DOI 10.3892/mmr.2012.1241; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Morris JP, 2010, J CLIN INVEST, V120, P508, DOI 10.1172/JCI40045; Ozawa T, 2001, ANAL CHEM, V73, P2516, DOI 10.1021/ac0013296; Paulmurugan R, 2002, P NATL ACAD SCI USA, V99, P15608, DOI 10.1073/pnas.242594299; Wigdal Susan S, 2008, Curr Chem Genomics, V2, P16, DOI 10.2174/1875397300802010016; Yang JP, 2011, CHINESE MED J-PEKING, V124, P1055, DOI 10.3760/cma.j.issn.0366-6999.2011.07.020; Yi CH, 2007, J CELL BIOL, V179, P619, DOI 10.1083/jcb.200708090; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	26	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66248	10.1371/journal.pone.0066248	http://dx.doi.org/10.1371/journal.pone.0066248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776643	gold, Green Published, Green Submitted			2022-12-25	WOS:000320755400125
J	Hu, Q; He, GC; Zhao, J; Soshilov, A; Denison, MS; Zhang, AQ; Yin, HJ; Fraccalvieri, D; Bonati, L; Xie, QH; Zhao, B				Hu, Qin; He, Guochun; Zhao, Jing; Soshilov, Anatoly; Denison, Michael S.; Zhang, Aiqian; Yin, Huijun; Fraccalvieri, Domenico; Bonati, Laura; Xie, Qunhui; Zhao, Bin			Ginsenosides Are Novel Naturally-Occurring Aryl Hydrocarbon Receptor Ligands	PLOS ONE			English	Article							AH RECEPTOR; BINDING DOMAIN; PROTEIN STRUCTURES; HOMOLOGY MODELS; PANAX-GINSENG; IN-VITRO; ACTIVATION; AGONISTS; INDUCTION; DOCKING	The aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor that mediates many of the biological and toxicological actions of structurally diverse chemicals. In this study, we examined the ability of a series of ginsenosides extracted from ginseng, a traditional Chinese medicine, to bind to and activate/inhibit the AHR and AHR signal transduction. Utilizing a combination of ligand and DNA binding assays, molecular docking and reporter gene analysis, we demonstrated the ability of selected ginsenosides to directly bind to and activate the guinea pig cytosolic AHR, and to stimulate/inhibit AHR-dependent luciferase gene expression in a recombinant guinea pig cell line. Comparative studies revealed significant species differences in the ability of ginsenosides to stimulate AHR-dependent gene expression in guinea pig, rat, mouse and human cell lines. Not only did selected ginsenosides preferentially activate the AHR from one species and not others, mouse cell line was also significantly less responsive to these chemicals than rat and guinea pig cell lines, but the endogenous gene CYP1A1 could still be inducted in mouse cell line. Overall, the ability of these compounds to stimulate AHR signal transduction demonstrated that these ginsenosides are a new class of naturally occurring AHR agonists.	[Hu, Qin; Zhang, Aiqian; Xie, Qunhui; Zhao, Bin] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, Beijing, Peoples R China; [He, Guochun; Zhao, Jing; Soshilov, Anatoly; Denison, Michael S.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Yin, Huijun] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing, Peoples R China; [Fraccalvieri, Domenico; Bonati, Laura] Univ Milano Bicocca, Dept Earth & Environm Sci, Milan, Italy	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); University of California System; University of California Davis; China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS; University of Milano-Bicocca	Zhao, B (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, POB 934, Beijing, Peoples R China.	binzhao@rcees.ac.cn	Fraccalvieri, Domenico/AAI-2355-2020		Chinese Academy of Sciences [KZCX2-EW-411]; National Natural Science Foundation of China [21177150, 20921063]; National Institutes of Environmental Health Sciences [R01-ES07685, P42-ES004699]; California Agricultural Experiment Station; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007685, P42ES004699] Funding Source: NIH RePORTER	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); California Agricultural Experiment Station; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Chinese Academy of Sciences Key Program of Knowledge Innovation (KZCX2-EW-411), National Natural Science Foundation of China (21177150 and 20921063), the National Institutes of Environmental Health Sciences (R01-ES07685, P42-ES004699) and the California Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLID VERS 5 8; [Anonymous], 2011, AH RECEPTOR BIOL TOX; [Anonymous], 2012, MAESTR VERS 9 3; [Anonymous], 2012, MACROMODEL VERS 9 9; Ashida H, 2000, FEBS LETT, V476, P213, DOI 10.1016/S0014-5793(00)01730-0; Attele AS, 2002, DIABETES, V51, P1851, DOI 10.2337/diabetes.51.6.1851; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Bordogna A, 2011, J COMPUT CHEM, V32, P81, DOI 10.1002/jcc.21601; Chen X, 1996, CLIN EXP PHARMACOL P, V23, P728, DOI 10.1111/j.1440-1681.1996.tb01767.x; Ciolino HP, 1998, CANCER RES, V58, P5707; Delescluse C, 2000, TOXICOLOGY, V153, P73, DOI 10.1016/S0300-483X(00)00305-X; Denison M.S., 1998, MOL BIOLOY APPROACHE, P3; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; DENISON MS, 1986, J BIOL CHEM, V261, P3987; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; DENISON MS, 2002, CURRENT PROTOCOLS TO; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fraccalvieri D, 2013, BIOCHEMISTRY-US, V52, P714, DOI 10.1021/bi301457f; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Garrison PM, 1996, FUND APPL TOXICOL, V30, P194, DOI 10.1006/faat.1996.0056; Han D, 2004, BIOFACTORS, V20, P11, DOI 10.1002/biof.5520200102; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Henry EC, 2003, MOL PHARMACOL, V63, P392, DOI 10.1124/mol.63.2.392; Hestermann EV, 2000, TOXICOL APPL PHARM, V168, P160, DOI 10.1006/taap.2000.9026; Hooper LV, 2011, CELL, V147, P486, DOI 10.1016/j.cell.2011.10.004; Hu WY, 2007, MOL PHARMACOL, V71, P1475, DOI 10.1124/mol.106.032748; Huang KC, 1999, PHARM CHINESE HERBS; Joh EH, 2011, BIOCHEM PHARMACOL, V82, P278, DOI 10.1016/j.bcp.2011.05.003; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kazlauskas A, 1999, J BIOL CHEM, V274, P13519, DOI 10.1074/jbc.274.19.13519; Lee KT, 2011, ARCH PHARM RES, V34, P1201, DOI 10.1007/s12272-011-0719-6; Li Y, 2011, CELL, V147, P620; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Motto I, 2011, J CHEM INF MODEL, V51, P2868, DOI 10.1021/ci2001617; Mukai R, 2010, ARCH BIOCHEM BIOPHYS, V501, P134, DOI 10.1016/j.abb.2010.05.002; Nagy SR, 2002, TOXICOL SCI, V65, P200, DOI 10.1093/toxsci/65.2.200; Pandini A, 2007, BIOCHEMISTRY-US, V46, P696, DOI 10.1021/bi061460t; Pandini A, 2009, BIOCHEMISTRY-US, V48, P5972, DOI 10.1021/bi900259z; Puga A, 2009, BIOCHEM PHARMACOL, V77, P713, DOI 10.1016/j.bcp.2008.08.031; SAFE S, 1990, CRIT REV TOXICOL, V21, P51, DOI 10.3109/10408449009089873; SAKAKIBARA K, 1975, CHEM PHARM BULL, V23, P1009; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SATO K, 1994, BIOL PHARM BULL, V17, P635; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Seidel SD, 2000, TOXICOL SCI, V55, P107, DOI 10.1093/toxsci/55.1.107; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Soshilov A, 2011, J BIOL CHEM, V286, P35275, DOI 10.1074/jbc.M111.246439; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; TODE T, 1993, J CANCER RES CLIN, V120, P24, DOI 10.1007/BF01200720; Uno S, 2009, TOXICOL APPL PHARM, V237, P119, DOI 10.1016/j.taap.2009.03.001; VECCHINI F, 1994, BIOCHEM BIOPH RES CO, V201, P1205, DOI 10.1006/bbrc.1994.1833; Wang YG, 2008, EUR J PHARMACOL, V601, P73, DOI 10.1016/j.ejphar.2008.10.057	53	12	13	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66258	10.1371/journal.pone.0066258	http://dx.doi.org/10.1371/journal.pone.0066258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776647	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400129
J	King, AJ; van der Lee, S; Mohangoo, A; van Gent, M; van der Ark, A; van de Waterbeemd, B				King, Audrey J.; van der Lee, Saskia; Mohangoo, Archena; van Gent, Marjolein; van der Ark, Arno; van de Waterbeemd, Bas			Genome-Wide Gene Expression Analysis of Bordetella pertussis Isolates Associated with a Resurgence in Pertussis: Elucidation of Factors Involved in the Increased Fitness of Epidemic Strains	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; MYCOBACTERIUM-TUBERCULOSIS; EVOLUTION; VACCINE; EFFECTOR; SWEDEN; BRONCHISEPTICA; NETHERLANDS; REEMERGENCE; DIVERSITY	Bordetella pertussis (B. pertussis) is the causative agent of whooping cough, which is a highly contagious disease in the human respiratory tract. Despite vaccination since the 1950s, pertussis remains the most prevalent vaccine-preventable disease in developed countries. A recent resurgence pertussis is associated with the expansion of B. pertussis strains with a novel allele for the pertussis toxin (ptx) promoter ptxP3 in place of resident ptxP1 strains. The recent expansion of ptxP3 strains suggests that these strains carry mutations that have increased their fitness. Compared to the ptxP1 strains, ptxP3 strains produce more Ptx, which results in increased virulence and immune suppression. In this study, we investigated the contribution of gene expression changes of various genes on the increased fitness of the ptxP3 strains. Using genome-wide gene expression profiling, we show that several virulence genes had higher expression levels in the ptxP3 strains compared to the ptxP1 strains. We provide the first evidence that wildtype ptxP3 strains are better colonizers in an intranasal mouse infection model. This study shows that the ptxP3 mutation and the genetic background of ptxP3 strains affect fitness by contributing to the ability to colonize in a mouse infection model. These results show that the genetic background of ptxP3 strains with a higher expression of virulence genes contribute to increased fitness.	[King, Audrey J.; van der Lee, Saskia; Mohangoo, Archena; van Gent, Marjolein] Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Screening LIS, Ctr Infect Dis Control, Bilthoven, Netherlands; [van der Ark, Arno; van de Waterbeemd, Bas] Natl Inst Publ Hlth & Environm RIVM, Dept Vaccinol, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	King, AJ (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Screening LIS, Ctr Infect Dis Control, Bilthoven, Netherlands.	audrey.king@rivm.nl			RIVM (SOR project)	RIVM (SOR project)	This project was supported by the RIVM (SOR project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2007, APMIS, V115, P736, DOI 10.1111/j.1600-0463.2007.apm_628.x; Advani A, 2011, VACCINE, V29, P3438, DOI 10.1016/j.vaccine.2011.02.070; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Bootsma RJ, 2002, PERCEPTION, V31, P901, DOI 10.1068/p3230; Bottero D, 2007, CLIN VACCINE IMMUNOL, V14, P1490, DOI 10.1128/CVI.00177-07; Coote JG, 2001, ADV MICROB PHYSIOL, V44, P141, DOI 10.1016/S0065-2911(01)44013-6; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; de Melker HE, 2000, EMERG INFECT DIS, V6, P348, DOI 10.3201/eid0604.000404; Deora R, 2002, J BACTERIOL, V184, P6942, DOI 10.1128/JB.184.24.6942-6951.2002; Deora R, 2001, MOL MICROBIOL, V40, P669, DOI 10.1046/j.1365-2958.2001.02415.x; French CT, 2009, CELL MICROBIOL, V11, P1735, DOI 10.1111/j.1462-5822.2009.01361.x; Gao Q, 2005, MICROBIOL-SGM, V151, P5, DOI 10.1099/mic.0.27539-0; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; Han HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017797; He QS, 2008, FUTURE MICROBIOL, V3, P329, DOI 10.2217/17460913.3.3.329; Heikkinen E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000904; Herrou J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006996; Jones AM, 2005, MOL MICROBIOL, V58, P700, DOI 10.1111/j.1365-2958.2005.04875.x; Kallonen T, 2009, EXPERT REV VACCINES, V8, P863, DOI [10.1586/erv.09.46, 10.1586/ERV.09.46]; Kallonen T, 2011, INFECT GENET EVOL, V11, P2034, DOI 10.1016/j.meegid.2011.09.012; King AJ, 2001, MICROBIOL-SGM, V147, P2885, DOI 10.1099/00221287-147-11-2885; King AJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-64; King AJ, 2008, BMC GENOMICS, V9, P1, DOI 10.1186/1471-2164-9-311; Komatsu E, 2010, CLIN VACCINE IMMUNOL, V17, P807, DOI 10.1128/CVI.00449-09; Kuwae A, 2006, J BIOL CHEM, V281, P6589, DOI 10.1074/jbc.M512711200; Lam C, 2012, INFECT GENET EVOL, V12, P492, DOI 10.1016/j.meegid.2012.01.001; Li WM, 2005, INT J TUBERC LUNG D, V9, P1314; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Medhekar B, 2009, MOL MICROBIOL, V71, P492, DOI 10.1111/j.1365-2958.2008.06543.x; Mei Jian, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P707; Mooi FR, 2001, EMERG INFECT DIS, V7, P526, DOI 10.3201/eid0707.017708; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Octavia S, 2012, J INFECT DIS, V205, P1220, DOI 10.1093/infdis/jis178; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Shrivastava R, 2009, CURR OPIN MICROBIOL, V12, P88, DOI 10.1016/j.mib.2009.01.001; Streefland M, 2007, VACCINE, V25, P2994, DOI 10.1016/j.vaccine.2007.01.015; Thalen M, 1999, J BIOTECHNOL, V75, P147, DOI 10.1016/S0168-1656(99)00155-8; Thalen M, 2006, BIOLOGICALS, V34, P213, DOI 10.1016/j.biologicals.2005.11.002; van de Waterbeemd B, 2009, BIOTECHNOL BIOENG, V103, P900, DOI 10.1002/bit.22326; van Gent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020340; van Gent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018014; Watanabe M, 2002, VACCINE, V20, P1429, DOI 10.1016/S0264-410X(01)00460-1; Watanabe Mineo, 2004, Expert Rev Anti Infect Ther, V2, P447, DOI 10.1586/14787210.2.3.447	46	75	78	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66150	10.1371/journal.pone.0066150	http://dx.doi.org/10.1371/journal.pone.0066150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776625	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400116
J	Wang, Y; Jiang, F; Zhuo, Z; Wu, XH; Wu, YD				Wang, Yang; Jiang, Fan; Zhuo, Zhu; Wu, Xian-Hui; Wu, Yun-Dong			A Method for WD40 Repeat Detection and Secondary Structure Prediction	PLOS ONE			English	Article							SER/THR-TRP TETRAD; PARKINSONS-DISEASE; STRUCTURE ASSIGNMENT; COMPARATIVE GENOMICS; DIVERSE FUNCTIONS; PROTEINS; FAMILY; IDENTIFICATION; LRRK2; ARCHITECTURE	WD40-repeat proteins (WD40s), as one of the largest protein families in eukaryotes, play vital roles in assembling protein-protein/DNA/RNA complexes. WD40s fold into similar beta-propeller structures despite diversified sequences. A program WDSP (WD40 repeat protein Structure Predictor) has been developed to accurately identify WD40 repeats and predict their secondary structures. The method is designed specifically for WD40 proteins by incorporating both local residue information and non-local family-specific structural features. It overcomes the problem of highly diversified protein sequences and variable loops. In addition, WDSP achieves a better prediction in identifying multiple WD40-domain proteins by taking the global combination of repeats into consideration. In secondary structure prediction, the average Q3 accuracy of WDSP in jack-knife test reaches 93.7%. A disease related protein LRRK2 was used as a representive example to demonstrate the structure prediction.	[Wang, Yang; Jiang, Fan; Zhuo, Zhu; Wu, Xian-Hui; Wu, Yun-Dong] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Lab Computat Chem & Drug Design, Shenzhen, Peoples R China; [Wu, Yun-Dong] Peking Univ, Coll Chem, Beijing 100871, Peoples R China	Peking University; University Town of Shenzhen; Peking University	Wu, XH (corresponding author), Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Lab Computat Chem & Drug Design, Shenzhen, Peoples R China.	wuxh@pkusz.edu.cn; wuyd@pkusz.edu.cn	Wang, Yang/AAN-7740-2020; z, z/GXZ-4805-2022; z, z/HHN-3970-2022; Jiang, Fan/E-2771-2012; Z, Z/AEN-2153-2022; Wu, Yun-Dong/G-8463-2013		National Science Foundation of China [21133002]; Shenzhen Peacock Program; Peking University Shenzhen Graduate School	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Peacock Program; Peking University Shenzhen Graduate School	Financial support by the National Science Foundation of China (21133002, http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm), the Shenzhen Peacock Program, and Peking University Shenzhen Graduate School is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MA, 2000, J MOL BIOL, V298, P521, DOI 10.1006/jmbi.2000.3684; Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039; Baldi P, 1999, BIOINFORMATICS, V15, P937, DOI 10.1093/bioinformatics/15.11.937; Biedermann S, 2011, TRENDS PLANT SCI, V16, P38, DOI 10.1016/j.tplants.2010.09.007; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Cai YD, 1998, J PROTEIN CHEM, V17, P363, DOI 10.1023/A:1022559300504; Chakraborty A, 2011, EPIGENETICS-US, V6, P665, DOI 10.4161/epi.6.6.16179; CHAN AWE, 1993, PROTEIN SCI, V2, P1574, DOI 10.1002/pro.5560021004; Coggill P, 2008, CURR PROTOC BIOINFOR, V2, P2; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; GIBRAT JF, 1987, J MOL BIOL, V198, P425, DOI 10.1016/0022-2836(87)90292-0; Goldberg D. E., 1989, GENETIC ALGORITHMS S; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jennings BH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-205; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Lee BD, 2012, TRENDS PHARMACOL SCI, V33, P365, DOI 10.1016/j.tips.2012.04.001; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lees J, 2012, NUCLEIC ACIDS RES, V40, pD465, DOI 10.1093/nar/gkr1181; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Martin J, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-17; Mata IF, 2005, NEUROGENETICS, V6, P171, DOI 10.1007/s10048-005-0005-1; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Migliori V, 2012, EPIGENETICS-US, V7, P815, DOI 10.4161/epi.21140; Mohri K, 2004, J BIOL CHEM, V279, P31697, DOI 10.1074/jbc.M403351200; MURZIN AG, 1992, PROTEINS, V14, P191, DOI 10.1002/prot.340140206; Mylona A, 2006, MOL CELL, V24, P221, DOI 10.1016/j.molcel.2006.08.013; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Pirovano W, 2010, METHODS MOL BIOL, V609, P327, DOI 10.1007/978-1-60327-241-4_19; RICHARDSON JS, 1978, P NATL ACAD SCI USA, V75, P2574, DOI 10.1073/pnas.75.6.2574; ROST B, 1994, J MOL BIOL, V235, P13, DOI 10.1016/S0022-2836(05)80007-5; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2001.4336; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Shen Z, 2010, MOL CELL, V40, P99, DOI 10.1016/j.molcel.2010.09.021; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Suganuma T, 2008, GENE DEV, V22, P1265, DOI 10.1101/gad.1676208; Tan EK, 2007, HUM MUTAT, V28, P641, DOI 10.1002/humu.20507; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Webber PJ, 2009, FEBS J, V276, P6436, DOI 10.1111/j.1742-4658.2009.07342.x; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Wu XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043005; Wu XH, 2010, BIOCHEMISTRY-US, V49, P10237, DOI 10.1021/bi101321y; Wu XH, 2010, PROTEINS, V78, P1186, DOI 10.1002/prot.22638; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Yu LH, 2000, PROTEIN SCI, V9, P2470, DOI 10.1110/ps.9.12.2470; Zhang W, 2008, PROTEINS, V71, P61, DOI 10.1002/prot.21654	58	26	30	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65705	10.1371/journal.pone.0065705	http://dx.doi.org/10.1371/journal.pone.0065705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776530	gold, Green Published, Green Submitted			2022-12-25	WOS:000320755400058
J	Brandani, GB; Schor, M; MacPhee, CE; Grubmuller, H; Zachariae, U; Marenduzzo, D				Brandani, Giovanni B.; Schor, Marieke; MacPhee, Cait E.; Grubmueller, Helmut; Zachariae, Ulrich; Marenduzzo, Davide			Quantifying Disorder through Conditional Entropy: An Application to Fluid Mixing	PLOS ONE			English	Article							PHASE-DIAGRAMS; MODEL; DOMAIN; ALGORITHMS; MEMBRANES; DYNAMICS	In this paper, we present a method to quantify the extent of disorder in a system by using conditional entropies. Our approach is especially useful when other global, or mean field, measures of disorder fail. The method is equally suited for both continuum and lattice models, and it can be made rigorous for the latter. We apply it to mixing and demixing in multicomponent fluid membranes, and show that it has advantages over previous measures based on Shannon entropies, such as a much diminished dependence on binning and the ability to capture local correlations. Further potential applications are very diverse, and could include the study of local and global order in fluid mixtures, liquid crystals, magnetic materials, and particularly biomolecular systems.	[Brandani, Giovanni B.; Schor, Marieke; MacPhee, Cait E.; Zachariae, Ulrich; Marenduzzo, Davide] Univ Edinburgh, Sch Phys & Astron, SUPA, Edinburgh, Midlothian, Scotland; [Grubmueller, Helmut] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, D-37077 Gottingen, Germany; [Zachariae, Ulrich] Univ Dundee, Coll Life Sci, Div Computat Biol, Dundee, Scotland; [Zachariae, Ulrich] Univ Dundee, Div Phys, Sch Engn Phys & Math, Dundee, Scotland	University of Edinburgh; Max Planck Society; University of Dundee; University of Dundee	Zachariae, U (corresponding author), Univ Edinburgh, Sch Phys & Astron, SUPA, Edinburgh, Midlothian, Scotland.	u.zachariae@dundee.ac.uk; dmarendu@ed.ac.uk	Brandani, Giovanni/GPX-0510-2022; Brandani, Giovanni/AAX-9654-2021; MacPhee, Cait/F-6679-2013	Brandani, Giovanni/0000-0003-3379-0187; Marenduzzo, Davide/0000-0003-3974-4915; MacPhee, Cait/0000-0001-8313-8387; Zachariae, Ulrich/0000-0003-3287-8494; Schor, Marieke/0000-0002-1080-9546	Scottish Universities' Physics Alliance; UK National Physical Laboratory; Engineering and Physical Sciences Research Council [EP/J007404/1] Funding Source: researchfish; EPSRC [EP/J007404/1] Funding Source: UKRI	Scottish Universities' Physics Alliance; UK National Physical Laboratory; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	MS and UZ acknowledge support from the Scottish Universities' Physics Alliance (www.supa.ac.uk). MS, CM and UZ acknowledge external funding from the UK National Physical Laboratory (www.npl.co.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins P., 2006, PHYS CHEM; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bethe H. A., 1935, P ROY SOC A-MATH PHY, V150, P552, DOI DOI 10.1098/RSPA.1935.0122; Camesasca M, 2006, MACROMOL THEOR SIMUL, V15, P595, DOI 10.1002/mats.200600037; Chaikin P. M., 2000, PRINCIPLES CONDENSED, V1; Feigenson GW, 2009, BBA-BIOMEMBRANES, V1788, P47, DOI 10.1016/j.bbamem.2008.08.014; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; Goni FM, 2008, BBA-MOL CELL BIOL L, V1781, P665, DOI 10.1016/j.bbalip.2008.09.002; Gozdz WT, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4731646; Hac AE, 2005, BIOPHYS J, V88, P317, DOI 10.1529/biophysj.104.040444; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hinderliter A, 2001, BIOCHEMISTRY-US, V40, P4181, DOI 10.1021/bi0024299; Huang K, 1987, STAT MECH; Kawasaki K., 1972, PHASE TRANSITIONS CR; KERSTEN D, 1987, J OPT SOC AM A, V4, P2395, DOI 10.1364/JOSAA.4.002395; KIKUCHI R, 1951, PHYS REV, V81, P988, DOI 10.1103/PhysRev.81.988; Kiselev VY, 2011, BIOPHYS J, V100, P1261, DOI 10.1016/j.bpj.2011.01.025; KURATA M, 1953, J CHEM PHYS, V21, P434, DOI 10.1063/1.1698926; Laurent B, 2013, PURE APPL CHEM, V85, P1, DOI 10.1351/PAC-CON-12-04-10; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Onsager L, 1944, PHYS REV, V65, P117, DOI 10.1103/PhysRev.65.117; ORLANDINI E, 1995, EUROPHYS LETT, V32, P463, DOI 10.1209/0295-5075/32/6/001; Pelizzola A, 2005, J PHYS A-MATH GEN, V38, pR309, DOI 10.1088/0305-4470/38/33/R01; PERCUS JK, 1977, J STAT PHYS, V16, P299, DOI 10.1007/BF01020384; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Schafer LV, 2010, BIOPHYS J, V99, pL91, DOI 10.1016/j.bpj.2010.08.072; Shannon C.E., 1949, MATH THEORY COMMUNIC, V117; Sole RV, 2004, LECT NOTES PHYS, V650, P189; Sugar IP, 1999, BIOPHYS J, V76, P2099, DOI 10.1016/S0006-3495(99)77366-2	31	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65617	10.1371/journal.pone.0065617	http://dx.doi.org/10.1371/journal.pone.0065617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762401	Green Published, gold			2022-12-25	WOS:000320440500046
J	Ogbomo, H; Zemp, FJ; Lun, XQ; Zhang, JQ; Stack, D; Rahman, MM; Mcfadden, G; Mody, CH; Forsyth, PA				Ogbomo, Henry; Zemp, Franz J.; Lun, Xueqing; Zhang, Jiqing; Stack, Danuta; Rahman, Masmudur M.; Mcfadden, Grant; Mody, Christopher H.; Forsyth, Peter A.			Myxoma Virus Infection Promotes NK Lysis of Malignant Gliomas In Vitro and In Vivo	PLOS ONE			English	Article							TGF-BETA; MHC-I; CELLS; EXPRESSION; GLIOBLASTOMA; VIROTHERAPY; THERAPY; SURFACE; NKG2D; RESISTANCE	Myxoma virus (MYXV) is a well-established oncolytic agent against different types of tumors. MYXV is also known for its immunomodulatory properties in down-regulating major histocompatibility complex (MHC) I surface expression (via the M153R gene product, a viral E3-ubiquitin ligase) and suppressing T cell killing of infected target cells. MHC I down-regulation, however, favors NK cell activation. Brain tumors including gliomas are characterized by high MHC I expression with impaired NK activity. We thus hypothesized that MYXV infection of glioma cells will promote NK cell-mediated recognition and killing of gliomas. We infected human gliomas with MYXV and evaluated their susceptibility to NK cell-mediated cytotoxicity. MYXV enhanced NK cell-mediated killing of glioma cells (U87 cells, MYXV vs. Mock: 51.73% vs. 28.63%, P =.0001, t test; U251 cells, MYXV vs. Mock: 40.4% vs. 20.03%, P.0007, t test). Using MYXV M153R targeted knockout (designated vMyx-M153KO) to infect gliomas, we demonstrate that M153R was responsible for reduced expression of MHC I on gliomas and enhanced NK cell-mediated antiglioma activity (U87 cells, MYXV vs. vMyx-M153KO: 51.73% vs. 25.17%, P =.0002, t test; U251 cells, MYXV vs. vMyx-M153KO: 40.4% vs. 19.27, P =.0013, t test). Consequently, NK cell-mediated lysis of established human glioma tumors in CB-17 SCID mice was accelerated with improved mouse survival (log-rank P =.0072). These results demonstrate the potential for combining MYXV with NK cells to effectively kill malignant gliomas.	[Ogbomo, Henry; Zemp, Franz J.; Lun, Xueqing; Zhang, Jiqing; Forsyth, Peter A.] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Ogbomo, Henry; Zemp, Franz J.; Lun, Xueqing; Zhang, Jiqing; Forsyth, Peter A.] Univ Calgary, Dept Biochem, Calgary, AB, Canada; [Ogbomo, Henry; Zemp, Franz J.; Lun, Xueqing; Zhang, Jiqing; Forsyth, Peter A.] Univ Calgary, Dept Mol Biol, Calgary, AB, Canada; [Ogbomo, Henry; Stack, Danuta; Mody, Christopher H.] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada; [Ogbomo, Henry; Stack, Danuta; Mody, Christopher H.] Univ Calgary, Dept Internal Med, Calgary, AB, Canada; [Rahman, Masmudur M.; Mcfadden, Grant] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Forsyth, Peter A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Neurooncol, Tampa, FL USA; [Forsyth, Peter A.] Univ S Florida, Tampa, FL USA	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; State University System of Florida; University of Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Forsyth, PA (corresponding author), Univ Calgary, Dept Oncol, Calgary, AB, Canada.	Peter.Forsyth@moffitt.org		McFadden, Grant/0000-0002-2556-3526; Mody, Christopher H./0000-0001-7264-3679	National Cancer Institute of Canada; Canadian Cancer Society Research Institute; National Cancer Institutes of Canada-Terry Fox Research Institute; Alberta Cancer Foundation; Alberta Innovates and Health Solutions postdoctoral fellowships; Canadian Institute for Health Research; Jessie Bowden Lloyd Professorship in Immunology; Alberta Innovates and Health Solutions; Killam Memorial Trust; Canadian Institute for Health Research Vanier Award; National Institutes of Health [AI080607, CA138541]; NATIONAL CANCER INSTITUTE [R01CA138541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080607] Funding Source: NIH RePORTER	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); National Cancer Institutes of Canada-Terry Fox Research Institute; Alberta Cancer Foundation; Alberta Innovates and Health Solutions postdoctoral fellowships; Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Jessie Bowden Lloyd Professorship in Immunology; Alberta Innovates and Health Solutions; Killam Memorial Trust; Canadian Institute for Health Research Vanier Award(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Cancer Institute of Canada; Canadian Cancer Society Research Institute; National Cancer Institutes of Canada-Terry Fox Research Institute; Families of Clark H. Smith and Kathleen Lorette (PAF), Alberta Cancer Foundation and Alberta Innovates and Health Solutions postdoctoral fellowships (HO), Canadian Institute for Health Research grants and Jessie Bowden Lloyd Professorship in Immunology (CHM), Alberta Innovates and Health Solutions, Killam Memorial Trust, and Canadian Institute for Health Research Vanier Award (FJZ), National Institutes of Health R01 grants (AI080607 and CA138541; GM's lab). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Breckenridge CA, 2012, NAT MED, V18, P1827, DOI 10.1038/nm.3013; Alvarez-Breckenridge CA, 2012, ADV VIROL, V2012, DOI 10.1155/2012/702839; Avril T, 2010, J NEUROIMMUNOL, V225, P22, DOI 10.1016/j.jneuroim.2010.04.003; BARBA D, 1989, J NEUROSURG, V70, P175, DOI 10.3171/jns.1989.70.2.0175; Bhat R, 2011, INT J CANCER, V128, P908, DOI 10.1002/ijc.25415; BOSHKOV LK, 1992, J IMMUNOL, V148, P881; Castriconi R, 2009, J IMMUNOL, V182, P3530, DOI 10.4049/jimmunol.0802845; Collin N, 2005, VIROLOGY, V343, P171, DOI 10.1016/j.virol.2005.07.032; Crane CA, 2010, NEURO-ONCOLOGY, V12, P7, DOI 10.1093/neuonc/nop009; Diaz RM, 2007, CANCER RES, V67, P2840, DOI 10.1158/0008-5472.CAN-06-3974; Eisele G, 2006, BRAIN, V129, P2416, DOI 10.1093/brain/awl205; Friese MA, 2003, CANCER RES, V63, P8996; Glynn SA, 2004, BRIT J CANCER, V91, P1800, DOI 10.1038/sj.bjc.6602221; Guerin JL, 2002, J VIROL, V76, P2912, DOI 10.1128/JVI.76.6.2912-2923.2002; Holmes TD, 2011, J IMMUNOL, V186, P1538, DOI 10.4049/jimmunol.1000951; Ishikawa E, 2004, ANTICANCER RES, V24, P1861; JACKSON EW, 1966, NATURE, V211, P313, DOI 10.1038/211313a0; Johnston JB, 2003, J VIROL, V77, P5877, DOI 10.1128/JVI.77.10.5877-5888.2003; JOLY E, 1991, SCIENCE, V253, P1283, DOI 10.1126/science.1891717; Liang YH, 2004, INT J CANCER, V111, P484, DOI 10.1002/ijc.20230; Liu J, 2010, MICROBES INFECT, V12, P1144, DOI 10.1016/j.micinf.2010.08.012; Lun XQ, 2005, CANCER RES, V65, P9982, DOI 10.1158/0008-5472.CAN-05-1201; Lun XQ, 2010, CANCER RES, V70, P598, DOI 10.1158/0008-5472.CAN-09-1510; Mansouri M, 2003, J VIROL, V77, P1427, DOI 10.1128/JVI.77.2.1427-1440.2003; Ogbomo H, 2006, BIOCHEM BIOPH RES CO, V339, P375, DOI 10.1016/j.bbrc.2005.11.025; Ogbomo H, 2011, TRENDS MOL MED, V17, P433, DOI 10.1016/j.molmed.2011.03.004; Ogbomo H, 2010, MED MICROBIOL IMMUN, V199, P93, DOI 10.1007/s00430-009-0139-0; Ogbomo H, 2008, NEOPLASIA, V10, P1402, DOI 10.1593/neo.08972; Parney IF, 2000, NEUROSURGERY, V46, P1169, DOI 10.1097/00006123-200005000-00030; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Preusser M, 2006, WIEN MED WOCHENSCHR, V156, P332, DOI 10.1007/s10354-006-0304-7; Sloan KE, 2005, CANCER RES, V65, P10930, DOI 10.1158/0008-5472.CAN-05-1890; Smallwood Sherin E, 2010, Curr Protoc Microbiol, VChapter 14, DOI 10.1002/9780471729259.mc14a01s17; Stanford MM, 2007, VET RES, V38, P299, DOI 10.1051/vetres:2006054; Stanford MM, 2007, J VIROL, V81, P1251, DOI 10.1128/JVI.01408-06; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Szentirmai O, 2006, NEUROSURGERY, V58, P365, DOI 10.1227/01.NEU.0000195114.24819.4F; Vauleon E, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/689171; Wu AH, 2007, J NEURO-ONCOL, V83, P121, DOI 10.1007/s11060-006-9265-3; Yang WQ, 2003, CANCER RES, V63, P3162	40	38	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66825	10.1371/journal.pone.0066825	http://dx.doi.org/10.1371/journal.pone.0066825			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762498	gold, Green Submitted, Green Published			2022-12-25	WOS:000320440500071
J	Shen, L; Shao, NY; Liu, XC; Maze, I; Feng, J; Nestler, EJ				Shen, Li; Shao, Ning-Yi; Liu, Xiaochuan; Maze, Ian; Feng, Jian; Nestler, Eric J.			diffReps: Detecting Differential Chromatin Modification Sites from ChIP-seq Data with Biological Replicates	PLOS ONE			English	Article							EXPRESSION ANALYSIS; BIOCONDUCTOR PACKAGE; HUMAN GENOME; COCAINE; GENE	ChIP-seq is increasingly being used for genome-wide profiling of histone modification marks. It is of particular importance to compare ChIP-seq data of two different conditions, such as disease vs. control, and identify regions that show differences in ChIP enrichment. We have developed a powerful and easy to use program, called diffReps, to detect those differential sites from ChIP-seq data, with or without biological replicates. In addition, we have developed two useful tools for ChIP-seq analysis in the diffReps package: one for the annotation of the differential sites and the other for finding chromatin modification "hotspots". diffReps is developed in PERL programming language and runs on all platforms as a command line script. We tested diffReps on two different datasets. One is the comparison of H3K4me3 between two human cell lines from the ENCODE project. The other is the comparison of H3K9me3 in a discrete region of mouse brain between cocaine-and saline-treated conditions. The results indicated that diffReps is a highly sensitive program in detecting differential sites from ChIP-seq data.	[Shen, Li; Shao, Ning-Yi; Liu, Xiaochuan; Feng, Jian; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY USA; [Shen, Li; Shao, Ning-Yi; Liu, Xiaochuan; Feng, Jian; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY USA; [Maze, Ian] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10021 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rockefeller University	Shen, L (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY USA.	li.shen@mssm.edu	Maze, Ian/P-8077-2018; SHAO, Ning-Yi/N-4947-2015; Shen, Li/B-3562-2008	SHAO, Ning-Yi/0000-0003-4231-828X; Shen, Li/0000-0002-5190-2851; Maze, Ian/0000-0003-1490-7781	Friedman Brain Institute; National Institutes of Health (NIH) [P01 DA008227, P50 MH096890]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH096890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227] Funding Source: NIH RePORTER	Friedman Brain Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the seed grant from Friedman Brain Institute to Dr. Li Shen, National Institutes of Health (NIH) grants P01 DA008227 and P50 MH096890 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2011, PLOS BIOL, V9, DOI [10.1371/journal.pbio.1001046, DOI 10.1371/JOURNAL.PBIO.1001046]; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Di Y, 2011, STAT APPL GENET MOL, V10, P1, DOI 10.2202/1544-6115.1637; Fasano S, 2009, BIOL PSYCHIAT, V66, P758, DOI 10.1016/j.biopsych.2009.03.014; Host L, 2011, J PSYCHOPHARMACOL, V25, P222, DOI 10.1177/0269881109348173; Kidder BL, 2011, NAT IMMUNOL, V12, P918, DOI 10.1038/ni.2117; Kramer OH, 2009, TRENDS PHARMACOL SCI, V30, P647, DOI 10.1016/j.tips.2009.09.007; Liang K, 2012, BIOINFORMATICS, V28, P121, DOI 10.1093/bioinformatics/btr605; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Maze I, 2011, P NATL ACAD SCI USA, V108, P3035, DOI 10.1073/pnas.1015483108; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Pierce RC, 1999, J NEUROSCI, V19, P8685; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenfeld JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-143; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Sokal RR, 1995, BIOMETRY; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Szalkowski AM, 2010, BRIEFINGS BIOINFORMA; Taslim C, 2011, BIOINFORMATICS, V27, P1569, DOI 10.1093/bioinformatics/btr165; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Warren Derek T., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009294; Xu H, 2008, BIOINFORMATICS, V24, P2344, DOI 10.1093/bioinformatics/btn402; Xu H, 2010, BIOINFORMATICS, V26, P1199, DOI 10.1093/bioinformatics/btq128; Zhang GC, 2007, NEUROSCI LETT, V427, P117, DOI 10.1016/j.neulet.2007.09.010; Zhang Y., 2008, GENOME BIOL, V9; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237; Zhuravliova E, 2009, NEUROCHEM RES, V34, P1076, DOI 10.1007/s11064-008-9877-4	34	205	209	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65598	10.1371/journal.pone.0065598	http://dx.doi.org/10.1371/journal.pone.0065598			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762400	Green Published, Green Submitted, gold			2022-12-25	WOS:000320440500045
J	O'Leary, SJ; Hice, LA; Feldheim, KA; Frisk, MG; McElroy, AE; Fast, MD; Chapman, DD				O'Leary, Shannon J.; Hice, Lyndie A.; Feldheim, Kevin A.; Frisk, Michael G.; McElroy, Anne E.; Fast, Mark D.; Chapman, Demian D.			Severe Inbreeding and Small Effective Number of Breeders in a Formerly Abundant Marine Fish	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; FLOUNDER PLATICHTHYS-FLESUS; JUVENILE WINTER FLOUNDER; PSEUDOPLEURONECTES-AMERICANUS; SEASONAL MOVEMENTS; BALTIC SEA; DEPRESSION; LARVAL; SOFTWARE; RELATEDNESS	In contrast to freshwater fish it is presumed that marine fish are unlikely to spawn with close relatives due to the dilution effect of large breeding populations and their propensity for movement and reproductive mixing. Inbreeding is therefore not typically a focal concern of marine fish management. We measured the effective number of breeders in 6 New York estuaries for winter flounder (Pseudopleuronectes americanus), a formerly abundant fish, using 11 microsatellite markers (6-56 alleles per locus). The effective number of breeders for 1-2 years was remarkably small, with point estimates ranging from 65-289 individuals. Excess homozygosity was detected at 10 loci in all bays (F-IS = 0.169-0.283) and individuals exhibited high average internal relatedness (IR; mean = 0.226). These both indicate that inbreeding is very common in all bays, after testing for and ruling out alternative explanations such as technical and sampling artifacts. This study demonstrates that even historically common marine fish can be prone to inbreeding, a factor that should be considered in fisheries management and conservation plans.	[O'Leary, Shannon J.; Hice, Lyndie A.; Frisk, Michael G.; McElroy, Anne E.; Fast, Mark D.; Chapman, Demian D.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Feldheim, Kevin A.] Field Museum, Pritzker Lab Mol Systemat & Evolut, Chicago, IL USA; [Fast, Mark D.] Univ Prince Edward Isl, Atlantic Vet Coll, Charlottetown, PE C1A 4P3, Canada; [Chapman, Demian D.] Inst Ocean Conservat Sci, Stony Brook, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Field Museum of Natural History (Chicago); University of Prince Edward Island	O'Leary, SJ (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	shannon.oleary@stonybrook.edu			Institute for Ocean Conservation Science; Pew Charitable Trusts; Pritzker Foundation; Laurie Landeau Foundation; Saltonstall-Kennedy Grant Program (NOAA); NY DOS	Institute for Ocean Conservation Science; Pew Charitable Trusts; Pritzker Foundation; Laurie Landeau Foundation; Saltonstall-Kennedy Grant Program (NOAA); NY DOS	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Genetic analyses were supported by the Institute for Ocean Conservation Science with operational funds from The Pew Charitable Trusts. Microsatellite amplification was carried out in the Pritzker Laboratory for Molecular Systematics and Evolution operated with support from the Pritzker Foundation. Shinnecock Bay fish were sampled during the Shinnecock Bay Restoration Project, which is funded by the Laurie Landeau Foundation and matched by a gift from the Simons Foundation. Further funding was granted by the Saltonstall-Kennedy Grant Program (NOAA) and a NY DOS grant for field work in Hempstead Bays.	ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Anderson JD, 2012, N AM J FISH MANAGE, V32, P656, DOI 10.1080/02755947.2012.686957; Armbruster P, 2005, HEREDITY, V95, P235, DOI 10.1038/sj.hdy.6800721; Bickley LK, 2013, EVOL APPL, V6, P279, DOI 10.1111/j.1752-4571.2012.00288.x; Buckley J, 1989, US FISH WILDL SERV B, V82; Buckley L, 2008, ESTUAR COAST, V31, P745, DOI 10.1007/s12237-008-9065-4; BUCKLEY LJ, 1991, MAR ECOL PROG SER, V74, P117, DOI 10.3354/meps074117; Castric V, 2002, HEREDITY, V89, P27, DOI 10.1038/sj.hdy.6800089; Chant RJ, 2000, ESTUAR COAST SHELF S, V51, P529, DOI 10.1006/ecss.2000.0694; Chapman TW, 1996, HEREDITY, V76, P65, DOI 10.1038/hdy.1996.8; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Crivello JF, 2004, J FISH BIOL, V65, P62, DOI 10.1111/j.0022-1112.2004.00424.x; DeLong AK, 2001, CAN J FISH AQUAT SCI, V58, P2233, DOI 10.1139/cjfas-58-11-2233; Dharmarajan G, 2013, J WILDLIFE MANAGE, V77, P226, DOI 10.1002/jwmg.458; Ferguson PL, 2001, ANAL CHEM, V73, P3890, DOI 10.1021/ac010327y; Florin AB, 2008, HEREDITY, V101, P27, DOI 10.1038/hdy.2008.22; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R, 1999, ANIM CONSERV, V2, P255, DOI 10.1111/j.1469-1795.1999.tb00071.x; Frasier TR, 2008, MOL ECOL RESOUR, V8, P1263, DOI 10.1111/j.1755-0998.2008.02358.x; Frisk MG, 2014, FISH FISH, V15, P242, DOI 10.1111/faf.12014; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hauser L, 2002, PNAS, V99, P1142; Hemmer-Hansen J, 2007, MOL ECOL, V16, P3104, DOI 10.1111/j.1365-294X.2007.03367.x; HENDRICKSON L, 2006, STATUS FISHERY RESOU; Hoarau G, 2005, P ROY SOC B-BIOL SCI, V272, P497, DOI 10.1098/rspb.2004.2963; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kenchington E., 2002, ICES J MARINE SCI Y, V13, P1; Lacy R. C., 1987, CONSERV BIOL, V1, P143, DOI DOI 10.1111/J.1523-1739.1987.TB00023.X; Langen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024689; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Liao W, 2009, ANIM CONSERV, V12, P54, DOI 10.1111/j.1469-1795.2008.00220.x; Liberg O, 2005, BIOL LETT-UK, V1, P17, DOI 10.1098/rsbl.2004.0266; Lobell M. J., 1939, 28 NEW YORK STAT 1 S, P63; Lotterhos KE, 2012, MOL ECOL, V21, P5009, DOI 10.1111/j.1365-294X.2012.12002.x; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; MANTEL N, 1967, CANCER RES, V27, P209; McCairns RJS, 2012, CONSERV GENET, V13, P1509, DOI 10.1007/s10592-012-0394-2; McClelland G, 2005, J FISH BIOL, V66, P1082, DOI 10.1111/j.0022-1112.2005.00659.x; MCCRACKEN FD, 1963, J FISH RES BOARD CAN, V20, P551, DOI 10.1139/f63-040; McNeely J. A., 1990, CONSERVING WORLDS BI; Mena L, 2006, MAR ENVIRON RES, V62, pS233; NEI M, 1978, GENETICS, V89, P583; NMFS (National Marine Fisheries Service), 2007, ANN COMM LAND STAT; Northeast Fisheries Science Center, 2011, 1117 NEFSC; O'Grady JJ, 2006, BIOL CONSERV, V133, P42, DOI 10.1016/j.biocon.2006.05.016; O'Leary SJ, 2013, CONSERV GENET RESOUR, V5, P569, DOI 10.1007/s12686-012-9854-8; Park SDE, 2001, THESIS U DUBLIN; Perlmutter A., 1947, Bulletin of the Bingham Oceanographic Collection, V11, P1; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; POOLE JOHN G., 1966, N Y FISH GAME J, V13, P206; Poulsen NA, 2006, MOL ECOL, V15, P321, DOI 10.1111/j.1365-294X.2005.02777.x; Pritchard JK, 2000, GENETICS, V155, P945; Raymond M, 1995, HEREDITY, V86; Robinson JD, 2013, EVOL APPL, V6, P290, DOI 10.1111/j.1752-4571.2012.00289.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sagarese SR, 2011, MAR COAST FISH, V3, P295, DOI 10.1080/19425120.2011.603957; Slate J, 2000, P ROY SOC B-BIOL SCI, V267, P1657, DOI 10.1098/rspb.2000.1192; SLATKIN M, 1995, GENETICS, V139, P457; Smedbol RK, 2002, FISH FISH, V3, P20, DOI 10.1046/j.1467-2979.2002.00062.x; Socrates JB, 2006, AFC30 NEW YORK STAT; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297; Todorov JR, 2002, MAR ENVIRON RES, V54, P691, DOI 10.1016/S0141-1136(02)00197-6; Turner TF, 2006, P R SOC B, V273, P3065, DOI 10.1098/rspb.2006.3677; VANGUELPEN L, 1979, T AM FISH SOC, V108, P26, DOI 10.1577/1548-8659(1979)108<26:SMOTWF>2.0.CO;2; Wang CY, 2007, HYDROBIOLOGIA, V586, P321, DOI 10.1007/s10750-007-0702-x; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Wright S., 1984, EVOLUTION GENETICS P; Wuenschel MJ, 2009, J FISH BIOL, V74, P1508, DOI 10.1111/j.1095-8649.2009.02217.x; Xu DD, 2012, CHIN J OCEANOL LIMN, V30, P604, DOI 10.1007/s00343-012-1197-5; Yencho MA, 2009, THESIS; Zarraonaindia I, 2009, MICROSATELLITE VARIA	77	42	43	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66126	10.1371/journal.pone.0066126	http://dx.doi.org/10.1371/journal.pone.0066126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762473	gold, Green Published, Green Submitted			2022-12-25	WOS:000321094800091
J	Dutia, R; Kim, AJ; Modes, M; Rothlein, R; Shen, JM; Tian, YE; Ihbais, J; Victory, SF; Valcarce, C; Wardlaw, SL				Dutia, Roxanne; Kim, Andrea J.; Modes, Matthew; Rothlein, Robert; Shen, Jane M.; Tian, Ye Edward; Ihbais, Jumana; Victory, Sam F.; Valcarce, Carmen; Wardlaw, Sharon L.			Effects of AgRP Inhibition on Energy Balance and Metabolism in Rodent Models	PLOS ONE			English	Article							AGOUTI-RELATED PROTEIN; CENTRAL-NERVOUS-SYSTEM; CENTRAL MELANOCORTIN SYSTEM; INCREASED DIETARY-FAT; MESSENGER-RNA; RAT HYPOTHALAMUS; INDUCED OBESITY; DEFICIENT MICE; NEUROPEPTIDE-Y; FOOD-INTAKE	Activation of brain melanocortin-4 receptors (MC4-R) by alpha-melanocyte-stimulating hormone (MSH) or inhibition by agouti-related protein (AgRP) regulates food intake and energy expenditure and can modulate neuroendocrine responses to changes in energy balance. To examine the effects of AgRP inhibition on energy balance, a small molecule, non-peptide compound, TTP2515, developed by TransTech Pharma, Inc., was studied in vitro and in rodent models in vivo. TTP2515 prevented AgRP from antagonizing alpha-MSH-induced increases in cAMP in HEK 293 cells overexpressing the human MC4-R. When administered to rats by oral gavage TTP2515 blocked icv AgRP-induced increases in food intake, weight gain and adiposity and suppression of T4 levels. In both diet-induced obese (DIO) and leptin-deficient mice, TTP2515 decreased food intake, weight gain, adiposity and respiratory quotient. TTP2515 potently suppressed food intake and weight gain in lean mice immediately after initiation of a high fat diet (HFD) but had no effect on these parameters in lean chow-fed mice. However, when tested in AgRP KO mice, TTP2515 also suppressed food intake and weight gain during HFD feeding. In several studies TTP2515 increased T4 but not T3 levels, however this was also observed in AgRP KO mice. TTP2515 also attenuated refeeding and weight gain after fasting, an effect not evident in AgRP KO mice when administered at moderate doses. This study shows that TTP2515 exerts many effects consistent with AgRP inhibition however experiments in AgRP KO mice indicate some off-target effects of this drug. TTP2515 was particularly effective during fasting and in mice with leptin deficiency, conditions in which AgRP is elevated, as well as during acute and chronic HFD feeding. Thus the usefulness of this drug in treating obesity deserves further exploration, to define the AgRP dependent and independent mechanisms by which TTP2515 exerts its effects on energy balance.	[Dutia, Roxanne; Kim, Andrea J.; Modes, Matthew; Wardlaw, Sharon L.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Rothlein, Robert; Shen, Jane M.; Tian, Ye Edward; Ihbais, Jumana; Victory, Sam F.; Valcarce, Carmen] TransTech Pharma Inc, High Point, NC USA	Columbia University	Wardlaw, SL (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA.	sw22@columbia.edu			National Insitutes of Health [DK 080003]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, R01DK080003] Funding Source: NIH RePORTER	National Insitutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by National Insitutes of Health grant DK 080003 to SLW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boghossian S, 2010, AM J PHYSIOL-REG I, V298, pR385, DOI 10.1152/ajpregu.00591.2009; Breen TL, 2005, BRAIN RES, V1032, P141, DOI 10.1016/j.brainres.2004.11.008; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; Chai BX, 2003, PEPTIDES, V24, P603, DOI 10.1016/S0196-9781(03)00104-9; Clegg DJ, 2003, ENDOCRINOLOGY, V144, P2941, DOI 10.1210/en.2002-0218; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Fekete C, 2004, ENDOCRINOLOGY, V145, P4816, DOI 10.1210/en.2004-0476; Fekete C, 2002, ENDOCRINOLOGY, V143, P3846, DOI 10.1210/en.2002-220338; Goto K, 2003, INT J MOL MED, V12, P379; Graham M, 1997, NAT GENET, V17, P273, DOI 10.1038/ng1197-273; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Hadley ME, 2006, PEPTIDES, V27, P921, DOI 10.1016/j.peptides.2005.01.029; Haskell-Luevano C, 1999, ENDOCRINOLOGY, V140, P1408, DOI 10.1210/en.140.3.1408; JACOBOWITZ DM, 1978, P NATL ACAD SCI USA, V75, P6300, DOI 10.1073/pnas.75.12.6300; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Koegler FH, 1999, PHYSIOL BEHAV, V67, P809, DOI 10.1016/S0031-9384(99)00104-3; Korner J, 2001, J NEUROENDOCRINOL, V13, P959, DOI 10.1046/j.1365-2826.2001.00716.x; Korner J, 2003, J NEUROENDOCRINOL, V15, P1116, DOI 10.1111/j.1365-2826.2003.01113.x; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lee M, 2007, FRONT BIOSCI-LANDMRK, V12, P3994, DOI 10.2741/2366; Lee M, 2007, AM J PHYSIOL-ENDOC M, V293, pE121, DOI 10.1152/ajpendo.00555.2006; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Makimura H, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-18; McMinn JE, 2000, AM J PHYSIOL-REG I, V279, pR695, DOI 10.1152/ajpregu.2000.279.2.R695; Miltenberger RJ, 1997, J NUTR, V127, pS1902, DOI 10.1093/jn/127.9.1902S; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Mul JD, OBESITY SILVER SPRIN; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Palou M, 2009, CELL PHYSIOL BIOCHEM, V23, P115, DOI 10.1159/000204100; Pierroz DD, 2002, DIABETES, V51, P1337, DOI 10.2337/diabetes.51.5.1337; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Samama P, 2003, REGUL PEPTIDES, V113, P85, DOI 10.1016/S0167-0115(02)00299-9; Seeley RJ, 2005, ENDOCRINOLOGY, V146, P3732, DOI 10.1210/en.2004-1663; Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593; Small CJ, 2001, DIABETES, V50, P248, DOI 10.2337/diabetes.50.2.248; Srisai D, 2011, ENDOCRINOLOGY, V152, P890, DOI 10.1210/en.2010-0716; Swart I, 2002, AM J PHYSIOL-REG I, V283, pR1020, DOI 10.1152/ajpregu.00501.2001; Tolle V, 2008, DIABETES, V57, P86, DOI 10.2337/db07-0733; Tracy AL, 2008, PHARMACOL BIOCHEM BE, V89, P263, DOI 10.1016/j.pbb.2007.12.018; Wortley KE, 2005, CELL METAB, V2, P421, DOI 10.1016/j.cmet.2005.11.004; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Ziotopoulou M, 2000, AM J PHYSIOL-ENDOC M, V279, pE838, DOI 10.1152/ajpendo.2000.279.4.E838	42	10	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65317	10.1371/journal.pone.0065317	http://dx.doi.org/10.1371/journal.pone.0065317			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762342	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000054
J	Pollack, JB; Yoskowitz, D; Kim, HC; Montagna, PA				Pollack, Jennifer Beseres; Yoskowitz, David; Kim, Hae-Cheol; Montagna, Paul A.			Role and Value of Nitrogen Regulation Provided by Oysters (Crassostrea virginica) in the Mission-Aransas Estuary, Texas, USA	PLOS ONE			English	Article							NATURAL COASTAL WETLANDS; CHESAPEAKE BAY; WATER-QUALITY; RELATIVE VALUE; GALVESTON BAY; SOUTH TEXAS; REEFS; RESTORATION; POPULATIONS; PHOSPHORUS	Suspension-feeding activities of oysters impart a potentially significant benefit to estuarine ecosystems via reduction of water column nutrients, plankton and seston biomass, and primary productivity which can have a significant impact on human well-being. This study considered nitrogen regulation by eastern oysters Crassostrea virginica in the Mission-Aransas Estuary, Texas, USA, as a function of denitrification, burial, and physical transport from the system via harvest. Oyster reefs were estimated to remove 502.5 kg N km(-2) through denitrification of biodeposits and 251.3 kg N km(-2) in burial of biodeposits to sediments. Nitrogen is also physically transported out of the estuary via harvest of oysters. Commercial harvest of oysters in the Mission-Aransas Estuary can remove approximately 21,665 kg N per year via physical transport from the system. We developed a transferable method to value the service of nitrogen regulation by oysters, where the potential cost equivalent value of nitrogen regulation is quantified via cost estimates for a constructed biological nutrient removal (BNR) supplement to a wastewater treatment plant. The potential annual engineered cost equivalent of the service of nitrogen regulation and removal provided by reefs in the Mission-Aransas Estuary is $293,993 yr(-1). Monetizing ecosystem services can help increase awareness at the stakeholder level of the importance of oysters beyond commercial fishery values alone.	[Pollack, Jennifer Beseres] Texas A&M Univ, Dept Life Sci, Corpus Christi, TX USA; [Yoskowitz, David; Montagna, Paul A.] Texas A&M Univ, Harte Res Inst, Corpus Christi, TX USA; [Kim, Hae-Cheol] Natl Ocean Atmospher Adm, IM Syst Grp, Natl Ctr Environm Predict, College Pk, MD USA	Texas A&M University System; Texas A&M University System; National Oceanic Atmospheric Admin (NOAA) - USA	Pollack, JB (corresponding author), Texas A&M Univ, Dept Life Sci, Corpus Christi, TX USA.	jennifer.pollack@tamucc.edu	Montagna, Paul A./J-8208-2017	Montagna, Paul A./0000-0003-4199-3312	National Oceanic and Atmospheric Administration under the Comparative Assessment of Marine Ecosystem (CAMEO) program [NA09NMF4720179]; Texas General Land Office Coastal Management Program [12-142]; Texas A&M University-Corpus Christi; Harte Research Institute	National Oceanic and Atmospheric Administration under the Comparative Assessment of Marine Ecosystem (CAMEO) program; Texas General Land Office Coastal Management Program; Texas A&M University-Corpus Christi; Harte Research Institute	This study was partially supported by grant number NA09NMF4720179 from the National Oceanic and Atmospheric Administration under the Comparative Assessment of Marine Ecosystem (CAMEO) program, and by grant number 12-142 from the Texas General Land Office Coastal Management Program. Support was also provided by Texas A&M University-Corpus Christi and the Harte Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 3 INT C LIF CYCL MAN; Barbier EB, 2007, ECON POLICY, P178, DOI 10.1111/j.1468-0327.2007.00174.x; Bayne B.L., 1983, P407; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; BOYNTON WR, 1995, ESTUARIES, V18, P285, DOI 10.2307/1352640; BREAUX A, 1995, J ENVIRON MANAGE, V44, P285, DOI 10.1006/jema.1995.0046; Brumbaugh R. D., 2008, BASINS COASTS NEWS, V2, P8; Byers JE, 2006, TRENDS ECOL EVOL, V21, P493, DOI 10.1016/j.tree.2006.06.002; Bystrom O, 2000, ENVIRON RESOUR ECON, V16, P347, DOI 10.1023/A:1008316619355; Cerco CF, 2007, ESTUAR COAST, V30, P331, DOI 10.1007/BF02700175; Coen LD, 1998, AM FISH S S, V22, P438; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; Craig LS, 2008, FRONT ECOL ENVIRON, V6, P529, DOI 10.1890/070080; DAME RF, 1989, MAR ECOL PROG SER, V54, P249, DOI 10.3354/meps054249; DAME RF, 1972, MAR BIOL, V17, P243, DOI 10.1007/BF00366299; Dame RF, 1996, ECOLOGY MARINE BIVAL; DELIA CF, 1992, WATER SCI TECHNOL, V26, P2635, DOI 10.2166/wst.1992.0365; DENNISON WC, 1993, BIOSCIENCE, V43, P86, DOI 10.2307/1311969; Environmental Protection Agency Office of Water, 2007, EPA823R07002 OFF WAT; Finkbeiner M, 2009, ATLAS SHALLOW WATER; Gaillard F, 2007, J AM HIST, V94, P856, DOI 10.2307/25095148; Grabowski JH, 2007, THEOR ECOL SER, P281; Grizzle RE, 2008, ESTUAR COAST, V31, P1208, DOI 10.1007/s12237-008-9098-8; Gunawardena M, 2005, ENVIRON MANAGE, V36, P535, DOI 10.1007/s00267-003-0286-9; Hicks R, 2004, WORKING PAPERS DEP E; Higgins CB, 2011, J ENVIRON QUAL, V40, P271, DOI 10.2134/jeq2010.0203; Hyun KH, 2001, AQUACULTURE, V199, P41, DOI 10.1016/S0044-8486(01)00509-9; Isaacs J, 2004, VALUE LOUISIAN UNPUB; Kasperski S, 2009, MAR RESOUR ECON, V24, P361, DOI 10.1086/mre.24.4.42629662; Kreeger DA, 2001, J EXP MAR BIOL ECOL, V260, P71, DOI 10.1016/S0022-0981(01)00242-8; Lindahl O, 2005, AMBIO, V34, P131, DOI 10.1639/0044-7447(2005)034[0131:IMWQBM]2.0.CO;2; Lipton D, 2008, J SHELLFISH RES, V27, P619, DOI 10.2983/0730-8000(2008)27[619:EBOARO]2.0.CO;2; McCay DPF, 2003, MAR ECOL PROG SER, V264, P197; Nelson KA, 2004, J EXP MAR BIOL ECOL, V298, P347, DOI 10.1016/S0022-0981(03)00367-8; NEWELL RIE, 1983, MAR ECOL PROG SER, V13, P47, DOI 10.3354/meps013047; Newell RIE, 2005, NATO SCI S SS IV EAR, V47, P93; Newell RIE, 2004, J SHELLFISH RES, V23, P51; Newell RIE, 2002, LIMNOL OCEANOGR, V47, P1367, DOI 10.4319/lo.2002.47.5.1367; Newell RIE, 1988, UNDERSTANDING ESTUAR, P536; NOAA Fisheries, 2011, OFF SCI TECHN ANN CO; NRC National Research Council., 2000, CLEAN COAST WAT UND; Parsons T.R., 1984, BIOL OCEANOGRAPHIC P, V3rd; Peterson CH, 2003, MAR ECOL PROG SER, V264, P297, DOI 10.3354/meps264297; Piazza BP, 2005, RESTOR ECOL, V13, P499, DOI 10.1111/j.1526-100X.2005.00062.x; Piehler MF, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00082.1; Pollack JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040839; Pollack JB, 2011, ESTUAR COAST, V34, P187, DOI 10.1007/s12237-010-9338-6; POWELL EN, 1995, FISH RES, V24, P199, DOI 10.1016/0165-7836(95)00370-P; Robillard MMR, 2010, J SHELLFISH RES, V29, P291, DOI 10.2983/035.029.0203; ROMBERGER HP, 1981, AQUACULTURE, V25, P77, DOI 10.1016/0044-8486(81)90101-0; ROTHSCHILD BJ, 1994, MAR ECOL PROG SER, V111, P29, DOI 10.3354/meps111029; Scranton Sewer Authority, 2006, LONG TERM CONTR PLAN; SHABMAN LA, 1978, COAST ZONE MANAGE J, V4, P231, DOI 10.1080/08920757809361777; Shumway S. E., 2012, WORLD AQUACULT, V34, P15, DOI DOI 10.1097/TA.0b013e318270160d; Smith KA, 2009, ESTUAR COAST, V32, P748, DOI 10.1007/s12237-009-9170-z; Smyth AR, 2013, ESTUAR COAST, V36, P44, DOI 10.1007/s12237-012-9554-3; SONIAT TM, 1984, CONTRIB MAR SCI, V27, P127; Stunz GW, 2010, MAR ECOL PROG SER, V406, P147, DOI 10.3354/meps08556; THOMPSON SP, 1995, ESTUARIES, V18, P399, DOI 10.2307/1352322; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; WELLS HW, 1961, ECOL MONOGR, V31, P239, DOI 10.2307/1948554; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; WilsonOrmond EA, 1997, MAR ECOL-P S Z N I, V18, P1, DOI 10.1111/j.1439-0485.1997.tb00424.x; YOON WB, 1992, MAR ECOL PROG SER, V90, P157, DOI 10.3354/meps090157	64	56	59	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65314	10.1371/journal.pone.0065314	http://dx.doi.org/10.1371/journal.pone.0065314			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762341	Green Published, Green Submitted, gold			2022-12-25	WOS:000321099000053
J	Watanabe, S				Watanabe, Shigeru			Preference for and Discrimination of Paintings by Mice	PLOS ONE			English	Article							MUSIC	I measured preference for paintings (Renoir vs. Picasso or Kandinsky vs. Mondrian) in mice. In general mice did not display a painting preference except for two mice: one preferred Renoir to Picasso, and the other preferred Kandinsky to Mondrian. Thereafter, I examined discrimination of paintings with new mice. When exposure to paintings of one artist was associated with an injection of morphine (3.0 mg/kg), mice displayed conditioned preference for those paintings, showing discrimination of paintings by Renoir from those by Picasso, and paintings by Kandinsky from those by Mondrian after the conditioning. They also exhibited generalization of the preference to novel paintings of the artists. After conditioning with morphine for a set of paintings consisting of two artists, mice showed discrimination between two sets of paintings also from the two artists but not in association with morphine. These results suggest that mice can discriminate not only between an artist's style but also among paintings of the same artist. When mice were trained to discriminate a pair of paintings by Kandinsky and Renoir in an operant chamber equipped with a touch screen, they showed transfer of the discrimination to new pairs of the artists, but did not show transfer of discrimination of paintings by other artists, suggesting generalization.	Keio Univ, Dept Psychol, Minato Ku, Tokyo, Japan	Keio University	Watanabe, S (corresponding author), Keio Univ, Dept Psychol, Minato Ku, Mita 2-15-45, Tokyo, Japan.	swat@flet.keio.ac.jp			Global COE Program by JSPS (Japan) [D-19]	Global COE Program by JSPS (Japan)	This work was supported by Global COE Program (D-19) by JSPS (Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awaya F, 2003, NEUROREPORT, V14, P1511, DOI 10.1097/00001756-200308060-00022; BORLONGAN CV, 1994, PHARMACOL BIOCHEM BE, V48, P677, DOI 10.1016/0091-3057(94)90331-X; Hauser MD, 2003, NAT NEUROSCI, V6, P663, DOI 10.1038/nn1080; Humphrey N K, 1972, Perception, V1, P395, DOI 10.1068/p010395; Ikkatai Y, 2011, ANIM COGN, V14, P227, DOI 10.1007/s10071-010-0356-3; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Otsuka Y, 2009, BEHAV PROCESS, V80, P121, DOI 10.1016/j.beproc.2008.10.009; Pike AWG, 2012, SCIENCE, V336, P1409, DOI 10.1126/science.1219957; Rensch B., 1957, Zeitschrift fuer Tierpsychologie, V14, P71; Rensch B., 1958, Zeitschrift fuer Tierpsychologie, V15, P447; Shimozuka T, REINFORCING DI UNPUB; WATANABE S, 1995, J EXP ANAL BEHAV, V63, P165, DOI 10.1901/jeab.1995.63-165; Watanabe S, 1998, BEHAV PROCESS, V43, P211, DOI 10.1016/S0376-6357(98)00014-X; Watanabe S, 2001, Anim Cogn, V4, P147, DOI 10.1007/s100710100112; Watanabe S, 2009, PHILOSOPHY, V121, P1; Watanabe S, 2011, ANIM COGN, V14, P797, DOI 10.1007/s10071-011-0412-7; Watanabe S, 2010, ANIM COGN, V13, P75, DOI 10.1007/s10071-009-0246-8; Wilson FA, 1994, BEHAV	18	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65335	10.1371/journal.pone.0065335	http://dx.doi.org/10.1371/journal.pone.0065335			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762346	Green Published, gold, Green Submitted			2022-12-25	WOS:000321099000056
J	Pozzi, N; Chen, ZW; Gohara, DW; Niu, WL; Heyduk, T; Di Cera, E				Pozzi, Nicola; Chen, Zhiwei; Gohara, David W.; Niu, Weiling; Heyduk, Tomasz; Di Cera, Enrico			Crystal Structure of Prothrombin Reveals Conformational Flexibility and Mechanism of Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; COAGULATION FACTOR XA; FACTOR-VA; MOLECULAR-DYNAMICS; MEMBRANE-BINDING; PROEXOSITE I; THROMBIN; RECOGNITION; SUBSTRATE; DOMAIN	The zymogen prothrombin is composed of fragment 1 containing a Gla domain and kringle-1, fragment 2 containing kringle-2, and a protease domain containing A and B chains. The prothrombinase complex assembled on the surface of platelets converts prothrombin to thrombin by cleaving at Arg-271 and Arg-320. The three-dimensional architecture of prothrombin and the molecular basis of its activation remain elusive. Here we report the first x-ray crystal structure of prothrombin as a Gladomainless construct carrying an Ala replacement of the catalytic Ser-525. Prothrombin features a conformation 80 angstrom long, with fragment 1 positioned at a 36 degrees angle relative to the main axis of fragment 2 coaxial to the protease domain. High flexibility of the linker connecting the two kringles suggests multiple arrangements for kringle-1 relative to the rest of the prothrombin molecule. Luminescence resonance energy transfer measurements detect two distinct conformations of prothrombin in solution, in a 3:2 ratio, with the distance between the two kringles either fully extended (54 +/- 2 angstrom) or partially collapsed (<= 34 angstrom) as seen in the crystal structure. A molecular mechanism of prothrombin activation emerges from the structure. Of the two sites of cleavage, Arg-271 is located in a disordered region connecting kringle-2 to the A chain, but Arg-320 is well defined within the activation domain and is not accessible to proteolysis in solution. Burial of Arg-320 prevents prothrombin autoactivation and directs prothrombinase to cleave at Arg-271 first. Reversal of the local electrostatic potential then redirects prothrombinase toward Arg-320, leading to thrombin generation via the prethrombin-2 intermediate.	[Pozzi, Nicola; Chen, Zhiwei; Gohara, David W.; Niu, Weiling; Heyduk, Tomasz; Di Cera, Enrico] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu	Pozzi, Nicola/AAV-4876-2021; Pozzi, Nicola/AAE-4910-2020	Pozzi, Nicola/0000-0003-2309-7100; Gohara, David/0000-0001-8799-9125	National Institutes of Health [HL49413, HL73813, HL112303]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073813, R29HL049413, R01HL049413, U54HL112303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL49413, HL73813, and HL112303 (to E. D. C.).	Anderson PJ, 2000, J BIOL CHEM, V275, P16428, DOI 10.1074/jbc.M001254200; Anderson PJ, 2000, J BIOL CHEM, V275, P16435, DOI 10.1074/jbc.M001255200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; BODE W, 1992, PROTEIN SCI, V1, P426; Butenas S, 1999, BLOOD, V94, P2169, DOI 10.1182/blood.V94.7.2169.419k22_2169_2178; Case DA, 2012, AMBER 12; Chen L, 2003, J BIOL CHEM, V278, P27564, DOI 10.1074/jbc.M302707200; Chen Q, 1997, BIOCHEMISTRY-US, V36, P4701, DOI 10.1021/bi961441r; Chen ZW, 2010, P NATL ACAD SCI USA, V107, P19278, DOI 10.1073/pnas.1010262107; Cnudde SE, 2006, BIOCHEMISTRY-US, V45, P11052, DOI 10.1021/bi060914j; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Deguchi H, 1997, BIOCHEM J, V321, P729, DOI 10.1042/bj3210729; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; GUINTO ER, 1995, P NATL ACAD SCI USA, V92, P11185, DOI 10.1073/pnas.92.24.11185; Haynes LM, 2012, J BIOL CHEM, V287, P38647, DOI 10.1074/jbc.M112.407791; Heyduk E, 1997, ANAL BIOCHEM, V248, P216, DOI 10.1006/abio.1997.2148; Heyduk T, 2002, CURR OPIN BIOTECH, V13, P292, DOI 10.1016/S0958-1669(02)00332-4; Huang MD, 2003, NAT STRUCT BIOL, V10, P751, DOI 10.1038/nsb971; KOTKOW KJ, 1993, J BIOL CHEM, V268, P15633; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Lee CJ, 2011, J THROMB HAEMOST, V9, P2123, DOI 10.1111/j.1538-7836.2011.04463.x; Manithody C, 2002, BIOCHEMISTRY-US, V41, P6780, DOI 10.1021/bi0255367; Martin PD, 1997, STRUCTURE, V5, P1681, DOI 10.1016/S0969-2126(97)00314-6; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; NI F, 1993, J BIOL CHEM, V268, P16899; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozhogina OA, 2009, J STRUCT BIOL, V168, P223, DOI 10.1016/j.jsb.2009.06.003; Papaconstantinou ME, 2008, CELL MOL LIFE SCI, V65, P3688, DOI 10.1007/s00018-008-8502-7; Petrovan RJ, 1998, BIOCHEMISTRY-US, V37, P1185, DOI 10.1021/bi971948h; Pozzi N, 2013, J BIOL CHEM, V288, P11601, DOI 10.1074/jbc.M113.451542; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Pozzi N, 2011, BIOCHEMISTRY-US, V50, P10195, DOI 10.1021/bi2015019; ROSING J, 1980, J BIOL CHEM, V255, P274; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schmidt A., 1872, PFLU GER ARCH, V6, P413, DOI [10.1007/BF01612263, DOI 10.1007/BF01612263]; SELVIN PR, 1994, P NATL ACAD SCI USA, V91, P10024, DOI 10.1073/pnas.91.21.10024; SELVIN PR, 1994, J AM CHEM SOC, V116, P6029, DOI 10.1021/ja00092a088; SORIANOGARCIA M, 1992, BIOCHEMISTRY-US, V31, P2554, DOI 10.1021/bi00124a016; TANEDA H, 1994, J BIOCHEM-TOKYO, V116, P589, DOI 10.1093/oxfordjournals.jbchem.a124565; VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211; Wood JP, 2011, BLOOD, V117, P1710, DOI 10.1182/blood-2010-09-311035; Yegneswaran S, 2004, J BIOL CHEM, V279, P49019, DOI 10.1074/jbc.M406645200; Yegneswaran S, 2003, J BIOL CHEM, V278, P33312, DOI 10.1074/jbc.M305906200	48	31	32	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22734	22744		10.1074/jbc.M113.466946	http://dx.doi.org/10.1074/jbc.M113.466946			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23775088	hybrid, Green Published			2022-12-25	WOS:000330596300051
J	Borges, CS; Missassi, G; Pacini, ESA; Kiguti, LRA; Sanabria, M; Silva, RF; Banzato, TP; Perobelli, JE; Pupo, AS; Kempinas, WG				Borges, Cibele S.; Missassi, Gabriela; Pacini, Enio S. A.; Kiguti, Luiz Ricardo A.; Sanabria, Marciana; Silva, Raquel F.; Banzato, Thais P.; Perobelli, Juliana E.; Pupo, Andre S.; Kempinas, Wilma G.			Slimmer or Fertile? Pharmacological Mechanisms Involved in Reduced Sperm Quality and Fertility in Rats Exposed to the Anorexigen Sibutramine	PLOS ONE			English	Article							EPIDIDYMAL SPERM; VAS-DEFERENS; SYMPATHOMIMETIC DRUGS; TRANSIT-TIME; IN-VITRO; INNERVATION; CONTRACTILITY; NOREPINEPHRINE; ADRENOCEPTORS; PROSTATE	Sperm acquire motility and fertility capacity during epididymal transit, under the control of androgens and sympathetic innervations. It is already known that the acceleration of epididymal sperm transit time can lead to lower sperm quality. In a previous work we showed that rats exposed to the anorexigen sibutramine, a non-selective serotonin-norepinephrine reuptake inhibitor, presented faster sperm transit time, lower epididymal sperm reserves and potentiation of the tension of epididymal duct to norepinephrine exposed acutely in vitro to sibutramine. In the present work we aimed to further investigate pharmacological mechanisms involved in these alterations and the impact on rat sperm quality. For this, adult male Wistar rats were treated with sibutramine (10 mg/kg/day) or vehicle for 30 days. Sibutramine decreased final body, seminal vesicle, ventral prostate and epididymal weights, as well as sperm transit time in the epididymal cauda. On the contrary of the in vitro pharmacological assays, in which sibutramine was added directly to the bath containing strips of distal epididymal cauda, the ductal tension was not altered after in vivo sub-chronic exposure to sibutramine. However, there is pharmacological evidence that the endogenous epididymal norepinephrine reserves were reduced in these animals. It was also shown that the decrease in prostate weight can be related to increased tension developed of the gland, due to sibutramine sympathomimetic effects. In addition, our results showed reduced sperm quality after in utero artificial insemination, a more sensitive procedure to assess fertility in rodents. The epididymal norepinephrine depletion exerted by sibutramine, associated with decreases in sperm transit time, quantity and quality, leading to reduced fertility in this experimental model, reinforces the concerns about the possible impact on fertility of man taking sibutramine as well as other non-selective serotonin-norepinephrine reuptake inhibitors, especially considering the lower reproductive efficiency of humans compared to males of other species.	[Borges, Cibele S.; Missassi, Gabriela; Sanabria, Marciana; Silva, Raquel F.; Banzato, Thais P.; Perobelli, Juliana E.; Kempinas, Wilma G.] UNESP Univ Estadual Paulista, Inst Biosci, Dept Morphol, Botucatu, SP, Brazil; [Pacini, Enio S. A.; Kiguti, Luiz Ricardo A.; Pupo, Andre S.] UNESP Univ Estadual Paulista, Inst Biosci, Dept Pharmacol, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Kempinas, WG (corresponding author), UNESP Univ Estadual Paulista, Inst Biosci, Dept Morphol, Botucatu, SP, Brazil.	kempinas@ibb.unesp.br	Kiguti, Luiz Ricardo LRA/J-7645-2012; Pupo, Andre Sampaio/C-8578-2013; dos Santos Borges, Cibele/I-2145-2014; Kempinas, Wilma De GravaS/E-4671-2012; Missassi, Gabriela/C-3806-2016; Kiguti, Luiz Ricardo/J-8138-2015; Silva, Raquel/B-8442-2015; PEROBELLI, JULIANA ELAINE/D-5722-2012	dos Santos Borges, Cibele/0000-0003-3711-811X; Kempinas, Wilma De GravaS/0000-0002-2112-5123; Missassi, Gabriela/0000-0001-8686-144X; Silva, Raquel/0000-0002-1637-6075; PEROBELLI, JULIANA ELAINE/0000-0002-6797-2117; Kiguti, Luiz Ricardo de Almeida/0000-0002-7609-9313; Arakaki Pacini, Enio Setsuo/0000-0002-8166-1964	FAPESP - The State of Sao Paulo Research Foundation [2010/13948-4, 2011/11840-4]; CNPq National Council for Scientific and Technological Development [304958/2009-3]	FAPESP - The State of Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP - The State of Sao Paulo Research Foundation (Grant numbers 2010/13948-4 and 2011/11840-4) and CNPq National Council for Scientific and Technological Development (Grant number 304958/2009-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann R P, 1982, Fundam Appl Toxicol, V2, P13, DOI 10.1016/S0272-0590(82)80059-6; Araujo JR, 2012, CURR NEUROPHARMACOL, V10, P49, DOI 10.2174/157015912799362788; Bellentani FF, 2011, J ANDROL, V32, P718, DOI 10.2164/jandrol.111.013466; BILLUPS KL, 1990, J UROLOGY, V143, P625, DOI 10.1016/S0022-5347(17)40043-7; Choi JW, 2011, PROTEOMICS, V11, P1300, DOI 10.1002/pmic.201000664; Clegg E.D., 2001, PRINC METHODS TOXICO, V4, P1263; Kempinas WD, 2010, COMPREHENSIVE TOXICOLOGY, VOL 11: REPRODUCTIVE AND ENDOCRINE TOXICOLOGY, 2ND EDITION, P149; Fernandez CDB, 2008, INT J ANDROL, V31, P427, DOI 10.1111/j.1365-2605.2007.00788.x; Filler R., 1993, MALE REPROD TOXICOLO, P334, DOI DOI 10.1016/B978-0-12-461207-5.50025-0; Garcia PV, 2012, FERTIL STERIL, V97, P1444, DOI 10.1016/j.fertnstert.2012.03.025; Gerendai I, 2001, AUTON NEUROSCI-BASIC, V92, P1, DOI 10.1016/S1566-0702(01)00292-2; Glandt M, 2011, J OBES, V2011, DOI 10.1155/2011/636181; Haynes WG, 2005, CLIN AUTON RES, V15, P189, DOI 10.1007/s10286-005-0287-2; Jackson HC, 1997, BRIT J PHARMACOL, V121, P1613, DOI 10.1038/sj.bjp.0701311; Janhunen SK, 2011, OBESITY, V19, P1979, DOI 10.1038/oby.2011.51; Jurkiewicz NH, 2012, EUR J PHARMACOL, V691, P52, DOI 10.1016/j.ejphar.2012.07.027; JURKIEWICZ NH, 1992, BRIT J PHARMACOL, V107, P610, DOI 10.1111/j.1476-5381.1992.tb12791.x; KASUYA Y, 1968, EUR J PHARMACOL, V4, P355, DOI 10.1016/0014-2999(68)90019-8; KEMPINAS MG, 1995, ANDROLOGIA, V27, P121; Kempinas WD, 1998, BIOL REPROD, V59, P897, DOI 10.1095/biolreprod59.4.897; Kempinas WD, 1998, BIOL REPROD, V59, P890, DOI 10.1095/biolreprod59.4.890; KENAKIN T, 1997, PHARM ANAL DRUG RECE, P331; Kim SE, 2007, J PHARMACOL EXP THER, V321, P753, DOI 10.1124/jpet.106.117747; KLINEFELTER GR, 1994, J ANDROL, V15, P318; Klinfelter G., 2002, EPIDIDYMIS MOL CLIN, P353; Kontani H, 2002, JPN J PHARMACOL, V90, P281, DOI 10.1254/jjp.90.281; LANGELOH A, 1987, N-S ARCH PHARMACOL, V336, P602, DOI 10.1007/BF00165750; LANGELOH A, 1987, N-S ARCH PHARMACOL, V336, P611, DOI 10.1007/BF00165751; Mangelsdorf I, 2003, REGUL TOXICOL PHARM, V37, P356, DOI 10.1016/S0273-2300(03)00026-6; Nisoli E, 2000, Obes Rev, V1, P127, DOI 10.1046/j.1467-789x.2000.00020.x; Nojimoto FD, 2009, TOXICOL APPL PHARM, V239, P233, DOI 10.1016/j.taap.2009.05.021; Pennefather JN, 2000, J AUTON PHARMACOL, V20, P193, DOI 10.1046/j.1365-2680.2000.00195.x; PHOLPRAMOOL C, 1984, J REPROD FERTIL, V71, P181; RATNASOORIYA WD, 1979, J REPROD FERTIL, V56, P633; RATNASOORIYA WD, 1980, J REPROD FERTIL, V58, P19; RATNASOORIYA WD, 1979, J REPROD FERTIL, V56, P643; Ricker DD, 1998, J ANDROL, V19, P1; Robaire B, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1071; ROBB GW, 1978, J REPROD FERTIL, V54, P103, DOI 10.1530/jrf.0.0540103; Rodrigues Alexandre Oliveira, 2002, Rev. Hosp. Clin., V57, P287, DOI 10.1590/S0041-87812002000600008; Scheen AJ, 2011, DIABETES CARE, V34, pS114, DOI 10.2337/dc11-s205; Seed J, 1996, REPROD TOXICOL, V10, P237, DOI 10.1016/0890-6238(96)00028-7; Sobey CG, 2001, ARTERIOSCL THROM VAS, V21, P28, DOI 10.1161/01.ATV.21.1.28; SPEDDING M, 1992, PHARMACOL REV, V44, P363; SUJARIT S, 1985, J REPROD FERTIL, V74, P497, DOI 10.1530/jrf.0.0740497; TRENDELENBURG U, 1970, J PHARMACOL EXP THER, V172, P91; VAALASTI A, 1979, AM J ANAT, V154, P231, DOI 10.1002/aja.1001540208; VENTURA S, 1991, BRIT J PHARMACOL, V102, P540, DOI 10.1111/j.1476-5381.1991.tb12207.x; WANG JM, 1991, BIOL REPROD, V44, P1171, DOI 10.1095/biolreprod44.6.1171; Zhou YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039062	50	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66091	10.1371/journal.pone.0066091	http://dx.doi.org/10.1371/journal.pone.0066091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776614	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400080
J	Li, DK; Miao, MH; Zhou, ZH; Wu, CH; Shi, HJ; Liu, XQ; Wang, SQ; Yuan, W				Li, De-Kun; Miao, Maohua; Zhou, ZhiJun; Wu, Chunhua; Shi, Huijing; Liu, Xiaoqin; Wang, Siqi; Yuan, Wei			Urine Bisphenol-A Level in Relation to Obesity and Overweight in School-Age Children	PLOS ONE			English	Article							IN-UTERO EXPOSURE; ENDOCRINE DISRUPTORS; OCCUPATIONAL-EXPOSURE; PHTHALATE METABOLITES; TEMPORAL VARIABILITY; US POPULATION; GIRLS; ADOLESCENTS; EPIDEMIC; PUBERTY	Bisphenol-A (BPA) is a potential endocrine disruptor impacting metabolic processes and increasing the risk of obesity. To determine whether urine BPA level is associated with overweight/obesity in school-age children, we examined 1,326 students in grades 4-12 from three schools (one elementary, one middle, and one high school) in Shanghai. More than 98% of eligible students participated. Total urine BPA concentration was measured and anthropometric measures were taken by trained research staff. Information on risk factors for childhood obesity was collected for potential confounders. Age-and gender-specific weight greater than 90th percentile of the underlying population was the outcome measure. After adjustment for potential confounders, a higher urine BPA level (>= 2 mu g/L), at the level corresponding to the median urine BPA level in the U.S. population, was associated with more than two-fold increased risk of having weight >90th percentile among girls aged 9-12 (adjusted odds ratio (aOR) = 2.32, 95% confidence interval: 1.15-4.65). The association showed a dose-response relationship with increasing urine BPA level associated with further increased risk of overweight (p = 0.006 for trend test). Other anthropometric measures of obesity showed similar results. The same association was not observed among boys. This gender difference of BPA effect was consistent with findings from experimental studies and previous epidemiological studies. Our study suggests that BPA could be a potential new environmental obesogen. Widespread exposure to BPA in the human population may also be contributing to the worldwide obesity epidemic.	[Li, De-Kun] Kaiser Permanente, Kaiser Fdn Res Inst, Div Res, Oakland, CA 94612 USA; [Li, De-Kun] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA USA; [Miao, Maohua; Liu, Xiaoqin; Wang, Siqi; Yuan, Wei] Collaborating Ctr Res Human Reprod, Dept Epidemiol & Social Sci Reprod Hlth, Shanghai Inst Planned Parenthood Res, Shanghai, Peoples R China; [Miao, Maohua; Liu, Xiaoqin; Wang, Siqi; Yuan, Wei] Collaborating Ctr Res Human Reprod, World Hlth Org, Shanghai, Peoples R China; [Zhou, ZhiJun; Wu, Chunhua] Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Shanghai, Peoples R China; [Zhou, ZhiJun; Wu, Chunhua] Fudan Univ, WHO Collaborating Ctr Occupat Hlth, Shanghai, Peoples R China; [Shi, Huijing] Fudan Univ, Dept Child & Adolescent Hlth, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Yuan, Wei] Natl Populat & Family Planning Key Lab Contracept, Shanghai, Peoples R China	Kaiser Permanente; Stanford University; World Health Organization; Fudan University; Fudan University; Fudan University	Li, DK (corresponding author), Kaiser Permanente, Kaiser Fdn Res Inst, Div Res, Oakland, CA 94612 USA.	dkl@dor.kaiser.org	Zhou, Zhiju/D-1616-2019; Shi, Huijing/GRR-8564-2022	Zhou, Zhiju/0000-0002-2407-2071; 	National Natural Science Foundation of China [81172684]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was funded in part by National Natural Science Foundation of China(#81172684). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Ben-Jonathan N, 2009, MOL CELL ENDOCRINOL, V304, P49, DOI 10.1016/j.mce.2009.02.022; Biro FM, 2001, J PEDIATR-US, V138, P636, DOI 10.1067/mpd.2001.114476; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Carwile JL, 2011, ENVIRON RES, V111, P825, DOI 10.1016/j.envres.2011.05.014; Chen CM, 2008, OBES REV, V9, P14, DOI 10.1111/j.1467-789X.2007.00433.x; Dodds EC, 1938, PROC R SOC SER B-BIO, V125, P222, DOI 10.1098/rspb.1938.0023; Dubois L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030153; Galloway T, 2010, ENVIRON HEALTH PERSP, V118, P1603, DOI 10.1289/ehp.1002367; Golub MS, 2010, BIRTH DEFECTS RES B, V89, P441, DOI 10.1002/bdrb.20275; He YH, 2009, J OCCUP HEALTH, V51, P432, DOI 10.1539/joh.O9006; He YH, 2009, ENVIRON RES, V109, P629, DOI 10.1016/j.envres.2009.04.003; Heindel JJ, 2009, MOL CELL ENDOCRINOL, V304, P90, DOI 10.1016/j.mce.2009.02.025; Heindel JJ, 2003, TOXICOL SCI, V76, P247, DOI 10.1093/toxsci/kfg255; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Hsu-Hage BH-H, 1992, ASIA PACIFIC J CLIN, P211; Hugo ER, 2008, ENVIRON HEALTH PERSP, V116, P1642, DOI 10.1289/ehp.11537; Jiang Y, 2007, SHANGHAI J PREVEN ME, V19, P544; Kidani T, 2010, J ATHEROSCLER THROMB, V17, P834, DOI 10.5551/jat.4051; Kim YH, 2003, BIOCHEM BIOPH RES CO, V312, P441, DOI 10.1016/j.bbrc.2003.10.135; Kosti Rena I., 2006, Central European Journal of Public Health, V14, P151; Kovacs M., 1992, CHILDRENS DEPRESSION; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Li D, 2010, HUM REPROD, V25, P519, DOI 10.1093/humrep/dep381; Li DK, 2011, FERTIL STERIL, V95, P625, DOI 10.1016/j.fertnstert.2010.09.026; Li DK, 2010, J ANDROL, V31, P500, DOI 10.2164/jandrol.110.010413; Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605; MartiHenneberg C, 1997, J PEDIATR-US, V131, P618, DOI 10.1016/S0022-3476(97)70073-8; Matsumoto A, 2003, ENVIRON HEALTH PERSP, V111, P101, DOI 10.1289/ehp.5512; Miao MH, 2011, BIRTH DEFECTS RES A, V91, P867, DOI 10.1002/bdra.22845; Miao MH, 2011, REPROD TOXICOL, V32, P64, DOI 10.1016/j.reprotox.2011.03.002; Miyamoto Ken-ichi, 2006, Environmental Sciences, V13, P15; National Toxicology Program USDOHAHS, 2008, NTP CERHR MON POT HU, V08-5994; Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x; Newbold RR, 2007, REPROD TOXICOL, V23, P290, DOI 10.1016/j.reprotox.2006.12.010; Newbold RR, 2010, HORM-INT J ENDOCRINO, V9, P206, DOI 10.14310/horm.2002.1271; Newbold RR, 2009, MOL CELL ENDOCRINOL, V304, P84, DOI 10.1016/j.mce.2009.02.024; Pantsiotou S, 2008, ACTA PAEDIATR, V97, P217, DOI 10.1111/j.1651-2227.2007.00598.x; Papadimitriou A, 2008, J CLIN ENDOCR METAB, V93, P4422, DOI 10.1210/jc.2008-0661; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Rubin BS, 2009, MOL CELL ENDOCRINOL, V304, P55, DOI 10.1016/j.mce.2009.02.023; Rubin BS, 2001, ENVIRON HEALTH PERSP, V109, P675, DOI 10.2307/3454783; Shan XY, 2010, INT J PEDIATR OBES, V5, P383, DOI 10.3109/17477160903572001; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; Somm E, 2009, ENVIRON HEALTH PERSP, V117, P1549, DOI 10.1289/ehp.11342; Sun Y, 2012, J ADOLESCENT HEALTH, V51, P279, DOI 10.1016/j.jadohealth.2011.12.019; Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010; Trasande L, 2012, JAMA-J AM MED ASSOC, V308, P1113, DOI 10.1001/2012.jama.11461; Wang TG, 2012, J CLIN ENDOCR METAB, V97, pE223, DOI 10.1210/jc.2011-1989; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Ye XY, 2011, ENVIRON HEALTH PERSP, V119, P983, DOI 10.1289/ehp.1002701	51	59	61	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65399	10.1371/journal.pone.0065399	http://dx.doi.org/10.1371/journal.pone.0065399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776476	Green Submitted, Green Published, gold			2022-12-25	WOS:000320322400021
J	Ye, HY; Zhang, HJ; Xu, AM; Hoo, RLC				Ye, Hongying; Zhang, Herbert J.; Xu, Aimin; Hoo, Ruby L. C.			Resistin Production from Adipose Tissue Is Decreased in db/db Obese Mice, and Is Reversed by Rosiglitazone	PLOS ONE			English	Article							INSULIN-RESISTANCE; ADIPONECTIN; ADIPOKINES; ADIPOCYTOKINES; INFLAMMATION; SENSITIVITY; EXPRESSION; DISEASE; HUMANS	Objective: This study was designed to (1) investigate the expression profiles of resistin in db/db mice and its dynamic association with metabolic parameters; and (2) evaluate the effects of Rosiglitazone on production of resistin. Methods: Db/db mice and their lean litter mates were used for this study. Epididymal fat tissue was excised from mice of different age (from 5 to 12 weeks) for ex vivo incubation. Resistin, along with adiponectin, in serum and conditioned culture medium of epididymal fat pads were measured with immunoassays. The gene expression of resistin was determined by real-time PCR. Rosiglitazone or the vehicle (PBS) was administered into db/db mice by daily intra-gastric gavage. Differentiated 3T3-L1 adipocytes were used for in vitro evaluation. Results: The secretion of resistin from the fat pads in db/db mice was significantly lower than that in lean mice (P<0.01). The mRNA expression of the resistin gene in fat tissue of db/db mice at the age of 5 weeks was decreased by 60.5% compared to lean controls (p<0.05). Serum levels of resistin were comparable between the obese and lean groups, perhaps due to the increased total fat mass in db/db mice. Correlation analysis showed that serum resistin levels were positively correlated to resistin secretion from fat pads(r = 0.844, P = 0.000), while negatively associated with the body weight (r = 20.515, P = 0.000) and fasting glucose level (r = -0.357, P = 0.002). Notably, treatment with rosiglitazone increased the serum resistin levels by 66.4%(P<0.05) in db/db mice. In 3T3-L1 adipocytes, Rosiglitazone (10 uM) markedly enhanced the secretion of resistin by 120% (P<0.01) and its gene expression by 78.1% (P<0.05). Conclusion: Both resistin gene expression and its secretion from the epididymal adipose tissue were decreased in db/db obese mice, while the insulin-sensitizing drug rosiglitazone increased resistin production. Our results do not support the role of resistin as an etiological link between obesity and diabetes.	[Ye, Hongying; Zhang, Herbert J.; Xu, Aimin; Hoo, Ruby L. C.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Ye, Hongying; Zhang, Herbert J.; Xu, Aimin; Hoo, Ruby L. C.] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China; [Ye, Hongying] Fudan Univ, Huashan Hosp, Dept Endocrinol, Shanghai 200433, Peoples R China	University of Hong Kong; University of Hong Kong; Fudan University	Hoo, RLC (corresponding author), Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China.	rubyhoo@hkucc.hku.hk			Chinese State Natural Science Funds [30600300]	Chinese State Natural Science Funds	This work was partly supported by Chinese State Natural Science Funds (Grant No: 30600300). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antuna-Puente B, 2008, DIABETES METAB, V34, P2, DOI 10.1016/j.diabet.2007.09.004; Barnes KM, 2009, CURR PROTEIN PEPT SC, V10, P96, DOI 10.2174/138920309787315239; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Haluzik MM, 2006, ENDOCRINOLOGY, V147, P4517, DOI 10.1210/en.2005-1624; Haugen F, 2001, FEBS LETT, V507, P105, DOI 10.1016/S0014-5793(01)02968-4; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Janowska J, 2006, METABOLISM, V55, P1495, DOI 10.1016/j.metabol.2006.06.020; Kusminski CM, 2005, CLIN SCI, V109, P243, DOI 10.1042/CS20050078; Leal VD, 2013, CLIN CHIM ACTA, V419, P87, DOI 10.1016/j.cca.2013.02.003; Liu Ge-li, 2006, Zhonghua Er Ke Za Zhi, V44, P114; Moore GBT, 2001, BIOCHEM BIOPH RES CO, V286, P735, DOI 10.1006/bbrc.2001.5460; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pfutzner Andreas, 2003, Clin Lab, V49, P571; Pittas AG, 2004, J CLIN ENDOCR METAB, V89, P447, DOI 10.1210/jc.2003-031005; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Wasim H, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-10; Way JM, 2001, J BIOL CHEM, V276, P25651, DOI 10.1074/jbc.C100189200; Xu AM, 2004, ENDOCRINOLOGY, V145, P487, DOI 10.1210/en.2003-1140; Xu AM, 2005, J BIOL CHEM, V280, P18073, DOI 10.1074/jbc.M414231200; Yaturu S, 2006, CYTOKINE, V34, P219, DOI 10.1016/j.cyto.2006.05.005; Zou CH, 2008, J NUTR BIOCHEM, V19, P277, DOI 10.1016/j.jnutbio.2007.06.006	21	13	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65543	10.1371/journal.pone.0065543	http://dx.doi.org/10.1371/journal.pone.0065543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776497	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400032
J	Blix, E; Perski, A; Berglund, H; Savic, I				Blix, Eva; Perski, Aleksander; Berglund, Hans; Savic, Ivanka			Long-Term Occupational Stress Is Associated with Regional Reductions in Brain Tissue Volumes	PLOS ONE			English	Article							SMALLER HIPPOCAMPAL VOLUME; MEDIAL PREFRONTAL CORTEX; GRAY-MATTER VOLUME; ANTERIOR CINGULATE; SENSITIVE PERIODS; CHRONIC BURNOUT; SURVIVORS; VULNERABILITY; DISORDER; MRI	There are increasing reports of cognitive and psychological declines related to occupational stress in subjects without psychiatric premorbidity or major life trauma. The underlying neurobiology is unknown, and many question the notion that the described disabilities represent a medical condition. Using PET we recently found that persons suffering from chronic occupational stress had limbic reductions in the 5-HT1A receptor binding potential. Here we examine whether chronic work-related stress is also associated with changes in brain structure. We performed MRI-based voxel-based morphometry and structural volumetry in stressed subjects and unstressed controls focusing on gray (GM) and white matter (WM) volumes, and the volumes of hippocampus, caudate, and putamen - structures known to be susceptible to neurotoxic changes. Stressed subjects exhibited significant reductions in the GM volumes of the anterior cingulate cortex and the dorsolateral prefrontal cortex. Furthermore, their caudate and putamen volumes were reduced, and the volumes correlated inversely to the degree of perceived stress. Our results add to previous data on chronic psychosocial stress, and indicate a morphological involvement of the frontostriatal circuits. The present findings of morphological changes in these regions confirm our previous conclusion that symptoms from occupational stress merit careful investigations and targeted treatment.	[Blix, Eva; Berglund, Hans; Savic, Ivanka] Karolinska Inst, Stockholm Brain Inst, Dept Womens & Childrens Hlth, Div Pediat Neurol, Stockholm, Sweden; [Perski, Aleksander] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm University	Savic, I (corresponding author), Karolinska Inst, Stockholm Brain Inst, Dept Womens & Childrens Hlth, Div Pediat Neurol, Stockholm, Sweden.	ivanka.savic-berglund@ki.se			Swedish Council for Working Life and Social Research (FAS); Swedish Research Council; AFA Insurance; Stockholm City Council; Centre for Gender Related Medicine, Karolinska Institute	Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission); AFA Insurance; Stockholm City Council; Centre for Gender Related Medicine, Karolinska Institute	The study was supported by the Swedish Council for Working Life and Social Research (FAS), Swedish Research Council, AFA Insurance, Stockholm City Council, as well as the Centre for Gender Related Medicine, Karolinska Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola K, 2006, SOC PSYCH PSYCH EPID, V41, P11, DOI 10.1007/s00127-005-0011-5; Andersen SL, 2008, J NEUROPSYCH CLIN N, V20, P292, DOI 10.1176/appi.neuropsych.20.3.292; Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Asberg Marie, 2010, Lakartidningen, V107, P1307; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baker LM, 2012, BRAIN IMAGING BEHAV; Bernal F, 2000, EXP NEUROL, V161, P686, DOI 10.1006/exnr.1999.7293; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Bremner JD, 2007, NEUROIMAG CLIN N AM, V17, P523, DOI 10.1016/j.nic.2007.07.003; Bremner JD, 2007, PROG BRAIN RES, V167, P171, DOI 10.1016/S0079-6123(07)67012-5; Brown ES, 2010, J AFFECT DISORDERS, V126, P415, DOI 10.1016/j.jad.2010.04.010; Brown SM, 2005, CEREB CORTEX, V15, P1714, DOI 10.1093/cercor/bhi048; Chen L, 2011, HUM BRAIN MAPP; CHEN Q, 1995, EXP NEUROL, V136, P212, DOI 10.1006/exnr.1995.1098; Chen SL, 2006, PSYCHIAT RES-NEUROIM, V146, P65, DOI 10.1016/j.pscychresns.2005.09.006; Chida Y, 2009, BIOL PSYCHOL, V80, P265, DOI 10.1016/j.biopsycho.2008.10.004; Ciumas C, 2006, NEUROLOGY, V67, P683, DOI 10.1212/01.wnl.0000230171.23913.cf; Ciumas C, 2010, NEUROIMAGE, V51, P606, DOI 10.1016/j.neuroimage.2010.02.051; Cohen RA, 2006, BIOL PSYCHIAT, V59, P975, DOI 10.1016/j.biopsych.2005.12.016; Colberg C, 2004, NEUROSCI LETT, V364, P130, DOI 10.1016/j.neulet.2004.04.052; Conrad CD, 1999, BEHAV NEUROSCI, V113, P902, DOI 10.1037/0735-7044.113.5.902; Conrad CD, 2008, REV NEUROSCIENCE, V19, P395; Copertaro A, 2010, MED LAV, V101, P427; Copertaro A, 2007, G Ital Med Lav Ergon, V29, P350; Critchley HD, 2009, INT J PSYCHOPHYSIOL, V73, P88, DOI 10.1016/j.ijpsycho.2009.01.012; Dedovic K, 2009, BRAIN RES, V1293, P49, DOI 10.1016/j.brainres.2009.06.044; Fernandez Torres B, 2006, Rev Esp Anestesiol Reanim, V53, P359; Filipovic BR, 2011, CENT EUR NEUROSURG, V72, P133, DOI 10.1055/s-0030-1253349; FLUGGE G, 1995, J NEUROSCI, V15, P7132; Fries E, 2009, INT J PSYCHOPHYSIOL, V72, P67, DOI 10.1016/j.ijpsycho.2008.03.014; Friess E, 2008, J PSYCHIATR RES, V42, P1154, DOI 10.1016/j.jpsychires.2008.01.005; Geuze E, 2008, NEUROIMAGE, V41, P675, DOI 10.1016/j.neuroimage.2008.03.007; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Goldstein JM, 2010, J NEUROSCI, V30, P431, DOI 10.1523/JNEUROSCI.3021-09.2010; Grossi G, 2005, J PSYCHOSOM RES, V59, P103, DOI 10.1016/j.jpsychores.2005.02.009; Grossi G, 2003, J PSYCHOSOM RES, V55, P309, DOI 10.1016/S0022-3999(02)00633-5; Helms G, 2006, J NEUROL NEUROSUR PS, V77, P489, DOI 10.1136/jnnp.2005.074682; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hunter RG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004328; Iijima M, 2007, PSYCHOPHARMACOLOGY, V190, P233, DOI 10.1007/s00213-006-0618-6; Isovich E, 2000, EUR J NEUROSCI, V12, P1071, DOI 10.1046/j.1460-9568.2000.00969.x; Jovanovic H, 2011, NEUROIMAGE, V55, P1178, DOI 10.1016/j.neuroimage.2010.12.060; Jovanovic H, 2006, PSYCHIAT RES-NEUROIM, V148, P185, DOI 10.1016/j.pscychresns.2006.05.002; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Langelaan S, 2007, INT J BEHAV MED, V14, P213, DOI 10.1007/BF03002995; Leuner B., 2012, NEUROSCIENCE; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; LOWY MT, 1993, J NEUROCHEM, V61, P1957, DOI 10.1111/j.1471-4159.1993.tb09839.x; Lyoo IK, 2011, ARCH GEN PSYCHIAT, V68, P701, DOI 10.1001/archgenpsychiatry.2011.70; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; Martin KP, 2011, CEREB CORTEX, V21, P2366, DOI 10.1093/cercor/bhr021; Matsuoka Y, 2003, BIOL PSYCHIAT, V54, P736, DOI 10.1016/S0006-3223(02)01907-8; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; McEwen BS, 2000, PROG BRAIN RES, V122, P25; McEwen BS, 1997, EUR NEUROPSYCHOPHARM, V7, P323, DOI 10.1016/S0924-977X(97)00064-3; Melamed S, 1999, J PSYCHOSOM RES, V46, P591, DOI 10.1016/S0022-3999(99)00007-0; Moch SL, 2003, ENDOCRINE, V21, P267, DOI 10.1385/ENDO:21:3:267; Mommersteeg PMC, 2006, HEALTH PSYCHOL, V25, P243, DOI 10.1037/0278-6133.25.2.243; Mommersteeg PMC, 2006, PSYCHONEUROENDOCRINO, V31, P216, DOI 10.1016/j.psyneuen.2005.07.003; MONTGOMERY S, 1978, ACTA PSYCHIAT SCAND, P33; Nardo D, 2010, J PSYCHIATR RES, V44, P477, DOI 10.1016/j.jpsychires.2009.10.014; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papagni SA, 2011, STRESS, V14, P227, DOI 10.3109/10253890.2010.522279; Pavlisa G, 2006, COLLEGIUM ANTROPOL, V30, P565; Pruessner JC, 1999, PSYCHOSOM MED, V61, P197, DOI 10.1097/00006842-199903000-00012; Qin SZ, 2009, BIOL PSYCHIAT, V66, P25, DOI 10.1016/j.biopsych.2009.03.006; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Rogers MA, 2009, PSYCHIAT RES-NEUROIM, V174, P210, DOI 10.1016/j.pscychresns.2009.06.001; Roozendaal B, 2004, J NEUROSCI, V24, P1385, DOI 10.1523/JNEUROSCI.4664-03.2004; Rydrnark I, 2006, BIOL PSYCHIAT, V60, P867, DOI 10.1016/j.biopsych.2006.04.029; Sandstrom A, 2005, BIOL PSYCHOL, V69, P271, DOI 10.1016/j.biopsycho.2004.08.003; Savic I, 2008, P NATL ACAD SCI USA, V105, P9403, DOI 10.1073/pnas.0801566105; SCHAUFELI WB, 1995, PSYCHOL REP, V76, P1083, DOI 10.2466/pr0.1995.76.3c.1083; Sheu YS, 2010, NEUROIMAGE, V53, P412, DOI 10.1016/j.neuroimage.2010.06.043; Siemiatkowski M, 2000, NEUROREPORT, V11, P3953; Sinha R, 2004, ANN NY ACAD SCI, V1032, P254, DOI 10.1196/annals.1314.032; Stenlund T, 2007, SCAND J PUBLIC HEALT, V35, P516, DOI 10.1080/14034940701271874; Thomaes K, 2010, J CLIN PSYCHIAT, V71, P1636, DOI 10.4088/JCP.08m04754blu; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; van Harmelen AL, 2010, BIOL PSYCHIAT, V68, P832, DOI 10.1016/j.biopsych.2010.06.011; Villarreal G, 2002, BIOL PSYCHIAT, V52, P119, DOI 10.1016/S0006-3223(02)01359-8; Wahlberg K, 2009, BIOL PSYCHIAT, V65, P742, DOI 10.1016/j.biopsych.2008.10.035; Wang JJ, 2007, SOC COGN AFFECT NEUR, V2, P227, DOI 10.1093/scan/nsm018; Wang JJ, 2005, P NATL ACAD SCI USA, V102, P17804, DOI 10.1073/pnas.0503082102; WATSON C, 1992, NEUROLOGY, V42, P1743, DOI 10.1212/WNL.42.9.1743; Wignall EL, 2004, BIOL PSYCHIAT, V56, P832, DOI 10.1016/j.biopsych.2004.09.015; Wong EYH, 2004, EUR J NEUROSCI, V20, P2491, DOI 10.1111/j.1460-9568.2004.03717.x; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Zhang J, 2011, PSYCHIAT RES-NEUROIM, V192, P84, DOI 10.1016/j.pscychresns.2010.09.001	92	70	71	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e64065	10.1371/journal.pone.0064065	http://dx.doi.org/10.1371/journal.pone.0064065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	169CU	23776438	Green Submitted, gold, Green Published			2022-12-25	WOS:000320755400007
J	Pitner, MKH; Saavedra, HI				Pitner, Mary Kathryn Harrison; Saavedra, Harold I.			Cdk4 and Nek2 Signal Binucleation and Centrosome Amplification in a Her2+Breast Cancer Model	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; BREAST-CANCER; CHROMOSOME INSTABILITY; CYCLIN D1; CYTOKINESIS FAILURE; P53-NULL CELLS; PROTEIN-KINASE; DUPLICATION; TUMORIGENESIS; ANEUPLOIDY	Centrosome amplification (CA) is a contributor to carcinogenesis, generating aneuploidy, and chromosome instability. Previous work shows that breast adenocarcinomas have a higher frequency of centrosome defects compared to normal breast tissues. Abnormal centrosome phenotypes are found in pre-malignant lesions, suggesting an early role in breast carcinogenesis. However, the role of CA in breast cancers remains elusive. Identification of pathways and regulatory molecules involved in the generation of CA is essential to understanding its role in breast tumorigenesis. We established a breast cancer model of CA using Her2-positive cells. Our goal was to identify centrosome cycle molecules that are deregulated by aberrant Her2 signaling and the mechanisms driving CA. Our results show some Her2+ breast cancer cell lines harbor both CA and binucleation. Abolishing the expression of Cdk4 abrogated both CA and binucleation in these cells. We also found the source of binucleation in these cells to be defective cytokinesis that is normalized by downregulation of Cdk4. Protein levels of Nek2 diminish upon Cdk4 knockdown and vice versa, suggesting a molecular connection between Cdk4 and Nek2. Knockdown of Nek2 reduces CA and binucleation in this model while its overexpression further enhances centrosome amplification. We conclude that CA is modulated through Cdk4 and Nek2 signaling and that binucleation is a likely source of CA in Her2+ breast cancer cells.	[Pitner, Mary Kathryn Harrison; Saavedra, Harold I.] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA	Emory University	Saavedra, HI (corresponding author), Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA.	hsaaved@emory.edu			National Institutes of Health [R01 CA151521]; Georgia Cancer Coalition; Emory University Integrated Cellular Imaging Microscopy Core of the Winship Cancer Institute comprehensive cancer center grant [P30CA138292]; NATIONAL CANCER INSTITUTE [R01CA151521, P30CA138292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition; Emory University Integrated Cellular Imaging Microscopy Core of the Winship Cancer Institute comprehensive cancer center grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research project was supported by R01 CA151521 from the National Institutes of Health, the Georgia Cancer Coalition, and by the Emory University Integrated Cellular Imaging Microscopy Core of the Winship Cancer Institute comprehensive cancer center grant P30CA138292. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adon AM, 2010, MOL CELL BIOL, V30, P694, DOI 10.1128/MCB.00253-09; Anderhub SJ, 2012, CANC LETT; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Bouchet BP, 2007, BRIT J CANCER, V97, P1218, DOI 10.1038/sj.bjc.6603936; Boveri T., 1914, FRAGE ENTSTEHUNG MAL; Carroll PE, 1999, ONCOGENE, V18, P1935, DOI 10.1038/sj.onc.1202515; Castellanos E, 2008, CURR BIOL, V18, P1209, DOI 10.1016/j.cub.2008.07.029; Chen DN, 2009, NATURE, V462, P925, DOI 10.1038/nature08544; Chong JL, 2009, NATURE, V462, P930, DOI 10.1038/nature08677; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; D'Assoro AB, 2004, ONCOGENE, V23, P4068, DOI 10.1038/sj.onc.1207568; Doxsey S, 2002, MOL CELL, V10, P439, DOI 10.1016/S1097-2765(02)00654-8; Duensing A, 2006, ONCOGENE, V25, P2943, DOI 10.1038/sj.onc.1209310; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Fukasawa K, 2008, BIOCH BIOPHYS ACTA; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gao YX, 2011, HUM PATHOL, V42, P1693, DOI 10.1016/j.humpath.2010.12.027; Gopinathan L, 2011, RESULTS PROBL CELL D, V53, P365, DOI 10.1007/978-3-642-19065-0_16; Guo HQ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1752; Hanashiro K, 2008, ONCOGENE; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Harrison MK, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-2; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hayward DG, 2006, CANCER LETT, V237, P155, DOI 10.1016/j.canlet.2005.06.017; Hayward DG, 2004, CANCER RES, V64, P7370, DOI 10.1158/0008-5472.CAN-04-0960; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Krzywicka-Racka A, 2011, J CELL BIOL, V194, P199, DOI 10.1083/jcb.201101073; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Montagna C, 2002, ONCOGENE, V21, P890, DOI 10.1038/sj.onc.1205146; Nelsen CJ, 2005, J BIOL CHEM, V280, P768, DOI 10.1074/jbc.M407105200; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Pihan GA, 2003, CANCER RES, V63, P1398; Pihan GA, 1998, CANCER RES, V58, P3974; Prigent C, 2005, EXP CELL RES, V303, P1, DOI 10.1016/j.yexcr.2004.04.052; Ray D, 2011, NEOPLASIA, V13, P439, DOI 10.1593/neo.101704; Reddy HKDL, 2005, CANCER RES, V65, P10174, DOI 10.1158/0008-5472.CAN-05-2639; Roberts PJ, 2012, JNCI-J NATL CANCER I, V104, P476, DOI 10.1093/jnci/djs002; Saavedra HI, 2000, ONCOGENE, V19, P3948, DOI 10.1038/sj.onc.1203723; Saavedra HI, 2003, CANCER CELL, V3, P333, DOI 10.1016/S1535-6108(03)00083-7; Saavedra HI, 1999, J BIOL CHEM, V274, P38083, DOI 10.1074/jbc.274.53.38083; Salisbury JL, 2004, J MAMMARY GLAND BIOL, V9, P275, DOI 10.1023/B:JOMG.0000048774.27697.30; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Schliekelman M, 2009, CANCER RES, V69, P45, DOI 10.1158/0008-5472.CAN-07-6330; Schneeweiss A, 2003, INT J CANCER, V107, P346, DOI 10.1002/ijc.11408; Sluder G, 1999, BIOL CELL, V91, P413, DOI 10.1016/S0248-4900(99)80083-5; Tarapore P, 2001, ONCOGENE, V20, P3173, DOI 10.1038/sj.onc.1204424; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Tsunoda N, 2009, CANCER SCI, V100, P111, DOI 10.1111/j.1349-7006.2008.01007.x; Weaver BAA, 2007, CANCER RES, V67, P10103, DOI 10.1158/0008-5472.CAN-07-2266; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Yu QY, 2006, CANCER CELL, V9, P23, DOI 10.1016/j.ccr.2005.12.012; Zeng X, 2010, ONCOGENE, V29, P5103, DOI 10.1038/onc.2010.253; Zeng X, 2010, ONCOGENE; Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001	63	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65971	10.1371/journal.pone.0065971	http://dx.doi.org/10.1371/journal.pone.0065971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776583	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400091
J	Rugani, R; Vallortigara, G; Regolin, L				Rugani, Rosa; Vallortigara, Giorgio; Regolin, Lucia			Numerical Abstraction in Young Domestic Chicks (Gallus gallus)	PLOS ONE			English	Article							INFANTS DISCRIMINATION; SMALL NUMEROSITIES; CONTOUR LENGTH; NUMBER SENSE; COMPETENCE; QUANTITY; JUDGMENTS; FOOD; REPRESENTATION; MECHANISMS	In a variety of circumstances animals can represent numerical values per se, although it is unclear how salient numbers are relative to non-numerical properties. The question is then: are numbers intrinsically distinguished or are they processed as a last resort only when no other properties differentiate stimuli? The last resort hypothesis is supported by findings pertaining to animal studies characterized by extensive training procedures. Animals may, nevertheless, spontaneously and routinely discriminate numerical attributes in their natural habitat, but data available on spontaneous numerical competence usually emerge from studies not disentangling numerical from quantitative cues. In the study being outlined here, we tested animals' discrimination of a large number of elements utilizing a paradigm that did not require any training procedures. During rearing, newborn chicks were presented with two stimuli, each characterized by a different number of heterogeneous (for colour, size and shape) elements and food was found in proximity of one of the two stimuli. At testing 3 day-old chicks were presented with stimuli depicting novel elements (for colour, size and shape) representing either the numerosity associated or not associated with food. The chicks approached the number associated with food in the 5vs.10 and 10vs.20 comparisons both when quantitative cues were unavailable (stimuli were of random sizes) or being controlled. The findings emerging from the study support the hypothesis that numbers are salient information promptly processed even by very young animals.	[Rugani, Rosa; Regolin, Lucia] Univ Padua, Dept Gen Psychol, Padua, Italy; [Vallortigara, Giorgio] Univ Trento, Ctr Mind Brain Sci, Rovereto, Trento, Italy	University of Padua; University of Trento	Rugani, R (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	rosa.rugani@unipd.it	Rugani, Rosa/C-2219-2013; Regolin, Lucia/N-9564-2019	Rugani, Rosa/0000-0001-5294-6306; Regolin, Lucia/0000-0001-8960-0309	University of Padova ('Progetto Giovani', Bando, Universita degli Studi di Padova) [GRIC101142]; ERC [PREMESOR ERC-2011-ADG_20110406]	University of Padova ('Progetto Giovani', Bando, Universita degli Studi di Padova); ERC(European Research Council (ERC)European Commission)	This study was supported by a research grant from University of Padova to R. R. ('Progetto Giovani', Bando 2010, Universita degli Studi di Padova, prot.: GRIC101142). G.V. was funded by an ERC Advanced Grant (PREMESOR ERC-2011-ADG_20110406). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew R.J., 1991, NEURAL BEHAV PLASTIC, P536; Baker JM, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00387; Baker JM, 2011, BEHAV PROCESS, V88, P72, DOI 10.1016/j.beproc.2011.08.006; Bateson P., 2000, VIENNA SERIES THEORE, P85; Beran MJ, 2006, J EXP PSYCHOL-ANIM B, V32, P111, DOI 10.1037/0097-7403.32.2.111; Beran MJ, 2001, J COMP PSYCHOL, V115, P181, DOI 10.1037//0735-7036.115.2.181; BOLHUIS JJ, 1991, BIOL REV, V66, P303, DOI 10.1111/j.1469-185X.1991.tb01145.x; BOYSEN ST, 1989, J COMP PSYCHOL, V103, P23, DOI 10.1037/0735-7036.103.1.23; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Breukelaar JWC, 1998, J EXP PSYCHOL ANIM B, V24, P84, DOI 10.1037/0097-7403.24.1.84; Call J, 2000, J COMP PSYCHOL, V114, P136, DOI 10.1037/0735-7036.114.2.136; Cantlon JF, 2007, J EXP PSYCHOL-ANIM B, V33, P32, DOI 10.1037/0097-7403.33.1.32; Cantlon JF, 2006, INFANCY, V9, P173, DOI 10.1207/s15327078in0902_5; Clearfield MW, 2001, J COGN DEV, V2, P243, DOI 10.1207/S15327647JCD0203_1; Clearfield MW, 1999, PSYCHOL SCI, V10, P408, DOI 10.1111/1467-9280.00177; DAVIS H, 1982, PSYCHOL BULL, V92, P547, DOI 10.1037/0033-2909.92.3.547; DAVIS H, 1988, BEHAV BRAIN SCI, V11, P561, DOI 10.1017/S0140525X00053437; Davis H., 1993, DEV NUMERICAL COMPET, P109; Emmerton Jacky, 1993, P377; Feigenson L, 2002, PSYCHOL SCI, V13, P150, DOI 10.1111/1467-9280.00427; Feigenson L, 2005, COGNITION, V97, P295, DOI 10.1016/j.cognition.2004.09.010; Feigenson L, 2002, COGNITIVE PSYCHOL, V44, P33, DOI 10.1006/cogp.2001.0760; Fontanari L, 2011, DEVELOPMENTAL SCI, V14, P1235, DOI 10.1111/j.1467-7687.2011.01074.x; GALLISTEL CR, 1992, COGNITION, V44, P43, DOI 10.1016/0010-0277(92)90050-R; Garland A, 2012, ANIM COGN, V15, P1129, DOI 10.1007/s10071-012-0537-3; Hauser MD, 2000, P ROY SOC B-BIOL SCI, V267, P829, DOI 10.1098/rspb.2000.1078; Hyde DC, 2011, DEVELOPMENTAL SCI, V14, P360, DOI 10.1111/j.1467-7687.2010.00987.x; Irie-Sugimoto N, 2009, ANIM COGN, V12, P193, DOI 10.1007/s10071-008-0185-9; JENKINS HM, 1973, J EXP ANAL BEHAV, V20, P163, DOI 10.1901/jeab.1973.20-163; Judge PG, 2005, J EXP PSYCHOL-ANIM B, V31, P79, DOI 10.1037/0097-7403.31.1.79; KREBS JR, 1974, BEHAVIOUR, V51, P99, DOI 10.1163/156853974X00165; Lipton JS, 2004, INFANCY, V5, P271, DOI 10.1207/s15327078in0503_2; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; Maclean EL, 2008, ANIM BEHAV, V76, P479, DOI 10.1016/j.anbehav.2008.01.025; Merritt DJ, 2009, J EXP PSYCHOL GEN, V138, P258, DOI 10.1037/a0015231; Olthof A, 1997, J EXP PSYCHOL ANIM B, V23, P325, DOI 10.1037/0097-7403.23.3.325; Pepperberg IM, 2012, ANIM COGN, V15, P711, DOI [10.1007/s10071-012-0470-5, 10.1007/s10071-012-0476-5]; Regolin L, 2005, ANIM BEHAV, V70, P855, DOI 10.1016/j.anbehav.2005.01.014; Regolin L, 2005, BEHAV BRAIN RES, V157, P1, DOI 10.1016/j.bbr.2004.06.012; Regolin L, 2011, BIOL LETTERS, V7, P654, DOI 10.1098/rsbl.2011.0051; Rosa Salva O, 2013, ANIM COGN, V16, P895, DOI 10.1007/s10071-013-0622-2; Rugani R, 2008, J EXP PSYCHOL-ANIM B, V34, P388, DOI 10.1037/0097-7403.34.3.388; Rugani R, 2007, J EXP PSYCHOL ANIM B, V33, P21, DOI 10.1037/0097-7403.33.1.21; Rugani R, 2013, ANIM COGN, V16, P557, DOI 10.1007/s10071-012-0593-8; Rugani R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00179; Rugani R, 2011, NEUROBIOL LEARN MEM, V95, P231, DOI 10.1016/j.nlm.2010.11.012; Rugani R, 2010, DEVELOPMENTAL SCI, V13, P790, DOI 10.1111/j.1467-7687.2009.00936.x; Rugani R, 2010, BIOL LETTERS, V6, P290, DOI 10.1098/rsbl.2009.0960; Scarf D, 2011, SCIENCE, V334, P1664, DOI 10.1126/science.1213357; Seron X, 2001, MIND LANG, V16, P76, DOI 10.1111/1468-0017.00158; Smith BR, 2003, J COMP PSYCHOL, V117, P217, DOI 10.1037/0735-7036.117.2.217; Uller C, 2003, ANIM COGN, V6, P105, DOI 10.1007/s10071-003-0167-x; Uller C, 2009, ANIM COGN, V12, P733, DOI 10.1007/s10071-009-0225-0; Vallortigara G, 2010, WIRES COGN SCI, V1, P882, DOI 10.1002/wcs.75; Ward C, 2007, ANIM COGN, V10, P71, DOI 10.1007/s10071-006-0042-7; Xu F, 2005, DEVELOPMENTAL SCI, V8, P88, DOI 10.1111/j.1467-7687.2005.00395.x; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	57	43	44	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65262	10.1371/journal.pone.0065262	http://dx.doi.org/10.1371/journal.pone.0065262			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776457	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400019
J	Kaabinejadian, S; Piazza, PA; McMurtrey, CP; Vernon, SR; Cate, SJ; Bardet, W; Schafer, FB; Jackson, KW; Campbell, DM; Buchli, R; Rinaldo, CR; Hildebrand, WH				Kaabinejadian, Saghar; Piazza, Paolo A.; McMurtrey, Curtis P.; Vernon, Stephen R.; Cate, Steven J.; Bardet, Wilfried; Schafer, Fredda B.; Jackson, Kenneth W.; Campbell, Diana M.; Buchli, Rico; Rinaldo, Charles R.; Hildebrand, William H.			Identification of Class I HLA T Cell Control Epitopes for West Nile Virus	PLOS ONE			English	Article							PEPTIDE LIGANDS; VACCINE DESIGN; CULTURE METHOD; BLOOD-DONORS; INFECTION; RESPONSES; ENCEPHALITIS; DISCOVERY; CALRETICULIN; VALIDATION	The recent West Nile virus (WNV) outbreak in the United States underscores the importance of understanding human immune responses to this pathogen. Via the presentation of viral peptide ligands at the cell surface, class I HLA mediate the T cell recognition and killing of WNV infected cells. At this time, there are two key unknowns in regards to understanding protective T cell immunity: 1) the number of viral ligands presented by the HLA of infected cells, and 2) the distribution of T cell responses to these available HLA/viral complexes. Here, comparative mass spectroscopy was applied to determine the number of WNV peptides presented by the HLA-A*11: 01 of infected cells after which T cell responses to these HLA/WNV complexes were assessed. Six viral peptides derived from capsid, NS3, NS4b, and NS5 were presented. When T cells from infected individuals were tested for reactivity to these six viral ligands, polyfunctional T cells were focused on the GTL9 WNV capsid peptide, ligands from NS3, NS4b, and NS5 were less immunogenic, and two ligands were largely inert, demonstrating that class I HLA reduce the WNV polyprotein to a handful of immune targets and that polyfunctional T cells recognize infections by zeroing in on particular HLA/WNV epitopes. Such dominant HLA/peptide epitopes are poised to drive the development of WNV vaccines that elicit protective T cells as well as providing key antigens for immunoassays that establish correlates of viral immunity.	[Kaabinejadian, Saghar; McMurtrey, Curtis P.; Vernon, Stephen R.; Cate, Steven J.; Bardet, Wilfried; Schafer, Fredda B.; Jackson, Kenneth W.; Hildebrand, William H.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Piazza, Paolo A.; Campbell, Diana M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Rinaldo, Charles R.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Buchli, Rico; Hildebrand, William H.] Pure Prot LLC, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hildebrand, WH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA.	William-hildebrand@ouhsc.edu		Delucia, Diana Campbell/0000-0002-1165-6799; Piazza, Paolo/0000-0002-2173-1342	National Institutes of Health [HHSN266200400027C, U01AI082057]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082057] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (www.nih.gov) Contract HHSN266200400027C (to W.H.H.) and National Institutes of Health grant U01AI082057(to W.H.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Bell EB, 2008, TRENDS IMMUNOL, V29, P405, DOI 10.1016/j.it.2008.06.002; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Brown CM, 2012, ANN INTERN MED, V157, P823, DOI 10.7326/0003-4819-157-11-201212040-00543; Buchli R, 2005, BIOCHEMISTRY-US, V44, P12491, DOI 10.1021/bi050255v; Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Custer B, 2009, TRANSFUSION, V49, P278, DOI 10.1111/j.1537-2995.2008.01952.x; De Filette M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-16; Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Duvall MG, 2008, EUR J IMMUNOL, V38, P350, DOI 10.1002/eji.200737768; Eneslatt K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032367; Rodriguez MDG, 2010, VECTOR-BORNE ZOONOT, V10, P151, DOI 10.1089/vbz.2008.0203; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Hickman HD, 2004, J IMMUNOL, V172, P2944, DOI 10.4049/jimmunol.172.5.2944; Jackson HM, 2004, J IMMUNOL METHODS, V291, P51, DOI 10.1016/j.jim.2004.04.017; Kim S, 2010, J IMMUNOL, V184, P4423, DOI 10.4049/jimmunol.0903955; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Larsen MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012697; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Leffell MS, 2007, TRANSPLANTATION, V83, P964, DOI 10.1097/01.tp.0000258588.09356.d7; Lin Y, 2009, CYTOTHERAPY, V11, P912, DOI 10.3109/14653240903136987; Martina BEE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018995; McMurtrey CP, 2008, P NATL ACAD SCI USA, V105, P2981, DOI 10.1073/pnas.0711874105; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07; Piazza P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015343; Prilliman K, 1997, IMMUNOGENETICS, V45, P379, DOI 10.1007/s002510050219; Prilliman KR, 1999, J IMMUNOL, V162, P7277; Robinson HL, 2005, NAT MED, V11, pS25, DOI 10.1038/nm1212; ROELSE J, 1994, J EXP MED, V180, P1591, DOI 10.1084/jem.180.5.1591; Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905; Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Smith HL, 2011, J INFECT DIS, V203, P513, DOI 10.1093/infdis/jiq074; Tan ACL, 2011, J IMMUNOL, V187, P1895, DOI 10.4049/jimmunol.1100664; Wahl A, 2006, EXPERT REV PROTEOMIC, V3, P641, DOI 10.1586/14789450.3.6.641; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Wearsch PA, 2004, J BIOL CHEM, V279, P25112, DOI 10.1074/jbc.M401721200; Weiskopf D, 2011, J IMMUNOL, V187, P4268, DOI 10.4049/jimmunol.1101970; Yewdell JW, 2007, CURR OPIN IMMUNOL, V19, P79, DOI 10.1016/j.coi.2006.11.010	45	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66298	10.1371/journal.pone.0066298	http://dx.doi.org/10.1371/journal.pone.0066298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762485	Green Published, Green Accepted, gold			2022-12-25	WOS:000320440500067
J	Oliver, JC; Ramos, D; Prudic, KL; Monteiro, A				Oliver, Jeffrey C.; Ramos, Diane; Prudic, Kathleen L.; Monteiro, Antonia			Temporal Gene Expression Variation Associated with Eyespot Size Plasticity in Bicyclus anynana	PLOS ONE			English	Article							WING PATTERN; PHENOTYPIC PLASTICITY; REACTION NORMS; EVOLUTION; LEPIDOPTERA; LESS	Seasonal polyphenism demonstrates an organism's ability to respond to predictable environmental variation with alternative phenotypes, each presumably better suited to its respective environment. However, the molecular mechanisms linking environmental variation to alternative phenotypes via shifts in development remain relatively unknown. Here we investigate temporal gene expression variation in the seasonally polyphenic butterfly Bicyclus anynana. This species shows drastic changes in eyespot size depending on the temperature experienced during larval development. The wet season form (larvae reared over 24 degrees C) has large ventral wing eyespots while the dry season form (larvae reared under 19 degrees C) has much smaller eyespots. We compared the expression of three proteins, Notch, Engrailed, and Distal-less, in the future eyespot centers of the two forms to determine if eyespot size variation is associated with heterochronic shifts in the onset of their expression. For two of these proteins, Notch and Engrailed, expression in eyespot centers occurred earlier in dry season than in wet season larvae, while Distal-less showed no temporal difference between the two forms. These results suggest that differences between dry and wet season adult wings could be due to a delay in the onset of expression of these eyespot-associated genes. Early in eyespot development, Notch and Engrailed may be functioning as repressors rather than activators of the eyespot gene network. Alternatively, temporal variation in the onset of early expressed genes between forms may have no functional consequences to eyespot size regulation and may indicate the presence of an 'hourglass' model of development in butterfly eyespots.	[Oliver, Jeffrey C.; Prudic, Kathleen L.; Monteiro, Antonia] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Oliver, Jeffrey C.; Prudic, Kathleen L.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Ramos, Diane] Daemen Coll, Dept Nat Sci, Amherst, NY USA	Yale University; Oregon State University	Oliver, JC (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	jeffrey.oliver@science.oregonstate.edu	Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X; Oliver, Jeffrey/0000-0003-2160-1086; Prudic, Kathleen/0000-0001-8242-7769	National Science Foundation [IOS 0818731, IOS 1146933]	National Science Foundation(National Science Foundation (NSF))	This work was supported by funding from the National Science Foundation (IOS 0818731 and IOS 1146933). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beldade P, 2005, EVOL DEV, V7, P101, DOI 10.1111/j.1525-142X.2005.05011.x; Beldade P, 2002, NATURE, V415, P315, DOI 10.1038/415315a; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; Brakefield PM, 1996, NATURE, V384, P236, DOI 10.1038/384236a0; Brunetti CR, 2001, CURR BIOL, V11, P1578, DOI 10.1016/S0960-9822(01)00502-4; DUBOULE D, 1994, DEVELOPMENT, P135; EMLEN DJ, 1994, P ROY SOC B-BIOL SCI, V256, P131, DOI 10.1098/rspb.1994.0060; FRENCH V, 1992, DEVELOPMENT, V116, P103; GWYNNE DT, 1984, EVOLUTION, V38, P1011, DOI 10.1111/j.1558-5646.1984.tb00371.x; Kalinka AT, 2010, NATURE, V468, P811, DOI 10.1038/nature09634; Kawajiri M, 2011, J THERM BIOL, V36, P306, DOI 10.1016/j.jtherbio.2011.06.003; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; Koch PB, 1996, J INSECT PHYSIOL, V42, P223, DOI 10.1016/0022-1910(95)00103-4; Kooi RE, 1999, J INSECT PHYSIOL, V45, P201, DOI 10.1016/S0022-1910(98)00093-6; Mansouri A, 1996, DEVELOPMENT, V122, P831; Monteiro A, 2001, ACTA BIOTHEOR, V49, P77, DOI 10.1023/A:1010226223287; Monteiro A, 2010, TRENDS EVOL BIOL, V2, pe2, DOI DOI 10.4081/EB.2010.E2; Monteiro A, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-52; Monteiro A, 2013, J EXP ZOOL PART B, V320B, P321, DOI 10.1002/jez.b.22503; NIJHOUT HF, 1978, J EXP ZOOL, V206, P119, DOI 10.1002/jez.1402060202; Oliver JC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002893; Oostra V, 2011, P ROY SOC B-BIOL SCI, V278, P789, DOI 10.1098/rspb.2010.1560; Reed RD, 2004, CURR BIOL, V14, P1159, DOI 10.1016/j.cub.2004.06.046; Reed RD, 2007, EVOL DEV, V9, P2, DOI 10.1111/j.1525-142X.2006.00133.x; Saenko SV, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-9; Sakamoto K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005121; Schlichting CD, 2002, EVOL ECOL, V16, P189, DOI 10.1023/A:1019624425971; Sibthorpe D, 2006, COMP BIOCHEM PHYS B, V145, P371, DOI 10.1016/j.cbpb.2006.08.013; WHEELER DE, 1981, SCIENCE, V213, P361, DOI 10.1126/science.213.4505.361; WINDIG JJ, 1994, J EVOLUTION BIOL, V7, P665, DOI 10.1046/j.1420-9101.1994.7060665.x	30	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65830	10.1371/journal.pone.0065830	http://dx.doi.org/10.1371/journal.pone.0065830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762437	Green Published, gold			2022-12-25	WOS:000320440500052
J	Sutherland, MC; Binder, KA; Cualing, PY; Vogel, JP				Sutherland, Molly C.; Binder, Kelsey A.; Cualing, Phillip Y.; Vogel, Joseph P.			Reassessing the Role of DotF in the Legionella pneumophila Type IV Secretion System	PLOS ONE			English	Article							LEGIONNAIRES-DISEASE; PROTEIN; IDENTIFICATION; GENES; TRANSLOCATION; MANIPULATION; TRAFFICKING; BACTERIUM; COMPLEX	Legionella pneumophila, the causative agent of a severe pneumonia termed Legionnaires' Disease, survives and replicates within both protozoan hosts and human alveolar macrophages. Intracellular survival is dependent upon secretion of a plethora of protein effectors that function to form a replicative vacuole, evade the endocytic pathway and subvert host immune defenses. Export of these factors requires a type IV secretion system (T4SS) called Dot/Icm that is composed of twenty-seven proteins. This report focuses on the DotF protein, which was previously postulated to have several different functions, one of which centered on binding Dot/Icm substrates. In this report, we examined if DotF functions as the T4SS inner membrane receptor for Dot/Icm substrates. Although we were able to recapitulate the previously published bacterial two-hybrid interaction between DotF and several substrates, the interaction was not dependent on the Dot/Icm substrates' signal sequences as predicted for a substrate: receptor interaction. In addition, binding did not require the cytoplasmic domain of DotF, which was anticipated to be involved in recognizing substrates in the cytoplasm. Finally, inactivation of dotF did not abolish intracellular growth of L. pneumophila or translocation of substrates, two phenotypes dependent on the T4SS receptor. These data strongly suggest that DotF does not act as the major receptor for Dot/Icm substrates and therefore likely performs an accessory function within the core-transmembrane subcomplex of the L. pneumophila Dot/Icm type IV secretion system.	[Sutherland, Molly C.; Cualing, Phillip Y.; Vogel, Joseph P.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Binder, Kelsey A.] Rocky Mt Natl Inst Hlth Labs, Hamilton, MT USA	Washington University (WUSTL)	Vogel, JP (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	jvogel@borcim.wustl.edu		Sutherland, Molly/0000-0002-7932-5339	National Institutes of Health [AI48052]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI48052 to JPV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Quadan T, 2012, TRENDS MICROBIOL, V20, P299, DOI 10.1016/j.tim.2012.03.005; Albers U, 2005, MICROBIOL-SGM, V151, P167, DOI 10.1099/mic.0.27563-0; Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Buscher BA, 2005, J BACTERIOL, V187, P2927, DOI 10.1128/JB.187.9.2927-2938.2005; Cambronne ED, 2007, PLOS PATHOG, V3, P1837, DOI 10.1371/journal.ppat.0030188; Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101; Coers J, 2000, MOL MICROBIOL, V38, P719, DOI 10.1046/j.1365-2958.2000.02176.x; Edelstein PH, 1999, P NATL ACAD SCI USA, V96, P8190, DOI 10.1073/pnas.96.14.8190; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Faulkner G, 2008, J BACTERIOL, V190, P7728, DOI 10.1128/JB.00751-08; FEELEY JC, 1979, J CLIN MICROBIOL, V10, P437, DOI 10.1128/JCM.10.4.437-441.1979; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Ge JN, 2011, CELL MICROBIOL, V13, P1870, DOI 10.1111/j.1462-5822.2011.01710.x; Gomez-Valero L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00208; Heidtman M, 2009, CELL MICROBIOL, V11, P230, DOI 10.1111/j.1462-5822.2008.01249.x; HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874; Huang L, 2011, CELL MICROBIOL, V13, P227, DOI 10.1111/j.1462-5822.2010.01531.x; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Lifshitz Z, 2013, P NATL ACAD SCI USA, V110, pE707, DOI 10.1073/pnas.1215278110; Luo ZQ, 2012, CELL MICROBIOL, V14, P19, DOI 10.1111/j.1462-5822.2011.01713.x; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Massis LM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00109; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; Morozova I, 2004, PLASMID, V51, P127, DOI 10.1016/j.plasmid.2003.12.004; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Ninio S, 2005, MOL MICROBIOL, V55, P912, DOI 10.1111/j.1365-2958.2004.04435.x; Ninio S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000278; Paumet F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007375; Purcell M, 1998, INFECT IMMUN, V66, P2245, DOI 10.1128/IAI.66.5.2245-2255.1998; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Segal G, 1999, INFECT IMMUN, V67, P2117, DOI 10.1128/IAI.67.5.2117-2124.1999; Sexton JA, 2005, MOL MICROBIOL, V57, P70, DOI 10.1111/j.1365-2958.2005.04667.x; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Steinert M, 2005, CELL MICROBIOL, V7, P307, DOI 10.1111/j.1462-5822.2005.00493.x; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Sutherland MC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002910; Sutherland MC, 2012, APPL ENVIRON MICROB, V78, P5457, DOI 10.1128/AEM.00669-12; Vincent CD, 2006, MOL MICROBIOL, V62, P1278, DOI 10.1111/j.1365-2958.2006.05446.x; Vincent CD, 2006, J BACTERIOL, V188, P8231, DOI 10.1128/JB.00937-06; Vincent CD, 2012, MOL MICROBIOL, V85, P378, DOI 10.1111/j.1365-2958.2012.08118.x; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Wiener MC, 2005, CURR OPIN STRUC BIOL, V15, P394, DOI 10.1016/j.sbi.2005.07.001; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	48	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65529	10.1371/journal.pone.0065529	http://dx.doi.org/10.1371/journal.pone.0065529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762385	Green Published, gold, Green Submitted			2022-12-25	WOS:000321094800057
J	Shibata, D; Choi, JY; Laitano, JC; Santello, M				Shibata, Daisuke; Choi, Jason Y.; Laitano, Juan C.; Santello, Marco			Haptic-Motor Transformations for the Control of Finger Position	PLOS ONE			English	Article							ISOMETRIC VOLUNTARY CONTRACTIONS; KINESTHETIC INFORMATION; OBJECT MANIPULATION; CONTACT POINTS; PRECISION GRIP; HAND SHAPE; MUSCLE; SENSE; RECEPTORS; COMMANDS	Dexterous manipulation relies on modulation of digit forces as a function of digit placement. However, little is known about the sense of position of the vertical distance between finger pads relative to each other. We quantified subjects' ability to match perceived vertical distance between the thumb and index finger pads (d(y)) of the right hand ("reference" hand) using the same or opposite hand ("test" hand) after a 10-second delay without vision of the hands. The reference hand digits were passively placed non-collinearly so that the thumb was higher or lower than the index finger (d(y) = 30 or -30 mm, respectively) or collinearly (d(y) = 0 mm). Subjects reproduced reference hand d(y) by using a congruent or inverse test hand posture while exerting negligible digit forces onto a handle. We hypothesized that matching error (reference hand d(y) minus test hand d(y)) would be greater (a) for collinear than non-collinear d(y)s, (b) when reference and test hand postures were not congruent, and (c) when subjects reproduced d(y) using the opposite hand. Our results confirmed our hypotheses. Underestimation errors were produced when the postures of reference and test hand were not congruent, and when test hand was the opposite hand. These findings indicate that perceived finger pad distance is reproduced less accurately (1) with the opposite than the same hand and (2) when higher-level processing of the somatosensory feedback is required for non-congruent hand postures. We propose that erroneous sensing of finger pad distance, if not compensated for during contact and onset of manipulation, might lead to manipulation performance errors as digit forces have to be modulated to perceived digit placement.	[Shibata, Daisuke] Arizona State Univ, Coll Hlth Solut, Kinesiol Program, Tempe, AZ USA; [Choi, Jason Y.; Laitano, Juan C.; Santello, Marco] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Santello, M (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85287 USA.	marco.santello@asu.edu			European Commission [FP7-ICT-2009-4-2-1]; Collaborative Project "THE Hand Embodied" [248587]	European Commission(European CommissionEuropean Commission Joint Research Centre); Collaborative Project "THE Hand Embodied"	This work was partially supported by the European Commission with the Collaborative Project no. 248587, "THE Hand Embodied", within the FP7-ICT-2009-4-2-1 program "Cognitive Systems and Robotics". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adamo D, 2009, EXP BRAIN RES, V192, P87, DOI 10.1007/s00221-008-1560-0; Adamo DE, 2012, EXP BRAIN RES, V217, P273, DOI 10.1007/s00221-011-2991-6; Allen TJ, 2008, EXP PHYSIOL, V93, P391, DOI 10.1113/expphysiol.2007.040741; BURGESS PR, 1982, ANNU REV NEUROSCI, V5, P171, DOI 10.1146/annurev.ne.05.030182.001131; BURKE D, 1988, J PHYSIOL-LONDON, V402, P347, DOI 10.1113/jphysiol.1988.sp017208; Craje C, 2011, EXP BRAIN RES, V212, P119, DOI 10.1007/s00221-011-2704-1; Dimitriou M, 2010, CURR BIOL, V20, P1763, DOI 10.1016/j.cub.2010.08.049; Dimitriou M, 2008, J NEUROSCI, V28, P12632, DOI 10.1523/JNEUROSCI.3357-08.2008; Drewing K, 2006, BRAIN RES, V1078, P92, DOI 10.1016/j.brainres.2005.12.026; EDIN BB, 1995, J PHYSIOL-LONDON, V487, P243, DOI 10.1113/jphysiol.1995.sp020875; EDIN BB, 1992, J NEUROPHYSIOL, V67, P1105, DOI 10.1152/jn.1992.67.5.1105; EDIN BB, 1991, J NEUROPHYSIOL, V65, P657, DOI 10.1152/jn.1991.65.3.657; FERRELL WR, 1980, J PHYSIOL-LONDON, V299, P85, DOI 10.1113/jphysiol.1980.sp013112; Flanagan JR, 1997, J NEUROSCI, V17, P1519; Friedman J, 2007, CORTEX, V43, P444, DOI 10.1016/S0010-9452(08)70469-6; Fu QS, 2011, J NEUROSCI, V31, P13576, DOI 10.1523/JNEUROSCI.1143-11.2011; Fu QS, 2010, J NEUROSCI, V30, P9117, DOI 10.1523/JNEUROSCI.4159-09.2010; Gandevia SC, 2006, J PHYSIOL-LONDON, V571, P703, DOI 10.1113/jphysiol.2005.103093; GANDEVIA SC, 1987, TRENDS NEUROSCI, V10, P81, DOI 10.1016/0166-2236(87)90030-0; Gilster R, 2012, EXP BRAIN RES, V217, P137, DOI 10.1007/s00221-011-2980-9; Goble DJ, 2008, J NEUROPHYSIOL, V99, P3063, DOI 10.1152/jn.90259.2008; Goble DJ, 2007, EXP BRAIN RES, V180, P693, DOI 10.1007/s00221-007-0890-7; Goble DJ, 2009, EXP BRAIN RES, V197, P403, DOI 10.1007/s00221-009-1922-2; GORDON AM, 1994, NEUROPSYCHOLOGIA, V32, P555, DOI 10.1016/0028-3932(94)90144-9; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P72; JOHANSSON RS, 1992, CURR OPIN NEUROBIOL, V2, P815, DOI 10.1016/0959-4388(92)90139-C; JOHANSSON RS, 1993, BIOMED RES-TOKYO, V14, P95; Lukos J, 2007, J NEUROSCI, V27, P3894, DOI 10.1523/JNEUROSCI.4693-06.2007; Lukos JR, 2008, J NEUROSCI, V28, P12765, DOI 10.1523/JNEUROSCI.4335-08.2008; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pesyna C, 2011, J NEUROSCI, V31, P3757, DOI 10.1523/JNEUROSCI.5158-10.2011; Proske U, 2006, MUSCLE NERVE, V34, P545, DOI 10.1002/mus.20627; Proske U, 2009, J PHYSIOL-LONDON, V587, P4139, DOI 10.1113/jphysiol.2009.175372; Santello M, 1997, SOMATOSENS MOT RES, V14, P203; Sartori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025203; Smith JL, 2009, J APPL PHYSIOL, V106, P950, DOI 10.1152/japplphysiol.91365.2008; VALLBO AB, 1971, J PHYSIOL-LONDON, V218, P405, DOI 10.1113/jphysiol.1971.sp009625; VALLBO AB, 1974, ACTA PHYSIOL SCAND, V90, P319, DOI 10.1111/j.1748-1716.1974.tb05594.x; Van Doren CL, 1998, EXP BRAIN RES, V120, P487, DOI 10.1007/s002210050422; Voudouris D, 2012, J MOTOR BEHAV, V44, P295, DOI 10.1080/00222895.2012.703975; Walsh LD, 2009, EXP BRAIN RES, V195, P603, DOI 10.1007/s00221-009-1832-3; Winter JA, 2005, J PHYSIOL-LONDON, V568, P1035, DOI 10.1113/jphysiol.2005.092619; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Zhang W, 2010, J NEUROPHYSIOL, V103, P2953, DOI 10.1152/jn.00140.2010	45	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e66140	10.1371/journal.pone.0066140	http://dx.doi.org/10.1371/journal.pone.0066140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762477	gold, Green Published, Green Submitted			2022-12-25	WOS:000321099000127
J	Tajiri, T; Matsumoto, H; Niimi, A; Ito, I; Oguma, T; Nakaji, H; Inoue, H; Iwata, T; Nagasaki, T; Kanemitsu, Y; Petrova, G; Mishima, M				Tajiri, Tomoko; Matsumoto, Hisako; Niimi, Akio; Ito, Isao; Oguma, Tsuyoshi; Nakaji, Hitoshi; Inoue, Hideki; Iwata, Toshiyuki; Nagasaki, Tadao; Kanemitsu, Yoshihiro; Petrova, Guergana; Mishima, Michiaki			Association of Eosinophilic Inflammation with FKBP51 Expression in Sputum Cells in Asthma	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; GLUCOCORTICOID-RECEPTOR; FK506-BINDING PROTEIN-51; IMMUNOPHILIN FKBP51; SQUIRREL-MONKEY; CORTICOSTEROIDS; RESISTANCE; INHIBITOR; APOPTOSIS; GENES	Background: Airway eosinophilia is a predictor of steroid responsiveness in steroid-naive asthma. However, the relationship between airway eosinophilia and the expression of FK506-binding protein 51 (FKBP51), a glucocorticoid receptor cochaperone that plays a role in steroid insensitivity in asthma, remains unknown. Objective: To evaluate the relationship between eosinophilic inflammation and FKBP51 expression in sputum cells in asthma. Methods: The FKBP51 mRNA levels in sputum cells from steroid-naive patients with asthma (n = 31) and stable asthmatic patients on inhaled corticosteroid (ICS) (n = 28) were cross-sectionally examined using real-time PCR. Associations between FKBP51 levels and clinical indices were analyzed. Results: In steroid-naive patients, the FKBP51 levels were negatively correlated with eosinophil proportions in blood (r = -0.52) and sputum (r = -0.57), and exhaled nitric oxide levels (r = -0.42) (all p<0.05). No such associations were observed in patients on ICS. In steroid-naive patients, improvement in forced expiratory volume in one second after ICS initiation was correlated with baseline eosinophil proportions in blood (r = 0.74) and sputum (r = 0.76) and negatively correlated with FKBP51 levels (r = -0.73) (all p<0.0001) (n = 20). Lastly, the FKBP51 levels were the lowest in steroid-naive asthmatic patients, followed by mild to moderate persistent asthmatic patients on ICS, and the highest in severe persistent asthmatic patients on ICS (p<0.0001). Conclusions: Lower FKBP51 expression in sputum cells may reflect eosinophilic inflammation and glucocorticoid responsiveness in steroid-naive asthmatic patients.	[Tajiri, Tomoko; Matsumoto, Hisako; Niimi, Akio; Ito, Isao; Oguma, Tsuyoshi; Nakaji, Hitoshi; Inoue, Hideki; Iwata, Toshiyuki; Nagasaki, Tadao; Kanemitsu, Yoshihiro; Petrova, Guergana; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Niimi, Akio] Nagoya City Univ, Dept Med Oncol & Immunol, Sch Med Sci, Div Resp Med, Nagoya, Aichi, Japan; [Nakaji, Hitoshi] Japanese Red Cross Wakayama Med Ctr, Dept Resp Med, Wakayama, Japan	Kyoto University; Nagoya City University	Matsumoto, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan.	hmatsumo@kuhp.kyoto-u.ac.jp		Ito, Isao/0000-0003-3109-898X; Inoue, Hideki/0000-0002-8624-6524; Petrova, Guergana/0000-0001-8168-742X				American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; [Anonymous], 1987, AM REV RESPIR DIS, V136, P225; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Baughman G, 1997, BIOCHEM BIOPH RES CO, V232, P437, DOI 10.1006/bbrc.1997.6307; Caldwell JM, 2010, J ALLERGY CLIN IMMUN, V125, P879, DOI 10.1016/j.jaci.2010.01.038; Chun E, 2011, J CLIN IMMUNOL, V31, P122, DOI 10.1007/s10875-010-9463-9; Cowan DC, 2010, THORAX, V65, P384, DOI 10.1136/thx.2009.126722; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; Druilhe A, 2003, APOPTOSIS, V8, P481, DOI 10.1023/A:1025590308147; Foresi A, 2000, ANN ALLERG ASTHMA IM, V84, P411, DOI 10.1016/S1081-1206(10)62274-0; Fukushima H, 2007, EUR J PHARMACOL, V570, P222, DOI 10.1016/j.ejphar.2007.05.021; HANSEL TT, 1989, J IMMUNOL METHODS, V122, P97, DOI 10.1016/0022-1759(89)90339-6; Jana AS, 2005, CHEST, V128, P1140; Kobayashi Y, 2005, J IMMUNOL, V175, P5744, DOI 10.4049/jimmunol.175.9.5744; Matsumoto H, 2005, THORAX, V60, P277, DOI 10.1136/thx.2004.028936; Matsumoto H, 2011, RESPIRATION, V81, P311, DOI 10.1159/000319566; Meijer RJ, 2002, CLIN EXP ALLERGY, V32, P1096, DOI 10.1046/j.1365-2222.2002.01412.x; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; National Institutes of Health NH Lung and Blood Institute, 2002, GLOB IN ASTHM MAN PR; Reynolds PD, 1999, J CLIN ENDOCR METAB, V84, P663, DOI 10.1210/jc.84.2.663; ROSEWICZ S, 1988, J BIOL CHEM, V263, P2581; Simpson JL, 2013, CLIN EXP ALLERGY, V43, P29, DOI 10.1111/j.1365-2222.2012.04075.x; SMITH DF, 1993, J BIOL CHEM, V268, P18365; Taylor S, 2010, METHODS, V50, pS1, DOI 10.1016/j.ymeth.2010.01.005; Vermeer H, 2003, J CLIN ENDOCR METAB, V88, P277, DOI 10.1210/jc.2002-020354; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Yang N, 2012, STEROIDS, V77, P1041, DOI 10.1016/j.steroids.2012.05.007; Zhang XY, 2008, INVEST OPHTH VIS SCI, V49, P1037, DOI 10.1167/iovs.07-1279	29	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65284	10.1371/journal.pone.0065284	http://dx.doi.org/10.1371/journal.pone.0065284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762334	gold, Green Published, Green Submitted			2022-12-25	WOS:000321099000052
J	Cipriano, DJ; Jung, J; Vivona, S; Fenn, TD; Brunger, AT; Bryant, Z				Cipriano, Daniel J.; Jung, Jaemyeong; Vivona, Sandro; Fenn, Timothy D.; Brunger, Axel T.; Bryant, Zev			Processive ATP-driven Substrate Disassembly by the N-Ethylmaleimide-sensitive Factor (NSF) Molecular Machine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SNARE COMPLEX; CRYSTAL-STRUCTURE; FUSION PROTEIN; SINGLE-MOLECULE; CONFORMATIONAL-CHANGES; TERMINAL DOMAIN; VESICLE FUSION; UVRD HELICASE; DNA; TRANSLOCATION	SNARE proteins promote membrane fusion by forming a four-stranded parallel helical bundle that brings the membranes into close proximity. Post-fusion, the complex is disassembled by an AAA+ ATPase called N-ethylmaleimide-sensitive factor (NSF). We present evidence that NSF uses a processive unwinding mechanism to disassemble SNARE proteins. Using a real-time disassembly assay based on fluorescence dequenching, we correlate NSF-driven disassembly rates with the SNARE-activated ATPase activity of NSF. Neuronal SNAREs activate the ATPase rate of NSF by similar to 26-fold. One SNARE complex takes an average of similar to 5 s to disassemble in a process that consumes similar to 50 ATP. Investigations of substrate requirements show that NSF is capable of disassembling a truncated SNARE substrate consisting of only the core SNARE domain, but not an unrelated four-stranded coiled-coil. NSF can also disassemble an engineered double-length SNARE complex, suggesting a processive unwinding mechanism. We further investigated processivity using single-turnover experiments, which show that SNAREs can be unwound in a single encounter with NSF. We propose a processive helicase-like mechanism for NSF in which similar to 1 residue is unwound for every hydrolyzed ATP molecule.	[Cipriano, Daniel J.; Jung, Jaemyeong; Vivona, Sandro; Fenn, Timothy D.; Brunger, Axel T.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Brunger, Axel T.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Jung, Jaemyeong; Brunger, Axel T.] Stanford Univ, Dept Photon Sci, Stanford, CA 94305 USA; [Cipriano, Daniel J.; Jung, Jaemyeong; Vivona, Sandro; Fenn, Timothy D.; Brunger, Axel T.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Brunger, Axel T.; Bryant, Zev] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Cipriano, Daniel J.; Bryant, Zev] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Bryant, Z (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	zevry@stanford.edu		Brunger, Axel/0000-0001-5121-2036	National Institutes of Health [R37-MH63105, DP2-OD004690]; Canadian Institutes of Health Research; American Heart Association; Pew Scholars Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH063105] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); American Heart Association(American Heart Association); Pew Scholars Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants R37-MH63105 (to A. T. B.) and DP2-OD004690 (to Z.B.).; Supported by postdoctoral fellowships from the Canadian Institutes of Health Research and from the American Heart Association.; Supported by a Pew Scholars Award. To whom correspondence should be addressed. Tel.: 650-724-3090; Fax: 650-723-8544; E-mail: zevry@stanford.edu.	Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; BJORNSON KP, 1994, BIOCHEMISTRY-US, V33, P14306, DOI 10.1021/bi00251a044; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 2009, ANNU REV BIOCHEM, V78, P903, DOI 10.1146/annurev.biochem.77.070306.103621; Burton RE, 2001, EMBO J, V20, P3092, DOI 10.1093/emboj/20.12.3092; Chang LF, 2012, NAT STRUCT MOL BIOL, V19, P268, DOI 10.1038/nsmb.2237; Davies J. M., 2008, THESIS STANFORD U; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Ernst JA, 2003, J BIOL CHEM, V278, P8630, DOI 10.1074/jbc.M211889200; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Haynes LP, 1998, FEBS LETT, V436, P1, DOI 10.1016/S0014-5793(98)01088-6; Hoskins JR, 2002, P NATL ACAD SCI USA, V99, P11037, DOI 10.1073/pnas.172378899; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Lauer JM, 2006, J BIOL CHEM, V281, P14823, DOI 10.1074/jbc.M512706200; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Matveeva E, 1998, FEBS LETT, V435, P211, DOI 10.1016/S0014-5793(98)01071-0; Matveeva EA, 1997, J BIOL CHEM, V272, P26413, DOI 10.1074/jbc.272.42.26413; May AP, 1999, NAT CELL BIOL, V1, P175, DOI 10.1038/11097; Moeller A, 2012, J STRUCT BIOL, V177, P335, DOI 10.1016/j.jsb.2011.12.018; Mogk A, 2008, BIOCHEM SOC T, V36, P120, DOI 10.1042/BST0360120; MORGAN A, 1994, J BIOL CHEM, V269, P29347; Okuno T, 2006, GENES CELLS, V11, P261, DOI 10.1111/j.1365-2443.2006.00940.x; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Scales SJ, 2001, P NATL ACAD SCI USA, V98, P14262, DOI 10.1073/pnas.251547598; Schumacher J, 2008, J MOL BIOL, V381, P1, DOI 10.1016/j.jmb.2008.05.075; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Soultanas P, 2012, MOL MICROBIOL, V84, P6, DOI 10.1111/j.1365-2958.2012.08012.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Swanton E, 2000, J CELL SCI, V113, P1783; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Whiteheart SW, 2001, INT REV CYTOL, V207, P71; Wimmer C, 2001, J BIOL CHEM, V276, P29091, DOI 10.1074/jbc.M011292200; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Yodh JG, 2010, Q REV BIOPHYS, V43, P185, DOI 10.1017/S0033583510000107; Yu RC, 1999, MOL CELL, V4, P97, DOI 10.1016/S1097-2765(00)80191-4; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Zhao CX, 2012, BBA-MOL CELL RES, V1823, P159, DOI 10.1016/j.bbamcr.2011.06.003; Zhao CX, 2010, J BIOL CHEM, V285, P761, DOI 10.1074/jbc.M109.056739	56	30	31	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23436	23445		10.1074/jbc.M113.476705	http://dx.doi.org/10.1074/jbc.M113.476705			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23775070	hybrid, Green Published			2022-12-25	WOS:000330598200050
J	Cervello, M; Bachvarov, D; Lampiasi, N; Cusimano, A; Azzolina, A; McCubrey, JA; Montalto, G				Cervello, Melchiorre; Bachvarov, Dimcho; Lampiasi, Nadia; Cusimano, Antonella; Azzolina, Antonina; McCubrey, James A.; Montalto, Giuseppe			Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; YES-ASSOCIATED PROTEIN; PROTEASOME INHIBITOR MG132; HIPPO PATHWAY; BETA-CATENIN; CYCLOOXYGENASE-2 INHIBITORS; SELECTIVE CYCLOOXYGENASE-1; POOR-PROGNOSIS; EXPRESSION; GROWTH	Molecular targeted therapy has shown promise as a treatment for advanced hepatocellular carcinoma (HCC). Sorafenib, a multikinase inhibitor, recently received FDA approval for the treatment of advanced HCC. However, although sorafenib is well tolerated, concern for its safety has been expressed. Celecoxib (Celebrex (R)) is a selective cyclooxygenase-2 (COX-2) inhibitor which exhibits antitumor effects in human HCC cells. The present study examined the interaction between celecoxib and sorafenib in two human liver tumor cell lines HepG2 and Huh7. Our data showed that each inhibitor alone reduced cell growth and the combination of celecoxib with sorafenib synergistically inhibited cell growth and increased apoptosis. To better understand the molecular mechanisms underlying the synergistic antitumor activity of the combination, we investigated the expression profile of the combination-treated liver cancer cell lines using microarray analysis. Combination treatment significantly altered expression levels of 1,986 and 2,483 transcripts in HepG2 and Huh7 cells, respectively. Genes functionally involved in cell death, signal transduction and regulation of transcription were predominantly up-regulated, while genes implicated in metabolism, cell-cycle control and DNA replication and repair were mainly down-regulated upon treatment. However, combination-treated HCC cell lines displayed specificity in the expression and activity of crucial factors involved in hepatocarcinogenesis. The altered expression of some of these genes was confirmed by semi-quantitative and quantitative RT-PCR and by Western blotting. Many novel genes emerged from our transcriptomic analyses, and further functional analyses may determine whether these genes can serve as potential molecular targets for more effective anti-HCC strategies.	[Cervello, Melchiorre; Lampiasi, Nadia; Cusimano, Antonella; Azzolina, Antonina; Montalto, Giuseppe] Natl Res Council CNR, Inst Biomed & Mol Immunol Alberto Monroy, Palermo, Italy; [Bachvarov, Dimcho] Ctr Hosp Univ Quebec, Canc Res Ctr, Hop Hotel Dieu Quebec, Quebec City, PQ, Canada; [Bachvarov, Dimcho] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ G1K 7P4, Canada; [McCubrey, James A.] E Carolina Univ, Dept Microbiol & Immunol, Brody Sch Med, Greenville, NC USA; [Montalto, Giuseppe] Univ Palermo, Biomed Dept Internal Med & Specialties, Palermo, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); Laval University; Laval University; University of North Carolina; East Carolina University; University of Palermo	Cervello, M (corresponding author), Natl Res Council CNR, Inst Biomed & Mol Immunol Alberto Monroy, Palermo, Italy.	cervello@ibim.cnr.it	Lampiasi, Nadia/AAC-8751-2019; Cervello, Melchiorre/K-5080-2016; Lampiasi, Nadia/AAR-8451-2020; Cervello, Melchiore/AAY-2923-2020	Lampiasi, Nadia/0000-0002-6831-4781; Lampiasi, Nadia/0000-0002-6831-4781; MONTALTO, Giuseppe/0000-0002-8731-8577; Bachvarov, Dimcho/0000-0001-6509-9599; McCubrey, James/0000-0001-6027-3156	Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca" (Ministry for Education, Universities and Research) - MIUR FIRB427 MERIT [RBNE08YYBM]; FRSQ-RR Cancer; Italian Ministry of Economy; Finance for the Project FaReBio di Qualita	Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca" (Ministry for Education, Universities and Research) - MIUR FIRB427 MERIT; FRSQ-RR Cancer; Italian Ministry of Economy; Finance for the Project FaReBio di Qualita	This work was supported in part by grants from the Italian "Ministero dell'Istruzione, dell'Universita e della Ricerca (Ministry for Education, Universities and Research) - MIUR FIRB427 MERIT n.RBNE08YYBM to M. C. and G. M.; D. B. is the Head of the Core Genomic Facility at the CHUQ-Cancer Research Centre, supported by FRSQ-RR Cancer. All the genomic experiments and data analyses were performed at this facility; M. C. has also been supported in part by a grant to the CNR from the Italian Ministry of Economy and Finance for the Project FaReBio di Qualita. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachvarov D, 2006, BIOL CHEM, V387, P15, DOI 10.1515/BC.2006.004; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bertini E, 2009, CELL CYCLE, V8, P49, DOI 10.4161/cc.8.1.7259; Cai CL, 2012, CELL CYCLE, V11, P1773, DOI 10.4161/cc.20121; CAO SS, 1989, CANCER CHEMOTH PHARM, V24, P181, DOI 10.1007/BF00300240; Cervello M, 2004, INT J MOL MED, V13, P741; Cervello M, 2001, EUR J CANCER, V37, P512, DOI 10.1016/S0959-8049(00)00421-4; Cervello M, 2006, WORLD J GASTROENTERO, V12, P5113; Cervello M, 2005, WORLD J GASTROENTERO, V11, P4638, DOI 10.3748/wjg.v11.i30.4638; Cervello M, 2012, CELL CYCLE, V11, P2843, DOI 10.4161/cc.21193; Cervello M, 2012, ONCOTARGET, V3, P236, DOI 10.18632/oncotarget.466; Cervello M, 2011, OMICS, V15, P383, DOI 10.1089/omi.2010.0092; Cusimano A, 2007, CANCER BIOL THER, V6, P1461; Cusimano A, 2010, CELL CYCLE, V9, P1399, DOI 10.4161/cc.9.7.11254; Cusimano A, 2009, ANN NY ACAD SCI, V1155, P300, DOI 10.1111/j.1749-6632.2009.03701.x; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fodera D, 2004, ANN NY ACAD SCI, V1028, P440, DOI 10.1196/annals.1322.052; French DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036713; Giannitrapani L, 2009, ANN NY ACAD SCI, V1155, P293, DOI 10.1111/j.1749-6632.2009.03698.x; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Hao HY, 2012, J CELL MOL MED, V16, P605, DOI 10.1111/j.1582-4934.2011.01338.x; Ho HK, 2009, J HEPATOL, V50, P118, DOI 10.1016/j.jhep.2008.08.015; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; Kern MA, 2002, HEPATOLOGY, V36, P885, DOI 10.1053/jhep.2002.36125; Koga H, 1999, HEPATOLOGY, V29, P688, DOI 10.1002/hep.510290355; Lampiasi N, 2006, INT J MOL MED, V17, P245; Lampiasi N, 2012, CANCER LETT, V322, P35, DOI 10.1016/j.canlet.2012.02.008; Lapi E, 2008, MOL CELL, V32, P803, DOI 10.1016/j.molcel.2008.11.019; Latasa MU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052711; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Mercier PL, 2011, MOL ONCOL, V5, P438, DOI 10.1016/j.molonc.2011.07.003; Miura S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-56; Montalto G, 2002, ANN NY ACAD SCI, V963, P13, DOI 10.1111/j.1749-6632.2002.tb04090.x; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nakamura M, 2008, ONCOGENE, V27, pS105, DOI 10.1038/onc.2009.48; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Poh WJ, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-14; Pyrzynska B, 2013, MOL ONCOL, V7, P67, DOI 10.1016/j.molonc.2012.08.003; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Schmidt CM, 2003, J GASTROINTEST SURG, V7, P1024, DOI 10.1016/j.gassur.2003.09.009; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Xu M, 2013, AM J PATHOL, V182, P84, DOI 10.1016/j.ajpath.2012.09.018; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yee KS, 2010, CELL CYCLE, V9, P1447, DOI 10.4161/cc.9.8.11480; Yu B, 2009, J HEPATOL, V50, P948, DOI 10.1016/j.jhep.2008.11.020; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	50	29	30	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65569	10.1371/journal.pone.0065569	http://dx.doi.org/10.1371/journal.pone.0065569			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776502	gold, Green Submitted, Green Published			2022-12-25	WOS:000320322400034
J	Cialabrini, L; Ruggieri, S; Kazanov, MD; Sorci, L; Mazzola, F; Orsomando, G; Osterman, AL; Raffaelli, N				Cialabrini, Lucia; Ruggieri, Silverio; Kazanov, Marat D.; Sorci, Leonardo; Mazzola, Francesca; Orsomando, Giuseppe; Osterman, Andrei L.; Raffaelli, Nadia			Genomics-Guided Analysis of NAD Recycling Yields Functional Elucidation of COG1058 as a New Family of Pyrophosphatases	PLOS ONE			English	Article							ESCHERICHIA-COLI MOEA; NICOTINAMIDE MONONUCLEOTIDE DEAMIDASE; ADP-RIBOSE; CRYSTAL-STRUCTURE; IONIZING-RADIATION; TRANSFER-RNA; METABOLISM; PROTEIN; ENZYME; IDENTIFICATION	We have recently identified the enzyme NMN deamidase (PncC), which plays a key role in the regeneration of NAD in bacteria by recycling back to the coenzyme the pyridine by-products of its non redox consumption. In several bacterial species, PncC is fused to a COG1058 domain of unknown function, highly conserved and widely distributed in all living organisms. Here, we demonstrate that the PncC-fused domain is endowed with a novel Co+2- and K+-dependent ADP-ribose pyrophosphatase activity, and discuss the functional connection of such an activity with NAD recycling. An in-depth phylogenetic analysis of the COG1058 domain evidenced that in most bacterial species it is fused to PncC, while in a-and some d-proteobacteria, as well as in archaea and fungi, it occurs as a stand-alone protein. Notably, in mammals and plants it is fused to FAD synthase. We extended the enzymatic characterization to a representative bacterial single-domain protein, which resulted to be a more versatile ADP-ribose pyrophosphatase, active also towards diadenosine 5'-diphosphate and FAD. Multiple sequence alignment analysis, and superposition of the available three-dimensional structure of an archaeal COG1058 member with the structure of the enzyme MoeA of the molybdenum cofactor biosynthesis, allowed identification of residues likely involved in catalysis. Their role has been confirmed by site-directed mutagenesis.	[Cialabrini, Lucia; Ruggieri, Silverio; Raffaelli, Nadia] Polytech Univ Marche, Dept Agr Food & Environm Sci, Ancona, Italy; [Kazanov, Marat D.] Russian Acad Sci, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia; [Sorci, Leonardo; Mazzola, Francesca; Orsomando, Giuseppe] Polytech Univ Marche, Dept Clin Sci, Ancona, Italy; [Osterman, Andrei L.] Sanford Burnham Med Res Inst, La Jolla, CA USA	Marche Polytechnic University; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Marche Polytechnic University; Sanford Burnham Prebys Medical Discovery Institute	Raffaelli, N (corresponding author), Polytech Univ Marche, Dept Agr Food & Environm Sci, Ancona, Italy.	n.raffaelli@univpm.it	SORCI, LEONARDO/AAD-7395-2019; Kazanov, Marat D/D-6381-2013; Orsomando, Giuseppe/L-2120-2015; Mazzola, Francesca/ADC-1197-2022	SORCI, LEONARDO/0000-0002-4356-8873; Kazanov, Marat D/0000-0002-2314-5507; Mazzola, Francesca/0000-0001-9140-012X; Orsomando, Giuseppe/0000-0001-6640-097X	Italian Ministry of Foreign Affairs, "Direzione Generale per la Promozione del Sistema Paese"; U.S. Department of Energy (DOE), Office of Biological and Environmental Research (BER) Genomic Science Program (GSP) as part of the Pacific Northwest National Laboratory (PNNL) Foundational Scientific Focus Area; Ministry of Education and Science of Russian Federation [8135, 8049]	Italian Ministry of Foreign Affairs, "Direzione Generale per la Promozione del Sistema Paese"(Ministry of Foreign Affairs and International Cooperation (Italy)); U.S. Department of Energy (DOE), Office of Biological and Environmental Research (BER) Genomic Science Program (GSP) as part of the Pacific Northwest National Laboratory (PNNL) Foundational Scientific Focus Area; Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation)	This research was partly supported by the Italian Ministry of Foreign Affairs, "Direzione Generale per la Promozione del Sistema Paese" to NR; by the U.S. Department of Energy (DOE), Office of Biological and Environmental Research (BER) Genomic Science Program (GSP) as part of the Pacific Northwest National Laboratory (PNNL) Foundational Scientific Focus Area to ALO; and by The Ministry of Education and Science of Russian Federation, projects 8135 and 8049 to MDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arn EA, 1996, J BIOL CHEM, V271, P31145, DOI 10.1074/jbc.271.49.31145; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHENG WL, 1995, J BACTERIOL, V177, P6711, DOI 10.1128/jb.177.23.6711-6717.1995; de Souza RF, 2012, MOL BIOSYST, V8, P1661, DOI 10.1039/c2mb05487f; Dunn CA, 1999, J BIOL CHEM, V274, P32318, DOI 10.1074/jbc.274.45.32318; Elias M, 2012, J BIOL CHEM, V287, P11, DOI 10.1074/jbc.R111.257329; Galeazzi L, 2011, J BIOL CHEM, V286, P40365, DOI 10.1074/jbc.M111.275818; Gazzaniga F, 2009, MICROBIOL MOL BIOL R, V73, P529, DOI 10.1128/MMBR.00042-08; Gerdes SY, 2006, J BACTERIOL, V188, P3012, DOI 10.1128/JB.188.8.3012-3023.2006; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Huang N, 2008, STRUCTURE, V16, P196, DOI 10.1016/j.str.2007.11.017; Huang N, 2009, STRUCTURE, V17, P939, DOI 10.1016/j.str.2009.05.012; JACOBSON EL, 1994, MOL CELL BIOCHEM, V138, P207, DOI 10.1007/BF00928463; Koch-Nolte F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.257mr1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin H, 2007, ORG BIOMOL CHEM, V5, P2541, DOI 10.1039/b706887e; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Llamas A, 2006, J BIOL CHEM, V281, P18343, DOI 10.1074/jbc.M601415200; LUDDEN PW, 1994, MOL CELL BIOCHEM, V138, P123, DOI 10.1007/BF00928453; Mair RW, 2012, FEMS MICROBIOL LETT, V331, P44, DOI 10.1111/j.1574-6968.2012.02550.x; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Nichols JD, 2007, BIOCHEMISTRY-US, V46, P78, DOI 10.1021/bi061551q; Okuda K, 2005, J BACTERIOL, V187, P4984, DOI 10.1128/JB.187.14.4984-4991.2005; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Raffaelli N, 1999, FEBS LETT, V444, P222, DOI 10.1016/S0014-5793(99)00068-X; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2047, DOI 10.1093/nar/gkn047; Rossi L, 2002, BIOCHIMIE, V84, P1229; Sanishvili R, 2004, J BIOL CHEM, V279, P42139, DOI 10.1074/jbc.M407694200; Schrag JD, 2001, J MOL BIOL, V310, P419, DOI 10.1006/jmbi.2001.4771; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Shull NP, 2005, NUCLEIC ACIDS RES, V33, P650, DOI 10.1093/nar/gki211; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sorci L, 2009, P NATL ACAD SCI USA, V106, P3083, DOI 10.1073/pnas.0811718106; Spinelli SL, 1999, J BIOL CHEM, V274, P2637, DOI 10.1074/jbc.274.5.2637; Stallings CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021807; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Tong L, 2010, BBA-PROTEINS PROTEOM, V1804, P1617, DOI 10.1016/j.bbapap.2010.02.007; Waller JC, 2010, P NATL ACAD SCI USA, V107, P10412, DOI 10.1073/pnas.0911586107; Xiang S, 2001, STRUCTURE, V9, P299, DOI 10.1016/S0969-2126(01)00588-3	47	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65595	10.1371/journal.pone.0065595	http://dx.doi.org/10.1371/journal.pone.0065595			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776507	gold, Green Published			2022-12-25	WOS:000320322400036
J	Euden, J; Mason, SA; Williams, AJ				Euden, Joanne; Mason, Sammy A.; Williams, Alan J.			Functional Characterization of the Cardiac Ryanodine Receptor Pore-Forming Region	PLOS ONE			English	Article							CALCIUM-RELEASE CHANNEL; TRANSMEMBRANE DOMAINS; CA2+-RELEASE CHANNEL; VOLTAGE-SENSOR; ION CONDUCTION; RYR1; SELECTIVITY; HELIX; MODEL; BLOCK	Ryanodine receptors are homotetrameric intracellular calcium release channels. The efficiency of these channels is underpinned by exceptional rates of cation translocation through the open channel and this is achieved at the expense of the high degree of selectivity characteristic of many other types of channel. Crystallization of prokaryotic potassium channels has provided insights into the structures and mechanisms responsible for ion selection and movement in these channels, however no equivalent structural detail is currently available for ryanodine receptors. Nevertheless both molecular modeling and cryo-electron microscopy have identified the probable pore-forming region (PFR) of the ryanodine receptor (RyR) and suggest that this region contains structural elements equivalent to those of the PFRs of potassium-selective channels. The aim of the current study was to establish if the isolated putative cardiac RyR (RyR2) PFR could form a functional ion channel. We have expressed and purified the RyR2 PFR and shown that function is retained following reconstitution into planar phospholipid bilayers. Our data provide the first direct experimental evidence to support the proposal that the conduction pathway of RyR2 is formed by structural elements equivalent to those of the potassium channel PFR.	[Euden, Joanne; Mason, Sammy A.; Williams, Alan J.] Cardiff Univ, Inst Mol & Expt Med, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	Euden, J (corresponding author), Cardiff Univ, Inst Mol & Expt Med, Cardiff CF10 3AX, S Glam, Wales.	eudenj@cardiff.ac.uk		euden, joanne/0000-0002-2844-6878; Williams, Alan/0000-0002-3770-8761	British Heart Foundation [RG/09/009/28069]	British Heart Foundation(British Heart Foundation)	British Heart Foundation Programme Grant no. RG/09/009/28069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balshaw D, 1999, P NATL ACAD SCI USA, V96, P3345, DOI 10.1073/pnas.96.7.3345; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2004, J MOL CELL CARDIOL, V37, P417, DOI 10.1016/j.yjmcc.2004.05.026; BORASO A, 1994, AM J PHYSIOL, V267, pH1010, DOI 10.1152/ajpheart.1994.267.3.H1010; Butterwick JA, 2010, J MOL BIOL, V403, P591, DOI 10.1016/j.jmb.2010.09.012; GOLA M, 1990, J PHYSIOL-LONDON, V420, P73, DOI 10.1113/jphysiol.1990.sp017902; HILLE B, 2001, ION CHANNELS EXCITAB, pCH12; Kang GB, 2007, PROTEIN PEPTIDE LETT, V14, P742; LINDSAY ARG, 1991, J PHYSIOL-LONDON, V439, P463, DOI 10.1113/jphysiol.1991.sp018676; LINDSAY ARG, 1991, BIOCHIM BIOPHYS ACTA, V1064, P89, DOI 10.1016/0005-2736(91)90415-5; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Mason SA, 2012, J GEN PHYSIOL, V140, P325, DOI 10.1085/jgp.201210851; McCusker EC, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.C111.228122; Mead F, 2002, BIOPHYS J, V82, P1953, DOI 10.1016/S0006-3495(02)75544-6; Mead-Savery FC, 2009, BIOPHYS J, V96, P1374, DOI 10.1016/j.bpj.2008.10.054; Meissner G, 2004, CELL CALCIUM, V35, P621, DOI 10.1016/j.ceca.2004.01.015; Pagliuca C, 2007, BIOCHEMISTRY-US, V46, P1079, DOI 10.1021/bi061530w; Ramachandran S, 2013, J BIOL CHEM; Ramachandran S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000367; Ranatunga KM, 2005, MOL PHARMACOL, V68, P840, DOI 10.1124/mol.105.012807; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Santos JS, 2008, J GEN PHYSIOL, V132, P651, DOI 10.1085/jgp.200810077; Shaya D, 2011, P NATL ACAD SCI US; Sugiharto S, 2008, BIOPHYS J, V95, P4698, DOI 10.1529/biophysj.107.125690; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Thompson AJ, 2003, BRIT J PHARMACOL, V140, P359, DOI 10.1038/sj.bjp.0705424; TINKER A, 1992, J GEN PHYSIOL, V100, P495, DOI 10.1085/jgp.100.3.495; TINKER A, 1993, J GEN PHYSIOL, V102, P1107, DOI 10.1085/jgp.102.6.1107; TINKER A, 1995, BIOPHYS J, V68, P111, DOI 10.1016/S0006-3495(95)80165-7; Welch W, 2004, BIOPHYS J, V87, P2335, DOI 10.1529/biophysj.104.044180; West DJ, 2007, CURR PHARM DESIGN, V13, P2428; WILLIAMS AJ, 1992, J MUSCLE RES CELL M, V13, P7, DOI 10.1007/BF01738423; Williams AJ, 2001, Q REV BIOPHYS, V34, P61, DOI 10.1017/S0033583501003675; Williams AJ, 2004, BIOL RES, V37, P527, DOI 10.4067/S0716-97602004000400006; Williams AJ, 2002, FRONT BIOSCI, V7, pD1223, DOI 10.2741/williams	36	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66542	10.1371/journal.pone.0066542	http://dx.doi.org/10.1371/journal.pone.0066542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776685	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000320322400110
J	Khan, S; Garg, A; Sharma, A; Camacho, N; Picchioni, D; Saint-Leger, A; de Pouplana, LR; Yogavel, M; Sharma, A				Khan, Sameena; Garg, Ankur; Sharma, Arvind; Camacho, Noelia; Picchioni, Daria; Saint-Leger, Adelaide; Ribas de Pouplana, Lluis; Yogavel, Manickam; Sharma, Amit			An Appended Domain Results in an Unusual Architecture for Malaria Parasite Tryptophanyl-tRNA Synthetase	PLOS ONE			English	Article							BINDING; AMINOACYLATION; RECOGNITION; EVOLUTION	Specific activation of amino acids by aminoacyl-tRNA synthetases (aaRSs) is essential for maintaining fidelity during protein translation. Here, we present crystal structure of malaria parasite Plasmodium falciparum tryptophanyl-tRNA synthetase (Pf-WRS) catalytic domain (AAD) at 2.6 angstrom resolution in complex with L-tryptophan. Confocal microscopy-based localization data suggest cytoplasmic residency of this protein. Pf-WRS has an unusual N-terminal extension of AlaX-like domain (AXD) along with linker regions which together seem vital for enzymatic activity and tRNA binding. Pf-WRS is not proteolytically processed in the parasites and therefore AXD likely provides tRNA binding capability rather than editing activity. The N-terminal domain containing AXD and linker region is monomeric and would result in an unusual overall architecture for Pf-WRS where the dimeric catalytic domains have monomeric AXDs on either side. Our PDB-wide comparative analyses of 47 WRS crystal structures also provide new mechanistic insights into this enzyme family in context conserved KMSKS loop conformations.	[Khan, Sameena; Garg, Ankur; Sharma, Arvind; Yogavel, Manickam; Sharma, Amit] ICGEB, Struct & Computat Biol Grp, New Delhi, India; [Camacho, Noelia; Picchioni, Daria; Saint-Leger, Adelaide; Ribas de Pouplana, Lluis] IRB Barcelona, Barcelona, Catalonia, Spain; [Ribas de Pouplana, Lluis] Catalan Inst Res & Adv Studies ICREA, Barcelona, Catalonia, Spain	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; ICREA	Sharma, A (corresponding author), ICGEB, Struct & Computat Biol Grp, New Delhi, India.	amit.icgeb@gmail.com	Sharma, Arvind/ABG-2614-2021; Manickam, Yogavel/O-4570-2015; de Pouplana, Lluis Ribas/AAA-4738-2019	Sharma, Arvind/0000-0002-7029-9867; Manickam, Yogavel/0000-0002-2119-062X; de Pouplana, Lluis Ribas/0000-0002-2087-0359; Garg, Ankur/0000-0003-2397-1670	Department of Biotechnology, Govt. of India; ICREA Funding Source: Custom	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); ICREA(ICREA)	The funding agency for this work is the Department of Biotechnology, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Bhatt TK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1522; Bhatt TK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-644; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; CUSACK S, 1995, NAT STRUCT BIOL, V2, P824, DOI 10.1038/nsb1095-824; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLECKNER J, 1995, CYTOKINE, V7, P70, DOI 10.1006/cyto.1995.1009; Fukunaga R, 2007, ACTA CRYSTALLOGR D, V63, P390, DOI 10.1107/S090744490605640X; Guo M, 2009, SCIENCE, V325, P744, DOI 10.1126/science.1174343; Hoepfner D, 2012, CELL HOST MICROBE, V11, P654, DOI 10.1016/j.chom.2012.04.015; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jackson KE, 2011, TRENDS PARASITOL, V27, P467, DOI 10.1016/j.pt.2011.05.005; Khan S, 2013, ACTA CRYSTALLOGR D; Khan S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00188; Kise Y, 2004, NAT STRUCT MOL BIOL, V11, P149, DOI 10.1038/nsmb722; KISSELEV L, 1993, TRENDS BIOCHEM SCI, V18, P263, DOI 10.1016/0968-0004(93)90178-P; KISSELEV LL, 1993, BIOCHIMIE, V75, P1027, DOI 10.1016/0300-9084(93)90002-A; LEMAIRE G, 1975, EUR J BIOCHEM, V51, P237, DOI 10.1111/j.1432-1033.1975.tb03924.x; Merritt EA, 2011, MOL BIOCHEM PARASIT, V177, P20, DOI 10.1016/j.molbiopara.2011.01.003; Naganuma M, 2009, P NATL ACAD SCI USA, V106, P8489, DOI 10.1073/pnas.0901572106; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Retailleau P, 2003, J MOL BIOL, V325, P39, DOI 10.1016/S0022-2836(02)01156-7; SALLAFRANQUE ML, 1986, BIOCHIM BIOPHYS ACTA, V882, P192, DOI 10.1016/0304-4165(86)90155-8; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Schimmel P, 2000, TRENDS BIOCHEM SCI, V25, P207, DOI 10.1016/S0968-0004(00)01553-X; SCHULMAN LH, 1983, P NATL ACAD SCI-BIOL, V80, P6755, DOI 10.1073/pnas.80.22.6755; Sokabe M, 2005, P NATL ACAD SCI USA, V102, P11669, DOI 10.1073/pnas.0502119102; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wolf YI, 1999, GENOME RES, V9, P689; Yu YD, 2004, J BIOL CHEM, V279, P8378, DOI 10.1074/jbc.M311284200	35	15	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66224	10.1371/journal.pone.0066224	http://dx.doi.org/10.1371/journal.pone.0066224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776638	gold, Green Submitted, Green Published			2022-12-25	WOS:000320322400090
J	Landmark, T; Romundstad, PR; Borchgrevink, PC; Kaasa, S; Dale, O				Landmark, Tormod; Romundstad, Pal R.; Borchgrevink, Petter C.; Kaasa, Stein; Dale, Ola			Longitudinal Associations between Exercise and Pain in the General Population - The HUNT Pain Study	PLOS ONE			English	Article							NORD-TRONDELAG HEALTH; LOW-BACK-PAIN; PHYSICAL-ACTIVITY; LEISURE-TIME; RISK-FACTORS; WORK; INDIVIDUALS; PREVALENCE; DISABILITY; VALIDITY	Background: Population-based studies have reported conflicting findings on the relationship between physical activity and pain, and most studies reporting a relationship are cross sectional. Temporal relationships are therefore difficult to infer and associations may be subject to confounding from a variety of other factors. The aim of the current study was to investigate the association between exercise and pain longitudinally and to use within subjects analyses to remove between subjects confounding. Methods: In the population-based HUNT 3 study, participants reported both pain and level of exercise. A random sub-sample of 6419 participants was in addition invited to report their last week pain and exercise every three months over a 12 month period (five measurements in total). We used multilevel mixed effects linear regression analyses to prospectively estimate the association between regular levels of exercise (measured in HUNT 3) and subsequent longitudinal reporting of pain. We also estimated within-subjects associations (i.e. the variation in pain as a function of variation in exercise, over time, within individuals) to avoid confounding from between subject factors. Results: Among those invited to participate (N = 6419), 4219 subjects returned at least two questionnaires. Compared with subjects who reported no or light exercise, those who reported moderate levels of exercise or more at baseline, reported less pain in repeated measures over a 12 month period in analyses adjusted for age, sex, education and smoking. Adjusting for baseline level of pain distinctly attenuated the findings. Within subjects, an increase in exercise was accompanied by a concurrent reduction in intensity of pain. However, we found no indication that exercise level at one occasion was related to pain reporting three months later. Conclusion: This longitudinal population-based study indicates that exercise is associated with lower level of pain and that this association is close in time.	[Landmark, Tormod; Kaasa, Stein] Norwegian Univ Sci & Technol, Fac Med, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Landmark, Tormod; Borchgrevink, Petter C.] St Olavs Univ Hosp, Natl Competence Ctr Complex Symptom Disorders, Trondheim, Norway; [Romundstad, Pal R.] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth, N-7034 Trondheim, Norway; [Borchgrevink, Petter C.; Dale, Ola] Norwegian Univ Sci & Technol, Fac Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Kaasa, Stein] St Olavs Univ Hosp, Dept Oncol, Trondheim, Norway; [Dale, Ola] St Olavs Univ Hosp, Dept Anaesthesia & Emergency Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Landmark, T (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway.	tormod.landmark@ntnu.no		Romundstad, Pal Richard/0000-0003-2061-4336	Research Council of Norway	Research Council of Norway(Research Council of Norway)	This work has been funded by the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell JA, 2009, J OCCUP REHABIL, V19, P8, DOI 10.1007/s10926-009-9164-5; Bergman S, 2007, BEST PRACT RES CL RH, V21, P191, DOI 10.1016/j.berh.2006.08.012; Borg G., 1998, BORGS PERCEIVED EXER, V8; Busch A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003786.pub2; Chen MJ, 2002, J SPORT SCI, V20, P873, DOI 10.1080/026404102320761787; Choi BKL, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006555.pub2; Dagenais S, 2009, SPINE J, V9, P944, DOI 10.1016/j.spinee.2009.07.007; Dugan SA, 2009, J PHYS ACT HEALTH, V6, P33, DOI 10.1123/jpah.6.1.33; Eriksen J, 2004, EUR J PAIN, V8, P517, DOI 10.1016/j.ejpain.2003.12.001; Gerdle B, 2004, J RHEUMATOL, V31, P1399; Gjesdal S, 2004, EUR J PUBLIC HEALTH, V14, P398, DOI 10.1093/eurpub/14.4.398; Glymour MM, 2005, AM J EPIDEMIOL, V162, P267, DOI 10.1093/aje/kwi187; Hayden JA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000335.pub2; Heneweer H, 2012, EUR SPINE J, V21, P1265, DOI 10.1007/s00586-011-2097-7; Heneweer H, 2011, EUR SPINE J, V20, P826, DOI 10.1007/s00586-010-1680-7; Heneweer H, 2009, PAIN, V143, P21, DOI 10.1016/j.pain.2008.12.033; Hildebrandt VH, 2000, INT ARCH OCC ENV HEA, V73, P507, DOI 10.1007/s004200000167; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Holth HS, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-159; Hoogendoorn WE, 1999, SCAND J WORK ENV HEA, V25, P387, DOI 10.5271/sjweh.451; Jacob T, 2004, MED SCI SPORT EXER, V36, P9, DOI 10.1249/01.MSS.0000106166.94343.02; Kraemer HC, 2001, AM J PSYCHIAT, V158, P848, DOI 10.1176/appi.ajp.158.6.848; Krueger AB, 2008, LANCET, V371, P1519, DOI 10.1016/S0140-6736(08)60656-X; Kurtze N, 2008, SCAND J PUBLIC HEALT, V36, P52, DOI 10.1177/1403494807085373; Landmark T, 2012, PAIN, V153, P1368, DOI 10.1016/j.pain.2012.02.004; Landmark T, 2011, PAIN, V152, P2241, DOI 10.1016/j.pain.2011.04.029; Manchikanti L, 2009, PAIN PHYSICIAN, V12, pE35; Mantyselka PT, 2003, JAMA-J AM MED ASSOC, V290, P2435, DOI 10.1001/jama.290.18.2435; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Nes BM, 2012, MED SCI SPORT EXER, V44, P1881, DOI 10.1249/MSS.0b013e318258b443; Ospina M., 2002, 28 ALB HER FDN MED R; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Sloan JA, 2005, J CLIN EPIDEMIOL, V58, P1217, DOI 10.1016/j.jclinepi.2005.07.009; Sprangers MAG, 2000, J CLIN EPIDEMIOL, V53, P895, DOI 10.1016/S0895-4356(00)00204-3; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Von Korff M, 2000, SPINE, V25, P3140, DOI 10.1097/00007632-200012150-00009; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE Jr, 2001, SCORE INTERPRET SING; Watkins EA, 2008, PAIN MED, V9, P166, DOI 10.1111/j.1526-4637.2007.00280.x	39	51	51	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65279	10.1371/journal.pone.0065279	http://dx.doi.org/10.1371/journal.pone.0065279			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776464	gold, Green Published, Green Submitted			2022-12-25	WOS:000320322400014
J	Narazaki, T; Sato, K; Abernathy, KJ; Marshall, GJ; Miyazaki, N				Narazaki, Tomoko; Sato, Katsufumi; Abernathy, Kyler J.; Marshall, Greg J.; Miyazaki, Nobuyuki			Loggerhead Turtles (Caretta caretta) Use Vision to Forage on Gelatinous Prey in Mid-Water	PLOS ONE			English	Article							FLIPPER BEAT FREQUENCY; ANIMAL-BORNE VIDEO; SEA-TURTLES; DERMOCHELYS-CORIACEA; GREEN TURTLES; LEATHERBACK TURTLES; WEDDELL SEALS; DIVE PROFILES; FEEDING-BEHAVIOR; DIVING BEHAVIOR	Identifying characteristics of foraging activity is fundamental to understanding an animals' lifestyle and foraging ecology. Despite its importance, monitoring the foraging activities of marine animals is difficult because direct observation is rarely possible. In this study, we use an animal-borne imaging system and three-dimensional data logger simultaneously to observe the foraging behaviour of large juvenile and adult sized loggerhead turtles (Caretta caretta) in their natural environment. Video recordings showed that the turtles foraged on gelatinous prey while swimming in mid-water (i.e., defined as epipelagic water column deeper than 1 m in this study). By linking video and 3D data, we found that mid-water foraging events share the common feature of a marked deceleration phase associated with the capture and handling of the sluggish prey. Analysis of high-resolution 3D movements during mid-water foraging events, including presumptive events extracted from 3D data using deceleration in swim speed as a proxy for foraging (detection rate = 0.67), showed that turtles swam straight toward prey in 171 events (i.e., turning point absent) but made a single turn toward the prey an average of 5.766.0 m before reaching the prey in 229 events (i.e., turning point present). Foraging events with a turning point tended to occur during the daytime, suggesting that turtles primarily used visual cues to locate prey. In addition, an incident of a turtle encountering a plastic bag while swimming in mid-water was recorded. The fact that the turtle's movements while approaching the plastic bag were analogous to those of a true foraging event, having a turning point and deceleration phase, also support the use of vision in mid-water foraging. Our study shows that integrated video and high-resolution 3D data analysis provides unique opportunities to understand foraging behaviours in the context of the sensory ecology involved in prey location.	[Narazaki, Tomoko; Sato, Katsufumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Int Coastal Res Ctr, Kashiwa, Chiba, Japan; [Abernathy, Kyler J.; Marshall, Greg J.] Natl Geog Remote Imaging, Washington, DC USA; [Miyazaki, Nobuyuki] Ocean Policy Res Fdn, Tokyo, Japan	University of Tokyo; National Geographic Society	Narazaki, T (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, Int Coastal Res Ctr, Kashiwa, Chiba, Japan.	tnarazaki@aori.u-tokyo.ac.jp		Miyazaki, Nobuyuki/0000-0001-8094-683X	program 'Bio-logging Science'; University of Tokyo (UTBLS); National Geographic Remote Imaging; JSPS [A1925501, 21-7432]; Japan Science Society [19-526]	program 'Bio-logging Science'; University of Tokyo (UTBLS); National Geographic Remote Imaging(National Geographic Society); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science Society	This work was supported by the program 'Bio-logging Science', The University of Tokyo (UTBLS), National Geographic Remote Imaging, a JSPS research grant (A1925501 to KS), a JSPS Research Fellowship for Young Scientists to TN (21-7432) and a Sasakawa Scientific Research Grant from The Japan Science Society to TN (19-526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2012, MAR ECOL PROG SER, V444, P289, DOI 10.3354/meps09371; Barnard CJ, 1983, ANIMAL BEHAV ECOLOGY; Bartol SM, 2002, J COMP PHYSIOL A, V187, P953, DOI 10.1007/s00359-001-0262-x; Bartol SM, 2003, CRC MAR BIOL SER, P79; Bartol SM, 2003, INT J COMP PSYCHOL, V26, P143; Bjorndal Karen A., 1997, P199; Casale P, 2008, MAR ECOL PROG SER, V372, P265, DOI 10.3354/meps07702; Constantino MA, 2003, ZOOLOGY, V106, P173, DOI 10.1078/0944-2006-00114; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; Dodd CK, 1988, BIOL REP, V88, P1; Doyle TK, 2008, J PLANKTON RES, V30, P963, DOI 10.1093/plankt/fbn052; Doyle TK, 2007, J EXP MAR BIOL ECOL, V343, P239, DOI 10.1016/j.jembe.2006.12.010; Endres CS, 2009, J EXP BIOL, V212, P3823, DOI 10.1242/jeb.033068; Fossette S, 2008, J ANIM ECOL, V77, P236, DOI 10.1111/j.1365-2656.2007.01344.x; Fossette S, 2012, BIOL LETTERS, V8, P351, DOI 10.1098/rsbl.2011.0965; Fossette S, 2010, J MARINE SYST, V81, P225, DOI 10.1016/j.jmarsys.2009.12.002; Haddock SHD, 1999, MAR BIOL, V133, P571, DOI 10.1007/s002270050497; Hanuise N, 2010, J EXP BIOL, V213, P3874, DOI 10.1242/jeb.044057; Hatase H, 2002, MAR ECOL PROG SER, V233, P273, DOI 10.3354/meps233273; Hawkes LA, 2006, CURR BIOL, V16, P990, DOI 10.1016/j.cub.2006.03.063; Hays GC, 2001, J EXP BIOL, V204, P4093; Hays GC, 2004, J EXP MAR BIOL ECOL, V303, P243, DOI 10.1016/j.jembe.2003.11.010; Hays GC, 2004, ECOLOGY, V85, P1137, DOI 10.1890/03-0251; Hays GC, 2007, MAR BIOL, V150, P1003, DOI 10.1007/s00227-006-0412-3; Heaslip SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033259; Heithaus MR, 2002, J MAR BIOL ASSOC UK, V82, P1049, DOI 10.1017/S0025315402006689; Hochscheid S, 1999, MAR ECOL PROG SER, V185, P101, DOI 10.3354/meps185101; Hooker SK, 2002, MAR MAMMAL SCI, V18, P680, DOI 10.1111/j.1748-7692.2002.tb01066.x; Houghton JDR, 2002, MAR ECOL PROG SER, V227, P63, DOI 10.3354/meps227063; Iwata T, 2012, MAR MAMMAL SCI, V28, P345, DOI 10.1111/j.1748-7692.2011.00482.x; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; Kamezaki N., 1995, UMIGAME NEWSLETTER J, V26, P12; Kokubun N, 2011, J EXP BIOL, V214, P3760, DOI 10.1242/jeb.058263; Kramer Donald L., 2001, P232; Levenson DH, 2004, COPEIA, P908, DOI 10.1643/CP-03-217R1; Liebsch N, 2007, DEEP-SEA RES PT II, V54, P256, DOI 10.1016/j.dsr2.2006.11.014; Madden KM, 2008, MAR ECOL PROG SER, V365, P263, DOI 10.3354/meps07396; Marshall CD, 2012, J EXP BIOL, V215, P4166, DOI 10.1242/jeb.074385; Mazur MM, 2003, ENVIRON BIOL FISH, V67, P397, DOI 10.1023/A:1025807711512; McClellan CM, 2007, BIOLOGY LETT, V3, P592, DOI 10.1098/rsbl.2007.0355; McClellan CM, 2010, J EXP MAR BIOL ECOL, V387, P44, DOI 10.1016/j.jembe.2010.02.020; Miller PJO, 2004, P ROY SOC B-BIOL SCI, V271, P2239, DOI 10.1098/rspb.2004.2863; Minamikawa S, 2000, J EXP BIOL, V203, P2967; Mitani Y, 2003, POLAR BIOL, V26, P311, DOI 10.1007/s00300-003-0487-y; Musick John A., 1997, P137; Myers AE, 2006, MAR ECOL PROG SER, V322, P259, DOI 10.3354/meps322259; Naito Y, 2010, POLAR SCI, V4, P309, DOI 10.1016/j.polar.2010.05.009; Naito Y, 2013, FUNCT ECOL, V27, P710, DOI 10.1111/1365-2435.12083; Narazaki T, 2009, J EXP BIOL, V212, P4019, DOI 10.1242/jeb.034637; Narazaki T, 2010, RECONSTRUCTION 3 D P; Narazaki T, 2009, THESIS U TOKYO TOKYO; NELSON DONALD R., 1963, SCIENCE, V142, P975, DOI 10.1126/science.142.3594.975; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; Nevitt GA, 2008, P NATL ACAD SCI USA, V105, P4576, DOI 10.1073/pnas.0709047105; OGDEN JC, 1983, J EXP MAR BIOL ECOL, V66, P199, DOI 10.1016/0022-0981(83)90160-0; Okuyama Junichi, 2010, Endangered Species Research, V10, P39, DOI 10.3354/esr00215; PLOTKIN PT, 1993, MAR BIOL, V115, P1, DOI 10.1007/BF00349379; Ponganis PJ, 2000, J EXP BIOL, V203, P3275; Reich KJ, 2010, MAR BIOL, V157, P113, DOI 10.1007/s00227-009-1300-4; Reina RD, 2005, J EXP MAR BIOL ECOL, V316, P1, DOI 10.1016/j.jembe.2004.10.002; Sato K, 2003, MAR MAMMAL SCI, V19, P384, DOI 10.1111/j.1748-7692.2003.tb01116.x; Schofield Gail, 2006, Endangered Species Research, V2, P71, DOI 10.3354/esr002071; Seminoff JA, 2006, MAR ECOL PROG SER, V322, P269, DOI 10.3354/meps322269; Seney EE, 2007, COPEIA, P478, DOI 10.1643/0045-8511(2007)7[478:HDAOLS]2.0.CO;2; Shiomi K, 2008, AQUAT BIOL, V3, P265, DOI 10.3354/ab00087; Simeone A, 2003, MAR BIOL, V143, P825, DOI 10.1007/s00227-003-1114-8; Southwood Amanda, 2008, Endangered Species Research, V5, P225, DOI 10.3354/esr00097; Sperling Jannie Bech, 2008, Marine Turtle Newsletter, P9; Takahashi A., 2004, Marine Ornithology, V32, P47; Takahashi A, 2008, POLAR BIOL, V31, P1291, DOI 10.1007/s00300-008-0502-4; Takuma S, 2010, THESIS U TOKYO TOKYO; Tomas J, 2002, MAR POLLUT BULL, V44, P211, DOI 10.1016/S0025-326X(01)00236-3; Vickers NJ, 2000, BIOL BULL, V198, P203, DOI 10.2307/1542524; Watanabe Y, 2004, MAR ECOL PROG SER, V279, P283, DOI 10.3354/meps279283; Watanabe Y, 2003, MAR ECOL PROG SER, V252, P283, DOI 10.3354/meps252283; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; Watanabe YY, 2011, J ANIM ECOL, V80, P57, DOI 10.1111/j.1365-2656.2010.01760.x; Watanuki Y, 2008, MAR ECOL PROG SER, V356, P283, DOI 10.3354/meps07266; Wilson RP, 2007, DEEP-SEA RES PT II, V54, P193, DOI 10.1016/j.dsr2.2006.11.017; Wilson RP, 2002, MAR BIOL, V140, P17, DOI 10.1007/s002270100659; WILSON RP, 1993, MAR ECOL PROG SER, V94, P101; Wilson RP, 2002, ANIM BEHAV, V63, P85, DOI 10.1006/anbe.2001.1883	82	50	50	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66043	10.1371/journal.pone.0066043	http://dx.doi.org/10.1371/journal.pone.0066043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776603	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400074
J	Cabezas-Cruz, A; Passos, LMF; Lis, K; Kenneil, R; Valdes, JJ; Ferrolho, J; Tonk, M; Pohl, AE; Grubhoffer, L; Zweygarth, E; Shkap, V; Ribeiro, MFB; Estrada-Pena, A; Kocan, KM; de la Fuente, J				Cabezas-Cruz, Alejandro; Passos, Lygia M. F.; Lis, Katarzyna; Kenneil, Rachel; Valdes, James J.; Ferrolho, Joana; Tonk, Miray; Pohl, Anna E.; Grubhoffer, Libor; Zweygarth, Erich; Shkap, Varda; Ribeiro, Mucio F. B.; Estrada-Pena, Agustin; Kocan, Katherine M.; de la Fuente, Jose			Functional and Immunological Relevance of Anaplasma marginale Major Surface Protein 1a Sequence and Structural Analysis	PLOS ONE			English	Article							CD4(+) T-LYMPHOCYTES; B-CELL EPITOPES; NEUTRALIZATION-SENSITIVE EPITOPE; TICK-BORNE TRANSMISSION; BOOPHILUS-MICROPLUS; MAMMALIAN RESERVOIR; CYCLIC TRANSMISSION; GENETIC DIVERSITY; SALIVARY-GLANDS; MOLECULAR-BASIS	Bovine anaplasmosis is caused by cattle infection with the tick-borne bacterium, Anaplasma marginale. The major surface protein 1a (MSP1a) has been used as a genetic marker for identifying A. marginale strains based on N-terminal tandem repeats and a 5'-UTR microsatellite located in the msp1a gene. The MSP1a tandem repeats contain immune relevant elements and functional domains that bind to bovine erythrocytes and tick cells, thus providing information about the evolution of host-pathogen and vector-pathogen interactions. Here we propose one nomenclature for A. marginale strain classification based on MSP1a. All tandem repeats among A. marginale strains were classified and the amino acid variability/frequency in each position was determined. The sequence variation at immunodominant B cell epitopes was determined and the secondary (2D) structure of the tandem repeats was modeled. A total of 224 different strains of A. marginale were classified, showing 11 genotypes based on the 5'-UTR microsatellite and 193 different tandem repeats with high amino acid variability per position. Our results showed phylogenetic correlation between MSP1a sequence, secondary structure, B-cell epitope composition and tick transmissibility of A. marginale strains. The analysis of MSP1a sequences provides relevant information about the biology of A. marginale to design vaccines with a cross-protective capacity based on MSP1a B-cell epitopes.	[Cabezas-Cruz, Alejandro; Valdes, James J.; Tonk, Miray; Grubhoffer, Libor] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Cabezas-Cruz, Alejandro; Valdes, James J.; Tonk, Miray; Grubhoffer, Libor] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, CR-37005 Ceske Budejovice, Czech Republic; [Passos, Lygia M. F.; Lis, Katarzyna; Kenneil, Rachel; Pohl, Anna E.; Zweygarth, Erich] Univ Munich, Inst Comparat Trop Med & Parasitol, Munich, Germany; [Passos, Lygia M. F.] Univ Fed Minas Gerais, Escola Vet, Dept Vet Prevent Med, Belo Horizonte, MG, Brazil; [Ferrolho, Joana] Pirbright Inst, Pirbright Lab, Pirbright, Surrey, England; [Shkap, Varda] Kimron Vet Inst, Div Parasitol, IL-50250 Bet Dagan, Israel; [Ribeiro, Mucio F. B.] Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil; [Estrada-Pena, Agustin] Univ Zaragoza, Fac Vet, Zaragoza, Spain; [Kocan, Katherine M.; de la Fuente, Jose] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA; [de la Fuente, Jose] IREC CSIC UCLM JCCM, Inst Invest Recursos Cineget, Ciudad Real, Spain	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Munich; Universidade Federal de Minas Gerais; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Kimron Veterinary Institute; Universidade Federal de Minas Gerais; University of Zaragoza; Oklahoma State University System; Oklahoma State University - Stillwater; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha	de la Fuente, J (corresponding author), Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA.	jose_delafuente@yahoo.com	Valdés, James/G-9812-2014; Tonk-Rügen, Miray/AAZ-3868-2020; Ferrolho, Joana/J-2307-2014; de la Fuente, José/AAU-1197-2020; Grubhoffer, Libor/G-9762-2014; Cabezas-Cruz, Alejandro/P-2755-2017	Valdés, James/0000-0002-0237-8061; Tonk-Rügen, Miray/0000-0001-8249-8452; Ferrolho, Joana/0000-0002-1300-4487; de la Fuente, José/0000-0001-7383-9649; Grubhoffer, Libor/0000-0003-0885-1849; Cabezas-Cruz, Alejandro/0000-0002-8660-730X; Estrada Pena, Agustin/0000-0001-7483-046X	POSTICK ITN (Post-graduate training network for capacity building to control ticks and tick-borne diseases) within the FP7-PEOPLE-ITN programme (EU) [238511]; European Social Fund; state budget of the Czech Republic;  [BFU2011-23896];  [CZ.1.07/2.3.00/30.0032]	POSTICK ITN (Post-graduate training network for capacity building to control ticks and tick-borne diseases) within the FP7-PEOPLE-ITN programme (EU); European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; ; 	This research was supported by POSTICK ITN (Post-graduate training network for capacity building to control ticks and tick-borne diseases) within the FP7-PEOPLE-ITN programme (EU Grant No. 238511) and BFU2011-23896 grant to JF. JJV was sponsored by project CZ.1.07/2.3.00/30.0032, co-financed by the European Social Fund and the state budget of the Czech Republic. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLRED DR, 1990, P NATL ACAD SCI USA, V87, P3220, DOI 10.1073/pnas.87.8.3220; Aubry P, 2011, TRANSBOUND EMERG DIS, V58, P1, DOI 10.1111/j.1865-1682.2010.01173.x; BARBET AF, 1987, INFECT IMMUN, V55, P2428, DOI 10.1128/IAI.55.10.2428-2435.1987; Barbet AF, 2001, INFECT IMMUN, V69, P3057, DOI 10.1128/IAI.69.5.3057-3066.2001; Barbet AF, 1999, INFECT IMMUN, V67, P102, DOI 10.1128/IAI.67.1.102-107.1999; Benz I, 2002, MOL MICROBIOL, V45, P267, DOI 10.1046/j.1365-2958.2002.03030.x; Blouin EF, 2003, VET PARASITOL, V111, P247, DOI 10.1016/S0304-4017(02)00378-3; Bowie MV, 2002, GENE, V282, P95, DOI 10.1016/S0378-1119(01)00845-9; Brown WC, 2002, INFECT IMMUN, V70, P5521, DOI 10.1128/IAI.70.10.5521-5532.2002; Brown WC, 2001, INFECT IMMUN, V69, P6853, DOI 10.1128/IAI.69.11.6853-6862.2001; Brown WC, 2001, J IMMUNOL, V166, P1114, DOI 10.4049/jimmunol.166.2.1114; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chavez ASO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036012; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; de la Fuente J, 2005, J VET MED B, V52, P226, DOI 10.1111/j.1439-0450.2005.00851.x; de la Fuente J, 2004, VET PARASITOL, V121, P307, DOI 10.1016/j.vetpar.2004.02.021; de la Fuente J, 2003, VET MICROBIOL, V91, P265, DOI 10.1016/S0378-1135(02)00309-7; de la Fuente J, 2001, INT J PARASITOL, V31, P1705, DOI 10.1016/S0020-7519(01)00287-9; de la Fuente J, 2001, INT J PARASITOL, V31, P145, DOI 10.1016/S0020-7519(00)00162-4; de la Fuente J, 2007, VET MICROBIOL, V119, P382; de la Fuente J, 2003, INT J APPL RES VET M, V1; de la Fuente Jose, 2005, Anim Health Res Rev, V6, P75; de la Fuente Jose, 2001, Animal Health Research Reviews, V2, P163; de la Fuente J, 2010, VET PARASITOL, V167, P175, DOI 10.1016/j.vetpar.2009.09.019; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; Elias I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-89; Estrada-Pena A, 2012, J MED ENTOMOL, V49, P794, DOI 10.1603/ME11223; Estrada-Pena A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-57; FELSENSTEIN J, 1989, SCIENCE, V246, P941, DOI 10.1126/science.246.4932.941; Futse JE, 2003, J CLIN MICROBIOL, V41, P3829, DOI 10.1128/JCM.41.8.3829-3834.2003; Garcia-Garcia JC, 2004, VET IMMUNOL IMMUNOP, V98, P137, DOI 10.1016/j.vetimm.2003.11.003; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kindt T. J., 2007, KUBY IMMUNOLOGY, p[xxii, 574, A, G, AN, 1]; Kocan KA, 2003, VET PARASITOL, V112, P295, DOI 10.1016/S0304-4017(03)00018-9; Kocan KM, 2010, VET PARASITOL, V167, P95, DOI 10.1016/j.vetpar.2009.09.012; Kocan KM, 2004, PARASITOLOGY, V129, pS285, DOI 10.1017/S0031182003004700; Kocan KM, 2003, CLIN MICROBIOL REV, V16, P698, DOI 10.1128/CMR.16.4.698-712.2003; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Leverich CK, 2008, INFECT IMMUN, V76, P4066, DOI 10.1128/IAI.00594-08; Lew AE, 2002, VET MICROBIOL, V86, P325, DOI 10.1016/S0378-1135(02)00017-2; Maritz-Olivier C, 2012, TICKS TICK-BORNE DIS, V3, P179, DOI 10.1016/j.ttbdis.2012.01.003; Mayrose I, 2007, BIOINFORMATICS, V23, P3244, DOI 10.1093/bioinformatics/btm493; Mayrose I, 2007, NUCLEIC ACIDS RES, V35, P69, DOI 10.1093/nar/gkl975; MCGAREY DJ, 1994, INFECT IMMUN, V62, P4594, DOI 10.1128/IAI.62.10.4594-4601.1994; OBERLE SM, 1988, INFECT IMMUN, V56, P1567, DOI 10.1128/IAI.56.6.1567-1573.1988; PALMER GH, 1987, INT J PARASITOL, V17, P1279, DOI 10.1016/0020-7519(87)90093-2; Palmer GH, 1999, PARASITOL TODAY, V15, P281, DOI 10.1016/S0169-4758(99)01469-6; Palmer GH, 2001, J CLIN MICROBIOL, V39, P631, DOI 10.1128/JCM.39.2.631-635.2001; PALMER GH, 1988, INFECT IMMUN, V56, P1526, DOI 10.1128/IAI.56.6.1526-1531.1988; PALMER GH, 1986, SCIENCE, V231, P1299, DOI 10.1126/science.3945825; PALMER GH, 1989, INFECT IMMUN, V57, P3666, DOI 10.1128/IAI.57.11.3666-3669.1989; Rodriguez SD, 2000, COMP IMMUNOL MICROB, V23, P239, DOI 10.1016/S0147-9571(99)00076-4; Ruiz PMG, 2005, VET PARASITOL, V128, P325, DOI 10.1016/j.vetpar.2004.11.017; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Santos PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033045; Shkap V, 2009, VET MICROBIOL, V134, P254, DOI 10.1016/j.vetmic.2008.08.004; SMITH RD, 1986, AM J VET RES, V47, P127; Suarez CE, 2011, VET PARASITOL, V180, P109, DOI 10.1016/j.vetpar.2011.05.032; Thomas R, 2002, J BIOL CHEM, V277, P2059, DOI 10.1074/jbc.M104364200; Ueti MW, 2007, INFECT IMMUN, V75, P2959, DOI 10.1128/IAI.00284-07; Valdez RA, 2002, CLIN DIAGN LAB IMMUN, V9, P417, DOI 10.1128/CDLI.9.2.417-424.2002; WICKWIRE KB, 1987, AM J VET RES, V48, P96; Zivkovic Zorica, 2007, BMC Vet Res, V3, P32, DOI 10.1186/1746-6148-3-32	67	42	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65243	10.1371/journal.pone.0065243	http://dx.doi.org/10.1371/journal.pone.0065243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776456	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400018
J	Lichtash, CT; Cui, JR; Guo, XQ; Chen, YDI; Hsueh, WA; Rotter, JI; Goodarzi, MO				Lichtash, Charlene T.; Cui, Jinrui; Guo, Xiuqing; Chen, Yii-Der I.; Hsueh, Willa A.; Rotter, Jerome I.; Goodarzi, Mark O.			Body Adiposity Index versus Body Mass Index and Other Anthropometric Traits as Correlates of Cardiometabolic Risk Factors	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; INTIMA-MEDIA THICKNESS; LIPOPROTEIN-LIPASE; FAT; GENE; ASSOCIATION; OBESITY; SCAN; SEX; AGE	Objective: The worldwide prevalence of obesity mandates a widely accessible tool to categorize adiposity that can best predict associated health risks. The body adiposity index (BAI) was designed as a single equation to predict body adiposity in pooled analysis of both genders. We compared body adiposity index (BAI), body mass index (BMI), and other anthropometric measures, including percent body fat (PBF), in their correlations with cardiometabolic risk factors. We also compared BAI with BMI to determine which index is a better predictor of PBF. Methods: The cohort consisted of 698 Mexican Americans. We calculated correlations of BAI, BMI, and other anthropometric measurements (PBF measured by dual energy X-ray absorptiometry, waist and hip circumference, height, weight) with glucose homeostasis indices (including insulin sensitivity and insulin clearance from euglycemic clamp), lipid parameters, cardiovascular traits (including carotid intima-media thickness), and biomarkers (C-reactive protein, plasminogen activator inhibitor-1 and adiponectin). Correlations between each anthropometric measure and cardiometabolic trait were compared in both sex-pooled and sex-stratified groups. Results: BMI was associated with all but two measured traits (carotid intima-media thickness and fasting glucose in men), while BAI lacked association with several variables. BAI did not outperform BMI in its associations with any cardiometabolic trait. BAI was correlated more strongly than BMI with PBF in sex-pooled analyses (r = 0.78 versus r = 0.51), but not in sex-stratified analyses (men, r = 0.63 versus r = 0.79; women, r = 0.69 versus r = 0.77). Additionally, PBF showed fewer correlations with cardiometabolic risk factors than BMI. Weight was more strongly correlated than hip with many of the cardiometabolic risk factors examined. Conclusions: BAI is inferior to the widely used BMI as a correlate of the cardiometabolic risk factors studied. Additionally, BMI's relationship with total adiposity may not be the sole determinate of its association with cardiometabolic risk.	[Lichtash, Charlene T.; Rotter, Jerome I.; Goodarzi, Mark O.] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Cui, Jinrui; Guo, Xiuqing; Chen, Yii-Der I.; Rotter, Jerome I.; Goodarzi, Mark O.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Hsueh, Willa A.] Methodist Hosp, Res Inst, Div Diabet Obes & Lipids, Diabet Res Ctr, Houston, TX 77030 USA; [Goodarzi, Mark O.] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Los Angeles, CA 90048 USA; [Goodarzi, Mark O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; The Methodist Hospital System; The Methodist Hospital - Houston; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Goodarzi, MO (corresponding author), Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.	mark.goodarzi@cshs.org	Goodarzi, Mark/AAH-7106-2021; Rotter, Jerome/AAY-6598-2021	Goodarzi, Mark/0000-0001-6364-5103; Lichtash, Charlene/0000-0003-3166-1373	National Institutes of Health [R01-HL088457, R01-DK079888, P30-DK063491, M01-RR00425]; General Clinical Research Center Grant from the National Center for Research Resources [UL1TR000124]; University of California Los Angeles Clinical & Translational Research Workshop; Cedars-Sinai Winnick Clinical Scholars Award; Cedars-Sinai Board of Governor's Chair in Medical Genetics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK079888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General Clinical Research Center Grant from the National Center for Research Resources; University of California Los Angeles Clinical & Translational Research Workshop; Cedars-Sinai Winnick Clinical Scholars Award; Cedars-Sinai Board of Governor's Chair in Medical Genetics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by National Institutes of Health grants R01-HL088457, R01-DK079888, P30-DK063491, M01-RR00425 (General Clinical Research Center Grant from the National Center for Research Resources), and UL1TR000124 (University of California Los Angeles Clinical & Translational Research Workshop), and the Cedars-Sinai Winnick Clinical Scholars Award (to M.O.G) and the Cedars-Sinai Board of Governor's Chair in Medical Genetics (J.I.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A Geliebter, 2012, OBESITY SILVER SPRIN, DOI [10.1038/oby.2012.187, DOI 10.1038/0BY.2012.187]; A Melmer, 2012, OBESITY SILVER SPRIN, DOI [10.1038/oby.2012.160, DOI 10.1038/0BY.2012.160]; Barreira TV, 2012, MAYO CLIN PROC, V87, P452, DOI 10.1016/j.mayocp.2011.12.017; Barreira TV, 2011, JAMA-J AM MED ASSOC, V306, P828, DOI 10.1001/jama.2011.1189; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; de Lima JG, 2012, OBESITY, V20, P1140, DOI 10.1038/oby.2012.3; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Eknoyan G, 2008, NEPHROL DIAL TRANSPL, V23, P47, DOI 10.1093/ndt/gfm517; Elisha B, 2013, EUR J NUTR, V52, P145, DOI 10.1007/s00394-011-0296-y; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Freedman DZ, 2012, SUPERGRAVITY, P1, DOI 10.1017/CBO9781139026833; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Godoy-Matos AF, 2012, OBESITY, V20, P440, DOI 10.1038/oby.2011.343; Goodarzi MO, 2005, DIABETES, V54, P1222, DOI 10.2337/diabetes.54.4.1222; Goodarzi MO, 2005, DIABETES, V54, P1228, DOI 10.2337/diabetes.54.4.1228; Goodarzi MO, 2004, DIABETES, V53, P214, DOI 10.2337/diabetes.53.1.214; Goodarzi MO, 2003, GENET MED, V5, P322, DOI 10.1097/01.GIM.0000076971.55421.AD; Jackson AS, 2002, INT J OBESITY, V26, P789, DOI 10.1038/sj.ijo.0802006; Johnson W, 2012, OBESITY, V20, P900, DOI 10.1038/oby.2011.346; Li XH, 2006, OBESITY, V14, P1192, DOI 10.1038/oby.2006.136; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; Schulze MB, 2012, DIABETOLOGIA, V55, P1660, DOI 10.1007/s00125-012-2499-z; Schulze MB, 2011, OBESITY, V19, P1729, DOI 10.1038/oby.2011.153; Selzer RH, 2001, ATHEROSCLEROSIS, V154, P185, DOI 10.1016/S0021-9150(00)00461-5; Snijder MB, 2012, OBESITY, V20, P1138, DOI 10.1038/oby.2011.338; Stepien M, 2014, ANGIOLOGY, V65, P22, DOI 10.1177/0003319712468291; Wang D, 2005, STROKE, V36, P540, DOI 10.1161/01.STR.0000155746.65185.4e; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	29	49	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65954	10.1371/journal.pone.0065954	http://dx.doi.org/10.1371/journal.pone.0065954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776578	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400089
J	Ruan, PY; Hayashida, M; Maruyama, O; Akutsu, T				Ruan, Peiying; Hayashida, Morihiro; Maruyama, Osamu; Akutsu, Tatsuya			Prediction of Heterodimeric Protein Complexes from Weighted Protein-Protein Interaction Networks Using Novel Features and Kernel Functions	PLOS ONE			English	Article							IDENTIFICATION; DATABASE	Since many proteins express their functional activity by interacting with other proteins and forming protein complexes, it is very useful to identify sets of proteins that form complexes. For that purpose, many prediction methods for protein complexes from protein-protein interactions have been developed such as MCL, MCODE, RNSC, PCP, RRW, and NWE. These methods have dealt with only complexes with size of more than three because the methods often are based on some density of subgraphs. However, heterodimeric protein complexes that consist of two distinct proteins occupy a large part according to several comprehensive databases of known complexes. In this paper, we propose several feature space mappings from protein-protein interaction data, in which each interaction is weighted based on reliability. Furthermore, we make use of prior knowledge on protein domains to develop feature space mappings, domain composition kernel and its combination kernel with our proposed features. We perform ten-fold cross-validation computational experiments. These results suggest that our proposed kernel considerably outperforms the naive Bayes-based method, which is the best existing method for predicting heterodimeric protein complexes.	[Ruan, Peiying; Hayashida, Morihiro; Akutsu, Tatsuya] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto, Japan; [Maruyama, Osamu] Kyushu Univ, Inst Math Ind, Nishi Ku, Fukuoka 812, Japan	Kyoto University; Kyushu University	Hayashida, M (corresponding author), Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji, Kyoto, Japan.	morihiro@kuicr.kyoto-u.ac.jp; takutsu@kuicr.kyoto-u.ac.jp		Akutsu, Tatsuya/0000-0001-9763-797X	MEXT, Japan [22240009, 24500361]	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by Grants-in-Aid #22240009 and #24500361 from MEXT, Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Ben-Hur A, 2005, BIOINFORMATICS, V21, pI38, DOI 10.1093/bioinformatics/bti1016; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chua Hon Nian, 2008, Journal of Bioinformatics and Computational Biology, V6, P435, DOI 10.1142/S0219720008003497; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Kiemer L, 2007, PROTEOMICS, V7, P932, DOI 10.1002/pmic.200600448; King AD, 2004, BIOINFORMATICS, V20, P3013, DOI 10.1093/bioinformatics/bth351; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Macropol K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-283; Maruyama O., 2011, ACM C BIOINF COMP BI, P499; Maruyama O, 2010, IEEE INT C BIOINFORM, P590, DOI 10.1109/BIBM.2010.5706634; Mewes HW, 2004, NUCLEIC ACIDS RES, V32, pD41, DOI 10.1093/nar/gkh092; Osuna E., 1997, 1602 AI MIT; Ozawa Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-350; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Qi Y, 2008, BIOINFORMATICS, V24, pI250, DOI 10.1093/bioinformatics/btn164; Sapkota A, 2011, MOL BIOSYST, V7, P2615, DOI 10.1039/c1mb05120b; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vapnik VN, 1998, STAT LEARNING THEORY, DOI DOI 10.1007/978-1-4419-1428-6_5864; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8; Zhao XM, 2009, J PROTEOME RES, V8, P4714, DOI 10.1021/pr900415b	27	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65265	10.1371/journal.pone.0065265	http://dx.doi.org/10.1371/journal.pone.0065265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776458	Green Published, gold			2022-12-25	WOS:000320755400020
J	Tang, Z; Xie, YT; Yang, F; Huang, Y; Wang, CD; Dai, KR; Zheng, XB; Zhang, XL				Tang, Ze; Xie, Youtao; Yang, Fei; Huang, Yan; Wang, Chuandong; Dai, Kerong; Zheng, Xuebin; Zhang, Xiaoling			Porous Tantalum Coatings Prepared by Vacuum Plasma Spraying Enhance BMSCs Osteogenic Differentiation and Bone Regeneration In Vitro and In Vivo	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GEOMETRIC CONTROL; IMPLANTS; SHAPE; BIOMATERIAL; PERFORMANCE; ADHESION; MATRIX; GROWTH; METAL	Tantalum, as a potential metallic implant biomaterial, is attracting more and more attention because of its excellent anticorrosion and biocompatibility. However, its significantly high elastic modulus and large mechanical incompatibility with bone tissue make it unsuitable for load-bearing implants. In this study, porous tantalum coatings were first successfully fabricated on titanium substrates by vacuum plasma spraying (VPS), which would exert the excellent biocompatibility of tantalum and alleviate the elastic modulus of tantalum for bone tissue. We evaluated cytocompatibility and osteogenesis activity of the porous tantalum coatings using human bone marrow stromal cells (hBMSCs) and its ability to repair rabbit femur bone defects. The morphology and actin cytoskeletons of hBMSCs were observed via electron microscopy and confocal, and the cell viability, proliferation and osteogenic differentiation potential of hBMSCs were examined quantitatively by PrestoBlue assay, Ki67 immunofluorescence assay, real-time PCR technology and ALP staining. For in vivo detection, the repaired femur were evaluated by histomorphology and double fluorescence labeling 3 months postoperation. Porous tantalum coating surfaces promoted hBMSCs adhesion, proliferation, osteogenesis activity and had better osseointegration and faster new bone formation rate than titanium coating control. Our observation suggested that the porous tantalum coatings had good biocompatibility and could enhance osseoinductivity in vitro and promote new bone formation in vivo. The porous tantalum coatings prepared by VPS is a promising strategy for bone regeneration.	[Tang, Ze; Huang, Yan; Wang, Chuandong; Dai, Kerong; Zhang, Xiaoling] Chinese Acad Sci, SIBS, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Tang, Ze; Huang, Yan; Wang, Chuandong; Dai, Kerong; Zhang, Xiaoling] SJTUSM, Shanghai, Peoples R China; [Tang, Ze; Yang, Fei; Dai, Kerong; Zhang, Xiaoling] SJTUSM, Shanghai Key Lab Orthopaed Implant, Dept Orthopaed Surg, Shanghai Peoples Hosp 9, Shanghai, Peoples R China; [Xie, Youtao; Zheng, Xuebin] Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Ceramics, CAS	Xie, YT (corresponding author), Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.	xieyoutao@mail.sic.ac.cn; xlzhang@sibs.ac.cn		Zhang, Xiaoling/0000-0002-0134-1347	Ministry of Science and Technology of China [2011DFA30790, 2010CB945600]; National Natural Science Foundation of China [81190133, 31101056]; Chinese Academy of Sciences [XDA01030404, KSCX2-EW-Q-1-07]; Science and Technology Commission of Shanghai Municipality [11QH1401600]; Shanghai Municipal Education Commission [J50206, 10SG22]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by grants from: The Ministry of Science and Technology of China (No.2011DFA30790, 2010CB945600), www.most.gov.cn; National Natural Science Foundation of China (No.81190133, 31101056), http://www.nsfc.gov.cn; Chinese Academy of Sciences (No.XDA01030404, KSCX2-EW-Q-1-07), http://www.cas.cn/; Science and Technology Commission of Shanghai Municipality (No.11QH1401600), www.stcsm.gov.cn; and Shanghai Municipal Education Commission (No.J50206, 10SG22), www.shmec.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama S K, 1996, Hum Cell, V9, P181; Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9; Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283; Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; de Groot K, 1998, P I MECH ENG H, V212, P137, DOI 10.1243/0954411981533917; Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Holt GE, 2009, J ARTHROPLASTY, V24, P1079, DOI 10.1016/j.arth.2008.08.010; Huang Y, 2009, BIOMATERIALS, V30, P5041, DOI 10.1016/j.biomaterials.2009.05.077; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360; Kaiser JP, 2004, J MATER SCI-MATER M, V15, P429, DOI 10.1023/B:JMSM.0000021115.55254.a8; Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.0.CO;2-F; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041; Long WJ, 2009, J ARTHROPLASTY, V24, P1086, DOI 10.1016/j.arth.2008.08.011; Lyons A Bruce, 2004, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0911s27; Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Miyazaki T, 2002, BIOMATERIALS, V23, P827, DOI 10.1016/S0142-9612(01)00188-0; Nadeau Melissa, 2007, Mcgill J Med, V10, P4; Ni SY, 2007, J BIOMED MATER RES B, V80B, P174, DOI 10.1002/jbm.b.30582; Rojewski MT, 2008, TRANSFUS MED HEMOTH, V35, P168, DOI 10.1159/000129013; Schwartz Z, 1999, Adv Dent Res, V13, P38; Shuler MS, 2007, J ARTHROPLASTY, V22, P26, DOI 10.1016/j.arth.2006.03.007; Sidhu KS, SPINE J, V1, P331; SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320; Smith PJ, 2000, CYTOMETRY, V40, P280, DOI 10.1002/1097-0320(20000801)40:4<280::AID-CYTO4>3.0.CO;2-7; Urbani S, 2006, CYTOTHERAPY, V8, P243, DOI 10.1080/14653240600735834; Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1; Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5	40	63	70	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66263	10.1371/journal.pone.0066263	http://dx.doi.org/10.1371/journal.pone.0066263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776648	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400130
J	Monti, MR; Morero, NR; Miguel, V; Argarana, CE				Monti, Mariela R.; Morero, Natalia R.; Miguel, Virginia; Argarana, Carlos E.			nfxB as a Novel Target for Analysis of Mutation Spectra in Pseudomonas aeruginosa	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; STATIONARY-PHASE MUTAGENESIS; ESCHERICHIA-COLI K-12; SECONDARY STRUCTURE; BASE-SUBSTITUTION; GO SYSTEM; FLUCTUATION ANALYSIS; GENETIC ADAPTATION; RESISTANCE; BACTERIA	nfxB encodes a negative regulator of the mexCD-oprJ genes for drug efflux in the opportunistic pathogen Pseudomonas aeruginosa. Inactivating mutations in this transcriptional regulator constitute one of the main mechanisms of resistance to ciprofloxacin (Cip(r)). In this work, we evaluated the use of nfxB/Cip(r) as a new test system to study mutation spectra in P. aeruginosa. The analysis of 240 mutations in nfxB occurring spontaneously in the wild-type and mutator backgrounds or induced by mutagens showed that nfxB/Cip(r) offers several advantages compared with other mutation detection systems. Identification of nfxB mutations was easy since the entire open reading frame and its promoter region were sequenced from the chromosome using a single primer. Mutations detected in nfxB included all transitions and transversions, 1-bp deletions and insertions, >1-bp deletions and duplications. The broad mutation spectrum observed in nfxB relies on the selection of loss-of-function changes, as we confirmed by generating a structural model of the NfxB repressor and evaluating the significance of each detected mutation. The mutation spectra characterized in the mutS, mutT, mutY and mutM mutator backgrounds or induced by the mutagenic agents 2-aminopurine, cisplatin and hydrogen peroxide were in agreement with their predicted mutational specificities. Additionally, this system allowed the analysis of sequence context effects since point mutations occurred at 85 different sites distributed over the entire nfxB. Significant hotspots and preferred sequence contexts were observed for spontaneous and mutagen-induced mutation spectra. Finally, we demonstrated the utility of a luminescence-based reporter for identification of nfxB mutants previous to sequencing analysis. Thus, the nfxB/Cip(r) system in combination with the luminescent reporter may be a valuable tool for studying mutational processes in Pseudomonas spp. wherein the genes encoding the NfxB repressor and the associated efflux pump are conserved.	[Monti, Mariela R.; Morero, Natalia R.; Miguel, Virginia; Argarana, Carlos E.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, CONICET,Ctr Invest Quim Biol Cordoba CIQUIBIC, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Argarana, CE (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, CONICET,Ctr Invest Quim Biol Cordoba CIQUIBIC, Ciudad Univ, RA-5000 Cordoba, Argentina.	carga@fcq.unc.edu.ar		MORERO, Natalia Rosalia/0000-0003-0092-5663	Secretaria de Ciencia y Tecnica-UNC [05/C447]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 20090100420]; Agencia Nacional de Promocion Cientifica y Tecnica [PICT 2011-1797]	Secretaria de Ciencia y Tecnica-UNC; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT)	This work was supported by grants from Secretaria de Ciencia y Tecnica-UNC (05/C447; www.secyt.unc.edu.ar), Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 20090100420; www.conicet.gov.ar), and Agencia Nacional de Promocion Cientifica y Tecnica (PICT 2011-1797, www.agencia.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bellinzoni M, 2009, J BACTERIOL, V191, P7531, DOI 10.1128/JB.00631-09; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Blazquez J, 2012, CURR OPIN MICROBIOL, V15, P561, DOI 10.1016/j.mib.2012.07.007; BROUWER J, 1981, P NATL ACAD SCI-BIOL, V78, P7010, DOI 10.1073/pnas.78.11.7010; BURNOUF D, 1987, P NATL ACAD SCI USA, V84, P3758, DOI 10.1073/pnas.84.11.3758; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Chuanchuen R, 2001, ANTIMICROB AGENTS CH, V45, P428, DOI 10.1128/AAC.45.2.428-432.2001; Ciofu O, 2005, ANTIMICROB AGENTS CH, V49, P2276, DOI 10.1128/AAC.49.6.2276-2282.2005; Ciofu O, 2010, MICROBIOL-SGM, V156, P1108, DOI 10.1099/mic.0.033993-0; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; Conibear TCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006289; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Esquisabel ABC, 2011, CLIN MICROBIOL INFEC, V17, P1817, DOI 10.1111/j.1469-0691.2011.03530.x; FOSTER PL, 1995, P NATL ACAD SCI USA, V92, P5487, DOI 10.1073/pnas.92.12.5487; Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson AL, 2000, MUTAT RES-FUND MOL M, V447, P187, DOI 10.1016/S0027-5107(99)00206-7; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jalal S, 2000, ANTIMICROB AGENTS CH, V44, P710, DOI 10.1128/AAC.44.3.710-712.2000; Jalal S, 1998, MICROB DRUG RESIST, V4, P257, DOI 10.1089/mdr.1998.4.257; Jatsenko T, 2010, MUTAT RES-FUND MOL M, V683, P106, DOI 10.1016/j.mrfmmm.2009.10.015; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; Juurik T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048511; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kasak L, 1997, P NATL ACAD SCI USA, V94, P3134, DOI 10.1073/pnas.94.7.3134; Kiser TH, 2010, PHARMACOTHERAPY, V30, P632, DOI 10.1592/phco.30.7.632; Kivisaar M, 2010, FEMS MICROBIOL LETT, V312, P1, DOI 10.1111/j.1574-6968.2010.02027.x; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Luria SE, 1943, GENETICS, V28, P491; Maki H, 2002, ANNU REV GENET, V36, P279, DOI 10.1146/annurev.genet.36.042602.094806; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; Miller JH, 1996, ANNU REV MICROBIOL, V50, P625, DOI 10.1146/annurev.micro.50.1.625; Morero NR, 2011, ANTIMICROB AGENTS CH, V55, P3668, DOI 10.1128/AAC.01826-10; Morgan C, 2006, MUTAT RES-GEN TOX EN, V603, P15, DOI 10.1016/j.mrgentox.2005.09.010; OKAZAKI T, 1991, FEMS MICROBIOL LETT, V79, P31, DOI 10.1016/0378-1097(91)90522-C; OKAZAKI T, 1992, FEMS MICROBIOL LETT, V97, P197; Oliver A, 2002, FEMS MICROBIOL LETT, V217, P31, DOI 10.1111/j.1574-6968.2002.tb11452.x; Oliver A, 2002, MOL MICROBIOL, V43, P1641, DOI 10.1046/j.1365-2958.2002.02855.x; Oliver A, 2010, INT J MED MICROBIOL, V300, P563, DOI 10.1016/j.ijmm.2010.08.009; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; ONO T, 1995, MUTAT RES-FUND MOL M, V326, P175, DOI 10.1016/0027-5107(94)00167-4; Peix A, 2009, INFECT GENET EVOL, V9, P1132, DOI 10.1016/j.meegid.2009.08.001; Pitsikas P, 2004, MUTAT RES-FUND MOL M, V550, P25, DOI 10.1016/j.mrfmmm.2004.01.008; Poole K, 1996, MOL MICROBIOL, V21, P713, DOI 10.1046/j.1365-2958.1996.281397.x; Rodriguez C, 2002, J BACTERIOL, V184, P5599, DOI 10.1128/JB.184.20.5599-5608.2002; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sanders LH, 2009, FEMS MICROBIOL LETT, V294, P89, DOI 10.1111/j.1574-6968.2009.01550.x; SARKAR S, 1992, GENETICA, V85, P173, DOI 10.1007/BF00120324; SCHAAPER RM, 1987, P NATL ACAD SCI USA, V84, P6220, DOI 10.1073/pnas.84.17.6220; SHIBA T, 1995, J BACTERIOL, V177, P5872, DOI 10.1128/jb.177.20.5872-5877.1995; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Tegova R, 2004, J BACTERIOL, V186, P2735, DOI 10.1128/JB.186.9.2735-2744.2004; Wong A, 2011, MICROBIOL-SGM, V157, P937, DOI 10.1099/mic.0.046870-0; YAREMA KJ, 1995, NUCLEIC ACIDS RES, V23, P4066, DOI 10.1093/nar/23.20.4066; Zheng Q, 2002, MATH BIOSCI, V176, P237, DOI 10.1016/S0025-5564(02)00087-1	62	16	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66236	10.1371/journal.pone.0066236	http://dx.doi.org/10.1371/journal.pone.0066236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762483	Green Published, gold			2022-12-25	WOS:000321094800094
J	Gonzalez, M; Brito, N; Frias, M; Gonzalez, C				Gonzalez, Mario; Brito, Nelida; Frias, Marcos; Gonzalez, Celedonio			Botrytis cinerea Protein O-Mannosyltransferases Play Critical Roles in Morphogenesis, Growth, and Virulence	PLOS ONE			English	Article							PMT GENE FAMILY; CELL-WALL; SACCHAROMYCES-CEREVISIAE; TRANSMEMBRANE TOPOLOGY; ENZYMATIC-ACTIVITY; MANNOSYLATION; GLYCOSYLATION; FUNGAL; EXPRESSION; MODEL	Protein O-glycosylation is crucial in determining the structure and function of numerous secreted and membrane-bound proteins. In fungi, this process begins with the addition of a mannose residue by protein O-mannosyltransferases (PMTs) in the lumen side of the ER membrane. We have generated mutants of the three Botrytis cinerea pmt genes to study their role in the virulence of this wide-range plant pathogen. B. cinerea PMTs, especially PMT2, are critical for the stability of the cell wall and are necessary for sporulation and for the generation of the extracellular matrix. PMTs are also individually required for full virulence in a variety of hosts, with a special role in the penetration of intact plant leaves. The most significant case is that of grapevine leaves, whose penetration requires the three functional PMTs. Furthermore, PMT2 also contributes significantly to fungal adherence on grapevine and tobacco leaves. Analysis of extracellular and membrane proteins showed significant changes in the pattern of protein secretion and glycosylation by the pmt mutants, and allowed the identification of new protein substrates putatively glycosylated by specific PMTs. Since plants do no possess these enzymes, PMTs constitute a promising target in the development of novel control strategies against B. cinerea.	[Gonzalez, Mario; Brito, Nelida; Frias, Marcos; Gonzalez, Celedonio] Univ La Laguna, Dept Bioquim & Biol Mol, E-38207 San Cristobal la Laguna, Tenerife, Spain	Universidad de la Laguna	Gonzalez, C (corresponding author), Univ La Laguna, Dept Bioquim & Biol Mol, E-38207 San Cristobal la Laguna, Tenerife, Spain.	cglez@ull.es	Gonzalez, Celedonio/K-8728-2014; ALAYÓN, NÉLIDA BRITO/K-8861-2014	Gonzalez, Celedonio/0000-0002-5859-6957; Gonzalez, Mario/0000-0003-1386-0571	Ministerio de Economia y Competitividad [AGL2010-22222]; Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion (ACIISI) [PI2007/009]; ACIISI; European Regional Development Fund	Ministerio de Economia y Competitividad(Spanish Government); Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion (ACIISI); ACIISI; European Regional Development Fund(European Commission)	Support for this research was provided by grants AGL2010-22222 from the Ministerio de Economia y Competitividad (http:www.mineco.gob.es) and PI2007/009 from the Agencia Canaria de Investigacion, Innovacion y Sociedad de la Informacion (ACIISI; http:agencia.itccanarias.org). MG and MF were supported by ACIISI. 85% of ACIISI funding came from the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applied Biosystems, 2008, GUID PERF REL QUANT; Benito EP, 1998, EUR J PLANT PATHOL, V104, P207, DOI 10.1023/A:1008698116106; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Bowman SM, 2005, MYCOLOGIA, V97, P872, DOI 10.3852/mycologia.97.4.872; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; BUTTNER P, 1994, CURR GENET, V25, P445, DOI 10.1007/BF00351784; Christiansen MN, 2010, ANAL CHEM, V82, P3500, DOI 10.1021/ac901717n; Delcan J, 2002, J PLANT PATHOL, V84, P3; DOSS RP, 1995, APPL ENVIRON MICROB, V61, P260, DOI 10.1128/AEM.61.1.260-265.1995; Doss RP, 1999, APPL ENVIRON MICROB, V65, P404; Espino JJ, 2005, PHYSIOL MOL PLANT P, V66, P213, DOI 10.1016/j.pmpp.2005.06.005; Espino JJ, 2010, PROTEOMICS, V10, P3020, DOI 10.1002/pmic.201000037; Fang WX, 2010, GLYCOBIOLOGY, V20, P542, DOI 10.1093/glycob/cwp206; Fernandez-Alvarez A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002563; Fernandez-Alvarez A, 2009, PLANT CELL, V21, P3397, DOI 10.1105/tpc.109.065839; Frias M, 2011, NEW PHYTOL, V192, P483, DOI 10.1111/j.1469-8137.2011.03802.x; Gentzsch M, 1996, EMBO J, V15, P5752, DOI 10.1002/j.1460-2075.1996.tb00961.x; Gil-ad NL, 2001, FEMS MICROBIOL LETT, V199, P109, DOI 10.1111/j.1574-6968.2001.tb10659.x; Girrbach V, 2003, J BIOL CHEM, V278, P12554, DOI 10.1074/jbc.M212582200; Girrbach V, 2000, J BIOL CHEM, V275, P19288, DOI 10.1074/jbc.M001771200; Gonzalez C, 2008, BIOTECHNOL LETT, V30, P1989, DOI 10.1007/s10529-008-9790-6; Gonzalez M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-213; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Goto M, 2009, EUKARYOT CELL, V8, P1465, DOI 10.1128/EC.00371-08; Gravel Patricia, 1996, P603, DOI 10.1007/978-1-60327-259-9_97; Halligan Brian D., 2009, V527, P283, DOI 10.1007/978-1-60327-834-8_21; HAMADA W, 1994, CURR GENET, V26, P251, DOI 10.1007/BF00309556; Hirayama H, 2008, J BIOCHEM, V143, P555, DOI 10.1093/jb/mvm249; Hutzler J, 2007, P NATL ACAD SCI USA, V104, P7827, DOI 10.1073/pnas.0700374104; Illergard K, 2009, PROTEINS, V77, P499, DOI 10.1002/prot.22458; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kriangkripipat T, 2009, EUKARYOT CELL, V8, P1475, DOI 10.1128/EC.00040-09; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laspidou CS, 2002, WATER RES, V36, P2711, DOI 10.1016/S0043-1354(01)00413-4; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Liu WW, 2011, FUNGAL GENET BIOL, V48, P377, DOI 10.1016/j.fgb.2010.12.004; Lommel M, 2004, MOL CELL BIOL, V24, P46, DOI 10.1128/MCB.24.1.46-57.2004; Lommel M, 2011, J BIOL CHEM, V286, P39768, DOI 10.1074/jbc.M111.281196; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Lussier M, 1999, BBA-GEN SUBJECTS, V1426, P323, DOI 10.1016/S0304-4165(98)00133-0; Mouyna I, 2010, MOL MICROBIOL, V76, P1205, DOI 10.1111/j.1365-2958.2010.07164.x; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Oka T, 2005, MICROBIOL-SGM, V151, P3657, DOI 10.1099/mic.0.28088-0; Oka T, 2004, MICROBIOL-SGM, V150, P1973, DOI 10.1099/mic.0.27005-0; Olson GM, 2007, EUKARYOT CELL, V6, P222, DOI 10.1128/EC.00182-06; Prill SKH, 2005, MOL MICROBIOL, V55, P546, DOI 10.1111/j.1365-2958.2004.04401.x; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; ROST B, 1995, PROTEIN SCI, V4, P521; Sambrook J, 2001, MOL CLONING LAB MANU; Sanders SL, 1999, J CELL BIOL, V145, P1177, DOI 10.1083/jcb.145.6.1177; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schumacher J, 2012, MORPHOGENESIS PATHOG, V22, P225, DOI DOI 10.1007/978-3-642-22916-9_11; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Strahl-Bolsinger S, 1999, J BIOL CHEM, V274, P9068, DOI 10.1074/jbc.274.13.9068; Strahl-Bolsinger S, 1999, BBA-GEN SUBJECTS, V1426, P297, DOI 10.1016/S0304-4165(98)00131-7; Tanaka N, 2005, BIOCHEM BIOPH RES CO, V330, P813, DOI 10.1016/j.bbrc.2005.03.033; ten Have A, 1998, MOL PLANT MICROBE IN, V11, P1009, DOI 10.1094/MPMI.1998.11.10.1009; ten Have A, 2010, FUNGAL GENET BIOL, V47, P53, DOI 10.1016/j.fgb.2009.10.008; Timpel C, 1998, J BIOL CHEM, V273, P20837, DOI 10.1074/jbc.273.33.20837; vanderVlugtBergmans CJB, 1997, MOL PLANT MICROBE IN, V10, P21, DOI 10.1094/MPMI.1997.10.1.21; vanKan JAL, 1997, MOL PLANT MICROBE IN, V10, P30, DOI 10.1094/MPMI.1997.10.1.30; Varela C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-7; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Willer T, 2002, GLYCOBIOLOGY, V12, P771, DOI 10.1093/glycob/cwf086; Willer T, 2005, MOL MICROBIOL, V57, P156, DOI 10.1111/j.1365-2958.2005.04692.x; Willger SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006321; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zheng L, 2000, MOL PLANT MICROBE IN, V13, P724, DOI 10.1094/MPMI.2000.13.7.724	70	32	33	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65924	10.1371/journal.pone.0065924	http://dx.doi.org/10.1371/journal.pone.0065924			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762450	gold, Green Published			2022-12-25	WOS:000321099000119
J	Rampton, M; Walton, SF; Holt, DC; Pasay, C; Kelly, A; Currie, BJ; McCarthy, JS; Mounsey, KE				Rampton, Melanie; Walton, Shelley F.; Holt, Deborah C.; Pasay, Cielo; Kelly, Andrew; Currie, Bart J.; McCarthy, James S.; Mounsey, Kate E.			Antibody Responses to Sarcoptes scabiei Apolipoprotein in a Porcine Model: Relevance to Immunodiagnosis of Recent Infection	PLOS ONE			English	Article							IMMUNOSORBENT-ASSAY ELISA; IMMUNE-RESPONSE; SEROLOGICAL DIAGNOSIS; CYTOKINE EXPRESSION; MANGE; MITE; PIGS; IGG; DERMOSCOPY; ANTIGENS	No commercial immunodiagnostic tests for human scabies are currently available, and existing animal tests are not sufficiently sensitive. The recombinant Sarcoptes scabiei apolipoprotein antigen Sar s 14.3 is a promising immunodiagnostic, eliciting high levels of IgE and IgG in infected people. Limited data are available regarding the temporal development of antibodies to Sar s 14.3, an issue of relevance in terms of immunodiagnosis. We utilised a porcine model to prospectively compare specific antibody responses to a primary infestation by ELISA, to Sar s 14.3 and to S. scabiei whole mite antigen extract (WMA). Differences in the antibody profile between antigens were apparent, with Sar s 14.3 responses detected earlier, and declining significantly after peak infestation compared to WMA. Both antigens resulted in >90% diagnostic sensitivity from weeks 8-16 post infestation. These data provide important information on the temporal development of humoral immune responses in scabies and further supports the development of recombinant antigen based immunodiagnostic tests for recent scabies infestations.	[Rampton, Melanie; Walton, Shelley F.; Mounsey, Kate E.] Univ Sunshine Coast, Sch Hlth & Sport Sci, Maroochydore, Qld, Australia; [Rampton, Melanie; Pasay, Cielo; McCarthy, James S.; Mounsey, Kate E.] Queensland Inst Med Res, Div Infect Dis, Herston, Qld 4006, Australia; [Holt, Deborah C.; Currie, Bart J.] Charles Darwin Univ, Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT 0909, Australia; [Kelly, Andrew] Univ Queensland, Dept Agr Forestry & Fisheries, Ctr Adv Anim Sci, Gatton, Qld, Australia; [McCarthy, James S.] Univ Queensland, Sch Med, Herston, Qld, Australia	University of the Sunshine Coast; QIMR Berghofer Medical Research Institute; Charles Darwin University; Menzies School of Health Research; Queensland Department of Agriculture & Fisheries; University of Queensland; University of Queensland	Mounsey, KE (corresponding author), Univ Sunshine Coast, Sch Hlth & Sport Sci, Maroochydore, Qld, Australia.	kmounsey@usc.edu.au	Holt, Deborah/A-8002-2012; McCarthy, James S/C-1681-2009; Walton, Shelley/A-9767-2012	Walton, Shelley/0000-0002-5857-6913; McCarthy, James/0000-0001-6596-9718; Holt, Deborah/0000-0003-4951-1891; Mounsey, Kate/0000-0003-0579-9424	Australian Research Council Discovery Early Career Researcher Award; NHMRC Practitioner Fellowship; Queensland Government Clinical Research Fellowship; NHMRC Project Grant	Australian Research Council Discovery Early Career Researcher Award(Australian Research Council); NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Queensland Government Clinical Research Fellowship; NHMRC Project Grant(National Health and Medical Research Council (NHMRC) of Australia)	KM is supported by an Australian Research Council Discovery Early Career Researcher Award (www.arc.gov.au). JMC is supported by an NHMRC Practitioner Fellowship and Queensland Government Clinical Research Fellowship. This project was also supported by an NHMRC Project Grant (www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlian LG, 2007, J MED ENTOMOL, V44, P1054, DOI 10.1603/0022-2585(2007)44[1054:IVETSS]2.0.CO;2; Arlian LG, 2004, J MED ENTOMOL, V41, P69, DOI 10.1603/0022-2585-41.1.69; Arlian LG, 2004, J MED ENTOMOL, V41, P74, DOI 10.1603/0022-2585-41.1.74; Arlian LG, 2003, AM J TROP MED HYG, V69, P652, DOI 10.4269/ajtmh.2003.69.652; ARLIAN LG, 1994, EXP PARASITOL, V78, P37, DOI 10.1006/expr.1994.1004; Arlian LG, 2006, J MED ENTOMOL, V43, P283, DOI 10.1603/0022-2585(2006)043[0283:ETSMAS]2.0.CO;2; Bergstrom FC, 2009, J IMMUNOL, V182, P7809, DOI 10.4049/jimmunol.0804205; Bornstein S., 1993, Veterinary Dermatology, V4, P107, DOI 10.1111/j.1365-3164.1993.tb00202.x; Bornstein S, 1996, VET DERMATOL, V7, P21, DOI 10.1111/j.1365-3164.1996.tb00222.x; Bornstein S, 1997, VET REC, V141, P8; Bornstein S, 1993, VET DERMATOL, V4, P123; Butler JE, 2009, IMMUNOGENETICS, V61, P209, DOI 10.1007/s00251-008-0336-9; Butler JE, 2009, DEV COMP IMMUNOL, V33, P321, DOI 10.1016/j.dci.2008.06.015; CARGILL CF, 1979, VET REC, V104, P11, DOI 10.1136/vr.104.1.11; Crawley A, 2003, VACCINE, V21, P2911, DOI 10.1016/S0264-410X(03)00142-7; DAVIES PR, 1995, VET PARASITOL, V60, P249, DOI 10.1016/0304-4017(95)00795-3; DAVIS DP, 1990, J MED ENTOMOL, V27, P727, DOI 10.1093/jmedent/27.5.727; Dougall A, 2005, AM J TROP MED HYG, V73, P977, DOI 10.4269/ajtmh.2005.73.977; Dupuy A, 2007, J AM ACAD DERMATOL, V56, P53, DOI 10.1016/j.jaad.2006.07.025; FAIN A, 1978, INT J DERMATOL, V17, P20, DOI 10.1111/j.1365-4362.1978.tb06040.x; Femenia F, 2005, LIFE SCI, V77, P808, DOI 10.1016/j.lfs.2005.01.017; FLAMING KP, 1994, COMP HAEMATOL INT, V4, P218, DOI 10.1007/BF00185177; Fukuyama S, 2010, BRIT J DERMATOL, V163, P892, DOI 10.1111/j.1365-2133.2010.09913.x; Haas N, 2005, ARCH DERMATOL RES, V296, P327, DOI 10.1007/s00403-004-0524-x; Harumal P, 2003, AM J TROP MED HYG, V68, P54, DOI 10.4269/ajtmh.2003.68.54; HILL PB, 1995, VET IMMUNOL IMMUNOP, V44, P105, DOI 10.1016/0165-2427(94)05298-7; Hollanders W, 1997, VET PARASITOL, V69, P117, DOI 10.1016/S0304-4017(96)01117-X; Inagaki N, 2006, EUR J PHARMACOL, V546, P189, DOI 10.1016/j.ejphar.2006.07.019; Jayaraj R, 2011, DIAGN MICR INFEC DIS, V71, P403, DOI 10.1016/j.diagmicrobio.2011.09.007; Juul-Madsen HR, 2010, VET IMMUNOL IMMUNOP, V133, P95, DOI 10.1016/j.vetimm.2009.07.006; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Kuhn C, 2008, VET PARASITOL, V153, P329, DOI 10.1016/j.vetpar.2008.02.007; Lalli PN, 2004, J PARASITOL, V90, P711, DOI 10.1645/GE-214R; Lowenstein M, 2004, PARASITOL RES, V94, P24, DOI 10.1007/s00436-004-1168-7; Markowska-Daniel I, 2010, POL J VET SCI, V13, P21; Martin M, 2005, REPROD FERT DEVELOP, V17, P439, DOI 10.1071/RD04064; McDonald M, 2004, LANCET INFECT DIS, V4, P240, DOI 10.1016/S1473-3099(04)00975-2; MORSY GH, 1989, VET PARASITOL, V33, P165, DOI 10.1016/0304-4017(89)90064-2; Morsy Tosson A., 1993, Journal of the Egyptian Society of Parasitology, V23, P221; Mounsey K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000756; Park JH, 2012, ANN DERMATOL, V24, P194, DOI 10.5021/ad.2012.24.2.194; Pence DB, 2002, REV SCI TECH OIE, V21, P385, DOI 10.20506/rst.21.2.1335; PENCE DB, 1994, J WILDLIFE MANAGE, V58, P624, DOI 10.2307/3809675; Perez JM, 2011, VET PARASITOL, V176, P258, DOI 10.1016/j.vetpar.2010.11.002; PORTER P, 1970, IMMUNOLOGY, V18, P565; Potocnjak D, 2012, VET ARHIV, V82, P167; Rambozzi L, 2004, VET RES, V35, P701, DOI 10.1051/vetres:2004039; Rasero R, 2010, BIOL CONSERV, V143, P1269, DOI 10.1016/j.biocon.2010.03.001; Roberts LJ, 2005, J INFECTION, V50, P375, DOI 10.1016/j.jinf.2004.08.033; Rodriguez-Cadenas F, 2010, VET IMMUNOL IMMUNOP, V133, P109, DOI 10.1016/j.vetimm.2009.07.004; ROTH JA, 1984, IMMUNOPHARMACOLOGY, V8, P121, DOI 10.1016/0162-3109(84)90015-8; Rupa P, 2009, VET IMMUNOL IMMUNOP, V132, P41, DOI 10.1016/j.vetimm.2009.09.013; Sarasa M, 2011, VET PARASITOL, V175, P306, DOI 10.1016/j.vetpar.2010.10.024; Sarasa M, 2010, EXP PARASITOL, V124, P265, DOI 10.1016/j.exppara.2009.10.008; Sivasubramanian G, 2012, AM J MED SCI, V343, P248, DOI 10.1097/MAJ.0b013e31823aff28; Smets K, 2000, VET PARASITOL, V90, P137, DOI 10.1016/S0304-4017(00)00222-3; Steer AC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000467; Tarigan S, 2005, VET PARASITOL, V133, P101, DOI 10.1016/j.vetpar.2005.03.044; VANNESTE DJJ, 1986, AM J DERMATOPATH, V8, P267, DOI 10.1097/00000372-198606000-00018; Walter B, 2011, ARCH DERMATOL, V147, P468, DOI 10.1001/archdermatol.2011.51; Walton SF, 2010, PARASITE IMMUNOL, V32, P532, DOI 10.1111/j.1365-3024.2010.01218.x; Walton SF, 2004, ADV PARASIT, V57, P309, DOI 10.1016/S0065-308X(04)57005-7; Walton SF, 2004, INT J PARASITOL, V34, P839, DOI 10.1016/j.ijpara.2004.04.002; Walton SF, 2007, CLIN MICROBIOL REV, V20, P268, DOI 10.1128/CMR.00042-06; Walton SF, 2010, CLIN VACCINE IMMUNOL, V17, P1428, DOI 10.1128/CVI.00195-10	65	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65354	10.1371/journal.pone.0065354	http://dx.doi.org/10.1371/journal.pone.0065354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762351	Green Submitted, Green Published, gold			2022-12-25	WOS:000321099000060
J	Wilson, AL; Schrecengost, RS; Guerrero, MS; Thomas, KS; Bouton, AH				Wilson, Ashley L.; Schrecengost, Randy S.; Guerrero, Michael S.; Thomas, Keena S.; Bouton, Amy H.			Breast Cancer Antiestrogen Resistance 3 (BCAR3) Promotes Cell Motility by Regulating Actin Cytoskeletal and Adhesion Remodeling in Invasive Breast Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CYCLIN D1 PROMOTER; C-SRC; TAMOXIFEN RESISTANCE; FOCAL ADHESIONS; RAC-GEF; PROTEIN; RHO; MIGRATION; CAS	Metastatic breast cancer is incurable. In order to improve patient survival, it is critical to develop a better understanding of the molecular mechanisms that regulate metastasis and the underlying process of cell motility. Here, we focus on the role of the adaptor molecule Breast Cancer Antiestrogen Resistance 3 (BCAR3) in cellular processes that contribute to cell motility, including protrusion, adhesion remodeling, and contractility. Previous work from our group showed that elevated BCAR3 protein levels enhance cell migration, while depletion of BCAR3 reduces the migratory and invasive capacities of breast cancer cells. In the current study, we show that BCAR3 is necessary for membrane protrusiveness, Rac1 activity, and adhesion disassembly in invasive breast cancer cells. We further demonstrate that, in the absence of BCAR3, RhoA-dependent signaling pathways appear to predominate, as evidenced by an increase in RhoA activity, ROCK-mediated phosphorylation of myosin light chain II, and large ROCK/mDia1-dependent focal adhesions. Taken together, these data establish that BCAR3 functions as a positive regulator of cytoskeletal remodeling and adhesion turnover in invasive breast cancer cells through its ability to influence the balance between Rac1 and RhoA signaling. Considering that BCAR3 protein levels are elevated in advanced breast cancer cell lines and enhance breast cancer cell motility, we propose that BCAR3 functions in the transition to advanced disease by triggering intracellular signaling events that are essential to the metastatic process.	[Wilson, Ashley L.; Guerrero, Michael S.; Thomas, Keena S.; Bouton, Amy H.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA; [Schrecengost, Randy S.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA	University of Virginia; Jefferson University	Bouton, AH (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA.	ahb8y@virginia.edu			National Cancer Institute [R01 CA096846, F31 CA165703, F31 CA130168, T32 CA009109]; Department of Defense [BC050339]; UVA Cancer Center through their NCI Cancer Center [P30 CA44579]; NIH; UVA Cancer Center; NATIONAL CANCER INSTITUTE [T32CA009109, F31CA165703, R01CA096846, P30CA044579] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); UVA Cancer Center through their NCI Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UVA Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (R01 CA096846 [AHB]; F31 CA165703 Predoctoral Fellowship [ALW]; F31 CA130168 Predoctoral Fellowship [MSG]; Institutional Cancer Training Grant T32 CA009109 [ALW, RSS, MSG]), Department of Defense Breast Cancer Research Program (BC050339 Predoctoral Fellowship [RSS]), and by the UVA Cancer Center through their NCI Cancer Center Support Grant (P30 CA44579). URLs for these agencies/sources are as follows: NIH: http://grants.nih.gov/grants/oer.htm; DOD BCRP: http://cdmrp.army.mil/bcrp/; UVA Cancer Center: http://www.medicine.virginia.edu/research/research-centers/cancer-center/home.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakura S, 2005, J CELL PHYSIOL, V204, P344, DOI 10.1002/jcp.20288; Biscardi JS, 1999, ADV CANCER RES, V76, P61; Borre PV, 2011, CELL SIGNAL, V23, P1030, DOI 10.1016/j.cellsig.2011.01.018; Bouton AH, 1997, HYBRIDOMA, V16, P403, DOI 10.1089/hyb.1997.16.403; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Burnham MR, 2000, MOL CELL BIOL, V20, P5865, DOI 10.1128/MCB.20.16.5865-5878.2000; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Cai DP, 1999, J IMMUNOL, V163, P2104; Cai DP, 2003, CANCER RES, V63, P6802; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Corkery B, 2009, ANN ONCOL, V20, P862, DOI 10.1093/annonc/mdn710; Finn RS, 2008, ANN ONCOL, V19, P1379, DOI 10.1093/annonc/mdn291; Guerrero MS, 2012, GENES CANC; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Mace PD, 2011, NAT STRUCT MOL BIOL, V18, P1381, DOI 10.1038/nsmb.2152; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Makkinje A, 2012, J BIOL CHEM; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Near RI, 2007, J CELL PHYSIOL, V212, P655, DOI 10.1002/jcp.21059; Near RI, 2009, MOL VIS, V15, P685; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riggins RB, 2003, J BIOL CHEM, V278, P28264, DOI 10.1074/jbc.M303535200; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Riggins RB, 2006, CANCER RES, V66, P7007, DOI 10.1158/0008-5472.CAN-05-3952; Schrecengost RS, 2007, CANCER RES, V67, P6174, DOI 10.1158/0008-5472.CAN-06-3455; Schuh NR, 2010, J BIOL CHEM, V285, P2309, DOI 10.1074/jbc.M109.046631; Sun GB, 2012, MOL CELL BIOL, V32, P3776, DOI 10.1128/MCB.00214-12; van der Flier S, 2000, JNCI-J NATL CANCER I, V92, P120, DOI 10.1093/jnci/92.2.120; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vervoort VS, 2007, GENE, V391, P161, DOI 10.1016/j.gene.2006.12.016; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	48	27	28	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65678	10.1371/journal.pone.0065678	http://dx.doi.org/10.1371/journal.pone.0065678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	23762409	gold, Green Published, Green Submitted			2022-12-25	WOS:000321099000092
J	Rosebeck, S; Rehman, AO; Apel, IJ; Kohrt, D; Appert, A; O'Donnell, MA; Ting, AT; Du, MQ; Baens, M; Lucas, PC; McAllister-Lucas, LM				Rosebeck, S.; Rehman, A. O.; Apel, I. J.; Kohrt, D.; Appert, A.; O'Donnell, M. A.; Ting, A. T.; Du, M-Q; Baens, M.; Lucas, P. C.; McAllister-Lucas, L. M.			The API2-MALT1 fusion exploits TNFR pathway-associated RIP1 ubiquitination to promote oncogenic NF-kappa B signaling	ONCOGENE			English	Article						MALT1; TRAF2; RIP1; lymphoma; ubiquitination	NECROSIS-FACTOR RECEPTOR; MALT LYMPHOMA; CELL LYMPHOMA; DNA-DAMAGE; ACTIVATION; KINASE; APOPTOSIS; BCL10; PROTEIN; POLYUBIQUITINATION	The API2-MALT1 fusion oncoprotein is created by the recurrent t(11;18)(q21;q21) chromosomal translocation in mucosa-associated lymphoid tissue (MALT) lymphoma. We identified receptor interacting protein-1 (RIP1) as a novel API2-MALT1-associated protein, and demonstrate that RIP1 is required for API2-MALT1 to stimulate canonical nuclear factor kappa B (NF-kappa B). API2-MALT1 promotes ubiquitination of RIP1 at lysine (K) 377, which is necessary for full NF-kappa B activation. Furthermore, we found that TNF receptor-associated factor 2 (TRAF2) recruitment is required for API2-MALT1 to induce RIP1 ubiquitination, NF-kappa B activation and cellular transformation. Although both TRAF2 and RIP1 interact with the API2 moiety of API2-MALT1, this moiety alone is insufficient to induce RIP1 ubiquitination or activate NF-kappa B, indicating that API2-MALT1-dependent RIP1 ubiquitination represents a gain of function requiring the concerted actions of both the API2 and MALT1 moieties of the fusion. Intriguingly, constitutive RIP1 ubiquitination was recently demonstrated in several solid tumors, and now our study implicates RIP1 ubiquitination as a critical component of API2-MALT1-dependent lymphomagenesis.	[Rosebeck, S.; Rehman, A. O.; Kohrt, D.; McAllister-Lucas, L. M.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI USA; [Apel, I. J.; Lucas, P. C.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Du, M-Q] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Mol Histopathol, Cambridge CB2 2QQ, England; [O'Donnell, M. A.; Ting, A. T.] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY USA; [Baens, M.] Catholic Univ Louvain, Ctr Human Genet, Human Genome Lab, B-3000 Louvain, Belgium; [Baens, M.] VIB, Dept Mol & Dev Genet, Human Genome Lab, Louvain, Belgium	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Icahn School of Medicine at Mount Sinai; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB)	Lucas, PC (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pathol, 5123 Rangos Res Bldg,4401 Penn Ave, Pittsburgh, PA 15224 USA.	lucaspc@upmc.edu; linda.mcallister@chp.edu		Du, Ming-Qing/0000-0002-1017-5045; Lucas, Peter/0000-0003-4880-7172	Shirley K Schlafer Foundation; Elizabeth Caroline Crosby Fund; University of Michigan Comprehensive Cancer Center [G007839]; National Cancer Institute, NIH [R01CA124540]; National Heart, Lung and Blood Institute, NIH [T32-HL007622-21A2]; Nancy Newton Loeb Pediatric Cancer Research Award; AACI Fellowship for Translational Cancer Research; NATIONAL CANCER INSTITUTE [R01CA124540] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082914, T32HL007622] Funding Source: NIH RePORTER	Shirley K Schlafer Foundation; Elizabeth Caroline Crosby Fund; University of Michigan Comprehensive Cancer Center; National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Nancy Newton Loeb Pediatric Cancer Research Award; AACI Fellowship for Translational Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Gabriel Nunez for contributing plasmids, Shaomeng Wang for providing smac mimetic compounds and Linda Klei for laboratory management. This work was supported by the Shirley K Schlafer Foundation, the Elizabeth Caroline Crosby Fund, and grants from the University of Michigan Comprehensive Cancer Center (G007839) and the National Cancer Institute, NIH (R01CA124540). SR was supported by the National Heart, Lung and Blood Institute, NIH (T32-HL007622-21A2), the Nancy Newton Loeb Pediatric Cancer Research Award and the AACI Fellowship for Translational Cancer Research.	Akagi T, 1999, ONCOGENE, V18, P5785, DOI 10.1038/sj.onc.1203018; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Baens M, 2006, CANCER RES, V66, P5270, DOI 10.1158/0008-5472.CAN-05-4590; Bellail AC, 2012, CANCER DISCOV, V2, P140, DOI 10.1158/2159-8290.CD-11-0172; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Biton S, 2011, CELL, V145, P92, DOI 10.1016/j.cell.2011.02.023; Cardamone MD, 2012, MOL CELL, V46, P91, DOI 10.1016/j.molcel.2012.01.025; Conze DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000518; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Duprez L, 2012, J BIOL CHEM, V287, P14863, DOI 10.1074/jbc.M111.288670; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Garrison JB, 2009, ONCOGENE, V28, P1584, DOI 10.1038/onc.2009.17; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hsu HL, 1996, IMMUNITY, V4, P387, DOI 10.1016/S1074-7613(00)80252-6; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Liu HX, 2001, BLOOD, V98, P1182, DOI 10.1182/blood.V98.4.1182; Liu HX, 2002, GASTROENTEROLOGY, V122, P1286, DOI 10.1053/gast.2002.33047; Lu JF, 2008, CANCER RES, V68, P9384, DOI 10.1158/0008-5472.CAN-08-2655; Lucas PC, 2007, ONCOGENE, V26, P5643, DOI 10.1038/sj.onc.1210342; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Morgan JA, 1999, CANCER RES, V59, P6205; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; O'Donnell MA, 2007, CURR BIOL, V17, P418, DOI 10.1016/j.cub.2007.01.027; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Peng C, 2012, J BIOL CHEM, V287, P25881, DOI 10.1074/jbc.M112.359521; Rosebeck S, 2011, SCIENCE, V331, P468, DOI 10.1126/science.1198946; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Staal J, 2011, EMBO J, V30, P1742, DOI 10.1038/emboj.2011.85; Stoffel A, 2004, P NATL ACAD SCI USA, V101, P9079, DOI 10.1073/pnas.0402415101; Streubel B, 2003, BLOOD, V101, P2335, DOI 10.1182/blood-2002-09-2963; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Yang YB, 2011, MOL CELL BIOL, V31, P2774, DOI 10.1128/MCB.01139-10; Yin Q, 2009, BIOCHEMISTRY-US, V48, P10558, DOI 10.1021/bi901462e; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	53	20	22	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2014	33	19					2520	2530		10.1038/onc.2013.195	http://dx.doi.org/10.1038/onc.2013.195			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AH3OK	23770847	Green Accepted			2022-12-25	WOS:000336033600012
J	Koizumi, H; Kurabayashi, N; Watanabe, Y; Sanada, K				Koizumi, Hiroko; Kurabayashi, Nobuhiro; Watanabe, Yuto; Sanada, Kamon			Increased Anxiety in Offspring Reared by Circadian Clock Mutant Mice	PLOS ONE			English	Article							MATERNAL-BEHAVIOR; REPRODUCTIVE-PERFORMANCE; WORK SCHEDULES; STRESS; DISORDER; DEPRESSION; GENE; POLYMORPHISM; SEROTONIN; BRAIN	The maternal care that offspring receive from their mothers early in life influences the offspring's development of emotional behavior in adulthood. Here we found that offspring reared by circadian clock-impaired mice show elevated anxiety-related behavior. Clock mutant mice harboring a mutation in Clock, a key component of the molecular circadian clock, display altered daily patterns of nursing behavior that is fragmented during the light period, instead of long bouts of nursing behavior in wild-type mice. Adult wild-type offspring fostered by Clock mutant mice exhibit increased anxiety-related behavior. This is coupled with reduced levels of brain serotonin at postnatal day 14, whose homeostasis during the early postnatal period is critical for normal emotional behavior in adulthood. Together, disruption of the circadian clock in mothers has an adverse impact on establishing normal anxiety levels in offspring, which may increase their risk of developing anxiety disorders.	[Koizumi, Hiroko; Watanabe, Yuto] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan; [Kurabayashi, Nobuhiro; Sanada, Kamon] Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Sanada, K (corresponding author), Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Tokyo 113, Japan.	kamon_sanada@gen.s.u-tokyo.ac.jp	KURABAYASHI, NOBUHIRO/G-4891-2014; SANADA, YOSHIKADO/G-5014-2014	Kurabayashi, Nobuhiro/0000-0003-3097-8539; Sanada, Kamon/0000-0002-0280-8957	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [24650161] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (B) (to KS), for Exploratory Research (to KS), and for Young Scientists (B) (to NK) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Castagne V., 2011, CURR PROTOC NEUROSCI; Dolatshad H, 2006, HUM REPROD, V21, P68, DOI 10.1093/humrep/dei313; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; GROTA LJ, 1974, HORM BEHAV, V5, P275, DOI 10.1016/0018-506X(74)90014-2; Han WJ, 2008, WORK EMPLOY SOC, V22, P67, DOI 10.1177/0950017007087417; HARLOW HF, 1965, P NATL ACAD SCI USA, V54, P90, DOI 10.1073/pnas.54.1.90; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hoshino K, 2006, ENDOCRINOLOGY, V147, P1916, DOI 10.1210/en.2005-1343; Kalinichev M, 2002, PHARMACOL BIOCHEM BE, V73, P131, DOI 10.1016/S0091-3057(02)00781-5; Kaufman J, 2001, DEV PSYCHOPATHOL, V13, P451, DOI 10.1017/S0954579401003030; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P716; Kennaway DJ, 2004, REPROD FERT DEVELOP, V16, P801, DOI 10.1071/RD04023; Kikusui T, 2005, BEHAV BRAIN RES, V162, P200, DOI 10.1016/j.bbr.2005.03.013; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Leonardo ED, 2006, ANNU REV PSYCHOL, V57, P117, DOI 10.1146/annurev.psych.57.102904.190118; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Miller BH, 2004, CURR BIOL, V14, P1367, DOI 10.1016/j.cub.2004.07.055; Moffitt TE, 2007, PSYCHOL MED, V37, P441, DOI 10.1017/S0033291706009640; MYERS MM, 1989, DEV PSYCHOBIOL, V22, P29, DOI 10.1002/dev.420220104; Nilsson KW, 2008, DRUG ALCOHOL DEPEN, V93, P51, DOI 10.1016/j.drugalcdep.2007.08.022; Nilsson KW, 2006, BIOL PSYCHIAT, V59, P121, DOI 10.1016/j.biopsych.2005.06.024; Nordquist N, 2010, UPSALA J MED SCI, V115, P2, DOI 10.3109/03009730903573246; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Pena CJ, 2013, BEHAV NEUROSCI, V127, P33, DOI 10.1037/a0031219; Rosenbaum E, 2009, MATERN CHILD HLTH J, V13, P732, DOI 10.1007/s10995-009-0488-8; ROY MA, 1995, PSYCHOL MED, V25, P1037, DOI 10.1017/S0033291700037533; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; RUPPENTHAL GC, 1976, J ABNORM PSYCHOL, V85, P341, DOI 10.1037/0021-843X.85.4.341; Sjoberg RL, 2006, INT J NEUROPSYCHOPH, V9, P443, DOI 10.1017/S1461145705005936; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; Strazdins L, 2006, J MARRIAGE FAM, V68, P394, DOI 10.1111/j.1741-3737.2006.00260.x; Strazdins L, 2004, SOC SCI MED, V59, P1517, DOI 10.1016/j.socscimed.2004.01.022; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Vinkers CH, 2010, BIOL PSYCHIAT, V67, P309, DOI 10.1016/j.biopsych.2009.08.013; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325	46	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66021	10.1371/journal.pone.0066021	http://dx.doi.org/10.1371/journal.pone.0066021			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776596	Green Published, Green Submitted, gold			2022-12-25	WOS:000320322400070
J	Li, J; Pu, P; Le, WD				Li, Jia; Pu, Pu; Le, Weidong			The SAX-3 Receptor Stimulates Axon Outgrowth and the Signal Sequence and Transmembrane Domain Are Critical for SAX-3 Membrane Localization in the PDE Neuron of C-elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; RHO-GTPASES; ACTIN CYTOSKELETON; CELL-MIGRATION; RAC ACTIVATION; NETRIN CUES; GUIDANCE; PROTEIN; MIDLINE; KINASE	SAX-3, a receptor for Slit in C. elegans, is well characterized for its function in axonal development. However, the mechanism that regulates the membrane localization of SAX-3 and the role of SAX-3 in axon outgrowth are still elusive. Here we show that SAX-3:: GFP caused ectopic axon outgrowth, which could be suppressed by the loss-of-function mutation in unc-73 (a guanine nucleotide exchange factor for small GTPases) and unc-115 (an actin binding protein), suggesting that they might act downstream of SAX-3 in axon outgrowth. We also examined genes related to axon development for their possible involvement in the subcellular localization of SAX-3. We found the unc-51 mutants appeared to accumulate SAX-3:: GFP in the neuronal cell body of the posterior deirid (PDE) neuron, indicating that UNC-51 might play a role in SAX-3 membrane localization. Furthermore, we demonstrate that the N-terminal signal sequence and the transmembrane domain are essential for the subcellular localization of SAX-3 in the PDE neurons.	[Li, Jia; Pu, Pu; Le, Weidong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Le, WD (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China.	wdle@sibs.ac.cn			National Natural Science Foundation [81171201, 30970925]; National Basic Research Program of China from Science and Technology Commission [2010CB945200, 2011CB510003]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China from Science and Technology Commission(National Basic Research Program of China)	This work is supported by grants from the National Natural Science Foundation (81171201 and 30970925), and the National Basic Research Program of China from Science and Technology Commission (2010CB945200 and 2011CB510003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernadskaya YY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002863; BRENNER S, 1974, GENETICS, V77, P71; Briancon-Marjollet A, 2008, MOL CELL BIOL, V28, P2314, DOI 10.1128/MCB.00998-07; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Demarco RS, 2012, PLOS GENET, V8, P513, DOI 10.1371/journal.pgen.1002665; Demarco RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001215; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Fritz JL, 2002, DEV BIOL, V252, P46, DOI 10.1006/dbio.2002.0842; Ghenea S, 2005, DEVELOPMENT, V132, P3679, DOI 10.1242/dev.01947; Gitai Z, 2003, NEURON, V37, P53, DOI 10.1016/S0896-6273(02)01149-2; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Levy-Strumpf N, 2007, NAT NEUROSCI, V10, P161, DOI 10.1038/nn1835; Li HC, 2008, J NEUROSCI, V28, P3595, DOI 10.1523/JNEUROSCI.5536-07.2008; Matsuura A, 1997, GENE, V192, P245, DOI 10.1016/S0378-1119(97)00084-X; MCINTIRE SL, 1992, NEURON, V8, P307, DOI 10.1016/0896-6273(92)90297-Q; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Norris AD, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-38; OGURA K, 1994, GENE DEV, V8, P2389, DOI 10.1101/gad.8.20.2389; Ogura K, 2006, DEVELOPMENT, V133, P3441, DOI 10.1242/dev.02503; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Struckhoff EC, 2003, DEVELOPMENT, V130, P693, DOI 10.1242/dev.00300; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Vanderzalm PJ, 2009, DEVELOPMENT, V136, P1201, DOI 10.1242/dev.026666; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Watari-Goshima N, 2007, NAT NEUROSCI, V10, P169, DOI 10.1038/nn1834; Winckler B, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001826; Wu YC, 2002, DEV BIOL, V250, P145, DOI 10.1006/dbio.2002.0785; Yang L, 2006, NEURON, V52, P595, DOI 10.1016/j.neuron.2006.09.039; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2	45	4	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65658	10.1371/journal.pone.0065658	http://dx.doi.org/10.1371/journal.pone.0065658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776520	gold, Green Published, Green Submitted			2022-12-25	WOS:000320322400041
J	Niedtfeld, I; Schulze, L; Krause-Utz, A; Demirakca, T; Bohus, M; Schmahl, C				Niedtfeld, Inga; Schulze, Lars; Krause-Utz, Annegret; Demirakca, Traute; Bohus, Martin; Schmahl, Christian			Voxel-Based Morphometry in Women with Borderline Personality Disorder with and without Comorbid Posttraumatic Stress Disorder	PLOS ONE			English	Article							STRUCTURAL BRAIN ABNORMALITIES; HIPPOCAMPAL VOLUME; AMYGDALA VOLUME; MRI; METAANALYSIS; PTSD; REGISTRATION; PREVALENCE; ALGORITHM; SYMPTOMS	Patients with Borderline Personality Disorder (BPD) showed reduced volume of amygdala and hippocampus, but similar findings are evident in Posttraumatic Stress Disorder (PTSD). Applying voxel-based morphometry (VBM) in a larger cohort of patients with BPD, we sought to extend earlier findings of volume abnormalities in limbic regions and to evaluate the influence of co-occurring PTSD in BPD patients. We used voxel-based morphometry to study gray matter volume (GMV) in 60 healthy controls (HC) and 60 patients with BPD. Subgroup analyses on 53 patients concerning the role of co-occurring PTSD were conducted. Additionally, regression analyses were calculated to assess the relation between borderline symptom severity as well as dissociative experiences and GMV. Differences in local GMV between patients with BPD and HC were observed in the amygdale and hippocampus as well as in the fusiform and cingulate gyrus. Co-occurring PTSD was accompanied by increased GMV in the superior temporal gyrus and dorsolateral prefrontal cortex. Independent of co-occurring PTSD, severity of BPD symptoms predicted smaller GMV in the amygdala and dorsal ACC. Dissociation was positively related to GMV in the middle temporal gyrus. We could replicate earlier findings of diminished limbic GMV in patients with BPD and additionally show that patients with co-morbid PTSD feature increased GMV in prefrontal regions associated with cognitive control.	[Niedtfeld, Inga; Krause-Utz, Annegret; Bohus, Martin; Schmahl, Christian] Heidelberg Univ, Med Fac Mannheim, Dept Psychosomat Med, Cent Inst Mental Hlth Mannheim, Mannheim, Germany; [Schulze, Lars] Free Univ Berlin, Div Clin Psychol & Psychotherapy, Deptartment Educ & Psychol, Berlin, Germany; [Demirakca, Traute] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth Mannheim, Dept Neuroimaging, Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Free University of Berlin; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Niedtfeld, I (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Psychosomat Med, Cent Inst Mental Hlth Mannheim, Mannheim, Germany.	inga.niedtfeld@zi-mannheim.de	Niedtfeld, Inga/GLV-3573-2022; Schmahl, Christian/E-8760-2012	Schmahl, Christian/0000-0003-0141-0821; Krause-Utz, Annegret/0000-0003-0661-6546; Schulze, Lars/0000-0003-4720-2411; Niedtfeld, Inga/0000-0002-6118-1664	Deutsche Forschungsgemeinschaft [DFG SCHM 1526/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Preparation of this manuscript was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG SCHM 1526/8-1) to Prof. Schmahl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Association AP, 1994, DIAGN STAT MAN MENT, V4th; Ball JS, 2009, CURR PSYCHIAT REP, V11, P63, DOI 10.1007/s11920-009-0010-4; Bohus M, 2007, PSYCHOPATHOLOGY, V40, P126, DOI 10.1159/000098493; Brambilla P, 2004, PSYCHIAT RES-NEUROIM, V131, P125, DOI 10.1016/j.pscychresns.2004.04.003; Brunner R, 2010, NEUROIMAGE, V49, P114, DOI 10.1016/j.neuroimage.2009.07.070; Crowell SE, 2009, PSYCHOL BULL, V135, P495, DOI 10.1037/a0015616; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; Driessen M, 2000, ARCH GEN PSYCHIAT, V57, P1115, DOI 10.1001/archpsyc.57.12.1115; Freyberger HJ, 1999, DTSCH ADAPTATION DIS; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Grant BF, 2008, J CLIN PSYCHIAT, V69, P533, DOI 10.4088/JCP.v69n0404; Guitart-Masip M, 2009, PROG NEURO-PSYCHOPH, V33, P1537, DOI 10.1016/j.pnpbp.2009.08.022; Hayasaka S, 2004, NEUROIMAGE, V23, P54, DOI 10.1016/j.neuroimage.2004.04.035; Hazlett EA, 2005, BIOL PSYCHIAT, V58, P614, DOI 10.1016/j.biopsych.2005.04.029; Herpertz SC, 2001, BIOL PSYCHIAT, V50, P292, DOI 10.1016/S0006-3223(01)01075-7; Irle E, 2005, BIOL PSYCHIAT, V57, P173, DOI 10.1016/j.biopsych.2004.10.004; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kluetsch RC, 2012, ARCH GEN PSYCHIAT, P1; Koenigsberg HW, 2009, BIOL PSYCHIAT, V66, P854, DOI 10.1016/j.biopsych.2009.06.010; Korzekwa MI, 2008, COMPR PSYCHIAT, V49, P380, DOI 10.1016/j.comppsych.2008.01.007; Krause-Utz A, 2010, EUR PSYCHIAT REV, V3, P63; Kuhlmann A, 2013, J PSYCHIATR NEUROSCI, V38, P129, DOI 10.1503/jpn.120039; Lanius RA, 2002, BIOL PSYCHIAT, V52, P305, DOI 10.1016/S0006-3223(02)01367-7; Lanius RA, 2010, AM J PSYCHIAT, V167, P640, DOI 10.1176/appi.ajp.2009.09081168; Lieb K, 2004, LANCET, V364, P453, DOI 10.1016/S0140-6736(04)16770-6; Loranger A. W, 1999, INT PERSONALITY DISO; Lyoo IK, 1998, J AFFECT DISORDERS, V50, P235, DOI 10.1016/S0165-0327(98)00104-9; Nenadic I, 2010, BRIT J PSYCHIAT, V196, P412, DOI 10.1192/bjp.bp.109.070441; New AS, 2007, NEUROPSYCHOPHARMACOL, V32, P1629, DOI 10.1038/sj.npp.1301283; Niedtfeld I, 2010, BIOL PSYCHIAT, V68, P383, DOI 10.1016/j.biopsych.2010.04.015; Nunes PM, 2009, J PERS DISORD, V23, P333, DOI 10.1521/pedi.2009.23.4.333; O'Neill A, 2012, BRAIN STRUCT FUNCT, V217, P767, DOI 10.1007/s00429-012-0379-4; Rodrigues E, 2011, EUR PSYCHIAT, V26, P452, DOI 10.1016/j.eurpsy.2010.07.005; Rusch N, 2003, NEUROIMAGE, V20, P385, DOI 10.1016/S1053-8119(03)00297-0; Sala M, 2011, J AFFECT DISORDERS, V131, P417, DOI 10.1016/j.jad.2010.11.036; Schmahl CG, 2003, PSYCHIAT RES-NEUROIM, V122, P193, DOI 10.1016/S0925-4927(03)00023-4; Schmahl Christian, 2009, J Psychiatry Neurosci, V34, P289; Simeon D, 2000, AM J PSYCHIAT, V157, P1782, DOI 10.1176/appi.ajp.157.11.1782; Skodol AE, 2002, BIOL PSYCHIAT, V51, P936, DOI 10.1016/S0006-3223(02)01324-0; Soloff P, 2008, PSYCHIAT RES-NEUROIM, V164, P223, DOI 10.1016/j.pscychresns.2008.02.003; Soloff PH, 2012, J PSYCHIATR RES, V46, P516, DOI 10.1016/j.jpsychires.2012.01.003; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Stiglmayr C, 2001, STATES AVERSIVE TENS, P135; Stiglmayr CE, 2008, ACTA PSYCHIAT SCAND, V117, P139, DOI 10.1111/j.1600-0447.2007.01126.x; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Elst LT, 2003, BIOL PSYCHIAT, V54, P163, DOI 10.1016/S0006-3223(03)01743-2; Vollm BA, 2009, CRIM BEHAV MENT HEAL, V19, P64, DOI 10.1002/cbm.716; Wittchen H.U., 1997, SKID STRUKTURIERTES; Zanarini MC, 2000, J NERV MENT DIS, V188, P26, DOI 10.1097/00005053-200001000-00005; Zetzsche T, 2006, BIOL PSYCHIAT, V60, P302, DOI 10.1016/j.biopsych.2005.11.020; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	56	57	59	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65824	10.1371/journal.pone.0065824	http://dx.doi.org/10.1371/journal.pone.0065824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776553	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400059
J	Stanisor, OI; van Diest, SA; Yu, ZM; Welting, O; Bekkali, N; Shi, J; de Jonge, WJ; Boeckxstaens, GE; van den Wijngaard, RM				Stanisor, Oana I.; van Diest, Sophie A.; Yu, Zhumei; Welting, Olaf; Bekkali, Noor; Shi, Jing; de Jonge, Wouter J.; Boeckxstaens, Guy E.; van den Wijngaard, Rene M.			Stress-Induced Visceral Hypersensitivity in Maternally Separated Rats Can Be Reversed by Peripherally Restricted Histamine-1-Receptor Antagonists	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; EARLY-LIFE; HISTAMINE; DISORDERS; MECHANISMS; EXPRESSION; KETOTIFEN; RISK	Background: The histamine-1 receptor (H1R) antagonist ketotifen increased the threshold of discomfort in hypersensitive IBS patients. The use of peripherally restricted and more selective H1R antagonists may further improve treatment possibilities. We examined the use of fexofenadine and ebastine to reverse post-stress visceral hypersensitivity in maternally separated rats. Methods: The visceromotor response to colonic distension was assessed in adult maternally separated and nonhandled rats pre- and 24 hours post water avoidance. Subsequently rats were treated with vehicle alone or different dosages of fexofenadine (1.8 and 18 mg/kg) or ebastine (0.1 and 1.0 mg/kg) and re-evaluated. Colonic tissue was collected to assess relative RMCP-2 and occludin expression levels by Western blot and histamine-1 receptor by RT-qPCR. beta-hexosaminidase release by RBL-2H3 cells was used to establish possible mast cell stabilizing properties of the antagonists. Key results: Water avoidance only induced enhanced response to distension in maternally separated rats. This response was reversed by 1.8 and 18 mg/kg fexofenadine. Reversal was also obtained by 1.0 but not 0.1 mg/kg ebastine. RMCP-2 expression levels were comparable in these two ebastine treatment groups but occludin was significantly higher in 1.0 mg/kg treated rats. There were no differences in histamine-1 receptor expression between nonhandled and maternally separated rats. Fexofenadine but not ebastine showed mast cell stabilizing quality. Conclusions: Our results indicate that the peripherally restricted 2nd generation H1-receptor antagonists fexofenadine and ebastine are capable of reversing post stress visceral hypersensitivity in rat. These data justify future IBS patient trials with these well tolerated compounds.	[Stanisor, Oana I.; van Diest, Sophie A.; Yu, Zhumei; Welting, Olaf; Bekkali, Noor; de Jonge, Wouter J.; van den Wijngaard, Rene M.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Yu, Zhumei; Shi, Jing] HUST, Tongji Med Coll, Dept Neurobiol, Wuhan, Peoples R China; [Boeckxstaens, Guy E.] Catholic Univ Louvain, Univ Hosp Gasthuisberg, Div Gastroenterol, B-3000 Louvain, Belgium	University of Amsterdam; Academic Medical Center Amsterdam; Huazhong University of Science & Technology; KU Leuven; University Hospital Leuven; Universite Catholique Louvain	van den Wijngaard, RM (corresponding author), Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	R.vandenWijngaard@AMC.UVA.NL	Boeckxstaens, Guy/AAP-2502-2020		European Union [202020]; Netherlands Top Institute Pharma [T1-215-1]; Netherlands Digestive Diseases Foundation (MLDS) [WO10-12]; Royal Netherlands Academy of Arts and Sciences (KNAW) [11CDP005]; Dutch Organization for Scientific Research (NWO-VIDI)	European Union(European Commission); Netherlands Top Institute Pharma; Netherlands Digestive Diseases Foundation (MLDS); Royal Netherlands Academy of Arts and Sciences (KNAW); Dutch Organization for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO))	OIS was supported by funding for the IPODD consortium under Grant Agreement 202020 of the Seventh Research Framework Programme of the European Union (http://www.IPODD.eu). SAvD was supported by the Netherlands Top Institute Pharma, grant number T1-215-1 (www.TIPharma.com) and the Netherlands Digestive Diseases Foundation (MLDS), project number WO10-12 (www.MLDS.NL/). ZY was supported by The China Exchange Programme (CEP) of the Royal Netherlands Academy of Arts and Sciences (KNAW), project number 11CDP005 (www.KNAW.NL). WJdJ was funded by a grant of the Dutch Organization for Scientific Research (NWO-VIDI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Belgnaoui A, 2005, PAIN, V113, P141, DOI 10.1016/j.pain.2004.10.002; Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Azpiroz F, 2007, NEUROGASTROENT MOTIL, V19, P62, DOI 10.1111/j.1365-2982.2006.00875.x; Barbara G, 2007, GASTROENTEROLOGY, V132, P26, DOI 10.1053/j.gastro.2006.11.039; Barreau F, 2007, PEDIATR RES, V62, P240, DOI 10.1203/PDR.0b013e3180db2949; Bertiaux-Vandaele N, 2011, AM J GASTROENTEROL, V106, P2165, DOI 10.1038/ajg.2011.257; Chitkara DK, 2008, AM J GASTROENTEROL, V103, P765, DOI 10.1111/j.1572-0241.2007.01722.x; Coeffier M, 2009, AM J GASTROENTEROL; Coelho AM, 1998, DIGEST DIS SCI, V43, P727, DOI 10.1023/A:1018853728251; Gareau MG, 2008, CURR MOL MED, V8, P274, DOI 10.2174/156652408784533760; Klooker TK, 2010, GUT, V59, P1213, DOI 10.1136/gut.2010.213108; Klooker TK, 2009, AM J GASTROENTEROL, V104, P2250, DOI 10.1038/ajg.2009.282; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Marone G, 2001, INT ARCH ALLERGY IMM, V124, P249, DOI 10.1159/000053725; Sander LE, 2006, GUT, V55, P498, DOI 10.1136/gut.2004.061762; Shim WS, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-29; Simons FER, 2011, J ALLERGY CLIN IMMUN, V128, P1139, DOI 10.1016/j.jaci.2011.09.005; Simpson K, 2000, DRUGS, V59, P301, DOI 10.2165/00003495-200059020-00020; Tashiro M, 2006, BRIT J CLIN PHARMACO, V61, P16, DOI 10.1111/j.1365-2125.2005.02514.x; Van Cauwenberge P, 2004, EXPERT OPIN PHARMACO, V5, P1807, DOI 10.1517/14656566.5.8.1807; van den Wijngaard RM, 2012, NEUROGASTROENT MOTIL, V24, P274, DOI 10.1111/j.1365-2982.2011.01840.x; van den Wijngaard RM, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01339.x; van den Wijngaard RM, 2010, AUTON NEUROSCI-BASIC, V153, P99, DOI 10.1016/j.autneu.2009.07.004; Welting O, 2005, NEUROGASTROENT MOTIL, V17, P838, DOI 10.1111/j.1365-2982.2005.00677.x	24	30	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66884	10.1371/journal.pone.0066884	http://dx.doi.org/10.1371/journal.pone.0066884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776699	Green Published, gold, Green Submitted			2022-12-25	WOS:000320322400119
J	Wang, YJ; Deng, DX; Ding, HD; Xu, XM; Zhang, R; Wang, SX; Bian, YL; Yin, ZT; Chen, Y				Wang, Yijun; Deng, Dexiang; Ding, Haidong; Xu, Xiangming; Zhang, Rong; Wang, Suxin; Bian, Yunlong; Yin, Zhitong; Chen, Yao			Gibberellin Biosynthetic Deficiency Is Responsible for Maize Dominant Dwarf11 (D11) Mutant Phenotype: Physiological and Transcriptomic Evidence	PLOS ONE			English	Article							GREEN-REVOLUTION; RICE; GENES; MODULATORS; GENETICS; HEIGHT; ROLES	Dwarf stature is introduced to improve lodging resistance and harvest index in crop production. In many crops including maize, mining and application of novel dwarf genes are urgent to overcome genetic bottleneck and vulnerability during breeding improvement. Here we report the characterization and expression profiling analysis of a newly identified maize dwarf mutant Dwarf11 (D11). The D11 displays severely developmental abnormalities and is controlled by a dominant Mendelian factor. The D11 seedlings responds to both GA(3) and paclobutrazol (PAC) application, suggesting that dwarf phenotype of D11 is caused by GA biosynthesis instead of GA signaling deficiency. In contrast, two well-characterized maize dominant dwarf plants D8 and D9 are all insensitive to exogenous GA(3) stimulation. Additionally, sequence variation of D8 and D9 genes was not identified in the D11 mutant. Microarray and qRT-PCR analysis results demonstrated that transcripts encoding GA biosynthetic and catabolic enzymes ent-kaurenoic acid oxidase (KAO), GA 20-oxidase (GA20ox), and GA 2-oxidase (GA2ox) are up-regulated in D11. Our results lay a foundation for the following D11 gene cloning and functional characterization. Moreover, results presented here may aid in crops molecular improvement and breeding, especially breeding of crops with plant height ideotypes.	[Wang, Yijun; Deng, Dexiang; Xu, Xiangming; Zhang, Rong; Wang, Suxin; Bian, Yunlong; Yin, Zhitong; Chen, Yao] Yangzhou Univ, Coll Agr, Key Lab Crop Genet & Physiol Jiangsu Prov, Key Lab Plant Funct Genom,Minist Educ, Yangzhou, Peoples R China; [Ding, Haidong] Yangzhou Univ, Coll Biosci & Biotechnol, Key Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou, Peoples R China	Yangzhou University; Yangzhou University	Wang, YJ (corresponding author), Yangzhou Univ, Coll Agr, Key Lab Crop Genet & Physiol Jiangsu Prov, Key Lab Plant Funct Genom,Minist Educ, Yangzhou, Peoples R China.	yjwang61@163.com	Wang, Yijun/GXW-1763-2022	Yin, Zhitong/0000-0003-2482-8681	National Natural Science Foundation of China [31201213]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Innovative Foundation of Yangzhou University [2011CXJ046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Innovative Foundation of Yangzhou University	This work was supported by grants from the National Natural Science Foundation of China (31201213), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and Innovative Foundation of Yangzhou University (2011CXJ046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cassani E, 2009, MOL BREEDING, V24, P375, DOI 10.1007/s11032-009-9298-3; Chandler PM, 2002, PLANT PHYSIOL, V129, P181, DOI 10.1104/pp.010917; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Emerson, 1912, J HERED, P385; FUJIOKA S, 1988, PLANT PHYSIOL, V88, P1367, DOI 10.1104/pp.88.4.1367; Gasperini D, 2012, J EXP BOT, V63, P4419, DOI 10.1093/jxb/ers138; HARBERD NP, 1989, GENETICS, V121, P827; Hartwig T, 2011, P NATL ACAD SCI USA, V108, P19814, DOI 10.1073/pnas.1108359108; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Huang J, 2010, J GENET GENOMICS, V37, P23, DOI 10.1016/S1673-8527(09)60022-9; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Jiang FK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037040; Jiang XS, 2012, PLANT J, V72, P768, DOI 10.1111/j.1365-313X.2012.05118.x; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; Larsson SJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003246; Lawit SJ, 2010, PLANT CELL PHYSIOL, V51, P1854, DOI 10.1093/pcp/pcq153; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Makarevitch I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030798; Multani DS, 2003, SCIENCE, V302, P81, DOI 10.1126/science.1086072; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Plackett ARG, 2012, PLANT CELL, V24, P941, DOI 10.1105/tpc.111.095109; Plackett ARG, 2011, TRENDS PLANT SCI, V16, P568, DOI 10.1016/j.tplants.2011.06.007; Qi WW, 2011, PLANT PHYSIOL, V157, P216, DOI 10.1104/pp.111.179945; Ramamoorthy R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028069; Song J, 2011, GENE, V482, P34, DOI 10.1016/j.gene.2011.05.008; Teng F, 2013, PLANT J, V73, P405, DOI 10.1111/tpj.12038; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tong HN, 2009, PLANT J, V58, P803, DOI 10.1111/j.1365-313X.2009.03825.x; [王立静 WANG Lijing], 2008, [华北农学报, Acta Agriculturae Boreali-Sinica], V23, P23; [王益军 Wang Yijun], 2010, [华北农学报, Acta Agriculturae Boreali-Sinica], V25, P90; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Weng JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029229; WINKLER RG, 1994, PLANTA, V193, P341, DOI 10.1007/BF00201811; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; [张素梅 ZHANG Sumei], 2007, [玉米科学, Maize Science], V15, P15	35	14	25	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66466	10.1371/journal.pone.0066466	http://dx.doi.org/10.1371/journal.pone.0066466			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776674	Green Published, Green Submitted, gold			2022-12-25	WOS:000320322400103
J	Ballas, ZK; Buchta, CM; Rosean, TR; Heusel, JW; Shey, MR				Ballas, Zuhair K.; Buchta, Claire M.; Rosean, Timothy R.; Heusel, Jonathan W.; Shey, Michael R.			Role of NK Cell Subsets in Organ-Specific Murine Melanoma Metastasis	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; CPG OLIGODEOXYNUCLEOTIDES; TUMOR-METASTASIS; T-CELLS; IN-VIVO; INDUCTION; MOTIFS; CD27	Tumor metastasis plays a major role in the morbidity and mortality of cancer patients. Among solid tumors that undergo metastasis, there is often a predilection to metastasize to a particular organ with, for example, prostate cancer preferentially metastasizing to bones and colon cancer preferentially metastasizing to the liver. Although many factors are thought to be important in establishing permissiveness for metastasis, the reasons for organ-specific predilection of each tumor are not understood. Using a B16 murine melanoma model, we tested the hypothesis that organ-specific NK cell subsets play a critical role in organ-specific metastasis of this tumor. Melanoma cells, given intravenously, readily colonized the lungs but not the liver. NK cell depletion (either iatrogenically or by using genetically targeted mice) resulted in substantial hepatic metastasis. Analysis of NK cell subsets, defined by the differential expression of a combination of CD27 and CD11b, indicated a significant difference in the distribution of NK cell subsets in the lung and liver with the mature subset being dominant in the lung and the immature subset being dominant in the liver. Several experimental approaches, including adoptive transfer, clearly indicated that the immature hepatic NK cell subset, CD27+ CD11b-, was protective against liver metastasis; this subset mediated its protection by a perforin-dependent cytotoxic mechanism. In contrast, the more mature NK cell subsets were more efficient at reducing pulmonary tumor load. These data indicate that organ-specific immune responses may play a pivotal role in determining the permissiveness of a given organ for the establishment of a metastatic niche.	[Ballas, Zuhair K.; Shey, Michael R.] Univ Iowa, Carver Coll Med, Iowa City VA Med Ctr, Iowa City, IA 52240 USA; [Ballas, Zuhair K.; Shey, Michael R.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA USA; [Buchta, Claire M.; Rosean, Timothy R.] Univ Iowa, Carver Coll Med, Interdisciplinary Grad Program Immunol, Iowa City, IA USA; [Heusel, Jonathan W.] Univ Iowa, Carver Coll Med, Dept Pathol, Iowa City, IA USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa; University of Iowa	Ballas, ZK (corresponding author), Univ Iowa, Carver Coll Med, Iowa City VA Med Ctr, Iowa City, IA 52240 USA.	ballasz@uiowa.edu; michael-shey@uiowa.edu	Heusel, Jon/AAC-8050-2021	Knaack, Aaron/0000-0001-7712-1415; Ballas, Zuhair/0000-0001-5569-1230	VA Nerit Review award; Iowa City VA Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007485] Funding Source: NIH RePORTER	VA Nerit Review award; Iowa City VA Medical Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a VA Nerit Review award; Iowa City VA Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLAS ZK, 1986, J IMMUNOL, V137, P2380; BALLAS ZK, 1990, J IMMUNOL, V145, P1039; Ballas ZK, 2001, J IMMUNOL, V167, P4878, DOI 10.4049/jimmunol.167.9.4878; Ballas ZK, 1996, J IMMUNOL, V157, P1840; Ballas ZK, 2007, IMMUNOL RES, V39, P15, DOI 10.1007/s12026-007-0066-3; Ballas ZK, 2012, ALCOHOL CLIN EXP RES, V36, P826, DOI 10.1111/j.1530-0277.2011.01678.x; Bottcher JP, 2011, DIGEST DIS, V29, P384, DOI 10.1159/000329801; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Coghlin C, 2010, J PATHOL, V222, P1, DOI 10.1002/path.2727; Guise T, 2010, SEMIN ONCOL, V37, pS2, DOI 10.1053/j.seminoncol.2010.10.007; Hartmann G, 2000, J IMMUNOL, V164, P1617, DOI 10.4049/jimmunol.164.3.1617; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hayakawa Y, 2006, IMMUNOL REV, V214, P47, DOI 10.1111/j.1600-065X.2006.00454.x; HERSEY P, 1979, BRIT J CANCER, V40, P113, DOI 10.1038/bjc.1979.147; Holtan SG, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/316314; Inngjerdingen M, 2011, TISSUE ANTIGENS, V78, P81, DOI 10.1111/j.1399-0039.2011.01714.x; Jovic V, 2001, TUMORI J, V87, P324, DOI 10.1177/030089160108700509; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kim S, 2006, BLOOD, V107, P1024, DOI 10.1182/blood-2005-04-1493; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Kline JN, 1999, J ALLERGY CLIN IMMUN, V104, P1258, DOI 10.1016/S0091-6749(99)70022-9; Krug A, 2001, EUR J IMMUNOL, V31, P2154, DOI 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U; Orange JS, 2006, CLIN IMMUNOL, V118, P1, DOI 10.1016/j.clim.2005.10.011; Shey Michael R., 2008, V447, P259, DOI 10.1007/978-1-59745-242-7_18; Silva A, 2008, INT IMMUNOL, V20, P625, DOI 10.1093/intimm/dxn022; Spano D, 2012, CLIN EXP METASTAS, V29, P381, DOI 10.1007/s10585-012-9457-5; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wu X, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/759765; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711	31	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65599	10.1371/journal.pone.0065599	http://dx.doi.org/10.1371/journal.pone.0065599			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776508	gold, Green Published, Green Submitted			2022-12-25	WOS:000320755400046
J	Falcon, E; Ozburn, A; Mukherjee, S; Roybal, K; McClung, CA				Falcon, Edgardo; Ozburn, Angela; Mukherjee, Shibani; Roybal, Kole; McClung, Colleen A.			Differential Regulation of the Period Genes in Striatal Regions following Cocaine Exposure	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; SEEKING BEHAVIOR; CLOCK PROTEIN; EXPRESSION; REWARD; SENSITIZATION; WITHDRAWAL; PATHWAY; OPIATE; BRAIN	Several studies have suggested that disruptions in circadian rhythms contribute to the pathophysiology of multiple psychiatric diseases, including drug addiction. In fact, a number of the genes involved in the regulation of circadian rhythms are also involved in modulating the reward value for drugs of abuse, like cocaine. Thus, we wanted to determine the effects of chronic cocaine on the expression of several circadian genes in the Nucleus Accumbens (NAc) and Caudate Putamen (CP), regions of the brain known to be involved in the behavioral responses to drugs of abuse. Moreover, we wanted to explore the mechanism by which these genes are regulated following cocaine exposure. Here we find that after repeated cocaine exposure, expression of the Period (Per) genes and Neuronal PAS Domain Protein 2 (Npas2) are elevated, in a somewhat regionally selective fashion. Moreover, NPAS2 (but not CLOCK (Circadian Locomotor Output Cycles Kaput)) protein binding at Per gene promoters was enhanced following cocaine treatment. Mice lacking a functional Npas2 gene failed to exhibit any induction of Per gene expression after cocaine, suggesting that NPAS2 is necessary for this cocaine-induced regulation. Examination of Per gene and Npas2 expression over twenty-four hours identified changes in diurnal rhythmicity of these genes following chronic cocaine, which were regionally specific. Taken together, these studies point to selective disruptions in Per gene rhythmicity in striatial regions following chronic cocaine treatment, which are mediated primarily by NPAS2.	[Falcon, Edgardo; Mukherjee, Shibani; Roybal, Kole; McClung, Colleen A.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Ozburn, Angela; McClung, Colleen A.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Ozburn, Angela; McClung, Colleen A.] Univ Pittsburgh, Sch Med, Translat Neurosci Program, Pittsburgh, PA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McClung, CA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	mcclungca@upmc.edu	Ozburn, Angela R/P-5409-2018; McClung, Colleen/AAA-5943-2019	Ozburn, Angela R/0000-0002-8387-1156; 	NIH/NIDA [DA028085, DA023988]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023988, F31DA028085] Funding Source: NIH RePORTER	NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	NIH/NIDA grants DA028085 to Edgardo Falcon and DA023988 to Colleen McClung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; Andretic R, 1999, SCIENCE, V285, P1066, DOI 10.1126/science.285.5430.1066; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Enwright JF, 2010, BRAIN RES, V1329, P10, DOI 10.1016/j.brainres.2010.02.081; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Halbout B, 2011, BEHAV PHARMACOL, V22, P76, DOI 10.1097/FBP.0b013e328341e9ca; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Iijima M, 2002, EUR J NEUROSCI, V16, P921, DOI 10.1046/j.1460-9568.2002.02140.x; Imbesi M, 2009, NEUROSCIENCE, V158, P537, DOI 10.1016/j.neuroscience.2008.10.044; Jones EM, 2003, AM FAM PHYSICIAN, V68, P1971; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kosobud Ann E K, 2007, ScientificWorldJournal, V7, P203; Lamont EW, 2005, P NATL ACAD SCI USA, V102, P4180, DOI 10.1073/pnas.0500901102; Li SX, 2010, J NEUROCHEM, V115, P353, DOI 10.1111/j.1471-4159.2010.06941.x; Liu Y, 2007, NEUROSCIENCE, V146, P265, DOI 10.1016/j.neuroscience.2007.01.009; Liu Y, 2005, NEUROSCIENCE, V130, P383, DOI 10.1016/j.neuroscience.2004.09.012; Lynch WJ, 2008, BRAIN RES, V1213, P166, DOI 10.1016/j.brainres.2008.02.106; Manev H, 2006, TRENDS PHARMACOL SCI, V27, P186, DOI 10.1016/j.tips.2006.02.003; Masubuchi S, 2000, EUR J NEUROSCI, V12, P4206, DOI 10.1046/j.1460-9568.2000.01313.x; Maywood ES, 2010, J NEUROSCI, V30, P10199, DOI 10.1523/JNEUROSCI.1694-10.2010; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Nestler EJ, 2004, TRENDS PHARMACOL SCI, V25, P210, DOI 10.1016/j.tips.2004.02.005; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Nikaido T, 2001, MOL PHARMACOL, V59, P894, DOI 10.1124/mol.59.4.894; Perreau-Lenz S, 2010, EUR NEUROPSYCHOPHARM, V20, P509, DOI 10.1016/j.euroneuro.2010.03.006; Pieper AA, 2006, POLYMORPHIC VARIATIO; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Shearman LP, 1999, NEUROSCIENCE, V89, P387, DOI 10.1016/S0306-4522(98)00325-X; Spanagel R, 2005, NAT MED, V11, P35, DOI 10.1038/nm1163; STEPHAN FK, 1984, PHYSIOL BEHAV, V32, P663, DOI 10.1016/0031-9384(84)90323-8; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Wasielewski JA, 2001, ALCOHOL RES HEALTH, V25, P94; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5; Yuferov V, 2005, EUR J HUM GENET, V13, P1101, DOI 10.1038/sj.ejhg.5201483; Yuferov V, 2003, SYNAPSE, V48, P157, DOI 10.1002/syn.10198; Zghoul T, 2007, PSYCHOPHARMACOLOGY, V190, P13, DOI 10.1007/s00213-006-0592-z; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	42	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66438	10.1371/journal.pone.0066438	http://dx.doi.org/10.1371/journal.pone.0066438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776671	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000320755400145
J	Garg, H; Li, H; Sivasithamparam, K; Barbetti, MJ				Garg, Harsh; Li, Hua; Sivasithamparam, Krishnapillai; Barbetti, Martin J.			Differentially Expressed Proteins and Associated Histological and Disease Progression Changes in Cotyledon Tissue of a Resistant and Susceptible Genotype of Brassica napus Infected with Sclerotinia sclerotiorum	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEINS; GLUTATHIONE-S-TRANSFERASES; HYDROGEN-PEROXIDE; GENE-EXPRESSION; DIHYDROLIPOYL DEHYDROGENASE; LEPTOSPHAERIA-MACULANS; OXALIC-ACID; PLANT; RESPONSES; STRESS	Sclerotinia rot caused by Sclerotinia sclerotiorum is one of the most serious diseases of oilseed rape. To understand the resistance mechanisms in the Brassica napus to S. sclerotiorum, comparative disease progression, histological and proteomic studies were conducted of two B. napus genotypes (resistant cv. Charlton, susceptible cv. RQ001-02M2). At 72 and 96 h post inoculation (hpi), lesion size on cotyledons was significantly (P <= 0.001) smaller in the resistant Charlton. Anatomical investigations revealed impeded fungal growth (at 24 hpi and onwards) and hyphal disintegration only on resistant Charlton. Temporal changes (12, 24, 48 and 72 hpi) in protein profile showed certain enzymes up-regulated only in resistant Charlton, such as those related to primary metabolic pathways, antioxidant defence, ethylene biosynthesis, pathogenesis related proteins, protein synthesis and protein folding, play a role in mediating defence responses against S. sclerotiorum. Similarly a eukaryotic translation initiation factor 5A enzyme with increased abundance in susceptible RQ001-02M2 and decreased levels in resistant Charlton has a role in increased susceptibility to this pathogen. This is the first time that the expression of these enzymes has been shown to be associated with mediating the defence response against S. sclerotinia in cotyledon tissue of a resistant cultivar of B. napus at a proteomics level. This study not only provides important new insights into the resistance mechanisms within B. napus against S. sclerotiorum, but opens the way for novel engineering of new B. napus varieties that over-express these key enzymes as a strategy to enhance resistance and better manage this devastating pathogen.	[Garg, Harsh; Li, Hua; Sivasithamparam, Krishnapillai; Barbetti, Martin J.] Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia; [Barbetti, Martin J.] Univ Western Australia, Fac Sci, Inst Agr, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Barbetti, MJ (corresponding author), Univ Western Australia, Fac Sci, Sch Plant Biol, Crawley, WA, Australia.	martin.barbetti@uwa.edu.au	Barbetti, Martin J/B-3455-2011	Barbetti, Martin J/0000-0002-5331-0817	School of Plant Biology at The University of Western Australia; Australian Centre for International Agricultural Research; Department of Agriculture and Food Western Australia	School of Plant Biology at The University of Western Australia; Australian Centre for International Agricultural Research; Department of Agriculture and Food Western Australia	This work has been supported by the School of Plant Biology at The University of Western Australia. HG gratefully acknowledges the financial assistance of the Australian Centre for International Agricultural Research by way of a John Allwright PhD fellowship. MB gratefully acknowledges the generous support of a half salary from Department of Agriculture and Food Western Australia during the time of these studies. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALWINE JC, 1973, J BACTERIOL, V115, P1; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; BOLAND GJ, 1994, CAN J PLANT PATHOL, V16, P93, DOI 10.1080/07060669409500766; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; Bouchereau A, 1999, PLANT SCI, V140, P103, DOI 10.1016/S0168-9452(98)00218-0; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Bringans S, 2008, PROTEOMICS, V8, P1081, DOI 10.1002/pmic.200700948; Broekaert WF, 2006, ANNU REV PHYTOPATHOL, V44, P393, DOI 10.1146/annurev.phyto.44.070505.143440; Calla B, 2009, PLANT GENOME-US, V2, P149, DOI 10.3835/plantgenome2008.02.0008; Carpentier SC, 2008, PHYSIOL PLANTARUM, V133, P117, DOI 10.1111/j.1399-3054.2008.01069.x; Cessna SG, 2000, PLANT CELL, V12, P2191, DOI 10.1105/tpc.12.11.2191; Colditz Frank, 2007, P283, DOI 10.1007/978-3-540-72617-3_18; CUSHMAN JC, 1993, PHOTOSYNTH RES, V35, P15, DOI 10.1007/BF02185408; De Gara L, 2003, PLANT PHYSIOL BIOCH, V41, P863, DOI 10.1016/S0981-9428(03)00135-9; Dickman MB, 2001, P NATL ACAD SCI USA, V98, P6957, DOI 10.1073/pnas.091108998; EDWARDS R, 1991, PLANTA, V184, P403, DOI 10.1007/BF00195343; Eynck C, 2012, MOL PLANT PATHOL, V13, P887, DOI 10.1111/j.1364-3703.2012.00798.x; Feng HZ, 2007, PLANT PHYSIOL, V144, P1531, DOI 10.1104/pp.107.098079; Garg H, 2008, AUSTRALAS PLANT PATH, V37, P106, DOI 10.1071/AP08002; Garg H, 2010, ANN BOT-LONDON, V106, P897, DOI 10.1093/aob/mcq196; Garg H, 2010, FIELD CROP RES, V117, P51, DOI 10.1016/j.fcr.2010.01.013; Garg H, 2010, EUR J PLANT PATHOL, V126, P305, DOI 10.1007/s10658-009-9547-7; Gazaryan IG, 2002, J BIOL CHEM, V277, P10064, DOI 10.1074/jbc.M108264200; Ge XT, 2012, FIELD CROP RES, V127, P248, DOI 10.1016/j.fcr.2011.11.022; GODOY G, 1990, PHYSIOL MOL PLANT P, V37, P179, DOI 10.1016/0885-5765(90)90010-U; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; GROSS GG, 1977, PLANTA, V136, P271, DOI 10.1007/BF00385995; Guimaraes RL, 2004, PLANT PHYSIOL, V136, P3703, DOI 10.1104/pp.104.049650; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hegedus DD, 2005, FEMS MICROBIOL LETT, V251, P177, DOI 10.1016/j.femsle.2005.07.040; Hegedus DD, 2008, PLANTA, V228, P241, DOI 10.1007/s00425-008-0733-1; Hind-Lanoiselet TL, 2004, DPI490; Hopkins MT, 2008, PLANT PHYSIOL, V148, P479, DOI 10.1104/pp.108.118869; Hu X, 2003, PLANT PHYSIOL, V133, P170, DOI 10.1104/pp.103.024026; ISHIDA A, 1987, PLANT CELL PHYSIOL, V28, P723; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Li C, 2009, 14 INT SCLER WORKSH; Li CX, 2008, AUSTRALAS PLANT PATH, V37, P162, DOI 10.1071/AP08005; Li Hua, 2007, Journal of General Plant Pathology, V73, P297, DOI 10.1007/s10327-007-0011-2; Li RG, 2004, FUNGAL GENET BIOL, V41, P754, DOI 10.1016/j.fgb.2004.03.002; Li RG, 2004, FUNGAL GENET BIOL, V41, P735, DOI 10.1016/j.fgb.2004.03.001; Liang Y, 2008, J AGR FOOD CHEM, V56, P1963, DOI 10.1021/jf073012d; Liang Y, 2009, PROTEOMICS, V9, P3156, DOI 10.1002/pmic.200800966; Liu JJ, 2006, PHYSIOL MOL PLANT P, V68, P3, DOI 10.1016/j.pmpp.2006.06.004; Liu RH, 2005, SCI CHINA SER C, V48, P460, DOI 10.1360/02yc0106; Liu XJ, 2006, J PLANT PHYSIOL, V163, P546, DOI 10.1016/j.jplph.2005.04.031; Loyall L, 2000, PLANT CELL, V12, P1939, DOI 10.1105/tpc.12.10.1939; LUMSDEN RD, 1979, PHYTOPATHOLOGY, V69, P890, DOI 10.1094/Phyto-69-890; Marra R, 2006, CURR GENET, V50, P307, DOI 10.1007/s00294-006-0091-0; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; MAUCH F, 1993, PLANT PHYSIOL, V102, P1193, DOI 10.1104/pp.102.4.1193; Mehta A, 2008, FEBS J, V275, P3731, DOI 10.1111/j.1742-4658.2008.06528.x; Micic Z, 2005, THEOR APPL GENET, V111, P233, DOI 10.1007/s00122-005-2004-x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Neill SJ, 2002, J EXP BOT, V53, P1237, DOI 10.1093/jexbot/53.372.1237; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Noji M, 2001, PLANT PHYSIOL, V126, P973, DOI 10.1104/pp.126.3.973; Osmark P, 1998, PLANT MOL BIOL, V38, P1243, DOI 10.1023/A:1006060224012; PELEMAN J, 1989, PLANT CELL, V1, P81, DOI 10.1105/tpc.1.1.81; Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805; Sakihama Y, 2000, BIOCHEM BIOPH RES CO, V279, P949, DOI 10.1006/bbrc.2000.4053; Sharma N, 2008, PROTEOMICS, V8, P3516, DOI 10.1002/pmic.200701141; Sharma N, 2007, PLANT SCI, V172, P95, DOI 10.1016/j.plantsci.2006.07.016; SHINSHI H, 1990, PLANT MOL BIOL, V14, P357, DOI 10.1007/BF00028772; Slaymaker DH, 2002, P NATL ACAD SCI USA, V99, P11640, DOI 10.1073/pnas.182427699; Subramanian B, 2005, J AGR FOOD CHEM, V53, P313, DOI 10.1021/jf048922z; Tahara EB, 2007, FASEB J, V21, P274, DOI 10.1096/fj.06-6686com; UPADHYAY RS, 1992, CURR MICROBIOL, V24, P181, DOI 10.1007/BF01579279; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; WINGATE VPM, 1988, PLANT PHYSIOL, V87, P206, DOI 10.1104/pp.87.1.206; Wirtz M, 2001, EUR J BIOCHEM, V268, P686, DOI 10.1046/j.1432-1327.2001.01920.x; Yajima W, 2006, PROTEOMICS, V6, P5995, DOI 10.1002/pmic.200600424; Yang B, 2007, PLANT SCI, V173, P156, DOI 10.1016/j.plantsci.2007.04.012; Yang B, 2010, PLANT MOL BIOL REP, V28, P253, DOI 10.1007/s11105-009-0149-5; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; Zhao JW, 2007, PLANTA, V227, P13, DOI 10.1007/s00425-007-0586-z; Zhao JW, 2009, MOL PLANT PATHOL, V10, P635, DOI [10.1111/J.1364-3703.2009.00558.X, 10.1111/j.1364-3703.2009.00558.x]; Zhao JW, 2006, THEOR APPL GENET, V112, P509, DOI 10.1007/s00122-005-0154-5	80	42	43	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65205	10.1371/journal.pone.0065205	http://dx.doi.org/10.1371/journal.pone.0065205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776450	gold, Green Published, Green Submitted			2022-12-25	WOS:000320755400013
J	Ueyama, T; Yamamoto, Y; Ueda, K; Yajima, A; Maeda, Y; Yamashita, Y; Ito, T; Tsuruo, Y; Ichinose, M				Ueyama, Takashi; Yamamoto, Yuta; Ueda, Kazuki; Yajima, Aiji; Maeda, Yoshimasa; Yamashita, Yasunobu; Ito, Takao; Tsuruo, Yoshihiro; Ichinose, Masao			Is Gastrectomy-Induced High Turnover of Bone with Hyperosteoidosis and Increase of Mineralization a Typical Osteomalacia?	PLOS ONE			English	Article							GROWTH-HORMONE; VITAMIN-D; OSTEOPENIA; DEFICIENCY; GHRELIN; RISK; RAT; HISTOMORPHOMETRY; FUNDECTOMY; REDUCTION	Gastrectomy (GX) is thought to result in osteomalacia due to deficiencies in Vitamin D and Ca. Using a GX rat model, we showed that GX induced high turnover of bone with hyperosteoidosis, prominent increase of mineralization and increased mRNA expression of both osteoclast-derived tartrate-resistant acid phosphatase 5b and osteocalcin. The increased 1, 25(OH)(2)D-3 level and unchanged PTH and calcitonin levels suggested that conventional bone and Ca metabolic pathways were not involved or changed in compensation. Thus, GX-induced bone pathology was different from a typical osteomalacia. Gene expression profiles through microarray analysis and data mining using Ingenuity Pathway Analysis indicated that 612 genes were up-regulated and 1,097 genes were down-regulated in the GX bone. These genes were related functionally to connective tissue development, skeletal and muscular system development and function, Ca signaling and the role of osteoblasts, osteoclasts and chondrocytes. Network analysis indicated 9 genes (Aldehyde dehydrogenase 1 family, member A1; Aquaporin 9; Interleukin 1 receptor accessory protein; Very low density lipoprotein receptor; Periostin, osteoblast specific factor; Aggrecan; Gremlin 1; Angiopoietin-like 4; Wingless-type MMTV integration site family, member 10B) were hubs connected with tissue development and immunological diseases. These results suggest that chronic systemic inflammation might underlie the GX-induced pathological changes in bone.	[Ueyama, Takashi; Yamamoto, Yuta; Ito, Takao; Tsuruo, Yoshihiro] Wakayama Med Univ, Grad Sch Med, Dept Anat & Cell Biol, Wakayama, Japan; [Ueda, Kazuki; Maeda, Yoshimasa; Yamashita, Yasunobu; Ichinose, Masao] Wakayama Med Univ, Grad Sch Med, Dept Internal Med 2, Wakayama, Japan; [Yajima, Aiji] Univ Texas SW Med Ctr Dallas, Kuro Os Lab, Dept Pathol, Dallas, TX 75390 USA; [Yajima, Aiji] Akita Univ, Sch Med, Div Renal Replacement Therapeut Sci, Akita 010, Japan	Wakayama Medical University; Wakayama Medical University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Akita University	Ueyama, T (corresponding author), Wakayama Med Univ, Grad Sch Med, Dept Anat & Cell Biol, Wakayama, Japan.	tueyama@wakayama-med.ac.jp	Yamamoto, Yuta/R-1143-2019; Ichinose, Masao/HAB-1645-2022	Yamamoto, Yuta/0000-0001-5225-6989; 	Ministry of Science and Education of Japan [23592229]; Grants-in-Aid for Scientific Research [24590895] Funding Source: KAKEN	Ministry of Science and Education of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This paper was in part supported by a Grant-in-Aid from the Ministry of Science and Education of Japan (23592229). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon R, 2006, J BIOL CHEM, V281, P19305, DOI 10.1074/jbc.M601728200; [Anonymous], 1986, LANCET, V1, P77; CHRISTIANSEN P, 1993, BONE, V14, P755, DOI 10.1016/8756-3282(93)90207-Q; Dorsam ST, 2010, MOL IMMUNOL, V47, P1181, DOI 10.1016/j.molimm.2010.01.003; Eom CS, 2011, ANN FAM MED, V9, P257, DOI 10.1370/afm.1243; Figura N, 2005, DIGEST DIS SCI, V50, P847, DOI 10.1007/s10620-005-2651-4; Fukushima N, 2005, J BONE MINER RES, V20, P790, DOI 10.1359/JBMR.041237; GARRICK R, 1971, ANN INTERN MED, V75, P221, DOI 10.7326/0003-4819-75-2-221; Gentili C, 2009, CURR PHARM DESIGN, V15, P1334, DOI 10.2174/138161209787846739; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hagiwara T, 2007, DIGEST DIS SCI, V52, P1219, DOI 10.1007/s10620-006-9253-7; Halleen JM, 2006, CLIN LAB, V52, P499; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; Kanno T, 2009, BIOCHEM BIOPH RES CO, V381, P666, DOI 10.1016/j.bbrc.2009.02.109; Knowles HJ, 2010, FASEB J, V24, P4648, DOI 10.1096/fj.10-162230; KOGA S, 1979, AM J SURG, V138, P635, DOI 10.1016/0002-9610(79)90335-0; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lehto-Axtelius D, 2002, SCAND J GASTROENTERO, V37, P437, DOI 10.1080/003655202317316079; Lehto-Axtelius D, 1998, REGUL PEPTIDES, V78, P41, DOI 10.1016/S0167-0115(98)00101-3; Lehto-Axtelius D, 2002, SCAND J GASTROENTERO, V37, P299, DOI 10.1080/003655202317284200; MALLUCHE H, 1990, KIDNEY INT, V38, P193, DOI 10.1038/ki.1990.187; Merle B, 2012, OSTEOPOROSIS INT, V23, P1199, DOI 10.1007/s00198-011-1892-7; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Kulak CAM, 2010, ARQ BRAS ENDOCRINOL, V54, P87, DOI 10.1590/S0004-27302010000200002; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Parfitt AM, 1990, METABOLIC BONE DIS C, P329; PERSSON P, 1993, SCAND J GASTROENTERO, V28, P301, DOI 10.3109/00365529309090245; Recker RR, 2011, BONE, V49, P955, DOI 10.1016/j.bone.2011.07.017; Rumenapf G, 1998, CALCIFIED TISSUE INT, V63, P433; Sipponen P, 2010, SCAND J GASTROENTERO, V45, P133, DOI 10.3109/00365520903434117; Stevens JR, 2010, J BONE MINER RES, V25, P2138, DOI 10.1002/jbmr.118; Suda T, 2003, J CELL BIOCHEM, V88, P259, DOI 10.1002/jcb.10331; Sun YX, 2003, MOL CELL BIOL, V23, P7973, DOI 10.1128/MCB.23.22.7973-7981.2003; Tokudome Y, 2009, J BIOMED MATER RES B, V90B, P229, DOI 10.1002/jbm.b.31277; Trouvin AP, 2010, CLIN INTERV AGING, V5, P345, DOI 10.2147/CIA.S10153; Ubara Y, 2005, KIDNEY INT, V68, P833, DOI 10.1111/j.1523-1755.2005.00464.x; Ueyama T, 2002, ENDOCRINOLOGY, V143, P3162, DOI 10.1210/en.143.8.3162; Wojtyczka A, 1998, CLIN SCI, V95, P735, DOI 10.1042/CS19980153; WRONSKI TJ, 1988, ENDOCRINOLOGY, V123, P681, DOI 10.1210/endo-123-2-681; Yajima A, 2007, AM J KIDNEY DIS, V49, P440, DOI 10.1053/j.ajkd.2006.11.045; Yamamoto Y, 2009, PHYSIOL GENOMICS, V39, P227, DOI 10.1152/physiolgenomics.00082.2009; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947; Zanotti S, 2008, J CELL BIOCHEM, V104, P1421, DOI 10.1002/jcb.21715; Zellin G, 2002, SCAND J GASTROENTERO, V37, P1149, DOI 10.1080/003655202760373353	45	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65685	10.1371/journal.pone.0065685	http://dx.doi.org/10.1371/journal.pone.0065685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776526	Green Published, gold, Green Submitted			2022-12-25	WOS:000320755400056
J	Wan, C; Sun, JP; Chen, WZ; Yuan, XH; Chong, HH; Prabakaran, P; Dimitrov, DS; He, YX				Wan, Chao; Sun, Jianping; Chen, Weizao; Yuan, Xiaohui; Chong, Huihui; Prabakaran, Ponraj; Dimitrov, Dimiter S.; He, Yuxian			Epitope Mapping of M36, a Human Antibody Domain with Potent and Broad HIV-1 Inhibitory Activity	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; IMMUNODEFICIENCY-VIRUS TYPE-1; AFFINITY-SELECTED PEPTIDES; ENVELOPE GLYCOPROTEIN; COMPUTATIONAL PREDICTION; NEUTRALIZING ANTIBODIES; ENTRY INHIBITORS; FUSION PROTEINS; GP120 ENVELOPE; BINDING-SITE	M36 is the first member of a novel class of potent HIV-1 entry inhibitors based on human engineered antibody domains (eAds). It exhibits broad inhibitory activity suggesting that its CD4-induced epitope is highly conserved. Here, we describe fine mapping of its epitope by using several approaches. First, a panel of mimotopes was affinity-selected from a random peptide library and potential m36-binding residues were computationally predicted. Second, homology modeling of m36 and molecular docking of m36 onto gp120 revealed potentially important residues in gp120-m36 interactions. Third, the predicted contact residues were verified by site-directed mutagenesis. Taken together, m36 epitope comprising three discontinuous sites including six key gp120 residues (Site C1: Thr123 and Pro124; Site C3: Glu370 and Ile371; Site C4: Met426 and Trp427) were identified. In the 3D structure of gp120, the sites C1 and C4 are located in the bridging sheet and the site C3 is within the b15-alpha 3 excursion, which play essential roles for the receptor- and coreceptor-binding and are major targets of neutralizing antibodies. Based on these results we propose a precise localization of the m36 epitope and suggest a mechanism of its broad inhibitory activity which could help in the development of novel HIV-1 therapeutics based on eAds.	[Wan, Chao; Sun, Jianping; Yuan, Xiaohui; Chong, Huihui; He, Yuxian] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Wan, Chao; Sun, Jianping; Yuan, Xiaohui; Chong, Huihui; He, Yuxian] Chinese Acad Med Sci, Inst Pathogen Biol, AIDS Res Ctr, Beijing 100730, Peoples R China; [Wan, Chao; Sun, Jianping; Yuan, Xiaohui; Chong, Huihui; He, Yuxian] Peking Union Med Coll, Beijing 100021, Peoples R China; [Chen, Weizao; Prabakaran, Ponraj; Dimitrov, Dimiter S.] NCI, Prot Interact Grp, CCRNP, CCR,NIH, Frederick, MD 21701 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	He, YX (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	yhe@ipb.pumc.edu.cn	Ponraj, Prabakaran/D-6325-2011	Ponraj, Prabakaran/0000-0002-4049-4813; chong, huihui/0000-0001-6965-2742	National Major projects for Infectious Diseases Control and Prevention [2012ZX10001008]; National Outstanding Youth Award of Natural Science Foundation of China [81025009]; National 973 Program of China [2010CB530100]; NATIONAL CANCER INSTITUTE [ZIABC011155] Funding Source: NIH RePORTER	National Major projects for Infectious Diseases Control and Prevention; National Outstanding Youth Award of Natural Science Foundation of China; National 973 Program of China(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Major projects for Infectious Diseases Control and Prevention (2012ZX10001008), National Outstanding Youth Award of Natural Science Foundation of China (81025009), and National 973 Program of China (2010CB530100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster C, 2002, AIDS, V16, P227, DOI 10.1097/00002030-200201250-00012; Berger EA, 1998, NAT STRUCT BIOL, V5, P671, DOI 10.1038/1362; Bublil EM, 2007, PROTEINS, V68, P294, DOI 10.1002/prot.21387; Bublil EM, 2006, FASEB J, V20, P1762, DOI 10.1096/fj.05-5509rev; Cao ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038126; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Chen WZ, 2008, P NATL ACAD SCI USA, V105, P17121, DOI 10.1073/pnas.0805297105; Chen WZ, 2012, BIOCHEM BIOPH RES CO, V425, P931, DOI 10.1016/j.bbrc.2012.08.013; Chen WZ, 2012, AIDS RES HUM RETROV, V28, P425, DOI [10.1089/aid.2011.0226, 10.1089/AID.2011.0226]; Chen WZ, 2010, ANTIVIR RES, V88, P107, DOI 10.1016/j.antiviral.2010.08.004; Chen WZ, 2009, CURR OPIN HIV AIDS, V4, P112, DOI 10.1097/COH.0b013e328322f95e; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Darbha R, 2004, BIOCHEMISTRY-US, V43, P1410, DOI 10.1021/bi035323x; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Este JA, 2007, LANCET, V370, P81, DOI 10.1016/S0140-6736(07)61052-6; Fauci AS, 2008, NATURE, V453, P289, DOI 10.1038/453289a; Forsman A, 2008, J VIROL, V82, P12069, DOI 10.1128/JVI.01379-08; Gong R, 2012, BIODRUGS, V26, P143, DOI 10.2165/11631400-000000000-00000; Gorlani A, 2012, AIDS RES HUM RETROV, V28, P198, DOI 10.1089/aid.2011.0133; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Mayrose I, 2007, BIOINFORMATICS, V23, P3244, DOI 10.1093/bioinformatics/btm493; McCoy LE, 2012, J EXP MED, V209, P1091, DOI 10.1084/jem.20112655; Meyerson JR, 2013, P NATL ACAD SCI USA, V110, P513, DOI 10.1073/pnas.1214810110; Moulard M, 2002, P NATL ACAD SCI USA, V99, P6913, DOI 10.1073/pnas.102562599; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Tarnovitski N, 2006, J MOL BIOL, V359, P190, DOI 10.1016/j.jmb.2006.03.008; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; White TA, 2011, J VIROL, V85, P12114, DOI 10.1128/JVI.05297-11; White TA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001249; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	43	8	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66638	10.1371/journal.pone.0066638	http://dx.doi.org/10.1371/journal.pone.0066638			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776690	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400152
J	Bloise, E; Bhuiyan, M; Audette, MC; Petropoulos, S; Javam, M; Gibb, W; Matthews, SG				Bloise, Enrrico; Bhuiyan, Manzerul; Audette, Melanie C.; Petropoulos, Sophie; Javam, Mohsen; Gibb, William; Matthews, Stephen G.			Prenatal Endotoxemia and Placental Drug Transport in The Mouse: Placental Size-Specific Effects	PLOS ONE			English	Article							P-GLYCOPROTEIN EXPRESSION; RESISTANCE PHOSPHOGLYCOPROTEIN ABCB1; ADVANCING GESTATION; FETAL PROTECTION; GENE-PRODUCT; CHORIOAMNIONITIS; PREGNANCY; PROTEIN; MODEL; GROWTH	Lipopolysaccharide (LPS) in high doses inhibits placental multidrug resistance P-glycoprotein (P-gp - Abcb1a/b) and breast cancer resistance protein (BCRP - Abcg2). This potentially impairs fetal protection against harmful factors in the maternal circulation. However, it is unknown whether LPS exposure, at doses that mimic sub-lethal clinical infection, alters placental multidrug resistance. We hypothesized that sub-lethal (fetal) LPS exposure reduces placental P-gp activity. Acute LPS (n = 19; 150 mu g/kg; ip) or vehicle (n = 19) were given to C57BL/6 mice at E15.5 and E17.5. Placentas and fetal-units were collected 4 and 24 h following injection. Chronic LPS (n = 6; 5 mu g/kg/day; ip) or vehicle (n = 5) were administered from E11.5-15.5 and tissues were collected 4 h after final treatment. P-gp activity was assessed by [3 H] digoxin accumulation. Placental Abcb1a/b, Abcg2, interleukin-6 (Il-6), Tnf-alpha, Il-10 and toll-like receptor-4 (Tlr-4) mRNA were measured by qPCR. Maternal plasma IL-6 was determined. At E15.5, maternal IL-6 was elevated 4 h after single (p < 0.001) and chronic (p < 0.05) LPS, but levels had returned to baseline by 24 h. Placental Il-6 mRNA was also increased after acute and chronic LPS treatments (p < 0.05), whereas Abcb1a/b and Abcg2 mRNA were unaffected. However, fetal [3 H] digoxin accumulation was increased (p < 0.05) 4 h after acute LPS, and maternal [H-3]digoxin myocardial accumulation was increased (p < 0.05) in mice exposed to chronic LPS treatments. There was a negative correlation between fetal [H-3]digoxin accumulation and placental size (p < 0.0001). Acute and chronic sub-lethal LPS exposure resulted in a robust inflammatory response in the maternal systemic circulation and placenta. Acute infection decreased placental P-gp activity in a time-and gestational age-dependent manner. Chronic LPS decreased P-gp activity in the maternal myocardium and there was a trend for fetuses with smaller placentas to accumulate more P-gp substrate than their larger counterparts. Collectively, we demonstrate that acute sub-lethal LPS exposure during pregnancy impairs fetal protection against potentially harmful xenobiotics in the maternal circulation.	[Bloise, Enrrico; Bhuiyan, Manzerul; Audette, Melanie C.; Javam, Mohsen; Matthews, Stephen G.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Petropoulos, Sophie] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Gibb, William] Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON, Canada; [Gibb, William] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Matthews, Stephen G.] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Matthews, Stephen G.] Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada	University of Toronto; McGill University; University of Ottawa; University of Ottawa; University of Toronto; University of Toronto	Bloise, E (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	enrrico.bloise@utoronto.ca	Petropoulos, Sophie/D-6861-2016; Petropoulos, Sophie/M-3090-2017; Matthews, Stephen/R-5147-2019; Bloise, Enrrico/O-6710-2018; Matthews, Stephen G/N-7555-2018	Petropoulos, Sophie/0000-0003-2293-8238; Matthews, Stephen/0000-0002-9654-9940; Bloise, Enrrico/0000-0003-0275-8686; Matthews, Stephen G/0000-0002-9654-9940	Canadian Institutes for Health Research [452740]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes for Health Research (grant: 452740; to S. G. M. and W. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bataineh MM, 2010, BIOPHARM DRUG DISPOS, V31, P506, DOI 10.1002/bdd.731; Audette MC, 2011, ENDOCRINOLOGY, V152, P3561, DOI 10.1210/en.2011-0104; Bayraktar M, 2009, AM J REPROD IMMUNOL, V62, P390, DOI 10.1111/j.1600-0897.2009.00756.x; Bloise E, 2010, PLACENTA, V31, P867, DOI 10.1016/j.placenta.2010.04.007; Bloise E, 2012, ENDOCRINOLOGY, V153, P3457, DOI 10.1210/en.2011-1921; Burton GJ, 2012, PLACENTA, V33, pS23, DOI 10.1016/j.placenta.2011.11.013; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Chong YT, 2012, MOL MED REP, V5, P812, DOI 10.3892/mmr.2011.691; Coan PM, 2008, J PHYSIOL-LONDON, V586, P4567, DOI 10.1113/jphysiol.2008.156133; DELANNOY IAM, 1992, BIOCHEM BIOPH RES CO, V189, P551, DOI 10.1016/0006-291X(92)91593-F; Desforges M, 2010, INT J DEV BIOL, V54, P377, DOI 10.1387/ijdb.082765md; Dopp JM, 2009, PHARMACOTHERAPY, V29, P365, DOI 10.1592/phco.29.4.365; Drewlo S, 2012, PLACENTA, V33, P952, DOI 10.1016/j.placenta.2012.09.007; Evseenko DA, 2007, DRUG METAB DISPOS, V35, P595, DOI 10.1124/dmd.106.011478; Griffin AJ, 2011, MUCOSAL IMMUNOL, V4, P371, DOI 10.1038/mi.2011.2; Gulati S, 2012, AM J REPROD IMMUNOL, V67, P235, DOI 10.1111/j.1600-0897.2011.01084.x; Iqbal M, 2012, PLACENTA, V33, P137, DOI 10.1016/j.placenta.2012.01.008; Iqbal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043022; Jones KL, 2007, P NATL ACAD SCI USA, V104, P16239, DOI 10.1073/pnas.0705971104; Kalabis GM, 2007, PLACENTA, V28, P1073, DOI 10.1016/j.placenta.2007.03.010; Kalabis GM, 2005, BIOL REPROD, V73, P591, DOI 10.1095/biolreprod.105.042242; Kaukola T, 2004, ANN NEUROL, V55, P186, DOI 10.1002/ana.10809; Koga K, 2010, AM J REPROD IMMUNOL, V63, P587, DOI 10.1111/j.1600-0897.2010.00848.x; Kumazaki K, 2004, HUM PATHOL, V35, P47, DOI 10.1016/j.humpath.2003.08.027; Ma YH, 2006, AM J REPROD IMMUNOL, V55, P12, DOI 10.1111/j.1600-0897.2005.00347.x; Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043; Mason CW, 2011, DRUG METAB DISPOS, V39, P1000, DOI 10.1124/dmd.111.038166; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Menon R, 2010, PLACENTA, V31, P113, DOI 10.1016/j.placenta.2009.11.012; Novembri R, 2011, PLACENTA, V32, P969, DOI 10.1016/j.placenta.2011.09.013; Omanwar Swati, 2004, Hepatobiliary Pancreat Dis Int, V3, P417; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Petropoulos S, 2010, PLACENTA, V31, P803, DOI 10.1016/j.placenta.2010.06.014; Petropoulos S, 2007, REPROD SCI, V14, P321, DOI 10.1177/1933719107303856; Petrovic V, 2008, DRUG METAB DISPOS, V36, P1944, DOI 10.1124/dmd.107.019851; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Sun M, 2006, PLACENTA, V27, P602, DOI 10.1016/j.placenta.2005.05.007; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Tomita M, 2009, J PHARM PHARMACOL, V61, P1319, DOI 10.1211/jpp/61.10.0007; Torricelli M, 2009, AM J REPROD IMMUNOL, V62, P224, DOI 10.1111/j.1600-0897.2009.00729.x; Wang JH, 2005, J NUCL MED, V46, P1537; Willoughby RE, 2002, CLIN PERINATOL, V29, P603, DOI 10.1016/S0095-5108(02)00058-1; Yeboah D, 2006, CAN J PHYSIOL PHARM, V84, P1251, DOI 10.1139/Y06-078; Zhou SF, 2008, XENOBIOTICA, V38, P802, DOI 10.1080/00498250701867889 	47	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65728	10.1371/journal.pone.0065728	http://dx.doi.org/10.1371/journal.pone.0065728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762418	Green Submitted, Green Published, gold			2022-12-25	WOS:000320440500049
J	Tannieres, M; Beury-Cirou, A; Vigouroux, A; Mondy, S; Pellissier, F; Dessaux, Y; Faure, D				Tannieres, Melanie; Beury-Cirou, Amelie; Vigouroux, Armelle; Mondy, Samuel; Pellissier, Franck; Dessaux, Yves; Faure, Denis			A Metagenomic Study Highlights Phylogenetic Proximity of Quorum-Quenching and Xenobiotic-Degrading Amidases of the AS-Family	PLOS ONE			English	Article							N-ACYLHOMOSERINE LACTONASE; HOMOSERINE LACTONE; SP STRAIN; SENSING SIGNALS; BACTERIA; GENE; IDENTIFICATION; DISCOVERY; HYDROLASE; MECHANISM	Quorum-sensing (QS) signals of the N-acylhomoserine lactone (NAHL) class are cleaved by quorum-quenching enzymes, collectively named NAHLases. Here, functional metagenomics allowed the discovery of a novel bacterial NAHLase in a rhizosphere that was treated with gamma-caprolactone. As revealed by rrs-DGGE and rrs-pyrosequencing, this treatment increased the percentage of the NAHL-degrading bacteria and strongly biased the structure of the bacterial community, among which Azospirillum dominated. Among the 29 760 fosmids of the metagenomic library, a single one was detected that expressed the qsdB gene conferring NAHL-degradation upon E. coli and decreased QS-regulated virulence in Pectobacterium. Phylogenetic analysis of the 34 orfs of the fosmid suggested that it would belong to an unknown Proteobacterium - probably a gamma-proteobacterium. qPCR quantification of the NAHLase-encoding genes attM, qsdA, and qsdB revealed their higher abundance in the gamma-caprolactone-treated rhizosphere as compared to an untreated control. The purified QsdB enzyme exhibited amidase activity. QsdB is the first amidase signature (AS) family member exhibiting NAHLase-activity. Point mutations in the AS-family catalytic triad K-S-S abolished the NAHLase activity of QsdB. This study extends the diversity of NAHLases and highlights a common phylogenic origin of AS-family enzymes involved in the degradation of natural compounds, such as NAHLs, and xenobiotics, such as nylon and linuron.	[Tannieres, Melanie; Beury-Cirou, Amelie; Mondy, Samuel; Dessaux, Yves; Faure, Denis] Ctr Natl Rech Sci, UPR2355, Inst Sci Vegetal, Gif Sur Yvette, France; [Beury-Cirou, Amelie] CNPPT, Achicourt, France; [Vigouroux, Armelle] Ctr Natl Rech Sci, UPR3082, LEBS, Gif Sur Yvette, France; [Pellissier, Franck] Ctr Natl Rech Sci, UPR2301, Inst Chim Subst Nat, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC)	Faure, D (corresponding author), Ctr Natl Rech Sci, UPR2355, Inst Sci Vegetal, Gif Sur Yvette, France.	faure@isv.cnrs-gif.fr	Mondy, Samuel/AAG-8805-2019	Mondy, Samuel/0000-0002-9203-6398; TANNIERES, Melanie/0000-0003-2335-3776	Reseau de Recherche sur le Developpement Soutenable (R2DS, Region Ile-de-France); Comite Nord Plants de Pommes de Terre (CNPPT, France); Centre de la Recherche Scientifique (CNRS); program Ecosphere Continentale et Cotiere (EC2CO, CNRS); French programs Ingenierie Ecologique (CNRS); Projets innovants (Fondation pour la Recherche sur la Biodiversite, FRB); PESTICIDES (Ministere de l'ecologie, du developpement durable, des transports et du logement)	Reseau de Recherche sur le Developpement Soutenable (R2DS, Region Ile-de-France); Comite Nord Plants de Pommes de Terre (CNPPT, France); Centre de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); program Ecosphere Continentale et Cotiere (EC2CO, CNRS); French programs Ingenierie Ecologique (CNRS); Projets innovants (Fondation pour la Recherche sur la Biodiversite, FRB); PESTICIDES (Ministere de l'ecologie, du developpement durable, des transports et du logement)	MT was supported by a PhD grant from Reseau de Recherche sur le Developpement Soutenable (R2DS, Region Ile-de-France), AB-C by a post-doctoral fellowship from Comite Nord Plants de Pommes de Terre (CNPPT, France). YD and DF were funded by Centre de la Recherche Scientifique (CNRS) and program Ecosphere Continentale et Cotiere (EC2CO, CNRS); DF received financial support from the French programs Ingenierie Ecologique (CNRS), Projets innovants (Fondation pour la Recherche sur la Biodiversite, FRB), and PESTICIDES (Ministere de l'ecologie, du developpement durable, des transports et du logement). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbey C, 2012, J PROTEOME RES, V11, P206, DOI 10.1021/pr200936q; Bers K, 2011, APPL ENVIRON MICROB, V77, P8754, DOI 10.1128/AEM.06162-11; Bijtenhoorn P, 2011, J BIOTECHNOL, V155, P86, DOI 10.1016/j.jbiotec.2010.12.016; Bijtenhoorn P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026278; Boyer M, 2009, FEMS MICROBIOL ECOL, V70, P1, DOI 10.1111/j.1574-6941.2009.00745.x; Carlier A, 2003, APPL ENVIRON MICROB, V69, P4989, DOI 10.1128/AEM.69.8.4989-4993.2003; Cha C, 1998, MOL PLANT MICROBE IN, V11, P1119, DOI 10.1094/MPMI.1998.11.11.1119; Cirou A, 2007, ENVIRON MICROBIOL, V9, P1511, DOI 10.1111/j.1462-2920.2007.01270.x; Cirou A, 2012, APPL ENVIRON MICROB, V78, P481, DOI 10.1128/AEM.06159-11; Cirou A, 2011, RES MICROBIOL, V162, P945, DOI 10.1016/j.resmic.2011.01.010; d'Angelo-Picard C, 2004, FEMS MICROBIOL ECOL, V51, P19, DOI 10.1016/j.femsec.2004.07.008; Dong YH, 2004, APPL ENVIRON MICROB, V70, P954, DOI 10.1128/AEM.70.2.954-960.2004; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Faure D, 2011, METAGENOMICS: CURRENT INNOVATIONS AND FUTURE TRENDS, P253; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fukuta Y, 2010, ENZYME MICROB TECH, V46, P237, DOI 10.1016/j.enzmictec.2009.09.010; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gabor EM, 2004, ENVIRON MICROBIOL, V6, P948, DOI 10.1111/j.1462-2920.2004.00643.x; Guan CH, 2007, APPL ENVIRON MICROB, V73, P3669, DOI 10.1128/AEM.02617-06; Hao YA, 2010, ENVIRON MICROBIOL, V12, P105, DOI 10.1111/j.1462-2920.2009.02049.x; Haudecoeur E, 2009, P NATL ACAD SCI USA, V106, P14587, DOI 10.1073/pnas.0808005106; Haudecoeur E, 2009, MOL PLANT MICROBE IN, V22, P529, DOI 10.1094/MPMI-22-5-0529; Huang JJ, 2006, APPL ENVIRON MICROB, V72, P1190, DOI 10.1128/AEM.72.2.1190-1197.2006; Huang JJ, 2003, APPL ENVIRON MICROB, V69, P5941, DOI 10.1128/AEM.69.10.5941-5949.2003; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KANAGAWA K, 1989, J BACTERIOL, V171, P3181, DOI 10.1128/jb.171.6.3181-3186.1989; Kaufmann GF, 2005, P NATL ACAD SCI USA, V102, P309, DOI 10.1073/pnas.0408639102; Kennedy J, 2011, J APPL MICROBIOL, V111, P787, DOI 10.1111/j.1365-2672.2011.05106.x; Labahn J, 2002, J MOL BIOL, V322, P1053, DOI 10.1016/S0022-2836(02)00886-0; Leveau JHJ, 2008, FEMS MICROBIOL ECOL, V65, P238, DOI 10.1111/j.1574-6941.2008.00436.x; Lin YH, 2003, MOL MICROBIOL, V47, P849, DOI 10.1046/j.1365-2958.2003.03351.x; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Mei GY, 2010, APPL ENVIRON MICROB, V76, P4933, DOI 10.1128/AEM.00477-10; Monier JM, 2011, CURR OPIN MICROBIOL, V14, P229, DOI 10.1016/j.mib.2011.04.010; Negoro S, 2012, J BIOL CHEM, V287, P5079, DOI 10.1074/jbc.M111.321992; OKADA H, 1983, NATURE, V306, P203, DOI 10.1038/306203a0; Park SY, 2005, APPL ENVIRON MICROB, V71, P2632, DOI 10.1128/AEM.71.5.2632-2641.2005; Park SY, 2003, MICROBIOL-SGM, V149, P1541, DOI 10.1099/mic.0.26269-0; Piel J, 2011, ANNU REV MICROBIOL, V65, P431, DOI 10.1146/annurev-micro-090110-102805; Riaz K, 2008, ENVIRON MICROBIOL, V10, P560, DOI 10.1111/j.1462-2920.2007.01475.x; Romero M, 2008, FEMS MICROBIOL LETT, V280, P73, DOI 10.1111/j.1574-6968.2007.01046.x; Schipper C, 2009, APPL ENVIRON MICROB, V75, P224, DOI 10.1128/AEM.01389-08; Smadja B, 2004, MOL PLANT MICROBE IN, V17, P1269, DOI 10.1094/MPMI.2004.17.11.1269; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taupp M, 2011, CURR OPIN BIOTECH, V22, P465, DOI 10.1016/j.copbio.2011.02.010; TSUCHIYA K, 1989, J BACTERIOL, V171, P3187, DOI 10.1128/jb.171.6.3187-3191.1989; Uroz S, 2003, MICROBIOL-SGM, V149, P1981, DOI 10.1099/mic.0.26375-0; Uroz S, 2008, APPL ENVIRON MICROB, V74, P1357, DOI 10.1128/AEM.02014-07; Uroz S, 2009, CHEMBIOCHEM, V10, P205, DOI 10.1002/cbic.200800521; Valina ALB, 2004, BIOCHEMISTRY-US, V43, P15657, DOI 10.1021/bi049025r; Wang WZ, 2010, APPL ENVIRON MICROB, V76, P2524, DOI 10.1128/AEM.02738-09; Wisniewski-Dye F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002430; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699; Zhang LH, 2003, TRENDS PLANT SCI, V8, P238, DOI 10.1016/S1360-1385(03)00063-3	55	20	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65473	10.1371/journal.pone.0065473	http://dx.doi.org/10.1371/journal.pone.0065473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762380	Green Published, Green Submitted, gold			2022-12-25	WOS:000321094800054
J	Weng, SJ; Estevez, ME; Berson, DM				Weng, Shijun; Estevez, Maureen E.; Berson, David M.			Mouse Ganglion-Cell Photoreceptors Are Driven by the Most Sensitive Rod Pathway and by Both Types of Cones	PLOS ONE			English	Article							KNOCKOUT OPN4(-/-) MICE; INNER PLEXIFORM LAYER; MAMMALIAN RETINA; BIPOLAR CELLS; CIRCADIAN CLOCK; AMACRINE CELLS; SUPRACHIASMATIC NUCLEUS; VISUAL SENSITIVITY; LIGHT RESPONSES; PRIMATE RETINA	Intrinsically photosensitive retinal ganglion cells (ipRGCs) are depolarized by light by two mechanisms: directly, through activation of their photopigment melanopsin; and indirectly through synaptic circuits driven by rods and cones. To learn more about the rod and cone circuits driving ipRGCs, we made multielectrode array (MEA) and patch-clamp recordings in wildtype and genetically modified mice. Rod-driven ON inputs to ipRGCs proved to be as sensitive as any reaching the conventional ganglion cells. These signals presumably pass in part through the primary rod pathway, involving rod bipolar cells and AII amacrine cells coupled to ON cone bipolar cells through gap junctions. Consistent with this interpretation, the sensitive rod ON input to ipRGCs was eliminated by pharmacological or genetic disruption of gap junctions, as previously reported for conventional ganglion cells. A presumptive cone input was also detectable as a brisk, synaptically mediated ON response that persisted after disruption of rod ON pathways. This was roughly three log units less sensitive than the rod input. Spectral analysis revealed that both types of cones, the M-and S-cones, contribute to this response and that both cone types drive ON responses. This contrasts with the blue-OFF, yellow-ON chromatic opponency reported in primate ipRGCs. The cone-mediated response was surprisingly persistent during steady illumination, echoing the tonic nature of both the rod input to ipRGCs and their intrinsic, melanopsin-based phototransduction. These synaptic inputs greatly expand the dynamic range and spectral bandpass of the non-image-forming visual functions for which ipRGCs provide the principal retinal input.	[Weng, Shijun; Estevez, Maureen E.; Berson, David M.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Weng, Shijun] Fudan Univ, Inst Brain Sci, Inst Neurobiol, Shanghai 200433, Peoples R China; [Weng, Shijun] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Brown University; Fudan University; Fudan University	Berson, DM (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.	David_Berson@brown.edu		Stabio, Maureen/0000-0002-2159-5301	National Eye Institute of the National Institutes of Health [R01 EY17137, EY12793, F32-EY021994]; National Science Foundation of China [31100796]; NATIONAL EYE INSTITUTE [F32EY021994, R01EY012793, R01EY017137] Funding Source: NIH RePORTER	National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This project was supported by grants from the National Eye Institute of the National Institutes of Health (http://www.nei.nih.gov/) to D. Berson (R01 EY17137 and EY12793) and to M. Estevez (F32-EY021994) and by a grant from National Science Foundation of China (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) to S. Weng (31100796). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El-Barr MM, 2009, J NEUROPHYSIOL, V102, P1945, DOI 10.1152/jn.00142.2009; Aggelopoulos NC, 2000, J PHYSIOL-LONDON, V523, P211, DOI 10.1111/j.1469-7793.2000.t01-1-00211.x; Altimus CM, 2010, NAT NEUROSCI, V13, P1107, DOI 10.1038/nn.2617; ALTIMUS CM, 2008, P NATL ACAD SCI US; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; BASSI CJ, 1986, PHYSIOL BEHAV, V38, P871, DOI 10.1016/0031-9384(86)90056-9; BASSI CJ, 1987, INVEST OPHTH VIS SCI, V28, P1811; Baver SB, 2008, EUR J NEUROSCI; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Brown TM, 2011, VISION RES, V51, P280, DOI 10.1016/j.visres.2010.08.010; BURKHARDT DA, 1994, J NEUROSCI, V14, P1091, DOI 10.1523/JNEUROSCI.14-03-01091.1994; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chang L, 2013, NEURON, V77, P559, DOI 10.1016/j.neuron.2012.12.012; CHUN MH, 1993, J COMP NEUROL, V332, P421, DOI 10.1002/cne.903320404; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dang L, 2004, MOL VIS, V10, P323; Deans MR, 2002, NEURON, V36, P703, DOI 10.1016/S0896-6273(02)01046-2; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; DEVRIES SH, 1995, P NATL ACAD SCI USA, V92, P10658, DOI 10.1073/pnas.92.23.10658; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Drouyer E, 2007, J NEUROSCI, V27, P9623, DOI 10.1523/JNEUROSCI.1391-07.2007; Dumitrescu ON, 2009, J COMP NEUROL, V517, P226, DOI 10.1002/cne.22158; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Ekesten B, 2000, VISION RES, V40, P2573, DOI 10.1016/S0042-6989(00)00122-X; Ekesten B, 2005, VISUAL NEUROSCI, V22, P893, DOI 10.1017/S0952523805226172; Estevez ME, 2012, J NEUROSCI, V32, P13608, DOI 10.1523/JNEUROSCI.1422-12.2012; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Gooley JJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000741; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hannibal J, 2004, CELL TISSUE RES, V316, P99, DOI 10.1007/s00441-004-0858-x; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Haverkamp S, 2005, J NEUROSCI, V25, P5438, DOI 10.1523/JNEUROSCI.1117-05.2005; Hoshi H, 2009, J NEUROSCI, V29, P8875, DOI 10.1523/JNEUROSCI.0912-09.2009; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Jusuf PR, 2007, EUR J NEUROSCI, V26, P2906, DOI 10.1111/j.1460-9568.2007.05924.x; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; Lall GS, 2010, NEURON, V66, P417, DOI 10.1016/j.neuron.2010.04.037; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; Lee EJ, 2003, EUR J NEUROSCI, V18, P2925, DOI 10.1046/j.1460-9568.2003.03049.x; Li HY, 2009, J NEUROSCI, V29, P15178, DOI 10.1523/JNEUROSCI.3517-09.2009; Li L, 1998, VISUAL NEUROSCI, V15, P851, DOI 10.1017/S0952523898155050; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lupi D, 2006, CHRONOBIOL INT, V23, P167, DOI 10.1080/07420520500545870; LUPI D, 2008, NAT NEUROSCI; Mangel S C, 2001, Prog Brain Res, V131, P505; MCGUIRE BA, 1984, J NEUROSCI, V4, P2920; Mills SL, 2001, J COMP NEUROL, V436, P336; Muller LPD, 2010, J COMP NEUROL, V518, P4813, DOI 10.1002/cne.22490; Nathan J, 2006, PHOTOCHEM PHOTOBIOL, V82, P1489, DOI 10.1562/2006-02-27-RA-818; NORMANN RA, 1979, J PHYSIOL-LONDON, V286, P491, DOI 10.1113/jphysiol.1979.sp012633; Ostergaard J, 2007, INVEST OPHTH VIS SCI, V48, P3812, DOI 10.1167/iovs.06-1322; Pan F, 2007, VISUAL NEUROSCI, V24, P609, DOI 10.1017/S0952523807070472; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Pang JJ, 2010, P NATL ACAD SCI USA, V107, P395, DOI 10.1073/pnas.0907178107; PENN JS, 1984, VISION RES, V24, P1673, DOI 10.1016/0042-6989(84)90325-0; Perez-Leon JA, 2006, EUR J NEUROSCI, V24, P1117, DOI 10.1111/j.1460-9568.2006.04999.x; Pickard GE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004984; ROHLICH P, 1994, NEURON, V13, P1159, DOI 10.1016/0896-6273(94)90053-1; ROSENWASSER AM, 1979, PHYSIOL BEHAV, V23, P17, DOI 10.1016/0031-9384(79)90115-X; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Schmidt TM, 2010, J NEUROSCI, V30, P16262, DOI 10.1523/JNEUROSCI.3656-10.2010; Schmidt TM, 2009, J NEUROSCI, V29, P476, DOI 10.1523/JNEUROSCI.4117-08.2009; Semo M, 2003, EUR J NEUROSCI, V17, P1793, DOI 10.1046/j.1460-9568.2003.02616.x; Sharpe LT, 1999, TRENDS NEUROSCI, V22, P497, DOI 10.1016/S0166-2236(99)01458-7; Tsai JW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000125; Tsukamoto Y, 2007, J NEUROSCI, V27, P6261, DOI 10.1523/JNEUROSCI.5646-06.2007; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; VERUKI ML, 2009, J NEUROPHYSIOL; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WASSLE H, 1995, J COMP NEUROL, V361, P537, DOI 10.1002/cne.903610315; Weng SJ, 2009, J BIOL RHYTHM, V24, P391, DOI 10.1177/0748730409343767; Wong KY, 2007, J PHYSIOL-LONDON, V582, P279, DOI 10.1113/jphysiol.2007.133751; Wong KY, 2012, J NEUROSCI, V32, P11478, DOI 10.1523/JNEUROSCI.1423-12.2012; Yin L, 2009, J NEUROSCI, V29, P2706, DOI 10.1523/JNEUROSCI.5471-08.2009; Zhang J, 2004, J COMP NEUROL, V470, P1, DOI 10.1002/cne.10967; Zhu YL, 2007, INVEST OPHTH VIS SCI, V48, P1268, DOI 10.1167/iovs.06-0925	85	54	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e66480	10.1371/journal.pone.0066480	http://dx.doi.org/10.1371/journal.pone.0066480			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762490	gold, Green Published, Green Submitted			2022-12-25	WOS:000321094800099
J	Tien, SC; Chang, ZF				Tien, S-C; Chang, Z-F			Oncogenic Shp2 disturbs microtubule regulation to cause HDAC6-dependent ERK hyperactivation	ONCOGENE			English	Article						ERK; HDAC6; microtubule acetylation; Shp2	TYROSINE-PHOSPHATASE SHP-2; SMALL-MOLECULE INHIBITOR; SIGNALING PATHWAY; DEACETYLASE HDAC6; PTPN11 MUTATIONS; NOONAN-SYNDROME; BREAST-CANCER; ACTIVATION; RECEPTOR; KINASE	Deregulation of Shp2, a non-receptor tyrosine phosphatase, causes hyperactivation of extracellular signal-regulated kinase (ERK), leading to growth abnormality. Here, we show that inhibition of RhoA-Dia is sufficient to upregulate ERK activation in epithelial cells. Oncogenic Shp2 expression attenuates RhoA-Dia signaling, by which microtubule (MT) is destabilized with reduced level of acetylation. Either MT stabilization, silencing of histone deacetylase 6 (HDAC6) or enforcing RhoA-Dia signal prevents oncogenic Shp2-induced ERK hyperactivation. We provide evidence that downregulation of RhoA-Dia-EB1 pathway by oncogenic Shp2 leads to HDAC6-mediated reduction in MT acetylation, in turn affecting ERK regulation. In response to serum stimulation, cells expressing wild-type Shp2 display transient ERK activation. In contrast, cells expressing oncogenic Shp2 have prolonged ERK activation. HDAC6 inhibition diminishes sustained activation of ERK and slows down the growth of these cells. Likewise, in human cancer cells, blocking Shp2 increases MT acetylation and decreases ERK phosphorylation, which are reversed by inhibition of Dia. As such, HDAC6 inhibition in these cells also reduces ERK activity. Our findings link MT regulation by HDAC6 to oncogenic Shp2 and ERK regulation, implicating the therapeutic potential of HDAC6 inhibitor in diseases involving Shp2 deregulation.	[Tien, S-C; Chang, Z-F] Natl Taiwan Univ, Inst Biochem & Mol Biol, Coll Med, Taipei 10764, Taiwan; [Chang, Z-F] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University	Chang, ZF (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, 155,Sect 2,Linong St, Taipei 112, Taiwan.	zfchang@ym.edu.tw			National Science Council, Taiwan [NSC98-3112-B-010-021]; UST-UCSD International Center of Excellence in Advanced Bio-Engineering; National Science Council I-RiCE Program, Taiwan [NSC101-2911-I-009-101]; Ministry of Education, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); UST-UCSD International Center of Excellence in Advanced Bio-Engineering; National Science Council I-RiCE Program, Taiwan; Ministry of Education, Taiwan(Ministry of Education, Taiwan)	We thank TS Jou (Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University) for providing MDCK cells and GP135 antibody, TP Yao (Department of Pharmacology and Cancer Bioloby, Duke University, Durham, North Carolina) for providing pCDNA-HDAC6-Flag and EGFP-tubulin-K40R plasmids and JC Kuo (Institute of Biochemistry and Molecular Biology, National Yang Ming University) for detyrosinated (Glu) tubulin antibody, the technical supports from the second core laboratory, Department of Medical Research, National Taiwan University Hospital and the Instrumentation Resource Center of National Yang-Ming University. This research is supported by grants from National Science Council, Taiwan (NSC98-3112-B-010-021), the UST-UCSD International Center of Excellence in Advanced Bio-Engineering sponsored by National Science Council I-RiCE Program, Taiwan (NSC101-2911-I-009-101), and Aim for Top University Plan in National Yang-Ming University sponsored by the Ministry of Education, Taiwan.	Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Chang YC, 2006, CELL DEATH DIFFER, V13, P2023, DOI 10.1038/sj.cdd.4401901; Cleghon V, 1998, MOL CELL, V2, P719, DOI 10.1016/S1097-2765(00)80287-7; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Kontaridis MI, 2004, MOL CELL BIOL, V24, P5340, DOI 10.1128/MCB.24.12.5340-5352.2004; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lee HH, 2008, J CELL BIOL, V181, P999, DOI 10.1083/jcb.200710187; Lee HH, 2010, J CELL SCI, V123, P3368, DOI 10.1242/jcs.071555; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Maroun CR, 2000, MOL CELL BIOL, V20, P8513, DOI 10.1128/MCB.20.22.8513-8525.2000; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2004, CURR OPIN HEMATOL, V11, P44, DOI 10.1097/00062752-200401000-00007; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Yoshida N, 2004, CANCER SCI, V95, P496, DOI 10.1111/j.1349-7006.2004.tb03239.x; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06; Zhou XD, 2008, CELL DEATH DIFFER, V15, P988, DOI 10.1038/cdd.2008.54	38	17	19	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 29	2014	33	22					2938	2946		10.1038/onc.2013.241	http://dx.doi.org/10.1038/onc.2013.241			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EI	23770849				2022-12-25	WOS:000337231800013
J	Yang, XW; Wang, P; Liu, JQ; Zhang, H; Xi, WD; Jia, XH; Wang, KK				Yang, X-W; Wang, P.; Liu, J-Q; Zhang, H.; Xi, W-D; Jia, X-H; Wang, K-K			Coordinated regulation of the immunoproteasome subunits by PML/RAR alpha and PU.1 in acute promyelocytic leukemia	ONCOGENE			English	Article						immunoproteasome subunits; PML/RAR alpha; PU.1; APL; ATRA	TRANS-RETINOIC ACID; ACUTE MYELOID-LEUKEMIA; I PRESENTATION PATHWAY; LONG-TERM EFFICACY; RAR-ALPHA; GRANULOCYTIC DIFFERENTIATION; CELL-DEVELOPMENT; FUSION PROTEIN; HLA-DR; PML	Recognition and elimination of malignant cells by cytotoxic T lymphocytes depends on antigenic peptides generated by proteasomes. It has been established that impairment of the immunoproteasome subunits, that is, PSMB8, PSMB9 and PSMB10 (PSMBs), is critical for malignant cells to escape immune recognition. We report here the regulatory mechanism of the repression of PU.1-dependent activation of PSMBs by PML/RAR alpha in the pathogenesis of acute promyelocytic leukemia (APL) and the unidentified function of all-trans retinoic acid (ATRA) as an immunomodulator in the treatment of APL. Chromatin immunoprecipitation and luciferase reporter assays showed that PU.1 directly bound to and coordinately transactivated the promoters of PSMBs, indicating that PSMBs were transcriptional targets of PU.1 and PU.1 regulated their basal expression. Analysis of expression profiling data from a large population of acute myeloid leukemia (AML) patients revealed that the expression levels of PSMBs were significantly lower in APL patients than in non-APL AML patients. Further evidence demonstrated that the decrease in their expression was achieved through PML/RAR alpha-mediated repression of both PU.1-dependent transactivation and PU.1 expression. Moreover, ATRA but not arsenic trioxide induced the expression of PSMBs in APL cells, indicating that ATRA treatment might activate the antigen-processing/ presentation machinery. Finally, the above observations were confirmed in primary APL samples. Collectively, our data demonstrate that PML/RARa suppresses PU.1-dependent activation of the immunosubunits, which may facilitate the escape of APL cells from immune surveillance in leukemia development, and ATRA treatment is able to reactivate their expression, which would promote more efficient T-cell-mediated recognition in the treatment.	[Yang, X-W; Wang, P.; Liu, J-Q; Zhang, H.; Xi, W-D; Jia, X-H; Wang, K-K] Shanghai Jiao Tong Univ, Sch Med SJTU SM, Ruijin Hosp, State Key Lab Med Genom,Shanghai Inst Hematol, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University	Wang, KK (corresponding author), Shanghai Jiao Tong Univ, Sch Med SJTU SM, Ruijin Hosp, State Key Lab Med Genom,Shanghai Inst Hematol, 197 Ruijin Rd 2, Shanghai 200025, Peoples R China.	kankanwang@shsmu.edu.cn	Xi, Wenda/GYR-3972-2022		Ministry of Science and Technology Grants of China [2009CB825607, 2012AA02A211, 2011CB910202]; National Natural Science Foundation Grants of China [31171257, 81270625, 31100942]	Ministry of Science and Technology Grants of China; National Natural Science Foundation Grants of China(National Natural Science Foundation of China (NSFC))	This work was supported, in part, by Ministry of Science and Technology Grants of China (2009CB825607, 2012AA02A211 and 2011CB910202) and National Natural Science Foundation Grants of China (31171257, 81270625 and 31100942).	Aptsiauri N, 2007, INT REV CYTOL, V256, P139, DOI 10.1016/S0074-7696(07)56005-5; Carotta S, 2010, IMMUNOL REV, V238, P63, DOI 10.1111/j.1600-065X.2010.00955.x; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Carter BZ, 2001, BLOOD, V97, P2784, DOI 10.1182/blood.V97.9.2784; Collins SJ, 2008, CURR OPIN HEMATOL, V15, P346, DOI 10.1097/MOH.0b013e3283007edf; DOUCAS V, 1993, P NATL ACAD SCI USA, V90, P9345, DOI 10.1073/pnas.90.20.9345; Goldberg AL, 1995, COLD SPRING HARB SYM, V60, P479, DOI 10.1101/SQB.1995.060.01.052; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Hallermalm K, 2001, BLOOD, V98, P1108, DOI 10.1182/blood.V98.4.1108; Hoemme C, 2008, BLOOD, V111, P2887, DOI 10.1182/blood-2007-03-079921; Hu J, 2009, P NATL ACAD SCI USA, V106, P3342, DOI 10.1073/pnas.0813280106; Hu ZB, 1998, BLOOD, V92, P1768, DOI 10.1182/blood.V92.5.1768.417k19_1768_1775; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Idres N, 2001, CANCER RES, V61, P700; JANSEN JH, 1995, P NATL ACAD SCI USA, V92, P7401, DOI 10.1073/pnas.92.16.7401; JINNAI I, 1990, LEUKEMIA RES, V14, P227, DOI 10.1016/0145-2126(90)90130-2; Kanada S, 2011, BLOOD, V117, P2211, DOI 10.1182/blood-2010-06-291898; LARSEN F, 1993, HUM MOL GENET, V2, P1589, DOI 10.1093/hmg/2.10.1589; LECCHI M, 1989, LEUKEMIA RES, V13, P221, DOI 10.1016/0145-2126(89)90015-5; Lin RJ, 2001, ONCOGENE, V20, P7204, DOI 10.1038/sj.onc.1204853; Lloberas J, 1999, IMMUNOL TODAY, V20, P184, DOI 10.1016/S0167-5699(99)01442-5; Lowenberg Bob, 2003, Hematology Am Soc Hematol Educ Program, P82; Maeda Y, 1996, BRIT J HAEMATOL, V93, P973, DOI 10.1046/j.1365-2141.1996.d01-1749.x; Meijerink J, 2001, J MOL DIAGN, V3, P55, DOI 10.1016/S1525-1578(10)60652-6; Nigten J, 2005, LEUKEMIA, V19, P799, DOI 10.1038/sj.leu.2403699; Olive V, 2007, DEVELOPMENT, V134, P3815, DOI 10.1242/dev.003467; Padua RA, 2003, NAT MED, V9, P1413, DOI 10.1038/nm949; Promsuwicha O, 2009, ASIAN PAC J ALLERGY, V27, P209; Robin M, 2006, BLOOD, V108, P1972, DOI 10.1182/blood-2006-03-013177; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; Ross ME, 2004, BLOOD, V104, P3679, DOI 10.1182/blood-2004-03-1154; ROUSSELOT P, 1994, ONCOGENE, V9, P545; Schlenk RF, 2004, LEUKEMIA, V18, P1798, DOI 10.1038/sj.leu.2403528; Seliger B, 2000, IMMUNOL TODAY, V21, P455, DOI 10.1016/S0167-5699(00)01692-3; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; Singh H, 2008, J IMMUNOL, V181, P1595, DOI 10.4049/jimmunol.181.3.1595; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Spain LM, 1999, J IMMUNOL, V163, P2681; Tomasson MH, 2008, BLOOD, V111, P4797, DOI 10.1182/blood-2007-09-113027; Tsuzuki S, 2000, MOL CELL BIOL, V20, P6276, DOI 10.1128/MCB.20.17.6276-6286.2000; Vertuani S, 2003, CANCER RES, V63, P8006; Wang KK, 2010, CANCER CELL, V17, P186, DOI 10.1016/j.ccr.2009.12.045; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; Zhang YM, 2013, CANCER-AM CANCER SOC, V119, P115, DOI 10.1002/cncr.27650; Zheng P, 1998, NATURE, V396, P373, DOI 10.1038/24628; Zheng PZ, 2005, P NATL ACAD SCI USA, V102, P7653, DOI 10.1073/pnas.0502825102; Zheng XM, 2007, HAEMATOLOGICA, V92, P323, DOI 10.3324/haematol.10541; Zhu XH, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-22; Zou DD, 2012, LEUKEMIA RES, V36, P219, DOI 10.1016/j.leukres.2011.09.012	52	18	19	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 22	2014	33	21					2700	2708		10.1038/onc.2013.224	http://dx.doi.org/10.1038/onc.2013.224			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AI9EH	23770850				2022-12-25	WOS:000337231700003
J	Andrew, EJ; Merchan, S; Lawless, C; Banks, AP; Wilkinson, DJ; Lydall, D				Andrew, Elizabeth J.; Merchan, Stephanie; Lawless, Conor; Banks, A. Peter; Wilkinson, Darren J.; Lydall, David			Pentose Phosphate Pathway Function Affects Tolerance to the G-Quadruplex Binder TMPyP4	PLOS ONE			English	Article							INTERACTIVE AGENTS; OXIDATIVE STRESS; ANTITUMOR-ACTIVITY; C-MYC; TELOMERASE; YEAST; PORPHYRINS; DNA; EXPRESSION; BINDING	G-quadruplexes form in guanine-rich regions of DNA and the presence of these structures at telomeres prevents the activity of telomerase in vitro. Ligands such as the cationic porphyrin TMPyP4 stabilise G-quadruplexes and are therefore under investigation for their potential use as anti-cancer drugs. In order to investigate the mechanism of action of TMPyP4 in vivo, we carried out a genome-wide screen in the budding yeast Saccharomyces cerevisiae. We found that deletion of key pentose phosphate pathway (PPP) genes increased the sensitivity of yeast to the presence of TMPyP4. The PPP plays an important role in the oxidative stress response and sensitivity to TMPyP4 also increased when genes involved in the oxidative stress response, CCS1 and YAP1, were deleted. For comparison we also report genome wide-screens using hydrogen peroxide, which causes oxidative stress, RHPS4, another G-quadruplex binder and hydroxyurea, an S phase poison. We found that a number of TMPyP4-sensitive strains are also sensitive to hydrogen peroxide in a genome-wide screen. Overall our results suggest that treatment with TMPyP4 results in light-dependent oxidative stress response in budding yeast, and that this, rather than G-quadruplex binding, is the major route to cytotoxicity. Our results have implications for the usefulness and mechanism of action of TMPyP4.	[Andrew, Elizabeth J.; Merchan, Stephanie; Lawless, Conor; Banks, A. Peter; Lydall, David] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wilkinson, Darren J.] Newcastle Univ, Sch Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Lydall, D (corresponding author), Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	david.lydall@ncl.ac.uk		Wilkinson, Darren James/0000-0003-0736-802X; Lawless, Conor/0000-0002-4186-8506	Biotechnology and Biological Sciences Research Council [BBF016980/1]; Wellcome Trust [WT093088MA]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Biotechnology and Biological Sciences Research Council Doctoral Training Grant [BBF016980/1] and the Wellcome Trust [WT093088MA]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinall SG, 2008, GENETICS, V180, P2251, DOI 10.1534/genetics.108.092577; Addinall SG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001362; Aoki K, 2003, CHEM PHARM BULL, V51, P899; BALAGURUMOORTHY P, 1994, J BIOL CHEM, V269, P21858; Banks AP, 2012, JOVE-J VIS EXP, DOI 10.3791/4018; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Chen H, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-43; Cookson JC, 2005, MOL PHARMACOL, V68, P1551, DOI 10.1124/mol.105.013300; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; CROKE DT, 1993, J PHOTOCH PHOTOBIO B, V18, P41, DOI 10.1016/1011-1344(93)80039-C; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Dixon IM, 2005, CHEMBIOCHEM, V6, P123, DOI 10.1002/cbic.200400113; Eichner A, 2013, PHOTOCHEMICAL PHOTOB, V12; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Grand CL, 2002, MOL CANCER THER, V1, P565; Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9; Granville DJ, 2001, HISTOL HISTOPATHOL, V16, P309, DOI 10.14670/HH-16.309; Han FXG, 1999, J AM CHEM SOC, V121, P3561, DOI 10.1021/ja984153m; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Huang H, 2008, PROTEINS, V73, P1076, DOI 10.1002/prot.22237; Izbicka E, 1999, ANTI-CANCER DRUG DES, V14, P355; Izbicka E, 1999, CANCER RES, V59, P639; Juhnke H, 1996, MOL GEN GENET, V252, P456, DOI 10.1007/BF02173011; Kruger A, 2011, ANTIOXID REDOX SIGN, V15, P311, DOI 10.1089/ars.2010.3797; Langbein S, 2006, BRIT J CANCER, V94, P578, DOI 10.1038/sj.bjc.6602962; Lawless C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-287; Lena S, 2010, ANGEW CHEM INT EDIT, V49, P3657, DOI 10.1002/anie.201000805; Li Q, 2002, EXPERT OPIN THER PAT, V12, P1663, DOI 10.1517/13543776.12.11.1663; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Martino L, 2009, J PHYS CHEM B, V113, P14779, DOI 10.1021/jp9066394; Mikami-Terao Y, 2008, CANCER LETT, V261, P226, DOI 10.1016/j.canlet.2007.11.017; Mikami-Terao Y, 2009, EXP EYE RES, V89, P200, DOI 10.1016/j.exer.2009.03.008; Morris MJ, 2012, NUCL ACIDS RES; Moye-Rowley WS, 2002, ANTIOXID REDOX SIGN, V4, P123, DOI 10.1089/152308602753625915; Ralser M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120093; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; Romera C, 2011, BIOCHIMIE, V93, P1310, DOI 10.1016/j.biochi.2011.06.008; SCHAAFFGERSTENSCHLAGER I, 1993, EUR J BIOCHEM, V217, P487, DOI 10.1111/j.1432-1033.1993.tb18268.x; Schoonover M, 2012, BIOORGAN MED CHEM, V20, P6904, DOI 10.1016/j.bmc.2012.10.017; Shi DF, 2001, J MED CHEM, V44, P4509, DOI 10.1021/jm010246u; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Slekar KH, 1996, J BIOL CHEM, V271, P28831, DOI 10.1074/jbc.271.46.28831; Smith JS, 2011, NAT STRUCT MOL BIOL, V18, P478, DOI 10.1038/nsmb.2033; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Wei CY, 2006, BIOCHEMISTRY-US, V45, P6681, DOI 10.1021/bi052356z; Wei CY, 2009, PHYS CHEM CHEM PHYS, V11, P4025, DOI 10.1039/b901027k; Wei CY, 2009, BIOPHYS CHEM, V143, P79, DOI 10.1016/j.bpc.2009.04.005; Zhao J, 2004, METAB ENG, V6, P164, DOI 10.1016/j.ymben.2004.02.004	50	15	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66242	10.1371/journal.pone.0066242	http://dx.doi.org/10.1371/journal.pone.0066242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776642	gold, Green Submitted, Green Published			2022-12-25	WOS:000320322400093
J	Walsh, F; Duffy, B				Walsh, Fiona; Duffy, Brion			The Culturable Soil Antibiotic Resistome: A Community of Multi-Drug Resistant Bacteria	PLOS ONE			English	Article							MEDIATED QUINOLONE RESISTANCE; PSEUDOMONAS-AERUGINOSA; MULTIPLEX PCR; GENES; ENVIRONMENT; NDM-1; MICROORGANISMS; SEQUENCE	Understanding the soil bacterial resistome is essential to understanding the evolution and development of antibiotic resistance, and its spread between species and biomes. We have identified and characterized multi-drug resistance (MDR) mechanisms in the culturable soil antibiotic resistome and linked the resistance profiles to bacterial species. We isolated 412 antibiotic resistant bacteria from agricultural, urban and pristine soils. All isolates were multi-drug resistant, of which greater than 80% were resistant to 16-23 antibiotics, comprising almost all classes of antibiotic. The mobile resistance genes investigated, (ESBL, blaNDM-1, and plasmid mediated quinolone resistance (PMQR) resistance genes) were not responsible for the respective resistance phenotypes nor were they present in the extracted soil DNA. Efflux was demonstrated to play an important role in MDR and many resistance phenotypes. Clinically relevant Burkholderia species are intrinsically resistant to ciprofloxacin but the soil Burkholderia species were not intrinsically resistant to ciprofloxacin. Using a phenotypic enzyme assay we identified the antibiotic specific inactivation of trimethoprim in 21 bacteria from different soils. The results of this study identified the importance of the efflux mechanism in the soil resistome and variations between the intrinsic resistance profiles of clinical and soil bacteria of the same family.	[Walsh, Fiona; Duffy, Brion] Res Stn Agroscope Changins Wadenswil ACW, Fed Dept Econ Affairs Educ & Res EAER, Bacteriol Res Lab, Wadenswil, Switzerland	Swiss Federal Research Station Agroscope	Walsh, F (corresponding author), Res Stn Agroscope Changins Wadenswil ACW, Fed Dept Econ Affairs Educ & Res EAER, Bacteriol Res Lab, Wadenswil, Switzerland.	fiona.walsh@agroscope.admin.ch	Walsh, Fiona/C-6652-2012	Walsh, Fiona/0000-0003-0789-1689	Swiss Federal Office for Agriculture; Swiss Federal Office for the Environment; Swiss Expert Committee for Biosafety (SECB)	Swiss Federal Office for Agriculture; Swiss Federal Office for the Environment; Swiss Expert Committee for Biosafety (SECB)	This project was funded by the Swiss Federal Office for Agriculture, the Swiss Federal Office for the Environment and the Swiss Expert Committee for Biosafety (SECB). Work was conducted within the European research network COST TD0803 Detecting evolutionary hotspots of antibiotic resistances in Europe (DARE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Alonso A, 2001, ENVIRON MICROBIOL, V3, P1, DOI 10.1046/j.1462-2920.2001.00161.x; Amann R, 2001, CURR OPIN BIOTECH, V12, P231, DOI 10.1016/S0958-1669(00)00204-4; American Academy of Microbiology, 2009, ANT RES EC PERSP OLD; Aminov RI, 2009, ENVIRON MICROBIOL, V11, P2970, DOI 10.1111/j.1462-2920.2009.01972.x; Bengoechea JA, 2000, MOL MICROBIOL, V37, P67, DOI 10.1046/j.1365-2958.2000.01956.x; BENVENISTE R, 1973, P NATL ACAD SCI USA, V70, P2276, DOI 10.1073/pnas.70.8.2276; Bhullar K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034953; Cases I, 2005, NAT REV MICROBIOL, V3, P105, DOI 10.1038/nrmicro1084; Clinical and Laboratory Standards Institute (CLSI), 2006, M7A5 CLSI; Colom K, 2003, FEMS MICROBIOL LETT, V223, P147, DOI 10.1016/S0378-1097(03)00306-9; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dolejska M, 2013, J ANTIMICROB CHEMOTH, V68, P34, DOI 10.1093/jac/dks357; Fajardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001619; Fernandez L, 2010, ANTIMICROB AGENTS CH, V54, P3372, DOI 10.1128/AAC.00242-10; Gay K, 2006, CLIN INFECT DIS, V43, P297, DOI 10.1086/505397; Leclercq R, 2013, Clin Microbiol Infect, V19, P141, DOI 10.1111/j.1469-0691.2011.03703.x; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Ma JY, 2009, ANTIMICROB AGENTS CH, V53, P519, DOI 10.1128/AAC.00886-08; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nordmann P, 2005, J ANTIMICROB CHEMOTH, V56, P463, DOI 10.1093/jac/dki245; Oliver A, 2001, ANTIMICROB AGENTS CH, V45, P616, DOI 10.1128/AAC.45.2.616-620.2001; Poirel L, 2011, J ANTIMICROB CHEMOTH, V66, P1730, DOI 10.1093/jac/dkr174; Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es060413l; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Rosenblatt-Farrell N, 2009, ENVIRON HEALTH PERSP, V117, pA248; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Wang CX, 2006, J ANTIMICROB CHEMOTH, V57, P1261, DOI 10.1093/jac/dkl116; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI DOI 10.1093/jac/dki412; Zheng BW, 2011, PROTEIN CELL, V2, P250, DOI 10.1007/s13238-011-1027-0	37	99	101	1	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65567	10.1371/journal.pone.0065567	http://dx.doi.org/10.1371/journal.pone.0065567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23776501	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000320322400033
J	Bai, XN; Zhao, AL; Lan, RT; Xin, YQ; Xie, H; Meng, Q; Jin, D; Yu, B; Sun, H; Lu, S; Xu, JG; Xiong, YW				Bai, Xiangning; Zhao, Ailan; Lan, Ruiting; Xin, Youquan; Xie, Hui; Meng, Qiong; Jin, Dong; Yu, Bo; Sun, Hui; Lu, Shan; Xu, Jianguo; Xiong, Yanwen			Shiga Toxin-Producing Escherichia coli in Yaks (Bos grunniens) from the Qinghai-Tibetan Plateau, China	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; ENTEROCYTE EFFACEMENT; SUBTILASE CYTOTOXIN; MOLECULAR ANALYSIS; VIRULENCE PROFILES; PUTATIVE ADHESINS; MULTIPLEX PCR; UNITED-STATES; BEEF-CATTLE; STRAINS	Shiga toxin (Stx)-producing Escherichia coli (STEC) are recognized as important human pathogens of public health concern. Many animals are the sources of STEC. In this study we determined the occurrence and characteristics of the STEC in yaks (Bos grunniens) from the Qinghai-Tibetan plateau, China. A total of 728 yak fecal samples was collected from June to August, 2012 and was screened for the presence of the stx(1) and stx(2) genes by TaqMan real-time PCR after the sample was enriched in modified Tryptone Soya Broth. Of the 138 (18.96%) stx(1) and/or stx(2)-positive samples, 85 (61.59%) were confirmed to have at least 1 STEC isolate present by culture isolation, from which 128 STEC isolates were recovered. All STEC isolates were serotyped, genotyped by pulsed-field gel electrophoresis (PFGE) and characterized for the presence of 16 known virulence factors. Fifteen different O serogroups and 36 different O: H serotypes were identified in the 128 STEC isolates with 21 and 4 untypable for the O and H antigens respectively. One stx(1) subtype (stx(1a)) and 5 stx(2) subtypes (stx(2a), stx(2b), stx(2c), stx(2d) and stx(2g)) were present in these STEC isolates. Apart from lpfA(O157/OI-141), lpfA(O157/OI-154), lpfA(O113), katP and toxB which were all absent, other virulence factors screened (eaeA, iha, efa1, saa, paa, cnf1, cnf2, astA, subA, exhA and espP) were variably present in the 128 STEC isolates. PFGE were successful for all except 5 isolates and separated them into 67 different PFGE patterns. For the 18 serotypes with 2 or more isolates, isolates of the same serotypes had the same or closely related PFGE patterns, demonstrating clonality of these serotypes. This study was the first report on occurrence and characteristics of STEC isolated from yaks (Bos grunniens) from the Qinghai-Tibetan plateau, China, and extended the genetic diversity and reservoir host range of STEC.	[Bai, Xiangning; Zhao, Ailan; Meng, Qiong; Jin, Dong; Yu, Bo; Sun, Hui; Lu, Shan; Xu, Jianguo; Xiong, Yanwen] Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing, Peoples R China; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Xin, Youquan; Xie, Hui] Qinghai Inst Endem Dis Prevent & Control, Xining, Qinghai Provinc, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; University of New South Wales Sydney	Xiong, YW (corresponding author), Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing, Peoples R China.	xiongyanwen@icdc.cn		Meng, Qiong/0000-0002-8378-9021; Lan, Ruiting/0000-0001-9834-5258	National Basic Research Program of China [2011CB504901]; Chinese National Natural Science Foundation [81290340, 81290345]; China Mega-Project for Infectious Disease [2011ZX10004-001, 2012ZX10004-215]; State Key Laboratory for Infectious Disease Prevention and Control Development [2008SKLID106, 2011SKLID203, 2012SKLID401]	National Basic Research Program of China(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Mega-Project for Infectious Disease; State Key Laboratory for Infectious Disease Prevention and Control Development	This work was supported by the National Basic Research Program of China (2011CB504901), Chinese National Natural Science Foundation Grants (81290340 and 81290345), China Mega-Project for Infectious Disease Grants (2011ZX10004-001 and 2012ZX10004-215) and State Key Laboratory for Infectious Disease Prevention and Control Development Grants (2008SKLID106, 2011SKLID203 and 2012SKLID401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpers K, 2009, EPIDEMIOL INFECT, V137, P389, DOI 10.1017/S0950268808001465; Auvray F, 2012, VET MICROBIOL, V158, P443, DOI 10.1016/j.vetmic.2012.02.029; Bandyopadhyay S, 2012, RES VET SCI, V93, P604, DOI 10.1016/j.rvsc.2011.12.011; Bandyopadhyay S, 2012, TROP ANIM HEALTH PRO, V44, P1063, DOI 10.1007/s11250-011-0041-9; Bandyopadhyay S, 2009, VET MICROBIOL, V138, P403, DOI 10.1016/j.vetmic.2009.04.016; Batisson I, 2003, INFECT IMMUN, V71, P4516, DOI 10.1128/IAI.71.8.4516-4525.2003; Bauwens A, 2011, THROMB HAEMOSTASIS, V105, P515, DOI 10.1160/TH10-02-0140; Bentancor A, 2012, VET MICROBIOL, V156, P336, DOI 10.1016/j.vetmic.2011.10.030; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Bosilevac JM, 2011, APPL ENVIRON MICROB, V77, P2103, DOI 10.1128/AEM.02833-10; Brandal LT, 2007, J MICROBIOL METH, V68, P331, DOI 10.1016/j.mimet.2006.09.013; Brunder W, 1999, MICROBIOL-UK, V145, P1005, DOI 10.1099/13500872-145-5-1005; Brunder W, 1996, MICROBIOL-SGM, V142, P3305, DOI 10.1099/13500872-142-11-3305; Buvens G, 2010, EUR J CLIN MICROBIOL, V29, P1395, DOI 10.1007/s10096-010-1014-z; Coombes BK, 2008, APPL ENVIRON MICROB, V74, P2153, DOI 10.1128/AEM.02566-07; Creuzburg K, 2011, ENVIRON MICROBIOL, V13, P439, DOI 10.1111/j.1462-2920.2010.02349.x; DebRoy Chitrita, 2011, Animal Health Research Reviews, V12, P169, DOI 10.1017/S1466252311000193; Doughty S, 2002, INFECT IMMUN, V70, P6761, DOI 10.1128/IAI.70.12.6761-6769.2002; Eggert M, 2012, EPIDEMIOLOGY INFECT, P1; Eklund M, 2002, J CLIN MICROBIOL, V40, P4585, DOI 10.1128/JCM.40.12.4585-4593.2002; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Gault G, 2011, EURO SURVEILL, V16; Grant J, 2008, EMERG INFECT DIS, V14, P1633, DOI 10.3201/eid1410.071341; Hauser E, 2013, APPL ENVIRON MICROB, V79, P2731, DOI 10.1128/AEM.03552-12; Huang XD, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-237; Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421; Hussein HS, 2005, J FOOD PROTECT, V68, P2224, DOI 10.4315/0362-028X-68.10.2224; Irino K, 2010, J CLIN MICROBIOL, V48, P988, DOI 10.1128/JCM.00010-10; Jenkins C, 2003, J CLIN MICROBIOL, V41, P1775, DOI 10.1128/JCM.41.4.1775-1778.2003; Jourdan-Da Silva N, 2011, EUROSURVEILLANCE, V17; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Knust Z, 2010, TOXINS, V2, P116, DOI 10.3390/toxins2010116; Manning SD, 2008, P NATL ACAD SCI USA, V105, P4868, DOI 10.1073/pnas.0710834105; Martin A, 2011, INT J FOOD MICROBIOL, V146, P99, DOI 10.1016/j.ijfoodmicro.2011.01.041; Mellmann A, 2008, EMERG INFECT DIS, V14, P1287, DOI 10.3201/eid1408.071082; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; Newton HJ, 2009, EMERG INFECT DIS, V15, P372, DOI [10.3201/eid1502.080631, 10.3201/eid1503.080631]; Nicholls L, 2000, MOL MICROBIOL, V35, P275, DOI 10.1046/j.1365-2958.2000.01690.x; Oporto B, 2008, ZOONOSES PUBLIC HLTH, V55, P73, DOI 10.1111/j.1863-2378.2007.01080.x; Orth D, 2007, DIAGN MICR INFEC DIS, V59, P235, DOI 10.1016/j.diagmicrobio.2007.04.013; Pass MA, 2000, J CLIN MICROBIOL, V38, P2001, DOI 10.1128/JCM.38.5.2001-2004.2000; Paton AW, 2001, INFECT IMMUN, V69, P6999, DOI 10.1128/IAI.69.11.6999-7009.2001; Paton AW, 2002, J CLIN MICROBIOL, V40, P271, DOI 10.1128/JCM.40.1.271-274.2002; Paton AW, 2005, J CLIN MICROBIOL, V43, P2944, DOI 10.1128/JCM.43.6.2944-2947.2005; Paton AW, 2004, J EXP MED, V200, P35, DOI 10.1084/jem.20040392; PATON AW, 1995, GENE, V153, P71, DOI 10.1016/0378-1119(94)00777-P; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Ray PE, 2001, PEDIATR NEPHROL, V16, P823, DOI 10.1007/s004670100660; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Sanchez S, 2010, VET MICROBIOL, V143, P420, DOI 10.1016/j.vetmic.2009.11.016; Sanchez S, 2010, VET MICROBIOL, V142, P445, DOI 10.1016/j.vetmic.2009.10.009; SAVARINO SJ, 1993, P NATL ACAD SCI USA, V90, P3093, DOI 10.1073/pnas.90.7.3093; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Schmidt H, 2001, INFECT IMMUN, V69, P6863, DOI 10.1128/IAI.69.11.6863-6873.2001; SCHMIDT H, 1995, INFECT IMMUN, V63, P1055, DOI 10.1128/IAI.63.3.1055-1061.1995; Schmidt MA, 2010, CELL MICROBIOL, V12, P1544, DOI 10.1111/j.1462-5822.2010.01518.x; Szalo IM, 2002, RES MICROBIOL, V153, P653, DOI 10.1016/S0923-2508(02)01379-7; Tarr CL, 2002, INFECT IMMUN, V70, P6853, DOI 10.1128/IAI.70.12.6853-6859.2002; Tarr PI, 2000, INFECT IMMUN, V68, P1400, DOI 10.1128/IAI.68.3.1400-1407.2000; Toma C, 2004, J CLIN MICROBIOL, V42, P4937, DOI 10.1128/JCM.42.11.4937-4946.2004; Torres AG, 2002, INFECT IMMUN, V70, P5416, DOI 10.1128/IAI.70.10.5416-5427.2002; Werber D, 2003, EUR J CLIN MICROBIOL, V22, P726, DOI 10.1007/s10096-003-1025-0; Wieler LH, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-17; Wolfson JJ, 2009, J CLIN MICROBIOL, V47, P3058, DOI 10.1128/JCM.00706-09; Xiong YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036144; Yamamoto T, 1996, INFECT IMMUN, V64, P1441, DOI 10.1128/IAI.64.4.1441-1445.1996; Zweifel C, 2006, VET MICROBIOL, V117, P328, DOI 10.1016/j.vetmic.2006.06.017	69	29	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65537	10.1371/journal.pone.0065537	http://dx.doi.org/10.1371/journal.pone.0065537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776496	Green Submitted, Green Published, gold			2022-12-25	WOS:000320755400039
J	Hartl, D; Klatt, S; Roch, M; Konthur, Z; Klose, J; Willnow, TE; Rohe, M				Hartl, Daniela; Klatt, Stephan; Roch, Manfred; Konthur, Zoltan; Klose, Joachim; Willnow, Thomas E.; Rohe, Michael			Soluble Alpha-APP (sAPPalpha) Regulates CDK5 Expression and Activity in Neurons	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; CYCLIN-DEPENDENT KINASE-5; SORTILIN-RELATED RECEPTOR; ALZHEIMERS-DISEASE; HIPPOCAMPAL-NEURONS; SECRETED FORMS; NEURODEGENERATIVE DISEASES; TAU PHOSPHORYLATION; CEREBROSPINAL-FLUID; ADULT NEUROGENESIS	A growing body of evidence suggests a role for soluble alpha-amyloid precursor protein (sAPPalpha) in pathomechanisms of Alzheimer disease (AD). This cleavage product of APP was identified to have neurotrophic properties. However, it remained enigmatic what proteins, targeted by sAPPalpha, might be involved in such neuroprotective actions. Here, we used high-resolution two-dimensional polyacrylamide gel electrophoresis to analyze proteome changes downstream of sAPPalpha in neurons. We present evidence that sAPPalpha regulates expression and activity of CDK5, a kinase that plays an important role in AD pathology. We also identified the cytoprotective chaperone ORP150 to be induced by sAPPalpha as part of this protective response. Finally, we present functional evidence that the sAPPalpha receptor SORLA is essential to mediate such molecular functions of sAPPalpha in neurons.	[Hartl, Daniela; Roch, Manfred; Klose, Joachim] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany; [Klatt, Stephan; Konthur, Zoltan] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Klatt, Stephan] Free Univ Berlin, Fac Biol Chem & Pharm, Berlin, Germany; [Konthur, Zoltan] Max Planck Inst Colloids & Interfaces, Potsdam, Germany; [Willnow, Thomas E.; Rohe, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Free University of Berlin; Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Hartl, D (corresponding author), Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany.	daniela.hartl@charite.de; michael.rohe@mdc-berlin.de	Konthur, Zoltán/E-4575-2010	Konthur, Zoltán/0000-0002-8767-9823; Klatt, Stephan/0000-0003-0064-3367; Willnow, Thomas/0000-0001-9515-7921	American Health Assistance Foundation [A2011601]; German Research Foundation [HA6155/2-2]	American Health Assistance Foundation(BrightFocus Foundation); German Research Foundation(German Research Foundation (DFG))	Studies were funded by grants from the American Health Assistance Foundation (to MR; www.brightfocus.org; project A2011601) and the German Research Foundation (to DH; www.dfg.de; project HA6155/2-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen OM, 2006, BIOCHEMISTRY-US, V45, P2618, DOI 10.1021/bi052120v; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3; Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; BHASIN R, 1991, P NATL ACAD SCI USA, V88, P10307, DOI 10.1073/pnas.88.22.10307; Chasseigneaux S, 2012, J NEUROCHEM, V120, P99, DOI 10.1111/j.1471-4159.2011.07584.x; Cheung ZH, 2012, TRENDS CELL BIOL, V22, P169, DOI 10.1016/j.tcb.2011.11.003; Crews L, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-67; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Futatsugi A, 2012, CELL CYCLE, V11, P1603, DOI 10.4161/cc.20009; Gillardon F, 2005, J CELL BIOCHEM, V95, P817, DOI 10.1002/jcb.20463; Gillardon F, 2005, PROTEOMICS, V5, P1299, DOI 10.1002/pmic.200400992; Gustafsen C, 2013, J NEUROSCI, V33, P64, DOI 10.1523/JNEUROSCI.2371-12.2013; Han P, 2005, J NEUROSCI, V25, P11542, DOI 10.1523/JNEUROSCI.3831-05.2005; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Hou ZB, 2007, J BIOL CHEM, V282, P18666, DOI 10.1074/jbc.C700052200; JIN LW, 1994, J NEUROSCI, V14, P5461; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kitao Y, 2001, J CLIN INVEST, V108, P1439, DOI 10.1172/JCI200112978; Klatt S, 2013, J PROTEOME RES, V12, P396, DOI 10.1021/pr300693f; Lalioti V, 2010, CELL CYCLE, V9, P284, DOI 10.4161/cc.9.2.10466; LANNFELT L, 1995, NAT MED, V1, P829, DOI 10.1038/nm0895-829; Lilja L, 2004, J BIOL CHEM, V279, P29534, DOI 10.1074/jbc.M312711200; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Ohsawa I, 1997, BIOCHEM BIOPH RES CO, V236, P59, DOI 10.1006/bbrc.1997.6903; Olsson A, 2003, EXP NEUROL, V183, P74, DOI 10.1016/S0014-4886(03)00027-X; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; QIU WQ, 1995, J NEUROSCI, V15, P2157, DOI 10.1523/JNEUROSCI.15-03-02157.1995; Ramos-Echazabal G, 2012, J CELL BIOCHEM, V113, P2364, DOI 10.1002/jcb.24108; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rohe M, 2008, J BIOL CHEM, V283, P14826, DOI 10.1074/jbc.M710574200; Rohe M, 2011, J PROTEOME RES, V10, P1459, DOI 10.1021/pr101008p; Rohe M, 2009, J NEUROSCI, V29, P15472, DOI 10.1523/JNEUROSCI.3960-09.2009; Roselli F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023097; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Sdek P, 2011, J CELL BIOL, V194, P407, DOI 10.1083/jcb.201012049; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; Sharma P, 1999, J BIOL CHEM, V274, P9600, DOI 10.1074/jbc.274.14.9600; Shukla V, 2012, ARCH MED RES, V43, P655, DOI 10.1016/j.arcmed.2012.10.015; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Tamatani M, 2001, NAT MED, V7, P317, DOI 10.1038/85463; Tripathi BK, 2009, MOL CELL BIOL, V29, P6488, DOI 10.1128/MCB.01098-09; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Williamson R, 2011, J ALZHEIMERS DIS, V27, P615, DOI 10.3233/JAD-2011-110617; Willnow TE, 2010, REV NEUROSCIENCE, V21, P315; Zabel C, 2002, MOL CELL PROTEOMICS, V1, P366, DOI 10.1074/mcp.M200016-MCP200; Zabel Claus, 2009, V519, P311, DOI 10.1007/978-1-59745-281-6_20; Zhang J, 2011, CELL CYCLE, V10, P1208, DOI 10.4161/cc.10.8.15328	54	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65920	10.1371/journal.pone.0065920	http://dx.doi.org/10.1371/journal.pone.0065920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776568	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000320755400080
J	Lin, D; Ding, J; Liu, JY; He, YF; Dai, Z; Chen, CZ; Cheng, WZ; Zhou, J; Wang, X				Lin, Dong; Ding, Jing; Liu, Jian-Ying; He, Yi-Feng; Dai, Zhi; Chen, Cai-Zhong; Cheng, Wei-Zhong; Zhou, Jian; Wang, Xin			Decreased Serum Hepcidin Concentration Correlates with Brain Iron Deposition in Patients with HBV-Related Cirrhosis	PLOS ONE			English	Article							SUBCLINICAL HEPATIC-ENCEPHALOPATHY; LIVER-DISEASE; BASAL GANGLIA; NEURODEGENERATIVE DISORDERS; MULTIPLE-SCLEROSIS; PROHEPCIDIN LEVELS; IN-VIVO; HEMOCHROMATOSIS; METABOLISM; ERYTHROPOIESIS	Purpose: Excessive brain iron accumulation contributes to cognitive impairments in hepatitis B virus (HBV)-related cirrhotic patients. The underlying mechanism remains unclear. Hepcidin, a liver-produced, 25-aminoacid peptide, is the major regulator of systemic iron metabolism. Abnormal hepcidin level is a key factor in some body iron accumulation or deficiency disorders, especially in those associated with liver diseases. Our study was aimed to explore the relationship between brain iron content in patients with HBV-related cirrhosis and serum hepcidin level. Methods: Seventy HBV-related cirrhotic patients and forty age-sex-matched healthy controls were enrolled. Brain iron content was quantified by susceptibility weighted phase imaging technique. Serum hepcidin as well as serum iron, serum transferrin, ferritin, soluble transferrin receptor, total iron binding capacity, and transferrin saturation were tested in thirty cirrhotic patients and nineteen healthy controls. Pearson correlation analysis was performed to investigate correlation between brain iron concentrations and serum hepcidin, or other iron parameters. Results: Cirrhotic patients had increased brain iron accumulation compared to controls in the left red nuclear, the bilateral substantia nigra, the bilateral thalamus, the right caudate, and the right putamen. Cirrhotic patients had significantly decreased serum hepcidin concentration, as well as lower serum transferring level, lower total iron binding capacity and higher transferrin saturation, compared to controls. Serum hepcidin level negatively correlated with the iron content in the right caudate, while serum ferritin level positively correlated with the iron content in the bilateral putamen in cirrhotic patients. Conclusions: Decreased serum hepcidin level correlated with excessive iron accumulation in the basal ganglia in HBV-related cirrhotic patients. Our results indicated that systemic iron overload underlined regional brain iron repletion. Serum hepcidin may be a clinical biomarker for brain iron deposition in cirrhotic patients, which may have therapeutic potential.	[Lin, Dong; Ding, Jing; Liu, Jian-Ying; Wang, Xin] Fudan Univ, Zhongshan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Wang, Xin] Inst Brain Sci, Shanghai, Peoples R China; [Wang, Xin] State Key Lab Med Neurobiol, Shanghai, Peoples R China; [He, Yi-Feng; Dai, Zhi; Zhou, Jian] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200433, Peoples R China; [Chen, Cai-Zhong; Cheng, Wei-Zhong] Fudan Univ, Zhongshan Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Zhou, Jian] Shanghai Key Lab Organ Transplantat, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Wang, X (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Neurol, Shanghai 200433, Peoples R China.	wang.xin@zs-hospital.sh.cn			State 863 High Technology R&D Project of China [2007AA02Z479]; Shanghai Municipal Human Resources and Social Security Bureau [2009001]	State 863 High Technology R&D Project of China; Shanghai Municipal Human Resources and Social Security Bureau	This work was supported by the State 863 High Technology R&D Project of China [grant number 2007AA02Z479] and grants from Shanghai Municipal Human Resources and Social Security Bureau (Grant No. 2009001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Krysha N, 2008, MULT SCLER J, V14, P602, DOI 10.1177/1352458507085550; Atanasiu V, 2007, EUR J HAEMATOL, V78, P1, DOI 10.1111/j.1600-0609.2006.00772.x; Berg D, 2000, NEURORADIOLOGY, V42, P9, DOI 10.1007/s002340050002; Bonkovsky HL, 1997, HEPATOLOGY, V25, P759, DOI 10.1002/hep.510250345; Burdo JR, 2003, BIOMETALS, V16, P63, DOI 10.1023/A:1020718718550; Burkhard PR, 2003, ARCH NEUROL-CHICAGO, V60, P521, DOI 10.1001/archneur.60.4.521; Cade JE, 2005, AM J CLIN NUTR, V82, P813, DOI 10.1093/ajcn/82.4.813; Casanova MF, 2003, PSYCHIAT RES, V121, P59, DOI 10.1016/S0165-1781(03)00202-6; Corengia C, 2005, AM J CLIN PATHOL, V124, P846, DOI 10.1309/X4UH5Q68Q4J3GDNV; Crompton DE, 2002, BLOOD CELL MOL DIS, V29, P522, DOI 10.1006/bcmd.2002.0589; Das A, 2001, J GASTROEN HEPATOL, V16, P531, DOI 10.1046/j.1440-1746.2001.02487.x; DIBISCEGLIE AM, 1992, GASTROENTEROLOGY, V102, P2108, DOI 10.1016/0016-5085(92)90339-Z; Eng SC, 2005, LIVER INT, V25, P513, DOI 10.1111/j.1478-3231.2005.01004.x; Fujita N, 2007, MOL MED, V13, P97, DOI 10.2119/2006-00057.Fujita; Gordon N, 2000, BRAIN DEV-JPN, V22, P465, DOI 10.1016/S0387-7604(00)00175-3; Groeneweg M, 1998, HEPATOLOGY, V28, P45, DOI 10.1002/hep.510280108; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P561, DOI 10.1002/jmri.22293; Haacke EM, 2009, J MAGN RESON IMAGING, V29, P537, DOI 10.1002/jmri.21676; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Hadley KB, 2006, AM J CLIN NUTR, V84, P150, DOI 10.1093/ajcn/84.1.150; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Hayflick SJ, 2003, CURR OPIN PEDIATR, V15, P572, DOI 10.1097/00008480-200312000-00005; Honda K, 2004, ANN NY ACAD SCI, V1012, P179, DOI 10.1196/annals.1306.015; House MJ, 2010, MAGN RESON MED, V63, P275, DOI 10.1002/mrm.22263; Jalan R, 1995, J HEPATOL, V23, P697, DOI 10.1016/0168-8278(95)80036-0; Jones EA, 1997, J NEUROL NEUROSUR PS, V63, P279, DOI 10.1136/jnnp.63.3.279; Ke Y, 2003, LANCET NEUROL, V2, P246, DOI 10.1016/S1474-4422(03)00353-3; Ke Y, 2007, PROG NEUROBIOL, V83, P149, DOI 10.1016/j.pneurobio.2007.07.009; Klos KJ, 2005, ARCH NEUROL-CHICAGO, V62, P1385, DOI 10.1001/archneur.62.9.1385; KOHGO Y, 1987, BLOOD, V70, P1955; Langkammer C, 2010, RADIOLOGY, V257, P455, DOI 10.1148/radiol.10100495; Lee WC, 1999, J GASTROEN HEPATOL, V14, P370, DOI 10.1046/j.1440-1746.1999.01853.x; Liu JY, 2013, J MAGN RESON IMAGING, V37, P179, DOI 10.1002/jmri.23811; Martinelli AL, 2004, J GASTROEN HEPATOL, V19, P1036, DOI 10.1111/j.1440-1746.2004.03410.x; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Nagashima M, 2006, HEPATOL RES, V36, P288, DOI 10.1016/j.hepres.2006.08.006; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Pantiga C, 2003, J NEUROPSYCH CLIN N, V15, P84, DOI 10.1176/appi.neuropsych.15.1.84; Pfefferbaum A, 2009, NEUROIMAGE, V47, P493, DOI 10.1016/j.neuroimage.2009.05.006; Ramey G, 2010, HAEMATOL-HEMATOL J, V95, P501, DOI 10.3324/haematol.2009.014399; SICILIANO M, 1995, HEPATOLOGY, V22, P1132, DOI 10.1016/0270-9139(95)90620-7; Singh B, 2011, CLIN CHIM ACTA, V412, P823, DOI 10.1016/j.cca.2011.02.014; van Deuren M, 2009, HAEMATOL-HEMATOL J, V94, P1297, DOI 10.3324/haematol.2009.005975; Vokurka M, 2006, PHYSIOL RES, V55, P667, DOI 10.33549/physiolres.930841; Weissenborn K, 2005, AIDS, V19, pS93, DOI 10.1097/01.aids.0000192076.03443.6d; World Health Organization/Centers for Disease Control and Prevention, 2007, ASS IR STAT POP; Worwood M, 1997, CLIN CHIM ACTA, V259, P3, DOI 10.1016/S0009-8981(96)06488-1; Wypijewska A, 2010, PARKINSONISM RELAT D, V16, P329, DOI 10.1016/j.parkreldis.2010.02.007; Yao B, 2009, NEUROIMAGE, V44, P1259, DOI 10.1016/j.neuroimage.2008.10.029; Yonal O, 2010, DIGEST DIS SCI, V55, P3548, DOI 10.1007/s10620-010-1183-8; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhang JQ, 2010, BRAIN RES, V1330, P124, DOI 10.1016/j.brainres.2010.03.036; Zhu WZ, 2009, RADIOLOGY, V253, P497, DOI 10.1148/radiol.2532082324	54	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65551	10.1371/journal.pone.0065551	http://dx.doi.org/10.1371/journal.pone.0065551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776499	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400041
J	Seidel, G; Weger, M; Stadlmuller, L; Pichler, T; Haas, A				Seidel, Gerald; Weger, Martin; Stadlmueller, Lisa; Pichler, Tamara; Haas, Anton			Association of Preoperative Optical Coherence Tomography Markers with Residual Inner Limiting Membrane in Epiretinal Membrane Peeling	PLOS ONE			English	Article							BRILLIANT BLUE-G; INDOCYANINE GREEN; MACULAR PUCKER; RETINAL DAMAGE; TRYPAN BLUE; SURGERY; FEATURES; REMOVAL	Purpose: To identify preoperative markers on spectral domain optical coherence tomography (SD-OCT) for residual inner limiting membrane (ILM) in epiretinal membrane (ERM) peeling. Methods: In this retrospective case series the preoperative SD-OCTs from 119 eyes of 119 consecutive patients who underwent surgery for idiopathic ERM by a single surgeon were evaluated for markers predisposing for ILM persistence after ERM removal. ILM persistence was determined via intraoperative indocyanine green staining. The main outcome measures were correlation of central foveal thickness (CFT), ERM thickness, extent of elevated ERM and retinal folding, intraretinal cysts, and discontinuation of the ERM, with ILM persistence after ERM peeling. Results: The persistence of the ILM was found in 50.4% (n = 60). After Bonferroni correction for multiple testing, a greater extent of elevated ERM and thicker ERMs were associated with persistence of the ILM (p < 0.005). The other parameters showed no statistically significant correlations with the persistence of the ILM (p >= 0.005). Conclusion: Residual ILM can be found in nearly half of the eyes after ERM peeling. A loose connection between the ERM and the retinal surface predisposes for ILM persistence. Preoperative SD-OCT is helpful in identifying risk markers for the persistence of the ILM in ERM surgery.	[Seidel, Gerald; Weger, Martin; Pichler, Tamara; Haas, Anton] Med Univ Graz, Dept Ophthalmol, Graz, Austria; [Stadlmueller, Lisa] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria	Medical University of Graz; Medical University of Graz	Seidel, G (corresponding author), Med Univ Graz, Dept Ophthalmol, Graz, Austria.	gerald.seidel@medunigraz.at		Seidel, Gerald/0000-0003-2622-2894				Abdelkader E, 2008, SURV OPHTHALMOL, V53, P368, DOI 10.1016/j.survophthal.2008.04.006; Bovey EH, 2004, RETINA-J RET VIT DIS, V24, P728, DOI 10.1097/00006982-200410000-00007; Enaida H, 2006, RETINA-J RET VIT DIS, V26, P631, DOI 10.1097/00006982-200607000-00007; Gandorfer A, 2003, INVEST OPHTH VIS SCI, V44, P316, DOI 10.1167/iovs.02-0545; Gandorfer A, 2001, AM J OPHTHALMOL, V132, P431, DOI 10.1016/S0002-9394(01)01087-X; Gandorfer A, 2012, RETINA-J RET VIT DIS, V32, P477, DOI 10.1097/IAE.0b013e3182246e2a; Gandorfer Arnd, 2008, Dev Ophthalmol, V42, P69, DOI 10.1159/000138974; Grewing R, 1996, BRIT J OPHTHALMOL, V80, P323, DOI 10.1136/bjo.80.4.323; Hattenbach LO, 2009, KLIN MONATSBL AUGENH, V226, P649, DOI 10.1055/s-0028-1109490; Henrich PB, 2011, INVEST OPHTH VIS SCI, V52, P4345, DOI 10.1167/iovs.10-6972; Hwang JU, 2012, INVEST OPHTH VIS SCI, V53, P3562, DOI 10.1167/iovs.12-9762; KAMPIK A, 1980, AM J OPHTHALMOL, V90, P797; Kiernan DF, 2010, AM J OPHTHALMOL, V149, P18, DOI 10.1016/j.ajo.2009.08.037; Kifuku K, 2009, BRIT J OPHTHALMOL, V93, P1016, DOI 10.1136/bjo.2008.150623; Kim JS, 2012, AM J OPHTHALMOL, V153, P692; Kwok AKH, 2005, CLIN EXP OPHTHALMOL, V33, P379, DOI 10.1111/j.1442-9071.2005.01015.x; Li K, 2003, BRIT J OPHTHALMOL, V87, P216, DOI 10.1136/bjo.87.2.216; Naumann GOH, 2008, APPL PATHOLOGY OPHTH, pxxii; Ooi YL, 2013, EYE, V27, P425, DOI 10.1038/eye.2012.260; Park DW, 2003, OPHTHALMOLOGY, V110, P62, DOI 10.1016/S0161-6420(02)01440-9; Shimozono M, 2012, AM J OPHTHALMOL, V153, P698, DOI 10.1016/j.ajo.2011.09.011; Shukla D, 2011, RETINA-J RET VIT DIS, V31, P2021, DOI 10.1097/IAE.0b013e318213618c; Tari SR, 2007, RETINA-J RET VIT DIS, V27, P567, DOI 10.1097/IAE.0b013e31802ea53d	23	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66217	10.1371/journal.pone.0066217	http://dx.doi.org/10.1371/journal.pone.0066217			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776634	gold, Green Published, Green Submitted			2022-12-25	WOS:000320755400123
J	Zhao, Y; Yu, B; Xiang, YH; Han, XJ; Xu, Y; So, KF; Xu, AD; Ruan, YW				Zhao, Ying; Yu, Bo; Xiang, Yong-Hui; Han, Xin-Jia; Xu, Ying; So, Kwok-Fai; Xu, An-Ding; Ruan, Yi-Wen			Changes in Retinal Morphology, Electroretinogram and Visual Behavior after Transient Global Ischemia in Adult Rats	PLOS ONE			English	Article							PHOTOPIC NEGATIVE RESPONSE; CAROTID-ARTERY OCCLUSION; CA1 PYRAMIDAL NEURONS; BLACK-WHITE BOX; ANXIETY-LIKE BEHAVIOR; GANGLION-CELL DEATH; VEIN OCCLUSION; OPTIC-NERVE; IMMUNOHISTOCHEMICAL CHANGES; FLASH ELECTRORETINOGRAM	The retina is a light-sensitive tissue of the central nervous system that is vulnerable to ischemia. The pathological mechanism underlying retinal ischemic injury is not fully understood. The purpose of this study was to investigate structural and functional changes of different types of rat retinal neurons and visual behavior following transient global ischemia. Retinal ischemia was induced using a 4-vessel occlusion model. Compared with the normal group, the number of beta III-tubulin positive retinal ganglion cells and calretinin positive amacrine cells were reduced from 6 h to 48 h following ischemia. The number of recoverin positive cone bipolar cells transiently decreased at 6 h and 12 h after ischemia. However, the fluorescence intensity of rhodopsin positive rod cells and fluorescent peanut agglutinin positive cone cells did not change after reperfusion. An electroretinogram recording showed that the a-wave, b-wave, oscillatory potentials and the photopic negative response were completely lost during ischemia. The amplitudes of the a-and b-waves were partially recovered at 1 h after ischemia, and returned to the control level at 48 h after reperfusion. However, the amplitudes of oscillatory potentials and the photopic negative response were still reduced at 48 h following reperfusion. Visual behavior detection showed there was no significant change in the time spent in the dark chamber between the control and 48 h group, but the distance moved, mean velocity in the black and white chambers and intercompartmental crosses were reduced at 48 h after ischemia. These results indicate that transient global ischemia induces dysfunction of retinal ganglion cells and amacrine cells at molecular and ERG levels. However, transient global ischemia in a 17 minute duration does not appear to affect photoreceptors.	[Xiang, Yong-Hui; Han, Xin-Jia; Xu, Ying; So, Kwok-Fai; Ruan, Yi-Wen] Jinan Univ, Guangdong Hongkong Macau Inst CNS Regenerat GHMIC, Dept Cent Nervous Syst Regenerat, Guangzhou, Guangdong, Peoples R China; [Zhao, Ying; Xu, An-Ding] Jinan Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Ruan, Yi-Wen] Jinan Univ, Sch Med, Dept Human Anat, Guangzhou, Guangdong, Peoples R China; [Yu, Bo] Shanghai Univ Tradit Chinese Med, Coll Med, Dept Human Anat, Shanghai, Peoples R China	Jinan University; Jinan University; Jinan University; Shanghai University of Traditional Chinese Medicine	Xu, AD (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	andingxu@gmail.com; tyiwen@jnu.edu.cn		Xu, Ying/0000-0002-9987-2057; Xu, An-Ding/0000-0003-3154-0985; So, Kwok-Fai/0000-0003-4039-4246	National Program on Key Basic Research Project of China (973 Program) [2011CB707501]; National Natural Science Foundation of China [30971530]; Open Fund of the First Affiliated Hospital of Jinan University	National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Fund of the First Affiliated Hospital of Jinan University	This work was supported by the following grants: National Program on Key Basic Research Project of China (973 Program, 2011CB707501), the National Natural Science Foundation of China (30971530), and the Open Fund of the First Affiliated Hospital of Jinan University (2012-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1996, GRAEF ARCH CLIN EXP, V234, P445, DOI 10.1007/BF02539411; BARNETT NL, 1995, EXP EYE RES, V61, P83, DOI 10.1016/S0014-4835(95)80061-1; BLANKS JC, 1983, J COMP NEUROL, V221, P31, DOI 10.1002/cne.902210103; BLOCK F, 1992, NEUROSCI LETT, V144, P124, DOI 10.1016/0304-3940(92)90731-L; Bradley BF, 2011, BEHAV BRAIN RES, V216, P285, DOI 10.1016/j.bbr.2010.08.006; Chen HL, 2008, DOC OPHTHALMOL, V117, P129, DOI 10.1007/s10633-008-9114-0; Chen HL, 2006, DOC OPHTHALMOL, V113, P53, DOI 10.1007/s10633-006-9015-z; Chun MH, 1999, NEUROSCI LETT, V260, P125, DOI 10.1016/S0304-3940(98)00973-2; DELCERRO M, 1995, CELL TRANSPLANT, V4, P133, DOI 10.1016/0963-6897(94)00045-L; Dijk F, 2004, BRAIN RES, V1026, P194, DOI 10.1016/j.brainres.2004.08.034; Dijk F, 2004, BRAIN RES, V997, P207, DOI 10.1016/j.brainres.2003.08.069; Gianfranceschi L, 1999, VISION RES, V39, P569, DOI 10.1016/S0042-6989(98)00169-2; Hernandez M, 2009, MOL VIS, V15, P2696; Hogue CW, 2008, CRIT CARE CLIN, V24, P83, DOI 10.1016/j.ccc.2007.09.004; Jehle T, 2008, INVEST OPHTH VIS SCI, V49, P1056, DOI 10.1167/iovs.07-1050; JOHNSON MA, 1993, ARCH OPHTHALMOL-CHIC, V111, P806, DOI 10.1001/archopht.1993.01090060094030; KLINE RP, 1978, P NATL ACAD SCI USA, V75, P5727, DOI 10.1073/pnas.75.11.5727; Kwon OJ, 2005, MOL CELLS, V19, P382; Lafuente MP, 2002, NEUROSCIENCE, V109, P157, DOI 10.1016/S0306-4522(01)00458-4; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lavinsky D, 2006, GRAEF ARCH CLIN EXP, V244, P199, DOI 10.1007/s00417-005-0006-7; Lee JH, 2011, ANAT CELL BIOL, V44, P25, DOI 10.5115/acb.2011.44.1.25; Li B, 2005, DOC OPHTHALMOL, V111, P23, DOI [10.1007/s10633-005-2629-8, 10.1007/S10633-005-2629-8]; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Luan LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018938; Madl Christian, 2004, Curr Opin Crit Care, V10, P213, DOI 10.1097/01.ccx.0000127542.32890.fa; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; Meier P, 2011, J VIS, V11, P22; Mi XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045469; NEITZ J, 1986, J COMP PSYCHOL, V100, P21, DOI 10.1037/0735-7036.100.1.21; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Ozden S, 2001, OPHTHALMOLOGICA, V215, P309, DOI 10.1159/000050880; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Ren C, 2013, NEUROPSYCHOPHARMACOL; Ruan YW, 2006, NEUROSCIENCE, V140, P191, DOI 10.1016/j.neuroscience.2006.01.039; Ruan YW, 2012, NEUROSCIENCE, V218, P268, DOI 10.1016/j.neuroscience.2012.05.035; Ruan YW, 2007, J NEUROSCI RES, V85, P193, DOI 10.1002/jnr.21101; Ruan YW, 2009, J NEUROSCI RES, V87, P61, DOI 10.1002/jnr.21816; Russo R, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.29; SABATES R, 1983, ARCH OPHTHALMOL-CHIC, V101, P232; Schmucker C, 2005, INVEST OPHTH VIS SCI, V46, P398, DOI 10.1167/iovs.04-0959; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Smythe JW, 1997, PHARMACOL BIOCHEM BE, V56, P507, DOI 10.1016/S0091-3057(96)00244-4; Smythe JW, 1998, BRAIN RES BULL, V45, P89, DOI 10.1016/S0361-9230(97)00311-0; STEFANSSON E, 1988, INVEST OPHTH VIS SCI, V29, P1050; Stevens WD, 2002, STROKE, V33, P1107, DOI 10.1161/01.STR.0000014204.05597.0C; Thomas BB, 2007, J NEUROSCI METH, V162, P84, DOI 10.1016/j.jneumeth.2006.12.010; Timothy C, 1999, PHARMACOL BIOCHEM BE, V62, P323, DOI 10.1016/S0091-3057(98)00157-9; Vidal-Sanz M, 2001, SURV OPHTHALMOL, V45, pS261, DOI 10.1016/S0039-6257(01)00205-3; Viswanathan S, 2001, INVEST OPHTH VIS SCI, V42, P514; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Wang X, 2011, EXP EYE RES, V93, P753, DOI 10.1016/j.exer.2011.09.022; Xu ZC, 1999, BIOL SIGNAL RECEPT, V8, P294; Yamamoto H, 2006, EXP EYE RES, V82, P767, DOI 10.1016/j.exer.2005.09.019	55	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65555	10.1371/journal.pone.0065555	http://dx.doi.org/10.1371/journal.pone.0065555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776500	gold, Green Published, Green Submitted			2022-12-25	WOS:000320755400042
J	Bian, S; Navaratnam, D; Santos-Sacchi, J				Bian, Shumin; Navaratnam, Dhasakumar; Santos-Sacchi, Joseph			Real Time Measures of Prestin Charge and Fluorescence during Plasma Membrane Trafficking Reveal Sub-Tetrameric Activity	PLOS ONE			English	Article							OUTER HAIR CELL; MOTILITY-RELATED CHARGE; MOTOR; CAPACITANCE; EXPRESSION; DEPENDENCE; TEMPERATURE; DENSITY; PROTEIN	Prestin (SLC26a5) is the outer hair cell integral membrane motor protein that drives cochlear amplification, and has been described as an obligate tetramer. We studied in real time the delivery of YFP-prestin to the plasma membrane of cells from a tetracycline-inducible cell line. Following the release of temperature block to reinstate trans Golgi network delivery of the integral membrane protein, we measured nonlinear capacitance (NLC) and membrane fluorescence during voltage clamp. Prestin was delivered exponentially to the plasma membrane with a time constant of less than 10 minutes, with both electrical and fluorescence methods showing high temporal correlation. However, based on disparity between estimates of prestin density derived from either fluorescence or NLC, we conclude that sub-tetrameric forms of prestin contribute to our electrical and fluorescence measures. Thus, in agreement with previous observations we find that functional prestin is not an obligate tetramer.	[Bian, Shumin; Navaratnam, Dhasakumar; Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Surg Otolaryngol, New Haven, CT 06520 USA; [Navaratnam, Dhasakumar; Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Navaratnam, Dhasakumar] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University	Santos-Sacchi, J (corresponding author), Yale Univ, Sch Med, Dept Surg Otolaryngol, New Haven, CT 06520 USA.	joseph.santos-sacchi@yale.edu			National Institutes of Health National Institute on Deafness and Other Communication Disorders [DC 000273, DC 008130]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000273, R01DC008130] Funding Source: NIH RePORTER	National Institutes of Health National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Support was provided by National Institutes of Health National Institute on Deafness and Other Communication Disorders grants DC 000273 (to JSS) and DC 008130 (to JSS and DN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2007, J MEMBRANE BIOL, V215, P49, DOI 10.1007/s00232-007-9004-5; Andreose JS, 1996, P NATL ACAD SCI USA, V93, P7661, DOI 10.1073/pnas.93.15.7661; Ashmore J. F, 1990, NEUROSCI RES       S, V12, pS39, DOI DOI 10.1016/0921-8696(90)90007-P; Bian SM, 2010, AM J PHYSIOL-CELL PH, V299, pC828, DOI 10.1152/ajpcell.00182.2010; Detro-Dassen S, 2008, J BIOL CHEM, V283, P4177, DOI 10.1074/jbc.M704924200; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Hallworth R, 2012, J NEUROPHYSIOL, V107, P5, DOI 10.1152/jn.00728.2011; IWASA KH, 1993, BIOPHYS J, V65, P492, DOI 10.1016/S0006-3495(93)81053-1; Kakehata S, 1996, J NEUROSCI, V16, P4881; Klann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029645; Meltzer J, 2001, NEUROSCI LETT, V313, P141, DOI 10.1016/S0304-3940(01)02266-2; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Oliver D, 1999, J PHYSIOL-LONDON, V519, P791, DOI 10.1111/j.1469-7793.1999.0791n.x; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Santos-Sacchi J, 2004, BIOPHYS J, V87, P714, DOI 10.1529/biophysj.103.033993; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; Santos-Sacchi J, 1998, NEUROSCI LETT, V256, P155, DOI 10.1016/S0304-3940(98)00788-5; SCHROER TA, 1991, ANNU REV PHYSIOL, V53, P629, DOI 10.1146/annurev.ph.53.030191.003213; Song L, 2005, BIOPHYS J, V88, P2350, DOI 10.1529/biophysj.104.053579; Song L, 2010, BIOPHYS J, V98, P371, DOI 10.1016/j.bpj.2009.10.027; Sturm AK, 2007, OTOLARYNG HEAD NECK, V136, P434, DOI 10.1016/j.otohns.2006.10.030; TARTAKOFF AM, 1986, EMBO J, V5, P1477, DOI 10.1002/j.1460-2075.1986.tb04385.x; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Wang X, 2010, BRAIN RES, V1333, P28, DOI 10.1016/j.brainres.2010.03.070	26	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66078	10.1371/journal.pone.0066078	http://dx.doi.org/10.1371/journal.pone.0066078			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762468	Green Submitted, gold, Green Published			2022-12-25	WOS:000320440500063
J	Gotschel, F; Berg, D; Gruber, W; Bender, C; Eberl, M; Friedel, M; Sonntag, J; Rungeler, E; Hache, H; Wierling, C; Nietfeld, W; Lehrach, H; Frischauf, A; Schwartz-Albiez, R; Aberger, F; Korf, U				Goetschel, Frank; Berg, Daniela; Gruber, Wolfgang; Bender, Christian; Eberl, Markus; Friedel, Myriam; Sonntag, Johanna; Ruengeler, Elena; Hache, Hendrik; Wierling, Christoph; Nietfeld, Wilfried; Lehrach, Hans; Frischauf, Annemarie; Schwartz-Albiez, Reinhard; Aberger, Fritz; Korf, Ulrike			Synergism between Hedgehog-GLI and EGFR Signaling in Hedgehog-Responsive Human Medulloblastoma Cells Induces Downregulation of Canonical Hedgehog-Target Genes and Stabilized Expression of GLI1	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SONIC-HEDGEHOG; CANCER; PATHWAY; TRANSCRIPTION; DEGRADATION; COOPERATION; MECHANISMS; PHENOTYPE; BEHAVIOR	Aberrant activation of Hedgehog (HH) signaling has been identified as a key etiologic factor in many human malignancies. Signal strength, target gene specificity, and oncogenic activity of HH signaling depend profoundly on interactions with other pathways, such as epidermal growth factor receptor-mediated signaling, which has been shown to cooperate with HH/GLI in basal cell carcinoma and pancreatic cancer. Our experimental data demonstrated that the Daoy human medulloblastoma cell line possesses a fully inducible endogenous HH pathway. Treatment of Daoy cells with Sonic HH or Smoothened agonist induced expression of GLI1 protein and simultaneously prevented the processing of GLI3 to its repressor form. To study interactions between HH- and EGF-induced signaling in greater detail, time-resolved measurements were carried out and analyzed at the transcriptomic and proteomic levels. The Daoy cells responded to the HH/EGF co-treatment by downregulating GLI1, PTCH, and HHIP at the transcript level; this was also observed when Amphiregulin (AREG) was used instead of EGF. We identified a novel crosstalk mechanism whereby EGFR signaling silences proteins acting as negative regulators of HH signaling, as AKT- and ERK-signaling independent process. EGFR/HH signaling maintained high GLI1 protein levels which contrasted the GLI1 downregulation on the transcript level. Conversely, a high-level synergism was also observed, due to a strong and significant upregulation of numerous canonical EGF-targets with putative tumor-promoting properties such as MMP7, VEGFA, and IL-8. In conclusion, synergistic effects between EGFR and HH signaling can selectively induce a switch from a canonical HH/GLI profile to a modulated specific target gene profile. This suggests that there are more wide-spread, yet context-dependent interactions, between HH/GLI and growth factor receptor signaling in human malignancies.	[Goetschel, Frank; Berg, Daniela; Bender, Christian; Sonntag, Johanna; Ruengeler, Elena; Korf, Ulrike] German Canc Res Ctr, Div Mol Genome Anal, Heidelberg, Germany; [Gruber, Wolfgang; Eberl, Markus; Frischauf, Annemarie; Aberger, Fritz] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Friedel, Myriam; Schwartz-Albiez, Reinhard] German Canc Res Ctr, Div Translat Immunol, Heidelberg, Germany; [Hache, Hendrik; Wierling, Christoph; Nietfeld, Wilfried; Lehrach, Hans] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Salzburg University; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society	Aberger, F (corresponding author), Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.	fritz.aberger@sbg.ac.at; u.korf@dkfz.de	Aberger, Fritz/B-6357-2012	Aberger, Fritz/0000-0003-2009-6305; Wierling, Christoph/0000-0002-8856-8412	German Federal Ministry of Education and Science (BMBF); Austrian Genome Research Program GEN-AU/Austrian Science Fund FWF [0315394A/0315394B, P20652]; Medical Systems Biology project [0315396B]	German Federal Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); Austrian Genome Research Program GEN-AU/Austrian Science Fund FWF; Medical Systems Biology project	Work was funded by the German Federal Ministry of Education and Science (BMBF) and by the Austrian Genome Research Program GEN-AU/Austrian Science Fund FWF as bi-national Medical Systems Biology projects 0315394A/0315394B and P20652, respectively (http://pybios.molgen.mpg.de/MoGLI). Further funding was received from the Medical Systems Biology project 0315396B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonov O, 1993, Ocul Immunol Inflamm, V1, P135, DOI 10.3109/09273949309086550; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigelow RLH, 2005, J INVEST DERMATOL, V124, P457, DOI 10.1111/j.0022-202X.2004.23590.x; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; De Larco JE, 2004, CLIN CANCER RES, V10, P4895, DOI 10.1158/1078-0432.CCR-03-0760; Eberl M, 2012, EMBO MOL MED, V4, P218, DOI 10.1002/emmm.201100201; Ericson J, 1995, INT J DEV BIOL, V39, P809; Fogarty MP, 2007, P NATL ACAD SCI USA, V104, P2973, DOI 10.1073/pnas.0605770104; Grizzi F, 2008, PEDIATR RES, V63, P584, DOI 10.1203/01.pdr.0000305884.29279.6b; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartmann W, 2005, AM J PATHOL, V166, P1153, DOI 10.1016/S0002-9440(10)62335-8; Henjes F, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.16; Hua H, 2011, CELL MOL LIFE SCI, V68, P3853, DOI 10.1007/s00018-011-0763-x; Huber H, 2001, EUR J CANCER, V37, P2064, DOI 10.1016/S0959-8049(01)00225-8; Ito TK, 2007, ONCOGENE, V26, P7194, DOI 10.1038/sj.onc.1210535; Ito TK, 2009, BLOOD, V113, P2363, DOI 10.1182/blood-2008-08-172742; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Jr HRJ, 2012, PLOS ONE, V7; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Laner-Plamberger S, 2009, ONCOGENE, V28, P1639, DOI 10.1038/onc.2009.10; Lauth M, 2007, ONCOGENE, V26, P5163, DOI 10.1038/sj.onc.1210321; Lauth M, 2011, FRONT BIOSCI-LANDMRK, V16, P2259, DOI 10.2741/3852; Loebke C, 2007, PROTEOMICS, V7, P558, DOI 10.1002/pmic.200600757; Mangelberger D, 2012, FRONT BIOSCI-LANDMRK, V17, P90, DOI 10.2741/3917; McMurray HR, 2008, NATURE, V453, P1112, DOI 10.1038/nature06973; Mimeault M, 2010, PHARMACOL REV, V62, P497, DOI 10.1124/pr.109.002329; Miyamoto S, 2004, CANCER RES, V64, P665, DOI 10.1158/0008-5472.CAN-03-1916; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Palma V, 2004, DEVELOPMENT, V131, P337, DOI 10.1242/dev.00930; RDevelopmentCoreTeam, 2011, R LANG ENV STAT COMP; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, CELL CYCLE, V5, P1612, DOI 10.4161/cc.5.15.3130; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Schnidar H, 2009, CANCER RES, V69, P1284, DOI 10.1158/0008-5472.CAN-08-2331; Seto M, 2009, MOL CARCINOGEN, V48, P703, DOI 10.1002/mc.20516; Simonini A, 2000, CIRCULATION, V101, P1519, DOI 10.1161/01.CIR.101.13.1519; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028; Wei LY, 2011, INT J CANCER, V129, P275, DOI 10.1002/ijc.25673; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Whisenant TC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000908; Willmarth NE, 2009, CELL SIGNAL, V21, P212, DOI 10.1016/j.cellsig.2008.10.003; Yarden Y, 2001, EUR J CANCER, V37, pS3	47	63	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65403	10.1371/journal.pone.0065403	http://dx.doi.org/10.1371/journal.pone.0065403			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762360	Green Published, gold			2022-12-25	WOS:000320440500036
J	Wang, LJ; Shi, SJ; Guo, ZY; Zhang, X; Han, SX; Yang, AG; Wen, WH; Zhu, Q				Wang, Lijuan; Shi, Shengjia; Guo, Zhangyan; Zhang, Xiang; Han, Suxia; Yang, Angang; Wen, Weihong; Zhu, Qing			Overexpression of YAP and TAZ Is an Independent Predictor of Prognosis in Colorectal Cancer and Related to the Proliferation and Metastasis of Colon Cancer Cells	PLOS ONE			English	Article							YES-ASSOCIATED PROTEIN; TUMOR-SUPPRESSOR; HIPPO PATHWAY; ORGAN SIZE; GROWTH-CONTROL; BREAST-CANCER; TRANSCRIPTION; ONCOGENE; DOMAIN; MICE	Background and Objective: Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ) are nuclear effectors of the Hippo pathway. Although they are abundantly expressed in the cytoplasm and nuclei of human colorectal cancer (CRC), and related to tumor proliferation status, there have been few studies on the predictive role of YAP and TAZ expression on the overall survival of patients with CRC. This study investigated YAP and TAZ expression in both CRC patients and colon cancer cell lines, and assessed their prognostic value. Methods: Paraffin-embedded specimens from 168 eligible patients were used to investigate YAP and TAZ expression by immunohistochemistry, and compared with experimental results in colon cancer HCT116 cell line to explore their clinical significance in CRC. Results: Statistically significant positive correlations were found between protein expression of YAP and TAZ in CRC tissues. Patients with higher YAP or TAZ expression showed a trend of shorter survival times; more importantly, our cohort study indicated that patients with both YAP and TAZ overexpression presented the worst outcomes. This was supported by multivariate analysis. In HCT116 colon cancer cells, the capacity for proliferation, metastasis, and invasion was dramatically reduced by knockdown of YAP and TAZ expressions by siRNA. Conclusions: Co-overexpression of YAP and TAZ is an independent predictor of prognosis for patients with CRC, and may account for the higher proliferation, metastasis, and poor survival outcome of these patients.	[Wang, Lijuan; Han, Suxia; Zhu, Qing] Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Oncol, Xian 710049, Peoples R China; [Shi, Shengjia; Guo, Zhangyan; Zhang, Xiang; Yang, Angang; Wen, Weihong] Fourth Mil Med Univ, Dept Immunol, State Key Lab Canc Biol, Xian 710032, Peoples R China	Xi'an Jiaotong University; Air Force Military Medical University	Wen, WH (corresponding author), Fourth Mil Med Univ, Dept Immunol, State Key Lab Canc Biol, Xian 710032, Peoples R China.	wenweih@fmmu.edu.cn; newzhuqing1972@yohoo.com	温, 家琦/GYV-3177-2022	Han, Suxia/0000-0002-1513-7427	National Natural Science Foundation of China [81072117]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81072117). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avruch J, 2012, CELL CYCLE, V11, P1090, DOI 10.4161/cc.11.6.19453; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan SW, 2011, ONCOGENE, V30, P600, DOI 10.1038/onc.2010.438; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Olson Michael F, 2005, Cancer Res, V65, P11247, DOI 10.1158/0008-5472.CAN-05-2713; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Rosenberg R, 2008, ANN SURG, V248, P968, DOI 10.1097/SLA.0b013e318190eddc; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang XD, 2012, EUR J CANCER, V48, P1227, DOI 10.1016/j.ejca.2011.10.001; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yuen HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054211; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhang X, 2011, CELL DEATH DIFFER, V18, P1346, DOI 10.1038/cdd.2011.6; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606	38	220	235	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e65539	10.1371/journal.pone.0065539	http://dx.doi.org/10.1371/journal.pone.0065539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762387	Green Published, gold, Green Submitted			2022-12-25	WOS:000320440500043
J	Seike, K; Shirai, K; Kogure, Y				Seike, Koji; Shirai, Kotaro; Kogure, Yukihisa			Disturbance of Shallow Marine Soft-Bottom Environments and Megabenthos Assemblages by a Huge Tsunami Induced by the 2011 M9.0 Tohoku-Oki Earthquake	PLOS ONE			English	Article							POLYCHAETE EUZONUS SP; YOLDIA-NOTABILIS; ANDAMAN SEA; IMPACT; SEDIMENTS; RECOVERY; BEHAVIOR; BURROWS; HASAKI; FAUNA	Huge tsunami waves associated with megathrust earthquakes have a severe impact on shallow marine ecosystems. We investigated the impact of a tsunami generated by the 2011 M9.0 Tohoku-Oki earthquake on the seafloor and large benthic animals in muddy and sandy ria coasts (Otsuchi and Funakoshi bays) in northeastern Japan. We conducted underwater field surveys using scuba equipment in water depths of <20 m before the tsunami (September 2010) and after the tsunami (September 2011 and September 2012). During the study period, episodic changes in topography and grain-size composition occurred on the seafloor of the study area. Megabenthos sampling revealed a distinct pattern of distribution succession for each benthic species. For example, the protobranch bivalve Yoldia notabilis (Bivalvia: Nuculanidae) and the heterodont bivalve Felaniella usta (Bivalvia: Ungulinidae) disappeared after the tsunami event, whereas the distribution of the venus clam Gomphina melanaegis (Bivalvia: Veneridae) remained unchanged. In addition, the patterns of succession for a single species, such as the giant button top shell Umbonium costatum (Gastropoda: Trochidae) and the heart urchin Echinocardium cordatum (Echinoidea: Loveniidae), varied between the two bays studied. Our data also show that reestablishment of some benthic animal populations began within 18 months of the tsunami disturbance.	[Seike, Koji; Shirai, Kotaro; Kogure, Yukihisa] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	University of Tokyo	Seike, K (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, 5-1-5 Kashiwanoha, Kashiwa, Chiba, Japan.	seike@aori.u-tokyo.ac.jp	Shirai, Kotaro/B-5758-2012; Seike, Koji/G-1050-2012	Shirai, Kotaro/0000-0003-3922-5971; Seike, Koji/0000-0002-6938-0350	Atmosphere and Ocean Research Institute, the University of Tokyo [113, 102, 137, 122]; Japan Society for the Promotion of Science [22-10734]; Tohoku Ecosystem-Associated Marine Sciences (TEAMS) project	Atmosphere and Ocean Research Institute, the University of Tokyo; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tohoku Ecosystem-Associated Marine Sciences (TEAMS) project	This research was supported by the Cooperative Program of the Atmosphere and Ocean Research Institute, the University of Tokyo (number 113 in 2010; numbers 102 and 137 in 2011; and number 122 in 2012 to KSe), and was partly supported by a Research Fellowship of the Japan Society for the Promotion of Science (22-10734 to KSe) and the Tohoku Ecosystem-Associated Marine Sciences (TEAMS) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, J JAPAN SOC CIVIL EN; Chavanich S, 2005, CORAL REEFS, V24, P535, DOI 10.1007/s00338-005-0016-2; Chavanich S, 2008, J NAT HIST, V42, P177, DOI 10.1080/00222930701847915; Feldens P, 2009, POL J ENVIRON STUD, V18, P63; Fujikura K, 2012, JPN J BENTHOL, V66, P129; Fujioka K, 1988, OTSUCHI MAR RES CENT, V14, P15; Furota T, 2012, JPN J BENTHOL, V66, P126; Geospatial Information Authority of Japan, 2012, DIG JAP PORT WEB SIT; Goto K, 2012, SEDIMENT GEOL, V282, P1, DOI 10.1016/j.sedgeo.2012.08.003; Goto K, 2011, MAR GEOL, V290, P46, DOI 10.1016/j.margeo.2011.10.004; Goto K, 2011, GEOMORPHOLOGY, V127, P107, DOI 10.1016/j.geomorph.2010.12.011; Higano Junya, 1993, Bulletin of National Research Institute of Fisheries Engineering, V14, P65; Hinata H, 2011, ESTUAR COAST SHELF S, V95, P268, DOI 10.1016/j.ecss.2011.08.009; Horikoshi M, 1977, OTSUCHI MAR RES CENT, V3, P41; Horikoshi M, 1978, OTSUCHI MAR RES CEN, V4, P53; Horikoshi M, 1976, OTSUCHI MAR RES CENT, V2, P65; Horikoshi M, 1979, OTSUCHI MAR RES CENT, V5, P37; Ide S, 2011, SCIENCE, V332, P1426, DOI 10.1126/science.1207020; Inoue M, 1988, OTSUCHI MAR RES CENT, V14, P11; Jaramillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035348; Kanaya Gen, 2012, Japanese Journal of Benthology, V67, P20; Kathiresan K, 2005, ESTUAR COAST SHELF S, V65, P601, DOI 10.1016/j.ecss.2005.06.022; Kendall MA, 2009, POL J ENVIRON STUD, V18, P69; Kristensen E, 2012, MAR ECOL PROG SER, V446, P285, DOI 10.3354/meps09506; Kuriyama Y, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000899; Kuriyama Y, 2008, MAR GEOL, V248, P1, DOI 10.1016/j.margeo.2007.10.006; McLachlan A, 2006, ECOLOGY SANDY SHORES; Miura O, 2012, J MOLLUS STUD, V78, P377, DOI 10.1093/mollus/eys025; Mori N, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049210; NAKAOKA M, 1992, MAR ECOL PROG SER, V88, P215, DOI 10.3354/meps088215; NAKAOKA M, 1994, MAR ECOL PROG SER, V114, P129, DOI 10.3354/meps114129; Nakaoka M, 2006, NAGISA WORLD C 2006, V2006, P49; Noda A, 2007, SEDIMENT GEOL, V200, P314, DOI 10.1016/j.sedgeo.2007.01.010; Okoshi K, 2012, JPN J BENTHOLOGY, V66, P117; Ozawa S, 2011, NATURE, V475, P373, DOI 10.1038/nature10227; Sato M, 2011, SCIENCE, V332, P1395, DOI 10.1126/science.1207401; Sato S., 2012, JPN J BENTHOL, V66, P122; Sato-Okoshi W, 2012, JPN J BENTHOL, V66, P124; Sawai Y, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053692; Sawall Y, 2010, HELGOLAND MAR RES, V64, P357, DOI 10.1007/s10152-010-0192-5; Seike K, 2008, MAR BIOL, V153, P1199, DOI 10.1007/s00227-007-0893-8; Seike K, 2009, PALAIOS, V24, P799, DOI 10.2110/palo.2009.p09-007r; SHORT AD, 1979, J GEOL, V87, P553, DOI 10.1086/628445; Short AD, 1979, HDB BEACH SHOREFACE; Simons M, 2011, SCIENCE, V332, P1421, DOI 10.1126/science.1206731; Suzuki T, 2012, JPN J BENTHOL, V66, P120; The 2011 Tohoku Earthquake Tsunami Joint Survey Group, 2012, TOH EARTHQ TSUN INF; The 2011 Tohoku Earthquake Tsunami Joint Survey Group (TETJSG), 2011, J JAPAN SOC CIVIL B, V67, P63, DOI DOI 10.2208/KAIGAN.67.63; Tsuchida E, 1990, OTSUCHI MAR RES CENT, V16, P1; TSUCHIDA E., 1993, OTSUCHI MAR RES CENT, V19, P1; Tsuchida Eiji, 1996, Otsuchi Marine Research Center Report, V21, P1; Udo K, 2012, COAST ENG J, V54, DOI 10.1142/S057856341250009X; Whanpetch N, 2010, ESTUAR COAST SHELF S, V87, P246, DOI 10.1016/j.ecss.2010.01.001; Ziebis W, 1996, NATURE, V382, P619, DOI 10.1038/382619a0	54	84	85	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65417	10.1371/journal.pone.0065417	http://dx.doi.org/10.1371/journal.pone.0065417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762365	Green Submitted, Green Published, gold			2022-12-25	WOS:000321094800047
J	Lin, HJ; Weng, SF; Yang, CM; Wu, MP				Lin, Huey-Juan; Weng, Shih-Feng; Yang, Chun-Ming; Wu, Ming-Ping			Risk of Hospitalization for Acute Cardiovascular Events among Subjects with Lower Urinary Tract Symptoms: A Nationwide Population-Based Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; OVERACTIVE BLADDER; ERECTILE DYSFUNCTION; NERVOUS-SYSTEM; HEALTH-CARE; INCONTINENCE; PREVALENCE; BURDEN; MEN	Background and Purpose: Lower urinary tract symptoms (LUTS) have been reported to be associated with metabolic syndrome and may predispose subjects to cardiovascular disease. The magnitude of the impact on the medical care remains to be elucidated. Based on a population-based claims dataset in Taiwan, we explored the association between LUTS and the risk of subsequent hospitalization for acute cardiovascular events. Materials and Methods: Among a representative sample of one million subjects from nationwide health insurance enrollees, subjects with codes of LUTS in service claims and without previous cardiovascular diseases including stroke were compared with age-and sex-matched non-LUTS subjects in subsequent hospitalization for acute coronary syndrome or stroke from the recruited date (between 2001-2004) to 2009. The risk of outcomes was assessed with Kaplan-Meier curves and the impact of LUTS was estimated with Poison regression analysis and Cox proportional hazards models. Results: We included 4,553 LUTS subjects and 22,765 matched non-LUTS subjects, with a mean age of 47 years and 43% of men. Hypertension, diabetes, and hyperlipidemia were more prevalent in the LUTS group. The incidence rate of the composite endpoint was significantly higher in the LUTS group than in the non-LUTS group (5.4/1000 vs. 4.0/1000 person-years). The difference mainly derived from stroke rather than acute coronary syndrome. After adjusting for age, sex, diabetes, hypertension, and hyperlipidemia in multivariable analysis, LUTS remained a significant predictor (hazard ratio, 1.29; 95% confidence incidence, 1.06-1.50). Conclusion: Subjects free of cardiovascular disease and presenting with LUTS are at risk of subsequent hospitalization for acute cardiovascular events, mainly stroke. The information might prompt practitioners encountering such patients to undergo appropriate diagnostic and preventive measures.	[Lin, Huey-Juan; Yang, Chun-Ming] Chi Mei Med Ctr, Dept Neurol, Tainan, Taiwan; [Weng, Shih-Feng; Wu, Ming-Ping] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Wu, Ming-Ping] Chi Mei Med Ctr, Dept Obstet & Gynecol, Div Urogynecol, Tainan, Taiwan; [Lin, Huey-Juan] Chia Nan Univ Pharm & Sci, Dept Cosmet Sci, Tainan, Taiwan; [Wu, Ming-Ping] Chia Nan Univ Pharm & Sci, Ctr Gen Educ, Tainan, Taiwan; [Weng, Shih-Feng] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan	Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chia Nan University of Pharmacy & Science; Chia Nan University of Pharmacy & Science	Wu, MP (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.	mpwu@mail.chimei.org.tw		Weng, Shih-Feng/0000-0001-8684-3487	Chi Mei Medical Center	Chi Mei Medical Center	The study was funded by Chi Mei Medical Center (http://www.chimei.org.tw/main/cmh_department/54220/english/2012/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KE, 2010, BJU INT, V106, P268, DOI 10.1111/j.1464-410X.2009.09073.x; Asche CV, 2012, BJU INT, V109, P572, DOI 10.1111/j.1464-410X.2011.10436.x; Baumhakel M, 2007, INT J CLIN PRACT, V61, P361, DOI 10.1111/j.1742-1241.2006.01274.x; Bouwman II, 2009, EUR J GEN PRACT, V15, P128, DOI 10.3109/13814780903329536; Coyne KS, 2009, BJU INT, V103, P4, DOI 10.1111/j.1464-410X.2009.08371.x; Glavind K, 2011, INT UROGYNECOL J, V22, P907, DOI 10.1007/s00192-011-1411-6; Hubeaux K, 2011, NEUROUROL URODYNAM, V30, P1467, DOI 10.1002/nau.21154; Irwin DE, 2006, EUR UROL, V50, P1306, DOI 10.1016/j.eururo.2006.09.019; Karatas OF, 2010, INT J CARDIOL, V144, P452, DOI 10.1016/j.ijcard.2009.03.099; Kirby MG, 2010, NEUROUROL URODYNAM, V29, P1360, DOI 10.1002/nau.20892; Lukacz ES, 2011, INT J CLIN PRACT, V65, P1026, DOI 10.1111/j.1742-1241.2011.02763.x; Malmsten UGH, 2010, EUR UROL, V58, P149, DOI 10.1016/j.eururo.2010.03.014; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; Parthasarathy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030969; Penson DF, 2011, J UROLOGY, V186, P2316, DOI 10.1016/j.juro.2011.07.067; Wehrberger C, 2011, UROLOGY, V78, P1063, DOI 10.1016/j.urology.2011.05.065; Wu MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057825; Wu MP, 2013, UROLOGY, V81, P61, DOI 10.1016/j.urology.2012.08.033; Zhang XW, 2011, UROL INT, V86, P173, DOI 10.1159/000321895	19	62	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66661	10.1371/journal.pone.0066661	http://dx.doi.org/10.1371/journal.pone.0066661			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23826095	Green Submitted, Green Published, gold			2022-12-25	WOS:000320322400114
J	Zhang, LF; Thomas, JC; Miragaia, M; Bouchami, O; Chaves, F; d'Azevedo, PA; Aanensen, DM; de Lencastre, H; Gray, BM; Robinson, DA				Zhang, Liangfen; Thomas, Jonathan C.; Miragaia, Maria; Bouchami, Ons; Chaves, Fernando; d'Azevedo, Pedro A.; Aanensen, David M.; de Lencastre, Herminia; Gray, Barry M.; Robinson, D. Ashley			Multilocus Sequence Typing and Further Genetic Characterization of the Enigmatic Pathogen, Staphylococcus hominis	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; COAGULASE-NEGATIVE STAPHYLOCOCCI; METHICILLIN-RESISTANT; LEVEL RESISTANCE; BLOOD CULTURES; IDENTIFICATION; NOVOBIOCIN; EMERGENCE; SKIN; INFECTIONS	Staphylococcus hominis is a commensal resident of human skin and an opportunistic pathogen. The species is subdivided into two subspecies, S. hominis subsp. hominis and S. hominis subsp. novobiosepticus, which are difficult to distinguish. To investigate the evolution and epidemiology of S. hominis, a total of 108 isolates collected from 10 countries over 40 years were characterized by classical phenotypic methods and genetic methods. One nonsynonymous mutation in gyrB, scored with a novel SNP typing assay, had a perfect association with the novobiocin-resistant phenotype. A multilocus sequence typing (MLST) scheme was developed from six housekeeping gene fragments, and revealed relatively high levels of genetic diversity and a significant impact of recombination on S. hominis population structure. Among the 40 sequence types (STs) identified by MLST, three STs (ST2, ST16 and ST23) were S. hominis subsp. novobiosepticus, and they distinguished between isolates from different outbreaks, whereas 37 other STs were S. hominis subsp. hominis, one of which was widely disseminated (ST1). A modified PCR assay was developed to detect the presence of ccrAB4 from the SCCmec genetic element. S. hominis subsp. novobiosepticus isolates were oxacillin-resistant and carriers of specific components of SCCmec (mecA class A, ccrAB3, ccrAB4, ccrC), whereas S. hominis subsp. hominis included both oxacillin-sensitive and -resistant isolates and a more diverse array of SCCmec components. Surprisingly, phylogenetic analyses indicated that S. hominis subsp. novobiosepticus may be a polyphyletic and, hence, artificial taxon. In summary, these results revealed the genetic diversity of S. hominis, the identities of outbreak-causing clones, and the evolutionary relationships between subspecies and clones. The pathogenic lifestyle attributed to S. hominis subsp. novobiosepticus may have originated on more than one occasion.	[Zhang, Liangfen; Thomas, Jonathan C.; Robinson, D. Ashley] Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA; [Miragaia, Maria; Bouchami, Ons; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Chaves, Fernando] Hosp Univ 12 Octubre, Microbiol Serv, Madrid, Spain; [d'Azevedo, Pedro A.] Univ Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, Brazil; [Aanensen, David M.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA; [Gray, Barry M.] Univ Illinois, Dept Pediat, Peoria, IL USA	University of Mississippi; University of Mississippi Medical Center; Universidade Nova de Lisboa; Hospital Universitario 12 de Octubre; Universidade Federal de Ciencias da Saude de Porto Alegre; Imperial College London; Rockefeller University; University of Illinois System; University of Illinois Peoria	Robinson, DA (corresponding author), Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA.	darobinson@umc.edu	Miragaia, Maria/J-2704-2015; Chaves, Fernando/C-6176-2016	Miragaia, Maria/0000-0002-1323-7184; /0000-0001-6816-8932; Bouchami, Ons/0000-0002-9425-3513; Thomas, Jonathan/0000-0002-1599-9123	National Institutes of Health [GM080602]; Spanish Network for Research in Infectious Diseases [RD06/0008]; Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/BIA-EVF/117507/2010, Pest-OE/EQB/LAO004/2011]; NIGMS NIH HHS [R01 GM080602, GM080602] Funding Source: Medline	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Network for Research in Infectious Diseases; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grant GM080602 from the National Institutes of Health (to DAR) and grant RD06/0008 from the Spanish Network for Research in Infectious Diseases (to FC). The work performed in Portugal was supported by grants PTDC/BIA-EVF/117507/2010 (to MM) and grant #Pest-OE/EQB/LAO004/2011 (to ITQB) from Fundacao para a Ciencia e Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannoehr J, 2007, J BACTERIOL, V189, P8685, DOI 10.1128/JB.01150-07; Bouchami O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021940; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cavanagh JP, 2012, J MICROBIOL METH, V89, P159, DOI 10.1016/j.mimet.2012.03.014; Chassain B, 2012, J CLIN MICROBIOL, V50, P3003, DOI 10.1128/JCM.00988-12; Chen LA, 2010, ANTIMICROB AGENTS CH, V54, P3347, DOI 10.1128/AAC.00001-10; CLSI, 2007, M100S17 CLSI; Cunha BA, 2007, HEART LUNG, V36, P380, DOI 10.1016/j.hrtlng.2006.11.002; d'Azevedo PA, 2008, J MED MICROBIOL, V57, P256, DOI 10.1099/jmm.0.47345-0; Santos OCDS, 2009, DIAGN MICR INFEC DIS, V64, P1, DOI 10.1016/j.diagmicrobio.2008.12.017; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELLENDER RD, 1995, J FOOD PROTECT, V58, P853, DOI 10.4315/0362-028X-58.8.853; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; FAGHRI MA, 1984, APPL ENVIRON MICROB, V47, P1054, DOI 10.1128/AEM.47.5.1054-1061.1984; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fitzgibbon JE, 2001, RES MICROBIOL, V152, P805, DOI 10.1016/S0923-2508(01)01264-5; Fournier B, 1998, ANTIMICROB AGENTS CH, V42, P121, DOI 10.1128/AAC.42.1.121; Fujimoto-Nakamura M, 2005, ANTIMICROB AGENTS CH, V49, P3810, DOI 10.1128/AAC.49.9.3810-3815.2005; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Garza-Gonzalez E, 2011, SCAND J INFECT DIS, V43, P930, DOI 10.3109/00365548.2011.598873; Gilad J, 2007, J CLIN MICROBIOL, V45, P685, DOI 10.1128/JCM.02228-06; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; GUNN BA, 1983, INT J SYST BACTERIOL, V33, P751, DOI 10.1099/00207713-33-4-751; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Heikens E, 2005, J CLIN MICROBIOL, V43, P2286, DOI 10.1128/JCM.43.5.2286-2290.2005; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Iyer MN, 2005, AM J OPHTHALMOL, V139, P930, DOI 10.1016/j.ajo.2004.10.060; Katayama Y, 2003, J BACTERIOL, V185, P2711, DOI 10.1128/JB.185.9.2711-2722.2003; Kim SD, 2000, INFECT CONT HOSP EP, V21, P213, DOI 10.1086/501747; KLOOS WE, 1975, J CLIN MICROBIOL, V1, P82, DOI 10.1128/JCM.1.1.82-88.1975; Kloos WE, 1998, INT J SYST BACTERIOL, V48, P799, DOI 10.1099/00207713-48-3-799; KLOOS WE, 1975, INT J SYST BACTERIOL, V25, P62, DOI 10.1099/00207713-25-1-62; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117, DOI 10.1128/CMR.7.1.117-140.1994; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Larson EL, 1998, AM J INFECT CONTROL, V26, P513, DOI 10.1016/S0196-6553(98)70025-2; Lebeaux D, 2012, ANTIMICROB AGENTS CH, V56, P315, DOI 10.1128/AAC.00547-11; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Oliveira DC, 2006, ANTIMICROB AGENTS CH, V50, P3457, DOI 10.1128/AAC.00629-06; Petinaki E, 2005, J ANTIMICROB CHEMOTH, V55, P811, DOI 10.1093/jac/dki072; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; Ruhe J, 2004, EUR J CLIN MICROBIOL, V23, P495, DOI 10.1007/s10096-004-1134-4; de Gopegui ER, 2011, ENFERM INFEC MICR CL, V29, P339, DOI 10.1016/j.eimc.2011.02.001; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; SMITH JM, 1994, J EVOLUTION BIOL, V7, P525, DOI 10.1046/j.1420-9101.1994.7050525.x; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Thomas JC, 2007, J CLIN MICROBIOL, V45, P616, DOI 10.1128/JCM.01934-06; Palazzo ICV, 2008, J ANTIMICROB CHEMOTH, V62, P1222, DOI 10.1093/jac/dkn375; Vickers AA, 2007, ANTIMICROB AGENTS CH, V51, P4484, DOI 10.1128/AAC.00708-07; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weinstein MP, 1998, J CLIN MICROBIOL, V36, P2089, DOI 10.1128/JCM.36.7.2089-2092.1998; Wohoush A, 2011, CLIN MICROBIOL INFEC, V17, P569, DOI 10.1111/j.1469-0691.2010.03372.x; Zhang LF, 2012, J MOL EVOL, V75, P43, DOI 10.1007/s00239-012-9520-5	63	59	65	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66496	10.1371/journal.pone.0066496	http://dx.doi.org/10.1371/journal.pone.0066496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776678	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400148
J	Santoro, AL; Bastviken, D; Gudasz, C; Tranvik, L; Enrich-Prast, A				Santoro, Ana Lucia; Bastviken, David; Gudasz, Cristian; Tranvik, Lars; Enrich-Prast, Alex			Dark Carbon Fixation: An Important Process in Lake Sediments	PLOS ONE			English	Article							ORGANIC-CARBON; BACTERIAL PRODUCTION; DIOXIDE FIXATION; ACTIVE BACTERIA; WATER INTERFACE; METHANE; CYCLE; TEMPERATE; OXIDATION; CO2	Close to redox boundaries, dark carbon fixation by chemoautotrophic bacteria may be a large contributor to overall carbon fixation. Still, little is known about the relative importance of this process in lake systems, in spite the potentially high chemoautotrophic potential of lake sediments. We compared rates of dark carbon fixation, bacterial production and oxygen consumption in sediments from four Swedish boreal and seven tropical Brazilian lakes. Rates were highly variable and dark carbon fixation amounted up to 80% of the total heterotrophic bacterial production. The results indicate that non-photosynthetic carbon fixation can represent a substantial contribution to bacterial biomass production, especially in sediments with low organic matter content.	[Santoro, Ana Lucia; Enrich-Prast, Alex] Univ Fed Rio de Janeiro, Dept Ecol, Inst Biol, Rio De Janeiro, Brazil; [Bastviken, David] Linkoping Univ, Dept Themat Studies Water & Environm Studies, Linkoping, Sweden; [Gudasz, Cristian; Tranvik, Lars] Uppsala Univ, Dept Ecol & Evolut Limnol, Uppsala, Sweden	Universidade Federal do Rio de Janeiro; Linkoping University; Uppsala University	Enrich-Prast, A (corresponding author), Univ Fed Rio de Janeiro, Dept Ecol, Inst Biol, Rio De Janeiro, Brazil.	aenrichprast@gmail.com	Prast, Alex Enrich/AAL-4722-2021; Enrich-Prast, Alex/H-5391-2012; Nilsson, Markus/C-6920-2012	Prast, Alex Enrich/0000-0003-3561-0936; wahlund, lars-olof/0000-0002-9905-8426; Martensson, Johanna/0000-0002-5936-1439; Nilsson, Markus/0000-0002-3140-8223; van Westen, Danielle/0000-0001-8649-9874; Tranvik, Lars J./0000-0003-3509-8266; Bastviken, David/0000-0003-0038-2152	STINT (Sweden); CNPq (Brazil); Brazilian Research Council (CNPq)	STINT (Sweden); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Ana Lucia Santoro received a STINT (Sweden) and CNPq (Brazil) scholarships to develop this research. Alex Enrich-Prast receives a research fellowship from the Brazilian Research Council (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2010, ISME J, V4, P1581, DOI 10.1038/ismej.2010.69; Bastviken D, 2003, ECOLOGY, V84, P969, DOI 10.1890/0012-9658(2003)084[0969:MAASOC]2.0.CO;2; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Buesing N, 2005, LIMNOL OCEANOGR-METH, V3, P101, DOI 10.4319/lom.2005.3.101; Camacho A, 2001, AQUAT SCI, V63, P91, DOI 10.1007/PL00001346; Christian BW, 2007, FUND APPL LIMNOL, V168, P189, DOI 10.1127/1863-9135/2007/0168-0189; Dalsgaard R, 2000, PROTOCOL HDB NICE NI; Dean WE, 1999, J PALEOLIMNOL, V21, P375, DOI 10.1023/A:1008066118210; DETMER AE, 1993, MAR ECOL PROG SER, V99, P197, DOI 10.3354/meps099197; DIJKHUIZEN L, 1984, A VAN LEEUW J MICROB, V50, P473, DOI 10.1007/BF02386221; Enrich-prast A, 2018, ENCY INLAND WATERS, P211, DOI [10.1016/B978-012370626-3.00126-5, DOI 10.1016/B978-012370626-3.00126-5]; Erb TJ, 2009, P NATL ACAD SCI USA, V106, P8871, DOI 10.1073/pnas.0903939106; Evrard V, 2008, AQUAT MICROB ECOL, V53, P257, DOI 10.3354/ame01248; Feisthauer S, 2008, ENVIRON MICROBIOL, V10, P1641, DOI 10.1111/j.1462-2920.2008.01573.x; Fenchel T., 1979, BACTERIA MINERAL CYC; Fenchel T, 2008, J EXP MAR BIOL ECOL, V366, P99, DOI 10.1016/j.jembe.2008.07.013; GALCHENKO VF, 1994, MICROBIOLOGY+, V63, P388; Garcia-Cantizano J, 2005, MICROB ECOL, V50, P230, DOI 10.1007/s00248-004-0144-9; Grey J, 2004, FRESHWATER BIOL, V49, P681, DOI 10.1111/j.1365-2427.2004.01217.x; Gudasz C, 2012, LIMNOL OCEANOGR, V57, P163, DOI 10.4319/lo.2012.57.1.0163; Gudasz C, 2010, NATURE, V466, P478, DOI 10.1038/nature09186; Hadas O, 2001, LIMNOL OCEANOGR, V46, P1968, DOI 10.4319/lo.2001.46.8.1968; Haglund AL, 2003, FEMS MICROBIOL ECOL, V46, P31, DOI 10.1016/S0168-6496(03)00190-9; Haglund AL, 2002, MICROBIAL ECOL, V43, P232, DOI 10.1007/s00248-002-2005-0; Heinen EA, 2004, J GREAT LAKES RES, V30, P113, DOI 10.1016/S0380-1330(04)70381-0; Heip CHR, 1995, OCEANOGR MAR BIOL, V33, P1; JORGENSEN BB, 1991, DEEP-SEA RES, V38, pS1083; Kankaala P, 2006, LIMNOL OCEANOGR, V51, P2821, DOI 10.4319/lo.2006.51.6.2821; Kranzberg G, 1985, ENVIRON POLLUT A, V39, P23; KUUPPOLEINIKKI P, 1992, HYDROBIOLOGIA, V229, P159, DOI 10.1007/BF00006998; Levin LA, 2009, DEEP-SEA RES PT II, V56, P1632, DOI 10.1016/j.dsr2.2009.05.010; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Marotta H, 2009, LIMNOLOGY, V10, P195, DOI 10.1007/s10201-009-0272-x; Merlin C, 2003, J BACTERIOL, V185, P6415, DOI 10.1128/JB.185.21.6415-6424.2003; Mitsch W.J., 2007, WETLANDS, V4th ed., DOI DOI 10.1017/CBO9781107415324.004; Molari M, 2013, GLOBAL BIOGEOCHEM CY, V27, P212, DOI 10.1002/gbc.20030; PEDROSALIO C, 1991, PROC INT ASSOC THE 2, V24, P1212; Pimenov NV, 2010, MICROBIOLOGY+, V79, P247, DOI 10.1134/S0026261710020177; Ravinet M, 2010, OIKOS, V119, P409, DOI 10.1111/j.1600-0706.2009.17859.x; Rawcliffe R, 2010, FRESHWATER BIOL, V55, P600, DOI 10.1111/j.1365-2427.2009.02280.x; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; SANDER BC, 1993, MICROB ECOL, V26, P79, DOI 10.1007/BF00177045; Sanseverino AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042723; SCHALLENBERG M, 1993, ECOLOGY, V74, P919, DOI 10.2307/1940816; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; Schink B, 2009, MOL MICROBIOL, V73, P975, DOI 10.1111/j.1365-2958.2009.06835.x; Shively JM, 1998, ANNU REV MICROBIOL, V52, P191, DOI 10.1146/annurev.micro.52.1.191; SOUTHWARD AJ, 1981, NATURE, V293, P616, DOI 10.1038/293616a0; Svensson JM, 2001, AQUAT MICROB ECOL, V23, P177, DOI 10.3354/ame023177; SWEERTS JPRA, 1991, LIMNOL OCEANOGR, V36, P1124, DOI 10.4319/lo.1991.36.6.1124; Taylor GT, 2001, LIMNOL OCEANOGR, V46, P148, DOI 10.4319/lo.2001.46.1.0148; THAUER RK, 1988, EUR J BIOCHEM, V176, P497, DOI 10.1111/j.1432-1033.1988.tb14307.x; Thomsen U, 1997, AQUAT MICROB ECOL, V12, P165, DOI 10.3354/ame012165; Tomaszek JA, 2003, HYDROBIOLOGIA, V504, P59, DOI 10.1023/B:HYDR.0000008508.81690.10; Trimmer M, 2012, SCI TOTAL ENVIRON, V434, P143, DOI 10.1016/j.scitotenv.2011.10.074	55	40	41	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e65813	10.1371/journal.pone.0065813	http://dx.doi.org/10.1371/journal.pone.0065813			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776549	Green Published, Green Submitted, gold			2022-12-25	WOS:000320755400067
J	Zhang, L; Zhang, DD; Yu, BW; Wang, SB; Liu, YL; Wang, J; Li, X; Shang, XY; Li, HY				Zhang, Ling; Zhang, Dandan; Yu, Baowen; Wang, Shangbo; Liu, Yanlin; Wang, Jian; Li, Xin; Shang, Xiaoyun; Li, Hongyuan			Prevalence of HIV Infection and Associated Risk Factors among Men Who Have Sex with Men (MSM) in Harbin, P. R. China	PLOS ONE			English	Article							EPIDEMIC; BEHAVIOR; HIV/AIDS; SHANGHAI; SYPHILIS	Objective: To assess the prevalence of HIV infection and characteristically risk of factors which associated with HIV infection among MSM in Harbin, China. Methods: A face-to-face questionnaire interview was conducted among 463 Men Who Have Sex with Men (MSM) who were recruited by the snowball sampling in Harbin from April, 2011 to July, 2011. The questionnaire mainly included demographics, AIDS knowledge, homosexual behavior and the status of intervention in MSM. Blood specimens were obtained and tested for the diagnoses of HIV, syphilis and hepatitis C virus (HCV). Associations between above exposed factors and HIV infection were analyzed using a univariate analysis and forward stepwise logistic regression. Results: The prevalence of HIV and syphilis was 9.5 and 14.3%. The awareness rate of AIDS was 86.8%. The rate of unprotected sexual behavior was 57.6% of MSM during the past 6 months. The univariate analysis identified that the age (age >= 35 years old), cohabitation, more than 10 years of homosexual behavior and more than 10 homosexual partners were risk factors which associated with the HIV infection, and that protected sex during the past 6 months was a protective factor for the HIV infection. The multivariate analysis identified that the duration of homosexual behavior and commercial sexual behavior were independent risk factors which associated with the HIV infection, and the protected sex during the past 6 months was a protective factor for the HIV infection. Conclusion: The prevalence of HIV among MSM in Harbin has been rapidly increasing in the past few years. Targeted, tailored, and comprehensive interventions are urgently needed to prevent the HIV infection from MSM.	[Zhang, Ling; Li, Xin; Shang, Xiaoyun; Li, Hongyuan] Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Peoples R China; [Zhang, Dandan] AntiTB Stn, Harbin, Peoples R China; [Yu, Baowen] Sanitat Supervis Stn, Harbin, Peoples R China; [Zhang, Ling; Wang, Shangbo; Liu, Yanlin; Wang, Jian] Ctr Dis Control & Prevent, Harbin, Peoples R China	Harbin Medical University; Chinese Center for Disease Control & Prevention	Li, HY (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Peoples R China.	lihongyuan00@126.com	Miragaia, Maria/J-2704-2015; Chaves, Fernando/C-6176-2016	Miragaia, Maria/0000-0002-1323-7184; /0000-0001-6816-8932; Bouchami, Ons/0000-0002-9425-3513; Thomas, Jonathan/0000-0002-1599-9123	NIGMS NIH HHS [R01 GM080602, GM080602] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adimora AA, 2006, SEX TRANSM DIS, V33, P596, DOI 10.1097/01.olq.0000233666.67788.fc; Center of control and prevention of STD and AIDS of Chinese Center for Disease Control and Prevention, 2007, CTR CONTR PREV STD A; China Ministry of Health, 2011, CHIN EST REP EN; China's Ministry of Health/ WHO / UNAIDS, 2005 UPD HIV AIDS EP; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; Feng TJ, 2008, SEX TRANSM DIS, V35, P1022, DOI 10.1097/OLQ.0b013e31818600f4; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; He N, 2007, AIDS CARE, V19, P109, DOI 10.1080/09540120600888394; He Q, 2008, AIDS BEHAV, V12, pS93, DOI 10.1007/s10461-008-9388-y; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Lau JTF, 2011, PUBLIC HEALTH, V125, P260, DOI 10.1016/j.puhe.2011.01.007; Lau JTF, 2008, SEX TRANSM DIS, V35, P406, DOI 10.1097/OLQ.0b013e318164467f; Li HM, 2011, PLOS ONE, V6; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; Mi GD, 2007, AIDS, V21, pS67, DOI 10.1097/01.aids.0000304699.85379.32; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; Office for AIDS prevention and control committee of the State Council, 2004, JOINT EV REP AIDS PR, P7; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Qian ZH, 2005, SEX TRANSM INFECT, V81, P442, DOI 10.1136/sti.2004.014258; Qiu RZ, 1997, AIDS SEXUAL ETHICS, P121; *STAT COUNC AIDS W, 2004, JOINT ASS HIV AIDS P; State Council AIDS Working Committee Office and UN Theme Group on AIDS in China, 2007, JOINT ASS HIV AIDS P; Guevara WJU, 2012, J SEX MED, V9, P1634, DOI 10.1111/j.1743-6109.2012.02713.x; USAID, 2007, HLTH POL INT VAL INV; USAID, 2006, VAL INV MSM PROGR AS; WANG J, 2008, CHIN J AIDS STD, V14, P75; Wang Lan, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P20; Wong FY, 2008, AIDS CARE, V20, P170, DOI 10.1080/09540120701534707; Xu Juan, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P975; Zhang BC, 2012, CHIN J AIDS STD PREV, V8, P197; Zhang DP, 2007, J INFECTION, V55, P456, DOI 10.1016/j.jinf.2007.06.015; Zhang XX, 2007, AIDS, V21, pS53, DOI 10.1097/01.aids.0000304697.39637.4c	33	59	65	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58440	10.1371/journal.pone.0058440	http://dx.doi.org/10.1371/journal.pone.0058440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23776678	Green Published, gold, Green Submitted			2022-12-25	WOS:000316849200068
J	Lee, JK; So, KA; Piyathilake, CJ; Kim, MK				Lee, Jae Kwan; So, Kyeong A.; Piyathilake, Chandrika J.; Kim, Mi Kyung			Mild Obesity, Physical Activity, Calorie Intake, and the Risks of Cervical Intraepithelial Neoplasia and Cervical Cancer	PLOS ONE			English	Article							BODY-MASS INDEX; POSTMENOPAUSAL BREAST-CANCER; NIH-AARP DIET; OVARIAN-CANCER; WOMEN; ASSOCIATION; PROSTATE; IMPACT; COHORT; EPIDEMIOLOGY	Objective: We investigated whether obesity, physical activity, and calorie intake are associated with the risks of cervical intraepithelial neoplasia (CIN) and cervical cancer. Methods: We enrolled 1125 women (age, 18-65 years) into a human papillomavirus cohort study established from 2006 to 2012. Multinomial logistic regression models were used to estimate crude and multivariate odds ratios (ORs) and the corresponding 95% confidence intervals (95% CIs), and to assess whether body mass index (BMI), height, weight, total calorie intake, and physical activity were associated with the risks of CIN and cervical cancer. Results: Cervical cancer risk was positively associated with BMI and inversely associated with physical activity. When compared with women with a normal BMI (18.5-23 kg/m(2)), the multivariate ORs (95% CIs) for those overweight (23-25 kg/m(2)) and mild obesity (>= 25 kg/m(2)) were 1.25 (0.79-2.00) and 1.70 (1.10-2.63), respectively. When compared with women with the lowest tertile of physical activity (<38.5 MET-hours/week), the ORs (95% CIs) for cervical cancer were 0.95 (0.61-1.48) and 0.61 (0.38-0.98) for women with medium physical activity (38.5-71.9 MET-hours/week) and those with high physical activity (72 MET-hours/week), respectively (p for linear trend = 0.03). The CIN2/3 risk was inversely associated with physical activity after adjustment for confounders. Compared with women with low physical activity (< 38.5 MET-hours/week), the ORs (95% CIs) for CIN2/3 were 0.64 (0.40-1.01) and 0.58 (0.36-0.93) for the medium and high physical activity groups, respectively (p for linear trend = 0.02). Total calorie intake was not statistically associated with the risks of CIN and cervical cancer after adjustment for confounders. Conclusion: Our results indicate that in addition to screening for and treatment of CIN, recommendations on the maintenance of an appropriate BMI with an emphasis on physical activity could be an important preventive strategy against the development of cervical cancer.	[Lee, Jae Kwan; So, Kyeong A.] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul 136705, South Korea; [Piyathilake, Chandrika J.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Kim, Mi Kyung] Natl Canc Ctr, Canc Epidemiol Branch, Goyang, South Korea	Korea University; Korea University Medicine (KU Medicine); University of Alabama System; University of Alabama Birmingham; National Cancer Center - Korea (NCC)	Kim, MK (corresponding author), Natl Canc Ctr, Canc Epidemiol Branch, Goyang, South Korea.	alrud@ncc.re.kr	Auger, Cyril/N-4702-2016; Kang, Moonkyu/AAR-8974-2021; Oak, Min-Ho/AAE-7405-2020	LEE, Jae Kwan/0000-0003-3101-6403; Kang, Moonkyu/0000-0002-2039-4866	Korea National Cancer Center [NCC-1110320, NCC-1310361]	Korea National Cancer Center	This study was supported by a grant-in-aid from the Korea National Cancer Center (grant no. NCC-1110320, NCC-1310361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Aldrich T, 2010, J MIDWIFERY WOM HEAL, V55, P344, DOI 10.1016/j.jmwh.2009.10.001; [Anonymous], 2002, WEIGHT CONTR PHYS AC; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Brown Pamela, 2002, W V Med J, V98, P271; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Castle Philip E, 2003, J Natl Cancer Inst Monogr, P29; Chang SC, 2006, CANCER EPIDEM BIOMAR, V15, P334, DOI 10.1158/1055-9965.EPI-05-0479; Choo V, 2002, LANCET, V360, P235, DOI 10.1016/S0140-6736(02)09512-0; Deurenberg-Yap M, 2001, INT J OBESITY, V25, P1554, DOI 10.1038/sj.ijo.0801739; Gierach GL, 2009, INT J CANCER, V124, P2139, DOI 10.1002/ijc.24059; Hwang JH, 2010, INT J GYNECOL CANCER, V20, P398, DOI 10.1111/IGC.0b013e3181d02ff2; Hwang JH, 2010, CANCER CAUSE CONTROL, V21, P51, DOI 10.1007/s10552-009-9433-9; Inoue M, 2008, AM J EPIDEMIOL, V168, P391, DOI 10.1093/aje/kwn146; James PT, 2001, OBES RES, V9, p228S, DOI 10.1038/oby.2001.123; Kim YO, 2009, BRIT J NUTR, V101, P1218, DOI 10.1017/S0007114508061497; Ko GTC, 1999, INT J OBESITY, V23, P1136, DOI 10.1038/sj.ijo.0801043; Korea Health Industry Development Institute Ministry of Health and Welfare, 2000, DEV NUTR DAT REC PRO; Lacey JV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-84; Lacey JV, 2003, CANCER-AM CANCER SOC, V98, P814, DOI 10.1002/cncr.11567; Lane Geoffrey, 2008, Menopause Int, V14, P33, DOI 10.1258/mi.2007.007036; Lee GJ, 2005, J KOREAN MED SCI, V20, P267, DOI 10.3346/jkms.2005.20.2.267; Lundqvist E, 2007, INT J CANCER, V121, P810, DOI 10.1002/ijc.22746; Maruthur NM, 2009, OBESITY, V17, P375, DOI 10.1038/oby.2008.480; Mitchell RS, 2008, AM J PREV MED, V35, P127, DOI 10.1016/j.amepre.2008.03.031; Modesitt SC, 2005, OBSTET GYNECOL SURV, V60, P683, DOI 10.1097/01.ogx.0000180866.62409.01; Nobbenhuis MAE, 1999, LANCET, V354, P20, DOI 10.1016/S0140-6736(98)12490-X; Patil V, 2006, Indian J Public Health, V50, P38; Pereira M A, 1997, Med Sci Sports Exerc, V29, pS1; Peters TM, 2009, CANCER EPIDEM BIOMAR, V18, P289, DOI 10.1158/1055-9965.EPI-08-0768; PRENTICE RL, 1979, BIOMETRIKA, V66, P403, DOI 10.1093/biomet/66.3.403; Rajkumar T, 2003, BRIT J CANCER, V88, P1388, DOI 10.1038/sj.bjc.6600902; Regional Office for the Western Pacific/World Health Organization International Obesity TaskForce/International Association for the Study of Obesity, 2000, AS PAC PERSP RED OB; Rieck G, 2006, BEST PRACT RES CL OB, V20, P227, DOI 10.1016/j.bpobgyn.2005.10.010; SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987; SCHIFFMAN MH, 1995, CANCER-AM CANCER SOC, V76, P1888, DOI 10.1002/1097-0142(19951115)76:10+<1888::AID-CNCR2820761305>3.0.CO;2-H; SCHILL W, 1993, BIOMETRIKA, V80, P339, DOI 10.2307/2337204; Schouten LJ, 2008, CANCER EPIDEM BIOMAR, V17, P902, DOI 10.1158/1055-9965.EPI-07-2524; Schouten LJ, 2004, JNCI-J NATL CANCER I, V96, P1635, DOI 10.1093/jnci/djh291; SHEPHARD RJ, 1995, CAN J APPL PHYSIOL, V20, P1, DOI 10.1139/h95-001; Song SH, 2008, GYNECOL ONCOL, V108, P543, DOI 10.1016/j.ygyno.2007.11.006; Song YM, 2004, STROKE, V35, P831, DOI 10.1161/01.STR.0000119386.22691.1C; Stefanescu B I, 2007, Rev Med Chir Soc Med Nat Iasi, V111, P155; Stein CJ, 2004, BRIT J CANCER, V90, P299, DOI 10.1038/sj.bjc.6601509; Tong SY, 2010, CANCER CAUSE CONTROL, V21, P23, DOI 10.1007/s10552-009-9430-z; TORNBERG SA, 1994, BRIT J CANCER, V69, P358, DOI 10.1038/bjc.1994.65; Ulmer H, 2012, GYNECOL ONCOL, V125, P330, DOI 10.1016/j.ygyno.2012.01.052; van Gils CH, 2009, CANCER EPIDEM BIOMAR, V18, P377, DOI 10.1158/1055-9965.EPI-08-0823; Velthuis MJ, 2009, MENOPAUSE, V16, P777, DOI [10.1097/GME.0b013e318197122a, 10.1097/gme.0b013e318197122a]; WANG SS, 2003, J NATL CANC I MONOGR, V31, P35, DOI DOI 10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A003480; WHO, 2004, LANCET, V363, P902; Wolin KY, 2009, BRIT J CANCER, V100, P611, DOI 10.1038/sj.bjc.6604917; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2000, INT ASS STUD OB INT; Yajnik C S, 2002, Obes Rev, V3, P217, DOI 10.1046/j.1467-789X.2002.00072.x; Yoo K Y, 1997, J Epidemiol, V7, P117; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	60	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e66555	10.1371/journal.pone.0066555	http://dx.doi.org/10.1371/journal.pone.0066555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23755196	Green Published, Green Submitted, gold			2022-12-25	WOS:000320322400111
J	Dahal, N; Abdelhamed, H; Lu, JJ; Karsi, A; Lawrence, ML				Dahal, Neeti; Abdelhamed, Hossam; Lu, Jingjun; Karsi, Attila; Lawrence, Mark L.			Tricarboxylic Acid Cycle and One-Carbon Metabolism Pathways Are Important in Edwardsiella ictaluri Virulence	PLOS ONE			English	Article							ESCHERICHIA-COLI; FUMARATE REDUCTASE; CHANNEL CATFISH; SUCCINATE-DEHYDROGENASE; MUTANT; REPLACEMENT; EXPRESSION; VACCINE; GENES; LIVE	Edwardsiella ictaluri is a Gram-negative facultative intracellular pathogen causing enteric septicemia of channel catfish (ESC). The disease causes considerable economic losses in the commercial catfish industry in the United States. Although antibiotics are used as feed additive, vaccination is a better alternative for prevention of the disease. Here we report the development and characterization of novel live attenuated E. ictaluri mutants. To accomplish this, several tricarboxylic acid cycle (sdhC, mdh, and frdA) and one-carbon metabolism genes (gcvP and glyA) were deleted in wild type E. ictaluri strain 93146 by allelic exchange. Following bioluminescence tagging of the E. ictaluri Delta sdhC, Delta mdh, Delta frdA, Delta gcvP, and Delta glyA mutants, their dissemination, attenuation, and vaccine efficacy were determined in catfish fingerlings by in vivo imaging technology. Immunogenicity of each mutant was also determined in catfish fingerlings. Results indicated that all of the E. ictaluri mutants were attenuated significantly in catfish compared to the parent strain as evidenced by 2,265-fold average reduction in bioluminescence signal from all the mutants at 144 h post-infection. Catfish immunized with the E. ictaluri Delta sdhC, Delta mdh, Delta frdA, and Delta glyA mutants had 100% relative percent survival (RPS), while E. ictaluri Delta gcvP vaccinated catfish had 31.23% RPS after re-challenge with the wild type E. ictaluri.	[Dahal, Neeti; Lu, Jingjun; Karsi, Attila; Lawrence, Mark L.] Mississippi State Univ, Coll Vet Med Sci, Dept Basic Sci, Mississippi State, MS 39762 USA; [Abdelhamed, Hossam] Benha Univ, Fac Vet Med, Dept Fish Dis & Management, Moshtohor Toukh, Egypt	Mississippi State University; Egyptian Knowledge Bank (EKB); Benha University	Karsi, A (corresponding author), Mississippi State Univ, Coll Vet Med Sci, Dept Basic Sci, Mississippi State, MS 39762 USA.	karsi@cvm.msstate.edu; lawrence@cvm.msstate.edu	Karsi, Attila/AAG-5046-2019; Dahanukar, Neelesh/B-2816-2012	Karsi, Attila/0000-0001-6845-3346; Dahanukar, Neelesh/0000-0001-7162-9023; Padhye, Anand/0000-0002-5971-4759; Molur, Sanjay/0000-0001-8230-518X; Modak, Nikhil/0000-0003-3303-7056	United States Department of Agriculture [2009-65119-05671]	United States Department of Agriculture(United States Department of Agriculture (USDA))	The research reported herein was supported by United States Department of Agriculture grant #2009-65119-05671 to MLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhamed H, 2013, VET MICROBIOL, V162, P858, DOI 10.1016/j.vetmic.2012.11.006; AINSWORTH AJ, 1990, DEV COMP IMMUNOL, V14, P201, DOI 10.1016/0145-305X(90)90091-R; Amend D.F., 1981, FISH BIOL SERODIAGNO, V49, P447; [Anonymous], 2006, CASE SUMMARY REPORT; Arias CR, 2003, J FISH DIS, V26, P415, DOI 10.1046/j.1365-2761.2003.00475.x; Barker HC, 2000, MOL MICROBIOL, V35, P1518, DOI 10.1046/j.1365-2958.2000.01820.x; Booth NJ, 2006, J AQUAT ANIM HEALTH, V18, P101, DOI 10.1577/H05-025.1; Cooper Richard K. Ii, 1996, Journal of Aquatic Animal Health, V8, P319, DOI 10.1577/1548-8667(1996)008&lt;0319:UOAMTT&gt;2.3.CO;2; Dozois CM, 2003, P NATL ACAD SCI USA, V100, P247, DOI 10.1073/pnas.232686799; Dung TT, 2008, MICROB DRUG RESIST, V14, P311, DOI 10.1089/mdr.2008.0848; Ge ZM, 2000, MICROB PATHOGENESIS, V29, P279, DOI 10.1006/mpat.2000.0391; GUEST JR, 1981, J GEN MICROBIOL, V122, P171; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Karsi A, 2007, PLASMID, V57, P286, DOI 10.1016/j.plasmid.2006.11.002; Karsi A, 2006, FEMS MICROBIOL LETT, V260, P216, DOI 10.1111/j.1574-6968.2006.00310.x; Karsi A, 2009, APPL ENVIRON MICROB, V75, P2166, DOI 10.1128/AEM.02449-08; Klesius PH, 1997, AQUACULTURE, V157, P147, DOI 10.1016/S0044-8486(97)00076-8; Klesius PH, 1999, ADV VETER MED AP, V41, P523; Lan MZ, 2007, FISH SHELLFISH IMMUN, V23, P521, DOI 10.1016/j.fsi.2006.11.002; Lawrence ML, 1997, INFECT IMMUN, V65, P4642, DOI 10.1128/IAI.65.11.4642-4651.1997; Lawrence ML, 1997, VET MICROBIOLOGY PAR; Maklashina E, 1998, J BACTERIOL, V180, P5989, DOI 10.1128/JB.180.22.5989-5996.1998; MEEDEL TH, 1974, J BACTERIOL, V118, P905, DOI 10.1128/JB.118.3.905-910.1974; Mercado-Lubo R, 2008, INFECT IMMUN, V76, P1128, DOI 10.1128/IAI.01226-07; METCALF WW, 1994, GENE, V138, P1, DOI 10.1016/0378-1119(94)90776-5; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; PLAMANN MD, 1983, MOL GEN GENET, V192, P15, DOI 10.1007/BF00327641; Santander J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015944; STAUFFER LT, 1994, GENE, V142, P17, DOI 10.1016/0378-1119(94)90349-2; Thune RL, 1999, J AQUAT ANIM HEALTH, V11, P358, DOI 10.1577/1548-8667(1999)011&lt;0358:AAMOEI&gt;2.0.CO;2; USDA, 2003, HIGHL NAHMS CATF 2 2; Waterstrat PR, 1988, J FISH DIS, V289-294; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0; Yimga MT, 2006, INFECT IMMUN, V74, P1130, DOI 10.1128/IAI.74.2.1130-1140.2006	35	31	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2013	8	6							e65973	10.1371/journal.pone.0065973	http://dx.doi.org/10.1371/journal.pone.0065973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173QU	23762452	gold, Green Published, Green Submitted			2022-12-25	WOS:000321094800082
J	Liu, ZY; Li, W; Wang, J; Pan, J; Sun, SP; Yu, YH; Zhao, B; Ma, YZ; Zhang, TJ; Qi, J; Liu, GJ; Lu, FM				Liu, Zhiyuan; Li, Wei; Wang, Jie; Pan, Jian; Sun, Shipeng; Yu, Yanhua; Zhao, Bing; Ma, Yuzhi; Zhang, Tingju; Qi, Jie; Liu, Guijian; Lu, Fengmin			Identification and Characterization of the First Escherichia coli Strain Carrying NDM-1 Gene in China	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; ACINETOBACTER-BAUMANNII; EMERGENCE; ENTEROBACTERIACEAE; RESISTANCE; CARBAPENEMASES; DISSEMINATION; WORLDWIDE; INFECTION; SPREAD	New Delhi metallo-beta-lactamase-1 (NDM-1), an acquired class B carbapenemase, is a significant clinical threat due to its extended hydrolysis of beta-lactams including carbapenems. In this study, we identified the first confirmed clinical isolate of Escherichia coli BJ01 harboring bla(NDM-1) in China. The isolate is highly resistant to all tested antimicrobials except polymyxin. bla(NDM-1), bla(CTX-M-57), and bla(TEM-1) were identified in the isolate. bla(NDM-1) was transferable to E. coli EC600 and DH5 alpha in both plasmid conjugation experiments and plasmid transformation tests. BJ01 was identified as a new sequence type, ST224, by multilocus sequence typing. Analysis of genetic environment shows complex transposon-like structures surrounding the blaNDM-1 gene. Genetic analysis revealed that the region flanking blaNDM-1 was very similar to previously identified NDM-positive Acinetobacter spp. isolated in China. The findings of this study raise attention to the emergence and spread of NDM-1-carrying Enterobacteriaceae in China.	[Liu, Zhiyuan; Wang, Jie; Pan, Jian; Sun, Shipeng; Zhao, Bing; Ma, Yuzhi; Zhang, Tingju; Qi, Jie; Liu, Guijian] China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China; [Liu, Zhiyuan; Lu, Fengmin] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Ctr Infect Dis, Beijing 100871, Peoples R China; [Li, Wei] Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing, Peoples R China; [Yu, Yanhua] Capital Med Univ, Beijing Youan Hosp, Dept Clin Lab, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; Peking University; Capital Medical University; Capital Medical University	Liu, GJ (corresponding author), China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China.	GuijianLiu234@gmail.com; Fengmingqqq@gmail.com	Li, Wei/I-8060-2014; Liu, ZH/H-7536-2012; Yang, Jian/H-3169-2011	Liu, ZH/0000-0002-0086-5659; Yang, Jian/0000-0002-2170-589X; He, Hong S./0000-0002-3983-2512; Li, Wei/0000-0002-9991-7892; Liu, Zhiyuan/0000-0002-4253-1753	Guang'anmen Hospital [2011S242]; Beijing You'an Project for Liver diseases and AIDS [JYAN-2011-064]	Guang'anmen Hospital; Beijing You'an Project for Liver diseases and AIDS	This work was supported by Internal Funding of Guang'anmen Hospital (Grant# 2011S242) and Beijing You'an Project for Liver diseases and AIDS ( Grant# JYAN-2011-064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birgy A, 2012, J CLIN MICROBIOL, V50, P1295, DOI 10.1128/JCM.06131-11; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Bonomo RA, 2011, CLIN INFECT DIS, V52, P485, DOI 10.1093/cid/ciq179; Chen SD, 2011, AM J INFECT CONTROL, V39, pE55, DOI 10.1016/j.ajic.2011.02.009; Chen Y, 2011, J ANTIMICROB CHEMOTH, V66, P1255, DOI 10.1093/jac/dkr082; Chen Y, 2012, J BACTERIOL, V194, P204, DOI 10.1128/JB.06202-11; Clinical and Laboratory Standards Institute (CLSI), 1999, M26A CLSI, V19, P1; CLSI, 2012, M100S22 CLSI; D'Andrea MM, 2011, J CLIN MICROBIOL, V49, P2755, DOI 10.1128/JCM.00016-11; Espinal P, 2011, ANTIMICROB AGENTS CH, V55, P5396, DOI 10.1128/AAC.00679-11; Fang H, 2008, J CLIN MICROBIOL, V46, P707, DOI 10.1128/JCM.01943-07; Fu Y, 2012, J ANTIMICROB CHEMOTH; Gaibani P, 2011, EUROSURVEILLANCE, V16, P2; Ho PL, 2012, J ANTIMICROB CHEMOTH, DOI [10.1093/jac/dks095, DOI 10.1093/JAC/DKS095.EPUB]; Hopkins TA, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2903479; Hu FP, 2012, J MED MICROBIOL, V61, P132, DOI 10.1099/jmm.0.036483-0; Hu HY, 2012, ANTIMICROB AGENTS CH, V56, P1698, DOI 10.1128/AAC.06199-11; Jovcic B, 2011, ANTIMICROB AGENTS CH, V55, P3929, DOI 10.1128/AAC.00226-11; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lascols C, 2011, J ANTIMICROB CHEMOTH, V66, P1992, DOI 10.1093/jac/dkr240; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Mulvey MR, 2011, EMERG INFECT DIS, V17, P103, DOI 10.3201/eid1701.101358; Nielsen J, 2012, FEMS YEAST RES, V12, P1, DOI [10.1111/j.1567-1364.2011.00764.x, 10.1111/j.1574-6941.2011.01260.x]; OBRIEN TF, 1985, SCIENCE, V230, P87, DOI 10.1126/science.2994226; Pfeifer Y, 2011, ANTIMICROB AGENTS CH, V55, P1318, DOI 10.1128/AAC.01585-10; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P4914, DOI 10.1128/AAC.00878-10; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rolain JM, 2010, CLIN MICROBIOL INFEC, V16, P1699, DOI 10.1111/j.1469-0691.2010.03385.x; Shakil S, 2011, J CHEMOTHERAPY, V23, P263, DOI 10.1179/joc.2011.23.5.263; Shi DS, 2012, EUR J CLIN MICROBIOL, V31, P797, DOI 10.1007/s10096-011-1377-9; Shibata N, 2003, J CLIN MICROBIOL, V41, P5407, DOI 10.1128/JCM.41.12.5407-5413.2003; Sowmiya M, 2012, INVEST OPHTH VIS SCI, V53, P5251, DOI 10.1167/iovs.12-10467; Struelens MJ, 2010, EUROSURVEILLANCE, V15, P9; Wang XS, 2013, CLIN INFECT DIS, V56, P161, DOI 10.1093/cid/cis782; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037152; Williamson DA, 2012, INT J ANTIMICROB AG, V39, P529, DOI 10.1016/j.ijantimicag.2012.02.017; Wilson ME, 2012, CURR INFECT DIS REP, V14, P213, DOI 10.1007/s11908-012-0252-x; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zhang R, 2011, J MED MICROBIOL, V60, P977, DOI 10.1099/jmm.0.015826-0; Zhou ZW, 2012, CAN J MICROBIOL, V58, P112, DOI [10.1139/W11-112, 10.1139/w11-112]	41	246	257	6	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2013	8	6							e66666	10.1371/journal.pone.0066666	http://dx.doi.org/10.1371/journal.pone.0066666			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	164VY	23762496	Green Published, Green Submitted, gold			2022-12-25	WOS:000320440500069
J	Wang, YP; Hu, YJ; Chao, C; Yuksel, M; Colle, I; Flavell, RA; Ma, Y; Yan, HP; Wen, L				Wang, Yipeng; Hu, Youjia; Chao, Chen; Yuksel, Muhammed; Colle, Isabelle; Flavell, Richard A.; Ma, Yun; Yan, Huiping; Wen, Li			Role of IRAK-M in Alcohol Induced Liver Injury	PLOS ONE			English	Article							INNATE IMMUNITY; KUPFFER CELLS; T-CELLS; NEGATIVE REGULATOR; DISEASE; MICE; LIPOPOLYSACCHARIDE; INTERLEUKIN-1; INFLAMMATION; PERMEABILITY	Increasing evidence suggests that innate immunity plays an important role in alcohol-induced liver injury and most studies have focused on positive regulation of innate immunity. The main objective of this study was to investigate the negative regulator of innate immunity, IL-1/Toll-like receptor (TLR) signaling pathways and interleukin receptor-associated kinase-M (IRAK-M) in alcoholic liver injury. We established an alcohol-induced liver injury model using wild type and IRAK-M deficient B6 mice and investigated the possible mechanisms. We found that in the absence of IRAK-M, liver damage by alcohol was worse with higher alanine transaminase (ALT), more immune cell infiltration and increased numbers of IFN gamma producing cells. We also found enhanced phagocytic activity in CD68(+) cells. Moreover, our results revealed altered gut bacteria after alcohol consumption and this was more striking in the absence of IRAK-M. Our study provides evidence that IRAK-M plays an important role in alcohol-induced liver injury and IRAK-M negatively regulates the innate and possibly the adaptive immune response in the liver reacting to acute insult by alcohol. In the absence of IRAK-M, the hosts developed worse liver injury, enhanced gut permeability and altered gut microbiota.	[Wang, Yipeng; Hu, Youjia; Chao, Chen; Yuksel, Muhammed; Wen, Li] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Wang, Yipeng; Yan, Huiping] Capital Med Univ, Beijing You An Hosp, Clin Res Ctr Autoimmune Liver Dis, Beijing, Peoples R China; [Yuksel, Muhammed; Colle, Isabelle] Ghent Univ Hosp, Dept Gastroenterol, Ghent, Belgium; [Yuksel, Muhammed; Colle, Isabelle; Ma, Yun] Univ London, Inst Liver Study, Kings Coll, Sch Med, London, England	Yale University; Yale University; Capital Medical University; Ghent University; Ghent University Hospital; University of London; King's College London	Wen, L (corresponding author), Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT 06520 USA.	li.wen@yale.edu	yuksel, muhammed/AAT-4783-2021; yuksel, muhammed/F-1706-2019; yuksel, muhammed/C-7861-2017; Wang, Yilong/E-3536-2015; Chen, Bingdi/I-5857-2012	yuksel, muhammed/0000-0002-3390-6007; Wen, Li/0000-0002-8805-2934; Wang, Yilong/0000-0001-7483-9296; Chen, Bingdi/0000-0002-2086-0898	National Institutes of Health [RC1DK087699]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK087699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (RC1DK087699 to LW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajakaiye M, 2011, MOL MED REP, V4, P597, DOI 10.3892/mmr.2011.471; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Apajalahti JHA, 1998, APPL ENVIRON MICROB, V64, P4084; Aziz-Seible RS, 2011, ALCOHOL CLIN EXP RES, V35, P717, DOI 10.1111/j.1530-0277.2010.01389.x; Biswas A, 2011, EUR J IMMUNOL, V41, P182, DOI 10.1002/eji.201040479; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Enomoto N, 2001, ALCOHOL CLIN EXP RES, V25, p51S, DOI 10.1097/00000374-200106001-00012; Flannery S, 2010, BIOCHEM PHARMACOL, V80, P1981, DOI 10.1016/j.bcp.2010.06.020; FOX ES, 1989, GASTROENTEROLOGY, V96, P456, DOI 10.1016/0016-5085(89)91571-0; Gao B, 2011, AM J PHYSIOL-GASTR L, V300, pG516, DOI 10.1152/ajpgi.00537.2010; Hubbard L. L., 2010, INFECT DIS REP, V2; Kim SK, 2011, DIGESTION, V84, P43, DOI 10.1159/000333212; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Kirpich IA, 2012, ALCOHOL CLIN EXP RES, V36, P835, DOI 10.1111/j.1530-0277.2011.01673.x; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Koop DR, 2006, ALCOHOL RES HEALTH, V29, P274; Laso FJ, 1999, ALCOHOL CLIN EXP RES, V23, P1306, DOI 10.1097/00000374-199908000-00003; Lech M, 2011, ANN RHEUM DIS, V70, P2207, DOI 10.1136/ard.2011.155515; Li TK, 2008, J GASTROEN HEPATOL, V23, pS2, DOI 10.1111/j.1440-1746.2007.05298.x; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Mandrekar P, 2009, J IMMUNOL, V183, P1320, DOI 10.4049/jimmunol.0803206; Mandrekar P, 2009, J HEPATOL, V50, P1258, DOI 10.1016/j.jhep.2009.03.007; Mathurin P, 2009, GUT, V58, P613, DOI 10.1136/gut.2007.145573; Mehal WZ, 2001, J IMMUNOL, V167, P667, DOI 10.4049/jimmunol.167.2.667; Mehal WZ, 1999, J IMMUNOL, V163, P3202; Mehal WZ, 2001, GASTROENTEROLOGY, V120, P250, DOI 10.1053/gast.2001.20947; Miller AM, 2011, ALCOHOL CLIN EXP RES, V35, P787, DOI 10.1111/j.1530-0277.2010.01399.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Sakaguchi S, 2011, DRUG METAB PHARMACOK, V26, P30, DOI 10.2133/dmpk.DMPK-10-RV-087; Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x; Seth D, 2011, J GASTROEN HEPATOL, V26, P1089, DOI 10.1111/j.1440-1746.2011.06756.x; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Szabo G, 2011, ALCOHOL CLIN EXP RES, V35, P782, DOI 10.1111/j.1530-0277.2010.01398.x; Uesugi T, 2001, HEPATOLOGY, V34, P101, DOI 10.1053/jhep.2001.25350; Vidali M, 2008, TRENDS MOL MED, V14, P63, DOI 10.1016/j.molmed.2007.12.005; Xie QF, 2007, MOL IMMUNOL, V44, P3453, DOI 10.1016/j.molimm.2007.03.018; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	38	51	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2013	8	2							e57085	10.1371/journal.pone.0057085	http://dx.doi.org/10.1371/journal.pone.0057085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	093IT	23776514	Green Published, gold, Green Submitted			2022-12-25	WOS:000315186000074
J	Lee, JO; Auger, C; Park, DH; Kang, M; Oak, MH; Kim, KR; Schini-Kerth, VB				Lee, Jung-Ok; Auger, Cyril; Park, Dong Hyun; Kang, Moonkyu; Oak, Min-Ho; Kim, Kyoung Rak; Schini-Kerth, Valerie B.			An Ethanolic Extract of Lindera obtusiloba Stems, YJP-14, Improves Endothelial Dysfunction, Metabolic Parameters and Physical Performance in Diabetic db/db Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; II-INDUCED HYPERTENSION; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; VASCULAR REACTIVITY; PIOGLITAZONE; PREVALENCE; CELLS; RISK; RATS	Lindera obtusiloba is a medicinal herb traditionally used in Asia for improvement of blood circulation, treatment of inflammation, and prevention of liver damage. A previous study has shown that an ethanolic extract of Lindera obtusiloba stems (LOE) has vasoprotective and antihypertensive effects. The possibility that Lindera obtusiloba improves endothelial function and metabolic parameters in type 2 diabetes mellitus (T2DM) remains to be examined. Therefore, the aim of the present study was to determine the potential of LOE to prevent the development of an endothelial dysfunction, and improve metabolic parameters including hyperglycemia, albuminuria and physical exercise capacity in db/db mice, an experimental model of T2DM. The effect of LOE (100 mg/kg/day by gavage for 8 weeks) on these parameters was compared to that of an oral antidiabetic drug, pioglitazone (30 mg/kg/day by gavage). Reduced blood glucose level, body weight and albumin-creatinine ratio were observed in the group receiving LOE compared to the control db/db group. The LOE treatment improved endothelium-dependent relaxations, abolished endothelium-dependent contractions to acetylcholine in the aorta, and normalized the increased vascular oxidative stress and expression of NADPH oxidase, cyclooxygenases, angiotensin II, angiotensin type 1 receptors and peroxynitrite and the decreased expression of endothelial NO synthase in db/db mice. The angiotensin-converting enzyme (ACE) activity was reduced in the LOE group compared to that in the control db/db group. LOE also inhibited the activity of purified ACE, COX-1 and COX-2 in a dose-dependent manner. In addition, LOE improved physical exercise capacity. Thus, the present findings indicate that LOE has a beneficial effect on the vascular system in db/db mice by improving endothelium-dependent relaxations and vascular oxidative stress most likely by normalizing the angiotensin system, and also on metabolic parameters, and these effects are associated with an enhanced physical exercise capacity.	[Lee, Jung-Ok; Auger, Cyril; Schini-Kerth, Valerie B.] Univ Strasbourg, CNRS, Fac Pharm, Lab Biophoton & Pharmacol,UMR 7213, Illkirch Graffenstaden, France; [Lee, Jung-Ok; Kang, Moonkyu; Kim, Kyoung Rak] Hanwha Pharma Co Ltd, Ctr Res & Dev, Chunchon, South Korea; [Park, Dong Hyun] YangJi Chem, Res Ctr, Suwon, South Korea; [Oak, Min-Ho] Mokpo Natl Univ, Coll Pharm, Muan, Jeonam, South Korea	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Mokpo National University	Schini-Kerth, VB (corresponding author), Univ Strasbourg, CNRS, Fac Pharm, Lab Biophoton & Pharmacol,UMR 7213, Illkirch Graffenstaden, France.	valerie.schini-kerth@unistra.fr	Auger, Cyril/N-4702-2016; Kang, Moonkyu/AAR-8974-2021; Oak, Min-Ho/AAE-7405-2020	LEE, Jae Kwan/0000-0003-3101-6403; Kang, Moonkyu/0000-0002-2039-4866	The Ministry of Knowledge Economy, Republic of Korea, under the Leading Industry Development for Gangwon Economic Region (LIDGER) program [70007579]; Hanwha Pharma. Co., Ltd; Hanwha Pharma. Co., Ltd, Chuncheon, Republic of Korea	The Ministry of Knowledge Economy, Republic of Korea, under the Leading Industry Development for Gangwon Economic Region (LIDGER) program(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Hanwha Pharma. Co., Ltd; Hanwha Pharma. Co., Ltd, Chuncheon, Republic of Korea	The study was supported, in part, by The Ministry of Knowledge Economy, Republic of Korea, under the Leading Industry Development for Gangwon Economic Region (LIDGER) program (number 70007579), and by Hanwha Pharma. Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Jung-Ok Lee, Moonkyu Kang and Kyoung Rak Kim are all employees of Hanwha Pharma. Co., Ltd, Chuncheon, Republic of Korea, whose company provided funding toward this study. Dong Hyun Park is an employee of YangJi Chemicals, Suwon, Republic of Korea, which is a daughter company of Hanwha. Hanwha has filed a European and US patent on YJP14 and endothelial dysfunction. The Korean FDA have approved further clinical studies regarding YJP-14 and endothelial dysfunction in diabetes. At present there are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.	Ajay M, 2006, VASC PHARMACOL, V45, P127, DOI 10.1016/j.vph.2006.05.001; Alhaider AA, 2011, CHEM-BIOL INTERACT, V192, P233, DOI 10.1016/j.cbi.2011.03.014; Bakker W, 2009, CELL TISSUE RES, V335, P165, DOI 10.1007/s00441-008-0685-6; Balletshofer BM, 2000, CIRCULATION, V101, P1780, DOI 10.1161/01.CIR.101.15.1780; Capellini VK, 2010, CURR VASC PHARMACOL, V8, P526; CHANG KC, 1993, J PHARMACOL EXP THER, V266, P992; Chen WG, 2010, BIOCHEMISTRY-US, V49, P3129, DOI 10.1021/bi9016632; Cohen RA, 2010, J CARDIOVASC PHARM, V55, P308, DOI 10.1097/FJC.0b013e3181d89670; Ding H, 2010, PFLUG ARCH EUR J PHY, V459, P977, DOI 10.1007/s00424-010-0807-3; Dunstan DW, 2002, DIABETES CARE, V25, P829, DOI 10.2337/diacare.25.5.829; Feletou M, 2010, CURR HYPERTENS REP, V12, P267, DOI 10.1007/s11906-010-0118-2; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Freise C, 2010, J NUTR BIOCHEM, V21, P1170, DOI 10.1016/j.jnutbio.2009.09.013; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Hartge Martin M, 2007, Diab Vasc Dis Res, V4, P84; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Henry RMA, 2004, ATHEROSCLEROSIS, V174, P49, DOI 10.1016/j.atherosclerosis.2004.01.002; Idris-Khodja N, 2012, N-S ARCH PHARMACOL, V385, P749, DOI 10.1007/s00210-012-0749-8; Ihm SH, 2009, ATHEROSCLEROSIS, V206, P47, DOI 10.1016/j.atherosclerosis.2009.01.036; Jimenez R, 2007, FREE RADICAL BIO MED, V43, P462, DOI 10.1016/j.freeradbiomed.2007.05.007; Johnson DK, 2002, ENDOTHELIUM-J ENDOTH, V9, P191, DOI 10.1080/10623320213638; Junker N, 2005, CANCER SCI, V96, P183, DOI 10.1111/j.1349-7006.2005.00026.x; Kanda Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE278, DOI 10.1152/ajpendo.00388.2009; Kusunoki M, 2011, EUR J PHARMACOL, V668, P486, DOI 10.1016/j.ejphar.2011.07.030; Lee JO, 2011, N-S ARCH PHARMACOL, V383, P635, DOI 10.1007/s00210-011-0643-9; Lewis TV, 1999, J AM COLL CARDIOL, V33, P805, DOI 10.1016/S0735-1097(98)00667-6; Liang W, 2008, J PHYSIOL SCI, V58, P405, DOI 10.2170/physiolsci.RP012808; Lim YK, 2002, ATHEROSCLEROSIS, V160, P311, DOI 10.1016/S0021-9150(01)00576-7; Mohan S, 2008, LAB INVEST, V88, P515, DOI 10.1038/labinvest.2008.23; Musicki B, 2010, J SEX MED, V7, P3023, DOI 10.1111/j.1743-6109.2010.01880.x; Nichols GA, 2001, DIABETES CARE, V24, P1614, DOI 10.2337/diacare.24.9.1614; ODriscoll G, 1997, J CLIN INVEST, V100, P678, DOI 10.1172/JCI119580; Okudan N, 2011, J MED FOOD, V14, P1298, DOI 10.1089/jmf.2010.0030; Ota H, 2010, ARTERIOSCL THROM VAS, V30, P2205, DOI 10.1161/ATVBAHA.110.210500; Park JH, 2011, J BIOCHEM MOL TOXIC, V25, P238, DOI 10.1002/jbt.20381; Park Y, 2008, AM J PHYSIOL-HEART C, V295, pH1982, DOI 10.1152/ajpheart.01261.2007; Plutzky J, 2011, AM J CARDIOL, V108, p25B, DOI 10.1016/j.amjcard.2011.03.014; Regensteiner JG, 2003, VASC MED, V8, P169, DOI 10.1191/1358863x03vm489oa; Sallam N, 2011, N-S ARCH PHARMACOL, V383, P483, DOI 10.1007/s00210-011-0614-1; Sarr M, 2006, CARDIOVASC RES, V71, P794, DOI 10.1016/j.cardiores.2006.05.022; Savage S, 1996, DIABETES CARE, V19, P1243, DOI 10.2337/diacare.19.11.1243; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Schmidt TS, 2007, CLIN SCI, V113, P47, DOI 10.1042/CS20070108; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Senador D, 2009, EXP PHYSIOL, V94, P648, DOI 10.1113/expphysiol.2008.046474; Sharma A, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/750126; Smith SR, 2005, METABOLISM, V54, P24, DOI 10.1016/j.metabol.2004.07.008; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; Sridulyakul P, 2006, CLIN HEMORHEOL MICRO, V34, P315; Stapleton PA, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-54; Thompson D, 2001, Obes Rev, V2, P189, DOI 10.1046/j.1467-789x.2001.00037.x; Ting HH, 1996, J CLIN INVEST, V97, P22, DOI 10.1172/JCI118394; Title LM, 2000, J AM COLL CARDIOL, V36, P758, DOI 10.1016/S0735-1097(00)00809-3; Urso C, 2011, MINERVA MED, V102, P59; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wang XR, 2011, AM J PHYSIOL-ENDOC M, V300, pE1135, DOI 10.1152/ajpendo.00001.2011; Wong WT, 2010, ANTIOXID REDOX SIGN, V13, P757, DOI 10.1089/ars.2009.2831; Ying CJ, 2003, HYPERTENS RES, V26, P823, DOI 10.1291/hypres.26.823; Yook C., 1997, COLORED MED PLANTS K, P588; Zanetti M, 2010, EXP GERONTOL, V45, P848, DOI 10.1016/j.exger.2010.07.002; Zhang HR, 2010, AM J PHYSIOL-HEART C, V299, pH985, DOI 10.1152/ajpheart.00489.2010; Zhang SL, 2007, PEDIATR NEPHROL, V22, P813, DOI 10.1007/s00467-007-0444-z; Zheng Z, 2011, DIABETES	64	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2013	8	6							e65227	10.1371/journal.pone.0065227	http://dx.doi.org/10.1371/journal.pone.0065227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	157CD	23755196	gold, Green Published, Green Submitted			2022-12-25	WOS:000319872300059
J	Liu, ZH; Yang, J; He, HS				Liu, Zhihua; Yang, Jian; He, Hong S.			Identifying the Threshold of Dominant Controls on Fire Spread in a Boreal Forest Landscape of Northeast China	PLOS ONE			English	Article							ENVIRONMENTAL CONTROLS; CLIMATE-CHANGE; WILDFIRE; MIXEDWOOD; AREA; FREQUENCY; PATTERNS; BEHAVIOR; WEATHER; REGIMES	The relative importance of fuel, topography, and weather on fire spread varies at different spatial scales, but how the relative importance of these controls respond to changing spatial scales is poorly understood. We designed a "moving window'' resampling technique that allowed us to quantify the relative importance of controls on fire spread at continuous spatial scales using boosted regression trees methods. This quantification allowed us to identify the threshold value for fire size at which the dominant control switches from fuel at small sizes to weather at large sizes. Topography had a fluctuating effect on fire spread across the spatial scales, explaining 20-30% of relative importance. With increasing fire size, the dominant control switched from bottom-up controls (fuel and topography) to top-down controls (weather). Our analysis suggested that there is a threshold for fire size, above which fires are driven primarily by weather and more likely lead to larger fire size. We suggest that this threshold, which may be ecosystem-specific, can be identified using our "moving window'' resampling technique. Although the threshold derived from this analytical method may rely heavily on the sampling technique, our study introduced an easily implemented approach to identify scale thresholds in wildfire regimes.	[Liu, Zhihua; Yang, Jian; He, Hong S.] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China; [He, Hong S.] Univ Missouri, Sch Nat Resources, Columbia, MO USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University of Missouri System; University of Missouri Columbia	Yang, J (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Peoples R China.	yangjian@iae.ac.cn	Li, Wei/I-8060-2014; Liu, ZH/H-7536-2012; Yang, Jian/H-3169-2011	Liu, ZH/0000-0002-0086-5659; Yang, Jian/0000-0002-2170-589X; He, Hong S./0000-0002-3983-2512; Li, Wei/0000-0002-9991-7892; Liu, Zhiyuan/0000-0002-4253-1753	National Natural Science Foundation of China [31100345, 41071121]; Hundred Talent Program of the Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talent Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was funded by National Natural Science Foundation of China (31100345 & 41071121) and the Hundred Talent Program of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agee JK, 2005, FOREST ECOL MANAG, V211, P83, DOI 10.1016/j.foreco.2005.01.034; Arienti MC, 2009, INT J WILDLAND FIRE, V18, P970, DOI 10.1071/WF08011; Bergeron Y, 2004, ECOLOGY, V85, P1916, DOI 10.1890/02-0716; Bergeron Y, 2002, SILVA FENN, V36, P81, DOI 10.14214/sf.553; BESSIE WC, 1995, ECOLOGY, V76, P747, DOI 10.2307/1939341; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Chang Y, 2007, INT J WILDLAND FIRE, V16, P34, DOI 10.1071/WF05093; Cumming SG, 2001, ECOL APPL, V11, P97, DOI 10.1890/1051-0761(2001)011[0097:FTAWIT]2.0.CO;2; Cyr D, 2007, LANDSCAPE ECOL, V22, P1325, DOI 10.1007/s10980-007-9109-3; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Falk DA, 2011, FRONT ECOL ENVIRON, V9, P446, DOI 10.1890/100052; Franklin J., 2000, TERRAIN ANAL PRINCIP; Hargrove WW, 2000, ECOL MODEL, V135, P243, DOI 10.1016/S0304-3800(00)00368-9; Hely C, 2000, J VEG SCI, V11, P813, DOI 10.2307/3236551; Hely C, 2010, INT J WILDLAND FIRE, V19, P1099, DOI 10.1071/WF09112; Johnson E.A., 1996, FIRE VEGETATION DYNA; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Larsen CPS, 1997, J BIOGEOGR, V24, P663, DOI 10.1111/j.1365-2699.1997.tb00076.x; Littell JS, 2009, ECOL APPL, V19, P1003, DOI 10.1890/07-1183.1; Liu Zhi-hua, 2008, Yingyong Shengtai Xuebao, V19, P487; Liu ZH, 2012, J VEG SCI, V23, P782, DOI 10.1111/j.1654-1103.2012.01397.x; Liu ZH, 2012, GLOBAL CHANGE BIOL, V18, P2041, DOI 10.1111/j.1365-2486.2012.02649.x; Liu ZH, 2010, FOREST ECOL MANAG, V259, P1255, DOI 10.1016/j.foreco.2009.12.022; McKenzie D, 2011, NATURE PRECED; Parisien MA, 2011, ECOL APPL, V21, P789, DOI 10.1890/10-0326.1; Parisien MA, 2009, ECOL MONOGR, V79, P127, DOI 10.1890/07-1289.1; Parks SA, 2011, INT J WILDLAND FIRE, V20, P815, DOI 10.1071/WF10051; Peters DPC, 2004, P NATL ACAD SCI USA, V101, P15130, DOI 10.1073/pnas.0403822101; Peterson GD, 2002, ECOSYSTEMS, V5, P329, DOI 10.1007/s10021-001-0077-1; Podur JJ, 2009, ECOL APPL, V19, P1246, DOI 10.1890/08-0790.1; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Ridgeway G., 2006, GEN BOOSTED REGRESSI, P5; Rollins MG, 2002, LANDSCAPE ECOL, V17, P539, DOI 10.1023/A:1021584519109; Schoennagel T, 2004, BIOSCIENCE, V54, P661, DOI 10.1641/0006-3568(2004)054[0661:TIOFFA]2.0.CO;2; Slocum MG, 2010, ECOSYSTEMS, V13, P828, DOI 10.1007/s10021-010-9357-y; Turetsky MR, 2011, NAT GEOSCI, V4, P27, DOI 10.1038/NGEO1027; Van Wagner CE, 1987, FTR35 PET NAT FOR I; Wotton BM, 2010, INT J WILDLAND FIRE, V19, P253, DOI 10.1071/WF09002; Wu ZW, 2011, ENVIRON MANAGE, V48, P1148, DOI 10.1007/s00267-011-9707-3; Xu C. H., 1997, ACTA ECOLOGICA SINIC, V17, P3; Xu HC, 1998, FOREST GREAT XING MO, P1; Yang J, 2008, ECOL APPL, V18, P1212, DOI 10.1890/07-0825.1; Zhou YL, 1991, VEGETATION GREAT XIN, P1	48	246	257	6	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e55618	10.1371/journal.pone.0055618	http://dx.doi.org/10.1371/journal.pone.0055618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085JH	23762496	Green Published, Green Submitted, gold			2022-12-25	WOS:000314610600137
J	Zhang, C; Zhou, YH; Xu, CL; Chi, FL; Ju, HN				Zhang, Chi; Zhou, Yu-Hao; Xu, Chun-Li; Chi, Feng-Ling; Ju, Hai-Ning			Efficacy of Intensive Control of Glucose in Stroke Prevention: A Meta-Analysis of Data from 59197 Participants in 9 Randomized Controlled Trials	PLOS ONE			English	Article							RISK	Background: The efficacy of treatments that lower glucose in reducing the risk of incident stroke remains unclear. We therefore did a systematic review and meta-analysis to evaluate the efficacy of intensive control of glucose in the prevention of stroke. Methodology/Principal Findings: We systematically searched Medline, EmBase, and the Cochrane Library for trials published between 1950 and June, 2012. We included randomized controlled trials that reported on the effects of intensive control of glucose on incident stroke compared with standard care. Summary estimates of relative risk (RR) reductions were calculated with a random effects model, and the analysis was further stratified by factors that could affect the treatment effects. Of 649 identified studies, we included nine relevant trials, which provided data for 59197 patients and 2037 events of stroke. Overall, intensive control of glucose as compared to standard care had no effect on incident stroke (RR, 0.96; 95% CI 0.88-1.06; P = 0.445). In the stratified analyses, a beneficial effect was seen in those trials when body mass index (BMI) more than 30 (RR, 0.86; 95% CI: 0.75-0.99; P = 0.041). No other significant differences were detected between the effect of intensive control of glucose and standard care when based on other subset factors. Conclusions/Significance: Our study indicated intensive control of glucose can effectively reduce the risk of incident stroke when patients with BMI more than 30.	[Zhang, Chi; Chi, Feng-Ling] Shanghai Seventh Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Zhou, Yu-Hao] Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China; [Xu, Chun-Li] Shanghai Seventh Peoples Hosp, Dept Neurol, Shanghai, Peoples R China; [Ju, Hai-Ning] Shanghai Seventh Peoples Hosp, Dept Cardiol, Shanghai, Peoples R China		Zhou, YH (corresponding author), Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China.	yuhao860407@yahoo.com.cn	; Pearce, Joshua/C-9240-2013	Chen, Maogen/0000-0001-9319-5334; Pearce, Joshua/0000-0001-9802-3056				Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Goff DC, 2007, AM J CARDIOL, V99, p4I, DOI 10.1016/j.amjcard.2007.03.002; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Malmberg K, 1996, EUR HEART J, V17, P1337; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1186/2046-4053-4-1, 10.1136/bmj.i4086, 10.1136/bmj.b2535]; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Wilcox R, 2007, STROKE, V38, P865, DOI 10.1161/01.STR.0000257974.06317.49; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	30	109	113	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2013	8	1							e54465	10.1371/journal.pone.0054465	http://dx.doi.org/10.1371/journal.pone.0054465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077IQ	23544104	Green Submitted, Green Published, gold			2022-12-25	WOS:000314021500075
J	Zhang, ZZ; Wang, W; Li, WL				Zhang, Zhengzhi; Wang, Wei; Li, Wanlong			Genetic Interactions Underlying the Biosynthesis and Inhibition of beta-Diketones in Wheat and Their Impact on Glaucousness and Cuticle Permeability	PLOS ONE			English	Article							CUTICULAR WAX BIOSYNTHESIS; FATTY-ACID ELONGASE; DROUGHT TOLERANCE; EPICUTICULAR WAXES; CONDENSING ENZYME; ABC TRANSPORTER; CELL EXPANSION; COA REDUCTASE; PISUM-SATIVUM; SURFACE WAXES	Cuticular wax composition greatly impacts plant responses to dehydration. Two parallel pathways exist in Triticeae for manipulating wax composition: the acyl elongation, reduction, and decarbonylation pathway that is active at the vegetative stage and yields primary alcohols and alkanes, and the beta-diketone pathway that predominates at the reproductive stage and synthesizes beta-diketones. Variation in glaucousness during the reproductive stage of wheat is mainly controlled by the wax production genes, W1 and W2, and wax inhibitor genes, Iw1 and Iw2. Little is known about the metabolic and physiological effects of the genetic interactions among these genes and their roles in shifting wax composition during plant development. We characterized the effect of W1, W2, Iw1, and Iw2 and analyzed their interaction using a set of six near-isogenic lines (NILs) by metabolic, molecular and physiological approaches. Loss of functional alleles of both W genes or the presence of either Iw gene depletes beta-diketones and results in the nonglaucous phenotype. Elimination of beta-diketones is compensated for by an increase in aldehydes and primary alcohols in the Iw NILs. Accordingly, transcription of CER4-6, which encodes an alcohol-forming fatty acyl-CoA reductase, was elevated 120-fold in Iw1/Iw2. CER4-6 was transcribed at much higher levels in seedlings than in adult plants, and showed little difference between the glaucous and nonglaucous NILs, suggesting that Iw2 counteracts the developmental repression of CER4-6 at the reproductive stage. While W1 and W2 redundantly function in beta-diketone biosynthesis, a combination of both functional alleles led to the beta-diketone hydroxylation. Consistent with this, transcription of MAH1-9, which encodes a mid-chain alkane hydroxylase, increased seven-fold only in W1W2. In parallel with the hydroxyl-beta-diketone production patterns, glaucousness was intensified and cuticle permeability was reduced significantly in W1W2 compared to the other NILs. This suggests that both W1 and W2 are required for enhancing drought tolerance.	[Zhang, Zhengzhi; Wang, Wei; Li, Wanlong] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Li, Wanlong] S Dakota State Univ, Dept Plant Sci, Brookings, SD 57007 USA	South Dakota State University; South Dakota State University	Li, WL (corresponding author), S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA.	wanlong.li@sdstate.edu	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	South Dakota Agricultural Experiment Station; South Dakota Wheat Commission; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	South Dakota Agricultural Experiment Station; South Dakota Wheat Commission; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding for this research was provided by South Dakota Agricultural Experiment Station and South Dakota Wheat Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2004, PLANT CELL, V16, P2463, DOI 10.1105/tpc.104.022897; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bach L, 2008, P NATL ACAD SCI USA, V105, P14727, DOI 10.1073/pnas.0805089105; BARBER HN, 1968, PHYTOCHEMISTRY, V7, P2089, DOI 10.1016/S0031-9422(00)85661-7; Beaudoin F, 2009, PLANT PHYSIOL, V150, P1174, DOI 10.1104/pp.109.137497; Bennett D, 2012, THEOR APPL GENET, V124, P697, DOI 10.1007/s00122-011-1740-3; Bernard A, 2012, PLANT CELL, V24, P3106, DOI 10.1105/tpc.112.099796; BIANCHI G, 1984, CEREAL CHEM, V61, P45; BIANCHI G, 1986, J AGR FOOD CHEM, V34, P429, DOI 10.1021/jf00069a012; Bianchi G., 1995, WAXES CHEM MOL BIOL, P175; Bird D, 2007, PLANT J, V52, P485, DOI 10.1111/j.1365-313X.2007.03252.x; Bonaventure G, 2003, PLANT CELL, V15, P1020, DOI 10.1105/tpc.008946; Broun P, 2004, P NATL ACAD SCI USA, V101, P4706, DOI 10.1073/pnas.0305574101; CHEESBROUGH TM, 1984, P NATL ACAD SCI-BIOL, V81, P6613, DOI 10.1073/pnas.81.21.6613; Cominelli E, 2008, PLANT J, V53, P53, DOI 10.1111/j.1365-313X.2007.03310.x; DeBono A, 2009, PLANT CELL, V21, P1230, DOI 10.1105/tpc.108.064451; Dietrich CR, 2005, PLANT J, V42, P844, DOI 10.1111/j.1365-313X.2005.02418.x; Dudnikov AJ, 2012, MOL BIOL REP, V39, P2355, DOI 10.1007/s11033-011-0986-9; Fiebig A, 2000, PLANT CELL, V12, P2001, DOI 10.1105/tpc.12.10.2001; Greer S, 2007, PLANT PHYSIOL, V145, P653, DOI 10.1104/pp.107.107300; Hansen JD, 1997, PLANT PHYSIOL, V113, P1091, DOI 10.1104/pp.113.4.1091; Hooker TS, 2007, PLANT CELL, V19, P904, DOI 10.1105/tpc.106.049304; Hooker TS, 2002, PLANT PHYSIOL, V129, P1568, DOI 10.1104/pp.003707; Javelle M, 2011, PLANT PHYSIOL, V157, P790, DOI 10.1104/pp.111.182147; Javelle M, 2010, PLANT PHYSIOL, V154, P273, DOI 10.1104/pp.109.150540; JENKS M. A., 2010, HORTICULTURAL REV, V23, P1, DOI [10.1002/9780470650752.ch1, DOI 10.1002/9780470650752.CH1]; JOHNSON DA, 1983, CROP SCI, V23, P318, DOI 10.2135/cropsci1983.0011183X002300020033x; KOLATTUKUDY PE, 1980, SCIENCE, V208, P990, DOI 10.1126/science.208.4447.990; Kosma DK, 2010, PLANT J, V63, P31, DOI 10.1111/j.1365-313X.2010.04229.x; Lam P, 2012, PLANT PHYSIOL, V159, P1385, DOI 10.1104/pp.112.199646; Li F, 2008, PLANT PHYSIOL, V148, P97, DOI 10.1104/pp.108.123471; Liu Q, 2007, EUPHYTICA, V155, P71, DOI 10.1007/s10681-006-9302-5; Liu SZ, 2009, GENETICS, V183, P1215, DOI 10.1534/genetics.109.108936; Lolle SJ, 1997, DEV BIOL, V189, P311, DOI 10.1006/dbio.1997.8671; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; MIKKELSEN JD, 1978, CARLSBERG RES COMMUN, V43, P15, DOI 10.1007/BF02906546; Millar AA, 1999, PLANT CELL, V11, P825, DOI 10.1105/tpc.11.5.825; Monneveux P, 2004, J AGRON CROP SCI, V190, P395, DOI 10.1111/j.1439-037X.2004.00116.x; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; Nawrath Christiane, 2002, Arabidopsis Book, V1, pe0021, DOI 10.1199/tab.0021; NELSON JC, 1995, GENOME, V38, P516, DOI 10.1139/g95-067; Panikashvili D, 2007, PLANT PHYSIOL, V145, P1345, DOI 10.1104/pp.107.105676; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; Raffaele S, 2008, PLANT CELL, V20, P752, DOI 10.1105/tpc.107.054858; Richards R.A., 1984, P 6 INT WHEAT GEN S, P447; RICHARDS RA, 1986, AUST J PLANT PHYSIOL, V13, P465, DOI 10.1071/PP9860465; Richardson A, 2007, PLANTA, V226, P1459, DOI 10.1007/s00425-007-0585-0; Rowland O, 2006, PLANT PHYSIOL, V142, P866, DOI 10.1104/pp.106.086785; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Schnurr JA, 2002, PLANT PHYSIOL, V129, P1700, DOI 10.1104/pp.003251; Seo PJ, 2011, PLANT CELL, V23, P1138, DOI 10.1105/tpc.111.083485; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Simmonds JR, 2008, EUPHYTICA, V159, P333, DOI 10.1007/s10681-007-9514-3; Sturaro M, 2005, PLANT PHYSIOL, V138, P478, DOI 10.1104/pp.104.058164; Suh MC, 2005, PLANT PHYSIOL, V139, P1649, DOI 10.1104/pp.105.070805; Tacke E, 1995, PLANT J, V8, P907, DOI 10.1046/j.1365-313X.1995.8060907.x; Todd J, 1999, PLANT J, V17, P119, DOI 10.1046/j.1365-313X.1999.00352.x; Tsunewaki K, 1999, GENES GENET SYST, V74, P33, DOI 10.1266/ggs.74.33; TULLOCH AP, 1980, CAN J BOT, V58, P2602, DOI 10.1139/b80-302; TULLOCH AP, 1973, PHYTOCHEMISTRY, V12, P2225, DOI 10.1016/0031-9422(73)85124-6; Vailleau F, 2002, P NATL ACAD SCI USA, V99, P10179, DOI 10.1073/pnas.152047199; Vioque J, 1997, ARCH BIOCHEM BIOPHYS, V340, P64, DOI 10.1006/abbi.1997.9932; von Wettstein-Knowles P., 1995, WAXES CHEM MOL BIOL, P91; VONWETTSTEINKNOWLES P, 1980, CARLSBERG RES COMMUN, V45, P125, DOI 10.1007/BF02906514; VONWETTSTEINKNOWLES P, 1972, PLANTA, V106, P113, DOI 10.1007/BF00383991; Xu XJ, 2002, PLANT PHYSIOL, V128, P924, DOI 10.1104/pp.010621; Xu XJ, 1997, PLANT PHYSIOL, V115, P501, DOI 10.1104/pp.115.2.501; Xue GP, 2006, PLANT MOL BIOL, V61, P863, DOI 10.1007/s11103-006-0055-2; Yu DM, 2008, PLANTA, V228, P675, DOI 10.1007/s00425-008-0770-9; Zhang JY, 2007, PLANT MOL BIOL, V64, P265, DOI 10.1007/s11103-007-9150-2; Zhang JY, 2005, PLANT J, V42, P689, DOI 10.1111/j.1365-313X.2005.02405.x; Zheng HQ, 2005, PLANT CELL, V17, P1467, DOI 10.1105/tpc.104.030155	75	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e54129	10.1371/journal.pone.0054129	http://dx.doi.org/10.1371/journal.pone.0054129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23349804	Green Published, gold, Green Submitted			2022-12-25	WOS:000313738900042
J	Zhang, ZH; Liu, ZH; Cui, ZT; Hu, YM; Wang, B; Tang, JH				Zhang, Zhanhui; Liu, Zonghua; Cui, Zitian; Hu, Yanmin; Wang, Bin; Tang, Jihua			Genetic Analysis of Grain Filling Rate Using Conditional QTL Mapping in Maize	PLOS ONE			English	Article							KERNEL WATER RELATIONS; WEIGHT RESPONSE; SINK; GROWTH; EXPRESSION; ENDOSPERM; TEMPERATURE; DISSECTION; DURATION; ENCODES	The grain filling rate (GFR) is an important dynamic trait that determines the final grain yield and is controlled by a network of genes and environment factors. To determine the genetic basis of the GFR, a conditional quantitative trait locus (QTL) analysis method was conducted using time-related phenotypic values of the GFR collected from a set of 243 immortalized F-2 (IF2) population, which were evaluated at two locations over 2 years. The GFR gradually rose in the 0-15 days after pollination (DAP) and 16-22 DAP, reaching a maximum at 23-29 DAP, and then gradually decreasing. The variation of kernel weight (KW) was mainly decided by the GFR, and not by the grain filling duration (GFD). Thirty-three different unconditional QTLs were identified for the GFR at the six sampling stages over 2 years. Among them, QTLs qGFR7b, qGFR9 and qGFR6d were identified at the same stages at two locations over 2 years. In addition, 14 conditional QTLs for GFR were detected at five stages. The conditional QTL qGFR7c was identified at stage V|IV (37-43 DAP) at two locations over 2 years, and qGFR7b was detected at the sixth stage (44-50 DAP) in all four environments, except at Anyang location in 2009. QTLs qQTL7b and qQTL6f were identified by unconditional and conditional QTL mapping at the same stages, and might represent major QTLs for regulating the GFR in maize in the IF2 population. Moreover, most of the QTLs identified were co-located with QTLs from previous studies that were associated with GFR, enzyme activities of starch synthesis, soluble carbohydrates, and grain filling related genes. These results indicated that the GFR is regulated by many genes, which are specifically expressed at different grain filling stages, and the specific expression of the genes between 16-35 DAP might be very important for deciding the final kernel weight.	[Zhang, Zhanhui; Liu, Zonghua; Cui, Zitian; Hu, Yanmin; Wang, Bin; Tang, Jihua] Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China	Henan Agricultural University	Tang, JH (corresponding author), Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China.	tangjihua1@163.com	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	National Project 973 of China [2012CB723001]; National High Technology Research and Development Program of China [2012AA10A305]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Project 973 of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from the National Project 973 of China (2012CB723001) and the National High Technology Research and Development Program of China (2012AA10A305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blewley JD, 1985, SEEDS PHYSL DEV GERM, P41; Borras L, 2006, FIELD CROP RES, V95, P223, DOI 10.1016/j.fcr.2005.03.001; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Borras L, 2003, ANN BOT-LONDON, V91, P857, DOI 10.1093/aob/mcg090; Borras L, 2001, CROP SCI, V41, P1816, DOI 10.2135/cropsci2001.1816; Borras L, 2009, CROP SCI, V49, P999, DOI 10.2135/cropsci2008.08.0475; Borras L, 2010, FIELD CROP RES, V118, P1, DOI 10.1016/j.fcr.2010.04.010; Carlson SJ, 1999, PLANT PHYSIOL, V121, P1025, DOI 10.1104/pp.121.3.1025; CAVALIERI AJ, 1985, CROP SCI, V25, P856, DOI 10.2135/cropsci1985.0011183X002500050031x; Cheng WH, 1996, PLANT CELL, V8, P971, DOI 10.1105/tpc.8.6.971; Gambin BL, 2007, FIELD CROP RES, V101, P1, DOI 10.1016/j.fcr.2006.09.001; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Guo M, 2010, PLANT CELL, V22, P1057, DOI 10.1105/tpc.109.073676; Gupta PK, 2006, GENOME, V49, P565, DOI 10.1139/G06-063; Hua JP, 2002, GENETICS, V162, P1885; Li ShaoChang, 2003, Acta Agronomica Sinica, V29, P775; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lid SE, 2002, P NATL ACAD SCI USA, V99, P5460, DOI 10.1073/pnas.042098799; Liu ZH, 2011, MOL BREEDING, V27, P25, DOI 10.1007/s11032-010-9410-8; Liu ZongHua, 2007, Acta Agronomica Sinica, V33, P782; Loffler CM, 2005, CROP SCI, V45, P1708, DOI 10.2135/cropsci2004.0370; Maitz M, 2000, PLANT J, V23, P29, DOI 10.1046/j.1365-313x.2000.00747.x; MUCHOW RC, 1990, FIELD CROP RES, V23, P145, DOI 10.1016/0378-4290(90)90109-O; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; PRIOUL JL, 1994, PLANT PHYSIOL, V104, P179, DOI 10.1104/pp.104.1.179; SAS Institute, 2009, SAS STAT 9 2 US GUID; SEKA D, 1995, CROP SCI, V35, P74, DOI 10.2135/cropsci1995.0011183X003500010013x; SEKA D, 1995, CROP SCI, V35, P80, DOI 10.2135/cropsci1995.0011183X003500010014x; Setter TL, 2001, J EXP BOT, V52, P1401, DOI 10.1093/jexbot/52.360.1401; Stewart DW, 1998, AGRON J, V90, P73, DOI 10.2134/agronj1998.00021962009000010014x; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Tang JH, 2010, THEOR APPL GENET, V120, P333, DOI 10.1007/s00122-009-1213-0; Thevenot C, 2005, J EXP BOT, V56, P945, DOI 10.1093/jxb/eri087; Vilhar B, 2002, PLANT PHYSIOL, V129, P23, DOI 10.1104/pp.001826; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wang GL, 1999, FIELD CROP RES, V61, P211, DOI 10.1016/S0378-4290(98)00163-4; Wilhelm EP, 1999, CROP SCI, V39, P1733, DOI 10.2135/cropsci1999.3961733x; Wu W, 2002, THEOR APPL GENET, V105, P1043, DOI 10.1007/s00122-002-1052-8; Wu WR, 1999, GENETICS, V151, P297; Yan HB, 2009, THEOR APPL GENET, V119, P815, DOI 10.1007/s00122-009-1091-5; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; ZENG ZB, 1994, GENETICS, V136, P1457; Zheng H, 2001, J MAIZE SCI, V9, P69; ZHU J, 1995, GENETICS, V141, P1633	44	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56344	10.1371/journal.pone.0056344	http://dx.doi.org/10.1371/journal.pone.0056344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23349804	Green Submitted, Green Published, gold			2022-12-25	WOS:000315159200037
J	Zhang, ZG; Vu, GP; Gong, H; Xia, C; Chen, YC; Liu, FY; Wu, JG; Lu, SW				Zhang, Zhigang; Vu, Gia-Phong; Gong, Hao; Xia, Chuan; Chen, Yuan-Chuan; Liu, Fenyong; Wu, Jianguo; Lu, Sangwei			Engineered External Guide Sequences Are Highly Effective in Inhibiting Gene Expression and Replication of Hepatitis B Virus in Cultured Cells	PLOS ONE			English	Article							P-MEDIATED INHIBITION; RNASE-P; ATTENUATED SALMONELLA; MESSENGER-RNA; CLEAVAGE; TYPHIMURIUM; STABILITY; SELECTION; DELIVERY; VECTORS	External guide sequences (EGSs) are RNA molecules that consist of a sequence complementary to a target mRNA and recruit intracellular ribonuclease P (RNase P), a tRNA processing enzyme, for specific degradation of the target mRNA. We have previously used an in vitro selection procedure to generate EGS variants that efficiently induce human RNase P to cleave a target mRNA in vitro. In this study, we constructed EGSs from a variant to target the overlapping region of the S mRNA, pre-S/L mRNA, and pregenomic RNA (pgRNA) of hepatitis B virus (HBV), which are essential for viral replication and infection. The EGS variant was about 50-fold more efficient in inducing human RNase P to cleave the mRNA in vitro than the EGS derived from a natural tRNA. Following Salmonella-mediated gene delivery, the EGSs were expressed in cultured HBV-carrying cells. A reduction of about 97% and 75% in the level of HBV RNAs and proteins and an inhibition of about 6,000- and 130-fold in the levels of capsid-associated HBV DNA were observed in cells treated with Salmonella vectors carrying the expression cassette for the variant and the tRNA-derived EGS, respectively. Our study provides direct evidence that the EGS variant is more effective in blocking HBV gene expression and DNA replication than the tRNA-derived EGS. Furthermore, these results demonstrate the feasibility of developing Salmonella-mediated gene delivery of highly active EGS RNA variants as a novel approach for gene-targeting applications such as anti-HBV therapy.	[Zhang, Zhigang; Xia, Chuan; Liu, Fenyong; Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hunan, Peoples R China; [Vu, Gia-Phong; Chen, Yuan-Chuan; Liu, Fenyong; Lu, Sangwei] Univ Calif Berkeley, Program Comparat Biochem, Berkeley, CA 94720 USA; [Gong, Hao; Liu, Fenyong; Lu, Sangwei] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Wuhan University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Liu, FY (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Hunan, Peoples R China.	liu_fy@berkeley.edu; jwu@whu.edu.cn; sangwei@berkeley.edu	zhang, zhengzhi/I-5403-2016; Wu, Jian/AAU-5221-2020; Vu, Gia-Phong/HCH-7906-2022; Zhang, Zhanhui/AAX-9545-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wong, Matthew Man-Kin/0000-0003-3296-3277; Wu, Jianguo/0000-0002-8326-2895; ALZAHARNA, Mazen/0000-0002-1111-958X; Wu, Jian/0000-0002-3394-1507; Cheung, Hon-Yeung/0000-0002-6750-3628; Chiu, Sung Kay/0000-0002-9927-7346	National Basic Research Program of China (973 Program) [2011CB504800, 2012CB518900]; National Natural Science Foundation of China [31100128, 81030031, 31230005, 812111146]; NIH [RO1-AI041927, RO1-AI091536, RO1-DE014842]; University of California at Berkeley; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091536, R01AI041927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014842] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at Berkeley; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research has been supported by grants from National Basic Research Program of China (973 Program; No. 2011CB504800 and 2012CB518900), National Natural Science Foundation of China (No. 31100128, 81030031, 31230005, and 812111146) and NIH (RO1-AI041927, RO1-AI091536, and RO1-DE014842). G. V. and Y. C. were partially supported by a predoctoral Block grant from University of California at Berkeley. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman S., 1999, RNA WORLD, P351; ARES M, 1990, GENE DEV, V4, P2132, DOI 10.1101/gad.4.12a.2132; Belongia E A, 2008, NIH Consens State Sci Statements, V25, P1; Block TM, 2013, ANTIVIR RES, V98, P27, DOI 10.1016/j.antiviral.2013.01.006; Cai DW, 2012, ANTIMICROB AGENTS CH, V56, P4277, DOI 10.1128/AAC.00473-12; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Clairmont C, 2000, J INFECT DIS, V181, P1996, DOI 10.1086/315497; Darji A, 1997, CELL, V91, P765, DOI 10.1016/S0092-8674(00)80465-1; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; Giladi H, 2003, MOL THER, V8, P769, DOI 10.1016/S1525-0016(03)00244-2; GOLD L, 1995, ANNU REV BIOCHEM, V64, P763, DOI 10.1146/annurev.bi.64.070195.003555; Gong H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002120; GOPALAN V, 2006, RNA WORLD; Grillot-Courvalin C, 1999, CURR OPIN BIOTECH, V10, P477, DOI 10.1016/S0958-1669(99)00013-0; GUERRIERTAKADA C, 1995, P NATL ACAD SCI USA, V92, P11115, DOI 10.1073/pnas.92.24.11115; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Hnatyszyn HJ, 2001, GENE THER, V8, P1863, DOI 10.1038/sj.gt.3301606; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; JOYCE GF, 1992, SCI AM, V267, P90, DOI 10.1038/scientificamerican1292-90; Kawa D, 1998, RNA, V4, P1397, DOI 10.1017/S1355838298980918; Kazantsev AV, 2006, NAT REV MICROBIOL, V4, P729, DOI 10.1038/nrmicro1491; Khan SA, 1998, MOL MICROBIOL, V29, P571, DOI 10.1046/j.1365-2958.1998.00952.x; LEVINE MM, 1987, J CLIN INVEST, V79, P888, DOI 10.1172/JCI112899; Li HJ, 2006, RNA, V12, P63, DOI 10.1261/rna.2184706; Liu FY, 2010, PROTEIN REV, V10, P257, DOI 10.1007/978-1-4419-1142-1_14; LIU FY, 1994, CELL, V77, P1093, DOI 10.1016/0092-8674(94)90448-0; LIU FY, 1995, GENE DEV, V9, P471, DOI 10.1101/gad.9.4.471; Loessner H, 2006, FEMS MICROBIOL LETT, V265, P81, DOI 10.1111/j.1574-6968.2006.00470.x; Ma M, 2000, NAT BIOTECHNOL, V18, P58, DOI 10.1038/71924; Marvin MC, 2009, J CELL BIOCHEM, V108, P1244, DOI 10.1002/jcb.22367; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Paglia P, 2000, GENE THER, V7, P1725, DOI 10.1038/sj.gt.3301290; Plehn-Dujowich D, 1998, P NATL ACAD SCI USA, V95, P7327, DOI 10.1073/pnas.95.13.7327; PYLE AM, 1990, P NATL ACAD SCI USA, V87, P8187, DOI 10.1073/pnas.87.21.8187; Scherer LJ, 2003, NAT BIOTECHNOL, V21, P1457, DOI 10.1038/nbt915; Seegar C., 2007, FIELDS VIROLOGY, P2978; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Su J, 2009, INFECT IMMUN, V77, P667, DOI 10.1128/IAI.01027-08; SZOSTAK JW, 1992, TRENDS BIOCHEM SCI, V17, P89, DOI 10.1016/0968-0004(92)90242-2; Uprichard SL, 2005, P NATL ACAD SCI USA, V102, P773, DOI 10.1073/pnas.0409028102; Werner M, 1998, RNA, V4, P847, DOI 10.1017/S1355838298980323; Xia C, 2013, MOL THER, V21, P995, DOI 10.1038/mt.2013.37; Yang Nan, 2008, Cancer Biol Ther, V7, P145; YUAN Y, 1994, SCIENCE, V263, P1269, DOI 10.1126/science.8122108; YUAN Y, 1992, P NATL ACAD SCI USA, V89, P8006, DOI 10.1073/pnas.89.17.8006; ZAUG AJ, 1995, RNA, V1, P363; Zhang L, 2007, CANCER RES, V67, P5859, DOI 10.1158/0008-5472.CAN-07-0098; Zhou TH, 2002, J BIOL CHEM, V277, P30112, DOI 10.1074/jbc.M200183200; Zhu JM, 2004, P NATL ACAD SCI USA, V101, P9073, DOI 10.1073/pnas.0403164101	51	243	268	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2013	8	6							e65268	10.1371/journal.pone.0065268	http://dx.doi.org/10.1371/journal.pone.0065268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FW	23349804	Green Submitted, gold, Green Published			2022-12-25	WOS:000320322400011
